"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,US,A,US 1811821 A,091-657-195-139-245,1931-06-23,1931,US 37119429 A,1929-06-15,US 37119429 A,1929-06-15,Robe,,TIDY PRODUCTS CORP,DAVID BLOOM,,https://lens.org/091-657-195-139-245,Granted Patent,no,0,12,1,1,0,A47G9/066;;A47G9/066,A47G9/06,,0,0,,,,EXPIRED
2,US,A,US 1232485 A,159-057-434-807-893,1917-07-10,1917,US 5833815 A,1915-10-28,US 5833815 A,1915-10-28,RECEPTACLE FOR AN ARTICLE OF FOOD.,,BLOOM DAVID,BLOOM DAVID,,https://lens.org/159-057-434-807-893,Granted Patent,no,0,7,1,1,0,B65D1/0223;;B65D1/0223,,,0,0,,,,EXPIRED
3,US,A,US 1824762 A,050-334-053-227-086,1931-09-29,1931,US 40638329 A,1929-11-11,US 40638329 A,1929-11-11,Container,,DAVID BLOOM,DAVID BLOOM,,https://lens.org/050-334-053-227-086,Granted Patent,no,0,5,1,1,0,B65D5/327;;B65D5/327;;B65D5/324;;B65D5/324,B65D5/32,,0,0,,,,EXPIRED
4,US,A,US 1159825 A,167-434-637-600-965,1915-11-09,1915,US 1914/0832211 A,1914-04-16,US 1914/0832211 A,1914-04-16,RECEPTACLE-CLOSURE.,,BLOOM DAVID,BLOOM DAVID,,https://lens.org/167-434-637-600-965,Granted Patent,no,0,0,1,1,0,B65D39/12;;B65D39/12,,,0,0,,,,EXPIRED
5,WO,A3,WO 2008/124313 A3,194-524-975-271-47X,2009-05-07,2009,US 2008/0058310 W,2008-03-26,US 73298407 A,2007-04-04,OPTICAL SYSTEMS FOR EXTERNAL CAVITY FREQUENCY UPCONVERTING LASER ARRAYS,"Surface emitting laser arrays with intra-cavity harmonic generation are coupled to an optical system (760, 765) that extracts harmonic light in both directions from an intra-cavity nonlinear optical material (715) in such a way that' the focusing properties of the light beams are matched.",ALCES TECHNOLOGY INC;;BLOOM DAVID,BLOOM DAVID,,https://lens.org/194-524-975-271-47X,Search Report,yes,4,0,8,8,0,H01S3/08059;;H01S3/0813;;H01S3/082;;H01S3/109;;H01S5/141;;H01S5/183;;H01S5/4062;;H01S5/423;;H01S5/141;;H01S3/109;;H01S3/082;;H01S3/08059;;H01S5/183;;H01S3/0813;;H01S5/423;;H01S5/4062,H01S5/183;;H01S5/00,,1,0,,,"WATSON J P ET AL: ""Laser sources at 460 nm based on intracavity doubling of extended-cavity surface-emitting lasers"", PROCEEDINGS OF THE SPIE - THE INTERNATIONAL SOCIETY FOR OPTICAL ENGINEERING SPIE-INT. SOC. OPT. ENG USA, vol. 5364, no. 1, 2004, pages 116 - 121, XP002485946, ISSN: 0277-786X",PENDING
6,US,A,US 1027685 A,026-769-274-377-072,1912-05-28,1912,US 1910/0599355 A,1910-12-27,US 1910/0599355 A,1910-12-27,RECEPTACLE-CLOSURE.,,BLOOM DAVID,BLOOM DAVID,,https://lens.org/026-769-274-377-072,Granted Patent,no,0,0,1,1,0,B65D41/02;;B65D41/02,,,0,0,,,,EXPIRED
7,US,A,US 1529110 A,102-064-512-257-805,1925-03-10,1925,US 67830723 A,1923-12-03,US 67830723 A,1923-12-03,Basket,,DAVID BLOOM,DAVID BLOOM,,https://lens.org/102-064-512-257-805,Granted Patent,no,0,2,1,1,0,B65D43/02;;B65D43/02;;B65D85/34;;B65D85/34,B65D8/00;;B65D43/02;;B65D85/34,,0,0,,,,EXPIRED
8,US,A,US 1836220 A,180-760-311-173-283,1931-12-15,1931,US 32330328 A,1928-12-03,US 32330328 A,1928-12-03,Container,,DAVID BLOOM,DAVID BLOOM,,https://lens.org/180-760-311-173-283,Granted Patent,no,0,6,1,1,0,B65D43/022;;B65D2543/00037;;B65D2543/00268;;B65D2543/0049;;B65D2543/00546;;B65D2543/00944;;B65D2543/00962;;B65D2401/10;;B65D43/022;;B65D2543/00944;;B65D2543/00962;;B65D2543/00546;;B65D2543/00268;;B65D2543/0049;;B65D2543/00037;;B65D2401/10,B65D43/02,,0,0,,,,EXPIRED
9,US,A,US 1675920 A,037-714-313-354-625,1928-07-03,1928,US 6959925 A,1925-11-17,US 6959925 A,1925-11-17,Jar closure,,DAVID BLOOM,DAVID BLOOM,,https://lens.org/037-714-313-354-625,Granted Patent,no,0,0,1,1,0,B65D45/28;;B65D45/28,B65D45/28,,0,0,,,,EXPIRED
10,CA,A,CA 141206 A,188-519-527-362-227,1912-06-18,1912,CA 141206D A,1911-09-18,CA 141206T A,1911-09-18,RECEPTACLE,,BLOOM DAVID,BLOOM DAVID,,https://lens.org/188-519-527-362-227,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
11,US,A,US 1532298 A,150-587-097-872-520,1925-04-07,1925,US 67178723 A,1923-10-30,US 67178723 A,1923-10-30,Basket,,DAVID BLOOM,DAVID BLOOM,,https://lens.org/150-587-097-872-520,Granted Patent,no,0,3,1,1,0,B65D25/108;;B65D43/02;;B65D85/34;;B65D25/108;;B65D43/02;;B65D85/34,B65D8/00;;B65D25/10;;B65D43/02;;B65D85/34,,0,0,,,,EXPIRED
12,US,A,US 1247924 A,007-659-408-475-297,1917-11-27,1917,US 16513917 A,1917-04-28,US 16513917 A,1917-04-28,RECEPTACLE-CLOSURE.,,BLOOM DAVID,BLOOM DAVID,,https://lens.org/007-659-408-475-297,Granted Patent,no,0,0,1,1,0,B65D51/1683;;Y10T292/1039;;Y10T292/1039;;B65D51/1683,,,0,0,,,,EXPIRED
13,US,A,US 1834085 A,103-240-867-849-216,1931-12-01,1931,US 32655228 A,1928-12-17,US 32655228 A,1928-12-17,Closure,,DAVID BLOOM,DAVID BLOOM,,https://lens.org/103-240-867-849-216,Granted Patent,no,0,47,1,1,0,A47G19/186;;A47G19/186;;B65D7/24;;B65D7/24;;B65D43/022;;B65D43/022;;B65D43/0231;;B65D43/0231;;B65D77/245;;B65D77/245;;B65D2543/00037;;B65D2543/00037;;B65D2543/00092;;B65D2543/00092;;B65D2543/00268;;B65D2543/00268;;B65D2543/0049;;B65D2543/0049;;B65D2543/00546;;B65D2543/00546;;B65D2543/00851;;B65D2543/00851;;B65D2543/00888;;B65D2543/00888;;B65D2543/00962;;B65D2543/00962,A47G19/18;;B65D1/10;;B65D43/02;;B65D77/24,,0,0,,,,EXPIRED
14,US,A,US 1030455 A,164-048-316-593-974,1912-06-25,1912,US 1911/0628907 A,1911-05-23,US 1911/0628907 A,1911-05-23,SHEET-METAL CAN.,,BLOOM DAVID,BLOOM DAVID,,https://lens.org/164-048-316-593-974,Granted Patent,no,0,1,1,1,0,F01P11/0214;;F01P11/0214,,,0,0,,,,EXPIRED
15,GB,A,GB 191120801 A,161-977-477-201-406,1912-03-21,1912,GB 191120801D A,1911-09-20,GB 191120801T A,1911-09-20,"Improvements in or connected with Closures for Bottles, Jars, Cans and like Vessels.",,BLOOM DAVID,BLOOM DAVID,,https://lens.org/161-977-477-201-406,Patent Application,no,0,0,1,1,0,B65D45/14;;B65D51/145,B65D45/14;;B65D51/14,,0,0,,,,DISCONTINUED
16,US,A,US 1353017 A,006-070-704-276-921,1920-09-14,1920,US 32046619 A,1919-08-28,US 32046619 A,1919-08-28,Receptacle-closure,,DAVID BLOOM,DAVID BLOOM,,https://lens.org/006-070-704-276-921,Granted Patent,no,0,2,1,1,0,B65D39/02;;B65D39/02,B65D39/02,,0,0,,,,EXPIRED
17,WO,A2,WO 2008/124313 A2,122-263-450-430-12X,2008-10-16,2008,US 2008/0058310 W,2008-03-26,US 73298407 A,2007-04-04,OPTICAL SYSTEMS FOR LASER ARRAYS,Surface emitting laser arrays with intra-cavity harmonic generation are coupled to an optical system that extracts harmonic light in both directions from an intra-cavity nonlinear optical material in such a way that the focusing properties of the light beams are matched.,ALCES TECHNOLOGY INC;;BLOOM DAVID,BLOOM DAVID,,https://lens.org/122-263-450-430-12X,Patent Application,yes,0,0,8,8,0,H01S3/08059;;H01S3/0813;;H01S3/082;;H01S3/109;;H01S5/141;;H01S5/183;;H01S5/4062;;H01S5/423;;H01S5/141;;H01S3/109;;H01S3/082;;H01S3/08059;;H01S5/183;;H01S3/0813;;H01S5/423;;H01S5/4062,H01S5/183;;H01S5/00,,0,0,,,,PENDING
18,US,A,US 1096992 A,191-684-342-875-779,1914-05-19,1914,US 1912/0675589 A,1912-02-05,US 1912/0675589 A,1912-02-05,SHOW-JAR.,,BLOOM DAVID,BLOOM DAVID,,https://lens.org/191-684-342-875-779,Granted Patent,no,0,1,1,1,0,B65D85/52;;B65D85/52,,,0,0,,,,EXPIRED
19,FR,A,FR 434518 A,086-320-084-492-906,1912-02-06,1912,FR 434518D A,1911-09-23,FR 434518T A,1911-09-23,"Perfectionnements aux systèmes de fermeture pour bouteilles, pots, boites et récipients analogues",,DAVID BLOOM,BLOOM DAVID,,https://lens.org/086-320-084-492-906,Granted Patent,no,0,1,1,1,0,B65D45/28,B65D45/28,"XX, 4",0,0,,,,EXPIRED
20,EP,B1,EP 1708585 B1,025-507-311-324-919,2010-09-15,2010,EP 05702051 A,2005-01-28,GB 2005000301 W;;GB 0401854 A,2004-01-28,PROTECTIVE BIB OR APRON,An apron for use by dentists and the like is provided with a main body portion and a collar portion for securing the apron to the wearer in which the collar portion is adjustably securable at any position within a predetermined range such that it forms a close fit around the wearer wherein the collar and body portions comprise an absorbent side and a substantially waterproof.,BLOOM CLAUDINE NICOLA;;BLOOM DAVID RICHARD;;PADAYACHY JAYSEELAN NADASEN,BLOOM CLAUDINE NICOLA;;BLOOM DAVID RICHARD,"PADAYACHY, JAYSEELAN NADASEN (2010-11-03);;BLOOM, DAVID RICHARD (2010-11-03);;BLOOM, CLAUDINE NICOLA (2010-11-03)",https://lens.org/025-507-311-324-919,Granted Patent,yes,4,0,16,16,0,A41B13/10;;A41B2400/52;;A41B13/10;;A41B2400/52,A41B13/10,,0,0,,,,ACTIVE
21,AT,T1,AT E481006 T1,106-645-024-686-652,2010-10-15,2010,AT 05702051 T,2005-01-28,GB 0401854 A;;GB 2005000301 W,2004-01-28,SCHUTZLATZ ODER SCHÜRZE,An apron for use by dentists and the like is provided with a main body portion and a collar portion for securing the apron to the wearer in which the collar portion is adjustably securable at any position within a predetermined range such that it forms a close fit around the wearer wherein the collar and body portions comprise an absorbent side and a substantially waterproof.,BLOOM CLAUDINE NICOLA;;BLOOM DAVID RICHARD;;PADAYACHY JAYSEELAN NADASEN,BLOOM CLAUDINE NICOLA;;BLOOM DAVID RICHARD,,https://lens.org/106-645-024-686-652,Granted Patent,no,0,0,16,16,0,A41B13/10;;A41B2400/52;;A41B13/10;;A41B2400/52,A41B13/10,,0,0,,,,INACTIVE
22,BR,A,BR PI0507242 A,058-473-578-299-091,2007-06-26,2007,BR PI0507242 A,2005-01-28,GB 0401854 A;;GB 2005000301 W,2004-01-28,babador ou avental protetor,An apron for use by dentists and the like is provided with a main body portion and a collar portion for securing the apron to the wearer in which the collar portion is adjustably securable at any position within a predetermined range such that it forms a close fit around the wearer wherein the collar and body portions comprise an absorbent side and a substantially waterproof.,BLOOM CLAUDINE NICOLA;;BLOOM DAVID RICHARD;;JAYSEELAN NADASEN PADAYACHY,BLOOM CLAUDINE NICOLA;;BLOOM DAVID RICHARD,,https://lens.org/058-473-578-299-091,Patent Application,no,0,0,16,16,0,A41B13/10;;A41B2400/52;;A41B13/10;;A41B2400/52,A41B13/10,,0,0,,,,DISCONTINUED
23,CA,A1,CA 2554738 A1,148-556-550-855-224,2005-08-11,2005,CA 2554738 A,2005-01-28,GB 0401854 A;;GB 2005000301 W,2004-01-28,PROTECTIVE BIB OR APRON,An apron for use by dentists and the like is provided with a main body porti on and a collar portion for securing the apron to the wearer in which the colla r portion is adjustably securable at any position within a predetermined range such that it forms a close fit around the wearer wherein the collar and body portions comprise an absorbent side and a substantially waterproof.,BLOOM DAVID RICHARD;;PADAYACHY JAYSEELAN NADASEN;;BLOOM CLAUDINE NICOLA,BLOOM DAVID RICHARD;;BLOOM CLAUDINE NICOLA,,https://lens.org/148-556-550-855-224,Patent Application,no,0,0,16,16,0,A41B13/10;;A41B2400/52;;A41B13/10;;A41B2400/52,A41B13/10,,0,0,,,,DISCONTINUED
24,WO,A2,WO 2005/072541 A2,148-595-559-432-764,2005-08-11,2005,GB 2005000301 W,2005-01-28,GB 0401854 A,2004-01-28,PROTECTIVE BIB OR APRON,An apron for use by dentists and the like is provided with a main body portion and a collar portion for securing the apron to the wearer in which the collar portion is adjustably securable at any position within a predetermined range such that it forms a close fit around the wearer wherein the collar and body portions comprise an absorbent side and a substantially waterproof.,BLOOM CLAUDINE NICOLA;;BLOOM DAVID RICHARD;;PADAYACHY JAYSEELAN NADASEN,BLOOM CLAUDINE NICOLA;;BLOOM DAVID RICHARD,,https://lens.org/148-595-559-432-764,Patent Application,yes,0,1,16,16,0,A41B13/10;;A41B2400/52;;A41B13/10;;A41B2400/52,A41B13/10,,0,0,,,,PENDING
25,DE,D1,DE 602005023582 D1,059-066-672-782-643,2010-10-28,2010,DE 602005023582 T,2005-01-28,GB 0401854 A;;GB 2005000301 W,2004-01-28,SCHUTZLATZ ODER SCHÜRZE,An apron for use by dentists and the like is provided with a main body portion and a collar portion for securing the apron to the wearer in which the collar portion is adjustably securable at any position within a predetermined range such that it forms a close fit around the wearer wherein the collar and body portions comprise an absorbent side and a substantially waterproof.,BLOOM CLAUDINE NICOLA;;BLOOM DAVID RICHARD;;PADAYACHI JAYSELAAN NADASEN,BLOOM CLAUDINE NICOLA;;BLOOM DAVID RICHARD,,https://lens.org/059-066-672-782-643,Granted Patent,no,0,0,16,16,0,A41B13/10;;A41B2400/52;;A41B13/10;;A41B2400/52,A41B13/10,,0,0,,,,ACTIVE
26,WO,A3,WO 2007/149569 A3,090-911-404-301-822,2008-02-21,2008,US 2007/0014613 W,2007-06-20,US 47208606 A,2006-06-21,MICRO-ELECTROMECHANICAL LIGHT MODULATOR WITH ANAMORPHIC OPTICS,Micro-electromechanical light modulators are combined with anamorphic and contrast enhancing optical elements to form optical display engines. Linear MEMS arrays are suitable for the étendue of low divergence light sources while handling high optical power for brightness. The output of an optical engine is a line image which may be scanned to form a two-dimensional image.,ALCES TECHNOLOGY INC;;BLOOM DAVID M,BLOOM DAVID M,,https://lens.org/090-911-404-301-822,Search Report,yes,4,0,5,5,0,G02B13/08;;G02B26/06;;G02B26/0833;;G02B13/08;;G02B26/06;;G02B26/0833,G02B26/00;;B81B3/00,,0,0,,,,PENDING
27,US,A1,US 2006/0114542 A1,094-752-307-439-520,2006-06-01,2006,US 90476604 A,2004-11-26,US 90476604 A,2004-11-26,DIFFERENTIAL INTERFEROMETRIC LIGHT MODULATOR AND IMAGE DISPLAY DEVICE,A light modulator incorporates a polarization sensitive prism and a novel MEMS ribbon device to impart a relative phase shift to polarization components of an incident light beam. A linear array of phase shifting elements in the MEMS device creates a linear image which is scanned to form a two dimensional scene. Alternatively the deflection of each cantilever in a linear array of atomic force microscope cantilevers may be measured simultaneously.,BLOOM DAVID M,BLOOM DAVID M,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2005-11-08),https://lens.org/094-752-307-439-520,Patent Application,yes,12,24,10,10,0,G02B26/0841;;G02B26/0841;;G02B26/06;;G02B26/06,G02F1/01,359/276,0,0,,,,ACTIVE
28,US,B2,US 8249127 B2,133-501-285-552-341,2012-08-21,2012,US 201213347580 A,2012-01-10,US 201213347580 A;;US 58047509 A;;US 73298407 A,2007-04-04,Optical systems for laser arrays,Surface emitting laser arrays with intra-cavity harmonic generation are coupled to an optical system that extracts harmonic light in both directions from an intra-cavity nonlinear optical material in such a way that the focusing properties of the light beams are matched.,BLOOM DAVID M;;ALCES TECHNOLOGY INC,BLOOM DAVID M,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2013-04-18),https://lens.org/133-501-285-552-341,Granted Patent,yes,8,0,8,8,0,H01S3/08059;;H01S3/0813;;H01S3/082;;H01S3/109;;H01S5/141;;H01S5/183;;H01S5/4062;;H01S5/423;;H01S5/141;;H01S3/109;;H01S3/082;;H01S3/08059;;H01S5/183;;H01S3/0813;;H01S5/423;;H01S5/4062,H01S3/08,372/101;;372/22;;372/21;;372/99;;372/98;;372/50.124,4,1,034-638-241-868-30X,10.1117/12.591288,"Watson, JP et al, ""Laser sources at 460 nm based on intracavity doubling of extended cavity surface emitting lasers"", Proc. SPIE, vol. 5364, p. 116-121 (2004).;;A. Mooradian et al., ""High Power Extended Vertical Cavity Surface Emitting Diode Lasers and Arrays and Their Applications"", Micro-Optics Conference, Tokyo, Japan, Nov. 2, 2005.;;International search report and written opinion of the international searching authority, PCT/US2008/058310, Mar. 24, 2009.;;Shchegrov, et al., ""Development of compact blue-green lasers for projection display based on Novalux extended-cavity surface emitting laser technology"", Proceedings of SPIE(2005).",ACTIVE
29,US,A1,US 2009/0237785 A1,158-067-114-604-205,2009-09-24,2009,US 5347708 A,2008-03-21,US 5347708 A,2008-03-21,Microfabricated optical wave plate,"A microfabricated optical wave plate comprises a reflective polarizer and a mirror separated by a fixed or variable distance. The wave plate imparts a relative phase delay on polarization components of incident light, thereby transforming the overall polarization of the light.",BLOOM DAVID M,BLOOM DAVID M,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2009-03-02),https://lens.org/158-067-114-604-205,Patent Application,yes,21,21,3,3,0,G02B27/286;;G02B27/286,G02B5/30;;G02B26/08,359/486;;359/500;;359/483,0,0,,,,INACTIVE
30,WO,B1,WO 2007/149569 B1,180-682-482-127-694,2008-04-03,2008,US 2007/0014613 W,2007-06-20,US 47208606 A,2006-06-21,MICRO-ELECTROMECHANICAL LIGHT MODULATOR WITH ANAMORPHIC OPTICS,Micro-electromechanical light modulators are combined with anamorphic and contrast enhancing optical elements to form optical display engines. Linear MEMS arrays are suitable for the étendue of low divergence light sources while handling high optical power for brightness. The output of an optical engine is a line image which may be scanned to form a two-dimensional image.,ALCES TECHNOLOGY INC;;BLOOM DAVID M,BLOOM DAVID M,,https://lens.org/180-682-482-127-694,Patent Application,no,0,0,5,5,0,G02B13/08;;G02B26/06;;G02B26/0833;;G02B13/08;;G02B26/06;;G02B26/0833,G02B26/00;;B81B3/00,,0,0,,,,PENDING
31,US,S,US D0281173 S,067-710-481-310-701,1985-10-29,1985,US 42557282 F,1982-09-28,US 42557282 F,1982-09-28,Color matching card,,BLOOM DAVID R,BLOOM DAVID R,,https://lens.org/067-710-481-310-701,Design Right,yes,7,7,1,1,0,,,D19/37,0,0,,,,EXPIRED
32,US,A1,US 2008/0273557 A1,119-213-347-382-39X,2008-11-06,2008,US 79956507 A,2007-05-02,US 79956507 A,2007-05-02,Illumination system for optical modulators,"A phase plate and lens modify light beams emitted by an array of lasers to form an efficient illumination source for a MEMS light modulator array. The phase of the electric field emitted by the lasers is modified such that the after passing through a lens the beam profile at the lens focal plane has an approximately rectangular shape appropriate for illuminating a light modulator array. The phase plate may be constructed from a glass plate with rectangular notches etched in it or with rectangular ridges formed on it. Furthermore a light source, such as a laser, may be coupled to an adiabatically tapered optical waveguide in which a phase adjusting block is introduced in analogy to notches in a bulk phase plate. Phase modified light beams output from the waveguide system have similar focusing properties to those passing through a bulk phase plate.",BLOOM DAVID M,BLOOM DAVID M,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2007-06-08),https://lens.org/119-213-347-382-39X,Patent Application,yes,4,11,2,2,0,G02B27/0927;;H01S5/005;;H01S5/14;;H01S5/4012;;H01S5/423;;H01S2301/206;;G02B19/0057;;G02B19/0014;;G03B21/2013;;G03B21/2033;;G03B21/208;;G02B27/0927;;H01S5/4012;;H01S5/005;;H01S5/14;;H01S5/423;;H01S2301/206;;G02B19/0057;;G03B21/208;;G03B21/2033;;G02B19/0014;;G03B21/2013,H01S3/098,372/18,0,0,,,,ACTIVE
33,GB,A,GB 2410416 A,120-745-266-712-724,2005-08-03,2005,GB 0401854 A,2004-01-28,GB 0401854 A,2004-01-28,Dentist's apron,"An apron for use by dentists, hairdressers etc. comprises a collar portion 5 attached to a body portion 3. The size of the collar portion can be varied within a predetermined range so that it forms a close fit around the wearer, preferable using a hook and loop material 9. One or both ends 11, 17 of the collar portion may extend beyond the edge of the body portion. The apron may comprise an absorbent material such as towelling, a disposable material or a plastics material.",BLOOM DAVID RICHARD;;PADAYACHY JAYSEELAN NADASEN,BLOOM DAVID RICHARD,,https://lens.org/120-745-266-712-724,Patent Application,no,6,2,16,16,0,A41B13/10;;A41B2400/52;;A41B13/10;;A41B2400/52,A41B13/10,A3V V1A3A         V1A3A;;A3V V6B2          V6B2;;A4V V9            V9,0,0,,,,DISCONTINUED
34,US,A1,US 2009/0323169 A1,026-180-751-653-462,2009-12-31,2009,US 16403008 A,2008-06-28,US 16403008 A,2008-06-28,"Scanned, one-dimensional, phased-array display system","A scanned, one-dimensional, phased-array display system combines imaging optics on one axis with Fourier transform optics on another. The display offers the energy efficiency and fault tolerance of phase modulator-based displays, and the compactness, flexibility and speed of optical MEMS. Also described is a mechanism to introduce amplitude variations on the Fourier axis if needed to compensate for image artifacts.",BLOOM DAVID M,BLOOM DAVID M,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2009-03-02),https://lens.org/026-180-751-653-462,Patent Application,yes,8,2,2,2,0,G02B26/10;;G02B27/0087;;H04N9/3129;;G02B26/10;;G02B27/0087;;H04N9/3129,G02B26/08,359/291,0,0,,,,ACTIVE
35,US,A1,US 2004/0157900 A1,177-004-694-715-526,2004-08-12,2004,US 77279904 A,2004-02-05,US 77279904 A;;US 44660203 P,2003-02-11,Isoxazole-containing thiourea inhibitors useful for treatment of varicella zoster virus,"
    This Invention provides a compound of the Formula: 

   wherein 

    X is 

    R ₁ , R ₂ , R ₃ and R ₄ are described in the specification and a pharmaceutical composition comprising the compound used for inhibiting replication of a herpes virus. 
",WYETH CORP,BLOOM JONATHAN DAVID,WYETH HOLDINGS CORPORATION (2004-02-02),https://lens.org/177-004-694-715-526,Patent Application,yes,0,1,4,4,0,C07D261/08;;C07D413/04;;C07D417/04;;A61P31/12;;C07D413/04;;C07D261/08;;C07D417/04,A61P31/12;;C07D261/08;;C07D413/04;;C07D417/04,514/378;;X54824,0,0,,,,EXPIRED
36,US,A,US 5798743 A,124-943-559-224-778,1998-08-25,1998,US 48219295 A,1995-06-07,US 48219295 A,1995-06-07,Clear-behind matrix addressing for display systems,"A display system uses a weighted PWM scheme to deliver control during a frame time for developing a plurality of grayscale levels in each of a plurality of pixels. Of all the weighted subframes, a predetermined number of the shortest subframes utilize a like subframe duration. However, to provide additional levels of grayscale, differing durations of `on` time are utilized in these like subframes. Thus, all but one of these like-time subframes has a dead zone time during which the pixels are never activated. A clear circuit turns `off` the illuminated pixels during the dead zone time.",SILICON LIGHT MACHINES INC,BLOOM DAVID M,SILICON LIGHT MACHINES CORPORATION (2008-06-23);;SILICON LIGHT MACHINES (1996-07-19),https://lens.org/124-943-559-224-778,Granted Patent,yes,38,43,3,3,0,G09G3/2018;;G09G3/2018,G09G3/20,345/90;;345/149,6,3,009-286-199-765-581;;028-775-209-892-098;;009-365-280-210-861,10.1109/5.53402;;10.1117/12.19865;;10.1016/0141-9382(91)90032-9,"R. Apte, F. Sandejas, W. Banyai, D. Bloom, Grating Light Valves For High Resolution Displays , Ginzton Laboratories, Stanford University, Stanford, CA 94305 4085.;;R. Apte, Grating Light Valves For High Resolution Displays Jun., 1994.;;O. Solgaard, Integrated Semiconductor Light Modulators For Fiber Optic And Display Applications , Feb., 1992.;;J. Neff, Two Dimensional Spatial Light Modulators: A Tutorial , Proceedings of the IEEE , vol. 78, No. 5 (May 1990), pp. 826 855.;;Gerhard Multhaupt, Viscoelastic Spatial Light Modulators and Schlieren Optical Systems for HDTV Projection Displays , SPIE vol. 1255 Large Screen projection Displays II (1990), pp. 69 78.;;Gerhard Multhaupt, Light Valve Technologies for High Definition Television Projection Displays , Displays , vol. 12, No. 3/4 (1991), pp. 115 128.",EXPIRED
37,US,A,US 6101036 A,143-134-375-063-067,2000-08-08,2000,US 10335398 A,1998-06-23,US 10335398 A,1998-06-23,Embossed diffraction grating alone and in combination with changeable image display,"A static diffracting grating display system provides a fixed image representing high digital content information. A plurality of physical diffracting features are fixed into the surface of a substrate. The diffracting features are positioned and oriented to selectively diffract or reflect a first incident beam of light which is then collected by a first display optical system. For color, preferably three light sources, red, green and blue, are used to form three incident beams of light. The period between adjacent ones of the diffracting features can be adjusted to appropriately form full-color image from the collected light. Preferably the diffracting features are formed by embossing a deformable substrate. Where the material of the deformable substrate is not reflective, a reflective coating is then applied. In some circumstances a protective overcoat applied over the reflective surface to obviate scratches or other damage to the diffracting features of the embossed surface. The diffracting features can also be formed using photolithographic techniques. To display changeable information in the image, a selectively deformable diffraction grating light valve is provided. A second incident beam of light is provided to illuminate the deformable diffraction grating light valve. A second display optical system collects light from the deformable diffraction grating light valve and merges this light with that collected from the static diffracting grating display system to form a unitary display.",SILICON LIGHT MACHINES INC,BLOOM DAVID M,SILICON LIGHT MACHINES CORPORATION (2008-06-23);;SILICON LIGHT MACHINES (1998-06-19),https://lens.org/143-134-375-063-067,Granted Patent,yes,100,71,1,1,0,G02B5/1828;;G03H2225/24;;G02B5/1828;;G03H2225/24,G02B5/18,359/567;;359/566;;359/572;;345/9;;345/31;;345/108;;348/771;;353/30,24,15,154-800-944-637-210;;091-131-233-230-685;;052-574-007-284-544;;049-400-534-653-649;;022-949-709-618-959;;020-669-540-688-441;;099-238-362-991-633;;031-674-958-708-951;;021-605-933-822-940;;009-286-199-765-581;;028-775-209-892-098;;009-365-280-210-861;;036-825-749-119-883;;052-055-696-490-751;;010-074-622-606-125,10.1117/12.962188;;10.1109/t-ed.1975.18217;;10.1063/1.88189;;10.1021/bk-1997-0670.ch018;;10.1117/1.601346;;10.1117/1.602097;;10.1016/0030-4018(93)90662-o;;10.1364/ao.28.004826;;20555956;;10.1117/12.950001;;10.1109/5.53402;;10.1117/12.19865;;10.1016/0141-9382(91)90032-9;;10.1889/1.1984964;;19823336;;10.1364/ol.18.001214;;10.1364/ol.17.000688;;19794599,"Rowe, D.P. et al., Laser Beam Scanning, SPIE, vol. 2088, Oct. 5, 1993, pp. 18 26.;;Hornbeck, L.J., Deformable Mirror Spatial Light Modulators, SPIE Critical Reviews Series vol. 1150 Spatial Light Modulators and Applications III, Aug. 8, 1989, pp. 86 102.;;R.N. Thomas, et al., The Mirror Matrix Tube: A Novel Light Valve for Projection Displays , IEEE Transactions on Electron Devices, vol. ED 22, No. 9, pp. 765 775, Sep. 1975.;;J. Guldberg, et al., An Aluminum/SiO2/Silicon on Sapphire Light Valve Matrix for Projection Displays, Applied Physics Letters, vol. 26, No. 7, pp. 391 393, Apr. 1975.;;Russick et al., Supercritical Carbon Dioxide Extraction of Solvent from Micromachined Structures, Supercritical Fluids, Chapter 18, pp. 255 269, 1997.;;Buhler et al., Linear Array of Complementary Metal Oxide Semiconductor Double Pass Metal Micromirrors, Optical Engineering, vol. 36, No. 5, pp. 1391 1398, May 1997.;;Gani et al., Variable Gratings for Optical Switching Rigorous Electromagnetic Simulation and Design, Optical Engineering, vol. 38, No. 3, pp. 552 557, Mar. 1999.;;T. Iwai et al., Real time Profiling of a Pure Phase Object Using an Auto Wigner Distribution Function, Optics Communications, vol. 95, nos. 4 6, Jan. 15, 1993, pp. 144 204.;;R. Tepe, R. Gerhard Multhaupt, W. Brinker and W. D. Molzow, Viscoelastic Spatial Light Modulator with Active Matrix Addressing, Applied Optics, vol. 28, No. 22, New York, USA, pp. 4826 4834, Nov. 15, 1989.;;W. Briker, R. Gerhard Multhaupt, W. D. Molzow and R. Tepe,, Deformation Behavior of Thin Viscoelastic Layers Used in an Active Matrix Addressed Spatial Light Modulator, SPIE vol. 1018, pp. 79 85, Germany 1988.;;T. Utsunomiya and H. Sato, Electrically Deformable Echellette Grating and its Application to Tunable Laser Resonator, Electronics and Communications in Japan, vol. 63 c, No. 10, pp. 94 100, Japan 1980.;;R. Apte, F. Sandejas, W. Benyai, D. Bloom, Grating Light Valves For High Resolution Display , Ginzton Laboratories, Stanford University, Stanford, CA 94304 408, Jun. 1994.;;R. Apte, Grating Light Valves For High Resolution Displays, Jun., 1994 Report 5192 Edward Ginzton Laboratory, Stanford Univ.;;O. Solgaard, Integrated Semiconductor Light Modulators For Fiber Optic And Display Applications, Edward Ginzeth Laboratory, Stanford University Feb., 1992.;;J. Neff, Two Dimensional Spatial Light Modulators: A Tutorial , Proceedings of the IEEE, vol. 78, No. 5, pp. 826 855, May,1990.;;Gerhard Multhaupt, Viscoelastic Spatial Light Modulators and Schlieren Optical Systems for HDTV Projection Displays , SPIE vol. 1255 Large Screen Projection Displays II, pp, pp. 69 78, 1990.;;Gerhard Multhaupt, Light Valve Technologies for High Definition Television Projection Displays , Displays, vol. 12, No. 3/4, pp. 115 128.;;Alvelda et al., Ferroelectric Microdisplays Using Distortion Compensated Pixel Layouts, SID 95 Digest, pp. 931 933, 1995.;;Phillip Alvelda, High Efficiency Color Microdisplays, SID 95 Digest, pp. 307 311, 1995.;;Worboys et al., Miniature Dispaly Technology for Integrated Helmut Systems, GEC Journal of Research, vol. 10, No. 2, pp. 111 118, 1993.;;Farn et al., Color Separation by use of Binary Optics, Optics Letters, vol. 18:15, pp. 1214 1216, 1993.;;Phillip Alvelda, VLSI Microdisplays and Optoelectric Technology, MIT, pp. 1 93, May, 1995 Massachusetts Inst. Technology.;;Phillip Alvelda, VLSI Microdisplay Technology, May, 1994. Massachusetts Inst. of Technology.;;O.Solgaard, F. Sandejas, and D. Bloom, Deformable Grating Optical Modulator, Optics letters, vol. 17, No. 9, New York, USA, pp. 688 690, May 1, 1992.",EXPIRED
38,US,B2,US 7220768 B2,174-902-997-844-689,2007-05-22,2007,US 77279904 A,2004-02-05,US 77279904 A;;US 44660203 P,2003-02-11,Isoxazole-containing thiourea inhibitors useful for treatment of varicella zoster virus,"This Invention provides a compound of the Formula: wherein X is R 1 , R 2 , R 3 and R 4 are described in the specification and a pharmaceutical composition comprising the compound used for inhibiting replication of a herpes virus.",WYETH CORP,BLOOM JONATHAN DAVID,WYETH HOLDINGS CORPORATION (2004-02-02),https://lens.org/174-902-997-844-689,Granted Patent,yes,2,0,4,4,0,C07D261/08;;C07D413/04;;C07D417/04;;A61P31/12;;C07D413/04;;C07D261/08;;C07D417/04,A61P31/12;;C07D261/08;;C07D413/04;;C07D417/04,514/378;;514/588,0,0,,,,INACTIVE
39,WO,A3,WO 2005/072541 A3,006-281-485-075-467,2005-12-15,2005,GB 2005000301 W,2005-01-28,GB 0401854 A,2004-01-28,PROTECTIVE BIB OR APRON,An apron for use by dentists and the like is provided with a main body portion and a collar portion for securing the apron to the wearer in which the collar portion is adjustably securable at any position within a predetermined range such that it forms a close fit around the wearer wherein the collar and body portions comprise an absorbent side and a substantially waterproof.,BLOOM CLAUDINE NICOLA;;BLOOM DAVID RICHARD;;PADAYACHY JAYSEELAN NADASEN,BLOOM CLAUDINE NICOLA;;BLOOM DAVID RICHARD,,https://lens.org/006-281-485-075-467,Search Report,yes,4,0,16,16,0,A41B13/10;;A41B2400/52;;A41B13/10;;A41B2400/52,A41B13/10,,0,0,,,,PENDING
40,MX,A,MX PA06008577 A,103-912-146-124-150,2007-03-15,2007,MX PA06008577 A,2005-01-28,GB 0401854 A;;GB 2005000301 W,2004-01-28,PROTECTIVE BIB OR APRON.,An apron for use by dentists and the like is provided with a main body portion and a collar portion for securing the apron to the wearer in which the collar portion is adjustably securable at any position within a predetermined range such that it forms a close fit around the wearer wherein the collar and body portions comprise an absorbent side and a substantially waterproof.,JAYSEELAN NADASEN PADAYACHY,BLOOM CLAUDINE NICOLA;;BLOOM DAVID RICHARD,,https://lens.org/103-912-146-124-150,Patent Application,no,0,0,16,16,0,A41B13/10;;A41B2400/52;;A41B13/10;;A41B2400/52,A41B13/10,,0,0,,,,DISCONTINUED
41,US,B2,US 7532651 B2,005-260-929-372-464,2009-05-12,2009,US 79956507 A,2007-05-02,US 79956507 A,2007-05-02,Illumination system for optical modulators,"A phase plate and lens modify light beams emitted by an array of lasers to form an efficient illumination source for a MEMS light modulator array. The phase of the electric field emitted by the lasers is modified such that the after passing through a lens the beam profile at the lens focal plane has an approximately rectangular shape appropriate for illuminating a light modulator array. The phase plate may be constructed from a glass plate with rectangular notches etched in it or with rectangular ridges formed on it. Furthermore a light source, such as a laser, may be coupled to an adiabatically tapered optical waveguide in which a phase adjusting block is introduced in analogy to notches in a bulk phase plate. Phase modified light beams output from the waveguide system have similar focusing properties to those passing through a bulk phase plate.",ALCES TECHNOLOGY INC,BLOOM DAVID M,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2007-06-08),https://lens.org/005-260-929-372-464,Granted Patent,yes,10,5,2,2,0,G02B27/0927;;H01S5/005;;H01S5/14;;H01S5/4012;;H01S5/423;;H01S2301/206;;G02B19/0057;;G02B19/0014;;G03B21/2013;;G03B21/2033;;G03B21/208;;G02B27/0927;;H01S5/4012;;H01S5/005;;H01S5/14;;H01S5/423;;H01S2301/206;;G02B19/0057;;G03B21/208;;G03B21/2033;;G02B19/0014;;G03B21/2013,H01S3/13;;H01S3/03;;H01S3/08,372/29.023;;372/64;;372/101,1,1,011-454-033-132-014,10.1117/1.1617310,"J. Yang et al., ""Analysis and optimization on single-zone binary flat-top beam shaper"", Opt. Eng. 42, p. 3106-3113, Nov. 2003, SPIE.",ACTIVE
42,WO,A2,WO 2007/019032 A2,070-380-194-261-635,2007-02-15,2007,US 2006/0028642 W,2006-07-24,US 16145205 A,2005-08-03,DIFFERENTIAL INTERFEROMETRIC LIGHT MODULATOR AND IMAGE DISPLAY SYSTEM,"A differential interferometric light modulator and image display system comprises a polarizing beam splitter, a polarization displacement device and a linear array of MEMS optical phase shifting devices to modulate a line image. The polarizing beam splitter acts as both the polarizer and the analyzer in an interferometer. The polarization displacement device divides polarized light from a polarizer into orthogonal polarization components which propagate parallel to one another. The MEMS optical phase shifting device array imparts a relative phase shift onto the polarization components and returns them to the polarization displacement device where they are recombined and sent to the analyzer. The MEMS optical phase shifting devices are electronically controlled and convert electronic image data into actual light modulation.",ALCES TECHNOLOGY INC;;BLOOM DAVID M,BLOOM DAVID M,,https://lens.org/070-380-194-261-635,Patent Application,yes,0,0,8,8,0,G02F1/21;;G02F1/21;;G02B26/001;;G02B26/001;;G02B26/06;;G02B26/06;;G02B26/0841;;G02B26/0841;;G02B27/281;;G02B27/281,G02F1/01,,1,0,,,See references of EP 1920292A4,PENDING
43,US,A1,US 2012/0106580 A1,113-206-492-088-564,2012-05-03,2012,US 201213347580 A,2012-01-10,US 201213347580 A;;US 58047509 A;;US 73298407 A,2007-04-04,Optical systems for laser arrays,Surface emitting laser arrays with intra-cavity harmonic generation are coupled to an optical system that extracts harmonic light in both directions from an intra-cavity nonlinear optical material in such a way that the focusing properties of the light beams are matched.,BLOOM DAVID M;;ALCES TECHNOLOGY INC,BLOOM DAVID M,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2013-04-18),https://lens.org/113-206-492-088-564,Patent Application,yes,2,0,8,8,0,H01S3/08059;;H01S3/0813;;H01S3/082;;H01S3/109;;H01S5/141;;H01S5/183;;H01S5/4062;;H01S5/423;;H01S5/141;;H01S3/109;;H01S3/082;;H01S3/08059;;H01S5/183;;H01S3/0813;;H01S5/423;;H01S5/4062,H01S3/10,372/22,0,0,,,,ACTIVE
44,CA,A1,CA 2588178 A1,137-036-102-371-041,2006-06-01,2006,CA 2588178 A,2005-11-16,US 90476604 A;;US 2005/0041595 W,2004-11-26,DIFFERENTIAL INTERFEROMETRIC LIGHT MODULATOR AND IMAGE DISPLAY DEVICE,,ALCES TECHNOLOGY INC,BLOOM DAVID M,,https://lens.org/137-036-102-371-041,Patent Application,no,0,0,10,10,0,G02B26/0841;;G02B26/0841;;G02B26/06;;G02B26/06,G02F1/01,,0,0,,,,DISCONTINUED
45,US,A1,US 2006/0114543 A1,008-460-502-752-770,2006-06-01,2006,US 16145205 A,2005-08-03,US 16145205 A;;US 90476604 A,2004-11-26,Differential interferometric light modulator and image display system,"A differential interferometric light modulator and image display system comprises a polarizing beam splitter, a polarization displacement device and a linear array of MEMS optical phase shifting devices to modulate a line image. The polarizing beam splitter acts as both the polarizer and the analyzer in an interferometer. The polarization displacement device divides polarized light from a polarizer into orthogonal polarization components which propagate parallel to one another. The MEMS optical phase shifting device array imparts a relative phase shift onto the polarization components and returns them to the polarization displacement device where they are recombined and sent to the analyzer. The MEMS optical phase shifting devices are electronically controlled and convert electronic image data into actual light modulation.",BLOOM DAVID M,BLOOM DAVID M,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2006-03-14),https://lens.org/008-460-502-752-770,Patent Application,yes,10,11,8,8,0,G02F1/21;;G02F1/21;;G02B26/001;;G02B26/001;;G02B26/06;;G02B26/06;;G02B26/0841;;G02B26/0841;;G02B27/281;;G02B27/281,G02F1/01,359/279,0,0,,,,ACTIVE
46,US,B1,US 7054051 B1,019-177-981-615-356,2006-05-30,2006,US 90476604 A,2004-11-26,US 90476604 A,2004-11-26,Differential interferometric light modulator and image display device,A light modulator incorporates a polarization sensitive prism and a novel MEMS ribbon device to impart a relative phase shift to polarization components of an incident light beam. A linear array of phase shifting elements in the MEMS device creates a linear image which is scanned to form a two dimensional scene. Alternatively the deflection of each cantilever in a linear array of atomic force microscope cantilevers may be measured simultaneously.,ALCES TECHNOLOGY INC,BLOOM DAVID M,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2005-11-08),https://lens.org/019-177-981-615-356,Granted Patent,yes,12,30,10,10,0,G02B26/0841;;G02B26/0841;;G02B26/06;;G02B26/06,G02F1/01,359/276,0,0,,,,ACTIVE
47,US,A1,US 2008/0247427 A1,061-241-700-283-903,2008-10-09,2008,US 73298407 A,2007-04-04,US 73298407 A,2007-04-04,Optical systems for laser arrays,Surface emitting laser arrays with intra-cavity harmonic generation are coupled to an optical system that extracts harmonic light in both directions from an intra-cavity nonlinear optical material in such a way that the focusing properties of the light beams are matched.,BLOOM DAVID M,BLOOM DAVID M,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2007-06-08),https://lens.org/061-241-700-283-903,Patent Application,yes,7,5,8,8,0,H01S3/08059;;H01S3/0813;;H01S3/082;;H01S3/109;;H01S5/141;;H01S5/183;;H01S5/4062;;H01S5/423;;H01S5/141;;H01S3/109;;H01S3/082;;H01S3/08059;;H01S5/183;;H01S3/0813;;H01S5/423;;H01S5/4062,H01S5/18,372/21;;372/99,0,0,,,,ACTIVE
48,EP,A4,EP 1920292 A4,100-310-249-798-783,2011-09-28,2011,EP 06800270 A,2006-07-24,US 2006/0028642 W;;US 16145205 A,2005-08-03,DIFFERENTIAL INTERFEROMETRIC LIGHT MODULATOR AND IMAGE DISPLAY SYSTEM,,ALCES TECHNOLOGY INC,BLOOM DAVID M,,https://lens.org/100-310-249-798-783,Search Report,no,0,0,8,8,0,G02B26/001;;G02B26/06;;G02B26/0841;;G02B27/281;;G02F1/21;;G02F1/21;;G02B26/001;;G02B26/0841;;G02B26/06;;G02B27/281,G02F1/01,,1,0,,,No further relevant documents disclosed,DISCONTINUED
49,US,A1,US 2016/0004991 A1,110-541-500-228-926,2016-01-07,2016,US 201514792371 A,2015-07-06,US 201514792371 A;;US 201462021425 P,2014-07-07,SYSTEM AND METHOD FOR DELIVERING SALES TRAINING VIDEOS,"Delivering sales training videos includes matching content attributes of the sales training videos data stored at the customer relationship management (CRM) system. Matched sales training videos are sent to one or more remote devices for playback. User-specified feedback data is received from the one or more remote devices. The user-specified feedback data indicates a particular object stored in the CRM system. Upon detection of an advancement of a stage of the particular object, at least one content attribute of the particular sales training video is updated. Future recommendations of sales training videos consider the updated content attribute.",LURNITURE CORP,BLOOM SAMUEL DAVID,LEVELJUMP SOFTWARE CORP (2015-07-03),https://lens.org/110-541-500-228-926,Patent Application,yes,7,4,1,1,0,G06Q10/063114;;G06Q10/063114,G06Q10/06,,0,0,,,,DISCONTINUED
50,US,A1,US 2006/0238851 A1,128-050-619-458-857,2006-10-26,2006,US 47208606 A,2006-06-21,US 47208606 A;;US 33627706 A;;US 16145205 A;;US 90476604 A,2004-11-26,Micro-electromechanical light modulator with anamorphic optics,Micro-electromechanical light modulators are combined with anamorphic and contrast enhancing optical elements to form optical display engines. Linear MEMS arrays are suitable for the étendue of low divergence light sources while handling high optical power for brightness. The output of an optical engine is a line image which may be scanned to form a two-dimensional image.,BLOOM DAVID M,BLOOM DAVID M,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2006-07-21),https://lens.org/128-050-619-458-857,Patent Application,yes,25,13,5,5,0,G02B13/08;;G02B26/06;;G02B26/0833;;G02B13/08;;G02B26/06;;G02B26/0833,G02F1/01,359/279,0,0,,,,ACTIVE
51,EP,A2,EP 1920292 A2,093-582-141-937-312,2008-05-14,2008,EP 06800270 A,2006-07-24,US 2006/0028642 W;;US 16145205 A,2005-08-03,DIFFERENTIAL INTERFEROMETRIC LIGHT MODULATOR AND IMAGE DISPLAY SYSTEM,,ALCES TECHNOLOGY INC,BLOOM DAVID M,,https://lens.org/093-582-141-937-312,Patent Application,yes,0,0,8,8,0,G02F1/21;;G02F1/21;;G02B26/001;;G02B26/001;;G02B26/06;;G02B26/06;;G02B26/0841;;G02B26/0841;;G02B27/281;;G02B27/281,G02F1/01,,0,0,,,,DISCONTINUED
52,US,A1,US 2008/0062521 A1,118-406-073-747-391,2008-03-13,2008,US 51203606 A,2006-08-28,US 51203606 A,2006-08-28,Micro-electromechanical light modulator with enhanced contrast,A system and method for increasing contrast in displays using micromechanical light modulators is described. Contrast is enhanced by an optical system that uses polarization to discriminate unmodulated light. Contrast obtained from polarization sensitive components of an optical system has a multiplicative effect on contrast already available.,BLOOM DAVID M,BLOOM DAVID M,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2007-03-20),https://lens.org/118-406-073-747-391,Patent Application,yes,5,7,2,2,0,G02B26/0808;;G02B26/0808;;G02B27/286;;G02B27/286,G02B5/30,359/486,0,0,,,,ACTIVE
53,US,B2,US 7623558 B2,033-711-602-591-679,2009-11-24,2009,US 73298407 A,2007-04-04,US 73298407 A,2007-04-04,Optical systems for laser arrays,Surface emitting laser arrays with intra-cavity harmonic generation are coupled to an optical system that extracts harmonic light in both directions from an intra-cavity nonlinear optical material in such a way that the focusing properties of the light beams are matched.,ALCES TECHNOLOGY INC,BLOOM DAVID M,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2007-06-08),https://lens.org/033-711-602-591-679,Granted Patent,yes,6,1,8,8,0,H01S3/08059;;H01S3/0813;;H01S3/082;;H01S3/109;;H01S5/141;;H01S5/183;;H01S5/4062;;H01S5/423;;H01S5/141;;H01S3/109;;H01S3/082;;H01S3/08059;;H01S5/183;;H01S3/0813;;H01S5/423;;H01S5/4062,H01S3/10,372/22;;372/21;;372/99;;372/98;;372/101;;372/50.11;;372/50.124,3,0,,,"A. Mooradian et al., ""High Power Extended Vertical Cavity Surface Emitting Diode Lasers and Arrays and Their Applications"", Micro-Optics Conference, Tokyo, Japan, Nov. 2, 2005.;;Watson, JP Et Al, ""Laser sources at 460 nm based on intracavity doubling of extended cavity surface emitting lasers"", Proc. SPIE, vol. 5364, p. 116-121 (2004).;;International search report and written opinion of the international searching authority, PCT/US2008/058310, Mar. 24, 2009.",ACTIVE
54,US,B2,US 7549759 B2,079-348-434-352-534,2009-06-23,2009,US 51203606 A,2006-08-28,US 51203606 A,2006-08-28,Micro-electromechanical light modulator with enhanced contrast,A system and method for increasing contrast in displays using micromechanical light modulators. Contrast is enhanced by an optical system that uses polarization to discriminate unmodulated light. Contrast obtained from polarization sensitive components of an optical system has a multiplicative effect on contrast already available.,ALCES TECHNOLOGY INC,BLOOM DAVID M,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2007-03-20),https://lens.org/079-348-434-352-534,Granted Patent,yes,5,4,2,2,0,G02B26/0808;;G02B26/0808;;G02B27/286;;G02B27/286,G02B7/182,359/850;;359/298;;359/496;;359/847,0,0,,,,ACTIVE
55,US,B2,US 7193766 B2,115-119-032-284-748,2007-03-20,2007,US 39100806 A,2006-03-28,US 39100806 A;;US 90476604 A,2004-11-26,Differential interferometric light modulator and image display device,A light modulator incorporates a polarization sensitive prism and a novel MEMS ribbon device to impart a relative phase shift to polarization components of an incident light beam. A linear array of phase shifting elements in the MEMS device creates a linear image which is scanned to form a two dimensional scene. Alternatively the deflection of each cantilever in a linear array of atomic force microscope cantilevers may be measured simultaneously.,ALCES TECHNOLOGY INC,BLOOM DAVID M,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2006-07-21),https://lens.org/115-119-032-284-748,Granted Patent,yes,20,8,10,10,0,G02B26/0841;;G02B26/0841;;G02B26/06;;G02B26/06,G02F1/01;;G01B9/02;;G02F1/03;;G11B7/00;;G11B7/20,359/279;;359/245;;359/247;;369/94;;369/100;;356/450;;356/487;;356/499;;324/76.36,0,0,,,,ACTIVE
56,US,B2,US 8368994 B2,124-173-012-075-520,2013-02-05,2013,US 16403008 A,2008-06-28,US 16403008 A,2008-06-28,"Scanned, one-dimensional, phased-array display system","A scanned, one-dimensional, phased-array display system combines imaging optics on one axis with Fourier transform optics on another. The display offers the energy efficiency and fault tolerance of phase modulator-based displays, and the compactness, flexibility and speed of optical MEMS. Also described is a mechanism to introduce amplitude variations on the Fourier axis if needed to compensate for image artifacts.",ALCES TECHNOLOGY INC;;BLOOM DAVID M,BLOOM DAVID M,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2009-03-02),https://lens.org/124-173-012-075-520,Granted Patent,yes,8,0,2,2,0,G02B26/10;;G02B27/0087;;H04N9/3129;;G02B26/10;;G02B27/0087;;H04N9/3129,G02B26/02;;G02F1/01,359/279;;359/276;;359/231,3,2,039-000-054-064-938;;000-776-284-555-890,10.1147/rd.132.0150;;10.1364/ol.3.000027;;19684685,"L B. Lesem et al., ""The Kinoform: A New Wavefront Reconstruction Device"", IBM J. Res. Develop., Mar. 1969, p. 150-155.;;J. R. Fienup, ""Reconstruction of an object from the modulus of its Fourier transform"", Optics Letters, Jul. 1978, p. 27-29.;;A. Georgiou, et al. ""Aspects of hologram calculation for video frames"", Journal of Optics A: Pure and Applied Optics, Feb. 2008, p. 035302 (9pp).",ACTIVE
57,WO,A2,WO 2007/149569 A2,153-790-336-825-338,2007-12-27,2007,US 2007/0014613 W,2007-06-20,US 47208606 A,2006-06-21,MICRO-ELECTROMECHANICAL LIGHT MODULATOR WITH ANAMORPHIC OPTICS,Micro-electromechanical light modulators are combined with anamorphic and contrast enhancing optical elements to form optical display engines. Linear MEMS arrays are suitable for the étendue of low divergence light sources while handling high optical power for brightness. The output of an optical engine is a line image which may be scanned to form a two-dimensional image.,ALCES TECHNOLOGY INC;;BLOOM DAVID M,BLOOM DAVID M,,https://lens.org/153-790-336-825-338,Patent Application,yes,0,0,5,5,0,G02B13/08;;G02B26/06;;G02B26/0833;;G02B13/08;;G02B26/06;;G02B26/0833,,,0,0,,,,PENDING
58,EP,A2,EP 1708585 A2,058-197-772-649-413,2006-10-11,2006,EP 05702051 A,2005-01-28,GB 2005000301 W;;GB 0401854 A,2004-01-28,PROTECTIVE BIB OR APRON,An apron for use by dentists and the like is provided with a main body portion and a collar portion for securing the apron to the wearer in which the collar portion is adjustably securable at any position within a predetermined range such that it forms a close fit around the wearer wherein the collar and body portions comprise an absorbent side and a substantially waterproof.,BLOOM CLAUDINE NICOLA;;BLOOM DAVID RICHARD;;PADAYACHI JAYSELAAN NADASEN,BLOOM CLAUDINE NICOLA;;BLOOM DAVID RICHARD,"PADAYACHY, JAYSEELAN NADASEN (2010-11-03);;BLOOM, DAVID RICHARD (2010-11-03);;BLOOM, CLAUDINE NICOLA (2010-11-03)",https://lens.org/058-197-772-649-413,Patent Application,yes,0,0,16,16,0,A41B13/10;;A41B2400/52;;A41B13/10;;A41B2400/52,A41B13/10,,0,0,,,,ACTIVE
59,AU,A1,AU 2005/207878 A1,088-326-205-474-078,2005-08-11,2005,AU 2005/207878 A,2005-01-28,GB 0401854 A;;GB 2005000301 W,2004-01-28,Protective bib or apron,An apron for use by dentists and the like is provided with a main body portion and a collar portion for securing the apron to the wearer in which the collar portion is adjustably securable at any position within a predetermined range such that it forms a close fit around the wearer wherein the collar and body portions comprise an absorbent side and a substantially waterproof.,BLOOM CLAUDINE NICOLA;;BLOOM DAVID RICHARD;;PADAYACHY JAYSEELAN NADASEN,BLOOM DAVID RICHARD;;BLOOM CLAUDINE NICOLA,,https://lens.org/088-326-205-474-078,Patent Application,no,0,0,16,16,0,A41B13/10;;A41B2400/52;;A41B13/10;;A41B2400/52,A41B13/10,,0,0,,,,DISCONTINUED
60,US,A1,US 2006/0187518 A1,062-843-217-002-600,2006-08-24,2006,US 39100806 A,2006-03-28,US 39100806 A;;US 90476604 A,2004-11-26,Differential Interferometric light modulator and image display device,A light modulator incorporates a polarization sensitive prism and a novel MEMS ribbon device to impart a relative phase shift to polarization components of an incident light beam. A linear array of phase shifting elements in the MEMS device creates a linear image which is scanned to form a two dimensional scene. Alternatively the deflection of each cantilever in a linear array of atomic force microscope cantilevers may be measured simultaneously.,BLOOM DAVID M,BLOOM DAVID M,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2006-07-21),https://lens.org/062-843-217-002-600,Patent Application,yes,21,3,10,10,0,G02B26/0841;;G02B26/0841;;G02B26/06;;G02B26/06,G02F1/03,359/245,0,0,,,,ACTIVE
61,WO,A1,WO 2006/057881 A1,079-192-724-788-450,2006-06-01,2006,US 2005/0041595 W,2005-11-16,US 90476604 A,2004-11-26,DIFFERENTIAL INTERFEROMETRIC LIGHT MODULATOR AND IMAGE DISPLAY DEVICE,A light modulator incorporates a polarization sensitive prism and a novel MEMS ribbon device to impart a relative phase shift to polarization components of an incident light beam. A linear array of phase shifting elements in the MEMS device creates a linear image which is scanned to form a two dimensional scene. Alternatively the deflection of each cantilever in a linear array of atomic force microscope cantilevers may be measured simultaneously.,ALCES TECHNOLOGY INC;;BLOOM DAVID M,BLOOM DAVID M,,https://lens.org/079-192-724-788-450,Patent Application,yes,2,3,10,10,0,G02B26/0841;;G02B26/0841;;G02B26/06;;G02B26/06,G02F1/01,,1,0,,,See also references of EP 1815291A4,PENDING
62,EP,A4,EP 1815291 A4,168-888-968-657-619,2009-10-28,2009,EP 05851730 A,2005-11-16,US 2005/0041595 W;;US 90476604 A,2004-11-26,DIFFERENTIAL INTERFEROMETRIC LIGHT MODULATOR AND IMAGE DISPLAY DEVICE,,ALCES TECHNOLOGY INC,BLOOM DAVID M,,https://lens.org/168-888-968-657-619,Search Report,no,4,0,10,10,0,G02B26/0841;;G02B26/0841;;G02B26/06;;G02B26/06,G02F1/01;;G01B9/02,,1,0,,,See also references of WO 2006057881A1,DISCONTINUED
63,US,B2,US 8121171 B2,023-725-023-458-771,2012-02-21,2012,US 58047509 A,2009-10-16,US 58047509 A;;US 73298407 A,2007-04-04,Optical systems for laser arrays,Surface emitting laser arrays with intra-cavity harmonic generation are coupled to an optical system that extracts harmonic light in both directions from an intra-cavity nonlinear optical material in such a way that the focusing properties of the light beams are matched.,BLOOM DAVID M;;ALCES TECHNOLOGY INC,BLOOM DAVID M,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2010-06-02),https://lens.org/023-725-023-458-771,Granted Patent,yes,8,0,8,8,0,H01S3/08059;;H01S3/0813;;H01S3/082;;H01S3/109;;H01S5/141;;H01S5/183;;H01S5/4062;;H01S5/423;;H01S5/141;;H01S3/109;;H01S3/082;;H01S3/08059;;H01S5/183;;H01S3/0813;;H01S5/423;;H01S5/4062,H01S3/08,372/101;;372/99;;372/98;;372/22;;372/21;;372/50.11;;372/50.124,4,1,034-638-241-868-30X,10.1117/12.591288,"Watson, JP et al, ""Laser sources at 460 nm based on intracavity doubling of extended cavity surface emitting lasers"", Proc. SPIE, vol. 5364, p. 116-121 (2004).;;A. Mooradian et al., ""High Power Extended Vertical Cavity Surface Emitting Diode Lasers and Arrays and Their Applications"", Micro-Optics Conference, Tokyo, Japan, Nov. 2, 2005.;;International search report and written opinion of the international searching authority, PCT/US2008/058310, Mar. 24, 2009.;;Shchegrov, et al., ""Development of compact blue-green lasers for projection display based on Novalux extended-cavity surface emitting laser technology"", date unknown.",ACTIVE
64,US,B2,US 7277216 B2,075-346-370-621-496,2007-10-02,2007,US 16145205 A,2005-08-03,US 16145205 A;;US 90476604 A,2004-11-26,Differential interferometric light modulator and image display system,"A differential interferometric light modulator and image display system comprises a polarizing beam splitter, a polarization displacement device and a linear array of MEMS optical phase shifting devices to modulate a line image. The polarizing beam splitter acts as both the polarizer and the analyzer in an interferometer. The polarization displacement device divides polarized light from a polarizer into orthogonal polarization components which propagate parallel to one another. The MEMS optical phase shifting device array imparts a relative phase shift onto the polarization components and returns them to the polarization displacement device where they are recombined and sent to the analyzer. The MEMS optical phase shifting devices are electronically controlled and convert electronic image data into actual light modulation.",ALCES TECHNOLOGY,BLOOM DAVID M,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2006-03-14),https://lens.org/075-346-370-621-496,Granted Patent,yes,10,3,8,8,0,G02F1/21;;G02F1/21;;G02B26/001;;G02B26/001;;G02B26/06;;G02B26/06;;G02B26/0841;;G02B26/0841;;G02B27/281;;G02B27/281,G02F1/01,359/276;;359/291,2,0,,,"M. Francon, Optical Interferometry, Academic Press, New York, 1966; chapter VII, ""Polarization Interferometers"".;;M. Francon andS. Mallick, Polarization Interferometers, John Wiley & Sons, New York, 1971; chapter 1, ""Introduction to Polarized Light"" and chapter 2, ""Birefringent Beam-splitters"".",ACTIVE
65,AU,A4,AU 2004/100487 A4,125-468-884-685-873,2004-07-15,2004,AU 2004/100487 A,2004-06-21,AU 2004/100487 A,2004-06-21,Apparatus for removing ticks,,VETERINARY COMPANIES OF AUSTRA,BLOOM LIONEL DAVID,,https://lens.org/125-468-884-685-873,Limited Patent,no,0,0,3,16,0,,A01K13/00;;A01M3/00;;A61B17/30;;A61B17/50,,0,0,,,,INACTIVE
66,US,A,US 4327966 A,130-278-624-784-123,1982-05-04,1982,US 12435980 A,1980-02-25,US 12435980 A,1980-02-25,Variable attenuator for laser radiation,"The invention relates to a variable attenuator having two phase gratings (1 and 2) with rectangular grooves. In a first embodiment of the present invention the gratings are slidably mounted (10, 20, 30) so that the gratings have the grooves parallel and the faces in close proximity. As one grating is translated relative to the other the light passing through the device may be varied from total extinction to substantially total transmittance. A single device can be fabricated to provide this attenuation for radiation spanning the visible spectrum. In other embodiments the gratings are fixed relative to one another and the entire device is moved relative to the beam to be attenuated.",BELL TELEPHONE LABOR INC,BLOOM DAVID M,,https://lens.org/130-278-624-784-123,Granted Patent,yes,7,87,1,1,0,G02B5/1828;;G02B7/004;;G02B26/02;;G21K1/04;;G21K1/04;;G02B7/004;;G02B5/1828;;G02B26/02,G02B5/18;;G02B7/00;;G02B26/02;;G21K1/04,350162R,1,0,,,"Guild, J., The Interference Systems of Crossed Diffraction Gratings, The Clarendon Press, Oxford, 1956, pp. 1-6, 26-47 and 96-98.",EXPIRED
67,AU,B4,AU 2004/100487 B4,184-197-755-083-073,2005-04-21,2005,AU 2004/100487 A,2004-06-21,AU 2004/100487 A,2004-06-21,Apparatus for removing ticks,,VETERINARY COMPANIES OF AUSTRALIA PTY LTD,BLOOM LIONEL DAVID,,https://lens.org/184-197-755-083-073,Limited Patent,no,0,1,3,16,0,,A01K13/00;;A01M3/00;;A61B17/30;;A61B17/50,,0,0,,,,INACTIVE
68,WO,A3,WO 2007/019032 A3,118-511-026-480-959,2007-03-29,2007,US 2006/0028642 W,2006-07-24,US 16145205 A,2005-08-03,DIFFERENTIAL INTERFEROMETRIC LIGHT MODULATOR AND IMAGE DISPLAY SYSTEM,"A differential interferometric light modulator and image display system comprises a polarizing beam splitter, a polarization displacement device and a linear array of MEMS optical phase shifting devices to modulate a line image. The polarizing beam splitter acts as both the polarizer and the analyzer in an interferometer. The polarization displacement device divides polarized light from a polarizer into orthogonal polarization components which propagate parallel to one another. The MEMS optical phase shifting device array imparts a relative phase shift onto the polarization components and returns them to the polarization displacement device where they are recombined and sent to the analyzer. The MEMS optical phase shifting devices are electronically controlled and convert electronic image data into actual light modulation.",ALCES TECHNOLOGY INC;;BLOOM DAVID M,BLOOM DAVID M,,https://lens.org/118-511-026-480-959,Search Report,yes,3,0,8,8,0,G02F1/21;;G02F1/21;;G02B26/001;;G02B26/001;;G02B26/06;;G02B26/06;;G02B26/0841;;G02B26/0841;;G02B27/281;;G02B27/281,G02F1/01,,1,0,,,See also references of EP 1920292A4,PENDING
69,US,A1,US 2010/0040094 A1,146-469-855-525-201,2010-02-18,2010,US 58047509 A,2009-10-16,US 58047509 A;;US 73298407 A,2007-04-04,Optical systems for laser arrays,Surface emitting laser arrays with intra-cavity harmonic generation are coupled to an optical system that extracts harmonic light in both directions from an intra-cavity nonlinear optical material in such a way that the focusing properties of the light beams are matched.,ALCES TECHNOLOGY INC,BLOOM DAVID M,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2010-06-02),https://lens.org/146-469-855-525-201,Patent Application,yes,9,0,8,8,0,H01S3/08059;;H01S3/0813;;H01S3/082;;H01S3/109;;H01S5/141;;H01S5/183;;H01S5/4062;;H01S5/423;;H01S5/141;;H01S3/109;;H01S3/082;;H01S3/08059;;H01S5/183;;H01S3/0813;;H01S5/423;;H01S5/4062,H01S3/10;;H01S3/08;;H01S5/00,372/22;;372/99;;372/50.124;;372/101,0,0,,,,ACTIVE
70,WO,A1,WO 2009/117551 A1,021-639-176-547-261,2009-09-24,2009,US 2009/0037623 W,2009-03-19,US 5347708 A,2008-03-21,MICROFABRICATED OPTICAL WAVE PLATE,"A microfabricated optical wave plate comprises a reflective polarizer and a mirror separated by a fixed or variable distance. The wave plate imparts a relative phase delay on polarization components of incident light, thereby transforming the overall polarization of the light.",ALCES TECHNOLOGY INC;;BLOOM DAVID M,BLOOM DAVID M,,https://lens.org/021-639-176-547-261,Patent Application,yes,4,0,3,3,0,G02B27/286;;G02B27/286,G02B5/30;;G02B5/02,,0,0,,,,PENDING
71,WO,A2,WO 2004/072052 A2,026-523-522-280-991,2004-08-26,2004,US 2004/0003725 W,2004-02-09,US 44660203 P,2003-02-11,ISOXASOLE-CONTAINING THIOUREA INHIBITORS USEFUL FOR TREATMENT OF VARICELLA ZOSTER VIRUS,"This invention provides a compound of the formula: (I), wherein X is (II), or (III), R1, R2, R3 and R4 are described in the specification and a pharmaceutical composition comprising the compound used for inhibiting replication of a herpes virus.",WYETH CORP;;BLOOM JONATHAN DAVID,BLOOM JONATHAN DAVID,,https://lens.org/026-523-522-280-991,Patent Application,yes,0,1,4,4,0,C07D261/08;;C07D413/04;;C07D417/04;;A61P31/12;;C07D413/04;;C07D261/08;;C07D417/04,A61P31/12;;C07D261/08;;C07D413/04;;C07D417/04,,0,0,,,,PENDING
72,US,B1,US 8881000 B1,047-701-427-506-180,2014-11-04,2014,US 201213347600 A,2012-01-10,US 201213347600 A;;US 201161528132 P,2011-08-26,System and method for informing users of an action to be performed by a web component,"A system and method is disclosed for informing a user of an action to be performed by a web component in a domain of a primary website. A web component is provided to a web browser for display in connection with a website. The web component includes code that is executed in a different web domain than the website. On receiving an indication that a user has moved a cursor over the web component, the web component generates an alert informing the user of the action to be performed by the web component before the user activates the web component.",BLOOM DAVID JEFFERY;;GOOGLE INC,BLOOM DAVID JEFFERY,GOOGLE LLC (2011-12-08),https://lens.org/047-701-427-506-180,Granted Patent,yes,0,10,1,1,0,G06Q50/01;;G06Q10/103;;G06Q10/103;;G06Q50/01,G06F17/21,715/235,6,1,004-647-660-152-759,10.1145/1755688.1755706,"Lundeen, Rich, Jesse Ou, and Travis Rhodes. ""New Ways I'm Going to Hack Your Web App."" Blackhat AD (2011), p. 1-11.;;Rydstedt, Gustav, et al. ""Busting frame busting: a study of clickjacking vulnerabilities at popular sites."" IEEE Oakland Web 2 (2010), p. 1-13.;;Balduzzi, Marco, et al. ""A solution for the automated detection of clickjacking attacks."" Proceedings of the 5th ACM Symposium on Information, Computer and Communications Security. ACM, 2010, p. 135-144.;;""Flying Around With Hovercards"", Twitter Blog, Feb. 3, 2010, retrieved from .;;Kincaid, Jason, Facebook Borrows Another Feature From Twitter (Or Was It FriendFeed?): The Hovercard, Apr. 19, 2010, retrieved from <http://techcrunch.com/2010/04/19/facebook-borrows-another-feature-from-twitter-or-was-it-friendfeed-the-hovercard>.;;""Likejacking"", Wikipedia-The Free Encyclopedia, last viewed on Jan. 16, 2012, retrieved from .",ACTIVE
73,EP,A1,EP 1815291 A1,073-195-085-389-888,2007-08-08,2007,EP 05851730 A,2005-11-16,US 2005/0041595 W;;US 90476604 A,2004-11-26,DIFFERENTIAL INTERFEROMETRIC LIGHT MODULATOR AND IMAGE DISPLAY DEVICE,,ALCES TECHNOLOGY INC,BLOOM DAVID M,,https://lens.org/073-195-085-389-888,Patent Application,yes,0,1,10,10,0,G02B26/0841;;G02B26/0841;;G02B26/06;;G02B26/06,G02F1/01;;G01B9/02,,0,0,,,,DISCONTINUED
74,US,B2,US 7446925 B2,072-552-957-208-447,2008-11-04,2008,US 47208606 A,2006-06-21,US 47208606 A;;US 33627706 A;;US 16145205 A;;US 90476604 A,2004-11-26,Micro-electromechanical light modulator with anamorphic optics,Micro-electromechanical light modulators are combined with anamorphic and contrast enhancing optical elements to form optical display engines. Linear MEMS arrays are suitable for the étendue of low divergence light sources while handling high optical power for brightness. The output of an optical engine is a line image which may be scanned to form a two-dimensional image.,ALCES TECHNOLOGY,BLOOM DAVID M,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2006-07-21),https://lens.org/072-552-957-208-447,Granted Patent,yes,25,14,5,5,0,G02B13/08;;G02B26/06;;G02B26/0833;;G02B13/08;;G02B26/06;;G02B26/0833,G02F26/00,359/279,0,0,,,,ACTIVE
75,US,S,US D0332738 S,135-632-750-994-309,1993-01-26,1993,US 57791290 F,1990-09-05,US 57791290 F,1990-09-05,Support stand,,COLE PARMER INSTR CO,BLOOM DAVID H,DEUTSCHE BANK AG NEW YORK BRANCH (2003-12-03);;COLE-PARMER INSTRUMENT COMPANY (1990-10-16);;BARNANT COMPANY THE A CORP. OF IL (1990-08-23),https://lens.org/135-632-750-994-309,Design Right,yes,20,5,1,1,0,,,78380,0,0,,,,EXPIRED
76,AU,A,AU 1996/060944 A,037-021-276-176-580,1996-12-30,1996,AU 1996/060944 A,1996-06-05,US 48219295 A;;US 9609253 W,1995-06-07,Binary time modulation with dead periods for matrix display systems,,ECHELLE INC,BLOOM DAVID M,,https://lens.org/037-021-276-176-580,Patent Application,no,0,0,3,3,0,G09G3/2018;;G09G3/2018,G09G3/20,,0,0,,,,PENDING
77,WO,A1,WO 1996/041326 A1,049-917-479-546-198,1996-12-19,1996,US 9609253 W,1996-06-05,US 48219295 A,1995-06-07,BINARY TIME MODULATION WITH DEAD PERIODS FOR MATRIX DISPLAY SYSTEMS,"A display system uses a weighted PWM scheme to deliver control during a frame time for developing a plurality of grayscale levels in each of a plurality of pixels. Of all the weighted subframes, a predetermined number of the shortest subframes utilize a like subframe duration. However, to provide additional levels of grayscale, differing durations of 'on' time are utilized in these like subframes. Thus, all but one of these like-time subframes has a dead zone time during which the pixels are never activated. A clear circuit turns 'off' the illuminated pixels during the dead zone time.",ECHELLE INC;;BLOOM DAVID M,BLOOM DAVID M,,https://lens.org/049-917-479-546-198,Patent Application,yes,3,3,3,3,0,G09G3/2018;;G09G3/2018,G09G3/20,,1,0,,,"PATENT ABSTRACTS OF JAPAN vol. 14, no. 525 (P - 1132) 19 November 1990 (1990-11-19)",PENDING
78,CA,A1,CA 2617726 A1,183-112-034-376-587,2007-02-15,2007,CA 2617726 A,2006-07-24,US 16145205 A;;US 2006/0028642 W,2005-08-03,DIFFERENTIAL INTERFEROMETRIC LIGHT MODULATOR AND IMAGE DISPLAY SYSTEM,,ALCES TECHNOLOGY INC,BLOOM DAVID M,,https://lens.org/183-112-034-376-587,Patent Application,no,0,0,8,8,0,G02F1/21;;G02F1/21;;G02B26/001;;G02B26/001;;G02B26/06;;G02B26/06;;G02B26/0841;;G02B26/0841;;G02B27/281;;G02B27/281,G02F1/01,,0,0,,,,DISCONTINUED
79,WO,A3,WO 2004/072052 A3,067-008-205-184-032,2004-11-11,2004,US 2004/0003725 W,2004-02-09,US 44660203 P,2003-02-11,ISOXASOLE-CONTAINING THIOUREA INHIBITORS USEFUL FOR TREATMENT OF VARICELLA ZOSTER VIRUS,"This invention provides a compound of the formula: (I), wherein X is (II), or (III), R1, R2, R3 and R4 are described in the specification and a pharmaceutical composition comprising the compound used for inhibiting replication of a herpes virus.",WYETH CORP;;BLOOM JONATHAN DAVID,BLOOM JONATHAN DAVID,,https://lens.org/067-008-205-184-032,Search Report,yes,2,0,4,4,0,C07D261/08;;C07D413/04;;C07D417/04;;A61P31/12;;C07D413/04;;C07D261/08;;C07D417/04,A61P31/12;;C07D261/08;;C07D413/04;;C07D417/04,,1,1,040-305-761-310-643,12551972;;10.1128/jvi.77.4.2349-2358.2003;;pmc141108,"VISALLI J R ET AL: ""Identification of Small Molecule Compounds That Selectively Inhibit Varicella-Zoster Virus Replication"", JOURNAL OF VIROLOGY, vol. 77, no. 4, February 2004 (2004-02-01), pages 2349 - 2358, XP002285183",PENDING
80,US,B2,US 7907338 B2,186-956-115-835-414,2011-03-15,2011,US 5347708 A,2008-03-21,US 5347708 A,2008-03-21,Microfabricated optical wave plate,"A microfabricated optical wave plate comprises a reflective polarizer and a mirror separated by a fixed or variable distance. The wave plate imparts a relative phase delay on polarization components of incident light, thereby transforming the overall polarization of the light.",ALCES TECHNOLOGY INC,BLOOM DAVID M,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2009-03-02),https://lens.org/186-956-115-835-414,Granted Patent,yes,21,1,3,3,0,G02B27/286;;G02B27/286,G02B27/28,359/486;;359/578;;359/847,2,0,,,"Written opinion of the international searching authority and international search report in application PCT/US2009/037623 mailed on Jul. 31, 2009.;;International Preliminary Report on Patentability issued on Sep. 21, 2010 for PCT/US2009/037623.",INACTIVE
81,US,A,US 6130770 A,184-568-988-356-423,2000-10-10,2000,US 10328598 A,1998-06-23,US 10328598 A,1998-06-23,Electron gun activated grating light valve,"A grating light valve is configured to either reflect or diffract an incident beam of light from a light source. Each grating light valve includes a plurality of deformable reflective ribbon structures. Preferably, the grating light valve is located within a vacuum chamber. A directable low power electron gun is also positioned within the chamber. To form an image the gun is scanned across an array of grating light valves and selectably irradiates predetermined ones of the ribbons to charge each such ribbon to a predetermined level. Depending upon the amount of charge so deposited onto the ribbon, it will deflect a predetermined distance toward an underlying substrate. The ribbons are preferably erased in one of two ways. According to the preferred embodiment, each ribbon includes a path of impedance to allow the charge to bleed into the substrate. The impedance is selected to discharge a fully charged ribbon in a period of a single frame. Alternatively, the electron gun can be used to generate high energy electrons. Upon impinging a ribbon a single high energy electron will cause the ribbon to emit more than one secondary electron. By applying a sufficient number of these high energy electrons, the charge on a ribbon can be removed.",SILICON LIGHT MACHINES INC,BLOOM DAVID M,SILICON LIGHT MACHINES CORPORATION (2008-06-23);;SILICON LIGHT MACHINES (1998-06-19),https://lens.org/184-568-988-356-423,Granted Patent,yes,100,33,1,1,0,G02B26/0808;;G02B26/0808;;Y10S359/90;;Y10S359/90,G02B26/08;;G02B27/44,359/224;;359/231;;359/290;;359/293;;359/572;;359/573;;359/900,24,15,049-400-534-653-649;;022-949-709-618-959;;020-669-540-688-441;;091-131-233-230-685;;052-574-007-284-544;;099-238-362-991-633;;031-674-958-708-951;;021-605-933-822-940;;063-135-548-145-71X;;009-286-199-765-581;;028-775-209-892-098;;009-365-280-210-861;;036-825-749-119-883;;052-055-696-490-751;;010-074-622-606-125,10.1021/bk-1997-0670.ch018;;10.1117/1.601346;;10.1117/1.602097;;10.1109/t-ed.1975.18217;;10.1063/1.88189;;10.1016/0030-4018(93)90662-o;;10.1364/ao.28.004826;;20555956;;10.1117/12.950001;;10.1109/isscc.1994.344701;;10.1109/5.53402;;10.1117/12.19865;;10.1016/0141-9382(91)90032-9;;10.1889/1.1984964;;19823336;;10.1364/ol.18.001214;;10.1364/ol.17.000688;;19794599,"Russick et al., Supercritical Carbon Dioxide Extraction of Solvent from Micromachined Structures, Supercritical Fluids, Chapter 18, pp 255 269, 1997.;;B u hler et al., Linear Array of Complementary Metal Oxide Semiconductor Double Pass Metal Micromirrors, Optical Engineering, vol. 36, No. 5, pp 1391 1398, May 1997.;;Gani et al., Variable Gratings for Optical Switching: Rigorous Electromagnetic Simulation and Design. Optical Engineering, vol. 38, No. 3, pp 552 557, Mar. 1999.;;R. N. Thomas, et al., The Mirror Matrix Tube: A Novel Light Valve for Projection Displays , IEEE Trans. Electron. Dev., vol. ED 22, No. 9, pp. 765 775, Sep. 1975.;;J. Guldberg, et al., An Aluminum/Sio2/Silicon on Sapphire Light Valve Matrix fro Projection Displays , Appl. Phy. Lett., vol. 26, No. 7, pp. 391 393, Apr. 1975.;;T. Iwai et al., Real time Profiling of a Pure Phase Object Using an Auto Wigner Distribution Function, Optics Communications, vol. 95, NoS. 4 6, Jan. 15, 1993, pp 199 204.;;R. Tepe, R. Gerhard Multhaupt, W. Brinker and W, D. Molzow, Viscoelastic Spatial Light Modulator with Active Matrix Addressing, Applied Optics, vol. 28, No. 22, New York, USA, pp.4826 4834, Nov. 15, 1989.;;W. Brinker, R. Gerhard Multhaupt, W, D. Molzow and R. Tepe,, Deformation Behavior of Thin Viscoelastic Layers Used in an Active Matrix Addressed Spatial Light Modulator, SPIE vol. 1018, pp. 79 85, Germany, 1988.;;T. Utsunomiya and H. Sato, Electrically Deformable Echellette Grating and its Application to Tunable Laser Resonator, Electronics and Communications in Japan, vol. 63 c, No. 10, pp. 94 110, Japan, 1980.;;C. Tew, L. Hornbeck, J. Lin, E. Chiu, K. Kornher, J. Conner, K. Komatsuzaki and P. Urbanus, Electronic Control of a Digital Micromirror Device for Projection Displays, TAM 7.5, USA.;;R. Apte, F. Sandejas, W. Banyai, D. Bloom, Grating Light Valves For High Resolution Displays , Ginzton Laboratories, Stanford University, Stanford, CA 94305 4085, Jun., 1994, Report No. 5192.;;R. Apte, et al. Grating Light Valves For High Resolution Displays, Jun., 1994, Ginzton Laboratories, Stanford Univ., CA.;;O. Solgaard, Integrated Semiconductor Light Modulators For Fiber Optic And Display Applications, Feb., 1992.;;J. Neff, Two Dimensional Spatial Light Modulators: A Tutorial , Proceedings of the IEEE, vol. 78, No. 5, pp. 826 855, May, 1990.;;Gerhard Multhaupt, Viscoelastic Spatial Light Modulators and Schlieren Optical Systems for HDTV Projection Displays , SPIE vol. 1255 Large Screen Projection Displays II, pp. 69 78, 1990.;;Gerhard Multhaupt, Light Valve Technologies for High Definition Television Projection Displays , vol. 12, No. 3/4, pp. 115 128, 1991.;;Alvelda et al., Ferroelectric Microdisplays Using Distortion Compensated Pixel Layouts, SID 95 Digest, pp. 931 933, 1995.;;Phillip Alvelda, High Efficiency Color Microdisplays, SID 95 Digest, pp. 307 311, 1995.;;Worboys et al., Miniature Display Technology for Integrated Helmut Systems, GEC Journal of Research, vol. 10, No. 2, pp. 111 118, 1993.;;Farn et al., Color Separation by use of Binary Optics, Optics Letters, vol. 18:15, pp. 1214 1216, 1993.;;Phillip Alvelda, VLSI Microdisplays and Optoelectric Technology, MIT, pp. 1 93, 1995.;;Phillip Alvelda, VLSI Microdisplay Technology, Oct. 14, 1994.;;F. Sandejas, R. Apte, W. Banyai, D. Bloom, Surface Microfabrication of Deformable Grating Light Valves For High Resolution Displays, The 7th International Conference on Solid State Sensors and Actuators, pp. 6 & 7, (no date).;;O.Solgaard, F. Sandejas, and D. Bloom, Deformable Grating Optical Modulator, Optics letters, vol. 17, No. 9, New York, USA, pp. 688 690, May 1, 1992.",EXPIRED
82,US,A,US 5771838 A,117-730-629-865-843,1998-06-30,1998,US 63255396 A,1996-04-15,US 63255396 A,1996-04-15,Bird feeder with feed recapture reservoir,"A bird feeder for recapturing bird feed for re-use, the bird feeder including a feed reservoir for receiving bird feed and having a feeder opening, a trough coupled to the feed reservoir at the feed opening for receiving feed from the feed reservoir, and a recapture reservoir coupled to the feed reservoir for receiving and collecting uncontaminated bird feed displaced from the trough.",BLOOM; DAVID SCOTT;;BLOOM; MICHAEL ANDREW;;BLOOM; DRUCELLA ANN;;BLOOM; TIMOTHY K.,BLOOM DAVID SCOTT;;BLOOM MICHAEL ANDREW;;BLOOM DRUCELLA ANN;;BLOOM TIMOTHY K,,https://lens.org/117-730-629-865-843,Granted Patent,yes,6,23,1,1,0,A01K39/012;;A01K39/012,A01K39/012,119/52.2;;119/464;;119/469;;119/477,0,0,,,,EXPIRED
83,US,S,US D0373226 S,036-564-143-990-604,1996-08-27,1996,US 2099594 F,1994-04-06,US 2099594 F,1994-04-06,Combined multi-chute bird feeder with recapture bin,,BLOOM DAVID S;;BLOOM MICHAEL A;;BLOOM DRUCELLA A;;BLOOM TIMOTHY K,BLOOM DAVID S;;BLOOM MICHAEL A;;BLOOM DRUCELLA A;;BLOOM TIMOTHY K,,https://lens.org/036-564-143-990-604,Design Right,yes,9,1,1,1,0,,,D30/124,3,0,,,"Hagerstrom Handcrafted Metal Ornaments Brochure; May 25, 1954; p. 21; Swing Feeder, No. 251.;;Blarney Woolen Mills Company Catalog; #152601 Wild Bird Window Habitat.;;Winterthur Fall 1990 Catalog; p. 26; #986 Bird Feeder.",EXPIRED
84,US,A1,US 2011/0016497 A1,027-309-199-441-810,2011-01-20,2011,US 50355109 A,2009-07-15,US 50355109 A,2009-07-15,Immersive Vehicle Multimedia System,"The invention relates to an immersive vehicle multimedia system that that is affected by vehicle sensors and collected data concerning environmental. The immersive vehicle multimedia system includes a vehicle, at least one sensor or other vehicle component gathering input as data from an external and internal vehicle environment, an immersive multimedia device connected to each sensor, and media content run through the multimedia device. The media content includes a primary script and a secondary script, the secondary script depending on the gathered input.",BLOOM DAVID;;ZABEL JEFF,BLOOM DAVID;;ZABEL JEFF,BAYERISCHE MOTOREN WERKE AKTIENGESELLSCHAFT (2009-07-13),https://lens.org/027-309-199-441-810,Patent Application,yes,11,15,2,2,0,B60K35/00;;B60K35/00;;H04N7/18;;H04N7/18;;H04N21/41422;;H04N21/41422,H04N7/18,725/75,0,0,,,,ACTIVE
85,US,A1,US 2019/0169680 A1,025-981-663-070-471,2019-06-06,2019,US 201716323203 A,2017-08-04,US 201716323203 A;;US 201662370817 P;;US 2017/0045608 W,2016-08-04,COMPOSITIONS AND METHODS FOR MEASURING BACTERIAL GROWTH,"The invention disclosed herein relates generally to the fields of microbiology, ecology and microfluidics. Particularly, the invention disclosed herein provides compositions and methods for isolating bacteria from complex microbial communities and measuring growth rates of the isolated bacteria in a given environmental condition.",UNIV DUKE,DAVID LAWRENCE;;BLOOM RACHAEL,DUKE UNIVERSITY (2019-03-28),https://lens.org/025-981-663-070-471,Patent Application,yes,0,1,4,4,2,C12Q1/04;;G01N33/56911;;C12Q1/689;;G01N33/56911;;C12Q1/04;;C12Q1/689;;C12Q1/06;;C12Q1/6851;;C12Q1/6853;;C12Q2531/113;;C12Q2600/158;;G01N1/28,C12Q1/689;;C12Q1/06;;C12Q1/6851;;C12Q1/6853;;G01N1/28,,0,0,,,,ACTIVE
86,US,B2,US 8947253 B2,001-541-024-275-93X,2015-02-03,2015,US 50355109 A,2009-07-15,US 50355109 A,2009-07-15,Immersive vehicle multimedia system,"The invention relates to an immersive vehicle multimedia system that that is affected by vehicle sensors and collected data concerning environmental. The immersive vehicle multimedia system includes a vehicle, at least one sensor or other vehicle component gathering input as data from an external and internal vehicle environment, an immersive multimedia device connected to each sensor, and media content run through the multimedia device. The media content includes a primary script and a secondary script, the secondary script depending on the gathered input.",BLOOM DAVID;;ZABEL JEFF;;BAYERISCHE MOTOREN WERKE AG,BLOOM DAVID;;ZABEL JEFF,BAYERISCHE MOTOREN WERKE AKTIENGESELLSCHAFT (2009-07-13),https://lens.org/001-541-024-275-93X,Granted Patent,yes,11,2,2,2,0,B60K35/00;;B60K35/00;;H04N7/18;;H04N7/18;;H04N21/41422;;H04N21/41422,H04N7/18;;B60K35/00;;H04N21/414,340/691.1;;340/438;;340/439;;340/440;;340/441;;340/5.64;;340/541;;701/124;;725/75;;710/124;;463/31;;463/37;;463/42;;358/426.02;;273/317,0,0,,,,ACTIVE
87,US,B2,US 11313000 B2,054-912-950-831-539,2022-04-26,2022,US 201716323203 A,2017-08-04,US 201716323203 A;;US 201662370817 P;;US 2017/0045608 W,2016-08-04,Compositions and methods for measuring bacterial growth,"The invention disclosed herein relates generally to the fields of microbiology, ecology and microfluidics. Particularly, the invention disclosed herein provides compositions and methods for isolating bacteria from complex microbial communities and measuring growth rates of the isolated bacteria in a given environmental condition.",UNIV DUKE,DAVID LAWRENCE;;BLOOM RACHAEL,DUKE UNIVERSITY (2019-03-28),https://lens.org/054-912-950-831-539,Granted Patent,yes,8,0,4,4,2,C12Q1/04;;G01N33/56911;;C12Q1/689;;G01N33/56911;;C12Q1/04;;C12Q1/689;;C12Q1/06;;C12Q1/6851;;C12Q1/6853;;C12Q2531/113;;C12Q2600/158;;G01N1/28,C12Q1/689;;C12Q1/04;;C12Q1/06;;C12Q1/6851;;C12Q1/6853;;G01N1/28;;G01N33/569,,23,20,066-734-590-976-959;;020-839-164-087-755;;023-717-486-286-101;;020-231-548-339-397;;042-163-050-641-376;;075-156-312-025-250;;064-627-437-074-071;;037-640-128-205-178;;000-811-948-275-375;;025-578-130-700-602;;079-021-676-652-340;;026-600-462-858-814;;001-356-804-848-765;;123-223-907-183-713;;053-478-016-598-47X;;058-081-611-640-165;;016-713-134-019-438;;068-646-991-287-372;;026-853-767-097-273;;017-947-493-441-284,27033300;;10.1039/c6lc00180g;;10.1073/pnas.1308523110;;23940318;;pmc3761572;;10.1126/science.1219385;;22955834;;pmc4164201;;10.1016/j.cell.2014.08.032;;25215495;;10.1126/science.1110591;;15831718;;pmc1395357;;11462219;;10.1002/bies.1091;;1444252;;10.1146/annurev.mi.46.100192.001041;;22009990;;pmc3266036;;10.1101/gr.126573.111;;17183309;;10.1038/4441022a;;16497592;;10.1016/j.cell.2006.02.017;;10.1287/isre.2014.0517;;10.1371/journal.pone.0053957;;23349773;;pmc3547972;;pmc2849220;;10.1128/aem.01754-09;;20173072;;10.1073/pnas.0913554107;;pmc2889069;;20435915;;pmc2937523;;10.1128/mmbr.00014-10;;20805407;;18242222;;10.1053/j.gastro.2007.11.059;;17183312;;10.1038/nature05414;;pmc2677729;;10.1038/nature07540;;19043404;;pmc3201933;;22039352;;10.1371/journal.pbio.1001184;;10.1128/aem.05276-11;;pmc3255609;;22020503,"Martin, M.J. et al. Innovative Food Science and Emerging Technologies 27:15-25 (2015; online Oct. 17, 2014). (Year: 2014).;;Liu, X. et al. Lab Chip 16:1636 (Apr. 2016). (Year: 2016).;;Eun, Y-J. et al. ACS Chem. Biol. 6:260 (Dec. 2010). (Year: 2010).;;International Search Report PCT/US2017/045608, dated Oct. 27, 2017.;;Bachmann, et al., “Availability of public goods shapes the evolution of competing metabolic strategies,” PNAS, 2013, 110(35):14302-7.;;Cordero, et al, “Ecological Populations of Bacteria Act as Socially Cohesive Units of Antibiotic Production and Resistance,” Science, vol. 337, 1228-1231, 2012.;;Donia, Cimermancic, et al., “A Systematic Analysis of Biosynthetic Gene Clusters in the Human Microbiome Reveals a Common Family of Antibiotics,” Cell 158, 1402-1414, Sep. 11, 2014.;;Eckburg, Bik, et al, “Diversity of the Human Intestinal Microbial Flora,” 2005 Science, vol. 308, 1635-1638.;;Koch, “Oligotrophs versus copiotrophs,” 2001 BioEssays, 23(7): 657-661.;;Kolter and Moreno “Genetics of Ribosomally Synthesized Peptide Antibiotics,” Annu. Rev. Microbiol. 1992. 46:141-63.;;Kostic, Gevers et al. “Genomic analysis identifies association of Fusobacterium with colorectal carcinoma,” 2012, Genome Research,22:292-298.;;Ley, et al., “Human gut microbes associated with obesity,” Nature , vol. 444, Dec. 2006, pp. 1022-1023.;;Ley, et al.“Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine,” Cell 124, 837-848, Feb. 24, 2006.;;Ma, et al., “Online Gambling Behavior: The Impacts of Cumulative Outcomes, Recent Outcomes, and Prior Use,” Information Systems Research vol. 25, No. 3, Sep. 2014, pp. 511-527.;;Maltby, et al, “Nutritional Basis for Colonization Resistance by Human Commensal Escherichia coli Strains HS and Nissle 1917 against E. coli O157:H7 in the Mouse Intestine,” PLoS ONE 8(1): e53957. doi:10.1371/journal. pone.0053957, 2013.;;Nichols, et al., “Use of Ichip for High-Throughput In Situ Cultivation of “Uncultivable” Microbial Species,” Applied and Environmental Microbiology, Apr. 2010, p. 2445-2450 vol. 76, No. 8.;;Rea, et al., “Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile,” PNAS, 107(20): 9352-9357, May 2010.;;Robinson, et al. “From Structure to Function: the Ecology of Host-Associated Microbial Communities,” Microbiology and Molecular Biology Reviews, Sep. 2010, p. 453-476 vol. 74, No. 3.;;Sartor “Microbial Influences in Inflammatory Bowel Diseases,” GASTROENTEROLOGY 2008;134:577-594.;;Tumbaugh, Ley et al.“An obesity-associated gut microbiome with increased capacity for energy harvest,” Nature, vol. 444, Dec. 2006, doi:10.1038/nature05414.;;Turnbaugh, et al., “A core gut microbiome in obese and lean twins,” Nature, vol. 457, Jan. 2009, doi: 10.1038/nature075402009.;;Vetsigian, “Structure and Evolution of Streptomyces Interaction Networks in Soil and In Silico,” 2011 PLoS Biol 9(10): e1001184.;;Goel et al., “Standardized Assay Medium To Measure Lactococcus lactis Enzyme Activities while Mimicking Intracellular Conditions,” Appl Evbiron Microbiol, 2012, 78(1): 134-143.",ACTIVE
88,US,B1,US 6532746 B1,137-513-093-106-711,2003-03-18,2003,US 5724602 A,2002-01-24,US 5724602 A,2002-01-24,Method and apparatus for securing an electronic component,"
    A securing apparatus is used to secure an electronic component, such as a thermoelectric cooler in a thermoelectric cooling system. The securing apparatus includes a clamping mechanism that clamps the electronic component between a first plate, such as a heat sink plate, and a second plate, such as a mounting plate. The clamping mechanism applies compression forces to the electronic component to secure the electronic component without using shear forces capable of damaging the electronic component. The clamping mechanism preferably provides thermal isolation between the heat sink plate and the mounting plate. 
",TYCO TELECOMM US INC,BLOOM ELIOT;;MAXHAM DAVID,TYCO TELECOMMUNICATIONS (US) INC (2002-01-10),https://lens.org/137-513-093-106-711,Granted Patent,yes,6,12,1,1,0,F25B21/02;;F25B21/02;;H01L23/38;;H01L23/38;;H01L23/4093;;H01L23/4093;;H01L2924/0002;;H01L2924/0002,F25B21/02;;H01L23/38;;H01L23/40,62/3.7;;62/3.2,0,0,,,,EXPIRED
89,WO,A1,WO 2018/027185 A1,186-060-297-114-420,2018-02-08,2018,US 2017/0045608 W,2017-08-04,US 201662370817 P,2016-08-04,COMPOSITIONS AND METHODS FOR MEASURING BACTERIAL GROWTH,"The invention disclosed herein relates generally to the fields of microbiology, ecology and microfluidics. Particularly, the invention disclosed herein provides compositions and methods for isolating bacteria from complex microbial communities and measuring growth rates of the isolated bacteria in a given environmental condition.",UNIV DUKE,DAVID LAWRENCE;;BLOOM RACHAEL,,https://lens.org/186-060-297-114-420,Patent Application,yes,5,2,4,4,2,C12Q1/04;;G01N33/56911;;C12Q1/689;;G01N33/56911;;C12Q1/04;;C12Q1/689;;C12Q1/06;;C12Q1/6851;;C12Q1/6853;;C12Q2531/113;;C12Q2600/158;;G01N1/28,A61K35/66;;A61K35/74;;C12Q1/02;;C12Q1/68;;G01N1/28,,0,0,,,,PENDING
90,US,A1,US 2022/0205021 A1,056-165-829-183-679,2022-06-30,2022,US 202217697231 A,2022-03-17,US 202217697231 A;;US 201916323203 A;;US 2017/0045608 W;;US 201662370817 P,2016-08-04,Compositions and Methods for Measuring Bacterial Growth,"The invention disclosed herein relates generally to the fields of microbiology, ecology and microfluidics. Particularly, the invention disclosed herein provides compositions and methods for isolating bacteria from complex microbial communities and measuring growth rates of the isolated bacteria in a given environmental condition.",UNIV DUKE,DAVID LAWRENCE;;BLOOM RACHAEL,,https://lens.org/056-165-829-183-679,Patent Application,yes,0,0,4,4,2,C12Q1/04;;G01N33/56911;;C12Q1/689;;G01N33/56911;;C12Q1/04;;C12Q1/689;;C12Q1/06;;C12Q1/6851;;C12Q1/6853;;C12Q2531/113;;C12Q2600/158;;G01N1/28,C12Q1/04;;C12Q1/689;;C12Q1/06;;C12Q1/6851;;C12Q1/6853;;G01N1/28;;G01N33/569,,0,0,,,,PENDING
91,US,B2,US 7836518 B2,190-872-967-104-650,2010-11-23,2010,US 62530709 A,2009-11-24,US 62530709 A;;GB 0401854 A;;US 49478906 A;;GB 2005000301 W,2004-01-28,Protective bib or apron,An apron for use by dentists and the like is provided with a main body portion and a collar portion for securing the apron to the wearer in which the collar portion is adjustably securable at any position within a predetermined range such that it forms a close fit around the wearer wherein the collar and body portions comprise an absorbent side and a substantially waterproof.,BLOOM DAVID RICHARD;;BLOOM CLAUDINE NICOLA;;PADAYACHY JAYSEELAN NADASEN,BLOOM DAVID RICHARD;;BLOOM CLAUDINE NICOLA;;PADAYACHY JAYSEELAN NADASEN,,https://lens.org/190-872-967-104-650,Granted Patent,yes,37,4,16,16,0,A41B13/10;;A41B2400/52;;A41B13/10;;A41B2400/52,A41D13/04;;A41B13/10,2/50;;2/48,0,0,,,,INACTIVE
92,US,A1,US 2007/0022509 A1,113-336-094-405-814,2007-02-01,2007,US 49478906 A,2006-07-27,GB 0401854 A;;GB 2005000301 W,2004-01-28,Protective bib or apron,An apron for use by dentists and the like is provided with a main body portion and a collar portion for securing the apron to the wearer in which the collar portion is adjustably securable at any position within a predetermined range such that it forms a close fit around the wearer wherein the collar and body portions comprise an absorbent side and a substantially waterproof.,BLOOM DAVID R;;BLOOM CLAUDINE N;;PADAYACHY JAYSEELAN N,BLOOM DAVID R;;BLOOM CLAUDINE N;;PADAYACHY JAYSEELAN N,,https://lens.org/113-336-094-405-814,Patent Application,yes,40,9,16,16,0,A41B13/10;;A41B2400/52;;A41B13/10;;A41B2400/52,A41B13/00;;A41B13/10,2/49.1,0,0,,,,DISCONTINUED
93,US,A1,US 2010/0132088 A1,158-325-890-367-74X,2010-06-03,2010,US 62530709 A,2009-11-24,US 62530709 A;;GB 0401854 A;;US 49478906 A;;GB 2005000301 W,2004-01-28,PROTECTIVE BIB OR APRON,An apron for use by dentists and the like is provided with a main body portion and a collar portion for securing the apron to the wearer in which the collar portion is adjustably securable at any position within a predetermined range such that it forms a close fit around the wearer wherein the collar and body portions comprise an absorbent side and a substantially waterproof.,BLOOM DAVID RICHARD;;BLOOM CLAUDINE NICOLA;;PADAYACHY JAYSEELAN NADASEN,BLOOM DAVID RICHARD;;BLOOM CLAUDINE NICOLA;;PADAYACHY JAYSEELAN NADASEN,,https://lens.org/158-325-890-367-74X,Patent Application,yes,0,5,16,16,0,A41B13/10;;A41B2400/52;;A41B13/10;;A41B2400/52,A41B13/00;;A41B13/10,2/49.1,0,0,,,,INACTIVE
94,CA,A1,CA 2335584 A1,003-061-166-531-062,1999-12-29,1999,CA 2335584 A,1999-06-18,US 10415998 A;;US 9913955 W,1998-06-24,METHOD AND APPARATUS FOR MODULATING AN INCIDENT LIGHT BEAM FOR FORMING A TWO-DIMENSIONAL IMAGE,"An apparatus and method for modulating an incident light beam for forming a two-dimensional projection image. The apparatus includes a plurality of elongated elements each having a reflective surface. These are suspended parallel to each other above a substrate with their respective ends supporte d, forming a column of adjacent reflecting surfaces grouped according to displa y elements. Alternate ones of each group are deformable by applying a voltage with respect to the substrate. An approximately flat center section of each deformed element is substantially parallel to and a predetermined distance from a center section of each undeformed element. A light beam incident to t he column of adjacent reflecting surfaces is reflected from a group of elongate d elements when the alternate ones are undeformed and diffracted when the alternate ones are deformed. A distance of movement is controlled or a ratio of between reflection and diffraction periods determines a display intensity for the corresponding display element.",SILICON LIGHT MACHINES INC,BLOOM DAVID M;;GODIL ASIF,,https://lens.org/003-061-166-531-062,Patent Application,no,0,0,13,13,0,G02B5/1828;;G02B26/0808;;G02B26/0808;;G02B5/1828;;G02B26/0808;;G02B5/1828,G02B5/18;;G02B26/08,,0,0,,,,DISCONTINUED
95,WO,A3,WO 1997/026569 A3,025-308-858-395-778,1997-07-24,1997,US US9700854,1997-01-17,"US 8/591,231",1996-01-18,METHOD AND APPARATUS FOR USING AN ARRAY OF GRATING LIGHT VALVES TO PRODUCE MULTICOLOR OPTICAL IMAGES,"A multicolor optical image-generating device comprised of an array of grating light valves (GLVs) organized to form light-modulating pixel units for spatially modulating incident rays of light. The pixel units are comprised of three subpixel components each including a plurality of elongated, equally spaced apart reflective grating elements arranged parallel to each other with their light-reflective surfaces also parallel to each other. Each subpixel component includes means for supporting the grating elements in relation to one another, and means for moving alternate elements relative to the other elements and between a first configuration wherein the component acts to reflect incident rays of light as a plane mirror, and a second configuration wherein the component diffracts the incident rays of light as they are reflected from the grating elements. The three subpixel components of each pixel unit are designed such that when red, green and blue light sources are trained on the array, colored light diffracted by particular subpixel components operating in the second configuration will be directed through a viewing aperture, and light simply reflected from particular subpixel components operating in the first configuration will not be directed through the viewing aperture.",THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY,"BLOOM, David, M.;;HUIBERS, Andrew",,https://lens.org/025-308-858-395-778,Search Report,yes,0,0,1,1,0,,G02B5/18;;G02B26/08,,0,0,,,,UNKNOWN
96,CA,A,CA 562045 A,031-595-424-135-831,1958-08-19,1958,CA 562045D A,,CA 562045T A,,RECOVERY OF CHLORONITROBENZENE,,GEN ANILINE & FILM CORP,BLOOM ALBERT;;GRAHAM DAVID E,,https://lens.org/031-595-424-135-831,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
97,US,B2,US 8368984 B2,060-300-651-378-770,2013-02-05,2013,US 91007210 A,2010-10-22,US 91007210 A,2010-10-22,Pseudo bipolar MEMS ribbon drive,A pseudo bipolar method for driving a MEMS ribbon device reduces charging effects in the device.,ALCES TECHNOLOGY INC;;YEH RICHARD;;BLOOM DAVID M,YEH RICHARD;;BLOOM DAVID M,ALCES TECHNOLGY INC (2011-06-01);;MANTISVISION LTD (2018-04-06),https://lens.org/060-300-651-378-770,Granted Patent,yes,1,0,2,2,0,G09G3/3433;;G09G2310/061;;G09G3/3433;;G09G2310/061,G02B26/00;;G02B26/08,359/199.2;;359/200.6;;359/290;;359/900,0,0,,,,ACTIVE
98,WO,A2,WO 2010/090901 A2,059-986-996-782-668,2010-08-12,2010,US 2010/0022039 W,2010-01-26,US 14980209 P,2009-02-04,INCORPORATION OF BIOLOGICALLY DERIVED CARBON INTO PETROLEUM PRODUCTS,Petroleum products comprising biologically based carbon are provided. A biologically based surfactant is added to petroleum and an emulsion composition having lower viscosity than the petroleum is formed. The petroleum is subjected to processing and the surfactant is co-processed with the petroleum to provide petroleum products comprising biologically based carbon.,ARCHER DANIELS MIDLAND CO;;BLOOM PAUL DAVID;;BLOOMER SCOTT,BLOOM PAUL DAVID;;BLOOMER SCOTT,,https://lens.org/059-986-996-782-668,Patent Application,yes,0,3,3,3,0,C10L1/026;;C10L1/026;;C10G33/00;;C10G33/00;;C10L1/1608;;C10L1/1608;;C10L1/1691;;C10L1/1691;;C10L1/1817;;C10L1/1817;;C10L1/188;;C10L1/188;;C10L1/1983;;C10L1/1983;;C10L1/1985;;C10L1/1985;;Y02E50/10;;Y02E50/10;;Y02T50/678;;Y02T50/678,C10L1/32;;C10L1/08,,0,0,,,,PENDING
99,US,A1,US 2012/0099171 A1,134-121-087-678-148,2012-04-26,2012,US 91007210 A,2010-10-22,US 91007210 A,2010-10-22,Pseudo Bipolar MEMS Ribbon Drive,A pseudo bipolar method for driving a MEMS ribbon device reduces charging effects in the device.,YEH RICHARD;;BLOOM DAVID M;;ALCES TECHNOLOGY INC,YEH RICHARD;;BLOOM DAVID M,ALCES TECHNOLGY INC (2011-06-01);;MANTISVISION LTD (2018-04-06),https://lens.org/134-121-087-678-148,Patent Application,yes,1,4,2,2,0,G09G3/3433;;G09G2310/061;;G09G3/3433;;G09G2310/061,G02B26/02,359/231,0,0,,,,ACTIVE
100,WO,A3,WO 2010/090901 A3,158-726-205-921-886,2010-11-18,2010,US 2010/0022039 W,2010-01-26,US 14980209 P,2009-02-04,INCORPORATION OF BIOLOGICALLY DERIVED CARBON INTO PETROLEUM PRODUCTS,Petroleum products comprising biologically based carbon are provided. A biologically based surfactant is added to petroleum and an emulsion composition having lower viscosity than the petroleum is formed. The petroleum is subjected to processing and the surfactant is co-processed with the petroleum to provide petroleum products comprising biologically based carbon.,ARCHER DANIELS MIDLAND CO;;BLOOM PAUL DAVID;;BLOOMER SCOTT,BLOOM PAUL DAVID;;BLOOMER SCOTT,,https://lens.org/158-726-205-921-886,Search Report,yes,5,0,3,3,0,C10L1/026;;C10L1/026;;C10G33/00;;C10G33/00;;C10L1/1608;;C10L1/1608;;C10L1/1691;;C10L1/1691;;C10L1/1817;;C10L1/1817;;C10L1/188;;C10L1/188;;C10L1/1983;;C10L1/1983;;C10L1/1985;;C10L1/1985;;Y02E50/10;;Y02E50/10;;Y02T50/678;;Y02T50/678,C10L1/32;;C10L1/08,,0,0,,,,PENDING
101,AT,T1,AT E217094 T1,113-844-994-077-036,2002-05-15,2002,AT 97904813 T,1997-01-17,US 59123196 A;;US 9700854 W,1996-01-18,VERFAHREN UND GERÄT ZUR ERZEUGUNG OPTISCHE FARBBILDER MITTELS EINES GITTER-LICHTVENTILARRAYS,"A modulator for modulating incident rays of light, the modulator having a plurality of equally spaced apart elements, each of which includes a light reflective planar surface. The elements are arranged parallel to each other with their light reflective surfaces parallel to each other. The modulator includes means for supporting elements in relation to one another and means for moving particular ones of the elements relative to others so that the moved elements transit between a first configuration wherein the modulator acts to reflect the incident rays of light as a plane mirror, and a second configuration wherein the modulator diffracts the light reflected therefrom. In operation, the light reflective surfaces of the elements remain parallel to each other in both the first and the second configurations. The perpendicular spacing between the reflective surfaces of respective elements is equal to m/4 times the wavelength of the incident rays of light, wherein m=an even whole number or zero when the elements are in the first configuration and m=an odd whole number when the elements are in the second configuration.",UNIV LELAND STANFORD JUNIOR,BLOOM DAVID M;;HUIBERS ANDREW,,https://lens.org/113-844-994-077-036,Granted Patent,no,0,0,13,13,0,B81C2201/115;;G02B5/1828;;G02B26/0808;;B81B3/001;;B81B3/001;;B81C2201/115;;G02B5/1828;;G02B26/0808,B81B3/00;;G02B5/18;;G02B26/08,,0,0,,,,DISCONTINUED
102,WO,A1,WO 1999/067671 A1,046-667-626-512-521,1999-12-29,1999,US 9913955 W,1999-06-18,US 10415998 A,1998-06-24,METHOD AND APPARATUS FOR MODULATING AN INCIDENT LIGHT BEAM FOR FORMING A TWO-DIMENSIONAL IMAGE,"An apparatus and method for modulating an incident light beam for forming a two-dimensional projection image. The apparatus includes a plurality of elongated elements each having a reflective surface. These are suspended parallel to each other above a substrate with their respective ends supported, forming a column of adjacent reflecting surfaces grouped according to display elements. Alternate ones of each group are deformable by applying a voltage with respect to the substrate. An approximately flat center section of each deformed element is substantially parallel to and a predetermined distance from a center section of each undeformed element. A light beam incident to the column of adjacent reflecting surfaces is reflected from a group of elongated elements when the alternate ones are undeformed and diffracted when the alternate ones are deformed. A distance of movement is controlled or a ratio of between reflection and diffraction periods determines a display intensity for the corresponding display element.",SILICON LIGHT MACHINES INC,BLOOM DAVID M;;GODIL ASIF,,https://lens.org/046-667-626-512-521,Patent Application,yes,4,12,13,13,0,G02B5/1828;;G02B26/0808;;G02B26/0808;;G02B5/1828;;G02B26/0808;;G02B5/1828,G02B5/18;;G02B26/08,,2,1,154-800-944-637-210,10.1117/12.962188,"HORNBECK L J: ""DEFORMABLE-MIRROR SPATIAL LIGHT MODULATORS"", SPATIAL LIGHT MODULATORS AND APPLICATIONS III, 7-8 AUGUST 1989, SAN DIEGO, vol. 1150, 7 August 1989 (1989-08-07), pages 86 - 102, XP000351394;;ROWE D P ET AL: ""LASER BEAM SCANNING"", PROCEEDINGS OF THE SPIE, vol. 2088, 5 October 1993 (1993-10-05), pages 18 - 26, XP000614108",PATENTED
103,US,A,US 2795621 A,066-590-604-129-33X,1957-06-11,1957,US 40137253 A,1953-12-30,US 40137253 A,1953-12-30,Recovery of chloronitrobenzenes,,GEN ANILINE & FILM CORP,ALBERT BLOOM;;GRAHAM DAVID E,,https://lens.org/066-590-604-129-33X,Granted Patent,no,2,3,1,1,0,C07C201/16;;C07C201/12;;C07C201/16;;C07C201/12,C07C201/16,,0,0,,,,EXPIRED
104,EP,A4,EP 2084747 A4,079-738-589-260-670,2012-05-30,2012,EP 07864561 A,2007-11-16,US 2007/0085022 W;;US 60208706 A,2006-11-20,MONOLITHIC IC AND MEMS MICROFABRICATION PROCESS,,ALCES TECHNOLOGY INC,YEH RICHARD;;BLOOM DAVID M,,https://lens.org/079-738-589-260-670,Search Report,no,2,0,9,9,0,B81C1/00246;;B81C2203/0742;;H01L27/06;;H01L27/06;;B81C2203/0742;;B81C1/00246,B81C1/00,,4,1,096-659-995-745-981,10.1109/84.709646,"BROSRIHAN T J ET AL: ""Optical IMEMS- a fabrication process for mems optical switches with integrated on-chip electronics"", TRANSDUCERS, SOLID-STATE SENSORS, ACTUATORS AND MICROSYSTEMS, 12TH INN ATIONAL CONFERENCE ON, 2003, PISCATAWAY, NJ, USA,IEEE, vol. 2, 9 June 2003 (2003-06-09), pages 1638 - 1642, XP010647532, ISBN: 978-0-7803-7731-8;;JIN X ET AL: ""The microfabrication of capacitive ultrasonic transducers"", JOURNAL OF MICROELECTROMECHANICAL SYSTEMS, IEEE SERVICE CENTER, US, vol. 7, no. 3, 3 September 1998 (1998-09-03), pages 295 - 301, XP002976182, ISSN: 1057-7157, DOI: 10.1109/84.709646;;BLOOM ET AL: ""The Grating light valve: revolutionizing display technology"", PROCEEDINGS OF SPIE, SPIE, US, vol. 3013, 1 February 1997 (1997-02-01), pages 165 - 171, XP009018300, ISSN: 0277-786X, DOI: 10.1117/12.273868;;See also references of WO 2008064135A1",DISCONTINUED
105,CA,A1,CA 2667742 A1,149-198-451-992-10X,2008-05-29,2008,CA 2667742 A,2007-11-16,US 60208706 A;;US 2007/0085022 W,2006-11-20,MONOLITHIC IC AND MEMS MICROFABRICATION PROCESS,Monolithic IC/MEMS processes are disclosed in which high-stress silicon n itride is used as a mechanical material while amorphous silicon serves as a sacrificial layer. Electronic circuits and micro-electromechanical devices a re built on separate areas of a single wafer. The sequence of IC and MEMS pr ocess steps is designed to prevent alteration of partially completed circuit s and devices by subsequent high process temperatures.,ALCES TECHNOLOGY INC,YEH RICHARD;;BLOOM DAVID M,,https://lens.org/149-198-451-992-10X,Patent Application,no,0,0,9,9,0,B81C1/00246;;B81C2203/0742;;H01L27/06;;H01L27/06;;B81C2203/0742;;B81C1/00246,H01L29/00,,0,0,,,,DISCONTINUED
106,US,B1,US 11280872 B1,022-007-065-946-594,2022-03-22,2022,US 202016781387 A,2020-02-04,US 202016781387 A;;US 201962869219 P;;US 201962801088 P,2019-02-04,Location tracking using one or more beacons,"A location tracking system using encoded light beams emitted from a stationary beacon and a receiver mounted onto an object within a three-dimensional (3D) space within the field of view of the stationary beacon. The receiver receives and processes the encoded light beams from two or more stationary beacons. The receiver is configured to decode information from the received light beams and to calculate the position of the object within the 3D space over a span of several meters, with resolution in the range of a few mm or cm. The receiver location is calculated as a single point at the intersection of three light beam or angular planes. A typical configuration of one-dimensional array beacon consists of a plurality of light sources mounted on a cylindrical curved surface of a particular radius. A vertical apodizing slit placed at the center of the circular curve limits the horizontal angular profile of encoded light beams as can be seen or received by the receiver in the far field to roughly 1-5 encoded light beams at a time. Each light source emits a light beam encoded with a unique code that allows the receiver to identify the light source that emitted the light beam. Certain signal processing techniques allow the receiver to detect, process, and decode information from the light beam including light intensity profile of each received light beam. This information is used by the receiver to infer a point where the receiver is located at the intersection of three angular planes where it is located relative to the beacons, and thus the location of the object is fully determined in 3D space.",SEE XYZ INC,GODIL ASIF;;BLOOM DAVID M,SEE XYZ INC (2021-10-20);;AG MICROSYSTEMS (2022-12-08),https://lens.org/022-007-065-946-594,Granted Patent,yes,8,3,1,1,0,G01S1/7038;;G01S1/7032;;G01S3/782;;G01S5/16;;G01S1/7038,G01S1/70,,0,0,,,,ACTIVE
107,US,A1,US 2011/0084343 A1,026-954-094-559-594,2011-04-14,2011,US 96859410 A,2010-12-15,US 96859410 A;;US 60208706 A,2006-11-20,Monolithic IC and MEMS microfabrication process,Monolithic IC/MEMS processes are disclosed in which high-stress silicon nitride is used as a mechanical material while amorphous silicon serves as a sacrificial layer. Electronic circuits and micro-electromechanical devices are built on separate areas of a single wafer. The sequence of IC and MEMS process steps is designed to prevent alteration of partially completed circuits and devices by subsequent high process temperatures.,ALCES TECHNOLOGY INC,YEH RICHARD;;BLOOM DAVID M,ALCES TECHNOLGY INC (2011-06-01);;MANTISVISION LTD (2018-04-06),https://lens.org/026-954-094-559-594,Patent Application,yes,18,0,9,9,0,B81C1/00246;;B81C2203/0742;;H01L27/06;;H01L27/06;;B81C2203/0742;;B81C1/00246,H01L21/20;;H01L29/66,257/414;;438/48;;X257E2109;;X257E29166,0,0,,,,ACTIVE
108,US,B2,US 8445307 B2,105-835-567-578-480,2013-05-21,2013,US 96859410 A,2010-12-15,US 96859410 A;;US 60208706 A,2006-11-20,Monolithic IC and MEMS microfabrication process,Monolithic IC/MEMS processes are disclosed in which high-stress silicon nitride is used as a mechanical material while amorphous silicon serves as a sacrificial layer. Electronic circuits and micro-electromechanical devices are built on separate areas of a single wafer. The sequence of IC and MEMS process steps is designed to prevent alteration of partially completed circuits and devices by subsequent high process temperatures.,YEH RICHARD;;BLOOM DAVID M;;ALCES TECHNOLOGY INC,YEH RICHARD;;BLOOM DAVID M,ALCES TECHNOLGY INC (2011-06-01);;MANTISVISION LTD (2018-04-06),https://lens.org/105-835-567-578-480,Granted Patent,yes,18,4,9,9,0,B81C1/00246;;B81C2203/0742;;H01L27/06;;H01L27/06;;B81C2203/0742;;B81C1/00246,H01L21/00,438/52;;438/50;;438/53;;438/54;;438/56;;438/704;;438/705;;438/706;;257/415;;257/416;;257/417;;257/418;;257/419,8,0,,,"Larry Hornbeck, ""Digital Light Processing and MEMS: An Overview"", Texas Instruments website, undated, 3 pages.;;Sandia National Laboratories (author unknown), ""SUMMiT V Overview"", Sandia National Laboratories website, undated, 3 pages.;;David Grosjean, et al. ""Using advance macrodefect inspection technology in MEMS processes"", Micro Magazine website, undated, 8 pages.;;Written Opinion of the International Searching Authority and International Search Report for PCT/US2007/085022 (Apr. 21, 2008).;;(D3) T. J. Brosnihan et al., ""Optical IMEMS-A Fabrication Process for MEMS Optical Switches with Integrated On-Chip Electronics,"" Transducers, Solid State Sensors, Actuators and Microsystems, 12th Intl. Conf. On, v. 2, p. 1638-1642, IEEE 2003.;;(D4) X. Jin et al., ""The Microfabrication of Capacitive Ultrasonic Transducers,"" J. Microelectromechanical Systems, v. 7, p. 295-301, IEEE 1998.;;(D5) D. M. Bloom, ""The Grating Light Valve: revolutionizing display technology,"" Proc. SPIE, v. 3013, p. 165-171, SPIE 1997.;;(ESSR) Extended European Search Report in EPO application 07864561.1-2203 / 2084747 PCT/US2007085022, European Patent Office, May 3, 2012.",ACTIVE
109,CN,C,CN 1302254 C,156-657-143-422-109,2007-02-28,2007,CN 01805903 A,2001-02-02,US 17966400 P,2000-02-02,Modular furnace system,,BTU INT,HARVEY DAVID BLOOM ROBERT BOUC,,https://lens.org/156-657-143-422-109,Granted Patent,no,5,0,9,9,0,B23K1/008;;B23K1/012;;F27B9/029;;F27B9/10;;F27B9/3011;;F27D17/004;;F27D2007/045;;B23K2101/40;;B23K1/012;;F27D17/004;;F27B9/029;;F27D2007/045;;F27B9/10;;B23K1/008;;F27B9/3011;;B23K2101/40,F27B9/02;;B23K1/008;;B23K1/012;;F27B9/10;;F27B9/12;;F27B9/30;;F27D7/04;;F27D17/00,,0,0,,,,EXPIRED
110,EP,A1,EP 1090322 A1,166-271-064-879-072,2001-04-11,2001,EP 99930488 A,1999-06-18,US 9913955 W;;US 10415998 A,1998-06-24,METHOD AND APPARATUS FOR MODULATING AN INCIDENT LIGHT BEAM FOR FORMING A TWO-DIMENSIONAL IMAGE,"An apparatus and method for modulating an incident light beam for forming a two-dimensional projection image. The apparatus includes a plurality of elongated elements each having a reflective surface. The elongated elements are suspended substantially parallel to each other above a substrate with their respective ends supported, forming a column of adjacent reflecting surfaces grouped according to display elements. Alternate ones of each group are deformable by a applying a voltage with respect to the substrate. An approximately flat center section of each deformed element is substantially parallel to and a predetermined distance from a center section of each undeformed element. Limiting the predetermined distance avoids hysteresis in deforming the elements and avoids adhesion of the elements to the substrate. A light beam incident to the column of adjacent reflecting surfaces is reflected from a group of elongated elements when the alternate ones are undeformed and diffracted when alternate ones are deformed. A distance of movement is controlled or a ratio of between reflection and diffraction periods determines a display intensity for the corresponding display element. Diffracted light is collected by a lens and reflected by a scanning mirror into an eyepiece or onto a display screen. A light shield having a slit of predetermined width is positioned at the pupil such that light collected by the lens other than light diffracted from the center sections of the elongated elements is prevented from passing through the slit. The scanning mirror sweeps a two-dimensional color image into the eyepiece or onto the display screen.",SILICON LIGHT MACHINES INC,BLOOM DAVID M;;GODIL ASIF,,https://lens.org/166-271-064-879-072,Patent Application,yes,0,0,13,13,0,G02B5/1828;;G02B26/0808;;G02B26/0808;;G02B5/1828;;G02B26/0808;;G02B5/1828,G02B5/18;;G02B26/08,,0,0,,,,EXPIRED
111,WO,A2,WO 1997/026569 A2,002-280-414-749-962,1997-07-24,1997,US 9700854 W,1997-01-17,US 59123196 A,1996-01-18,METHOD AND APPARATUS FOR USING AN ARRAY OF GRATING LIGHT VALVES TO PRODUCE MULTICOLOR OPTICAL IMAGES,"A multicolor optical image-generating device comprised of an array of grating light valves (GLVs) organized to form light-modulating pixel units for spatially modulating incident rays of light. The pixel units are comprised of three subpixel components each including a plurality of elongated, equally spaced apart reflective grating elements arranged parallel to each other with their light-reflective surfaces also parallel to each other. Each subpixel component includes means for supporting the grating elements in relation to one another, and means for moving alternate elements relative to the other elements and between a first configuration wherein the component acts to reflect incident rays of light as a plane mirror, and a second configuration wherein the component diffracts the incident rays of light as they are reflected from the grating elements. The three subpixel components of each pixel unit are designed such that when red, green and blue light sources are trained on the array, colored light diffracted by particular subpixel components operating in the second configuration will be directed through a viewing aperture, and light simply reflected from particular subpixel components operating in the first configuration will not be directed through the viewing aperture.",UNIV LELAND STANFORD JUNIOR,BLOOM DAVID M;;HUIBERS ANDREW,,https://lens.org/002-280-414-749-962,Patent Application,no,0,21,13,13,0,B81C2201/115;;G02B5/1828;;G02B26/0808;;B81B3/001;;B81B3/001;;B81C2201/115;;G02B5/1828;;G02B26/0808,B81B3/00;;G02B5/18;;G02B26/08,,0,0,,,,PATENTED
112,US,B1,US 6219015 B1,022-257-211-887-927,2001-04-17,2001,US 59123196 A,1996-01-18,US 59123196 A;;US 40413995 A;;US 6268893 A;;US 87607892 A,1992-04-28,Method and apparatus for using an array of grating light valves to produce multicolor optical images,"A multicolor optical image-generating device comprised of an array of grating light valves (GLVs) organized to form light-modulating pixel units for spatially modulating incident rays of light. The pixel units are comprised of three subpixel components each including a plurality of elongated, equally spaced apart reflective grating elements arranged parallel to each other with their light-reflective surfaces also parallel to each other. Each subpixel component includes means for supporting the grating elements in relation to one another, and means for moving alternate elements relative to the other elements and between a first configuration wherein the component acts to reflect incident rays of light as a plane mirror, and a second configuration wherein the component diffracts the incident rays of light as they are reflected from the grating elements. The three subpixel components of each pixel unit are designed such that when red, green and blue light sources are trained on the array, colored light diffracted by particular subpixel components operating in the second configuration will be directed through a viewing aperture, and light simply reflected from particular subpixel components operating in the first configuration will not be directed through the viewing aperture.",UNIV LELAND STANFORD JUNIOR,BLOOM DAVID M;;HUIBERS ANDREW,BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY THE (1996-01-05),https://lens.org/022-257-211-887-927,Granted Patent,yes,5,80,13,13,0,B81C2201/115;;G02B5/1828;;G02B26/0808;;B81B3/001;;B81B3/001;;B81C2201/115;;G02B5/1828;;G02B26/0808,B81B3/00;;G02B5/18;;G02B26/08,345/87,0,0,,,,EXPIRED
113,WO,B1,WO 1999/067671 B1,034-322-336-451-450,2000-02-10,2000,US 9913955 W,1999-06-18,US 10415998 A,1998-06-24,METHOD AND APPARATUS FOR MODULATING AN INCIDENT LIGHT BEAM FOR FORMING A TWO-DIMENSIONAL IMAGE,"An apparatus and method for modulating an incident light beam for forming a two-dimensional projection image. The apparatus includes a plurality of elongated elements each having a reflective surface. These are suspended parallel to each other above a substrate with their respective ends supported, forming a column of adjacent reflecting surfaces grouped according to display elements. Alternate ones of each group are deformable by applying a voltage with respect to the substrate. An approximately flat center section of each deformed element is substantially parallel to and a predetermined distance from a center section of each undeformed element. A light beam incident to the column of adjacent reflecting surfaces is reflected from a group of elongated elements when the alternate ones are undeformed and diffracted when the alternate ones are deformed. A distance of movement is controlled or a ratio of between reflection and diffraction periods determines a display intensity for the corresponding display element.",SILICON LIGHT MACHINES INC,BLOOM DAVID M;;GODIL ASIF,,https://lens.org/034-322-336-451-450,Patent Application,no,0,0,13,13,0,G02B5/1828;;G02B26/0808;;G02B26/0808;;G02B5/1828;;G02B26/0808;;G02B5/1828,G02B5/18;;G02B26/08,,0,0,,,,PATENTED
114,US,B1,US 6215579 B1,081-539-085-831-10X,2001-04-10,2001,US 10415998 A,1998-06-24,US 10415998 A,1998-06-24,Method and apparatus for modulating an incident light beam for forming a two-dimensional image,"An apparatus and method for modulating an incident light beam for forming a two-dimensional projection image. The apparatus includes a plurality of elongated elements each having a reflective surface. The elongated elements are suspended substantially parallel to each other above a substrate with their respective ends supported, forming a column of adjacent reflecting surfaces grouped according to display elements. Alternate ones of each group are deformable by a applying a voltage with respect to the substrate. An approximately flat center section of each deformed element is substantially parallel to and a predetermined distance from a center section of each undeformed element. Limiting the predetermined distance avoids hysteresis in deforming the elements and avoids adhesion of the elements to the substrate. A light beam incident to the column of adjacent reflecting surfaces is reflected from a group of elongated elements when the alternate ones are undeformed and diffracted when alternate ones are deformed. A distance of movement is controlled or a ratio of between reflection and diffraction periods determines a display intensity for the corresponding display element. Diffracted light is collected by a lens and reflected by a scanning mirror into an eyepiece or onto a display screen. A light shield having a slit of predetermined width is positioned at the pupil such that light collected by the lens other than light diffracted from the center sections of the elongated elements is prevented from passing through the slit. The scanning mirror sweeps a two-dimensional color image into the eyepiece or onto the display screen.",SILICON LIGHT MACHINES INC,BLOOM DAVID M;;GODIL ASIF,SILICON LIGHT MACHINES CORPORATION (2008-06-23);;SILICON LIGHT MACHINES (2001-02-22),https://lens.org/081-539-085-831-10X,Granted Patent,yes,103,149,13,13,0,G02B5/1828;;G02B26/0808;;G02B26/0808;;G02B5/1828;;G02B26/0808;;G02B5/1828,G02B5/18;;G02B26/08,359/298;;359/290;;359/291;;359/295;;359/197;;359/224;;359/318;;359/572;;359/573,21,12,154-800-944-637-210;;091-131-233-230-685;;052-574-007-284-544;;049-400-534-653-649;;022-949-709-618-959;;020-669-540-688-441;;009-286-199-765-581;;028-775-209-892-098;;009-365-280-210-861;;036-825-749-119-883;;052-055-696-490-751;;010-074-622-606-125,10.1117/12.962188;;10.1109/t-ed.1975.18217;;10.1063/1.88189;;10.1021/bk-1997-0670.ch018;;10.1117/1.601346;;10.1117/1.602097;;10.1109/5.53402;;10.1117/12.19865;;10.1016/0141-9382(91)90032-9;;10.1889/1.1984964;;19823336;;10.1364/ol.18.001214;;10.1364/ol.17.000688;;19794599,"Rowe, D.P. et al., ""Laser Beam Scanning,"" SPIE, vol. 2088, Oct. 5, 1993, pp. 18-26.;;Hornbeck. L.J., ""Deformable-Mirror Spatial Light Modulators,"" Spatial Light Modulators and Applications III, Aug. 8, 1989, pp. 86-102.;;R. N. Thomas, et al., ""The Mirror-Matrix Tube: A Novel Light Valve for Projection Displays"", IEEE Transactions on Electron Devices, vol. ED-22, No. 9, pp. 765-775, Sep. 1975.;;J. Guldberg, et al., ""An Aluminum/SiO2/Silicon-on-Sapphire Light Valve Matrix for Projection Displays,"" Applied Physics Letters, vol. 26, No. 7, pp. 391-393, Apr. 1975.;;Russick et al., ""Supercritical Carbon Dioxide Extraction of Solvent from Micromachined Structures,"" Supercritical Fluids, Chapter 18, pp. 255-269, 1997.;;Buhler et al., ""Linear Array of Complementary Metal Oxide Semiconductor Double-Pass Metal Micromirrors,"" Optical Engineering, vol. 36, No. 5, pp. 1391-1398, May 1997.;;Gani et al., ""Variable Gratings for Optical Switching: Rigorous Electromagnetic Simulation and Design,"" Optical Engineering, vol. 38, No. 3, pp. 552-557, Mar. 1999.;;R. Apte, F. Sandejas, W. Banyai, D. Bloom, ""Grating Light Valves For High Resolution Displays"", Ginzton Laboratories, Stanford University, Stanford, CA 94305-4085, Jun. 1994.;;R. Apte, ""Grating Light Valves For High Resolution Displays,"" Jun. 1994.;;O. Solgaard, ""Integrated Semiconductor Light Modulators For Fiber-Optic And Display Applications,"" Feb. 1992.;;J. Neff, ""Two-Dimensional Spatial Light Modulators: A Tutorial"", Proceedings of the IEEE, vol. 78, No. 5, pp. 826-855, May, 1990.;;Gerhard-Multhaupt, ""Visoelastic Spatial Light Modulators and Schlieren-Optical Systems for HDTV Projection Displays"", SPIE vol. 1255 Large Screen Projection Displays II, pp. 69-78, 1990.;;Gerhard-Multhaupt, ""Light-Valve Technologies for High-Definition Television Projection Displays"", Displays, vol. 12, No. 3/4, pp. 115-128, 1991.;;Alvelda et al., ""Ferroelectric Microdisplays Using Distortion-Compensated Pixel Layouts,"" SID 95 Digest, pp. 931-933, 1995.;;Phillip Alvelda, ""High-Efficiency Color Microdisplays,"" SID 95 Digest, pp. 307-311, 1995.;;Worboys et al., ""Miniature Display Technology for Integrated Helmut Systems,"" GEC Journal of Research, vol. 10, No. 2, pp. 111-118, 1993.;;Farn et al., ""Color Separation by use of Binary Optics,"" Optics Letters, vol. 18:15, pp. 1214-1216, 1993.;;Phillip Alvelda, ""VLSI Microdisplays and Optoelectric Technology,"" MIT, pp. 1-93, 1995.;;Phillip Alvelda, ""VLSI Microdisplay technology,"" Oct. 14, 1994.;;F. Sandejas, R. Apte, W. Banyai, D. Bloom, ""Surface Microfabrication of Deformable Grating Light Valves For High Resolution Displays,"" The 7th International Conference on Solid-State Sensors and Actuators, pp. 6 & 7, (no date).;;O.Solgaard, F. Sandejas, and D. Bloom, ""Deformable Grating Optical Modulator,"" Optics letters, vol. 17, No. 9, New York, USA, pp. 688-690, May 1, 1992.",EXPIRED
115,DE,T2,DE 69712311 T2,140-330-332-266-090,2002-12-19,2002,DE 69712311 T,1997-01-17,US 59123196 A;;US 9700854 W,1996-01-18,VERFAHREN UND GERÄT ZUR ERZEUGUNG OPTISCHE FARBBILDER MITTELS EINES GITTER-LICHTVENTILARRAYS,"A modulator for modulating incident rays of light, the modulator having a plurality of equally spaced apart elements, each of which includes a light reflective planar surface. The elements are arranged parallel to each other with their light reflective surfaces parallel to each other. The modulator includes means for supporting elements in relation to one another and means for moving particular ones of the elements relative to others so that the moved elements transit between a first configuration wherein the modulator acts to reflect the incident rays of light as a plane mirror, and a second configuration wherein the modulator diffracts the light reflected therefrom. In operation, the light reflective surfaces of the elements remain parallel to each other in both the first and the second configurations. The perpendicular spacing between the reflective surfaces of respective elements is equal to m/4 times the wavelength of the incident rays of light, wherein m=an even whole number or zero when the elements are in the first configuration and m=an odd whole number when the elements are in the second configuration.",UNIV LELAND STANFORD JUNIOR,BLOOM DAVID M;;HUIBERS ANDREW,,https://lens.org/140-330-332-266-090,Granted Patent,no,0,1,13,13,0,B81C2201/115;;G02B5/1828;;G02B26/0808;;B81B3/001;;B81B3/001;;B81C2201/115;;G02B5/1828;;G02B26/0808,B81B3/00;;G02B5/18;;G02B26/08,,0,0,,,,EXPIRED
116,DE,B,DE 1047187 B,193-575-381-174-828,1958-12-24,1958,DE G0016845 A,1955-04-01,DE G0016845 A,1955-04-01,Verfahren zur Herstellung von praktisch reinem 3-Chlornitrobenzol,,GEN ANILINE & FILM CORP,BLOOM ALBERT;;GRAHAM DAVID E,,https://lens.org/193-575-381-174-828,Patent Application,no,1,0,2,2,0,C07C201/16,C07C201/16,,0,0,,,,DISCONTINUED
117,EP,B1,EP 0875010 B1,085-849-103-669-732,2002-05-02,2002,EP 97904813 A,1997-01-17,US 9700854 W;;US 59123196 A,1996-01-18,METHOD AND APPARATUS FOR USING AN ARRAY OF GRATING LIGHT VALVES TO PRODUCE MULTICOLOR OPTICAL IMAGES,"A modulator for modulating incident rays of light, the modulator having a plurality of equally spaced apart elements, each of which includes a light reflective planar surface. The elements are arranged parallel to each other with their light reflective surfaces parallel to each other. The modulator includes means for supporting elements in relation to one another and means for moving particular ones of the elements relative to others so that the moved elements transit between a first configuration wherein the modulator acts to reflect the incident rays of light as a plane mirror, and a second configuration wherein the modulator diffracts the light reflected therefrom. In operation, the light reflective surfaces of the elements remain parallel to each other in both the first and the second configurations. The perpendicular spacing between the reflective surfaces of respective elements is equal to m/4 times the wavelength of the incident rays of light, wherein m=an even whole number or zero when the elements are in the first configuration and m=an odd whole number when the elements are in the second configuration.",UNIV LELAND STANFORD JUNIOR,BLOOM DAVID M;;HUIBERS ANDREW,,https://lens.org/085-849-103-669-732,Granted Patent,yes,2,0,13,13,0,B81C2201/115;;G02B5/1828;;G02B26/0808;;B81B3/001;;B81B3/001;;B81C2201/115;;G02B5/1828;;G02B26/0808,B81B3/00;;G02B5/18;;G02B26/08,,1,0,,,"SOLGAARD O ET AL: ""DEFORMABLE GRATING OPTICAL MODULATOR"" OPTICS LETTERS, vol. 17, no. 9, 1 May 1992, pages 688-690, XP000265233",EXPIRED
118,CA,C,CA 2243347 C,076-203-739-333-901,2005-05-10,2005,CA 2243347 A,1997-01-17,US 59123196 A;;US 9700854 W,1996-01-18,METHOD AND APPARATUS FOR USING AN ARRAY OF GRATING LIGHT VALVES TO PRODUCE MULTICOLOR OPTICAL IMAGES,"A multicolor optical image-generating device comprised of an array of gratin g light valves (GLVs) organized to form light-modulating pixel units for spatially modulating incident rays of light. The pixel units are comprised of three subpixel components each including a plurality of elongated, equally spaced apart reflective grating elements arranged parallel to each other with their light-reflective surfaces also parallel to each other. Each subpixel component includes means for supporting the grating elements in relation to one another, and means for moving alternate elements relative to the other elements and betwe en a first configuration wherein the component acts to reflect incident rays of light as a plane mirror, and a second configuration wherein the component diffracts the incident rays of light as they are reflected from the grating elements. The three subpixel components of each pixel unit are designed such that when red, green and blue light sources are trained on the array, colored light diffracted by particul ar subpixel components operating in the second configuration will be directed through a viewing aperture, and light simply reflected from particular subpixel components operating in the first configuration will not be directed through the viewing aperture.",UNIV LELAND STANFORD JUNIOR,HUIBERS ANDREW;;BLOOM DAVID M,,https://lens.org/076-203-739-333-901,Granted Patent,no,0,0,13,13,0,B81C2201/115;;G02B5/1828;;G02B26/0808;;B81B3/001;;B81B3/001;;B81C2201/115;;G02B5/1828;;G02B26/0808,B81B3/00;;G02B5/18;;G02B26/08,,0,0,,,,EXPIRED
119,US,B2,US 7875484 B2,163-408-052-076-104,2011-01-25,2011,US 60208706 A,2006-11-20,US 60208706 A,2006-11-20,Monolithic IC and MEMS microfabrication process,Monolithic IC/MEMS processes are disclosed in which high-stress silicon nitride is used as a mechanical material while amorphous silicon serves as a sacrificial layer. Electronic circuits and micro-electromechanical devices are built on separate areas of a single wafer. The sequence of IC and MEMS process steps is designed to prevent alteration of partially completed circuits and devices by subsequent high process temperatures.,ALCES TECHNOLOGY INC,YEH RICHARD;;BLOOM DAVID M,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2007-03-20),https://lens.org/163-408-052-076-104,Granted Patent,yes,12,3,9,9,0,B81C1/00246;;B81C2203/0742;;H01L27/06;;H01L27/06;;B81C2203/0742;;B81C1/00246,H01L21/00,438/52;;438/50;;438/53;;438/54;;438/56;;438/704;;438/705;;438/706;;257/415;;257/416;;257/417;;257/418;;257/419,3,0,,,"Larry Hornbeck, ""Digital Light Processing and MEMS: An Overview"", Texas Instruments website, undated, 3 pages.;;Sandia National Laboratories (author unknown), ""SUMMiT V Overview"", Sandia National Laboratories website, undated, 3 pages.;;David Grosjean, et al. ""Using advance macrodefect inspection technology in MEMS processes"", Micro Magazine website, undated, 8 pages.",INACTIVE
120,US,A,US 5847569 A,194-552-467-023-101,1998-12-08,1998,US 69492596 A,1996-08-08,US 69492596 A,1996-08-08,Electrical contact probe for sampling high frequency electrical signals,"An all-electrical high frequency contact sampling probe provides sub-micron spatial resolution and picosecond or sub-picosecond temporal resolution. In a preferred embodiment, the probe is a monolithic integration of a sampling circuit with a cantilever and probe tip, where the distance between the circuit and the tip is less than a wavelength of interest in an RF signal �V.sub.RF !. The sampling circuit �44! uses Schottky diodes �SD! for sampling the RF signal �V.sub.RF ! from a device under test at a rate determined by local oscillator signals �50, 52!. An IF signal �V.sub.IF ! produced by the sampling probe is an equivalent time representation of the RF signal. Applications include testing signals at interior nodes of high speed integrated circuits.",UNIV LELAND STANFORD JUNIOR,HO FRANCIS;;BLOOM DAVID M,BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY THE (1996-08-08),https://lens.org/194-552-467-023-101,Granted Patent,yes,6,27,1,1,0,G01R1/06772;;G01R1/06772;;G01R19/2509;;G01R19/2509;;Y10S977/852;;Y10S977/852,G01R1/067;;G01R19/25,324/752;;324/754,2,1,015-743-544-315-839,10.1007/978-3-642-85176-6_44,"J. Nees et al., Picosencond Detector, Optical Temporal Analyzer, and Free Standing Circuit probe l OSA Proc. on Ultafast electronics and Optoelectronics 1993, vol. 14, pp. 186 188. (unvaailable month).;;J.A. Nees et al., Integrated atomic force microscope and ultrafast sampling probe , Ultrafast Phenomena, 1994 Technical Digest Series, vol. 7, pp. 307 309. Optical Society of America (unavilable month).",EXPIRED
121,US,A1,US 2008/0119000 A1,097-102-593-799-176,2008-05-22,2008,US 60208706 A,2006-11-20,US 60208706 A,2006-11-20,Monolithic IC and MEMS microfabrication process,Monolithic IC/MEMS processes are disclosed in which high-stress silicon nitride is used as a mechanical material while amorphous silicon serves as a sacrificial layer. Electronic circuits and micro-electromechanical devices are built on separate areas of a single wafer. The sequence of IC and MEMS process steps is designed to prevent alteration of partially completed circuits and devices by subsequent high process temperatures.,YEH RICHARD;;BLOOM DAVID M,YEH RICHARD;;BLOOM DAVID M,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2007-03-20),https://lens.org/097-102-593-799-176,Patent Application,yes,12,18,9,9,0,B81C1/00246;;B81C2203/0742;;H01L27/06;;H01L27/06;;B81C2203/0742;;B81C1/00246,H01L21/00,438/50,0,0,,,,INACTIVE
122,CA,A1,CA 2243347 A1,165-208-619-923-586,1997-07-24,1997,CA 2243347 A,1997-01-17,US 59123196 A;;US 9700854 W,1996-01-18,METHOD AND APPARATUS FOR USING AN ARRAY OF GRATING LIGHT VALVES TO PRODUCE MULTICOLOR OPTICAL IMAGES,"A multicolor optical image-generating device comprised of an array of grating light valves (GLVs) organized to form light-modulating pixel units for spatially modulating incident rays of light. The pixel units are comprised of three subpixel components each including a plurality of elongated, equally spaced apart reflective grating elements arranged parallel to each other with their light-reflective surfaces also parallel to each other. Each subpixel component includes means for supporting the grating elements in relation to one another, and means for moving alternate elements relative to the other elements and between a first configuration wherein the component acts to reflect incident rays of light as a plane mirror, and a second configuration wherein the component diffracts the incident rays of light as they are reflected from the grating elements. The three subpixel components of each pixel unit are designed such that when red, green and blue light sources are trained on the array, colored light diffracted by particular subpixel components operating in the second configuration will be directed through a viewing aperture, and light simply reflected from particular subpixel components operating in the first configuration will not be directed through the viewing aperture.",UNIV LELAND STANFORD JUNIOR,HUIBERS ANDREW;;BLOOM DAVID M,,https://lens.org/165-208-619-923-586,Patent Application,no,0,0,13,13,0,B81C2201/115;;G02B5/1828;;G02B26/0808;;B81B3/001;;B81B3/001;;B81C2201/115;;G02B5/1828;;G02B26/0808,B81B3/00;;G02B5/18;;G02B26/08,,0,0,,,,EXPIRED
123,US,A,US 2789147 A,009-827-992-598-415,1957-04-16,1957,US 47410254 A,1954-12-09,US 47410254 A,1954-12-09,"Purification of 2-butyne-1, 4-diol by fractional crystallization",,GEN ANILINE & FILM CORP,ALBERT BLOOM;;GRAHAM DAVID E,,https://lens.org/009-827-992-598-415,Granted Patent,no,0,0,1,1,0,C07C33/046;;C07C33/046,C07C33/046,,0,0,,,,EXPIRED
124,CA,A,CA 562044 A,032-837-782-080-100,1958-08-19,1958,CA 562044D A,,CA 562044T A,,RECOVERY OF 3-CHLORONITROBENZENE,,GEN ANILINE & FILM CORP,GRAHAM DAVID E;;BLOOM ALBERT,,https://lens.org/032-837-782-080-100,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
125,US,A,US 2795620 A,076-097-566-748-220,1957-06-11,1957,US 40137153 A,1953-12-30,US 40137153 A,1953-12-30,Recovery of 3-chloronitrobenzene,,GEN ANILINE & FILM CORP,ALBERT BLOOM;;GRAHAM DAVID E,,https://lens.org/076-097-566-748-220,Granted Patent,no,2,2,1,1,0,C07C201/16;;C07C201/12;;C07C201/16;;C07C201/12,C07C201/16,,0,0,,,,EXPIRED
126,WO,A1,WO 2008/064135 A1,018-965-740-226-019,2008-05-29,2008,US 2007/0085022 W,2007-11-16,US 60208706 A,2006-11-20,MONOLITHIC IC AND MEMS MICROFABRICATION PROCESS,Monolithic IC/MEMS processes are disclosed in which high-stress silicon nitride is used as a mechanical material while amorphous silicon serves as a sacrificial layer. Electronic circuits and micro-electromechanical devices are built on separate areas of a single wafer. The sequence of IC and MEMS process steps is designed to prevent alteration of partially completed circuits and devices by subsequent high process temperatures.,ALCES TECHNOLOGY INC;;YEH RICHARD;;BLOOM DAVID M,YEH RICHARD;;BLOOM DAVID M,,https://lens.org/018-965-740-226-019,Patent Application,yes,3,0,9,9,0,B81C1/00246;;B81C2203/0742;;H01L27/06;;H01L27/06;;B81C2203/0742;;B81C1/00246,H01L29/00,,1,0,,,See also references of EP 2084747A4,PENDING
127,US,A,US 3063980 A,034-437-195-925-21X,1962-11-13,1962,US 67064757 A,1957-07-09,US 67064757 A,1957-07-09,Process for reducing aromatic nitrogen compounds,,GEN ANILINE & FILM CORP,ALBERT BLOOM;;GRAHAM DAVID E,,https://lens.org/034-437-195-925-21X,Granted Patent,no,10,14,1,1,0,C07C241/02;;C07C241/02;;C07C209/36;;C07C209/36;;C07C245/08;;C07C245/08,C07C241/02,,0,0,,,,EXPIRED
128,EP,B1,EP 1090322 B1,119-812-112-153-087,2003-03-05,2003,EP 99930488 A,1999-06-18,US 9913955 W;;US 10415998 A,1998-06-24,METHOD AND APPARATUS FOR MODULATING AN INCIDENT LIGHT BEAM FOR FORMING A TWO-DIMENSIONAL IMAGE,"An apparatus and method for modulating an incident light beam for forming a two-dimensional projection image. The apparatus includes a plurality of elongated elements each having a reflective surface. The elongated elements are suspended substantially parallel to each other above a substrate with their respective ends supported, forming a column of adjacent reflecting surfaces grouped according to display elements. Alternate ones of each group are deformable by a applying a voltage with respect to the substrate. An approximately flat center section of each deformed element is substantially parallel to and a predetermined distance from a center section of each undeformed element. Limiting the predetermined distance avoids hysteresis in deforming the elements and avoids adhesion of the elements to the substrate. A light beam incident to the column of adjacent reflecting surfaces is reflected from a group of elongated elements when the alternate ones are undeformed and diffracted when alternate ones are deformed. A distance of movement is controlled or a ratio of between reflection and diffraction periods determines a display intensity for the corresponding display element. Diffracted light is collected by a lens and reflected by a scanning mirror into an eyepiece or onto a display screen. A light shield having a slit of predetermined width is positioned at the pupil such that light collected by the lens other than light diffracted from the center sections of the elongated elements is prevented from passing through the slit. The scanning mirror sweeps a two-dimensional color image into the eyepiece or onto the display screen.",SILICON LIGHT MACHINES INC,BLOOM DAVID M;;GODIL ASIF,,https://lens.org/119-812-112-153-087,Granted Patent,yes,4,2,13,13,0,G02B5/1828;;G02B26/0808;;G02B26/0808;;G02B5/1828;;G02B26/0808;;G02B5/1828,G02B5/18;;G02B26/08,,2,0,,,"HORNBECK L J: ""DEFORMABLE-MIRROR SPATIAL LIGHT MODULATORS"" SPATIAL LIGHT MODULATORS AND APPLICATIONS III, 7-8 AUGUST 1989, SAN DIEGO, vol. 1150, 7 August 1989 (1989-08-07), pages 86-102, XP000351394;;ROWE D P ET AL: ""LASER BEAM SCANNING"" PROCEEDINGS OF THE SPIE, vol. 2088, 5 October 1993 (1993-10-05), pages 18-26, XP000614108",EXPIRED
129,WO,A3,WO 1997/026569 A3,011-972-233-621-074,1997-10-09,1997,US 9700854 W,1997-01-17,US 59123196 A,1996-01-18,METHOD AND APPARATUS FOR USING AN ARRAY OF GRATING LIGHT VALVES TO PRODUCE MULTICOLOR OPTICAL IMAGES,"A multicolor optical image-generating device comprised of an array of grating light valves (GLVs) organized to form light-modulating pixel units for spatially modulating incident rays of light. The pixel units are comprised of three subpixel components each including a plurality of elongated, equally spaced apart reflective grating elements arranged parallel to each other with their light-reflective surfaces also parallel to each other. Each subpixel component includes means for supporting the grating elements in relation to one another, and means for moving alternate elements relative to the other elements and between a first configuration wherein the component acts to reflect incident rays of light as a plane mirror, and a second configuration wherein the component diffracts the incident rays of light as they are reflected from the grating elements. The three subpixel components of each pixel unit are designed such that when red, green and blue light sources are trained on the array, colored light diffracted by particular subpixel components operating in the second configuration will be directed through a viewing aperture, and light simply reflected from particular subpixel components operating in the first configuration will not be directed through the viewing aperture.",UNIV LELAND STANFORD JUNIOR,BLOOM DAVID M;;HUIBERS ANDREW,,https://lens.org/011-972-233-621-074,Search Report,yes,2,0,13,13,0,B81C2201/115;;G02B5/1828;;G02B26/0808;;B81B3/001;;B81B3/001;;B81C2201/115;;G02B5/1828;;G02B26/0808,B81B3/00;;G02B5/18;;G02B26/08,,1,1,010-074-622-606-125,10.1364/ol.17.000688;;19794599,"SOLGAARD O ET AL: ""DEFORMABLE GRATING OPTICAL MODULATOR"", OPTICS LETTERS, vol. 17, no. 9, 1 May 1992 (1992-05-01), pages 688 - 690, XP000265233",PATENTED
130,DE,D1,DE 69712311 D1,032-365-988-908-599,2002-06-06,2002,DE 69712311 T,1997-01-17,US 59123196 A;;US 9700854 W,1996-01-18,VERFAHREN UND GERÄT ZUR ERZEUGUNG OPTISCHE FARBBILDER MITTELS EINES GITTER-LICHTVENTILARRAYS,"A modulator for modulating incident rays of light, the modulator having a plurality of equally spaced apart elements, each of which includes a light reflective planar surface. The elements are arranged parallel to each other with their light reflective surfaces parallel to each other. The modulator includes means for supporting elements in relation to one another and means for moving particular ones of the elements relative to others so that the moved elements transit between a first configuration wherein the modulator acts to reflect the incident rays of light as a plane mirror, and a second configuration wherein the modulator diffracts the light reflected therefrom. In operation, the light reflective surfaces of the elements remain parallel to each other in both the first and the second configurations. The perpendicular spacing between the reflective surfaces of respective elements is equal to m/4 times the wavelength of the incident rays of light, wherein m=an even whole number or zero when the elements are in the first configuration and m=an odd whole number when the elements are in the second configuration.",UNIV LELAND STANFORD JUNIOR,BLOOM DAVID M;;HUIBERS ANDREW,,https://lens.org/032-365-988-908-599,Granted Patent,no,0,0,13,13,0,B81C2201/115;;G02B5/1828;;G02B26/0808;;B81B3/001;;B81B3/001;;B81C2201/115;;G02B5/1828;;G02B26/0808,B81B3/00;;G02B5/18;;G02B26/08,,0,0,,,,EXPIRED
131,EP,A2,EP 0875010 A2,028-407-576-303-292,1998-11-04,1998,EP 97904813 A,1997-01-17,US 9700854 W;;US 59123196 A,1996-01-18,METHOD AND APPARATUS FOR USING AN ARRAY OF GRATING LIGHT VALVES TO PRODUCE MULTICOLOR OPTICAL IMAGES,"A modulator for modulating incident rays of light, the modulator having a plurality of equally spaced apart elements, each of which includes a light reflective planar surface. The elements are arranged parallel to each other with their light reflective surfaces parallel to each other. The modulator includes means for supporting elements in relation to one another and means for moving particular ones of the elements relative to others so that the moved elements transit between a first configuration wherein the modulator acts to reflect the incident rays of light as a plane mirror, and a second configuration wherein the modulator diffracts the light reflected therefrom. In operation, the light reflective surfaces of the elements remain parallel to each other in both the first and the second configurations. The perpendicular spacing between the reflective surfaces of respective elements is equal to m/4 times the wavelength of the incident rays of light, wherein m=an even whole number or zero when the elements are in the first configuration and m=an odd whole number when the elements are in the second configuration.",UNIV LELAND STANFORD JUNIOR,BLOOM DAVID M;;HUIBERS ANDREW,,https://lens.org/028-407-576-303-292,Patent Application,yes,9,0,13,13,0,B81C2201/115;;G02B5/1828;;G02B26/0808;;B81B3/001;;B81B3/001;;B81C2201/115;;G02B5/1828;;G02B26/0808,B81B3/00;;G02B5/18;;G02B26/08,,0,0,,,,EXPIRED
132,EP,A1,EP 2084747 A1,186-913-028-769-789,2009-08-05,2009,EP 07864561 A,2007-11-16,US 2007/0085022 W;;US 60208706 A,2006-11-20,MONOLITHIC IC AND MEMS MICROFABRICATION PROCESS,,ALCES TECHNOLOGY INC,YEH RICHARD;;BLOOM DAVID M,,https://lens.org/186-913-028-769-789,Patent Application,yes,0,0,9,9,0,B81C1/00246;;B81C2203/0742;;H01L27/06;;H01L27/06;;B81C2203/0742;;B81C1/00246,B81C1/00,,0,0,,,,DISCONTINUED
133,WO,A1,WO 2016/030392 A1,198-061-696-864-931,2016-03-03,2016,EP 2015069472 W,2015-08-25,US 201462070443 P;;US 201462122088 P,2014-08-26,NOVEL IMMUNIZATION AGENTS AND METHODS OF USE,The present invention relates to a vaccine composition comprising an effective amount of a replication-competent controlled recombinant virus. Further encompassed are uses in immunization and methods of immunization employing compositions comprising a replication-competent controlled recombinant virus of the invention.,HSF PHARMACEUTICALS,VOELLMY RICHARD;;BLOOM DAVID C,,https://lens.org/198-061-696-864-931,Patent Application,yes,2,6,16,16,22,A61K2039/5254;;C12N2710/16611;;C12N2710/16634;;C12N2830/002;;C12N2710/10334;;C12N2710/10343;;C12N2710/16643;;C12N2800/40;;A61P31/20;;A61P31/22;;A61P37/04;;Y02A50/30;;A61K39/12;;A61K2039/5254;;C12N2830/002;;C12N2710/10334;;C12N2710/16634;;C12N2800/40;;C12N2710/10343;;C12N2710/16611;;C12N2710/16643;;A61K39/12;;C12N2710/16034,A61K39/12;;A61K39/00,,6,6,010-388-527-287-252;;117-031-312-350-996;;036-647-713-063-786;;022-264-114-862-715;;024-853-664-395-451;;053-981-848-159-929,15925546;;10.1016/j.ymthe.2005.03.029;;10.1089/10430349950018869;;10048394;;24449891;;pmc3918795;;10.1073/pnas.1318563111;;10.1038/sj.gt.3302622;;16231051;;10.1210/me.7.4.515;;10.1210/mend.7.4.8388996;;8388996;;10.2174/156652306777934829;;16918333,"VILABOA N ET AL: ""Novel Gene Switches for Targeted and Timed Expression of Proteins of Interest"", MOLECULAR THERAPY, NATURE PUBLISHING GROUP, GB, vol. 12, no. 2, 1 August 2005 (2005-08-01), pages 290 - 298, XP004991975, ISSN: 1525-0016, DOI: 10.1016/J.YMTHE.2005.03.029;;YAO F ET AL: ""A NOVEL TETRACYCLINE-INDUCIBLE VIRAL REPLICATION SWITCH"", HUMAN GENE THERAPY, MARY ANN LIEBERT, NEW YORK ,NY, US, vol. 10, no. 3, 10 February 1999 (1999-02-10), pages 419 - 427, XP000877364, ISSN: 1043-0342, DOI: 10.1089/10430349950018869;;PATRICK KETZER ET AL: ""Artificial riboswitches for gene expression and replication control of DNA and RNA viruses"", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 111, no. 5, 4 February 2014 (2014-02-04), US, pages E554 - E562, XP055226626, ISSN: 0027-8424, DOI: 10.1073/pnas.1318563111;;R ARGNANI ET AL: ""Replication-competent herpes simplex vectors: design and applications"", GENE THERAPY, vol. 12, 1 October 2005 (2005-10-01), GB, pages S170 - S177, XP055226624, ISSN: 0969-7128, DOI: 10.1038/sj.gt.3302622;;LIEBERMAN B A ET AL: ""The constitution of a progesterone response element"", MOLECULAR ENDOCRINOLOGY, THE ENDOCRINE SOCIETY, US, vol. 7, no. 4, 1 January 1993 (1993-01-01), pages 515 - 527, XP009187072, ISSN: 0888-8809;;VILABOA NURIA ET AL: ""REGULATABLE GENE EXPRESSION SYSTEMS FOR GENE THERAPY"", CURRENT GENE THERAPY, BENTHAM SCIENCE PUBLISHERS LTD, NL, vol. 6, no. 4, 1 August 2006 (2006-08-01), pages 421 - 438, XP009079164, ISSN: 1566-5232, DOI: 10.2174/156652306777934829",PENDING
134,AT,T1,AT E233911 T1,079-360-405-885-19X,2003-03-15,2003,AT 99930488 T,1999-06-18,US 10415998 A;;US 9913955 W,1998-06-24,VERFAHREN UND VORRICHTUNG ZUR MODULATION EINES LICHTSTRAHLS FÜR EINE ZWEIDIMENSIONALE BILDDARSTELLUNG,"An apparatus and method for modulating an incident light beam for forming a two-dimensional projection image. The apparatus includes a plurality of elongated elements each having a reflective surface. The elongated elements are suspended substantially parallel to each other above a substrate with their respective ends supported, forming a column of adjacent reflecting surfaces grouped according to display elements. Alternate ones of each group are deformable by a applying a voltage with respect to the substrate. An approximately flat center section of each deformed element is substantially parallel to and a predetermined distance from a center section of each undeformed element. Limiting the predetermined distance avoids hysteresis in deforming the elements and avoids adhesion of the elements to the substrate. A light beam incident to the column of adjacent reflecting surfaces is reflected from a group of elongated elements when the alternate ones are undeformed and diffracted when alternate ones are deformed. A distance of movement is controlled or a ratio of between reflection and diffraction periods determines a display intensity for the corresponding display element. Diffracted light is collected by a lens and reflected by a scanning mirror into an eyepiece or onto a display screen. A light shield having a slit of predetermined width is positioned at the pupil such that light collected by the lens other than light diffracted from the center sections of the elongated elements is prevented from passing through the slit. The scanning mirror sweeps a two-dimensional color image into the eyepiece or onto the display screen.",SILICON LIGHT MACHINES INC,BLOOM DAVID M;;GODIL ASIF,,https://lens.org/079-360-405-885-19X,Granted Patent,no,0,0,13,13,0,G02B5/1828;;G02B26/0808;;G02B26/0808;;G02B5/1828;;G02B26/0808;;G02B5/1828,G02B5/18;;G02B26/08,,0,0,,,,DISCONTINUED
135,AU,A,AU 1999/047021 A,172-976-479-581-937,2000-01-10,2000,AU 1999/047021 A,1999-06-18,US 10415998 A;;US 9913955 W,1998-06-24,Method and apparatus for modulating an incident light beam for forming a two-dimensional image,"An apparatus and method for modulating an incident light beam for forming a two-dimensional projection image. The apparatus includes a plurality of elongated elements each having a reflective surface. The elongated elements are suspended substantially parallel to each other above a substrate with their respective ends supported, forming a column of adjacent reflecting surfaces grouped according to display elements. Alternate ones of each group are deformable by a applying a voltage with respect to the substrate. An approximately flat center section of each deformed element is substantially parallel to and a predetermined distance from a center section of each undeformed element. Limiting the predetermined distance avoids hysteresis in deforming the elements and avoids adhesion of the elements to the substrate. A light beam incident to the column of adjacent reflecting surfaces is reflected from a group of elongated elements when the alternate ones are undeformed and diffracted when alternate ones are deformed. A distance of movement is controlled or a ratio of between reflection and diffraction periods determines a display intensity for the corresponding display element. Diffracted light is collected by a lens and reflected by a scanning mirror into an eyepiece or onto a display screen. A light shield having a slit of predetermined width is positioned at the pupil such that light collected by the lens other than light diffracted from the center sections of the elongated elements is prevented from passing through the slit. The scanning mirror sweeps a two-dimensional color image into the eyepiece or onto the display screen.",SILICON LIGHT MACHINES INC,BLOOM DAVID M;;GODIL ASIF,,https://lens.org/172-976-479-581-937,Patent Application,no,0,0,13,13,0,G02B5/1828;;G02B26/0808;;G02B26/0808;;G02B5/1828;;G02B26/0808;;G02B5/1828,G02B5/18;;G02B26/08,,0,0,,,,DISCONTINUED
136,CN,A,CN 1420979 A,070-645-916-545-279,2003-05-28,2003,CN 01805903 A,2001-02-02,US 17966400 P,2000-02-02,Modular furnace system,,BTU INT,BLOOM DAVID;;BOUCHARD ROBERT;;HARVEY DAVID S,,https://lens.org/070-645-916-545-279,Patent Application,no,0,3,9,9,0,B23K1/008;;B23K1/012;;F27B9/029;;F27B9/10;;F27B9/3011;;F27D17/004;;F27D2007/045;;B23K2101/40;;B23K1/012;;F27D17/004;;F27B9/029;;F27D2007/045;;F27B9/10;;B23K1/008;;F27B9/3011;;B23K2101/40,B23K1/008;;B23K1/012;;F27B9/02;;F27B9/10;;F27B9/30;;F27D7/04;;F27D17/00,,0,0,,,,EXPIRED
137,US,B2,US 9036243 B2,001-591-948-785-441,2015-05-19,2015,US 201314032383 A,2013-09-20,US 201314032383 A;;US 201261705000 P,2012-09-24,Digital drive signals for analog MEMS ribbon arrays,On/off digital drive signals are used to create arbitrary spatial and temporal ribbon movement patterns in MEMS ribbon arrays.,BLOOM DAVID M;;LEONE MATTHEW A;;ALCES TECHNOLOGY INC,BLOOM DAVID M;;LEONE MATTHEW A,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2013-10-17),https://lens.org/001-591-948-785-441,Granted Patent,yes,16,0,9,9,0,G01B11/2527;;F21K9/60;;F21K9/65;;G02F1/155;;G09G3/3433;;G02B26/0808;;G02F1/0128;;G09G2300/0426;;G02B27/0068;;G02B26/0816;;G02B26/085;;G09G2300/0473;;G02B26/0858;;G02F1/29;;G02B26/101;;G02F1/0123;;G02B26/06;;G02B26/02;;H04N13/254;;G02B26/0841;;G01C3/08;;G06V10/145;;G02F1/155;;G09G3/3433;;G02B26/0808;;G02F1/0128;;G09G2300/0426;;G02B27/0068;;G02B26/0816;;G02B26/085;;G09G2300/0473;;G02B26/0858;;G02F1/29;;G02B26/101;;G02F1/0123;;G02B26/06;;G02B26/02;;H04N13/204;;H04N13/254;;G01B11/2527;;F21K9/60;;F21K9/65;;G06V10/145;;G02B26/0833;;G02F1/13306;;G02B26/0841;;G01C3/08,G02B26/00;;F21K99/00;;G01B11/25;;G01C3/08;;G02B26/06;;G02B26/08;;G02B26/10;;G02B27/00;;G02F1/01;;G02F1/133;;G02F1/155;;G02F1/29;;G06V10/145;;G09G3/34;;H04N13/02,359/290;;359/198.1;;359/199.2;;359/200.6;;359/200.8;;359/201.2;;359/204.5;;359/221.2;;359/223.1;;359/279;;359/291;;359/292;;359/298;;359/318,2,2,023-831-110-301-456;;127-634-449-541-086,10.1109/iret-set.1962.5008839;;10.1109/transducers.2011.5969183,"Inose et al., ""A Telemetering System by Code Modulation-Delta-Sigma Modulation"", IRE Transactions on Space Electronics and Telemetry, Sep. 1962, p. 204-209.;;Rombach et al., ""Modulated Electro-Mechanical Continuous-Time Lowpass Sigma-Delta-Modulator for Micromachined Gyroscopes"", IEEE Transducers Jun. 2011, Beijing, China, p. 1092-1095.",INACTIVE
138,WO,A2,WO 2010/062689 A2,038-487-904-619-428,2010-06-03,2010,US 2009/0062778 W,2009-10-30,US 10963408 P,2008-10-30,REDUCTION OF HMF ETHERS WITH METAL CATALYST,"This disclosure describes methods of reducing hydroxymethylfurfural ether and ester derivatives to produce, in the case of ethers, 5-(alkoxymethyl)-tetrahydrofuran-2- methanol and (5-alkoxymethyl)-furan-2 -methanol derivatives, or in the case of esters, 5-(acyloxymethyl)- tetrahydrofuran-2 -methanol and 5-(acyloxymethyl)- furan-2- methanol derivatives. Exemplified methods describe purification thereof. In addition, the disclosure relates to n-alkoxy hexane diol compounds, which are derivative compounds useful for replacement of petroleum based carbitol compounds, and can be made by further reduction of the 5-(alkoxymethyl)-tetrahydrofuran-2- methanol and (5-alkoxymethyl)-furan-2-methanol derivatives. The compounds made by the methods of the present teaching are useful as solvents and as starting materials for making other compositions that meet the requirements of bio-based industrial chemicals from renewable resources.",ARCHER DANIELS MIDLAND CO;;BLOOM PAUL DAVID;;SANBORN ALEXANDRA J,BLOOM PAUL DAVID;;SANBORN ALEXANDRA J,,https://lens.org/038-487-904-619-428,Patent Application,yes,1,19,27,27,0,C07C41/26;;C07C41/26;;C07D307/54;;C07D307/54;;C07C41/26;;C07C41/26;;C07C43/13;;C07C43/13;;C07C43/13;;C07C43/13;;C07D307/12;;C07D307/12;;C07D307/12;;C07D307/12;;C07D307/16;;C07D307/16;;C07D307/16;;C07D307/16;;C07D307/42;;C07D307/44;;C07D307/44;;C07D307/44;;C07D307/44;;C07D307/54;;C07D307/54;;C08K5/06;;C08K5/06;;C08K5/06;;C08K5/06;;C09K3/00;;C09K3/00,C07D307/20;;C07D307/24;;C07D307/28;;C07D307/34,,2,0,,,"PEVZNER ET AL., ZHURNAL ORGANICHESKOI KHIMII, vol. 23, no. 6, 1987, pages 1292 - 4;;See also references of EP 2350035A4",PENDING
139,WO,A2,WO 2005/080581 A2,042-092-141-061-072,2005-09-01,2005,US 2005/0005461 W,2005-02-17,US 54537504 P,2004-02-17,INSULATED HERPESVIRUS-DERIVED GENE EXPRESSION CASSETTES FOR SUSTAINED AND REGULATABLE GENE EXPRESSION,"Disclosed are genetic expression cassettes, and vector comprising them useful for the delivery of nucleic acid segments encoding selected therapeutic constructs (including for example, peptides, polypeptides, ribozymes, and catalytic RN molecules), to selected cells and tissues of vertebrate animals. The disclosed genetic constructs are useful in the development of gene therapy vectors, including for example, viral vectors such as HSV, retroviral, lentiviral, AV, and rAAV vectors. The expression cassettes disclosed herein provide new tools in the field of gene therapy, and for the treatment of mammalian, and in particular, human diseases, disorders, and dysfunctions. The disclosed compositions may be utilized in a variety of investigative, diagnostic and therapeutic regimens, including the prevention and treatment of a variety of human diseases.",UNIV FLORIDA;;BLOOM DAVID C;;AMELIO ANTONIO L,BLOOM DAVID C;;AMELIO ANTONIO L,,https://lens.org/042-092-141-061-072,Patent Application,yes,0,7,6,6,111,A61K31/713;;A61K31/713;;A61K48/00;;A61K48/00;;C12N15/85;;C12N15/85;;C12N15/86;;C12N15/86;;C12N2710/16611;;C12N2710/16611;;C12N2710/16622;;C12N2710/16633;;C12N2710/16642;;C12N2710/16642;;C12N2710/16643;;C12N2710/16643;;C12N2830/007;;C12N2830/007;;C12N2830/40;;C12N2830/40;;C12N2830/60;;C12N2830/60,A61K48/00;;C12N15/85;;C12N15/869,,0,0,,,,PENDING
140,US,A1,US 2014/0211193 A1,090-005-014-980-087,2014-07-31,2014,US 201314033147 A,2013-09-20,US 201314033147 A;;US 201261705000 P,2012-09-24,Structured light and time of flight depth capture with a MEMS ribbon linear array spatial light modulator,A fast spatial light modulator based on a linear MEMS ribbon array enables a depth capture system to operate in structured light and time-of-flight modes. Time-of-flight depth information may be used to phase unwrap structured light depth information. Combined structured light and time-of-flight systems offer precise depth resolution over a wide range of distances.,BLOOM DAVID M;;LEONE MATTHEW A;;ALCES TECHNOLOGY INC,BLOOM DAVID M;;LEONE MATTHEW A,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2013-10-17),https://lens.org/090-005-014-980-087,Patent Application,yes,8,58,9,9,0,G01B11/2527;;F21K9/60;;F21K9/65;;G02F1/155;;G09G3/3433;;G02B26/0808;;G02F1/0128;;G09G2300/0426;;G02B27/0068;;G02B26/0816;;G02B26/085;;G09G2300/0473;;G02B26/0858;;G02F1/29;;G02B26/101;;G02F1/0123;;G02B26/06;;G02B26/02;;H04N13/254;;G02B26/0841;;G01C3/08;;G06V10/145;;G02F1/155;;G09G3/3433;;G02B26/0808;;G02F1/0128;;G09G2300/0426;;G02B27/0068;;G02B26/0816;;G02B26/085;;G09G2300/0473;;G02B26/0858;;G02F1/29;;G02B26/101;;G02F1/0123;;G02B26/06;;G02B26/02;;H04N13/204;;H04N13/254;;G01B11/2527;;F21K9/60;;F21K9/65;;G06V10/145;;G02B26/0833;;G02F1/13306;;G02B26/0841;;G01C3/08,G06V10/145;;G01C3/08,356/5.01,2,1,054-063-002-531-401,10.1109/gcce.2012.6379648,"Cho, Shung Han; Kwanghyuk Bae; Hyu-Min Kyung; Tae-Chan Kim. ""Fast and Efficient Method to Suppress Depth Ambiguity for Time-of-Flight Sensors."" Appeared in Consumer Electronics (GCCE), 2012 IEEE 1st Global Conference on 2-5 Oc.t 2012. http://ieeexplore.ieee.org/xpls/icp.jsp?arnumber=6379648;;Su, Xianyu; Qican Xhang. ""Dynamic 3-D Shape Measurement Method: A Review."" Appeared in Optics and Lasers in Engineering Journal. 8 May 2009. http://hanquier.m.free.fr/Worcester/references/Others%20papers/dynamic%203D%20shape.pdf",INACTIVE
141,US,A1,US 2006/0114544 A1,113-620-127-226-520,2006-06-01,2006,US 33627706 A,2006-01-20,US 33627706 A;;US 16145205 A;;US 90476604 A,2004-11-26,Polarization light modulator,"Polarization light modulators are based on an interferometric design in which a polarizing beam splitter serves as a polarizer and analyzer. A polarization displacement device shifts orthogonally polarized light beams parallel to the long axis of their elongated cross sections. Phase shifts are imparted to the orthogonally polarized beams by linear array MEMS optical phase shift devices. The output of the light modulator is a line image which may be scanned to form a two-dimensional image. Features to improve brightness, contrast and overall compactness of design are disclosed.",BLOOM DAVID M;;PETERMAN MARK C,BLOOM DAVID M;;PETERMAN MARK C,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2006-03-14),https://lens.org/113-620-127-226-520,Patent Application,yes,12,23,9,9,0,G02B26/06;;G02B26/0808;;G02B26/0825;;G02B27/283;;G02B26/06;;G02B27/283;;G02B26/0808;;G02B26/0825,G02F1/01,359/279,0,0,,,,ACTIVE
142,CA,A1,CA 2977587 A1,140-167-792-041-434,2016-10-06,2016,CA 2977587 A,2016-03-28,US 201514677789 A;;US 2016/0024434 W,2015-04-02,MATTER TRACKING SYSTEM,"A system is described that can detect, track and analyze a bubble of a secondary substance contained within a primary substance along a part of a fluid line. For example, the system can detect the presence of the bubble within the primary substance along the part of the fluid line, which can include assigning a digital signature to the bubble. In addition, the system can track the movement of the bubble in order to ensure that the bubble is accounted for only once as it passes through the part of the fluid line. Furthermore, the system can analyze the bubble, such as determine its direction of travel, speed of travel, volume and size.",CAREFUSION 303 INC,OSCOLAI BILL;;BLOOM MARK;;BROWN DAVID,,https://lens.org/140-167-792-041-434,Patent Application,no,0,0,14,14,0,G01N2291/02433;;G06T2207/10016;;G06T7/246;;G01N2291/02433;;G06T2207/10016;;G06T7/246;;H04N23/56;;H04N23/80;;G01N21/17;;G01N2021/177;;G06T2207/10004,A61B1/06;;A61M1/28;;A61M5/168;;A61M31/00;;A61M39/28;;B65B1/00,,0,0,,,,PENDING
143,US,B2,US 7754823 B2,161-308-441-941-121,2010-07-13,2010,US 8777205 A,2005-03-24,US 8777205 A;;US 55570204 P,2004-03-24,"Vegetable based dioxanone derivatives, synthesis and uses thereof","The present invention is directed to carboxylic acid and ester moieties that are attached to a carbon chain that is between 2 and 24 carbons in length wherein, the chain contains at least one dioxanone ring system, said dioxanone being formed from two adjacent carbons in the chain and/or at least one carbon in the chain is substituted with a pendant dioxanone ring system. In preferred embodiments, the carbon chain is a fatty acid residue. The carbons of said chain can be optionally substituted, saturated or unsaturated. When two or more said ester moieties are present, the invention is directed to a polyester such as a triglyceride, that contains multiple carbon chains wherein each chain is independently derivatized such that the triglyceride contains at least one dioxanone ring system, said dioxanone being formed from two adjacent carbons in at least one of said chains. The present invention is also directed to a method of preparing a dioxanone containing composition or fatty acid derivative. The present invention is also directed to coating formulations and polymers that utilize a dioxanone containing composition or fatty acid derivative, and methods of making such coatings and polymers.",ARCHER DANIELS MIDLAND CO,BINDER THOMAS PAUL;;BLOOM PAUL DAVID,ARCHER-DANIELS-MIDLAND COMPANY (2005-06-21),https://lens.org/161-308-441-941-121,Granted Patent,yes,20,1,11,11,0,C07D307/20;;C07D319/12;;C07D407/06;;C07D407/14;;C07D407/06;;C07D407/14;;C07D307/20;;C07D319/12,C08G63/91;;A61K31/225;;A61K31/335;;C07C235/06;;C07D307/20;;C07D319/12;;C07D407/06;;C08G63/66;;C08G69/40;;C11C3/00,525/415;;528/73;;514/452;;514/547,11,4,007-328-337-071-335;;126-668-742-145-129;;028-493-354-977-914;;055-140-839-336-643,10.1021/i360067a005;;10.1007/bf02667121;;10.1016/0008-6215(93)80040-l;;8495442;;10.1016/0008-6215(91)84028-d;;1794127,"USPTO STIC structure search Sep. 18, 2008.;;Friedrich, J.P., ""Low-Pressure Hydroformylation of Methyl Oleate with an Activated Rhodium Catalyst,"" Ind. Eng. Chem. Prod. Res. Dev. 17:205-207, American Chemical Society (1978).;;Rao, G. Venkateswara, ""Protection of Unsaturation by Cupric Nitrate During Heterogeneous Catalytic Hydrogenation of Aliphatic Epoxy to Hydroxy Groups,"" J. Am. Oil Chem. Soc. 45:408, American Oil Chemists Society (1968).;;Database Caplus, Accession No. 1974:505413, English language abstract for Stoilov, L. and Iovchev, A., ""Replacement of the double bond of monoenic fatty acids by the 1,4-dioxane ring,"" Doklady Bolgarskoi Akademii Nauk 26:1355-1357 (1973), Chemical Abstracts Service (1973).;;Database Caplus, Accession No. 1976:105922, English language abstract for Kochetkov et al., ""New sugars from the antigenic lipopolysaccharides of Shigella,"" Biiorganicheskaya Khimiya 1:1238-1240 (1975), Chemical Abstracts Service (1976).;;Database Caplus, Accession No. 1981:498186, English language abstract for Orosco, L.R. and Chizhov, O.S., ""Glucolactylic acids. III. Synthesis of 2-O-[(S)-1-carboxyethyl]-D-glucose and its R-isomer,"" Bioorganicheskaya Khimiya 7:741-749 (1981), Chemical Abstracts Service (1981).;;Osman, S.F. and Fett, W.F., ""Structure of the acidic exopolysaccharide of Pseudomonas marginalis Strains ATCC 10844,"" Carbohydrate Research 242:271-275 (1993).;;Oxley, D. and Wilkinson, S.G., ""Structure of an acidic glycan present in the lipopolysaccharide extract from the reference strain for Serratia marcescens serogroup O18,"" Carbohydrate Research 215:293-301 (1991).;;Partial International Search Report for International Patent Application No. PCT/US2005/009968, 5 pages, European Patent Office, The Hague, Netherlands, mailed Sep. 1, 2005.;;Partial English Language Translation for German Patent, DE 10 54 444 B (Document FP1, listed on form PTO/SB/08A of First Supplemental Information Disclosure Statement previously submitted on Jan. 4, 2006).;;English Language Translation for German Patent, DE 195 42 933 A1(Document FP3, listed on form PTO/SB/08A of First Supplemental Information Disclosure Statement previously submitted on Jan. 4, 2006).",ACTIVE
144,US,A1,US 2018/0364001 A1,186-383-088-036-178,2018-12-20,2018,US 201816005929 A,2018-06-12,US 201816005929 A;;US 201762521001 P,2017-06-16,SAFETY MAGAZINE SYSTEM FOR BLANK AMMUNITION,"In one aspect, a magazine safety system for preventing loading of a live ammunition cartridge into a firing chamber of a firearm is provided. The firearm has an associated ammunition caliber. The safety system includes a safety block comprising an inner member configured for insertion along an inner surface of a wall of a magazine well of the firearm, the magazine well having an opening for receiving a magazine. An outer member is configured to attach to the inner member along an outer surface of the wall of the magazine well and one or more fasteners secure the inner member to the outer member to secure the wall of the magazine well between the inner member and the outer member. The inner member has a thickness configured reduce an axial extent of the opening to permit insertion of a first magazine sized to carry blank ammunition rounds having a length which is less than live ammunition cartridges having the associated ammunition caliber, while preventing insertion of a second magazine sized to carry live ammunition cartridges having the associated ammunition caliber.",DOTY JOSEPH W;;BLOOM DAVID J,DOTY JOSEPH W;;BLOOM DAVID J,,https://lens.org/186-383-088-036-178,Patent Application,yes,0,1,2,2,0,F41A17/34;;F41A17/34,F41A17/34,,0,0,,,,INACTIVE
145,US,B2,US 7286277 B2,016-305-309-830-44X,2007-10-23,2007,US 33627706 A,2006-01-20,US 33627706 A;;US 16145205 A;;US 90476604 A,2004-11-26,Polarization light modulator,"Polarization light modulators are based on an interferometric design in which a polarizing beam splitter serves as a polarizer and analyzer. A polarization displacement device shifts orthogonally polarized light beams parallel to the long axis of their elongated cross sections. Phase shifts are imparted to the orthogonally polarized beams by linear array MEMS optical phase shift devices. The output of the light modulator is a line image which may be scanned to form a two-dimensional image. Features to improve brightness, contrast and overall compactness of design are disclosed.",ALCES TECHNOLOGY INC,BLOOM DAVID M;;PETERMAN MARK C,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2006-03-14),https://lens.org/016-305-309-830-44X,Granted Patent,yes,12,10,9,9,0,G02B26/06;;G02B26/0808;;G02B26/0825;;G02B27/283;;G02B26/06;;G02B27/283;;G02B26/0808;;G02B26/0825,G02F1/01,359/279,0,0,,,,ACTIVE
146,EP,B1,EP 3277154 B1,020-757-614-134-637,2020-10-07,2020,EP 16773900 A,2016-03-28,US 201514677789 A;;US 2016/0024434 W,2015-04-02,MATTER TRACKING SYSTEM,,CAREFUSION 303 INC,OSCOLAI BILL;;BLOOM MARK;;BROWN DAVID,"CAREFUSION 303, INC. (2020-08-19)",https://lens.org/020-757-614-134-637,Granted Patent,yes,6,0,14,14,0,G01N2291/02433;;G06T2207/10016;;G06T7/246;;G01N2291/02433;;G06T2207/10016;;G06T7/246;;H04N23/56;;H04N23/80;;G01N21/17;;G01N2021/177;;G06T2207/10004,A61B1/06;;A61M1/28;;A61M5/168;;A61M31/00;;A61M39/28;;B65B1/00;;G06T7/246,,1,0,,,"WANG H Y ET AL: ""A method for bubble volume calculating in vertical two-phase flow"", JOURNAL OF PHYSICS: CONFERENCE SERIES, INSTITUTE OF PHYSICS PUBLISHING, BRISTOL, GB, vol. 147, no. 1, 1 February 2009 (2009-02-01), page 12018, XP020155886, ISSN: 1742-6596",ACTIVE
147,US,A1,US 2015/0281671 A1,029-084-817-850-047,2015-10-01,2015,US 201414226515 A,2014-03-26,US 201414226515 A,2014-03-26,Compact 3D depth capture systems,"Compact 3D depth capture systems are based on a 3D system driver/interface, a 3D system camera, and a 3D system projector. The systems are compatible with integration in to mobile electronic devices such as smart phones and tablet computers.",BLOOM DAVID M;;LEONE MATTHEW A;;ALCES TECHNOLOGY INC,BLOOM DAVID M;;LEONE MATTHEW A,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2014-10-29),https://lens.org/029-084-817-850-047,Patent Application,yes,8,24,10,10,0,G01B11/2527;;G01B11/254;;G01B11/254;;G01B11/2527;;G01B11/2527,H04N13/02;;G01B11/25;;G06K9/52;;G06T7/00,,0,0,,,,ACTIVE
148,EP,A1,EP 0968453 A1,044-225-277-100-463,2000-01-05,2000,EP 98911822 A,1998-03-19,US 9805397 W;;US 82139097 A,1997-03-20,DISPLAY DEVICE INCORPORATING ONE-DIMENSIONAL HIGH-SPEED GRATING LIGHT VALVE ARRAY,,SILICON LIGHT MACHINES INC,BLOOM DAVID M;;GODIL ASIF A,,https://lens.org/044-225-277-100-463,Patent Application,yes,0,0,15,15,0,G02B5/1828;;G02B26/0808;;G02B26/10;;G02B27/017;;G02B26/08;;G02B27/017;;G02B5/1828;;G02B26/10;;G02B26/0808,G02B5/18;;B41J2/445;;G02B26/08;;G02B26/10;;G02B27/01,,0,0,,,,EXPIRED
149,US,A1,US 2015/0231168 A1,037-523-234-760-842,2015-08-20,2015,US 201514686541 A,2015-04-14,US 201514686541 A;;US 59013605 A;;US 2005/0005461 W;;US 54537504 P,2004-02-17,METHODS FOR SUSTAINED AND REGULATABLE GENE EXPRESSION USING VIRAL BASED EXPRESSION VECTORS,"Disclosed are genetic expression cassettes, and vectors comprising them useful for the delivery of isolated nucleic acid segments including those expressing or encoding one or more selected therapeutic constructs (including, without limitation, therapeutic peptides, polypeptides, ribozymes, or catalytic RNA molecules), to one or more selected cells or tissues of a vertebrate animal. Methods employing the disclosed genetic constructs in the development of gene therapy-based viral vector systems are also disclosed. The expression cassettes and viral vectors disclosed herein provide new tools for methods of treating mammalian, and in particular, human diseases, disorders, and/or dysfunctions. The disclosed compositions and methods find particular utility in a variety of investigative, diagnostic, and therapeutic regimens, including, for example, in the treatment or amelioration of symptoms of a variety of mammalian, and particularly, human conditions.",UNIV FLORIDA,BLOOM DAVID C;;AMELIO ANTONIO L,UNIVERSITY OF FLORIDA RESEARCH FOUNDATION INC (2015-05-04),https://lens.org/037-523-234-760-842,Patent Application,yes,1,2,6,6,104,A61K31/713;;A61K31/713;;A61K48/00;;A61K48/00;;C12N15/85;;C12N15/85;;C12N15/86;;C12N15/86;;C12N2710/16611;;C12N2710/16611;;C12N2710/16622;;C12N2710/16633;;C12N2710/16642;;C12N2710/16642;;C12N2710/16643;;C12N2710/16643;;C12N2830/007;;C12N2830/007;;C12N2830/40;;C12N2830/40;;C12N2830/60;;C12N2830/60,A61K31/713;;A61K48/00;;C12N15/85;;C12N15/86;;C12N15/869,,0,0,,,,ACTIVE
150,US,A1,US 2011/0003727 A1,043-649-722-041-629,2011-01-06,2011,US 87630810 A,2010-09-07,US 87630810 A;;US 70899807 A;;US 42814603 A;;US 37680702 P;;US 40350502 P;;US 43441902 P,2002-05-02,HYDROGENATED AND PARTIALLY HYDROGENATED HEAT-BODIED OILS AND USES THEREOF,"The present disclosure presents materials comprising hydrogenated and/or partially hydrogenated polymerized vegetable oils. Non-limiting applications of the polymerized oils, including coatings, binders, blends, and greases are presented. Methods for forming these materials are also disclosed.",ARCHER DANIELS MIDLAND CO,BLOOM PAUL D;;HOLZGRAEFE DAVID P,,https://lens.org/043-649-722-041-629,Patent Application,yes,6,13,4,18,0,C08F8/04;;C11C3/00;;C11C3/12;;C08F8/04;;C11C3/12;;C11C3/00,C10M101/00;;C08F8/04;;C08L91/00;;C08L91/06,508/506;;524/313;;106/244;;106/245,0,0,,,,EXPIRED
151,WO,A1,WO 2018/089247 A1,077-687-096-067-514,2018-05-17,2018,US 2017/0059674 W,2017-11-02,US 201615349667 A,2016-11-11,ULCER DETECTION APPARATUS AND METHOD WITH VARYING THRESHOLDS,"A method determines the emergence of an ulcer or a pre-ulcer on at least one foot of a patient provides one or more processors and a modality for receiving at least one foot. The method generates, using a plurality of temperature sensors, discrete temperature data values after receipt of the at last one foot. The plurality of discrete temperature data values represents temperatures at different locations of the at least one foot. Next, the method compares, using a prescribed function, each of the discrete temperature data values to one of a plurality of different predetermined values. The predetermined values are different for at least two different locations of the at least one foot. The method then produces output information indicating an emergence of an ulcer or a pre-ulcer on the at least one foot as a result of comparing.",PODIMETRICS INC,LINDERS DAVID;;PETERSEN BRIAN;;BLOOM JONATHAN,,https://lens.org/077-687-096-067-514,Patent Application,yes,5,0,7,7,0,A61B5/6829;;A61B5/015;;A61B5/445;;A61B5/447;;A61B5/6892;;A61B5/6829;;A61B5/015;;A61B5/445;;A61B5/447;;A61B5/6892,A61B5/00;;A61B5/01;;G08B23/00,,0,0,,,,PENDING
152,WO,A1,WO 2015/035144 A1,155-263-631-544-57X,2015-03-12,2015,US 2014/0054260 W,2014-09-05,US 201361874680 P,2013-09-06,USER GREY CELL,"In various embodiments, a user grey cell is disclosed. The user grey cell comprises a simplified logical implementation of a black box cell identified in a software and/or hardware design. The internal functionality of the black box cell is undefined, hidden, or encrypted, and thus is not available for timing analysis. The user grey cell for the black box cell provides sufficient clocking and register information to allow for accurate CDC, false path, and multi-cycle path analysis, and provides a way for designers to locate and repair clock domain crossing violations before the design is implemented in hardware. In various embodiments, a method for user grey cell analysis is disclosed. The method comprises identifying one or more black box cells in a user design. The method further comprises determining which of the input and/or output pins of each of the black box cells are in use by the user design. The method further comprises selecting a user grey cell for one or more of the black box cells, wherein a user grey cell comprises a simplified logic implementation for the black box cell, sufficient to perform CDC, false path, and multi-cycle path analysis. The selected user grey cells may be used in place of the black box cells for CDC, false path, and multi-cycle path analysis.",BLUE PEARL SOFTWARE INC,BLOOM SCOTT ARON;;WALLACE DAVID E,,https://lens.org/155-263-631-544-57X,Patent Application,yes,5,0,4,4,0,G06F30/34;;G06F30/30;;G06F2119/12;;G06F30/34;;G06F30/30;;G06F2119/12;;G06F30/32,G06F17/50;;G06F19/00,,0,0,,,,PENDING
153,WO,A3,WO 2010/144754 A3,158-007-487-563-763,2011-03-31,2011,US 2010/0038238 W,2010-06-10,US 48268609 A,2009-06-11,DISPLAY SYSTEM,A display system is based on a linear array phase modulator and a phase edge discriminator optical system.,ALCES TECHNOLOGY INC;;BLOOM DAVID M;;LEONE MATTHEW A,BLOOM DAVID M;;LEONE MATTHEW A,,https://lens.org/158-007-487-563-763,Search Report,yes,4,0,6,18,0,G02B26/06;;G02B26/06;;G02B26/101;;G02B26/101;;H04N9/3132;;H04N9/3132,G02B26/10;;G02B27/18;;H04N5/74,,0,0,,,,PENDING
154,US,S,US D0313023 S,183-092-100-508-555,1990-12-18,1990,US 20302688 F,1988-06-06,US 20302688 F,1988-06-06,Front control panel for a vehicular compact disc player,,FORD MOTOR CO,KOLENDA DAVID F;;BLOOM KENNETH H,FORD MOTOR COMPANY A CORP. OF DE (1988-05-26);;FORD GLOBAL TECHNOLOGIES INC. A MICHIGAN CORPORATION (1997-03-01),https://lens.org/183-092-100-508-555,Design Right,yes,21,151,1,1,0,,,D14/258,4,0,,,"Stereo Review; May 1987; p. 59; center--Sony model CDX-R7.;;HFD; 12/16/85; p. 80; top--Sanyo radio and compact disc player.;;Crutchfield Catalog; Summer 1987; p. 29; top--Sony model CD-XR88.;;""The Luxurious Sounds from Lincoln"", Ford Audio Systems, FAS-88L-01.",EXPIRED
155,WO,A1,WO 2016/160658 A1,180-230-816-066-506,2016-10-06,2016,US 2016/0024434 W,2016-03-28,US 201514677789 A,2015-04-02,MATTER TRACKING SYSTEM,"A system is described that can detect, track and analyze a bubble of a secondary substance contained within a primary substance along a part of a fluid line. For example, the system can detect the presence of the bubble within the primary substance along the part of the fluid line, which can include assigning a digital signature to the bubble. In addition, the system can track the movement of the bubble in order to ensure that the bubble is accounted for only once as it passes through the part of the fluid line. Furthermore, the system can analyze the bubble, such as determine its direction of travel, speed of travel, volume and size.",CAREFUSION 303 INC,OSCOLAI BILL;;BLOOM MARK;;BROWN DAVID,,https://lens.org/180-230-816-066-506,Patent Application,yes,7,0,14,14,0,G01N2291/02433;;G06T2207/10016;;G06T7/246;;G01N2291/02433;;G06T2207/10016;;G06T7/246;;H04N23/56;;H04N23/80;;G01N21/17;;G01N2021/177;;G06T2207/10004,A61B1/06;;A61M1/28;;A61M5/168;;A61M31/00;;A61M39/28;;B65B1/00,,2,1,027-043-112-285-945,10.1088/1742-6596/147/1/012018,"WANG H Y ET AL.: ""Journal of Physics: Conference Series"", vol. 147, 1 February 2009, INSTITUTE OF PHYSICS PUBLISHING, article ""A method for bubble volume calculating in vertical two-phase flow"", pages: 12018;;See also references of EP 3277154A4",PENDING
156,WO,A1,WO 1998/041893 A1,186-072-404-909-113,1998-09-24,1998,US 9805397 W,1998-03-19,US 82139097 A,1997-03-20,DISPLAY DEVICE INCORPORATING ONE-DIMENSIONAL HIGH-SPEED GRATING LIGHT VALVE ARRAY,A display system for providing a two-dimensional image includes an essentially one-dimensional light valve array. The diffractive light valve array includes modulator elements which diffract or reflect light incident thereon to an extent determined by an image element to be represented. The display system is arranged such that diffracted light from the light valve array passes through a magnifying lens and is separated from the reflected light from the array. A magnified virtual image of the array formed by the diffracted light is viewed through the magnifying lens. A scanning arrangement between the viewer and the magnifying lens scans the image of the light valve array across the field of view of the viewer sufficiently quickly that the viewer perceives the scanned image as a two-dimensional image. In another arrangement a printer is formed by scanning a real image of the diffractive light valve array over a printing or recording medium.,SILICON LIGHT MACHINES INC,BLOOM DAVID M;;GODIL ASIF A,,https://lens.org/186-072-404-909-113,Patent Application,yes,5,14,15,15,0,G02B5/1828;;G02B26/0808;;G02B26/10;;G02B27/017;;G02B26/08;;G02B27/017;;G02B5/1828;;G02B26/10;;G02B26/0808,G02B5/18;;G02B26/08;;B41J2/445;;G02B26/10;;G02B27/01,G2J JB7WX         JB7WX,1,1,031-674-958-708-951,10.1364/ao.28.004826;;20555956,"TEPE R ET AL: ""VISCOELASTIC SPATIAL LIGHT MODULATOR WITH ACTIVE MATRIX ADDRESSING"", APPLIED OPTICS, vol. 28, no. 22, 15 November 1989 (1989-11-15), pages 4826 - 4834, XP000071462",PATENTED
157,EP,A2,EP 1203245 A2,038-610-339-106-187,2002-05-08,2002,EP 00952655 A,2000-08-08,US 0021664 W;;US 37264999 A,1999-08-11,ACHROMATIC DIFFRACTIVE OPTICAL MODULATOR,,LIGHTCONNECT INC,GODIL ASIF A;;BLOOM DAVID M,,https://lens.org/038-610-339-106-187,Patent Application,yes,0,0,6,23,0,G02B5/1828;;G02B6/266;;G02B6/29352;;G02B6/3516;;G02B6/357;;G02B6/3584;;G02B26/0808;;H01S5/005;;G02B26/0808;;G02B6/266;;G02B5/1828;;G02B6/3584;;G02B6/3516;;G02B6/29352;;G02B6/357;;H01S5/005,G02B26/00;;G02B5/18;;G02B6/26;;G02B6/34;;G02B6/35;;G02B26/08;;G02F1/035;;H01S5/00,,0,0,,,,DISCONTINUED
158,US,B2,US 8730557 B2,043-143-295-018-863,2014-05-20,2014,US 201213657530 A,2012-10-22,US 201213657530 A;;US 201161550810 P,2011-10-24,Low voltage drive for MEMS ribbon array light modulators,A series bias voltage increases the sensitivity of a MEMS ribbon to control signal voltages. This effect is obtained because of the nonlinear dependence of ribbon deflection on applied voltage. The resulting low-voltage operation of MEMS ribbons makes them more compatible with high speed electronics.,BLOOM DAVID M;;LEONE MATTHEW A;;ALCES TECHNOLOGY INC,BLOOM DAVID M;;LEONE MATTHEW A,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2013-03-25),https://lens.org/043-143-295-018-863,Granted Patent,yes,6,1,2,2,0,G02B26/0841;;G09G3/3466;;G09G2310/08;;G09G2320/0252;;G02B26/00;;G02B26/0841;;G09G2310/08;;G09G2320/0252;;G09G3/3466,G02B26/00;;G02B26/08;;G02F1/29,359/290;;359/292;;359/298,0,0,,,,ACTIVE
159,WO,A2,WO 2001/011419 A2,084-044-771-768-31X,2001-02-15,2001,US 0021662 W,2000-08-08,US 37271299 A;;US 37264999 A;;US 17168599 P;;US 54878800 A;;US 54978100 A,1999-08-11,DYNAMIC SPECTRAL SHAPING FOR FIBER-OPTIC APPLICATION,"The present invention is directed towards dynamic spectral shaping. Using a grating (150), the spectral band is spread across a diffractive MEMS (200) or other suitable device operable as a controllable grating providing a controllable reflectivity as a function of wavelength. The device may be the deformable grating modulator invented by Bloom et. al. (US patent no. 5,311,360) or other suitable device. The invention also includes the coupling in and out of the fiber (105) and may use polarization optics (130, 140) to ensure the grating is used in only one polarization where the diffraction efficiency is higher.",LIGHTCONNECT INC,GODIL ASIF A;;BLOOM DAVID M,,https://lens.org/084-044-771-768-31X,Patent Application,yes,0,20,6,23,0,G02B6/266;;G02B6/2793;;G02B6/2931;;G02B6/29313;;G02B6/29395;;G02B26/0808;;H01S3/06754;;H01S3/10023;;H01S5/005;;H01S2301/04;;H01S5/005;;H01S3/10023,G02B6/00;;G02B6/26;;G02B6/34;;G02B6/35;;G02B26/08;;H01S3/067;;H01S3/10;;H01S5/00;;H04B10/29;;H04B10/294,,0,0,,,,PENDING
160,US,B2,US 9175957 B2,095-297-204-293-404,2015-11-03,2015,US 201314032459 A,2013-09-20,US 201314032459 A;;US 201261705000 P,2012-09-24,Grayscale patterns from binary spatial light modulators,Brightness-by-column grayscale and spatial Σ-Δ modulation grayscale allow grayscale patterns to be produced using a binary spatial light modulator as fast as the bright/dark switching speed.,BLOOM DAVID M;;LEONE MATTHEW A;;ALCES TECHNOLOGY INC,BLOOM DAVID M;;LEONE MATTHEW A,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2013-10-17),https://lens.org/095-297-204-293-404,Granted Patent,yes,2,0,9,9,0,G01B11/2527;;F21K9/60;;F21K9/65;;G02F1/155;;G09G3/3433;;G02B26/0808;;G02F1/0128;;G09G2300/0426;;G02B27/0068;;G02B26/0816;;G02B26/085;;G09G2300/0473;;G02B26/0858;;G02F1/29;;G02B26/101;;G02F1/0123;;G02B26/06;;G02B26/02;;H04N13/254;;G02B26/0841;;G01C3/08;;G06V10/145;;G02F1/155;;G09G3/3433;;G02B26/0808;;G02F1/0128;;G09G2300/0426;;G02B27/0068;;G02B26/0816;;G02B26/085;;G09G2300/0473;;G02B26/0858;;G02F1/29;;G02B26/101;;G02F1/0123;;G02B26/06;;G02B26/02;;H04N13/204;;H04N13/254;;G01B11/2527;;F21K9/60;;F21K9/65;;G06V10/145;;G02B26/0833;;G02F1/13306;;G02B26/0841;;G01C3/08,G01C3/08;;F21K99/00;;G01B11/25;;G02B26/02;;G02B26/06;;G02B26/08;;G02B26/10;;G02B27/00;;G02F1/01;;G02F1/133;;G02F1/155;;G02F1/29;;G06V10/145;;G09G3/34;;H04N13/02,,2,1,014-382-749-502-411,10.1889/1.1833710,"Doherty et al., ""Phased Reset Timing for Improved Digital Micromirror Device (DMD) Brightness"", Society for Information Display, 1998.;;Dudley et al., ""Emerging Digital Micromirror Device (DMD) Applications"", Society of Photo-Optical Instrumentation Engineers, 2003.",INACTIVE
161,US,B2,US 7951862 B2,105-265-950-923-003,2011-05-31,2011,US 87630810 A,2010-09-07,US 87630810 A;;US 70899807 A;;US 42814603 A;;US 37680702 P;;US 40350502 P;;US 43441902 P,2002-05-02,Hydrogenated and partially hydrogenated heat-bodied oils and uses thereof,"The present disclosure presents materials comprising hydrogenated and/or partially hydrogenated polymerized vegetable oils. Non-limiting applications of the polymerized oils, including coatings, binders, blends, and greases are presented. Methods for forming these materials are also disclosed.",ARCHER DANIELS MIDLAND CO,BLOOM PAUL D;;HOLZGRAEFE DAVID P,,https://lens.org/105-265-950-923-003,Granted Patent,yes,6,13,4,18,0,C08F8/04;;C11C3/00;;C11C3/12;;C08F8/04;;C11C3/12;;C11C3/00,C09D11/02;;C08F8/04;;C08L91/00;;C08L91/06,524/270;;524/313;;524/277,1,0,,,"Fred L. Fox ""Oils for Organic Coatings"" edited by Wayne R. Fuller (p. 24, line 17 to p. 25, line 25), Sep. 1965.",EXPIRED
162,US,B1,US 6826330 B1,155-914-698-976-39X,2004-11-30,2004,US 54978100 A,2000-04-14,US 54978100 A;;US 54878800 A;;US 37271299 A;;US 37264999 A;;US 17168599 P,1999-08-11,Dynamic spectral shaping for fiber-optic application,"
    The present invention is directed towards dynamic spectral shaping. Using a grating, the spectral band is spread across a MEMS or other suitable device array. The device may be the deformable grating modulator invented by Bloom et. al. (U.S. Pat. No. 5,311,360) or other suitable device. The invention also includes the coupling in and out of the fiber and may use polarization optics to ensure the grating is used in only one polarization where the diffraction efficiency is higher. 
",LIGHTCONNECT INC,GODIL ASIF A;;BLOOM DAVID M,LIGHTCONNECT (2000-06-07);;LIGHTCONNECT INC (2000-12-11);;NEOPHOTONICS CORPORATION (2010-03-11),https://lens.org/155-914-698-976-39X,Granted Patent,yes,47,33,1,23,0,G02B26/0808;;G02B26/0808;;G02B5/1828;;G02B5/1828;;G02B6/266;;G02B6/266;;G02B6/2793;;G02B6/2793;;G02B6/3516;;G02B6/3516;;G02B6/3592;;G02B6/3592;;H01S5/005;;H01S5/005,G02B5/18;;G02B6/26;;G02B6/34;;G02B6/35;;G02B26/08;;H01S5/00,385/37;;385/10;;385/33,3,3,046-917-547-643-055;;033-962-722-216-001;;062-505-227-937-061,10.1109/50.701404;;10.1016/s0030-4018(99)00302-8;;10.1109/68.720287,"Parker, Michael C. ""Dynamic Digital Holographic Wavelength Filtering"", Journal of Lightwave Technology, vol. 16, No. 7, Jul. 1998.;;Wang, Lei and Weiner, A.M. ""Programmable Spectral Phase Coding of an Amplified Spontaneous Emission Light Source"", Optics Communications, 167 (1999) 211-224, Aug. 15, 1999.;;Ford, Joseph E. and Walker, James A. ""Dynamic Spectral Power Equalization Using Micro-Opto-Mechanics"", IEEE Photonics Technology Letters, vol. 10, No. 10, Oct. 1998.",EXPIRED
163,AU,A1,AU 2016/243544 A1,182-188-844-775-541,2017-08-24,2017,AU 2016/243544 A,2016-03-28,US 201514677789 A;;US 2016/0024434 W,2015-04-02,Matter tracking system,"A system is described that can detect, track and analyze a bubble of a secondary substance contained within a primary substance along a part of a fluid line. For example, the system can detect the presence of the bubble within the primary substance along the part of the fluid line, which can include assigning a digital signature to the bubble. In addition, the system can track the movement of the bubble in order to ensure that the bubble is accounted for only once as it passes through the part of the fluid line. Furthermore, the system can analyze the bubble, such as determine its direction of travel, speed of travel, volume and size.",CAREFUSION 303 INC,OSCOLAI BILL;;BLOOM MARK;;BROWN DAVID,,https://lens.org/182-188-844-775-541,Patent Application,no,0,0,14,14,0,G01N2291/02433;;G06T2207/10016;;G06T7/246;;G01N2291/02433;;G06T2207/10016;;G06T7/246;;H04N23/56;;H04N23/80;;G01N21/17;;G01N2021/177;;G06T2207/10004,A61B1/06;;A61M1/28;;A61M5/168;;A61M31/00;;A61M39/28;;B65B1/00,,0,0,,,,ACTIVE
164,KR,A,KR 20170002386 A,021-618-619-432-728,2017-01-06,2017,KR 20167028909 A,2015-03-20,US 201414226515 A;;US 2015/0021883 W,2014-03-26,3D COMPACT 3D DEPTH CAPTURE SYSTEMS,"소형 3D 깊이 캡처 시스템은 3D 시스템 드라이버/인터페이스, 3D 시스템 카메라 및 3D 시스템 프로젝터에 기반한다. 이 시스템은 스마트 폰 및 태블릿 컴퓨터와 같이 휴대 전자 기기에 통합되어 호환될 수 있다.",ALCES TECH INC,BLOOM DAVID M;;LEONE MATTHEW A,,https://lens.org/021-618-619-432-728,Patent Application,no,0,0,10,10,0,G01B11/2527;;G01B11/254;;G01B11/254;;G01B11/2527;;G01B11/2527,G01B11/25,,0,0,,,,PENDING
165,DK,T3,DK 0968453 T3,031-130-236-987-842,2002-03-25,2002,DK 98911822 T,1998-03-19,US 82139097 A;;US 9805397 W,1997-03-20,Visningsanordning omfattende et endimensionalt array af gitterdannende højhastighedslysventiler,,SILICON LIGHT MACHINES INC,BLOOM DAVID M;;GODIL ASIF A,,https://lens.org/031-130-236-987-842,Granted Patent,no,0,0,15,15,0,G02B5/1828;;G02B26/0808;;G02B26/10;;G02B27/017;;G02B26/08;;G02B27/017;;G02B5/1828;;G02B26/10;;G02B26/0808,G02B5/18;;B41J2/445;;G02B26/08;;G02B26/10;;G02B27/01,,0,0,,,,EXPIRED
166,US,A1,US 2014/0034498 A1,037-001-867-614-281,2014-02-06,2014,US 201314056183 A,2013-10-17,US 201314056183 A;;US 71132704 A,2004-09-10,Localized Chemical Microgradients,"A device for creating microgradients in solution is disclosed. The device contains a microfluidic channel with openings at each end and two or more small apertures to a bath. Electrodes are placed in the openings at either end of the channel and an electrical power supply is connected to the electrodes. Several distinct current paths exist from one end of the channel to the other. For example current may flow from one electrode, through a portion of the channel, through an aperture into the bath, back through another aperture into the channel, and along another portion of the channel to the other electrode. Current flows along all possible connected paths when an electric field is applied along the channel and induces fluid flow into and out of the apertures in the channel. Fluid flow through the apertures results in the formation of microgradients in solution near the microfluidic channel device.",PETERMAN MARK C;;BLOOM DAVID M;;ONDA VIA INC,PETERMAN MARK C;;BLOOM DAVID M,ONDAVIA INC (2013-11-08),https://lens.org/037-001-867-614-281,Patent Application,yes,1,0,3,3,0,G01N27/447;;G01N27/447;;B01D57/02,B01D57/02,204/451,1,0,,,"Mark C. Peterman, The Artificial Synapse Chip: From Proteins to Prostheses, Stanford University, July 2003",DISCONTINUED
167,AU,A1,AU 2009/319998 A1,036-746-586-213-748,2010-06-03,2010,AU 2009/319998 A,2009-10-30,US 10963408 P;;US 2009/0062778 W,2008-10-30,Reduction of HMF ethers with metal catalyst,,ARCHER DANIELS MIDLAND CO,BLOOM PAUL DAVID;;SANBORN ALEXANDRA J,,https://lens.org/036-746-586-213-748,Patent Application,no,0,0,27,27,0,C07C41/26;;C07C41/26;;C07D307/54;;C07D307/54;;C07C41/26;;C07C41/26;;C07C43/13;;C07C43/13;;C07C43/13;;C07C43/13;;C07D307/12;;C07D307/12;;C07D307/12;;C07D307/12;;C07D307/16;;C07D307/16;;C07D307/16;;C07D307/16;;C07D307/42;;C07D307/44;;C07D307/44;;C07D307/44;;C07D307/44;;C07D307/54;;C07D307/54;;C08K5/06;;C08K5/06;;C08K5/06;;C08K5/06;;C09K3/00;;C09K3/00,C07D307/20;;C07D307/24;;C07D307/28;;C07D307/34,,0,0,,,,ACTIVE
168,US,A1,US 2010/0315565 A1,047-464-703-420-572,2010-12-16,2010,US 48268609 A,2009-06-11,US 48268609 A,2009-06-11,Display system,A display system is based on a linear array phase modulator and a phase edge discriminator optical system.,ALCES TECHNOLOGY INC,BLOOM DAVID M;;LEONE MATTHEW A,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2010-06-02),https://lens.org/047-464-703-420-572,Patent Application,yes,11,5,6,18,0,G02B26/06;;G02B26/06;;G02B26/101;;G02B26/101;;H04N9/3132;;H04N9/3132,H04N9/31,348/744;;X348E09025,0,0,,,,INACTIVE
169,EP,A1,EP 3277154 A1,055-376-289-675-480,2018-02-07,2018,EP 16773900 A,2016-03-28,US 201514677789 A;;US 2016/0024434 W,2015-04-02,MATTER TRACKING SYSTEM,,CAREFUSION 2200 INC,OSCOLAI BILL;;BLOOM MARK;;BROWN DAVID,"CAREFUSION 303, INC. (2020-08-19)",https://lens.org/055-376-289-675-480,Patent Application,yes,0,0,14,14,0,G01N2291/02433;;G06T2207/10016;;G06T7/246;;G01N2291/02433;;G06T2207/10016;;G06T7/246;;H04N23/56;;H04N23/80;;G01N21/17;;G01N2021/177;;G06T2207/10004,A61B1/06;;A61M1/28;;A61M5/168;;A61M31/00;;A61M39/28;;B65B1/00,,0,0,,,,ACTIVE
170,US,A1,US 2014/0085426 A1,082-637-917-999-200,2014-03-27,2014,US 201314032415 A,2013-09-20,US 201314032415 A;;US 201261705000 P,2012-09-24,Structured light systems with static spatial light modulators,Structured light systems are based on temporally modulated light sources and static spatial light modulators.,LEONE MATTHEW A;;BLOOM DAVID M;;ALCES TECHNOLOGY INC,LEONE MATTHEW A;;BLOOM DAVID M,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2013-10-17),https://lens.org/082-637-917-999-200,Patent Application,yes,28,19,9,9,0,G01B11/2527;;F21K9/60;;F21K9/65;;G02F1/155;;G09G3/3433;;G02B26/0808;;G02F1/0128;;G09G2300/0426;;G02B27/0068;;G02B26/0816;;G02B26/085;;G09G2300/0473;;G02B26/0858;;G02F1/29;;G02B26/101;;G02F1/0123;;G02B26/06;;G02B26/02;;H04N13/254;;G02B26/0841;;G01C3/08;;G06V10/145;;G02F1/155;;G09G3/3433;;G02B26/0808;;G02F1/0128;;G09G2300/0426;;G02B27/0068;;G02B26/0816;;G02B26/085;;G09G2300/0473;;G02B26/0858;;G02F1/29;;G02B26/101;;G02F1/0123;;G02B26/06;;G02B26/02;;H04N13/204;;H04N13/254;;G01B11/2527;;F21K9/60;;F21K9/65;;G06V10/145;;G02B26/0833;;G02F1/13306;;G02B26/0841;;G01C3/08,G06V10/145;;F21K99/00;;H04N13/02,348/46;;362/227;;362/277;;362/259,0,0,,,,DISCONTINUED
171,WO,A1,WO 2022/005547 A1,093-280-040-082-008,2022-01-06,2022,US 2021/0025590 W,2021-04-02,US 202016914954 A,2020-06-29,TECHNIQUES FOR PROVIDING INTERACTIVE INTERFACES FOR LIVE STREAMING EVENTS,Techniques are described herein for providing an interactive interface for live streaming events. A user may view a broadcasted live streaming event via the interactive interface. A sub-group of participants of the live streaming event may be identified from a larger group of participants based at least in part on respective locations of respective computing devices of the sub-group participants. A graphical representation can be generated for the group using images of each of the sub-group participants. A selection of the sub-group can be received from the interactive interface and the graphical representation can be presented in response to receiving the selection. Various features of the interactive interface provide for a more enriching experience for both the performer(s) and viewing participants of the broadcasted live streaming event.,AMAZON TECH INC,BLOOM STEVE JOHN;;NAKAYAMA DAVID HIKARU,,https://lens.org/093-280-040-082-008,Patent Application,yes,4,4,3,3,0,H04N21/2187;;H04N21/44218;;H04N21/42203;;H04N21/4223;;H04N21/4788;;H04N21/25841;;H04N21/4312;;H04N21/25866;;H04N7/157;;G06Q50/01;;H04N21/2187;;H04N21/25883;;H04N21/25891;;H04N21/4788,H04N21/2187;;G06Q50/10;;H04N7/15;;H04N21/258;;H04N21/422;;H04N21/4223;;H04N21/431;;H04N21/442;;H04N21/4788,,0,0,,,,PENDING
172,EP,A4,EP 1974235 A4,106-987-742-483-446,2011-10-19,2011,EP 07762536 A,2007-01-16,US 2007/0001165 W;;US 33627706 A,2006-01-20,POLARIZATION LIGHT MODULATOR,,ALCES TECHNOLOGY INC,BLOOM DAVID M;;PETERMAN MARK C,,https://lens.org/106-987-742-483-446,Search Report,no,4,0,9,9,0,G02B26/06;;G02B26/0808;;G02B26/0825;;G02B27/283;;G02B26/06;;G02B27/283;;G02B26/0808;;G02B26/0825,G02B26/06;;G02B26/08;;G02B27/28,,1,0,,,See also references of WO 2007087201A2,ACTIVE
173,WO,A1,WO 2007/014293 A1,121-884-189-738-15X,2007-02-01,2007,US 2006/0029242 W,2006-07-25,US 70256705 P;;US 72237905 P,2005-07-25,DIGITAL IMAGING SYSTEM AND METHOD TO PRODUCE MOSAIC IMAGES,"A digital imaging system and method using multiple cameras arranged and aligned to create a much larger virtual image sensor array. Each camera has a lens with an optical axis aligned parallel to the optical axes of the other camera lenses, and a digital image sensor array with one or more non-contiguous pixelated sensors. The non-contiguous sensor arrays are spatially arranged relative to their respective optical axes so that each sensor images a portion of a target region that is substantially different from other portions of the target region imaged by other sensors, and preferably overlaps adjacent portions imaged by the other sensors. In this manner, the portions imaged by one set of sensors completely fill the image gaps found between other portions imaged by other sets of sensors, so that a seamless mosaic image of the target region may be produced.",UNIV CALIFORNIA;;STONE GARY F;;BLOOM DAVID A,STONE GARY F;;BLOOM DAVID A,,https://lens.org/121-884-189-738-15X,Patent Application,yes,4,22,2,2,0,H04N5/2624;;H04N23/698;;H04N25/41;;H04N5/2624;;H04N23/698;;H04N25/41,H04N5/225;;H04N5/262,,0,0,,,,PENDING
174,US,A1,US 2006/0130692 A1,149-707-039-338-766,2006-06-22,2006,US 90521004 A,2004-12-21,US 90521004 A,2004-12-21,Alignment tool for precise pattern transfer,"Multi-point confocal microscopy, bright field microscope imaging, computer-controlled positioning stages, and an algorithm for automated leveling are the basis for a powerful but simple tool for aligning stamps used in precise pattern transfer to substrates. The system is relatively inexpensive and brings a capability similar to that of a photolithographic mask aligner to the world of elastomeric-stamp-based lithography. Alignment of the stamp and substrate is possible without contact between the two before printing.",ALCES TECHNOLOGY INC,PETERMAN MARK C;;BLOOM DAVID M,LABRADOR RESEARCH LLC (2008-12-31);;ALCES TECHNOLOGY INC (2004-12-10),https://lens.org/149-707-039-338-766,Patent Application,yes,4,9,2,2,0,G02B21/0024;;G02B21/26;;G03F9/7026;;G03F9/7034;;G03F9/7042;;G03F9/7088;;G03F9/7034;;G02B21/26;;G03F9/7042;;G02B21/0024;;G03F9/7088;;G03F9/7026,B41F1/34,101/485,0,0,,,,INACTIVE
175,CA,A,CA 1146454 A,156-036-370-182-270,1983-05-17,1983,CA 327061 A,1979-05-07,US 90877478 A,1978-05-23,CREATION OF F.SUP. .SUB.2COLOR CENTERS,"BLOOM, D. M. 1-5 CREATION OF F? COLOR CENTERS Production of F? color centers in alkali halide crystals with densities high enough for efficient use in lasers is achieved by a two-step, highly selective photoionization mechanism. This mechanism is coupled with the use of suitable divalent metal ions as efficient and stable electron traps to allow nearly 100 percent conversion of F2 color centers to F? color centers. The two-step photoionization mechanism comprises photo-exciting the F2 color center to the first bound state, which requires lower energy than the corresponding transition for F color centers, then photoionizing the F2 color center from the first bound state, and finally, capturing the electron thus liberated on the divalent metal ions.",WESTERN ELECTRIC CO,BLOOM DAVID M;;MOLLENAUER LINN F,,https://lens.org/156-036-370-182-270,Granted Patent,no,0,0,9,9,0,H01S3/1681;;H01S3/1681,C09K11/00;;C09K11/08;;H01S3/00;;H01S3/094;;H01S3/16,148-1.0,0,0,,,,EXPIRED
176,US,A,US 5764280 A,160-609-355-034-085,1998-06-09,1998,US 82139197 A,1997-03-20,US 82139197 A,1997-03-20,Display system including an image generator and movable scanner for same,"A display device includes a plurality of modulatable light sources providing a one-dimensional array of display-elements, and a scanning unit, carried or worn by the user, which causes the user to perceive the array as a two-dimensional image. The scanning unit is movable with respect to the array while still allowing the user to view the array as a two-dimensional image.",SILICON LIGHT MACHINES INC,BLOOM DAVID M;;GODIL ASIF A,SILICON LIGHT MACHINES INC (1997-03-17);;SILICON LIGHT MACHINES CORPORATION (2002-04-01);;SILICON LIGHT MACHINES (1996-07-19),https://lens.org/160-609-355-034-085,Granted Patent,yes,11,31,3,3,0,B60K35/00;;B60K35/00;;B62J50/22;;B62J50/22;;G02B27/017;;G02B27/017;;G02B26/0875;;G02B26/0875;;G02B26/0883;;G02B26/0883;;G02B2027/0138;;G02B2027/0138;;G09G3/003;;G09G3/003;;G09G3/02;;G09G3/02;;H04N13/167;;H04N13/167;;H04N13/189;;H04N13/189;;H04N13/194;;H04N13/194;;H04N13/286;;H04N13/286;;H04N13/324;;H04N13/324;;H04N13/341;;H04N13/341;;H04N13/344;;H04N13/344;;H04N13/398;;H04N13/398,B60K35/00;;B62J99/00;;G02B26/08;;G02B27/00;;G02B27/01;;G09G3/00;;H04N13/00,348/53;;345/8,0,0,,,,EXPIRED
177,WO,A2,WO 2007/087201 A2,173-776-787-588-743,2007-08-02,2007,US 2007/0001165 W,2007-01-16,US 33627706 A,2006-01-20,POLARIZATION LIGHT MODULATOR,"Polarization light modulators are based on an interferometric design in which a polarizing beam splitter serves as a polarizer and analyzer. A polarization displacement device shifts orthogonally polarized light beams parallel to the long axis of their elongated cross sections. Phase shifts are imparted to the orthogonally polarized beams by linear array MEMS optical phase shift devices. The output of the light modulator is a line image which may be scanned to form a two-dimensional image. Features to improve brightness, contrast and overall compactness of design are disclosed.",ALCES TECHNOLOGY INC;;BLOOM DAVID M;;PETERMAN MARK C,BLOOM DAVID M;;PETERMAN MARK C,,https://lens.org/173-776-787-588-743,Patent Application,yes,4,0,9,9,0,G02B26/06;;G02B26/0808;;G02B26/0825;;G02B27/283;;G02B26/06;;G02B27/283;;G02B26/0808;;G02B26/0825,G02F1/01,,1,0,,,See also references of EP 1974235A4,PENDING
178,WO,A1,WO 1998/041894 A1,002-426-329-731-214,1998-09-24,1998,US 9805511 W,1998-03-19,US 82139197 A,1997-03-20,DISPLAY SYSTEM INCLUDING AN IMAGE GENERATOR AND MOVABLE SCANNER FOR SAME,"A display device includes a plurality of modulatable light sources providing a one-dimensional array of display-elements, and a scanning unit, carried or worn by the user, which causes the user to perceive the array as a two-dimensional image. The scanning unit is movable with respect to the array while still allowing the user to view the array as a two-dimensional image.",SILICON LIGHT MACHINES INC,BLOOM DAVID M;;GODIL ASIF A,,https://lens.org/002-426-329-731-214,Patent Application,yes,6,1,3,3,0,B60K35/00;;B60K35/00;;B62J50/22;;B62J50/22;;G02B27/017;;G02B27/017;;G02B26/0875;;G02B26/0875;;G02B26/0883;;G02B26/0883;;G02B2027/0138;;G02B2027/0138;;G09G3/003;;G09G3/003;;G09G3/02;;G09G3/02;;H04N13/167;;H04N13/167;;H04N13/189;;H04N13/189;;H04N13/194;;H04N13/194;;H04N13/286;;H04N13/286;;H04N13/324;;H04N13/324;;H04N13/341;;H04N13/341;;H04N13/344;;H04N13/344;;H04N13/398;;H04N13/398,B60K35/00;;B62J99/00;;G02B26/08;;G02B27/00;;G02B27/01;;G09G3/00;;H04N13/00,,0,0,,,,PENDING
179,AU,A,AU 2001/016537 A,059-119-235-159-331,2001-03-05,2001,AU 2001/016537 A,2000-08-08,US 37271299 A;;US 37264999 A;;US 17168599 P;;US 54878800 A;;US 54978100 A;;US 0021662 W,1999-08-11,Dynamic spectral shaping for fiber-optic application,,LIGHTCONNECT INC,GODIL ASIF A;;BLOOM DAVID M,,https://lens.org/059-119-235-159-331,Patent Application,no,0,0,6,23,0,G02B6/266;;G02B6/2793;;G02B6/2931;;G02B6/29313;;G02B6/29395;;G02B26/0808;;H01S3/06754;;H01S3/10023;;H01S5/005;;H01S2301/04;;H01S5/005;;H01S3/10023,G02B6/00;;G02B6/26;;G02B6/34;;G02B6/35;;G02B26/08;;H01S3/067;;H01S3/10;;H01S5/00;;H04B10/29;;H04B10/294,,0,0,,,,DISCONTINUED
180,US,A1,US 2021/0409787 A1,083-784-509-652-167,2021-12-30,2021,US 202016914954 A,2020-06-29,US 202016914954 A,2020-06-29,TECHNIQUES FOR PROVIDING INTERACTIVE INTERFACES FOR LIVE STREAMING EVENTS,Techniques are described herein for providing an interactive interface for live streaming events. A user may view a broadcasted live streaming event via the interactive interface. A sub-group of participants of the live streaming event may be identified from a larger group of participants based at least in part on respective locations of respective computing devices of the sub-group participants. A graphical representation can be generated for the group using images of each of the sub-group participants. A selection of the sub-group can be received from the interactive interface and the graphical representation can be presented in response to receiving the selection. Various features of the interactive interface provide for a more enriching experience for both the performer(s) and viewing participants of the broadcasted live streaming event.,AMAZON TECH INC,BLOOM STEVE JOHN;;NAKAYAMA DAVID HIKARU,,https://lens.org/083-784-509-652-167,Patent Application,yes,3,3,3,3,0,H04N21/2187;;H04N21/44218;;H04N21/42203;;H04N21/4223;;H04N21/4788;;H04N21/25841;;H04N21/4312;;H04N21/25866;;H04N7/157;;G06Q50/01;;H04N21/2187;;H04N21/25883;;H04N21/25891;;H04N21/4788,H04N21/2187;;H04N21/258;;H04N21/4788,,0,0,,,,PENDING
181,US,A,US 4220928 A,093-980-352-793-922,1980-09-02,1980,US 90877378 A,1978-05-23,US 90877378 A,1978-05-23,Adaptive correction of linear phase aberrations in laser amplifier systems,"Linear phase aberrations in laser amplifier systems are adaptively corrected by a device which propagates an object beam formed by reflection of a laser beam from a target backwards through a laser amplifier chain in order to sample the linear phase aberrations and produces a conjugate image beam by degenerate four-wave mixing in a medium having a third order nonlinearity in susceptibility. The conjugate image beam which is amplified as it propagates back through the laser amplifier chain has the linear phase aberrations removed. The device also corrects for birefringent aberrations contained in the laser amplifier chain when (1) the medium has an isotropic nonlinearity; (2) the polarization of the pump beams, required for four-wave mixing, lies in the plane formed by the object beam and the pump beams; and (3) the angle between the object beams and the pump beams is substantially 90 degrees. The degenerate four-wave mixing is accomplished in one embodiment by gain saturation in Nd:YAG.",BELL TELEPHONE LABOR INC,BLOOM DAVID M;;LIAO PAUL F,,https://lens.org/093-980-352-793-922,Granted Patent,yes,1,31,1,1,0,G02F1/3538;;G02F1/3538;;H01S3/2316;;H01S3/2316;;H01S3/10076;;H01S3/10076;;H01S3/108;;H01S3/108,G02F1/35;;H01S3/23,330/4.3,8,1,008-594-560-074-473,20111195;;10.1364/ao.10.001695,"Jensen et al., ""Observation of the Time-Reversed . . . Wave"", 2/78, pp. 166-168, Appl. Phys. Lett., vol. 32, #3.;;Hellwarth, ""Generation of Time Reversed . . . Refraction"", 1/77, pp. 1-3, J. Opt. Soc. Am., vol. 67, #1.;;Yariv et al., ""Amplified Reflection . . . Mixing"", 7/77, pp. 16-18, OpticsLetters, vol. 1, #1, GZ54.;;""Generation of Time Reversed . . . Waves"", p. 26, Hellwarth et al., 5/78, Laser Focus.;;Bloom et al., ""Observation of Amplified . . . Vapor"", 3/78, pp. 58-60, Optics Letters, vol. 2, #3.;;Bloom et al., ""Conjugate Wave Front . . . Mixing"", 11/77, pp. 592-594, Appl. Phys. Lett., vol. 31, #9.;;Hill, ""Simple Transient Holograms in Ruby"", 7/71, pp. 1695-1697, Applied Optics, vol. 10, #7, G-254.;;Abrams et al., ""Degenerate Four-Wave . . . Media"", 4/78, pp. 94-96, Optics Letters, vol. 2, #4.",EXPIRED
182,NO,D0,NO 994515 D0,106-314-440-167-521,1999-09-17,1999,NO 994515 A,1999-09-17,US 82139097 A;;US 9805397 W,1997-03-20,"Fremvisningsanordning omfattende en éndimensjonal, höyhastighets gitterlysventiloppstilling",,SILICON LIGHT MACHINES INC,BLOOM DAVID M;;GODIL ASIF A,,https://lens.org/106-314-440-167-521,Patent Application,no,0,0,15,15,0,G02B5/1828;;G02B26/0808;;G02B26/10;;G02B27/017;;G02B26/08;;G02B27/017;;G02B5/1828;;G02B26/10;;G02B26/0808,G02B5/18;;B41J2/445;;G02B26/08;;G02B26/10;;G02B27/01,,0,0,,,,DISCONTINUED
183,WO,A9,WO 2001/011419 A9,198-832-864-281-886,2002-07-18,2002,US 0021662 W,2000-08-08,US 37271299 A;;US 37264999 A;;US 17168599 P;;US 54878800 A;;US 54978100 A,1999-08-11,DYNAMIC SPECTRAL SHAPING IN OPTICAL FIBRE COMMUNICATION,"The present invention is directed towards dynamic spectral shaping. Using a grating (150), the spectral band is spread across a diffractive MEMS (200) or other suitable device operable as a controllable grating providing a controllable reflectivity as a function of wavelength. The device may be the deformable grating modulator invented by Bloom et. al. (US patent no. 5,311,360) or other suitable device. The invention also includes the coupling in and out of the fiber (105) and may use polarization optics (130, 140) to ensure the grating is used in only one polarization where the diffraction efficiency is higher.",LIGHTCONNECT INC,GODIL ASIF A;;BLOOM DAVID M,,https://lens.org/198-832-864-281-886,Patent Application,no,0,0,6,23,0,G02B6/266;;G02B6/2793;;G02B6/2931;;G02B6/29313;;G02B6/29395;;G02B26/0808;;H01S3/06754;;H01S3/10023;;H01S5/005;;H01S2301/04;;H01S5/005;;H01S3/10023,G02B6/00;;G02B6/26;;G02B6/34;;G02B6/35;;G02B26/08;;H01S3/067;;H01S3/10;;H01S5/00;;H04B10/29;;H04B10/294,,0,0,,,,PENDING
184,US,A1,US 2016/0292866 A1,019-702-397-043-806,2016-10-06,2016,US 201514677789 A,2015-04-02,US 201514677789 A,2015-04-02,MATTER TRACKING SYSTEM,"A system is described that can detect, track and analyze a bubble of a secondary substance contained within a primary substance along a part of a fluid line. For example, the system can detect the presence of the bubble within the primary substance along the part of the fluid line, which can include assigning a digital signature to the bubble. In addition, the system can track the movement of the bubble in order to ensure that the bubble is accounted for only once as it passes through the part of the fluid line. Furthermore, the system can analyze the bubble, such as determine its direction of travel, speed of travel, volume and size.",CAREFUSION 303 INC,BLOOM MARK;;OSCOLAI BILL;;BROWN DAVID,CAREFUSION 303 INC (2015-09-15),https://lens.org/019-702-397-043-806,Patent Application,yes,15,7,14,14,0,G01N2291/02433;;G06T2207/10016;;G06T7/246;;G01N2291/02433;;G06T2207/10016;;G06T7/246;;H04N23/56;;H04N23/80;;G01N21/17;;G01N2021/177;;G06T2207/10004,G06T7/00;;G01N21/17;;H04N5/225;;H04N5/232,,3,1,095-685-303-423-07X,10.1007/s00348-009-0815-2,"StÃ¶hr, M., C. Garbe, D. Engelmann, P. Geissler, S. Gomes, F. Hering, H.-G. Wagner and B. Jahne, â4-D particle tracking velocimetry applied to gas-liquid reactors. In Proc. Of the Int. Workshop of Scientific Computing in Chemical Engineering II, Hamburg-Harburg, 1999.;;StÃ¶hr publication date: screen shot taken from google search results. See attached PDF titled StÃ¶hr publication date.;;Ohmi K., S. P. Pandy, A. Sapkota, ""Particle tracking velocimetry with an ant colony optimization algorithm, Exp Fluids (2010) 48:589-605 DOI 10.1007/s00348-009-0815-2",ACTIVE
185,US,A1,US 2014/0085562 A1,052-009-212-079-628,2014-03-27,2014,US 201314032459 A,2013-09-20,US 201314032459 A;;US 201261705000 P,2012-09-24,Grayscale patterns from binary spatial light modulators,Brightness-by-column grayscale and spatial Σ-Δ modulation grayscale allow grayscale patterns to be produced using a binary spatial light modulator as fast as the bright/dark switching speed.,BLOOM DAVID M;;LEONE MATTHEW A;;ALCES TECHNOLOGY INC,BLOOM DAVID M;;LEONE MATTHEW A,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2013-10-17),https://lens.org/052-009-212-079-628,Patent Application,yes,0,6,9,9,0,G01B11/2527;;F21K9/60;;F21K9/65;;G02F1/155;;G09G3/3433;;G02B26/0808;;G02F1/0128;;G09G2300/0426;;G02B27/0068;;G02B26/0816;;G02B26/085;;G09G2300/0473;;G02B26/0858;;G02F1/29;;G02B26/101;;G02F1/0123;;G02B26/06;;G02B26/02;;H04N13/254;;G02B26/0841;;G01C3/08;;G06V10/145;;G02F1/155;;G09G3/3433;;G02B26/0808;;G02F1/0128;;G09G2300/0426;;G02B27/0068;;G02B26/0816;;G02B26/085;;G09G2300/0473;;G02B26/0858;;G02F1/29;;G02B26/101;;G02F1/0123;;G02B26/06;;G02B26/02;;H04N13/204;;H04N13/254;;G01B11/2527;;F21K9/60;;F21K9/65;;G06V10/145;;G02B26/0833;;G02F1/13306;;G02B26/0841;;G01C3/08,G02F1/133;;G02B26/08;;G06V10/145,349/57;;359/292,0,0,,,,INACTIVE
186,US,A1,US 2016/0033758 A1,106-553-808-402-381,2016-02-04,2016,US 201514871517 A,2015-09-30,US 201514871517 A;;US 201314032459 A;;US 201261705000 P,2012-09-24,Grayscale patterns from binary spatial light modulators,Brightness-by-column grayscale and spatial Σ-Δ modulation grayscale allow grayscale patterns to be produced using a binary spatial light modulator as fast as the bright/dark switching speed.,BLOOM DAVID M;;LEONE MATTHEW A;;ALCES TECHNOLOGY INC,BLOOM DAVID M;;LEONE MATTHEW A,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2015-10-26),https://lens.org/106-553-808-402-381,Patent Application,yes,3,2,9,9,0,G01B11/2527;;F21K9/60;;F21K9/65;;G02F1/155;;G09G3/3433;;G02B26/0808;;G02F1/0128;;G09G2300/0426;;G02B27/0068;;G02B26/0816;;G02B26/085;;G09G2300/0473;;G02B26/0858;;G02F1/29;;G02B26/101;;G02F1/0123;;G02B26/06;;G02B26/02;;H04N13/254;;G02B26/0841;;G01C3/08;;G06V10/145;;G02F1/155;;G09G3/3433;;G02B26/0808;;G02F1/0128;;G09G2300/0426;;G02B27/0068;;G02B26/0816;;G02B26/085;;G09G2300/0473;;G02B26/0858;;G02F1/29;;G02B26/101;;G02F1/0123;;G02B26/06;;G02B26/02;;H04N13/204;;H04N13/254;;G01B11/2527;;F21K9/60;;F21K9/65;;G06V10/145;;G02B26/0833;;G02F1/13306;;G02B26/0841;;G01C3/08,G02B26/08;;G02F1/133;;G06V10/145,,0,0,,,,ACTIVE
187,GB,A,GB 2117168 A,088-163-417-626-244,1983-10-05,1983,GB 8308021 A,1983-03-23,GB 8208376 A,1982-03-23,METHOD AND APPARATUS FOR USE IN PROCESSING SIGNALS,,BLOOM PHILLIP JEFFREY;;MARSHALL GARTH DAVID,BLOOM PHILLIP JEFFREY;;MARSHALL GARTH DAVID,,https://lens.org/088-163-417-626-244,Patent Application,no,0,5,10,10,0,G03B31/00;;G10L21/04;;G11B27/034;;G11B27/10;;G10L21/04;;G11B27/10;;G03B31/00;;G11B27/034,G03B31/00;;G10L21/04;;G11B27/034;;G11B27/10,G5R RB264         RB81;;G5R RB29X         RB81;;G5R RB293         RB81;;G5R RB340         RB81;;G5R RB341         RB81;;G5R RB36Y         RB81;;G5R RB361         RB81;;G5R RB37Y         RB81;;G5R RB373         RB81;;G5R RB38Y         RB81;;G5R RB60X         RB81;;G5R RB77Y         RB81;;G5R RB771         RB81;;G5R RB784         RB81;;G5R RB788         RB81;;G5R RB81          RB81,0,0,,,,EXPIRED
188,US,B2,US 9389069 B2,166-050-983-218-604,2016-07-12,2016,US 201414226515 A,2014-03-26,US 201414226515 A,2014-03-26,Compact 3D depth capture systems,"Compact 3D depth capture systems are based on a 3D system driver/interface, a 3D system camera, and a 3D system projector. The systems are compatible with integration in to mobile electronic devices such as smart phones and tablet computers.",BLOOM DAVID M;;LEONE MATTHEW A;;ALCES TECHNOLOGY INC,BLOOM DAVID M;;LEONE MATTHEW A,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2014-10-29),https://lens.org/166-050-983-218-604,Granted Patent,yes,20,8,10,10,0,G01B11/2527;;G01B11/254;;G01B11/254;;G01B11/2527;;G01B11/2527,G01B11/25,,13,9,136-459-007-966-432;;069-095-624-769-095;;004-769-363-651-450;;070-519-983-844-538;;020-043-222-388-123;;016-099-816-860-630;;005-561-162-808-435;;032-333-700-027-711;;059-044-108-448-030,10.1016/j.optlaseng.2009.09.001;;10.1364/ao.17.002930;;20203900;;10.1109/jsen.2009.2031228;;10.1364/ao.46.000036;;17167551;;10.1117/12.678150;;19516395;;10.1364/oe.14.002644;;10.1109/isie.2008.4677260;;10.1109/3dimpvt.2011.56;;10.1109/jstsp.2012.2195157;;10.1109/cvpr.2007.383291,"International Search Report and Written Opinion of the International Searching Authority in PCT/US2015/021883, Jul. 14, 2015.;;Search report and written opinion of the international searching authority in PCT/US2011/021198 Sep. 28, 2011.;;Gorthi et al., ""Fringe Projection Techniques: Whither we are?"", Optics and Lasers in Engineering preprint, Sep. 2009.;;Blais, ""Review of 20 Years of Range Sensor Development"", National Research Council Canada, Jan. 2004.;;Indebetouw, ""Profile measurement using projection of running fringes"", Applied Optics, v 17, p. 2930, Sep. 1978.;;Kimachi et al., ""Real-Time Phase-Stamp Range Finder Using Correlation Image Sensor"", IEEE Sensors J., v. 9, p. 1784, Dec. 2009.;;Zhang et al., ""Generic nonsinusoidal phase error correction for three-dimensional shape measurement using a digital video projector"", Applied Optics, v. 46, p. 36, Jan. 2007.;;Zhang et al., ""High-resolution, real-time 3D absolute coordinate measurement based on a phase-shifting method"", Optics Express, v. 14, p. 2644, Apr. 2006.;;Ando et al., ""Spatio-temporal phase-encoding profilometry using correlation image sensor"", IEEE International Symposium on Industrial Electronics, p. 786, 2008.;;Pethe, ""Super resolution 3D scanning using spatial light modulator and band correction"", University of Kentucky Masters Thesis, 2008.;;Garcia et al., ""Temporally-Consistent Phase Unwrapping for a Stereo-Assisted Structured Light System"", IEEE 2011 Intl. Conf. 3D Imaging, Modeling, Processing, Visualization and Transmission, 2011.;;Garcia et al., ""Consistent Stereo-Assisted Absolute Phase Unwrapping Methods for Structured Light Systems"", IEEE J. Selected Topics in Signal Processing, v. 6, p. 411, 2012.;;Weise et al., ""Fast 3D Scanning with Automatic Motion Compensation"", IEEE, 2007.",ACTIVE
189,US,S,US D0324629 S,170-931-739-286-052,1992-03-17,1992,US 29273289 F,1989-01-03,US 29273289 F,1989-01-03,Paint mixing paddle,,B & B DECORATING COMPANY,BLOOM DAVID R;;BAXTER TERRY J,B & B DECORATING COMPANY (1988-12-27),https://lens.org/170-931-739-286-052,Design Right,yes,9,2,1,1,0,,,D 8 14,0,0,,,,EXPIRED
190,EP,A4,EP 3123717 A4,190-119-482-257-501,2017-08-30,2017,EP 15769750 A,2015-03-20,US 201414226515 A;;US 2015/0021883 W,2014-03-26,COMPACT 3D DEPTH CAPTURE SYSTEMS,,ALCES TECH INC,BLOOM DAVID M;;LEONE MATTHEW A,,https://lens.org/190-119-482-257-501,Search Report,no,2,0,10,10,0,G01B11/2527;;G01B11/254;;G01B11/2527;;G01B11/254;;G01B11/2527,G01B11/25;;H04M1/00;;H04N13/00;;H04N13/02;;H04N13/04,,0,0,,,,DISCONTINUED
191,EP,A1,EP 0117335 A1,181-274-901-923-606,1984-09-05,1984,EP 83306261 A,1983-10-14,US 47066483 A,1983-02-28,High speed photodiodes.,A high speed planar photodiode having a bandwidth in excess of 50 GHz is fabricated on gallium arsenide and includes a Schottky diode having an optically transparent metal barrier (11) or a heterojunction diode having an optically transparent heterojunction region. The diode is surrounded by a nonconducting region (21) to minimise fringing fields and beam leads may be provided to minimise lead inductance. A high speed MESFET phototransistor using the planar photodiode is also disclosed.,HEWLETT PACKARD CO,WANG SHIH-YUAN;;BLOOM DAVID M,,https://lens.org/181-274-901-923-606,Patent Application,yes,1,2,2,2,0,H01L31/0304;;H01L31/108;;H01L31/109;;H01L31/1123;;H01L31/0304;;Y02E10/544;;H01L31/1123;;H01L31/109;;H01L31/108,H01L31/0304;;H01L31/108;;H01L31/109;;H01L31/112,,2,2,097-548-620-515-99X;;055-119-993-350-746,10.1063/1.92828;;10.1063/1.93877,"APPLIED PHYSICS LETTERS, vol. 39, no. 8, October 1981, New York, US W.C. BALLAMY et al.:""Low barrier height Schottky mixer diode using super thin silicon films by molecular beam epitaxy"", pages 629-630;;APPLIED PHYSICS LETTERS, Vol. 42, no. 2, January 1983, New York, US S.Y. WANG et al.: ""20-GHz bandwidth GaAs photodiode"", pages 190-192",DISCONTINUED
192,AU,B2,AU 2016/243544 B2,196-973-182-063-706,2020-04-09,2020,AU 2016/243544 A,2016-03-28,US 201514677789 A;;US 2016/0024434 W,2015-04-02,Matter tracking system,"A system is described that can detect, track and analyze a bubble of a secondary substance contained within a primary substance along a part of a fluid line. For example, the system can detect the presence of the bubble within the primary substance along the part of the fluid line, which can include assigning a digital signature to the bubble. In addition, the system can track the movement of the bubble in order to ensure that the bubble is accounted for only once as it passes through the part of the fluid line. Furthermore, the system can analyze the bubble, such as determine its direction of travel, speed of travel, volume and size.",CAREFUSION 303 INC,OSCOLAI BILL;;BLOOM MARK;;BROWN DAVID,,https://lens.org/196-973-182-063-706,Granted Patent,no,1,0,14,14,0,G01N2291/02433;;G06T2207/10016;;G06T7/246;;G01N2291/02433;;G06T2207/10016;;G06T7/246;;H04N23/56;;H04N23/80;;G01N21/17;;G01N2021/177;;G06T2207/10004,A61B1/06;;A61M1/28;;A61M5/168;;A61M31/00;;A61M39/28;;B65B1/00,,0,0,,,,ACTIVE
193,US,A,US 5212057 A,010-486-519-777-293,1993-05-18,1993,US 45548389 A,1989-12-22,US 45548389 A;;US 26276988 A,1988-10-26,Biological system for constructing and testing viral vaccines,"Disclosed is a novel biological system for 1) the evaluation of potential complications of live virus vaccines prior to actual testing in animals or in the field, and 2) the construction of vaccine vectors in which the ability to grow within specific organs or tissues has selectively been eliminated from the virus.",UNIV FLORIDA,MOYER RICHARD W;;BLOOM DAVID C,UNIVERSITY OF FLORIDA (1989-12-19),https://lens.org/010-486-519-777-293,Granted Patent,yes,1,5,1,1,0,C12N15/86;;C12N2710/24143;;C12N2710/24145;;C12P7/00;;C12Q1/70;;C12N15/86;;C12N2710/24145;;C12P7/00;;C12N2710/24143;;C12Q1/70,C12N15/863;;C12P7/00;;C12Q1/70,435/5;;435/235.1;;435/236;;435/320.1;;435/238,4,4,009-372-903-326-197;;084-276-249-520-605;;028-091-728-498-319;;029-303-786-464-692,10.1073/pnas.80.17.5364;;6310573;;pmc384256;;pmc255954;;10.1128/jvi.61.11.3550-3554.1987;;2822962;;3551937;;10.1002/bies.950050604;;3945343;;10.1038/319549a0,"Panicali et al., Proc. Natl. Acad. Sci. U.S.A., vol. 80, pp. 5364 5368, Sep. 1983, Construction of Live Vaccines by Using Genetically Engineered Poxviruses: Biological Activity of Recombinant Vaccinia Virus Expressing Influenza Virus Hemagglutinin.;;Rodriguez et al., J. Virol., vol. 61, No. 11, Nov. 1987, pp. 3550 3554, Mapping and Nucleotide Sequence of the Vaccinia Virus Gene that Encodes a 14 Kilodalton Fusion Protein .;;Piccini, A., and E. Paoletti (1986) The use of vaccinia virus for the construction of recombinant vaccines, Bioessays 5:248 252.;;Brown, F., G. C. Schild, and G. L. Ada (1986) Recombinant vaccinia viruses as vaccines, Nature 319:549 550.",EXPIRED
194,EP,B1,EP 1974235 B1,013-737-634-590-822,2013-12-25,2013,EP 07762536 A,2007-01-16,US 2007/0001165 W;;US 33627706 A,2006-01-20,POLARIZATION LIGHT MODULATOR,,ALCES TECHNOLOGY INC,BLOOM DAVID M;;PETERMAN MARK C,,https://lens.org/013-737-634-590-822,Granted Patent,yes,6,0,9,9,0,G02B26/06;;G02B26/0808;;G02B26/0825;;G02B27/283;;G02B26/06;;G02B27/283;;G02B26/0808;;G02B26/0825,G02B26/06;;G02B26/08;;G02B27/28,,0,0,,,,ACTIVE
195,US,A1,US 2007/0154456 A1,034-452-570-536-423,2007-07-05,2007,US 59013605 A,2005-02-17,US 59013605 A;;US 54537504 P;;US 2005/0005461 W,2004-02-17,Insulated herpesvirus-derived gene expression cassettes for sustained and regulatable gene expression,"Disclosed are genetic expression cassettes, and vector comprising them useful for the delivery of nucleic acid segments encoding selected therapeutic constructs (including for example, peptides, polypeptides, ribozymes, and catalytic RN molecules), to selected cells and tissues of vertebrate animals. The disclosed genetic constructs are useful in the development of gene therapy vectors, including for example, viral vectors such as HSV, retroviral, lentiviral, AV, and rAAV vectors. The expression cassettes disclosed herein provide new tools in the field of gene therapy, and for the treatment of mammalian, and in particular, human diseases, disorders, and dysfunctions. The disclosed compositions may be utilized in a variety of investigative, diagnostic and therapeutic regimens, including the prevention and treatment of a variety of human diseases.",UNIV FLORIDA RESERCH FOUNDATIO,BLOOM DAVID C;;AMELIO ANTONIO L,UNIVERSITY OF FLORIDA RESEARCH FOUNDATION INC (2006-10-28),https://lens.org/034-452-570-536-423,Patent Application,yes,1,11,6,6,111,A61K31/713;;A61K31/713;;A61K48/00;;A61K48/00;;C12N15/85;;C12N15/85;;C12N15/86;;C12N15/86;;C12N2710/16611;;C12N2710/16611;;C12N2710/16622;;C12N2710/16633;;C12N2710/16642;;C12N2710/16642;;C12N2710/16643;;C12N2710/16643;;C12N2830/007;;C12N2830/007;;C12N2830/40;;C12N2830/40;;C12N2830/60;;C12N2830/60,A61K48/00;;C12N15/85;;C12N15/86;;C12N15/861;;C12N15/869,424/93.2;;435/456;;435/325;;977/802,0,0,,,,ACTIVE
196,US,A1,US 2006/0054502 A1,048-167-911-063-528,2006-03-16,2006,US 71132704 A,2004-09-10,US 71132704 A,2004-09-10,Localized Chemical Microgradients,"A device for creating microgradients in solution is disclosed. The device contains a microfluidic channel with openings at each end and two or more small apertures to a bath. Electrodes are placed in the openings at either end of the channel and an electrical power supply is connected to the electrodes. Several distinct current paths exist from one end of the channel to the other. For example current may flow from one electrode, through a portion of the channel, through an aperture into the bath, back through another aperture into the channel, and along another portion of the channel to the other electrode. Current flows along all possible connected paths when an electric field is applied along the channel and induces fluid flow into and out of the apertures in the channel. Fluid flow through the apertures results in the formation of microgradients in solution near the microfluidic channel device.",ALCES TECHNOLOGY INC,PETERMAN MARK C;;BLOOM DAVID M,ONDA VIA INC (2009-10-11);;LABRADOR RESEARCH LLC (2008-12-31);;PETERMAN MARK (2009-08-20);;ALCES TECHNOLOGY INC (2004-08-10),https://lens.org/048-167-911-063-528,Patent Application,yes,4,7,3,3,0,G01N27/447;;G01N27/447;;B01D57/02,G01N27/447;;C07K1/26,204/450;;204/600,0,0,,,,ACTIVE
197,US,B1,US 9492249 B1,061-086-002-766-37X,2016-11-15,2016,US 201514639626 A,2015-03-05,US 201514639626 A;;US 201461948082 P,2014-03-05,Dental tool,"Dentals tools are provided for assisting with the gripping and manipulation of an abutment during a dental procedure. A dental tool can have a resilient collar that defines a central bore for frictionally receiving the abutment. Once inserted into the central bore, the dentist can transport the abutment to a worksite within a patient's mouth.",LEFMAN JONATHAN ALAN;;BLOOM DAVID GIL,LEFMAN JONATHAN ALAN;;BLOOM DAVID GIL,,https://lens.org/061-086-002-766-37X,Granted Patent,yes,5,8,1,1,0,A61C3/00;;A61C8/0089;;A61C8/005;;A61C8/0089;;A61C8/005;;A61C3/00,A61C1/12;;A61C3/14;;A61C8/00,,0,0,,,,ACTIVE
198,US,B2,US 8947509 B2,069-051-370-919-350,2015-02-03,2015,US 201414226416 A,2014-03-26,US 201414226416 A;;US 68734010 A,2010-01-14,Structured light system,"A structured light system based on a fast, linear array light modulator and an anamorphic optical system captures three-dimensional shape information at high rates and has strong resistance to interference from ambient light. A structured light system having a modulated light source offers improved signal to noise ratios. A wand permits single point detection of patterns in structured light systems.",BLOOM DAVID M;;LEONE MATTHEW A;;ALCES TECHNOLOGY INC,BLOOM DAVID M;;LEONE MATTHEW A,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2014-10-29),https://lens.org/069-051-370-919-350,Granted Patent,yes,8,7,6,18,0,G01B11/25;;G01B11/25;;H04N13/254;;H04N13/254,H04N13/02;;G01B11/25,348/46,14,10,016-099-816-860-630;;136-459-007-966-432;;069-095-624-769-095;;004-769-363-651-450;;070-519-983-844-538;;020-043-222-388-123;;016-099-816-860-630;;005-561-162-808-435;;032-333-700-027-711;;059-044-108-448-030,10.1109/isie.2008.4677260;;10.1016/j.optlaseng.2009.09.001;;10.1364/ao.17.002930;;20203900;;10.1109/jsen.2009.2031228;;10.1364/ao.46.000036;;17167551;;10.1117/12.678150;;19516395;;10.1364/oe.14.002644;;10.1109/isie.2008.4677260;;10.1109/3dimpvt.2011.56;;10.1109/jstsp.2012.2195157;;10.1109/cvpr.2007.383291,"""Super Resolution 3D Scanning Using Spatial Light Modulator and Band Correction"", University of Kentucky Masters Theses, to Pethe.;;Ando, S.; Ono, N., ""Spatio-temporal phase-encoding profilometry using correlation image sensor,"" Industrial Electronics, 2008. ISIE 2008. IEEE International Symposium on , vol., No., pp. 786,791, Jun. 30, 2008-Jul. 2, 2008.;;Search report and written opinion of the international searching authority in PCT/US2011/021198 Sep. 28, 2011.;;Gorthi et al., ""Fringe Projection Techniques: Whither we are?"", Optics and Lasers in Engineering preprint, Sep. 2009.;;Blais, ""Review of 20 Years of Range Sensor Development"", National Research Council Canada, Jan. 2004.;;Indebetouw, ""Profile measurement using projection of running fringes"", Applied Optics, v 17, p. 2930, Sep. 1978.;;Kimachi et al., ""Real-Time Phase-Stamp Range Finder Using Correlation Image Sensor"", IEEE Sensors J., v. 9, p. 1784, Dec. 2009.;;Zhang et al., ""Generic nonsinusoidal phase error correction for three-dimensional shape measurement using a digital video projector"", Applied Optics, v. 46, p. 36, Jan. 2007.;;Zhang et al., ""High-resolution, real-time 3D absolute coordinate measurement based on a phase-shifting method"", Optics Express, v. 14, p. 2644, Apr. 2006.;;Ando et al., ""Spatio-temporal phase-encoding profilometry using correlation image sensor"", IEEE International Symposium on Industrial Electronics, p. 786, 2008.;;Pethe, ""Super resolution 3D scanning using spatial light modulator and band correction"", University of Kentucky Masters Thesis, 2008.;;Garcia et al., ""Temporally-Consistent Phase Unwrapping for a Stereo-Assisted Structured Light System"", IEEE 2011 Intl. Conf. 3D Imaging, Modeling, Processing, Visualization and Transmission, 2011.;;Garcia et al., ""Consistent Stereo-Assisted Absolute Phase Unwrapping Methods for Structured Light Systems"", IEEE J. Selected Topics in Signal Processing, v. 6, p. 411, 2012.;;Weise et al., ""Fast 3D Scanning with Automatic Motion Compensation"", IEEE, 2007.",INACTIVE
199,BR,B1,BR PI0914384 B1,113-851-596-165-802,2017-04-18,2017,BR PI0914384 A,2009-10-30,US 2009/0062778 W;;US 10963408 P,2008-10-30,método para produzir pelo menos um composto desejado,,ARCHER DANIELS MIDLAN COMPANY,ALEXANDRA J SANBORN;;PAUL DAVID BLOOM,,https://lens.org/113-851-596-165-802,Granted Patent,no,0,0,27,27,0,C07C41/26;;C07C41/26;;C07D307/54;;C07D307/54;;C07C41/26;;C07C41/26;;C07C43/13;;C07C43/13;;C07C43/13;;C07C43/13;;C07D307/12;;C07D307/12;;C07D307/12;;C07D307/12;;C07D307/16;;C07D307/16;;C07D307/16;;C07D307/16;;C07D307/42;;C07D307/44;;C07D307/44;;C07D307/44;;C07D307/44;;C07D307/54;;C07D307/54;;C08K5/06;;C08K5/06;;C08K5/06;;C08K5/06;;C09K3/00;;C09K3/00,C07D307/20;;C07D307/24;;C07D307/28;;C07D307/34,,0,0,,,,ACTIVE
200,NO,L,NO 994515 L,135-614-858-355-681,1999-09-17,1999,NO 994515 A,1999-09-17,US 82139097 A;;US 9805397 W,1997-03-20,"Fremvisningsanordning omfattende en éndimensjonal, höyhastighets gitterlysventiloppstilling","Et fremvisningssystem for tilveie- bringelse av et todimensjonalt bilde omfatter en i hovedsaken éndimensjonal lysventiloppstilling. Den diffraktive lysventiloppstilling omfatter modulator- elementer som oppspalter eller reflek- terer lys som er innfallende på disse, i en grad som bestemmes av et bildeelement som skal representeres. Fremvisningssys- temet er anordnet slik at oppspaltet lys fra lysventiloppstillingen passerer gjennom en forstørrelseslinse og separe- res fra det reflekterte lys fra oppstil- lingen. Et forstørret, virtuelt bilde av oppstillingen som dannes av det oppspal- tede lys, betraktes gjennom forstørrel- seslinsen. Et avsøkingsarrangement mel- lom betrakteren og forstørrelseslinsen avsøker bildet av lysventiloppstillingen over betrakterens synsfelt tilstrekkelig raskt til at betrakteren oppfatter det avsøkte bilde som et todimensjonalt bilde. I et annet arrangement dannes en skriver ved å avsøke et reelt bilde av den diffraktive lysventiloppstilling over et trykkende eller registrerende medium.",SILICON LIGHT MACHINES INC,BLOOM DAVID M;;GODIL ASIF A,,https://lens.org/135-614-858-355-681,Abstract,no,0,0,15,15,0,G02B5/1828;;G02B26/0808;;G02B26/10;;G02B27/017;;G02B26/08;;G02B27/017;;G02B5/1828;;G02B26/10;;G02B26/0808,G02B5/18;;B41J2/445;;G02B26/08;;G02B26/10;;G02B27/01,,0,0,,,,DISCONTINUED
201,US,B2,US 9636354 B2,166-623-967-560-309,2017-05-02,2017,US 201514686541 A,2015-04-14,US 201514686541 A;;US 59013605 A;;US 2005/0005461 W;;US 54537504 P,2004-02-17,Methods for sustained and regulatable gene expression using viral based expression vectors,"Disclosed are genetic expression cassettes, and vectors comprising them useful for the delivery of isolated nucleic acid segments including those expressing or encoding one or more selected therapeutic constructs (including, without limitation, therapeutic peptides, polypeptides, ribozymes, or catalytic RNA molecules), to one or more selected cells or tissues of a vertebrate animal. Methods employing the disclosed genetic constructs in the development of gene therapy-based viral vector systems are also disclosed. The expression cassettes and viral vectors disclosed herein provide new tools for methods of treating mammalian, and in particular, human diseases, disorders, and/or dysfunctions. The disclosed compositions and methods find particular utility in a variety of investigative, diagnostic, and therapeutic regimens, including, for example, in the treatment or amelioration of symptoms of a variety of mammalian, and particularly, human conditions.",UNIV FLORIDA,BLOOM DAVID C;;AMELIO ANTONIO L,UNIVERSITY OF FLORIDA RESEARCH FOUNDATION INC (2015-05-04),https://lens.org/166-623-967-560-309,Granted Patent,yes,4,0,6,6,104,A61K31/713;;A61K31/713;;A61K48/00;;A61K48/00;;C12N15/85;;C12N15/85;;C12N15/86;;C12N15/86;;C12N2710/16611;;C12N2710/16611;;C12N2710/16622;;C12N2710/16633;;C12N2710/16642;;C12N2710/16642;;C12N2710/16643;;C12N2710/16643;;C12N2830/007;;C12N2830/007;;C12N2830/40;;C12N2830/40;;C12N2830/60;;C12N2830/60,C12N5/00;;A61K31/713;;A61K48/00;;C12N15/00;;C12N15/85;;C12N15/86;;C12N15/869,,34,33,013-518-606-477-742;;025-467-091-156-437;;045-132-346-589-711;;012-464-370-234-762;;077-021-354-462-20X;;033-694-002-155-29X;;162-838-749-269-997;;000-576-877-090-383;;090-929-054-315-137;;033-047-630-439-815;;070-694-159-161-42X;;051-206-399-099-077;;056-591-163-039-305;;007-687-709-465-111;;030-518-488-585-14X;;047-766-985-380-524;;112-474-220-577-764;;112-474-220-577-764;;016-087-297-804-267;;051-101-400-051-96X;;084-731-970-237-743;;159-938-484-611-960;;010-749-971-686-146;;015-575-389-306-958;;026-344-896-477-891;;009-716-490-588-215;;097-266-454-941-575;;025-233-200-231-044;;014-753-975-988-237;;107-362-083-347-585;;034-907-439-223-323;;087-851-559-755-992;;135-711-348-500-353,pmc136840;;11752162;;10.1128/jvi.76.2.717-729.2002;;10.1128/jvi.80.5.2358-2368.2006;;pmc1395413;;16474142;;10.1016/s0092-8674(00)81967-4;;10458613;;pmc114183;;10.1128/jvi.75.9.4386-4393.2001;;11287587;;10729137;;10.1128/jvi.74.8.3613-3622.2000;;pmc111871;;10.1128/jvi.70.4.2449-2459.1996;;8642650;;pmc190088;;8107194;;10.1128/jvi.68.3.1283-1292.1994;;pmc236581;;pmc1900208;;10.1128/jvi.02447-06;;17267480;;9261434;;pmc191991;;10.1128/jvi.71.9.7039-7047.1997;;pmc236580;;8107193;;10.1128/jvi.68.3.1271-1282.1994;;2474674;;10.1128/jvi.63.9.3844-3851.1989;;pmc250978;;10.1128/jvi.69.4.2264-2270.1995;;pmc188896;;7884873;;3035069;;10.1099/0022-1317-68-6-1761;;11773630;;pmc117416;;10.1073/pnas.022301899;;10.1146/annurev.mi.49.100195.003331;;8561476;;10.1146/annurev.micro.49.1.675;;10.1006/viro.2001.1265;;11878908;;15507638;;pmc525101;;10.1128/jvi.78.22.12508-12518.2004;;15507638;;pmc525101;;10.1128/jvi.78.22.12508-12518.2004;;10.1128/jvi.71.4.3197-3207.1997;;9060683;;pmc191452;;pmc112048;;10.1128/jvi.74.12.5604-5618.2000;;10823868;;10.1099/0022-1317-82-5-1117;;11297686;;pmc111666;;10644361;;10.1128/jvi.74.4.1885-1891.2000;;pmc237268;;10.1128/jvi.68.12.8045-8055.1994;;7966594;;8551638;;pmc189902;;10.1128/jvi.70.2.976-984.1996;;10.1128/jvi.72.7.5343-5350.1998;;9620987;;pmc110155;;9658140;;pmc109900;;10.1128/jvi.72.8.6888-6892.1998;;10.1128/jvi.66.4.2157-2169.1992;;1312626;;pmc289008;;1312625;;10.1128/jvi.66.4.2150-2156.1992;;pmc289007;;pmc136830;;11752144;;10.1128/jvi.76.2.532-540.2002;;10.1128/jvi.75.14.6660-6675.2001;;pmc114389;;11413333;;10.1101/gad.954702;;11825869;;14759373;;10.1016/s1097-2765(04)00029-2;;10.1128/jvi.64.10.5019-5028.1990;;pmc247993;;2168984,"Ahmed, M et al., “Regions of the herpes simplex virus type 1 latency-associated transcript that protect cells from apoptosis in vitro and protect neuronal cells in vivo,” J. Virol., 76(2):717-729 (2002).;;Amelio, AL, et al., “A chromatin insulator-like element in the herpes simplex virus type 1 latency-associated transcript region binds CCCTC-binding factor and displays enhancer-blocking and silencing activities,” J. Virol. 80(5):2358-2368 (Mar. 2006).;;Bell, AC et al., “The protein CTCF is required for the enhancer blocking activity of vertebrate insulators,” Cell, 98(3):387-396 (1999).;;Berthomme, H et al., “Enhancer and long-term expression functions of herpes simplex virus type 1 latency-associated promoter are both located in the same region,” J. Virol., 75(9):4386-4393 (2001).;;Berthomme, H et al., “Evidence for a bidirectional element located downstream from the herpes simplex virus type 1 latency-associated promoter that increases its activity during latency,” J. Virol., 74(8):3613-3622 (Apr. 2000).;;Bloom, DC et al., “A 348-bp region in the latency associated transcript facilitates herpes simplex virus type 1 reactivation,” J. Virol., 70(4):2449-2459 (1996).;;Bloom, DC et al., “Molecular analysis of herpes simplex virus type 1 during epinephrine induced reactivation of latently infected rabbits in vivo,” J. Virol., 68(3):1283-1292 (1994).;;Chen, Q et al., “CTCF-dependent chromatin boundary element between the latency-associated transcript and ICP0 promoters in the herpes simplex virus type 1 genome,” J. Virol., 81(10):5192-5201 (May 2007).;;Devi-Rao, GB et al., “Herpes simplex virus genome replication and transcription during induced reactivation in the rabbit eye,” J. Virol., 71(9):7039-7047 (1997).;;Devi-Rao, GB et al., “Herpes simplex virus type 1 DNA replication and gene expression during explant induced reactivation of latently infected murine sensory ganglia,” J. Virol., 68(3):1271-1282 (1994).;;Dobson, AT et al., “Identification of the latency-associated transcript promoter by expression of rabbit beta-globin mRNA in mouse sensory nerve ganglia latently infected with a recombinant herpes simplex virus,” J. Virol., 63(9):3844-3851 (1989).;;Dobson, AT et al., “In vivo deletion analysis of the Herpes simplex virus type 1 latency associated transcript promoter,” J. Virol., 69(4):2264-2270 (1995).;;Dressler, GR et al., “Latent herpes simplex virus type 1 DNA is not extensively methylated in vivo,” J. Gen. Virol., 68(Pt 6):1761-1765 (1987).;;European Patent Office, International Search Report, and Written Opinion of the International Search Authority for PCT/US2005/005461 dated Dec. 20, 2005.;;Feldman, LT et al., “Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice,” Proc. Nat'l. Acad. Sci. USA, 99(2):978-983 (2002).;;Glorioso JC et al., “Development and application of herpes simplex virus vectors for human gene therapy,” Annu. Rev. Microbiol., 49:675-710 (Oct. 1995).;;Jarman, RG et al., “The region of the HSV-1 latency-associated transcript required for epinephrine-induced reactivation in the rabbit does not include the 2.0 kb intron,” Virology, 292(1):59-69 (2002).;;Kubat, NJ et al., “The herpes simplex virus type 1 latency-associated transcript (LAT) enhancer/rcr Is hyperacetylated during latency independently of LAT transcription,” J. Virol., 78(22):12508-12518 (Nov. 2004).;;Kubat, NJ et al., “The herpes simplex virus type 1 latency-associated transcript (LAT) enhancer/rcr is hyperacetylated during latency independently of LAT transcription,” J. Virol., 78(22):12508-12518 (2004).;;Lachmann, RH et al.,“Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system,” J. Virol., 71(4):3197-3207 (Apr. 1997).;;Palmer, JA et al., “Development and optimization of herpes simplex virus vectors for multiple long-term delivery to the peripheral nervous system,” J. Virol., 74(12):5604-5618 (Jun. 2000).;;Perng, GC et al., “The effect of latency-associated transcript on the herpes simplex virus type 1 latency-reactivation phenotype is mouse strain-dependent,” J. Gen. Virol., 82(Pt 5):1117-1122 (2001).;;Perng, GC et al., “The latency-associated transcript gene enhances establishment of herpes simplex virus type 1 latency in rabbits,” J. Virol., 74(4):1885-1891 (2000).;;Perng, GC et al., “The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency,” J. Virol., 68(12):8045-8055 (1994).;;Perng, G-C et al., “The spontaneous reactivation function of the herpes simplex virus type 1 LAT gene resides completely within the first 1.5 kilobases of the 8.3-kilobase primary transcript,” J. Virol., 70(2):976-984 (Feb. 1996).;;Sawtell, NM et al., “The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation,” J. Virol., 72(7):5343-5350 (1998).;;Sawtell, NM, “The probability of in vivo reactivation of herpes simplex virus type 1 increases with the number of latently infected neurons in the ganglia,” J. Virol., 72(8):6888-6892 (1998).;;Sawtell, NM, and Thompson, RL, “Herpes simplex virus type 1 latency associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency,” J. Virol., 66(4):2157-2169 (1992a).;;Sawtell, NM, and Thompson, RL, “Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia,” J. Virol., 66(4):2150-2156 (1992b).;;Thomas, DL et al., “The 2-kilobase intron of the herpes simplex virus type 1 latency-associated transcript has a half-life of approximately 24 hours in SY5Y and COS-1 cells,” J. Virol., 76(2):532-540 (2002).;;Thompson, RL, and Sawtell, NM, “Herpes simplex virus type 1 latency-associated transcript gene promotes neuronal survival,” J. Virol., 75(14):6660-6675 (2001).;;West, AG et al., “Insulators: many functions, many mechanisms,” Genes Develop., 16(3):271-288 (Feb. 2002).;;Yusufzai, TM et al., “CTCF tethers an insulator to subnuclear sites, suggesting shared insulator mechanisms across species,” Mol. Cell, 13(2):291-298 (2004).;;Zwaagstra, JC et al., “Activity of herpes simplex virus type 1 latency-associated transcript (LAT) promoter in neuron-derived cells: Evidence for neuron specificity and for a large LAT transcript,” J. Virol., 64(10):5019-5028 (1990).",ACTIVE
202,AU,A,AU 2000/065314 A,004-403-848-499-833,2001-03-05,2001,AU 2000/065314 A,2000-08-08,US 37264999 A;;US 0021664 W,1999-08-11,Achromatic optical modulator,,LIGHTCONNECT INC,GODIL ASIF A;;BLOOM DAVID M,,https://lens.org/004-403-848-499-833,Patent Application,no,0,0,6,23,0,G02B5/1828;;G02B6/266;;G02B6/29352;;G02B6/3516;;G02B6/357;;G02B6/3584;;G02B26/0808;;H01S5/005;;G02B26/0808;;G02B6/266;;G02B5/1828;;G02B6/3584;;G02B6/3516;;G02B6/29352;;G02B6/357;;H01S5/005,G02B26/00;;G02B5/18;;G02B6/26;;G02B6/34;;G02B6/35;;G02B26/08;;G02F1/035;;H01S5/00,,0,0,,,,DISCONTINUED
203,US,A1,US 2009/0268983 A1,052-953-049-716-35X,2009-10-29,2009,US 49376106 A,2006-07-25,US 49376106 A;;US 70256705 P;;US 72237905 P,2005-07-25,Digital imaging system and method using multiple digital image sensors to produce large high-resolution gapless mosaic images,"A digital imaging system and method using multiple cameras arranged and aligned to create a much larger virtual image sensor array. Each camera has a lens with an optical axis aligned parallel to the optical axes of the other camera lenses, and a digital image sensor array with one or more non-contiguous pixelated sensors. The non-contiguous sensor arrays are spatially arranged relative to their respective optical axes so that each sensor images a portion of a target region that is substantially different from other portions of the target region imaged by other sensors, and preferably overlaps adjacent portions imaged by the other sensors. In this manner, the portions imaged by one set of sensors completely fill the image gaps found between other portions imaged by other sets of sensors, so that a seamless mosaic image of the target region may be produced.",UNIV CALIFORNIA,STONE GARY F;;BLOOM DAVID A,REGENTS OF THE UNIVERSITY OF CALIFORNIA THE (2006-07-25);;LAWRENCE LIVERMORE NATIONAL SECURITY LLC (2007-09-24),https://lens.org/052-953-049-716-35X,Patent Application,yes,10,307,2,2,0,H04N5/2624;;H04N23/698;;H04N25/41;;H04N5/2624;;H04N23/698;;H04N25/41,G06K9/36;;H04N5/225,382/284;;348/218.1;;X348E05024;;348/335;;348/262,0,0,,,,DISCONTINUED
204,US,A1,US 2015/0074623 A1,102-309-621-429-197,2015-03-12,2015,US 201414478452 A,2014-09-05,US 201414478452 A;;US 201361874680 P,2013-09-06,USER GREY CELL,"In various embodiments, a user grey cell is disclosed. The user grey cell comprises a simplified logical implementation of a black box cell identified in a software and/or hardware design. The internal functionality of the black box cell is undefined, hidden, or encrypted, and thus is not available for timing analysis. The user grey cell for the black box cell provides sufficient clocking and register information to allow for accurate CDC, false path, and multi-cycle path analysis, and provides a way for designers to locate and repair clock domain crossing violations before the design is implemented in hardware. In various embodiments, a method for user grey cell analysis is disclosed. The method comprises identifying one or more black box cells in a user design. The method further comprises determining which of the input and/or output pins of each of the black box cells are in use by the user design. The method further comprises selecting a user grey cell for one or more of the black box cells, wherein a user grey cell comprises a simplified logic implementation for the black box cell, sufficient to perform CDC, false path, and multi-cycle path analysis. The selected user grey cells may be used in place of the black box cells for CDC, false path, and multi-cycle path analysis.",BLUE PEARL SOFTWARE INC,BLOOM SCOTT ARON;;WALLACE DAVID E,BLUE PEARL SOFTWARE INC (2017-09-05),https://lens.org/102-309-621-429-197,Patent Application,yes,4,1,4,4,0,G06F30/34;;G06F30/30;;G06F2119/12;;G06F30/34;;G06F30/30;;G06F2119/12;;G06F30/32,G06F17/50,716/103,0,0,,,,INACTIVE
205,US,B2,US 8723923 B2,121-206-401-604-907,2014-05-13,2014,US 68734010 A,2010-01-14,US 68734010 A,2010-01-14,Structured light system,"A structured light system based on a fast, linear array light modulator and an anamorphic optical system captures three-dimensional shape information at high rates and has strong resistance to interference from ambient light. A structured light system having a modulated light source offers improved signal to noise ratios. A wand permits single point detection of patterns in structured light systems.",BLOOM DAVID M;;LEONE MATTHEW A;;ALCES TECHNOLOGY,BLOOM DAVID M;;LEONE MATTHEW A,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2010-06-02),https://lens.org/121-206-401-604-907,Granted Patent,yes,9,13,6,18,0,G01B11/25;;G01B11/25;;H04N13/254;;H04N13/254,H04N13/02,348/46,8,5,016-099-816-860-630;;136-459-007-966-432;;069-095-624-769-095;;070-519-983-844-538;;020-043-222-388-123,10.1109/isie.2008.4677260;;10.1016/j.optlaseng.2009.09.001;;10.1364/ao.17.002930;;20203900;;10.1364/ao.46.000036;;17167551;;10.1117/12.678150;;19516395;;10.1364/oe.14.002644,"""Super Resolution 3D Scanning Using Spatial Light Modulator and Band Correction"", University of Kentucky Master's Theses, to Pethe.;;Ando, S.; Ono, N., ""Spatio-temporal phase-encoding profilometry using correlation image sensor,"" Industrial Electronics, 2008. Isie 2008. IEEE International Symposium on , vol., No., pp. 786,791, Jun. 30, 2008-Jul. 2, 2008.;;Search report and written opinion of the international searching authority in PCT/US2011/021198 Sep. 28, 2011.;;Gorthi et al., ""Fringe Projection Techniques: Whither we are?"", Optics and Lasers in Engineering preprint, Sep. 2009.;;Blais, ""Review of 20 Years of Range Sensor Development"", National Research Council Canada, Jan. 2004.;;Indebetouw, ""Profile measurement using projection of running fringes"", Applied Optics, v 17, p. 2930, Sep. 1978.;;Song Zhang et al., ""Generic nonsinusoidal phase error correction for three-dimensional shape measurement using a digital video projector"", Applied Optics, v 46, p. 36 (Jan 1, 2007).;;Song Zhang et al., ""High-resolution, real-time 3D absolute coordinate measurement based on a phase-shifting method"", Optics Express, v 14, p. 2644 (Apr. 3, 2006).",ACTIVE
206,US,B2,US 7842746 B2,141-391-202-683-916,2010-11-30,2010,US 70899807 A,2007-02-21,US 70899807 A;;US 42814603 A;;US 37680702 P;;US 40350502 P;;US 43441902 P,2002-05-02,Hydrogenated and partially hydrogenated heat-bodied oils and uses thereof,"The present disclosure presents materials comprising hydrogenated and/or partially hydrogenated polymerized vegetable oils. Non-limiting applications of the polymerized oils, including coatings, binders, blends, and greases are presented. Methods for forming these materials are also disclosed.",ARCHER DANIELS MIDLAND CO,BLOOM PAUL D;;HOLZGRAEFE DAVID P,ARCHER-DANIELS-MIDLAND COMPANY (2007-02-16),https://lens.org/141-391-202-683-916,Granted Patent,yes,32,26,4,18,0,C08F8/04;;C11C3/00;;C11C3/12;;C08F8/04;;C11C3/12;;C11C3/00,C08F8/04;;C09D11/02;;C08L91/00;;C08L91/06,524/270;;524/277;;524/313,16,3,123-722-678-856-22X;;126-668-742-145-129;;095-584-283-759-840,10.1016/s0040-4039(00)72950-9;;10.1007/bf02667121;;10.1021/jf00081a053,"Fred L. Fox ""Oils for Organic Coatings"" edited by Wayne R. Fuller (p. 24, line 17 to p. 25, line 25), Sep. 1965.;;Jennifer A. Ball, Development and Effectiveness of Three Hydrocolloid-Lipid Emulsion Coatings on Preservation of Quality Characteristics in Green Bell Peppers (1999) (unpublished Ph.D. dissertation, Virginia Tech University)(Abstract).;;""General Classification of Pesticides: Rodenticides"" from PRN Bulletins & Articles, available at http://www.prn2.usm.my/mainsite/bulletin/sun/1997/sun12.html (last visited Feb. 21, 2007).;;Polymer additives to asphalt marketing pamphlet from Rub-R-Road; available at http://www.rub-r-road.com/index.php (last visited Feb. 21, 2007).;;Subbarao. R. et al., ""Protection of unsaturation during heterogeneous catalytic hydrogenation of aliphatic epoxy to hydroxy groups."" Tetrahedron Letters, 1966, 4:379-381.;;Rao et al., ""Protection of unsaturation by cupric nitrate during heterogeneous catalytic hydrogenation of aliphatic epoxy to hydroxy groups."" Journal of American Oil Chemist Society, 1968, 45 (5): 408.;;Salman, O., ""Polymer coating on urea prills to reduce dissolution rate."" Journal of Agricultural Food Chemistry, 1988, 36: 616-621.;;""Linseed Oils"" in ADM marketing pamphlet, available at www.admworld.com (last visited Feb. 21, 2007).;;Fred L. Fox, Oils for Organic Coatings, in Federation Series on Coatings Technology-Unit Three, Oils for Organic Coatings, 1-47 (Published by Federation of Societies for Paint Technology, Philadelphia, PA, 1965).;;""How to Make Your Own Home-Made Natural Skin Care Products-Lip Balms"" in Aromantic marketing pamphlet, available at www.aromantic.co.uk/articles/skin-care-products-pt1.htm (last visited Feb. 21, 2007).;;""Technical Advisory Notes: IFAD Agricultural Technologies for Rural Poverty Alleviation"" in IFAD marketing pamphlet, available at http://www.ifad.org/lrkm/tans/4.htm (last visited Feb. 21, 2007).;;""Skin-Care Recipes"" in Kitchen, Crafts & More pamphlet, available at http://www.kitchencraftsnmore.net/bath3.html (last visited Feb. 21, 2007).;;""Differential Scanning Calorimetry"" in University of Cambridge, Materials Science & Metallurgy website available at www.msm.cam.ac.uk/phase-trans/2002/Thermal2.pdf (last visited Feb. 21, 2007).;;""Iodine Value"" in Encyclopedia Britannica on-line, available at www.britannica.com/eb/article-9042683 (last visited Feb. 21, 2007).;;Kurt C. Frisch, Fundamental Chemistry and Catalysis of Polyurethanes, in Polyurethane Technology, P.F. Bruins, ed. p. 1-38 (published by Interscience Publishers, New York, 1969).;;Takeoka, G.R., et al., ""Effect of Heating in the Characteristics and Composition of Frying Oils and Fats. I. Chemical Composition,"" Tektran, Agricultural Service, available online at www.nal.usda.gov/ttic-/tektran/data/000007/94/0000079483.html (1998).",ACTIVE
207,US,A1,US 2013/0100520 A1,150-940-949-718-537,2013-04-25,2013,US 201213657530 A,2012-10-22,US 201213657530 A;;US 201161550810 P,2011-10-24,Low voltage drive for MEMS ribbon array light modulators,A series bias voltage increases the sensitivity of a MEMS ribbon to control signal voltages. This effect is obtained because of the nonlinear dependence of ribbon deflection on applied voltage. The resulting low-voltage operation of MEMS ribbons makes them more compatible with high speed electronics.,BLOOM DAVID M;;LEONE MATTHEW A,BLOOM DAVID M;;LEONE MATTHEW A,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2013-03-25),https://lens.org/150-940-949-718-537,Patent Application,yes,1,0,2,2,0,G02B26/0841;;G09G3/3466;;G09G2310/08;;G09G2320/0252;;G02B26/00;;G02B26/0841;;G09G2310/08;;G09G2320/0252;;G09G3/3466,G02B26/00,359/291,0,0,,,,ACTIVE
208,AU,A,AU 1998/065736 A,177-589-834-369-474,1998-10-12,1998,AU 1998/065736 A,1998-03-19,US 82139197 A;;US 9805511 W,1997-03-20,Display system including an image generator and movable scanner for same,,SILICON LIGHT MACHINES INC,BLOOM DAVID M;;GODIL ASIF A,,https://lens.org/177-589-834-369-474,Patent Application,no,0,0,3,3,0,B60K35/00;;B60K35/00;;B62J50/22;;B62J50/22;;G02B27/017;;G02B27/017;;G02B26/0875;;G02B26/0875;;G02B26/0883;;G02B26/0883;;G02B2027/0138;;G02B2027/0138;;G09G3/003;;G09G3/003;;G09G3/02;;G09G3/02;;H04N13/167;;H04N13/167;;H04N13/189;;H04N13/189;;H04N13/194;;H04N13/194;;H04N13/286;;H04N13/286;;H04N13/324;;H04N13/324;;H04N13/341;;H04N13/341;;H04N13/344;;H04N13/344;;H04N13/398;;H04N13/398,B60K35/00;;B62J99/00;;G02B26/08;;G02B27/00;;G02B27/01;;G09G3/00;;H04N13/00,,0,0,,,,PENDING
209,US,B2,US 10444141 B2,184-272-037-350-509,2019-10-15,2019,US 201514677789 A,2015-04-02,US 201514677789 A,2015-04-02,Systems and methods for tracking particles in a fluid flow,"A system is described that can detect, track and analyze a bubble of a secondary substance contained within a primary substance along a part of a fluid line. For example, the system can detect the presence of the bubble within the primary substance along the part of the fluid line, which can include assigning a digital signature to the bubble. In addition, the system can track the movement of the bubble in order to ensure that the bubble is accounted for only once as it passes through the part of the fluid line. Furthermore, the system can analyze the bubble, such as determine its direction of travel, speed of travel, volume and size.",CAREFUSION 303 INC,BLOOM MARK;;OSCOLAI CATHAL;;BROWN DAVID,CAREFUSION 303 INC (2015-09-15),https://lens.org/184-272-037-350-509,Granted Patent,yes,25,0,14,14,0,G01N2291/02433;;G06T2207/10016;;G06T7/246;;G01N2291/02433;;G06T2207/10016;;G06T7/246;;H04N23/56;;H04N23/80;;G01N21/17;;G01N2021/177;;G06T2207/10004,G01N21/17;;G06T7/246;;H04N5/225;;H04N5/232,,6,3,095-685-303-423-07X;;095-685-303-423-07X;;027-043-112-285-945,10.1007/s00348-009-0815-2;;10.1007/s00348-009-0815-2;;10.1088/1742-6596/147/1/012018,"Stöhr, M., C. Garbe, D. Engelmann, P. Geissler, S. Gomes, F. Hering, H.-G. Wagner and B. Jahne, 4-D particle tracking velocimetry applied to gas-liquid reactors. In Proc. Of the Int. Workshop of Scientific Computing in Chemical Engineering II, Hamburg-Harburg, 1999.;;Stöhr publication date: screen shot taken from google search results. See attached PDF titled Stöhr publication date.;;Ohmi K., S. P. Pandy, A. Sapkota, Particle tracking velocimetry with an ant colony optimization algorithm, Exp Fluids (2010) 48:589-605 DOI 10.1007/s00348-009-0815-2.;;Stohr, M., C. Garbe, D. Engelmann, P. Geissler, S. Gomes, F. Hering, H.-G. Wagner and B. Jahne, 4-D particle tracking velocimetry applied to gas-liquid reactors. In Proc. Of the Int. Workshop of Scientific Computing in Chemical Engineering II, Hamburg-Harburg, 1999 (Year: 1999).;;Ohmi K., S. P. Pandy, A. Sapkota, Particle tracking velocimetry with an ant colony optimization algorithm, Exp Fluids (2010) 48:589-605 DOI 10.1007/S00348-009-0815-2 (Year: 2010).;;Wang, H.Y. and F. Dong (2009), “A method for bubble volume calculating in vertical two-phase flow.” Journal of Physics: Conference Series, The 6th International Symposium on Measurement Techniques for Multiphase Flows, IOP Publishing, Bristol, GB. vol. 147, No. 1, p. 12018.",ACTIVE
210,MX,A,MX 2011004526 A,194-883-796-454-152,2011-12-14,2011,MX 2011004526 A,2009-10-30,US 10963408 P;;US 2009/0062778 W,2008-10-30,REDUCTION OF HMF ETHERS WITH METAL CATALYST.,"This disclosure describes methods of reducing hydroxymethylfurfural ether and ester derivatives to produce, in the case of ethers, 5-(alkoxymethyl)-tetrahydrofuran-2- methanol and (5-alkoxymethyl)-furan-2 -methanol derivatives, or in the case of esters, 5-(acyloxymethyl)- tetrahydrofuran-2 -methanol and 5-(acyloxymethyl)- furan-2- methanol derivatives. Exemplified methods describe purification thereof. In addition, the disclosure relates to n-alkoxy hexane diol compounds, which are derivative compounds useful for replacement of petroleum based carbitol compounds, and can be made by further reduction of the 5-(alkoxymethyl)-tetrahydrofuran-2- methanol and (5-alkoxymethyl)-furan-2-methanol derivatives. The compounds made by the methods of the present teaching are useful as solvents and as starting materials for making other compositions that meet the requirements of bio-based industrial chemicals from renewable resources.",ARCHER DANIELS MIDLAND CO,BLOOM PAUL DAVID;;SANBORN ALEXANDRA J,,https://lens.org/194-883-796-454-152,Patent Application,no,0,0,27,27,0,C07C41/26;;C07C41/26;;C07D307/54;;C07D307/54;;C07C41/26;;C07C41/26;;C07C43/13;;C07C43/13;;C07C43/13;;C07C43/13;;C07D307/12;;C07D307/12;;C07D307/12;;C07D307/12;;C07D307/16;;C07D307/16;;C07D307/16;;C07D307/16;;C07D307/42;;C07D307/44;;C07D307/44;;C07D307/44;;C07D307/44;;C07D307/54;;C07D307/54;;C08K5/06;;C08K5/06;;C08K5/06;;C08K5/06;;C09K3/00;;C09K3/00,C07D307/20;;C07D307/24;;C07D307/28;;C07D307/34,,0,0,,,,ACTIVE
211,EP,A4,EP 3277154 A4,192-977-687-652-015,2019-01-02,2019,EP 16773900 A,2016-03-28,US 201514677789 A;;US 2016/0024434 W,2015-04-02,MATTER TRACKING SYSTEM,,CAREFUSION 303 INC,OSCOLAI BILL;;BLOOM MARK;;BROWN DAVID,"CAREFUSION 303, INC. (2020-08-19)",https://lens.org/192-977-687-652-015,Search Report,no,1,0,14,14,0,G01N2291/02433;;G06T2207/10016;;G06T7/246;;G01N2291/02433;;G06T2207/10016;;G06T7/246;;H04N23/56;;H04N23/80;;G01N21/17;;G01N2021/177;;G06T2207/10004,A61B1/06;;A61M1/28;;A61M5/168;;A61M31/00;;A61M39/28;;B65B1/00;;G06T7/246,,2,1,027-043-112-285-945,10.1088/1742-6596/147/1/012018,"WANG H Y ET AL: ""A method for bubble volume calculating in vertical two-phase flow"", JOURNAL OF PHYSICS: CONFERENCE SERIES, INSTITUTE OF PHYSICS PUBLISHING, BRISTOL, GB, vol. 147, no. 1, 1 February 2009 (2009-02-01), pages 12018, XP020155886, ISSN: 1742-6596;;See also references of WO 2016160658A1",ACTIVE
212,AU,A,AU 1998/065690 A,029-559-612-585-119,1998-10-12,1998,AU 1998/065690 A,1998-03-19,US 82139097 A;;US 9805397 W,1997-03-20,Display device incorporating one-dimensional high-speed grating light valve array,,SILICON LIGHT MACHINES INC,BLOOM DAVID M;;GODIL ASIF A,,https://lens.org/029-559-612-585-119,Patent Application,no,0,0,15,15,0,G02B5/1828;;G02B26/0808;;G02B26/10;;G02B27/017;;G02B26/08;;G02B27/017;;G02B5/1828;;G02B26/10;;G02B26/0808,B41J2/445;;G02B5/18;;G02B26/08;;G02B26/10;;G02B27/01,,0,0,,,,PENDING
213,US,A1,US 2011/0169915 A1,038-805-453-693-848,2011-07-14,2011,US 68734010 A,2010-01-14,US 68734010 A,2010-01-14,Structured light system,"A structured light system based on a fast, linear array light modulator and an anamorphic optical system captures three-dimensional shape information at high rates and has strong resistance to interference from ambient light. A structured light system having a modulated light source offers improved signal to noise ratios. A wand permits single point detection of patterns in structured light systems.",ALCES TECHNOLOGY INC,BLOOM DAVID M;;LEONE MATTHEW A,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2010-06-02),https://lens.org/038-805-453-693-848,Patent Application,yes,8,29,6,18,0,G01B11/25;;G01B11/25;;H04N13/254;;H04N13/254,H04N13/02,348/46;;X348E13074,2,1,016-099-816-860-630,10.1109/isie.2008.4677260,"""SUPER RESOLUTION 3D SCANNING USING SPATIAL LIGHT MODULATOR AND BAND CORRECTION"", University of Kentucky Master's Theses, to Pethe;;Ando, S.; Ono, N., ""Spatio-temporal phase-encoding profilometry using correlation image sensor,"" Industrial Electronics, 2008. ISIE 2008. IEEE International Symposium on , vol., no., pp.786,791, June 30 2008-July 2 2008",ACTIVE
214,US,B2,US 8970676 B2,051-278-820-420-841,2015-03-03,2015,US 201414226404 A,2014-03-26,US 201414226404 A;;US 68734010 A,2010-01-14,Structured light system,"A structured light system based on a fast, linear array light modulator and an anamorphic optical system captures three-dimensional shape information at high rates and has strong resistance to interference from ambient light. A structured light system having a modulated light source offers improved signal to noise ratios. A wand permits single point detection of patterns in structured light systems.",BLOOM DAVID M;;LEONE MATTHEW A;;ALCES TECHNOLOGY,BLOOM DAVID M;;LEONE MATTHEW A,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2014-10-29),https://lens.org/051-278-820-420-841,Granted Patent,yes,8,3,6,18,0,G01B11/25;;G01B11/25;;H04N13/254;;H04N13/254,H04N13/02;;G01B11/25,348/46,14,10,016-099-816-860-630;;136-459-007-966-432;;069-095-624-769-095;;004-769-363-651-450;;070-519-983-844-538;;020-043-222-388-123;;016-099-816-860-630;;005-561-162-808-435;;032-333-700-027-711;;059-044-108-448-030,10.1109/isie.2008.4677260;;10.1016/j.optlaseng.2009.09.001;;10.1364/ao.17.002930;;20203900;;10.1109/jsen.2009.2031228;;10.1364/ao.46.000036;;17167551;;10.1117/12.678150;;19516395;;10.1364/oe.14.002644;;10.1109/isie.2008.4677260;;10.1109/3dimpvt.2011.56;;10.1109/jstsp.2012.2195157;;10.1109/cvpr.2007.383291,"""Super Resolution 3D Scanning Using Spatial Light Modulator and Band Correction"", University of Kentucky Master's Theses, to Pethe.;;Ando, S.; Ono, N., ""Spatio-temporal phase-encoding profilometry using correlation image sensor,"" Industrial Electronics, 2008. ISIE 2008. IEEE International Symposium on , vol., No., pp. 786,791, Jun. 30-Jul. 2, 2008.;;Search report and written opinion of the international searching authority in PCT/US2011/021198 Sep. 28, 2011.;;Gorthi et al., ""Fringe Projection Techniques: Whither we are?"", Optics and Lasers in Engineering preprint, Sep. 2009.;;Blais, ""Review of 20 Years of Range Sensor Development"", National Research Council Canada, Jan. 2004.;;Indebetouw, ""Profile measurement using projection of running fringes"", Applied Optics, v 17, p. 2930, Sep. 1978.;;Kimachi et al., ""Real-Time Phase-Stamp Range Finder Using Correlation Image Sensor"", IEEE Sensors J., v. 9, p. 1784, Dec. 2009.;;Zhang et al., ""Generic nonsinusoidal phase error correction for three-dimensional shape measurement using a digital video projector"", Applied Optics, v. 46, p. 36, Jan. 2007.;;Zhang et al., ""High-resolution, real-time 3D absolute coordinate measurement based on a phase-shifting method"", Optics Express, v. 14, p. 2644, Apr. 2006.;;Ando et al., ""Spatio-temporal phase-encoding profilometry using correlation image sensor"", IEEE International Symposium on Industrial Electronics, p. 786, 2008.;;Pethe, ""Super resolution 3D scanning using spatial light modulator and band correction"", University of Kentucky Masters Thesis, 2008.;;Garcia et al., ""Temporally-Consistent Phase Unwrapping for a Stereo-Assisted Structured Light System"", IEEE 2011 Intl. Conf. 3D Imaging, Modeling, Processing, Visualization and Transmission, 2011.;;Garcia et al., ""Consistent Stereo-Assisted Absolute Phase Unwrapping Methods for Structured Light Systems"", IEEE J. Selected Topics in Signal Processing, v. 6, p. 411, 2012.;;Weise et al., ""Fast 3D Scanning with Automatic Motion Compensation"", IEEE, 2007.",INACTIVE
215,EP,B1,EP 0968453 B1,060-557-435-958-133,2002-01-30,2002,EP 98911822 A,1998-03-19,US 9805397 W;;US 82139097 A,1997-03-20,DISPLAY DEVICE INCORPORATING ONE-DIMENSIONAL HIGH-SPEED GRATING LIGHT VALVE ARRAY,,SILICON LIGHT MACHINES INC,BLOOM DAVID M;;GODIL ASIF A,,https://lens.org/060-557-435-958-133,Granted Patent,yes,5,0,15,15,0,G02B5/1828;;G02B26/0808;;G02B26/10;;G02B27/017;;G02B26/08;;G02B27/017;;G02B5/1828;;G02B26/10;;G02B26/0808,G02B5/18;;B41J2/445;;G02B26/08;;G02B26/10;;G02B27/01,,1,0,,,"TEPE R ET AL: ""VISCOELASTIC SPATIAL LIGHT MODULATOR WITH ACTIVE MATRIX ADDRESSING"" APPLIED OPTICS, vol. 28, no. 22, 15 November 1989, pages 4826-4834, XP000071462",EXPIRED
216,US,A,US 5231349 A,056-329-577-490-506,1993-07-27,1993,US 58542590 A,1990-12-24,US 58542590 A;;US 19699888 A;;US 31874489 A,1988-05-20,Millimeter-wave active probe system,"Three classes of active probes all with coaxial inputs and coplanar waveguide probe tips are described. A millimeter-wave active probe for generating signals with frequencies about 50 gHz and supplying same to millimeter-wafer including a substrate upon which a frequency multiplier consisting of filter sections and impedance matching sections and nonlinear elements are integrated in uniplanar transmission line medium. Also disclosed is a harmonic mixer probe to step down RF received from an integrated circuit to a lower frequency by mixing it with the harmonics of a local oscillator signal. Also disclosed is an S-parameter active probe for on-wafer measurement of the S-parameters of a two port millimeter-wave device or integrated circuit by injecting millimeter-wave frequencies and simultaneously tapping off a portion of the injected signal, the transmitted signal and the reflected signal and stepping all signals down in frequency to a frequency compatible with currently available test equipment such as the HP8510 automatic network analyzer. This is the first and only all-electronic millimeter-wave on-wafer S-parameter measurement device available at present.",UNIV LELAND STANFORD JUNIOR,MAJIDI-AHY GHOLAMREZA;;BLOOM DAVID M,,https://lens.org/056-329-577-490-506,Granted Patent,yes,27,33,1,4,0,G01R1/06772;;G01R1/06772,G01R1/067,H2E EAHP          EAHP,1,0,,,"Improved Millimeter Wave Signal Analysis , by David, RF & Microwave Symposium & Exhibit., Apr. 1983, pp. 1 5, 8 21.",EXPIRED
217,BR,A2,BR PI0914384 A2,137-723-315-692-951,2016-10-18,2016,BR PI0914384 A,2009-10-30,US 2009/0062778 W;;US 10963408 P,2008-10-30,"método para produzir pelo menos um composto desejado, uso pelo menos um composto substituinte, método para produzir um composto derivado, composto n-alcóxi-hexanodiol, método de produção de um composto, uso do composto, composto que possui pelo menos 37% de origem biológica e composto derivado",,ARCHER DANIELS MIDLAN COMPANY,SANBORN ALEXANDRA J;;BLOOM PAUL DAVID,,https://lens.org/137-723-315-692-951,Patent Application,no,0,0,27,27,0,C07C41/26;;C07C41/26;;C07D307/54;;C07D307/54;;C07C41/26;;C07C41/26;;C07C43/13;;C07C43/13;;C07C43/13;;C07C43/13;;C07D307/12;;C07D307/12;;C07D307/12;;C07D307/12;;C07D307/16;;C07D307/16;;C07D307/16;;C07D307/16;;C07D307/42;;C07D307/44;;C07D307/44;;C07D307/44;;C07D307/44;;C07D307/54;;C07D307/54;;C08K5/06;;C08K5/06;;C08K5/06;;C08K5/06;;C09K3/00;;C09K3/00,C07D307/20;;C07D307/24;;C07D307/28;;C07D307/34,,0,0,,,,ACTIVE
218,US,A1,US 2011/0175864 A1,150-087-431-629-411,2011-07-21,2011,US 201113076121 A,2011-03-30,US 201113076121 A;;US 48268609 A,2009-06-11,Display system,A display system is based on a linear array phase modulator and a phase edge discriminator optical system.,ALCES TECHNOLOGY INC,BLOOM DAVID M;;LEONE MATTHEW A,ALCES TECHNOLGY INC (2011-06-14);;MANTISVISION LTD (2018-04-06),https://lens.org/150-087-431-629-411,Patent Application,yes,2,1,6,18,0,G02B26/06;;G02B26/06;;G02B26/101;;G02B26/101;;H04N9/3132;;H04N9/3132,G09G5/00,345/204,0,0,,,,ACTIVE
219,US,B2,US 9023617 B2,167-693-491-507-421,2015-05-05,2015,US 59013605 A,2005-02-17,US 59013605 A;;US 54537504 P;;US 2005/0005461 W,2004-02-17,Insulated herpesvirus-derived gene expression cassettes for sustained and regulatable gene expression,"Disclosed are genetic expression cassettes, and vector comprising them useful for the delivery of nucleic acid segments encoding selected therapeutic constructs (including for example, peptides, polypeptides, ribozymes, and catalytic RN molecules), to selected cells and tissues of vertebrate animals. The disclosed genetic constructs are useful in the development of gene therapy vectors, including for example, viral vectors such as HSV, retroviral, lentiviral, AV, and rAAV vectors. The expression cassettes disclosed herein provide new tools in the field of gene therapy, and for the treatment of mammalian, and in particular, human diseases, disorders, and dysfunctions. The disclosed compositions may be utilized in a variety of investigative, diagnostic and therapeutic regimens, including the prevention and treatment of a variety of human diseases.",BLOOM DAVID C;;AMELIO ANTONIO L;;UNIV FLORIDA,BLOOM DAVID C;;AMELIO ANTONIO L,UNIVERSITY OF FLORIDA RESEARCH FOUNDATION INC (2006-10-28),https://lens.org/167-693-491-507-421,Granted Patent,yes,2,0,6,6,111,A61K31/713;;A61K31/713;;A61K48/00;;A61K48/00;;C12N15/85;;C12N15/85;;C12N15/86;;C12N15/86;;C12N2710/16611;;C12N2710/16611;;C12N2710/16622;;C12N2710/16633;;C12N2710/16642;;C12N2710/16642;;C12N2710/16643;;C12N2710/16643;;C12N2830/007;;C12N2830/007;;C12N2830/40;;C12N2830/40;;C12N2830/60;;C12N2830/60,C12N15/86;;A61K48/00;;C12N15/85;;C12N15/869,435/69.1;;435/325,15,10,025-467-091-156-437;;051-101-400-051-96X;;016-087-297-804-267;;015-575-389-306-958;;034-907-439-223-323;;077-021-354-462-20X;;112-474-220-577-764;;030-518-488-585-14X;;000-576-877-090-383;;025-467-091-156-437,10.1128/jvi.80.5.2358-2368.2006;;pmc1395413;;16474142;;pmc112048;;10.1128/jvi.74.12.5604-5618.2000;;10823868;;10.1128/jvi.71.4.3197-3207.1997;;9060683;;pmc191452;;8551638;;pmc189902;;10.1128/jvi.70.2.976-984.1996;;10.1101/gad.954702;;11825869;;10729137;;10.1128/jvi.74.8.3613-3622.2000;;pmc111871;;15507638;;pmc525101;;10.1128/jvi.78.22.12508-12518.2004;;10.1146/annurev.mi.49.100195.003331;;8561476;;10.1146/annurev.micro.49.1.675;;pmc1900208;;10.1128/jvi.02447-06;;17267480;;10.1128/jvi.80.5.2358-2368.2006;;pmc1395413;;16474142,"GenBank HSV complete genome downloaded Jul. 31, 2010.;;GenBank LAP promoter regions downloaded Jul. 31, 2010.;;Bloom, D.C., ""ChiPping away at LAT function."" Invited symposium talk, 29th International Herpesvirus Workshop, pp. 1-36. Jul. 25-30, 2004, Reno, NV, USA.;;Amelio, A.L., McAnany, P.J., and D.C. Bloom. ""Identification of a Chromatin Insulator-like element within the HSV-1 LAT Region that Binds CCCTC-Binding Factor and Displays Enhancer-Blocking Activity."" J. Virol. 80:2358-2368, Mar. 2006.;;Amelio AL, and Bloom DC., ""Identification of a Chromatin Insulator with Enhancer-Blocking Activity Located within the HSV-1 LAT region."" p. 1. Poster presentation, 30th International Herpesvirus Workshop, Jul. 2005, Turku, Finland (Abstract attached).;;Amelio, A.L., ""Factors involved in epigenetic regulation of the HSV-1 reactivation critical region (rcr) during latency and reactivation."" pp. 1-204. Doctoral Dissertation, University of Florida. Dec. 2005.;;Palmer J A et al., Development and Optimization of Herpes Simplex Virus Vectors for Multiple Long-Term Delivery to the Peripheral Nervous System. Journal of Virology, The American Society for Microbiology, US, vol. 74, No. 12, Jun. 2000, pp. 5604-5618.;;Lachmann R H et al., Utilization of the Herpes Simplex Virus Type 1 Latency-Associated Regulatory Region to Drive Stable Reporter Gene Expression in the Nervous System. Journal of Virology, The American Society for Microbiology, US, vol. 71, No. 4, Apr. 1997, pp. 3197-3207.;;Perng Guey-Chuen et al., The Spontaneous Reactivation Function of the Herpes Simplex Virus Type 1 Lat Gene Resides Completely Within the First 1.5 Kilobases of the 8.3-Kilobase Primary Transcript. Journal of Virology, vol. 70, No. 2, 1996, pp. 976-984.;;West A G et al., Insulators: Many Functions, Many Mechanisms Genes and Development, Cold Spring Harbor Laboratory Press, New York, US, vol. 16, No. 3, Feb. 1, 2002, pp. 271-288.;;Berthomme Herve et al., Evidence for a Bidirectional Element Located Downstream From the Herpes Simple Virus Type 1 Latency-Associated Promoter That Increases Its Activity During Latency. Journal of Virology, vol. 74, No. 8, Apr. 2000, pp. 3613-3622.;;Kubat, N. J . et al., The Herpes Simplex Virus Type 1 Latency-Associated Transcript (Lat) Enhancer/Rcr Is Hyperacetylated During Latency Independently of LAT Transcription. Journal of Virology, vol. 78, No. 22, Nov. 2004, pp. 12508-12518.;;Glorioso J C et al., Development and Application of Herpes Simplex Virus Vectors for Human Gene Therapy. Annual Review of Microbiology, Annual Reviews Inc., Palo Alto, CA, US, vol. 49, 1995, pp. 675-710.;;Chen, Qi et al., ""CTCF-Dependent Chromatin Boundary Element between the Latency-Associated Transcript and ICP0 Promoters in the Herpes Simplex Virus Type 1 Genome,"" Journal of Virology, 81:5192-5201, May 2007.;;Amelio, Antonio L., ""A Chromatin Insulator-Like Element in the Herpes Simplex Virus Type 1 Latency-Associated Transcript Region Binds CCCTC-Binding Factor and Displays Enhancer-Blocking and Silencing Activities,"" Journal of Virology 80:2358-2368, Mar. 2006.",ACTIVE
220,AU,B2,AU 2009/319998 B2,192-642-577-324-614,2015-07-16,2015,AU 2009/319998 A,2009-10-30,US 10963408 P;;US 2009/0062778 W,2008-10-30,Reduction of HMF ethers with metal catalyst,"This disclosure describes methods of reducing hydroxymethylfurfural ether and ester derivatives to produce, in the case of ethers, 5-(alkoxymethyl)-tetrahydrofuran-2- methanol and (5-alkoxymethyl)-furan-2 -methanol derivatives, or in the case of esters, 5-(acyloxymethyl)- tetrahydrofuran-2 -methanol and 5-(acyloxymethyl)- furan-2- methanol derivatives. Exemplified methods describe purification thereof. In addition, the disclosure relates to n-alkoxy hexane diol compounds, which are derivative compounds useful for replacement of petroleum based carbitol compounds, and can be made by further reduction of the 5-(alkoxymethyl)-tetrahydrofuran-2- methanol and (5-alkoxymethyl)-furan-2-methanol derivatives. The compounds made by the methods of the present teaching are useful as solvents and as starting materials for making other compositions that meet the requirements of bio-based industrial chemicals from renewable resources.",ARCHER DANIELS MIDLAND CO,BLOOM PAUL DAVID;;SANBORN ALEXANDRA J,,https://lens.org/192-642-577-324-614,Granted Patent,no,3,0,27,27,0,C07C41/26;;C07C43/13;;C07D307/12;;C07D307/16;;C07D307/44;;C07D307/54;;C08K5/06;;C09K3/00;;C07C41/26;;C07C43/13;;C07D307/12;;C07D307/16;;C07D307/44;;C07D307/54;;C08K5/06;;C07D307/42;;C07C43/13;;C07D307/12;;C07D307/44;;C07C41/26;;C08K5/06;;C07D307/16;;C07D307/54;;C07C43/13;;C07D307/12;;C07D307/44;;C07C41/26;;C08K5/06;;C07D307/16;;C07D307/54;;C09K3/00,C07D307/20;;C07D307/24;;C07D307/28;;C07D307/34,,1,1,001-006-789-913-484,10.1021/jo9721655,"MICHAEL E. JUNG ET AL: "". . . L-2',3'-Dideoxyisonucleosides via Regioselective Opening of Optically Active C 2 -Symmetric 1,4-Pentadiene Bis-epoxide"", Journal of Organic Chemistry 1998, vol 63, no. 9, 1 May 1998, p. 2975-2981, compound 27.",ACTIVE
221,US,A1,US 2017/0042631 A1,197-865-587-494-641,2017-02-16,2017,US 201515306214 A,2015-04-21,US 201515306214 A;;US 201461982787 P;;US 2015/0026916 W,2014-04-22,INTRA-OPERATIVE MEDICAL IMAGE VIEWING SYSTEM AND METHOD,"An intra-operative medical image viewing system can allow a surgeon to maintain a viewing perspective on the patient while calling-up visual images on-the-fly. A digital image source has at least one image file representative of an anatomical or pathological feature of a patient. A display is worn by the surgeon or positioned between the surgeon and her patient during surgery. The display is selectively transparent, and exhibits to the surgeon an image derived from the image file. An image control unit retrieves the image file from the image source and controls the display so that at least a portion of the image depiction can be exhibited and modified at will by the surgeon. A plurality of peripheral devices are each configured to receive an image control input from the surgeon and, in response, generate an image control signal. Each peripheral accepts a different user-interface modality.",SURGERATI LLC,DOO FLORENCE XINI;;BLOOM DAVID C,SURGERATI LLC (2015-04-21),https://lens.org/197-865-587-494-641,Patent Application,yes,3,58,2,2,0,A61B90/37;;A61B90/37;;A61B2017/00203;;A61B2017/00203;;A61B2017/00207;;A61B2017/00207;;A61B2017/00212;;A61B2017/00212;;A61B2034/2048;;A61B2034/2048;;A61B2034/2065;;A61B2034/2065;;A61B2090/366;;A61B2090/366;;A61B2090/367;;A61B2090/367;;A61B2090/371;;A61B2090/371;;A61B2090/372;;A61B2090/372;;A61B2090/502;;A61B2090/502;;H04N13/344;;H04N13/344;;H04N13/398;;H04N13/398,A61B90/00;;H04N13/04,,0,0,,,,DISCONTINUED
222,AU,A,AU 1983/013708 A,012-411-520-995-382,1983-10-24,1983,AU 1983/013708 A,1983-03-23,GB 8208376 A,1982-03-23,METHOD AND APPARATUS FOR USE IN PROCESSING SIGNALS,,BLOOM PHILLIP JEFFERY,JEFFREY BLOOM PHILLIP;;DAVID MARSHALL GARTH,,https://lens.org/012-411-520-995-382,Patent Application,no,0,0,10,10,0,G03B31/00;;G10L21/04;;G11B27/034;;G11B27/10;;G10L21/04;;G11B27/10;;G03B31/00;;G11B27/034,G03B31/00;;G10L21/04;;G11B27/034;;G11B27/10,,0,0,,,,DISCONTINUED
223,US,A,US 2809139 A,030-562-875-956-914,1957-10-08,1957,US 31675252 A,1952-10-24,US 31675252 A,1952-10-24,Method for heat treating chromium base alloy,,RESEARCH CORP,BLOOM DAVID S;;GRANT NICHOLAS J,,https://lens.org/030-562-875-956-914,Granted Patent,no,6,21,1,1,0,C22C27/06;;C22F1/10;;C22C27/06;;C22F1/10,C22C27/06;;C22F1/10,C7A AA23Y         -           -;;C7A AA233         -           -;;C7A AA235         -           -;;C7A AA237         -           -;;C7A AA239         -           -;;C7A AA24X         -           -;;C7A AA241         -           -;;C7A AA243         -           -;;C7A AA245         -           -;;C7A AA247         -           -;;C7A AA249         -           -;;C7A AA25X         -           -;;C7A AA25Y         -           -;;C7A AA250         -           -;;C7A AA28Y         -           -;;C7A AA280         -           -;;C7A AA289         -           -;;C7A AA290         -           -;;C7A AA293         -           -;;C7A AA296         -           -;;C7A AA299         -           -;;C7A AA30Y         -           -;;C7A AA300         -           -;;C7A AA303         -           -;;C7A AA305         -           -;;C7A AA307         -           -;;C7A AA309         -           -;;C7A AA31X         -           -;;C7A AA311         -           -;;C7A AA313         -           -;;C7A AA316         -           -;;C7A AA319         -           -;;C7A AA320         -           -;;C7A AA323         -           -;;C7A AA326         -           -;;C7A AA329         -           -;;C7A AA33Y         -           -;;C7A AA330         -           -;;C7A AA337         -           -;;C7A AA339         -           -;;C7A AA34Y         -           -;;C7A AA340         -           -;;C7A AA341         -           -;;C7A AA343         -           -;;C7A AA345         -           -;;C7A AA347         -           -;;C7A AA349         -           -;;C7A AA35X         -           -;;C7A AA35Y         -           -;;C7A AA350         -           -;;C7A AA352         -           -;;C7A AA37Y         -           -;;C7A AA377         -           -;;C7A AA379         -           -;;C7A AA38X         -           -;;C7A AA381         -           -;;C7A AA383         -           -;;C7A AA385         -           -;;C7A AA387         -           -;;C7A AA389         -           -;;C7A AA39Y         -           -;;C7A AA390         -           -;;C7A AA394         -           -;;C7A AA396         -           -;;C7A AA398         -           -;;C7A AA40Y         -           -;;C7A AA400         -           -;;C7A AA402         -           -;;C7A AA404         -           -;;C7A AA406         -           -;;C7A AA409         -           -;;C7A AA41Y         -           -;;C7A AA416         -           -;;C7A AA418         -           -;;C7A AA42X         -           -;;C7A AA422         -           -;;C7A AA425         -           -;;C7A AA428         -           -;;C7A AA43X         -           -;;C7A AA432         -           -;;C7A AA435         -           -;;C7A AA437         -           -;;C7A AA439         -           -;;C7A AA44Y         -           -;;C7A AA449         -           -;;C7A AA45X         -           -;;C7A AA451         -           -;;C7A AA453         -           -;;C7A AA455         -           -;;C7A AA457         -           -,0,0,,,,EXPIRED
224,WO,A1,WO 2015/164402 A1,036-999-190-900-168,2015-10-29,2015,US 2015/0026916 W,2015-04-21,US 201461982787 P,2014-04-22,INTRA-OPERATIVE MEDICAL IMAGE VIEWING SYSTEM AND METHOD,"An intra-operative medical image viewing system can allow a surgeon to maintain a viewing perspective on the patient while calling-up visual images on-the-fly. A digital image source has at least one image file representative of an anatomical or pathological feature of a patient. A display is worn by the surgeon or positioned between the surgeon and her patient during surgery. The display is selectively transparent, and exhibits to the surgeon an image derived from the image file. An image control unit retrieves the image file from the image source and controls the display so that at least a portion of the image depiction can be exhibited and modified at will by the surgeon. A plurality of peripheral devices are each configured to receive an image control input from the surgeon and, in response, generate an image control signal. Each peripheral accepts a different user-interface modality.",SURGERATI LLC,DOO FLORENCE X;;BLOOM DAVID C,,https://lens.org/036-999-190-900-168,Patent Application,yes,5,36,2,2,0,A61B90/37;;A61B90/37;;A61B2017/00203;;A61B2017/00203;;A61B2017/00207;;A61B2017/00207;;A61B2017/00212;;A61B2017/00212;;A61B2034/2048;;A61B2034/2048;;A61B2034/2065;;A61B2034/2065;;A61B2090/366;;A61B2090/366;;A61B2090/367;;A61B2090/367;;A61B2090/371;;A61B2090/371;;A61B2090/372;;A61B2090/372;;A61B2090/502;;A61B2090/502;;H04N13/344;;H04N13/344;;H04N13/398;;H04N13/398,A61B19/00,,0,0,,,,PENDING
225,US,A,US 2815704 A,083-877-717-353-949,1957-12-10,1957,US 45328254 A,1954-08-31,US 45328254 A,1954-08-31,Elevating and depth gauging means for tractor implements,,SEARS ROCBUCK AND CO,BLOOM MERLE W;;PHILLIPS DAVID H,,https://lens.org/083-877-717-353-949,Granted Patent,no,4,11,1,1,0,A01B63/02;;A01B63/02;;A01B63/04;;A01B63/04,A01B63/02;;A01B63/04,,0,0,,,,EXPIRED
226,CA,A,CA 768959 A,091-094-789-117-047,1967-10-10,1967,CA 768959D A,,CA 768959T A,,MOULDING PLASTICS,,ICI LTD,WISE DAVID V;;BLOOM LESLIE I,,https://lens.org/091-094-789-117-047,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
227,US,A,US 4681449 A,096-648-832-705-973,1987-07-21,1987,US 64845684 A,1984-09-07,US 64845684 A,1984-09-07,High speed testing of electronic circuits by electro-optic sampling,"Non-contact measurement of signals up to and beyond 100 GHz is provided by electro-optical sampling the field in a transmission line. A first laser signal is employed to optically generate signals in a III-V compound semiconductor such as gallium arsenide. The signal is transmitted to microstrip on the semiconductor surface, and a second polarized laser signal is passed through the crystal and its polarization is modulated by the electric field in the microstrip. The polarization presents a measure of the field strength and hence the signal. By varying the relative delay between two beams, an equivalent time representation of the sampled signal is obtained.",UNIV STANFORD,BLOOM DAVID M;;KOLNER BRIAN H,BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY THE A CORP OF CA (1984-09-05),https://lens.org/096-648-832-705-973,Granted Patent,yes,6,102,1,1,0,G01R1/071;;G01R1/071;;G01R31/2656;;G01R31/2656,G01R1/07;;G01R31/265,356/364;;356/365;;X324 77K,9,5,024-266-544-400-184;;103-747-114-308-100;;067-817-870-433-908;;049-197-292-054-123;;135-736-669-939-253,10.1109/mwsym.1986.1132184;;10.1049/el:19860339;;10.1007/978-3-642-82918-5_28;;10.1109/tmtt.1986.1133549;;10.1063/1.96387,"Electro Optic Sampling: Testing Picosecond Electronics Part II Applications , Valdmanis & Mourou, Laser Focus/Electro Optics, 3/1986, pp. 96 106.;;Internal Microwave Propagation and Distortion Characteristics of Travelling Wave Amplifiers Studied by Electro Optic Sampling , Rodwell et al., 1986 IEEE MTT S Digest, pp. 333 336.;;Direct Electro Optic Sampling of Analog and Digital GaAs Integrated Circuits , Freeman et al., 1985 IEEE GaAs IC Symposium, pp. 147 150.;;Gate Propagation Delay and Logic Timing of GaAs Integrated Circuits Measured by Electro Optic Sampling , Rodwell et al., Electronics Letters, 4/24/86, pp. 499 501.;;Electrooptic Sampling of Gallium Arsenide Integrated Circuits , Weingarten et al., 6/1986 Topical Meeting on Ultrafast Phenomena.;;Internal Microwave Propagation and Distortion Characteristics of Travelling Wave Amplifiers Studied by Electrooptic Sampling , Rodwell et al., 11/1986 IEEE Transactions on Microwave Theory and Techniques.;;Electro Optic Sampling of Planar Digital GaAs Integrated Circuits , Freeman et al., Applied Physics Letters, 11/15/1985, pp. 1083 1084.;;Direct Picosecond Electro Optic Sampling of Gate GaAs Integrated Circuits , Laser Focus/Electro Optics, 2/1986, pp. 20 16, Forest.;;Electro Optic Sampling: Testing Picosecond Electronics Part I Principles and Embodiments , Valdmanis and Mourou, 2/1986, pp. 89 96, Laser Focus/Electro Optics.",EXPIRED
228,WO,A3,WO 2001/011419 A3,097-937-557-968-820,2001-09-13,2001,US 0021662 W,2000-08-08,US 37271299 A;;US 37264999 A;;US 17168599 P;;US 54878800 A;;US 54978100 A,1999-08-11,DYNAMIC SPECTRAL SHAPING IN OPTICAL FIBRE COMMUNICATION,"The present invention is directed towards dynamic spectral shaping. Using a grating (150), the spectral band is spread across a diffractive MEMS (200) or other suitable device operable as a controllable grating providing a controllable reflectivity as a function of wavelength. The device may be the deformable grating modulator invented by Bloom et. al. (US patent no. 5,311,360) or other suitable device. The invention also includes the coupling in and out of the fiber (105) and may use polarization optics (130, 140) to ensure the grating is used in only one polarization where the diffraction efficiency is higher.",LIGHTCONNECT INC,GODIL ASIF A;;BLOOM DAVID M,,https://lens.org/097-937-557-968-820,Search Report,yes,8,0,6,23,0,G02B6/266;;G02B6/2793;;G02B6/2931;;G02B6/29313;;G02B6/29395;;G02B26/0808;;H01S3/06754;;H01S3/10023;;H01S5/005;;H01S2301/04;;H01S5/005;;H01S3/10023,G02B6/00;;G02B6/26;;G02B6/34;;G02B6/35;;G02B26/08;;H01S3/067;;H01S3/10;;H01S5/00;;H04B10/29;;H04B10/294,,3,3,062-505-227-937-061;;046-917-547-643-055;;033-962-722-216-001,10.1109/68.720287;;10.1109/50.701404;;10.1016/s0030-4018(99)00302-8,"FORD J E ET AL: ""DYNAMIC SPECTRAL POWER EQUALIZATION USING MICRO-OPTO-MECHANICS"", IEEE PHOTONICS TECHNOLOGY LETTERS,US,IEEE INC. NEW YORK, vol. 10, no. 10, 1 October 1998 (1998-10-01), pages 1440 - 1442, XP000786675, ISSN: 1041-1135;;PARKER M C ET AL: ""DYNAMIC DIGITAL HOLOGRAPHIC WAVELENGTH FILTERING"", JOURNAL OF LIGHTWAVE TECHNOLOGY,US,IEEE. NEW YORK, vol. 16, no. 7, 1 July 1998 (1998-07-01), pages 1259 - 1269, XP000778824, ISSN: 0733-8724;;WANG L ET AL: ""Programmable spectral phase coding of an amplified spontaneous emission light source"", OPTICS COMMUNICATIONS,NL,NORTH-HOLLAND PUBLISHING CO. AMSTERDAM, vol. 167, no. 1-6, 15 August 1999 (1999-08-15), pages 211 - 224, XP004176872, ISSN: 0030-4018",PENDING
229,US,B1,US 6268952 B1,167-046-808-612-625,2001-07-31,2001,US 35312299 A,1999-07-14,US 35312299 A;;US 9270398 P,1998-07-14,Micromechanical light steering optical switch,"An optical switch uses a micromachined adjustable phase hologram device to route optical signals from an input fiber to selected output fibers is described. The adjustable phase hologram includes a large number of micromachined reflective ribbons which can be individually controlled and adjusted to produce a wide range of phase profiles to route the light beams from the input fiber. This optical switch is capable of dealing directly with optical signals, has fast switching speeds, is capable of routing WDM input signals, is polarization independent, is scalable to large switches, and avoids the complexity of other switches.",LIGHTCONNECT INC,GODIL ASIF A;;BLOOM DAVID M,LIGHTCONNECT INC (2000-12-11);;NEOPHOTONICS CORPORATION (2010-06-08),https://lens.org/167-046-808-612-625,Granted Patent,yes,8,89,1,1,0,G02B26/0808;;G02B26/0808;;G02B6/3516;;G02B6/3516;;G02B6/3556;;G02B6/3556;;G02B6/356;;G02B6/356,G02B6/35;;G02B26/08,359/291;;359/290;;359/247;;359/572,0,0,,,,EXPIRED
230,WO,A2,WO 2011/088254 A2,166-190-669-557-506,2011-07-21,2011,US 2011/0021198 W,2011-01-13,US 68730610 A;;US 68734010 A,2010-01-14,STRUCTURED LIGHT SYSTEM,"A structured light system based on a fast, linear array light modulator and an anamorphic optical system captures three-dimensional shape information at high rates and has strong resistance to interference from ambient light. A structured light system having a modulated light source offers improved signal to noise ratios. A wand permits single point detection of patterns in structured light systems.",ALCES TECHNOLOGY INC;;BLOOM DAVID M;;LEONE MATTHEW A,BLOOM DAVID M;;LEONE MATTHEW A,,https://lens.org/166-190-669-557-506,Patent Application,yes,0,1,4,18,0,G02B26/06;;G02F1/0136;;G02F2203/50,,,0,0,,,,PENDING
231,WO,A2,WO 2001/011395 A2,173-362-415-788-875,2001-02-15,2001,US 0021664 W,2000-08-08,US 37264999 A,1999-08-11,ACHROMATIC OPTICAL MODULATOR,"Micromachined grating modulators which exhibit achromatic behavior are described. One embodiment includes narrow and wide ribbons (120, 130) suspended above a substrate and alternatingly interleaved with each other. Narrow and wide reflective surfaces (122, 132) are formed on the narrow and wide ribbons. Compensating reflective surfaces (142) are formed in the gaps (140) between and beneath the ribbons. The width of the ribbons as well as the width of the gaps and the compensating reflecting surfaces are designed so that incident optical beam can be modulated or attenuated in an achromatic fashion.",LIGHTCONNECT INC,GODIL ASIF A;;BLOOM DAVID M,,https://lens.org/173-362-415-788-875,Patent Application,yes,0,1,6,23,0,G02B5/1828;;G02B6/266;;G02B6/29352;;G02B6/3516;;G02B6/357;;G02B6/3584;;G02B26/0808;;H01S5/005;;G02B26/0808;;G02B6/266;;G02B5/1828;;G02B6/3584;;G02B6/3516;;G02B6/29352;;G02B6/357;;H01S5/005,G02B5/18;;G02B6/26;;G02B26/00;;G02B6/34;;G02B6/35;;G02B26/08;;G02F1/035;;H01S5/00,,0,0,,,,PENDING
232,WO,A3,WO 2011/088254 A3,171-577-724-674-244,2011-11-24,2011,US 2011/0021198 W,2011-01-13,US 68730610 A;;US 68734010 A,2010-01-14,STRUCTURED LIGHT SYSTEM,"A structured light system based on a fast, linear array light modulator and an anamorphic optical system captures three-dimensional shape information at high rates and has strong resistance to interference from ambient light. A structured light system having a modulated light source offers improved signal to noise ratios. A wand permits single point detection of patterns in structured light systems.",ALCES TECHNOLOGY INC;;BLOOM DAVID M;;LEONE MATTHEW A,BLOOM DAVID M;;LEONE MATTHEW A,,https://lens.org/171-577-724-674-244,Search Report,yes,4,0,4,18,0,G02B26/06;;G02F1/0136;;G02F2203/50,G03B21/20;;G03B21/14;;G03B35/00;;H04N5/225,,0,0,,,,PENDING
233,WO,A2,WO 2011/088249 A2,169-928-322-034-957,2011-07-21,2011,US 2011/0021193 W,2011-01-13,US 68734010 A;;US 68730610 A,2010-01-14,COMPACT DISPLAY SYSTEM,A display system is based on a linear array phase modulator and a phase edge discriminator optical system.,ALCES TECHNOLOGY INC;;BLOOM DAVID M;;LEONE MATTHEW A,BLOOM DAVID M;;LEONE MATTHEW A,,https://lens.org/169-928-322-034-957,Patent Application,yes,0,0,4,18,0,G02B26/06;;G02F1/0136;;G02F2203/50,,,0,0,,,,PENDING
234,US,A,US 5801825 A,189-386-135-063-850,1998-09-01,1998,US 63748696 A,1996-04-24,US 63748696 A,1996-04-24,Solder reflow furnace having a boroscope viewing assembly,"A boroscope viewing assembly allows viewing of the process chamber of a solder reflow furnace. A boroscope is removably supported within a cylindrical viewing port permanently mounted through the furnace housing. Coolant gas is flowable along the viewing port annularly surrounding the boroscope to cool the boroscope. The flow of coolant into the process chamber keeps flux vapors away from the boroscope. A sealing assembly seals the boroscope to the viewing port. The sealing assembly can be a gland fitting on the boroscope eyepiece or a compression sealing assembly. When the boroscope is removed, a plug can be placed in the end of the viewing port to seal the process chamber.",BTU INT,NUTTER FRANCIS C;;BLOOM DAVID A,BTU INTERNAITONAL INC (1996-04-23),https://lens.org/189-386-135-063-850,Granted Patent,yes,12,12,1,1,0,B23K1/008;;G02B23/2492;;B23K1/008;;G02B23/2492,B23K1/008;;G02B23/24,G2J JRF           JRF,0,0,,,,EXPIRED
235,CN,A,CN 105801528 A,034-591-649-748-912,2016-07-27,2016,CN 201610072994 A,2009-10-30,US 10963408 P;;CN 200980140509 A,2008-10-30,Reduction of HMF ethers with metal catalyst,"Methods of making reduced derivatives of hydroxymethyl furfural using metal catalysts are described. The derivatives may have tetrahydrofuran or furan nucleus with alkoxymethyl ether or ester moieties on the 5'carbon and methanol on the 2'carbon. Suitable metal catalyst include Raney nickel, a nickel catalyst with a zirconium promoter, a chromite catalyst with a barium, a palladium catalyst, such as palladium on carbon, or a ruthenium catalyst. Also provided are a new class of compounds, which are n-alkoxy hexane diols (i.e., 1,2 or 1,5 hexane diol ethers) and methods of making the same by reduction of furan or tetrahydrofuran derivatives.",ARCHER DANIELS MIDLAND CO,BLOOM PAUL DAVID;;SANBORN ALEXANDRA J,,https://lens.org/034-591-649-748-912,Patent Application,no,0,1,27,27,0,C07C41/26;;C07C41/26;;C07D307/54;;C07D307/54;;C07C41/26;;C07C41/26;;C07C43/13;;C07C43/13;;C07C43/13;;C07C43/13;;C07D307/12;;C07D307/12;;C07D307/12;;C07D307/12;;C07D307/16;;C07D307/16;;C07D307/16;;C07D307/16;;C07D307/42;;C07D307/44;;C07D307/44;;C07D307/44;;C07D307/44;;C07D307/54;;C07D307/54;;C08K5/06;;C08K5/06;;C08K5/06;;C08K5/06;;C09K3/00;;C09K3/00,C07D307/12;;C07D307/42,,3,2,151-600-308-188-092;;058-248-810-034-493,11882002;;10.1021/jm011045t;;10.1021/jm00128a030;;2754710,"MARMINON ET AL.: ""Syntheses and Antiproliferative Activities of New Rebeccamycin Derivatives with the Sugar Unit Linked to Both Indole Nitrogens"", 《J. MED. CHEM.》;;IYENGAR ET AL.: ""New 2-Substituted Indoloquinone Mitomycin Analogues"", 《J. MED. CHEM.》;;REGISTRY: ""RN 89630-82-0"", 《STN COLUMBUS》",ACTIVE
236,GB,B,GB 2117168 B,062-498-647-374-119,1985-09-18,1985,GB 8308021 A,1983-03-23,GB 8208376 A,1982-03-23,METHOD AND APPARATUS FOR USE IN PROCESSING SIGNALS,,BLOOM PHILLIP JEFFREY;;MARSHALL GARTH DAVID,BLOOM PHILLIP JEFFREY;;MARSHALL GARTH DAVID,,https://lens.org/062-498-647-374-119,Granted Patent,no,0,0,10,10,0,G03B31/00;;G10L21/04;;G11B27/034;;G11B27/10;;G10L21/04;;G11B27/10;;G03B31/00;;G11B27/034,G03B31/00;;G10L21/04;;G11B27/034;;G11B27/10,G5RB264;;G5RB293;;G5RB29X;;G5RB340;;G5RB341;;G5RB361;;G5RB36Y;;G5RB373;;G5RB37Y;;G5RB38Y;;G5RB60X;;G5RB771;;G5RB77Y;;G5RB784;;G5RB788;;G5RB81,0,0,,,,EXPIRED
237,US,B2,US 7940449 B2,053-217-509-983-629,2011-05-10,2011,US 68730610 A,2010-01-14,US 68730610 A;;US 48268609 A,2009-06-11,Compact display system,A display system is based on a linear array phase modulator and a phase edge discriminator optical system.,ALCES TECHNOLOGY INC,BLOOM DAVID M;;LEONE MATTHEW A,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2010-06-02),https://lens.org/053-217-509-983-629,Granted Patent,yes,5,0,2,18,0,G02B26/06;;G02B26/06,G02F1/01;;G02B26/00,359/279;;359/238;;359/276;;359/290,5,5,068-763-699-784-614;;079-046-540-639-770;;010-371-954-988-773;;031-621-040-486-807;;112-981-541-153-256,10.1086/432029;;19687878;;10.1364/ol.4.000286;;10.1364/ao.38.006604;;18324196;;10.1364/ao.11.000479;;20111535;;10.1016/j.optcom.2006.12.034,"Jose E. Oti et al., The Optical Differentiation Coronagraph, The Astrophysical Journal, v. 630, p. 631-636, Sep. 1, 2005.;;Steven K. Case, Fourier processing in the object plane, Optics Letters, v. 4, p. 286-288, Sep. 1, 1979.;;Carole C. Montarou et al., Analysis and design of modified Wollaston prisms, Applied Optics, v. 38, p. 6604-6616, Nov. 1, 1999.;;S. Mallick et al., Spatial Differentiation by a Lateral Shear Interferometer, Applied Optics, v. 11, p. 479-480, Feb. 1, 1972.;;Lei Wu et al., Analysis of the lateral displacement and the optical path difference in wide-field-of-view polarization interference imaging spectrometer, Optics Communications, v. 273, p. 67-73, 2007.",INACTIVE
238,US,B2,US 7382449 B2,079-719-829-497-893,2008-06-03,2008,US 90521004 A,2004-12-21,US 90521004 A,2004-12-21,Alignment tool for precise pattern transfer,"Multi-point confocal microscopy, bright field microscope imaging, computer-controlled positioning stages, and an algorithm for automated leveling are the basis for a powerful but simple tool for aligning stamps used in precise pattern transfer to substrates. The system is relatively inexpensive and brings a capability similar to that of a photolithographic mask aligner to the world of elastomeric-stamp-based lithography. Alignment of the stamp and substrate is possible without contact between the two before printing.",ALCES TECHNOLOGY,PETERMAN MARK C;;BLOOM DAVID M,LABRADOR RESEARCH LLC (2008-12-31);;ALCES TECHNOLOGY INC (2004-12-10),https://lens.org/079-719-829-497-893,Granted Patent,yes,4,5,2,2,0,G02B21/0024;;G02B21/26;;G03F9/7026;;G03F9/7034;;G03F9/7042;;G03F9/7088;;G03F9/7034;;G02B21/26;;G03F9/7042;;G02B21/0024;;G03F9/7088;;G03F9/7026,G01C1/06,356/139.04;;356/614,1,0,,,"Keyence Corporation, Woodcliff Lake, NJ; LT-9000 product literature; accessed Sep. 30, 2004 at www.keyence.com.",INACTIVE
239,US,A,US 4983910 A,072-893-423-124-551,1991-01-08,1991,US 19699888 A,1988-05-20,US 19699888 A,1988-05-20,Millimeter-wave active probe,"A millimeter-wave active probe for use in injecting signals with frequencies above 50GHz to millimeter-wave and ultrafast devices and integrated circuits including a substrate upon which a frequency multiplier consisting of filter sections and impedance matching sections are fabricated in uniplanar transmission line format. A coaxial input and uniplanar 50 ohm transmission line couple an approximately 20 GHz input signal to a low pass filter which rolls off at approximately 25 GHz. An input impedance matching section couples the energy from the low pass filter to a pair of matched, antiparallel beam lead diodes. These diodes generate odd-numberd harmonics which are coupled out of the diodes by an output impedance matching network and bandpass filter which suppresses the fundamental and third harmonics and selects the fifth harmonic for presentation at an output.",UNIV STANFORD,MAJIDI-AHY GHOLAMREZA;;BLOOM DAVID M,STANFORD UNIVERSITY 350 CAMBRIDGE AVENUE SUITE 250 PALO ALTO CA 94306 A CORP. OF CA (1988-05-31),https://lens.org/072-893-423-124-551,Granted Patent,yes,12,94,1,4,0,G01R1/06772;;G01R1/06772,G01R1/067,H2E EAH           EAH;;H2E EAHP          EAHP;;U1S S2088,1,0,,,"Piosecond Optical Sampling of GaAs Integrated Circuits by Weingarten et al, IEEE Journ. of Quant. Electron, vol. 24, 2, 2/88 pp. 198 220.",EXPIRED
240,CA,C,CA 2977587 C,082-995-079-977-730,2022-12-06,2022,CA 2977587 A,2016-03-28,US 201514677789 A;;US 2016/0024434 W,2015-04-02,MATTER TRACKING SYSTEM,"A system is described that can detect, track and analyze a bubble of a secondary substance contained within a primary substance along a part of a fluid line. For example, the system can detect the presence of the bubble within the primary substance along the part of the fluid line, which can include assigning a digital signature to the bubble. In addition, the system can track the movement of the bubble in order to ensure that the bubble is accounted for only once as it passes through the part of the fluid line. Furthermore, the system can analyze the bubble, such as determine its direction of travel, speed of travel, volume and size.",CAREFUSION 303 INC,OSCOLAI BILL;;BLOOM MARK;;BROWN DAVID,,https://lens.org/082-995-079-977-730,Granted Patent,no,0,0,14,14,0,G01N2291/02433;;G06T2207/10016;;G06T7/246;;G01N2291/02433;;G06T2207/10016;;G06T7/246;;H04N23/56;;H04N23/80;;G01N21/17;;G01N2021/177;;G06T2207/10004,A61M5/36,,0,0,,,,PENDING
241,MX,B,MX 362580 B,110-488-034-849-281,2019-01-25,2019,MX 2014015367 A,2009-10-30,US 10963408 P;;US 2009/0062778 W,2008-10-30,REDUCTION OF HMF ETHERS WITH METAL CATALYST.,"This disclosure describes methods of reducing hydroxymethylfurfural ether and ester derivatives to produce, in the case of ethers, 5-(alkoxymethyl)-tetrahydrofuran-2- methanol and (5-alkoxymethyl)-furan-2 -methanol derivatives, or in the case of esters, 5-(acyloxymethyl)- tetrahydrofuran-2 -methanol and 5-(acyloxymethyl)- furan-2- methanol derivatives. Exemplified methods describe purification thereof. In addition, the disclosure relates to n-alkoxy hexane diol compounds, which are derivative compounds useful for replacement of petroleum based carbitol compounds, and can be made by further reduction of the 5-(alkoxymethyl)-tetrahydrofuran-2- methanol and (5-alkoxymethyl)-furan-2-methanol derivatives. The compounds made by the methods of the present teaching are useful as solvents and as starting materials for making other compositions that meet the requirements of bio-based industrial chemicals from renewable resources.",ARCHER DANIELS MIDLAND CO,PAUL DAVID BLOOM;;ALEXANDRA J SANBORN,,https://lens.org/110-488-034-849-281,Granted Patent,no,0,0,27,27,0,C07C41/26;;C07C41/26;;C07D307/54;;C07D307/54;;C07C41/26;;C07C41/26;;C07C43/13;;C07C43/13;;C07C43/13;;C07C43/13;;C07D307/12;;C07D307/12;;C07D307/12;;C07D307/12;;C07D307/16;;C07D307/16;;C07D307/16;;C07D307/16;;C07D307/42;;C07D307/44;;C07D307/44;;C07D307/44;;C07D307/44;;C07D307/54;;C07D307/54;;C08K5/06;;C08K5/06;;C08K5/06;;C08K5/06;;C09K3/00;;C09K3/00,C07D307/16;;C07D307/54,,0,0,,,,ACTIVE
242,US,A1,US 2014/0210948 A1,114-119-006-385-645,2014-07-31,2014,US 201414226404 A,2014-03-26,US 201414226404 A;;US 68734010 A,2010-01-14,Structured light system,"A structured light system based on a fast, linear array light modulator and an anamorphic optical system captures three-dimensional shape information at high rates and has strong resistance to interference from ambient light. A structured light system having a modulated light source offers improved signal to noise ratios. A wand permits single point detection of patterns in structured light systems.",BLOOM DAVID M;;LEONE MATTHEW A;;ALCES TECHNOLOGY INC,BLOOM DAVID M;;LEONE MATTHEW A,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2014-10-29),https://lens.org/114-119-006-385-645,Patent Application,yes,1,1,6,18,0,G01B11/25;;G01B11/25;;H04N13/254;;H04N13/254,H04N13/02,348/46,2,1,016-099-816-860-630,10.1109/isie.2008.4677260,"""SUPER RESOLUTION 3D SCANNING USING SPATIAL LIGHT MODULATOR AND BAND CORRECTION"", University of Kentucky Master's Theses, to Pethe;;Ando, S.; Ono, N., ""Spatio-temporal phase-encoding profilometry using correlation image sensor,"" Industrial Electronics, 2008. ISIE 2008. IEEE International Symposium on , vol., no., pp.786,791, June 30 2008-July 2 2008.",INACTIVE
243,EP,A2,EP 1203463 A2,157-068-712-226-708,2002-05-08,2002,EP 00979122 A,2000-08-08,US 0021662 W;;US 37271299 A;;US 37264999 A;;US 17168599 P;;US 54878800 A;;US 54978100 A,1999-08-11,DYNAMIC SPECTRAL SHAPING IN OPTICAL FIBRE COMMUNICATION,,LIGHTCONNECT INC,GODIL ASIF A;;BLOOM DAVID M,,https://lens.org/157-068-712-226-708,Patent Application,yes,0,0,6,23,0,G02B6/266;;G02B6/2793;;G02B6/2931;;G02B6/29313;;G02B6/29395;;G02B26/0808;;H01S3/06754;;H01S3/10023;;H01S5/005;;H01S2301/04;;H01S5/005;;H01S3/10023,G02B6/00;;G02B6/26;;G02B6/34;;G02B6/35;;G02B26/08;;H01S3/067;;H01S3/10;;H01S5/00;;H04B10/29;;H04B10/294,,0,0,,,,DISCONTINUED
244,US,B1,US 8451353 B1,151-166-470-061-55X,2013-05-28,2013,US 201113291867 A,2011-11-08,US 201113291867 A,2011-11-08,Multiple-linear-array MEMS display chips,"Single-chip, multiple-linear-array MEMS form the basis for high-resolution, high-frame-rate video displays.",BLOOM DAVID M;;LEONE MATTHEW A;;ALCES TECHNOLOGY INC,BLOOM DAVID M;;LEONE MATTHEW A,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2012-01-03),https://lens.org/151-166-470-061-55X,Granted Patent,yes,6,2,2,2,0,G02B26/0841;;G02B26/0841;;G02B26/105;;G02B26/105,H04N3/12;;B41J2/47,348/294;;347/255;;347/239,0,0,,,,ACTIVE
245,US,B2,US 10352639 B2,199-461-970-464-973,2019-07-16,2019,US 201816005929 A,2018-06-12,US 201816005929 A;;US 201762521001 P,2017-06-16,Safety magazine system for blank ammunition,"In one aspect, a magazine safety system for preventing loading of a live ammunition cartridge into a firing chamber of a firearm is provided. The firearm has an associated ammunition caliber. The safety system includes a safety block comprising an inner member configured for insertion along an inner surface of a wall of a magazine well of the firearm, the magazine well having an opening for receiving a magazine. An outer member is configured to attach to the inner member along an outer surface of the wall of the magazine well and one or more fasteners secure the inner member to the outer member to secure the wall of the magazine well between the inner member and the outer member. The inner member has a thickness configured reduce an axial extent of the opening to permit insertion of a first magazine sized to carry blank ammunition rounds having a length which is less than live ammunition cartridges having the associated ammunition caliber, while preventing insertion of a second magazine sized to carry live ammunition cartridges having the associated ammunition caliber.",DOTY JOSEPH W;;BLOOM DAVID J,DOTY JOSEPH W;;BLOOM DAVID J,,https://lens.org/199-461-970-464-973,Granted Patent,yes,25,2,2,2,0,F41A17/34;;F41A17/34,F41A17/34,,0,0,,,,INACTIVE
246,US,A1,US 2013/0114123 A1,195-900-212-817-801,2013-05-09,2013,US 201113291867 A,2011-11-08,US 201113291867 A,2011-11-08,MULTIPLE-LINEAR-ARRAY MEMS DISPLAY CHIPS,"Single-chip, multiple-linear-array MEMS form the basis for high-resolution, high-frame-rate video displays.",BLOOM DAVID M;;LEONE MATTHEW A;;ALCES TECHNOLOGY INC,BLOOM DAVID M;;LEONE MATTHEW A,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2012-01-03),https://lens.org/195-900-212-817-801,Patent Application,yes,0,1,2,2,0,G02B26/0841;;G02B26/0841;;G02B26/105;;G02B26/105,G02B26/00,359/292;;359/291,0,0,,,,ACTIVE
247,WO,A3,WO 2007/087201 A3,195-505-501-670-359,2008-06-26,2008,US 2007/0001165 W,2007-01-16,US 33627706 A,2006-01-20,POLARIZATION LIGHT MODULATOR,"Polarization light modulators are based on an interferometric design in which a polarizing beam splitter serves as a polarizer and analyzer. A polarization displacement device shifts orthogonally polarized light beams parallel to the long axis of their elongated cross sections. Phase shifts are imparted to the orthogonally polarized beams by linear array MEMS optical phase shift devices. The output of the light modulator is a line image which may be scanned to form a two-dimensional image. Features to improve brightness, contrast and overall compactness of design are disclosed.",ALCES TECHNOLOGY INC;;BLOOM DAVID M;;PETERMAN MARK C,BLOOM DAVID M;;PETERMAN MARK C,,https://lens.org/195-505-501-670-359,Search Report,yes,2,0,9,9,0,G02B26/06;;G02B26/0808;;G02B26/0825;;G02B27/283;;G02B26/06;;G02B27/283;;G02B26/0808;;G02B26/0825,G02B26/06,,0,0,,,,PENDING
248,EP,A2,EP 1974235 A2,040-123-935-054-495,2008-10-01,2008,EP 07762536 A,2007-01-16,US 2007/0001165 W;;US 33627706 A,2006-01-20,POLARIZATION LIGHT MODULATOR,,ALCES TECHNOLOGY INC,BLOOM DAVID M;;PETERMAN MARK C,,https://lens.org/040-123-935-054-495,Patent Application,yes,0,0,9,9,0,G02B26/06;;G02B26/0808;;G02B26/0825;;G02B27/283;;G02B26/06;;G02B27/283;;G02B26/0808;;G02B26/0825,G02B26/08;;G02B26/06;;G02B27/28,,0,0,,,,ACTIVE
249,WO,A3,WO 2010/062689 A3,061-133-825-269-621,2010-07-22,2010,US 2009/0062778 W,2009-10-30,US 10963408 P,2008-10-30,REDUCTION OF HMF ETHERS WITH METAL CATALYST,"This disclosure describes methods of reducing hydroxymethylfurfural ether and ester derivatives to produce, in the case of ethers, 5-(alkoxymethyl)-tetrahydrofuran-2- methanol and (5-alkoxymethyl)-furan-2 -methanol derivatives, or in the case of esters, 5-(acyloxymethyl)- tetrahydrofuran-2 -methanol and 5-(acyloxymethyl)- furan-2- methanol derivatives. Exemplified methods describe purification thereof. In addition, the disclosure relates to n-alkoxy hexane diol compounds, which are derivative compounds useful for replacement of petroleum based carbitol compounds, and can be made by further reduction of the 5-(alkoxymethyl)-tetrahydrofuran-2- methanol and (5-alkoxymethyl)-furan-2-methanol derivatives. The compounds made by the methods of the present teaching are useful as solvents and as starting materials for making other compositions that meet the requirements of bio-based industrial chemicals from renewable resources.",ARCHER DANIELS MIDLAND CO;;BLOOM PAUL DAVID;;SANBORN ALEXANDRA J,BLOOM PAUL DAVID;;SANBORN ALEXANDRA J,,https://lens.org/061-133-825-269-621,Search Report,yes,5,0,27,27,0,C07C41/26;;C07C41/26;;C07D307/54;;C07D307/54;;C07C41/26;;C07C41/26;;C07C43/13;;C07C43/13;;C07C43/13;;C07C43/13;;C07D307/12;;C07D307/12;;C07D307/12;;C07D307/12;;C07D307/16;;C07D307/16;;C07D307/16;;C07D307/16;;C07D307/42;;C07D307/44;;C07D307/44;;C07D307/44;;C07D307/44;;C07D307/54;;C07D307/54;;C08K5/06;;C08K5/06;;C08K5/06;;C08K5/06;;C09K3/00;;C09K3/00,C07D307/20;;C07D307/24;;C07D307/28;;C07D307/34,,1,0,,,See also references of EP 2350035A4,PENDING
250,WO,A2,WO 2010/144754 A2,107-835-225-776-674,2010-12-16,2010,US 2010/0038238 W,2010-06-10,US 48268609 A,2009-06-11,DISPLAY SYSTEM,A display system is based on a linear array phase modulator and a phase edge discriminator optical system.,ALCES TECHNOLOGY INC;;BLOOM DAVID M;;LEONE MATTHEW A,BLOOM DAVID M;;LEONE MATTHEW A,,https://lens.org/107-835-225-776-674,Patent Application,yes,0,0,6,18,0,G02B26/06;;G02B26/06;;G02B26/101;;G02B26/101;;H04N9/3132;;H04N9/3132,G02B26/10;;G02B27/18;;H04N5/74,,0,0,,,,PENDING
251,WO,A3,WO 2011/088249 A3,119-742-523-568-710,2011-11-10,2011,US 2011/0021193 W,2011-01-13,US 68734010 A;;US 68730610 A,2010-01-14,COMPACT DISPLAY SYSTEM,A display system is based on a linear array phase modulator and a phase edge discriminator optical system.,ALCES TECHNOLOGY INC;;BLOOM DAVID M;;LEONE MATTHEW A,BLOOM DAVID M;;LEONE MATTHEW A,,https://lens.org/119-742-523-568-710,Search Report,yes,4,0,4,18,0,G02B26/06;;G02F1/0136;;G02F2203/50,G02F2/00;;G02F1/29,,0,0,,,,PENDING
252,CN,A,CN 106464857 A,136-594-224-928-151,2017-02-22,2017,CN 201580021523 A,2015-03-20,US 201414226515 A;;US 2015/0021883 W,2014-03-26,Compact 3D depth capture systems,"Compact 3D depth capture systems are based on a 3D system driver/interface, a 3D system camera, and a 3D system projector. The systems are compatible with integration in to mobile electronic devices such as smart phones and tablet computers.",ALCES TECH INC,BLOOM DAVID M;;LEONE MATTHEW A,,https://lens.org/136-594-224-928-151,Patent Application,no,7,10,10,10,0,G01B11/2527;;G01B11/254;;G01B11/254;;G01B11/2527;;G01B11/2527,H04N13/02;;H04N13/00;;H04N13/04,,0,0,,,,ACTIVE
253,US,B2,US 9316826 B2,156-127-128-096-431,2016-04-19,2016,US 201514871517 A,2015-09-30,US 201514871517 A;;US 201314032459 A;;US 201261705000 P,2012-09-24,Grayscale patterns from binary spatial light modulators,Brightness-by-column grayscale and spatial Σ-Δ modulation grayscale allow grayscale patterns to be produced using a binary spatial light modulator as fast as the bright/dark switching speed.,BLOOM DAVID M;;LEONE MATTHEW A;;ALCES TECHNOLOGY INC,BLOOM DAVID M;;LEONE MATTHEW A,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2015-10-26),https://lens.org/156-127-128-096-431,Granted Patent,yes,5,0,9,9,0,G01B11/2527;;F21K9/60;;F21K9/65;;G02F1/155;;G09G3/3433;;G02B26/0808;;G02F1/0128;;G09G2300/0426;;G02B27/0068;;G02B26/0816;;G02B26/085;;G09G2300/0473;;G02B26/0858;;G02F1/29;;G02B26/101;;G02F1/0123;;G02B26/06;;G02B26/02;;H04N13/254;;G02B26/0841;;G01C3/08;;G06V10/145;;G02F1/155;;G09G3/3433;;G02B26/0808;;G02F1/0128;;G09G2300/0426;;G02B27/0068;;G02B26/0816;;G02B26/085;;G09G2300/0473;;G02B26/0858;;G02F1/29;;G02B26/101;;G02F1/0123;;G02B26/06;;G02B26/02;;H04N13/204;;H04N13/254;;G01B11/2527;;F21K9/60;;F21K9/65;;G06V10/145;;G02B26/0833;;G02F1/13306;;G02B26/0841;;G01C3/08,G02B26/08;;F21K99/00;;G01B11/25;;G01C3/08;;G02B26/02;;G02B26/06;;G02B26/10;;G02B27/00;;G02F1/01;;G02F1/133;;G02F1/155;;G02F1/29;;G06V10/145;;G09G3/34;;H04N13/02,,2,1,014-382-749-502-411,10.1889/1.1833710,"Doherty et al., ""Phased Reset Timing for Improved Digital Micromirror Device (DMD) Brightness"", Society for Information Display, 1998.;;Dudley et al., ""Emerging Digital Micromirror Device (DMD) Applications"", Society of Photo-Optical Instrumentation Engineers, 2003.",ACTIVE
254,EP,A4,EP 2350035 A4,146-639-035-610-32X,2012-07-25,2012,EP 09829644 A,2009-10-30,US 2009/0062778 W;;US 10963408 P,2008-10-30,REDUCTION OF HMF ETHERS WITH METAL CATALYST,,ARCHER DANIELS MIDLAND CO,BLOOM PAUL DAVID;;SANBORN ALEXANDRA J,,https://lens.org/146-639-035-610-32X,Search Report,no,4,0,27,27,0,C07C41/26;;C07C41/26;;C07D307/54;;C07D307/54;;C07C41/26;;C07C41/26;;C07C43/13;;C07C43/13;;C07C43/13;;C07C43/13;;C07D307/12;;C07D307/12;;C07D307/12;;C07D307/12;;C07D307/16;;C07D307/16;;C07D307/16;;C07D307/16;;C07D307/42;;C07D307/44;;C07D307/44;;C07D307/44;;C07D307/44;;C07D307/54;;C07D307/54;;C08K5/06;;C08K5/06;;C08K5/06;;C08K5/06;;C09K3/00;;C09K3/00,C07D307/20;;C07D307/24;;C07D307/28;;C07D307/34,,2,1,001-006-789-913-484,10.1021/jo9721655,"MICHAEL E. JUNG ET AL: ""-2',3'-Dideoxyisonucleosides via Regioselective Opening of Optically Active C 2 -Symmetric 1,4-Pentadiene Bis-epoxide 1"", THE JOURNAL OF ORGANIC CHEMISTRY, vol. 63, no. 9, 1 May 1998 (1998-05-01), pages 2975 - 2981, XP055029934, ISSN: 0022-3263, DOI: 10.1021/jo9721655;;See also references of WO 2010062689A2",ACTIVE
255,US,A,US 4255719 A,005-209-756-800-016,1981-03-10,1981,US 4372879 A,1979-05-30,US 4372879 A,1979-05-30,Maintenance of optimal orientation in F2+ color center lasers,Intense optical pumping of the 1S.sigma..sub.g .fwdarw.2P.sigma..sub.u transition of the F.sub.2.sup.+ color center as required for laser action produces a slow orientational bleaching of the F.sub.2.sup.+ color centers that is eventually debilitating to the F.sub.2.sup.+ color center laser action. This bleaching is prevented by periodically or continuously subjecting the color centers to a two-step pumping with polarized radiation such that the centers are all returned to the optimal orientation for absorbing pumping radiation for laser action.,BELL TELEPHONE LABOR INC,BLOOM DAVID M;;MOLLENAUER LINN F,,https://lens.org/005-209-756-800-016,Granted Patent,yes,1,2,1,1,0,H01S3/1681;;H01S3/1681,H01S3/16,331 945 F,4,3,026-528-055-615-643;;010-532-575-357-263;;049-957-091-988-113,10.1103/physrevlett.24.1296;;10.1002/pssb.2220430126;;10.1063/1.321983,"""Reorientation of M Centers In KCl"" Schneider; Phys. Rev. Lett. vol. 24, No. 23 pp. 1296-1298, Jun. 1970.;;""The F.sub.2.sup.+ Center in KCl Crystals Part II: Optical Properties and Analogy with the H.sub.2.sup.+ Molecule"" Aegerter et al.; Phys. Stat. Sol. (1971) (b), vol. 23, pp. 245-261.;;""Broadly Tunable Lasers Using Color Centers""; Mollenauer et al.; Jrnl. App. Physics vol. 46, No. 7, (Jul. 1975) pp. 3109-3118.;;""Broadly Tunable CW Lasers Using F.sub.2.sup.+ Centers for 1.26-1.48 and 0.82-1.07 .mu.m Bands""; Mollenauer et al.; Optics Lett. Vol. 3, No. 2, Aug. l978, pp. 48-50.",EXPIRED
256,CN,A,CN 102177146 A,028-504-131-017-685,2011-09-07,2011,CN 200980140509 A,2009-10-30,US 2009/0062778 W;;US 10963408 P,2008-10-30,Reduction of HMF ethers with metal catalyst,"This disclosure describes methods of reducing hydroxymethylfurfural ether and ester derivatives to produce, in the case of ethers, 5-(alkoxymethyl)-tetrahydrofuran-2- methanol and (5-alkoxymethyl)-furan-2 -methanol derivatives, or in the case of esters, 5-(acyloxymethyl)- tetrahydrofuran-2 -methanol and 5-(acyloxymethyl)- furan-2- methanol derivatives. Exemplified methods describe purification thereof. In addition, the disclosure relates to n-alkoxy hexane diol compounds, which are derivative compounds useful for replacement of petroleum based carbitol compounds, and can be made by further reduction of the 5-(alkoxymethyl)-tetrahydrofuran-2- methanol and (5-alkoxymethyl)-furan-2-methanol derivatives.; The compounds made by the methods of the present teaching are useful as solvents and as starting materials for making other compositions that meet the requirements of bio-based industrial chemicals from renewable resources.",ARCHER DANIELS MIDLAND CO,DAVID BLOOM PAUL;;SANBORN ALEXANDRA J,,https://lens.org/028-504-131-017-685,Patent Application,no,3,2,27,27,0,C07C41/26;;C07C41/26;;C07D307/54;;C07D307/54;;C07C41/26;;C07C41/26;;C07C43/13;;C07C43/13;;C07C43/13;;C07C43/13;;C07D307/12;;C07D307/12;;C07D307/12;;C07D307/12;;C07D307/16;;C07D307/16;;C07D307/16;;C07D307/16;;C07D307/42;;C07D307/44;;C07D307/44;;C07D307/44;;C07D307/44;;C07D307/54;;C07D307/54;;C08K5/06;;C08K5/06;;C08K5/06;;C08K5/06;;C09K3/00;;C09K3/00,C07D307/20;;C07D307/24;;C07D307/28;;C07D307/34,,0,0,,,,ACTIVE
257,DE,A1,DE 2921059 A1,084-621-805-029-361,1979-11-29,1979,DE 2921059 A,1979-05-23,US 90877478 A,1978-05-23,VERFAHREN ZUR ERZEUGUNG VON F HOCH + TIEF 2 -FARBZENTREN,,WESTERN ELECTRIC CO,BLOOM DAVID MICHAEL;;MOLLENAUER LINN FEDERICK,,https://lens.org/084-621-805-029-361,Patent Application,no,0,0,9,9,0,H01S3/1681;;H01S3/1681,C09K11/00;;C09K11/08;;H01S3/00;;H01S3/094;;H01S3/16,,1,1,002-719-175-588-185,10.1002/pssb.2220430125,"physica status solidi, Vol. 43, 1971, S. 227 bis 243",DISCONTINUED
258,US,B2,US 8970827 B2,115-287-054-332-248,2015-03-03,2015,US 201314033147 A,2013-09-20,US 201314033147 A;;US 201261705000 P,2012-09-24,Structured light and time of flight depth capture with a MEMS ribbon linear array spatial light modulator,A fast spatial light modulator based on a linear MEMS ribbon array enables a depth capture system to operate in structured light and time-of-flight modes. Time-of-flight depth information may be used to phase unwrap structured light depth information. Combined structured light and time-of-flight systems offer precise depth resolution over a wide range of distances.,BLOOM DAVID M;;LEONE MATTHEW A;;ALCES TECHNOLOGY INC,BLOOM DAVID M;;LEONE MATTHEW A,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2013-10-17),https://lens.org/115-287-054-332-248,Granted Patent,yes,8,6,9,9,0,G01B11/2527;;F21K9/60;;F21K9/65;;G02F1/155;;G09G3/3433;;G02B26/0808;;G02F1/0128;;G09G2300/0426;;G02B27/0068;;G02B26/0816;;G02B26/085;;G09G2300/0473;;G02B26/0858;;G02F1/29;;G02B26/101;;G02F1/0123;;G02B26/06;;G02B26/02;;H04N13/254;;G02B26/0841;;G01C3/08;;G06V10/145;;G02F1/155;;G09G3/3433;;G02B26/0808;;G02F1/0128;;G09G2300/0426;;G02B27/0068;;G02B26/0816;;G02B26/085;;G09G2300/0473;;G02B26/0858;;G02F1/29;;G02B26/101;;G02F1/0123;;G02B26/06;;G02B26/02;;H04N13/204;;H04N13/254;;G01B11/2527;;F21K9/60;;F21K9/65;;G06V10/145;;G02B26/0833;;G02F1/13306;;G02B26/0841;;G01C3/08,G01C3/08;;F21K99/00;;G01B11/25;;G02B26/08;;G02F1/133;;G06V10/145;;H04N13/02,356/5.01;;356/3.01;;356/3.09;;356/4.01;;356/4.07;;356/5.09;;356/9;;356/625,2,1,054-063-002-531-401,10.1109/gcce.2012.6379648,"Cho, Shung Han; Kwanghyuk Bae; Hyu-Min Kyung; Tae-Chan Kim. ""Fast and Efficient Method to Suppress Depth Ambiguity for Time-of-Flight Sensors."" Appeared in Consumer Electronics (GCCE), 2012 IEEE 1st Global Conference on Oct. 2-5, 2012. http://ieeexplore.ieee.org/xpls/icp.jsp?arnumber=6379648.;;Su, Xianyu; Qican Xhang. ""Dynamic 3-D Shape Measurement Method: A Review."" Appeared in Optics and Lasers in Engineering Journal. May 8, 2009. http://hanquier.m.free.fr/Worcester/references/Others%20papers/dynamie/%203D%20shape.pdf.",INACTIVE
259,US,A,US 5003253 A,098-999-023-359-254,1991-03-26,1991,US 31874489 A,1989-03-03,US 31874489 A;;US 19699888 A,1988-05-20,Millimeter-wave active probe system,"Three classes of active probes all with coaxial inputs and coplanar waveguide probe tips are described. A millimeter-wave active probe for generating signals with frequencies above 50 gHz and supplying same to millimeter-wave and ultrafast devices and integrated circuits on-wafer including a substrate upon which a frequency multiplier consisting of filter sections and impedance matching sections and nonlinear elements are integrated in uniplanar transmission line medium. Also disclosed is a harmonic mixer probe to step down RF received from an integrated circuit to a lower frequency by mixing it with the harmonics of a local oscillator signal. Also disclosed is an S-parameter active probe for on-wafer measurement of the S-parameters of a two port millimeter-wave device or integrated circuit by injecting millimeter-wave frequencies and simultaneously tapping off a portion of the injected signal, the transmitted signal and the reflected signal and stepping all signals down in frequency to a frequency compatible with currently available test equipment such as the HP8510 automatic network analyzer. This is the first and only all-electronic millimeter-wave on-wafer S-parameter measurement device available at present.",UNIV LELAND STANFORD JUNIOR,MAJIDI-AHY GHOLAMREZA;;BLOOM DAVID M,BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY THE A CORP. OF CA (1989-03-24),https://lens.org/098-999-023-359-254,Granted Patent,yes,23,60,2,4,0,G01R1/06772;;G01R1/06772,G01R31/26;;G01R1/067;;G01R1/24;;H01L21/66,H2E EAH           EAH;;H2E EAHP          EAHP;;U1S S2088,1,0,,,"Picosecond Optical Sampling of GaAs Integrated Circuits , by Weingarten et al, IEEE Journal of Quant. Elect., vol. 24, 2, 2/68.",EXPIRED
260,CN,A,CN 107249430 A,141-249-474-564-059,2017-10-13,2017,CN 201680010999 A,2016-03-28,US 201514677789 A;;US 2016/0024434 W,2015-04-02,Matter tracking system,"A system is described that can detect, track and analyze a bubble of a secondary substance contained within a primary substance along a part of a fluid line. For example, the system can detect the presence of the bubble within the primary substance along the part of the fluid line, which can include assigning a digital signature to the bubble. In addition, the system can track the movement of the bubble in order to ensure that the bubble is accounted for only once as it passes through the part of the fluid line. Furthermore, the system can analyze the bubble, such as determine its direction of travel, speed of travel, volume and size.",CAREFUSION 303 INC,OSCOLAI BILL;;BLOOM MARK;;BROWN DAVID,,https://lens.org/141-249-474-564-059,Patent Application,no,7,2,14,14,0,G01N2291/02433;;G06T2207/10016;;G06T7/246;;G01N2291/02433;;G06T2207/10016;;G06T7/246;;H04N23/56;;H04N23/80;;G01N21/17;;G01N2021/177;;G06T2207/10004,A61B1/06;;A61M1/28;;A61M5/168;;A61M31/00;;A61M39/28;;B65B1/00,,0,0,,,,ACTIVE
261,US,A1,US 2019/0241943 A1,001-800-162-875-558,2019-08-08,2019,US 201916271564 A,2019-02-08,US 201916271564 A;;US 201862628170 P,2018-02-08,RAPID PHENOTYPING AND IDENTIFICATION OF MICROBES FROM A COMPLEX MICROBIAL COMMUNITY,"The invention disclosed herein relates generally to the fields of microbiology, ecology and microfluidics. Particularly, the invention disclosed herein provides compositions and methods for isolating, identifying and phenotyping bacteria from complex microbial communities and measuring growth rates of the isolated bacteria in a given environmental condition.",UNIV DUKE,VILLA MAX;;DAVID LAWRENCE;;BLOOM RACHAEL,DUKE UNIVERSITY (2019-03-25),https://lens.org/001-800-162-875-558,Patent Application,yes,0,5,1,1,2,C12Q1/6851;;C12Q1/689;;C12Q1/06;;C12Q1/6851;;C12Q1/06;;C12Q1/689;;C12Q1/686,C12Q1/6851;;C12Q1/06;;C12Q1/686;;C12Q1/689,,0,0,,,,DISCONTINUED
262,US,A,US 4758092 A,023-380-188-725-080,1988-07-19,1988,US 83602086 A,1986-03-04,US 83602086 A,1986-03-04,Method and means for optical detection of charge density modulation in a semiconductor,"Disclosed is a technique for probing dynamic sheet charge density variations in integrated semiconductor devices. Using a specially designed non-invasive Nomarski phase contrast interferometer a sheet charge density sensitivity of 2.6.times.10.sup.8 e/cm.sup.2 / .sqroot.Hz is extracted from experimental data for 1 mA of detected photocurrent. The charge density sensitivity makes possible .mu.V signal level detection in an active device, and with digital signals the corresponding signal/noise level is sufficiently high that multi-mega-baud data can be captured in real time.",UNIV STANFORD,HEINRICH HARLEY K;;BLOOM DAVID M,BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY THE (1986-03-03),https://lens.org/023-380-188-725-080,Granted Patent,yes,6,153,1,1,0,G01R29/14;;G01R31/308;;G01R29/14;;G01R31/308,G01R29/14;;G01R31/308,356/364;;356/365;;356/367;;356/433;;X324158D;;X324158R;;X324 73R,0,0,,,,EXPIRED
263,US,A1,US 2020/0080929 A1,018-511-245-101-482,2020-03-12,2020,US 201916573545 A,2019-09-17,US 201916573545 A;;US 201514677789 A,2015-04-02,MATTER TRACKING SYSTEM,"A system is described that can detect, track and analyze a bubble of a secondary substance contained within a primary substance along a part of a fluid line. For example, the system can detect the presence of the bubble within the primary substance along the part of the fluid line, which can include assigning a digital signature to the bubble. In addition, the system can track the movement of the bubble in order to ensure that the bubble is accounted for only once as it passes through the part of the fluid line. Furthermore, the system can analyze the bubble, such as determine its direction of travel, speed of travel, volume and size.",CAREFUSION 303 INC,BLOOM MARK;;OSCOLAI CATHAL;;BROWN DAVID,CAREFUSION 303 INC (2015-09-22),https://lens.org/018-511-245-101-482,Patent Application,yes,16,0,14,14,0,G01N2291/02433;;G06T2207/10016;;G06T7/246;;G01N2291/02433;;G06T2207/10016;;G06T7/246;;H04N23/56;;H04N23/80;;G01N21/17;;G01N2021/177;;G06T2207/10004,G01N21/17;;G06T7/246;;H04N5/225;;H04N5/232,,0,0,,,,ACTIVE
264,US,A1,US 2006/0141940 A1,024-701-312-237-035,2006-06-29,2006,US 24850205 A,2005-10-12,US 24850205 A;;US 61791404 P;;US 66500105 P,2004-10-12,Intelligent bridge between PSTN and asynchronous communication channel,"An intelligent communications bridge device (“Meterpod”) of a remote Supervisory Control and Data Acquisition (SCADA) system advantageously facilitates monitoring, reporting and control of public utility meters. The Meterpod is an intelligent gateway that installs onto existing metering and monitoring equipment and provides a wireless communications link from the remote equipment being monitored or controlled to the host computer or program tracking or controlling the device providing clear advantages over existing remote telemetry equipment in that it can (1) support any wireless communications protocol, including CDMA, GSM/GPRS, VSAT, and GPRS standards, (2) be installed and configured in minutes by regular maintenance personnel, and (3) provide control capabilities beyond the remote device by utilizing a broad array of additional interfaces (RJ-11, Ethernet, RS-232 and RS-485) that all come standard, supporting customer sites that cannot be monitored using existing fixed wireless or radio frequency (RF) monitoring solutions.",BLOOM DAVID L;;BASSER WILLIAM I,BLOOM DAVID L;;BASSER WILLIAM I,AXISSCOMM LLC (2005-10-11),https://lens.org/024-701-312-237-035,Patent Application,yes,10,35,1,1,0,G01D4/002;;G01D4/002;;G01D2204/18;;Y02B90/20;;Y02B90/20;;Y04S20/30;;Y04S20/30,H04B1/38,455/73,0,0,,,,DISCONTINUED
265,EP,A1,EP 3123717 A1,037-341-953-150-20X,2017-02-01,2017,EP 15769750 A,2015-03-20,US 201414226515 A;;US 2015/0021883 W,2014-03-26,COMPACT 3D DEPTH CAPTURE SYSTEMS,,ALCES TECH INC,BLOOM DAVID M;;LEONE MATTHEW A,,https://lens.org/037-341-953-150-20X,Patent Application,yes,0,0,10,10,0,G01B11/2527;;G01B11/254;;G01B11/254;;G01B11/2527;;G01B11/2527,H04N13/02;;H04N13/00;;H04N13/04,,0,0,,,,DISCONTINUED
266,US,A1,US 2014/0168750 A1,135-567-250-007-444,2014-06-19,2014,US 201314032383 A,2013-09-20,US 201314032383 A;;US 201261705000 P,2012-09-24,Digital drive signals for analog MEMS ribbon arrays,On/off digital drive signals are used to create arbitrary spatial and temporal ribbon movement patterns in MEMS ribbon arrays.,BLOOM DAVID M;;LEONE MATTHEW A;;ALCES TECHNOLOGY INC,BLOOM DAVID M;;LEONE MATTHEW A,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2013-10-17),https://lens.org/135-567-250-007-444,Patent Application,yes,15,0,9,9,0,G01B11/2527;;F21K9/60;;F21K9/65;;G02F1/155;;G09G3/3433;;G02B26/0808;;G02F1/0128;;G09G2300/0426;;G02B27/0068;;G02B26/0816;;G02B26/085;;G09G2300/0473;;G02B26/0858;;G02F1/29;;G02B26/101;;G02F1/0123;;G02B26/06;;G02B26/02;;H04N13/254;;G02B26/0841;;G01C3/08;;G06V10/145;;G02F1/155;;G09G3/3433;;G02B26/0808;;G02F1/0128;;G09G2300/0426;;G02B27/0068;;G02B26/0816;;G02B26/085;;G09G2300/0473;;G02B26/0858;;G02F1/29;;G02B26/101;;G02F1/0123;;G02B26/06;;G02B26/02;;H04N13/204;;H04N13/254;;G01B11/2527;;F21K9/60;;F21K9/65;;G06V10/145;;G02B26/0833;;G02F1/13306;;G02B26/0841;;G01C3/08,G02B26/08;;G06V10/145,359/291,0,0,,,,INACTIVE
267,HU,T2,HU E029859 T2,154-856-937-861-858,2017-04-28,2017,HU E09829644 A,2009-10-30,US 10963408 P,2008-10-30,REDUCTION OF HMF ETHERS WITH METAL CATALYST,,ARCHER DANIELS MIDLAND CO,BLOOM PAUL DAVID;;SANBORN ALEXANDRA J,,https://lens.org/154-856-937-861-858,Amended Patent,no,0,0,27,27,0,C07C41/26;;C07C41/26;;C07D307/54;;C07D307/54;;C07C41/26;;C07C41/26;;C07C43/13;;C07C43/13;;C07C43/13;;C07C43/13;;C07D307/12;;C07D307/12;;C07D307/12;;C07D307/12;;C07D307/16;;C07D307/16;;C07D307/16;;C07D307/16;;C07D307/42;;C07D307/44;;C07D307/44;;C07D307/44;;C07D307/44;;C07D307/54;;C07D307/54;;C08K5/06;;C08K5/06;;C08K5/06;;C08K5/06;;C09K3/00;;C09K3/00,,,0,0,,,,PENDING
268,US,B2,US 9798845 B2,148-368-058-029-766,2017-10-24,2017,US 201414478452 A,2014-09-05,US 201414478452 A;;US 201361874680 P,2013-09-06,User grey cell,"In various embodiments, a user grey cell is disclosed. The user grey cell comprises a simplified logical implementation of a black box cell identified in a software and/or hardware design. The internal functionality of the black box cell is undefined, hidden, or encrypted, and thus is not available for timing analysis. The user grey cell for the black box cell provides sufficient clocking and register information to allow for accurate CDC, false path, and multi-cycle path analysis, and provides a way for designers to locate and repair clock domain crossing violations before the design is implemented in hardware. In various embodiments, a method for user grey cell analysis is disclosed. The method comprises identifying one or more black box cells in a user design. The method further comprises determining which of the input and/or output pins of each of the black box cells are in use by the user design. The method further comprises selecting a user grey cell for one or more of the black box cells, wherein a user grey cell comprises a simplified logic implementation for the black box cell, sufficient to perform CDC, false path, and multi-cycle path analysis. The selected user grey cells may be used in place of the black box cells for CDC, false path, and multi-cycle path analysis.",BLUE PEARL SOFTWARE INC,BLOOM SCOTT ARON;;WALLACE DAVID E,BLUE PEARL SOFTWARE INC (2017-09-05),https://lens.org/148-368-058-029-766,Granted Patent,yes,9,0,4,4,0,G06F30/34;;G06F30/30;;G06F2119/12;;G06F30/34;;G06F30/30;;G06F2119/12;;G06F30/32,G06F17/50;;G06F9/45,,3,0,,,"International Search Report for International Application No. PCT/US2014/054260 dated Dec. 16, 2014.;;Written Opinion of the International Searching Authority for International Application No. PCT/US2014/054260 dated Dec. 16, 2014.;;International Preliminary Report on Patentability for International Application No. PCT/US14/054260 dated Mar. 8, 2016.",INACTIVE
269,US,A,US 4183795 A,173-303-661-673-23X,1980-01-15,1980,US 90877478 A,1978-05-23,US 90877478 A,1978-05-23,Creation of F2+ color centers,"Production of F.sub.2.sup.+ color centers in alkali halide crystals with densities high enough for efficient use in lasers is achieved by a two-step, highly selective photoionization mechanism. This mechanism is coupled with the use of suitable divalent metal ions as efficient and stable electron traps to allow nearly 100 percent conversion of F.sub.2 color centers to F.sub.2.sup.+ color centers. The two-step photoionization mechanism comprises photo-exciting the F.sub.2 color center to the first bound state, which requires lower energy than the corresponding transition for F color centers, then photoionizing the F.sub.2 color center from the first bound state, and finally, capturing the electron thus liberated on the divalent metal ions.",BELL TELEPHONE LABOR INC,BLOOM DAVID M;;MOLLENAUER LINN F,,https://lens.org/173-303-661-673-23X,Granted Patent,yes,1,5,9,9,0,H01S3/1681;;H01S3/1681,C09K11/00;;C09K11/08;;H01S3/00;;H01S3/094;;H01S3/16,204157100R,0,0,,,,EXPIRED
270,EP,A2,EP 2350035 A2,176-083-101-377-173,2011-08-03,2011,EP 09829644 A,2009-10-30,US 2009/0062778 W;;US 10963408 P,2008-10-30,REDUCTION OF HMF ETHERS WITH METAL CATALYST,,ARCHER DANIELS MIDLAND CO,BLOOM PAUL DAVID;;SANBORN ALEXANDRA J,,https://lens.org/176-083-101-377-173,Patent Application,yes,0,0,27,27,0,C07C41/26;;C07C41/26;;C07D307/54;;C07D307/54;;C07C41/26;;C07C41/26;;C07C43/13;;C07C43/13;;C07C43/13;;C07C43/13;;C07D307/12;;C07D307/12;;C07D307/12;;C07D307/12;;C07D307/16;;C07D307/16;;C07D307/16;;C07D307/16;;C07D307/42;;C07D307/44;;C07D307/44;;C07D307/44;;C07D307/44;;C07D307/54;;C07D307/54;;C08K5/06;;C08K5/06;;C08K5/06;;C08K5/06;;C09K3/00;;C09K3/00,C07D307/20;;C07D307/24;;C07D307/28;;C07D307/34,,0,0,,,,ACTIVE
271,EP,A1,EP 4173299 A1,169-744-567-083-048,2023-05-03,2023,EP 21722012 A,2021-04-02,US 202016914954 A;;US 2021/0025590 W,2020-06-29,TECHNIQUES FOR PROVIDING INTERACTIVE INTERFACES FOR LIVE STREAMING EVENTS,,AMAZON TECH INC,BLOOM STEVE JOHN;;NAKAYAMA DAVID HIKARU,,https://lens.org/169-744-567-083-048,Patent Application,yes,0,0,3,3,0,H04N21/2187;;H04N21/44218;;H04N21/42203;;H04N21/4223;;H04N21/4788;;H04N21/25841;;H04N21/4312;;H04N21/25866;;H04N7/157;;G06Q50/01;;H04N21/2187;;H04N21/25883;;H04N21/25891;;H04N21/4788,H04N21/2187;;G06Q50/10;;H04N7/15;;H04N21/258;;H04N21/422;;H04N21/4223;;H04N21/431;;H04N21/442;;H04N21/4788,,0,0,,,,PENDING
272,MX,A,MX 9100221 A,187-270-886-390-433,1992-02-28,1992,MX 9100221 A,1991-07-15,US 55804490 A,1990-07-26,SISTEMA Y METODO DE RETENCION DE CALOR AISLANTE,,ALLEGHENY LUDLUM CORP,BURK DAVID LAWRENCE;;BLOOM WILLIAM MILLARD,,https://lens.org/187-270-886-390-433,Patent Application,no,0,0,8,8,0,B21B45/00;;B21B45/008;;B21B45/008;;C21D9/0006;;C21D9/0006;;F27D1/0013;;F27D1/0013;;F27D1/06;;F27D1/06;;F27D1/144;;F27D1/144;;Y02P70/10;;Y02P70/10,B21B45/00;;C21D9/00;;F27D1/00;;F27D1/06;;F27D1/14,,0,0,,,,PENDING
273,CA,A1,CA 2634406 A1,190-068-235-785-924,2007-08-02,2007,CA 2634406 A,2007-01-16,US 33627706 A;;US 2007/0001165 W,2006-01-20,POLARIZATION LIGHT MODULATOR,,ALCES TECHNOLOGY INC,BLOOM DAVID M;;PETERMAN MARK C,,https://lens.org/190-068-235-785-924,Patent Application,no,0,0,9,9,0,G02B26/06;;G02B26/0808;;G02B26/0825;;G02B27/283;;G02B26/06;;G02B27/283;;G02B26/0808;;G02B26/0825,G02B26/06,,0,0,,,,DISCONTINUED
274,EP,A3,EP 0311406 A3,008-245-197-190-932,1990-08-08,1990,EP 88309330 A,1988-10-06,US 10655487 A,1987-10-06,TRANSMISSON LINE,"A non-linear transmission line comprises a 50 ohm coplanar monolithic waveguide formed on top of a gallium arsenide substrate (42) having a layer (36) of lightly doped epitaxial gallium arsenide with a heavily doped buried layer (44), said epitaxial layer (36) having spaced, electrically isolated islands. A self aligned Schottky diode junction is formed at the intersection of each isolation island with the centre conductor (24) of the transmission line. The second conductor (26) of the transmission line is coupled through a contact window and an ohmic contact (46,48) to the buried layer in each isolation island.  ",THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY,"RODWELL, MARK J.W.;;BLOOM, DAVID M.",,https://lens.org/008-245-197-190-932,Search Report,yes,3,0,4,12,0,H03H7/325;;H03H7/325,H01L29/93;;H01P1/00;;H03H7/32;;H03K5/12,,2,0,,,"ARCHIV DER ELEKTRISCHE UBERTRAGUNG, vol. 22, no. 10, October 1968, pages 472-479, Stüttgart, DE; E. LÜDER: ""Laufzeitketten mit nichtlinearen Kapazitäten"";;PROCEEDINGS EIGHTS BIENNIAL CORNELL ELECTRICAL ENGINEERING CONFERENCE, Cornell University, Ithaca, New York, 11th,12th,13th August 1981, pages 53-63; G.E. BREHM et al.: ""High capacitance ratio monolithic varactor diode""",DISCONTINUED
275,WO,A3,WO 2005/080581 A3,009-292-331-682-355,2006-04-27,2006,US 2005/0005461 W,2005-02-17,US 54537504 P,2004-02-17,INSULATED HERPESVIRUS-DERIVED GENE EXPRESSION CASSETTES FOR SUSTAINED AND REGULATABLE GENE EXPRESSION,"Disclosed are genetic expression cassettes, and vector comprising them useful for the delivery of nucleic acid segments encoding selected therapeutic constructs (including for example, peptides, polypeptides, ribozymes, and catalytic RN molecules), to selected cells and tissues of vertebrate animals. The disclosed genetic constructs are useful in the development of gene therapy vectors, including for example, viral vectors such as HSV, retroviral, lentiviral, AV, and rAAV vectors. The expression cassettes disclosed herein provide new tools in the field of gene therapy, and for the treatment of mammalian, and in particular, human diseases, disorders, and dysfunctions. The disclosed compositions may be utilized in a variety of investigative, diagnostic and therapeutic regimens, including the prevention and treatment of a variety of human diseases.",UNIV FLORIDA;;BLOOM DAVID C;;AMELIO ANTONIO L,BLOOM DAVID C;;AMELIO ANTONIO L,,https://lens.org/009-292-331-682-355,Search Report,yes,2,0,6,6,0,A61K31/713;;A61K31/713;;A61K48/00;;A61K48/00;;C12N15/85;;C12N15/85;;C12N15/86;;C12N15/86;;C12N2710/16611;;C12N2710/16611;;C12N2710/16622;;C12N2710/16633;;C12N2710/16642;;C12N2710/16642;;C12N2710/16643;;C12N2710/16643;;C12N2830/007;;C12N2830/007;;C12N2830/40;;C12N2830/40;;C12N2830/60;;C12N2830/60,A61K48/00;;C12N15/85;;C12N15/869,,7,7,051-101-400-051-96X;;016-087-297-804-267;;015-575-389-306-958;;034-907-439-223-323;;077-021-354-462-20X;;112-474-220-577-764;;030-518-488-585-14X,pmc112048;;10.1128/jvi.74.12.5604-5618.2000;;10823868;;10.1128/jvi.71.4.3197-3207.1997;;9060683;;pmc191452;;8551638;;pmc189902;;10.1128/jvi.70.2.976-984.1996;;10.1101/gad.954702;;11825869;;10729137;;10.1128/jvi.74.8.3613-3622.2000;;pmc111871;;15507638;;pmc525101;;10.1128/jvi.78.22.12508-12518.2004;;10.1146/annurev.mi.49.100195.003331;;8561476;;10.1146/annurev.micro.49.1.675,"PALMER J A ET AL: ""Development and optimization of herpes simplex virus vectors for multiple long-term delivery to the peripheral nervous system"", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 74, no. 12, June 2000 (2000-06-01), pages 5604 - 5618, XP002164866, ISSN: 0022-538X;;LACHMANN R H ET AL: ""UTILIZATION OF THE HERPES SIMPLEX VIRUS TYPE 1 LATENCY-ASSOCIATED REGULATORY REGION TO DRIVE STABLE REPORTER GENE EXPRESSION IN THE NERVOUS SYSTEM"", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 71, no. 4, April 1997 (1997-04-01), pages 3197 - 3207, XP000654376, ISSN: 0022-538X;;PERNG GUEY-CHUEN ET AL: ""The spontaneous reactivation function of the herpes simplex virus type 1 LAT gene resides completely within the first 1.5 kilobases of the 8.3-kilobase primary transcript"", JOURNAL OF VIROLOGY, vol. 70, no. 2, 1996, pages 976 - 984, XP002336979, ISSN: 0022-538X;;WEST A G ET AL: ""Insulators: Many functions, many mechanisms"", GENES AND DEVELOPMENT, COLD SPRING HARBOR LABORATORY PRESS, NEW YORK, US, vol. 16, no. 3, 1 February 2002 (2002-02-01), pages 271 - 288, XP002249349, ISSN: 0890-9369;;BERTHOMME HERVE ET AL: ""Evidence for a bidirectional element located downstream from the herpes simple virus type 1 latency-associated promoter that increases its activity during latency"", JOURNAL OF VIROLOGY, vol. 74, no. 8, April 2000 (2000-04-01), pages 3613 - 3622, XP002336980, ISSN: 0022-538X;;KUBAT NICOLE J ET AL: ""The herpes simplex virus type 1 latency-associated transcript (LAT) enhancer/rcr is hyperacetylated during latency independently of LAT transcription"", JOURNAL OF VIROLOGY, vol. 78, no. 22, November 2004 (2004-11-01), pages 12508 - 12518, XP002336981, ISSN: 0022-538X;;GLORIOSO J C ET AL: ""DEVELOPMENT AND APPLICATION OF HERPES SIMPLEX VIRUS VECTORS FOR HUMAN GENE THERAPY"", ANNUAL REVIEW OF MICROBIOLOGY, ANNUAL REVIEWS INC., PALO ALTO, CA, US, vol. 49, 1995, pages 675 - 710, XP000783620, ISSN: 0066-4227",PENDING
276,US,B2,US 8139282 B2,053-974-074-857-778,2012-03-20,2012,US 201113076121 A,2011-03-30,US 201113076121 A;;US 48268609 A,2009-06-11,Display system,A display system is based on a linear array phase modulator and a phase edge discriminator optical system.,BLOOM DAVID M;;LEONE MATTHEW A;;ALCES TECHNOLOGY INC,BLOOM DAVID M;;LEONE MATTHEW A,ALCES TECHNOLGY INC (2011-06-14);;MANTISVISION LTD (2018-04-06),https://lens.org/053-974-074-857-778,Granted Patent,yes,2,0,6,18,0,G02B26/06;;G02B26/06;;G02B26/101;;G02B26/101;;H04N9/3132;;H04N9/3132,G02F1/01;;G02B3/00;;G02B26/00,359/276;;359/237;;359/649,5,5,068-763-699-784-614;;079-046-540-639-770;;010-371-954-988-773;;031-621-040-486-807;;112-981-541-153-256,10.1086/432029;;19687878;;10.1364/ol.4.000286;;10.1364/ao.38.006604;;18324196;;10.1364/ao.11.000479;;20111535;;10.1016/j.optcom.2006.12.034,"Jose E. Oti et al., The Optical Differentiation Coronagraph, The Astrophysical Journal, v. 630, p. 631-636, Sep. 1, 2005.;;Steven K. Case, Fourier processing in the object plane, Optics Letters, v. 4, p. 286-288, Sep. 1, 1979.;;Carole C. Montarou et al., Analysis and design of modified Wollaston prisms, Applied Optics, v. 38, p. 6604-6616, Nov. 1, 1999.;;S. Mallick et al., Spatial Differentiation by a Lateral Shear Interferometer, Applied Optics, v. 11, p. 479-480, Feb. 1, 1972.;;Lei Wu et al., Analysis of the lateral displacement and the optical path difference in wide-field-of-view polarization interference imaging spectrometer, Optics Communications, v. 273, p. 67-73, 2007.",ACTIVE
277,TW,A,TW 201523312 A,059-007-053-732-460,2015-06-16,2015,TW 103130921 A,2014-09-05,US 201361874680 P,2013-09-06,User grey cell,"In various embodiments, a user grey cell is disclosed. The user grey cell comprises a simplified logical implementation of a black box cell identified in a software and/or hardware design. The internal functionality of the black box cell is undefined, hidden, or encrypted, and thus is not available for timing analysis. The user grey cell for the black box cell provides sufficient clocking and register information to allow for accurate CDC, false path, and multi-cycle path analysis, and provides a way for designers to locate and repair clock domain crossing violations before the design is implemented in hardware. In various embodiments, a method for user grey cell analysis is disclosed. The method comprises identifying one or more black box cells in a user design. The method further comprises determining which of the input and/or output pins of each of the black box cells are in use by the user design. The method further comprises selecting a user grey cell for one or more of the black box cells, wherein a user grey cell comprises a simplified logic implementation for the black box cell, sufficient to perform CDC, false path, and multi-cycle path analysis. The selected user grey cells may be used in place of the black box cells for CDC, false path, and multi-cycle path analysis.",BLUE PEARL SOFTWARE INC,BLOOM SCOTT ARON;;WALLACE DAVID E,,https://lens.org/059-007-053-732-460,Patent of Addition,no,0,0,4,4,0,G06F30/34;;G06F30/30;;G06F2119/12;;G06F30/34;;G06F30/30;;G06F2119/12;;G06F30/32,G06F17/50,,0,0,,,,PENDING
278,CN,A,CN 103626639 A,116-550-362-197-721,2014-03-12,2014,CN 201310556918 A,2009-10-30,US 10963408 P;;CN 200980140509 A,2008-10-30,Reduction of HMF ethers with metal catalyst,"Methods of making reduced derivatives of hydroxymethyl furfural using metal catalysts are described. The derivatives may have tetrahydrofuran or furan nucleus with alkoxymethyl ether or ester moieties on the 5 carbon and methanol on the 2' carbon. Suitable metal catalyst include Raney nickel, a nickel catalyst with a zirconium promoter, a chromite catalyst with a barium, a palladium catalyst, such as palladium on carbon, or a ruthenium catalyst. Also provided are a new class of compounds, which are n-alkoxy hexane diols (i.e., 1,2 or 1,5 hexane diol ethers) and methods of making the same by reduction of furan or tetrahydrofuran deivatives. The composition can be used to prepare the starting material of other compositions, and can be used to satisfy the requirement of the industrial chemical product of the reproductive resource based on the biology.",ARCHER DANIELS MIDLAND CO,BLOOM PAUL DAVID;;SANBORN ALEXANDRA J,,https://lens.org/116-550-362-197-721,Patent Application,no,0,0,27,27,0,C07C41/26;;C07C41/26;;C07D307/54;;C07D307/54;;C07C41/26;;C07C41/26;;C07C43/13;;C07C43/13;;C07C43/13;;C07C43/13;;C07D307/12;;C07D307/12;;C07D307/12;;C07D307/12;;C07D307/16;;C07D307/16;;C07D307/16;;C07D307/16;;C07D307/42;;C07D307/44;;C07D307/44;;C07D307/44;;C07D307/44;;C07D307/54;;C07D307/54;;C08K5/06;;C08K5/06;;C08K5/06;;C08K5/06;;C09K3/00;;C09K3/00,C07C43/13;;C07C41/26,,0,0,,,,ACTIVE
279,US,A1,US 2010/0315694 A1,135-695-148-340-490,2010-12-16,2010,US 68730610 A,2010-01-14,US 68730610 A;;US 48268609 A,2009-06-11,Compact display system,A display system is based on a linear array phase modulator and a phase edge discriminator optical system.,ALCES TECHNOLOGY INC,BLOOM DAVID M;;LEONE MATTHEW A,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2010-06-02),https://lens.org/135-695-148-340-490,Patent Application,yes,5,0,2,18,0,G02B26/06;;G02B26/06,G02F1/01,359/279,0,0,,,,INACTIVE
280,US,B2,US 7940448 B2,184-966-050-926-775,2011-05-10,2011,US 48268609 A,2009-06-11,US 48268609 A,2009-06-11,Display system,A display system is based on a linear array phase modulator and a phase edge discriminator optical system.,ALCES TECHNOLOGY INC,BLOOM DAVID M;;LEONE MATTHEW A,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2010-06-02),https://lens.org/184-966-050-926-775,Granted Patent,yes,11,5,6,18,0,G02B26/06;;G02B26/06;;G02B26/101;;G02B26/101;;H04N9/3132;;H04N9/3132,G02F1/01;;G02B26/00,359/276;;359/238;;359/279;;359/290,6,5,068-763-699-784-614;;079-046-540-639-770;;010-371-954-988-773;;031-621-040-486-807;;112-981-541-153-256,10.1086/432029;;19687878;;10.1364/ol.4.000286;;10.1364/ao.38.006604;;18324196;;10.1364/ao.11.000479;;20111535;;10.1016/j.optcom.2006.12.034,"Jose E. Oti et al., The Optical Differentiation Coronagraph, The Astrophysical Journal, v. 630, p. 631-636, Sep. 1, 2005.;;Steven K. Case, Fourier processing in the object plane, Optics Letters, v. 4, p. 286-288, Sep. 1, 1979.;;Carole C. Montarou et al., Analysis and design of modified Wollaston prisms, Applied Optics, v. 38, p. 6604-6616, Nov. 1, 1999.;;S. Mallick et al., Spatial Differentiation by a Lateral Shear Interferometer, Applied Optics, v. 11, p. 479-480, Feb. 1, 1972.;;Lei Wu et al., Analysis of the lateral displacement and the optical path difference in wide-field-of-view polarization interference imaging spectrometer, Optics Communications, v. 273, p. 67-73, 2007.;;International Search Report and Written Opinion of the International Searching Authority in application PCT/US2010/038238 which corresponds to U.S. Appl. No. 12/482,686.",INACTIVE
281,GB,A,GB 1033540 A,022-504-644-973-308,1966-06-22,1966,GB 4343763 A,1963-11-04,GB 4343763 A,1963-11-04,Moulding plastics,"1,033,540. Injection moulding. IMPERIAL CHEMICAL INDUSTRIES Ltd. Oct. 27, 1964 [Nov. 4, 1961; Dec. 24, 1963], Nos. 43437/63 and 50886/63. Heading B5A. In a process for injection moulding a shaped body on to a surface of a member the moulding composition is a vinyl chloride polymer and the surface is first coated with a plasticized vinyl chloride polymer or copolymer, e.g. a latex or plastisol. The coating composition contains from 30-150 parts by weight of plasticizer to each 100 parts of polymer or copolymer, and is applied hot or cold to the surface by spreading or by moulding. The moulding composition may contain a blowing agent. Where the surface to be coated is smooth it is roughened before being coated. The gelling of the coating may be completed during the moulding. The invention is described as applied to a shoe soling process, the coating being applied to an upper on a last which closes a mould cavity into which the moulding composition is injected. The apparatus may include a plurality of lasts. If the coating layer is applied by moulding the mould cavity has a movable wall so that the cavity is small during the coating and is enlarged before or during the moulding. The invention is also described as applied to the forming of a laminate comprising a chrome tanned leather substrate to which a latex coating is applied before injection moulding a layer of the moulding composition thereon.",ICI LTD,WISE DAVID VICTOR;;BLOOM LESLIE ISAAC,,https://lens.org/022-504-644-973-308,Granted Patent,no,0,3,1,2,0,B29C45/0001;;C08J5/124;;C08J2327/06,B29C45/00;;C08J5/12,B5A AB1           AB1;;B5A A1R14B        -;;B5A A1R14C1X      -;;B5A A1R14D        -;;B5A A1R214A       AB1;;B5A A1R214B       AB1;;B5A A1R214D       AB1;;B5A A1R214H       AB1;;B5A A1R27         -;;B5A A1R314C1E     AB1;;B5A A1R322        AB1;;B5A A1R427        AB1;;B5A A1R467        AB1;;B5A A20T14        AB1,0,0,,,,EXPIRED
282,WO,A3,WO 2001/011395 A3,046-647-288-592-11X,2001-06-07,2001,US 0021664 W,2000-08-08,US 37264999 A,1999-08-11,ACHROMATIC DIFFRACTIVE OPTICAL MODULATOR,"Micromachined grating modulators which exhibit achromatic behavior are described. One embodiment includes narrow and wide ribbons (120, 130) suspended above a substrate and alternatingly interleaved with each other. Narrow and wide reflective surfaces (122, 132) are formed on the narrow and wide ribbons. Compensating reflective surfaces (142) are formed in the gaps (140) between and beneath the ribbons. The width of the ribbons as well as the width of the gaps and the compensating reflecting surfaces are designed so that incident optical beam can be modulated or attenuated in an achromatic fashion.",LIGHTCONNECT INC,GODIL ASIF A;;BLOOM DAVID M,,https://lens.org/046-647-288-592-11X,Search Report,yes,12,0,6,23,0,G02B5/1828;;G02B6/266;;G02B6/29352;;G02B6/3516;;G02B6/357;;G02B6/3584;;G02B26/0808;;H01S5/005;;G02B26/0808;;G02B6/266;;G02B5/1828;;G02B6/3584;;G02B6/3516;;G02B6/29352;;G02B6/357;;H01S5/005,G02B5/18;;G02B6/26;;G02B6/34;;G02B6/35;;G02B26/08;;G02F1/035;;G02B26/00;;H01S5/00,,1,1,124-520-788-803-576,10.1016/s0924-4247(97)01731-7,"KURTH S ET AL: ""Silicon mirrors and micromirror arrays for spatial laser beam modulation"", SENSORS AND ACTUATORS A,CH,ELSEVIER SEQUOIA S.A., LAUSANNE, vol. 66, no. 1-3, 1 April 1998 (1998-04-01), pages 76 - 82, XP004143972, ISSN: 0924-4247",PENDING
283,US,B2,US 10883922 B2,046-293-911-502-724,2021-01-05,2021,US 201916573545 A,2019-09-17,US 201916573545 A;;US 201514677789 A,2015-04-02,Matter tracking system,"A system is described that can detect, track and analyze a bubble of a secondary substance contained within a primary substance along a part of a fluid line. For example, the system can detect the presence of the bubble within the primary substance along the part of the fluid line, which can include assigning a digital signature to the bubble. In addition, the system can track the movement of the bubble in order to ensure that the bubble is accounted for only once as it passes through the part of the fluid line. Furthermore, the system can analyze the bubble, such as determine its direction of travel, speed of travel, volume and size.",CAREFUSION 303 INC,BLOOM MARK;;OSCOLAI CATHAL;;BROWN DAVID,CAREFUSION 303 INC (2015-09-22),https://lens.org/046-293-911-502-724,Granted Patent,yes,25,0,14,14,0,G01N2291/02433;;G06T2207/10016;;G06T7/246;;G01N2291/02433;;G06T2207/10016;;G06T7/246;;H04N23/56;;H04N23/80;;G01N21/17;;G01N2021/177;;G06T2207/10004,G01N21/17;;G06T7/246;;H04N5/225;;H04N5/232,,6,3,095-685-303-423-07X;;095-685-303-423-07X;;027-043-112-285-945,10.1007/s00348-009-0815-2;;10.1007/s00348-009-0815-2;;10.1088/1742-6596/147/1/012018,"Stohr, M., C. Garbe, D. Engelmann, P. Geissler, S. Gomes, F. Hering, H.-G. Wagner and B. Jahne, 4-D particle tracking velocimetry applied to gas-liquid reactors. In Proc. of the Int. Workshop of Scientific Computing in Chemical Engineering II, Hamburg-Harburg, 1999 (Year: 1999).;;Ohmi K., S. P. Pandy, A. Sapkota, Particle tracking velocimetry with an ant colony optimization algorithm, Exp Fluids (2010) 48:589-605 DOI 10.1007/S00348-009-0815-2 (Year: 2010).;;Ohmi K., S. P. Pandy, A. Sapkota, “Particle tracking velocimetry with an ant colony optimization algorithm.” Exp Fluids (2010) 48:589-605 DOI 10.1007/s00348-009-0815-2.;;Stohr, M., C. Garbe, D. Engelmann, P. Geissler, S. Gomes, F. Hering, H.-G. Wagner and B. Jahne, “4-D particle tracking velocimetry applied to gas-liquid reactors.” In Proc. of the Int. Workshop of Scientific Computing in Chemical Engineering II, Hamburg-Harburg, 1999. pp. 1-9.;;Stohr publication date: screen shot taken from google search results. See attached PDF titled Stohr publication date. 1 page.;;Wang, H.Y. and F. Dong (2009), “A method for bubble volume calculating in vertical two-phase flow.” Journal of Physics: Conference Series, The 6th International Symposium on Measurement Techniques for Multiphase Flows, IOP Publishing, Bristol, GB. vol. 147, No. 1, p. 12018.",ACTIVE
284,US,B1,US 6169624 B1,082-069-149-935-040,2001-01-02,2001,US 37264999 A,1999-08-11,US 37264999 A,1999-08-11,Achromatic optical modulators,Micromachined grating modulators which exhibit achromatic behavior are described. One embodiment includes narrow and wide ribbons suspended above a substrate and alternatingly interleaved with each other. Narrow and wide reflective surfaces are formed on the narrow and wide ribbons. Compensating reflective surfaces are formed in the gaps between and beneath the ribbons. The width of the ribbons as well as the width of the gaps and the compensating reflecting surfaces are designed so that incident optical beam can be modulated or attenuated in an achromatic fashion.,GODIL ASIF A.;;BLOOM DAVID M.,GODIL ASIF A;;BLOOM DAVID M,LIGHTCONNECT INC (2000-12-11);;NEOPHOTONICS CORPORATION (2010-06-08),https://lens.org/082-069-149-935-040,Granted Patent,yes,1,41,6,23,0,G02B5/1828;;G02B6/266;;G02B6/29352;;G02B6/3516;;G02B6/357;;G02B6/3584;;G02B26/0808;;H01S5/005;;G02B26/0808;;G02B6/266;;G02B5/1828;;G02B6/3584;;G02B6/3516;;G02B6/29352;;G02B6/357;;H01S5/005,G02B26/00;;G02B5/18;;G02B6/26;;G02B6/34;;G02B6/35;;G02B26/08;;G02F1/035;;H01S5/00,359/237;;359/254;;359/263;;359/318;;385/8;;385/27,0,0,,,,EXPIRED
285,US,A1,US 2014/0204180 A1,102-150-872-466-660,2014-07-24,2014,US 201414226416 A,2014-03-26,US 201414226416 A;;US 68734010 A,2010-01-14,Structured light system,"A structured light system based on a fast, linear array light modulator and an anamorphic optical system captures three-dimensional shape information at high rates and has strong resistance to interference from ambient light. A structured light system having a modulated light source offers improved signal to noise ratios. A wand permits single point detection of patterns in structured light systems.",BLOOM DAVID M;;LEONE MATTHEW A;;ALCES TECHNOLOGY INC,BLOOM DAVID M;;LEONE MATTHEW A,MANTISVISION LTD (2018-04-06);;ALCES TECHNOLOGY INC (2014-10-29),https://lens.org/102-150-872-466-660,Patent Application,yes,1,3,6,18,0,G01B11/25;;G01B11/25;;H04N13/254;;H04N13/254,H04N13/02,348/46,2,1,016-099-816-860-630,10.1109/isie.2008.4677260,"""SUPER RESOLUTION 3D SCANNING USING SPATIAL LIGHT MODULATOR AND BAND CORRECTION"", University of Kentucky Master's Theses, to Pethe;;Ando, S.; Ono, N., ""Spatio-temporal phase-encoding profilometry using correlation image sensor,"" Industrial Electronics, 2008. ISIE 2008. IEEE International Symposium on , vol., no., pp.786,791, June 30 2008-July 2 2008.",INACTIVE
286,WO,A1,WO 1983/003483 A1,122-302-443-632-910,1983-10-13,1983,GB 8300087 W,1983-03-23,GB 8208376 A,1982-03-23,METHOD AND APPARATUS FOR USE IN PROCESSING SIGNALS,"New dialogue is post-synchronised with guide track dialogue by using signal processing apparatus in which the analog guide track signal x1(t) undergoes speech parameter measurement processing in a processor (43) to provide a speech parameter vector A(kT). The new dialogue signal x2(t') is processed to give waveform data which can be stored on disc (25) and a speech parameter vector B(jT) from a parameter extraction processor (42). The variables k and j are data frame numbers, and T is an analysis interval. Some parameters of the vector B are used in a process (48) to classify sucessive passages of the new dialogue signal into speech and silence, to produce classification data f(jT). The vectors A and B and the classification data are utilized in a time warp processor SBC2 to determine a time-warping function w(kT) giving the values of j in terms of the values of k associated with the corresponding speech features, and thereby, indicating the amount of expansion or compression of the waveform data of the new dialogue signal needed to align the time-dependent features of the new dialogue signal with the corresponding features of the guide track signal. Editing instructions are generated in signal editor computer SBC1 from the w(kT) data, feature classification data, pitch data p(jT) and the data stream x2 (nD) so that the editing of x2(nD) can be carried out by the computer SBC1 in which periods of silence or speech are lengthened or shortened to give the desired alignment. The edited data x2(nD) is converted to analog by a converter unit (29), and low pass filtered to provide an audio output signal to be recorded as the synchronise new dialogue.",BLOOM PHILLIP JEFFREY;;MARSHALL GARTH DAVID,BLOOM PHILLIP JEFFREY;;MARSHALL GARTH DAVID,,https://lens.org/122-302-443-632-910,Patent Application,yes,3,4,10,10,0,G03B31/00;;G10L21/04;;G11B27/034;;G11B27/10;;G10L21/04;;G11B27/10;;G03B31/00;;G11B27/034,G03B31/00;;G10L21/04;;G11B27/034;;G11B27/10,H4R RPMB          RPMB,0,0,,,,PENDING
287,EP,B1,EP 2350035 B1,144-093-095-147-520,2016-01-13,2016,EP 09829644 A,2009-10-30,US 2009/0062778 W;;US 10963408 P,2008-10-30,REDUCTION OF HMF ETHERS WITH METAL CATALYST,,ARCHER DANIELS MIDLAND CO,BLOOM PAUL DAVID;;SANBORN ALEXANDRA J,,https://lens.org/144-093-095-147-520,Granted Patent,yes,9,0,27,27,0,C07C41/26;;C07C41/26;;C07D307/54;;C07D307/54;;C07C41/26;;C07C41/26;;C07C43/13;;C07C43/13;;C07C43/13;;C07C43/13;;C07D307/12;;C07D307/12;;C07D307/12;;C07D307/12;;C07D307/16;;C07D307/16;;C07D307/16;;C07D307/16;;C07D307/42;;C07D307/44;;C07D307/44;;C07D307/44;;C07D307/44;;C07D307/54;;C07D307/54;;C08K5/06;;C08K5/06;;C08K5/06;;C08K5/06;;C09K3/00;;C09K3/00,C07D307/20;;C07D307/24;;C07D307/28;;C07D307/34,,1,0,,,"MICHAEL E. JUNG ET AL: ""-2',3'-Dideoxyisonucleosides via Regioselective Opening of Optically Active C 2 -Symmetric 1,4-Pentadiene Bis-epoxide 1"", THE JOURNAL OF ORGANIC CHEMISTRY, vol. 63, no. 9, 1 May 1998 (1998-05-01), pages 2975-2981, XP55029934, ISSN: 0022-3263, DOI: 10.1021/jo9721655",ACTIVE
288,US,A,US 5982553 A,159-543-100-398-448,1999-11-09,1999,US 82139097 A,1997-03-20,US 82139097 A,1997-03-20,Display device incorporating one-dimensional grating light-valve array,A display system for providing a two dimensional image includes an essentially one dimensional light valve array. The diffractive light valve array includes modulator elements which diffract or reflect light incident thereon to an extent determined by an image element to be represented. The display system is arranged such diffracted light from the light-valve array passes through a magnifying lens and is separated from the reflected light from the array. A magnified virtual image of the array formed by the diffracted light is viewed through the magnifying lens. A scanning arrangement between the viewer and the magnifying lens scans the image of the light-valve array across the field of view of the viewer sufficiently quickly that the viewer perceives the scanned image as a two-dimensional image. In another arrangement a printer is formed by scanning a real image of the diffractive light valve array over a printing or recording medium.,SILICON LIGHT MACHINES INC,BLOOM DAVID M;;GODIL ASIF A,SILICON LIGHT MACHINES INC (1997-03-17);;SILICON LIGHT MACHINES CORPORATION (2008-06-23),https://lens.org/159-543-100-398-448,Granted Patent,yes,100,750,15,15,0,G02B5/1828;;G02B26/0808;;G02B26/10;;G02B27/017;;G02B26/08;;G02B27/017;;G02B5/1828;;G02B26/10;;G02B26/0808,G02B5/18;;B41J2/445;;G02B26/08;;G02B26/10;;G02B27/01,359/627;;359/619,20,12,009-286-199-765-581;;028-775-209-892-098;;009-365-280-210-861;;036-825-749-119-883;;052-055-696-490-751;;010-074-622-606-125;;031-674-958-708-951;;021-605-933-822-940;;099-238-362-991-633;;049-400-534-653-649;;020-669-540-688-441;;022-949-709-618-959,10.1109/5.53402;;10.1117/12.19865;;10.1016/0141-9382(91)90032-9;;10.1889/1.1984964;;19823336;;10.1364/ol.18.001214;;10.1364/ol.17.000688;;19794599;;10.1364/ao.28.004826;;20555956;;10.1117/12.950001;;10.1016/0030-4018(93)90662-o;;10.1021/bk-1997-0670.ch018;;10.1117/1.602097;;10.1117/1.601346,"Apte et al., Grating Light Valves For High Resolution Displays , Solid State Sensor and Actuators Workshop, Hilton Head Island, SC, Jun., 1994.;;R. Apte, Grating Light Valves For High Resolution Displays, Jun., 1994.;;O. Solgaard, Integrated Semiconductor Light Modulators For Fiber Optic And Display Applications, Feb., 1992.;;J. Neff, Two Dimensional Spatial Light Modulators: A Tutorial , Proceedings of the IEEE, vol. 78, No. 5, pp. 826 855, May, 1990.;;Gerhard Multhaupt, Viscoelastic Spatial Light Modulators and Schlieren Optical Systems for HDTV Projection Displays , SPIE vol. 1255 Large Screen Projection Displays II, pp. 69 78, 1990.;;Gerhard Multhaupt, Light Valve Technologies for High Definition Television Projection Displays , Displays, vol. 12, No. 3/4, pp. 115 128, 1991.;;Alvelda et al., Ferroelectric Microdisplays Using Distortion Compensated Pixel Layouts, SID 95 Digest, pp. 931 933, 1995.;;Phillip Alvelda, High Efficiency Color Microdisplays, SID 95 Digest, pp. 307 311, 1995.;;Worboys et al., Miniature Display Technology for Integrated Helmut Systems, GEC Journal of Research, vol. 10, No. 2, pp.111 118, 1993.;;Farn et al., Color Separation by use of Binary Optics, Optics Letters, vol. 18:15, pp. 1214 1216, 1993.;;Phillip Alvelda, VLSI Microdisplays and Optoelectric Technology, MIT, pp. 1 93, 1995.;;Phillip Alvelda, VLSI Microdisplay Technology, MIT, Oct. 14, 1994.;;Solgaard et al., Deformable Grating Optical Modulator, Optics letters, vol. 17, No. 9, New York, USA, pp. 688 690, May 1, 1992.;;Tepe et al., Visoelastic Spatial Light modulator with Active Matrix Addressing, Applied Optics, vol. 28, No. 22, New York, USA, pp. 4826 4834, Nov. 15, 1989.;;Brinker et al., Deformation Behavior of Thin Viscoelastic Layers Used in an Active Matrix Addressed Spatial Light Modulator, SPIE vol. 1018, pp. 79 85, Germany, 1988.;;T. Utsunomiya and H. Sato, Electrically Deformable Echellette Grating and its Application to Tunable Laser Resonator, Electronics and Communications in Japan, vol. 63 c, No. 10, pp. 94 100, Japan, 1980.;;T. Iwai et al., Real time Profiling of a Pure Phase Object Using an Auto Wigner Distribution Function, Optics Communications, vol. 95, No. 4 6, pp. 199 204, Jan. 15, 1993.;;Russick et al., Supercritical Carbon Dioxide Extraction of Solvent from Micromachined Structures, Supercritical Fluids, Chapter 18, pp. 255 269, 1997.;;Gani et al., Variable Gratings for Optical Switching: Rigorous Electromagnetic Simulation and Design, Optical Engineering, vol. 38, No. 3, pp. 552 557, Mar. 1999.;;Buhler et al., Linear Array of Complementary Metal Oxide Semiconductor Double Pass Metal Micromirrors, Optical Engineering, vol. 36, No. 5, pp. 1391 1398, May 1997.",EXPIRED
289,WO,A1,WO 2015/148325 A1,164-176-745-565-986,2015-10-01,2015,US 2015/0021883 W,2015-03-20,US 201414226515 A,2014-03-26,COMPACT 3D DEPTH CAPTURE SYSTEMS,"Compact 3D depth capture systems are based on a 3D system driver/interface, a 3D system camera, and a 3D system projector. The systems are compatible with integration in to mobile electronic devices such as smart phones and tablet computers.",ALCES TECHNOLOGY INC,BLOOM DAVID M;;LEONE MATTHEW A,,https://lens.org/164-176-745-565-986,Patent Application,yes,5,1,10,10,0,G01B11/2527;;G01B11/254;;G01B11/254;;G01B11/2527;;G01B11/2527,H04N13/02;;H04N13/00;;H04N13/04,,1,0,,,See also references of EP 3123717A4,PENDING
290,US,B2,US 8585881 B2,169-172-650-612-165,2013-11-19,2013,US 71132704 A,2004-09-10,US 71132704 A,2004-09-10,Localized chemical microgradients,"A device for creating microgradients in solution is disclosed. The device contains a microfluidic channel with openings at each end and two or more small apertures to a bath. Electrodes are placed in the openings at either end of the channel and an electrical power supply is connected to the electrodes. Several distinct current paths exist from one end of the channel to the other. For example current may flow from one electrode, through a portion of the channel, through an aperture into the bath, back through another aperture into the channel, and along another portion of the channel to the other electrode. Current flows along all possible connected paths when an electric field is applied along the channel and induces fluid flow into and out of the apertures in the channel. Fluid flow through the apertures results in the formation of microgradients in solution near the microfluidic channel device.",PETERMAN MARK C;;BLOOM DAVID M;;ONDA VIA INC,PETERMAN MARK C;;BLOOM DAVID M,ONDA VIA INC (2009-10-11);;LABRADOR RESEARCH LLC (2008-12-31);;PETERMAN MARK (2009-08-20);;ALCES TECHNOLOGY INC (2004-08-10),https://lens.org/169-172-650-612-165,Granted Patent,yes,4,0,3,3,0,G01N27/447;;G01N27/447;;B01D57/02,B01D57/02,204/450,4,3,014-234-978-449-20X;;149-071-991-893-665;;024-968-142-168-85X,11959483;;10.1016/s0956-5663(02)00015-5;;10.1021/ac035154m;;15053643;;15218102;;pmc454196;;10.1073/pnas.0402089101,"Kathryn G. Klemic et al., ""Micromolded PDMS planar electrode . . . ,"" Biosensors and Bioelectronics v. 17, p. 597, 2002.;;A. Tixier, et al., ""Catching and attaching cells using an array of microholes,"" IEEE-EMBS Conference on Microtechnologies in Medicine & Biology, Poster 106, Oct. 12, 2000.;;Mark C. Peterman et al., ""Fluid Flow Past an Aperture in a Microfluidic Channel,"" Analytical Chemistry v. 76, p. 1850, Apr. 1, 2004.;;Mark C. Peterman et al., ""Localized chemical release from an artificial synapse chip,"" PNAS v. 101, p. 9951, Jul. 6, 2004.",ACTIVE
291,CN,A,CN 103098078 A,049-054-665-478-626,2013-05-08,2013,CN 201080069079 A,2010-09-13,US 2010/0048678 W,2010-09-13,Smile detection systems and methods,Systems and methods of smile detection are disclosed. An exemplary method comprises generating a search map for a subset of an image. The method also comprises identifying a plurality of candidates representing mouth corners. The method also comprises generating parabolas between each pair of candidates representing mouth corners. The method also comprises analyzing contour of at least one of the parabolas to determine whether the mouth curves substantially upward to form a smile or curves substantially downward to form a frown.,HEWLETT PACKARD DEVELOPMENT CO,DALTON DAN L;;BLOOM DANIEL;;STAUDACHER DAVID,,https://lens.org/049-054-665-478-626,Patent Application,no,1,4,7,7,0,G06V40/175;;G06V40/174;;G06V40/175,G06K9/52;;G06T7/60,,1,0,,,"刘伟锋: ""人脸表情识别研究"", 《中国博士学位论文全文数据库信息科技辑》, 15 March 2007 (2007-03-15), pages 1 - 81",INACTIVE
292,US,B2,US 6458566 B2,090-414-155-718-450,2002-10-01,2002,US 17809898 A,1998-10-23,US 17809898 A,1998-10-23,Method of identification of differentially expressed MRNA,"
    The method provided by the present invention sets forth a novel combination of methods and principles which allows for the rapid and accurate isolation and identification of a large number of differentially expressed mRNAs. 
",EINSTEIN COLL MED,ALLAND DAVID;;BLOOM BARRY R;;KRAMNIK IGOR,ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (1999-02-01),https://lens.org/090-414-155-718-450,Granted Patent,yes,3,11,2,2,9,C12N15/1072;;C12N15/1072;;C12Q1/689;;C12Q1/689;;Y10T436/143333;;Y10T436/143333,C12N15/10;;C12Q1/68;;C12Q1/689,435/91.2;;435/6;;435/91.1;;435/91.51;;436/94;;536/23.1;;536/24.3;;536/24.33,12,10,030-738-395-947-361;;051-443-369-777-067;;078-427-252-154-544;;040-369-023-420-878;;043-078-291-995-300;;073-418-725-534-218;;078-427-252-154-544;;049-535-708-535-887;;081-077-947-278-085;;017-260-008-035-864,10.1073/pnas.87.3.1213;;2405397;;pmc53441;;pmc186132;;10.1128/iai.62.2.476-483.1994;;7507894;;2408039;;10.1073/pnas.87.5.1889;;pmc53589;;9368357;;10.1111/j.1574-6968.1997.tb12701.x;;10.1016/s0378-1097(97)00398-4;;10.1016/0378-1119(93)90678-v;;7690337;;pmc330815;;10.1093/nar/18.10.2887;;2161516;;2408039;;10.1073/pnas.87.5.1889;;pmc53589;;10.2144/96211st04;;8816243;;10.1016/0378-1119(94)90247-x;;7523251;;8700511,"Green et al., Systematic screening of yeast artificial -chromosome libraries by use of the polymerase chain reaction. Proc. Natl. Acad. Sci. USA 87, 1213-1217, 1990.*;;Plum et al., Induction of Mycobacterium avium gene expression following phagocytosis by human macrophages. Infection and Immunity, 62, 476-483, Feb. 1994.*;;Stratagene Catalog (1994), pp. 154-157. Published by Stratagene Cloning Systems, 11011 North Torrey Pines Road, LA Jolla, CA 92037.*;;Straus et al., Genomic subtraction for cloning DNA corresponding to deletion mutations. Proc. Natl. Acad. Sci. USA 87, 1889-1893, 1990.*;;Hughes et al., Development of mycobacterial species-specific DNA probes by subtraction hybridization. FEMS Microbiology Lett. 156, 31-36, Nov. 1, 1997.*;;Kinger et al., Identification and cloning of genes differentially expressed in the virulent strain of mycobacterium tuberculosis. Gene 131, 113-117, 1993.*;;Riley et al., A novel, rapid method for the isolation of terminal sequences from yeast artificial chromosome (YAC) clones. Nucleic Acids Res. 18, 2887-2890, 1990.*;;Straus et al., Genomic subtraction for cloning DNA corresponding to deletion mutations. Proc. Natl. Acad. Sci. USA 87, 1889-1893, Mar. 1990.*;;Gingrich et al., partial CviJl digestion as an alterative approach to generate cosmid sublibraries for large scale sequencing projects. BioTechniques 21, 99-104, Jul. 1996.*;;Maniatis et al., Molecular Cloning: A laboratory Manual, pp. 382-386, 1982, published by Cold Spring Harbor Laboratory, Box 100, Cold Spring Harbor, New York.*;;Robinson et al., Isolation of maltose-regulated genes from the Hyperthermophilic archaeum, Pyrococcus furisus, by subtractive hybridization. Gene, 148, 137-141, 1994.*;;Ray et al., Isolation and characterization of genes associated with chromosome-6 mediated tumor suppression in human malignant melanoma. Oncogene 12, 2527-2533, 1996.",EXPIRED
293,EP,A1,EP 2616993 A1,145-477-345-216-963,2013-07-24,2013,EP 10857368 A,2010-09-13,US 2010/0048678 W,2010-09-13,SMILE DETECTION SYSTEMS AND METHODS,,HEWLETT PACKARD DEVELOPMENT CO,DALTON DAN L;;BLOOM DANIEL;;STAUDACHER DAVID,"HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (2019-05-15)",https://lens.org/145-477-345-216-963,Patent Application,yes,0,0,7,7,0,G06V40/175;;G06V40/174;;G06V40/175,G06K9/52;;G06K9/00;;G06T7/60,,0,0,,,,DISCONTINUED
294,US,A,US 5014018 A,022-585-382-460-971,1991-05-07,1991,US 10655487 A,1987-10-06,US 10655487 A,1987-10-06,Nonlinear transmission line for generation of picosecond electrical transients,"There is disclosed herein a non linear transmission line comprised of a 50 ohm coplanar monolithic waveguide formed on top of a gallium arsenide substrate having a layer of lightly doped epitaxial gallium arsenide with a heavily doped buried layer, said epitaxial layer having spaced, electrically isolated islands. A self aligned Schottky diode junction is formed at the intersection of each isolation island with the center conductor of the transmission line. The second conductor of the transmission line is coupled through a contact window and an ohmic contact to the buried layer in each isolation island.",UNIV STANFORD,RODWELL MARK J W;;BLOOM DAVID M,BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY THE 350 CAMBRIDGE AVENUE SUITE 250 PALO ALTO CA 94305 A CORP. OF CA (1987-10-05),https://lens.org/022-585-382-460-971,Granted Patent,yes,4,91,4,12,0,H03H7/325;;H03H7/325,H01P1/00;;H01L29/93;;H03H7/32;;H03K5/12,333/20;;307/263;;333/247;;357/15,8,6,108-651-613-843-015;;011-464-360-811-259;;139-230-985-325-058;;102-418-415-486-476;;014-183-718-956-355;;103-747-114-308-100,10.1063/1.1735612;;10.1147/rd.44.0391;;10.1049/el:19870077;;10.1007/bf00886158;;10.1080/00207218508939060;;10.1049/el:19860339,"Pengelly, Microwave Field Effect Transistors Theory, Design and Applications, Research Studies Press (John Wiley & Sons), N.Y. 1982, p. 420.;;Landauer, R., Jour of Applies Physics (1960) 31:479 484 Parametric Amplification along Nonlinear Transmission Lines .;;Landauer, R., IBM Journal (1960) Shock Waves in Nonlinear Transmission Lines and Their Effect on Parametric Amplification pp. 391 401.;;Khokhlov, R. V., Radiotekhnika i elektronika (1961) 6: 77 89 On the Theory of Shock Radio Waves in Non Linear Lines .;;Nonlinear Transmission Line for Picosecond Pulse Compression and Broadband Phase Modulation , Electronics Letter (1987) 23:109 110.;;Jager, D. and Tegude, F., Applied Physics (1978) 15:393 397 Nonlinear Wave Propagation along Periodic Loaded Transmission Line .;;Jager, D., Int J Electronics (1985) 58:649 668, Characteristics of Travelling Waves Along the Non Linear Transmission Lines for Monolithic Integrated Circuits: a Review .;;Gate Propagation Delay and Logic Timing of GaAs Integrated Circuits Measured by Electro Optic Sampling Electronics Letter (1986) 22:2 pages.",EXPIRED
295,SG,A,SG 10201911740S A,095-116-195-257-480,2020-07-29,2020,SG 10201911740S A,2019-12-05,US 201862776383 P,2018-12-06,SYSTEMS AND METHODS FOR ANALYZING A RAIL,,ENSCO INC,ANTHONY KIM;;JEFFREY BLOOM;;DAVID G FORD,,https://lens.org/095-116-195-257-480,Unknown,no,0,0,5,5,0,B61K9/08;;G01N21/95;;G01N2201/0216;;G02B7/1824;;B61L23/042;;B61L23/042;;B61K9/08;;B61L23/041;;E05F15/70;;G01N2201/068;;G01N21/55;;G02B7/182;;E05Y2900/51;;G01N2201/0216;;G01N21/95,,,0,0,,,,PENDING
296,EP,A4,EP 2616993 A4,186-910-132-729-126,2017-04-19,2017,EP 10857368 A,2010-09-13,US 2010/0048678 W,2010-09-13,SMILE DETECTION SYSTEMS AND METHODS,,HEWLETT PACKARD DEVELOPMENT CO LP,DALTON DAN L;;BLOOM DANIEL;;STAUDACHER DAVID,"HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (2019-05-15)",https://lens.org/186-910-132-729-126,Search Report,no,3,0,7,7,0,G06V40/175;;G06V40/174;;G06V40/175,G06K9/52;;G06K9/00;;G06T7/60,,2,1,011-156-079-100-143,15484916;;10.1109/tsmcb.2004.825931,"PANTIC M ET AL: ""Facial Action Recognition for Facial Expression Analysis From Static Face Images"", IEEE TRANSACTIONS ON SYSTEMS, MAN AND CYBERNETICS. PART B:CYBERNETICS, IEEE SERVICE CENTER, PISCATAWAY, NJ, US, vol. 34, no. 3, 1 June 2004 (2004-06-01), pages 1449 - 1461, XP011112972, ISSN: 1083-4419, DOI: 10.1109/TSMCB.2004.825931;;See also references of WO 2012036669A1",DISCONTINUED
297,US,A1,US 2012/0063648 A1,044-012-271-768-789,2012-03-15,2012,US 88052410 A,2010-09-13,US 88052410 A,2010-09-13,PROCESSING AN IMAGE OF A PERSONS FACE,"An image contains a representation of a person's face, where the image has plural points each comprising multiple components of a color space. For each of the plural points, at least two of the color space components are combined to produce a respective aggregate value. The image is processed to convert at least some of the points of the image based on the calculated aggregate values.",DALTON DAN L;;BLOOM DANIEL;;STAUDACHER DAVID,DALTON DAN L;;BLOOM DANIEL;;STAUDACHER DAVID,HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2010-09-09),https://lens.org/044-012-271-768-789,Patent Application,yes,2,6,2,2,0,G06V40/165;;G06V40/165,G06K9/00,382/118;;382/162,3,1,151-934-660-750-160,10.1109/34.1000242,"Oravec, M. - ""Extraction of Facial Features from Color Images"" - RadioEngineering - September 2008, Vol. 17, No. 3, pages 115-120;;Hsu, R.L. - ""Face Detection in Color Images"" - IEEE 2002, Vol. 24, No. 5, pages 696-706;;Brakel, R.B.J. - ""Eye Tracking - Additional component computer graphics"" - January 2008, pages 1-18",INACTIVE
298,US,B2,US 11787452 B2,148-644-943-270-286,2023-10-17,2023,US 202318104497 A,2023-02-01,US 202318104497 A;;US 201916705137 A;;US 201862776383 P,2018-12-06,Systems and methods for analyzing a rail,"A deployable measurement system for analyzing a rail of a railroad track includes a housing, a reflecting assembly coupled to the housing, a movement assembly coupled to the housing, and an optical measurement system disposed within the housing. Both the housing and the reflecting assembly are moveable between a stored position and a deployed position. The movement assembly includes a deployment assembly that moves the reflecting assembly from the stored position to the deployed position, and a retraction assembly that moves the reflecting assembly from the deployed position to the stored position. The optical measurement system emits and receives light. The reflecting assembly reflects the emitted light toward the rail. The reflecting assembly reflects light reflected off of the rail toward the optical measurement system. The light received by the optical measurement system is used to measure parameters related to the rail.",ENSCO INC,KIM ANTHONY;;FORD DAVID G;;BLOOM JEFFREY,ENSCO INC (2019-12-10),https://lens.org/148-644-943-270-286,Granted Patent,yes,14,0,5,5,0,B61K9/08;;G01N21/95;;G01N2201/0216;;G02B7/1824;;B61L23/042;;B61L23/042;;B61K9/08;;B61L23/041;;E05F15/70;;G01N2201/068;;G01N21/55;;G02B7/182;;E05Y2900/51;;G01N2201/0216;;G01N21/95,B61K9/08;;B61L23/04;;E05F15/70;;G01N21/55;;G01N21/95;;G02B7/182,,5,0,,,"Deutzer Technische Kohle, “Third Rail Measurement,” Web page, <http://deutzer.de/en/services-en/u-bahn-en/350-dritteschieneubahn-en>, retrieved from the Internet on Jun. 4, 2020 (9 pages).;;Deutzer Technische Kohle, “Third Rail Wear,” Web page, <http://deutzer.de/en/services-en/u-bahn-en/351-dsvubahn-en>, retrieved from the Internet on Jun. 4, 2020 (8 pages).;;KLD Labs, “Third Rail Monitoring,” Web page, <http://www.kldlabs.com/?page_id=67>, retrieved from the Internet on Jun. 4, 2020 (2 pages).;;Robat Kontrol, “Third Rail Measurement,” Web page, <http://robat.com.tr/3rayolcum-en.html>, retrieved from the Internet on Jun. 4, 2020 (1 page).;;DMA, “Third/Power Rail Measurement System (TRMS),” Web page, <https://www.air-rail.org/en/products/railway/brands/dma/third-power-rail-measurement-system-trms>, retrieved from the Internet on Aug. 5, 2020 (2 pages).",ACTIVE
299,US,B2,US 6946733 B2,175-696-119-462-734,2005-09-20,2005,US 64007303 A,2003-08-13,US 64007303 A,2003-08-13,Ball grid array package having testing capability after mounting,A ball grid array package that can be readily tested before or after mounting to a printed circuit board. The ball grid array includes a substrate having a top surface and a bottom surface. Several conductive pads are located on the top surface. Several passive circuit elements are located on the top surface between the conductive pads. An insulative coating is placed on top of the passive circuit elements and the substrate. The insulative coating has openings over the conductive pads. The openings are adapted to be accessible by an electrical probe. Conductive vias extend through the substrate between the top and bottom surfaces. The vias electrically connect with the conductive pad on the top surface. Several conductive balls are located on the bottom surface. Each conductive ball is electrically connected to one of the vias.,CTS CORP,POOLE DAVID;;BLOOM TERRY R;;COOPER RICHARD,CTS CORPORATION (2003-08-06),https://lens.org/175-696-119-462-734,Granted Patent,yes,79,10,2,2,0,H01C1/14;;H05K1/0268;;H05K1/141;;H05K1/167;;H05K3/28;;H05K3/3436;;H05K2201/10045;;H05K1/0268;;H05K1/141;;H05K1/167;;H05K3/28;;H05K3/3436;;H01C1/14;;H05K2201/10045,H01C1/14;;H05K1/02;;H05K1/14;;H05K1/16;;H05K3/28;;H05K3/34,257/737;;257/528;;257/774,0,0,,,,EXPIRED
300,WO,A1,WO 2012/036669 A1,113-579-788-000-586,2012-03-22,2012,US 2010/0048678 W,2010-09-13,US 2010/0048678 W,2010-09-13,SMILE DETECTION SYSTEMS AND METHODS,Systems and methods of smile detection are disclosed. An exemplary method comprises generating a search map for a subset of an image. The method also comprises identifying a plurality of candidates representing mouth corners. The method also comprises generating parabolas between each pair of candidates representing mouth corners. The method also comprises analyzing contour of at least one of the parabolas to determine whether the mouth curves substantially upward to form a smile or curves substantially downward to form a frown.,HEWLETT PACKARD DEVELOPMENT CO;;DALTON DAN L;;BLOOM DANIEL;;STAUDACHER DAVID,DALTON DAN L;;BLOOM DANIEL;;STAUDACHER DAVID,,https://lens.org/113-579-788-000-586,Patent Application,yes,3,1,7,7,0,G06V40/175;;G06V40/174;;G06V40/175,G06T7/60;;G06K9/52,,2,0,,,"SUSAN, Q, Y, LIN: ""Investigation into Markerless Facial Expression Recognition Techniques"", BACHELOR OF SCIENCE IN COMPUTER SCIENCE WITH HONOURS, 31 May 2008 (2008-05-31), XP055113008;;See also references of EP 2616993A4",PENDING
301,US,A1,US 2023/0174122 A1,121-389-166-289-269,2023-06-08,2023,US 202318104497 A,2023-02-01,US 202318104497 A;;US 201916705137 A;;US 201862776383 P,2018-12-06,SYSTEMS AND METHODS FOR ANALYZING A RAIL,"A deployable measurement system for analyzing a rail of a railroad track includes a housing, a reflecting assembly coupled to the housing, a movement assembly coupled to the housing, and an optical measurement system disposed within the housing. Both the housing and the reflecting assembly are moveable between a stored position and a deployed position. The movement assembly includes a deployment assembly that moves the reflecting assembly from the stored position to the deployed position, and a retraction assembly that moves the reflecting assembly from the deployed position to the stored position. The optical measurement system emits and receives light. The reflecting assembly reflects the emitted light toward the rail. The reflecting assembly reflects light reflected off of the rail toward the optical measurement system. The light received by the optical measurement system is used to measure parameters related to the rail.",ENSCO INC,KIM ANTHONY;;FORD DAVID G;;BLOOM JEFFREY,ENSCO INC (2019-12-10),https://lens.org/121-389-166-289-269,Patent Application,yes,1,0,5,5,0,B61K9/08;;G01N21/95;;G01N2201/0216;;G02B7/1824;;B61L23/042;;B61L23/042;;B61K9/08;;B61L23/041;;E05F15/70;;G01N2201/068;;G01N21/55;;G02B7/182;;E05Y2900/51;;G01N2201/0216;;G01N21/95,B61K9/08;;B61L23/04;;E05F15/70;;G01N21/55;;G01N21/95;;G02B7/182,,0,0,,,,ACTIVE
302,US,A1,US 2012/0076368 A1,140-542-185-784-166,2012-03-29,2012,US 89141310 A,2010-09-27,US 89141310 A,2010-09-27,FACE IDENTIFICATION BASED ON FACIAL FEATURE CHANGES,A face is detected within a series of imaging frames. One or more changes to a facial feature of the face are detected in progressive frames of the series. The face is identified based on the detected changes.,STAUDACHER DAVID;;BLOOM DANIEL;;DALLON DAN L,STAUDACHER DAVID;;BLOOM DANIEL;;DALLON DAN L,HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2010-09-24),https://lens.org/140-542-185-784-166,Patent Application,yes,28,15,1,1,0,G06V40/176;;G06V40/168;;G06V40/176;;G06V40/168,G06K9/46,382/118,1,0,,,"Horn, Brian K.P. & Schunck, Brian G. ""Determining Optical Flow"", Massachusetts Institute of Technology Artificial Intellignece Laboratory. AI Memo No. 572. April 1980.",DISCONTINUED
303,US,B2,US 9282238 B2,088-717-433-183-895,2016-03-08,2016,US 91572510 A,2010-10-29,US 91572510 A,2010-10-29,Camera system for determining pose quality and providing feedback to a user,"A camera system may include an image sensor to generate real-time image data of a scene having a subject. A pose evaluator can generate a pose metric signal having a pose value that provides a variable measure of a pose quality for the subject in the scene. A pose feedback indicator can provide user-perceptible feedback demonstrating the value of the pose metric signal, such that the variable measure of the pose quality is provided.",STAUDACHER DAVID;;BLOOM DANIEL;;DALTON DAN L;;HEWLETT PACKARD DEVELOPMENT CO,STAUDACHER DAVID;;BLOOM DANIEL;;DALTON DAN L,HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2010-10-26),https://lens.org/088-717-433-183-895,Granted Patent,yes,16,2,2,2,0,H04N23/64;;H04N23/64,H04N5/228;;H04N5/232,,1,0,,,"Publication, http://www.inventionreaction.com/new-invention/Smile-Recognition-Camera-Captures-Perfect-Photo, Publication Date Nov. 6, 2007, pp. 1-4.",ACTIVE
304,US,A1,US 2013/0170755 A1,110-064-274-332-215,2013-07-04,2013,US 201013823047 A,2010-09-13,US 2010/0048678 W,2010-09-13,SMILE DETECTION SYSTEMS AND METHODS,Systems and methods of smile detection are disclosed. An exemplary method comprises generating a search map ( 400 ) for a subset of an image ( 300 ). The method also comprises identifying a plurality of candidates ( 400 a - f ) representing mouth corners. The method also comprises generating parabolas ( 410 ) between each pair of candidates representing mouth corners. The method also comprises analyzing contour of at least one of the parabolas to determine whether the mouth curves substantially upward to form a smile or curves substantially downward to form a frown.,DALTON DAN L;;BLOOM DANIEL;;STAUDACHER DAVID,DALTON DAN L;;BLOOM DANIEL;;STAUDACHER DAVID,HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2010-09-09),https://lens.org/110-064-274-332-215,Patent Application,yes,5,18,7,7,0,G06V40/175;;G06V40/174;;G06V40/175,G06K9/00,382/195,2,1,011-156-079-100-143,15484916;;10.1109/tsmcb.2004.825931,"Pantic, et al. (Facial Action Recognition for Facial Expression Analysis from Static Face Images"", PP. 1449-1461, IEEE, 2004.;;Schubert (EMOTIONFACE: Prototype Facial Expression Display of Emotion In Music), PP. 1-5, Proceeding of ICAD, 2004.",INACTIVE
305,US,A1,US 2020/0180667 A1,198-389-886-333-866,2020-06-11,2020,US 201916705137 A,2019-12-05,US 201916705137 A;;US 201862776383 P,2018-12-06,SYSTEMS AND METHODS FOR ANALYZING A RAIL,"A deployable measurement system for analyzing a rail of a railroad track includes a housing, a reflecting assembly coupled to the housing, a movement assembly coupled to the housing, and an optical measurement system disposed within the housing. Both the housing and the reflecting assembly are moveable between a stored position and a deployed position. The movement assembly includes a deployment assembly that moves the reflecting assembly from the stored position to the deployed position, and a retraction assembly that moves the reflecting assembly from the deployed position to the stored position. The optical measurement system emits and receives light. The reflecting assembly reflects the emitted light toward the rail. The reflecting assembly reflects light reflected off of the rail toward the optical measurement system. The light received by the optical measurement system is used to measure parameters related to the rail.",ENSCO INC,KIM ANTHONY;;FORD DAVID G;;BLOOM JEFFREY,ENSCO INC (2019-12-10),https://lens.org/198-389-886-333-866,Patent Application,yes,10,12,5,5,0,B61K9/08;;G01N21/95;;G01N2201/0216;;G02B7/1824;;B61L23/042;;B61L23/042;;B61K9/08;;B61L23/041;;E05F15/70;;G01N2201/068;;G01N21/55;;G02B7/182;;E05Y2900/51;;G01N2201/0216;;G01N21/95,B61L23/04;;B61K9/08;;E05F15/70;;G01N21/55;;G01N21/95;;G02B7/182,,0,0,,,,ACTIVE
306,US,A1,US 2012/0105662 A1,163-529-543-691-030,2012-05-03,2012,US 91572510 A,2010-10-29,US 91572510 A,2010-10-29,CAMERA SYSTEM PROVIDING A MEASURE OF POSE QUALITY,"A camera system may include an image sensor to generate real-time image data of a scene having a subject. A pose evaluator can generate a pose metric signal having a pose value that provides a variable measure of a pose quality for the subject in the scene. A pose feedback indicator can provide user-perceptible feedback demonstrating the value of the pose metric signal, such that the variable measure of the pose quality is provided.",STAUDACHER DAVID;;BLOOM DANIEL;;DALTON DAN L,STAUDACHER DAVID;;BLOOM DANIEL;;DALTON DAN L,HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2010-10-26),https://lens.org/163-529-543-691-030,Patent Application,yes,6,25,2,2,0,H04N23/64;;H04N23/64,H04N5/228,348/222.1;;X348E05031,0,0,,,,ACTIVE
307,US,A1,US 2012/0269428 A1,003-107-889-096-392,2012-10-25,2012,US 201113093523 A,2011-04-25,US 201113093523 A,2011-04-25,Mouth Corner Candidates,A device to apply detection schemes to texture information of a face detected within an image to generate mouth corner candidates and identify best matching mouth corners by applying a geometric model to the moth corner candidates.,BLOOM DANIEL;;DALTON DAN L;;STAUDACHER DAVID,BLOOM DANIEL;;DALTON DAN L;;STAUDACHER DAVID,HEWLETT PACKARD DEVELOPMENT COMPANY L.P (2011-04-25),https://lens.org/003-107-889-096-392,Patent Application,yes,10,3,2,2,0,G06V40/175;;G06V40/165;;G06V40/165;;G06V40/175,G06K9/00;;G06K9/62,382/164;;382/209,1,1,009-612-733-037-965,10.5244/c.2.23,"Chris Harris and Mike Stephens, ""A Combined Corner And Edge Detector"" Proceedings of 4th Alvey Vision Conference, pages 147 - 152, 1988",INACTIVE
308,US,A1,US 2001/0049094 A1,036-810-061-088-140,2001-12-06,2001,US 17809898 A,1998-10-23,US 17809898 A,1998-10-23,METHOD OF IDENTIFICATION OF DIFFERENTIALLY EXPRESSED MRNA,"
   The method provided by the present invention sets forth a novel combination of methods and principles which allows for the rapid and accurate isolation and identification of a large number of differentially expressed mRNAs. 
",ALLAND DAVID;;BLOOM BARRY R.;;KRAMNIK IGOR,ALLAND DAVID;;BLOOM BARRY R;;KRAMNIK IGOR,ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (1999-02-01),https://lens.org/036-810-061-088-140,Patent Application,yes,0,1,2,2,0,C12N15/1072;;C12N15/1072;;C12Q1/689;;C12Q1/689;;Y10T436/143333;;Y10T436/143333,C12N15/10;;C12Q1/68;;C12Q1/689,435/6;;435/91.1;;435/91.2;;536/23.1,0,0,,,,EXPIRED
309,US,B2,US 8983202 B2,135-408-518-721-81X,2015-03-17,2015,US 201013823047 A,2010-09-13,US 2010/0048678 W,2010-09-13,Smile detection systems and methods,Systems and methods of smile detection are disclosed. An exemplary method comprises generating a search map ( 400 ) for a subset of an image ( 300 ). The method also comprises identifying a plurality of candidates ( 400 a - f ) representing mouth corners. The method also comprises generating parabolas ( 410 ) between each pair of candidates representing mouth corners. The method also comprises analyzing contour of at least one of the parabolas to determine whether the mouth curves substantially upward to form a smile or curves substantially downward to form a frown.,DALTON DAN L;;BLOOM DANIEL;;STAUDACHER DAVID;;HEWLETT PACKARD DEVELOPMENT CO,DALTON DAN L;;BLOOM DANIEL;;STAUDACHER DAVID,HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2010-09-09),https://lens.org/135-408-518-721-81X,Granted Patent,yes,12,4,7,7,0,G06V40/175;;G06V40/174;;G06V40/175,G06K9/00;;G06K9/46,382/195;;382/118,5,2,011-156-079-100-143;;014-321-308-479-720,15484916;;10.1109/tsmcb.2004.825931;;10.1016/j.rti.2003.08.003,"Pantic, et al. (Facial Action Recognition for Facial Expression Analysis from Static Face Images pp. 1449-1461, IEEE, 2004.;;Schubert (EMOTIONFACE: Prototype Facial Expression Display of Emotion in Music), pp. 1-5, Proceeding of ICAD, 2004.;;Chiang, ""A Novel Method for Detecting Lips, Eyes, and Faces in Real Time"", Publication Date: 2003; On pp. 277-287.;;International Search Report and Written Opinion received in PCT Application No. PCT/US2010/048678, mailed Jun. 1, 2011, 8 pages.;;Susan, Q, Y, Lin, ""Investigation into Markerless Facial Expression Recognition Techniques"", Bachelor of Science in Computer Science with Honours, The University of Bath, May 31, 2008.",INACTIVE
310,US,B2,US 8891876 B2,168-799-803-298-414,2014-11-18,2014,US 201113093523 A,2011-04-25,US 201113093523 A,2011-04-25,Mouth corner candidates,A device to apply detection schemes to texture information of a face detected within an image to generate mouth corner candidates and identify best matching mouth corners by applying a geometric model to the moth corner candidates.,BLOOM DANIEL;;DALTON DAN L;;STAUDACHER DAVID;;HEWLETT PACKARD DEVELOPMENT CO,BLOOM DANIEL;;DALTON DAN L;;STAUDACHER DAVID,HEWLETT PACKARD DEVELOPMENT COMPANY L.P (2011-04-25),https://lens.org/168-799-803-298-414,Granted Patent,yes,13,0,2,2,0,G06V40/175;;G06V40/165;;G06V40/165;;G06V40/175,G06K9/66;;G06K9/00,382/195;;382/100;;382/118;;382/164;;382/181;;382/190,1,1,009-612-733-037-965,10.5244/c.2.23,"Chris Harris and Mike Stephens, ""A Combined Corner and Edge Detector"" Proceedings of 4th Alvey Vision Conference, pp. 147-152, 1988.",INACTIVE
311,EP,A2,EP 0311406 A2,194-751-672-552-653,1989-04-12,1989,EP 88309330 A,1988-10-06,US 10655487 A,1987-10-06,Transmisson line.,"A non-linear transmission line comprises a 50 ohm coplanar monolithic waveguide formed on top of a gallium arsenide substrate (42) having a layer (36) of lightly doped epitaxial gallium arsenide with a heavily doped buried layer (44), said epitaxial layer (36) having spaced, electrically isolated islands. A self aligned Schottky diode junction is formed at the intersection of each isolation island with the centre conductor (24) of the transmission line. The second conductor (26) of the transmission line is coupled through a contact window and an ohmic contact (46,48) to the buried layer in each isolation island.  ",UNIV LELAND STANFORD JUNIOR,RODWELL MARK J W;;BLOOM DAVID M,,https://lens.org/194-751-672-552-653,Patent Application,yes,0,5,4,12,0,H03H7/325;;H03H7/325,H01L29/93;;H01P1/00;;H03H7/32;;H03K5/12,,0,0,,,,DISCONTINUED
312,US,A1,US 2005/0035450 A1,037-514-801-105-533,2005-02-17,2005,US 64007303 A,2003-08-13,US 64007303 A,2003-08-13,Ball grid array package having testing capability after mounting,A ball grid array package that can be readily tested before or after mounting to a printed circuit board. The ball grid array includes a substrate having a top surface and a bottom surface. Several conductive pads are located on the top surface. Several passive circuit elements are located on the top surface between the conductive pads. An insulative coating is placed on top of the passive circuit elements and the substrate. The insulative coating has openings over the conductive pads. The openings are adapted to be accessible by an electrical probe. Conductive vias extend through the substrate between the top and bottom surfaces. The vias electrically connect with the conductive pad on the top surface. Several conductive balls are located on the bottom surface. Each conductive ball is electrically connected to one of the vias.,POOLE DAVID;;BLOOM TERRY R.;;COOPER RICHARD,POOLE DAVID;;BLOOM TERRY R;;COOPER RICHARD,CTS CORPORATION (2003-08-06),https://lens.org/037-514-801-105-533,Patent Application,yes,75,0,2,2,0,H01C1/14;;H05K1/0268;;H05K1/141;;H05K1/167;;H05K3/28;;H05K3/3436;;H05K2201/10045;;H05K1/0268;;H05K1/141;;H05K1/167;;H05K3/28;;H05K3/3436;;H01C1/14;;H05K2201/10045,H01C1/14;;H05K1/02;;H05K1/14;;H05K1/16;;H05K3/28;;H05K3/34,257/738;;257/737;;257/774,0,0,,,,EXPIRED
313,US,B2,US 11590992 B2,045-144-699-930-207,2023-02-28,2023,US 201916705137 A,2019-12-05,US 201916705137 A;;US 201862776383 P,2018-12-06,Systems and methods for analyzing a rail,"A deployable measurement system for analyzing a rail of a railroad track includes a housing, a reflecting assembly coupled to the housing, a movement assembly coupled to the housing, and an optical measurement system disposed within the housing. Both the housing and the reflecting assembly are moveable between a stored position and a deployed position. The movement assembly includes a deployment assembly that moves the reflecting assembly from the stored position to the deployed position, and a retraction assembly that moves the reflecting assembly from the deployed position to the stored position. The optical measurement system emits and receives light. The reflecting assembly reflects the emitted light toward the rail. The reflecting assembly reflects light reflected off of the rail toward the optical measurement system. The light received by the optical measurement system is used to measure parameters related to the rail.",ENSCO INC,KIM ANTHONY;;FORD DAVID G;;BLOOM JEFFREY,ENSCO INC (2019-12-10),https://lens.org/045-144-699-930-207,Granted Patent,yes,13,2,5,5,0,B61K9/08;;G01N21/95;;G01N2201/0216;;G02B7/1824;;B61L23/042;;B61L23/042;;B61K9/08;;B61L23/041;;E05F15/70;;G01N2201/068;;G01N21/55;;G02B7/182;;E05Y2900/51;;G01N2201/0216;;G01N21/95,B61K9/08;;B61L23/04;;E05F15/70;;G01N21/55;;G01N21/95;;G02B7/182,,5,0,,,"Deutzer Technische Kohle, “Third Rail Measurement,” Web page, <http://deutzer.de/en/services-en/u-bahn-en/350-dritteschieneubahn-en>, retrieved from the Internet on Jun. 4, 2020 (9 pages).;;Deutzer Technische Kohle, “Third Rail Wear,” Web page, <http://deutzer.de/en/services-en/u-bahn-en/351-dsvubahn-en>, retrieved from the Internet on Jun. 4, 2020 (8 pages).;;KLD Labs, “Third Rail Monitoring,” Web page, <http://www.kldlabs.com/?page_id=67>, retrieved from the Internet on Jun. 4, 2020 (2 pages).;;Robat Kontrol, “Third Rail Measurement,” Web page, <http://robat.com.tr/3rayolcum-en.html>, retrieved from the Internet on Jun. 4, 2020 (1 page).;;DMA, “Third/Power Rail Measurement System (TRMS),” Web page, <https://www.air-rail.org/en/products/railway/brands/dma/third-power-rail-measurement-system-trms>, retrieved from the Internet on Aug. 5, 2020 (2 pages).",ACTIVE
314,US,B2,US 8559712 B2,096-550-799-135-87X,2013-10-15,2013,US 88052410 A,2010-09-13,US 88052410 A,2010-09-13,Processing an image of a person's face,"An image contains a representation of a person's face, where the image has plural points each comprising multiple components of a color space. For each of the plural points, at least two of the color space components are combined to produce a respective aggregate value. The image is processed to convert at least some of the points of the image based on the calculated aggregate values.",DALTON DAN L;;BLOOM DANIEL;;STAUDACHER DAVID;;HEWLETT PACKARD DEVELOPMENT CO,DALTON DAN L;;BLOOM DANIEL;;STAUDACHER DAVID,HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2010-09-09),https://lens.org/096-550-799-135-87X,Granted Patent,yes,5,5,2,2,0,G06V40/165;;G06V40/165,G06K9/00;;G06K9/40,382/167;;382/103;;382/274,6,2,151-934-660-750-160;;014-321-308-479-720,10.1109/34.1000242;;10.1016/j.rti.2003.08.003,"Oravec, M.-""Extraction of Facial Features from Color Images""-RadioEngineering-Sep. 2008, vol. 17, No. 3, pp. 115-120.;;Hsu, R.L.-""Face Detection in Color Images""-IEEE 2002, vol. 24, No. 5, pp. 696-706.;;Brakel, R.B.J.-""Eye Tracking-Additional component computer graphics""-Jan. 2008, pp. 1-18.;;Xiaozheng Jane Zhang et al., ""Finding Lips in Unconstrained Imagery for Improved Automatic Speech Recognition"", Visual 2007, LNCS 4781,2007, pp. 185-192.;;Cheng-Chin Chiang et al., ""A Novel Method for Detecting Lips, Eyes and Faces in Real Time"", Real-Time Imaging 9, Elsevier Ltd., 2003, pp. 277-287.;;Stew Wen Chin et al., ""New Lips Detection and Tracking System"", Proceedings of the International MultiConference of Engineers and Computer Scientists 2009 vol. I, IMECS 2009, Mar. 18-20, 2009, Hong Kong, 6 pages.",INACTIVE
315,US,A,US 5614834 A,180-980-967-539-326,1997-03-25,1997,US 40485995 A,1995-03-15,US 40485995 A,1995-03-15,Sampling receivers,"A Golay sampling receiver is used for optical sampling of voltage and charge at the internal nodes of analog and digital integrated circuits. The sampling receiver uses very high sampling rates together with narrow banding to recover very small signals in the presence of noise. The sampling system is based on harmonic mixing, which is the interaction of a laser sampling train with the electro-optic modulator formed in the GaBs substrate of the device under test. The application of the Golay sampling receiver to an electro-optic sampling system allows the flexibility of running the signal under test at a subharmonic of the laser pulse repetition rate, as well as any harmonic of these subharmonics. The subharmonics are determined by the length code used in the Golay receiver. For a given signal to be sampled, the fundamental frequency is chosen to be a function of the fixed sample rate divided by the code length, and the baseband offset.",US ARMY,BLACK ALISTAIR;;APTE RAJ B;;BLOOM DAVID M,AIR FORCE UNITED STATES (1995-02-15),https://lens.org/180-980-967-539-326,Granted Patent,yes,6,5,1,1,0,G01R31/311;;G01R31/311,G01R31/311,324/753;;364/822;;364/713;;364/807,2,2,122-878-373-657-128;;037-053-217-979-961,10.1109/3.115;;10.1063/1.96598,"Weingarten Kurt J. et al, Picosecond Optical Sampling of GaAs Integrated Circuits , IEEE Journal of Quantum Electronics, vol. 24, No. 2, Feb. 1988, pp. 198 218.;;Heinrich, H.K. et al, Noninvasive sheet charge density probe for integrated silicon devices , Appl. Phys. Lett. 48 (16), 21 Apr. 1986, pp. 1066 1068.",EXPIRED
316,US,A,US 4858234 A,026-364-975-576-984,1989-08-15,1989,US 9347687 A,1987-09-04,US 9347687 A,1987-09-04,Method and apparatus for error recovery in a multibus computer system,A bus adapter interconnecting a system bus and an I/O bus over an interconnect bus generates a first READ signal by decoding the command lines of the I/O bus and supplying the READ command signal across the interconnect bus. The command lines are also provided across the interconnect bus and are decoded on the system bus side of the interconnect bus to form a second READ signal. The first and second READ signals and a parity error signal are processed on the system bus side of the interconnect bus to generate a NON-RECOVERABLE ERROR signal to initiate a system shut-down when a parity error occurs during a disconnected WRITE transaction and to generate a RECOVERABLE ERROR signal to initiate a repeat of the transaction when a parity error occurs during a READ transaction.,DIGITAL EQUIPMENT CORP,HARTWELL DAVID W;;BLOOM ELBERT;;TRIOLO VICTORIA M,DIGITAL EQUIPMENT CORPORATION 146 MAIN STREET MAYNARD MASSACHUSETTS 01754 A CORP. OF MASSACHUSETTS (1987-09-02);;HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (1999-12-09),https://lens.org/026-364-975-576-984,Granted Patent,yes,8,22,1,1,0,G06F11/0745;;G06F11/0793;;G06F11/10;;G06F11/14;;G06F11/0745;;G06F11/14;;G06F11/10;;G06F11/0793,G06F11/00;;G06F11/07;;G06F11/10;;G06F11/14,371/14;;364/900,1,0,,,"Shu Shia Chow; PILA Hardware Specification; 1982; pp. 1, 5 8.",EXPIRED
317,US,B1,US 10175653 B1,040-175-244-379-72X,2019-01-08,2019,US 201615357469 A,2016-11-21,US 201615357469 A;;US 201662397679 P,2016-09-21,Watch glow light band,"Watch bands with multiple light tubes, each light having a light fiber and at least one light-emitting diode for providing light to each light tube. The light-emitting diode may produce a wide color gamut for the light fiber to produce light in each light tube. Each light-emitting diode may produce a different color and light intensity different from the other light tubes in the watch band. The light tubes doubles as the structure for attaching a watch body to a user's wrist and as a carrier of light to add variety and style to the watch band. The watch band may have a variety of different attachment mechanisms for attaching and securing the watch body to the user's wrist.",APPLE INC,BLOOM DAVID H;;HE MIAO;;MCCLAIN MEGAN A,APPLE INC (2016-11-10),https://lens.org/040-175-244-379-72X,Granted Patent,yes,7,13,1,1,0,A44C5/0007;;A44C15/0015;;G02B6/0006;;G02B6/001;;H05B45/20;;H05B47/125;;Y02B20/40;;G04B45/0015;;A44C5/0053;;A44C5/24;;A44C15/0015;;G02B6/0006;;G02B6/001;;G04B45/00;;A44C5/0007;;G04G17/08;;H05B45/20;;H05B47/175;;H05B47/125,G04B45/00;;A44C5/00;;A44C5/24;;A44C15/00;;F21V8/00;;H05B37/02;;H05B44/00,,0,0,,,,ACTIVE
318,US,A,US 5267020 A,199-292-152-471-229,1993-11-30,1993,US 25902788 A,1988-10-17,US 25902788 A;;US 10655487 A,1987-10-06,Gallium arsenide monolithically integrated sampling head using equivalent time sampling having a bandwidth greater than 100 ghz,"A high bandwidth RF sampler using equivalent time sampling comprising an RF coplanar waveguide integrated with sampling diodes on a gallium arsenide substrate. A monolithic, integrated nonlinear transmission line is integrated on the same substrate to receive sample pulses. These pulses are reshaped by the nonlinear transmission line to have a very fast edge. This edge is differentiated by a shunt inductance of a short circuit termination of a slot line portion of the RF signal coplanar waveguide. The resulting delta function sample pulses cause the sample diodes and integrated capacitors to develop an intermediate output frequency which is a replica of the RF signal at a lower frequency and no voltage conversion loss. RF signals of up to 300 Ghz can be sampled using this circuit.",UNIV STANFORD,MARSLAND ROBERT A;;RODWELL MARK;;BLOOM DAVID M,STANFORD UNIVERSITY A CORP. OF CA (1989-01-04),https://lens.org/199-292-152-471-229,Granted Patent,yes,4,22,4,12,0,H01L27/0605;;H03H7/325;;H03H7/325;;H01L27/0605,H01L21/822;;H01L27/06;;H01P3/02;;H03H7/32;;H01L27/04;;H03K17/74,257/368;;333/20;;257/52;;257/471;;257/528;;257/798,17,9,108-651-613-843-015;;011-464-360-811-259;;139-230-985-325-058;;102-418-415-486-476;;014-183-718-956-355;;108-651-613-843-015;;139-230-985-325-058;;102-418-415-486-476;;108-651-613-843-015,10.1063/1.1735612;;10.1147/rd.44.0391;;10.1049/el:19870077;;10.1007/bf00886158;;10.1080/00207218508939060;;10.1063/1.1735612;;10.1049/el:19870077;;10.1007/bf00886158;;10.1063/1.1735612,"Microwave Sampling Effective for Ultra Broad Band Frequency Conversion , Moore et al., MSN & CT, 1986, pp. 113 126.;;Landauer, Rolf, Parametric Amplification along Nonlinear Transmission Lines , Journal of Applied Physics (Mar. 1960), vol. 31, No. 3, pp. 479 489.;;Landauer, R., Shock Waves in Nonlinear Transmission Lines and Their Effect on Parametric Amplification , IBM Journal (Oct. 1960), pp. 391 401.;;Rodwell et al., Nonlinear Transmission Line For Picosecond Pulse Compression and Broadband Phase Modulation , Electronic Letters (Jan. 1987), vol. 23, No. 3, pp. 109 110.;;Jager et al., Nonlinear Wave Propagation along Periodic Loaded Transmission Line , Appl. Phys. 15 (1978), pp. 393 397.;;Jager, D., Characteristics of Travelling Waves Along the Non Linear Transmission Lines for Monolithic Integrated Circuits: A Review , Int. J. Electronics (1985), vol. 58, No. 4, pp. 649 668.;;Gibson, Hewlett Packard Journal (Feb. 1986), vol. 37, No. 2, pp. 4 10.;;Merkelo, A de to 20 GHz Thin Film Signal Sampler for Microwave Instrumentation , Hewlett Packard (Apr. 1973), pp. 10 13.;;Grove, A DC To 12.4 GHz Feedthrough Sampler For Oscilloscopes and Other RF Systems , IEEE Transactions on Microwave Theory and Techniques (Dec. 1966), vol. MTT 14, No. 12, pp. 12 15.;;Howard et al., The Wideband Sampling Gate An Analysis, Characterization and Application Discussion , Hewlett Packard Publication, pp. 1 11.;;Landauer, Journal of Applied Physics vol. 31:3:479 484 (1960).;;Landauer, IBM Journal pp. 391 401 (1960).;;Rodwell et al., Electronics Letters, vol. 23:3:109 110 (1987).;;Jager et al., Appl. Phys. vol. 15:393 397 (1978).;;Jager, Int. J. Electronics vol. 58:4:649 668 (1985).;;Landauer, (1960) Journal of Applied Physics 31(3):479 484, Parametric Amplification Along Nonlinear Transmission Lines.;;Proposal To The Defense Advanced Research Projects Agency For a Program of Research in Millimeter Wave Characterization of GaAs Devices and IC s , Sept. 1988.",EXPIRED
319,US,A1,US 2019/0269682 A1,014-084-408-981-762,2019-09-05,2019,US 201716332211 A,2017-09-12,US 201716332211 A;;US 201662393166 P;;US 2017/0051176 W,2016-09-12,USE OF ATR AND CHK1 INHIBITOR COMPOUNDS,The invention relates to kinase inhibitor compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating or preventing herpesvirus infection and/or herpesvirus-associated diseases and disorders.,UNIV FLORIDA,FISHER CHRISTOPHER;;EDWARDS TERRI G;;BLOOM DAVID C,UNIVERSITY OF FLORIDA RESEARCH FOUNDATION INCORPORATED (2019-06-25),https://lens.org/014-084-408-981-762,Patent Application,yes,4,1,4,4,0,A61K45/06;;A61K31/36;;A61K31/4709;;A61K31/4745;;A61K31/4965;;A61K31/497;;A61K31/505;;A61K31/5355;;A61K31/5517;;A61P31/22;;A61P31/22;;A61K31/439;;A61K31/4965;;A61K31/497;;A61K31/5377;;A61K31/5517;;A61K31/505;;A61K31/4745;;A61K31/5355;;A61K31/4709;;A61K45/06;;A61K31/36,A61K31/4965;;A61K31/439;;A61K31/497;;A61K31/5377;;A61K31/5517;;A61P31/22,,2,2,083-298-778-430-93X;;003-323-336-373-632,10.1186/s12985-016-0470-1;;26817608;;pmc4728825;;23222511;;pmc3542617;;10.1038/cddis.2012.181,"Botting et al., “H2AX phosphorylation and DNA damage kinase activity are dispensable for herpes simplex virus replication”, Virology Journal, pages 1-11, Jan 27, 2016 (Year: 2016);;Fokas et al., “Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation”, Cell Death and Disease, December 6, 2012 (Year: 2012)",ACTIVE
320,US,A,US 5378939 A,155-136-029-878-786,1995-01-03,1995,US 68691691 A,1991-04-16,US 68691691 A;;US 55835690 A;;US 25902788 A;;US 10655487 A,1987-10-06,Gallium arsenide monolithically integrated sampling head using equivalent time sampling having a bandwidth greater than 100 Ghz,"A high bandwidth RF sampler using equivalent time sampling comprising an RF coplanar waveguide integrated with sampling diodes on a gallium arsenide substrate. A monolithic, integrated coplanar strip nonlinear transmission line is integrated on the same substrate to receive sample pulses. These pulses are reshaped by the nonlinear transmission line to have a very fast edge. This edge is differentiated by a shunt inductance of a short circuit termination of a slot line portion of the RF signal coplanar waveguide. The resulting delta function sample pulses cause the sample diodes and integrated capacitors to develop an intermediate output frequency which is a replica of the RF signal at a lower frequency and no voltage conversion loss. RF signals of up to 300 Ghz can be sampled using this circuit.",UNIV LELAND STANFORD JUNIOR,MARSLAND ROBERT A;;RODWELL MARK;;BLOOM DAVID M,STANFORD UNIVERSITY AKA THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (1991-05-29),https://lens.org/155-136-029-878-786,Granted Patent,yes,17,55,1,12,0,H01L27/0605;;H01L27/0605;;H03H7/325;;H03H7/325,H01L27/06;;H03H7/32,307/352;;307/353;;307/263;;328/151;;330/20,58,43,079-348-915-926-869;;034-648-811-983-748;;150-924-603-857-919;;058-698-360-350-947;;118-906-990-904-164;;021-133-413-293-843;;064-165-799-233-726;;162-897-446-967-819;;176-025-329-124-177;;044-756-961-748-066;;057-917-244-068-910;;121-646-991-939-932;;094-700-573-083-198;;054-262-910-827-840;;026-540-030-442-995;;102-418-415-486-476;;108-105-863-882-158;;076-005-970-844-782;;040-932-214-113-301;;101-886-142-250-708;;092-989-508-430-883;;014-183-718-956-355;;013-898-387-548-113;;052-460-435-753-604;;108-651-613-843-015;;011-464-360-811-259;;074-872-429-127-710;;013-955-110-929-659;;171-514-241-720-412;;111-104-799-438-418;;167-240-924-284-39X;;139-153-091-547-974;;034-232-704-492-645;;070-670-309-675-885;;139-230-985-325-058;;103-747-114-308-100;;130-028-198-982-271;;118-148-991-034-690;;012-215-706-447-001;;039-326-105-487-966;;098-767-344-948-858;;096-022-490-964-232;;039-398-915-943-17X,10.1109/tmtt.1985.1133110;;10.1109/tmtt.1982.1131186;;10.1109/22.58648;;10.1109/22.58640;;10.1049/el:19790417;;10.1088/0022-3727/10/5/005;;10.1109/tmtt.1983.1131654;;10.1109/euma.1983.333240;;10.1109/tmtt.1983.1131546;;10.1109/16.2503;;10.1049/el:19770471;;10.1109/tmtt.1986.1133427;;10.1109/proc.1973.9297;;10.1109/t-ed.1975.18246;;10.1109/t-ed.1972.17593;;10.1007/bf00886158;;10.1143/jpsj.51.1686;;10.1016/0038-1101(74)90024-0;;10.1007/bf00931418;;10.1007/bf00896149;;10.1109/tmtt.1976.1128910;;10.1080/00207218508939060;;10.1049/el:19730147;;10.1063/1.96709;;10.1063/1.1735612;;10.1147/rd.44.0391;;10.1109/55.724;;10.1063/1.100785;;10.1049/el:19890005;;10.1109/iedm.1988.32957;;10.1109/jssc.1972.1050238;;10.1049/sbew016e;;10.1109/tmtt.1980.1130215;;10.1109/tmtt.1981.1130387;;10.1049/el:19870077;;10.1049/el:19860339;;10.1109/gaas.1989.69330;;10.1109/proc.1973.9296;;10.1049/el:19810657;;10.1049/el:19820401;;10.1109/tmtt.1982.1131185;;10.1109/jrproc.1957.278385;;10.1007/978-3-642-70780-3_48,"J. W. Archer & M. T. Faber, High Output, Single and Dual Diode, Millimeter Wave Frequency Doublers , IEEE Transactions on Microwave Theory & Techniques , MTT 33, No. 6, Jun. 1985, pp. 533 538.;;Y. Ayasli, et al., A Monolithic GaAs 1 13 GHz Travelling Wave Amplifier , IEEE Transactions on Microwave Theory & Techniques , vol. MTT 30, No. 7, Jul. 1982, pp. 976 981.;;I. J. Bahl, et al., GaAs IC s Fabricated with the High Performance, High Yield Multi function Self Aligned Gate Process for Radar and EW Applicatons , IEEE Transactions on Microwave Theory & Techniques , vol. MTT 38, No. 9, Sep. 1990, pp. 1232 1241.;;I. J. Bahl, et al., Multification SAG Process for High Yield, Low Cost GaAs Microwave Integrated Circuits , IEEE Transactions on Microwave Theory & Techniques , vol. 38, No. 9, Sep. 1990, pp. 1175 1182.;;E. M. Bastida, et al., Periodic Slow Wave Low Loss Structuring for Monolithic GaAs Microwave Integrated Circuits , Electronics Letters, vol. 15, No. 9, Sep. 13, 1979, pp. 581 582.;;M. Birk & Q. A. Kerns, Varactor Transmission Lines , Engineering note number EE 922, May 22, 1963, Lawrence Radiation Laboratory, University of California, Berkeley.;;G. E. Brehm. et al., High Capacitance Ratio Monolithic Varactor Diode , Proc. Eighth Biennial Cornell Elec. Eng. Conf. Aug. 11 13, 1981, pp. 53 63.;;R. H. Freeman & A. E. Karbowiak, An Investigation of Nonlinear Transmission Lines and Shock Waves , Journal of Physics , D: Applied Physics, vol. 10, pp. 633 643, 1977.;;Y. Fukuoka & T. Itoh, Slow Wave Coplanar Waveguide on Periodically Doped Semiconductor Substrate , IEEE Transactions on Microwave Theory and Techniques , vol. MTT 31, No. 12, Dec. 1983, pp. 1013 1017.;;Y. Fukuoka & T. Itoh, Design Consideration of Uniform and Periodic Coplanar Schottky Variable Phase Shifter , pp. 278 282. Publication, Date unknown.;;Y. Fukuoka, Y. C. Shih, T. Itoh, Analysis of Slow Wave Coplanar Waveguide for Monolithic Integrated Circuits , IEEE Transactions on Microwave Theory and Techniques , vol. MTT 31, No. 7, Jul. 1983. pp. 567 573.;;A. E. Geissberger, et al. A New Refractory Self Aligned Gate Technology for GaAs Microwave Power FET s and MMIC s , IEEE Transactions on Electron Devices , vol. 35, No. 5, May 1988, pp. 615 622.;;S. R. Gibson, Gallium Arsenide Lowers Cost and Improves Performance of Microwave Counters , Hewlett Packard Journal 37(2):4 10, Feb. 1986.;;W. M. Grove, A DC to 12.4 GHz Feedthrough Sampler for Oscilloscopes and Other RF Systems , IEEE Transactions on Microwave Theory and Techniques , vol. MTT 14, No. 12, Dec. 1966, pp. 12 15.;;U. Gunther & E. Voges, Variable Capacitance MIS Microstrip Lines , A.E.C. , Band 27, Heft 3, 1973, pp. 131 139.;;H. Hasegawa & H. Okizaki, M.I.S. and Schottky Slow Wave CoPlanar Strip lines on GaAs Substrates , Electronics Letters , vol. 13, No. 22, Oct. 27, 1977, pp. 663 664.;;G. Hasnain, A. Dienes, J. R. Whinnery, Dispersion of Picosecond Pulses in Coplanar Transmission Lines , IEEE Transactions on Microwave Theory and Techniques , vol. MTT 34, No. 6, Jun. 1986, pp. 738 741.;;R. Hirota & K. Suzuki, Theoretical and Experimental Studies of Lattice Solitons in Nonlinear Lumped Networks , IEEE Proc. , vol. 61, No. 10, Oct., 1973, pp. 1483 1491.;;D. Howard, et al., The Wideband Sampling Gate An Analysis, Characterization and Application Discussion , Hewlett Packard Publication, pp. 1 11.;;G. W. Hughes & R. M. White, Microwave Properties of Nonlinear MIS and Schottky Barrier Microstrip , IEEE Transactions on Electron Devices , vol. ED 22, No. 10, Oct. 1975, pp. 945 956.;;J. M. Jaffe, A High Frequency Variable Delay Line , IEEE Transactions on Electron Devices , Dec. 1972, pp. 1292 1294.;;D. J ger & F. J. Tegude, Nonlinear Wave Propagation Along Periodic Loaded Transmission Line , Applied Physics 15, pp. 393 397 (1978).;;D. J ger, Experiments on KdV Solitons , Journal of the Physical Society of Japan , vol. 51, No. 5, May 1982, pp. 1686 1693.;;D. J ger, W. Rabus, W. Eickhoff, Bias Dependent Small Signal Parameters of Schottky Contact Microstrip Lines , Solid State Electronics , vol. 17, 1974, pp. 777 783.;;D. J ger, Soliton Propagation along Periodic Loaded Transmission Line , Appl. Phys. , vol. 16, 1978, pp. 35 38.;;D. J ger & J. P. Becker, Distributed Variable Capacitance Microstrip Lines for Microwave Applications , Appl. Phys. , vol. 12, 1977, pp. 203 207.;;D. J ger, Slow Wave Propagation Along Variable Schottky Contact Microstrip Line , IEEE Transactions on Microwave Theory and Techniques , vol. MTT 24, No. 9, Sep. 1976, pp. 566 573.;;D. J ger, Characteristics of travelling waves along the non linear transmission lines for monolithic integrated circuits: a review , Int. J. Electronics , 1985, vol. 58, No. 4, pp. 649 669.;;D. J ger & W. Rabus, Bias Dependent Phase Delay of Schottky Contact Microstrip Line , Electronics Letters , vol. 9, No. 10, May 17, 1973, pp. 201 203.;;M. B. Ketchen, et al., Generation of subpicosecond electrical pulses on coplanar transmission lines , Appl. Phys. Lett. , vol. 48, No. 12, Mar. 24, 1986, pp. 751 753.;;R. V. Khokhlov, On the Theory of Shock Radio Waves In Non Linear Lines , Radiotekhnika i elektronika 6(6):77 89, 1971.;;R. Landauer, Parametric Amplification Along Nonlinear Transmission Lines , Journal of Applied Physics , vol. 31, No. 3, Mar. 1960, pp. 479 484.;;R. Landauer, Shock Waves in Nonlinear Transmission Lines and Their Effect on Parametric Amplification , IBM Journal , Oct. 1960, pp. 391 401.;;E. L der, Delay lines comprising non linear capacitances , received Mar. 22, 1968, published Oct. 1968 in Archiv der Elektrischen Ubertragung , Band 22, Heft 10, Seiten 461 508.;;C. J. Madden, et al,. Generation of 3,5 ps Fall Time Shock Waves on a Monolithic GaAs Nonlinear Transmission Line , IEEE Electron Device Letters , vol. 9, No. 6, Jun. 1988. p. 304.;;C. J. Madden, et al., Hyperabrupt doped GaAs nonlinear transmission line for picosecond shock wave generation , Appl. Phys. Lett. 54 (11), 13 Mar. 1989, pp. 1019 1021.;;R. Majidi Ahy & D. M. Bloom, Millimetre Wave Active Probe Frequency Multiplier for On Wafer Characterization of GaAs Devices and ICs , Electronics Letters , 5th Jan. 1989, vol. 25, No. 1, pp. 6 8.;;R. A. Marsland, et al., Picosecond Pulse Generation and Sampling With GaAs Monolithic Integrated Circuits , Paper delivered at the Picosecond Electronics and Optoelectronics Meeting of the Optical Society of America, Salt Lake City, Utah, Mar. 8 10, 1989 p. 99.;;R. A. Marsland, et al., 100 Ghz GaAs MMIC Sampling Head , IEDM , Dec. 14, 1988.;;J. Merkelo and R. D. Hall, Broad band Thin Film Signal Sampler , IEEE Journal of Solid State Circuits , vol. SC 7, No. 1, Feb. 1972, pp. 50 54.;;J. Merkelo, A dc to 20 GHz Thin film Signal Sampler for Microwave Instrumentation , Hewlett Packard Journal , Apr. 1973, pp. 10 13.;;S. Moore, et al., Microwave Sampling Effective for Ultrabroadband Frequency Conversion , MSN & CT, Feb. 1986, pp. 113 126.;;R. S. Pengelly, Microwave Field Effect Transistors Theory, Design and Applications , Research Studies Press. p. 420.;;J. Perini, Periodically Loaded Transmission Lines , IEEE Transactions on Microwave Theory and Techniques , vol. MTT 28, No. 9, Sep. 1980, pp. 1029 1031.;;R. A. Pucel, Design Considerations for Monolithic Microwave Circuits , IEEE Transactions on Microwave Theory and Techniques , vol. MTT 29, No. 6, Jun. 1981, pp. 513 534.;;W. Rabus, ber die Frequenzvervielfachung L ngs Schottky Kontakt Leitungen , A.E.U. , Band 28, Heft 1, Jan. 1974.;;R. B. Riley, An Analysis Of A Nonlinear Transmission Line , Technical Report No. 1707 1, Stanford Electronics Laboratories, Jan. 20, 1961, pp. 1 61.;;M. Rodwell, et al., Nonlinear Transmission Line for Picosecond Pulse Compression and Broadband Phase Modulation , Electronics Letters , vol. 23, No. 3, Jan. 29, 1987, pp. 109 110.;;M. Rodwell, et al., Gate Porpagation Delay and Logic Timing of GaAs Integrated Circuits Measured by Electro Optic Sampling , Electronics Letters , vol. 22, No. 9, Feb. 24, 1986, pp. 499 500.;;R. A. Sadler. et al., A Buried p Layer Self Aligned Process for High Yield LSI Circuits , ITT Gallium Arsenide Technology Center.;;A. C. Scott, F. Y. F. Chu, D. W. McLaughlin, The Soliton: A New Concept in Applied Science , Proc, IEEE , vol. 61, No. 10, Oct. 1973, pp. 1443 1482.;;S. Seki & H. Hasegawa, Cross Tie Slow Wave Coplanar Waveguide on Semi insulating GaAs Substrates , Electronics Letters , vol. 17, No. 25, Dec. 10, 1981, pp. 940 941.;;Y. Shih & T. Itoh, Analysis of Printed Transmission Lines for Monolithic Integrated Circuits , Electronics Letters , vol. 18, No. 14, Jul. 8, 1982, pp. 585 586.;;E. W. Strid & K. R. Gleason, A DC 12 GHz Monolithic GaAsFET Distributed Amplifier , IEEE Transactions on Microwave Theory and Techniques , vol. MTT 30, No. 7, Jul. 1982, pp. 969 975.;;K. J. Weingarten et al., Picosecond Optical Sampling of GaAs Integrated Circuits , invited paper to IEEE Journal of Quantun Electronics on Ultrafast Optics and Electronics , pub. Feb. 1988 Stanford University. pp. 1 27.;;R. L. Wigington & N. S. Nahman, Transient Analysis of Coaxial Cables Considering Skin Effect , Proceedings of the IRE , Feb. 1957, pp. 166 174.;;P. Wolf, Picosecond Sampling with Josephson Junctions , Springer Series in Electrophysics, vol. 21, pp. 236 243.;;P. Kennis, et al., Properties of Microstrip and Coplanar Lines on Semiconductor Substrate , Proc. 12th Eur. Conf. , Sep. 1982, pp. 328 333.",EXPIRED
321,AU,A,AU 2001/063664 A,187-864-559-979-636,2001-12-17,2001,AU 2001/063664 A,2001-06-08,AU PQ805800 A;;AU 1982/001006 W;;AU 2001/063664 A,2000-06-08,Crossbow with adjustable limbs,,MIDDLETON DAVID;;WALTERS BRYAN;;JENNINGS MIKE;;BLOOM KEN,MIDDLETON DAVID;;WALTERS BRYAN;;JENNINGS MIKE;;BLOOM KEN,,https://lens.org/187-864-559-979-636,Patent Application,no,0,1,1,3,0,F41B5/12,F41B5/12;;F41B5/14,,0,0,,,,PENDING
322,US,A,US 5488305 A,039-838-754-348-244,1996-01-30,1996,US 31375894 A,1994-09-28,US 31375894 A;;US 98489192 A,1992-12-02,System and method for high-speed potentiometry using scanning probe microscope,"A potentiometry apparatus for measuring a periodic electrical waveform existing proximate the surface of a sample such as a semiconductor wafer is disclosed herein. The potentiometry apparatus includes a pulse generator for generating a sequence of electrical pulses at a pulse frequency offset from the frequency of the surface waveform by a mixing frequency. A cantilever coupled to the pulse generator serves to carry the electrical pulses to a position proximate the surface of the sample. In a capacitive displacement mode the cantilever is mechanically displaced so as to generate a time-expanded representation of the electrical surface waveform having a repetition frequency equal to the mixing frequency. During displacement mode operation an optical detection circuit may be employed to monitor deflection of the cantilever. In a tunneling current mode the cantilever is again employed to carry the electrical pulses to a position proximate the surface of the sample. In this mode a tunneling current propagating through the cantilever at the mixing frequency provides a time,expanded representation of the electrical surface waveform.",UNIV LELAND STANFORD JUNIOR,BLOOM DAVID M;;HO FRANCIS;;HOU ALFRED S,,https://lens.org/039-838-754-348-244,Granted Patent,yes,10,24,2,2,0,G01Q60/32;;G01Q60/32;;G01Q10/06;;G01Q10/06;;Y10S977/849;;Y10S977/849;;Y10S977/852;;Y10S977/852;;Y10S977/86;;Y10S977/86;;Y10S977/861;;Y10S977/861;;Y10S977/864;;Y10S977/864;;Y10S977/868;;Y10S977/868;;Y10S977/873;;Y10S977/873,G01Q60/38;;G01B5/28;;G01B21/30;;G01Q10/06;;G01Q70/14,324/537;;324/750;;324/765;;250/306,8,4,000-707-003-794-942;;149-642-398-397-595;;037-859-696-108-540;;022-093-489-117-769,10.1109/tmtt.1966.1126342;;10.1063/1.99224;;10.1063/1.105227;;10.1063/1.102096,"Anders et al., Potentiometry for Thin Film Structures using Atomic Force Microscopy , J. Vac. Sci Technol. A8(1):394 399 (Jan./Feb. 1990).;;Girard, Developments in Voltage Contrast , Scanning Microscopy 2(1):151 160 (1988) Month Unavailable.;;Gopinath et al., Voltage Contrast: A Review , Scanning Electron Microscopy I:375 380 (1978) Month unavailable.;;Grove, Sampling for Oscilloscopes and Other RF Systems: Dc Through X Band , IEEE Transactions on Microwave Theory and Techniques MTT 14(12):629 635 (1966) Month unavailable.;;Hwang et al., Applications of Scanning Kelvin Probe Force Microscope (SKPFM) for Failure Analysis , ISTFA 92: The 18th International Symposium for Testing & Failure Analysis, Los Angeles, California, pp. 9 14 (17 23 Oct. 1992).;;Martin et al., High Resolution Capacitance Measurement and Potentiometry by Force Microscopy , Appl. Phys. Lett. 52(13):1103 1105 (1988) Month unavailable.;;Nonnenmacher et al., Kelvin Probe Force Microscopy , Appl. Phys. Lett. 58(25):2921 2923 (1991) Month unavailable.;;Williams et al., Scanning Capacitance Microscopy on a 25 nm Scale , Appl. Phys. Lett. 52(2):203 205 (1989) Month unavailable.",EXPIRED
323,DE,A1,DE 1938595 A1,119-458-124-744-336,1970-07-23,1970,DE 1938595 A,1969-07-30,US 78832668 A,1968-12-31,UEberzug fuer zusammengesetzte Gegenstaende sowie Verfahren zu seiner Herstellung,,TEXAS INSTRUMENTS INC,DAVID WAKEFIELD GENE FELIX REE;;ALLISON BLOOM JOHN,,https://lens.org/119-458-124-744-336,Patent Application,no,0,1,6,6,0,C22C5/00;;C23C16/36;;C23C24/00;;Y10T29/49888;;Y10T29/49888;;C22C5/00;;C23C16/36;;C23C24/00,C22C5/00;;C23C16/36;;C23C24/00,,0,0,,,,DISCONTINUED
324,US,A1,US 2002/0078864 A1,148-827-935-226-551,2002-06-27,2002,US 7970502 A,2002-02-21,US 7970502 A;;US 47860700 A,2000-01-06,Folding table,"
   A folding table having a first and second tabletop portions pivotably connected to first and second pairs of legs respectively. The folding table may comprise a pair of buttresses protruding from each of the first and second pair of legs, such that when the table is in the collapsed position, each pair of buttresses extend through openings in a corresponding table top portion. 
",ADAMS WILLIAM E.;;FOUNTAIN DAVID M.;;BLOOM THEODORE,ADAMS WILLIAM E;;FOUNTAIN DAVID M;;BLOOM THEODORE,,https://lens.org/148-827-935-226-551,Patent Application,yes,0,3,3,8,0,A47B3/02;;A47B3/083;;A47B3/02;;A47B3/083,A47B3/02;;A47B3/083,108/115,0,0,,,,EXPIRED
325,US,B2,US 6715429 B2,005-706-524-226-067,2004-04-06,2004,US 7970502 A,2002-02-21,US 7970502 A;;US 47860700 A,2000-01-06,Folding table,"
    A folding table having a first and second tabletop portions pivotably connected to first and second pairs of legs respectively. The folding table may comprise a pair of buttresses protruding from each of the first and second pair of legs, such that when the table is in the collapsed position, each pair of buttresses extend through openings in a corresponding table top portion. 
",ADAMS MFG CORP,ADAMS WILLIAM E;;FOUNTAIN DAVID M;;BLOOM THEODORE,,https://lens.org/005-706-524-226-067,Granted Patent,yes,20,9,3,8,0,A47B3/02;;A47B3/083;;A47B3/02;;A47B3/083,A47B3/02;;A47B3/083,108/118;;108/179;;108/157.16,1,0,,,"IKEA Catalog, (C) 1990, p. 75.",EXPIRED
326,CA,C,CA 1305560 C,077-278-106-888-600,1992-07-21,1992,CA 576396 A,1988-09-02,US 9347987 A,1987-09-04,METHOD AND APPARATUS FOR INTERCONNECTING BUSSES IN A MULTIBUS COMPUTER SYSTEM,"A bus adapter connecting a high-speed pended bus to a slower speed non-pended bus includes a first module functioning as a node of the pended bus and a second module functioning as a node of the non-pended bus. An interconnect bus extends between the two modules. Control signals on the interconnect bus generated by the first module comprise status signals having an indefinite assertion duration, and are deasserted only in response to control signals on the interconnect bus generated by the second module, which have a finite duration. Control signals on the interconnect bus generated by the first module are synchronized by a dual-rank synchronizer controlled by two phases of a multiphase clock signal derived from the clock signal of the nonpended bus. Control signals on the interconnect bus generated by the second module are synchronized by a dual-rank synchronizer controlled by two phases of a multiphase clock signal derived from the pended bus clock signal.",DIGITAL EQUIPMENT CORP,TRIOLO VICTORIA M;;BLOOM ELBERT;;HARTWELL DAVID W,,https://lens.org/077-278-106-888-600,Granted Patent,no,0,0,6,6,0,G06F5/06;;G06F5/06;;G06F13/405;;G06F13/405;;G06F13/4226;;G06F13/4226,G06F13/36;;G06F5/06;;G06F13/40;;G06F13/42,D23540231    M,0,0,,,,EXPIRED
327,US,B2,US 11730734 B2,197-783-697-158-746,2023-08-22,2023,US 201716332211 A,2017-09-12,US 201716332211 A;;US 201662393166 P;;US 2017/0051176 W,2016-09-12,Use of ATR and Chk1 inhibitor compounds,The invention relates to kinase inhibitor compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating or preventing herpesvirus infection and/or herpesvirus-associated diseases and disorders.,UNIV FLORIDA,FISHER CHRISTOPHER;;EDWARDS TERRI G;;BLOOM DAVID C,UNIVERSITY OF FLORIDA RESEARCH FOUNDATION INCORPORATED (2019-06-25),https://lens.org/197-783-697-158-746,Granted Patent,yes,6,0,4,4,0,A61K45/06;;A61K31/36;;A61K31/4709;;A61K31/4745;;A61K31/4965;;A61K31/497;;A61K31/505;;A61K31/5355;;A61K31/5517;;A61P31/22;;A61P31/22;;A61K31/439;;A61K31/4965;;A61K31/497;;A61K31/5377;;A61K31/5517;;A61K31/505;;A61K31/4745;;A61K31/5355;;A61K31/4709;;A61K45/06;;A61K31/36,A61K31/4965;;A61K31/36;;A61K31/439;;A61K31/4709;;A61K31/4745;;A61K31/497;;A61K31/505;;A61K31/5355;;A61K31/5377;;A61K31/5517;;A61K45/06;;A61P31/22,,6,4,083-298-778-430-93X;;003-323-336-373-632;;099-382-315-524-254;;127-013-145-214-930,10.1186/s12985-016-0470-1;;26817608;;pmc4728825;;23222511;;pmc3542617;;10.1038/cddis.2012.181;;10.1128/jvi.01884-17;;29263259;;pmc5827400;;26057167;;10.3390/v7062752;;pmc4488719,"Botting et al., “H2AX phosphorylation and DNA damage kinase activity are dispensable for herpes simplex virus replication”, Virology Journal, pp. 1-11, Jan. 27, 2016 (Year: 2016).;;Fokas et al., “Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation”, Cell Death and Disease, Dec. 6, 2012 (Year: 2012).;;International Search Report and Written Opinion, dated Jan. 12, 2018, in connection with Application No. PCT/US2017/051176.;;Edwards et al. The ATM and Rad3-Related (ATR) Protein Kinase Pathway Is Activated by Herpes Simplex Virus 1 and Required for Efficient Viral Replication. J Virol. Feb. 26, 2018;92(6). pii: e01884-17. doi:10.1128/JVI.01884-17. Print Mar. 15, 2018.;;Hollingworth et al. Activation of DNA Damage Response Pathways during Lytic Replication of KSHV. Viruses. Jun. 5, 2015;7(6):2908-27. doi: 10.3390/v7062752.;;Sauerbrei. Infect Drug Resist. Jun. 13, 2016;9:129-41. doi: 10.2147/IDR.S96164. eCollection 2016. Review.",ACTIVE
328,US,A1,US 2009/0140433 A1,108-833-225-705-97X,2009-06-04,2009,US 27612308 A,2008-11-21,US 27612308 A;;US 494107 P,2007-11-30,MEMS chip-to-chip interconnects,A chip-to-chip interconnect system suited for MEMS that do not require low-resistance connections is described. The interconnects may be fabricated simultaneously with MEMS ribbon structures such as are found in MEMS optical modulators.,ALCES TECHNOLOGY INC,BLOOM DAVID M;;LEONE MATTHEW A;;YEH RICHARD,ALCES TECHNOLOGY INC (2010-06-02),https://lens.org/108-833-225-705-97X,Patent Application,yes,22,9,1,1,0,B81C3/008;;B81C3/008;;B81B7/0006;;B81B7/0006;;B81B2207/07;;B81B2207/07,H01L23/48;;H01L21/4763,257/773;;438/618;;X257E21532;;X257E23169,0,0,,,,DISCONTINUED
329,EP,A3,EP 0364879 A3,037-073-160-060-169,1992-12-30,1992,EP 89118950 A,1989-10-12,US 25902788 A,1988-10-17,GALLIUM ARSENIDE MONOLITHICALLY INTEGRATED SAMPLING HEAD USING EQUIVALENT TIME SAMPLING HAVING A BANDWIDTH GREATER THAN 100 GHZ,"A high bandwidth RF sampler using equivalent time sampling comprising an RF coplanar waveguide integrated with sampling diodes on a gallium arsenide substrate. A monolithic, integrated nonlinear transmission line is integrated on the same substrate to receive sample pulses. These pulses are reshaped by the nonlinear transmission line to have a very fast edge. This edge is differentiated by a shunt inductance of a short circuit termination of a slot line portion of the RF signal coplanar waveguide. The resulting delta function sample pulses cause the sample diodes and integrated capacitors to develop an intermediate output frequency which is a replica of the RF signal at a lower frequency and no voltage conversion loss. RF signals of up to 300 Ghz can be sampled using this circuit.",STANFORD UNIVERSITY,"MARSLAND, ROBERT A.;;RODWELL, MARK;;BLOOM, DAVID M.",STANFORD UNIVERSITY (1992-11-19),https://lens.org/037-073-160-060-169,Search Report,yes,1,0,4,12,0,H01L27/0605;;H03H7/325;;H03H7/325;;H01L27/0605,H01L27/04;;H01L21/822;;H01L27/06;;H01P3/02;;H03H7/32;;H03K17/74,,2,1,115-984-183-087-852,10.1049/el:19880066,"ELECTRONICS LETTERS vol. 24, no. 2, 21 January 1988, ENAGE GB pages 100 - 101 M. J. W. RODWELL ET AL. 'Generation of 7.8 ps electrical transients on a monolithic nonliear transmission line';;PATENT ABSTRACTS OF JAPAN vol. 012, no. 150 (E-606)10 May 1988 & JP-A-62 264 723 ( YOKOGAWA ELECTRIC CORP ) 17 November 1987",DISCONTINUED
330,US,A1,US 2002/0151008 A1,065-097-203-280-471,2002-10-17,2002,US 91895101 A,2001-07-31,US 91895101 A;;US 17734998 A,1998-10-23,"IniB, iniA and iniC genes of mycobacteria and methods of use","
   This invention relates to the identification, cloning, sequencing and characterization of the iniB, iniA and iniC genes of mycobacteria which are induced by a broad class of antibiotics that act by inhibiting cell wall biosynthesis, including the first line antituberculosis agents, isoniazid and ethambutol. The present invention provides purified and isolated iniB, iniA, iniC and iniB promoter nucleic acids which may comprise the iniBAC operon, as well as mutated forms of these nucleic acids. The present invention also provides one or more single-stranded nucleic acid probes which specifically hybridize to the iniB, iniA, iniC and iniB promoter nucleic acids, and mixtures thereof, which may be formulated in kits, and used in the diagnosis of drug-resistant mycobacterial strain. The present invention also provides methods for the screening and identification of drugs effective against Mycobacterium tuberculosis using induction of the iniB promoter. 
",ALLAND DAVID;;BLOOM BARRY R.;;JACOBS WILLIAM R.,ALLAND DAVID;;BLOOM BARRY R;;JACOBS WILLIAM R,ALBERT EINSTEIN COLLEGE OF MEDICINE INC (2015-09-09),https://lens.org/065-097-203-280-471,Patent Application,yes,0,4,3,3,0,A61K2039/53;;A61K2039/53;;C07K14/35;;C07K14/35;;C12N15/74;;C12N15/74;;Y02A50/30;;Y02A50/30;;Y10S435/863;;Y10S435/863;;Y10S435/864;;Y10S435/864;;Y10S435/865;;Y10S435/865;;Y10S435/866;;Y10S435/866,C07K14/35;;C12N15/74,435/183;;435/252.3;;536/23.2;;536/24.3;;435/6,0,0,,,,EXPIRED
331,US,A1,US 2017/0093191 A1,135-867-655-143-668,2017-03-30,2017,US 201514869813 A,2015-09-29,US 201514869813 A,2015-09-29,POWER MANAGEMENT SYSTEM,"Systems and methods for managing power across electronic devices and a charge reservoir are discussed herein. A power management system includes a charge reservoir configured to store power, a first charger assembly, and a switch coupled to the charge reservoir and the first charger assembly. The charging monitor may be coupled to the switch. The charging monitor may be configured to query a charge state of a first electronic device, receive the charge state of the first electronic device from the first electronic device, compare the charge state of the first electronic device to a threshold value, and activate the switch when the charge state is less than the threshold value. The activation may cause power to be transferred from the charge reservoir to the first electronic device via the first charger assembly.",APPLE INC,ARNOLD PETER;;MEYER ADAM S;;BLOOM DAVID H,APPLE INC (2015-09-28),https://lens.org/135-867-655-143-668,Patent Application,yes,6,1,2,2,0,H02J7/0018;;H02J7/34;;H02J7/342;;H02J7/34;;H02J7/0018;;H02J7/0069;;H02J7/342;;H02J7/0036,H02J7/00,,0,0,,,,DISCONTINUED
332,WO,A1,WO 2001/094870 A1,147-037-831-503-769,2001-12-13,2001,AU 1982/001006 W,2001-06-08,AU PQ805800 A,2000-06-08,CROSSBOW WITH ADJUSTABLE LIMBS,"A crossbow includes stock (28); resilient limbs (11, 12) and adjustment member (32). Limbs (11, 12) are pivotally connected to base (13) by way of pins (14, 15) and are further supported by pins (16, 17) located in channels (18, 19). Limbs (11, 12) are also connected to arms (20, 21). Rotation of adjustment nut (27) causes arms (20, 21) and limbs (11, 12) to move and results in pins (16, 17) sliding in channels (18, 19). Movement of limbs (11, 12) varies the distance between ends (30, 31) of limbs (11, 12) and hence varies the tension in bowstring (19) attached adjacent ends (30, 31).",MIDDLETON DAVID;;WALTERS BRYAN;;JENNINGS MIKE;;BLOOM KEN,MIDDLETON DAVID;;WALTERS BRYAN;;JENNINGS MIKE;;BLOOM KEN,,https://lens.org/147-037-831-503-769,Patent Application,yes,3,5,2,3,0,F41B5/12,F41B5/12,,0,0,,,,PENDING
333,EP,A1,EP 0329776 A1,148-179-290-997-267,1989-08-30,1989,EP 88908549 A,1988-09-01,US 9347987 A,1987-09-04,METHOD AND APPARATUS FOR INTERCONNECTING BUSSES IN A MULTIBUS COMPUTER SYSTEM.,"Un adaptateur de bus reliant un bus à grande vitesse mis en file d'attente (25) à un bus à vitesse inférieure sans file d'attente (45) comprend un premier module (69) fonctionnant en tant que point nodal du bus mis en file d'attente et un deuxième module (61) fonctionnant en tant que point nodal du bus sans file d'attente. Un bus d'interconnexion (611) s'étend entre les deux modules. Les signaux de commande sur le bus d'interconnexion qui sont produits par le premier module comprennent des signaux d'état présentant une durée d'excitation indéfinie, et sont désexcités uniquement en réponse à des signaux de commande sur le bus d'interconnexion qui sont produits par le deuxième module et ont une durée finie. Les signaux de commande sur le bus d'interconnexion qui sont produits par le premier module sont synchronisés par un synchroniseur à double rangée commandé par deux phases d'un signal d'horloge multiphase dérivé du signal d'horloge du bus sans file d'attente. Les signaux de commande sur le bus d'interconnexion qui sont produits par le deuxième module sont synchronisés par un synchroniseur à double rangée commandé par deux phases d'un signal d'horloge multiphase dérivé du signal d'horloge du bus mis en file d'attente.",DIGITAL EQUIPMENT CORP,TRIOLO VICTORIA M;;BLOOM ELBERT;;HARTWELL DAVID W,,https://lens.org/148-179-290-997-267,Patent Application,yes,0,0,6,6,0,G06F5/06;;G06F5/06;;G06F13/405;;G06F13/405;;G06F13/4226;;G06F13/4226,G06F13/36;;G06F5/06;;G06F13/40;;G06F13/42,,1,0,,,See references of WO 8902127A1,DISCONTINUED
334,WO,A1,WO 2018/049400 A1,176-840-889-737-183,2018-03-15,2018,US 2017/0051176 W,2017-09-12,US 201662393166 P,2016-09-12,USE OF ATR AND CHK1 INHIBITOR COMPOUNDS,The invention relates to kinase inhibitor compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating or preventing herpesvirus infection and/or herpesvirus-associated diseases and disorders.,UNIV FLORIDA,FISHER CHRISTOPHER;;EDWARDS TERRI G;;BLOOM DAVID C,,https://lens.org/176-840-889-737-183,Patent Application,yes,2,4,4,4,0,A61K45/06;;A61K31/36;;A61K31/4709;;A61K31/4745;;A61K31/4965;;A61K31/497;;A61K31/505;;A61K31/5355;;A61K31/5517;;A61P31/22;;A61P31/22;;A61K31/439;;A61K31/4965;;A61K31/497;;A61K31/5377;;A61K31/5517;;A61K31/505;;A61K31/4745;;A61K31/5355;;A61K31/4709;;A61K45/06;;A61K31/36,A61K31/497;;A61K31/4965;;A61K31/7068;;C07K14/035,,2,2,127-013-145-214-930;;075-645-845-721-336,26057167;;10.3390/v7062752;;pmc4488719;;27358569;;10.2147/idr.s96164;;pmc4912341,"HOLLINGWORTH, R ET AL.: ""Activation of DNA Damage Response Pathways During Lytic Replication of KSHV"", VIRUSES, vol. 7, no. 6, 5 June 2015 (2015-06-05), pages 2908 - 2927, XP055473590;;SAUERBREI, A: ""Optimal Management of Genital Herpes: Current Perspectives"", INFECTION AND DRUG RESISTANCE, vol. 9, 13 June 2016 (2016-06-13), pages 129 - 141, XP055473593",PENDING
335,FR,A,FR 1289683 A,099-777-177-086-212,1962-04-06,1962,FR 856945 A,1961-03-27,FR 856945 A;;GB 1085860 A,1960-03-28,Procédé et appareils pour le moulage d'objets en mousse de matière synthétique,,,BLOOM DAVID;;COUCHMAN TIMOTHY;;LINGWOOD ROBERT NEVIL GARROD,,https://lens.org/099-777-177-086-212,Granted Patent,no,0,1,1,6,0,B29C44/445;;B29L2031/7132;;B29C44/3426,,,0,0,,,,EXPIRED
336,EP,A2,EP 0364879 A2,108-032-619-807-442,1990-04-25,1990,EP 89118950 A,1989-10-12,US 25902788 A,1988-10-17,Gallium arsenide monolithically integrated sampling head using equivalent time sampling having a bandwidth greater than 100 GHZ.,"A high bandwidth RF sampler using equivalent time sampling comprising an RF coplanar waveguide integrated with sampling diodes on a gallium arsenide substrate. A monolithic, integrated nonlinear transmission line is integrated on the same substrate to receive sample pulses. These pulses are reshaped by the nonlinear transmission line to have a very fast edge. This edge is differentiated by a shunt inductance of a short circuit termination of a slot line portion of the RF signal coplanar waveguide. The resulting delta function sample pulses cause the sample diodes and integrated capacitors to develop an intermediate output frequency which is a replica of the RF signal at a lower frequency and no voltage conversion loss. RF signals of up to 300 Ghz can be sampled using this circuit.",UNIV STANFORD,MARSLAND ROBERT A;;RODWELL MARK;;BLOOM DAVID M,STANFORD UNIVERSITY (1992-11-19),https://lens.org/108-032-619-807-442,Patent Application,yes,0,4,4,12,0,H01L27/0605;;H03H7/325;;H03H7/325;;H01L27/0605,H01L27/04;;H01L21/822;;H01L27/06;;H01P3/02;;H03H7/32;;H03K17/74,,0,0,,,,DISCONTINUED
337,US,A,US 4979097 A,123-721-743-428-80X,1990-12-18,1990,US 9347987 A,1987-09-04,US 9347987 A,1987-09-04,Method and apparatus for interconnecting busses in a multibus computer system,"A bus adapter connecting a high-speed pended bus to a slower speed non-pended bus includes a first module functioning as a node of the pended bus and a second module functioning as a node of the non-pended bus. An interconnect bus extends between the two modules. Control signals on the interconnect bus generated by the first module comprise status signals having an indefinite assertion duration, and are deasserted only in response to control signals on the interconnect bus generated by the second module, which have a finite duration. Control signals on the interconnect bus generated by the first module are synchronized by a dual-rank synchronizer controlled by two phases of a multiphase clock signal derived from the clock signal of the non-pended bus. Control signals on the interconnect bus generated by the second module are synchronized by a dual-rank synchronizer controlled by two phases of a multiphase clock signal derived from the pended bus clock signal.",DIGITAL EQUIPMENT CORP,TRIOLO VICTORIA M;;BLOOM ELBERT;;HARTWELL DAVID W,DIGITAL EQUIPMENT CORPORATION (1987-09-02);;HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (1999-12-09),https://lens.org/123-721-743-428-80X,Granted Patent,yes,17,40,6,6,0,G06F5/06;;G06F5/06;;G06F13/405;;G06F13/405;;G06F13/4226;;G06F13/4226,G06F13/36;;G06F5/06;;G06F13/40;;G06F13/42,364/200;;364/228.3;;364/240;;364/240.1;;364/240.2,0,0,,,,EXPIRED
338,US,A,US 5381101 A,149-013-014-209-355,1995-01-10,1995,US 98489192 A,1992-12-02,US 98489192 A,1992-12-02,System and method of measuring high-speed electrical waveforms using force microscopy and offset sampling frequencies,A potentiometry apparatus for measuring a periodic electrical waveform existing proximate the surface of a sample such as a semiconductor wafer is disclosed herein. The potentiometry apparatus includes a pulse generator for generating a sequence of electrical pulses at a pulse frequency offset from the frequency of the surface waveform by a mixing frequency. A cantilever coupled to the pulse generator serves to carry the electrical pulses to a position proximate the surface of the sample. In a capacitive displacement mode the cantilever is mechanically displaced so as to generate a time-expanded representation of the electrical surface waveform having a repetition frequency equal to the mixing frequency. During displacement mode operation an optical detection circuit may be employed to monitor deflection of the cantilever. In a tunneling current mode the cantilever is again employed to carry the electrical pulses to a position proximate the surface of the sample. In this mode a tunneling current propagating through the cantilever at the mixing frequency provides a time-expanded representation of the electrical surface waveform.,UNIV LELAND STANFORD JUNIOR,BLOOM DAVID M;;HO FRANCIS;;HOU ALFRED S,BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY THE (1993-02-05),https://lens.org/149-013-014-209-355,Granted Patent,yes,7,77,2,2,0,G01Q60/32;;G01Q60/32;;G01Q10/06;;G01Q10/06;;Y10S977/849;;Y10S977/849;;Y10S977/852;;Y10S977/852;;Y10S977/86;;Y10S977/86;;Y10S977/861;;Y10S977/861;;Y10S977/864;;Y10S977/864;;Y10S977/868;;Y10S977/868;;Y10S977/873;;Y10S977/873,G01Q60/38;;G01B5/28;;G01B21/30;;G01Q10/06;;G01Q70/14,324/676;;324/158;;250/306;;73/105,8,4,000-707-003-794-942;;149-642-398-397-595;;022-093-489-117-769;;037-859-696-108-540,10.1109/tmtt.1966.1126342;;10.1063/1.99224;;10.1063/1.102096;;10.1063/1.105227,"Sampling for Oscilloscopes and Other RF Systems: DC Through X Band ; W. M. Grove; IEEE Transactions on Microwave Theory and Techniques; vol. MTT 14; No. 12, Dec., 1966; pp. 629 635.;;High resolution capacitance measurement and potentiometry by force microscopy Yves Martin et al.; Applied Physics Lett. 52 (13), Mar. 28, 1988; pp. 1103 1105.;;Voltage Contrast: A Review ; A. Gopinath et al.; Scanning Electron Microscopy; 1978, vol. I; pp. 375 380.;;Developments in Voltage Contrast ; P. Girard; Scanning Microscopy; vol. 2, No. 1, 1988; pp. 151 160.;;Scanning capacitance microscopy on a 25 nm scale ; C. C. Williams et al; Applied Physics Letter 55 (2); 10 Jul. 1989; pp. 203 205.;;Potentiometry for thin film structures using atomic force microscopy ; M. Anders et al.; J. Vac. Sci. Technol. A8(1), Jan./Feb. 1990; pp. 394 399.;;Klevin probe force microscopy ; M. Nonnenmacher et al.; Applied Physics Letter, 58 (25); 24 Jun. 1991; pp. 2921 2923.;;Applications of Scanning Kelvin Probe Force Microscope (SKPFM) for Failure Analysis ; T. T. Hwang et al.; ISTFA 92: The 18th International Symposium for Testing & Failure Analysis; Los Angeles, Calif.; 17 23 Oct. 1992; pp. 9 14.",EXPIRED
339,US,B1,US 6443074 B1,151-152-604-147-192,2002-09-03,2002,US 47860700 A,2000-01-06,US 47860700 A,2000-01-06,Folding table,"
    A table having a base including legs, first and second table top portions that form a table top surface when the table is in the assembled position, and pivotable connectors that connect the first and second table top portions to the base. The pivotable connectors allow for the first and second table top portions and the legs to collapse into a vertical position such that the table can be easily stored and carried. The table top is supported when it is in assembled position by a variety of devices such that the table top will not flex or deform. Pivotable connections are also provided between the legs allowing the legs to form a crisscross pattern when the table is in the assembled position. 
",ADAMS MFG CORP,ADAMS WILLIAM E;;FOUNTAIN DAVID M;;BLOOM THEODORE,ADAMS MANUFACTURING CORP (1999-12-27),https://lens.org/151-152-604-147-192,Granted Patent,yes,16,7,3,8,0,A47B3/02;;A47B3/083;;A47B3/02;;A47B3/083,A47B3/02;;A47B3/083,108/118;;108/179;;108/157.16,1,0,,,"IKEA Catalog, (C)1990, p. 75.",EXPIRED
340,US,A,US 4837767 A,169-259-365-876-34X,1989-06-06,1989,US 9348087 A,1987-09-04,US 9348087 A,1987-09-04,Bus adapter module with improved error recovery in a multibus computer system,A bus adapter interconnecting a system bus and an I/O bus over an interconnect bus generates a first READ signal by decoding the command lines of the I/O bus and supplying the READ command signal across the interconnect bus. The command lines are also provided across the interconnect bus and are decoded on the system bus side of the interconnect bus to form a second READ signal. The first and second READ signals and a parity error signal are processed on the system bus side of the interconnect bus to generate a NON-RECOVERABLE ERROR signal to initiate a system shut-down when a parity error occurs during a disconnected WRITE transaction and to generate a RECOVERABLE ERROR signal to initiate a repeat of the transaction when a parity error occurs during a READ transaction.,DIGITAL EQUIPMENT CORP,HARTWELL DAVID W;;BLOOM ELBERT;;TRIOLO VICTORIA M,DIGITAL EQUIPMENT CORPORATION 146 MAIN STREET MAYNARD MA 01754 A CORP. OF MA (1987-09-02);;HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (1999-12-09),https://lens.org/169-259-365-876-34X,Granted Patent,yes,4,18,1,1,0,G06F11/10;;G06F11/141;;G06F11/141;;G06F11/10,G06F11/10;;G06F11/14,371/49;;364/200;;364/900;;375/7,1,0,,,"Shu Shia Chow; PILA Hardware Specification; 1982; pp. 1, 5 8.",EXPIRED
341,WO,A1,WO 1989/002127 A1,198-982-618-856-756,1989-03-09,1989,US 8802955 W,1988-09-01,US 9347987 A,1987-09-04,METHOD AND APPARATUS FOR INTERCONNECTING BUSSES IN A MULTIBUS COMPUTER SYSTEM,"A bus adapter connecting a high-speed pended bus (25) to a slower speed non-pended bus (45) includes a first module (69) functioning as a node of the pended bus and a second module (61) functioning as a node of the non-pended bus. An interconnect bus (611) extends between the two modules. Control signals on the interconnect bus generated by the first module comprise status signals having an indefinite assertion duration, and are deasserted only in response to control signals on the interconnect bus generated by the second module, which have a finite duration. Control signals on the interconnect bus generated by the first module are synchronized by a dual-rank synchronizer controlled by two phases of a multiphase clock signal derived from the clock signal of the non-pended bus. Control signals on the interconnect bus generated by the second module are synchronized by a dual-rank synchronizer controlled by two phases of a multiphase clock signal derived from the pended bus clock signal.",DIGITAL EQUIPMENT CORP,TRIOLO VICTORIA M;;BLOOM ELBERT;;HARTWELL DAVID W,,https://lens.org/198-982-618-856-756,Patent Application,yes,2,6,6,6,0,G06F5/06;;G06F5/06;;G06F13/405;;G06F13/405;;G06F13/4226;;G06F13/4226,G06F13/36;;G06F5/06;;G06F13/40;;G06F13/42,,2,0,,,"A.M. Lister: ""Fundamentals of Operating Systems"", third edition, 1984, McMillan Education Ltd, (London, GB), pages 71-72;;Patent Abstracts of Japan, volume 9, no: 318 (E-366)(2041), 13 December 1985; & JP-A-60150349 (NIPPON DENKI K.K.) 8 August 1985",PENDING
342,US,A1,US 2023/0414608 A1,039-220-528-139-757,2023-12-28,2023,US 202318343285 A,2023-06-28,US 202318343285 A;;US 201916332211 A;;US 2017/0051176 W;;US 201662393166 P,2016-09-12,USE OF ATR AND CHK1 INHIBITOR COMPOUNDS,The invention relates to kinase inhibitor compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating or preventing herpesvirus infection and/or herpesvirus-associated diseases and disorders.,UNIV FLORIDA,FISHER CHRISTOPHER;;EDWARDS TERRI G;;BLOOM DAVID C,UNIVERSITY OF FLORIDA RESEARCH FOUNDATION INCORPORATED (2019-06-25),https://lens.org/039-220-528-139-757,Patent Application,yes,0,0,4,4,0,A61K45/06;;A61K31/36;;A61K31/4709;;A61K31/4745;;A61K31/4965;;A61K31/497;;A61K31/505;;A61K31/5355;;A61K31/5517;;A61P31/22;;A61P31/22;;A61K31/439;;A61K31/4965;;A61K31/497;;A61K31/5377;;A61K31/5517;;A61K31/505;;A61K31/4745;;A61K31/5355;;A61K31/4709;;A61K45/06;;A61K31/36,A61K31/4965;;A61K31/36;;A61K31/439;;A61K31/4709;;A61K31/4745;;A61K31/497;;A61K31/505;;A61K31/5355;;A61K31/5377;;A61K31/5517;;A61K45/06;;A61P31/22,,0,0,,,,PENDING
343,WO,A1,WO 2017/058389 A1,130-467-628-041-581,2017-04-06,2017,US 2016/0047868 W,2016-08-19,US 201514869813 A,2015-09-29,POWER MANAGEMENT SYSTEM,"Systems and methods for managing power across electronic devices (210) and a charge reservoir (204) are discussed herein. A power management system (200) includes a charge reservoir (204) configured to store power, a first charger assembly (202), and a switch (212) coupled to the charge reservoir (204) and the first charger assembly (202). The charging monitor (206) may be coupled to the switch (212). The charging monitor(206) may be configured to query a charge state of a first electronic device (210), receive the charge state of the first electronic device from the first electronic device (210), compare the charge state of the first electronic device to a threshold value, and activate the switch (212) when the charge state is less than the threshold value. The activation may cause power to be transferred from the charge reservoir (204) to the first electronic device (210) via the first charger assembly (202).",APPLE INC,ARNOLD PETER;;MEYER ADAM S;;BLOOM DAVID H,,https://lens.org/130-467-628-041-581,Patent Application,yes,6,1,2,2,0,H02J7/0018;;H02J7/34;;H02J7/342;;H02J7/34;;H02J7/0018;;H02J7/0069;;H02J7/342;;H02J7/0036,H02J7/00;;H02J7/34,,0,0,,,,PENDING
344,US,A,US 4864496 A,180-688-228-827-852,1989-09-05,1989,US 9348887 A,1987-09-04,US 9348887 A,1987-09-04,Bus adapter module for interconnecting busses in a multibus computer system,"A control adapter module in a bus adapter connecting a high-speed pended bus to a slower speed non-pended bus functions as a node of the non-pended bus. An interconnect bus extends between the control module and a response adapter module functioning as a node on the pended bus. Control signals on the interconnect bus generated by the response module comprise status signals having an indefinite assertion duration, and are deasserted only in response to control signals on the interconnect bus generated by the control module, which have a finite duration. Control signals on the interconnect bus generated by the response module are synchronized by a dual-rank synchronizer controlled by two phases of a multiphase clock signal derived from the clock signal of the non-pended bus. Control signals on the interconnect bus generated by the control module are synchronized by a dual-rank synchronizer controlled by two phases of a multiphase clock signal derived from the pended bus clock signal.",DIGITAL EQUIPMENT CORP,TRIOLO VICTORIA M;;BLOOM ELBERT;;HARTWELL DAVID W,DIGITAL EQUIPMENT CORPORATION 146 MAIN STREET MAYNARD MASSACHUSETTS 01754 A CORP. OF MA (1987-09-02);;HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (1999-12-09),https://lens.org/180-688-228-827-852,Granted Patent,yes,1,83,1,1,0,G06F13/405;;G06F13/405,G06F13/40,364/200;;364/240.2,0,0,,,,EXPIRED
345,EP,A4,EP 3119273 A4,024-344-281-605-014,2017-10-25,2017,EP 15765569 A,2015-03-19,US 201461968696 P;;US 2015/0021568 W,2014-03-21,METHOD AND APPARATUS OF MONITORING FOOT INFLAMMATION,,PODIMETRICS INC,PETERSEN BRIAN;;BLOOM JONATHAN DAVID;;LINDERS DAVID ROBERT;;ENGLER JEFFREY MARK,,https://lens.org/024-344-281-605-014,Search Report,no,2,0,10,40,0,A61B5/103;;A61B5/6829;;A61B5/6892;;A61B5/0008;;A61B5/0022;;A61B5/445;;A61B5/4887;;A61B5/7275;;A61B2562/0271;;A61B5/7203;;A61B5/7246;;A61B5/0077;;A61B5/6807;;A61B5/725;;A61B5/7253;;G16H50/30;;G16H30/40;;G16H40/63;;G16H50/20;;A61B5/0075;;A61B5/447;;A61B2576/02;;A61B5/015;;A43B3/34;;A61B5/445;;A61B5/103;;A61B5/0022;;A61B5/7275;;A61B5/0008;;A61B5/6892;;A61B5/6829;;A61B5/4887;;A61B2562/0271;;A61B5/6807;;A61B5/7246;;A61B5/725;;A61B5/0077;;A61B5/7253;;A61B5/7203;;G16H40/63;;G16H50/30;;G16H50/20;;G16H30/40;;A43B3/34;;A61B5/015;;A61B5/0075;;A61B5/447;;A61B5/6802;;A61B5/7282;;A61B2576/02,A61B5/01;;A43B17/00;;A61B5/00;;A61B5/103;;A61B90/00,,1,0,,,"CHANJUAN LIU ET AL: ""Infrared dermal thermography on diabetic feet soles to predict ulcerations: a case study"", OPTOMECHATRONIC MICRO/NANO DEVICES AND COMPONENTS III : 8 - 10 OCTOBER 2007, LAUSANNE, SWITZERLAND;PROCEEDINGS OF SPIE, vol. 8572, 22 March 2013 (2013-03-22), Bellingham, Wash., pages 85720N, XP055227016, ISBN: 978-1-62841-730-2, DOI: 10.1117/12.2001807",DISCONTINUED
346,EP,A1,EP 3119273 A1,145-422-259-775-015,2017-01-25,2017,EP 15765569 A,2015-03-19,US 201461968696 P;;US 2015/0021568 W,2014-03-21,METHOD AND APPARATUS OF MONITORING FOOT INFLAMMATION,,PODIMETRICS INC,PETERSEN BRIAN;;BLOOM JONATHAN DAVID;;LINDERS DAVID ROBERT;;ENGLER JEFFREY MARK,,https://lens.org/145-422-259-775-015,Patent Application,yes,0,0,10,40,0,A61B5/103;;A61B5/6829;;A61B5/6892;;A61B5/0008;;A61B5/0022;;A61B5/445;;A61B5/4887;;A61B5/7275;;A61B2562/0271;;A61B5/7203;;A61B5/7246;;A61B5/0077;;A61B5/6807;;A61B5/725;;A61B5/7253;;G16H50/30;;G16H30/40;;G16H40/63;;G16H50/20;;A61B5/0075;;A61B5/447;;A61B2576/02;;A61B5/015;;A43B3/34;;A61B5/445;;A61B5/103;;A61B5/0022;;A61B5/7275;;A61B5/0008;;A61B5/6892;;A61B5/6829;;A61B5/4887;;A61B2562/0271;;A61B5/6807;;A61B5/7246;;A61B5/725;;A61B5/0077;;A61B5/7253;;A61B5/7203;;G16H40/63;;G16H50/30;;G16H50/20;;G16H30/40;;A43B3/34;;A61B5/015;;A61B5/0075;;A61B5/447;;A61B5/6802;;A61B5/7282;;A61B2576/02,A61B5/01;;A61B5/00;;A61B5/103,,0,0,,,,DISCONTINUED
347,WO,A1,WO 2015/143218 A1,113-965-682-787-048,2015-09-24,2015,US 2015/0021568 W,2015-03-19,US 201461968696 P,2014-03-21,METHOD AND APPARATUS OF MONITORING FOOT INFLAMMATION,"A method and apparatus for evaluating foot inflammation each uses at least one temperature detection modality to form a first thermogram and a second thermogram of the sole of at least one foot. Each thermogram forms a substantially continuous set of two-dimensional temperature values across the sole of the (at least one) foot. The thermograms have features; namely, the first thermogram has first features and the second thermogram has second features. The method and apparatus thus control a device to apply at least one transformation to the first and second thermograms to align the first features with corresponding second features, and determine, at any thermogram location, if at least one of the thermograms presents one of a plurality of patterns indicative of inflammation. Finally, the method and apparatus each produce output information indicating the result of the determination of whether the thermograms present one of the plurality of patterns.",PODIMETRICS INC,PETERSEN BRIAN;;BLOOM JONATHAN DAVID;;LINDERS DAVID ROBERT;;ENGLER JEFFREY MARK,,https://lens.org/113-965-682-787-048,Patent Application,yes,8,17,10,40,0,A61B5/103;;A61B5/6829;;A61B5/6892;;A61B5/0008;;A61B5/0022;;A61B5/445;;A61B5/4887;;A61B5/7275;;A61B2562/0271;;A61B5/7203;;A61B5/7246;;A61B5/0077;;A61B5/6807;;A61B5/725;;A61B5/7253;;G16H50/30;;G16H30/40;;G16H40/63;;G16H50/20;;A61B5/0075;;A61B5/447;;A61B2576/02;;A61B5/015;;A43B3/34;;A61B5/445;;A61B5/103;;A61B5/0022;;A61B5/7275;;A61B5/0008;;A61B5/6892;;A61B5/6829;;A61B5/4887;;A61B2562/0271;;A61B5/6807;;A61B5/7246;;A61B5/725;;A61B5/0077;;A61B5/7253;;A61B5/7203;;G16H40/63;;G16H50/30;;G16H50/20;;G16H30/40;;A43B3/34;;A61B5/015;;A61B5/0075;;A61B5/447;;A61B5/6802;;A61B5/7282;;A61B2576/02,A61B5/01;;A61B5/00;;A61B5/103,,1,1,054-450-884-182-038,10.1117/12.2001807,"CHANJUAN LIU ET AL.: ""Infrared Dermal Thermography on Diabetic Feet Soles to Predict Ulcerations: a Case Study"", ADVANCED BIOMEDICAL AND CLINICAL DIAGNOSTIC SYSTEMS XI, vol. 8572, 31 January 2013 (2013-01-31), pages 85720N, XP055227016",PENDING
348,CN,A,CN 106132291 A,006-609-327-540-315,2016-11-16,2016,CN 201580015377 A,2015-03-19,US 201461968696 P;;US 2015/0021568 W,2014-03-21,Method and apparatus of monitoring foot inflammation,"A method and apparatus for evaluating foot inflammation each uses at least one temperature detection modality to form a first thermogram and a second thermogram of the sole of at least one foot. Each thermogram forms a substantially continuous set of two-dimensional temperature values across the sole of the (at least one) foot. The thermograms have features; namely, the first thermogram has first features and the second thermogram has second features. The method and apparatus thus control a device to apply at least one transformation to the first and second thermograms to align the first features with corresponding second features, and determine, at any thermogram location, if at least one of the thermograms presents one of a plurality of patterns indicative of inflammation. Finally, the method and apparatus each produce output information indicating the result of the determination of whether the thermograms present one of the plurality of patterns.",PODIMETRICS INC,PETERSEN BRIAN;;BLOOM JONATHAN DAVID;;LINDERS DAVID ROBERT;;ENGLER JEFFREY MARK,,https://lens.org/006-609-327-540-315,Patent Application,no,7,8,10,40,0,A61B5/103;;A61B5/6829;;A61B5/6892;;A61B5/0008;;A61B5/0022;;A61B5/445;;A61B5/4887;;A61B5/7275;;A61B2562/0271;;A61B5/7203;;A61B5/7246;;A61B5/0077;;A61B5/6807;;A61B5/725;;A61B5/7253;;G16H50/30;;G16H30/40;;G16H40/63;;G16H50/20;;A61B5/0075;;A61B5/447;;A61B2576/02;;A61B5/015;;A43B3/34;;A61B5/445;;A61B5/103;;A61B5/0022;;A61B5/7275;;A61B5/0008;;A61B5/6892;;A61B5/6829;;A61B5/4887;;A61B2562/0271;;A61B5/6807;;A61B5/7246;;A61B5/725;;A61B5/0077;;A61B5/7253;;A61B5/7203;;G16H40/63;;G16H50/30;;G16H50/20;;G16H30/40;;A43B3/34;;A61B5/015;;A61B5/0075;;A61B5/447;;A61B5/6802;;A61B5/7282;;A61B2576/02,A61B5/01;;A61B5/00;;A61B5/103,,1,1,054-450-884-182-038,10.1117/12.2001807,"CHANJUAN LIU ET AL: ""Infrared Dermal Thermography on Diabetic Feet Soles to Predict Ulcerations:a Case Study"", 《ADVANCED BIOMEDICAL AND CLINICAL DIAGNOSTIC SYSTEMS XI》",DISCONTINUED
349,US,B2,US 9326723 B2,122-362-000-689-015,2016-05-03,2016,US 201514662738 A,2015-03-19,US 201514662738 A;;US 201313799828 A;;US 201461968696 P;;US 201261618889 P,2012-04-02,Method and apparatus of monitoring foot inflammation,"A method and apparatus for evaluating foot inflammation each uses at least one temperature detection modality to form a first thermogram and a second thermogram of the sole of at least one foot. Each thermogram forms a substantially continuous set of two-dimensional temperature values across the sole of the (at least one) foot. The thermograms have features; namely, the first thermogram has first features and the second thermogram has second features. The method and apparatus thus control a device to apply at least one transformation to the first and second thermograms to align the first features with corresponding second features, and determine, at any thermogram location, if at least one of the thermograms presents one of a plurality of patterns indicative of inflammation. Finally, the method and apparatus each produce output information indicating the result of the determination of whether the thermograms present one of the plurality of patterns.",PODIMETRICS INC,PETERSEN BRIAN;;BLOOM JONATHAN DAVID;;LINDERS DAVID ROBERT;;ENGLER JEFFREY MARK,PODIMETRICS INC (2015-04-03),https://lens.org/122-362-000-689-015,Granted Patent,yes,77,9,29,40,0,A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/0075;;A61B5/0077;;A61B5/445;;A61B5/6807;;A61B5/706;;A61B5/7282;;A61B5/7425;;A61B2576/02;;A61B5/6892,A61B5/00;;A61B5/01,,21,12,011-960-216-107-569;;007-838-305-831-66X;;068-143-875-175-23X;;024-859-176-557-439;;141-122-278-757-410;;006-812-101-420-47X;;046-674-946-125-024;;025-202-460-116-235;;001-294-432-545-630;;011-960-216-107-569;;098-193-165-103-972;;036-248-133-890-891,10.1088/0143-0815/9/2/006;;3391016;;10.1002/dmrr.2231;;22271717;;10.2337/diacare.25.6.1066;;12032116;;19162769;;10.1109/iembs.2008.4649266;;21198163;;10.1117/1.3524233;;10.1586/erd.10.35;;20822392;;10.1117/1.jbo.18.12.126004;;24337494;;10.1117/1.jbo.20.2.026003;;25671671;;11442293;;10.1109/10.930906;;10.1088/0143-0815/9/2/006;;3391016;;pmc3876354;;10.1177/193229681300700504;;24124937;;25098361;;10.1089/dia.2014.0052,"Tamura et al., ""A bed temperature monitoring system for assessing body movement during sleep,"" Clin. Phys. Physiol. Meas., 1988, vol. 9, No. 2, 139-145.;;European Patent Office, Supplementary European Search Report-Application No. EP 13 77 2800, dated Jun. 26, 2015, 7 pages.;;International Searching Authority, International Search Report-International Application No. PCT/US2015/021568, dated Aug. 13, 2015, together with the Written Opinion of the International Searching Authority, 15 pages.;;Bharara, M, Bharara, M-PI-Technology Summary, 5 pages, undated.;;Bharara et al., ""Coming events cast their shadows before: detecting inflammation in the acute diabetic foot and the foot in remission,"" Diabetes/Metabolism Research and Reviews, vol. 28, pp. 15-20, 2012.;;Brioschi et al., ""Automated Computer Diagnosis of IR Medical Imaging,"" FLIR Technical Series, Application Note for Research & Science, FLIR Systems, Inc., 6 pages, 2011.;;Caselli, M.D. et al., ""The Forefoot-to-Rearfoot Plantar Pressure Ratio Is Increased in Severe Diabetic Neuropathy and Can Predict Foot Ulceration,"" Diabetes Care, vol. 25, No. 6, pp. 1066-1071, Jun. 2002.;;Chen et al., ""Development of a Thermal and Hyperspectral Imaging System for Wound Characterization and Metabolic Correlation,"" John Hopkins Apl Technical Digest, vol. 26, No. 1, pp. 67-74, 2005.;;Dabiri et al., ""Electronic Orthotics Shoe: Preventing Ulceration in Diabetics Patients,"" 30th Annual International IEEE EMBS Conference, pp. 771-774, Aug. 2008.;;Kaabouch et al., ""Predicting neuropathic ulceration: analysis of static temperature distributions in thermal images,"" Journal of Biomedical Optics, vol. 15, No. 6, pp. 061715-1-061715-6, 2010.;;Kerstin Roback, ""An overview of temperature monitoring devices for early detection of diabetic foot disorders,"" Linkoping University Post Print, 18 pages, undated.;;Liu et al., ""Infrared Dermal Thermography on Diabetic Feet Soles to Predict Ulcerations: a Case Study,"" Proc. of SPIE, vol. 8572, pp. 85720N-1-85720N-9, 2013.;;Liu et al., ""Statistical analysis of spectral data: a methodology for designing an intelligent monitoring system for the diabetic foot,"" Predicting neuropathic ulceration: analysis of static temperature distributions in thermal images, Journal of Biomedical Optics, vol. 18(12), pp. 126004-1-126004-11, Dec. 2013.;;Liu et al., ""Automatic detection of diabetic foot complications with infrared thermography by asymmetric analysis,"" Journal of Biomedical Optics, vol. 20(2), pp. 026003-1-026003-10, Feb. 2015.;;Medgadget.com, ""TempTouch for Foot Ulcer Detection,"" Xilas, Inc., 2 pages, Apr. 19, 2005.;;Morley et al., ""In-Shoe Multisensory Data Acquisition System,"" IEEE Transactions on Biomedical Engineering, vol. 48, No. 7, pp. 815-820, Jul. 2001.;;Tamura et al., ""A bed temperature monitoring system for assessing body movement during sleep,"" Clin. Phys. Physiol. Meas., 1988, vol. 9, No. 2, pp. 139-145.;;van Netten et al., ""Infrared Thermal Imaging for Automated Detection of Diabetic Foot Complications,"" Journal of Diabetes Science and Technology, vol. 7, Issue 5, pp. 1122-1129, Sep. 2013.;;van Neeten et al., ""Diagnostic Values for Skin Temperature Assessment to Detect Diabetes-Related Foot Complications,"" Diabetes Technology & Therapeutics, vol. 16, No. 11, pp. 714-721, Nov. 11, 2014.;;Visual Footcare Technologies, LLC, ""TempStat,"" Visual Footcare Technologies, LLC, Thermal Imaging Device, One unit: $125, 1 page, undated.;;Korean Intellectual Property Office, International Search Report-International Application No. PCT/US2013/030997, dated Jul. 8, 2013, together with the Written Opinion of the International Searching Authority, 13 pages.",ACTIVE
350,US,A1,US 2022/0211277 A1,136-541-096-878-989,2022-07-07,2022,US 202217703785 A,2022-03-24,US 202217703785 A;;US 201615144658 A;;US 201514662738 A;;US 201313799828 A;;US 201461968696 P;;US 201261618889 P,2012-04-02,METHOD AND APPARATUS OF MONITORING FOOT INFLAMMATION,"A method and apparatus for evaluating emergence of an ulcer each uses at least one temperature detection modality to form a first thermogram and a second thermogram of the sole of at least one foot. Each thermogram forms a substantially continuous set of two-dimensional temperature values across the sole of the (at least one) foot. The thermograms have features; namely, the first thermogram has first features and the second thermogram has second features. The method and apparatus thus control a device to apply at least one transformation to the first and second thermograms to align the first features with corresponding second features, and determine, at any thermogram location, if at least one of the thermograms presents one of a plurality of patterns indicative of inflammation. Finally, the method and apparatus each produce output information indicating the result of the determination of whether the thermograms present one of the plurality of patterns.",PODIMETRICS INC,PETERSEN BRIAN;;BLOOM JONATHAN DAVID;;LINDERS DAVID ROBERT;;ENGLER JEFFREY MARK,,https://lens.org/136-541-096-878-989,Patent Application,yes,5,1,1,40,0,A43B3/34;;A61B5/01;;A61B5/447;;A61B5/6892;;A61B2562/0271;;A61B2576/02;;G16H30/40;;G16H50/20;;G16H50/30;;G16H40/63;;A61B5/445;;A61B5/103;;A61B5/0022;;A61B5/7275;;A61B5/0008;;A61B5/6892;;A61B5/6829;;A61B5/4887;;A61B2562/0271;;A61B5/6807;;A61B5/7246;;A61B5/725;;A61B5/0077;;A61B5/7253;;A61B5/7203;;G16H40/63;;G16H50/30;;G16H50/20;;G16H30/40;;A43B3/34;;A61B5/015;;A61B5/0075;;A61B5/447;;A61B5/6802;;A61B5/7282;;A61B2576/02,A43B3/34;;A61B5/01;;A61B5/00;;G16H30/40;;G16H40/63;;G16H50/20;;G16H50/30,,0,0,,,,PENDING
351,US,B2,US 11304608 B2,067-717-709-086-008,2022-04-19,2022,US 201615144658 A,2016-05-02,US 201615144658 A;;US 201514662738 A;;US 201313799828 A;;US 201461968696 P,2013-03-13,Method and apparatus of monitoring foot inflammation,"A method and apparatus for evaluating foot inflammation each uses at least one temperature detection modality to form a first thermogram and a second thermogram of the sole of at least one foot. Each thermogram forms a substantially continuous set of two-dimensional temperature values across the sole of the (at least one) foot. The thermograms have features; namely, the first thermogram has first features and the second thermogram has second features. The method and apparatus thus control a device to apply at least one transformation to the first and second thermograms to align the first features with corresponding second features, and determine, at any thermogram location, if at least one of the thermograms presents one of a plurality of patterns indicative of inflammation. Finally, the method and apparatus each produce output information indicating the result of the determination of whether the thermograms present one of the plurality of patterns.",PODIMETRICS INC,PETERSEN BRIAN;;BLOOM JONATHAN DAVID;;LINDERS DAVID ROBERT;;ENGLER JEFFREY MARK,PODIMETRICS INC (2015-04-03),https://lens.org/067-717-709-086-008,Granted Patent,yes,88,1,10,40,0,A61B5/103;;A61B5/6829;;A61B5/6892;;A61B5/0008;;A61B5/0022;;A61B5/445;;A61B5/4887;;A61B5/7275;;A61B2562/0271;;A61B5/7203;;A61B5/7246;;A61B5/0077;;A61B5/6807;;A61B5/725;;A61B5/7253;;G16H50/30;;G16H30/40;;G16H40/63;;G16H50/20;;A61B5/0075;;A61B5/447;;A61B2576/02;;A61B5/015;;A43B3/34;;A61B5/445;;A61B5/103;;A61B5/0022;;A61B5/7275;;A61B5/0008;;A61B5/6892;;A61B5/6829;;A61B5/4887;;A61B2562/0271;;A61B5/6807;;A61B5/7246;;A61B5/725;;A61B5/0077;;A61B5/7253;;A61B5/7203;;G16H40/63;;G16H50/30;;G16H50/20;;G16H30/40;;A43B3/34;;A61B5/015;;A61B5/0075;;A61B5/447;;A61B5/6802;;A61B5/7282;;A61B2576/02,A61B5/01;;A43B3/00;;A61B5/00;;A61B5/103;;G16H30/40;;G16H40/63;;G16H50/20;;G16H50/30,,25,13,007-838-305-831-66X;;068-143-875-175-23X;;024-859-176-557-439;;141-122-278-757-410;;046-674-946-125-024;;001-294-432-545-630;;006-812-101-420-47X;;098-193-165-103-972;;085-854-205-805-543;;069-929-432-816-633;;139-091-359-267-244;;025-202-460-116-235;;054-450-884-182-038,10.1002/dmrr.2231;;22271717;;10.2337/diacare.25.6.1066;;12032116;;19162769;;10.1109/iembs.2008.4649266;;21198163;;10.1117/1.3524233;;10.1117/1.jbo.18.12.126004;;24337494;;11442293;;10.1109/10.930906;;10.1586/erd.10.35;;20822392;;pmc3876354;;10.1177/193229681300700504;;24124937;;10.1109/iembs.2001.1017387;;9239625;;10.2337/dc16-2294;;28465454;;10.1117/1.jbo.20.2.026003;;25671671;;10.1117/12.2001807,"Bharara, Bharara, M-PI-Technology Summary, 5 pages, undated.;;Bharara et al., “Coming events cast their shadows before: detecting inflammation in the acute diabetic foot and the foot in remission,” Diabetes/Metabolism Research and Reviews, vol. 28, pp. 15-20, 2012.;;Brioschi et al., “Automated Computer Diagnosis of IR Medical Imaging,” FLIR Technical Series, Application Note for Research & Science, FLIR Systems, Inc., 2011.;;Caselli et al., “The Forefoot-to-Rearfoot Plantar Pressure Ratio Is Increased in Severe Diabetic Neuropathy and Can Predict Foot Ulceration,” Diabetes Care, vol. 25, No. 6, pp. 1066-1071, Jun. 2002.;;Chen et al., “Development of a Thermal and Hyperspectral Imaging System for Wound Characterization and Metabolic Correlation,” John Hopkins Apl Technical Digest, vol. 26, No. 1, pp. 67-74, 2005.;;Dabiri et al., “Electronic Orthotics Shoe: Preventing Ulceration in Diabetics Patients,” 30th Annual International IEEE EMBS Conference, pp. 771-774, Aug. 2008.;;Kaabouch et al., “Predicting neuropathic ulceration: analysis of static temperature distributions in thermal images,” Journal of Biomedical Optics, vol. 15, No. 6, pp. 061715-1-061715-6, Nov./Dec. 2010.;;Liu et al., “Infrared Dermal Thermography on Diabetic Feet Soles to Predict Ulcerations: a Case Study,” Proceedings of SPIE, vol. 8572, pp. 85720N-1-85720N-9, 2013.;;Liu et al., “Statistical analysis of spectral data: a methodology for designing an intelligent monitoring system for the diabetic foot,” Journal of Biomedical Optics, vol. 18, No. 12, pp. 126004-1-126004-11, Dec. 2013.;;Medgadget.com, “TempTouch for Foot Ulcer Detection,” Xilas, Inc., 2 pages, Apr. 19, 2005.;;Morley et al., “In-Shoe Multisensory Data Acquisition System,” IEEE Transactions on Biomedical Engineering, vol. 48, No. 7, pp. 815-820, Jul. 2001.;;Roback, “An overview of temperature monitoring devices for early detection of diabetic foot disorders,” Linkoping University Post Print, 18 pages, undated.;;Van Netten et al., “Infrared Thermal Imaging for Automated Detection of Diabetic Foot Complications,” Journal of Diabetes Science and Technology, vol. 7, No. 5, pp. 1122-1129, Sep. 2013.;;Visual Footcare Technologies, LLC, “TempStat,” Visual Footcare Technologies, LLC, Thermal Imagine Device, One unit: $125, 2 pages, undated.;;Korean Intellectual Property Office, International Search Report—International Application No. PCT/US2013/030997, dated Jul. 8, 2013, together with the Written Opinion of the International Searching Authority, 13 pages.;;European Patent Office, Supplementary European Search Report—Application No. EP 13 77 2800, dated Jun. 26, 2015, 7 pages.;;Ammer et al., Thermal Imaging of Skin Changes on the Feet of Type II Diabetics, 2001 Conference Proceedings of the 23rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Istanbul, Turkey, Oct. 25-28, 2001, 4 pages.;;Armstrong et al., Monitoring Healing of Acute Charcot's Arthropathy with Infrared Dermal Thermometry, Journal of Rehabilitation Research and Development, vol. 34, No. 3, pp. 317-321, Jul. 1997.;;Frykberg et al., Feasibility and Efficacy of a Smart Mat Technology to Predict Development of Diabetic Plantar Ulcers, Diabetes Care, vol. 40, pp. 973-980, Jul. 2017.;;European Patent Office, Notice of Opposition to a European Patent—European Patent No. 2833783B1, dated May 31, 2018, 8 pages.;;Japanese Patent Office, Decision of Refusal, Appl. No. 2016-558325, dated Sep. 2, 2019, 10 pages, together with English translation.;;Chinese National Intellectual Property Administration, Office Action, Appl. No. 201580015377.7, dated Jan. 8, 2019, 9 pages.;;Chinese National Intellectual Property Administration, Office Action, Appl. No. 201580015377.7, dated Aug. 16, 2019, 9 pages.;;Liu C., et al., “Automatic detection of diabetic foot complications with infrared thermography by asymmetric anlysis,” Journal of Biomedical Optics, vol. 20(2), (Feb. 2015), pp. 026003-1-026003-10 [11 pages].;;Liu C., et al., “Infrared Dermal Thermography on Diabetic Feet Soles to Predict Ulcerations: a Case Study,” Advanced Biomedical and Clinical Diagnostic System XI, vol. 8572, 85720N, downloaded from http://proceedings.spiedigitallibrary.org/ on Jul. 8, 2013 [9 pages].",ACTIVE
352,US,A1,US 2016/0256056 A1,183-719-787-990-478,2016-09-08,2016,US 201615144658 A,2016-05-02,US 201615144658 A;;US 201514662738 A;;US 201313799828 A;;US 201461968696 P,2013-03-13,Method and Apparatus of Monitoring Foot Inflammation,"A method and apparatus for evaluating foot inflammation each uses at least one temperature detection modality to form a first thermogram and a second thermogram of the sole of at least one foot. Each thermogram forms a substantially continuous set of two-dimensional temperature values across the sole of the (at least one) foot. The thermograms have features; namely, the first thermogram has first features and the second thermogram has second features. The method and apparatus thus control a device to apply at least one transformation to the first and second thermograms to align the first features with corresponding second features, and determine, at any thermogram location, if at least one of the thermograms presents one of a plurality of patterns indicative of inflammation. Finally, the method and apparatus each produce output information indicating the result of the determination of whether the thermograms present one of the plurality of patterns.",PODIMETRICS INC,PETERSEN BRIAN;;BLOOM JONATHAN DAVID;;LINDERS DAVID ROBERT;;ENGLER JEFFREY MARK,PODIMETRICS INC (2015-04-03),https://lens.org/183-719-787-990-478,Patent Application,yes,12,16,10,40,0,A61B5/103;;A61B5/6829;;A61B5/6892;;A61B5/0008;;A61B5/0022;;A61B5/445;;A61B5/4887;;A61B5/7275;;A61B2562/0271;;A61B5/7203;;A61B5/7246;;A61B5/0077;;A61B5/6807;;A61B5/725;;A61B5/7253;;G16H50/30;;G16H30/40;;G16H40/63;;G16H50/20;;A61B5/0075;;A61B5/447;;A61B2576/02;;A61B5/015;;A43B3/34;;A61B5/445;;A61B5/103;;A61B5/0022;;A61B5/7275;;A61B5/0008;;A61B5/6892;;A61B5/6829;;A61B5/4887;;A61B2562/0271;;A61B5/6807;;A61B5/7246;;A61B5/725;;A61B5/0077;;A61B5/7253;;A61B5/7203;;G16H40/63;;G16H50/30;;G16H50/20;;G16H30/40;;A43B3/34;;A61B5/015;;A61B5/0075;;A61B5/447;;A61B5/6802;;A61B5/7282;;A61B2576/02,A61B5/01;;A61B5/00,,0,0,,,,ACTIVE
353,US,A1,US 2015/0190059 A1,121-914-000-158-421,2015-07-09,2015,US 201514662738 A,2015-03-19,US 201514662738 A;;US 201313799828 A;;US 201461968696 P;;US 201261618889 P,2012-04-02,Method and Apparatus of Monitoring Foot Inflammation,"A method and apparatus for evaluating foot inflammation each uses at least one temperature detection modality to form a first thermogram and a second thermogram of the sole of at least one foot. Each thermogram forms a substantially continuous set of two-dimensional temperature values across the sole of the (at least one) foot. The thermograms have features; namely, the first thermogram has first features and the second thermogram has second features. The method and apparatus thus control a device to apply at least one transformation to the first and second thermograms to align the first features with corresponding second features, and determine, at any thermogram location, if at least one of the thermograms presents one of a plurality of patterns indicative of inflammation. Finally, the method and apparatus each produce output information indicating the result of the determination of whether the thermograms present one of the plurality of patterns.",PODIMETRICS INC,PETERSEN BRIAN;;BLOOM JONATHAN DAVID;;LINDERS DAVID ROBERT;;ENGLER JEFFREY MARK,PODIMETRICS INC (2015-04-03),https://lens.org/121-914-000-158-421,Patent Application,yes,0,24,29,40,0,A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/0075;;A61B5/0077;;A61B5/445;;A61B5/6807;;A61B5/706;;A61B5/7282;;A61B5/7425;;A61B2576/02;;A61B5/6892,A61B5/01;;A61B5/00,,0,0,,,,ACTIVE
354,CA,A1,CA 2943381 A1,060-642-009-778-355,2015-09-24,2015,CA 2943381 A,2015-03-19,US 201461968696 P;;US 2015/0021568 W,2014-03-21,METHOD AND APPARATUS OF MONITORING FOOT INFLAMMATION,"A method and apparatus for evaluating foot inflammation each uses at least one temperature detection modality to form a first thermogram and a second thermogram of the sole of at least one foot. Each thermogram forms a substantially continuous set of two-dimensional temperature values across the sole of the (at least one) foot. The thermograms have features; namely, the first thermogram has first features and the second thermogram has second features. The method and apparatus thus control a device to apply at least one transformation to the first and second thermograms to align the first features with corresponding second features, and determine, at any thermogram location, if at least one of the thermograms presents one of a plurality of patterns indicative of inflammation. Finally, the method and apparatus each produce output information indicating the result of the determination of whether the thermograms present one of the plurality of patterns.",PODIMETRICS INC,PETERSEN BRIAN;;BLOOM JONATHAN DAVID;;LINDERS DAVID ROBERT;;ENGLER JEFFREY MARK,,https://lens.org/060-642-009-778-355,Patent Application,no,0,0,10,40,0,A61B5/103;;A61B5/6829;;A61B5/6892;;A61B5/0008;;A61B5/0022;;A61B5/445;;A61B5/4887;;A61B5/7275;;A61B2562/0271;;A61B5/7203;;A61B5/7246;;A61B5/0077;;A61B5/6807;;A61B5/725;;A61B5/7253;;G16H50/30;;G16H30/40;;G16H40/63;;G16H50/20;;A61B5/0075;;A61B5/447;;A61B2576/02;;A61B5/015;;A43B3/34;;A61B5/445;;A61B5/103;;A61B5/0022;;A61B5/7275;;A61B5/0008;;A61B5/6892;;A61B5/6829;;A61B5/4887;;A61B2562/0271;;A61B5/6807;;A61B5/7246;;A61B5/725;;A61B5/0077;;A61B5/7253;;A61B5/7203;;G16H40/63;;G16H50/30;;G16H50/20;;G16H30/40;;A43B3/34;;A61B5/015;;A61B5/0075;;A61B5/447;;A61B5/6802;;A61B5/7282;;A61B2576/02,A61B5/01;;A61B5/00;;A61B5/103,,0,0,,,,PENDING
355,CA,C,CA 2943381 C,109-362-238-060-224,2023-10-03,2023,CA 2943381 A,2015-03-19,US 201461968696 P;;US 2015/0021568 W,2014-03-21,METHOD AND APPARATUS OF MONITORING FOOT INFLAMMATION,"A method and apparatus for evaluating foot inflammation each uses at least one temperature detection modality to form a first thermogram and a second thermogram of the sole of at least one foot. Each thermogram forms a substantially continuous set of two-dimensional temperature values across the sole of the (at least one) foot. The thermograms have features; namely, the first thermogram has first features and the second thermogram has second features. The method and apparatus thus control a device to apply at least one transformation to the first and second thermograms to align the first features with corresponding second features, and determine, at any thermogram location, if at least one of the thermograms presents one of a plurality of patterns indicative of inflammation. Finally, the method and apparatus each produce output information indicating the result of the determination of whether the thermograms present one of the plurality of patterns.",PODIMETRICS INC,PETERSEN BRIAN;;BLOOM JONATHAN DAVID;;LINDERS DAVID ROBERT;;ENGLER JEFFREY MARK,,https://lens.org/109-362-238-060-224,Granted Patent,no,0,0,10,40,0,A61B5/103;;A61B5/6829;;A61B5/6892;;A61B5/0008;;A61B5/0022;;A61B5/445;;A61B5/4887;;A61B5/7275;;A61B2562/0271;;A61B5/7203;;A61B5/7246;;A61B5/0077;;A61B5/6807;;A61B5/725;;A61B5/7253;;G16H50/30;;G16H30/40;;G16H40/63;;G16H50/20;;A61B5/0075;;A61B5/447;;A61B2576/02;;A61B5/015;;A43B3/34;;A61B5/445;;A61B5/103;;A61B5/0022;;A61B5/7275;;A61B5/0008;;A61B5/6892;;A61B5/6829;;A61B5/4887;;A61B2562/0271;;A61B5/6807;;A61B5/7246;;A61B5/725;;A61B5/0077;;A61B5/7253;;A61B5/7203;;G16H40/63;;G16H50/30;;G16H50/20;;G16H30/40;;A43B3/34;;A61B5/015;;A61B5/0075;;A61B5/447;;A61B5/6802;;A61B5/7282;;A61B2576/02,A61B5/01;;A61B5/00;;A61B5/103,,0,0,,,,PENDING
356,WO,A1,WO 2001/014223 A1,057-721-067-631-009,2001-03-01,2001,US 0040558 W,2000-08-03,US 37867599 A,1999-08-20,CONTAINER FOR A LIQUID MATERIAL,"A container (10) for a liquid material, such as paint or paint related material, is disclosed having a cylindrical metal can (12) with a closed bottom wall and an open top. The can furthermore has a predetermined inside diameter. A cylindrical plastic bottle (24) has a threaded opening at its top which is selectively closed by a threaded plastic cap (32). The bottle and cap are dimensioned so that, with the cap secured to the bottle, the bottle and cap are insertable into and completely nested within the can. A circular metal lid (36) is dimensioned to overlie and cover the open top of the can and, in doing so, be frictionally secured to the can.",PRC DESOTO INT INC,BLOOM WILLIAM H;;GAMPLE JOHN W;;RICHARDSON DAVID G,,https://lens.org/057-721-067-631-009,Patent Application,yes,3,0,2,2,0,B65D77/0486;;B65D85/84,B65D77/04;;B65D85/84,,0,0,,,,PENDING
357,US,B1,US 6863833 B1,087-322-049-494-880,2005-03-08,2005,US 17733002 A,2002-06-21,US 17733002 A;;US 30197201 P,2001-06-29,Microfabricated apertures for supporting bilayer lipid membranes,"The invention provides microfabricated silicon substrates and devices having extremely small apertures (termed “nanoapertures”) and methods for producing such nanoapertures. The devices have a nanoaperture (which may have a diameter ranging from about a few millimeters to as small as a few nm) across a substrate effective to connect two regions separated by the substrate. The devices are suitable for the formation of lipid bilayer membranes across the apertures, and for use in devices such as biosensors. Substrates and devices may include multiple nanoapertures, which may each support a lipid bilayer membrane, allowing fault tolerant devices such as fault-tolerant biosensors, and allowing devices able to sense more than one target molecule.",UNIV LELAND STANFORD JUNIOR,BLOOM DAVID M;;PETERMAN MARK C;;ZIEBARTH JONATHAN M,BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY THE (2002-09-09),https://lens.org/087-322-049-494-880,Granted Patent,yes,11,149,1,1,0,B81B1/004;;B81B2201/0214;;B81B2203/0353;;B81C1/00158;;G01N33/48721;;B81C1/00158;;B81B1/004;;B81B2203/0353;;G01N33/48721;;B81B2201/0214,B81B1/00;;B82B1/00;;B82B3/00,216/2;;216/39;;216/56;;216/57;;216/79;;216/99;;204/403.08;;204/516;;204/518;;436/71;;436/72;;427/2.23;;427/245,5,3,011-622-542-770-663;;064-107-022-415-103;;092-953-242-419-104,11102877;;10.1016/s1367-5931(00)00139-3;;11195496;;10.1021/ac000528m;;10.1109/5.649660,"60/268365.*;;60/240691.*;;Steven G. Boxer ""Molecular transport and organization in supported lipid membranes"" Model Systems pp. 704-709.;;Anette Stromberg et al. ""Microfluidic Device for Combinatorial Fusion of Liposomes and Cells"" Analytical Chemistry 73(1):126-130 (Jan.2001).;;Ming C. Wu ""Micromachining for Optical and Optoelectronic Systems"" Proceedings of the IEEE, 85(11):1833-1856 (Nov. 1997).",EXPIRED
358,KR,A,KR 20090063268 A,190-552-998-381-527,2009-06-17,2009,KR 20097008546 A,2006-10-24,US 2006/0041456 W,2006-10-24,ELEVATOR CROSS-DISPATCHING SYSTEM WITH INTER GROUP RELATIVE SYSTEM RESPONSE (IRSR) DISPATCHING,"During elevator modernization, a cross-dispatching system receives hall calls and assigns each hall call to either a group of existing elevator car controllers or a group of new elevator car controllers. The cross-dispatching system creates an inter group relative system response (iRSR) value for the hall call for both the existing group of elevators and the new group of elevators, based upon information from each group such as car location, in-service status, load, and direction. If the group assigned the hall call does not answer the call within a redispatch time period, the cross-dispatching system again calculates the iRSR for each group and reassigns the hall call.",OTIS ELEVATOR CO,HUGHES DAVID M;;BLOOM JERROLD C;;GRANT JOHN W,,https://lens.org/190-552-998-381-527,Patent Application,no,0,0,12,12,0,B66B1/2458;;B66B1/14;;B66B1/2458;;B66B1/2458;;B66B1/34;;B66B19/007;;B66B19/007;;B66B2201/102;;B66B2201/102;;B66B2201/211;;B66B2201/211;;B66B2201/233;;B66B2201/233,B66B1/14;;B66B1/34,,0,0,,,,INACTIVE
359,AU,A,AU 2000/075714 A,003-812-777-685-268,2001-03-05,2001,AU 2000/075714 A,2000-08-08,US 37271299 A;;US 0021665 W,1999-08-11,Single lens reflective fiber optic component geometry,,LIGHTCONNECT INC,THACKARA JOHN I;;GODIL ASIF A;;BLOOM DAVID M,,https://lens.org/003-812-777-685-268,Patent Application,no,0,0,2,23,0,G02B26/0808;;G02B26/0808;;H01S5/005;;H01S5/005,G02B6/35;;G02B26/08;;H01S5/00,,0,0,,,,DISCONTINUED
360,GB,B,GB 2454444 B,012-147-218-192-714,2011-11-02,2011,GB 0904701 A,2006-10-24,US 2006/0041456 W,2006-10-24,Elevator cross-dispatching system with inter group relative system response (IRSR) dispatching,,OTIS ELEVATOR CO,GRANT JOHN W;;HUGHES DAVID M;;BLOOM JERROLD C,,https://lens.org/012-147-218-192-714,Granted Patent,no,7,0,12,12,0,B66B1/2458;;B66B1/14;;B66B1/2458;;B66B1/2458;;B66B1/34;;B66B19/007;;B66B19/007;;B66B2201/102;;B66B2201/102;;B66B2201/211;;B66B2201/211;;B66B2201/233;;B66B2201/233,B66B1/24,,0,0,,,,ACTIVE
361,EP,A4,EP 3537957 A4,084-977-895-810-385,2020-08-12,2020,EP 17869671 A,2017-11-02,US 201615349667 A;;US 2017/0059674 W,2016-11-11,ULCER DETECTION APPARATUS AND METHOD WITH VARYING THRESHOLDS,,PODIMETRICS INC,LINDERS DAVID R;;PETERSEN BRIAN J;;BLOOM JONATHAN D,,https://lens.org/084-977-895-810-385,Search Report,no,4,0,7,7,0,A61B5/6829;;A61B5/015;;A61B5/445;;A61B5/447;;A61B5/6892;;A61B5/6829;;A61B5/015;;A61B5/445;;A61B5/447;;A61B5/6892,A61B5/00;;A61B5/01;;G08B23/00,,3,1,025-202-460-116-235,10.1117/1.jbo.20.2.026003;;25671671,"LIU CHANJUAN ET AL: ""Automatic detection of diabetic foot complications with infrared thermography by asymmetric analysis"", JOURNAL OF BIOMEDICAL OPTICS, SPIE, vol. 20, no. 2, 1 February 2015 (2015-02-01), pages 26003, XP060053732, ISSN: 1083-3668, [retrieved on 20150211], DOI: 10.1117/1.JBO.20.2.026003;;CHANJUAN LIU ET AL: ""Infrared dermal thermography on diabetic feet soles to predict ulcerations: a case study"", PROCEEDINGS OF SPIE/ IS & T, vol. 8572, 22 March 2013 (2013-03-22), US, pages 85720N, XP055227016, ISBN: 978-1-62841-730-2, DOI: 10.1117/12.2001807;;See also references of WO 2018089247A1",DISCONTINUED
362,EP,A2,EP 0468716 A2,092-605-281-179-86X,1992-01-29,1992,EP 91306628 A,1991-07-22,US 55804490 A,1990-07-26,Insulating heat retention system and method.,"An insulating heat re-radiation - retention and infiltration air free system and method is provided for processing heated articles, including upper and lower heat shields (24,26) to form, in combination with spaced apart rollers (22) employed to support the articles, a substantial infiltration air-free enclosure, each of the heat shields (24,26) are made-up of substantially high purity 100% ceramic fibre which is relatively non-porous and gap free and having fibre hot faces, the fibre of the heat shields (24,26) being compressed and maintained in a high density condition, the fibre of the lower heat shield (26) being formed to contact the circumferences of the rollers (22) in a manner to prevent air from passing into the enclosure, the upper and lower heat shields (24,26) being maintained in close proximity with the heated articles.",ALLEGHENY LUDLUM CORP,BURK DAVID LAWRENCE;;BLOOM WILLIAM MILLARD;;HAVRANEK TERENCE LOUIS,,https://lens.org/092-605-281-179-86X,Patent Application,yes,0,11,8,8,0,B21B45/00;;B21B45/008;;B21B45/008;;C21D9/0006;;C21D9/0006;;F27D1/0013;;F27D1/0013;;F27D1/06;;F27D1/06;;F27D1/144;;F27D1/144;;Y02P70/10;;Y02P70/10,B21B45/00;;C21D9/00;;F27D1/00;;F27D1/06;;F27D1/14,,0,0,,,,DISCONTINUED
363,AT,T1,AT E208048 T1,092-214-929-261-973,2001-11-15,2001,AT 93910831 T,1993-04-28,US 87607892 A;;US 9303939 W,1992-04-28,MODULATION EINES LICHTSTRAHLS,"A modulator for modulating incident rays of light, the modulator comprising a plurality of equally spaced apart beam elements, each of which includes a light reflective planar surface. The elements are arranged parallel to each other with their light reflective surfaces parallel to each other. The modulator includes means for supporting the beam elements in relation to one another and means for moving the beam elements relative to one another so that the beams move between a first configuration wherein the modulator acts to reflect the incident rays of light as a plane mirror, and a second configuration wherein the modulator diffracts the incident rays of light as they are reflected therefrom. In operation, the light reflective surfaces of the beam elements remain parallel to each other in both the first and the second configurations and the perpendicular spacing between the reflective surfaces of adjacent beam elements is equal to m/4 times the wavelength of the incident rays of light, wherein m=an even whole number or zero when the beam elements are in the first configuration and m=an odd number when the beam elements are in the second configuration.",UNIV LELAND STANFORD JUNIOR,BLOOM DAVID M;;SANDEJAS FRANCISCO S A;;SOLGAARD OLAV,,https://lens.org/092-214-929-261-973,Granted Patent,no,0,0,9,19,0,B81C2201/115;;G02B5/1828;;G02B26/0808;;B81B3/001;;Y10S359/90;;B81B3/001;;G02B5/1828;;B81C2201/115;;G02B26/0808;;Y10S359/90,B81B3/00;;G02B5/18;;G02B26/08,,0,0,,,,DISCONTINUED
364,US,A,US 5311360 A,090-395-150-760-333,1994-05-10,1994,US 87607892 A,1992-04-28,US 87607892 A;;US 9502963 W,1992-04-28,Method and apparatus for modulating a light beam,"A modulator for modulating an incident beam of light, the modulator comprising a plurality of equally spaced-apart elements, each of which includes a light-reflective planar surface. The elements are arranged parallel to each other with their light-reflective surfaces parallel to each other. The modulator includes means for supporting the elements in relation to one another and means for moving particular ones of the elements relative to others so that the moved elements transit between a first configuration wherein the modulator acts to reflect the incident beam of light as a plane mirror, and a second configuration wherein the modulator diffracts the light reflected therefrom. In operation the light-reflective surfaces of the elements remain parallel to each other in both the first and second configurations. The perpendicular spacing between the reflective surfaces of the respective elements is equal to m/4 .times. the wavelength of the incident beam of light, wherein m equals an even whole number or zero when the elements are in the first configuration and m equals an odd whole number when the elements are in the second configuration.",UNIV LELAND STANFORD JUNIOR,BLOOM DAVID M;;SANDEJAS FRANCISCO S A;;SOLGAARD OLAV,LELAND STANFORD JR. UNIVERSITY (1992-05-29),https://lens.org/090-395-150-760-333,Granted Patent,yes,2,804,6,19,0,B81C2201/115;;G02B5/1828;;G02B26/0808;;B81B3/001;;Y10S359/90;;B81B3/001;;G02B5/1828;;B81C2201/115;;G02B26/0808;;Y10S359/90,B81B3/00;;G02B5/18;;G02B26/08,359/572;;359/213;;359/224;;359/226;;359/855;;345/108;;348/203,3,3,009-286-199-765-581;;028-775-209-892-098;;009-365-280-210-861,10.1109/5.53402;;10.1117/12.19865;;10.1016/0141-9382(91)90032-9,"Neff, John A., et al.; Two Dimensional Spatial Light Modulators: A Tutorial ; Proceedings of the IEEE, vol. 78, No. 5 (May 1990), pp. 826 855.;;Gerhard Multhaupt, R. et al.; Viscoelastic Spatial Light Modulators and Schlieren Optical Systems for HDTV Projection Displays ; SPIE vol. 1255 Large Screen Projection Displays II (1990), pp. 69 78.;;Gerhard Multhaupt, R.; Light Valve Technologies for High Definition Television Projection Displays , Displays, vol. 12, No. 3/4 (1991), pp. 115 128.",EXPIRED
365,DE,D1,DE 69331056 D1,188-311-692-167-262,2001-12-06,2001,DE 69331056 T,1993-04-28,US 87607892 A;;US 9303939 W,1992-04-28,MODULATION EINES LICHTSTRAHLS,"A modulator for modulating incident rays of light, the modulator comprising a plurality of equally spaced apart beam elements, each of which includes a light reflective planar surface. The elements are arranged parallel to each other with their light reflective surfaces parallel to each other. The modulator includes means for supporting the beam elements in relation to one another and means for moving the beam elements relative to one another so that the beams move between a first configuration wherein the modulator acts to reflect the incident rays of light as a plane mirror, and a second configuration wherein the modulator diffracts the incident rays of light as they are reflected therefrom. In operation, the light reflective surfaces of the beam elements remain parallel to each other in both the first and the second configurations and the perpendicular spacing between the reflective surfaces of adjacent beam elements is equal to m/4 times the wavelength of the incident rays of light, wherein m=an even whole number or zero when the beam elements are in the first configuration and m=an odd number when the beam elements are in the second configuration.",UNIV LELAND STANFORD JUNIOR,BLOOM DAVID M;;SANDEJAS FRANCISCO S A;;SOLGAARD OLAV,,https://lens.org/188-311-692-167-262,Granted Patent,no,0,0,9,19,0,B81C2201/115;;G02B5/1828;;G02B26/0808;;B81B3/001;;Y10S359/90;;B81B3/001;;G02B5/1828;;B81C2201/115;;G02B26/0808;;Y10S359/90,B81B3/00;;G02B5/18;;G02B26/08,,0,0,,,,EXPIRED
366,DE,T2,DE 69331056 T2,187-507-088-815-399,2002-07-11,2002,DE 69331056 T,1993-04-28,US 87607892 A;;US 9303939 W,1992-04-28,MODULATION EINES LICHTSTRAHLS,"A modulator for modulating incident rays of light, the modulator comprising a plurality of equally spaced apart beam elements, each of which includes a light reflective planar surface. The elements are arranged parallel to each other with their light reflective surfaces parallel to each other. The modulator includes means for supporting the beam elements in relation to one another and means for moving the beam elements relative to one another so that the beams move between a first configuration wherein the modulator acts to reflect the incident rays of light as a plane mirror, and a second configuration wherein the modulator diffracts the incident rays of light as they are reflected therefrom. In operation, the light reflective surfaces of the beam elements remain parallel to each other in both the first and the second configurations and the perpendicular spacing between the reflective surfaces of adjacent beam elements is equal to m/4 times the wavelength of the incident rays of light, wherein m=an even whole number or zero when the beam elements are in the first configuration and m=an odd number when the beam elements are in the second configuration.",UNIV LELAND STANFORD JUNIOR,BLOOM DAVID M;;SANDEJAS FRANCISCO S A;;SOLGAARD OLAV,,https://lens.org/187-507-088-815-399,Granted Patent,no,0,0,9,19,0,B81C2201/115;;G02B5/1828;;G02B26/0808;;B81B3/001;;Y10S359/90;;B81B3/001;;G02B5/1828;;B81C2201/115;;G02B26/0808;;Y10S359/90,B81B3/00;;G02B5/18;;G02B26/08,,0,0,,,,EXPIRED
367,CA,A1,CA 2133335 A1,010-525-462-054-631,1993-11-11,1993,CA 2133335 A,1993-04-28,US 87607892 A;;US 9502963 W,1992-04-28,MODULATING A LIGHT BEAM,"2133335 9322694 PCTABS00027 A modulator (10) for modulating incident rays of light, the modulator having several equally spaced beam elements (18), each having a light reflective planar surface. The beam elements are arranged and supported (12) parallel to each other, with their reflective surfaces parallel. During operation, the elements remain parallel, but the modulator moves the beams so that the perpendicular spacing of their reflective surfaces changes between two configurations. In both configurations, the spacing equals m/4 times the wavelength of incident light. In the first configuration, m equals an even whole number or zero, and the modulator acts to reflect the incident rays of light as a plane mirror. In the second configuration, m equals an odd number and the modulator diffracts the incident rays as they are reflected.",UNIV LELAND STANFORD JUNIOR,BLOOM DAVID M;;SANDEJAS FRANCISCO S A;;SOLGAARD OLAV,,https://lens.org/010-525-462-054-631,Patent Application,no,0,0,6,19,0,B81C2201/115;;G02B5/1828;;G02B26/0808;;B81B3/001;;Y10S359/90;;B81B3/001;;G02B5/1828;;B81C2201/115;;G02B26/0808;;Y10S359/90,B81B3/00;;G02B5/18;;G02B26/08,,0,0,,,,EXPIRED
368,EP,A1,EP 2240162 A1,073-244-217-810-434,2010-10-20,2010,EP 08857189 A,2008-12-05,US 2008/0013434 W;;US 99280407 P,2007-12-06,NANOPARTICLES COMPRISING A NON-IONIZABLE POLYMER AND AN AMINE-FUNCTIONALIZED METHACRYLATE COPOLYMER,,BEND RES INC;;BLOOM COREY J;;CREW MARSHALL DAVID;;MILLER WARREN KENYON,BLOOM COREY J;;CREW MARSHALL DAVID;;MILLER WARREN KENYON,,https://lens.org/073-244-217-810-434,Patent Application,yes,0,0,5,5,0,A61K9/5138;;A61K9/5138;;A61K9/0048;;A61K9/0048;;A61K9/10;;A61K9/10;;A61K9/19;;A61K9/19;;A61K9/5161;;A61K9/5161;;A61K9/5192;;A61K9/5192,A61K9/51;;A61K9/10;;A61K9/14;;A61K9/19,,0,0,,,,DISCONTINUED
369,TW,B,TW 432398 B,078-861-753-887-107,2001-05-01,2001,TW 88113090 A,1999-07-31,US 13208198 A,1998-08-10,Low cross talk ball grid array resistor network,A resistor network for terminating active electronic devices has low cross talk noise between the adjoining resistors and the conductors that connect the resistors to other electronic packages. A substrate has a top and a bottom surface. Resistors are located on the top surface. Conductors are also located on the top surface and are electrically connected to each end of the resistors. Vias extend through the substrate and electrically connect to the conductors. Solder spheres are positioned on the bottom surface and are electrically connected to the vias. An end of each of the resistors is electrically connected in common through a common conductor. The commoned resistors are electrically connected to a common via through the common conductor. The resistor network minimizes cross talk noise between the resistors and provides a high density interconnection.,CTS CORP,BLOOM TERRY R;;COOPER RICHARD O;;POOLE DAVID L,,https://lens.org/078-861-753-887-107,Granted Patent,no,0,0,10,10,0,H01C1/02;;H01C7/006;;H01C7/006;;H01C17/242;;H01C17/242;;H01L23/5386;;H01L23/5386;;H01L2924/0002;;H01L2924/0002;;H01L2924/15311;;H01L2924/15311;;H01L2924/3011;;H01L2924/3011,H01C13/02;;H01C1/02;;H01C7/00;;H01C17/242;;H01L23/538;;H01R12/00;;H03H7/24;;H03H7/38;;H05K1/02;;H05K1/11,,0,0,,,,EXPIRED
370,US,A1,US 2018/0132730 A1,089-203-281-249-688,2018-05-17,2018,US 201615349667 A,2016-11-11,US 201615349667 A,2016-11-11,Ulcer Detection Apparatus and Method with Varying Thresholds,"A method determines the emergence of an ulcer or a pre-ulcer on at least one foot of a patient provides one or more processors and a modality for receiving at least one foot. The method generates, using a plurality of temperature sensors, discrete temperature data values after receipt of the at last one foot. The plurality of discrete temperature data values represents temperatures at different locations of the at least one foot. Next, the method compares, using a prescribed function, each of the discrete temperature data values to one of a plurality of different predetermined values. The predetermined values are different for at least two different locations of the at least one foot. The method then produces output information indicating an emergence of an ulcer or a pre-ulcer on the at least one foot as a result of comparing.",PODIMETRICS INC,LINDERS DAVID R;;PETERSEN BRIAN J;;BLOOM JONATHAN D,PODIMETRICS INC (2016-12-02),https://lens.org/089-203-281-249-688,Patent Application,yes,4,6,7,7,0,A61B5/6829;;A61B5/015;;A61B5/445;;A61B5/447;;A61B5/6892;;A61B5/6829;;A61B5/015;;A61B5/445;;A61B5/447;;A61B5/6892,A61B5/01;;A61B5/00,,0,0,,,,DISCONTINUED
371,AU,A,AU 2000/076276 A,093-120-614-842-756,2001-03-19,2001,AU 2000/076276 A,2000-08-03,US 37867599 A;;US 0040558 W,1999-08-20,Container for a liquid material,,PRC DESOTO INT INC,BLOOM WILLIAM H;;GAMPLE JOHN W;;RICHARDSON DAVID G,,https://lens.org/093-120-614-842-756,Patent Application,no,0,0,2,2,0,B65D77/0486;;B65D85/84,B65D77/04;;B65D85/84,,0,0,,,,DISCONTINUED
372,US,B1,US 8365061 B1,150-786-549-818-317,2013-01-29,2013,US 201113287599 A,2011-11-02,US 201113287599 A,2011-11-02,Cross-origin communication in browser frames,"A device may create a child frame within a container frame displayed by a browser program. The child frame may be associated with an origin that is different than an origin associated with the container frame. The device may determine whether the child frame is locked to prohibit reading of information relating to the child frame. The determination of whether the child frame is locked including checking whether a first variable is present in the child frame. The device may determine one or more values relating to the child frame, where the one or more values are determined by checking whether a second set of variables is present in the child frame, where each variable, in the second set, corresponds to a single bit of the one or more values.",GOOGLE INC;;BLOOM DAVID;;SCHORR JOSEPH;;LISBAKKEN BEN;;SCUDDER JEFFREY W,BLOOM DAVID;;SCHORR JOSEPH;;LISBAKKEN BEN;;SCUDDER JEFFREY W,GOOGLE LLC (2011-10-05),https://lens.org/150-786-549-818-317,Granted Patent,yes,10,15,1,1,0,G06F16/958;;G06F16/958,G06F17/00,715/205;;715/234;;715/240,2,0,,,"Wikipedia, ""JSONP"", http://en.wikipedia.org/wiki/JSONP, Oct. 30, 2011, 4 pages.;;Mozilla Developer Network, ""window.postMessage"", https://developer.mozilla.org/en/DOM/window.postMessage Oct. 18, 2011, 7 pages.",ACTIVE
373,US,A1,US 2007/0151480 A1,150-896-548-737-950,2007-07-05,2007,US 70899807 A,2007-02-21,US 70899807 A;;US 42814603 A;;US 37680702 P;;US 40350502 P;;US 43441902 P,2002-05-02,Hydrogenated and partially hydrogenated heat-bodied oils and uses thereof,"The present disclosure presents materials comprising hydrogenated and/or partially hydrogenated polymerized vegetable oils. Non-limiting applications of the polymerized oils, including coatings, binders, blends, and greases are presented. Methods for forming these materials are also disclosed.",ARCHER DANIELS MIDLAND CO,BLOOM PAUL D;;FURCICH STEVEN J;;HOLZGRAEFE DAVID P,ARCHER-DANIELS-MIDLAND COMPANY (2007-02-16),https://lens.org/150-896-548-737-950,Patent Application,yes,26,58,4,18,0,C08F8/04;;C11C3/00;;C11C3/12;;C08F8/04;;C11C3/12;;C11C3/00,C08L91/00;;C08F8/04,106/220;;524/270;;524/313;;524/277;;106/222;;106/224;;106/229,0,0,,,,EXPIRED
374,US,A1,US 2020/0033947 A1,054-077-248-811-582,2020-01-30,2020,US 201816183610 A,2018-11-07,US 201816183610 A;;US 201862712100 P,2018-07-30,STYLUS WITH SHEAR FORCE FEEDBACK,"Touch-based input devices, such as a stylus, can provide feedback in the form of shear forces applied to the user. A stylus can produce shear forces that act on a user to provide unique tactile sensations. For example, a shear device can be included at a grip region of a stylus to provide shear sensations at the user's hands (e.g., fingers). The shear forces can be unaligned forces that urge one part of the user's hand in one direction and another part of the user's hand in an opposite direction or that tend to maintain the other part of the user's hand in a stationary location.",APPLE INC,BLOOM DAVID H;;JACKSON BENJAMIN G;;TAYLOR STEVEN J,APPLE INC (2018-11-01),https://lens.org/054-077-248-811-582,Patent Application,yes,6,3,6,6,0,G06F3/03545;;G06F3/016;;G06F3/0346;;G06F3/03545;;G06F3/016;;G06F3/03545;;G06F3/016,G06F3/01;;G06F3/0354,,0,0,,,,ACTIVE
375,EP,A1,EP 2201753 A1,074-644-767-221-254,2010-06-30,2010,EP 08833363 A,2008-09-24,US 2008/0077433 W;;US 99509407 P;;US 23577508 A,2007-09-24,TARGET ACQUISITION SYSTEM,,GLOBAL DEVICE MAN,HARRIS DAVID P;;CORMACK RANDALL WAYNE;;BLOOM JONATHAN G,,https://lens.org/074-644-767-221-254,Patent Application,yes,0,0,5,5,0,G06F3/0481;;G06F3/04845;;G06F2203/04806;;H04N5/2628;;G16H40/63;;G16Z99/00;;H04N5/2628;;G06F3/0481;;G06F2203/04806;;G06F3/04845;;G16H40/63;;G16Z99/00,G06F3/048;;G16Z99/00;;H04N5/44,,0,0,,,,DISCONTINUED
376,CN,A,CN 1056495 A,127-728-398-393-868,1991-11-27,1991,CN 91102965 A,1991-05-04,US 51919290 A,1990-05-04,"SUBSTITUTED 5-(2-(2-(2-ARYL-2 HYDROXYETHYL) AMINO) PROPYL)-1,3-BENZODIOXOLES","The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.",AMERICAN CYANAMID CO,BLOOM JONATHAN DAVID;;CLAUS THOMAS HARRISON;;DEVRIES VERN GORDON,,https://lens.org/127-728-398-393-868,Patent Application,no,0,0,40,44,0,C07D317/46;;C07D413/06;;A61P3/10;;A61P3/04;;A61P3/08;;C07D317/46;;C07D413/06;;C07D317/46,A23K1/16;;A61K31/335;;A61K31/357;;A61K31/36;;A61K31/42;;A61P3/04;;A61P3/08;;A61P3/10;;C07D263/04;;C07D291/04;;C07D317/46;;C07D317/58;;C07D317/62;;C07D405/06;;C07D413/06;;C07D419/06,,0,0,,,,EXPIRED
377,EP,A1,EP 3537957 A1,131-099-607-632-403,2019-09-18,2019,EP 17869671 A,2017-11-02,US 201615349667 A;;US 2017/0059674 W,2016-11-11,ULCER DETECTION APPARATUS AND METHOD WITH VARYING THRESHOLDS,,PODIMETRICS INC,LINDERS DAVID R;;PETERSEN BRIAN J;;BLOOM JONATHAN D,,https://lens.org/131-099-607-632-403,Patent Application,yes,0,0,7,7,0,A61B5/6829;;A61B5/015;;A61B5/445;;A61B5/447;;A61B5/6892;;A61B5/6829;;A61B5/015;;A61B5/445;;A61B5/447;;A61B5/6892,A61B5/00;;A61B5/01;;G08B23/00,,0,0,,,,DISCONTINUED
378,NO,D0,NO 975694 D0,133-787-484-678-410,1997-12-05,1997,NO 975694 A,1997-12-05,US 47375995 A;;US 9608803 W,1995-06-07,Lysfordoblende diffraksjonsgitter-samlesystem,"A reflective/diffractive light valve system collects light from multiple dimensions around a single light source. From these multiple collection dimensions, the light is directed to impinge on the valve from multiple directions. When the valve is configured to be reflective, the light returns to the source. On the other hand, when the valve is configured to be diffractive, light from a first and third order diffraction are transmitted from the valve for each of the collection dimensions which greatly enhances the efficiency of the system.",SILICON LIGHT MACHINES INC,STAKER BRYAN P;;BLOOM DAVID M;;LOUCKS BRYAN E,,https://lens.org/133-787-484-678-410,Patent Application,no,0,0,16,16,0,G02B26/0808;;G02B27/42;;H04N5/7458;;H04N9/31;;G02B19/0047;;G02B19/0028;;G02B27/10;;G02B26/0808;;H04N9/31;;G02B27/42;;H04N5/7458;;G02B19/0028;;G02B19/0047,G02B19/00;;G02B27/42;;G02B27/18;;G02B27/54;;H04N5/74;;H04N9/31,,0,0,,,,DISCONTINUED
379,US,A,US 6086034 A,197-986-460-179-16X,2000-07-11,2000,US 97822597 A,1997-11-25,US 97822597 A;;US 60826196 A,1996-02-28,Independently adjustable mouse pad,"A mouse pad support is mounted on a keyboard support that has a keyboard support arm attachable to a fixed structure such as the underside of a desk top, and a tiltable keyboard support platform thereon. A mouse pad support arm is coupled to the keyboard support arm via a rotational swivel fitting with a vertical axis for moving the mouse pad arm and mouse pad support table to any position around the keyboard in a circular arc in a horizontal plane. The height of the swivel fitting is adjustably fixed over a range. The mouse pad arm is kept in a horizontal plane because its rotational coupling to the keyboard support arm is made at an angularly fixed part on the keyboard support arm, such as on a parallelogram linkage associated with setting the elevation of the keyboard platform. The keyboard platform tilts relative to the angularly fixed part, whereby mouse position is independent of keyboard platform tilt. The mouse support arm is long enough for the mouse support table to clear the corners of the keyboard platform, but the mouse support table also is adjustably attached to the mouse pad support arm via an off-center rotational joint such that the spacing between the mouse pad and the keyboard can be adjusted by rotating the mouse support table. This off-center joint preferably employs a ball and socket universal joint with a friction adjustment, enabling an adjustable degree of tilt of the mouse pad support table as well.",KNOLL INC,MCALLISTER MICHAEL L;;BLOOM DAVID A;;LEE JEFFREY P,WESTINGHOUSE ELECTRIC CORPORATION (1996-02-19);;KNOLL INC (1996-03-21),https://lens.org/197-986-460-179-16X,Granted Patent,yes,31,47,2,2,0,A47B2021/0321;;A47B2021/0335;;A47B2021/0342;;A47B2200/009;;G06F3/0202;;G06F3/0395;;Y10S248/918;;G06F3/0395;;A47B2021/0342;;A47B2200/009;;G06F3/0202;;A47B2021/0321;;A47B2021/0335;;Y10S248/918,G06F3/02;;G06F3/039,248/278.1;;248/118;;248/346.01;;248/918,0,0,,,,EXPIRED
380,US,B2,US 6821769 B2,049-198-168-163-431,2004-11-23,2004,US 91895101 A,2001-07-31,US 91895101 A;;US 17734998 A,1998-10-23,"IniB, iniA and iniC genes of mycobacteria and methods of use","
    This invention relates to the identification, cloning, sequencing and characterization of the iniB, iniA and iniC genes of mycobacteria which are induced by a broad class of antibiotics that act by inhibiting cell wall biosynthesis, including the first line antituberculosis agents, isoniazid and ethambutol. The present invention provides purified and isolated iniB, iniA, iniC and iniB promoter nucleic acids which may comprise the iniBAC operon, as well as mutated forms of these nucleic acids. The present invention also provides one or more single-stranded nucleic acid probes which specifically hybridize to the iniB, iniA, iniC and iniB promoter nucleic acids, and mixtures thereof, which may be formulated in kits, and used in the diagnosis of drug-resistant mycobacterial strain. The present invention also provides methods for the screening and identification of drugs effective against Mycobacterium tuberculosis using induction of the iniB promoter. 
",EINSTEIN COLL MED,ALLAND DAVID;;BLOOM BARRY R;;JACOBS JR WILLIAM R,ALBERT EINSTEIN COLLEGE OF MEDICINE INC (2015-09-09),https://lens.org/049-198-168-163-431,Granted Patent,yes,0,11,3,3,14,A61K2039/53;;A61K2039/53;;C07K14/35;;C07K14/35;;C12N15/74;;C12N15/74;;Y02A50/30;;Y02A50/30;;Y10S435/863;;Y10S435/863;;Y10S435/864;;Y10S435/864;;Y10S435/865;;Y10S435/865;;Y10S435/866;;Y10S435/866,C07K14/35;;C12N15/74,435/253.1;;424/168.1;;424/248.1;;435/320.1;;435/863;;435/864;;435/865;;435/866;;536/23.1;;536/23.7;;536/24.32,11,11,028-862-168-091-90X;;007-260-063-128-542;;038-553-755-377-818;;033-100-816-282-684;;003-285-896-697-382;;030-977-446-496-934;;043-078-291-995-300;;005-232-753-884-184;;024-157-353-079-17X;;051-443-369-777-067;;108-966-894-946-534,10.1093/nar/25.17.3389;;9254694;;pmc146917;;pmc146371;;9016539;;10.1093/nar/25.1.217;;10.1126/science.8284673;;8284673;;10.1038/31159;;9634230;;10.1038/nbt0198-45;;9447592;;8807080;;10.1128/aac.40.7.1754;;pmc163413;;10.1016/0378-1119(93)90678-v;;7690337;;2481799;;10.1111/j.1365-2958.1989.tb00257.x;;10.1126/science.280.5369.1607;;9616124;;pmc186132;;10.1128/iai.62.2.476-483.1994;;7507894;;7507252;;10.1073/pnas.91.2.639;;pmc43004,"Altschul et al., Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids REs., 25:3389-3402, 1997.;;Bairoch et al., The Prosite database, its status in 1997. Nucleic Acids Res., 25:217-221, 1997.;;Banerjee et al., inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tubreculosis. Science, 263:227-230, 1994.;;Cole et al., Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence, Nature, 393:537-544, 1998.;;de Saizieu et al., Bacterial transcript imaging by hybridization of total RNA to olignucleotide arrays. Nature Biotech., 16:45-48, 1998.;;Garbe et al., Isoniazid induced expression of the antigen 85 complex in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy, 40:1754-1756, 1996.;;Kinger and Tyagi, Identification and Cloning of genes differentially expressed in the virulent strain of Mycobacterium tuberculosis. Gene, 131:113-117, 1993.;;Mathiopoulos and Sonenshein, Identification of Bacillus subtilis expressed early during sporulation. Mol. Microbiol., 3:1071-1081, 1989.;;Mdluli et al., Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid. Science, 280:1607-1610, 1998.;;Plum and Clark-Cutiss, Induction of Mycobacterium avium gene expression following phagocytosis by human macrophages. Infect. and Immun. 62:476-483, 1994.;;Wong and McClelland, Stress-inducible gene of salmonella typhimurium identified by arbitrarily primed PCR of RNA. Proc. Natl. Acad. Sci. USA, 91:639-643, 1994.",EXPIRED
381,US,B2,US 8172043 B2,076-148-546-102-980,2012-05-08,2012,US 44712709 A,2009-04-24,US 2006/0041456 W,2006-10-24,Elevator cross-dispatching system with inter group relative system response (IRSR) dispatching,"During elevator modernization, a cross-dispatching system receives hall calls and assigns each hall call to either a group of existing elevator car controllers or a group of new elevator car controllers. The cross-dispatching system creates an inter group relative system response (iRSR) value for the hall call for both the existing group of elevators and the new group of elevators, based upon information from each group such as car location, in-service status, load, and direction. If the group assigned the hall call does not answer the call within a redispatch time period, the cross-dispatching system again calculates the iRSR for each group and reassigns the hall call.",HUGHES DAVID M;;BLOOM JERROLD C;;GRANT JOHN W;;OTIS ELEVATOR CO,HUGHES DAVID M;;BLOOM JERROLD C;;GRANT JOHN W,OTIS ELEVATOR COMPANY (2006-10-13),https://lens.org/076-148-546-102-980,Granted Patent,yes,20,18,12,12,0,B66B1/2458;;B66B1/14;;B66B1/2458;;B66B1/2458;;B66B1/34;;B66B19/007;;B66B19/007;;B66B2201/102;;B66B2201/102;;B66B2201/211;;B66B2201/211;;B66B2201/233;;B66B2201/233,B66B1/18,187/382;;187/391,1,0,,,"International Search Report and Written Opinion, Feb. 22, 2007, 6 pages.",ACTIVE
382,EP,A1,EP 0830628 A1,140-830-382-829-729,1998-03-25,1998,EP 96917142 A,1996-06-05,US 9608803 W;;US 47375995 A,1995-06-07,DIFFRACTION GRATING LIGHT DOUBLING COLLECTION SYSTEM,"A reflective/diffractive light valve system collects light from multiple dimensions around a single light source. From these multiple collection dimensions, the light is directed to impinge on the valve from multiple directions. When the valve is configured to be reflective, the light returns to the source. On the other hand, when the valve is configured to be diffractive, light from a first and third order diffraction are transmitted from the valve for each of the collection dimensions which greatly enhances the efficiency of the system.",SILICON LIGHT MACHINES INC,STAKER BRYAN P;;BLOOM DAVID M;;LOUCKS BRYAN E,,https://lens.org/140-830-382-829-729,Patent Application,yes,0,0,16,16,0,G02B26/0808;;G02B27/42;;H04N5/7458;;H04N9/31;;G02B19/0047;;G02B19/0028;;G02B27/10;;G02B26/0808;;H04N9/31;;G02B27/42;;H04N5/7458;;G02B19/0028;;G02B19/0047,G02B19/00;;G02B27/42;;G02B27/54;;G02B27/18;;H04N5/74;;H04N9/31,,0,0,,,,EXPIRED
383,US,A,US 4178079 A,003-907-381-259-627,1979-12-11,1979,US 90878078 A,1978-05-23,US 90878078 A,1978-05-23,Sub-picosecond optical gating by degenerate four-wave mixing,"A high speed, wide angular aperture, spectrally selective optical gate is achieved by using degenerate four-wave mixing. The apparatus utilizes two counterpropagating pump beams to interact with a probe beam through a third order nonlinearity in the susceptibility of a medium to produce an image beam which is counterdirectional to the probe beam. The image beam is produced only during the time that the two pump beams and the probe beam are coincident in time and space in media having a fast nonlinearity. In slow media, fast gating is achieved by turning off both pump beams after the probe beam and the pump beams have interacted. This apparatus produces gate times which are not limited by the speed of relaxation of the nonlinearity in the medium utilized.",BELL TELEPHONE LABOR INC,BJORKLUND GARY C;;BLOOM DAVID M;;LIAO PAUL F,,https://lens.org/003-907-381-259-627,Granted Patent,yes,0,8,1,1,0,G02F1/3534;;G02F1/3534,G02F1/35,350/353,4,3,141-864-544-087-062;;031-632-836-127-176;;098-998-755-021-107,10.1007/978-3-662-22574-5;;10.1364/josa.67.000001;;10.1063/1.89791,"Topics in Applied Physics, vol. 18, ""Ultrashort Light Pulses"", Editor, S. L. Shapiro, (1977), Ippen et al., pp. 90-92.;;Hellwarth et al., ""J. Opt. Soc. Am."", vol. 67, No. 1, Jan. 1977, pp. 1-3.;;Bloom et al., ""Applied Physics Letters"", Nov. 1, 1977, pp. 592-594.;;Bloom et al., ""Optics Letters"", Mar. 1978, pp. 58-60.",EXPIRED
384,EP,A2,EP 0940956 A2,028-260-779-360-488,1999-09-08,1999,EP 99301614 A,1999-03-03,US 3593198 A,1998-03-05,Digital baseband modulator,"A digital baseband modulator having a flexible architecture that is readily adaptible to a variety of digital modulation types is provided. A symbol builder maps the input data to a series of modulation states corresponding to data symbols that are represented as state indexes. A pair of digital filters accepts the state indexes being generated by the symbol builder to provide both up-sampling and filtering functions. The digital filters are implemented using random access memory (RAM) to implement blocks of interpolating look-up multipliers which may be readily configured between fast, normal, and long modes. The filtered output data from the digital filters is provided to a resampler that converts the filtered output data to an output sample rate that corresponds to the sample rate of output DACs and corresponding analog low pass filters.",HEWLETT PACKARD CO,SCHWARTZ DAVID J;;BLOOM ALAN R;;ANKLAM WILLIAM J,"AGILENT TECHNOLOGIES INC. A DELAWARE CORPORATION (2001-08-08);;AGILENT TECHNOLOGIES, INC. (A DELAWARE CORPORATION (2001-10-10);;AGILENT TECHNOLOGIES, INC. (2007-01-24)",https://lens.org/028-260-779-360-488,Patent Application,yes,0,7,5,5,0,H04L27/0008;;H04L27/0008,H04L27/20;;H04J13/00;;H04L27/00,,0,0,,,,DISCONTINUED
385,US,A,US 5884652 A,088-778-703-813-105,1999-03-23,1999,US 86324697 A,1997-05-27,US 86324697 A,1997-05-27,2/3 handle pressure balancer system,A pressure balancer system 10 having a pressure balancer 20 and a temperature controller 24 on one side of the system and a volume controller 14 on the other side of the system. The pressure balancer 20 receives hot and cold water which it discharges into the temperature controller 24 at substantially constant preselected pressure. The temperature controller 24 is adjustable to set the temperature of the flow to keep the temperature of the anti-scald below the maximum temperature of between 115.degree. F. and 120.degree. F. The volume controller received the temperature adjusted flow from the temperature controller and will set the volume of the flow at the desired volume for discharge therefrom.,EMHART INC,YEH YUHUNG EDWARD;;COOK WILLIAM DAVID;;BLOOM MARK STEVEN,NEWFREY LLC (1997-06-13),https://lens.org/088-778-703-813-105,Granted Patent,yes,12,23,4,4,0,E03C1/04;;F16K11/074;;G05D23/1353;;G05D23/136;;Y10T137/87692;;Y10T137/87249;;Y10T137/2514;;F16K17/003;;F16K31/60;;F16K19/006;;F16K15/021;;F16K15/18;;E03C1/04;;G05D23/1353;;G05D23/136;;Y10T137/87692;;Y10T137/87249;;Y10T137/2514;;E03C1/04;;G05D23/136;;G05D23/1353;;F16K11/074,E03C1/04;;F16K11/074;;G05D23/13,137/98;;137/597;;137/607,2,0,,,"TempShield The Chicago Faucet Company, no date.;;Monitor II Delta Faucet Company, no date.",EXPIRED
386,CN,A,CN 101874402 A,144-976-817-725-820,2010-10-27,2010,CN 200880117442 A,2008-09-24,US 2008/0077433 W;;US 99509407 P;;US 23577508 A,2007-09-24,Target acquisition system,A targeting system and method for remotely controlling the zoom and pan features of a device for display in an operating room is provided.,GLOBAL DEVICE MAN,HARRIS DAVID P;;WAYNE CORMACK RANDALL;;BLOOM JONATHAN G,,https://lens.org/144-976-817-725-820,Patent Application,no,0,2,5,5,0,G06F3/0481;;G06F3/04845;;G06F2203/04806;;H04N5/2628;;G16H40/63;;G16Z99/00;;H04N5/2628;;G06F3/0481;;G06F2203/04806;;G06F3/04845;;G16H40/63;;G16Z99/00,H04N5/44;;G06F3/048;;G16Z99/00,,0,0,,,,DISCONTINUED
387,US,A1,US 2009/0219491 A1,159-250-871-335-972,2009-09-03,2009,US 28857708 A,2008-10-20,US 28857708 A;;US 99962207 P,2007-10-18,Method of combining multiple Gaussian beams for efficient uniform illumination of one-dimensional light modulators,An illumination system for transforming at least one laser light beam having a non-uniform distribution in a first axis and a second axis to a beam having a substantially uniform distribution in the first axis while preserving the non-uniform distribution in the second axis. The transformed beam may be imaged as a line image onto a one-dimensional light modulation device. The illumination system may comprise a light tunnel having two sides that interact with the at least one laser light beam in the first axis and two sides that do not interact with the light in the second axis.,EVANS & SUTHERLAND COMPUTER CO,WILLIAMS FORREST;;CHRISTENSEN ROBERT;;BLOOM DAVID M;;TANNER ALLEN,ALCES TECHNOLOGY INC (2009-03-25);;EVANS & SUTHERLAND COMPUTER CORPORATION (2008-12-29),https://lens.org/159-250-871-335-972,Patent Application,yes,99,24,1,1,0,G02B27/0927;;G02B27/0994;;H01S5/005;;H04N9/3129;;H04N9/3152;;G02B19/0052;;G02B19/0028;;G03B21/2013;;G03B21/2033;;G03B21/208;;G03B21/2033;;G02B27/0994;;H04N9/3129;;H01S5/005;;H04N9/3152;;G02B27/0927;;G02B19/0052;;G02B19/0028;;G03B21/208;;G03B21/2013,G02B26/00;;G03B21/28;;H01S3/00,353/37;;359/290;;362/553,0,0,,,,DISCONTINUED
388,US,A,US 5730408 A,011-460-477-974-619,1998-03-24,1998,US 60826196 A,1996-02-28,US 60826196 A,1996-02-28,Independently adjustable mouse pad and keyboard support apparatus,"A mouse pad support is mounted on a keyboard support that has a keyboard support arm attachable to a fixed structure such as the underside of a desk top, and a tiltable keyboard support platform thereon. A mouse pad support arm is coupled to the keyboard support arm via a rotational swivel fitting with a vertical axis for moving the mouse pad arm and mouse pad support table to any position around the keyboard in a circular arc in a horizontal plane. The height of the swivel fitting is adjustably fixed over a range. The mouse pad arm is kept in a horizontal plane because its rotational coupling to the keyboard support arm is made at an angularly fixed part on the keyboard support arm, such as on a parallelogram linkage associated with setting the elevation of the keyboard platform. The keyboard platform tilts relative to the angularly fixed part, whereby mouse position is independent of keyboard platform tilt. The mouse support arm is long enough for the mouse support table to clear the corners of the keyboard platform, but the mouse support table also is adjustably attached to the mouse pad support arm via an off-center rotational joint such that the spacing between the mouse pad and the keyboard can be adjusted by rotating the mouse support table. This off-center joint preferably employs a ball and socket universal joint with a friction adjustment, enabling an adjustable degree of tilt of the mouse pad support table as well.",KNOLL INC,MCALLISTER MICHAEL L;;BLOOM DAVID A;;LEE JEFFREY P,WESTINGHOUSE ELECTRIC CORPORTION (1996-02-19);;KNOLL INC (1996-03-21),https://lens.org/011-460-477-974-619,Granted Patent,yes,27,41,2,2,0,A47B2021/0321;;A47B2021/0335;;A47B2021/0342;;A47B2200/009;;G06F3/0202;;G06F3/0395;;Y10S248/918;;G06F3/0395;;A47B2021/0342;;A47B2200/009;;G06F3/0202;;A47B2021/0321;;A47B2021/0335;;Y10S248/918,G06F3/02;;G06F3/039,248/288.51;;248/918;;248/346.01;;248/118;;108/140;;108/69,0,0,,,,EXPIRED
389,US,S,US D0307873 S,019-239-281-198-783,1990-05-15,1990,US 42040189 F,1989-10-12,US 42040189 F,1989-10-12,Domestic scale weight display module,,SUNBEAM CORP,HART RICHARD S;;BLOOM DAVID H;;BRANSKY JEFFERY D,SUNBEAM PRODUCTS INC (1995-05-12);;PELSTAR L.L.C (2002-02-01),https://lens.org/019-239-281-198-783,Design Right,yes,1,2,1,1,0,,,D10/94,3,0,,,"Linens, Domestics & Bath-Jan./Feb./1984-p. 30-Scale Readout Module at top-right.;;Form-""93""-1/1981-p. 48-Readout Module at top-left.;;Hong Kong Enterprises-10/81-p. 297-Scale Readouts at center-left.",EXPIRED
390,HK,A1,HK 1136537 A1,017-624-053-628-348,2010-07-02,2010,HK 10101877 A,2010-02-23,US 2006/0041456 W,2006-10-24,CONTROL SYSTEM AND METHOD OF CONTROLLING OPERATION OF ELEVATORS DURING AN ELEVATOR MODERNIZATION PROJECT,,OTIS ELEVATOR CO,HUGHES DAVID M;;BLOOM JERROLD C;;GRANT JOHN W,,https://lens.org/017-624-053-628-348,Patent Application,no,0,0,12,12,0,B66B1/2458;;B66B1/14;;B66B1/2458;;B66B1/2458;;B66B1/34;;B66B19/007;;B66B19/007;;B66B2201/102;;B66B2201/102;;B66B2201/211;;B66B2201/211;;B66B2201/233;;B66B2201/233,B66B/,,0,0,,,,DISCONTINUED
391,EP,B1,EP 0638177 B1,065-008-334-353-653,2001-10-31,2001,EP 93910831 A,1993-04-28,US 9303939 W;;US 87607892 A;;US 9502963 W,1992-04-28,MODULATING A LIGHT BEAM,,UNIV LELAND STANFORD JUNIOR,BLOOM DAVID M;;SANDEJAS FRANCISCO S A;;SOLGAARD OLAV,,https://lens.org/065-008-334-353-653,Granted Patent,yes,3,0,3,19,0,,G02B5/18;;G02B26/00;;G02B26/08,,1,0,,,"OPTICS LETTERS, vol. 17, no. 9, 1 May 1992 pages 688-690, XP 000265233 SOLGAARD O ET AL 'DEFORMABLE GRATING OPTICAL MODULATOR'",EXPIRED
392,US,B2,US 11009955 B2,100-579-439-866-611,2021-05-18,2021,US 201816183610 A,2018-11-07,US 201816183610 A;;US 201862712100 P,2018-07-30,Stylus with shear force feedback,"Touch-based input devices, such as a stylus, can provide feedback in the form of shear forces applied to the user. A stylus can produce shear forces that act on a user to provide unique tactile sensations. For example, a shear device can be included at a grip region of a stylus to provide shear sensations at the user's hands (e.g., fingers). The shear forces can be unaligned forces that urge one part of the user's hand in one direction and another part of the user's hand in an opposite direction or that tend to maintain the other part of the user's hand in a stationary location.",APPLE INC,BLOOM DAVID H;;JACKSON BENJAMIN G;;TAYLOR STEVEN J,APPLE INC (2018-11-01),https://lens.org/100-579-439-866-611,Granted Patent,yes,7,1,6,6,0,G06F3/03545;;G06F3/016;;G06F3/0346;;G06F3/03545;;G06F3/016;;G06F3/03545;;G06F3/016,G06F3/01;;G06F3/0354,,0,0,,,,ACTIVE
393,US,A1,US 2009/0102933 A1,111-376-102-573-900,2009-04-23,2009,US 23577508 A,2008-09-23,US 23577508 A;;US 99509407 P,2007-09-24,Target Acquisition System,A targeting system and method for remotely controlling the zoom and pan features of a device for display in an operating room is provided.,GLOBAL DEVICE MAN,HARRIS DAVID P;;CORMACK RANDALL WAYNE;;BLOOM JONATHAN G,GLOBAL DEVICE MANAGEMENT (2007-10-12),https://lens.org/111-376-102-573-900,Patent Application,yes,12,50,5,5,0,G06F3/0481;;G06F3/04845;;G06F2203/04806;;H04N5/2628;;G16H40/63;;G16Z99/00;;H04N5/2628;;G06F3/0481;;G06F2203/04806;;G06F3/04845;;G16H40/63;;G16Z99/00,H04N5/232;;G06F3/041;;G06F3/048;;G16Z99/00;;H04N5/262;;H04N7/18,348/211.4;;348/240.99;;345/173;;715/781;;X348E05042;;348/77;;X348E05055,0,0,,,,DISCONTINUED
394,GB,A,GB 1282012 A,188-392-325-970-798,1972-07-19,1972,GB 3558069 A,1969-07-15,US 78832668 A,1968-12-31,CARBONITRIDE COATINGS FOR ASSEMBLY OF PARTS,"1282012 Boron and silicon compounds TEXAS INSTRUMENTS Inc 15 July 1969 [31 Dec 1968] 35580/69 Heading C1A [Also in Division C7] An assembly of parts connected by e.g. welding or brazing, made of ferrous metals, ceramic materials or W, Mo, Nb, Ta or Ti is coated with a metal- or B- or Si-carbon-nitrogen compound by softening the welding or brazing material and contacting the assembly with a gas stream containing nitrogen, carbon, and an element selected from boron, silicon, and the transition metals of Groups IVb, Vb, and VIb. The element may be in the form of a halide, e.g. titanium tetrachloride or bromide. The carbon containing gas may be natural gas, methane, ethane, propane, butane, pentane, decane, penta-decane, octa-decane, benzene, chlorobenzene, dichlorobenzene or dibromobenzene. Compounds containing both carbon and nitrogen may be used, e.g. diamine ethylene, triaminoethylene, pyridine, trimethylamine or triethylamine. The gas stream may also include hydrogen. Compounds containing the element, carbon, hydrogen, and nitrogen may be used, e.g. tetrabis (dimethylamine) titanium and several similar compounds are described. Boron, silicon and titanium carbo-nitrides are disclosed.",TEXAS INSTRUMENTS INC,WAKEFIELD GENE FELIX;;REEDY CARL DAVID;;BLOOM JOHN ALLISON,,https://lens.org/188-392-325-970-798,Granted Patent,no,0,2,6,6,0,C22C5/00;;C23C16/36;;C23C24/00;;Y10T29/49888;;Y10T29/49888;;C22C5/00;;C23C16/36;;C23C24/00,C22C5/00;;C23C16/36;;C23C24/00,C1A AE1RX         AE1R;;C1A AE1RX         AVF2;;C1A AE10A         AE1R;;C1A AE10A         AE2R;;C1A AE2RX         AE2R;;C1A APB2C         APB2C;;C1A AVF2          AVF2;;C7A AB23X;;C7A AB23Y;;C7A AB279;;C7A AB289;;C7A AB309;;C7A AB319;;C7A AB32Y;;C7A AB320;;C7A AB349;;C7A AB369;;C7A AB389;;C7A AB399;;C7A AB419;;C7A AB439;;C7A AB459;;C7A AB46Y;;C7A AB473;;C7A AB475;;C7A AB477;;C7A AB519;;C7A AB52Y;;C7A AB535;;C7A AB537;;C7A AB549;;C7A AB559;;C7A AB610;;C7A AB613;;C7A AB616;;C7A AB619;;C7A AB62X;;C7A AB621;;C7A AB624;;C7A AB627;;C7A AB630;;C7A AB635;;C7A AB66X;;C7A AB661;;C7A AB663;;C7A AB665;;C7A AB667;;C7A AB669;;C7A AB670;;C7A A712;;C7F F1B2          6;;C7F F1B5          6;;C7F F2E           6;;C7F F2F           6;;C7F F2Z2          6;;C7F F2Z4          6;;C7F F2Z8          6;;C7F F3C           6;;C7F F4D           6;;C7F F4E           6;;C7F F4K           6,0,0,,,,EXPIRED
395,DE,B,DE 1017608 B,068-906-390-920-257,1957-10-17,1957,DE P0014179 A,1955-05-25,US 1017608X A,1954-05-26,"Verfahren zur Herstellung von 15-Halogen- oder 15-Oxy-4-pregnen-14 alpha, 17 alpha-diol-3, 20-dionen",,PFIZER & CO C,AGNELLE EUGENE JOSEPH;;BLOOM BARRY MALCOLM;;LAUBACH GERALD DAVID,,https://lens.org/068-906-390-920-257,Patent Application,no,0,0,1,1,0,C07J5/00,C07J5/00,,1,0,,,None,DISCONTINUED
396,EP,A4,EP 2240162 A4,078-946-389-380-213,2013-10-09,2013,EP 08857189 A,2008-12-05,US 2008/0013434 W;;US 99280407 P,2007-12-06,NANOPARTICLES COMPRISING A NON-IONIZABLE POLYMER AND AN AMINE-FUNCTIONALIZED METHACRYLATE COPOLYMER,,BEND RES INC;;BLOOM COREY J;;CREW MARSHALL DAVID;;MILLER WARREN KENYON,BLOOM COREY J;;CREW MARSHALL DAVID;;MILLER WARREN KENYON,,https://lens.org/078-946-389-380-213,Search Report,no,1,0,5,5,0,A61K9/5138;;A61K9/5138;;A61K9/0048;;A61K9/0048;;A61K9/10;;A61K9/10;;A61K9/19;;A61K9/19;;A61K9/5161;;A61K9/5161;;A61K9/5192;;A61K9/5192,A61K9/51;;A61K9/10;;A61K9/14;;A61K9/19,,6,5,119-668-941-485-878;;019-830-573-082-887;;115-796-930-595-191;;020-182-044-695-154;;033-991-940-219-246,10.1016/0168-3659(90)90103-z;;10.1016/j.ijpharm.2006.01.041;;16600538;;17643878;;10.1016/j.ijpharm.2007.05.066;;10.1016/j.ijpharm.2006.03.035;;16678366;;9971890;;10.1016/s0168-3659(98)00108-4,"BODMEIER R ET AL: ""Indomethacin polymeric nanosuspensions prepared by microfujidization"", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 12, no. 3, May 1990 (1990-05-01), pages 223 - 233, XP025484313, ISSN: 0168-3659, [retrieved on 19900501], DOI: 10.1016/0168-3659(90)90103-Z;;DILLEN K ET AL: ""Evaluation of ciprofloxacin-loaded Eudragit<(>R) RS100 or RL100/PLGA nanoparticles"", INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER BV, NL, vol. 314, no. 1, 11 May 2006 (2006-05-11), pages 72 - 82, XP027972311, ISSN: 0378-5173, [retrieved on 20060511];;HASAN ET AL: ""Effect of the microencapsulation of nanoparticles on the reduction of burst release"", INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER BV, NL, vol. 344, no. 1-2, 27 September 2007 (2007-09-27), pages 53 - 61, XP022275352, ISSN: 0378-5173, DOI: 10.1016/J.IJPHARM.2007.05.066;;HUANG J ET AL: ""Nifedipine solid dispersion in microparticles of ammonio methacrylate copolymer and ethylcellulose binary blend for controlled drug delivery"", INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER BV, NL, vol. 319, no. 1-2, 17 August 2006 (2006-08-17), pages 44 - 54, XP027972435, ISSN: 0378-5173, [retrieved on 20060817];;SCHMIDT C ET AL: ""Incorporation of polymeric nanoparticles into solid dosage forms"", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 57, no. 2, February 1999 (1999-02-01), pages 115 - 125, XP004157769, ISSN: 0168-3659, DOI: 10.1016/S0168-3659(98)00108-4;;See also references of WO 2009073216A1",DISCONTINUED
397,AU,A,AU 1996/059810 A,084-947-662-364-903,1996-12-30,1996,AU 1996/059810 A,1996-06-05,US 47375995 A;;US 9608803 W,1995-06-07,Diffraction grating light doubling collection system,"A reflective/diffractive light valve system collects light from multiple dimensions around a single light source. From these multiple collection dimensions, the light is directed to impinge on the valve from multiple directions. When the valve is configured to be reflective, the light returns to the source. On the other hand, when the valve is configured to be diffractive, light from a first and third order diffraction are transmitted from the valve for each of the collection dimensions which greatly enhances the efficiency of the system.",ECHELLE INC,STAKER BRYAN P;;BLOOM DAVID M;;LOUCKS BRYAN E,,https://lens.org/084-947-662-364-903,Patent Application,no,0,0,16,16,0,G02B26/0808;;G02B27/42;;H04N5/7458;;H04N9/31;;G02B19/0047;;G02B19/0028;;G02B27/10;;G02B26/0808;;H04N9/31;;G02B27/42;;H04N5/7458;;G02B19/0028;;G02B19/0047,G02B27/18;;G02B19/00;;G02B27/42;;G02B27/54;;H04N5/74;;H04N9/31,,0,0,,,,PENDING
398,CN,A,CN 110049716 A,096-119-579-003-404,2019-07-23,2019,CN 201780076191 A,2017-11-02,US 201615349667 A;;US 2017/0059674 W,2016-11-11,Ulcer detection apparatus and method with varying thresholds,"A method determines the emergence of an ulcer or a pre-ulcer on at least one foot of a patient provides one or more processors and a modality for receiving at least one foot. The method generates, using a plurality of temperature sensors, discrete temperature data values after receipt of the at last one foot. The plurality of discrete temperature data values represents temperatures at different locations of the at least one foot. Next, the method compares, using a prescribed function, each of the discrete temperature data values to one of a plurality of different predetermined values. The predetermined values are different for at least two different locations of the at least one foot. The method then produces output information indicating an emergence of an ulcer or a pre-ulcer on the at least one foot as a result of comparing.",PODIMETRICS INC,LINDERS DAVID R;;PETERSEN BRIAN J;;BLOOM JONATHAN D,,https://lens.org/096-119-579-003-404,Patent Application,no,7,0,7,7,0,A61B5/6829;;A61B5/015;;A61B5/445;;A61B5/447;;A61B5/6892;;A61B5/6829;;A61B5/015;;A61B5/445;;A61B5/447;;A61B5/6892,A61B5/00;;A61B5/01;;G08B23/00,,0,0,,,,ACTIVE
399,US,A,US 5977863 A,045-710-416-585-196,1999-11-02,1999,US 13208198 A,1998-08-10,US 13208198 A,1998-08-10,Low cross talk ball grid array resistor network,A resistor network for terminating active electronic devices has low cross talk noise between the adjoining resistors and the conductors that connect the resistors to other electronic packages. A substrate has a top and a bottom surface. Resistors are located on the top surface. Conductors are also located on the top surface and are electrically connected to each end of the resistors. Vias extend through the substrate and electrically connect to the conductors. Solder spheres are positioned on the bottom surface and are electrically connected to the vias. An end of each of the resistors is electrically connected in common through a common conductor. The commoned resistors are electrically connected to a common via through the common conductor. The resistor network minimizes cross talk noise between the resistors and provides a high density interconnection.,CTS CORP,BLOOM TERRY R;;COOPER RICHARD O;;POOLE DAVID L,CTS CORPORATION (1998-08-04),https://lens.org/045-710-416-585-196,Granted Patent,yes,11,39,10,10,0,H01C1/02;;H01C7/006;;H01C7/006;;H01C17/242;;H01C17/242;;H01L23/5386;;H01L23/5386;;H01L2924/0002;;H01L2924/0002;;H01L2924/15311;;H01L2924/15311;;H01L2924/3011;;H01L2924/3011,H01C13/02;;H01C1/02;;H01C7/00;;H01C17/242;;H01L23/538;;H01R12/00;;H03H7/24;;H03H7/38;;H05K1/02;;H05K1/11,338/320;;338/260;;338/324;;338/325,0,0,,,,EXPIRED
400,EP,B1,EP 0830628 B1,047-675-285-581-92X,2001-04-18,2001,EP 96917142 A,1996-06-05,US 9608803 W;;US 47375995 A,1995-06-07,DIFFRACTION GRATING LIGHT DOUBLING COLLECTION SYSTEM,"A reflective/diffractive light valve system collects light from multiple dimensions around a single light source. From these multiple collection dimensions, the light is directed to impinge on the valve from multiple directions. When the valve is configured to be reflective, the light returns to the source. On the other hand, when the valve is configured to be diffractive, light from a first and third order diffraction are transmitted from the valve for each of the collection dimensions which greatly enhances the efficiency of the system.",SILICON LIGHT MACHINES INC,STAKER BRYAN P;;BLOOM DAVID M;;LOUCKS BRYAN E,,https://lens.org/047-675-285-581-92X,Granted Patent,yes,2,3,16,16,0,G02B26/0808;;G02B27/42;;H04N5/7458;;H04N9/31;;G02B19/0047;;G02B19/0028;;G02B27/10;;G02B26/0808;;H04N9/31;;G02B27/42;;H04N5/7458;;G02B19/0028;;G02B19/0047,G02B19/00;;G02B27/42;;G02B27/18;;G02B27/54;;H04N5/74;;H04N9/31,,0,0,,,,EXPIRED
401,CN,C,CN 1037348 C,088-208-031-257-518,1998-02-11,1998,CN 91102965 A,1991-05-04,US 51919290 A,1990-05-04,"Method for preparing substituted 5 -(2 -(2 -(2 -aryl -2 hydroxyethyl) amino) propyl -1, 3 -benzodioxoles amylene","The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.",AMERICAN CYANAMID CO,BLOOM JONATHAN DAVID;;CLAUS THOMAS HARRISON;;DEVRIES VERN GORDON,,https://lens.org/088-208-031-257-518,Granted Patent,no,3,0,40,44,0,C07D317/46;;C07D413/06;;A61P3/10;;A61P3/04;;A61P3/08;;C07D317/46;;C07D413/06;;C07D317/46,A23K1/16;;A61K31/335;;A61K31/357;;A61K31/36;;A61K31/42;;A61P3/04;;A61P3/08;;A61P3/10;;C07D263/04;;C07D291/04;;C07D317/46;;C07D317/58;;C07D317/62;;C07D405/06;;C07D413/06;;C07D419/06,,0,0,,,,EXPIRED
402,US,A,US 5808797 A,120-624-786-293-438,1998-09-15,1998,US 63860596 A,1996-04-26,US 63860596 A;;US 59123196 A;;US 40413995 A;;US 6268893 A;;US 87607892 A,1992-04-28,Method and apparatus for modulating a light beam,"A modulator for modulating incident rays of light, the modulator having a plurality of equally spaced apart elements, each of which includes a light reflective planar surface. The elements are arranged parallel to each other with their light reflective surfaces parallel to each other. The modulator includes means for supporting elements in relation to one another and means for moving particular ones of the elements relative to others so that the moved elements transit between a first configuration wherein the modulator acts to reflect the incident rays of light as a plane mirror, and a second configuration wherein the modulator diffracts the light reflected therefrom. In operation, the light reflective surfaces of the elements remain parallel to each other in both the first and the second configurations. The perpendicular spacing between the reflective surfaces of respective elements is equal to m/4 times the wavelength of the incident rays of light, wherein m=an even whole number or zero when the elements are in the first configuration and m=an odd whole number when the elements are in the second configuration.",SILICON LIGHT MACHINES INC,BLOOM DAVID M;;SANDEJAS FRANCISCO S A;;SOLGAARD OLAV,,https://lens.org/120-624-786-293-438,Granted Patent,yes,100,601,13,13,0,B81C2201/115;;G02B5/1828;;G02B26/0808;;B81B3/001;;B81B3/001;;B81C2201/115;;G02B5/1828;;G02B26/0808,B81B3/00;;G02B5/18;;G02B26/08,359/572;;345/108;;348/755,6,3,009-286-199-765-581;;028-775-209-892-098;;009-365-280-210-861,10.1109/5.53402;;10.1117/12.19865;;10.1016/0141-9382(91)90032-9,"R. Apte, F. Sandejas, W. Banyai, D. Bloom, Grating Light Valves For High Resolution Displays , Ginzton Laboratories, Stanford University, Stanford, CA 94305 4085, Jun. 1994.;;R. Apte, Grating Light Valves For High Resolution Displays Jun. 1994, Ginzton Laboratories, Stanford Univ., Stanford, CA.;;O. Solgaard, Integrated Semiconductor Light Modulators For Fiber Optic And Display Applications, Feb., 1992, Stanford Univ., Stanford, CA.;;J. Neff, Two Dimensional Spatial Light Modulators: A Tutorial , Proceedings of the IEEE, vol. 78, No. 5 (May 1990), pp. 826 855.;;Gerhard Multhaupt, Viscoelastic Spatial Light Modulators and Schlieren Optical Systems for HDTV Projection Displays , SPIE vol. 1255 Large Screen Displays II (1990), pp. 69 78.;;Gerhard Multhaupt, Light Valve Technologies for High Definition Television Projection Displays , Displays, vol. 12, No. 3/4 (1991), pp. 115 128.",EXPIRED
403,BR,A,BR 9103143 A,151-932-047-988-702,1992-05-05,1992,BR 9103143 A,1991-07-23,US 55804490 A,1990-07-26,"SISTEMA DE CONSERVACAO DE RE-RADIACAO TERMICA PARA INFLUENCIAR A TEMPERATURA DE ARTIGOS METALICOS QUENTES,RECINTO SUBSTANCIALMENTE ISENTO DE INFILTACAO DE AR;CONSERVACAO DE RE-RADIACAO TERMICA;E METODO PARA CONTROLAR A TEMPERATURA DE UMA BARRA DE TRANSFERENCIA METALICA",,ALLEGHENY LUDLUM CORP,BURK DAVID LAWRENCE;;BLOOM WILLIAM MILLARD;;HAVRANEK TERENCE LOUIS,,https://lens.org/151-932-047-988-702,Patent Application,no,0,0,8,8,0,B21B45/00;;B21B45/008;;B21B45/008;;C21D9/0006;;C21D9/0006;;F27D1/0013;;F27D1/0013;;F27D1/06;;F27D1/06;;F27D1/144;;F27D1/144;;Y02P70/10;;Y02P70/10,B21B45/00;;C21D9/00;;F27D1/00;;F27D1/06;;F27D1/14,,0,0,,,,DISCONTINUED
404,US,A,US 4198162 A,155-245-916-459-986,1980-04-15,1980,US 90877978 A,1978-05-23,US 90877978 A,1978-05-23,Tunable wide angular aperture filter by degenerate four-wave mixing,"A wide angular aperture, tunable filter device is achieved by using degenerate four-wave mixing. The apparatus utilizes two counter-propagating pump beams at substantially the same frequency to interact with an object beam, containing a spread of frequency components through a third order nonlinearity in the susceptibility of a medium. This produces a conjugate image beam formed with frequency components close to the frequency of the pump beams. By tuning the frequency of the pump beams the object beam frequency spectrum may be scanned while preserving all of the spatial information in the object beam. Apparatus for generating velocity contours of moving objects is also disclosed.",BELL TELEPHONE LABOR INC,BJORKLUND GARY C;;BLOOM DAVID M;;LIAO PAUL F,,https://lens.org/155-245-916-459-986,Granted Patent,yes,3,16,1,1,0,G02F1/3534;;G02F1/3538;;G02F1/3538;;G02F1/3534,G02F1/35,356/349,4,3,066-943-723-381-90X;;061-768-827-216-362;;098-998-755-021-107,19680405;;10.1364/ol.2.000058;;10.1063/1.89976;;10.1063/1.89791,"Bloom, D. M. et al., ""Observation of Amplified . . . ,"" Optics Letters, vol. 2, No. 3, Mar. 1978, pp. 58-60.;;Jensen, S. M. et al., ""Observation of Time Reversed . . . ,"" Applied Physics Letters, vol. 32, No. 3, Feb. 1978, pp. 166-168.;;Bloom, D. M. et al., ""Conjugate Wave-Front. . . ,"" Applied Physics Letters, vol. 31, No. 9, Nov. 1977, pp. 592-594.;;Hellwarth, R. W., ""Generation of Time Reversed . . . ,"" J. Opt. Sec. Am., vol. 67, No. 1, Jan. 1977, pp. 1-3.",EXPIRED
405,CN,A,CN 111158506 A,184-741-689-397-918,2020-05-15,2020,CN 201910388625 A,2019-05-10,US 201816183610 A;;US 201862712100 P,2018-07-30,Stylus with shear force feedback,"The invention discloses a stylus with shear force feedback. Touch-based input devices, such as a stylus, can provide feedback in the form of shear forces applied to the user. A stylus can produce shear forces that act on a user to provide unique tactile sensations. For example, a shear device can be included at a grip region of a stylus to provide shear sensations at the user's hands (e.g., fingers). The shear forces can be unaligned forces that urge one part of the user's hand in one direction and another part of the user's hand in an opposite direction or that tend to maintain the other partof the user's hand in a stationary location.",APPLE INC,BLOOM DAVID H;;JACKSON BENJAMIN G;;TAYLOR STEVEN J,,https://lens.org/184-741-689-397-918,Patent Application,no,16,0,6,6,0,G06F3/03545;;G06F3/016;;G06F3/0346;;G06F3/03545;;G06F3/016;;G06F3/03545;;G06F3/016,G06F3/0354;;G06F3/01;;G06F3/0346,,1,0,,,"邓鹏: ""“面向移动终端的力触觉建模与再现方法研究”"", 《中国优秀硕士学位论文全文数据库(信息科技辑)》, no. 2017, pages 138 - 2163",ACTIVE
406,AT,T1,AT E200712 T1,189-753-834-416-91X,2001-05-15,2001,AT 96917142 T,1996-06-05,US 47375995 A;;US 9608803 W,1995-06-07,BEUGUNGSGITTERSYSTEM MIT VERDOPPELTER LICHTSAMMLUNG,"A reflective/diffractive light valve system collects light from multiple dimensions around a single light source. From these multiple collection dimensions, the light is directed to impinge on the valve from multiple directions. When the valve is configured to be reflective, the light returns to the source. On the other hand, when the valve is configured to be diffractive, light from a first and third order diffraction are transmitted from the valve for each of the collection dimensions which greatly enhances the efficiency of the system.",SILICON LIGHT MACHINES INC,STAKER BRYAN P;;BLOOM DAVID M;;LOUCKS BRYAN E,,https://lens.org/189-753-834-416-91X,Granted Patent,no,0,0,16,16,0,G02B26/0808;;G02B27/42;;H04N5/7458;;H04N9/31;;G02B19/0047;;G02B19/0028;;G02B27/10;;G02B26/0808;;H04N9/31;;G02B27/42;;H04N5/7458;;G02B19/0028;;G02B19/0047,G02B27/18;;G02B19/00;;G02B27/42;;G02B27/54;;H04N5/74;;H04N9/31,,0,0,,,,DISCONTINUED
407,WO,A1,WO 2009/042630 A1,021-476-801-906-538,2009-04-02,2009,US 2008/0077433 W,2008-09-24,US 99509407 P;;US 23577508 A,2007-09-24,TARGET ACQUISITION SYSTEM,A targeting system and method for remotely controlling the zoom and pan features of a device for display in an operating room is provided.,GLOBAL DEVICE MAN;;HARRIS DAVID PETER;;CORMACK RANDALL WAYNE;;BLOOM JONATHAN G,HARRIS DAVID P;;CORMACK RANDALL WAYNE;;BLOOM JONATHAN G,,https://lens.org/021-476-801-906-538,Patent Application,yes,4,1,5,5,0,G06F3/0481;;G06F3/04845;;G06F2203/04806;;H04N5/2628;;G16H40/63;;G16Z99/00;;H04N5/2628;;G06F3/0481;;G06F2203/04806;;G06F3/04845;;G16H40/63;;G16Z99/00,H04N5/44;;G06F3/048;;G16Z99/00,,1,0,,,See also references of EP 2201753A4,PENDING
408,EP,A4,EP 0638177 A4,019-724-066-659-232,1995-12-06,1995,EP 93910831 A,1993-04-28,US 9303939 W;;US 87607892 A;;US 9502963 W,1992-04-28,MODULATING A LIGHT BEAM.,,UNIV LELAND STANFORD JUNIOR,BLOOM DAVID M;;SANDEJAS FRANCISCO S A;;SOLGAARD OLAV,,https://lens.org/019-724-066-659-232,Search Report,no,1,0,3,19,0,,G02B5/18;;G02B26/00;;G02B26/08,,2,1,010-074-622-606-125,10.1364/ol.17.000688;;19794599,"SOLGAARD O ET AL: ""DEFORMABLE GRATING OPTICAL MODULATOR"", OPTICS LETTERS, vol. 17, no. 9, 1 May 1992 (1992-05-01), pages 688 - 690, XP000265233;;See also references of WO 9322694A1",EXPIRED
409,US,A1,US 2010/0297237 A1,050-343-690-053-677,2010-11-25,2010,US 74675208 A,2008-12-05,US 74675208 A;;US 99280407 P;;US 2008/0013434 W,2007-12-06,NANOPARTICLES COMPRISING A NON-IONIZABLE POLYMER AND AN AMINE-FUNCTIONALIZED METHACRYLATE COPOLYMER,"A pharmaceutical composition comprises nanoparticles comprising a poorly water soluble drug, a poorly aqueous soluble non-ionizable polymer, and an amine-functionalized methacrylate copolymer.",BEND RES INC,BLOOM COREY J;;CREW MARSHALL DAVID;;MILLER WARREN KENYON,PFIZER INC (2008-01-22);;BEND RESEARCH INC (2008-11-03),https://lens.org/050-343-690-053-677,Patent Application,yes,100,5,5,5,0,A61K9/5138;;A61K9/5138;;A61K9/0048;;A61K9/0048;;A61K9/10;;A61K9/10;;A61K9/19;;A61K9/19;;A61K9/5161;;A61K9/5161;;A61K9/5192;;A61K9/5192,A61K31/42;;A61K9/10;;A61K9/14;;A61K31/4196;;A61K31/47;;A61K31/5415,424/486;;424/400;;424/484;;424/488;;514/378;;514/313;;514/383;;514/226.5;;977/773,0,0,,,,INACTIVE
410,NO,L,NO 975694 L,109-958-679-144-922,1998-02-06,1998,NO 975694 A,1997-12-05,US 47375995 A;;US 9608803 W,1995-06-07,Lysfordoblende diffraksjonsgitter-samlesystem,"A reflective/diffractive light valve system collects light from multiple dimensions around a single light source. From these multiple collection dimensions, the light is directed to impinge on the valve from multiple directions. When the valve is configured to be reflective, the light returns to the source. On the other hand, when the valve is configured to be diffractive, light from a first and third order diffraction are transmitted from the valve for each of the collection dimensions which greatly enhances the efficiency of the system.",SILICON LIGHT MACHINES INC,STAKER BRYAN P;;BLOOM DAVID M;;LOUCKS BRYAN E,,https://lens.org/109-958-679-144-922,Abstract,no,0,0,16,16,0,G02B26/0808;;G02B27/42;;H04N5/7458;;H04N9/31;;G02B19/0047;;G02B19/0028;;G02B27/10;;G02B26/0808;;H04N9/31;;G02B27/42;;H04N5/7458;;G02B19/0028;;G02B19/0047,G02B19/00;;G02B27/42;;G02B27/18;;G02B27/54;;H04N5/74;;H04N9/31,,0,0,,,,DISCONTINUED
411,ES,T3,ES 2164661 T3,165-439-340-212-822,2002-03-01,2002,ES 93910831 T,1993-04-28,US 87607892 A,1992-04-28,MODULACION DE UN HAZ DE LUZ.,"A modulator for modulating incident rays of light, the modulator comprising a plurality of equally spaced apart beam elements, each of which includes a light reflective planar surface. The elements are arranged parallel to each other with their light reflective surfaces parallel to each other. The modulator includes means for supporting the beam elements in relation to one another and means for moving the beam elements relative to one another so that the beams move between a first configuration wherein the modulator acts to reflect the incident rays of light as a plane mirror, and a second configuration wherein the modulator diffracts the incident rays of light as they are reflected therefrom. In operation, the light reflective surfaces of the beam elements remain parallel to each other in both the first and the second configurations and the perpendicular spacing between the reflective surfaces of adjacent beam elements is equal to m/4 times the wavelength of the incident rays of light, wherein m=an even whole number or zero when the beam elements are in the first configuration and m=an odd number when the beam elements are in the second configuration.",UNIV LELAND STANFORD JUNIOR,BLOOM DAVID M;;SANDEJAS FRANCISCO S A;;SOLGAARD OLAV,,https://lens.org/165-439-340-212-822,Granted Patent,no,0,0,9,19,0,B81C2201/115;;G02B5/1828;;G02B26/0808;;B81B3/001;;Y10S359/90;;B81B3/001;;G02B5/1828;;B81C2201/115;;G02B26/0808;;Y10S359/90,B81B3/00;;G02B5/18;;G02B26/08,,0,0,,,,EXPIRED
412,US,A1,US 2007/0143729 A1,164-465-692-746-214,2007-06-21,2007,US 60044106 A,2006-11-15,US 60044106 A;;US 73710105 P,2005-11-15,High speed camera bandwidth converter,Image data from a CMOS sensor with 10 bit resolution is reformatted to allow the data to pass through communications equipment that is designed to transport data with 8 bit resolution. The incoming image data has 1280 columns and 1024 rows with 10 bit resolution. The communication equipment can transport image data that has 1280 columns and 1024 rows with 8 bit resolution. This invention transports image data that has 1000 columns and 1023 rows with 10 bit resolution through the communication equipment by reformatting the image data.,UNIV CA,BOWER DAN E;;BLOOM DAVID A;;CURRY JAMES R,REGENTS OF THE UNIVERSITY OF CALIFORNIA THE (2006-11-09);;LAWRENCE LIVERMORE NATIONAL SECURITY LLC (2007-09-24),https://lens.org/164-465-692-746-214,Patent Application,yes,8,1,1,3,0,H04N7/0117;;H04N7/0117,G06F17/50,716/16,0,0,,,,DISCONTINUED
413,EP,A3,EP 0940956 A3,187-694-209-790-869,2002-11-20,2002,EP 99301614 A,1999-03-03,US 3593198 A,1998-03-05,Digital baseband modulator,"A digital baseband modulator having a flexible architecture that is readily adaptible to a variety of digital modulation types is provided. A symbol builder maps the input data to a series of modulation states corresponding to data symbols that are represented as state indexes. A pair of digital filters accepts the state indexes being generated by the symbol builder to provide both up-sampling and filtering functions. The digital filters are implemented using random access memory (RAM) to implement blocks of interpolating look-up multipliers which may be readily configured between fast, normal, and long modes. The filtered output data from the digital filters is provided to a resampler that converts the filtered output data to an output sample rate that corresponds to the sample rate of output DACs and corresponding analog low pass filters.",AGILENT TECHNOLOGIES INC,SCHWARTZ DAVID J;;BLOOM ALAN R;;ANKLAM WILLIAM J,"AGILENT TECHNOLOGIES INC. A DELAWARE CORPORATION (2001-08-08);;AGILENT TECHNOLOGIES, INC. (A DELAWARE CORPORATION (2001-10-10);;AGILENT TECHNOLOGIES, INC. (2007-01-24)",https://lens.org/187-694-209-790-869,Search Report,yes,2,0,5,5,0,H04L27/0008;;H04L27/0008,H04L27/20;;H04J13/00;;H04L27/00,,1,1,029-486-364-268-40X,10.1002/j.1538-7305.1990.tb00124.x,"SILLER JR C A ET AL: ""APPLICATION OF MEMORY-BASED DIGITAL FILTERING TO HIGH-SPEED DIGITAL RADIO"", AT & T TECHNICAL JOURNAL, AMERICAN TELEPHONE AND TELEGRAPH CO., vol. 69, no. 5, September 1990 (1990-09-01), Short Hills, USA, pages 100 - 115, XP000224083, ISSN: 8756-2324",DISCONTINUED
414,WO,A1,WO 2008/051217 A1,194-839-251-031-629,2008-05-02,2008,US 2006/0041456 W,2006-10-24,US 2006/0041456 W,2006-10-24,ELEVATOR CROSS-DISPATCHING SYSTEM WITH INTER GROUP RELATIVE SYSTEM RESPONSE (IRSR) DISPATCHING,"During elevator modernization, a cross-dispatching system receives hall calls and assigns each hall call to either a group of existing elevator car controllers or a group of new elevator car controllers. The cross-dispatching system creates an inter group relative system response (iRSR) value for the hall call for both the existing group of elevators and the new group of elevators, based upon information from each group such as car location, in-service status, load, and direction. If the group assigned the hall call does not answer the call within a redispatch time period, the cross-dispatching system again calculates the iRSR for each group and reassigns the hall call.",OTIS ELEVATOR CO;;HUGHES DAVID M;;BLOOM JERROLD C;;GRANT JOHN W,HUGHES DAVID M;;BLOOM JERROLD C;;GRANT JOHN W,,https://lens.org/194-839-251-031-629,Patent Application,yes,3,18,12,12,0,B66B1/2458;;B66B1/14;;B66B1/2458;;B66B1/2458;;B66B1/34;;B66B19/007;;B66B19/007;;B66B2201/102;;B66B2201/102;;B66B2201/211;;B66B2201/211;;B66B2201/233;;B66B2201/233,B66B1/14,,0,0,,,,PENDING
415,US,A,US 5945885 A,155-693-871-382-944,1999-08-31,1999,US 3593198 A,1998-03-05,US 3593198 A,1998-03-05,Digital baseband modulator adaptable to different modulation types,"A digital baseband modulator having a flexible architecture that is readily adaptible to a variety of digital modulation types is provided. A symbol builder maps the input data to a series of modulation states corresponding to data symbols that are represented as state indexes. A pair of digital filters accepts the state indexes being generated by the symbol builder to provide both up-sampling and filtering functions. The digital filters are implemented using random access memory (RAM) to implement blocks of interpolating look-up multipliers which may be readily configured between fast, normal, and long modes. The filtered output data from the digital filters is provided to a resampler that converts the filtered output data to an output sample rate that corresponds to the sample rate of output DACs and corresponding analog low pass filters.",HEWLETT PACKARD CO,SCHWARTZ DAVID J;;BLOOM ALAN R;;ANKLAM WILLIAM J,HEWLETT-PACKARD COMPANY A DELAWARE CORPORATION (1998-05-20);;HEWLETT-PACKARD COMPANY (1998-08-13);;AGILENT TECHNOLOGIES INC (1999-11-01),https://lens.org/155-693-871-382-944,Granted Patent,yes,5,41,5,5,0,H04L27/0008;;H04L27/0008,H04L27/20;;H04J13/00;;H04L27/00,332/100;;332/103;;332/119;;375/205;;375/298;;375/303;;375/308,0,0,,,,EXPIRED
416,EP,A1,EP 0638177 A1,195-158-361-696-456,1995-02-15,1995,EP 93910831 A,1993-04-28,US 9303939 W;;US 87607892 A;;US 9502963 W,1992-04-28,MODULATING A LIGHT BEAM.,,UNIV LELAND STANFORD JUNIOR,BLOOM DAVID M;;SANDEJAS FRANCISCO S A;;SOLGAARD OLAV,,https://lens.org/195-158-361-696-456,Patent Application,yes,0,0,3,19,0,,G02B5/18;;G02B26/00;;G02B26/08,,0,0,,,,EXPIRED
417,PT,E,PT 638177 E,198-560-152-281-013,2002-03-28,2002,PT 93910831 T,1993-04-28,US 87607892 A,1992-04-28,MODULACAO DE UM FEIXE DE LUZ,"A modulator for modulating incident rays of light, the modulator comprising a plurality of equally spaced apart beam elements, each of which includes a light reflective planar surface. The elements are arranged parallel to each other with their light reflective surfaces parallel to each other. The modulator includes means for supporting the beam elements in relation to one another and means for moving the beam elements relative to one another so that the beams move between a first configuration wherein the modulator acts to reflect the incident rays of light as a plane mirror, and a second configuration wherein the modulator diffracts the incident rays of light as they are reflected therefrom. In operation, the light reflective surfaces of the beam elements remain parallel to each other in both the first and the second configurations and the perpendicular spacing between the reflective surfaces of adjacent beam elements is equal to m/4 times the wavelength of the incident rays of light, wherein m=an even whole number or zero when the beam elements are in the first configuration and m=an odd number when the beam elements are in the second configuration.",UNIV LELAND STANFORD JUNIOR,BLOOM DAVID M;;SANDEJAS FRANCISCO S A;;SOLGAARD OLAV,,https://lens.org/198-560-152-281-013,Granted Patent,no,0,0,9,19,0,B81C2201/115;;G02B5/1828;;G02B26/0808;;B81B3/001;;Y10S359/90;;B81B3/001;;G02B5/1828;;B81C2201/115;;G02B26/0808;;Y10S359/90,B81B3/00;;G02B5/18;;G02B26/08,,0,0,,,,EXPIRED
418,US,B2,US 8866915 B2,040-091-156-016-381,2014-10-21,2014,US 201213490438 A,2012-06-06,US 201213490438 A;;US 60044106 A;;US 73710105 P,2005-11-15,"High speed, real-time, camera bandwidth converter","Image data from a CMOS sensor with 10 bit resolution is reformatted in real time to allow the data to stream through communications equipment that is designed to transport data with 8 bit resolution. The incoming image data has 10 bit resolution. The communication equipment can transport image data with 8 bit resolution. Image data with 10 bit resolution is transmitted in real-time, without a frame delay, through the communication equipment by reformatting the image data.",BOWER DAN E;;BLOOM DAVID A;;CURRY JAMES R;;L LIVERMORE NAT SECURITY LLC,BOWER DAN E;;BLOOM DAVID A;;CURRY JAMES R,LAWRENCE LIVERMORE NATIONAL SECURITY LLC (2012-06-01),https://lens.org/040-091-156-016-381,Granted Patent,yes,16,0,2,3,0,H03M7/3064;;H03M7/3064,H04N5/225;;H03M7/30,348/207.1;;348/211.1;;348/425.3;;725/118,2,0,,,"Dierickx et al., ""IBIS4 SXGA Image Sensor"", Fill Factory, Jun. 2001.;;""Basler A500k Users's Manual"", Basler Vision Technologies, Dec. 2004.",INACTIVE
419,DE,T2,DE 69935051 T2,081-709-893-579-44X,2007-11-15,2007,DE 69935051 T,1999-07-29,US 13208198 A,1998-08-10,BGA Widerstandsnetzwerk mit geringem Übersprechen,,CTS CORP,BLOOM TERRY R;;COOPER RICHARD O;;POOLE DAVID L,,https://lens.org/081-709-893-579-44X,Granted Patent,no,0,0,10,10,0,H01C1/02;;H01C7/006;;H01C7/006;;H01C17/242;;H01C17/242;;H01L23/5386;;H01L23/5386;;H01L2924/0002;;H01L2924/0002;;H01L2924/15311;;H01L2924/15311;;H01L2924/3011;;H01L2924/3011,H01C1/012;;H01C13/02;;H01C1/02;;H01C7/00;;H01C17/242;;H01L23/538;;H01R12/00;;H03H7/24;;H03H7/38;;H05K1/02;;H05K1/11,,0,0,,,,EXPIRED
420,US,S,US D0307727 S,121-102-084-865-065,1990-05-08,1990,US 93949286 F,1986-12-08,US 93949286 F,1986-12-08,Scale base,,SUNBEAM CORP,HART RICHARD S;;BLOOM DAVID H;;BRANSKY JEFFERY D,SUNBEAM PRODUCTS INC (1995-05-12);;SUNBEAM CORPORATION A CORP. OF DE (1986-11-13),https://lens.org/121-102-084-865-065,Design Right,yes,3,0,1,1,0,,,D10/94,4,0,,,"Linens, Domestics & Bath-Jan./Feb. 1984-p. 30-Scales at top-right.;;Form 93-1/81-p. 48-Scales w/Readout at top-left.;;Linens, Domestics & Bath-9/85-p. 34-Scales at bottom of upper left.;;Hong Kong Enterprises-10/81-p. 297-Scales at center-left-#918.",EXPIRED
421,GB,A,GB 2454444 A,136-493-031-870-78X,2009-05-06,2009,GB 0904701 A,2006-10-24,US 2006/0041456 W,2006-10-24,Elevator cross-dispatching system with inter group relative system response (IRSR) dispatching,"During elevator modernization, a cross-dispatching system receives hall calls and assigns each hall call to either a group of existing elevator car controllers or a group of new elevator car controllers. The cross-dispatching system creates an inter group relative system response (iRSR) value for the hall call for both the existing group of elevators and the new group of elevators, based upon information from each group such as car location, in-service status, load, and direction. If the group assigned the hall call does not answer the call within a redispatch time period, the cross-dispatching system again calculates the iRSR for each group and reassigns the hall call.",OTIS ELEVATOR CO,GRANT JOHN W;;HUGHES DAVID M;;BLOOM JERROLD C,,https://lens.org/136-493-031-870-78X,Patent Application,no,3,0,12,12,0,B66B1/2458;;B66B1/14;;B66B1/2458;;B66B1/2458;;B66B1/34;;B66B19/007;;B66B19/007;;B66B2201/102;;B66B2201/102;;B66B2201/211;;B66B2201/211;;B66B2201/233;;B66B2201/233,B66B1/24,,0,0,,,,ACTIVE
422,EP,B1,EP 0980079 B1,140-245-629-590-653,2007-02-07,2007,EP 99306022 A,1999-07-29,US 13208198 A,1998-08-10,Low cross-talk ball grid array resistor network,,CTS CORP,BLOOM TERRY R;;COOPER RICHARD O;;POOLE DAVID L,,https://lens.org/140-245-629-590-653,Granted Patent,yes,3,0,10,10,0,H01C1/02;;H01C7/006;;H01C7/006;;H01C17/242;;H01C17/242;;H01L23/5386;;H01L23/5386;;H01L2924/0002;;H01L2924/0002;;H01L2924/15311;;H01L2924/15311;;H01L2924/3011;;H01L2924/3011,H01C1/012;;H01C13/02;;H01C1/02;;H01C7/00;;H01C17/242;;H01L23/538;;H01R12/00;;H03H7/24;;H03H7/38;;H05K1/02;;H05K1/11,,0,0,,,,EXPIRED
423,EP,A4,EP 2201753 A4,158-706-475-000-982,2012-03-14,2012,EP 08833363 A,2008-09-24,US 2008/0077433 W;;US 99509407 P;;US 23577508 A,2007-09-24,TARGET ACQUISITION SYSTEM,,GLOBAL DEVICE MAN,HARRIS DAVID P;;CORMACK RANDALL WAYNE;;BLOOM JONATHAN G,,https://lens.org/158-706-475-000-982,Search Report,no,4,0,5,5,0,G06F3/0481;;G06F3/04845;;G06F2203/04806;;H04N5/2628;;G16H40/63;;G16Z99/00;;H04N5/2628;;G06F3/0481;;G06F2203/04806;;G06F3/04845;;G16H40/63;;G16Z99/00,G06F3/048;;G16Z99/00;;H04N5/44,,2,0,,,"""GlobalControl TM. Advanced Video & Data Communication Systems for the OR"", 4 February 2005 (2005-02-04), pages 1 - 6, XP002668381, Retrieved from the Internet <URL:http://web.archive.org/web/20050204031845/http://gdmworld.com/global2.htm> [retrieved on 20120131];;See also references of WO 2009042630A1",DISCONTINUED
424,CA,A1,CA 2047872 A1,037-538-368-251-842,1992-01-27,1992,CA 2047872 A,1991-07-25,US 55804490 A,1990-07-26,INSULATING HEAT RETENTION SYSTEM AND METHOD,"PATENT Attorney's Docket No. BR-1527 An insulating heat re-radiation - retention and infiltration air free system and method is provided for processing heated articles, including upper and lower heat shields to form, in combination with spaced apart rollers employed to support the articles, a substantial infiltration air- free enclosure, each of the heat shields are made-up of substantially high purity 100% ceramic fiber which is relatively non-porous and gap free and having fiber hot faces, the fiber of the heat shields being compressed and maintained in a high density condition, the fiber of the lower heat shield being formed to contact the circumferences of the rollers in a manner to prevent air from passing into the enclosure, the upper and lower heat shields being maintained in close proximity with the heated articles. 39",ALLEGHENY LUDLUM CORP,BURK DAVID L;;BLOOM WILLIAM M;;HAVRANEK TERENCE L,,https://lens.org/037-538-368-251-842,Patent Application,no,0,0,8,8,0,B21B45/00;;B21B45/008;;B21B45/008;;C21D9/0006;;C21D9/0006;;F27D1/0013;;F27D1/0013;;F27D1/06;;F27D1/06;;F27D1/144;;F27D1/144;;Y02P70/10;;Y02P70/10,B21B45/00;;C21D9/00;;F27D1/00;;F27D1/06;;F27D1/14,,0,0,,,,DISCONTINUED
425,WO,A1,WO 2001/011410 A1,062-122-305-349-532,2001-02-15,2001,US 0021665 W,2000-08-08,US 37271299 A,1999-08-11,SINGLE LENS REFLECTIVE FIBER OPTIC COMPONENT GEOMETRY,A single lens reflective fiber optic component geometry is described. The geometry uses a single lens to couple light from one or more input optical fibers to one or more optical output fibers via a reflective light processing element.,LIGHTCONNECT INC,THACKARA JOHN I;;GODIL ASIF A;;BLOOM DAVID M,,https://lens.org/062-122-305-349-532,Patent Application,yes,3,4,2,23,0,G02B26/0808;;G02B26/0808;;H01S5/005;;H01S5/005,G02B6/35;;G02B26/08;;H01S5/00,,2,1,107-652-417-159-118,10.1117/1.601332,"PATENT ABSTRACTS OF JAPAN vol. 004, no. 146 (P - 031) 15 October 1980 (1980-10-15);;GLOECKNER S ET AL: ""MICRO-OPTO-MECHANICAL BEAM DEFLECTORS"", OPTICAL ENGINEERING,US,SOC. OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS. BELLINGHAM, vol. 36, no. 5, 1 May 1997 (1997-05-01), pages 1339 - 1345, XP000692363, ISSN: 0091-3286",PENDING
426,JP,A,JP 2000124015 A,076-615-738-850-801,2000-04-28,2000,JP 22272799 A,1999-08-05,US 13208198 A,1998-08-10,LOW-CROSSTALK BALL GRID ARRAY RESISTOR CIRCUIT NETWORK,"PROBLEM TO BE SOLVED: To provide a resistor circuit network which terminates an active electronic device and in which crosstalk noises among adjacent resistors and conductors which connect the resistors to another electronic package are low. SOLUTION: A substrate 11 has an upper surface 12 and a lower surface 13. Resistors 14 are positioned on the upper surface 12, and conductors 16 are also positioned on the upper surface 12 and electrically connected to the end sections 15 of the resistors 14, respectively. Solder balls 28 are arranged on the lower surface 13 and electrically connected to via holes 18. One end sections 17 of the resistors 14 are commonly connected electrically to each other through one common conductor 20. Then the commonly connected resistors 4 are connected electrically to a single common via hole 22 through the common conductor 20. Consequently, a resistor circuit network can be obtained with which the occurrence of crosstalk noises among the resistors is minimized, and intermediate connections can be formed at high density.",CTS CORP,BLOOM TERRY R;;COOPER RICHARD O;;POOLE DAVID L,,https://lens.org/076-615-738-850-801,Patent Application,no,0,0,10,10,0,H01C1/02;;H01C7/006;;H01C7/006;;H01C17/242;;H01C17/242;;H01L23/5386;;H01L23/5386;;H01L2924/0002;;H01L2924/0002;;H01L2924/15311;;H01L2924/15311;;H01L2924/3011;;H01L2924/3011,H01C13/02;;H01C1/02;;H01C7/00;;H01C17/242;;H01L23/538;;H01R12/00;;H03H7/24;;H03H7/38;;H05K1/02;;H05K1/11,,0,0,,,,PENDING
427,US,A,US 4352566 A,081-376-479-661-218,1982-10-05,1982,US 16085080 A,1980-06-19,US 16085080 A,1980-06-19,Detection of birefringence in irregularly shaped objects,"An apparatus utilizing four-wave degenerate mixing detects birefringence in irregularly shaped objects (6). Laser radiation (120) having a specified polarization is brought to a focus and then sent through the irregularly shaped object. The emerging radiation impinges upon a nonlinear material (8) to form a conjugate beam by means of four-wave degenerate mixing. The conjugate beam, which passes back through the object, is picked off and detected at a replica of the focus point. The detector (10, 11 and 12) includes a polarization detector (10) which is arranged so that a signal is detected only when the object has birefringence.",BELL TELEPHONE LABOR INC,BJORKLUND GARY C;;BLOOM DAVID M;;LIAO PAUL F,,https://lens.org/081-376-479-661-218,Granted Patent,yes,3,1,1,1,0,G01N21/23;;G02F1/3538;;G01N21/23;;G02F1/3538,G01N21/23;;G02F1/35,356/364,5,4,100-543-300-684-237;;098-998-755-021-107;;100-350-081-175-932;;061-768-827-216-362,19680316;;10.1364/ol.1.000016;;10.1063/1.89791;;19693166;;10.1364/ol.5.000185;;10.1063/1.89976,"Hellwarth, R. W., ""Generation of Time-Reversed Wave Fronts by Nonlinear Refraction"", JOSA, vol. 67, No. 1, Jan. 77, pp. 1-3.;;Yariv, A. et al., ""Amplified Reflection, Phase Conjugation, and Oscillation in Degenerate Four-Wave Mixing"", Optics Letters, vol. 1, No. 1, Jul. 1977, pp. 16-18.;;Bloom et al., ""Conjugate Wave-Front Generation and Image Reconstruction by Four-Wave Mixing"", App. Phys. Letters, vol. 31, No. 9, pp. 592-594.;;Martin, G. et al., ""Generation of a Time-Reversed Replica of a Non-uniformly Polarized Image-Bearing Optical Beam"", Optics Letters, May 1980, pp. 185-187.;;Jensen et al., ""Observation of the Time-Reversed Replica of a Monochromatic Optical Wave"", App. Phys. Lett., vol. 32, No. 3, Feb. 1978, pp. 166-168.",EXPIRED
428,EP,A2,EP 0980079 A2,178-641-269-670-388,2000-02-16,2000,EP 99306022 A,1999-07-29,US 13208198 A,1998-08-10,Low cross-talk ball grid array resistor network,A resistor network for terminating active electronic devices has low cross-talk noise between the adjoining resistors and the conductors that connect the resistors to other electronic packages. A substrate has a top and a bottom surface. Resistors are located on the top surface. Conductors are also located on the top surface and are electrically connected to each end of the resistors. Vias extend through the substrate and electrically connect to the conductors. Solder spheres are positioned on the bottom surface and are electrically connected to the vias. An end of each of the resistors is electrically connected in common through a common conductor. The commoned resistors are electrically connected to a common via through the common conductor. The resistor network minimizes cross-talk noise between the resistors and provides a high density interconnection.,CTS CORP,BLOOM TERRY R;;COOPER RICHARD O;;POOLE DAVID L,,https://lens.org/178-641-269-670-388,Patent Application,yes,0,0,10,10,0,H01C1/02;;H01C7/006;;H01C7/006;;H01C17/242;;H01C17/242;;H01L23/5386;;H01L23/5386;;H01L2924/0002;;H01L2924/0002;;H01L2924/15311;;H01L2924/15311;;H01L2924/3011;;H01L2924/3011,H01C13/02;;H01C1/02;;H01C7/00;;H01C17/242;;H01L23/538;;H01R12/00;;H03H7/24;;H03H7/38;;H05K1/02;;H05K1/11,,0,0,,,,EXPIRED
429,WO,A1,WO 2009/073216 A1,173-145-957-681-000,2009-06-11,2009,US 2008/0013434 W,2008-12-05,US 99280407 P,2007-12-06,NANOPARTICLES COMPRISING A NON-IONIZABLE POLYMER AND AN AMINE-FUNCTIONALIZED METHACRYLATE COPOLYMER,"A pharmaceutical composition comprises nanoparticles comprising a poorly water soluble drug, a poorly aqueous soluble non-ionizable polymer, and an amine-functionalized methacrylate copolymer.",BEND RES INC;;BLOOM COREY J;;CREW MARSHALL DAVID;;MILLER WARREN KENYON,BLOOM COREY J;;CREW MARSHALL DAVID;;MILLER WARREN KENYON,,https://lens.org/173-145-957-681-000,Patent Application,yes,6,4,5,5,0,A61K9/5138;;A61K9/5138;;A61K9/0048;;A61K9/0048;;A61K9/10;;A61K9/10;;A61K9/19;;A61K9/19;;A61K9/5161;;A61K9/5161;;A61K9/5192;;A61K9/5192,A61K9/14,,1,0,,,See also references of EP 2240162A4,PENDING
430,US,A,US 5629801 A,020-613-582-047-981,1997-05-13,1997,US 47375995 A,1995-06-07,US 47375995 A,1995-06-07,Diffraction grating light doubling collection system,"A reflective/diffractive light valve system collects light from multiple dimensions around a single light source. From these multiple collection dimensions, the light is directed to impinge on the valve from multiple directions. When the valve is configured to be reflective, the light returns to the source. On the other hand, when the valve is configured to be diffractive, light from a first and third order diffraction are transmitted from the valve for each of the collection dimensions which greatly enhances the efficiency of the system.",SILICON LIGHT MACHINES INC,STAKER BRYAN P;;BLOOM DAVID M;;LOUCKS BRYAN E,SILICON LIGHT MACHINES CORPORATION (2008-06-23);;SILICON LIGHT MACHINES (1996-07-19),https://lens.org/020-613-582-047-981,Granted Patent,yes,35,69,16,16,0,G02B26/0808;;G02B27/42;;H04N5/7458;;H04N9/31;;G02B19/0047;;G02B19/0028;;G02B27/10;;G02B26/0808;;H04N9/31;;G02B27/42;;H04N5/7458;;G02B19/0028;;G02B19/0047,G02B19/00;;G02B27/42;;G02B27/54;;H04N5/74;;G02B27/18;;H04N9/31,359/572;;359/558;;359/263;;353/82;;353/122;;348/759;;349/5,6,3,009-286-199-765-581;;028-775-209-892-098;;009-365-280-210-861,10.1109/5.53402;;10.1117/12.19865;;10.1016/0141-9382(91)90032-9,"R. Apte, F. Sandejas, W. Banyai, D. Bloom, Grating Light Valves For High Resolution Displays , Ginzton Laboratories, Stanford University, Stanford, CA 94305 4085.;;R. Apte, Grating Light Valves For High Resolution Displays Jun., 1994.;;O. Solgaard, Integrated Semiconductor Light Modulators For Fiber Optic And Display Applications, Feb., 1992.;;J. Neff, Two Dimensional Spatial Light Modulators: A Tutorial , Proceedings of the IEEE, vol. 78, No. 5 (May 1990), pp. 826 855.;;Gerhard Multhaupt, Viscoelastic Spatial Light Modulators and Schlieren Optical Systems for HDTV Projection Displays , SPIE vol. 1255 Large Screen Projection Displays II (1990), pp. 69 78.;;Gerhard Multhaupt, Light Valve Technologies for High Definition Television Projection Displays , Displays, vol. 12, No. 3/4 (1991), pp. 115 128.",EXPIRED
431,AU,A,AU 1993/041186 A,129-955-449-566-38X,1993-11-29,1993,AU 1993/041186 A,1993-04-28,US 87607892 A;;US 9502963 W,1992-04-28,Modulating a light beam,"A modulator for modulating incident rays of light, the modulator comprising a plurality of equally spaced apart beam elements, each of which includes a light reflective planar surface. The elements are arranged parallel to each other with their light reflective surfaces parallel to each other. The modulator includes means for supporting the beam elements in relation to one another and means for moving the beam elements relative to one another so that the beams move between a first configuration wherein the modulator acts to reflect the incident rays of light as a plane mirror, and a second configuration wherein the modulator diffracts the incident rays of light as they are reflected therefrom. In operation, the light reflective surfaces of the beam elements remain parallel to each other in both the first and the second configurations and the perpendicular spacing between the reflective surfaces of adjacent beam elements is equal to m/4 times the wavelength of the incident rays of light, wherein m=an even whole number or zero when the beam elements are in the first configuration and m=an odd number when the beam elements are in the second configuration.",LELAND STANFORD JUNIOR UNIVERSITY THE,BLOOM DAVID M;;SANDEJAS FRANCISCO S A;;SOLGAARD OLAV,,https://lens.org/129-955-449-566-38X,Patent Application,no,0,0,6,19,0,B81C2201/115;;G02B5/1828;;G02B26/0808;;B81B3/001;;Y10S359/90;;B81B3/001;;G02B5/1828;;B81C2201/115;;G02B26/0808;;Y10S359/90,B81B3/00;;G02B5/18;;G02B26/08,,0,0,,,,PENDING
432,US,A,US 5101652 A,124-679-713-885-890,1992-04-07,1992,US 55804490 A,1990-07-26,US 55804490 A,1990-07-26,INSULATING HEAT RETENTION SYSTEM AND METHOD,"An insulating heat re-radiation - retention and infiltration air free system and method is provided for processing heated articles, including upper and lower heat shields to form, in combination with spaced apart rollers employed to support the articles, a substantial infiltration air-free enclosure, each of the heat shields are made-up of substantially high purity 100% ceramic fiber which is relatively non-porous and gap free and having fiber hot faces, the fiber of the heat shields being compressed and maintained in a high density condition, the fiber of the lower heat shield being formed to contact the circumferences of the rollers in a manner to prevent air from passing into the enclosure, the upper and lower heat shields being maintained in close proximity with the heated articles.",ALLEGHENY LUDLUM CORP,BURK DAVID L;;BLOOM WILLIAM M;;HAVRANEK TERENCE L,ALLEGHENY LUDLUM CORPORATION (1990-07-25),https://lens.org/124-679-713-885-890,Granted Patent,yes,9,16,8,8,0,B21B45/00;;B21B45/008;;B21B45/008;;C21D9/0006;;C21D9/0006;;F27D1/0013;;F27D1/0013;;F27D1/06;;F27D1/06;;F27D1/144;;F27D1/144;;Y02P70/10;;Y02P70/10,B21B45/00;;C21D9/00;;F27D1/00;;F27D1/06;;F27D1/14,72/200;;72/202,4,0,,,"Theory and Design of Reradiating Type Heat Retention Panels , Ginzburg et al., Iron and Steel Engineer, Rolling Mill Issue, Dec. 1989, pp. 17 25.;;Thermal Insulation of Hot Mill Roller Tables , Laws (Source date unknown) pp. 272 276.;;The Making, Shaping and Treating of Steel , United States Steel, pp. 661 667, 936 940.;;Iron and Steel Engineers, Published Dec., 1979 Entitled: Jet Heat Recuperation of Waste Furnace Gases on Strip Lines By W. M. Bloom.",EXPIRED
433,US,A1,US 2012/0260300 A1,152-158-999-817-43X,2012-10-11,2012,US 201213490438 A,2012-06-06,US 201213490438 A;;US 60044106 A;;US 73710105 P,2005-11-15,"HIGH SPEED, REAL-TIME, CAMERA BANDWIDTH CONVERTER","Image data from a CMOS sensor with 10 bit resolution is reformatted in real time to allow the data to stream through communications equipment that is designed to transport data with 8 bit resolution. The incoming image data has 10 bit resolution. The communication equipment can transport image data with 8 bit resolution. Image data with 10 bit resolution is transmitted in real-time, without a frame delay, through the communication equipment by reformatting the image data.",BOWER DAN E;;BLOOM DAVID A;;CURRY JAMES R;;L LIVERMORE NAT SECURITY LLC,BOWER DAN E;;BLOOM DAVID A;;CURRY JAMES R,LAWRENCE LIVERMORE NATIONAL SECURITY LLC (2012-06-01),https://lens.org/152-158-999-817-43X,Patent Application,yes,11,3,2,3,0,H03M7/3064;;H03M7/3064,H04N21/60,725/118,1,0,,,"Dierickx et al., ""IBIS4 SXGA Image Sensor"", Fill Factory, June 2001.",INACTIVE
434,US,A,US 3322680 A,197-634-606-997-095,1967-05-30,1967,US 26374263 A,1963-03-08,GB 4752762 A,1962-12-17,Polymeric compositions containing a fluorescent brightening agent,,EASTMAN KODAK CO,HEDBERG DAVID G;;BLOOM MELVIN S;;OTIS MARSHALL V,,https://lens.org/197-634-606-997-095,Granted Patent,no,5,13,3,22,0,C07D263/64;;C08K5/35;;G03C1/8155;;D01F1/06;;Y10T428/2971;;Y10T428/2971;;C07D263/64;;C08K5/35;;G03C1/8155;;D01F1/06,C07D263/62;;C07D263/64;;C08K5/35;;D01F1/10;;G03C1/815,,0,0,,,,EXPIRED
435,WO,A1,WO 1996/041224 A1,002-763-321-242-210,1996-12-19,1996,US 9608803 W,1996-06-05,US 47375995 A,1995-06-07,DIFFRACTION GRATING LIGHT DOUBLING COLLECTION SYSTEM,"A reflective/diffractive light valve system collects light from multiple dimensions around a single light source. From these multiple collection dimensions, the light is directed to impinge on the valve from multiple directions. When the valve is configured to be reflective, the light returns to the source. On the other hand, when the valve is configured to be diffractive, light from a first and third order diffraction are transmitted from the valve for each of the collection dimensions which greatly enhances the efficiency of the system.",ECHELLE INC;;STAKER BRYAN P;;BLOOM DAVID M;;LOUCKS BRYAN E,STAKER BRYAN P;;BLOOM DAVID M;;LOUCKS BRYAN E,,https://lens.org/002-763-321-242-210,Patent Application,yes,2,11,16,16,0,G02B26/0808;;G02B27/42;;H04N5/7458;;H04N9/31;;G02B19/0047;;G02B19/0028;;G02B27/10;;G02B26/0808;;H04N9/31;;G02B27/42;;H04N5/7458;;G02B19/0028;;G02B19/0047,G02B19/00;;G02B27/42;;G02B27/54;;G02B27/18;;H04N5/74;;H04N9/31,,0,0,,,,PATENTED
436,JP,A,JP H11331284 A,029-523-667-248-860,1999-11-30,1999,JP 4416999 A,1999-02-23,US 3593198 A,1998-03-05,DIGITAL BASE BAND MODULATOR,"PROBLEM TO BE SOLVED: To provide a base band modulator, which can be easily adapted to various digital modulation systems, by providing first and second digital/analog converters(DAC) or the like for generating an in-phase (I) base band signal and a quadrature phase (Q) base band signal an output sample rate. SOLUTION: I state and Q state indexes are supplied to digital filters 104 and 106. Filtered I and Q symbol values, provided by the digital filters 104 and 106 are supplied to a resampler 108. The resampled symbol values, provided by the resampler 108 are supplied to digital analog converters(DACs) 110 and 112 and converted to an analog voltage at the output sample rate. Since the digital filters 104 and 106 can be easily constituted, the versatility of a digital base band modulator 100 is maximized.",HEWLETT PACKARD CO,SCHWARTZ DAVID J;;BLOOM ALAN R;;ANKLAM WILLIAM J,,https://lens.org/029-523-667-248-860,Patent Application,no,0,0,5,5,0,H04L27/0008;;H04L27/0008,H04L27/20;;H04J13/00;;H04L27/00,,0,0,,,,EXPIRED
437,EP,A3,EP 0468716 A3,047-915-084-110-70X,1992-12-23,1992,EP 91306628 A,1991-07-22,US 55804490 A,1990-07-26,INSULATING HEAT RETENTION SYSTEM AND METHOD,"An insulating heat re-radiation - retention and infiltration air free system and method is provided for processing heated articles, including upper and lower heat shields (24,26) to form, in combination with spaced apart rollers (22) employed to support the articles, a substantial infiltration air-free enclosure, each of the heat shields (24,26) are made-up of substantially high purity 100% ceramic fibre which is relatively non-porous and gap free and having fibre hot faces, the fibre of the heat shields (24,26) being compressed and maintained in a high density condition, the fibre of the lower heat shield (26) being formed to contact the circumferences of the rollers (22) in a manner to prevent air from passing into the enclosure, the upper and lower heat shields (24,26) being maintained in close proximity with the heated articles.",ALLEGHENY LUDLUM CORPORATION,"BURK, DAVID LAWRENCE;;BLOOM, WILLIAM MILLARD;;HAVRANEK, TERENCE LOUIS",,https://lens.org/047-915-084-110-70X,Search Report,yes,8,0,8,8,0,B21B45/00;;B21B45/008;;B21B45/008;;C21D9/0006;;C21D9/0006;;F27D1/0013;;F27D1/0013;;F27D1/06;;F27D1/06;;F27D1/144;;F27D1/144;;Y02P70/10;;Y02P70/10,B21B45/00;;C21D9/00;;F27D1/00;;F27D1/06;;F27D1/14,,2,0,,,"IRON AND STEEL ENGINEER vol. 66, no. 6, June 1989, PITTSBURGH US pages 24 - 29 E. A. UPTON ET AL.: 'Heat retaining panel performance at a 56-in. hot strip mill';;IRON AND STEEL ENGINEER vol. 66, no. 12, December 1989, PITTSBURGH US pages 17 - 25 V. B. GINZBURG ET AL. 'Theory and design of reradiating type heat retention panels'",DISCONTINUED
438,CA,A1,CA 3042250 A1,074-280-872-175-021,2018-05-17,2018,CA 3042250 A,2017-11-02,US 201615349667 A;;US 2017/0059674 W,2016-11-11,ULCER DETECTION APPARATUS AND METHOD WITH VARYING THRESHOLDS,"A method determines the emergence of an ulcer or a pre-ulcer on at least one foot of a patient provides one or more processors and a modality for receiving at least one foot. The method generates, using a plurality of temperature sensors, discrete temperature data values after receipt of the at last one foot. The plurality of discrete temperature data values represents temperatures at different locations of the at least one foot. Next, the method compares, using a prescribed function, each of the discrete temperature data values to one of a plurality of different predetermined values. The predetermined values are different for at least two different locations of the at least one foot. The method then produces output information indicating an emergence of an ulcer or a pre-ulcer on the at least one foot as a result of comparing.",PODIMETRICS INC,LINDERS DAVID R;;PETERSEN BRIAN J;;BLOOM JONATHAN D,,https://lens.org/074-280-872-175-021,Patent Application,no,0,0,7,7,0,A61B5/6829;;A61B5/015;;A61B5/445;;A61B5/447;;A61B5/6892;;A61B5/6829;;A61B5/015;;A61B5/445;;A61B5/447;;A61B5/6892,A61B5/01;;A61B5/00;;G08B23/00,,0,0,,,,PENDING
439,US,A1,US 2021/0200318 A1,122-935-989-321-241,2021-07-01,2021,US 202117202089 A,2021-03-15,US 202117202089 A;;US 201816183610 A;;US 201862712100 P,2018-07-30,STYLUS WITH SHEAR FORCE FEEDBACK,"Touch-based input devices, such as a stylus, can provide feedback in the form of shear forces applied to the user. A stylus can produce shear forces that act on a user to provide unique tactile sensations. For example, a shear device can be included at a grip region of a stylus to provide shear sensations at the user's hands (e.g., fingers). The shear forces can be unaligned forces that urge one part of the user's hand in one direction and another part of the user's hand in an opposite direction or that tend to maintain the other part of the user's hand in a stationary location.",APPLE INC,BLOOM DAVID H;;JACKSON BENJAMIN G;;TAYLOR STEVEN J,,https://lens.org/122-935-989-321-241,Patent Application,yes,0,2,6,6,0,G06F3/03545;;G06F3/016;;G06F3/0346;;G06F3/03545;;G06F3/016;;G06F3/03545;;G06F3/016,G06F3/01;;G06F3/0354,,0,0,,,,ACTIVE
440,EP,A3,EP 0980079 A3,129-820-994-102-814,2002-01-02,2002,EP 99306022 A,1999-07-29,US 13208198 A,1998-08-10,Low cross-talk ball grid array resistor network,A resistor network for terminating active electronic devices has low cross-talk noise between the adjoining resistors and the conductors that connect the resistors to other electronic packages. A substrate has a top and a bottom surface. Resistors are located on the top surface. Conductors are also located on the top surface and are electrically connected to each end of the resistors. Vias extend through the substrate and electrically connect to the conductors. Solder spheres are positioned on the bottom surface and are electrically connected to the vias. An end of each of the resistors is electrically connected in common through a common conductor. The commoned resistors are electrically connected to a common via through the common conductor. The resistor network minimizes cross-talk noise between the resistors and provides a high density interconnection.,CTS CORP,BLOOM TERRY R;;COOPER RICHARD O;;POOLE DAVID L,,https://lens.org/129-820-994-102-814,Search Report,yes,3,0,10,10,0,H01C1/02;;H01C7/006;;H01C7/006;;H01C17/242;;H01C17/242;;H01L23/5386;;H01L23/5386;;H01L2924/0002;;H01L2924/0002;;H01L2924/15311;;H01L2924/15311;;H01L2924/3011;;H01L2924/3011,H01C13/02;;H01C1/02;;H01C7/00;;H01C17/242;;H01L23/538;;H01R12/00;;H03H7/24;;H03H7/38;;H05K1/02;;H05K1/11,,0,0,,,,EXPIRED
441,US,B2,US 9233078 B2,163-543-493-650-142,2016-01-12,2016,US 74675208 A,2008-12-05,US 74675208 A;;US 99280407 P;;US 2008/0013434 W,2007-12-06,Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer,"A pharmaceutical composition comprises nanoparticles comprising a poorly water soluble drug, a poorly aqueous soluble non-ionizable polymer, and an amine-functionalized methacrylate copolymer.",BLOOM COREY J;;CREW MARSHALL DAVID;;MILLER WARREN KENYON;;BEND RES INC,BLOOM COREY J;;CREW MARSHALL DAVID;;MILLER WARREN KENYON,PFIZER INC (2008-01-22);;BEND RESEARCH INC (2008-11-03),https://lens.org/163-543-493-650-142,Granted Patent,yes,100,1,5,5,0,A61K9/5138;;A61K9/5138;;A61K9/0048;;A61K9/0048;;A61K9/10;;A61K9/10;;A61K9/19;;A61K9/19;;A61K9/5161;;A61K9/5161;;A61K9/5192;;A61K9/5192,A61K31/47;;A61K9/00;;A61K9/10;;A61K9/19;;A61K9/51;;A61K31/4196;;A61K31/5415,,79,72,003-571-904-906-04X;;111-867-922-837-533;;119-668-941-485-878;;066-096-399-843-134;;054-335-292-435-771;;087-565-695-455-735;;072-037-222-430-702;;058-824-227-667-632;;092-336-664-933-089;;015-714-720-040-924;;032-505-827-034-650;;018-417-372-069-779;;024-490-053-097-930;;098-947-239-453-173;;085-251-472-468-235;;093-034-511-083-004;;169-204-991-805-559;;068-415-037-271-085;;070-947-268-845-663;;029-148-840-307-966;;119-122-859-763-459;;028-163-841-784-966;;022-128-391-256-231;;069-221-673-539-59X;;064-606-200-359-500;;174-784-131-766-662;;044-401-659-486-787;;098-861-505-143-77X;;067-814-700-972-681;;122-821-104-012-033;;121-710-804-304-151;;080-045-508-651-228;;045-658-726-355-809;;009-965-442-151-227;;001-560-172-708-040;;034-644-848-878-302;;009-807-758-506-131;;005-011-839-424-294;;026-102-898-190-657;;037-950-455-763-306;;043-082-903-697-972;;064-604-226-265-642;;068-148-200-880-216;;136-143-741-385-295;;032-363-810-864-905;;048-254-383-700-313;;120-518-535-909-315;;020-895-468-484-385;;066-394-361-307-77X;;037-134-045-861-83X;;028-217-398-100-398;;067-995-195-259-919;;004-382-489-377-69X;;022-863-115-592-125;;078-769-616-108-97X;;038-192-364-607-443;;022-719-243-940-116;;018-888-014-102-189;;081-854-827-689-406;;046-414-361-320-616;;023-530-038-077-023;;067-097-986-709-416;;007-559-457-342-628;;001-456-292-671-326;;032-753-041-706-956;;056-450-653-736-69X;;013-320-933-494-247;;085-018-875-201-219;;025-129-775-479-227;;011-647-950-269-457;;012-102-263-066-603;;030-636-163-258-383,10.1080/02652040310001619992;;14718187;;10.1039/b605640g;;10.1016/0168-3659(90)90103-z;;12882808;;10.1167/iovs.02-1068;;15233861;;10.1211/0022357023835;;10.1016/s0378-5173(97)00083-5;;12506087;;10.1167/iovs.01-1156;;11996827;;10.1016/s0378-5173(02)00080-7;;10.1111/j.2042-7158.1987.tb03144.x;;2894445;;10.1002/jps.2600600902;;4935981;;12881116;;10.1080/0265204031000093591;;10.3109/02652040309178075;;10.1016/s0378-5173(01)00760-8;;11472825;;13678795;;10.1016/s0928-0987(03)00178-7;;10397606;;10.1023/a:1018826103261;;10.1080/107175400455128;;11195426;;14657301;;10.1148/radiol.2293031004;;10.1016/0378-5173(89)90281-0;;3520598;;10.1533/9781855738379.1.29;;10.1016/j.ejpb.2003.10.018;;15018976;;12739765;;10.1023/a:1023290514575;;10.1016/0168-3659(85)90057-4;;10.3109/02652048609049580;;3508173;;10.1248/cpb.36.4941;;3246054;;11672871;;10.1016/s0169-409x(01)00200-9;;10.1002/marc.200500631;;10.1002/mabi.200600189;;17366516;;10.1016/s0142-9612(01)00127-2;;11761166;;14661026;;pmc2346610;;10.1038/nbt920;;7904628;;10.1111/j.2042-7158.1993.tb05614.x;;12601049;;10.1167/iovs.02-0791;;10994037;;10.1111/j.2042-7158.1994.tb05702.x;;7897587;;10.1111/j.2042-7158.1994.tb03711.x;;8201534;;10.1016/s0010-7824(00)00113-x;;10906504;;10.3109/02652049709015336;;9132474;;10.1016/s0939-6411(03)00138-3;;14602172;;15296959;;10.1016/j.ejpb.2004.02.016;;16118015;;10.1016/j.biomaterials.2005.04.041;;16045324;;10.1021/ja052594h;;10.1007/s11095-006-9609-x;;16550476;;8094245;;10.1023/a:1018977130559;;10.1016/s0142-9612(01)00284-8;;11922464;;10.3109/03639049609065914;;10.3168/jds.s0022-0302(93)77712-7;;12434408;;10.1002/jps.10227;;12102196;;10.1016/s0142-9612(02)00080-7;;10.1016/s0928-0987(02)00057-x;;12113891;;15139521;;10.1023/b:pham.0000022411.47059.76;;10.1021/ja029267j;;14611213;;10.1016/s0378-5173(99)00171-4;;10486437;;10.1016/0168-3659(93)90103-c;;8331530;;10.1002/jps.2600820608;;7168872;;10.1248/cpb.30.4479;;10.1016/s0939-6411(03)00190-5;;15018984;;10.1248/cpb.30.673;;10.1002/jps.2600691209;;7463321;;2830037;;10.1248/cpb.35.3800;;15312996;;10.1016/j.jconrel.2004.05.016;;9608398;;10.3109/02652049809006863;;11906809;;10.1016/s1350-9462(01)00017-9;;15018982;;10.1016/s0939-6411(03)00187-5;;1359070;;10.1111/j.2042-7158.1992.tb03649.x;;10.1021/la0478595;;15620331;;10.1016/0169-409x(95)00017-2;;15907581;;10.1016/j.jconrel.2005.02.015;;8828763;;10.1111/j.1525-1594.1996.tb04535.x;;18572650;;10.1021/js9605226;;9423162;;11943393;;10.1016/s0168-3659(02)00025-1;;15149170;;10.1021/bc034113u;;15312997;;10.1016/j.jconrel.2004.06.003,"Al-Kassas, R., ""Design and In Vitro Evaluation of Gentamicin-Eudragit Microspheres Intended for Intra-Ocular Administration,"" Journal of Microencapsulation, 21:1(2004)71-81.;;Amrite, A.C., S.P. Ayalasomayajula, and U. Kompella, ""Ocular Distribution of Intact Nano- and Micro Particles Following Subconjunctival and Systemic Routes of Administration,"" Drug Delivery Techn., vol. 2, No. 3, 2003.;;Barbu, E., L. Verestiuc, T.G. Nevell, and J. Tsibouldis, ""Polymeric Materials for Ophthalmic Drug Delivery: Trends and Perspectives,"" J. of Materials Chemistry, 16(2006)3439-3443.;;Bodmeier et al., ""Preparation and Evaluation of Drug-Containing Polymeric Nanosuspensions,"" presented at the 5th International Conference on Pharmaceutical Technology, Paris, France, 1989. Proceedings vol. 2, pp. 265-268.;;Bodmeier, et al., ""Indomethacin Polymer Nanosuspension Prepared by Microfluidization"", Journal of Controlled Release, 12 (1990) 223-233.;;Bourges, J.-L., S.E. Gautier, F. Delie, R.A. Bejjani, J.-C. Jeanny, R. Gurny, D. BenEzra, and F.F. Behar-Cohen, ""Ocular Drug Delivery Targeting the Regina and Retinal Pigment Epithelium Using Polylactide Nanoparticles,"" Investigative Ophthalmology and Visual Science, 44:8(2003)3562-3569.;;Briancon, S., H. fessi, F. Lecomet, and J. Lieto, ""Study and Scale-Up of a Nanoprecipitation Process,"" Industrial Crystallization 1999 (IChemE), pp. 1-10.;;Bucolo, C., A. Maltese, F. Maugeri, B. Busa, G. Puglisi, and R. Pignatello, ""Eudragit RL100 Nanoparticle System for the Ophthalmic Delivery of Cloricromene,"" Journal of Pharmacy and Pharmacology, 56(2004)841 846.;;Calvo, P., J.L. Vila-Jato, and M.J. Alonso, ""Evaluation of Cationic Polymer-Coated Nanocapsules as Ocular Drug Carriers,"" International Journal of Pharmaceutics, 153(1997)41-50.;;Carrasquillo, K.G., J.A. Ricker, I.K. Rigas, J.W. Miller, E.S. Gragoudas, and A.P. Adamis, ""Controlled Delivery of the Anti-VEGF Aptamer EYE001 with Poly(lactic-co-glycolic) Acid Microspheres,"" Investigative Ophthalmology and Visual Science, 44:1(2003)290-299.;;Cavalli, R., M.R. Gasco, P. Chetoni, S. Burgalassi, and M.F. Saettone, ""Solid Lipid Nanoparticles (SLN) as Ocular Delivery System for Tobramycin,"" International J. Pharmaceutics, 238(2002)241-245.;;Chen et al., ""Comparison of Albumin and Casein Microspheres as a Carrier for Doxorubicin,"" J. Pharm. Pharmacol.39(1987)978-985.;;Chiou, W.L., and S.Riegelman, J. Pharm. Sci., 60:9(1971)1281-1302.;;Couvreur, Microspheres and Drug Therapy, Elsevier, (1984) pp. 103-115.;;De, T.K., D.J. Rodman, B.A. Holm, P.N. Prasad, and E.J. Bergey, ""Brimonidine Formulation in Polyacrylic Acid Nanoparticles for Ophthalmic Delivery,"" J. Microencapsualtion, 20:3)2003)361-374.;;Decampos, A.M., A. Sanchez, and M.J. Alonso, ""Chitosan Nanoparticles: A New Vehicle for the Improvement of the Delivery of Drugs to the Ocular Surface. Application to Cyclosporin A,"" International J. of Pharmaceutics, 224(2001)159-168.;;Decampos., A.M., A. Sanchez, R. Gref, P. Calvo, and M.J. Alonso, ""The Effect of a PGE Versus a Chitosan Coating on the Interaction of Drug Colloidal Carriers with the Ocular Mucosa,"" European Journal of Pharmaceutical Sciences, 20(2003)73-81.;;Dejaeghere, F., E. Allemann, J.-C. Leroux, W. Stevels, J. Feijen, E. Doelker, and R. Gurny, ""Formulation of Lyoprotection of Poly(Lactic Acid-Co-Ethylene Oxide) Nanoparticles: Influence on Physical Stability and in Vitro cell Uptake,"" Pharmaceutical Research, 16:6(1999)859-866.;;Desai, S.D., and J. Blanchard, ""Pluronic F127-Based Ocular Delivery System Containing Biodegradable Polyisobutylcyanoacrylate Nanocapsules of Pilocarpine,"" Drug Delivery, 7(2000)201-207.;;Fee, C.A., and R.I. Pettigrew, ""National Institute of Biomedical Imaging and Bioengineering: Poised for the Future,"" National Institute of Biomedical Imaging and Bioengineering, 229:3(2003)636-637.;;Fessi, H., F. Puisieux, J.Ph. Devissaguet, N. Ammoury, and S. Benita, ""Nanocapsule Formation by Interfacial Polymer Deposition Following Solvent Displacement,"" International J. of Pharmaceutics, 55(1989)R1-R4.;;Ford, J.L., Pharm. Acta Helv., 61:3(1986)69-87.;;Fox et al., from Proteins in Food Processing, R.Y. Yada (ed), CRC Press, 2004, Chapter 3: The Caseins pp. 29-71.;;Gavini, E., P. Chetoni, M. Cossu, M.G. Alvarez, M.F. Saettone, and P. Giunchedi, ""PLGA Microspheres for the Ocular Delivery of a Peptide Drug, Vancomycin Using Emulsification/Spray-Drying as the Preparation Method: In Vitro/In Vivo Studies,"" European Journal of Pharmaceutics and Biopharmaceutics, 57(2004)207-212.;;Giannavola, C., C. Bucolo, A. Maltese, D. Paolino, M.A. Vandelli, G. Puglisi, V.H.L. Lee, and M. Fresta, ""Influence of Preparation Conditions on Acyclovir-Loaded Poly-d,l-Lactic Acid Nanospheres and Effect of PEG Coating on Ocular Drug Bioavailability."" Pharmaceutical Research, 20:4(2003)584-590.;;Gurny, Drug Develop. Ind. Pharm. 7(1), 1-25, 1981.;;Gurny, R., T. Boye, and H. Ibrahim, ""Ocular Therapy with Nanoparticulate Systems for Controlled Drug Delivery,"" Journal of Controlled Release, 2(1985)353-361.;;Harmia, J. Microencapsulation, 1986 vol. 3, No. 1, p. 3-12.;;Hasegawa, H., et al., Chem. Pharm. Bull., 33:4(1985)1615-1619; Chem. Pharm. Bull., 34:5(1986)2183-2190; Chem. Pharm. Bull., 36:12(1988) 4941-4950.;;Herrero-Vanrell, R., and M.F. Refojo, ""Biodegradable Microspheres for Vitreoretinal Drug Delivery,"" Advanced Drug Delivery Reviews, 52(2001)5 16.;;Hornig et al., ""Novel Nanoparticles Based on Dextran Esters with Unsaturated Moieties,"" Macromolecular Rapid Commun., 2005, 26, 1908-1912.;;Hornig et al., ""Structure Design of Multifunctional Furoate and Pyroglutamate Esters of Dextran by Polymer-Analogous Reactions,"" Macromol. Biosci. 2007, 7, 297-306.;;Hsiue, G.-H., S.-H. Hsu, C.-C. Yang, S.-H. Lee,a nd I.-K. Yang, ""Preparation of Controlled Release Ophthalmic Drops, for Glaucoma Therapy Using Thermosensitive poly-N-Isopropylacrylamide,"" Biomaterials, 23(2002)457 462.;;Kim, S., Y.T. Lim, E.G. Soltesz, A.M. DeGrand, J. Lee, A. Nakayama, J.A. Parker, T. Mihaljevic, R.G. Laurence, D.M. Dor, L.H. Cohn, M.G. Bawendi, and J.V. Frangioni,""Near-Infrared Fluorescent Type II Quantum Dots for Sentinel Lymph Node Mapping,"" Nature Biotechnology, 22:1(2004)93-97.;;Knepp et al., Synthesis, Properties, and Intratumoral Evaluation of Mitoxantrone-Loaded Casein Microspheres in Lewis Lung Carcinoma, J. Pharm. Pharmacol., 45(1993)887-891.;;Kompella, U.B., N. Bandi, and S.P. Ayalasomayajula, ""Subconjunctival Nano- and Microparticles Sustain Retinal Delivery of Budesonide, A Corticosteroid Capable of Inhibiting VEGF Expression,"" Investigative Ophthalmology and Visual Science, 44:3(2003)1192-1201.;;Kumar, M.N.V., ""Nano and Microparticles as Controlled Drug Delivery devices,"" J. Pharm. Pharmaceutical Sciences, 3:2(2000)234-258.;;Latha et al., Casein as a Carrier Matrix for 5-Fluorouracil: Drug Release from Microspheres, Drug-Protein Conjugates and In-Vivo Degradation of Microspheres in Rat Muscle, J. Pharm. Pharmacol., 46(1994)858-862.;;Latha et al., Glutaraldehyde Cross-Linked Bovine Casein Microspheres as a Matrix for the Controlled Release of Theophylline: In Vitro Studies, J. Pharm. Pharmacol., 46(1994)8-13.;;Latha et al., Progesterone Release from Glutaraldehyde Cross-Linked Casein Microspheres: In Vitro Studies and In Vivo Response in Rabbits, Contraception, 61(2000)329-334.;;Lecorre, P., J.H. Rytting, V. Gajan, F. Chevanne, and R. LeVerge, ""In Vitro Controlled Release Kinetics of Local Anaesthetics from Poly(D,L-lactice) and Poly (lactice-co-glycolide) Microspheres,"" Journal of Microencapsulation, 1997, pp. 243-255.;;Lellemand, F., O. Felt-Baeyens, K. Besseghir, F. Behar-Cohen, and R. Gurny, ""Cyclosporine A Delivery to the Eye: A Pharmaceutical Challenge,"" European J. of Pharmaceutics and Biopharmaceutics, 56(2003)307 318.;;Lemarchand, C., R. Gref, and P. Couvreur, ""Polysaccharide-Decorated Nanoparticles,"" European J. of Pharmaceutics and Biopharmaceutics, 58(204,327-341.;;Lemarchand, et al., ""Influence of polysaccharide coating on the interactions of nanoparticles with biological systems,"" Biomaterials, 27(2006)108-118.;;Liebert, et al., ""Nanoparticles on the Basis of Highly Functionalized Dextrans,"" J. Am. Chem. Soc. 2005, 127, 10484-10485.;;Longmuir, K.J., R.T. Robertson, S.M. Haynes, J.L. Baratta, and A.J. Waring, ""Effective Targeting of Liposomes to Liver and Hepatocytes In Vivo by Incorporation of a Plasmodium Amino Acid Sequence,"" Pharmaceutical Research, 23:4(2006)759-769.;;Losa, C., L. Marchal-Heussler, F. Orallo, J.L. Vila Jato, and M.J. Alonso, ""Design of New Formulations for Topical Ocular Administration: Polymeric Nanocapsules Containing Metipranolol,"" Pharmaceutical Research, 10:1(1993)80-87.;;Merodio, M., J.M. Irache, F. Valamanesch, and M. Mirshahi, ""Ocular Disposition and Tolerance of Ganciclovir-Loaded Albumin Nanoparticles after Intravitreal Injection in Rats,"" Biomaterials, 23(2002)1587-1594.;;Mirshahi et al., Development of Drug Delivery Systems from Vegetal Proteins: Legumin Nanoparticles, Drug Dev. Indust.Pharm., 22:8(1996)841-846.;;Mora-Gutierrez et al., Modeling Calcium-Induced Solubility in Caprine Milk Caseins Using a Thermodynamic Linkage Approach, J. Dairy Sci., 76(1993)3698-3710.;;Ohio State FST 822 Class Lecture, Casein, 2006, 5 pp.;;Pignatello, R., C. Bucolo, and G. Puglisi, ""Ocular Tolerability of Eudragit RS100 and RL100 Nanosuspensions as Carriers for Ophthalmic Controlled Drug Delivery,"" Journal of Pharmaceutical Sciences, 91:12(2002)2636-2641.;;Pignatello, R., C. Bucolo, G. Spedalieri, A. Maltese, and G. Puglisi, ""Flurbiprofen-Loaded Acrylate Polymer Nanosuspensions for Ophthalmic Application,"" Biomaterials, 23(2002)3247-3255.;;Pignatello, R., C. Bucolo, P. Ferra, A. Maltese, A. Puleo, and G. Puglisi, ""Eudragit RS100 Nanosuspensions for the Ophthalmic Controlled Delivery of Ibuprofen,"" European Journal of Pharmaceutical Sciences, 16(2002)53 61.;;Qaddoumi, M.G., H. Ueda, J. Yang, J. Davda, V. Labhasetwar, and V.H.L. Lee, ""The Characteristics and Mechanisms of Uptake of PLGA Nanoparticles in Rabbit Conjuctival Epithelial Cell Layers,"" Pharmaceutical Research, 21:4(2004)641-648.;;Raveendran, P, J. Fu, and S.L. Wallen, ""Completely 'Green' Synthesis and Stabilization of Metal Nanoparticles,"" J. American Chemical Society, 125(2003)13940-13941.;;Santinho et al., Influence of Formulation on the Physiochemical Properties of Casein Microparticles, Int'l J. Pharm., 186(1999)191-198.;;Scholes, P.D., A.G.A. Coombes, L. Ilium, S.S. Savis, M. Vert, and M.C. Davies, ""The Preparation of Sub-200 nm Poly(lactide-co-glycolide) Microspheres for Site-Specific Drug Delivery,"" J. Controlled Release, 25(1993)145-153.;;Sjostrom, et al., Journal of Pharmaceutical Sciences, vol. 82, No. 6 Jun. 1993, pp. 584-589.;;Sugimoto, I., K. Sasaki, A. Kuchiki, T. Ishihara, and H. Nakagawa, Chem. Pharm. Bull, 30:12(1982)4479-4488.;;Suverkrup, R., S. Grunthal, O. Krasichkova, S. Maier, A. Weischselbaum, B. Neff, M. Diestelhorst, S. Dinslage, and A. Lux, ""The Ophthalmic Lyophilisate Carrier System (OLCS): Development of a Novel Dosage Form, Freeze-Drying Technique, and In Vitro Quality Control Tests,"" European J. Pharmaceutics and Biopharmaceutics, 57(2004)269-277.;;Takayama, K., N. Nambu, and T. Nagai., Chem. Pharm. Bull., 30:2(1982)673-678.;;Takenaka, H., Y. Kawashima and S.Y. Lin, J. Pharm. Sci., 69:12(1980)1388-1392.;;Takeuchi, H., T. Handa and Y. Kawashima, Chem. Pharm. Bull., 35:9(1987)3800-3806.;;Tuovinen, L., E. Ruhanen, T. Kinnarinen, S. Ronkko, J. Pelkonen, A. Urtti, S. Peltonen, and K. Jarvinen, ""Starch Acetate Microparticles for Drug Delivery Into Retinal Pigment Epithelium-In Vitro Study,"" J. of Controlled Release, 98(2004)407-413.;;Ueda, M., A. Iwara, and J. Kreuter, ""Influence of the Preparation Methods on the Drug Release Behaviour of Loperamide-Loaded Nanoparticles,"" J. Microencapsulation, 15:3(1998)361-372.;;University of Guelph, Dairy Chemistry and Physics, 2006, 16 pp.;;Vandamme, Th.F., ""Microemulsions as Ocular Drug Delivery Systems: Recent Developments and Future Challenges,"" Progress in Retinal and Eye Research, 21(2002)15-34.;;Vandervoort, J., and A. Ludwig, ""Preparation and Evaluation of Drug-Loaded Gelatin Nanoparticles for Topical Ophthalmic Use,"" European J. of Pharmaceutics and Biopharmaceutics, 57(2004)251-261.;;Willmott et al., Doxorubicin-Loaded Casein Microspheres: Protean Nature of Drug Incorporation J. Pharm. Pharmacol. 42(1992)472-475.;;Zahr, A.S., M. de Villiers, and M.V. Pishko, ""Encapsulation of Drug Nanoparticles in Self-Assembled Macromolecular Nanoshells,"" Langmuir, 21(2005)503 410.;;Zimmer, A., and J. Kreuter, ""Microspheres and Nanoparticles Used in Ocular Delivery Systems,"" Advanced Drug Delivery Reviews, 16(1995)61-73.;;Aliabadi, H.M. et al., ""Micelles of methoxy poly(ethylene oxide)-b-poly(epsilon-caprolactone as vehicles for the solubilization and controlled delivery of cyclosporine A,"" Journal of Controlled Release, vol. 104, No. 2, pp. 301-311 (May 2005).;;Celikkaya, E. et al., ""Rifampicin carrying poly (D,L-lactide)/poly(ethylene glycol) microspheres: loading and release,"" Artificial Organs, Blackwell Scientific Publications, vol. 20, No. 7, pp. 743-751 (Jul. 1996).;;Hsieh Ming-Fa et al.m ""Nano-sized micelles of block copolymers of methoxy poly(ethylene glycol)-poly(epsilon-caprolactone)-graft-2-hydroxyethyl cellulose for doxorubicin delivery"" Journal of Nanoscience and Nanotechnology, vol. 8, No. 5, pp. 2362-2368 (May 2008).;;Liggins, et al., ""Solid-State Characterization of Paclitaxel,"" Journal of Pharmaceutical Sciences, vol. 86, No. 12, pp. 1458-1463(Dec. 1997).;;Mu, L., et al., ""Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanosphers for controlled release of paclitaxel (TaxolR)),"" Journal of Controlled Release, vol. 80., No. 1-3, pp. 129-144 (Apr. 2002).;;Shuai et al., ""Core-Cross-Linked Polymeric Micelles as Paclitaxel Carriers,"" Bioconjug. Chem., vol. 15, No. 3, pp. 441-448 (May 2004).;;Shuai, X. et al., ""Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery"" Journal of Controlled Release, vol. 98, No. 3, pp. 415-426 (Aug. 2004).",INACTIVE
442,DE,D1,DE 69935051 D1,111-216-997-721-00X,2007-03-22,2007,DE 69935051 T,1999-07-29,US 13208198 A,1998-08-10,BGA Widerstandsnetzwerk mit geringem Übersprechen,,CTS CORP,BLOOM TERRY R;;COOPER RICHARD O;;POOLE DAVID L,,https://lens.org/111-216-997-721-00X,Granted Patent,no,0,0,10,10,0,H01C1/02;;H01C7/006;;H01C7/006;;H01C17/242;;H01C17/242;;H01L23/5386;;H01L23/5386;;H01L2924/0002;;H01L2924/0002;;H01L2924/15311;;H01L2924/15311;;H01L2924/3011;;H01L2924/3011,H01C1/012;;H01C13/02;;H01C1/02;;H01C7/00;;H01C17/242;;H01L23/538;;H01R12/00;;H03H7/24;;H03H7/38;;H05K1/02;;H05K1/11,,0,0,,,,EXPIRED
443,US,B2,US 11231784 B2,089-515-775-137-03X,2022-01-25,2022,US 202117202089 A,2021-03-15,US 202117202089 A;;US 201816183610 A;;US 201862712100 P,2018-07-30,Stylus with shear force feedback,"Touch-based input devices, such as a stylus, can provide feedback in the form of shear forces applied to the user. A stylus can produce shear forces that act on a user to provide unique tactile sensations. For example, a shear device can be included at a grip region of a stylus to provide shear sensations at the user's hands (e.g., fingers). The shear forces can be unaligned forces that urge one part of the user's hand in one direction and another part of the user's hand in an opposite direction or that tend to maintain the other part of the user's hand in a stationary location.",APPLE INC,BLOOM DAVID H;;JACKSON BENJAMIN G;;TAYLOR STEVEN J,,https://lens.org/089-515-775-137-03X,Granted Patent,yes,8,0,6,6,0,G06F3/03545;;G06F3/016;;G06F3/0346;;G06F3/03545;;G06F3/016;;G06F3/03545;;G06F3/016,G06F3/01;;G06F3/0354,,0,0,,,,ACTIVE
444,US,B1,US 6268201 B1,130-973-182-515-106,2001-07-31,2001,US 17734998 A,1998-10-23,US 17734998 A,1998-10-23,"IniB, iniA and iniC genes of mycobacteria and methods of use","This invention relates to the identification, cloning, sequencing and characterization of the iniB, iniA and iniC genes of mycobacteria which are induced by a broad class of antibiotics that act by inhibiting cell wall biosynthesis, including the first line antituberculosis agents, isoniazid and ethambutol. The present invention provides purified and isolated iniB, iniA, iniC and iniB promoter nucleic acids which may comprise the iniBAC operon, as well as mutated forms of these nucleic acids. The present invention also provides one or more single-stranded nucleic acid probes which specifically hybridize to the iniB, iniA, iniC and iniB promoter nucleic acids, and mixtures thereof, which may be formulated in kits, and used in the diagnosis of drug-resistant mycobacterial strain. The present invention also provides methods for the screening and identification of drugs effective against Mycobacterium tuberculosis using induction of the iniB promoter.",EINSTEIN COLL MED,ALLAND DAVID;;BLOOM BARRY R;;JACOBS JR WILLIAM R,HOWARD HUGHES MEDICAL INSTITUTE (1998-12-22);;ALBERT EINSTEIN COLLEGE OF MEDICINE (2019-01-01);;ALBERT EINSTEIN COLLEGE OF MEDICINE INC (2015-09-09);;ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (1999-01-19),https://lens.org/130-973-182-515-106,Granted Patent,yes,0,16,3,3,14,A61K2039/53;;A61K2039/53;;C07K14/35;;C07K14/35;;C12N15/74;;C12N15/74;;Y02A50/30;;Y02A50/30;;Y10S435/863;;Y10S435/863;;Y10S435/864;;Y10S435/864;;Y10S435/865;;Y10S435/865;;Y10S435/866;;Y10S435/866,C07K14/35;;C12N15/74,435/253.1;;424/168.1;;424/248.1;;435/863;;435/864;;435/865;;435/866;;536/23.1;;536/23.7;;536/24.32,0,0,,,,EXPIRED
445,US,A1,US 2010/0025161 A1,184-482-003-259-008,2010-02-04,2010,US 44712709 A,2009-04-24,US 2006/0041456 W,2006-10-24,Elevator Cross-Dispatching System with Inter Group Relative System Response (IRSR) Dispatching,"During elevator modernization, a cross-dispatching system receives hall calls and assigns each hall call to either a group of existing elevator car controllers or a group of new elevator car controllers. The cross-dispatching system creates an inter group relative system response (iRSR) value for the hall call for both the existing group of elevators and the new group of elevators, based upon information from each group such as car location, in-service status, load, and direction. If the group assigned the hall call does not answer the call within a redispatch time period, the cross-dispatching system again calculates the iRSR for each group and reassigns the hall call.",OTIS ELEVATOR CO,HUGHES DAVID M;;BLOOM JERROLD C;;GRANT JOHN W,OTIS ELEVATOR COMPANY (2006-10-13),https://lens.org/184-482-003-259-008,Patent Application,yes,19,2,12,12,0,B66B1/2458;;B66B1/14;;B66B1/2458;;B66B1/2458;;B66B1/34;;B66B19/007;;B66B19/007;;B66B2201/102;;B66B2201/102;;B66B2201/211;;B66B2201/211;;B66B2201/233;;B66B2201/233,B66B1/18,187/247,0,0,,,,ACTIVE
446,CA,C,CA 2133335 C,189-979-918-025-731,2003-03-18,2003,CA 2133335 A,1993-04-28,US 87607892 A;;US 9502963 W,1992-04-28,MODULATING A LIGHT BEAM,"A modulator (10) for modulating incident rays of light, the modulator having several equally spaced beam elements (18), each having a light reflective planar surface. The beam elements are arrange d and supported (12) parallel to each other, with their reflective surfaces parallel. During operation, the elements remain parallel , but the modulator moves the beams so that the per- pendicular spacing of their reflective surfaces changes between two configurations. In both configurations, the spacing equals m/4 times the wavelength of incident light. In the first configuration, m equals an even whole number or zero, and the modulator acts to reflect the incident rays of light as a plane mirror. In the second configuration, m equals an odd number and the modula- tor diffracts the incident rays as they are reflected.",,BLOOM DAVID M;;SANDEJAS FRANCISCO S A;;SOLGAARD OLAV,,https://lens.org/189-979-918-025-731,Granted Patent,no,0,0,6,19,0,B81C2201/115;;G02B5/1828;;G02B26/0808;;B81B3/001;;Y10S359/90;;B81B3/001;;G02B5/1828;;B81C2201/115;;G02B26/0808;;Y10S359/90,B81B3/00;;G02B5/18;;G02B26/08,,0,0,,,,EXPIRED
447,WO,A1,WO 1993/022694 A1,195-259-507-903-431,1993-11-11,1993,US 9303939 W,1993-04-28,US 87607892 A;;US 9502963 W,1992-04-28,MODULATING A LIGHT BEAM,"A modulator (10) for modulating incident rays of light, the modulator having several equally spaced beam elements (18), each having a light reflective planar surface. The beam elements are arranged and supported (12) parallel to each other, with their reflective surfaces parallel. During operation, the elements remain parallel, but the modulator moves the beams so that the perpendicular spacing of their reflective surfaces changes between two configurations. In both configurations, the spacing equals m/4 times the wavelength of incident light. In the first configuration, m equals an even whole number or zero, and the modulator acts to reflect the incident rays of light as a plane mirror. In the second configuration, m equals an odd number and the modulator diffracts the incident rays as they are reflected.",UNIV LELAND STANFORD JUNIOR,BLOOM DAVID M;;SANDEJAS FRANCISCO S A;;SOLGAARD OLAV,,https://lens.org/195-259-507-903-431,Patent Application,yes,2,21,6,19,0,B81B3/001;;G02B5/1828;;G02B26/0808,B81B3/00;;G02B5/18;;G02B26/08,,1,0,,,See also references of EP 0638177A4,PATENTED
448,DE,T2,DE 69603857 T2,036-640-320-517-511,2000-01-13,2000,DE 69603857 T,1996-06-05,US 48045995 A;;US 9609255 W,1995-06-07,HERSTELLUNGSVERFAHREN UND VORRICHTUNG FÜR EINEN LICHTSCHALTER MIT EBENEN BEUGUNGSGITTER,"A deformable grating aparatus for modulating light is made by forming an insulating layer on a substrate, forming a first conductive layer on the insulating layer and then forming a sacrificial layer thereon. The sacrificial layer and the first conducting layer are then etched to define bit lines and busses to bonding pads. Then a layer of resilient material is formed onto the etched layers and a reflective conducting layer is formed on the resilient layer. A dielectric layer is deposited on the reflective conducting layer. The dielectric layer, the reflective conducting layer, the resilient layer and the sacrificial layer are all then etched to form a grating including a plurality of parallel elements. Thereafter the sacrificial layer is removed below the parallel elements, to suspend the parallel elements over the first conducting layer. The surface is treated to prevent the grating from adhering to the first conducting layer. A light modulator includes a substrate with an insulating layer, and a plurality of parallel conductive layers formed on the insulating layer. The ribbons are spaced apart from the conductive layers by an air space and mounted to the substrate in gaps between the conductive layers.",SILICON LIGHT MACHINES SUNNYVA,BORNSTEIN JONATHAN;;BANYAI WILLIAM;;BLOOM DAVID;;WHITTEN RALPH;;STAKER BRYAN,,https://lens.org/036-640-320-517-511,Granted Patent,no,0,0,16,16,0,G02B5/1828;;G02B26/0808;;Y10S359/904;;G02B5/18;;G02B5/1828;;G02B26/0808;;Y10S359/904,G02B5/18;;G02B26/08,,0,0,,,,EXPIRED
449,US,A,US 5871692 A,164-980-984-034-784,1999-02-16,1999,US 78264797 A,1997-01-14,US 78264797 A,1997-01-14,"Method and apparatus for cleaning, decontaminating, and sterilizing catheters","A method for cleaning, decontaminating, and sterilizing catheters (10) using a combination of liquid and gaseous/plasma sterilization techniques to ensure the complete and efficient sterilization of a catheter (10). Angiographic dye and saline are removed from the interior (36) of the balloon (14) and its lumen (16). The outer surfaces of the catheter (10) and a guide wire lumen (18) of the catheter (10) are cleaned, decontaminated, and sterilized (42) with a liquid sterilant. The liquid sterilant fills a balloon (14) and a balloon lumen (16) of the catheter (10). The liquid sterilant is retained in the balloon (14) and the lumen (16) for a select amount of time. Thereafter, the liquid sterilant is drained from the balloon (14) and the balloon lumen (16). The filling, retaining, and draining steps are repeated until an interior (36) of the balloon (14) and the balloon lumen (16) are sterilized. Residual liquid sterilant is rinsed from the interior (36) of the balloon (14) and the balloon lumen (16). The catheter (10) is dried and then a plasma or gaseous sterilant is used to sterilize at least the outer surfaces and the guide wire lumen (18) of the catheter (10).",STERIS CORP;;CLEVELAND CLINIC FOUNDATION,HAIRE DONNA M;;WOLF-BLOOM DAVID F;;MALCHESKY PAUL S,CLEVELAND CLINIC FOUNDATION THE (1997-01-13);;STERIS CORPORATION (1997-01-13),https://lens.org/164-980-984-034-784,Granted Patent,yes,11,53,4,4,0,A61L2/20;;A61L2/20;;A61L2/14;;A61L2/14;;A61L2/18;;A61L2/18,A61L2/14;;A61L2/18;;A61L2/20,422/28;;422/34;;422/292;;422/300;;422/22;;604/266,2,0,,,"Cathetron Automated Catheter Reprocessing, Cathetron: The Only Catheter Reprocessing. No Date Available.;;The Plain Dealer, Hospitals Recycling Surgical Gear , Jan. 12, 1997.",EXPIRED
450,WO,A2,WO 1998/030249 A2,197-232-642-647-808,1998-07-16,1998,US 9800635 W,1998-01-13,US 78264797 A,1997-01-14,"METHOD AND APPARATUS FOR CLEANING, DECONTAMINATING, AND STERILIZING CATHETERS","A method for cleaning, decontaminating, and sterilizing catheters (10) using a combination of liquid and gaseous/plasma sterilization techniques to ensure the complete and efficient sterilization of a catheter (10). Angiographic dye and saline are removed from the interior (36) of the balloon (14) and its lumen (16). The outer surfaces of the catheter (10) and a guide wire lumen (18) of the catheter (10) are cleaned, decontaminated, and sterilized (42) with a liquid sterilant. The liquid sterilant fills a balloon (14) and a balloon lumen (16) of the catheter (10). The liquid sterilant is retained in the balloon (14) and the lumen (16) for a selected amount of time. Thereafter, the liquid sterilant is drained from the balloon (14) and the balloon lumen (16). The filling, retaining, and draining steps are repeated until an interior (36) of the balloon (14) and the balloon lumen (16) are sterilized. Residual liquid sterilant is rinsed from the interior (36) of the balloon (14) and the balloon lumen (16). The catheter (10) is dried and then a plasma or gaseous sterilant is used to sterilize at least the outer surfaces and the guide wire lumen (18) of the catheter (10).",STERIS CORP,HAIRE DONNA M;;WOLF-BLOOM DAVID F;;MALCHESKY PAUL S,,https://lens.org/197-232-642-647-808,Patent Application,no,0,21,4,4,0,A61L2/20;;A61L2/20;;A61L2/14;;A61L2/14;;A61L2/18;;A61L2/18,A61L2/14;;A61L2/18;;A61L2/20,,0,0,,,,PENDING
451,EP,A4,EP 2758957 A4,078-716-642-916-728,2015-04-01,2015,EP 12833593 A,2012-09-21,US 201113242695 A;;US 2012/0056465 W,2011-09-23,SYSTEM AND METHOD FOR OPTIMIZING CALL FLOWS OF A SPOKEN DIALOG SYSTEM,,SYNCHRONOSS TECHNOLOGIES INC,SUENDERMANN DAVID;;LISCOMBE JACKSON;;BLOOM JONATHAN;;LI GRACE;;PIERACCINI ROBERTO,VERINT AMERICAS INC. (2017-09-06),https://lens.org/078-716-642-916-728,Search Report,no,0,0,5,5,0,H04M3/4936;;H04M3/5166;;H04M2201/39;;H04M2201/40;;H04M2203/355;;H04M3/4936;;H04M3/5166;;H04M2201/40;;H04M2203/355;;H04M2201/39,G10L15/00;;H04M3/493;;H04M3/51,,3,1,174-144-069-379-956,10.2316/p.2011.747-038,"D SUENDERMANN ET AL: ""Large-Scale Experiments on Data-Driven Design of Commercial Spoken Dialog Systems"", 31 August 2011 (2011-08-31), Florence, italy, XP055169706, Retrieved from the Internet <URL:http://www.suendermann-oeft.de/su/pdf/interspeech2011.pdf> [retrieved on 20150213];;DAVID SUENDERMANN ET AL: ""Deploying Contender: Early Lessons in Data, Measurement, and Testing of Multiple Call Flow Decisions"", INTERNET AND MULTIMEDIA SYSTEMS AND APPLICATIONS / 747: HUMAN-COMPUTER INTERACTION, 31 May 2011 (2011-05-31), Calgary,AB,Canada, XP055169731, ISBN: 978-0-88-986871-7, DOI: 10.2316/P.2011.747-038;;See also references of WO 2013043956A1",DISCONTINUED
452,US,A,US 5256996 A,173-229-603-421-648,1993-10-26,1993,US 91208192 A,1992-07-06,US 91208192 A;;US 10655487 A;;US 25902788 A;;US 55835690 A,1987-10-06,Integrated coplanar strip nonlinear transmission line,An integrated coplanar strip nonlinear transmission line comprising a substrate of gallium arsenide upon which a heavily doped buried layer and a lightly doped surface layer of epitaxially grown gallium arsenide are grown. Two parallel conductors are integ This work was funded by the United States Government's Office of Naval Research under contract No. N99914-85-K-0381. The United States Government has a paid up license in this technology.,UNIV LELAND STANFORD JUNIOR,MARSLAND ROBERT A;;RODWELL MARK J W;;BLOOM DAVID M,,https://lens.org/173-229-603-421-648,Granted Patent,yes,12,56,1,12,0,H01L27/0605;;H03H7/325;;H01L27/0605;;H03H7/325,H01L27/06;;H03H7/32,333/20;;257/275;;257/480,17,9,013-955-110-929-659;;074-872-429-127-710;;139-153-091-547-974;;108-651-613-843-015;;011-464-360-811-259;;139-230-985-325-058;;014-183-718-956-355;;103-747-114-308-100;;102-418-415-486-476,10.1063/1.100785;;10.1109/55.724;;10.1049/sbew016e;;10.1063/1.1735612;;10.1147/rd.44.0391;;10.1049/el:19870077;;10.1080/00207218508939060;;10.1049/el:19860339;;10.1007/bf00886158,"Hyperabrupt doped GaAs Nonlinear Transmission Line for Picosecond Shockwave Generation; C. J. Madden, R. A. Marsland, M. J. W. Rodwell, D. M. Bloom and Y. C. Pao; Appl. Phys. Lett. 54(11), Mar. 13, 1989.;;Generation of 3.5 ps Fall Time Shock Waves on a Monolithic GaAs Nonlinear Transmission Line; C. J. Madden, M. J. Rodwell, R. A. Marsland, D. M. Bloom, and Y. C. Yao; IEEE Electronic Device Letters, vol. 9, No. 6, Jun. 1988.;;Picosecond Pulse Generation and Sampling with GaAS Monolithic Integrated Circuits; R. A. Marsland, C. J. Madden, V. Valdivia, M. J. W. Rodwell, D. M. Bloom; Picosecond Electronics and Optoelectronics Meeting of the Optical Society of America, Mar. 8 10, 1989.;;100 GHz GaAs MMIC Sampling Heat; R. A. Marsland; International Electron Devices Meeting, San Francisco, Calif., Dec. 11 14, 1988.;;Microwave Field Effect Transistors Theory, Design and Application; R. S. Pengelly; Research Studies Press.;;Parametric Amplification along Nonlinear Transmission Lines; Rolf Landauer; Journal of Applied Physics 31(3):479 484, 1960.;;Shock Waves in Nonlinear Transmission Lines and Their Effect on Parametric Amplification; R. Landauer; IBM Journal, Oct. 1960; pp. 391 401.;;On The Theory of Shock Radio Waves In Non Linear Lines; R. V. Khokhlov; (1971) Radiotekhnika i electronika 6(6):77 88.;;Nonlinear Transmission Line for Picosecond Pulse Compression and Boardband Phase Modulation; Rodwell, et al.; (1987) Electronics Letters; vol. 23, No. 3; Jan. 29, 1987.;;Characteristics of Travelling Waves Along the Non linear Transmission Lines for Monolithic Integrated Circuits: a Review; D. Jager; Int. J. Electronics; (1985); 58(4):649 668.;;Gate Propagation Delay and Logic Timing of GaAs Integrated Circuits Measured by Electro Optic Sampling; Rodwell, et al.; Electronics Letters 22(9):499 500; (1986).;;Gallim Arsenide Lowers Cost and Improves Performance of Microwave Counters; S. R. Gibson; (1986) Hewlett Packard Journal 37(2):4 10.;;Microwave Sampling Effect for Ultrabroadband Frequency Conversion; Moore et al; (1986) MSN & CT, pp. 113 126.;;A dc to 20 GHz Thin Film Signal Sampler for Microwave Instrumentation; J. Merkelo; Apr. 1973; Hewlett Packard Journal, pp. 10 13.;;A DC to 12.4 GHz Feedthrough Sampler For Oscilloscopes and Other RF Systems; Grove; IEEE Transactions on Microwave Theory and Techniques; vol. MTT 14, No. 12, Dec. 1966; pp. 12 15.;;The Wideband Sampling Gate An Analysis, Characterization and Application Discussion; Howard et al.; Hewlett Packard Publication, pp. 1 11.;;Nonlinear Wave Propagation Along Periodic Loaded Transmission Line; Jager, et al.; Appl. Phys. 15 (1978), pp. 393 397.",EXPIRED
453,US,A1,US 2014/0265611 A1,189-242-235-924-520,2014-09-18,2014,US 201313830869 A,2013-03-14,US 201313830869 A;;US 201313829744 A,2013-03-14,Intelligent Inductive Power System For Medical Device and System,"A system includes an inductive backplane, at least one communications interface, a control unit and an intelligent power module. The inductive backplane is configured to secure and inductively power a plurality of detachable medical device modules. The control unit controls, via the at least one communications interface, at least one attribute of each medical device module when the medical device module is secured to the inductive backplane. The intelligent power module monitors at least one parameter of the detachable medical device modules. Related apparatus, systems, techniques and articles are also described.",CAREFUSION 303 INC,FERN DAVID GEORGE;;HALBERT DONALD;;BLOOM MARK PATRICK;;CHAUHAN JEET,,https://lens.org/189-242-235-924-520,Patent Application,yes,9,22,5,7,0,A61B5/0002;;A61B2560/045;;H02J50/10;;A61M5/1415;;H02J7/00034;;H02J2310/23;;H02J50/10;;A61B5/0002;;A61B2560/045;;A61M5/1415;;H02J7/00034,H01F38/14,307/104,0,0,,,,DISCONTINUED
454,WO,A3,WO 1998/030249 A3,001-182-486-856-876,1998-09-11,1998,US 9800635 W,1998-01-13,US 78264797 A,1997-01-14,"Method and apparatus for cleaning, decontaminatingand sterilizing catheters","A method for cleaning, decontaminating, and sterilizing catheters (10) using a combination of liquid and gaseous/plasma sterilization techniques to ensure the complete and efficient sterilization of a catheter (10). Angiographic dye and saline are removed from the interior (36) of the balloon (14) and its lumen (16). The outer surfaces of the catheter (10) and a guide wire lumen (18) of the catheter (10) are cleaned, decontaminated, and sterilized (42) with a liquid sterilant. The liquid sterilant fills a balloon (14) and a balloon lumen (16) of the catheter (10). The liquid sterilant is retained in the balloon (14) and the lumen (16) for a selected amount of time. Thereafter, the liquid sterilant is drained from the balloon (14) and the balloon lumen (16). The filling, retaining, and draining steps are repeated until an interior (36) of the balloon (14) and the balloon lumen (16) are sterilized. Residual liquid sterilant is rinsed from the interior (36) of the balloon (14) and the balloon lumen (16). The catheter (10) is dried and then a plasma or gaseous sterilant is used to sterilize at least the outer surfaces and the guide wire lumen (18) of the catheter (10).",STERIS CORP,HAIRE DONNA M;;WOLF-BLOOM DAVID F;;MALCHESKY PAUL S,,https://lens.org/001-182-486-856-876,Search Report,yes,3,0,4,4,0,A61L2/20;;A61L2/20;;A61L2/14;;A61L2/14;;A61L2/18;;A61L2/18,A61L2/14;;A61L2/18;;A61L2/20,,0,0,,,,PENDING
455,JP,A,JP 2013176747 A,012-332-520-215-248,2013-09-09,2013,JP 2012043311 A,2012-02-29,JP 2012043311 A,2012-02-29,"MATERIAL DISCHARGE DEVICE, MATERIAL DISCHARGE METHOD, COATING SYSTEM AND METHOD OF MANUFACTURING COATING STRUCTURE","PROBLEM TO BE SOLVED: To provide a droplet material discharge device capable of suppressing clogging of a nozzle caused by a substance which tends to subside and discharging a prescribed amount of the substance from the nozzle, even when using a fluid material containing the substance as a material to be discharged from the nozzle of a discharge head.SOLUTION: A material discharge device 100 includes: a discharge head 3 having a nozzle capable of discharging a fluid material; a material supply part for supplying the fluid material to the discharge head 3; and means such as a pump 4 for sucking the material which is not discharged from the nozzle, of the material supplied to the discharge head 3, from the discharge head 3 and sending it to the material supply part during a discharge operation from the discharge head 3. The material supply part includes: an open container 1 opened to the external space of the atmospheric pressure, for temporarily storing the material sucked and sent from the discharge head 3; and a sealed container 2 sealed from the external space of the atmospheric pressure, for temporarily storing the material sent from the open container 1 in such a state that it can be supplied to the discharge head 3.",RICOH CO LTD;;RICOH UK PRODUCTS LTD,SUZUKI KAZUYA;;OLIVER BLOOM;;MARTIN BALL;;DAVID HOLYHEAD;;CHRIS RAYMER,,https://lens.org/012-332-520-215-248,Patent Application,no,6,0,1,1,0,,B05C11/10;;B05C5/00;;B05D1/26;;B05D3/00;;G03G5/05,,0,0,,,,PENDING
456,WO,A1,WO 2013/043956 A1,071-246-234-821-246,2013-03-28,2013,US 2012/0056465 W,2012-09-21,US 201113242695 A,2011-09-23,SYSTEM AND METHOD FOR OPTIMIZING CALL FLOWS OF A SPOKEN DIALOG SYSTEM,"A dialog manager for a spoken dialog system includes a computer, a processor, and memory, comprising: a decision module for selecting a path from a plurality of alternative paths for a given call, wherein each path implements one of a plurality of strategies for a call flow; and a weighting module for weighting the path selection decision, wherein the weighting module is operatively connected to a probability estimator for estimating a probability value that a given path of the plurality of paths is the best performing path, wherein incoming calls are directed to each of the alternative paths selected by the decision module.",SYNCHRONOSS TECHNOLOGIES INC,SUENDERMANN DAVID;;LISCOMBE JACKSON;;BLOOM JONATHAN;;LI GRACE;;PIERACCINI ROBERTO,,https://lens.org/071-246-234-821-246,Patent Application,yes,3,0,5,5,0,H04M3/4936;;H04M3/5166;;H04M2201/39;;H04M2201/40;;H04M2203/355;;H04M3/4936;;H04M3/5166;;H04M2201/40;;H04M2203/355;;H04M2201/39,G10L15/00,,4,2,174-144-069-379-956;;174-144-069-379-956,10.2316/p.2011.747-038;;10.2316/p.2011.747-038,"SUENDERMANN ET AL.: ""Deploying Contender: Early Lessons in Data, Measurement, and Testing of Multiple Call Flow Decisions"", PROCEEDINGS OF THE HUMAN-COMPUTER INTERACTION, 16 May 2011 (2011-05-16), WASHINGTON, DC, USA, XP055131815, Retrieved from the Internet <URL:http://thepieraccinis.com/publications/2011/hci20110311.pdf> [retrieved on 20121113];;DAVID SUENDERMANN, LARGE-SCALE EXPERIMENTS ON DATA-DRIVEN DESIGN OF COMMERCIAL SPOKEN DIALOG SYSTEMS;;DAVID SUENDERMANN, DEPLOYING CONTENDER: EARLY LESSONS IN DATA, MEASUREMENT, AND TESTING OF MULTIPLE CALL FLOW DECISIONS;;See also references of EP 2758957A4",PENDING
457,DE,D1,DE 69603857 D1,102-546-828-190-637,1999-09-23,1999,DE 69603857 T,1996-06-05,US 48045995 A;;US 9609255 W,1995-06-07,HERSTELLUNGSVERFAHREN UND VORRICHTUNG FÜR EINEN LICHTSCHALTER MIT EBENEN BEUGUNGSGITTER,"A deformable grating aparatus for modulating light is made by forming an insulating layer on a substrate, forming a first conductive layer on the insulating layer and then forming a sacrificial layer thereon. The sacrificial layer and the first conducting layer are then etched to define bit lines and busses to bonding pads. Then a layer of resilient material is formed onto the etched layers and a reflective conducting layer is formed on the resilient layer. A dielectric layer is deposited on the reflective conducting layer. The dielectric layer, the reflective conducting layer, the resilient layer and the sacrificial layer are all then etched to form a grating including a plurality of parallel elements. Thereafter the sacrificial layer is removed below the parallel elements, to suspend the parallel elements over the first conducting layer. The surface is treated to prevent the grating from adhering to the first conducting layer. A light modulator includes a substrate with an insulating layer, and a plurality of parallel conductive layers formed on the insulating layer. The ribbons are spaced apart from the conductive layers by an air space and mounted to the substrate in gaps between the conductive layers.",SILICON LIGHT MACHINES INC,BORNSTEIN JONATHAN;;BANYAI WILLIAM;;BLOOM DAVID;;WHITTEN RALPH;;STAKER BRYAN,,https://lens.org/102-546-828-190-637,Granted Patent,no,0,0,16,16,0,G02B5/1828;;G02B26/0808;;Y10S359/904;;G02B5/18;;G02B5/1828;;G02B26/0808;;Y10S359/904,G02B5/18;;G02B26/08,,0,0,,,,EXPIRED
458,WO,A3,WO 1998/030249 A3,140-663-042-606-144,1998-07-16,1998,US US9800635,1998-01-13,"US 8/782,647",1997-01-14,"METHOD AND APPARATUS FOR CLEANING, DECONTAMINATING, AND STERILIZING CATHETERS","A method for cleaning, decontaminating, and sterilizing catheters (10) using a combination of liquid and gaseous/plasma sterilization techniques to ensure the complete and efficient sterilization of a catheter (10). Angiographic dye and saline are removed from the interior (36) of the balloon (14) and its lumen (16). The outer surfaces of the catheter (10) and a guide wire lumen (18) of the catheter (10) are cleaned, decontaminated, and sterilized (42) with a liquid sterilant. The liquid sterilant fills a balloon (14) and a balloon lumen (16) of the catheter (10). The liquid sterilant is retained in the balloon (14) and the lumen (16) for a selected amount of time. Thereafter, the liquid sterilant is drained from the balloon (14) and the balloon lumen (16). The filling, retaining, and draining steps are repeated until an interior (36) of the balloon (14) and the balloon lumen (16) are sterilized. Residual liquid sterilant is rinsed from the interior (36) of the balloon (14) and the balloon lumen (16). The catheter (10) is dried and then a plasma or gaseous sterilant is used to sterilize at least the outer surfaces and the guide wire lumen (18) of the catheter (10).",STERIS CORPORATION,"HAIRE, Donna, M.;;WOLF-BLOOM, David, F.;;MALCHESKY, Paul, S.",,https://lens.org/140-663-042-606-144,Search Report,yes,0,0,1,1,0,,A61L2/14;;A61L2/18;;A61L2/20,,0,0,,,,UNKNOWN
459,US,A1,US 2003/0072192 A1,136-510-688-312-944,2003-04-17,2003,US 15521702 A,2002-05-28,US 15521702 A;;US 56392300 A,2000-05-04,Programming of nonvolatile memory cells,"
   A method for programming an NROM cell which includes the steps of applying a drain, a source and a gate voltage to the cell and verifying a programmed or a non-programmed state of the cell. If the cell is in the non-programmed state, the method includes the steps of increasing the drain voltage and maintaining the gate voltage at a constant level during at least a part of the step of increasing. The steps of applying, verifying, increasing and maintaining are repeated until the cell reaches the programmed state. 
",BLOOM ILAN;;EITAN BOAZ;;COHEN ZEEV;;FINZI DAVID;;MAAYAN EDUARDO,BLOOM ILAN;;EITAN BOAZ;;COHEN ZEEV;;FINZI DAVID;;MAAYAN EDUARDO,SPANSION ISRAEL LTD (2002-07-12);;TOWER SEMICONDUCTORS LTD (2002-09-11),https://lens.org/136-510-688-312-944,Patent Application,yes,99,40,10,10,0,G11C11/5671;;G11C16/0475;;G11C16/3454;;G11C16/3468;;G11C16/3481;;G11C16/3481;;G11C16/3468;;G11C11/5671;;G11C16/3454;;G11C16/0475,G11C11/56;;G11C16/02;;G11C16/04;;G11C16/34;;H01L21/8247;;H01L27/115;;H01L29/788;;H01L29/792,3652,0,0,,,,EXPIRED
460,DE,A1,DE 1445694 A1,068-034-241-659-168,1968-12-19,1968,DE 1445694 A,1963-12-16,GB 4752762 A;;US 27328363 A;;US 26374263 A,1962-12-17,Verfahren zur Herstellung fluoreszierender Verbindungen von Stilbentyp,,EASTMAN KODAK CO,GEORGE HEDBERG JUN DAVID;;SIGMUND BLOOM MELVIN;;VOIGT OTIS MARSHALL,,https://lens.org/068-034-241-659-168,Patent Application,no,0,0,10,22,0,C07D263/64;;C08K5/35;;D01F1/06;;G03C1/8155,C07D263/62;;C07D263/64;;C08K5/35;;D01F1/10;;G03C1/815,,0,0,,,,EXPIRED
461,US,A1,US 2013/0077767 A1,163-214-780-237-097,2013-03-28,2013,US 201113242695 A,2011-09-23,US 201113242695 A,2011-09-23,SYSTEM AND METHOD FOR OPTIMIZING CALL FLOWS OF A SPOKEN DIALOG SYSTEM,"A dialog manager for a spoken dialog system. A decision module selects a path from a plurality of alternative paths for a given call, wherein each path implements one of a plurality of strategies for a call flow. A weighting module weights the path selection decision and is connected to a probability estimator for estimating the probability value that a given one of the plurality of paths is the best-performing path.",SUENDERMANN DAVID;;LISCOMBE JACKSON;;BLOOM JONATHAN;;LI GRACE;;PIERACCINI ROBERTO,SUENDERMANN DAVID;;LISCOMBE JACKSON;;BLOOM JONATHAN;;LI GRACE;;PIERACCINI ROBERTO,SYNCHRONOSS TECHNOLOGIES INC (2012-05-07);;VERINT AMERICAS INC (2017-02-01);;SPEECHCYCLE INC (2012-04-12),https://lens.org/163-214-780-237-097,Patent Application,yes,2,3,5,5,0,H04M3/4936;;H04M3/5166;;H04M2201/39;;H04M2201/40;;H04M2203/355;;H04M3/4936;;H04M3/5166;;H04M2201/40;;H04M2203/355;;H04M2201/39,H04M1/64,379/88.01,0,0,,,,ACTIVE
462,US,A1,US 2018/0228311 A1,022-246-042-668-817,2018-08-16,2018,US 201815896828 A,2018-02-14,US 201815896828 A;;US 201762458830 P,2017-02-14,Package Delivery Securement Device,A package securement device includes a containment device in the form of either a bag or a box for receiving packages. The containment device includes an opening allowing for removal and insertion of packages. Access may be given to the interior of the containment device through an electronic device with a credential receiver configured to receive a credential input by a user. A communication module with a wireless transmitter connected to the electronic device transmits and receive a wireless communication regarding a status of the containment bag. A remote user interface may be used to monitor and control access to the containment device.,SPECTRUM BRANDS INC,BLOOM MARK;;BROWN TROY;;DOWNEY DAVID;;GORKOVENKO ELENA;;LOVETT MATTHEW,ASSA ABLOY AMERICAS RESIDENTIAL INC (2023-06-20),https://lens.org/022-246-042-668-817,Patent Application,yes,0,23,2,2,0,G06Q20/322;;G07C9/00309;;G07C2209/62;;A47G29/141;;H04W4/35;;A47G29/20;;A47G2029/144;;A47G2029/149;;G07C9/00912;;B64U2101/64;;A47G29/141;;B64C39/024;;H04W4/35;;A47G29/20;;G07C2009/0092;;A47G2029/146;;A47G2029/144;;A47G2029/149;;G07C9/00912;;G06Q20/322;;G07C2209/62;;G07C9/00309;;B64U2101/00;;B64U2101/60,A47G29/14;;A47G29/20;;B64C39/02;;G07C9/00;;G07F17/12;;H04W4/35,,0,0,,,,ACTIVE
463,AU,A,AU 1998/058234 A,115-535-987-485-238,1998-08-03,1998,AU 1998/058234 A,1998-01-13,US 78264797 A;;US 9800635 W,1997-01-14,"Method and apparatus for cleaning, decontaminating, and sterilizing catheters",,STERIS CORP,HAIRE DONNA M;;WOLF-BLOOM DAVID F;;MALCHESKY PAUL S,,https://lens.org/115-535-987-485-238,Patent Application,no,0,1,4,4,0,A61L2/20;;A61L2/20;;A61L2/14;;A61L2/14;;A61L2/18;;A61L2/18,A61L2/14;;A61L2/18;;A61L2/20,,0,0,,,,PENDING
464,EP,A1,EP 2758957 A1,184-480-457-198-650,2014-07-30,2014,EP 12833593 A,2012-09-21,US 201113242695 A;;US 2012/0056465 W,2011-09-23,SYSTEM AND METHOD FOR OPTIMIZING CALL FLOWS OF A SPOKEN DIALOG SYSTEM,,SYNCHRONOSS TECHNOLOGIES INC,SUENDERMANN DAVID;;LISCOMBE JACKSON;;BLOOM JONATHAN;;LI GRACE;;PIERACCINI ROBERTO,VERINT AMERICAS INC. (2017-09-06),https://lens.org/184-480-457-198-650,Patent Application,yes,0,0,5,5,0,H04M3/4936;;H04M3/5166;;H04M2201/39;;H04M2201/40;;H04M2203/355;;H04M3/4936;;H04M3/5166;;H04M2201/40;;H04M2203/355;;H04M2201/39,G10L15/00;;H04M3/493;;H04M3/51,,0,0,,,,DISCONTINUED
465,CA,A,CA 732099 A,091-861-375-890-296,1966-04-12,1966,CA 732099D A,,CA 732099T A,,COMPOSITIONS CONTAINING A FLUORESCENT BRIGHTENING AGENT,,EASTMAN KODAK CO,OTIS MARSHALL V;;BLOOM MELVIN S;;HEDBERG DAVID G JR,,https://lens.org/091-861-375-890-296,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
466,WO,A3,WO 2001/084552 A3,171-006-951-680-709,2002-02-21,2002,IL 0100399 W,2001-05-03,US 56392300 A,2000-05-04,PROGRAMMING OF NONVOLATILE MEMORY CELLS,"A method for programming an NROM cell which includes the steps of applying a drain (VD), a source (VS) and a gate voltage (VG) to the cell and verifying a programmed or a non-programmed state of the cell. If the cell is in the non-programmed state, the method includes the steps of increasing the drain voltage and maintaining the gate voltage at a constant level during at least a part of the step of increasing. The steps of applying, verifying, increasing and maintaining are repeated until the cell reaches the programmed state.",SAIFUN SEMICONDUCTORS LTD;;BLOOM ILAN;;EITAN BOAZ;;COHEN ZEEV;;FINZI DAVID;;MAAYAN EDUARDO,BLOOM ILAN;;EITAN BOAZ;;COHEN ZEEV;;FINZI DAVID;;MAAYAN EDUARDO,,https://lens.org/171-006-951-680-709,Search Report,yes,1,0,10,10,0,G11C11/5671;;G11C16/0475;;G11C16/3454;;G11C16/3468;;G11C16/3481;;G11C16/3481;;G11C16/3468;;G11C11/5671;;G11C16/3454;;G11C16/0475,G11C11/56;;G11C16/02;;G11C16/04;;G11C16/34;;H01L21/8247;;H01L27/115;;H01L29/788;;H01L29/792,,0,0,,,,PENDING
467,US,B1,US 6396741 B1,170-807-535-344-46X,2002-05-28,2002,US 56392300 A,2000-05-04,US 56392300 A,2000-05-04,Programming of nonvolatile memory cells,"
    A method for programming an NROM cell which includes the steps of applying a drain, a source and a gate voltage to the cell and verifying a programmed of a non-programmed state of the cell. If the cell is in the non-programmed state, the method includes the steps of increasing the drain voltage and maintaining the gate voltage at a constant level during at least a part of the step of increasing. The steeps of applying, verifying, increasing and maintaining are repeated until the cell reaches the programmed state. 
",SAIFUN SEMICONDUCTORS LTD;;TOWER SEMICONDUCTORS LTD,BLOOM ILAN;;EITAN BOAZ;;COHEN ZEEV;;FINZI DAVID;;MAAYAN EDUARDO,SPANSION ISRAEL LTD (2000-06-05),https://lens.org/170-807-535-344-46X,Granted Patent,yes,43,136,10,10,0,G11C11/5671;;G11C16/0475;;G11C16/3454;;G11C16/3468;;G11C16/3481;;G11C16/3481;;G11C16/3468;;G11C11/5671;;G11C16/3454;;G11C16/0475,G11C11/56;;G11C16/04;;G11C16/02;;G11C16/34;;H01L21/8247;;H01L27/115;;H01L29/788;;H01L29/792,365/185.22;;365/185.19;;365/185.28,9,2,121-595-543-899-220;;066-403-392-428-330,10.1109/edl.1987.26563;;10.1109/t-ed.1981.20336,"U.S. application No. 08/905,286, Eitan, filed Jul. 30, 1997.;;U.S. application No. 09/082,280, Eitan, filed May 20, 1998.;;U.S. application No. 09/348,720, Eitan, filed Jul. 6, 1999.;;U.S. application No. 09/413,408, Eitan, filed Oct. 6, 1999.;;U.S. application No. 09/536,125, Eitan, filed Mar. 28, 2000.;;Chan et al., ""A True Single-Transistor Oxide-Nitride-Oxide EEPROM Device,"" IEEE Electron Device Letters, vol. EDL-8, No. 3, Mar. 1987.;;Eitan et al., ""Hot-Electron Injection into the Oxide in n-Channel MOS Devices,"" IEEE Transactions on Electron Devices, vol. ED-38, No. 3, pp. 328-340, Mar. 1981.;;Roy, Anariban ""Characterization and Modeling of Charge Trapping and Retention in Novel Multi-Dielectic Nonvolatile Semiconductor Memory Device,"" Doctoral Dissertation, Sherman Fairchild Center, Department of Computer Science and Electrical Engineering, pp. 1-35, 1989.;;Bruno Ricco, ""Nonvolatile Multilevel Memories for Digital Application"", IEEE, vol. 86, No. 12, issued Dec. 1998, pp. 2399-2421.",EXPIRED
468,US,A1,US 2006/0047218 A1,111-066-637-042-539,2006-03-02,2006,US 26052105 A,2005-10-26,US 26052105 A;;US 12505102 A,2002-04-17,User-retainable temperature and impedance monitoring methods and devices,"A user-retainable monitoring system is disclosed. At least a pair of sensors is provided in association with a support member. The support member is preferably of a type that may be worn by or at least temporarily implanted in a patient. Possible sensor types include temperature sensors and impedance sensors. Temperature sensors may be used to detect a temperature differential between areas of tissue indicative of pathology. Impedance sensors are used to detect subcutaneous fluid detection. The support member may take the form of a bandage, drain or other structure. Monitor structures as described may have stand-alone utility or be connected to a processor or data recorder to enable various functions.",BLOOM MATTHEW;;HEINRICHS WM LEROY;;KOVACS GREGORY T;;SALZBERG DAVID,BLOOM MATTHEW;;HEINRICHS WM LEROY;;KOVACS GREGORY T;;SALZBERG DAVID,THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (2002-08-29),https://lens.org/111-066-637-042-539,Patent Application,yes,35,56,3,3,0,A61B5/0031;;A61B5/01;;A61B5/0535;;A61B5/413;;A61B5/445;;A61B5/0535;;A61B5/01;;A61B5/445;;A61B5/0031;;A61B5/413,A61B5/00;;A61B5/05;;A61B5/053,600/547;;600/549;;128/903,0,0,,,,DISCONTINUED
469,AU,A,AU 2001/056618 A,157-037-182-118-475,2001-11-12,2001,AU 2001/056618 A,2001-05-03,IL 0100399 W;;US 56392300 A,2000-05-04,Programming of nonvolatile memory cells,,SAIFUN SEMICONDUCTORS LTD,BLOOM ILAN;;EITAN BOAZ;;COHEN ZEEV;;FINZI DAVID;;MAAYAN EDUARDO,,https://lens.org/157-037-182-118-475,Patent Application,no,0,0,10,10,0,G11C11/5671;;G11C16/0475;;G11C16/3454;;G11C16/3468;;G11C16/3481;;G11C16/3481;;G11C16/3468;;G11C11/5671;;G11C16/3454;;G11C16/0475,G11C16/02;;G11C11/56;;G11C16/04;;G11C16/34;;H01L21/8247;;H01L27/115;;H01L29/788;;H01L29/792,,0,0,,,,DISCONTINUED
470,WO,A2,WO 2001/084552 A2,153-853-621-573-93X,2001-11-08,2001,IL 0100399 W,2001-05-03,US 56392300 A,2000-05-04,PROGRAMMING OF NONVOLATILE MEMORY CELLS,"A method for programming an NROM cell which includes the steps of applying a drain (VD), a source (VS) and a gate voltage (VG) to the cell and verifying a programmed or a non-programmed state of the cell. If the cell is in the non-programmed state, the method includes the steps of increasing the drain voltage and maintaining the gate voltage at a constant level during at least a part of the step of increasing. The steps of applying, verifying, increasing and maintaining are repeated until the cell reaches the programmed state.",SAIFUN SEMICONDUCTORS LTD;;BLOOM ILAN;;EITAN BOAZ;;COHEN ZEEV;;FINZI DAVID;;MAAYAN EDUARDO,BLOOM ILAN;;EITAN BOAZ;;COHEN ZEEV;;FINZI DAVID;;MAAYAN EDUARDO,,https://lens.org/153-853-621-573-93X,Patent Application,yes,0,6,10,10,0,G11C11/5671;;G11C16/0475;;G11C16/3454;;G11C16/3468;;G11C16/3481;;G11C16/3481;;G11C16/3468;;G11C11/5671;;G11C16/3454;;G11C16/0475,G11C11/56;;G11C16/02;;G11C16/04;;G11C16/34;;H01L21/8247;;H01L27/115;;H01L29/788;;H01L29/792,,0,0,,,,PENDING
471,US,B2,US 10264906 B2,119-376-905-034-549,2019-04-23,2019,US 201815896828 A,2018-02-14,US 201815896828 A;;US 201762458830 P,2017-02-14,Package delivery securement device,A package securement device includes a containment device in the form of either a bag or a box for receiving packages. The containment device includes an opening allowing for removal and insertion of packages. Access may be given to the interior of the containment device through an electronic device with a credential receiver configured to receive a credential input by a user. A communication module with a wireless transmitter connected to the electronic device transmits and receive a wireless communication regarding a status of the containment bag. A remote user interface may be used to monitor and control access to the containment device.,SPECTRUM BRANDS INC,BLOOM MARK;;BROWN TROY;;DOWNEY DAVID;;GORKOVENKO ELENA;;LOVETT MATTHEW,ASSA ABLOY AMERICAS RESIDENTIAL INC (2023-06-20),https://lens.org/119-376-905-034-549,Granted Patent,yes,9,12,2,2,0,G06Q20/322;;G07C9/00309;;G07C2209/62;;A47G29/141;;H04W4/35;;A47G29/20;;A47G2029/144;;A47G2029/149;;G07C9/00912;;B64U2101/64;;A47G29/141;;B64C39/024;;H04W4/35;;A47G29/20;;G07C2009/0092;;A47G2029/146;;A47G2029/144;;A47G2029/149;;G07C9/00912;;G06Q20/322;;G07C2209/62;;G07C9/00309;;B64U2101/00;;B64U2101/60,G07C9/00;;A47G29/14;;A47G29/20;;B64C39/02;;G07F17/12;;H04W4/35,,0,0,,,,ACTIVE
472,US,B2,US 8831208 B2,051-145-802-128-805,2014-09-09,2014,US 201113242695 A,2011-09-23,US 201113242695 A,2011-09-23,System and method for optimizing call flows of a spoken dialog system,"A dialog manager for a spoken dialog system. A decision module selects a path from a plurality of alternative paths for a given call, wherein each path implements one of a plurality of strategies for a call flow. A weighting module weights the path selection decision and is connected to a probability estimator for estimating the probability value that a given one of the plurality of paths is the best-performing path.",SUENDERMANN DAVID;;LISCOMBE JACKSON;;BLOOM JONATHAN;;LI GRACE;;PIERACCINI ROBERTO;;SYNCHRONOSS TECHNOLOGIES INC,SUENDERMANN DAVID;;LISCOMBE JACKSON;;BLOOM JONATHAN;;LI GRACE;;PIERACCINI ROBERTO,SYNCHRONOSS TECHNOLOGIES INC (2012-05-07);;VERINT AMERICAS INC (2017-02-01);;SPEECHCYCLE INC (2012-04-12),https://lens.org/051-145-802-128-805,Granted Patent,yes,2,8,5,5,0,H04M3/4936;;H04M3/5166;;H04M2201/39;;H04M2201/40;;H04M2203/355;;H04M3/4936;;H04M3/5166;;H04M2201/40;;H04M2203/355;;H04M2201/39,H04M3/00,379/272;;379/88.01;;379/265.11;;379/273;;704/238,8,4,098-640-950-144-050;;174-144-069-379-956;;182-623-286-687-259;;096-139-784-680-517,10.1109/slt.2010.5700873;;10.2316/p.2011.747-038;;10.1007/978-1-4419-9610-7;;10.3115/1556328.1556332,"D. Suendermann, J. Liscombe, R. Pieraccini: ""Minimally Invasive Surgery for Spoken Dialog Systems."" In Proc. of the Interspeech 2010, 11th annual Conference of the International Speech Communication Association, Makuhari, Japan, Sep. 2010.;;D. Suendermann, J. Liscombe, and R. Pieraccini: ""Contender."" In Proc. of the SLT 2010, IEEE Workshop on Spoken Language Technology, Berkeley, USA, Dec. 2010.;;D. Suendermann, J. Liscombe, J. Bloom, G. Li, and R. Pieraccini: ""Deploying Contender: Early Lessons in Data, Measurement, and Testing of Multiple Call Flow Decisions."" In Proc. of the HCI 2011, IASTED International Conference on Human-Computer Interaction, Washington, USA, May 2011.;;D. Suendermann, J. Liscombe, J. Bloom, G. Li, and R. Pieraccini: ""Large-Scale Experiments on Data-Driven Design of Commercial Spoken Dialog Systems."" In Proc. of the Interspeech 2011, 12th Annual Conference of the International Speech Communication Association, Florence, Italy, Aug. 2011.;;D. Suendermann: ""Advances in Commercial Deployment of Spoken Dialog Systems."" Published: Feb. 23, 2011.;;K. Acomb, J. Bloom, K. Dayanidhi, P. Hunter, P. Krogh, E. Levin, and R. Pieraccini: ""Technical Support Dialog Systems: Issues, Problems, and Solutions."" HLT 2007 Workshop: Bridging the Gap: Academic and Industrial Research in Dialog Technology , Rochester, NY, USA, Apr. 26, 2007.;;D. Suendermann: ""Speech Scientists Are Dead. Interaction Designers Are Dead. Who Is Next?"" [cached]. In Newsletter of the SLTC, Speech and Language Processing Technical Committee of the IEEE Signal Processing Society, Apr. 2010.;;D. Suendermann: ""Five Techniques Multi-Modal Apps (Should) Inherit from Speech Science."" In Proc. of the AVIxD 2010, 9th Annual Workshop of the Association for Voice Interaction Design, New York, USA, Aug. 2010.",ACTIVE
473,EP,A4,EP 1287527 A4,146-611-891-148-129,2006-02-08,2006,EP 01929943 A,2001-05-03,IL 0100399 W;;US 56392300 A,2000-05-04,PROGRAMMING OF NONVOLATILE MEMORY CELLS,,SAIFUN SEMICONDUCTORS LTD,BLOOM ILAN;;EITAN BOAZ;;COHEN ZEEV;;FINZI DAVID;;MAAYAN EDUARDO,,https://lens.org/146-611-891-148-129,Search Report,no,2,0,10,10,0,G11C11/5671;;G11C16/0475;;G11C16/3454;;G11C16/3468;;G11C16/3481;;G11C16/3481;;G11C16/3468;;G11C11/5671;;G11C16/3454;;G11C16/0475,G11C5/00;;G11C11/56;;G11C16/02;;G11C16/04;;G11C16/34;;H01L21/8247;;H01L27/115;;H01L29/788;;H01L29/792,,0,0,,,,DISCONTINUED
474,DE,B,DE 1255077 B,002-439-938-974-767,1967-11-30,1967,DE E0026039 A,1963-12-16,GB 4752762 A;;US 26374263 A,1962-12-17,Verfahren zum optischen Aufhellen von Gebilden aus polymeren Stoffen,,EASTMAN KODAK CO,JUN DAVID GEORGE HEDBERG;;BLOOM MELVIN SIGMUND;;OTIS MARSHALL VOIGT,,https://lens.org/002-439-938-974-767,Patent Application,no,0,0,9,22,0,C07D263/64;;C07D263/64;;C08K5/35;;C08K5/35;;D01F1/06;;D01F1/06;;G03C1/8155;;G03C1/8155,C07D263/62;;C07D263/64;;C08K5/35;;D01F1/10;;G03C1/815,,0,0,,,,EXPIRED
475,EP,A2,EP 1287527 A2,080-958-600-985-77X,2003-03-05,2003,EP 01929943 A,2001-05-03,IL 0100399 W;;US 56392300 A,2000-05-04,PROGRAMMING OF NONVOLATILE MEMORY CELLS,,SAIFUN SEMICONDUCTORS LTD,BLOOM ILAN;;EITAN BOAZ;;COHEN ZEEV;;FINZI DAVID;;MAAYAN EDUARDO,,https://lens.org/080-958-600-985-77X,Patent Application,yes,0,0,10,10,0,G11C11/5671;;G11C16/0475;;G11C16/3454;;G11C16/3468;;G11C16/3481;;G11C16/3481;;G11C16/3468;;G11C11/5671;;G11C16/3454;;G11C16/0475,G11C11/56;;G11C5/00;;G11C16/04;;G11C16/02;;G11C16/34;;H01L21/8247;;H01L27/115;;H01L29/788;;H01L29/792,,0,0,,,,DISCONTINUED
476,JP,A,JP 2013176829 A,053-138-015-719-38X,2013-09-09,2013,JP 2012043305 A,2012-02-29,JP 2012043305 A,2012-02-29,"POLISHING METHOD, POLISHING DEVICE AND METHOD FOR MANUFACTURING PHOTORECEPTOR","PROBLEM TO BE SOLVED: To provide a polishing method, a polishing device and a method for manufacturing a photoreceptor that can suppress the removal unevenness of residues on a polished surface of an object having been polished.SOLUTION: A polishing method includes a step of polishing a polished surface of a photoreceptor 10, and a step of bringing the polished surface of the photoreceptor 10 having been polished into contact with the residue removing member 22 and rotating at least one of the photoreceptor 10 and residue removing member 22 so that a contact surface of the residue removing member 22 may move relatively to the polished surface of the photoreceptor 10. The polishing device 100 includes means of polishing the polished surface of the photoreceptor 10, a motor 32 rotating the photoreceptor 10, the residue removing member 22, a motor 20 rotating the residue removing member 22, and a control section 38 which brings the polished surface of the photoreceptor 10 having been polished into contact with the residue removing member 22, and rotating at least one of the photoreceptor 10 and residue removing member 22 so that the contact surface of the residue removing member 22 may move relatively to the polished surface of the photoreceptor 10.",RICOH CO LTD;;RICOH UK PRODUCTS LTD,SUZUKI KAZUYA;;OLIVER BLOOM;;MARTIN BALL;;DAVID HOLYHEAD;;CHRIS RAYMER,,https://lens.org/053-138-015-719-38X,Patent Application,no,3,0,2,2,0,,B24B29/00;;G03G5/00,,0,0,,,,INACTIVE
477,AT,T1,AT E553298 T1,190-855-668-887-38X,2012-04-15,2012,AT 06788580 T,2006-07-26,US 70404605 P;;US 74760406 P;;US 2006/0029062 W,2005-07-29,"HUBKOLBENPUMPE MIT LUFTVENTIL, ARRETIERUNG UND TELLERVENTILEN","A poppet assembly includes a poppet housing (41) having an axis and first and second sets of housing ports (41a, 41b), which are axially spaced. A poppet seat (44) is provided in the housing, the seat having a set of seat ports (44a), and a poppet (43) is also located in the housing and is retained by the seat. The poppet has a set of poppet ports (43a), is biased against the seat in a first position and can be moved to a second position away from the seat. A poppet actuator (45), which is located in the seat, partially surrounds the poppet and is biased away from the poppet. When the poppet is in its first position, the first set of housing ports (41b) are in fluid communication with the second set of housing ports (41a) through the poppet ports (43a), and when it is in its second position, the first set of housing ports (41b) are in fluid communication with the seat ports (44a).",GRACO MINNESOTA INC,BAUCK MARK;;ISAIS JOHN;;WEINBERGER MARK;;PITTMAN DAVID;;BLOOM MICHAEL,,https://lens.org/190-855-668-887-38X,Granted Patent,no,0,0,28,28,0,F04B9/12;;F04B9/125;;F16K11/02;;F04B49/00;;F04B35/00;;F04B9/08;;F04B9/12;;F04B9/125;;F16K11/02,,,0,0,,,,ACTIVE
478,EP,A4,EP 0567640 A4,113-070-272-328-095,1994-11-17,1994,EP 93908774 A,1992-09-30,US 77795591 A,1991-10-17,IONIC CONDUCTORS FOR SOLID OXIDE FUEL CELLS.,,US ENERGY,KRUMPELT MICHAEL;;BLOOM IRA DAVID;;PULLOCKARAN JOSE DEVASSY;;MYLES KEVIN MICHAEL,,https://lens.org/113-070-272-328-095,Search Report,no,0,0,6,6,0,H01M6/18;;H01M6/18;;H01M8/124;;H01M8/124;;Y02E60/50;;Y02P70/50;;Y02P70/50,C01B25/36;;C01B25/455;;C01B33/20;;C01B37/04;;C01B37/08;;C01B39/06;;C01B39/54;;H01B1/06;;H01M6/18;;H01M8/02;;H01M8/12,,2,0,,,No further relevant documents disclosed;;See also references of WO 9308613A1,DISCONTINUED
479,US,S,US D0275286 S,113-387-571-969-840,1984-08-28,1984,US 41152682 F,1982-08-25,US 41152682 F,1982-08-25,Printer,,DATA SPECIALTIES INC,CLESS GERHARD;;CASTELLANOS RAFAEL A;;EISCHEN ALBERT L;;BLOOM DAVID H,ZEBRA TECHNOLOGIES CORPORATION (1986-12-09);;DATA SPECIALITES INC. A CORP. OF IL (1982-08-04);;ZIH CORP (2003-11-04),https://lens.org/113-387-571-969-840,Design Right,yes,3,2,1,1,0,,,D14/111,0,0,,,,EXPIRED
480,EP,A1,EP 0567640 A1,191-718-393-040-926,1993-11-03,1993,EP 93908774 A,1992-09-30,US 77795591 A,1991-10-17,IONIC CONDUCTORS FOR SOLID OXIDE FUEL CELLS.,"L'invention concerne un électrolyte efficace à des températures situées dans une plage de 600 °C à 800 °C. L'électrolyte conduit la charge ioniquement ainsi qu'électroniquement. Les conducteurs ioniques comprennent des structures moléculaires possédant des plans ou des canaux suffisamment importants pour transporter des oxydes ou des protons hydratés et comportant des charges résultantes positives ou négatives. Les structures moléculaires représentatives comprennent des phosphates d'aluminium substitués, des orthosilicates, des silicoaluminates, des cordiérites, des apatites, des sodalites et des hollandites.",US ENERGY,KRUMPELT MICHAEL;;BLOOM IRA DAVID;;PULLOCKARAN JOSE DEVASSY;;MYLES KEVIN MICHAEL,,https://lens.org/191-718-393-040-926,Patent Application,yes,0,0,6,6,0,H01M6/18;;H01M6/18;;H01M8/124;;H01M8/124;;Y02E60/50;;Y02P70/50;;Y02P70/50,C01B25/36;;C01B25/455;;C01B33/20;;C01B37/04;;C01B37/08;;C01B39/06;;C01B39/54;;H01B1/06;;H01M6/18;;H01M8/02;;H01M8/12,,0,0,,,,DISCONTINUED
481,US,A1,US 2003/0199783 A1,036-275-042-180-994,2003-10-23,2003,US 12505102 A,2002-04-17,US 12505102 A,2002-04-17,User-retainable temperature and impedance monitoring methods and devices,"
   A user-retainable monitoring system is disclosed. At least a pair of sensors is provided in association with a support member. The support member is preferably of a type that may be worn by or at least temporarily implanted in a patient. Possible sensor types include temperature sensors and impedance sensors. Temperature sensors may be used to detect a temperature differential between areas of tissue indicative of pathology. Impedance sensors are used to detect subcutaneous fluid detection. The support member may take the form of a bandage, drain or other structure. Monitor structures as described may have stand-alone utility or be connected to a processor or data recorder to enable various functions. 
",BLOOM MATTHEW;;HEINRICHS WM. LEROY;;KOVACS GREGORY T.A.;;SALZBERG DAVID,BLOOM MATTHEW;;HEINRICHS WM LEROY;;KOVACS GREGORY T A;;SALZBERG DAVID,THE BOARD OF TRUSTEES OF LELAND STANFORD JUNIOR UNIVERSITY (2002-08-29),https://lens.org/036-275-042-180-994,Patent Application,yes,6,116,3,3,0,A61B5/0031;;A61B5/01;;A61B5/0535;;A61B5/413;;A61B5/445;;A61B5/0535;;A61B5/01;;A61B5/445;;A61B5/0031;;A61B5/413,A61B5/00;;A61B5/053,600/549,0,0,,,,EXPIRED
482,EP,A1,EP 2514198 A1,174-651-668-678-006,2012-10-24,2012,EP 09852366 A,2009-12-16,US 2009/0006569 W,2009-12-16,SYSTEM AND METHOD FOR PROTECTING ADVERTISING CUE MESSAGES,,THOMSON LICENSING,SRIDHAR AVINASH;;STEIN ALAN JAY;;BLOOM JEFFREY ADAM;;CAMPANA DAVID ANTHONY,,https://lens.org/174-651-668-678-006,Patent Application,yes,0,0,8,8,0,H04N21/23476;;H04N21/2351;;H04N21/4325;;H04N21/4353;;H04N21/4542;;H04N21/4623;;H04N21/812;;H04N21/8456;;H04N7/10;;H04N21/23476;;H04N21/2351;;H04N21/2668;;H04N21/4353;;H04N21/454;;H04N21/4542;;H04N21/812;;H04N21/4542;;H04N21/2351;;H04N21/4353;;H04N21/4623;;H04N21/812;;H04N21/4325;;H04N21/23476;;H04N21/8456,H04N7/10,,0,0,,,,DISCONTINUED
483,US,S,US D0822053 S,194-004-236-987-934,2018-07-03,2018,US 201829632119 F,2018-01-05,US 201829632119 F;;US 201529543045 F;;US 201313799828 A,2013-03-13,Electronic display device with graphical user interface,,PODIMETRICS INC,LINDERS DAVID R;;PETERSEN BRIAN;;BLOOM JONATHAN D;;PETERSEN DANIEL J,PODIMETRICS INC (2015-10-27),https://lens.org/194-004-236-987-934,Design Right,no,0,25,3,3,0,,,1404;;D14/486;;D14/495,0,0,,,,ACTIVE
484,CA,A,CA 699341 A,040-687-084-495-551,1964-12-08,1964,CA 699341D A,,CA 699341T A,,PROCESS FOR THE PREPARATION OF ISOCYANATES,,GEN ANILINE & FILM CORP,BLOOM ALBERT;;GRAHAM DAVID E;;NORMINGTON JAMES B;;FREYERMUTH HARLAN B,,https://lens.org/040-687-084-495-551,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
485,US,S,US D0302682 S,097-919-659-014-316,1989-08-08,1989,US 90430786 F,1986-09-04,US 90430786 F,1986-09-04,Printer controller,,AMERICAN TELEPHONE AND TELEGRAPH COMPANY AT&T TELETYPE,BLOOM DAVID H;;CAMPORESE RALPH;;KASTILAHN WILLIAM C;;WELCH ROBERT J,AT&T TELETYPE CORPORATION A CORP. OF DE (1985-06-19),https://lens.org/097-919-659-014-316,Design Right,yes,8,2,1,1,0,,,D14/107,2,0,,,"Design, 8-1985, p. 80 (Desk Top Computer top, left, corner box).;;Time Magazine, May 16, 1983, p. 75 (Atari 1200 XL Home Computer).",EXPIRED
486,US,A1,US 2012/0246672 A1,115-447-213-824-54X,2012-09-27,2012,US 200913514396 A,2009-12-16,US 2009/0006569 W,2009-12-16,SYSTEM AND METHOD FOR PROTECTING ADVERTISING CUE MESSAGES,An apparatus and method for encoding and decoding a broadcast data stream that includes encrypted advertisement cue messages. The encrypted advertisement cue message data representing a advertisement to be inserted into a stream and data representing an insertion time within said broadcast data stream that is associated with said advertisement. The advertisement cue messages are encrypted and encrypted using a encryption technique. The encrypted advertisement cue message masks the insertion time for the advertisement and prevents automatically skipping of the advertisement data.,SRIDHAR AVINASH;;CAMPANA DAVID ANTHONY;;STEIN ALAN JAY;;BLOOM JEFFREY ADAM,SRIDHAR AVINASH;;CAMPANA DAVID ANTHONY;;STEIN ALAN JAY;;BLOOM JEFFREY ADAM,THOMSON LICENSING (2010-02-17),https://lens.org/115-447-213-824-54X,Patent Application,yes,4,47,8,8,0,H04N21/23476;;H04N21/2351;;H04N21/4325;;H04N21/4353;;H04N21/4542;;H04N21/4623;;H04N21/812;;H04N21/8456;;H04N7/10;;H04N21/23476;;H04N21/2351;;H04N21/2668;;H04N21/4353;;H04N21/454;;H04N21/4542;;H04N21/812;;H04N21/4542;;H04N21/2351;;H04N21/4353;;H04N21/4623;;H04N21/812;;H04N21/4325;;H04N21/23476;;H04N21/8456,H04N21/2347,725/31,0,0,,,,DISCONTINUED
487,GB,A,GB 834082 A,004-825-448-630-45X,1960-05-04,1960,GB 2924757 A,1957-09-17,GB 2924757 A,1957-09-17,Process for the preparation of organic isocyanates,"In a process for the preparation of isocyanates, an organic primary amine is reacted with slightly more than one half molar proportion of phosgene for each amino group in the amine, at about 0-10 DEG C. in an inert organic solvent to produce a slurry of a carbamyl chloride-hydrochloride in said solvent, and the slurry so obtained is reacted at a temperature of 100-200 DEG C. with further phosgene in excess of that required to fully react with the carbamyl chloride-hydrochloride so that the desired isocyanate is formed, and the process is characterized in that the inert organic solvent employed in the reaction consists of at least one of the following compounds: dialkyl ethers of mono -, di -, or tri - alkylene glycols of the formula <FORM:0834082/IV (b)/1> (where R is alkyl, n is 1, 2 or 3, and R1 is H or methyl or ethyl), mono- or di-alkyl (1-8 C) phenyl ethers, dialkyl (1-8 C) ketones, alkyl (1-4 C) phenyl ketones, dialkyl (2-14 C atoms) esters of aliphatic di-carboxylic acids of at least 5 carbon atoms, dialkyl (2-14 C) esters of aromatic dicarboxylic acids; alkyl, aryl, or mixed alkyl-aryl triester of orthophosphoric acid; a mixture of one or more of the above solvents with a normally liquid alkylated benzene hydrocarbon containing 1-3 alkyl substituents or a mixture of such alkylated benzene hydrocarbons. Specified alkylated benzene hydrocarbons are toluene, xylenes, trimethyl benzenes, butyl benzenes, and others. Commercial aromatic petroleum solvents containing 75-98.5% aromatics and of boiling range 106-182.2 DEG C. may be used. Specified dialkyl ethers of glycols include those of ethylene, diethylene, triethylene, propylene and dipropylene glycol, e.g. dimethyl, ethyl propyl and propyl butyl ethers. Amongst examples of the other types of compounds used as an inert solvent are anisole, isobutyl phenyl ether, 1-methoxy-3-amyloxybenzene, methyl propyl ketone diisobutyl ketone, acetophenone, or butyl phenyl ketone, dihexyl suberate, di-ethoxy ethyl sebacate, didecyl phthalate, esters of diphenic and 1,8 naphthalic acid, triamyl phosphate, triphenyl phosphate and tri-(2-ethyl hexyl) phosphate. Many mono- and di-amines are specified as starting materials. Specification 805,249 is referred to.",GEN ANILINE & FILM CORP,BLOOM ALBERT;;FREYERMUTH HARLAN BENJAMIN;;NORMINGTON JAMES BROWN;;GRAHAM DAVID E,,https://lens.org/004-825-448-630-45X,Granted Patent,no,0,0,1,1,0,C07C263/04;;C07C263/10,C07C263/10,C2C CMH;;C2C CNH;;C2C C22Y;;C2C C22Y;;C2C C220;;C2C C220;;C2C C221;;C2C C222;;C2C C225;;C2C C226;;C2C C227;;C2C C227;;C2C C276;;C2C C30Y;;C2C C30Y;;C2C C32Y;;C2C C321;;C2C C349;;C2C C36Y;;C2C C364;;C2C C45Y;;C2C C453;;C2C C622;;C2C C630;;C2C C632;;C2C C642;;C2C C660;;C2C C699;;C2C C704;;C2C C707;;C2C C714;;C2C C774;;C2C C776,0,0,,,,EXPIRED
488,DE,B,DE 1162357 B,124-140-399-015-977,1964-02-06,1964,DE G0022959 A,1957-09-19,US 1162357X A,1956-09-21,Verfahren zur Herstellung von Isocyanaten,,GEN ANILINE & FILM CORP,BLOOM ALBERT;;FREYERMUTH HARLAN BENJAMIN;;NORMINGTON JAMES BROWN;;GRAHAM DAVID E,,https://lens.org/124-140-399-015-977,Patent Application,no,5,0,1,1,0,C07C263/04;;C07C209/36;;C07C263/10,,,0,0,,,,DISCONTINUED
489,KR,A,KR 20120104238 A,174-028-425-866-614,2012-09-20,2012,KR 20127015190 A,2009-12-16,US 2009/0006569 W,2009-12-16,SYSTEM AND METHOD FOR PROTECTING ADVERTISING CUE MESSAGES,,THOMSON LICENSING,SRIDHAR AVINASH;;STEIN ALAN JAY;;BLOOM JEFFREY ADAM;;CAMPANA DAVID ANTHONY,,https://lens.org/174-028-425-866-614,Patent Application,no,0,0,8,8,0,H04N21/23476;;H04N21/2351;;H04N21/4325;;H04N21/4353;;H04N21/4542;;H04N21/4623;;H04N21/812;;H04N21/8456;;H04N7/10;;H04N21/23476;;H04N21/2351;;H04N21/2668;;H04N21/4353;;H04N21/454;;H04N21/4542;;H04N21/812;;H04N21/4542;;H04N21/2351;;H04N21/4353;;H04N21/4623;;H04N21/812;;H04N21/4325;;H04N21/23476;;H04N21/8456,H04N21/2668,,0,0,,,,DISCONTINUED
490,WO,A1,WO 2009/108827 A1,030-666-747-402-200,2009-09-03,2009,US 2009/0035393 W,2009-02-27,US 6758808 P,2008-02-29,"FUSED TRICYCLIC PYRAZOLO[1, 5-A]PYRIMIDINES, METHODS FOR PREPARATION AND USES THEREOF","Fused, tricyclic pyrazolo{1,5-a]pyrimidine compounds of formula A or of formula B: and pharmaceutically acceptable salts thereof are described, which selectively inhibit Raf kinase activity and are useful for treating disorders mediated by certain Raf kinases.",WYETH CORP;;LEVIN JEREMY IAN;;DIAMANTIDIS GEORGE;;BLOOM JONATHAN DAVID;;ZAPF CHRISTOPH WOLFGANG,LEVIN JEREMY IAN;;DIAMANTIDIS GEORGE;;BLOOM JONATHAN DAVID;;ZAPF CHRISTOPH WOLFGANG,,https://lens.org/030-666-747-402-200,Patent Application,yes,2,71,1,1,0,A61P35/00;;C07D471/20;;C07D471/22;;C07D491/20,C07D471/20;;A61P35/00;;C07D471/22;;C07D491/20,,0,0,,,,PENDING
491,CN,A,CN 102656882 A,004-133-995-590-963,2012-09-05,2012,CN 200980162998 A,2009-12-16,US 2009/0006569 W,2009-12-16,System and method for protecting advertising cue messages,An apparatus and method for encoding and decoding a broadcast data stream that includes encrypted advertisement cue messages. The encrypted advertisement cue message data representing an advertisement to be inserted into a stream and data representing an insertion time within said broadcast data stream that is associated with said advertisement. The advertisement cue messages are encrypted and encrypted using a encryption technique. The encrypted advertisement cue message masks the insertion time for the advertisement and prevents automatically skipping of the advertisement data.,THOMSON LICENSING,AVINASH SRIDHAR;;JAY STEIN ALAN;;ADAM BLOOM JEFFREY;;ANTHONY CAMPANA DAVID,,https://lens.org/004-133-995-590-963,Patent Application,no,0,4,8,8,0,H04N21/23476;;H04N21/2351;;H04N21/4325;;H04N21/4353;;H04N21/4542;;H04N21/4623;;H04N21/812;;H04N21/8456;;H04N7/10;;H04N21/23476;;H04N21/2351;;H04N21/2668;;H04N21/4353;;H04N21/454;;H04N21/4542;;H04N21/812;;H04N21/4542;;H04N21/2351;;H04N21/4353;;H04N21/4623;;H04N21/812;;H04N21/4325;;H04N21/23476;;H04N21/8456,H04N7/10,,0,0,,,,DISCONTINUED
492,US,B2,US 6963772 B2,153-544-068-061-306,2005-11-08,2005,US 12505102 A,2002-04-17,US 12505102 A,2002-04-17,User-retainable temperature and impedance monitoring methods and devices,"A user-retainable monitoring system is disclosed. At least a pair of sensors is provided in association with a support member. The support member is preferably of a type that may be worn by or at least temporarily implanted in a patient. Possible sensor types include temperature sensors and impedance sensors. Temperature sensors may be used to detect a temperature differential between areas of tissue indicative of pathology. Impedance sensors are used to detect subcutaneous fluid detection. The support member may take the form of a bandage, drain or other structure. Monitor structures as described may have stand-alone utility or be connected to a processor or data recorder to enable various functions.",UNIV LELAND STANFORD JUNIOR,BLOOM MATTHEW;;HEINRICHS WM LEROY;;KOVACS GREGORY T A;;SALZBERG DAVID,THE BOARD OF TRUSTEES OF LELAND STANFORD JUNIOR UNIVERSITY (2002-08-29),https://lens.org/153-544-068-061-306,Granted Patent,yes,29,153,3,3,0,A61B5/0031;;A61B5/01;;A61B5/0535;;A61B5/413;;A61B5/445;;A61B5/0535;;A61B5/01;;A61B5/445;;A61B5/0031;;A61B5/413,A61B5/00;;A61B5/053,600/547;;600/549,27,27,018-087-465-898-921;;088-913-944-569-296;;038-887-310-908-76X;;000-518-604-843-233;;057-835-585-458-184;;022-334-579-726-175;;093-155-144-542-838;;081-174-613-885-736;;173-077-263-718-591;;068-507-593-723-642;;057-283-151-896-846;;121-571-875-976-820;;073-980-456-124-023;;060-618-120-293-874;;020-528-735-678-172;;133-051-014-858-597;;099-108-573-355-72X;;057-160-580-668-833;;057-975-400-584-980;;077-546-698-661-239;;029-869-039-787-466;;065-313-323-215-782;;044-263-318-619-200;;039-580-593-922-78X;;030-277-652-186-657;;099-385-836-953-760;;125-257-405-478-608,10.1111/j.1532-950x.1988.tb00284.x;;3238881;;4402324;;5891545;;10.1016/0002-9378(65)90509-0;;8974407;;8703289;;10.1016/0002-9610(69)90090-7;;5794046;;7152403;;10.1177/107110078200300310;;10.1016/s0950-821x(89)80074-x;;2767257;;2858618;;792468;;4782114;;10.3109/02844317309056417;;4609525;;10.1016/0007-1226(74)90028-9;;9972759;;10.1213/00000539-199902000-00028;;7871847;;10.3349/ymj.1994.35.4.429;;1998461;;10.1016/s1079-2104(96)80217-4;;8863303;;535349;;6207620;;10.1055/s-2007-1023400;;9914364;;10.1007/s003830050519;;10.1016/0305-4179(91)90134-3;;2054068;;10.1088/0143-0815/12/4/007;;1778036;;1499254;;10.1088/0143-0815/13/2/003;;10.1016/0305-4179(91)90135-4;;2054069;;5929048;;10.1097/00006534-196638060-00003;;13759724;;pmc1939622;;10.1159/000027260;;9438586;;6009814,"Stein, L.E., et al., A comparison steady state and transient thermography techniques using a healing tendon model Veterinary Surgery, 1988. 17(2): p. 90-6.;;Viitanen, S.M. and J. Viljanto, Wound healing. A thermographic study. Annales Chirugiae et Gynaecologiae Fenniae, 1972. 61(2): p. 101-6.;;Kliot, D.A. and S.J. Birnbaum, Thermographic studies of wound healing. American Journal of Obstetrics & Gynecology, 1965. 93(4): p. 515-21.;;Horzic, M., D. Bunoza, and K. Maric, Three-dimensional observation of wound temperature in primary healing. Ostomy Wound Manage, 1996. 42(8): p. 38-40, 42-4, 46-7.;;Horzic, M., D. Bunoza, and K. Maric, Contact Thermography in a study of primary healing of surgical wounds. Ostomy Wound Management, 1996. 42(1): p. 36-8.;;Waterman, N.G., L. Goldberg, and T. Appel, Tissue temperatures in localized pyogenic infections. American Journal of Surgery, 1969. 118(1): p. 31-5.;;Golbranson, F.L., E.G. Yu, and R.H. Gelberman, The use of skin temperature determinations in lower extremity amputation level selection. Foot & Ankle, 1982. 3(3): p. 170-2.;;Stoner, H.B., L. Taylor, and R.W. Marcuson, The value of skin temperature measurements in forecasting the healing of a below-knee amputation for end-stage ischaemia of the leg in peripheral vascular disease. European Journal of Vascular Surgery, 1989. 3(4): p. 355-61.;;Sandier, D.A. and J.F. Martin, Liquid crystal termography as a screening test for deep-vein thromobosis. Lancet, 1985. 1(8430): p. 665-7.;;Gaiziunas, A.G. and M.H. Hast, Temperature gradients and prediction of flap viability . Journal of Otolaryngology, 1976. 5(5): p. 399-402.;;Holmstrom, H., Temperature changes of wound fluid inbipedicle tube flaps. An experimental study. Scandinavian Journal of Plastic & Reconstructive Surgery, 1973. 7(2): p. 102-4.;;Hackett, M.E., The use of thermography in the assessment of depth of burn and blood supply of flaps, with preliminary reports on its use in Dupuytren's contracture and treatment of varicose ulcers. Br J. Plast Surg, 1974. 27(4): p. 311-7.;;Frank, S.M., et al., Temperature monitoring practices during regional anesthesia [see comments].Anesthesia & Analgesia, 1999. 88(2): p. 373-7.;;Park, E.S., et al., Comparison of sympathetic skin response and digital infrared thermographic imaging in peripheral neuropathy. Yonsei Medical Journal, 1994. 35(4): p. 429-37.;;Palmer, J.B., et al., A cellist with arm pain: thermal asymmetry in scalenus anticus syndrome. Archives of Physical Medicine & Rehabilitation, 1991. 72(3): p. 237-42.;;Pogrel, M.A., C. McNeill, and J.M. Kim, The assessment of trapezius muscle symptoms of patients with temporomandibular disorders by the use of liquid crystal thermography. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, & Endodontics, 1996. 82(2): p. 145-51.;;Robicsek, F., et al., The application of thermography in the study of coronary blood flow. Collected Works on Cariopulomary Disease, 1979. 22: p. 49-56.;;Robicsek, F., et al., The value of thermography in the early diagnosis of postoperative sternal wound infections. Thoracic & Cardiovascular Surgeon, 1984. 32(4): p. 260-5.;;Saxena, A.K., et al., Thermography of Clostridium perfringens infection in childhood. Pediatric Surgery International, 1999. 15(1): p. 75-6.;;Cole, R.P., et al., Thermographic assessment of burns using a nonpermeable membrane as wound covering. Burns, 1991. 17(2): p. 117-22.;;Ferguson, J.C. and C.J. Martin, A study of skin temperatures, sweat rate and heat loss for burned patients. Clinical Physics & Physiological Measurement, 1991. 12(4): p. 327-75.;;Boylan, A., C.J. Martin, and G.G. Gardner, Infrared emissivity of burn wounds. Clinical Physics & Physiological Measurement, 1992. 13(2): p. 125-7.;;Wyllie, F.J. and A.B. Sutherland, Measurement of surface temperature as an aid to the diagnosis of burn depth. Burns, 1991. 17(2): p. 123-7.;;Mladick, R., N. Georgiade, and F. Thorne, A clinical evaluation of the use of thermography in determining degree of burn injury. Plastic & Reconstructive Surgery, 1966. 38(6): p. 512-8.;;Lawson, R.W., G. Webster, D., Thermographic Assessment of Burns and Frostbite. Can. Med. Ass. J., 1961.84: p. 1129.;;Yamagami, S. and H. Yamagami, Direct measurement of wound temperature during phacoemulsification. Ophthalmologica, 1998. 212(1): p. 50-2.;;Yamarnoto, K. and S. Osako, Temperature and humidity in the surgical wound cavity following tympanaplasty. Jibinkoka, 1966. 38(11): p. 1165-9.",EXPIRED
493,WO,A1,WO 1993/008613 A1,113-090-563-835-300,1993-04-29,1993,US 9208167 W,1992-09-30,US 77795591 A,1991-10-17,IONIC CONDUCTORS FOR SOLID OXIDE FUEL CELLS,"An electrolyte that operates at temperatures ranging from 600 °C to 800 °C is provided. The electrolyte conducts charge ionically as well as electronically. The ionic conductors include molecular framework structures having planes or channels large enough to transport oxides or hydrated protons and having net-positive or net-negative charges. Representative molecular framework structures include substituted aluminum phosphates, orthosilicates, silicoaluminates, cordierites, apatites, sodalites, and hollandites.",US ENERGY,KRUMPELT MICHAEL;;BLOOM IRA DAVID;;PULLOCKARAN JOSE DEVASSY;;MYLES KEVIN MICHAEL,,https://lens.org/113-090-563-835-300,Patent Application,yes,4,0,6,6,0,H01M6/18;;H01M6/18;;H01M8/124;;H01M8/124;;Y02E60/50;;Y02P70/50;;Y02P70/50,C01B25/36;;C01B25/455;;C01B33/20;;C01B37/04;;C01B37/08;;C01B39/06;;C01B39/54;;H01B1/06;;H01M6/18;;H01M8/02;;H01M8/12,,1,0,,,See also references of EP 0567640A4,PENDING
494,US,B1,US 10705629 B1,146-895-084-175-363,2020-07-07,2020,US 201715599341 A,2017-05-18,US 201715599341 A;;US 201662370341 P,2016-08-03,Customizable control system,A system is provided that includes a display or other support surface to which a repositionable control device may be removably mounted. The display may emit light. The repositionable control device may be a repositionable knob that has light sensors. The display may be directed to emit the light in a predetermined time-varying search pattern while the light sensors make measurements of the emitted light. The repositionable knob may wirelessly transmit the light sensor measurements to control circuitry associated with the display. The control circuitry may process the light sensor measurements or other sensor measurements to determine the location of the repositionable control device on the display. Visible tick marks or other scale information may be displayed around the periphery of the knob. An electromagnetic actuator may provide adjustable detents. Wireless power may be received by the knob.,APPLE INC,ARNOLD PETER M;;BAUGH BRENTON A;;GLEESON BRIAN T;;BLOOM DAVID,APPLE INC (2017-05-10),https://lens.org/146-895-084-175-363,Granted Patent,yes,20,17,1,1,0,G06F3/0362;;G06F3/0362;;G06F3/016;;G06F3/0312;;G06F3/0312;;G06F3/03547;;G06F3/0393;;G06F3/044;;G09G5/10;;G09G5/10;;G09G2330/02;;G09G2354/00;;G09G2354/00;;G09G2360/145;;G09G2360/145,G06F3/0362;;G06F3/03;;G06F3/044;;G09G5/10,,0,0,,,,ACTIVE
495,WO,A1,WO 2011/075098 A1,176-834-828-635-49X,2011-06-23,2011,US 2009/0006569 W,2009-12-16,US 2009/0006569 W,2009-12-16,SYSTEM AND METHOD FOR PROTECTING ADVERTISING CUE MESSAGES,An apparatus and method for encoding and decoding a broadcast data stream that includes encrypted advertisement cue messages. The encrypted advertisement cue message data representing a advertisement to be inserted into a stream and data representing an insertion time within said broadcast data stream that is associated with said advertisement. The advertisement cue messages are encrypted and encrypted using a encryption technique. The encrypted advertisement cue message masks the insertion time for the advertisement and prevents automatically skipping of the advertisement data.,THOMSON LICENSING;;SRIDHAR AVINASH;;STEIN ALAN JAY;;BLOOM JEFFREY ADAM;;CAMPANA DAVID ANTHONY,SRIDHAR AVINASH;;STEIN ALAN JAY;;BLOOM JEFFREY ADAM;;CAMPANA DAVID ANTHONY,,https://lens.org/176-834-828-635-49X,Patent Application,yes,3,5,8,8,0,H04N21/23476;;H04N21/2351;;H04N21/4325;;H04N21/4353;;H04N21/4542;;H04N21/4623;;H04N21/812;;H04N21/8456;;H04N7/10;;H04N21/23476;;H04N21/2351;;H04N21/2668;;H04N21/4353;;H04N21/454;;H04N21/4542;;H04N21/812;;H04N21/4542;;H04N21/2351;;H04N21/4353;;H04N21/4623;;H04N21/812;;H04N21/4325;;H04N21/23476;;H04N21/8456,H04N7/10,,1,0,,,See also references of EP 2514198A4,PENDING
496,EP,A4,EP 2514198 A4,188-813-096-378-012,2013-07-03,2013,EP 09852366 A,2009-12-16,US 2009/0006569 W,2009-12-16,SYSTEM AND METHOD FOR PROTECTING ADVERTISING CUE MESSAGES,,THOMSON LICENSING,SRIDHAR AVINASH;;STEIN ALAN JAY;;BLOOM JEFFREY ADAM;;CAMPANA DAVID ANTHONY,,https://lens.org/188-813-096-378-012,Search Report,no,3,0,8,8,0,H04N21/23476;;H04N21/2351;;H04N21/4325;;H04N21/4353;;H04N21/4542;;H04N21/4623;;H04N21/812;;H04N21/8456;;H04N7/10;;H04N21/23476;;H04N21/2351;;H04N21/2668;;H04N21/4353;;H04N21/454;;H04N21/4542;;H04N21/812;;H04N21/4542;;H04N21/2351;;H04N21/4353;;H04N21/4623;;H04N21/812;;H04N21/4325;;H04N21/23476;;H04N21/8456,H04N7/10,,1,0,,,See also references of WO 2011075098A1,DISCONTINUED
497,US,B2,US 11103138 B2,020-122-008-203-701,2021-08-31,2021,US 201615056611 A,2016-02-29,US 201615056611 A;;US 201313799847 A;;US 201261618889 P,2012-04-02,Method and apparatus for detecting and monitoring a foot pre-ulcer,"A method of monitoring a patient's foot forms a thermogram of the sole of at least one foot of the patient, and determines whether the thermogram presents at least one of a plurality of prescribed patterns. The method also compares the thermogram against a prior thermogram of the same foot, and produces output information indicating the emergence of an ulcer on a given portion on the at least one foot as a function of 1) whether the thermogram is determined to present the at least one pattern, and 2) the comparison with the prior thermogram, which shows non-ulcerated tissue at the given location.",PODIMETRICS INC,LINDERS DAVID ROBERT;;BLOOM JONATHAN DAVID;;ENGLER JEFFREY MARK;;PETERSEN BRIAN JUDE;;GEBOFF ADAM;;KALE DAVID CHARLES,PODIMETRICS INC (2013-03-15),https://lens.org/020-122-008-203-701,Granted Patent,yes,79,1,29,40,0,A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/0075;;A61B5/0077;;A61B5/445;;A61B5/6807;;A61B5/706;;A61B5/7282;;A61B5/7425;;A61B2576/02;;A61B5/6892,A61B5/01;;A61B5/00;;G16H40/63;;G16H50/30,,20,11,007-838-305-831-66X;;068-143-875-175-23X;;024-859-176-557-439;;141-122-278-757-410;;046-674-946-125-024;;001-294-432-545-630;;006-812-101-420-47X;;098-193-165-103-972;;085-854-205-805-543;;069-929-432-816-633;;139-091-359-267-244,10.1002/dmrr.2231;;22271717;;10.2337/diacare.25.6.1066;;12032116;;19162769;;10.1109/iembs.2008.4649266;;21198163;;10.1117/1.3524233;;10.1117/1.jbo.18.12.126004;;24337494;;11442293;;10.1109/10.930906;;10.1586/erd.10.35;;20822392;;pmc3876354;;10.1177/193229681300700504;;24124937;;10.1109/iembs.2001.1017387;;9239625;;10.2337/dc16-2294;;28465454,"Bharara, Bharara, M—PI—Technology Summary, 5 pages, undated.;;Bharara et al., “Coming events cast their shadows before: detecting inflammation in the acute diabetic foot and the foot in remission,” Diabetes/Metabolism Research and Reviews, vol. 28, pp. 15-20, 2012.;;Brioschi et al., “Automated Computer Diagnosis of IR Medical Imaging,” FLIR Technical Series, Application Note for Research & Science, FLIR Systems, Inc., 2011.;;Caselli et al., “The Forefoot-to-Rearfoot Plantar Pressure Ratio is Increased in Severe Diabetic Neuropathy and Can Predict Foot Ulceration,” Diabetes Care, vol. 25, No. 6, pp. 1066-1071, Jun. 2002.;;Chen et al., “Development of a Thermal and Hyperspectral Imaging System for Wound Characterization and Metabolic Correlation,”John Hopkins Apl Technical Digest, vol. 26, No. 1, pp. 67-74, 2005.;;Dabiri et al., “Electronic Orthotics Shoe: Preventing Ulceration in Diabetics Patients,” 30th Annual International IEEE EMBS Conference, pp. 771-774, Aug. 2008.;;Kaabouch et al., “Predicting neuropathic ulceration: analysis of static temperature distributions in thermal images,” Journal of Biomedical Optics, vol. 15, No. 6, pp. 061715-1-061715-6, Nov./Dec. 2010.;;Liu et al., “Infrared Dermal Thermography on Diabetic Feet Soles to Predict Ulcerations: a Case Study,”Proceedings of SPIE, vol. 8572, pp. 85720N-1-85720N-9, 2013.;;Liu et al., “Statistical analysis of spectral data: a methodology for designing an intelligent monitoring system for the diabetic foot,” Journal of Biomedical Optics, vol. 18, No. 12, pp. 126004-1-126004-11, Dec. 2013.;;Medgadget.com, “TempTouch for Foot Ulcer Detection,” Xilas, Inc., 2 pages, Apr. 19, 2005.;;Morley et al., “In-Shoe Multisensory Data Acquisition System,” IEEE Transactions on Biomedical Engineering, vol. 48, No. 7, pp. 815-820, Jul. 2001.;;Roback, “An overview of temperature monitoring devices for early detection of diabetic foot disorders,” Linkoping University Post Print, 18 pages, undated.;;Van Netten et al., “Infrared Thermal Imaging for Automated Detection of Diabetic Foot Complications,” Journal of Diabetes Science and Technology, vol. 7, No. 5, pp. 1122-1129, Sep. 2013.;;Visual Footcare Technologies, LLC, “TempStat,” Visual Footcare Technologies, LLC, Thermal Imagine Device, One unit: $125, 2 pages, undated.;;Korean Intellectual Property Office, International Search Report—International Application No. PCT/US2013/030997, dated Jul. 8, 2013, together with the Written Opinion of the International Searching Authority, 13 pages.;;European Patent Office, Supplementary European Search Report—Application No. EP 13 77 2800, dated Jun. 26, 2015, 7 pages.;;Ammer et al. Thermal Imaging of Skin Changes on the Feet of Type II Diabetics, 2001 Conference Proceedings of the 23rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Istanbul, Turkey, Oct. 25-28, 2001, 4 pages.;;Armstrong et al. Monitoring Healing of Acute Charcot's Arthropathy with Infrared Dermal Thermometry, Journal of Rehabilitation Research and Development, vol. 34, No. 3, pp. 317-321, Jul. 1997.;;Frykberg et al. Feasibility and Efficacy of a Smart Mat Technology to Predict Development of Diabetic Plantar Ulcers, Diabetes Care, vol. 40, pp. 973-980, Jul. 2017.;;European Patent Office Notice of Opposition to a European Patent—European Patent No. 2833783B1, dated May 31, 2018, 8 pages.",ACTIVE
498,US,B2,US 9095305 B2,171-917-668-934-66X,2015-08-04,2015,US 201313803866 A,2013-03-14,US 201313803866 A;;US 201313799828 A;;US 201261618889 P,2012-04-02,Method and apparatus for indicating the emergence of a pre-ulcer and its progression,"A method of monitoring a patient's foot provides an open platform for receiving at least one foot. The platform has at least one temperature sensor for generating a plurality of temperature data values after receipt of the at least one foot. The method then forms a thermogram of the sole of the at least one foot from the temperature data, and determines whether the thermogram presents at least one of a plurality of prescribed patterns. Next, the method produces output information indicating the emergence of a pre-ulcer or progression of a known pre-ulcer in the at least one foot as a function of whether the thermogram is determined to present the at least one pattern.",PODIMETRICS INC,ENGLER JEFFREY MARK;;LINDERS DAVID ROBERT;;BLOOM JONATHAN DAVID;;PETERSEN BRIAN JUDE;;GEBOFF ADAM;;KALE DAVID CHARLES,PODIMETRICS INC (2013-03-15),https://lens.org/171-917-668-934-66X,Granted Patent,yes,72,31,29,40,0,A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/0075;;A61B5/0077;;A61B5/445;;A61B5/6807;;A61B5/706;;A61B5/7282;;A61B5/7425;;A61B2576/02;;A61B5/6892,A61B5/01;;A61B5/00,,16,9,011-960-216-107-569;;068-143-875-175-23X;;024-859-176-557-439;;006-812-101-420-47X;;001-294-432-545-630;;007-838-305-831-66X;;141-122-278-757-410;;046-674-946-125-024;;098-193-165-103-972,10.1088/0143-0815/9/2/006;;3391016;;10.2337/diacare.25.6.1066;;12032116;;19162769;;10.1109/iembs.2008.4649266;;10.1586/erd.10.35;;20822392;;11442293;;10.1109/10.930906;;10.1002/dmrr.2231;;22271717;;21198163;;10.1117/1.3524233;;10.1117/1.jbo.18.12.126004;;24337494;;pmc3876354;;10.1177/193229681300700504;;24124937,"Tamura et al. (Article entitled ""A bed temperature monitoring system for assessing movement during sleep,"" Clin. Phys. Meas., 1988, vol. 9, No. 2, 139-145).;;Bharara, M, Bharara, M-Pi-Technology Summary, 5 pages, undated.;;Caselli, M.D. et al., ""The Forefoot-to-Rearfoot Plantar Pressure Ratio Is Increased in Severe Diabetic Neuropathy and Can Predict Foot Ulceration,"" Diabetes Care, vol. 25, No. 6, pp. 1066-1071, Jun. 2002.;;Dabiri et al., ""Electronic Orthotics Shoe: Preventing Ulceration in Diabetics Patients,"" 30th Annual International IEEE EMBS Conference, pp. 771-774, Aug. 2008.;;Kerstin Roback, ""An overview of temperature monitoring devices for early detection of diabetic foot disorders,"" Linkoping University Post Print, 18 pages, undated.;;Medgadget.com, ""TempTouch for Foot Ulcer Detection,"" Xilas, Inc., 2 pages, Apr. 19, 2005.;;Morley et al., ""In-Shoe Multisensory Data Acquisition System,"" IEEE Transactions on Biomedical Engineering, vol. 48, No. 7, pp. 815-820, Jul. 2001.;;Visual Footcare Technologies, LLC, ""TempStat,"" Visual Footcare Technologies, LLC, Thermal Imagine Device, One unit: $125, 2 pages, undated.;;Korean Intellectual Property Office, International Search Report-International Application No. PCT/US2013/030997, dated Jul. 8, 2013, together with the Written Opinion of the International Searching Authority, 13 pages.;;Bharara et al., ""Coming events cast their shadows before: detecting inflammation in the acute diabetic foot and the foot in remission,"" Diabetes/Metabolism Research and Reviews, vol. 28, pp. 15-20, 2012.;;Brioschi et al., ""Automated Computer Diagnosis of IR Medical Imaging,"" FLIR Technical Series, Application Note for Research & Science, FLIR Systems, Inc., 6 pages, 2011.;;Chen et al., ""Development of a Thermal and Hyperspectral Imaging System for Wound Characterization and Metabolic Correlation,"" John Hopkins Apl Technical Digest, vol. 26, No. 1, pp. 67-74, 2005.;;Kaabouch et al., ""Predicting neuropathic ulceration: analysis of static temperature distributions in thermal images,"" Journal of Biomedical Optics, vol. 15, No. 6, pp. 061715-1-061715-6, 2010.;;Liu et al., ""Infrared Dermal Thermography on Diabetic Feet Soles to Predict Ulcerations: a Case Study,"" Proc. of SPIE, vol. 8572, pp. 85720N-1-85720N-9, 2013.;;Liu et al., ""Statistical analysis of spectral data: a methodology for designing an intelligent monitoring system for the diabetic foot,"" Predicting neuropathic ulceration: analysis of static temperature distributions in thermal images, Journal of Biomedical Optics, vol. 18(12), pp. 126004-1-126004-11, Dec. 2013.;;Van Netten et al., ""Infrared Thermal Imaging for Automated Detection of Diabetic Foot Complications,"" Journal of Diabetes Science and Technology, vol. 7, Issue 5, pp. 1122-1129, Sep. 2013.",ACTIVE
499,US,B2,US 9259178 B2,154-984-473-171-336,2016-02-16,2016,US 201313799828 A,2013-03-13,US 201313799828 A;;US 201261618889 P,2012-04-02,Method and apparatus for indicating the risk of an emerging ulcer,"A method of monitoring at least one foot of a patient provides an open platform for receiving at least one foot. The open platform has at least one temperature sensor for generating a plurality of temperature data values after receipt of the at least one foot. The method also forms a thermogram of the sole of the at least one foot from the temperature data values, and determines whether the thermogram presents at least one of a plurality of prescribed patterns. Finally, the method produces output information indicating the risk of an ulcer emerging on the foot as a function of whether the thermogram is determined to present the at least one prescribed pattern.",PODIMETRICS INC,BLOOM JONATHAN DAVID;;LINDERS DAVID ROBERT;;ENGLER JEFFREY MARK;;PETERSEN BRIAN JUDE;;GEBOFF ADAM;;KALE DAVID CHARLES,PODIMETRICS INC (2013-03-15),https://lens.org/154-984-473-171-336,Granted Patent,yes,73,6,29,40,0,A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/0075;;A61B5/0077;;A61B5/445;;A61B5/6807;;A61B5/706;;A61B5/7282;;A61B5/7425;;A61B2576/02;;A61B5/6892,A61B5/00;;A61B5/01,,17,9,011-960-216-107-569;;068-143-875-175-23X;;024-859-176-557-439;;006-812-101-420-47X;;001-294-432-545-630;;046-674-946-125-024;;098-193-165-103-972;;007-838-305-831-66X;;141-122-278-757-410,10.1088/0143-0815/9/2/006;;3391016;;10.2337/diacare.25.6.1066;;12032116;;19162769;;10.1109/iembs.2008.4649266;;10.1586/erd.10.35;;20822392;;11442293;;10.1109/10.930906;;10.1117/1.jbo.18.12.126004;;24337494;;pmc3876354;;10.1177/193229681300700504;;24124937;;10.1002/dmrr.2231;;22271717;;21198163;;10.1117/1.3524233,"Tamura et al. (Article entitled ""A bed temperature monitoring system for assessing movement during sleep,"" Clin. Phys. Meas., 1988, vol. 9, No. 2, 139-145).;;Bharara, M, Bharara, M-PI-Technology Summary, 5 pages, undated.;;Caselli, M.D. et al., ""The Forefoot-to-Rearfoot Plantar Pressure Ratio is Increased in Severe Diabetic Neuropathy and Can Predict Foot Ulceration,"" Diabetes Care, vol. 25, No. 6, pp. 1066-1071, Jun. 2002.;;Dabiri et al., ""Electronic Orthotics Shoe: Preventing Ulceration in Diabetics Patients,"" 30th Annual International IEEE EMBS Conference, pp. 771-774, Aug. 2008.;;Kerstin Roback, ""An overview of temperature monitoring devices for early detection of diabetic foot disorders,"" Linkoping University Post Print, 18 pages, undated.;;Medgadget.com, ""TempTouch for Foot Ulcer Detection,"" Xilas, Inc., 2 pages, Apr. 19, 2005.;;Morley et al., ""In-Shoe Multisensory Data Acquisition System,"" IEEE Transactions on Biomedical Engineering, vol. 48, No. 7, pp. 815-820, Jul. 2001.;;Visual Footcare Technologies, LLC, ""TempStat,"" Visual Footcare Technologies, LLC, Thermal Imagine Device, One unit: $125, 2 pages, undated.;;Korean Intellectual Property Office, International Search Report-International Application No. PCT/US2013/030997, dated Jul. 8, 2013, together with the Written Opinion of the International Searching Authority, 13 pages.;;European Patent Office, Supplementary European Search Report-Application No. EP 13 77 2800, dated Jun. 26, 2015, 7 pages.;;Liu et al., ""Statistical analysis of spectral data: a methodology for designing an intelligent monitoring system for the diabetic foot,"" Predicting neuropathic ulceration: analysis of static temperature distributions in thermal images, Journal of Biomedical Optics, vol. 18(12), pp. 126004-1-126004-11, Dec. 2013.;;Van Netten et al., ""Infrared Thermal Imaging for Automated Detection of Diabetic Foot Complications,"" Journal of Diabetes Science and Technology, vol. 7, Issue 5, pp. 1122-1129, Sep. 2013.;;Bharara et al. ""Coming events cast their shadows before: detecting inflammation in the acute diabetic foot and the foot in remission,"" Diabetes/Metabolism Research and Reviews, vol. 28, pp. 15-20, 2012.;;Brioschi et al. ""Automated Computer Diagnosis of IR Medical Imaging,"" FLIR Technical Series, Application Note for Research & Science, FLUR Systems, Inc., 2011.;;Chen et al. ""Development of a Thermal and Hyperspectral Imaging System for Wound Characterization and Metabolic Correlation,"" John Hopkins Apl Technical Digest, vol. 26, No. 1, pp. 67-74, 2005.;;Kaabouch et al. ""Predicting neuropathic ulceration: analysis of static temperature distributions in thermal images,"" Journal of biomedical Optics, vol. 15, Sec. 6, pp. 061715-1 - 061715-6, 2010.;;Liu et al. ""Infrared Dermal Thermography on Diabetic Feet Soles to Predict Ulcerations: a Case Study,"" Proc. of SPIE, vol. 8572, pp. 85720N-1 - 85720N-9, 2013.",ACTIVE
500,US,A1,US 2023/0240542 A1,021-897-770-054-410,2023-08-03,2023,US 202318121039 A,2023-03-14,US 202318121039 A;;US 202117459656 A;;US 201615056611 A;;US 201313799847 A;;US 201261618889 P,2012-04-02,METHOD AND APPARATUS FOR INDICATING THE EMERGENCE OF AN ULCER,"A method of monitoring a patient's foot forms a thermogram of the sole of at least one foot of the patient, and determines whether the thermogram presents at least one of a plurality of prescribed patterns. The method also compares the thermogram against a prior thermogram of the same foot, and produces output information indicating the emergence of an ulcer on a given portion on the at least one foot as a function of 1) whether the thermogram is determined to present the at least one pattern, and 2) the comparison with the prior thermogram, which shows non-ulcerated tissue at the given location.",PODIMETRICS INC,LINDERS DAVID ROBERT;;BLOOM JONATHAN DAVID;;ENGLER JEFFREY MARK;;PETERSEN BRIAN JUDE;;GEBOFF ADAM;;KALE DAVID CHARLES,,https://lens.org/021-897-770-054-410,Patent Application,yes,2,2,29,40,0,A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/0075;;A61B5/0077;;A61B5/445;;A61B5/6807;;A61B5/706;;A61B5/7282;;A61B5/7425;;A61B2576/02;;A61B5/6892,A61B5/01;;A61B5/00;;G16H40/63;;G16H50/30,,0,0,,,,PENDING
501,US,B2,US 9271672 B2,070-875-998-683-184,2016-03-01,2016,US 201313799847 A,2013-03-13,US 201313799847 A;;US 201261618889 P,2012-04-02,Method and apparatus for indicating the emergence of an ulcer,"A method of monitoring a patient's foot forms a thermogram of the sole of at least one foot of the patient, and determines whether the thermogram presents at least one of a plurality of prescribed patterns. The method also compares the thermogram against a prior thermogram of the same foot, and produces output information indicating the emergence of an ulcer on a given portion on the at least one foot as a function of 1) whether the thermogram is determined to present the at least one pattern, and 2) the comparison with the prior thermogram, which shows non-ulcerated tissue at the given location.",PODIMETRICS INC,LINDERS DAVID ROBERT;;BLOOM JONATHAN DAVID;;ENGLER JEFFREY MARK;;PETERSEN BRIAN JUDE;;GEBOFF ADAM;;KALE DAVID CHARLES,PODIMETRICS INC (2013-03-15),https://lens.org/070-875-998-683-184,Granted Patent,yes,69,7,29,40,0,A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/0075;;A61B5/0077;;A61B5/445;;A61B5/6807;;A61B5/706;;A61B5/7282;;A61B5/7425;;A61B2576/02;;A61B5/6892,A61B5/00;;A61B5/01,,14,8,011-960-216-107-569;;068-143-875-175-23X;;024-859-176-557-439;;001-294-432-545-630;;007-838-305-831-66X;;141-122-278-757-410;;046-674-946-125-024;;098-193-165-103-972,10.1088/0143-0815/9/2/006;;3391016;;10.2337/diacare.25.6.1066;;12032116;;19162769;;10.1109/iembs.2008.4649266;;11442293;;10.1109/10.930906;;10.1002/dmrr.2231;;22271717;;21198163;;10.1117/1.3524233;;10.1117/1.jbo.18.12.126004;;24337494;;pmc3876354;;10.1177/193229681300700504;;24124937,"Tamura et al., ""A bed temperature monitoring system for assessing body movement during sleep,"" Clin. Phys. Physiol. Meas., 1988, vol. 9, No. 2, 139-145.;;Caselli, M.D. et al., ""The Forefoot-to-Rearfoot Plantar Pressure Ratio is Increased in Severe Diabetic Neuropathy and Can Predict Foot Ulceration,"" Diabetes Care, vol. 25, No. 6, pp. 1066-1071, Jun. 2002.;;Dabiri et al., ""Electronic Orthotics Shoe: Preventing Ulceration in Diabetics Patients,"" 30th Annual International IEEE EMBS Conference, pp. 771-774, Aug. 2008.;;Medgadget.com, ""TempTouch for Foot Ulcer Detection,"" Xilas, Inc., 2 pages, Apr. 19, 2005.;;Morley et al., ""In-Shoe Multisensory Data Acquisition System,"" IEEE Transactions on Biomedical Engineering, vol. 48, No. 7, pp. 815-820, Jul. 2001.;;Bharara et al., ""Coming events cast their shadows before: detecting inflammation in the acute diabetic foot and the foot in remission,"" Diabetes/Metabolism Research and Reviews, vol. 28, pp. 15-20, 2012.;;Brioschi et al., ""Automated Computer Diagnosis of IR Medical Imaging,"" FLIR Technical Series, Application Note for Research & Science, FLIR Systems, Inc., 6 pages, 2011.;;Chen et al., ""Development of a Thermal and Hyperspectral Imaging System for Wound Characterization and Metabolic Correlation,"" John Hopkins Apl Technical Digest, vol. 26, No. 1, pp. 67-74, 2005.;;Kaabouch et al., ""Predicting neuropathic ulceration: analysis of static temperature distributions in thermal images,"" Journal of Biomedical Optics, vol. 15, No. 6, pp. 061715-1-061715-6, 2010.;;Liu et al. ""Infrared Dermal Thermography on Diabetic Feet Soles to Predict Ulcerations: a Case Study,"" Proc. of SPIE, vol. 8572, pp. 85720N-1-85720N-9, 2013.;;Korean Intellectual Property Office, International Search Report-International Application No. PCT/US2013/030997, dated Jul. 8, 2013, together with the Written Opinion of the International Searching Authority, 13 pages.;;Liu et al., ""Statistical analysis of spectral data: a methodology for designing an intelligent monitoring system for the diabetic foot,"" Predicting neuropathic ulceration: analysis of static temperature distributions in thermal images, Journal of Biomedical Optics, vol. 18(12), pp. 126004-1-126004-11, Dec. 2013.;;Van Netten et al., ""Infrared Thermal Imaging for Automated Detection of Diabetic Foot Complications,"" Journal of Diabetes Science and Technology, vol. 7, Issue 5, pp. 1122-1129, Sep. 2013.;;European Patent Office, Supplementary European Search Report-Application No. EP 13 77 2800, dated Jun. 26, 2015, 7 pages.",ACTIVE
502,EP,A1,EP 2833783 A1,157-606-146-876-743,2015-02-11,2015,EP 13772800 A,2013-03-13,US 201261618889 P;;US 2013/0030997 W,2012-04-02,METHOD AND APPARATUS FOR INDICATING THE EMERGENCE OF A PRE-ULCER AND ITS PROGRESSION,,PODIMETRICS INC,BLOOM JONATHAN DAVID;;LINDERS DAVID ROBERT;;ENGLER JEFFREY MARK;;PETERSEN BRIAN JUDE;;GEBOFF ADAM;;KALE DAVID CHARLES,"PODIMETRICS, INC. (2017-07-12)",https://lens.org/157-606-146-876-743,Patent Application,yes,0,0,29,40,0,A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/0075;;A61B5/0077;;A61B5/445;;A61B5/6807;;A61B5/706;;A61B5/7282;;A61B5/7425;;A61B2576/02;;A61B5/6892,A61B5/01;;A61B5/00;;G01J5/02,,0,0,,,,ACTIVE
503,US,A1,US 2013/0261495 A1,171-768-969-256-157,2013-10-03,2013,US 201313799847 A,2013-03-13,US 201313799847 A;;US 201261618889 P,2012-04-02,Method and Apparatus for Indicating the Emergence of an Ulcer,"A method of monitoring a patient's foot forms a thermogram of the sole of at least one foot of the patient, and determines whether the thermogram presents at least one of a plurality of prescribed patterns. The method also compares the thermogram against a prior thermogram of the same foot, and produces output information indicating the emergence of an ulcer on a given portion on the at least one foot as a function of 1) whether the thermogram is determined to present the at least one pattern, and 2) the comparison with the prior thermogram, which shows non-ulcerated tissue at the given location.",PODIMETRICS INC;;PODIMETRICS INC,LINDERS DAVID ROBERT;;BLOOM JONATHAN DAVID;;ENGLER JEFFREY MARK;;PETERSEN BRIAN JUDE;;GEBOFF ADAM;;KALE DAVID CHARLES,PODIMETRICS INC (2013-03-15),https://lens.org/171-768-969-256-157,Patent Application,yes,1,11,29,40,0,A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/0075;;A61B5/0077;;A61B5/445;;A61B5/6807;;A61B5/706;;A61B5/7282;;A61B5/7425;;A61B2576/02;;A61B5/6892,A61B5/01,600/549,1,1,011-960-216-107-569,10.1088/0143-0815/9/2/006;;3391016,"Tamura et al., ""A bed temperature monitoring system for assessing body movement during sleep,"" Clin. Phys. Physiol. Meas., 1988, Vol. 9, No. 2, 139-145",ACTIVE
504,US,A1,US 2013/0261496 A1,017-100-228-972-371,2013-10-03,2013,US 201313803866 A,2013-03-14,US 201313803866 A;;US 201313799828 A;;US 201261618889 P,2012-04-02,Method and Apparatus for Indicating the Emergence of a Pre-Ulcer and its Progression,"A method of monitoring a patient's foot provides an open platform for receiving at least one foot. The platform has at least one temperature sensor for generating a plurality of temperature data values after receipt of the at least one foot. The method then forms a thermogram of the sole of the at least one foot from the temperature data, and determines whether the thermogram presents at least one of a plurality of prescribed patterns. Next, the method produces output information indicating the emergence of a pre-ulcer or progression of a known pre-ulcer in the at least one foot as a function of whether the thermogram is determined to present the at least one pattern.",PODIMETRICS INC,ENGLER JEFFREY MARK;;LINDERS DAVID ROBERT;;BLOOM JONATHAN DAVID;;PETERSEN BRIAN JUDE;;GEBOFF ADAM;;KALE DAVID CHARLES,PODIMETRICS INC (2013-03-15),https://lens.org/017-100-228-972-371,Patent Application,yes,1,34,29,40,0,A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/0075;;A61B5/0077;;A61B5/445;;A61B5/6807;;A61B5/706;;A61B5/7282;;A61B5/7425;;A61B2576/02;;A61B5/6892,A61B5/01;;A61B5/00,600/549,0,0,,,,ACTIVE
505,EP,B1,EP 2833783 B1,082-785-062-611-497,2017-09-06,2017,EP 13772800 A,2013-03-13,US 201261618889 P;;US 2013/0030997 W,2012-04-02,METHOD AND APPARATUS FOR INDICATING THE EMERGENCE OF A PRE-ULCER AND ITS PROGRESSION,,PODIMETRICS INC,BLOOM JONATHAN DAVID;;LINDERS DAVID ROBERT;;ENGLER JEFFREY MARK;;PETERSEN BRIAN JUDE;;GEBOFF ADAM;;KALE DAVID CHARLES,"PODIMETRICS, INC. (2017-07-12)",https://lens.org/082-785-062-611-497,Granted Patent,yes,2,0,29,40,0,A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/0075;;A61B5/0077;;A61B5/445;;A61B5/6807;;A61B5/706;;A61B5/7282;;A61B5/7425;;A61B2576/02;;A61B5/6892,A61B5/01;;A61B5/00;;G01J5/02,,4,4,059-192-451-753-774;;085-854-205-805-543;;069-929-432-816-633;;139-091-359-267-244,3731992;;10.2337/diacare.9.3.267;;10.1109/iembs.2001.1017387;;9239625;;10.2337/dc16-2294;;28465454,"STESS R M ET AL: ""Use of liquid crystals thermography in the evaluation of the diabetic foot"", DIABETES CARE, AMERICAN DIABETES ASSOCIATION, ALEXANDRIA, VA, US, vol. 9, no. 3, 1 May 1986 (1986-05-01), pages 267 - 272, XP008112489, ISSN: 0149-5992, DOI: 10.2337/DIACARE.9.3.267;;K. AMMER ET AL.: ""Thermal imaging of skin changes on the feet of type II diabetics"", 23RD ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, 25 October 2001 (2001-10-25), pages 2870 - 2872, XP010592263;;ARMSTRONG DG ET AL.: ""Lavery LA.Monitoring healing of acute Charcot's arthropathy with infrared dermal thermometry"", J REHABIL RES DEV., vol. 34, no. 3, July 1997 (1997-07-01), pages 317 - 321, XP055497625;;""Feasibility and Efficacy of a Smart Mat Technology to Predict Development of Diabetic Plantar Ulcers"", DIABETES CARE, vol. 40, 2017, pages 973 - 980, XP055497630, Retrieved from the Internet <URL:https://doi.orp,/10.2337/dcl6-2294>",ACTIVE
506,CN,A,CN 108245138 A,049-937-502-191-128,2018-07-06,2018,CN 201711444050 A,2013-03-13,US 201261618889 P;;CN 201380018934 A,2012-04-02,Apparatus for monitoring patient's foot,"The invention provides an apparatus for monitoring a patient's foot. A method of monitoring a patient's foot provides an open platform for receiving at least one foot. The platform has at least one temperature sensor for generating a plurality of temperature data values after receipt of the at least one foot. The method then forms a thermogram of the sole of the at least one foot from the temperature data, and determines whether the thermogram presents at least one of a plurality of prescribed patterns. Next, the method produces output information indicating the emergence of a pre-ulcer or progression of a known pre-ulcer in the at least one foot as a function of whether the thermogram is determined to present the at least one pattern.",PODIMETRICS INC,BLOOM JONATHAN DAVID;;LINDERS DAVID ROBERT;;ENGLER JEFFREY MARK;;PETERSEN BRIAN JUDE;;GEBOFF ADAM;;KALE DAVID CHARLES,,https://lens.org/049-937-502-191-128,Patent Application,no,6,0,29,40,0,A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/0075;;A61B5/0077;;A61B5/445;;A61B5/6807;;A61B5/706;;A61B5/7282;;A61B5/7425;;A61B2576/02;;A61B5/6892,A61B5/01,,2,0,,,"刘砚燕 等: ""红外温度检测足部皮肤温度预防糖尿病足并发症效果的Ｍｅｔａ分析"", 《解放军护理杂志》;;TAKASHI NAGASE 等: ""Variations of plantar thermographic patterns in normal controls and non-ulcer diabetic patients: Novel classification using angiosome concept"", 《JOURNAL OF PLASTIC, RECONSTRUCTIVE & AESTHETIC SURGERY》",ACTIVE
507,US,A1,US 2021/0386297 A1,083-118-513-083-898,2021-12-16,2021,US 202117459656 A,2021-08-27,US 202117459656 A;;US 201615056611 A;;US 201313799847 A;;US 201261618889 P,2012-04-02,METHOD AND APPARATUS FOR INDICATING THE EMERGENCE OF AN ULCER,"A method of monitoring a patient's foot forms a thermogram of the sole of at least one foot of the patient, and determines whether the thermogram presents at least one of a plurality of prescribed patterns. The method also compares the thermogram against a prior thermogram of the same foot, and produces output information indicating the emergence of an ulcer on a given portion on the at least one foot as a function of 1) whether the thermogram is determined to present the at least one pattern, and 2) the comparison with the prior thermogram, which shows non-ulcerated tissue at the given location.",PODIMETRICS INC,LINDERS DAVID ROBERT;;BLOOM JONATHAN DAVID;;ENGLER JEFFREY MARK;;PETERSEN BRIAN JUDE;;GEBOFF ADAM;;KALE DAVID CHARLES,PODIMETRICS INC (2013-03-15),https://lens.org/083-118-513-083-898,Patent Application,yes,3,2,29,40,0,A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/0075;;A61B5/0077;;A61B5/445;;A61B5/6807;;A61B5/706;;A61B5/7282;;A61B5/7425;;A61B2576/02;;A61B5/6892,A61B5/00;;A61B5/01;;G16H40/63;;G16H50/30,,0,0,,,,ACTIVE
508,US,A1,US 2016/0192844 A1,120-517-707-555-863,2016-07-07,2016,US 201615056611 A,2016-02-29,US 201615056611 A;;US 201313799847 A;;US 201261618889 P,2012-04-02,Method and Apparatus for Indicating the Emergence of an Ulcer,"A method of monitoring a patient's foot forms a thermogram of the sole of at least one foot of the patient, and determines whether the thermogram presents at least one of a plurality of prescribed patterns. The method also compares the thermogram against a prior thermogram of the same foot, and produces output information indicating the emergence of an ulcer on a given portion on the at least one foot as a function of 1) whether the thermogram is determined to present the at least one pattern, and 2) the comparison with the prior thermogram, which shows non-ulcerated tissue at the given location.",PODIMETRICS INC,LINDERS DAVID ROBERT;;BLOOM JONATHAN DAVID;;ENGLER JEFFREY MARK;;PETERSEN BRIAN JUDE;;GEBOFF ADAM;;KALE DAVID CHARLES,PODIMETRICS INC (2013-03-15),https://lens.org/120-517-707-555-863,Patent Application,yes,13,8,29,40,0,A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/0075;;A61B5/0077;;A61B5/445;;A61B5/6807;;A61B5/706;;A61B5/7282;;A61B5/7425;;A61B2576/02;;A61B5/6892,A61B5/00;;A61B5/01,,0,0,,,,ACTIVE
509,CA,C,CA 2907979 C,085-335-865-685-247,2023-09-26,2023,CA 2907979 A,2013-03-13,US 201261618889 P;;US 2013/0030997 W,2012-04-02,METHOD AND APPARATUS FOR INDICATING THE EMERGENCE OF A PRE-ULCER AND ITS PROGRESSION,"A method of monitoring a patient's foot provides an open platform for receiving at least one foot. The platform has at least one temperature sensor for generating a plurality of temperature data values after receipt of the at least one foot. The method then forms a thermogram of the sole of the at least one foot from the temperature data, and determines whether the thermogram presents at least one of a plurality of prescribed patterns. Next, the method produces output information indicating the emergence of a pre-ulcer or progression of a known pre-ulcer in the at least one foot as a function of whether the thermogram is determined to present the at least one pattern.",PODIMETRICS INC,BLOOM JONATHAN DAVID;;LINDERS DAVID ROBERT;;ENGLER JEFFREY MARK;;PETERSEN BRIAN JUDE;;GEBOFF ADAM;;KALE DAVID CHARLES,,https://lens.org/085-335-865-685-247,Granted Patent,no,0,0,29,40,0,A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/0075;;A61B5/0077;;A61B5/445;;A61B5/6807;;A61B5/706;;A61B5/7282;;A61B5/7425;;A61B2576/02;;A61B5/6892,A61B5/01,,0,0,,,,PENDING
510,US,A1,US 2013/0261494 A1,164-475-169-177-853,2013-10-03,2013,US 201313799828 A,2013-03-13,US 201313799828 A;;US 201261618889 P,2012-04-02,Method and Apparatus for Indicating the Risk of an Emerging Ulcer,"A method of monitoring at least one foot of a patient provides an open platform for receiving at least one foot. The open platform has at least one temperature sensor for generating a plurality of temperature data values after receipt of the at least one foot. The method also forms a thermogram of the sole of the at least one foot from the temperature data values, and determines whether the thermogram presents at least one of a plurality of prescribed patterns. Finally, the method produces output information indicating the risk of an ulcer emerging on the foot as a function of whether the thermogram is determined to present the at least one prescribed pattern.",PODIMETRICS INC,BLOOM JONATHAN DAVID;;LINDERS DAVID ROBERT;;ENGLER JEFFREY MARK;;PETERSEN BRIAN JUDE;;GEBOFF ADAM;;KALE DAVID CHARLES,PODIMETRICS INC (2013-03-15),https://lens.org/164-475-169-177-853,Patent Application,yes,5,78,29,40,0,A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/0075;;A61B5/0077;;A61B5/445;;A61B5/6807;;A61B5/706;;A61B5/7282;;A61B5/7425;;A61B2576/02;;A61B5/6892,A61B5/00;;A61B5/01,600/549,0,0,,,,ACTIVE
511,EP,A4,EP 2833783 A4,016-485-973-074-997,2015-08-05,2015,EP 13772800 A,2013-03-13,US 201261618889 P;;US 2013/0030997 W,2012-04-02,METHOD AND APPARATUS FOR INDICATING THE EMERGENCE OF A PRE-ULCER AND ITS PROGRESSION,,PODIMETRICS INC,BLOOM JONATHAN DAVID;;LINDERS DAVID ROBERT;;ENGLER JEFFREY MARK;;PETERSEN BRIAN JUDE;;GEBOFF ADAM;;KALE DAVID CHARLES,"PODIMETRICS, INC. (2017-07-12)",https://lens.org/016-485-973-074-997,Search Report,no,10,0,29,40,0,A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/0075;;A61B5/0077;;A61B5/445;;A61B5/6807;;A61B5/706;;A61B5/7282;;A61B5/7425;;A61B2576/02;;A61B5/6892,A61B5/01;;A61B5/00;;G01J5/02,,0,0,,,,ACTIVE
512,DK,T3,DK 2833783 T3,068-225-656-120-676,2017-11-27,2017,DK 13772800 T,2013-03-13,US 201261618889 P;;US 2013/0030997 W,2012-04-02,"METODE OG APPARAT TIL INDIKATION AF FOREKOMST AF BEGYNDENDE, ÅBENT SÅR OG DETS PROGRESSION",,PODIMETRICS INC,ENGLER JEFFREY MARK;;GEBOFF ADAM;;KALE DAVID CHARLES;;BLOOM JONATHAN DAVID;;LINDERS DAVID ROBERT;;PETERSEN BRIAN JUDE,,https://lens.org/068-225-656-120-676,Granted Patent,no,0,0,29,40,0,A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/0075;;A61B5/0077;;A61B5/445;;A61B5/6807;;A61B5/706;;A61B5/7282;;A61B5/7425;;A61B2576/02;;A61B5/6892,A61B5/01;;A61B5/00;;G01J5/02,,0,0,,,,ACTIVE
513,US,B2,US 11627883 B2,103-099-221-298-048,2023-04-18,2023,US 202117459656 A,2021-08-27,US 202117459656 A;;US 201615056611 A;;US 201313799847 A;;US 201261618889 P,2012-04-02,Method and apparatus for indicating the emergence of an ulcer,"A method of monitoring a patient's foot forms a thermogram of the sole of at least one foot of the patient, and determines whether the thermogram presents at least one of a plurality of prescribed patterns. The method also compares the thermogram against a prior thermogram of the same foot, and produces output information indicating the emergence of an ulcer on a given portion on the at least one foot as a function of 1) whether the thermogram is determined to present the at least one pattern, and 2) the comparison with the prior thermogram, which shows non-ulcerated tissue at the given location.",PODIMETRICS INC,LINDERS DAVID ROBERT;;BLOOM JONATHAN DAVID;;ENGLER JEFFREY MARK;;PETERSEN BRIAN JUDE;;GEBOFF ADAM;;KALE DAVID CHARLES,PODIMETRICS INC (2013-03-15),https://lens.org/103-099-221-298-048,Granted Patent,yes,91,3,29,40,0,A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/0075;;A61B5/0077;;A61B5/445;;A61B5/6807;;A61B5/706;;A61B5/7282;;A61B5/7425;;A61B2576/02;;A61B5/6892,A61B5/01;;A61B5/00;;G16H40/63;;G16H50/30,,17,12,085-854-205-805-543;;069-929-432-816-633;;007-838-305-831-66X;;068-143-875-175-23X;;024-859-176-557-439;;139-091-359-267-244;;141-122-278-757-410;;025-202-460-116-235;;054-450-884-182-038;;001-294-432-545-630;;006-812-101-420-47X;;098-193-165-103-972,10.1109/iembs.2001.1017387;;9239625;;10.1002/dmrr.2231;;22271717;;10.2337/diacare.25.6.1066;;12032116;;19162769;;10.1109/iembs.2008.4649266;;10.2337/dc16-2294;;28465454;;21198163;;10.1117/1.3524233;;10.1117/1.jbo.20.2.026003;;25671671;;10.1117/12.2001807;;11442293;;10.1109/10.930906;;10.1586/erd.10.35;;20822392;;pmc3876354;;10.1177/193229681300700504;;24124937,"Ammer et al. Thermal Imaging of Skin Changes on the Feet of Type II Diabetics, 2001 Conference Proceedings of the 23rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Istanbul, Turkey, Oct. 25-28, 2001, 4 pages.;;Armstrong et al. Monitoring Healing of Acute Charcot's Arthropathy with Infrared Dermal Thermometry, Journal of Rehabilitation Research and Development, vol. 34, No. 3, Jul. 1997, pp. 317-321.;;Bharara, M.P, et al. “Coming events cast their shadows before: detecting inflammation in the acute diabetic foot and the foot in remission,” Diabetes/Metabolism Research and Reviews, 2012, vol. 28, pp. 15-20.;;Brioschi et al. “Automated Computer Diagnosis of IR Medical Imaging,” FLIR Technical Series, Application Note for Research & Science, FLIR Systems, Inc., 2011.;;Caselli, M.D. et al. “The Forefoot-to-Rearfoot Plantar Pressure Ratio is Increased in Severe Diabetic Neurpathy and Can Predict Foot Ulceration,” Diabetes Care, vol. 25, No. 6, Jun. 2002, pp. 1066-1071.;;Dabiri et al. “Electronic Orthotics Shoe: Preventing Ulceration in Diabetic Patients,” 30th Annual International IEEE EMBS Conference, Aug. 2008, pp. 771-774.;;European Patent Office, Notice of Opposition to a European Patent—European Patent Application No. 2833783B1, dated May 31, 2018, 8 pages.;;European Patent Office, Supplementary European Search Report for Application No. EP 13772800, dated Jun. 26, 2015, 7 pages.;;Frykberg et al. Feasibility and Efficacy of a Smart Mat Technology to Predict Development of Diabetic Plantar Ulcers, Diabetes Care, vol. 40, Jul. 2017, pp. 973-980.;;Kaabouch et al. “Predicting neurpathic ulceration: analysis of static temperature distributions in thermal images,” Journal of biomedical Optics, vol. 15, Sec. 6,2010, pp. 061715-1-061715-6.;;Korean Intellectual Property Office, International Search Report, International Application No. PCT/US2013/030997, dated Jul. 8, 2013, together with the Written Opinion of the International Searching Authority, 13 pages.;;Liu C., et al., “Automatic detection of diabetic foot complications with infrared thermography by asymmetric anlysis,” Journal of Biomedical Optics, vol. 20(2), (Feb. 2015), pp. 026003-1-026003-10 [11 pages].;;Liu C., et al., “Infrared Dermal Thermography on Diabetic Feet Soles to Predict Ulcerations: a Case Study,” Advanced Biomedical and Clinical Diagnostic System XI, vol. 8572, 85720N, downloaded from http://proceedings.spiedigitallibrary.org/ on Jul. 8, 2013 [9 pages].;;Medgadget.com “TempTouch for Foot Ulcer Detection,” Xilas, Inc., Apr. 19, 2005, 2 pages.;;Morley et al. “In Shoe-Multisensory Data Acquisition System,” IEEE Transactions on Biomedical Engineering, vol. 18, No. 7, Jul. 2001, pp. 815-820.;;Roback “An overview of temperature monitoring devices for early detection of diabetic foot disorders,” Linkoping University Post Print, 2010, 18 pages.;;Van Netten et al. “Infrared Thermal Imaging for Automated Detection of Daibetic Foot Complications” Journal of Diabetes Science and Technology, vol. 7, Issue 5, Sep. 2013, pp. 1122-1129.",ACTIVE
514,CN,A,CN 104219994 A,148-391-499-397-914,2014-12-17,2014,CN 201380018934 A,2013-03-13,US 2013/0030997 W;;US 201261618889 P,2012-04-02,Method and apparatus for indicating emergence of pre-ulcer and its progression,"A method of monitoring a patient's foot provides an open platform for receiving at least one foot. The platform has at least one temperature sensor for generating a plurality of temperature data values after receipt of the at least one foot. The method then forms a thermogram of the sole of the at least one foot from the temperature data, and determines whether the thermogram presents at least one of a plurality of prescribed patterns. Next, the method produces output information indicating the emergence of a pre-ulcer or progression of a known pre-ulcer in the at least one foot as a function of whether the thermogram is determined to present the at least one pattern.",PODIMETRICS INC,BLOOM JONATHAN DAVID;;LINDERS DAVID ROBERT;;ENGLER JEFFREY MARK;;PETERSEN BRIAN JUDE;;GEBOFF ADAM;;KALE DAVID CHARLES,,https://lens.org/148-391-499-397-914,Patent Application,no,5,10,29,40,0,A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/0075;;A61B5/0077;;A61B5/445;;A61B5/6807;;A61B5/706;;A61B5/7282;;A61B5/7425;;A61B2576/02;;A61B5/6892,A61B5/01;;G01J5/02,,0,0,,,,ACTIVE
515,DK,T4,DK 2833783 T4,158-968-591-779-591,2020-10-19,2020,DK 13772800 T,2013-03-13,US 201261618889 P;;US 2013/0030997 W,2012-04-02,"FREMGANGSMÅDE OG ANORDNING TIL INDIKATION AF FOREKOMST AF BEGYNDENDE, ÅBENT SÅR OG DETS PROGRESSION",,PODIMETRICS INC,ENGLER JEFFREY MARK;;GEBOFF ADAM;;KALE DAVID CHARLES;;BLOOM JONATHAN DAVID;;LINDERS DAVID ROBERT;;PETERSEN BRIAN JUDE,,https://lens.org/158-968-591-779-591,Amended Patent,no,0,0,29,40,0,A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/0075;;A61B5/0077;;A61B5/445;;A61B5/6807;;A61B5/706;;A61B5/7282;;A61B5/7425;;A61B2576/02;;A61B5/6892,A61B5/01;;A61B5/00;;G01J5/02,,0,0,,,,ACTIVE
516,WO,A1,WO 2013/151705 A1,059-364-814-591-646,2013-10-10,2013,US 2013/0030997 W,2013-03-13,US 201261618889 P,2012-04-02,METHOD AND APPARATUS FOR INDICATING THE EMERGENCE OF A PRE-ULCER AND ITS PROGRESSION,"A method of monitoring a patient's foot provides an open platform for receiving at least one foot. The platform has at least one temperature sensor for generating a plurality of temperature data values after receipt of the at least one foot. The method then forms a thermogram of the sole of the at least one foot from the temperature data, and determines whether the thermogram presents at least one of a plurality of prescribed patterns. Next, the method produces output information indicating the emergence of a pre-ulcer or progression of a known pre-ulcer in the at least one foot as a function of whether the thermogram is determined to present the at least one pattern.",PODIMETRICS INC,BLOOM JONATHAN DAVID;;LINDERS DAVID ROBERT;;ENGLER JEFFREY MARK;;PETERSEN BRIAN JUDE;;GEBOFF ADAM;;KALE DAVID CHARLES,,https://lens.org/059-364-814-591-646,Patent Application,yes,7,2,29,40,0,A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/0075;;A61B5/0077;;A61B5/445;;A61B5/6807;;A61B5/706;;A61B5/7282;;A61B5/7425;;A61B2576/02;;A61B5/6892,A61B5/01;;G01J5/02,,0,0,,,,PENDING
517,EP,B2,EP 2833783 B2,117-906-472-071-960,2020-08-12,2020,EP 13772800 A,2013-03-13,US 201261618889 P;;US 2013/0030997 W,2012-04-02,METHOD AND APPARATUS FOR INDICATING THE EMERGENCE OF A PRE-ULCER AND ITS PROGRESSION,,PODIMETRICS INC,BLOOM JONATHAN DAVID;;LINDERS DAVID ROBERT;;ENGLER JEFFREY MARK;;PETERSEN BRIAN JUDE;;GEBOFF ADAM;;KALE DAVID CHARLES,"PODIMETRICS, INC. (2017-07-12)",https://lens.org/117-906-472-071-960,Granted Patent,yes,0,0,29,40,0,A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/0075;;A61B5/0077;;A61B5/445;;A61B5/6807;;A61B5/706;;A61B5/7282;;A61B5/7425;;A61B2576/02;;A61B5/6892,A61B5/01;;A61B5/00;;G01J5/02,,3,3,085-854-205-805-543;;069-929-432-816-633;;139-091-359-267-244,10.1109/iembs.2001.1017387;;9239625;;10.2337/dc16-2294;;28465454,"K. AMMER ET AL.: ""Thermal imaging of skin changes on the feet of type II diabetics"", 23RD ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, 25 October 2001 (2001-10-25), pages 2870 - 2872;;ARMSTRONG DG ET AL.: ""Lavery LA.Monitoring healing of acute Charcot's arthropathy with infrared dermal thermometry"", J REHABIL RES DEV., vol. 34, no. 3, July 1997 (1997-07-01), pages 317 - 321;;""Feasibility and Efficacy of a Smart Mat Technology to Predict Development of Diabetic Plantar Ulcers"", DIABETES CARE, vol. 40, 2017, pages 973 - 980, Retrieved from the Internet <URL:https://doi.orp,/10.2337/dcl6-2294>",ACTIVE
518,WO,A9,WO 2013/151705 A9,036-537-488-815-875,2014-12-04,2014,US 2013/0030997 W,2013-03-13,US 201261618889 P,2012-04-02,METHOD AND APPARATUS FOR INDICATING THE EMERGENCE OF A PRE-ULCER AND ITS PROGRESSION,"A method of monitoring a patient's foot provides an open platform for receiving at least one foot. The platform has at least one temperature sensor for generating a plurality of temperature data values after receipt of the at least one foot. The method then forms a thermogram of the sole of the at least one foot from the temperature data, and determines whether the thermogram presents at least one of a plurality of prescribed patterns. Next, the method produces output information indicating the emergence of a pre-ulcer or progression of a known pre-ulcer in the at least one foot as a function of whether the thermogram is determined to present the at least one pattern.",PODIMETRICS INC,BLOOM JONATHAN DAVID;;LINDERS DAVID ROBERT;;ENGLER JEFFREY MARK;;PETERSEN BRIAN JUDE;;GEBOFF ADAM;;KALE DAVID CHARLES,,https://lens.org/036-537-488-815-875,Search Report,yes,0,0,29,40,0,A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/0075;;A61B5/0077;;A61B5/445;;A61B5/6807;;A61B5/706;;A61B5/7282;;A61B5/7425;;A61B2576/02;;A61B5/6892,A61B5/01;;G01J5/02,,0,0,,,,PENDING
519,CA,A1,CA 2907979 A1,135-487-992-990-070,2013-10-10,2013,CA 2907979 A,2013-03-13,US 201261618889 P;;US 2013/0030997 W,2012-04-02,METHOD AND APPARATUS FOR INDICATING THE EMERGENCE OF A PRE-ULCER AND ITS PROGRESSION,"A method of monitoring a patient's foot provides an open platform for receiving at least one foot. The platform has at least one temperature sensor for generating a plurality of temperature data values after receipt of the at least one foot. The method then forms a thermogram of the sole of the at least one foot from the temperature data, and determines whether the thermogram presents at least one of a plurality of prescribed patterns. Next, the method produces output information indicating the emergence of a pre-ulcer or progression of a known pre-ulcer in the at least one foot as a function of whether the thermogram is determined to present the at least one pattern.",PODIMETRICS INC,BLOOM JONATHAN DAVID;;LINDERS DAVID ROBERT;;ENGLER JEFFREY MARK;;PETERSEN BRIAN JUDE;;GEBOFF ADAM;;KALE DAVID CHARLES,,https://lens.org/135-487-992-990-070,Patent Application,no,0,0,29,40,0,A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/447;;A61B5/015;;A61B5/7275;;A61B5/0008;;A61B5/0022;;A61B2562/0276;;G16H50/30;;G16H40/63;;A61B5/0075;;A61B5/0077;;A61B5/445;;A61B5/6807;;A61B5/706;;A61B5/7282;;A61B5/7425;;A61B2576/02;;A61B5/6892,A61B5/01;;G01J5/02,,0,0,,,,PENDING
520,US,B1,US 6360285 B1,007-946-518-222-92X,2002-03-19,2002,US 26923494 A,1994-06-30,US 26923494 A,1994-06-30,Apparatus for determining memory bank availability in a computer system,"
    In accordance with the present invention, an apparatus includes a system bus having memory bank available signals. Coupled to the system bus are at least two memory modules, each having at least one memory bank. Each memory module includes a mechanism for associating each memory bank with one of the memory bank available signals. Further, each memory module includes logic for determining an availability status of each memory bank and for providing the associated memory bank busy signal with values reflecting the availability status of the memory bank. Additionally, at least two commander modules are coupled to the system bus and include logic, responsive to the memory bank available signals for preventing the commander module from gaining control of the system bus when the commander is attempting to access a memory bank determined to be unavailable. With such an arrangement, only commander modules seeking to access memory banks which are available will be allowed to gain control of the system bus. This avoids stalling the system bus and improves system performance by allowing all initiated transactions to complete as quickly as possible. 
",COMPAQ COMPUTER CORP,FENWICK DAVID M;;FOLEY DENIS;;HARTWELL DAVID;;HETHERINGTON RICKY C;;KECK DALE R;;BLOOM ELBERT,DIGITAL EQUIPMENT CORPORATION (1994-06-29);;COMPAQ COMPUTER CORPORATION (1999-12-09);;HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2001-05-31),https://lens.org/007-946-518-222-92X,Granted Patent,yes,16,27,1,1,0,G06F13/16;;G06F13/16,G06F13/16,710/17;;711/5,0,0,,,,EXPIRED
521,US,A1,US 2017/0213012 A1,007-742-171-386-532,2017-07-27,2017,US 201615005955 A,2016-01-25,US 201615005955 A,2016-01-25,SYSTEMS AND METHODS FOR CAPACITIVE IDENTIFICATION,"Capacitive identification systems and methods are described. The system may include a capacitive detector configured to identify objects having capacitive identifiers. A capacitive identifier may be a patterned dielectric ink that, when placed in an electromagnetic field generated by the capacitive detector, detectably alters the capacitance of neighboring sensors in the detector. The capacitive detector may be disposed within an opaque housing structure of a device and configured to detect the capacitive identifier through the opaque housing structure. The capacitive detector may include a capacitive sensing array and processing circuitry formed on a common printed circuit. The capacitive detector may be formed in an infusion pump system. The capacitive identifier may be disposed on a pump cassette for the infusion pump system.",CAREFUSION 303 INC,O'SCOLAI CATHAL;;BLOOM MARK PATRICK;;BROWN DAVID PATRICK;;WEBER HARRY;;PESSOTTO MICHAEL,CAREFUSION 303 INC (2016-01-14),https://lens.org/007-742-171-386-532,Patent Application,yes,9,9,1,1,0,A61M5/14212;;A61M2205/121;;A61M2205/128;;A61M2205/3375;;A61M2205/60;;A61M2205/6054;;A61M2205/6081;;G06K7/081;;G06K7/10366;;A61M2205/6072;;G16H20/17;;G06K7/10366;;A61M2205/6072;;A61M2205/128;;A61M2205/60;;A61M2205/6081;;A61M2205/3375;;A61M5/14212;;A61M2205/121;;A61M2205/6054;;G06K7/081;;G16H20/17,G06F19/00;;A61M5/142;;G06K7/10,,0,0,,,,DISCONTINUED
522,DK,T3,DK 0830624 T3,041-059-262-363-957,2000-09-25,2000,DK 96917143 T,1996-06-05,US 48218895 A;;US 9608804 W,1995-06-07,Lysventil med fladt afbøjningsgitter,"A diffraction grating light valve modulates an incident beam of light. A plurality of elongated elements each have a reflective surface. The elongated elements are suspended with their respective ends substantially coplanar. Alternate ones of the elongated elements are electrically coupled for receiving a first bias voltage. The interdigitated elongated elements are electrically coupled for receiving a second bias voltage. By applying a appropriate first and second biasing voltages, all the reflective surfaces can be maintained in a first plane. When all the elongated elements are in the first plane, the diffraction grating light valve reflects the beam of light. A predetermined group of the elongated elements, preferably alternate ones, are deformable to be substantially coplanar in a second plane which is parallel to the first plane. When the predetermined group of elements is in the second plane, the diffraction grating light valve diffracts the beam of light.",SILICON LIGHT MACHINES INC,BLOOM DAVID M;;CORBIN DAVE B;;BANYAI WILLIAM C;;STAKER BRYAN P,,https://lens.org/041-059-262-363-957,Granted Patent,no,0,0,20,20,0,G02B5/1828;;G02B26/0808;;Y10S359/904;;G02B5/18;;G02B5/1828;;G02B26/0808;;Y10S359/904,G02B5/18;;G02B26/08,,0,0,,,,EXPIRED
523,EP,A1,EP 3370606 A1,098-869-360-243-396,2018-09-12,2018,EP 16863080 A,2016-11-04,US 201562251879 P;;US 2016/0060638 W,2015-11-06,FOOTWEAR SYSTEM FOR ULCER OR PRE-ULCER DETECTION,,PODIMETRICS INC,LINDERS DAVID R;;PETERSEN BRIAN J;;PETERSEN DANIEL J;;BLOOM JONATHAN D,,https://lens.org/098-869-360-243-396,Patent Application,yes,0,0,10,10,0,A61B5/0002;;G16H50/20;;G16H40/63;;G01K1/026;;G01K2213/00;;A43B7/00;;A61B5/015;;A61B5/445;;A61B5/447;;A61B5/6807;;A61B5/7282;;A61B5/7405;;A61B5/742;;A61B2505/07;;G01K13/20;;A43B3/34;;A61B5/0002;;G16H40/63;;G01K2213/00;;G16H50/20;;G01K1/026;;G01K1/00;;A43B7/00;;G01K13/20;;A43B3/34;;A61B5/015;;A61B5/445;;A61B5/447;;A61B5/6807;;A61B5/7282;;A61B5/7405;;A61B5/742;;A61B2505/07,A61B5/00;;A61B5/01,,0,0,,,,DISCONTINUED
524,NO,L,NO 975696 L,075-783-378-396-823,1997-12-05,1997,NO 975696 A,1997-12-05,US 48218895 A;;US 9608804 W,1995-06-07,Flat diffraksjonsgitter-lysventil,"A diffraction grating light valve modulates an incident beam of light. A plurality of elongated elements each have a reflective surface. The elongated elements are suspended with their respective ends substantially coplanar. Alternate ones of the elongated elements are electrically coupled for receiving a first bias voltage. The interdigitated elongated elements are electrically coupled for receiving a second bias voltage. By applying a appropriate first and second biasing voltages, all the reflective surfaces can be maintained in a first plane. When all the elongated elements are in the first plane, the diffraction grating light valve reflects the beam of light. A predetermined group of the elongated elements, preferably alternate ones, are deformable to be substantially coplanar in a second plane which is parallel to the first plane. When the predetermined group of elements is in the second plane, the diffraction grating light valve diffracts the beam of light.",SILICON LIGHT MACHINES INC,BLOOM DAVID M;;CORBIN DAVE B;;BANYAI WILLIAM C;;STAKER BRYAN P,,https://lens.org/075-783-378-396-823,Abstract,no,0,0,20,20,0,G02B5/1828;;G02B26/0808;;Y10S359/904;;G02B5/18;;G02B5/1828;;G02B26/0808;;Y10S359/904,G02B5/18;;G02B26/08,,0,0,,,,DISCONTINUED
525,US,B2,US 11395622 B2,026-710-027-583-008,2022-07-26,2022,US 201615343892 A,2016-11-04,US 201615343892 A;;US 201562251879 P,2015-11-06,Footwear system for ulcer or pre-ulcer detection,"A footwear system having a plurality of temperature sensors determines the emergence of an ulcer or pre-ulcer on a person's foot. After the plurality of temperature sensors generate a plurality of discrete temperature data values, the system and method form a temperature map representing substantially the actual geometric shape of at least a portion of the foot, and the distribution of temperatures of the at least a portion of the foot. Next, the method and system determine whether the temperature map presents at least one of a plurality of prescribed patterns, and produces output information indicating an emergence of an ulcer or a pre-ulcer on a given portion on the foot. The output information is produced as a function of whether the temperature map is determined to present the at least one of the plurality of prescribed patterns.",PODIMETRICS INC,LINDERS DAVID R;;PETERSEN BRIAN J;;PETERSEN DANIEL J;;BLOOM JONATHAN D,PODIMETRICS INC (2016-11-16),https://lens.org/026-710-027-583-008,Granted Patent,yes,104,1,10,10,0,A61B5/0002;;G16H50/20;;G16H40/63;;G01K1/026;;G01K2213/00;;A43B7/00;;A61B5/015;;A61B5/445;;A61B5/447;;A61B5/6807;;A61B5/7282;;A61B5/7405;;A61B5/742;;A61B2505/07;;G01K13/20;;A43B3/34;;A61B5/0002;;G16H40/63;;G01K2213/00;;G16H50/20;;G01K1/026;;G01K1/00;;A43B7/00;;G01K13/20;;A43B3/34;;A61B5/015;;A61B5/445;;A61B5/447;;A61B5/6807;;A61B5/7282;;A61B5/7405;;A61B5/742;;A61B2505/07,A61B5/00;;A43B3/34;;A43B7/00;;A61B5/01;;G01K1/00;;G01K1/02;;G01K13/20;;G16H40/63;;G16H50/20,,28,12,085-854-205-805-543;;069-929-432-816-633;;139-091-359-267-244;;007-838-305-831-66X;;068-143-875-175-23X;;024-859-176-557-439;;141-122-278-757-410;;046-674-946-125-024;;001-294-432-545-630;;006-812-101-420-47X;;098-193-165-103-972;;025-202-460-116-235,10.1109/iembs.2001.1017387;;9239625;;10.2337/dc16-2294;;28465454;;10.1002/dmrr.2231;;22271717;;10.2337/diacare.25.6.1066;;12032116;;19162769;;10.1109/iembs.2008.4649266;;21198163;;10.1117/1.3524233;;10.1117/1.jbo.18.12.126004;;24337494;;11442293;;10.1109/10.930906;;10.1586/erd.10.35;;20822392;;pmc3876354;;10.1177/193229681300700504;;24124937;;10.1117/1.jbo.20.2.026003;;25671671,"Ammer et al., Thermal Imaging of Skin Changes on the Feet of Type II Diabetics, 2001 Conference Proceedings of the 23rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Istanbul, Turkey, Oct. 25-28, 2001, 4 pages.;;Armstrong et al., Monitoring Healing of Acute Charcot's Arthropathy with Infrared Dermal Thermometry, Journal of Rehabilitation Research and Development, vol. 34, No. 3, pp. 317-321, Jul. 1997.;;Frykberg et al., Feasibility and Efficacy of a Smart Mat Technology to Predict Development of Diabetic Plantar Ulcers, Diabetes Care, vol. 40, pp. 973-980, Jul. 2017.;;European Patent Office, Notice of Opposition to a European Patent—European Patent No. 2833783B1, dated May 31, 2018, 8 pages.;;International Searching Authority, International Search Report—International Application No. PCT/US2016/06038, dated Mar. 2, 2017, together with the Written Opinion of the International Searching Authority, 12 pages.;;Bharara et al., “Coming events cast their shadows before: detecting inflammation in the acute diabetic foot and the foot in remission,” Diabetes/Metabolism Research and Reviews, vol. 28, pp. 15-20, 2012.;;Bharara, M, Bharara, M—PI—Technology Summary, 5 pages, undated.;;Bloom, Declaration of Jonathan D. Bloom under 37 CFR §1.56, pp. 1-3, Feb. 28, 2016.;;Brioschi et al., “Automated Computer Diagnosis of IR Medical Imaging,” FLIR Technical Series, Application Note for Research & Science, FLIR Systems, Inc., 2011.;;Caselli, M.D. et al., “The Forefoot-to-Rearfoot Plantar Pressure Ratio Is Increased in Severe Diabetic Neuropathy and Can Predict Foot Ulceration,” Diabetes Care, vol. 25, No. 6, pp. 1066-1071, Jun. 2002.;;Chen et al., “Development of a Thermal and Hyperspectral Imaging System for Wound Characterization and Metabolic Correlation,” John Hopkins Apl Technical Digest, vol. 26, No. 1, pp. 67-74, 2005.;;Dabiri et al., “Electronic Orthotics Shoe: Preventing Ulceration in Diabetics Patients,” 30th Annual International IEEE EMBS Conference, pp. 771-774, Aug. 2008.;;Engler, “Rock Health Presentation” of Aug. 24, 2012, 19 pages.;;Engler, et al., Description of Public Disclosures reported in Medcitynews.com and CloudTop Articles along with Exhibits A-D, 32 pages, Sep. 2015.;;Engler, Declaration of Jeffrey M. Engler under 37 CFR §1.56, 2 pages, Feb. 28, 2016.;;Kaabouch et al., “Predicting neuropathic ulceration: analysis of static temperature distributions in thermal images,” Journal of biomedical Optics, vol. 15, Sec. 6, pp. 061715-1-061715-6, 2010.;;Liu et al., “Infrared Dermal Thermography on Diabetic Feet Soles to Predict Ulcerations: a Case Study,” Proc. of SPIE, vol. 8572, pp. 85720N-1-85720N-9, 2013.;;Liu et al., “Statistical analysis of spectral data: a methodology for designing an intelligent monitoring system for the diabetic foot,” Predicting neuropathic ulceration: analysis of static temperature distributions in thermal images, Journal of Biomedical Optics, vol. 18(12), pp. 126004-1-126004-11, Dec. 2013.;;Medgadget.com, “TempTouch for Foot Ulcer Detection,” Xilas, Inc., 2 pages, Apr. 19, 2005.;;Morley et al., “In-Shoe Multisensory Data Acquisition System,” IEEE Transactions on Biomedical Engineering, vol. 48, No. 7, pp. 815-820, Jul. 2001.;;Roback, “An overview of temperature monitoring devices for early detection of diabetic foot disorders,” Linkoping University Post Print, 18 pages, 2010.;;Siren Care, “Siren Care—Best Diabetic Socks Tracking Your Foot Health”, https://siren.care/how-it-works , 4 pages, Jan. 6, 2017.;;Van Netten et al., “Infrared Thermal Imaging for Automated Detection of Diabetic Foot Complications,” Journal of Diabetes Science and Technology, vol. 7, Issue 5, pp. 1122-1129, Sep. 2013.;;Visual Footcare Technologies, LLC, “TempStat,” Visual Footcare Technologies, LLC, Thermal Imagine Device, One unit: $125, 1 page, undated.;;Korean Intellectual Property Office, International Search Report—International Application No. PCT/US2013/030997, dated Jul. 8, 2013, together with the Written Opinion of the International Searching Authority, 13 pages.;;European Patent Office, Supplementary European Search Report—Application No. EP 13 77 2800, dated Jun. 26, 2015, 7 pages.;;Liu et al., “Automatic detection of diabetic foot complications with infrared thermography by asymmetric analysis,” Journal of Biomedical Optics, 20(2), 11 pages (2015).;;Supplementary European Search Report for European Patent Application No. 16863080, dated Apr. 30, 2019 (12 pages).",ACTIVE
526,EP,B1,EP 0830624 B1,144-498-642-892-008,2000-04-26,2000,EP 96917143 A,1996-06-05,US 9608804 W;;US 48218895 A,1995-06-07,FLAT DIFFRACTION GRATING LIGHT VALVE,"A diffraction grating light valve modulates an incident beam of light. A plurality of elongated elements each have a reflective surface. The elongated elements are suspended with their respective ends substantially coplanar. Alternate ones of the elongated elements are electrically coupled for receiving a first bias voltage. The interdigitated elongated elements are electrically coupled for receiving a second bias voltage. By applying a appropriate first and second biasing voltages, all the reflective surfaces can be maintained in a first plane. When all the elongated elements are in the first plane, the diffraction grating light valve reflects the beam of light. A predetermined group of the elongated elements, preferably alternate ones, are deformable to be substantially coplanar in a second plane which is parallel to the first plane. When the predetermined group of elements is in the second plane, the diffraction grating light valve diffracts the beam of light.",SILICON LIGHT MACHINES INC,BLOOM DAVID M;;CORBIN DAVE B;;BANYAI WILLIAM C;;STAKER BRYAN P,,https://lens.org/144-498-642-892-008,Granted Patent,yes,2,0,20,20,0,G02B5/1828;;G02B26/0808;;Y10S359/904;;G02B5/18;;G02B5/1828;;G02B26/0808;;Y10S359/904,G02B5/18;;G02B26/08,,3,0,,,"OPTICS LETTERS, vol. 17, no. 9, 1 May 1992, pages 688-690, XP000265233 SOLGAARD O ET AL: ""DEFORMABLE GRATING OPTICAL MODULATOR"";;PROCEEDINGS OF THE SPIE: ELECTRO-OPTIC AND MAGNETO-OPTIC MATERIALS, vol. 1018, 22 - 23 September 1988, HAMBURG, DE, pages 79-84, XP002013958 BRINKLER W ET AL: ""Deformation Behavior of Thin Viscoelastic Layers used in an Active-Matrix Addressed Spatial Light Modulator"";;ELECTRONICS AND COMMUNICATIONS IN JAPAN, vol. 63-c, no. 10, 1980, NEW YORK US, pages 94-100, XP002013959 UTSUNOMIYA ET AL: ""Electrically Deformable Echelette Grating and its Application to Tunable Laser Resonator""",EXPIRED
527,WO,A1,WO 2001/011394 A1,162-715-380-886-812,2001-02-15,2001,US 0021647 W,2000-08-08,US 37264999 A;;US 17168599 P;;US 54878800 A,1999-08-11,POLARIZATION INDEPENDENT GRATING MODULATOR,A fiber-optic modulator based on a micromachined grating device which is both polarization independent and achromatic in behavior is described. The device is a two dimensional grating or periodic structure which is symmetric in the X and Y axes. It is comprised of a membrane (210) with holes cut in it that moves downward with the application of a voltage which starts diffracting light. The hole region may have a raised island (230) to provide achromatic behavior.,LIGHTCONNECT INC,GODIL ASIF A;;CHUI BENJAMIN W;;BLOOM DAVID M;;HONER KENNETH A,,https://lens.org/162-715-380-886-812,Patent Application,yes,8,2,5,23,0,G02B26/0808;;G02B26/0808;;G02B5/1828;;G02B5/1828;;G02B6/266;;G02B6/266;;G02B6/2793;;G02B6/2793;;G02B6/3516;;G02B6/3516;;G02B6/357;;G02B6/357;;G02B6/3584;;G02B6/3584;;G02B6/3594;;G02B6/3594;;H01S5/005;;H01S5/005,G02B5/18;;G02B6/26;;G02B6/34;;G02B6/35;;G02B26/08;;H01S5/00,,5,4,154-800-944-637-210;;035-016-645-296-344;;098-193-261-415-490;;053-397-623-539-637,10.1117/12.962188;;10.1117/1.601599;;10.1364/ao.31.003971;;20725374;;10.1117/1.601598,"PATENT ABSTRACTS OF JAPAN vol. 013, no. 395 (P - 927) 4 September 1989 (1989-09-04);;HORNBECK L J: ""DEFORMABLE-MIRROR SPATIAL LIGHT MODULATORS"", SPATIAL LIGHT MODULATORS AND APPLICATIONS III, 7-8 AUGUST 1989, SAN DIEGO, 7 August 1989 (1989-08-07), XP000351394;;KRISHNAMOORTHY MALI R ET AL: ""DEVELOPMENT OF MICROELECTROMECHANICAL DEFORMABELE MIRRORS FOR PHASEMODULATION OF LIGHT"", OPTICAL ENGINEERING,US,SOC. OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS. BELLINGHAM, vol. 36, no. 2, 1 February 1997 (1997-02-01), pages 542 - 548, XP000686879, ISSN: 0091-3286;;WARDE C ET AL: ""CHARGE-TRANSFER-PLATE SPATIAL LIGHT MODULATORS"", APPLIED OPTICS,US,OPTICAL SOCIETY OF AMERICA,WASHINGTON, vol. 31, no. 20, 10 July 1992 (1992-07-10), pages 3971 - 3979, XP000289217, ISSN: 0003-6935;;BIFANO T G ET AL: ""CONTINUOUS-MEMBRANE SURFACE-MICROMACHINED SILICON DEFORMABLE MIRROR"", OPTICAL ENGINEERING,US,SOC. OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS. BELLINGHAM, vol. 36, no. 5, 1 May 1997 (1997-05-01), pages 1354 - 1359, XP000692365, ISSN: 0091-3286",PENDING
528,WO,A3,WO 2010/036851 A3,157-990-910-204-248,2010-11-04,2010,US 2009/0058302 W,2009-09-25,US 10035008 P,2008-09-26,SINGLE CHAIN ANTIBODY LIBRARY DESIGN,"The invention provides polynucleotide vectors and linkers and methods for designing and making single chain variable fragment (""ScFv"") libraries. The invention also provides polynucleotide vectors and linkers and methods for reformatting the ScFv library into Fab and IgG formats for high throughput production and screening.",WYETH LLC;;HUFTON SIMON EVAN;;FINLAY WILLIAM JAMES JONATHAN;;BROADBENT IAN DAVID;;BLOOM LAIRD,HUFTON SIMON EVAN;;FINLAY WILLIAM JAMES JONATHAN;;BROADBENT IAN DAVID;;BLOOM LAIRD,,https://lens.org/157-990-910-204-248,Search Report,yes,7,0,6,6,0,C07K16/005;;C07K16/005;;C07K2317/55;;C07K2317/55;;C07K2317/56;;C07K2317/56;;C07K2317/622;;C07K2317/622;;C12N15/1037;;C12N15/1037,C07K16/00;;C12N15/10,,5,5,133-610-424-256-319;;058-100-863-730-475;;064-741-687-897-846;;023-636-761-733-822;;049-928-993-608-092,15737606;;pmc7092915;;10.1016/j.bbrc.2005.02.003;;15063787;;10.1016/j.bbrc.2004.03.074;;10.1016/s0378-1119(96)00627-0;;10.1016/j.jmb.2009.03.019;;19285987;;10656818;;10.1006/jmbi.1999.3444,"LIU Z-X ET AL: ""Identification of single-chain antibody fragments specific against SARS-associated coronavirus from phage-displayed antibody library"", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 329, no. 2, 8 April 2005 (2005-04-08), pages 437 - 444, XP004767115, ISSN: 0006-291X;;VOLKEL T ET AL: ""Isolation of endothelial cell-specific human antibodies from a novel fully synthetic scFv library"", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 317, no. 2, 30 April 2004 (2004-04-30), pages 515 - 521, XP004500241, ISSN: 0006-291X;;PERSIC L ET AL: ""An integrated vector system for the eukaryotic expression of antibodies or their fragments after selection from phage display libraries"", GENE, ELSEVIER, AMSTERDAM, NL LNKD- DOI:10.1016/S0378-1119(96)00628-2, vol. 187, no. 1, 10 March 1997 (1997-03-10), pages 9 - 18, XP004093234, ISSN: 0378-1119;;FINLAY W J ET AL: ""Affinity Maturation of a Humanized Rat Antibody for Anti-RAGE Therapy: Comprehensive Mutagenesis Reveals a High Level of Mutational Plasticity Both Inside and Outside the Complementarity-Determining Regions"", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, vol. 388, no. 3, 8 May 2009 (2009-05-08), pages 541 - 558, XP026046499, ISSN: 0022-2836, [retrieved on 20090313];;KNAPPIK A ET AL: ""Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides"", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB LNKD- DOI:10.1006/JMBI.1999.3444, vol. 296, no. 1, 11 February 2000 (2000-02-11), pages 57 - 86, XP004461525, ISSN: 0022-2836",PENDING
529,US,B1,US 10938734 B1,018-701-368-394-534,2021-03-02,2021,US 201715614384 A,2017-06-05,US 201715614384 A,2017-06-05,Scheduling mechanisms for end system SUBVLs,"A device for avionics full-duplex switched Ethernet (AFDX) communication can include a transmit port for transmitting AFDX data and a processor. The processor can be configured to obtain AFDX data frames for transmission over a plurality of sub-virtual links (subVLs) of a virtual link (VL), and maintain, for each of the plurality of subVLs, a corresponding data queue by storing AFDX data frames associated with that subVL in the corresponding data queue. The processor can transmit the AFDX data frames from the plurality of data queues on the plurality subVLs via the transmit port according to a scheduling policy that is based on subVL prioritization. The scheduling policy that is based on subVL prioritization can include static priority (SPn) scheduling, earliest deadline first (EDF) scheduling, or least laxity first (LLF) scheduling.",ROCKWELL COLLINS INC,NELSON BRENT J;;MILLER DAVID A;;ZAEHRING JAMES M;;BLOOM NICHOLAS H,ROCKWELL COLLINS INC (2017-06-02),https://lens.org/018-701-368-394-534,Granted Patent,yes,8,1,1,1,0,H04L69/26;;H04L67/12;;H04L2012/4028;;H04L12/40169;;H04L12/4641;;H04L49/355;;H04L47/564;;H04L47/6295;;H04L47/6275;;H04L47/568;;H04L47/6215;;H04L49/3027;;H04L47/2416;;H04L67/12;;H04L47/2441;;H04L12/4641;;H04L69/26;;H04L49/70;;H04L2012/4028;;H04L47/564,H04L12/40;;H04L12/46;;H04L47/2416;;H04L47/56;;H04L49/111,,2,0,,,"AFDX Workshop Avionics Databus Solutions, Oct. 2010, 55 pages.;;Architecting ARINC 664, Part 7 (AFDX) Solutions, May 22, 2009, 25 pages.",ACTIVE
530,WO,A1,WO 1996/041217 A1,075-968-439-676-361,1996-12-19,1996,US 9608804 W,1996-06-05,US 48218895 A,1995-06-07,FLAT DIFFRACTION GRATING LIGHT VALVE,"A diffraction grating light valve modulates an incident beam of light. A plurality of elongated elements each have a reflective surface. The elongated elements are suspended with their respective ends substantially coplanar. Alternate ones of the elongated elements are electrically coupled for receiving a first bias voltage. The interdigitated elongated elements are electrically coupled for receiving a second bias voltage. By applying an appropriate first and second biasing voltages, all the reflective surfaces can be maintained in a first plane. When all the elongated elements are in the first plane, the diffraction grating light valve reflects the beam of light. A predetermined group of the elongated elements, preferably alternate ones, are deformable to be substantially coplanar in a second plane which is parallel to the first plane. When the predetermined group of elements is in the second plane, the diffraction grating light valve diffracts the beam of light.",ECHELLE INC;;BLOOM DAVID M;;CORBIN DAVE B;;BANYAI WILLIAM C;;STAKER BRYAN P,BLOOM DAVID M;;CORBIN DAVE B;;BANYAI WILLIAM C;;STAKER BRYAN P,,https://lens.org/075-968-439-676-361,Patent Application,yes,2,14,20,20,0,G02B5/1828;;G02B26/0808;;Y10S359/904;;G02B5/18;;G02B5/1828;;G02B26/0808;;Y10S359/904,G02B5/18;;G02B26/08,,3,2,010-074-622-606-125;;021-605-933-822-940,10.1364/ol.17.000688;;19794599;;10.1117/12.950001,"SOLGAARD O ET AL: ""DEFORMABLE GRATING OPTICAL MODULATOR"", OPTICS LETTERS, vol. 17, no. 9, 1 May 1992 (1992-05-01), pages 688 - 690, XP000265233;;BRINKLER W ET AL: ""Deformation Behavior of Thin Viscoelastic Layers used in an Active-Matrix Addressed Spatial Light Modulator"", PROCEEDINGS OF THE SPIE: ELECTRO-OPTIC AND MAGNETO-OPTIC MATERIALS, vol. 1018, 22 September 1988 (1988-09-22) - 23 September 1988 (1988-09-23), HAMBURG, DE, pages 79 - 84, XP002013958;;UTSUNOMIYA ET AL: ""Electrically Deformable Echelette Grating and its Application to Tunable Laser Resonator"", ELECTRONICS AND COMMUNICATIONS IN JAPAN, vol. 63-c, no. 10, 1980, NEW YORK US, pages 94 - 100, XP002013959",PATENTED
531,NO,D0,NO 975696 D0,071-054-241-290-846,1997-12-05,1997,NO 975696 A,1997-12-05,US 48218895 A;;US 9608804 W,1995-06-07,Flat diffraksjonsgitter-lysventil,"A diffraction grating light valve modulates an incident beam of light. A plurality of elongated elements each have a reflective surface. The elongated elements are suspended with their respective ends substantially coplanar. Alternate ones of the elongated elements are electrically coupled for receiving a first bias voltage. The interdigitated elongated elements are electrically coupled for receiving a second bias voltage. By applying a appropriate first and second biasing voltages, all the reflective surfaces can be maintained in a first plane. When all the elongated elements are in the first plane, the diffraction grating light valve reflects the beam of light. A predetermined group of the elongated elements, preferably alternate ones, are deformable to be substantially coplanar in a second plane which is parallel to the first plane. When the predetermined group of elements is in the second plane, the diffraction grating light valve diffracts the beam of light.",SILICON LIGHT MACHINES INC,BLOOM DAVID M;;CORBIN DAVE B;;BANYAI WILLIAM C;;STAKER BRYAN P,,https://lens.org/071-054-241-290-846,Patent Application,no,0,0,20,20,0,G02B5/1828;;G02B26/0808;;Y10S359/904;;G02B5/18;;G02B5/1828;;G02B26/0808;;Y10S359/904,G02B5/18;;G02B26/08,,0,0,,,,DISCONTINUED
532,DE,C3,DE 1445694 C3,157-331-572-787-786,1973-12-20,1973,DE 1445694 A,1963-12-16,GB 4752762 A;;US 27328363 A;;US 26374263 A,1962-12-17,DE 1445694 C3,,"EASTMAN KODAK CO., ROCHESTER, N.Y. (V.ST.A.)","HEDBERG JUN., DAVID GEORGE;;BLOOM, MELVIN SIGMUND;;OTIS, MARSHALL VOIGT;;KINGSPORT, TENN.",,https://lens.org/157-331-572-787-786,Granted Patent,no,0,0,10,22,0,C07D263/64;;C08K5/35;;D01F1/06;;G03C1/8155,C07D263/62;;C07D263/64;;C08K5/35;;D01F1/10;;G03C1/815,,0,0,,,,EXPIRED
533,WO,A1,WO 1996/027810 A1,164-775-441-551-862,1996-09-12,1996,US 9502963 W,1995-03-07,US 9502963 W;;US 6268893 A;;US 87607892 A,1992-04-28,DEFORMABLE GRATING APPARATUS INCLUDING STICTION PREVENTION MEANS,"A modulator for modulating incident light, the modulator comprising a plurality of equally spaced elements (116), each including a light reflective planar surface. The elements are parallel to each other with their light reflective surfaces parallel to each other. The modulator includes means for moving the elements relative to one another between a first configuration wherein the modulator reflects the incident light as a plane mirror, and a second configuration wherein the modulator diffracts the incident rays of light as they are reflected. At least one of the facing surfaces (114) (110) of the elements and underlying substrate (108) is configured to reduce any tendency to stick as they are pulled together. The light reflective surfaces of the elements remain parallel to each other in both the first and the second configurations and the perperdicular spacing between the reflective surfaces of adjacent elements is equal to m/4 times the wavelength of the incident light, wherein m = an even whole number or zero when the elements are in the first configuration and m = an odd number when the elements are in the second configuration.",UNIV LELAND STANFORD JUNIOR,BLOOM DAVID M;;SANDEJAS FRANCISCO S A;;SOLGAARD OLAV;;APTE RAJ B,,https://lens.org/164-775-441-551-862,Patent Application,yes,6,3,1,19,0,B81B3/001;;B81C2201/115;;G02B5/1828;;G02B26/0808,B81B3/00;;G02B5/18;;G02B26/08,,0,0,,,,PENDING
534,US,A,US 5677783 A,171-745-567-828-392,1997-10-14,1997,US 40413995 A,1995-03-13,US 40413995 A;;US 6268893 A;;US 87607892 A,1992-04-28,Method of making a deformable grating apparatus for modulating a light beam and including means for obviating stiction between grating elements and underlying substrate,"A modulator for modulating incident rays of light, the modulator comprising a plurality of equally spaced apart beam elements, each of which includes a light reflective planar surface. The elements are arranged parallel to each other with their light reflective surfaces parallel to each other. The modulator includes means for supporting the beam elements in relation to one another and means for moving the beam elements relative to one another so that the beams move between a first configuration wherein the modulator acts to reflect the incident rays of light as a plane mirror, and a second configuration wherein the modulator diffracts the incident rays of light as they are reflected therefrom. In operation, the light reflective surfaces of the beam elements remain parallel to each other in both the first and the second configurations and the perpendicular spacing between the reflective surfaces of adjacent beam elements is equal to m/4 times the wavelength of the incident rays of light, wherein m=an even whole number or zero when the beam elements are in the first configuration and m=an odd number when the beam elements are in the second configuration.",UNIV LELAND STANFORD JUNIOR,BLOOM DAVID M;;SANDEJAS FRANCISCO S A;;SOLGAARD OLAV;;APTE RAJ B,,https://lens.org/171-745-567-828-392,Granted Patent,yes,11,94,9,19,0,B81C2201/115;;G02B5/1828;;G02B26/0808;;B81B3/001;;Y10S359/90;;B81B3/001;;G02B5/1828;;B81C2201/115;;G02B26/0808;;Y10S359/90,B81B3/00;;G02B5/18;;G02B26/08,359/224;;359/291;;359/295;;359/572;;359/846;;359/900;;156/644.1;;216/2;;437/927,0,0,,,,EXPIRED
535,US,A1,US 2013/0151353 A1,010-510-447-491-778,2013-06-13,2013,US 201313759886 A,2013-02-05,US 201313759886 A;;US 201113245786 A;;US 77060010 A;;US 40667506 A;;US 23810009 P;;US 67312805 P,2005-04-20,METHODS AND SYSTEMS FOR INSERTING MEDIA CONTENT,"A method and system for providing a content object is disclosed with an in-stream ad unit inserted into the content object for a content object player. The content object is audio and/or video. The processed content object is downloaded or streamed to the content object player. A method for content insertion is provided. In this method, a first media data is received from a server and a placement request is transmitted to a content provider service. As a result, a placement response is received from the content provider service. The placement response includes data identifying a second media data associated with the first media data. The second media data is retrieved and merged with the first media data. After the merge, the first and second media data are transmitted to the server.",LIMELIGHT NETWORKS INC;;LIMELIGHT NETWORKS INC,COBB JONATHAN W;;BLOOM RYAN B;;ROWLEY DAVID;;ANDERSON SCOTT;;MAHYARI ABBAS,LIMELIGHT NETWORKS INC (2013-04-11),https://lens.org/010-510-447-491-778,Patent Application,yes,0,6,6,34,0,G06Q30/0277;;G06Q30/0277;;G06Q30/02;;G06Q30/02;;H04N21/23424;;H04N21/23424;;H04N21/2368;;H04N21/2368,G06Q30/02,705/14.73,0,0,,,,ACTIVE
536,WO,A3,WO 2015/153889 A3,037-512-535-852-704,2015-12-10,2015,US 2015/0024094 W,2015-04-02,US 201461973995 P,2014-04-02,MATERIALS AND METHODS FOR THE TREATMENT OF LATENT VIRAL INFECTION,The subject invention pertains to materials and methods for the treatment of latent viral infections.,UNIV FLORIDA;;UNIV DUKE,BLOOM DAVID C;;PHELAN DANE M;;CULLEN BRYAN R;;KENNEDY E MATTHEW,,https://lens.org/037-512-535-852-704,Search Report,yes,4,0,4,4,30,A61K38/465;;A61K38/465;;A61K31/045;;A61K31/52;;A61K31/522;;A61K31/7072;;A61K45/06;;A61K45/06;;A61K48/00;;C07K2319/80;;C12N7/00;;C12N9/22;;C12N9/22;;C12N2710/16611;;C12N2710/16661;;C12Y301/00;;C12Y301/00,C12N15/62;;C12N15/31;;C12N15/66,,0,0,,,,PENDING
537,AU,B2,AU 2002/345965 B2,108-622-587-235-602,2006-09-14,2006,AU 2002/345965 A,2002-06-25,US 30193401 P;;US 0220526 W,2001-06-29,Artificial synapse chip interface for electronic prosthetic retina,The invention provides microfabricated devices and methods for directing the growth of a cell process to form an artificial synapse. The devices are called artificial synapse chips. The artificial synapse comprises a nanofabricated aperture (about 50-100 nm in size) that connects the cell process to a chemical or electrical means of neuronal excitation. Such an aperture width mimics the length scales of a natural synapse and thus emphasizes the localized spatial relationship between a neuron and a stimulation source. The invention further provides devices and methods for regenerating a nerve fiber into an electrode. The invention thus provides a regeneration electrode that uses a novel neural interface for stimulation and that uses novel surface methods for directing neuronal growth making possible in vivo connection of the devices to neural circuitry in a retina and other anatomical locations.,UNIV LELAND STANFORD JUNIOR,PETERMAN MARK;;FISHMAN HARVEY A;;BENT STACEY FRANCINE;;BLOOM DAVID;;BLUMENKRANZ MARK,,https://lens.org/108-622-587-235-602,Granted Patent,no,0,0,15,15,0,A61N1/0543;;A61N1/326;;A61N1/36046;;C12M35/00;;C12M35/02;;C12M35/08;;C12N5/0619;;C12N2503/00;;C12N2535/10;;A61N1/36046;;A61N1/0543;;C12M35/00;;C12M35/02;;C12M35/08;;A61N1/326;;C12N5/0619;;C12N2503/00;;C12N2535/10,C12M3/00;;A61K9/22;;A61L27/00;;A61N1/05;;A61N1/36;;C12M1/42;;C12N5/0793,,6,6,052-681-725-250-166;;001-329-508-866-308;;000-409-659-443-429;;064-942-415-563-86X;;049-325-662-859-361;;039-712-372-889-64X,10.1016/s0165-0270(98)00156-3;;10065993;;10.1016/s0168-9002(99)00445-3;;11248444;;10.1016/s0304-3940(01)01628-7;;9740002;;10.1002/(sici)1097-4636(199810)42:1<13::aid-jbm3>3.0.co;2-r;;9622516;;10.1021/bp980035r;;10.1016/s0925-4005(98)00071-9,"D3: Maher MP, Pine J, Wright J, Tai YC. The neurochip: a new multielectrode device for stimulating and recording from cultured neurons. Journal of Neuroscience Methods. 87(1):45-56, 1999.;;D6: Litke AM. The retinal readout system: a status report. Nuclear Instruments and Methods in Physics Research A. 435: 242-249, 1999.;;D1: Yeung CK, Lauer L, Offenhausser A, Knoll W. Modulation of the growth and guidance of rat brain stem neurons using patterned extracellular matrix proteins. Neuroscience Letters. 301(2):147-50, 2001 (Mar).;;D4: Saneinejad S, Shoichet MS. Patterned glass surfaces direct cell adhesion and process outgrowth of primary neurons of the central nervous system. Journal of Biomedical Materials Research. 42(1):13-9, 1998.;;D5: Tai HC, Buettner HM. Neurite outgrowth and growth cone morphology on micropatterned surfaces. Biotechnology Progress. 14(3):364-70, 1998.;;D2: Heuschkel MO, Guerin L, Buisson B, Bertrand D, Renaud P. Buried microchannels in photopolymer for delivering of solutions to neurons in a network. Sensors and Actuators B. 48:356-361, 1998.",EXPIRED
538,EP,B1,EP 2178519 B1,170-895-010-430-990,2012-04-25,2012,EP 08762998 A,2008-06-30,IB 2008001776 W;;US 94952207 P,2007-07-13,Nanoparticles comprising a non-ionizable polymer and an anionic cellulosic polymer,"A pharmaceutical composition comprises nanoparticles comprising a poorly water soluble drug, a poorly aqueous soluble non-ionizable polymer, and an anionic cellulosic polymer.",BEND RES INC,BLOOM COREY JAY;;CREW MARSHALL DAVID;;MILLER WARREN KENYON;;SMITHEY DANIEL TOD,,https://lens.org/170-895-010-430-990,Granted Patent,yes,1,0,6,6,0,A61K9/5161;;A61K9/5192;;A61K31/00;;A61K31/415;;A61K31/42;;A61K31/635;;A61K47/38;;A61K2300/00;;A61K9/5161;;A61K31/00;;A61K47/38;;A61K31/415;;A61K31/42;;A61K9/5192;;A61K31/635;;A61K2300/00,A61K31/00;;A61K9/51;;A61K31/415;;A61K31/42;;A61K31/4706;;A61K31/635;;A61K47/38,,1,0,,,"PINON-SEGUNDO E ET AL: ""Preparation and characterization of triclosan nanoparticles for periodontal treatment"" INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER BV, NL, vol. 294, no. 1-2, 27 April 2005 (2005-04-27), pages 217-232, XP004825476 ISSN: 0378-5173",ACTIVE
539,US,A,US 3944569 A,109-850-922-063-168,1976-03-16,1976,US 39210473 A,1973-08-27,US 39210473 A;;US 17749771 A,1971-09-02,Aminomethyl-substituted 1-naphthol phthalides and naphthalides,"This invention relates to a class of phthalein indicator dyes useful as optical filter agents in photographic processes to protect a selectively exposed photosensitive material from further exposure during processing in the presence of incident light. Such dyes comprise 3,3-disubstituted phthalides and 3,3-disubstituted naphthalides wherein the 3,3 substituents are p-hydroxy carbocyclic aryl radicals wherein one or both of the radicals possess a --CH.sub.2 --NRR' group ortho to the p-hydroxy group and the --CH.sub.2 --NRR' group(s) is capable of rendering the indicator dye substantially non-diffusible in aqueous solution.",POLAROID CORP,BLOOM STANLEY M;;IDELSON ELBERT M;;SIMON MYRON S;;WALLER DAVID P,,https://lens.org/109-850-922-063-168,Granted Patent,yes,2,0,1,2,0,G03C8/48;;G03C8/48,G03C8/48,2603433 R,0,0,,,,EXPIRED
540,US,B2,US 10507232 B2,187-011-267-129-096,2019-12-17,2019,US 201515300807 A,2015-04-02,US 201515300807 A;;US 201461973995 P;;US 2015/0024094 W,2014-04-02,Materials and methods for the treatment of latent viral infection,The subject invention pertains to materials and methods for the treatment of latent viral infections.,UNIV FLORIDA;;UNIV DUKE,BLOOM DAVID C;;PHELAN DANE M;;CULLEN BRYAN R;;KENNEDY MATTHEW E,DUKE UNIVERSITY (2015-04-13);;UNIVERSITY OF FLORIDA RESEARCH FOUNDATION INCORPORATED (2016-09-29),https://lens.org/187-011-267-129-096,Granted Patent,yes,26,0,4,4,30,A61K38/465;;A61K38/465;;A61K31/045;;A61K31/52;;A61K31/522;;A61K31/7072;;A61K45/06;;A61K45/06;;A61K48/00;;C07K2319/80;;C12N7/00;;C12N9/22;;C12N9/22;;C12N2710/16611;;C12N2710/16661;;C12Y301/00;;C12Y301/00,A61K38/46;;A61K31/045;;A61K31/52;;A61K31/522;;A61K31/7072;;A61K45/06;;A61K48/00;;C12N7/00;;C12N9/22,,7,2,070-516-636-559-94X;;011-997-584-919-850,pmc3882405;;10.3748/wjg.v19.i48.9328;;24409059;;10.1016/j.cell.2013.02.022;;23452860;;pmc3664290,"(Molecular Therapy, Feb. 2014 vol. 22, p. 303-311).;;Reddy et al. (World Journal of Gastroenterology, Dec. 2013, vol. 19, p. 9328-9333).;;Qi, L. S. et al. “Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression” Cell, Feb. 28, 2013, pp. 1173-1183, vol. 152.;;Written Opinion in International Application No. PCT/US15/24094, dated Oct. 8, 2015, pp. 1-10.;;Invitation to Pay Additional Fees for Application No. PCT/US2015/024094 dated Aug. 3, 2015.;;International Search Report for Application No. PCT/US2015/024094 dated Oct. 8, 2015.;;International Preliminary Report on Patentability for Application No. PCT/US2015/024094 dated Oct. 13, 2016.",ACTIVE
541,WO,A2,WO 2009/010837 A2,192-357-179-741-874,2009-01-22,2009,IB 2008001776 W,2008-06-30,US 94952207 P,2007-07-13,NANOPARTICLES COMPRISING A NON-IONIZABLE POLYMER AND AN ANIONIC CELLULOSIC POLYMER,"A pharmaceutical composition comprises nanoparticles comprising a poorly water soluble drug, a poorly aqueous soluble non-ionizable polymer, and an anionic cellulosic polymer.",PFIZER PROD INC;;BLOOM COREY JAY;;CREW MARSHALL DAVID;;MILLER WARREN KENYON;;SMITHEY DANIEL TOD,BLOOM COREY JAY;;CREW MARSHALL DAVID;;MILLER WARREN KENYON;;SMITHEY DANIEL TOD,,https://lens.org/192-357-179-741-874,Patent Application,yes,3,15,6,6,0,A61K9/5161;;A61K9/5192;;A61K31/00;;A61K31/415;;A61K31/42;;A61K31/635;;A61K47/38;;A61K2300/00;;A61K9/5161;;A61K31/00;;A61K47/38;;A61K31/415;;A61K31/42;;A61K9/5192;;A61K31/635;;A61K2300/00,A61K9/51;;A61K47/38,,1,1,119-668-941-485-878,10.1016/0168-3659(90)90103-z,"BODMEIER; CHEN, J. CONTROLLED RELEASE, vol. 12, 1990, pages 223 - 233",PENDING
542,AT,T1,AT E192241 T1,063-830-253-161-610,2000-05-15,2000,AT 96917143 T,1996-06-05,US 48218895 A;;US 9608804 W,1995-06-07,FLACHES BEUGUNGSGITTERLICHTVENTIL,"A diffraction grating light valve modulates an incident beam of light. A plurality of elongated elements each have a reflective surface. The elongated elements are suspended with their respective ends substantially coplanar. Alternate ones of the elongated elements are electrically coupled for receiving a first bias voltage. The interdigitated elongated elements are electrically coupled for receiving a second bias voltage. By applying a appropriate first and second biasing voltages, all the reflective surfaces can be maintained in a first plane. When all the elongated elements are in the first plane, the diffraction grating light valve reflects the beam of light. A predetermined group of the elongated elements, preferably alternate ones, are deformable to be substantially coplanar in a second plane which is parallel to the first plane. When the predetermined group of elements is in the second plane, the diffraction grating light valve diffracts the beam of light.",SILICON LIGHT MACHINES INC,BLOOM DAVID M;;CORBIN DAVE B;;BANYAI WILLIAM C;;STAKER BRYAN P,,https://lens.org/063-830-253-161-610,Granted Patent,no,0,0,20,20,0,G02B5/1828;;G02B26/0808;;Y10S359/904;;G02B5/18;;G02B5/1828;;G02B26/0808;;Y10S359/904,G02B5/18;;G02B26/08,,0,0,,,,DISCONTINUED
543,PT,E,PT 830624 E,086-589-005-930-819,2000-08-31,2000,PT 96917143 T,1996-06-05,US 48218895 A,1995-06-07,VALVULA DE LUZ COM REDE DE DIFRACCAO PLANA,"A diffraction grating light valve modulates an incident beam of light. A plurality of elongated elements each have a reflective surface. The elongated elements are suspended with their respective ends substantially coplanar. Alternate ones of the elongated elements are electrically coupled for receiving a first bias voltage. The interdigitated elongated elements are electrically coupled for receiving a second bias voltage. By applying a appropriate first and second biasing voltages, all the reflective surfaces can be maintained in a first plane. When all the elongated elements are in the first plane, the diffraction grating light valve reflects the beam of light. A predetermined group of the elongated elements, preferably alternate ones, are deformable to be substantially coplanar in a second plane which is parallel to the first plane. When the predetermined group of elements is in the second plane, the diffraction grating light valve diffracts the beam of light.",SILICON LIGHT MACHINES INC,BLOOM DAVID M;;BANYAI WILLIAM C;;STAKER BRYAN P;;CORBIN DAVE B,,https://lens.org/086-589-005-930-819,Granted Patent,no,0,0,20,20,0,G02B5/1828;;G02B26/0808;;Y10S359/904;;G02B5/18;;G02B5/1828;;G02B26/0808;;Y10S359/904,G02B5/18;;G02B26/08,,0,0,,,,EXPIRED
544,EP,A2,EP 2352758 A2,170-060-650-255-080,2011-08-10,2011,EP 09741510 A,2009-09-25,US 2009/0058302 W;;US 10035008 P,2008-09-26,SINGLE CHAIN ANTIBODY LIBRARY DESIGN,,WYETH LLC,HUFTON SIMON EVAN;;FINLAY WILLIAM JAMES JONATHAN;;BROADBENT IAN DAVID;;BLOOM LAIRD,,https://lens.org/170-060-650-255-080,Patent Application,yes,0,0,6,6,0,C07K16/005;;C07K16/005;;C07K2317/55;;C07K2317/55;;C07K2317/56;;C07K2317/56;;C07K2317/622;;C07K2317/622;;C12N15/1037;;C12N15/1037,C07K16/00;;C12N15/10,,1,0,,,See references of WO 2010036851A3,DISCONTINUED
545,WO,A2,WO 2010/036851 A2,103-765-227-755-782,2010-04-01,2010,US 2009/0058302 W,2009-09-25,US 10035008 P,2008-09-26,SINGLE CHAIN ANTIBODY LIBRARY DESIGN,"The invention provides polynucleotide vectors and linkers and methods for designing and making single chain variable fragment (""ScFv"") libraries. The invention also provides polynucleotide vectors and linkers and methods for reformatting the ScFv library into Fab and IgG formats for high throughput production and screening.",WYETH LLC;;HUFTON SIMON EVAN;;FINLAY WILLIAM JAMES JONATHAN;;BROADBENT IAN DAVID;;BLOOM LAIRD,HUFTON SIMON EVAN;;FINLAY WILLIAM JAMES JONATHAN;;BROADBENT IAN DAVID;;BLOOM LAIRD,,https://lens.org/103-765-227-755-782,Patent Application,yes,0,0,6,6,63,C07K16/005;;C07K16/005;;C07K2317/55;;C07K2317/55;;C07K2317/56;;C07K2317/56;;C07K2317/622;;C07K2317/622;;C12N15/1037;;C12N15/1037,C07K16/00,,0,0,,,,PENDING
546,EP,A1,EP 0830624 A1,063-494-652-102-597,1998-03-25,1998,EP 96917143 A,1996-06-05,US 9608804 W;;US 48218895 A,1995-06-07,FLAT DIFFRACTION GRATING LIGHT VALVE,"A diffraction grating light valve modulates an incident beam of light. A plurality of elongated elements each have a reflective surface. The elongated elements are suspended with their respective ends substantially coplanar. Alternate ones of the elongated elements are electrically coupled for receiving a first bias voltage. The interdigitated elongated elements are electrically coupled for receiving a second bias voltage. By applying a appropriate first and second biasing voltages, all the reflective surfaces can be maintained in a first plane. When all the elongated elements are in the first plane, the diffraction grating light valve reflects the beam of light. A predetermined group of the elongated elements, preferably alternate ones, are deformable to be substantially coplanar in a second plane which is parallel to the first plane. When the predetermined group of elements is in the second plane, the diffraction grating light valve diffracts the beam of light.",SILICON LIGHT MACHINES INC,BLOOM DAVID M;;CORBIN DAVE B;;BANYAI WILLIAM C;;STAKER BRYAN P,,https://lens.org/063-494-652-102-597,Patent Application,yes,0,1,20,20,0,G02B5/1828;;G02B26/0808;;Y10S359/904;;G02B5/18;;G02B5/1828;;G02B26/0808;;Y10S359/904,G02B5/18;;G02B26/08,,0,0,,,,EXPIRED
547,US,A1,US 2012/0216618 A1,085-382-421-216-687,2012-08-30,2012,US 201213406752 A,2012-02-28,US 201213406752 A;;US 201161447642 P,2011-02-28,METHODS AND SYSTEMS FOR IMAGING INTERNAL RAIL FLAWS,"A method for imaging internal flaws of a rail is disclosed. The method may include transmitting multiple ultrasound pulses into the rail along transverse and longitudinal axes of the rail, acquiring reflected ultrasound data from the rail, processing the reflected ultrasound data by applying an ultrasound migration technique to the reflected ultrasound data, and mapping the internal flaws of the rail based on the reflected ultrasound data processed by the ultrasound migration technique.",BLOOM JEFFREY A;;ROLIN AMAURY;;RADZEVICIUS STANLEY;;MCNEW DAVID;;CARR GARY A,BLOOM JEFFREY A;;ROLIN AMAURY;;RADZEVICIUS STANLEY;;MCNEW DAVID;;CARR GARY A,ENSCO INC (2012-03-28),https://lens.org/085-382-421-216-687,Patent Application,yes,0,5,1,1,0,G01N29/043;;G01N29/069;;G01N29/28;;G01N29/4445;;G01N2291/2623;;G01N29/043;;G01N29/069;;G01N29/28;;G01N29/4445;;G01N2291/2623,G01N29/04,73/636,0,0,,,,DISCONTINUED
548,CN,A,CN 101336236 A,106-542-149-169-032,2008-12-31,2008,CN 200680051971 A,2006-12-01,US 74177205 P,2005-12-01,Anthranilic acid derivatives useful in treating infection with hepatitis c virus,"The present invention is directed to compounds of formula (I): wherein R<1> is selected from the group consisting of -C(O)R and (a), wherein R<6> and R<7> are independently selected from H, alkyl, cycloalkyl, heterocycloalkyl, heteroaryl or aryl, any of which may be optionally substituted, G is selected from H or hydroxyl, Y is O, NH or S, X is selected from the group consisting of H, halo, alkyl, cycloalkyl, perfluoroalkyl, alkoxy, alkylthio, amino, alkylamino, dialkylamino, and CN, and n is 0, 1, 2 or 3, or a prodrug, a pharmaceutically acceptable salt, or a pharmaceutically active metabolite thereof. This invention is also directed to compositions containing compounds of the invention and methods of using both the inventive compounds and compositions thereof to treat or prevent Hepatitis C virus infection, or to inhibit replication of a Hepatitis C virus.",WYETH CORP,DAVID BLOOM JONATHAN;;SHABANA INSAF;;THOMAS NITTOLI;;GORDON SUTHERLAND ALAN;;KAREN WHELESS,,https://lens.org/106-542-149-169-032,Patent Application,no,0,1,8,8,0,A61P31/12;;A61P31/14;;A61P43/00;;C07D317/66;;C07C235/24;;C07C237/04;;C07C251/48;;C07C317/36,C07D317/66;;A61K31/36;;A61P31/12;;C07C235/24;;C07C237/04;;C07C251/48,,0,0,,,,DISCONTINUED
549,US,A1,US 2003/0223748 A1,134-261-145-927-814,2003-12-04,2003,US 37190703 A,2003-06-16,US 37190703 A;;US 35916702 P,2002-02-20,System and method for seamless spectral control,"
   A design for a 1N Optical Wavelength Switch incorporates mode conditioning optics which allows seamless control between actuators thus making possible increased channel count (decreasing the channel grid from 100 GHz to 50 GHz) and combining optical channels into groups which can be controlled as a band. In an exemplary embodiment, a new device referred to herein as a Diffractive Steering Element (DSE) is used to implement the invention in a 1N wavelength selective switch which provides power equalization on a channel-by-channel basis. 
",STOWE TIMOTHY D.;;GUSTAFSON ERIC K.;;BLOOM DAVID M.;;GODIL ASIF A.,STOWE TIMOTHY D;;GUSTAFSON ERIC K;;BLOOM DAVID M;;GODIL ASIF A,LIGHTCONNECT INC (2003-06-20),https://lens.org/134-261-145-927-814,Patent Application,yes,3,22,1,1,0,G02B6/272;;G02B6/272;;G02B6/2931;;G02B6/2931;;G02B6/29313;;G02B6/29313;;G02B6/29395;;G02B6/29395;;G02B6/3516;;G02B6/3516;;G02B6/3518;;G02B6/3518;;G02B6/3534;;G02B6/3534;;G02B6/3558;;G02B6/3558;;G02B6/356;;G02B6/356;;G02B6/3566;;G02B6/3566;;G02B6/3584;;G02B6/3584;;G02B6/3594;;G02B6/3594;;G02B6/4206;;G02B6/4206;;H04Q11/0005;;H04Q11/0005;;H04J14/02;;H04J14/02;;H04J14/0221;;H04J14/0221;;H04Q2011/0013;;H04Q2011/0013;;H04Q2011/0016;;H04Q2011/0016;;H04Q2011/0024;;H04Q2011/0024;;H04Q2011/003;;H04Q2011/003;;H04Q2011/0035;;H04Q2011/0035;;H04Q2011/0039;;H04Q2011/0039;;H04Q2011/0049;;H04Q2011/0049,G02B6/34;;G02B6/35;;G02B6/42;;H04J14/02;;H04Q11/00,398/48,0,0,,,,DISCONTINUED
550,US,B2,US 9183576 B2,124-568-735-172-355,2015-11-10,2015,US 201313759886 A,2013-02-05,US 201313759886 A;;US 201113245786 A;;US 77060010 A;;US 40667506 A;;US 23810009 P;;US 67312805 P,2005-04-20,Methods and systems for inserting media content,"A method and system for providing a content object is disclosed with an in-stream ad unit inserted into the content object for a content object player. The content object is audio and/or video. The processed content object is downloaded or streamed to the content object player. A method for content insertion is provided. In this method, a first media data is received from a server and a placement request is transmitted to a content provider service. As a result, a placement response is received from the content provider service. The placement response includes data identifying a second media data associated with the first media data. The second media data is retrieved and merged with the first media data. After the merge, the first and second media data are transmitted to the server.",LIMELIGHT NETWORKS INC,COBB JONATHAN W;;BLOOM RYAN B;;ROWLEY DAVID;;ANDERSON SCOTT;;MAHYARI ABBAS,LIMELIGHT NETWORKS INC (2013-04-11),https://lens.org/124-568-735-172-355,Granted Patent,yes,53,5,6,34,0,G06Q30/0277;;G06Q30/0277;;G06Q30/02;;G06Q30/02;;H04N21/23424;;H04N21/23424;;H04N21/2368;;H04N21/2368,G06Q30/02;;H04N21/234;;H04N21/2368,,10,1,045-005-027-457-963,10.4135/9781452229669,"Govoni, ""Dictionary of marketing communications"", 2004, Sage Publications.;;Green, ""Adding Streaming Media to Your Web Site with Windows Media Technologies"", 1999, Microsoft Corporation.;;U.S. Appl. No. 11/406,675. filed Apr. 18, 2006, Non-Final Rejection mailed Nov. 28, 2008, 160 pages.;;U.S. Appl. No. 11/406,675, filed Apr. 18, 2006, Final Rejection mailed Apr. 27, 2009, 53 pages.;;U.S. Appl. No. 11/406,675, filed Apr. 18, 2006, Non-Final Rejection mailed Sep. 15, 2009, 63 pages.;;U.S. Appl. No. 11/406,675, filed Apr. 18, 2006, Non-Final Rejection mailed May 25, 2010, 179 pages.;;U.S. Appl. No. 11/406,675, filed Apr. 18, 2006, Final Rejection mailed Dec. 21, 2010, 202 pages.;;U.S. Appl. No. 11/406,675, filed Apr. 18, 2006, Non-Final Rejection mailed Jul. 20, 2011, 261 pages.;;U.S. Appl. No. 11/406,675, filed Apr. 18, 2006, Final Rejection mailed Mar. 16, 2012, 113 pages.;;U.S. Appl. No. 11/406,675, filed Apr. 18, 2006, Notice of Allowance mailed Aug. 17, 2012, 64 pages.",ACTIVE
551,US,A,US 5459610 A,042-088-230-086-456,1995-10-17,1995,US 6268893 A,1993-05-20,US 6268893 A;;US 87607892 A;;US 9502963 W,1992-04-28,Deformable grating apparatus for modulating a light beam and including means for obviating stiction between grating elements and underlying substrate,"A modulator for modulating incident rays of light, the modulator comprising a plurality of equally spaced apart beam elements, each of which includes a light reflective planar surface. The elements are arranged parallel to each other with their light reflective surfaces parallel to each other. The modulator includes means for supporting the beam elements in relation to one another and means for moving the beam elements relative to one another so that the beams move between a first configuration wherein the modulator acts to reflect the incident rays of light as a plane mirror, and a second configuration wherein the modulator diffracts the incident rays of light as they are reflected therefrom. At least one of the facing surfaces of the beam elements and underlying substrate is configured to reduce any tendency to stick as they are pulled together. In operation, the light reflective surfaces of the beam elements remain parallel to each other in both the first and the second configurations and the perpendicular spacing between the reflective surfaces of adjacent beam elements is equal to m/4 times the wavelength of the incident rays of light, wherein m=an even whole number or zero when the beam elements are in the first configuration and m=an odd number when the beam elements are in the second configuration.",UNIV LELAND STANFORD JUNIOR,BLOOM DAVID M;;SANDEJAS FRANCISCO S A;;SOLGAARD OLAV;;APTE RAJ B,BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY THE (1993-07-08),https://lens.org/042-088-230-086-456,Granted Patent,yes,6,199,6,19,0,B81C2201/115;;G02B5/1828;;G02B26/0808;;B81B3/001;;Y10S359/90;;B81B3/001;;G02B5/1828;;B81C2201/115;;G02B26/0808;;Y10S359/90,B81B3/00;;G02B5/18;;G02B26/08,359/572;;359/213;;359/224;;359/226;;345/108;;348/203,0,0,,,,EXPIRED
552,US,A,US 4750809 A,146-763-460-461-175,1988-06-14,1988,US 72937685 A,1985-05-01,US 72937685 A,1985-05-01,Pulse compression,"A pulse compressor compresses a relatively long width optical pulse (of the kind which may be transform limited) to a short width pulse. The compressor includes a color generator which broadens the bandwidth of the long pulse to include any additional colors required for compression to the short pulse. The compressor also includes a grating which has a groove spacing and which is aligned with the output of the color generator at a grazing incidence angle effective for producing a compact grating structure, reduced ellipticity of the beam output from the compressor and high efficiency of light transmission through the device.",SPECTRA PHYSICS,KAFKA JAMES D;;BAER THOMAS M;;KOLNER BRIAN H;;BLOOM DAVID M,SPECTRA-PHYSICS INC. A CORP OF CA (1985-04-25);;SPECTRA-PHYSICS LASERS INC. A DE CORPORATION (1991-06-04),https://lens.org/146-763-460-461-175,Granted Patent,yes,0,74,1,1,0,H01S3/0057;;H01S3/0057;;Y10S359/90;;Y10S359/90,H01S3/00,350/162.17;;350/162.11;;350/349;;350/168;;350/320,8,7,096-177-646-564-953;;085-347-927-596-169;;033-867-174-273-316;;128-593-109-648-352;;059-826-541-065-985;;033-148-113-388-311;;144-072-741-429-491,10.1016/0375-9601(68)90584-7;;10.1063/1.1652638;;10.1364/ao.18.000737;;20208808;;10.1063/1.93749;;10.1063/1.94302;;10.1063/1.94897;;10.1364/josab.1.000139,"E. B. Treacy, Compression of Picosecond Light Pulses, Phys. Lett. 28A, 34, (1968).;;M. A. Duguay and J. W. Hansen, Compression of Pulses from Mode Locked HeNe Laser, Appl. Phys. Lett. 14, No. 1, pp. 14 15, (1969).;;J. D. McMullen, Analysis of Compression of Frequency Chirped Optical Pulses by a Strongly Dispersive Grating Pair, Appl. Opt. 18, 737, (1979).;;B. Nicolaus and D. Grischkowsky, 12x Pulse Compression Using Optical Fibers, Appl. Phys. Lett. 42, pp. 1 2, (1983).;;B. Nikolaus and D. Grischkowsky, 90 fs Tunable Optical Pulses Obtained by Two Stage Pulse Compression, Appl. Phys. Lett. 43, pp. 228 230, (1983).;;A. M. Johnson, R. H. Stolen and W. M. Simpson, 80x Single Stage Compression of Frequency Doubled Nd:YAG Laser Pulses, Appl. Phys. Lett. 44, 729, (1984).;;W. J. Tomlinson, R. H. Stolen, and C. V. Shank, Compression of Optical Pulses Chirped by Self Phase Modulation in Fibers, Optical Society of America, vol. 1, No. 2, 139, (Apr. 1984).;;C. G. Dupuy and P. Bado, Five Times Compression of Mode Locked Argon Ion Laser Pulses, paper TUE 2 delivered at CLEO 1984.",EXPIRED
553,EP,A2,EP 2178519 A2,134-341-343-972-659,2010-04-28,2010,EP 08762998 A,2008-06-30,IB 2008001776 W;;US 94952207 P,2007-07-13,Nanoparticles comprising a non-ionizable polymer and an anionic cellulosic polymer,"A pharmaceutical composition comprises nanoparticles comprising a poorly water soluble drug, a poorly aqueous soluble non-ionizable polymer, and an anionic cellulosic polymer.",BEND RES INC,BLOOM COREY JAY;;CREW MARSHALL DAVID;;MILLER WARREN KENYON;;SMITHEY DANIEL TOD,,https://lens.org/134-341-343-972-659,Patent Application,yes,0,0,6,6,0,A61K9/5161;;A61K9/5192;;A61K31/00;;A61K31/415;;A61K31/42;;A61K31/635;;A61K47/38;;A61K2300/00;;A61K9/5161;;A61K31/00;;A61K47/38;;A61K31/415;;A61K31/42;;A61K9/5192;;A61K31/635;;A61K2300/00,A61K31/00;;A61K9/51;;A61K31/415;;A61K31/42;;A61K31/4706;;A61K31/635;;A61K47/38,,0,0,,,,ACTIVE
554,GR,T3,GR 3033806 T3,142-568-240-423-59X,2000-10-31,2000,GR 20000401506 T,2000-06-28,US 48218895 A;;US 9608804 W,1995-06-07,FLAT DIFFRACTION GRATING LIGHT VALVE,"A diffraction grating light valve modulates an incident beam of light. A plurality of elongated elements each have a reflective surface. The elongated elements are suspended with their respective ends substantially coplanar. Alternate ones of the elongated elements are electrically coupled for receiving a first bias voltage. The interdigitated elongated elements are electrically coupled for receiving a second bias voltage. By applying a appropriate first and second biasing voltages, all the reflective surfaces can be maintained in a first plane. When all the elongated elements are in the first plane, the diffraction grating light valve reflects the beam of light. A predetermined group of the elongated elements, preferably alternate ones, are deformable to be substantially coplanar in a second plane which is parallel to the first plane. When the predetermined group of elements is in the second plane, the diffraction grating light valve diffracts the beam of light.",SILICON LIGHT MACHINES INC,BLOOM DAVID M;;CORBIN DAVE B;;BANYAI WILLIAM C;;STAKER BRYAN P,,https://lens.org/142-568-240-423-59X,Granted Patent,no,0,0,20,20,0,G02B5/1828;;G02B26/0808;;Y10S359/904;;G02B5/18;;G02B5/1828;;G02B26/0808;;Y10S359/904,G02B5/18;;G02B26/08,,0,0,,,,EXPIRED
555,EP,A4,EP 3370606 A4,182-070-638-614-604,2019-06-12,2019,EP 16863080 A,2016-11-04,US 201562251879 P;;US 2016/0060638 W,2015-11-06,FOOTWEAR SYSTEM FOR ULCER OR PRE-ULCER DETECTION,,PODIMETRICS INC,LINDERS DAVID R;;PETERSEN BRIAN J;;PETERSEN DANIEL J;;BLOOM JONATHAN D,,https://lens.org/182-070-638-614-604,Search Report,no,2,0,10,10,0,A61B5/0002;;G16H50/20;;G16H40/63;;G01K1/026;;G01K2213/00;;A43B7/00;;A61B5/015;;A61B5/445;;A61B5/447;;A61B5/6807;;A61B5/7282;;A61B5/7405;;A61B5/742;;A61B2505/07;;G01K13/20;;A43B3/34;;A61B5/0002;;G16H40/63;;G01K2213/00;;G16H50/20;;G01K1/026;;G01K1/00;;A43B7/00;;G01K13/20;;A43B3/34;;A61B5/015;;A61B5/445;;A61B5/447;;A61B5/6807;;A61B5/7282;;A61B5/7405;;A61B5/742;;A61B2505/07,A61B5/00;;A43B3/00;;A61B5/01;;G01K1/00;;G16H30/40;;G16H50/20,,1,1,025-202-460-116-235,10.1117/1.jbo.20.2.026003;;25671671,"LIU CHANJUAN ET AL: ""Automatic detection of diabetic foot complications with infrared thermography by asymmetric analysis"", JOURNAL OF BIOMEDICAL OPTICS, SPIE, vol. 20, no. 2, 1 February 2015 (2015-02-01), pages 26003, XP060053732, ISSN: 1083-3668, [retrieved on 20150211], DOI: 10.1117/1.JBO.20.2.026003",DISCONTINUED
556,CA,A1,CA 2737351 A1,004-362-429-494-933,2010-04-01,2010,CA 2737351 A,2009-09-25,US 10035008 P;;US 2009/0058302 W,2008-09-26,SINGLE CHAIN ANTIBODY LIBRARY DESIGN,"The invention provides polynucleotide vectors and linkers and methods for designing and making single chain variable fragment (""ScFv"") libraries. The invention also provides polynucleotide vectors and linkers and methods for reformatting the ScFv library into Fab and IgG formats for high throughput production and screening.",WYETH LLC,HUFTON SIMON EVAN;;FINLAY WILLIAM JAMES JONATHAN;;BROADBENT IAN DAVID;;BLOOM LAIRD,,https://lens.org/004-362-429-494-933,Patent Application,no,0,0,6,6,63,C07K16/005;;C07K16/005;;C07K2317/55;;C07K2317/55;;C07K2317/56;;C07K2317/56;;C07K2317/622;;C07K2317/622;;C12N15/1037;;C12N15/1037,C12N15/11;;C07K16/00;;C12N15/00;;C12N15/09;;C12N15/13;;C12N15/63;;C40B30/00;;C40B40/08;;C40B50/06;;C40B80/00,,0,0,,,,DISCONTINUED
557,WO,A3,WO 2009/010837 A3,071-348-819-096-93X,2009-03-12,2009,IB 2008001776 W,2008-06-30,US 94952207 P,2007-07-13,NANOPARTICLES COMPRISING A NON-IONIZABLE POLYMER AND AN ANIONIC CELLULOSIC POLYMER,"A pharmaceutical composition comprises nanoparticles comprising a poorly water soluble drug, a poorly aqueous soluble non-ionizable polymer, and an anionic cellulosic polymer.",PFIZER PROD INC;;BLOOM COREY JAY;;CREW MARSHALL DAVID;;MILLER WARREN KENYON;;SMITHEY DANIEL TOD,BLOOM COREY JAY;;CREW MARSHALL DAVID;;MILLER WARREN KENYON;;SMITHEY DANIEL TOD,,https://lens.org/071-348-819-096-93X,Search Report,yes,1,0,6,6,0,A61K9/5161;;A61K9/5192;;A61K31/00;;A61K31/415;;A61K31/42;;A61K31/635;;A61K47/38;;A61K2300/00;;A61K9/5161;;A61K31/00;;A61K47/38;;A61K31/415;;A61K31/42;;A61K9/5192;;A61K31/635;;A61K2300/00,A61K9/51;;A61K47/38,,1,1,063-416-990-191-007,10.1016/j.ijpharm.2004.11.010;;15814246,"PINON-SEGUNDO E ET AL: ""Preparation and characterization of triclosan nanoparticles for periodontal treatment"", INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER BV, NL, vol. 294, no. 1-2, 27 April 2005 (2005-04-27), pages 217 - 232, XP004825476, ISSN: 0378-5173",PENDING
558,US,A1,US 2010/0124764 A1,024-044-843-043-224,2010-05-20,2010,US 56676709 A,2009-09-25,US 56676709 A;;US 10035008 P,2008-09-26,SINGLE CHAIN ANTIBODY LIBRARY DESIGN,The invention provides polynucleotide vectors and linkers and methods for designing and making single chain variable fragment (“ScFv”) libraries. The invention also provides polynucleotide vectors and linkers and methods for reformatting the ScFv library into Fab and IgG formats for high throughput production and screening.,WYETH CORP,HUFTON SIMON EVAN;;FINLAY WILLIAM JAMES JONATHAN;;BROADBENT IAN DAVID;;BLOOM LAIRD,WYETH LLC (2009-11-03),https://lens.org/024-044-843-043-224,Patent Application,yes,0,14,6,6,63,C07K16/005;;C07K16/005;;C07K2317/55;;C07K2317/55;;C07K2317/56;;C07K2317/56;;C07K2317/622;;C07K2317/622;;C12N15/1037;;C12N15/1037,C12P21/00;;C07H21/04;;C40B40/06;;C40B50/00,435/69.1;;536/23.1;;506/23;;506/16,0,0,,,,DISCONTINUED
559,WO,A2,WO 2015/153889 A2,024-539-360-334-814,2015-10-08,2015,US 2015/0024094 W,2015-04-02,US 201461973995 P,2014-04-02,MATERIALS AND METHODS FOR THE TREATMENT OF LATENT VIRAL INFECTION,The subject invention pertains to materials and methods for the treatment of latent viral infections.,UNIV FLORIDA;;UNIV DUKE,BLOOM DAVID C;;PHELAN DANE M;;CULLEN BRYAN R;;KENNEDY E MATTHEW,,https://lens.org/024-539-360-334-814,Patent Application,yes,0,97,4,4,30,A61K38/465;;A61K38/465;;A61K31/045;;A61K31/52;;A61K31/522;;A61K31/7072;;A61K45/06;;A61K45/06;;A61K48/00;;C07K2319/80;;C12N7/00;;C12N9/22;;C12N9/22;;C12N2710/16611;;C12N2710/16661;;C12Y301/00;;C12Y301/00,A61K48/00;;A61K31/52,,0,0,,,,PENDING
560,US,B1,US 6461064 B1,071-300-558-527-283,2002-10-08,2002,US 4276998 A,1998-03-17,US 4276998 A;;US 71179696 A,1996-09-10,Service station assembly for a drum-based wide format print engine,"
    This invention relates to an improved wide format color digital print engine, and in particular to a drum-based large format digital ink jet print engine having a vertically articulated carriage portion which carries both the print heads and an imaging array, adjustable saber angles for print heads, a novel service station, and an extremely robust weight-bearing carriage architecture. In particular, the present invention provides a highly manufacturable print engine benefiting from a discrete few controlled mounting locations so that accurate mounting of the cooperating sub-assemblies allow a very stable carriage assembly for driving said carriage laterally with respect to a printing medium coupled to the exterior of a drum. 
",LEONARD BENJAMIN PATRICK;;HANSON MICHAEL DAVID;;ANDERSON KERRY RAY;;BLOOM GREGG MICHAEL,LEONARD BENJAMIN PATRICK;;HANSON MICHAEL DAVID;;ANDERSON KERRY RAY;;BLOOM GREGG MICHAEL,MACDERMID ACUMEN INC (2007-10-23);;HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2007-11-01),https://lens.org/071-300-558-527-283,Granted Patent,yes,11,27,1,2,0,B41J11/42;;B41J11/42;;B41J19/16;;B41J19/16;;B41J19/20;;B41J19/20;;B41J19/202;;B41J19/202,B41J11/42;;B41J19/20,400/328;;400/320;;400/352;;347/33,0,0,,,,EXPIRED
561,US,A1,US 2010/0266692 A1,091-955-984-757-957,2010-10-21,2010,US 45181208 A,2008-06-30,US 45181208 A;;US 94952207 P;;IB 2008001776 W,2007-07-13,NANOPARTICLES COMPRISING A NON-IONIZABLE POLYMER AND AN ANIONIC CELLULOSIC POLYMER,"A pharmaceutical composition comprises nanoparticles comprising a poorly water soluble drug, a poorly aqueous soluble non-ionizable polymer, and an anionic cellulosic polymer.",BLOOM COREY JAY;;CREW MARSHALL DAVID;;MILLER WARREN KENYON;;SMITHEY DANIEL TOD,BLOOM COREY JAY;;CREW MARSHALL DAVID;;MILLER WARREN KENYON;;SMITHEY DANIEL TOD,BEND RESEARCH INC (2008-11-03),https://lens.org/091-955-984-757-957,Patent Application,yes,3,19,6,6,0,A61K9/5161;;A61K9/5192;;A61K31/00;;A61K31/415;;A61K31/42;;A61K31/635;;A61K47/38;;A61K2300/00;;A61K9/5161;;A61K31/00;;A61K47/38;;A61K31/415;;A61K31/42;;A61K9/5192;;A61K31/635;;A61K2300/00,A61K9/14;;A61K31/415;;A61K31/42;;A61K31/47,424/488;;424/499;;514/378;;514/313;;514/406;;977/773,1,0,,,CAS Registry Record for Eplerenone (Reg. No. 107724-20-9). Entered STN 26 April 1987. 4 printed pages.,DISCONTINUED
562,WO,A1,WO 2017/079628 A1,146-154-565-346-364,2017-05-11,2017,US 2016/0060638 W,2016-11-04,US 201562251879 P,2015-11-06,FOOTWEAR SYSTEM FOR ULCER OR PRE-ULCER DETECTION,"A footwear system having a plurality of temperature sensors determines the emergence of an ulcer or pre-ulcer on a person's foot. After the plurality of temperature sensors generate a plurality of discrete temperature data values, the system and method form a temperature map representing substantially the actual geometric shape of at least a portion of the foot, and the distribution of temperatures of the at least a portion of the foot. Next, the method and system determine whether the temperature map presents at least one of a plurality of prescribed patterns, and produces output information indicating an emergence of an ulcer or a pre-ulcer on a given portion on the foot. The output information is produced as a function of whether the temperature map is determined to present the at least one of the plurality of prescribed patterns.",PODIMETRICS INC,LINDERS DAVID R;;PETERSEN BRIAN J;;PETERSEN DANIEL J;;BLOOM JONATHAN D,,https://lens.org/146-154-565-346-364,Patent Application,yes,5,16,10,10,0,A61B5/0002;;G16H50/20;;G16H40/63;;G01K1/026;;G01K2213/00;;A43B7/00;;A61B5/015;;A61B5/445;;A61B5/447;;A61B5/6807;;A61B5/7282;;A61B5/7405;;A61B5/742;;A61B2505/07;;G01K13/20;;A43B3/34;;A61B5/0002;;G16H40/63;;G01K2213/00;;G16H50/20;;G01K1/026;;G01K1/00;;A43B7/00;;G01K13/20;;A43B3/34;;A61B5/015;;A61B5/445;;A61B5/447;;A61B5/6807;;A61B5/7282;;A61B5/7405;;A61B5/742;;A61B2505/07,A61B5/00;;A61B5/01,,0,0,,,,PENDING
563,US,A1,US 2017/0127999 A1,192-550-771-517-366,2017-05-11,2017,US 201615343892 A,2016-11-04,US 201615343892 A;;US 201562251879 P,2015-11-06,Footwear System for Ulcer or Pre-Ulcer Detection,"A footwear system having a plurality of temperature sensors determines the emergence of an ulcer or pre-ulcer on a person's foot. After the plurality of temperature sensors generate a plurality of discrete temperature data values, the system and method form a temperature map representing substantially the actual geometric shape of at least a portion of the foot, and the distribution of temperatures of the at least a portion of the foot. Next, the method and system determine whether the temperature map presents at least one of a plurality of prescribed patterns, and produces output information indicating an emergence of an ulcer or a pre-ulcer on a given portion on the foot. The output information is produced as a function of whether the temperature map is determined to present the at least one of the plurality of prescribed patterns.",PODIMETRICS INC,LINDERS DAVID R;;PETERSEN BRIAN J;;PETERSEN DANIEL J;;BLOOM JONATHAN D,PODIMETRICS INC (2016-11-16),https://lens.org/192-550-771-517-366,Patent Application,yes,2,14,10,10,0,A61B5/0002;;G16H50/20;;G16H40/63;;G01K1/026;;G01K2213/00;;A43B7/00;;A61B5/015;;A61B5/445;;A61B5/447;;A61B5/6807;;A61B5/7282;;A61B5/7405;;A61B5/742;;A61B2505/07;;G01K13/20;;A43B3/34;;A61B5/0002;;G16H40/63;;G01K2213/00;;G16H50/20;;G01K1/026;;G01K1/00;;A43B7/00;;G01K13/20;;A43B3/34;;A61B5/015;;A61B5/445;;A61B5/447;;A61B5/6807;;A61B5/7282;;A61B5/7405;;A61B5/742;;A61B2505/07,A61B5/00;;A61B5/01,,0,0,,,,ACTIVE
564,AU,A,AU 1996/059811 A,112-008-397-779-101,1996-12-30,1996,AU 1996/059811 A,1996-06-05,US 48218895 A;;US 9608804 W,1995-06-07,Flat diffraction grating light valve,"A diffraction grating light valve modulates an incident beam of light. A plurality of elongated elements each have a reflective surface. The elongated elements are suspended with their respective ends substantially coplanar. Alternate ones of the elongated elements are electrically coupled for receiving a first bias voltage. The interdigitated elongated elements are electrically coupled for receiving a second bias voltage. By applying a appropriate first and second biasing voltages, all the reflective surfaces can be maintained in a first plane. When all the elongated elements are in the first plane, the diffraction grating light valve reflects the beam of light. A predetermined group of the elongated elements, preferably alternate ones, are deformable to be substantially coplanar in a second plane which is parallel to the first plane. When the predetermined group of elements is in the second plane, the diffraction grating light valve diffracts the beam of light.",ECHELLE INC,BLOOM DAVID M;;CORBIN DAVE B;;BANYAI WILLIAM C;;STAKER BRYAN P,,https://lens.org/112-008-397-779-101,Patent Application,no,0,0,20,20,0,G02B5/1828;;G02B26/0808;;Y10S359/904;;G02B5/18;;G02B5/1828;;G02B26/0808;;Y10S359/904,G02B5/18;;G02B26/08,,0,0,,,,PENDING
565,US,B1,US 11435888 B1,137-160-243-324-837,2022-09-06,2022,US 201715669734 A,2017-08-04,US 201715669734 A;;US 201662397465 P,2016-09-21,System with position-sensitive electronic device interface,"Systems are provided that include electronic equipment and electronic devices. A system may include electronic equipment such as a thermostat or other equipment in a vehicle or home, vehicle navigation equipment, networking equipment, computer equipment, equipment with speakers for playing audio, and other electronic equipment. An electronic device such as a portable electronic device may be placed in the vicinity of electronic equipment by a user. In response to detecting that the electronic device is adjacent to the electronic equipment, control circuitry in the electronic device can automatically display content of the electric device such as a user control interface for the electronic device or information related to operation of the electronic equipment. The system may monitor the position of the electronic device relative to the electronic equipment and can dynamically update the displayed content based on the current device position.",APPLE INC,GLEESON BRIAN T;;MEYER ADAM S;;BLOOM DAVID H;;ARNOLD PETER M,APPLE INC (2017-07-11),https://lens.org/137-160-243-324-837,Granted Patent,yes,88,0,1,1,0,G08C23/04;;G08C17/02;;G08C17/04;;H04L41/12;;H04L41/24;;G06F3/165;;H04W4/023;;G06F1/1694;;G06F1/1698;;G06F3/04847;;H04M1/72415;;G06F3/04847;;G08C17/02;;G08C23/04;;G08C17/04;;G06F3/0488;;H04L41/22;;H04L41/0879;;G08C2201/34;;H04W24/00;;G08C2201/91;;G08C2201/92;;G06F3/165;;G06F3/04842;;B60R16/0231,G06F3/04847;;B60R16/023;;G06F3/04842;;G06F3/0488;;G06F3/16;;G08C17/02;;G08C17/04;;G08C23/04;;H04L41/08;;H04L41/22;;H04W24/00,,0,0,,,,ACTIVE
566,ES,T3,ES 2147380 T3,157-346-517-668-516,2000-09-01,2000,ES 96917143 T,1996-06-05,US 48218895 A,1995-06-07,VALVULA DE LUZ CON RED PLANA DE DIFRACCION.,"A diffraction grating light valve modulates an incident beam of light. A plurality of elongated elements each have a reflective surface. The elongated elements are suspended with their respective ends substantially coplanar. Alternate ones of the elongated elements are electrically coupled for receiving a first bias voltage. The interdigitated elongated elements are electrically coupled for receiving a second bias voltage. By applying a appropriate first and second biasing voltages, all the reflective surfaces can be maintained in a first plane. When all the elongated elements are in the first plane, the diffraction grating light valve reflects the beam of light. A predetermined group of the elongated elements, preferably alternate ones, are deformable to be substantially coplanar in a second plane which is parallel to the first plane. When the predetermined group of elements is in the second plane, the diffraction grating light valve diffracts the beam of light.",SILICON LIGHT MACHINES INC,BLOOM DAVID M;;CORBIN DAVE B;;BANYAI WILLIAM C;;STAKER BRYAN P,,https://lens.org/157-346-517-668-516,Granted Patent,no,0,0,20,20,0,G02B5/1828;;G02B26/0808;;Y10S359/904;;G02B5/18;;G02B5/1828;;G02B26/0808;;Y10S359/904,G02B5/18;;G02B26/08,,0,0,,,,EXPIRED
567,CN,A,CN 116802577 A,068-894-314-804-785,2023-09-22,2023,CN 202180092461 A,2021-02-01,US 2021/0016051 W,2021-02-01,Automatically constructing diagnostic fault models from vehicle engineering documents,"Systems and methods for integrating system information of communication and/or electrical systems to provide a mapping of diagnostic fault codes generated by both systems. The design outputs of the two systems are used to generate a unified mapping. When the system generates a diagnostic fault code set, a unified mapping is applied by a troubleshooting tool to direct maintenance personnel to a fault mode and a failure source. The result can be applied to a troubleshooting tool of a vehicle system.",GARRETT TRANSP I INC;;BAYERISCHE MOTOREN WERKE AG,USCHANSKY MICHAEL;;SABANI NEERAJ;;MRAZEK DAVID;;KRUCKA JAN;;GRASREINER SEBASTIAN;;BLOOM MICHAEL,,https://lens.org/068-894-314-804-785,Patent Application,no,0,0,3,3,0,G05B23/0251,G05B23/02,,0,0,,,,PENDING
568,CA,A1,CA 3039590 A1,088-743-589-689-090,2017-05-11,2017,CA 3039590 A,2016-11-04,US 201562251879 P;;US 2016/0060638 W,2015-11-06,FOOTWEAR SYSTEM FOR ULCER OR PRE-ULCER DETECTION,"A footwear system having a plurality of temperature sensors determines the emergence of an ulcer or pre-ulcer on a person's foot. After the plurality of temperature sensors generate a plurality of discrete temperature data values, the system and method form a temperature map representing substantially the actual geometric shape of at least a portion of the foot, and the distribution of temperatures of the at least a portion of the foot. Next, the method and system determine whether the temperature map presents at least one of a plurality of prescribed patterns, and produces output information indicating an emergence of an ulcer or a pre-ulcer on a given portion on the foot. The output information is produced as a function of whether the temperature map is determined to present the at least one of the plurality of prescribed patterns.",PODIMETRICS INC,LINDERS DAVID R;;PETERSEN BRIAN J;;PETERSEN DANIEL J;;BLOOM JONATHAN D,,https://lens.org/088-743-589-689-090,Patent Application,no,0,0,10,10,0,A61B5/0002;;G16H50/20;;G16H40/63;;G01K1/026;;G01K2213/00;;A43B7/00;;A61B5/015;;A61B5/445;;A61B5/447;;A61B5/6807;;A61B5/7282;;A61B5/7405;;A61B5/742;;A61B2505/07;;G01K13/20;;A43B3/34;;A61B5/0002;;G16H40/63;;G01K2213/00;;G16H50/20;;G01K1/026;;G01K1/00;;A43B7/00;;G01K13/20;;A43B3/34;;A61B5/015;;A61B5/445;;A61B5/447;;A61B5/6807;;A61B5/7282;;A61B5/7405;;A61B5/742;;A61B2505/07,A61B5/00;;A61B5/01,,0,0,,,,PENDING
569,AU,A,AU 2000/066257 A,143-659-715-131-268,2001-03-05,2001,AU 2000/066257 A,2000-08-08,US 37264999 A;;US 17168599 P;;US 54878800 A;;US 0021647 W,1999-08-11,Polarization independent grating modulator,,LIGHTCONNECT INC,GODIL ASIF A;;CHUI BENJAMIN W;;BLOOM DAVID M;;HONER KENNETH A,,https://lens.org/143-659-715-131-268,Patent Application,no,0,0,5,23,0,G02B26/0808;;G02B26/0808;;G02B5/1828;;G02B5/1828;;G02B6/266;;G02B6/266;;G02B6/2793;;G02B6/2793;;G02B6/3516;;G02B6/3516;;G02B6/357;;G02B6/357;;G02B6/3584;;G02B6/3584;;G02B6/3594;;G02B6/3594;;H01S5/005;;H01S5/005,G02B5/18;;G02B6/26;;G02B6/34;;G02B6/35;;G02B26/08;;H01S5/00,,0,0,,,,DISCONTINUED
570,EP,A1,EP 1203246 A1,186-275-860-461-949,2002-05-08,2002,EP 00953884 A,2000-08-08,US 0021647 W;;US 37264999 A;;US 17168599 P;;US 54878800 A,1999-08-11,POLARIZATION INDEPENDENT GRATING MODULATOR,,LIGHTCONNECT INC,GODIL ASIF A;;CHUI BENJAMIN W;;BLOOM DAVID M;;HONER KENNETH A,,https://lens.org/186-275-860-461-949,Patent Application,yes,0,0,5,23,0,G02B26/0808;;G02B26/0808;;G02B5/1828;;G02B5/1828;;G02B6/266;;G02B6/266;;G02B6/2793;;G02B6/2793;;G02B6/3516;;G02B6/3516;;G02B6/357;;G02B6/357;;G02B6/3584;;G02B6/3584;;G02B6/3594;;G02B6/3594;;H01S5/005;;H01S5/005,G02B5/18;;G02B6/26;;G02B6/34;;G02B6/35;;G02B26/08;;H01S5/00,,1,0,,,See references of WO 0111394A1,DISCONTINUED
571,US,A,US 5841579 A,113-287-938-169-367,1998-11-24,1998,US 48218895 A,1995-06-07,US 48218895 A,1995-06-07,Flat diffraction grating light valve,"A diffraction grating light valve modulates an incident beam of light. A plurality of elongated elements each have a reflective surface. The elongated elements are suspended with their respective ends substantially coplanar. Alternate ones of the elongated elements are electrically coupled for receiving a first bias voltage. The interdigitated elongated elements are electrically coupled for receiving a second bias voltage. By applying a appropriate first and second biasing voltages, all the reflective surfaces can be maintained in a first plane. When all the elongated elements are in the first plane, the diffraction grating light valve reflects the beam of light. A predetermined group of the elongated elements, preferably alternate ones, are deformable to be substantially coplanar in a second plane which is parallel to the first plane. When the predetermined group of elements is in the second plane, the diffraction grating light valve diffracts the beam of light.",SILICON LIGHT MACHINES INC,BLOOM DAVID M;;CORBIN DAVE B;;BANYAI WILLIAM C;;STRAKER BRYAN P,SILICON LIGHT MACHINES CORPORATION (2002-04-01);;SILICON LIGHT MACHINES (1996-07-19),https://lens.org/113-287-938-169-367,Granted Patent,yes,100,228,20,20,0,G02B5/1828;;G02B26/0808;;Y10S359/904;;G02B5/18;;G02B5/1828;;G02B26/0808;;Y10S359/904,G02B5/18;;G02B26/08,359/572;;359/290;;359/291;;359/224;;359/226;;345/108,9,4,009-286-199-765-581;;028-775-209-892-098;;009-365-280-210-861;;010-074-622-606-125,10.1109/5.53402;;10.1117/12.19865;;10.1016/0141-9382(91)90032-9;;10.1364/ol.17.000688;;19794599,"R. Apte, F. Sandejas, W. Banyai, D. Bloom, Grating Light Valves For High Resolution Displays , Solid State Sensor and Actuators Workshop, Hilton Head Island, SC (Jun. 13 16, 1994).;;R. Apte, Grating Light Valves For High Resolution Displays Jun., 1994.;;O. Solgaard, Integrated Semiconductor Light Modulators For Fiber Optic And Display Applications , Feb., 1992.;;J. Neff, Two Dimensional Spatial Light Modulators: A Tutorial , Proceedings of the IEEE, vol. 78, No. 5 (May 1990), pp. 826 855.;;Gerhard Multhaupt, Viscoelastic Spatial Light Modulators and Schlieren Optical Systems for HDTV Projection Displays , SPIE vol. 1255 Large Screen Projection Displays II (1990), pp. 69 78.;;Gerhard Multhaupt, Light Valve Technologies for High Definition Television Projection Displays , Displays, vol. 12, No. 3/4 (1991), pp. 115 128.;;F. Sandejas, R. Apte, W. Banyai, D. Bloom, Surface Microfabrication of Deformable Grating Light Valves For High Resolution Displays, The 7th International Conference on Solid State Sensors and Actuators, pp. 6 & 7, (no date).;;O.Solgaard, F. Sandejas, and D. Bloom, Deformable Grating Optical Modulator, Optics letters, vol. 17, No. 9, May 1, 1992, New York, USA, pp. 688 690.;;R. Apte, F. Sandejas, W. Banyai, D. Bloom, Grating Light Valves For High Resolution Displays , Ginzton Laboratories, Stanford University, Sanford, CA 94305 4085.",EXPIRED
572,CN,A,CN 108471946 A,166-739-004-162-898,2018-08-31,2018,CN 201680075557 A,2016-11-04,US 201562251879 P;;US 2016/0060638 W,2015-11-06,Footwear system for ulcer or pre-ulcer detection,"A footwear system having a plurality of temperature sensors determines the emergence of an ulcer or pre-ulcer on a person's foot. After the plurality of temperature sensors generate a plurality of discrete temperature data values, the system and method form a temperature map representing substantially the actual geometric shape of at least a portion of the foot, and the distribution of temperatures of the at least a portion of the foot. Next, the method and system determine whether the temperature map presents at least one of a plurality of prescribed patterns, and produces output informationindicating an emergence of an ulcer or a pre-ulcer on a given portion on the foot. The output information is produced as a function of whether the temperature map is determined to present the at leastone of the plurality of prescribed patterns.",PODIMETRICS INC,LINDERS DAVID R;;PETERSEN BRIAN J;;PETERSEN DANIEL J;;BLOOM JONATHAN D,,https://lens.org/166-739-004-162-898,Patent Application,no,8,13,10,10,0,A61B5/0002;;G16H50/20;;G16H40/63;;G01K1/026;;G01K2213/00;;A43B7/00;;A61B5/015;;A61B5/445;;A61B5/447;;A61B5/6807;;A61B5/7282;;A61B5/7405;;A61B5/742;;A61B2505/07;;G01K13/20;;A43B3/34;;A61B5/0002;;G16H40/63;;G01K2213/00;;G16H50/20;;G01K1/026;;G01K1/00;;A43B7/00;;G01K13/20;;A43B3/34;;A61B5/015;;A61B5/445;;A61B5/447;;A61B5/6807;;A61B5/7282;;A61B5/7405;;A61B5/742;;A61B2505/07,A61B5/00;;A61B5/01,,0,0,,,,ACTIVE
573,US,A1,US 2017/0020994 A1,199-337-203-955-060,2017-01-26,2017,US 201515300807 A,2015-04-02,US 201515300807 A;;US 201461973995 P;;US 2015/0024094 W,2014-04-02,MATERIALS AND METHODS FOR THE TREATMENT OF LATENT VIRAL INFECTION,The subject invention pertains to materials and methods for the treatment of latent viral infections.,UNIV FLORIDA;;UNIV DUKE,BLOOM DAVID C;;PHELAN DANE M;;CULLEN BRYAN R;;KENNEDY MATTHEW E,DUKE UNIVERSITY (2015-04-13);;UNIVERSITY OF FLORIDA RESEARCH FOUNDATION INCORPORATED (2016-09-29),https://lens.org/199-337-203-955-060,Patent Application,yes,4,8,4,4,30,A61K38/465;;A61K38/465;;A61K31/045;;A61K31/52;;A61K31/522;;A61K31/7072;;A61K45/06;;A61K45/06;;A61K48/00;;C07K2319/80;;C12N7/00;;C12N9/22;;C12N9/22;;C12N2710/16611;;C12N2710/16661;;C12Y301/00;;C12Y301/00,A61K38/46;;A61K45/06;;C12N9/22,,2,1,070-516-636-559-94X,pmc3882405;;10.3748/wjg.v19.i48.9328;;24409059,"(Molecular Therapy, February 2014 Vol. 22, p. 303-311);;Reddy et al. (World Journal of Gastroenterology, December 2013, Vol. 19, p. 9328-9333).",ACTIVE
574,WO,A1,WO 1990/001195 A1,100-821-913-895-86X,1990-02-08,1990,US 8903111 W,1989-07-21,US 22349988 A,1988-07-25,MULTIMEDIA INTERFACE AND METHOD FOR COMPUTER SYSTEM,"A multimedia interface (150) presents information and receives user commands for a computer system (160). The multimedia interface (150) operates in parallel with another application software module (52, 54), such as an expert system. To add multimedia features to the application software module (52, 54), the module is modified so as to generate multimedia commands at the same time as it displays text on a text monitor. The multimedia commands, which are held in a queue (74), provide additional information in the form of video images and generated speech corresponding to the displayed text. In addition, the multimedia commands are split into at least two sets: one set which is dispatched to the user substantially immediately after displaying the corresponding text, and one set which is dispatched only upon request by the user. In the preferred embodiment, the multimedia interface (150) presents information to the user through text, graphics, video, speech production, and printed output. User inputs are made through a special-function keypad (56) and voice recognition (62). The preferred embodiment is a portable expert system which fits in a single portable suitcase sized package (200).",ELECTRIC POWER RES INST,ISLE BRIAN A;;BLOOM CHARLES P;;BUTLER ARCH W;;SPOOR DAVID;;WUNDERLIN DAVID J;;BEDROS RENEE,,https://lens.org/100-821-913-895-86X,Patent Application,yes,4,17,6,6,0,G06F3/16;;G06F3/16;;G06F17/00;;G06F1/1628;;G06F1/1628;;G06F3/0489;;G06F3/0489;;G06F16/40;;G06F16/40;;G06Q10/10;;G06Q10/10;;Y10S379/908;;Y10S379/908;;Y10S715/978;;Y10S715/978,G06F1/16;;G06F3/023;;G06F3/048;;G06F3/16;;G06F17/30;;G06Q10/10,,1,0,,,See also references of EP 0433305A4,PENDING
575,US,A,US 4931950 A,150-498-554-958-190,1990-06-05,1990,US 22349988 A,1988-07-25,US 22349988 A,1988-07-25,Multimedia interface and method for computer system,"A multimedia interface presents information and receives user commands for a computer system. The multimedia interface operates in parallel with another application software module, such as an expert system. To add multimedia features to the application software module, the module is modified so as to generate multimedia commands at the same time as it displays text on a text monitor. The multimedia commands, which are held in a queue, provide additional information in the form of video images and generated speech corresponding to the displayed text. In addition, the multimedia commands are split into at least two sets: one set which is dispatched to the user substantially immediately after displaying the corresponding text, and one set which is dispatched only upon request by the user. In the preferred embodiment, the multimedia interface presents information to the user through text, graphics, video speech production, and printed output. User inputs are made through a special-function keypad and voice recognition. The preferred embodiment is a portable expert system which fits in a single portable suitcase sized package.",ELECTRIC POWER RES INST,ISLE BRIAN A;;BLOOM CHARLES P;;BUTLER ARCH W;;SPOOR DAVID;;WUNDERLIN DAVID J;;BEDROS RENEE,ELECTRIC POWER RESEARCH INSTITUTE INC. A CORP. OF DISTRICT OF COLUMBIA (1989-07-12);;ELECTRIC POWER RESEARCH INSTITUTE INC. A CORP. OF THE DISTRICT OF COLUMBIA (1988-08-16),https://lens.org/150-498-554-958-190,Granted Patent,yes,11,340,6,6,0,G06F3/16;;G06F3/16;;G06F17/00;;G06F1/1628;;G06F1/1628;;G06F3/0489;;G06F3/0489;;G06F16/40;;G06F16/40;;G06Q10/10;;G06Q10/10;;Y10S379/908;;Y10S379/908;;Y10S715/978;;Y10S715/978,G06F1/16;;G06F3/023;;G06F3/048;;G06F3/16;;G06F17/30;;G06Q10/10,364/513;;364/188;;364/551.01;;364/579;;364/514;;364/200;;364/274.7;;364/275.7;;381/110,1,0,,,"Gas Turbine Expert System ; EPRI Identification No. AP86 11; Video Tape; 1986, Dec.; Electric Power Research Institute; Palo Alto, Calif.",EXPIRED
576,AU,A,AU 1989/040499 A,069-863-452-288-39X,1990-02-19,1990,AU 1989/040499 A,1989-07-21,US 22349988 A,1988-07-25,MULTIMEDIA INTERFACE AND METHOD FOR COMPUTER SYSTEM,,ELECTRIC POWER RES INST,ISLE BRIAN A;;BUTLER ARCH W;;BLOOM CHARLES P;;SPOOR DAVID;;WUNDERLIN DAVID J;;BEDROS RENEE,,https://lens.org/069-863-452-288-39X,Patent Application,no,0,0,6,6,0,G06F3/16;;G06F3/16;;G06F17/00;;G06F1/1628;;G06F1/1628;;G06F3/0489;;G06F3/0489;;G06F16/40;;G06F16/40;;G06Q10/10;;G06Q10/10;;Y10S379/908;;Y10S379/908;;Y10S715/978;;Y10S715/978,G06F1/16;;G06F3/023;;G06F3/048;;G06F3/16;;G06F17/30;;G06Q10/10,,0,0,,,,PENDING
577,EP,A1,EP 0433305 A1,178-309-134-671-805,1991-06-26,1991,EP 89909367 A,1989-07-21,US 22349988 A,1988-07-25,MULTIMEDIA INTERFACE AND METHOD FOR COMPUTER SYSTEM.,"Une interface (150) multi-support présente des informations et reçoit des instructions de l'utilisateur par un système informatique (160). L'interface (150) multi-support fonctionne en parallèle avec un autre module (52, 54) de logiciel d'application tel qu'un système expert. Afin d'ajouter des caractéristiques multi-support au module (52, 54) de logiciel d'application, le module est modifié de manière à produire des instructions multi-support en même temps qu'il affiche un texte sur un moniteur de texte. Les instructions multi-support maintenues dans une file d'attente (74), fournissent des informations supplémentaires sous forme d'images vidéo et de paroles générées correspondant au texte affiché. De plus les instructions multi-support sont subdivisées en au moins deux ensembles: un ensemble acheminé à l'utilisateur sensiblement immédiatement après affichage du texte correspondant, et un ensemble acheminé uniquement sur demande de l'utilisateur. Dans le mode de réalisation préféré, l'interface (150) multi-support présente des informations à l'utilisateur pour texte, graphique, vidéo, production de parole et sortie imprimée. Les entrées de l'utilisateur se font par un clavier (56) à fonctions spéciales et reconnaissance de la voix (62). Le mode de réalisation préféré est un système expert portatif s'adaptant dans un seul ensemble (200) ayant la taille d'une valise portative.",ELECTRIC POWER RES INST,ISLE BRIAN A;;BLOOM CHARLES P;;BUTLER ARCH W;;SPOOR DAVID;;WUNDERLIN DAVID J;;BEDROS RENEE,,https://lens.org/178-309-134-671-805,Patent Application,yes,0,0,6,6,0,G06F3/16;;G06F3/16;;G06F17/00;;G06F1/1628;;G06F1/1628;;G06F3/0489;;G06F3/0489;;G06F16/40;;G06F16/40;;G06Q10/10;;G06Q10/10;;Y10S379/908;;Y10S379/908;;Y10S715/978;;Y10S715/978,G06F1/16;;G06F3/023;;G06F3/048;;G06F3/16;;G06F17/30;;G06Q10/10,,0,0,,,,DISCONTINUED
578,EP,A4,EP 0433305 A4,186-272-710-130-382,1992-06-10,1992,EP 89909367 A,1989-07-21,US 22349988 A,1988-07-25,MULTIMEDIA INTERFACE AND METHOD FOR COMPUTER SYSTEM,,"ELECTRIC POWER RESEARCH INSTITUTE, INC","ISLE, BRIAN, A.;;BLOOM, CHARLES, P.;;BUTLER, ARCH, W.;;SPOOR, DAVID;;WUNDERLIN, DAVID, J.;;BEDROS, RENEE",,https://lens.org/186-272-710-130-382,Search Report,no,1,0,6,6,0,G06F3/16;;G06F3/16;;G06F17/00;;G06F1/1628;;G06F1/1628;;G06F3/0489;;G06F3/0489;;G06F16/40;;G06F16/40;;G06Q10/10;;G06Q10/10;;Y10S379/908;;Y10S379/908;;Y10S715/978;;Y10S715/978,G06F1/16;;G06F3/023;;G06F3/048;;G06F3/16;;G06F17/30;;G06Q10/10,,4,2,022-278-236-929-735;;172-834-303-238-162,10.1109/60.4202;;10.1109/ms.1987.230090,"IEEE TRANSACTIONS ON ENERGY CONVERSION. vol. 3, no. 1, March 1988, NEW YORK, US pages 71 - 77; C.G. KOCH ET AL.: 'INTELLIGENT USER INTERFACE FOR EXPERT SYSTEMS APPLIED TO POWER PLANT MAINTENANCE AND TROUBLESHOOTING';;CONFERENCE ON OFFICE INFORMATION SYSTEMS 23 March 1988, PALO ALTO, CA , US pages 219 - 227; S. CHRISTODOULAKIS ET AL.: 'BROWSING WITHIN TIME-DRIVEN MULTIMEDIA DOCUMENTS';;IEEE SOFTWARE. vol. 4, no. 2, March 1987, NEW YORK, US pages 4 - 14; S. GIBBS ET AL.: 'MUSE: A MULTIMEDIA FILING SYSTEM';;See also references of WO 9001195A1",DISCONTINUED
579,US,B2,US 8632533 B2,185-839-919-689-732,2014-01-21,2014,US 71079110 A,2010-02-23,US 71079110 A;;US 15462309 P,2009-02-23,Fluid-assisted electrosurgical device,"The invention provides an electrosurgical device and methods of use thereof. The device comprises a first electrode, a second electrode and at least one fluid outlet. In one embodiment, the first electrode has a distal portion with an electrically conductive spherical surface, the second electrode has a distal portion with an electrically conductive spherical surface, and at least one of the first electrode and the second electrode have a blade portion.",GREELEY ROGER D;;EARLES DONALD;;FLANAGAN DAVID;;BLOOM ELIOT;;CONLEY BRIAN;;BARRY JONATHAN;;MEDTRONIC ADVANCED ENERGY LLC,GREELEY ROGER D;;EARLES DONALD;;FLANAGAN DAVID;;BLOOM ELIOT;;CONLEY BRIAN;;BARRY JONATHAN,MEDTRONIC ADVANCED ENERGY LLC (2010-03-01),https://lens.org/185-839-919-689-732,Granted Patent,yes,113,31,13,13,0,A61B18/1402;;A61B18/148;;A61B2018/00029;;A61B2018/00345;;A61B2018/00404;;A61B2018/00434;;A61B2018/00589;;A61B2018/00601;;A61B2018/00619;;A61B2018/0063;;A61B2018/00642;;A61B2018/00702;;A61B2018/00791;;A61B2018/00875;;A61B2018/1253;;A61B2018/126;;A61B2018/1412;;A61B2018/1415;;A61B2018/1467;;A61B2018/1472;;A61B2218/002;;A61B18/1402;;A61B18/148;;A61B2018/00029;;A61B2018/00345;;A61B2018/00404;;A61B2018/00434;;A61B2018/00589;;A61B2018/00601;;A61B2018/00619;;A61B2018/0063;;A61B2018/00642;;A61B2018/00702;;A61B2018/00791;;A61B2018/00875;;A61B2018/1253;;A61B2018/126;;A61B2018/1412;;A61B2018/1415;;A61B2018/1467;;A61B2018/1472;;A61B2218/002;;A61B18/18,A61B18/18,606/37;;606/48,2,0,,,"Reexam Cert 4794 for 5,697,536, Jun. 10, 2003, Eggers et al.;;International Search Report dated Apr. 21, 2010 issued in related International Patent Application No. PCT/US2010/025058.",ACTIVE
580,US,A1,US 2014/0107647 A1,063-582-928-212-536,2014-04-17,2014,US 201314136674 A,2013-12-20,US 201314136674 A;;US 71079110 A;;US 15462309 P,2009-02-23,FLUID-ASSISTED ELECTROSURGICAL DEVICE,"The disclosure provides a fluid-assisted electrosurgical device. The device comprises a first electrode, a second electrode and at least one fluid outlet. In one embodiment, the first electrode has a distal portion with an electrically conductive spherical surface, the second electrode has a distal portion with an electrically conductive spherical surface, and at least one of the first electrode and the second electrode have a blade portion.",MEDTRONIC ADVANCED ENERGY LLC,GREELEY ROGER D;;EARLES DONALD;;FLANAGAN DAVID;;BLOOM ELIOT;;CONLEY BRIAN;;BARRY JONATHAN,,https://lens.org/063-582-928-212-536,Patent Application,yes,0,1,13,13,0,A61B18/1402;;A61B18/148;;A61B2018/00029;;A61B2018/00345;;A61B2018/00404;;A61B2018/00434;;A61B2018/00589;;A61B2018/00601;;A61B2018/00619;;A61B2018/0063;;A61B2018/00642;;A61B2018/00702;;A61B2018/00791;;A61B2018/00875;;A61B2018/1253;;A61B2018/126;;A61B2018/1412;;A61B2018/1415;;A61B2018/1467;;A61B2018/1472;;A61B2218/002;;A61B18/1402;;A61B18/148;;A61B2018/00029;;A61B2018/00345;;A61B2018/00404;;A61B2018/00434;;A61B2018/00589;;A61B2018/00601;;A61B2018/00619;;A61B2018/0063;;A61B2018/00642;;A61B2018/00702;;A61B2018/00791;;A61B2018/00875;;A61B2018/1253;;A61B2018/126;;A61B2018/1412;;A61B2018/1415;;A61B2018/1467;;A61B2018/1472;;A61B2218/002;;A61B18/18,A61B18/18,606/48,0,0,,,,ACTIVE
581,US,A1,US 2004/0164805 A1,089-453-885-834-812,2004-08-26,2004,US 69111503 A,2003-10-21,US 69111503 A;;US 69339800 A;;US 23884600 P,2000-10-06,Constant current biasing circuit for linear power amplifiers,"
   A constant current bias approach that receives an input bias voltage and maintains a temperature independent constant current bias in a linear amplifier device. Integrated sense circuitry protects against unacceptable input voltages to guarantee bias stability. Fabrication in multiple semiconductor technologies and assembly into a single package allows for optimum cost and performance of DC bias and RF amplifier sections. 
",ANDRYS PAUL;;BLOOM MARK;;FINLAY HUGH J.;;RIPLEY DAVID;;SHIE TERRY;;HOHEISEL KEVIN,ANDRYS PAUL;;BLOOM MARK;;FINLAY HUGH J;;RIPLEY DAVID;;SHIE TERRY;;HOHEISEL KEVIN,,https://lens.org/089-453-885-834-812,Patent Application,yes,13,0,15,17,0,H03F1/0261;;H03F1/302;;H03F3/343;;H03F2200/18;;H03F2200/453;;H03F2200/513;;H03F3/343;;H03F1/302;;H03F1/0261;;H03F2200/18;;H03F2200/453;;H03F2200/513,H03F1/02;;H03F3/24;;H03F1/30;;H03F3/343;;H03G3/10,330/296,0,0,,,,EXPIRED
582,US,B1,US 6639470 B1,192-981-764-612-802,2003-10-28,2003,US 69339800 A,2000-10-21,US 69339800 A;;US 23884600 P,2000-10-06,Constant current biasing circuit for linear power amplifiers,"
    A constant current bias approach that receives an input bias voltage and maintains a temperature independent constant current bias in a linear amplifier device. Integrated sense circuitry protects against unacceptable input voltages to guarantee bias stability. Fabrication in multiple semiconductor technologies and assembly into a single package allows for optimum cost and performance of DC bias and RF amplifier sections. 
",SKYWORKS SOLUTIONS INC,ANDRYS PAUL;;BLOOM MARK;;FINLAY HUGH J;;RIPLEY DAVID;;SHIE TERRY;;HOHEISEL KEVIN,WASHINGTON SUB INC (2002-06-25);;CONEXANT SYSTEMS INC (2005-03-16);;ALPHA INDUSTRIES INC (2002-06-25),https://lens.org/192-981-764-612-802,Granted Patent,yes,15,39,15,17,0,H03F1/0261;;H03F1/302;;H03F3/343;;H03F2200/18;;H03F2200/453;;H03F2200/513;;H03F3/343;;H03F1/302;;H03F1/0261;;H03F2200/18;;H03F2200/453;;H03F2200/513,H03F1/02;;H03F1/30;;H03F3/343;;H03F3/24;;H03G3/10,330/296;;330/285;;327/309,0,0,,,,EXPIRED
583,US,A1,US 2003/0206701 A1,018-518-667-361-534,2003-11-06,2003,US 41407803 A,2003-04-14,US 41407803 A;;US 85587301 A;;US 54878800 A;;US 37264999 A;;US 17168599 P,1999-08-11,Polarization independent grating modulator,"
   A fiber-optic modulator based on a micromachined grating device which is both polarization independent and achromatic in behavior is described. The device is a two dimensional grating or periodic structure which is symmetric in the X and Y axes. It is comprised of a membrane with holes cut in it that moves downward with the application of a voltage which starts diffracting light. The hole region may have a raised island to provide achromatic behavior. 
",A. GODIL ASIF;;CHUI BENJAMIN WAI-HO;;BLOOM DAVID M.;;HONER KENNETH A.,A GODIL ASIF;;CHUI BENJAMIN WAI-HO;;BLOOM DAVID M;;HONER KENNETH A,,https://lens.org/018-518-667-361-534,Patent Application,yes,3,5,1,23,0,G02B6/3516;;G02B6/3516;;G02B5/1828;;G02B5/1828;;G02B6/266;;G02B6/266;;G02B6/34;;G02B6/34;;G02B6/3552;;G02B6/3552;;G02B26/0808;;G02B26/0808;;H01S5/005;;H01S5/005,G02B5/18;;G02B6/26;;G02B6/34;;G02B6/35;;G02B26/08;;H01S5/00,385/76;;359/237,0,0,,,,DISCONTINUED
584,US,B1,US 6501600 B1,159-366-559-176-780,2002-12-31,2002,US 54878800 A,2000-04-13,US 54878800 A;;US 37264999 A;;US 17168599 P,1999-08-11,Polarization independent grating modulator,"
    A fiber-optic modulator based on a micromachined grating device which is both polarization independent and achromatic in behavior is described. The device is a two dimensional grating or periodic structure which is symmetric in the X and Y axes. It is comprised of a membrane with holes cut in it that moves downward with the application of a voltage which starts diffracting light. The hole region may have a raised island to provide achromatic behavior. 
",LIGHTCONNECT INC,GODIL ASIF A;;CHUI BENJAMIN WAI-HO;;BLOOM DAVID M;;HONER KENNETH A,LIGHTCONNECT INC (2000-12-11);;NEOPHOTONICS CORPORATION (2010-06-08),https://lens.org/159-366-559-176-780,Granted Patent,yes,36,9,5,23,0,G02B26/0808;;G02B26/0808;;G02B5/1828;;G02B5/1828;;G02B6/266;;G02B6/266;;G02B6/2793;;G02B6/2793;;G02B6/3516;;G02B6/3516;;G02B6/357;;G02B6/357;;G02B6/3584;;G02B6/3584;;G02B6/3594;;G02B6/3594;;H01S5/005;;H01S5/005,G02B5/18;;G02B6/26;;G02B6/34;;G02B6/35;;G02B26/08;;H01S5/00,359/569;;359/558;;359/566;;359/572,8,7,046-917-547-643-055;;033-962-722-216-001;;062-505-227-937-061;;154-800-944-637-210;;035-016-645-296-344;;098-193-261-415-490;;053-397-623-539-637,10.1109/50.701404;;10.1016/s0030-4018(99)00302-8;;10.1109/68.720287;;10.1117/12.962188;;10.1117/1.601599;;10.1364/ao.31.003971;;20725374;;10.1117/1.601598,"Parker, Michael C. ""Dynamic Digital Holographic Wavelength Filtering"", Journal of Lightwave Technology, vol. 16, No. 7, Jul. 1998.;;Wang, Lei and Weiner, A.M. ""Programmable Spectral Phase Coding of an Amplified Spontaneous Emission Light Source"", Optics Communications, 167 (1999) 211-224, Aug. 15, 1999.;;Ford, Joseph E. and Walker, James A. ""Dynamic Spectral Equalization Using Micro-Opto-Mechanics"", IEEE Photonics Technology Letters, vol. 10, No. 10, Oct. 1998.;;Minoru, N., ""Bidirectional Optical Tuner"", Patent Abstracts of Japan, vol. 013, No. 395, Sep. 4, 1989, (JP 01142505).;;Hornbeck, L., ""Deformable-Mirror Spatial Light Modulators"", Spatial Light Modulators and Applications III, Aug. 7-8, 1989, San Diego, CA, SPIE Critical Reviews Series, vol. 1150, pp. 86-102.;;Mali, R. et al., ""Development of microelectromechanical deformable mirrors for phase modulation of light"", Opt. Eng., vol. 36, No. 2, Feb. 1997, pp. 542-548.;;Warde, C. et al., ""Charge-transfer-plate spatial light modulators"", Applied Optics, vol. 31, No. 20, pp. 3971-3979.;;Bifano, T. et al. ""Continuous-membrane surface-micromachined silicon deformable mirror"", Opt. Eng., vol. 36, No. 5, May 1997, pp. 1354-1360.",EXPIRED
585,US,B2,US 9486283 B2,124-876-559-380-239,2016-11-08,2016,US 201314136674 A,2013-12-20,US 201314136674 A;;US 71079110 A;;US 15462309 P,2009-02-23,Fluid-assisted electrosurgical device,"The disclosure provides a fluid-assisted electrosurgical device. The device comprises a first electrode, a second electrode and at least one fluid outlet. In one embodiment, the first electrode has a distal portion with an electrically conductive spherical surface, the second electrode has a distal portion with an electrically conductive spherical surface, and at least one of the first electrode and the second electrode have a blade portion.",MEDTRONIC ADVANCED ENERGY LLC,GREELEY ROGER D;;EARLES DONALD;;FLANAGAN DAVID;;BLOOM ELIOT;;CONLEY BRIAN;;BARRY JONATHAN,,https://lens.org/124-876-559-380-239,Granted Patent,yes,122,5,13,13,0,A61B18/1402;;A61B18/148;;A61B2018/00029;;A61B2018/00345;;A61B2018/00404;;A61B2018/00434;;A61B2018/00589;;A61B2018/00601;;A61B2018/00619;;A61B2018/0063;;A61B2018/00642;;A61B2018/00702;;A61B2018/00791;;A61B2018/00875;;A61B2018/1253;;A61B2018/126;;A61B2018/1412;;A61B2018/1415;;A61B2018/1467;;A61B2018/1472;;A61B2218/002;;A61B18/1402;;A61B18/148;;A61B2018/00029;;A61B2018/00345;;A61B2018/00404;;A61B2018/00434;;A61B2018/00589;;A61B2018/00601;;A61B2018/00619;;A61B2018/0063;;A61B2018/00642;;A61B2018/00702;;A61B2018/00791;;A61B2018/00875;;A61B2018/1253;;A61B2018/126;;A61B2018/1412;;A61B2018/1415;;A61B2018/1467;;A61B2018/1472;;A61B2218/002;;A61B18/18,A61B18/14;;A61B18/00;;A61B18/12;;A61B18/18,,0,0,,,,ACTIVE
586,US,B2,US 7443246 B2,133-937-597-274-923,2008-10-28,2008,US 69111503 A,2003-10-21,US 69111503 A;;US 69339800 A;;US 23884600 P,2000-10-06,Constant current biasing circuit for linear power amplifiers,A constant current bias approach that receives an input bias voltage and maintains a temperature independent constant current bias in a linear amplifier device. Integrated sense circuitry protects against unacceptable input voltages to guarantee bias stability. Fabrication in multiple semiconductor technologies and assembly into a single package allows for optimum cost and performance of DC bias and RF amplifier sections.,SKYWORKS SOLUTIONS INC,ANDRYS PAUL;;BLOOM MARK;;FINLAY HUGH J;;RIPLEY DAVID;;SHIE TERRY;;HOHEISEL KEVIN,,https://lens.org/133-937-597-274-923,Granted Patent,yes,13,18,15,17,0,H03F1/0261;;H03F1/302;;H03F3/343;;H03F2200/18;;H03F2200/453;;H03F2200/513;;H03F3/343;;H03F1/302;;H03F1/0261;;H03F2200/18;;H03F2200/453;;H03F2200/513,H03F3/04;;H03F1/02;;H03F3/24;;H03F1/30;;H03F3/343;;H03G3/10,330/296;;330/285,0,0,,,,EXPIRED
587,CA,C,CA 2752054 C,130-500-753-013-135,2015-06-23,2015,CA 2752054 A,2010-02-23,US 15462309 P;;US 2010/0025058 W,2009-02-23,FLUID-ASSISTED ELECTROSURGICAL DEVICE AND METHODS OF USE THEREOF,"The invention provides an electrosurgical device and methods of use thereof. The device comprises a first electrode, a second electrode and at least one fluid outlet. In one embodiment, the first electrode has a distal portion with an electrically conductive spherical surface, the second electrode has a distal portion with an electrically conductive spherical surface, and at least one of the first electrode and the second electrode have a blade portion.",SALIENT SURGICAL TECH INC,GREELEY ROGER D;;EARLES DONALD;;FLANAGAN DAVID;;BLOOM ELIOT;;CONLEY BRIAN;;BARRY JONATHAN,,https://lens.org/130-500-753-013-135,Granted Patent,no,0,0,13,13,0,A61B18/1402;;A61B18/148;;A61B2018/00029;;A61B2018/00345;;A61B2018/00404;;A61B2018/00434;;A61B2018/00589;;A61B2018/00601;;A61B2018/00619;;A61B2018/0063;;A61B2018/00642;;A61B2018/00702;;A61B2018/00791;;A61B2018/00875;;A61B2018/1253;;A61B2018/126;;A61B2018/1412;;A61B2018/1415;;A61B2018/1467;;A61B2018/1472;;A61B2218/002;;A61B18/1402;;A61B18/148;;A61B2018/00029;;A61B2018/00345;;A61B2018/00404;;A61B2018/00434;;A61B2018/00589;;A61B2018/00601;;A61B2018/00619;;A61B2018/0063;;A61B2018/00642;;A61B2018/00702;;A61B2018/00791;;A61B2018/00875;;A61B2018/1253;;A61B2018/126;;A61B2018/1412;;A61B2018/1415;;A61B2018/1467;;A61B2018/1472;;A61B2218/002;;A61B18/18,A61B18/14,,0,0,,,,INACTIVE
588,US,A1,US 2001/0051834 A1,158-556-077-430-791,2001-12-13,2001,US 92290901 A,2001-08-06,US 92290901 A;;US 82563201 A;;US 71266200 A;;US 27531999 A,1999-03-24,Method for composite cell-based implants,"
   This invention is a method for the implantation of a combination of cells or cell-microcarrier aggregates wherein one component comprises a solid implantable construct and a second component comprises an injectable formulation. For example, in one embodiment, the solid implant may be first implanted to fill the majority of the cavity receiving the implant, and then cells or cell-microcarrier aggregates in an injectable format, with or without the addition of gelling materials to promote rapid gelling in situ, may be injected into spaces surrounding the solid implant in order to secure the solid implant in the site and/or to promote rapid adherence and/or integration of the solid implant to surrounding tissues. Also contemplated in this embodiment is that the cellular composition of the injectable component may differ from that of the solid component. For example, the solid implant may result from the culturing of chondrocytes on microcarriers or scaffolds, thereby resulting in an implant having cartilage-like properties, whereas the injectable cells or aggregates may result from the culturing of stem cells, resulting thereby in cells capable of producing cells of a chondrogenic, fibroblastic, myoblastic or osteoblastic phenotype. In this example, cells in the injectable aggregates may promote the fixation to or rapid integration of the solid cartilage implant into surrounding cartilage, connective tissue, muscle or bone, respectively. 
",CHONDROS INC,FRONDOZA CARMELITA G;;HUNGERFORD DAVID S;;SHIKANI ALAN H;;DOMB ABRAHAM J;;FINK DAVID J;;BLOOM LEONARD,CHONDROS INC (2001-07-03),https://lens.org/158-556-077-430-791,Patent Application,yes,0,88,3,16,0,A61L27/3817;;A61L27/3817;;A61F2/08;;A61F2/08;;A61K9/0024;;A61K9/0024;;A61K9/1652;;A61K9/1652;;A61K9/5036;;A61K9/5036;;A61K35/12;;A61K35/12;;A61K47/36;;A61K47/36;;A61L27/3633;;A61L27/3633;;A61L27/3641;;A61L27/3641;;A61L27/3804;;A61L27/3804;;A61L27/3813;;A61L27/3813;;A61L27/3839;;A61L27/3839;;A61L27/3852;;A61L27/3852;;A61L2400/06;;C08B15/005;;C08B15/005;;C08B33/00;;C08B33/00;;C08B37/00;;C08B37/00;;C08B37/0021;;C08B37/0021;;C08B37/006;;C08B37/006;;C08H1/00;;C08H1/00;;C08J3/12;;C08J3/12;;C08J2305/08;;C08J2305/08;;C12N5/0075;;C12N5/0075;;C12N5/0654;;C12N5/0654;;C12N5/0655;;C12N5/0655;;C12N2500/02;;C12N2500/02;;C12N2531/00;;C12N2531/00;;C12N2533/70;;C12N2533/70;;C12N2533/72;;C12N2533/72,A61F2/08;;A61K9/00;;A61K9/16;;A61K9/50;;A61K35/12;;A61K47/36;;A61L27/38;;C08B15/00;;C08B33/00;;C08B37/00;;C08B37/02;;C08H1/00;;C08J3/12;;C12N5/00;;C12N5/077,623/23.72;;623/23.63;;623/915,0,0,,,,EXPIRED
589,US,A1,US 2004/0117033 A1,023-403-212-497-030,2004-06-17,2004,US 73136603 A,2003-12-09,US 73136603 A;;US 92290901 A;;US 82563201 A;;US 71266200 A;;US 27531999 A,1999-03-24,Method for composite cell-based implants,"
   This invention is a method for the implantation of a combination of cells or cell-microcarrier aggregates wherein one component comprises a solid implantable construct and a second component comprises an injectable formulation. For example, in one embodiment, the solid implant may be first implanted to fill the majority of the cavity receiving the implant, and then cells or cell-microcarrier aggregates in an injectable format, with or without the addition of gelling materials to promote rapid gelling in situ, may be injected into spaces surrounding the solid implant in order to secure the solid implant in the site and/or to promote rapid adherence and/or integration of the solid implant to surrounding tissues. Also contemplated in this embodiment is that the cellular composition of the injectable component may differ from that of the solid component. For example, the solid implant may result from the culturing of chondrocytes on microcarriers or scaffolds, thereby resulting in an implant having cartilage-like properties, whereas the injectable cells or aggregates may result from the culturing of stem cells, resulting thereby in cells capable of producing cells of a chondrogenic, fibroblastic, myoblastic or osteoblastic phenotype. In this example, cells in the injectable aggregates may promote the fixation to or rapid integration of the solid cartilage implant into surrounding cartilage, connective tissue, muscle or bone, respectively. 
",FRONDOZA CARMELITA G.;;HUNGERFORD DAVID S.;;SHIKANI ALAN H.;;DOMB ABRAHAM J.;;FINK DAVID J.;;BLOOM LEONARD,FRONDOZA CARMELITA G;;HUNGERFORD DAVID S;;SHIKANI ALAN H;;DOMB ABRAHAM J;;FINK DAVID J;;BLOOM LEONARD,,https://lens.org/023-403-212-497-030,Patent Application,yes,5,55,3,16,0,A61L27/3817;;A61L27/3817;;A61F2/08;;A61F2/08;;A61K9/0024;;A61K9/0024;;A61K9/1652;;A61K9/1652;;A61K9/5036;;A61K9/5036;;A61K35/12;;A61K35/12;;A61K47/36;;A61K47/36;;A61L27/3633;;A61L27/3633;;A61L27/3641;;A61L27/3641;;A61L27/3804;;A61L27/3804;;A61L27/3813;;A61L27/3813;;A61L27/3839;;A61L27/3839;;A61L27/3852;;A61L27/3852;;A61L2400/06;;C08B15/005;;C08B15/005;;C08B33/00;;C08B33/00;;C08B37/00;;C08B37/00;;C08B37/0021;;C08B37/0021;;C08B37/006;;C08B37/006;;C08H1/00;;C08H1/00;;C08J3/12;;C08J3/12;;C08J2305/08;;C08J2305/08;;C12N5/0075;;C12N5/0075;;C12N5/0654;;C12N5/0654;;C12N5/0655;;C12N5/0655;;C12N2500/02;;C12N2500/02;;C12N2531/00;;C12N2531/00;;C12N2533/70;;C12N2533/70;;C12N2533/72;;C12N2533/72,A61F2/08;;A61K9/00;;A61K9/16;;A61K9/50;;A61K35/12;;A61K47/36;;A61L27/38;;C08B15/00;;C08B33/00;;C08B37/00;;C08B37/02;;C08H1/00;;C08J3/12;;C12N5/00;;C12N5/077,623/23.72;;623/901;;623/902,0,0,,,,DISCONTINUED
590,US,B2,US 6662805 B2,126-145-482-792-502,2003-12-16,2003,US 92290901 A,2001-08-06,US 92290901 A;;US 82563201 A;;US 71266200 A;;US 27531999 A,1999-03-24,Method for composite cell-based implants,"
    This invention is a method for the implantation of a combination of cells or cell-microcarrier aggregates wherein one component comprises a solid implantable construct and a second component comprises an injectable formulation. For example, in one embodiment, the solid implant may be first implanted to fill the majority of the cavity receiving the implant, and then cells or cell-microcarrier aggregates in an injectable format, with or without the addition of gelling materials to promote rapid gelling in situ, may be injected into spaces surrounding the solid implant in order to secure the solid implant in the site and/or to promote rapid adherence and/or integration of the solid implant to surrounding tissues. Also contemplated in this embodiment is that the cellular composition of the injectable component may differ from that of the solid component. For example, the solid implant may result from the culturing of chondrocytes on microcarriers or scaffolds, thereby resulting in an implant having cartilage-like properties, whereas the injectable cells or aggregates may result from the culturing of stem cells, resulting thereby in cells capable of producing cells of a chondrogenic, fibroblastic, myoblastic or osteoblastic phenotype. In this example, cells in the injectable aggregates may promote the fixation to or rapid integration of the solid cartilage implant into surrounding cartilage, connective tissue, muscle or bone, respectively. 
",UNIV JOHNS HOPKINS;;CHONDROS INC,FRONDOZA CARMELITA G;;HUNGERFORD DAVID S;;SHIKANI ALAN H;;DOMB ABRAHAM J;;FINK DAVID J;;BLOOM LEONARD,CHONDROS INC (2001-07-03),https://lens.org/126-145-482-792-502,Granted Patent,yes,7,54,3,16,0,A61L27/3817;;A61L27/3817;;A61F2/08;;A61F2/08;;A61K9/0024;;A61K9/0024;;A61K9/1652;;A61K9/1652;;A61K9/5036;;A61K9/5036;;A61K35/12;;A61K35/12;;A61K47/36;;A61K47/36;;A61L27/3633;;A61L27/3633;;A61L27/3641;;A61L27/3641;;A61L27/3804;;A61L27/3804;;A61L27/3813;;A61L27/3813;;A61L27/3839;;A61L27/3839;;A61L27/3852;;A61L27/3852;;A61L2400/06;;C08B15/005;;C08B15/005;;C08B33/00;;C08B33/00;;C08B37/00;;C08B37/00;;C08B37/0021;;C08B37/0021;;C08B37/006;;C08B37/006;;C08H1/00;;C08H1/00;;C08J3/12;;C08J3/12;;C08J2305/08;;C08J2305/08;;C12N5/0075;;C12N5/0075;;C12N5/0654;;C12N5/0654;;C12N5/0655;;C12N5/0655;;C12N2500/02;;C12N2500/02;;C12N2531/00;;C12N2531/00;;C12N2533/70;;C12N2533/70;;C12N2533/72;;C12N2533/72,A61F2/08;;A61K9/00;;A61K9/16;;A61K9/50;;A61K35/12;;A61K47/36;;A61L27/38;;C08B15/00;;C08B33/00;;C08B37/00;;C08B37/02;;C08H1/00;;C08J3/12;;C12N5/00;;C12N5/077,128/898;;623/23.72,0,0,,,,EXPIRED
591,US,A,US 4805237 A,041-609-890-786-487,1989-02-14,1989,US 19172988 A,1988-05-10,US 19172988 A;;US 72082185 A,1985-04-08,Parametric diode amplifier,"A parametric photodiode amplifier suitable for detecting light of frequency f and intensity P and having intersecting I:V curves for zero incident light and for incident light of intensity P. These photodiodes typically have an intrinsic density of carriers that is on the order of or less than the density of carriers produced by incident light of intensity P. When the photodiode is biased by an LO signal and is illuminated with modulated light of carrier frequency f, the photodiode output signal contains IF components at the difference between the frequencies of the modulation signal and the frequencies of on the order of the 23 lower harmonics of the LO signal.",HEWLETT PACKARD CO,DONALD DAVID K;;WANG SHIH-YUAN;;RANGANATH TIRUMALA R;;NEWTON STEVEN A;;TRUTNA WILLIAM R;;BLOOM DAVID M;;DAVID FRANK K,,https://lens.org/041-609-890-786-487,Granted Patent,yes,3,4,1,2,0,H04B10/60;;H04B10/64;;H04B10/60;;H04B10/64,H04B10/148,455/619;;X250214AG;;330/4.9,6,3,105-205-254-636-014;;092-782-175-431-854;;016-174-129-817-902,10.1049/el:19700015;;10.1109/iedm.1973.188656;;10.1063/1.1754889,"Drucheuskii et al. Extension of Dynamic Range Instrum. & Exp Tech (USA), vol. 23, No. 3, Pt 2 May Jun. 1980 Published Dec. 1980 pp. 758 760.;;Davis Optical and Electronic Mixing Electronics Letters, Jan. 22, 1970, vol. 6, No. 2, pp. 25, 26.;;W. D. Gill et al., Photovoltaic Properties of Cu 2 S CdS Heterojunctions, Journal of Applied Physics, vol. 41, No. 9, Aug. 1970.;;G. Lubberts, et al., Photodetection by Light Induced Barrier Modulation in Cu Diffused Au CdS Diodes, Jour. of Appl. Phys., vol. 45, No. 5, May 1974.;;Hall, J. L. and Morey, W. W., Optical Heterodyne Measurement of Neon Laser s Millimeter Wave Difference Frequency, Applied Physics Letters, vol. 10, No. 5, Mar. 1, 1967, pp. 152 155.;;Wang, Shih Yuan, Ultra High speed Photodiode, Laser Focus/Electro Optics, vol. 19, Dec. 1983, pp. 99 106.",EXPIRED
592,WO,A3,WO 2004/087869 A3,013-354-035-647-075,2007-11-15,2007,US 2004/0008926 W,2004-03-24,US 45727903 P;;US 3636508 A;;US 80804204 A,2003-03-25,HERPESVIRUS RIBOZYMES AND VECTORS,"Hammerhead ribozymes that target components critical to HSV replication (ICP4, UL20, UL30, and UL54) were synthesized and shown to efficiently cleave target RNA encoding a portion of these components in in vitro assays. Several cloned cell lines stably expressing these ribozymes were established. HSV-mediated plaque formation was dramatically reduced in cells stably transfected with an anti-HSV ribozyme compared to non­transfected cells.",UNIV FLORIDA;;LEWIN ALFRED S;;BLOOM DAVID C;;SCHULTZ GREGORY S;;TULI SONAL S;;LIU JIA,LEWIN ALFRED S;;BLOOM DAVID C;;SCHULTZ GREGORY S;;TULI SONAL S;;LIU JIA,,https://lens.org/013-354-035-647-075,Search Report,yes,2,0,4,6,0,C07K14/005;;C12N15/1133;;C12N2310/111;;C12N2310/121;;C12N2510/02;;C12N2710/16622;;C07K14/005;;C12N2310/121;;C12N15/1133;;C12N2310/111;;C12N2510/02;;C12N2710/16622,C07H21/04;;C12N15/113,,0,0,,,,PENDING
593,CO,A2,CO 6382184 A2,142-916-619-129-609,2012-02-15,2012,CO 10160884 A,2010-12-22,US 5550008 P,2008-05-23,PROTEINAS FIJADORAS DE RECEPTORES DE INTERLEUKINAS-21,"1.- Una proteína fijadora aislada o fragmento fijador de antígenos de la misma que se fija a IL-21 R, en donde la proteína fijadora o fragmento fijador de antígenos de la misma comprende al menos una secuencia aminoácida que es al menos aproximadamente 95% idéntica a una secuencia aminoácida seleccionada del grupo que consta de SEQ LD NOs: 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42,44,46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 96, 98, 100, 102, 104, 106, 108, 110, 112, 114, 116, 118, 120,122, 124, 126, 128, 130, 132, 134, 136, 138, 140, 142, 144, 146, 148, 150, 152, 154, 156, 158, 160, 162, 165-168, 171-193, 213-229, 240, 242, 244, 246, y 248.2.- La proteína fijadora aislada o fragmento fijador de antígenos de la reivindicación 1, en donde la proteína fijadora o fragmento fijador de antígenos es un anticuerpo.3.- La proteína fijadora aislada o fragmento fijador de antígenos de la reivindicación 1, en donde la proteína fijadora o fragmento fijador de antígenos es un scFv.",WYETH LLC;;MEDIMMUNE LTD,BLOOM LAIRD;;GILL DAVINDER;;ARCHER VIIA VALGE;;LOWE DAVID;;YOUNG DEBORAH ANN;;VUGMEYSTER YULIA,,https://lens.org/142-916-619-129-609,Patent Application,no,0,0,22,22,0,C07K14/54;;C07K16/2866;;C07K2317/21;;C07K2317/565;;C07K2317/622;;C07K2317/73;;C07K2317/732;;C07K2317/92;;C07K2317/52;;A61P29/00;;A61P37/06;;A61P37/08;;A61P43/00;;C07K14/54;;C07K2317/92;;C07K2317/732;;C07K2317/73;;C07K2317/565;;C07K16/2866;;C07K2317/622;;C07K2317/21;;C07K2317/52,C07K14/715;;C07K16/28,,0,0,,,,DISCONTINUED
594,US,B2,US 7838659 B2,006-461-810-255-145,2010-11-23,2010,US 3636508 A,2008-02-25,US 3636508 A;;US 80804204 A;;US 45727903 P,2003-03-25,Herpesvirus ribozymes and vectors,"Hammerhead ribozymes that target components critical to HSV replication (ICP4, U L 20, U L 30, and U L 54) were synthesized and shown to efficiently cleave target RNA encoding a portion of these components in in vitro assays. Several cloned cell lines stably expressing these ribozymes were established. HSV-mediated plaque formation was dramatically reduced in cells stably transfected with an anti-HSV ribozyme compared to non-transfected cells.",UNIV FLORIDA,LEWIN ALFRED S;;BLOOM DAVID C;;SCHULTZ GREGORY S;;TULI SONAL SANJEEV;;LIU JIA,UNIVERSITY OF FLORIDA RESEARCH FOUNDATION INC (2008-02-21),https://lens.org/006-461-810-255-145,Granted Patent,yes,4,0,4,6,18,C07K14/005;;C12N15/1133;;C12N2310/111;;C12N2310/121;;C12N2510/02;;C12N2710/16622;;C07K14/005;;C12N2310/121;;C12N15/1133;;C12N2310/111;;C12N2510/02;;C12N2710/16622,C07H21/04;;C12N15/113,536/24.5,0,0,,,,INACTIVE
595,CH,A,CH 412316 A,062-139-735-314-349,1966-04-30,1966,CH 47765 A,1963-12-17,GB 4752762 A;;US 27328363 A;;US 26374263 A,1962-12-17,Utilisation de composés stilbéniques pour rendre des objets fluorescents,,EASTMAN KODAK CO,EDWARD BOWES KNOTT;;MIROSLAV VASA MIJOVIC;;DAVID GEORGE SAUNDERS;;DAVID GEORGE HEDBERG;;MARSHALL VOIGT OTIS;;MELVIN SIGMUND BLOOM,,https://lens.org/062-139-735-314-349,Granted Patent,no,0,0,10,22,0,C07D263/64;;C08K5/35;;D01F1/06;;G03C1/8155,C07D263/62;;C07D263/64;;C08K5/35;;D01F1/10;;G03C1/815,"57B,18/02",0,0,,,,EXPIRED
596,EP,A2,EP 1689329 A2,036-007-041-942-351,2006-08-16,2006,EP 04810885 A,2004-11-12,US 2004/0037867 W;;US 51911403 P,2003-11-12,CARDIAC VALVE ANNULUS REDUCTION SYSTEM,,MEDTRONIC VASCULAR INC,DOUK NAREAK;;RAFIEE NASSER;;BLOOM ELIOT;;FOGG DOUGLAS A;;HUYNH RANY;;BARONE DAVID D,,https://lens.org/036-007-041-942-351,Patent Application,yes,0,0,6,6,0,A61B17/00234;;A61B17/0401;;A61B2017/00243;;A61B2017/00783;;A61B2017/0414;;A61B2017/0496;;A61B2017/06052;;A61B2017/06176;;A61F2/2445;;A61F2002/30545;;A61F2220/0016;;A61F2250/001;;A61F2/2445;;A61B17/00234;;A61B17/0401;;A61B2017/06052;;A61B2017/00243;;A61B2017/0496;;A61F2250/001;;A61B2017/0414;;A61F2220/0016;;A61F2002/30545;;A61B2017/06176;;A61B2017/00783,A61F2/24;;A61B17/00;;A61B17/04;;A61B17/06;;A61F2/04,,0,0,,,,DISCONTINUED
597,TW,A,TW 200722622 A,075-955-134-466-934,2007-06-16,2007,TW 95127808 A,2006-07-28,US 70404605 P;;US 74760406 P,2005-07-29,"Reciprocating piston pump with air valve, detent and poppets",An air valving system for a reciprocating piston pump 5 which uses piston 10 actuated poppet assemblies 40 to control the main air valve 16 shift. The valve exhaust is vented 50 directly to atmosphere rather than through the main exhaust to insure reliability. A ramped detent 32 prevents the air valve 16 from centering.,GRACO MINNESOTA INC,BAUCK MARK L;;ISAIS JR;;WEINBERGER MARK T;;PITTMAN DAVID M;;BLOOM MICHAEL E,,https://lens.org/075-955-134-466-934,Patent of Addition,no,0,2,28,28,0,F04B9/12;;F04B9/125;;F16K11/02;;F04B49/00;;F04B35/00;;F04B9/08;;F04B9/12;;F04B9/125;;F16K11/02,F04B9/00,,0,0,,,,INACTIVE
598,BR,A,BR 9916042 A,118-934-924-845-803,2001-12-04,2001,BR 9916042 A,1999-12-06,US 20854098 A;;US 9928892 W,1998-12-09,"Composto, composição farmacêutica, e, processospara inibir a replicação de um vìrus herpes, e detratamento de um paciente que sofra de umainfecção do vìrus herpes","""COMPOSTO, COMPOSIçãO FARMACêUTICA, E, PROCESSOSPARA INIBIR A REPLICAçãO DE UM VìRUS HERPES, E DETRATAMENTO DE UM PACIENTE QUE SOFRA DE UMAINFECçãO DO VìRUS HERPES"". Os compostos da fórmula (1),em que R~ 1~ a R~ 5~ são independentemente selecionados dehidrogênio, alquila de 1 a 6 átomos de carbono, alquenila de 2 a 6átomos de carbono, alquinila de 2 a 6 átomos de carbono,per-haloalquila de 1 a 6 átomos de carbono, cicloalquila de 3 a 10átomos de carbono, heterocicloalquila de 3 a 10 membros decarbono, arila, heteroarila, halógeno, -CN, -NO~ 2~, -CO~ 2~R~6~, -COR~ 6~, -OR~ 6~ -SR~ 6~, -SOR~ 6~, -SO~ 2~R~ 6~,-CON~ 7~R~ 8~, NR~ 6~N(R~ 7~R~ 8~), -N(R~ 7~R~ 8~) ouW-Y-(CH~ 2~)~ n~-Z; ou R~ 2~ e R~ 3~ ou R~ 3~ e R~ 4~,tomados juntos de uma heterocicloalquila de 3 a 7 membros, ouheteroarila de 3 a 7 membros; R~ 6~ e R~ 7~ sãoindependentemente hidrogênio, alquila de 1 a 6 átomos decarbono, per-haloalquila de 1 a 6 átomos de carbono, ou arila; R~8~ é hidrogênio, alquila de 1 a 6 átomos de carbono,per-haloalquila de 1 a 6 átomos de carbono, cicloalquila de 3 a 10átomos de carbono, heterocicloalquila de 3 a 10 membros, arila ouheteroarila, ou R^ 7^ e R^ 8^ tomados juntos podem formar umaheterocicloalquila de 3 a 7 membros; A é heteroarila; W é 0, NR~6~, ou está ausente; Y é -(CO)- ou -(CO~ 2~)-, ou está ausente; Zé alquíla de 1 a 4 átomos de carbono, -CN, -CO~ 2~R~ 6~ COR~6~, CONR~ 7~R~ 8~, -OCOR~ 6~, -NR~ 6~COR~ 7~, -OCONR~6~, -OR~ 6~, -SR~ 6~, -SOR~ 6~, -SO~ 2~R~ 6~, SR~ 6~N(R~7~R~ 8~), -N(R~ 7~R~ 8~) ou fenila; G é arila ou heteroarila; X éuma ligação, NH, alquila de 1 a 6 átomos de carbono, alquenila de1 a 6 átomos de carbono, alcóxi de 1 a 6 átomos de carbono, outioalquila de 1 a 6 átomos de carbono, alquilamino de 1 a 6 átomosde carbono, ou (CH)J; J é alquila de 1 a 6 átomos de carbono,cicloalquila de 3 a 7 átomos de carbono, fenila ou benzila; e n é umnúmero inteiro de 1 a 6, útil no tratamento de doenças associadascom os vírus herpes, incluindo o citomegalovírus humano, o vírusdo herpes simplex, o vírus Epstein-Barr, o vírus varicela-zoster, oherpesvírus humano 6 e 7,1 e o herpesvírus de Kaposi.",AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;GEORGEDUSHIN RUSSELL;;LANG STANLEY ALBERT;;O'HARA BRYAN MARK,,https://lens.org/118-934-924-845-803,Patent Application,no,0,0,21,89,0,C07D213/75;;C07D213/81;;C07D405/12;;C07D417/12;;C07D307/85;;C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81,C07D213/81;;A61K/;;A61K31/12;;A61K31/33;;A61K31/425;;A61K31/44;;A61K31/4427;;A61K31/443;;A61K31/4436;;A61K31/444;;A61P/;;A61P31/12;;A61P31/22;;C07D/;;C07D213/75;;C07D401/12;;C07D405/12;;C07D417/12,,0,0,,,,DISCONTINUED
599,US,B2,US 9989575 B2,165-616-843-120-131,2018-06-05,2018,US 201514837641 A,2015-08-27,US 201514837641 A;;US 201562154879 P,2015-04-30,Detection of ECU ground fault with can bus voltage measurements,A method is disclosed for detecting ground faults in a communications system. The method includes measuring a predetermined number of voltage points; determining if the measured voltage points represent recessive or dominant bits; identifying which of the predetermined number of voltage points represent inter-frame bits and which represent frame data bits based on whether the measured voltage points are recessive or dominant; calculating a maximum average voltage for the inter-frame bits; calculating an average frame voltage for all dominant bits within a frame; determining a high average dominant voltage count based on a number of frames for which the average frame voltage is greater than a high voltage threshold; and determining if a ground fault exists based on the average frame voltage and the high average dominant voltage count.,GM GLOBAL TECH OPERATIONS LLC,DU XINYU;;JIANG SHENGBING;;NAGOSE ATUL;;GUMPERT DAVID B;;BLOOM AARON B;;NINER ROD,GM GLOBAL TECHNOLOGY OPERATIONS LLC (2015-08-26),https://lens.org/165-616-843-120-131,Granted Patent,yes,6,5,6,6,0,G01R31/50;;G01R31/52;;G01R31/52;;G01R19/00;;G01R19/003;;G01R19/0084;;G01R19/2503;;G01R31/007;;G01R31/007;;G01R31/083;;H04L1/24,G01R31/02;;G01R31/00;;H04L1/24,,0,0,,,,ACTIVE
600,NZ,A,NZ 589330 A,021-497-332-860-380,2012-12-21,2012,NZ 58933009 A,2009-05-26,US 5550008 P;;US 2009/0045182 W,2008-05-23,INTERLEUKIN-21 RECEPTOR BINDING PROTEINS,"Disclosed are binding proteins and antigen-binding fragments thereof that bind interleukin-21 receptor (IL-21R), in particular, human IL-21R, and their use in regulating IL-21R-assciated activities. The binding proteins disclosed are useful in treating and/or diagnosing IL-21R-associated disorders, such as inflammatory disorder, autoimmune disease, allergies, transplant rejection, hyperproliferative disorders of the blood, and other immune system disorders.",WYETH LLC;;MEDIMMUNE LTD,BLOOM LAIRD;;GILL DAVINDER;;VUGMEYSTER YULIA;;YOUNG DEBORAH A;;LOWE DAVID;;VALGE-ARCHER VIIA,,https://lens.org/021-497-332-860-380,Patent Application,no,0,0,22,22,0,C07K14/54;;C07K16/2866;;C07K2317/21;;C07K2317/565;;C07K2317/622;;C07K2317/73;;C07K2317/732;;C07K2317/92;;C07K2317/52;;A61P29/00;;A61P37/06;;A61P37/08;;A61P43/00;;C07K14/54;;C07K2317/92;;C07K2317/732;;C07K2317/73;;C07K2317/565;;C07K16/2866;;C07K2317/622;;C07K2317/21;;C07K2317/52,C07K14/715;;C07K16/28,,0,0,,,,DISCONTINUED
601,WO,A3,WO 2005/046488 A3,143-227-236-676-026,2005-11-24,2005,US 2004/0037867 W,2004-11-12,US 51911403 P,2003-11-12,CARDIAC VALVE ANNULUS REDUCTION SYSTEM,"A catheter-based, annulus reduction device and system (100, 200) for cardiac valve repair and method of using the same. The system is usable for treating mitral valve regurgitation and comprises a catheter (252), a reduction ring (220) carried within the catheter, the reduction ring including a plurality of exit ports (224) formed in a side wall of the reduction ring and filament (214) received in the reduction ring. The filament includes a plurality of radially extendible barbs (212) corresponding to the sidewall openings. The reduction ring carrying the filament is deployed adjacent a mitral valve annulus and the filament is translated relative to the reduction ring to deploy the barbs through the exit ports and into the annulus and to further translate the reduction ring with deployed barbs to reshape the annulus.",MEDTRONIC VASCULAR INC;;DOUK NAREAK;;RAFIEE NASSER;;BLOOM ELIOT;;FOGG DOUGLAS A;;HUYNH RANY;;BARONE DAVID D,DOUK NAREAK;;RAFIEE NASSER;;BLOOM ELIOT;;FOGG DOUGLAS A;;HUYNH RANY;;BARONE DAVID D,,https://lens.org/143-227-236-676-026,Search Report,yes,1,0,6,6,0,A61B17/00234;;A61B17/0401;;A61B2017/00243;;A61B2017/00783;;A61B2017/0414;;A61B2017/0496;;A61B2017/06052;;A61B2017/06176;;A61F2/2445;;A61F2002/30545;;A61F2220/0016;;A61F2250/001;;A61F2/2445;;A61B17/00234;;A61B17/0401;;A61B2017/06052;;A61B2017/00243;;A61B2017/0496;;A61F2250/001;;A61B2017/0414;;A61F2220/0016;;A61F2002/30545;;A61B2017/06176;;A61B2017/00783,A61B17/00;;A61B17/04;;A61B17/06;;A61F2/04;;A61F2/24,,0,0,,,,PENDING
602,DE,B4,DE 102016107923 B4,111-439-631-749-129,2021-06-02,2021,DE 102016107923 A,2016-04-28,US 201562154879 P;;US 201514837641 A,2015-04-30,Detektion eines ECU-Erdungsfehlers mit Spannungsmessungen am CAN-Bus,"Verfahren zum Detektieren von Erdungsfehlern in einem Kommunikationssystem (10), wobei das Verfahren die Schritte umfasst, dass:eine vorbestimmte Anzahl von Spannungspunkten gemessen wird;ermittelt wird, ob die gemessenen Spannungspunkte rezessive oder dominante Bits repräsentieren;auf der Grundlage dessen, ob die gemessenen Spannungspunkte rezessiv oder dominant sind, identifiziert wird, welche aus der vorbestimmten Anzahl von Spannungspunkten Zwischenrahmenbits repräsentieren und welche Rahmendatenbits repräsentieren;eine maximale Durchschnittsspannung für die Zwischenrahmenbits berechnet wird;eine Durchschnittsrahmenspannung für alle dominanten Bits in einem Rahmen berechnet wird;ein Zählerwert für eine hohe dominante Durchschnittsspannung (CVA) auf der Grundlage einer Anzahl von Rahmen ermittelt wird, bei denen die Durchschnittsrahmenspannung größer als ein hoher Spannungsschwellenwert (Thigh) ist; undauf der Grundlage der Durchschnittsrahmenspannung und dem Zählerwert für eine hohe dominante Durchschnittsspannung (CVA) festgestellt wird, ob ein Erdungsfehler existiert.",GM GLOBAL TECH OPERATIONS LLC,DU XINYU;;JIANG SHENGBING;;NAGOSE ATUL;;GUMPERT DAVID B;;BLOOM AARON B;;NINER ROD,,https://lens.org/111-439-631-749-129,Granted Patent,no,3,0,6,6,0,G01R31/50;;G01R31/52;;G01R31/52;;G01R19/00;;G01R19/003;;G01R19/0084;;G01R19/2503;;G01R31/007;;G01R31/007;;G01R31/083;;H04L1/24,G01R31/50;;B60R16/023,,0,0,,,,ACTIVE
603,US,A1,US 2009/0131644 A1,103-745-467-987-269,2009-05-21,2009,US 3636508 A,2008-02-25,US 3636508 A;;US 80804204 A;;US 45727903 P,2003-03-25,HERPESVIRUS RIBOZYMES AND VECTORS,"Hammerhead ribozymes that target components critical to HSV replication (ICP4, U L 20, U L 30, and U L 54) were synthesized and shown to efficiently cleave target RNA encoding a portion of these components in in vitro assays. Several cloned cell lines stably expressing these ribozymes were established. HSV-mediated plaque formation was dramatically reduced in cells stably transfected with an anti-HSV ribozyme compared to non-transfected cells.",LEWIN ALFRED S;;BLOOM DAVID C;;SCHULTZ GREGORY S;;TULI SONAL SANJEEV;;LIU JIA,LEWIN ALFRED S;;BLOOM DAVID C;;SCHULTZ GREGORY S;;TULI SONAL SANJEEV;;LIU JIA,UNIVERSITY OF FLORIDA RESEARCH FOUNDATION INC (2008-02-21),https://lens.org/103-745-467-987-269,Patent Application,yes,3,2,4,6,18,C07K14/005;;C12N15/1133;;C12N2310/111;;C12N2310/121;;C12N2510/02;;C12N2710/16622;;C07K14/005;;C12N2310/121;;C12N15/1133;;C12N2310/111;;C12N2510/02;;C12N2710/16622,C12N15/113;;C07H21/02,536/23.1,0,0,,,,INACTIVE
604,DE,B,DE 1020330 B,010-038-319-243-466,1957-12-05,1957,DE P0015567 A,1956-01-28,US 1020330X A,1955-01-28,"Verfahren zur Herstellung von 4,9 (11)-Pregnadien-14,17,21-triol-3,20-dion und dessen 21-Estern",,PFIZER & CO C,BLOOM BARRY MALCOLM;;KITA DONALD ALBERT;;LAUBACH GERALD DAVID;;HEIGHT JACKSON;;SHULL GILBERT MALCOLM,,https://lens.org/010-038-319-243-466,Patent Application,no,0,0,1,1,0,C12P33/00,C12P33/00,,0,0,,,,DISCONTINUED
605,WO,A1,WO 2009/143523 A1,044-313-392-530-266,2009-11-26,2009,US 2009/0045182 W,2009-05-26,US 5550008 P,2008-05-23,INTERLEUKIN-21 RECEPTOR BINDING PROTEINS,"The present invention provides binding proteins and antigen-binding fragments thereof that specifically bind to the human interleukin-21 receptor (IL-21R). The binding proteins can act as, e.g., antagonists of IL-21R activity, thereby modulating immune responses in general, and those mediated by IL-21R in particular. The disclosed compositions and methods may be used, e.g., in diagnosing and/or treating IL-21R-associated disorders, e.g., inflammatory disorders, autoimmune diseases, allergies, transplant rejection, cancer, and other immune system disorders.",WYETH CORP;;MEDIMMUNE LTD;;BLOOM LAIRD;;GILL DAVINDER;;VUGMEYSTER YULIA;;YOUNG DEBORAH A;;LOWE DAVID;;VALGE-ARCHER VIIA,BLOOM LAIRD;;GILL DAVINDER;;VUGMEYSTER YULIA;;YOUNG DEBORAH A;;LOWE DAVID;;VALGE-ARCHER VIIA,,https://lens.org/044-313-392-530-266,Patent Application,yes,2,7,22,22,248,C07K14/54;;C07K16/2866;;C07K2317/21;;C07K2317/565;;C07K2317/622;;C07K2317/73;;C07K2317/732;;C07K2317/92;;C07K2317/52;;A61P29/00;;A61P37/06;;A61P37/08;;A61P43/00;;C07K14/54;;C07K2317/92;;C07K2317/732;;C07K2317/73;;C07K2317/565;;C07K16/2866;;C07K2317/622;;C07K2317/21;;C07K2317/52,C07K14/715;;C07K16/28,,0,0,,,,PENDING
606,US,A1,US 2007/0051377 A1,195-810-943-507-867,2007-03-08,2007,US 53181904 A,2004-11-12,US 51911403 P;;US 2004/0037867 W,2003-11-12,Cardiac valve annulus reduction system,"A catheter-based, annulus reduction device and system for cardiac valve repair and method of using the same. The system is usable for treating mitral valve regurgitation and comprises a catheter, a reduction ring carried within the catheter, the reduction ring including a plurality of exit ports formed in a side wall of the reduction ring and filament received in the reduction ring. The filament includes a plurality of radially extendible barbs corresponding to the sidewall openings. The reduction ring carrying the filament is deployed adjacent a mitral valve annulus and the filament is translated relative to the reduction ring to deploy the barbs through the exit ports and into the annulus and to further translate the reduction ring with deployed barbs to reshape the annulus.",MEDTRONIC VASCULAR INC,DOUK NAREAK;;RAFIEE NASSER;;BLOOM ELIOT;;FOGG DOUGLAS A;;HUYNH RANY;;BARONE DAVID D,MEDTRONIC VASCULAR INC (2005-05-31),https://lens.org/195-810-943-507-867,Patent Application,yes,23,352,6,6,0,A61B17/00234;;A61B17/0401;;A61B2017/00243;;A61B2017/00783;;A61B2017/0414;;A61B2017/0496;;A61B2017/06052;;A61B2017/06176;;A61F2/2445;;A61F2002/30545;;A61F2220/0016;;A61F2250/001;;A61F2/2445;;A61B17/00234;;A61B17/0401;;A61B2017/06052;;A61B2017/00243;;A61B2017/0496;;A61F2250/001;;A61B2017/0414;;A61F2220/0016;;A61F2002/30545;;A61B2017/06176;;A61B2017/00783,A61B19/00;;A61B17/00;;A61B17/04;;A61B17/06;;A61F2/04;;A61F2/24,128/897,0,0,,,,ACTIVE
607,WO,A2,WO 2005/046488 A2,199-169-530-829-82X,2005-05-26,2005,US 2004/0037867 W,2004-11-12,US 51911403 P,2003-11-12,CARDIAC VALVE ANNULUS REDUCTION SYSTEM,"A catheter-based, annulus reduction device and system (100, 200) for cardiac valve repair and method of using the same. The system is usable for treating mitral valve regurgitation and comprises a catheter (252), a reduction ring (220) carried within the catheter, the reduction ring including a plurality of exit ports (224) formed in a side wall of the reduction ring and filament (214) received in the reduction ring. The filament includes a plurality of radially extendible barbs (212) corresponding to the sidewall openings. The reduction ring carrying the filament is deployed adjacent a mitral valve annulus and the filament is translated relative to the reduction ring to deploy the barbs through the exit ports and into the annulus and to further translate the reduction ring with deployed barbs to reshape the annulus.",MEDTRONIC VASCULAR INC;;DOUK NAREAK;;RAFIEE NASSER;;BLOOM ELIOT;;FOGG DOUGLAS A;;HUYNH RANY;;BARONE DAVID D,DOUK NAREAK;;RAFIEE NASSER;;BLOOM ELIOT;;FOGG DOUGLAS A;;HUYNH RANY;;BARONE DAVID D,,https://lens.org/199-169-530-829-82X,Patent Application,yes,0,111,6,6,0,A61B17/00234;;A61B17/0401;;A61B2017/00243;;A61B2017/00783;;A61B2017/0414;;A61B2017/0496;;A61B2017/06052;;A61B2017/06176;;A61F2/2445;;A61F2002/30545;;A61F2220/0016;;A61F2250/001;;A61F2/2445;;A61B17/00234;;A61B17/0401;;A61B2017/06052;;A61B2017/00243;;A61B2017/0496;;A61F2250/001;;A61B2017/0414;;A61F2220/0016;;A61F2002/30545;;A61B2017/06176;;A61B2017/00783,A61B17/00;;A61B17/04;;A61B17/06;;A61F2/04;;A61F2/24,,0,0,,,,PENDING
608,US,A,US 5666551 A,191-879-255-114-146,1997-09-09,1997,US 59080296 A,1996-01-24,US 59080296 A;;US 27029794 A,1994-06-30,Distributed data bus sequencing for a system bus with separate address and data bus protocols,"A data bus sequencer for use by nodes coupled to a system bus for associating data transactions and address transactions on the bus. A mechanism for tracking address and command transactions occurring on the bus produces, for each address and command transaction occurring on the address bus, a corresponding sequence number tag. Those sequence number tags corresponding to address and command transactions for which data transactions are to be initiated by the node are stored by the data bus sequencer. The data bus sequencer further includes circuitry for counting the number of data transactions occurring on the data bus, comparing the counted number of data transactions to the stored sequence number tags and initiating data transactions on the data bus in response to the comparison.",DIGITAL EQUIPMENT CORP,FENWICK DAVID M;;FOLEY DENIS J;;VAN DOREN STEPHEN R;;HARTWELL DAVID W;;BLOOM ELBERT;;HETHERINGTON RICKY C,COMPAQ INFORMATION TECHNOLOGIES GROUP L.P (1999-12-09);;HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2002-10-01),https://lens.org/191-879-255-114-146,Granted Patent,yes,4,25,2,2,0,G06F11/076;;G06F13/4217;;G06F11/076;;G06F13/4217,G06F11/00;;G06F13/42,395/200.37;;395/287;;395/306;;395/309;;X364DIG  1;;364/240,0,0,,,,EXPIRED
609,US,B2,US 7001608 B2,077-777-973-333-570,2006-02-21,2006,US 18421002 A,2002-06-27,US 18421002 A;;US 30193401 P,2001-06-29,Artificial synapse chip interface for electronic prosthetic retina,The invention provides microfabricated devices and methods for directing the growth of a cell process to form an artificial synapse. The devices are called artificial synapse chips. The artificial synapse comprises a nanofabricated aperture (about 50–100 nm in size) that connects the cell process to a chemical or electrical means of neuronal excitation. Such an aperture width mimics the length scales of a natural synapse and thus emphasizes the localized spatial relationship between a neuron and a stimulation source. The invention further provides devices and methods for regenerating a nerve fiber into an electrode. The invention thus provides a regeneration electrode that uses a novel neural interface for stimulation and that uses novel surface methods for directing neuronal growth making possible in vivo connection of the devices to neural circuitry in a retina and other anatomical locations.,TRUSTEES OF THE LEALAND STANFO,FISHMAN HARVEY A;;BLUMENKRANZ MARK;;BENT STACEY F;;BLOOM DAVID M;;PETERMAN MARK C,BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY THE (2002-08-31),https://lens.org/077-777-973-333-570,Granted Patent,yes,6,48,15,15,0,A61N1/0543;;A61N1/326;;A61N1/36046;;C12M35/00;;C12M35/02;;C12M35/08;;C12N5/0619;;C12N2503/00;;C12N2535/10;;A61N1/36046;;A61N1/0543;;C12M35/00;;C12M35/02;;C12M35/08;;A61N1/326;;C12N5/0619;;C12N2503/00;;C12N2535/10,A61F2/14;;A61K9/22;;A61L27/00;;A61N1/05;;A61N1/36;;C12M1/42;;C12M3/00;;C12N5/0793,424/427;;623/4.1;;623/6.63;;623/24;;623/25;;623/26;;435/325;;435/395;;424/422,24,19,017-638-478-647-912;;057-870-761-641-441;;022-535-493-415-289;;031-293-709-625-208;;045-244-593-667-111;;049-543-795-239-305;;001-831-941-176-280;;000-117-437-031-635;;093-770-441-646-769;;013-254-993-069-450;;056-066-354-227-629;;039-712-372-889-64X;;000-409-659-443-429;;052-681-725-250-166;;046-961-728-035-33X;;064-942-415-563-86X;;049-325-662-859-361;;001-329-508-866-308;;030-546-208-614-902,10.1109/7333.918281;;11482368;;10.1021/la980037l;;9860180;;10.1163/156856298x00721;;10.1007/s004170050320;;10502058;;10646274;;10.1109/10.817614;;10541906;;10.1007/s004170050390;;11030816;;10.1001/archopht.118.10.1350;;10614941;;10.1016/s0142-9612(99)00164-7;;11011682;;10.1007/s004170000149;;10.1620/tjem.189.295;;10739165;;10.3109/00207459408986289;;8050852;;10.1016/s0925-4005(98)00071-9;;11248444;;10.1016/s0304-3940(01)01628-7;;10.1016/s0165-0270(98)00156-3;;10065993;;11324335;;10.1007/s004220000218;;9740002;;10.1002/(sici)1097-4636(199810)42:1<13::aid-jbm3>3.0.co;2-r;;9622516;;10.1021/bp980035r;;10.1016/s0168-9002(99)00445-3;;10.1002/1521-396x(200011)182:1<505::aid-pssa505>3.0.co;2-#,"""Circuit"" Merriam-Webster Online Dictionary http://www.m-w.com/cgi-bin/dictionary?book=Dictionary&va=circuit accessed Feb. 14, 2005.;;Chow et al, IEEE Transactions on Neural Systems and Rehabilitation Engineering, Mar. 2001, vol. 9, No. 1, pp. 86-95.;;Fishman et al, ARVO Annual Meeting Abstract Search and Program Planner, Abstract No. 2846, vol. 2002 from Annual Meeting of the Association For Research in Vision and Ophthalmology, Ft. Lauderdale, FL, May 5-10, 2002.;;Bernard, Andre et al. ""Printing Patterns of Proteins"" (1998) Langmuir, vol. 14, No. 9, pp. 2225-2229.;;L. Lu et al., ""Retinal pigment epithelium cell culture on thin biodegradable poly(DL-lactic-co-glycolic acid) films"", J. Biomater Science Edn. vol. 9, No. 11, pp. 1187-1205 (1998).;;T. Dintelmann et al., ""Comparative study of ROS degradation by IPE and RPE cells in vitro"", Graefe's Arch Clin. Exp. Opthamology 1999, No. 237, pp 830-839.;;C.D. James et al., ""Aligned Microcontact Printing of Micrometer-Scale Poly-L-Lysine Structures for Controlled Growth of cultured Neurons on Planar Microelectrode Arrays"", IEEE Transaction On Biomedical Engineering, vol. 47, No. 1, Jan. 2000, pp. 17-21.;;U. Hartmann et al., ""Human and porcine anterior lens capsule as support for growing and grafting retinal pigment epithelium and iris pigment epithelium"", Graefe's Arch Clin Exp Ophthalmology (1999), vol. 237, pp. 940-945.;;G. Thumann et al., Transplantation of Autologous Iris Pigment Epithelium After Removal of Choroidal Neovascular Membrances, Arch Ophthalomology (Oct. 2000), vol. 118, pp. 1350-1355.;;L. Lu et al., ""Retinal pigment epithelial cell function on substrates with chemically micopatterned surfaces"", Biomaterials (Dec. 1999), vol. 20, No. 23/24, pp. 2351-2361.;;A. Lappas et al., ""Clinical investigation: Iris pigment epithelial cell translocation in exudative age-related mascular degeneration, A pilot study in patents"", Graefe's Archive for clinical Experimental Ophthalmology, Abstract, vol. 238 issue, p. 1 and 2 electronic version, ISSN: 1435-702X, http://link.springer-ny.com/link/service/journals/00417/bibs/0238008/02380631.htm.;;Giordano et al., ""Retinal pigment epithelium cells cultured on synthetic biodegradable polymers"", (Abstract), http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&List<SUB>-</SUB>uids=897...6.;;T. Abe et al., ""Auto iris pigment epithelial cell transplantation in patients with age-related macular degeneration: short-term results"", (Abstract), http://www.n.../query.fcgi?cmd=Retrieve&dblist=PubMed&List<SUB>-</SUB>uids=10896035&dopt=Abstrac.;;T. Abe et al., ""Functional analysis after auto iris pigment epithelial cell transplantation in patients with age-related macular degeneration"", (Abstract), http://www.n.../query.fcgi?cmd=Retrieve&db=PubMed&List<SUB>-</SUB>uids=10739164&dopt=Abstrac.;;J. Nicolini et al., ""The anterior lens capsule used as support material in RPE cell-transplantation"", (Abstract), http://www.ncbi.nlm.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&List<SUB>-</SUB>uids=11C...7.;;Sandyk, R. ""Paroxysmal Itching in Multiple Sclerosis During Treatment with External Magnetic Fields"" (1994) Published in Int. J. Neurosci. 75(1-2): 65-71.;;Heuschkel, M.O. et al. Buried Microchannels in Photopolymer for Delivering of Solutions to Neurons in a Network. (1998) Published in Sensors and Actuators B 48: 356-361.;;Yeung, C.K. et al. ""Modulation of the Growth and Guidance of Rat Brain Stem Neurons Using Patterned Extracelluar Matrix Proteins."" (2001) Published in Neuroscience Letters 301: 147-150.;;Maher, Michael et al. ""The Neurochip: A New Multielectrode Device for Stimulating and Recording from Cultured Neurons"" (1999) Published in Journal of Neuroscience Methods 87: 45-56.;;Jenkner, Martin et al. ""Interfacning a Silicon Chip to Pairs of Smail Neurons Connected by Electrical Synapses"" (2001) Published in Biol. Cybern 84: 239-249.;;Seneinejad, Samar et al. ""Patterned Glass Surface Direct Cell Adhesion and Process Outgrowth of Primary Neurons of the Central Nervous System"" (1998) Published in J. Biomed. Mater. Res. 42: 13-19.;;Tai, Hsin-Chien et al. ""Neurite Outrgrowth and Growth Cone Morphology on Micropatterned Surfaces"" (1998) Published in Biotechnol. Prog. 14: 364-370.;;Litke, A.M. ""The Retinal Readout System: A Status Report"" (1999) Nuclear Instruments and Methods in Physics Research A 435: 242-249.;;Mayne, A.H. ""Biologically Interfaced Porous Silicon Devices"" (2000) Published in Phys. Stat. Sol. 182: 505-513.",EXPIRED
610,EP,A1,EP 2297199 A1,111-469-714-284-838,2011-03-23,2011,EP 09751751 A,2009-05-26,US 2009/0045182 W;;US 5550008 P,2008-05-23,INTERLEUKIN-21 RECEPTOR BINDING PROTEINS,,WYETH LLC;;MEDIMMUNE LTD,BLOOM LAIRD;;GILL DAVINDER;;VUGMEYSTER YULIA;;YOUNG DEBORAH A;;LOWE DAVID;;VALGE-ARCHER VIIA,,https://lens.org/111-469-714-284-838,Patent Application,yes,0,0,22,22,0,C07K14/54;;C07K16/2866;;C07K2317/21;;C07K2317/565;;C07K2317/622;;C07K2317/73;;C07K2317/732;;C07K2317/92;;C07K2317/52;;A61P29/00;;A61P37/06;;A61P37/08;;A61P43/00;;C07K14/54;;C07K2317/92;;C07K2317/732;;C07K2317/73;;C07K2317/565;;C07K16/2866;;C07K2317/622;;C07K2317/21;;C07K2317/52,C07K14/715;;C07K16/28,,0,0,,,,DISCONTINUED
611,TW,B,TW I432647 B,036-949-166-629-720,2014-04-01,2014,TW 95127808 A,2006-07-28,US 70404605 P;;US 74760406 P,2005-07-29,"Reciprocating piston pump with air valve, detent and poppets","A poppet assembly includes a poppet housing (41) having an axis and first and second sets of housing ports (41a, 41b), which are axially spaced. A poppet seat (44) is provided in the housing, the seat having a set of seat ports (44a), and a poppet (43) is also located in the housing and is retained by the seat. The poppet has a set of poppet ports (43a), is biased against the seat in a first position and can be moved to a second position away from the seat. A poppet actuator (45), which is located in the seat, partially surrounds the poppet and is biased away from the poppet. When the poppet is in its first position, the first set of housing ports (41b) are in fluid communication with the second set of housing ports (41a) through the poppet ports (43a), and when it is in its second position, the first set of housing ports (41b) are in fluid communication with the seat ports (44a).",GRACO MINNESOTA INC,BAUCK MARK L;;ISAIS JR;;WEINBERGER MARK T;;PITTMAN DAVID M;;BLOOM MICHAEL E,,https://lens.org/036-949-166-629-720,Granted Patent,no,0,0,28,28,0,F04B9/12;;F04B9/125;;F16K11/02;;F04B49/00;;F04B35/00;;F04B9/08;;F04B9/12;;F04B9/125;;F16K11/02,,,0,0,,,,INACTIVE
612,BR,A,BR 9916041 A,095-576-463-402-806,2001-12-04,2001,BR 9916041 A,1999-12-06,US 20831698 A;;US 9928844 W,1998-12-09,"Composto, composição farmacêutica, e, métodospara inibir a replicação de um vìrus do herpes epara tratar um paciente sofrendo de uma infecçãopor vìrus do herpes","""COMPOSTO, COMPOSIçãO FARMACêUTICA, E, MéTODOSPARA INIBIR A REPLICAçãO DE UM VìRUS DO HERPES EPARA TRATAR UM PACIENTE SOFRENDO DE UMA INFECçãOPOR VìRUS DO HERPES"". Em que R~ 1~-R~ 5~ sãoindependentemente selecionados dentre hidrogênio, alquila de 1 a6 átomos de carbono, alquenila de 2 a 6 átomos de carbono,alquinila de 2 a 6 átomos de carbono, per-haloalquila de 1 a 6átomos de carbono, cicloalquila de 3 a 10 átomos de carbono,heterocicloalquila de 3 a 10 membros de carbono, arila, heteroarila,halogênio, -CN, -NO~ 2~, -CO~ 2~R~ 6~, COR~ 6~, -OR~ 6~,-SR~ 6~, -SOR~ 6~, -SO~ 2~R~ 6~, -CONR~ 7~R~ 8~, -NR~6~N (R~ 7~R~ 8~), -N(R~ 7~R~ 8~) ou W-Y-(CH~ 2~)~ n~-Z,com a condição de que pelo menos um de R~ 1~-R~ 5~ não éhidrogênio; ou R~ 2~ e R~ 3~ ou R~ 3~ e R~ 4~, tomados juntos,formam uma heterocicloalquila de 3 a 7 membros ou heteroarila de3 a 7 membros; R~ 6~ e R~ 7~ são independentementehidrogênio, alquila de 1 a 6 átomos de carbono, perhaloalquila de 1a 6 átomos de carbono, ou arila; R~ 8~ é hidrogênio, alquila de 1 a6 átomos de carbono, per-haloalquila de 1 a 6 átomos de carbono,cicloalquila de 3 a 10 átomos de carbono, heterocicloalquila de 3 a10 membros, arila ou heteroarila, ou R~ 7~ e R~ 8~, tomadosjuntos, podem formar uma heterocicloalquila de 3 a 7 membros; R~9~-R~ 12~ são independentemente hidrogênio, alquila de 1 a 4átomos de carbono, per-haloalquila de 1 a 4 átomos de carbono,halogênio, alcoxi de 1 a 4 átomos de carbono, ou ciano, ou R~ 9~e R~ 10~ ou R~ 11~, e R~ 12~ podem ser tomados juntos paraformar arila de 5 a 7 átomos de carbono; W é 0, NR~ 6~ ou estáausente; Y é -(CO)-ou -(CO~ 2~)-, ou está ausente; Z é alquila de 1a 4 átomos de carbono, -CN, -CO~ 2~R~ 6~, -COR~ 6~, CONR~7~R~ 8~, -OCOR~ 6~, -NR~ 6~COR~ 7~, -OCONR~ 6~, -OR~6~, -SOR~ 6~, -SO~ 2~ R~ 6~, SR~ 6~N(R~ 7~R~ 8~), -N (R~7~R~ 8~) ou fenila; G é alquila de 1 a 6 átomos de carbono, X éuma ligação, -NH, alquila de 1 a 6 átomos de carbono, alquenila de1 a 6 átomos de carbono, alcoxi de 1 a 6 átomos de carbono,tioalquila de 1 a 6 átomos de carbono, alquilamino de 1 a 6 átomosde carbono, ou (CH)J; J é alquila de 1 a 6 átomos de carbono,cicloalquila de 3 a 7 átomos de carbono, fenila ou benzila; e n é uminteiro de 1 a 6; ou sais 1 farmacêuticos dos mesmos, sãoutilizáveis no tratamento de doenças associadas com vírus doherpes incluindo citomegalovírus humano, vírus de herpes simplex,vírus Epstein-Barr, vírus de varicella-zoster, vírus de herpeshumano 6 e 7, e vírus de herpes de Kaposi.",AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;GEORGEDUSHIN RUSSELL;;LANG STANLEY ALBERT;;O'HARA BRYAN MARK,,https://lens.org/095-576-463-402-806,Patent Application,no,0,0,18,18,0,C07C335/20;;C07C335/22;;C07D207/09;;C07D207/14;;C07D211/58;;C07D261/10;;A61P31/22,C07D249/04;;A61K31/17;;A61K31/341;;A61K31/343;;A61K31/345;;A61K31/36;;A61K31/381;;A61K31/40;;A61K31/403;;A61K31/4192;;A61K31/42;;A61K31/433;;A61K31/437;;A61K31/4409;;A61K31/4468;;A61K31/47;;A61K31/4965;;A61K31/5375;;A61K31/56;;A61P31/22;;C07C335/20;;C07C335/22;;C07C337/06;;C07D207/09;;C07D207/14;;C07D207/34;;C07D209/48;;C07D211/58;;C07D213/81;;C07D215/48;;C07D217/26;;C07D221/12;;C07D241/24;;C07D261/08;;C07D261/10;;C07D265/30;;C07D285/06;;C07D295/12;;C07D307/56;;C07D307/73;;C07D307/85;;C07D317/68;;C07D333/38;;C07D333/70,,0,0,,,,DISCONTINUED
613,CL,A1,CL 2009001284 A1,150-685-700-940-292,2009-11-27,2009,CL 2009001284 A,2009-05-25,US 5550008 P,2008-05-23,Anticuerpos o fragmentos de union a antigeno del mismo que se unen a il-21r; composicion farmaceutica que lo comprende; acidos nucleicos codificantes; vectores de expresion y celulas huesped aisladas; kit de diagnostico que comprende a dichos anticuerpos,Proteína o fragmento de unión a antígeno que se une a il-21r; secuencia aminoacidica; composición farmacéutica que comprende dicha proteína o fragmento; ácido nucleico que codifica dicha proteína o fragmento; vector de expresión que comprende el ácido nucleico; célula huésped transformada; kit de diagnóstico.,WYETH CORP;;MEDIMMUNE LTD,VUGMEYSTER YULIA;;BLOOM LAIRD;;GILL DAVINDER;;YOUNG DEBORAH A;;LOWE DAVID;;VALGE-ARCHER VIIA,,https://lens.org/150-685-700-940-292,Patent Application,no,0,0,22,22,0,C07K14/54;;C07K16/2866;;C07K2317/21;;C07K2317/565;;C07K2317/622;;C07K2317/73;;C07K2317/732;;C07K2317/92;;C07K2317/52;;A61P29/00;;A61P37/06;;A61P37/08;;A61P43/00;;C07K14/54;;C07K2317/92;;C07K2317/732;;C07K2317/73;;C07K2317/565;;C07K16/2866;;C07K2317/622;;C07K2317/21;;C07K2317/52,C07K14/435;;C07K16/28;;C12N15/13,,0,0,,,,PENDING
614,US,A1,US 2012/0264919 A1,172-879-199-766-019,2012-10-18,2012,US 201213453090 A,2012-04-23,US 201213453090 A;;US 47220909 A;;US 5550008 P,2008-05-23,INTERLEUKIN-21 RECEPTOR BINDING PROTEINS,"The present invention provides binding proteins and antigen-binding fragments thereof that specifically bind to the human interleukin-21 receptor (IL-21R). The binding proteins can act as, e.g., antagonists of IL-21R activity, thereby modulating immune responses in general, and those mediated by IL-21R in particular. The disclosed compositions and methods may be used, e.g., in diagnosing and/or treating IL-21R-associated disorders, e.g., inflammatory disorders, autoimmune diseases, allergies, transplant rejection, cancer, and other immune system disorders.",BLOOM LAIRD;;GILL DAVINDER;;VUGMEYSTER YULIA;;YOUNG DEBORAH A;;LOWE DAVID;;VALGE-ARCHER VIIA;;MEDIMMUNE LTD;;WYETH LLC,BLOOM LAIRD;;GILL DAVINDER;;VUGMEYSTER YULIA;;YOUNG DEBORAH A;;LOWE DAVID;;VALGE-ARCHER VIIA,,https://lens.org/172-879-199-766-019,Patent Application,yes,0,0,22,22,248,C07K14/54;;C07K16/2866;;C07K2317/21;;C07K2317/565;;C07K2317/622;;C07K2317/73;;C07K2317/732;;C07K2317/92;;C07K2317/52;;A61P29/00;;A61P37/06;;A61P37/08;;A61P43/00;;C07K14/54;;C07K2317/92;;C07K2317/732;;C07K2317/73;;C07K2317/565;;C07K16/2866;;C07K2317/622;;C07K2317/21;;C07K2317/52,C07K16/28;;C12N1/19;;C12N1/21;;C12N5/10;;C12N15/13;;C12N15/63,530/387.9;;536/23.53;;435/320.1;;435/331;;435/252.3;;435/254.2;;435/419,0,0,,,,DISCONTINUED
615,CN,A,CN 102105491 A,036-648-457-631-864,2011-06-22,2011,CN 200980128968 A,2009-05-26,US 2009/0045182 W;;US 5550008 P,2008-05-23,Interleukin-21 receptor binding proteins,"The present invention provides binding proteins and antigen-binding fragments thereof that specifically bind to the human interleukin-21 receptor (IL-21R). The binding proteins can act as, e.g., antagonists of IL-21R activity, thereby modulating immune responses in general, and those mediated by IL-21R in particular. The disclosed compositions and methods may be used, e.g., in diagnosing and/or treating IL-21R-associated disorders, e.g., inflammatory disorders, autoimmune diseases, allergies, transplant rejection, cancer, and other immune system disorders.",WYETH CORP;;MEDIMMUNE LTD,LAIRD BLOOM;;DAVINDER GILL;;YULIA VUGMEYSTER;;YOUNG DEBORAH A;;DAVID LOWE;;VIIA VALGE-ARCHER,,https://lens.org/036-648-457-631-864,Patent Application,no,4,0,22,22,0,C07K14/54;;C07K16/2866;;C07K2317/21;;C07K2317/565;;C07K2317/622;;C07K2317/73;;C07K2317/732;;C07K2317/92;;C07K2317/52;;A61P29/00;;A61P37/06;;A61P37/08;;A61P43/00;;C07K14/54;;C07K2317/92;;C07K2317/732;;C07K2317/73;;C07K2317/565;;C07K16/2866;;C07K2317/622;;C07K2317/21;;C07K2317/52,C07K14/715;;C07K16/28,,1,0,,,"孙稳平: ""白细胞介素21及其研究进展"", 《动物医学进展》",DISCONTINUED
616,AU,A1,AU 2009/248809 A1,084-720-354-151-280,2009-11-26,2009,AU 2009/248809 A,2009-05-26,US 5550008 P;;US 2009/0045182 W,2008-05-23,Interleukin-21 receptor binding proteins,,MEDIMMUNE LTD;;WYETH LLC,LOWE DAVID;;VUGMEYSTER YULIA;;YOUNG DEBORAH A;;VALGE-ARCHER VIIA;;GILL DAVINDER;;BLOOM LAIRD,,https://lens.org/084-720-354-151-280,Patent Application,no,0,0,22,22,0,C07K14/54;;C07K16/2866;;C07K2317/21;;C07K2317/565;;C07K2317/622;;C07K2317/73;;C07K2317/732;;C07K2317/92;;C07K2317/52;;A61P29/00;;A61P37/06;;A61P37/08;;A61P43/00;;C07K14/54;;C07K2317/92;;C07K2317/732;;C07K2317/73;;C07K2317/565;;C07K16/2866;;C07K2317/622;;C07K2317/21;;C07K2317/52,C07K14/715;;C07K16/28,,0,0,,,,DISCONTINUED
617,US,B2,US 7335763 B2,103-560-374-178-525,2008-02-26,2008,US 80804204 A,2004-03-24,US 80804204 A;;US 45727903 P,2003-03-25,Herpesvirus ribozymes and vectors,"Hammerhead ribozymes that target components critical to HSV replication (ICP4, UL20, UL30, and UL54) were synthesized and shown to efficiently cleave target RNA encoding a portion of these components in in vitro assays. Several cloned cell lines stably expressing these ribozymes were established. HSV-mediated plaque formation was dramatically reduced in cells stably transfected with an anti-HSV ribozyme compared to non-transfected cells.",UNIV FLORIDA,LEWIN ALFRED SAMUEL;;BLOOM DAVID CLAIR;;SCHULTZ GREGORY SCOTT;;TULI SONAL SANJEEN;;LIU JIA,FLORIDA RESEARCH FOUNDATION INC. UNIVERSITY OF (2006-04-14),https://lens.org/103-560-374-178-525,Granted Patent,yes,3,0,2,6,18,C07K14/005;;C12N2510/02;;C12N2710/16622;;C07K14/005;;C12N2710/16622;;C12N2510/02,C07H21/04,536/24.5,0,0,,,,ACTIVE
618,SA,B1,SA 109300315 B1,176-549-893-071-587,2012-08-28,2012,SA 109300315 A,2009-05-23,US 5550008 P,2008-05-23,INTERLEUKIN - 21 RECEPTOR BINDING PROTEINS,الملخص: يتعلق الاختراع الحالي بتوفير proteins ارتباط وأجزاء ارتباط مولد مضاد (antigen) منه الذي يرتبط بصفة خاصة مع مستقبل interleukin‑21 الآدمي (IL‑21R). تعمل proteins الارتباط، مثلا، كمضادات نشاط IL-21R، مما يساعد على تنظيم الاستجابات المناعية (immune responses)، بصفة عامة وتحديدا الاستجابات المحثة بواسطة IL-21R. يمكن استخدام التركيبات والطرق الموضحة، مثلا، في علاج و/أو تشخيص اضطرابات تصاحب IL‑21R، مثل، الاضطرابات الالتهابية، أمراض المناعة الذاتية، الحساسية، رفض الازدراع، السرطان، واضطرابات الجهاز المناعي الأخرى.,MEDLMMUNE LTD;;WYETH CORP,LAIRD BLOOM;;DAVINDER GILL;;YULIA VUGMEYSTER;;A YOUNG DEBORAH;;DAVID LOWE;;VIIA BALGE -ARCHER,,https://lens.org/176-549-893-071-587,Granted Patent,no,0,0,22,22,0,C07K14/54;;C07K16/2866;;C07K2317/21;;C07K2317/565;;C07K2317/622;;C07K2317/73;;C07K2317/732;;C07K2317/92;;C07K2317/52;;A61P29/00;;A61P37/06;;A61P37/08;;A61P43/00;;C07K14/54;;C07K2317/92;;C07K2317/732;;C07K2317/73;;C07K2317/565;;C07K16/2866;;C07K2317/622;;C07K2317/21;;C07K2317/52,,,0,0,,,,ACTIVE
619,US,B2,US 8163884 B2,172-455-858-223-888,2012-04-24,2012,US 47220909 A,2009-05-26,US 47220909 A;;US 5550008 P,2008-05-23,Interleukin-21 receptor binding proteins,"The present invention provides binding proteins and antigen-binding fragments thereof that specifically bind to the human interleukin-21 receptor (IL-21R). The binding proteins can act as, e.g., antagonists of IL-21R activity, thereby modulating immune responses in general, and those mediated by IL-21R in particular. The disclosed compositions and methods may be used, e.g., in diagnosing and/or treating IL-21R-associated disorders, e.g., inflammatory disorders, autoimmune diseases, allergies, transplant rejection, cancer, and other immune system disorders.",BLOOM LAIRD;;GILL DAVINDER;;VUGMEYSTER YULIA;;YOUNG DEBORAH A;;LOWE DAVID;;VALGE-ARCHER VIIA;;WYETH LLC;;MEDIMMUNE LTD,BLOOM LAIRD;;GILL DAVINDER;;VUGMEYSTER YULIA;;YOUNG DEBORAH A;;LOWE DAVID;;VALGE-ARCHER VIIA,MEDIMMUNE LIMITED (2010-02-24);;WYETH (2009-08-28),https://lens.org/172-455-858-223-888,Granted Patent,yes,25,0,22,22,248,C07K14/54;;C07K16/2866;;C07K2317/21;;C07K2317/565;;C07K2317/622;;C07K2317/73;;C07K2317/732;;C07K2317/92;;C07K2317/52;;A61P29/00;;A61P37/06;;A61P37/08;;A61P43/00;;C07K14/54;;C07K2317/92;;C07K2317/732;;C07K2317/73;;C07K2317/565;;C07K16/2866;;C07K2317/622;;C07K2317/21;;C07K2317/52,C07K16/28;;A61K39/00;;A61K39/395;;C12P21/02,530/387.9;;530/388.23;;530/389.2;;530/391.3;;424/139.1;;424/143.1;;435/69.1;;536/23.5,26,20,045-942-104-775-903;;000-600-847-247-981;;113-312-037-752-557;;006-915-320-541-273;;000-846-762-321-716;;081-714-876-868-721;;000-187-846-822-036;;069-658-664-429-198;;020-543-089-488-192;;040-589-760-023-703;;012-563-552-099-390;;056-313-508-135-31X;;034-605-117-022-20X;;038-524-253-028-017;;111-799-486-928-874;;020-239-342-947-756;;052-786-164-188-577;;028-267-246-750-311;;019-906-978-737-464;;002-584-557-858-587,12850000;;10.1016/s0006-291x(03)01131-8;;10.1016/s0014-5793(02)03254-4;;12297282;;10.1016/1043-4666(93)90047-9;;8392875;;10.1016/s1074-7613(02)00295-9;;10.3410/f.1006586.82161;;11970879;;15084263;;10.1016/s0092-8674(04)00335-6;;10.1038/nri1688;;16138102;;16621990;;10.4049/jimmunol.176.9.5247;;11846609;;10.1006/meth.2001.1262;;10.1073/pnas.200360997;;pmc17218;;11016959;;10.4049/jimmunol.173.9.5361;;15494482;;10.1038/35040504;;11081504;;10.1016/j.cellimm.2006.07.011;;16979605;;15147560;;10.1111/j.1365-2567.2004.01886.x;;pmc1782493;;10.3410/f.1089413.542647;;10.4049/jimmunol.179.5.3325;;17709549;;10.1056/nejmoa063842;;16908486;;15728477;;10.4049/jimmunol.174.5.2696;;10.1172/jci119110;;8981930;;pmc507749;;11418623;;10.4049/jimmunol.167.1.1;;011418623;;12429707;;10.1189/jlb.72.5.856;;11526908;;10.1016/s1389-0352(01)00021-6,"Paul, Fundamental Immunology, 3rd Edition, 1993, pp. 292-295, under the heading ""Fv Structure and Diversity in Three Dimensions"").;;Casset et al, Biochemical and Biophysical Research Communications, 2003; vol. 307, pp. 198-205.;;Asano et al. (2002), ""Antitumor Activity of Interleukin-21 Prepared by Novel Refolding Procedure from Inclusion Bodies Expressed in Escherichia coli,"" FEBS Lett. 528:70-6.;;Cosman, David (1993) ""The Hematopoietin Receptor Superfamily,"" Cytokine 5:95-106.;;Kasaian et al. (2002), ""IL-21 Limits NK Cell Responses and Promotes Antigen-Specific T Cell Activation: A Mediator of the Transition from Innate to Adaptive Immunity"", Immunity 16:559-69.;;King et al. (2004), ""Homeostatic Expansion of T Cells During Immune Insufficiency Generates Autoimmunity,"" Cell 117:265-77.;;Leonard and Spolski (2005), ""Interleukin-21: A Modulator of Lymphoid Proliferation, Apoptosis and Differentiation,"" Nat. Rev. Immunol. 5:688-98.;;Liu et al. (2006), ""Autoreactive T Cells Mediate NK Cell Degeneration in Autoimmune Disease,"" J. Immunol. 176:5247-54.;;Livak and Schmittgen (2001), ""Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2(-Delta Delta C(T)) Method,"" Methods 25:402-08.;;Ozaki et al. (2000), ""Cloning of a Type I Cytokine Receptor Most Related to the IL-2 Receptorbeta Chain"", Proc. Natl. Acad. Sci. U.S.A. 97:11439-44.;;Ozaki et al. (2004), ""Regulation of B Cell Differentiation and Plasma Cell Generation by IL-21, a Novel Inducer of Blimp-1 and Bcl-6"", J. Immunol. 173:5361-71.;;Parrish-Novak et al. (2000), ""Interleukin 21 and Its Receptor Are Involved in NK Cell Expansion and Regulation of Lymphocyte Function"", Nature 408:57-63.;;Shang et al. (2006), ""IgE isotype switch and IgE production are enhanced in IL-21-deficient but not IFN-gamma-deficient mice in a Th2-biased response,"" Cell. Immunol. 241:66-74.;;Sivakumar et al. (2004), ""Interleukin-21 is a T-helper cytokine that regulates humoral immunity and cell-mediated anti-tumor responses,"" Immunology 112:177-82.;;Stebbings et al. (2007), ""'Cytokine Storm'"" in the Phase I Trial of Monoclonal Antibody TGN1412: Better Understanding the Causes to Improve PreClinical Testing of Immunotherapeutics, J. Immunol. 179(5):3325-31.;;Suntharalingam et al. (2006), ""Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412,"" N. Engl. J. Med. 355:1018-28.;;Vollmer et al. (2005), ""Differential Effects of IL-21 during Initiation and Progression of Autoimmunity against Neuroantigen,"" J. Immunol. 174:2696-2701.;;Wing, et al. (1996), ""Mechanism of First-Dose Cytokine-Release Syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11A/CD18 (LFA-1) on NK Cells, ""J. Clin. Invest. 98:2819-26.;;Asao et al. (2001), ""Cutting Edge: The Common gamma-Chain is an Indispensable Subunit of the IL-21 Receptor Complex,"" J. Immunol., 167:1-5.;;Parrish-Novak et al. (2002), ""Interleukin-21 and the IL-21 Receptor: Novel Effectors of NK and T Cell Responses"" J. Leukoc. Biol. 72:856-63.;;Muyldermans (2001), ""Single Domain Camel Antibodies: Current Status,"" Rev. Mol. Biotechnol. 74:277-302.;;International Preliminary Report on Patentability and Written Opinion of the International Searching Authority, with transmittal, issued in Applicants' corresponding International Application No. PCT/US2009/045182, mailed Dec. 2, 2010, 6 pp.;;Communication Pursuant to Rules 161(1) and 162 EPC, issued in Applicants' corresponding EPO Application No. 09751751.0, dated Jan. 28, 2011, 2 pp.;;Examination Report, issued in Applicants' corresponding New Zealand Application No. 589330, dated Apr. 11, 2011, 2 pp.;;International Preliminary Report on Patentability and Written Opinion of the International Searching Authority, with transmittal, issued in Applicants' related International Application No. PCT/US2009/045188, mailed Dec. 2, 2010, 7 pp.;;Communication Pursuant to Rules 161(1) and 162 EPC, issued in Applicants' related EPO Application No. 09751754.4, dated Jan. 28, 2011, 2 pp.",INACTIVE
620,MX,A,MX 2010012811 A,011-255-817-669-774,2011-05-19,2011,MX 2010012811 A,2009-05-26,US 5550008 P;;US 2009/0045182 W,2008-05-23,INTERLEUKIN-21 RECEPTOR BINDING PROTEINS.,"The present invention provides binding proteins and antigen-binding fragments thereof that specifically bind to the human interleukin-21 receptor (IL-21R). The binding proteins can act as, e.g., antagonists of IL-21R activity, thereby modulating immune responses in general, and those mediated by IL-21R in particular. The disclosed compositions and methods may be used, e.g., in diagnosing and/or treating IL-21R-associated disorders, e.g., inflammatory disorders, autoimmune diseases, allergies, transplant rejection, cancer, and other immune system disorders.",WYETH LLC,YOUNG DEBORAH A;;GILL DAVINDER;;BLOOM LAIRD;;VUGMEYSTER YULIA;;LOWE DAVID;;VALGE-ARCHER VIIA,,https://lens.org/011-255-817-669-774,Patent Application,no,0,0,22,22,0,C07K14/54;;C07K16/2866;;C07K2317/21;;C07K2317/565;;C07K2317/622;;C07K2317/73;;C07K2317/732;;C07K2317/92;;C07K2317/52;;A61P29/00;;A61P37/06;;A61P37/08;;A61P43/00;;C07K14/54;;C07K2317/92;;C07K2317/732;;C07K2317/73;;C07K2317/565;;C07K16/2866;;C07K2317/622;;C07K2317/21;;C07K2317/52,C07K14/715;;C07K16/28,,0,0,,,,ACTIVE
621,ZA,B,ZA 201008335 B,134-334-228-936-876,2014-04-30,2014,ZA 201008335 A,2010-11-19,US 5550008 P;;US 2009/0045182 W,2008-05-23,INTERLEUKIN-21 RECEPTOR BINDING PROTEINS,,WYETH LLC;;MEDIMMUNE LTD,BLOOM LAIRD;;GILL DAVINDER;;VUGMEYSTER YULIA;;YOUNG DEBORAH A;;LOWE DAVID;;VALGE-ARCHER VIIA,,https://lens.org/134-334-228-936-876,Granted Patent,no,0,0,22,22,0,C07K14/54;;C07K16/2866;;C07K2317/21;;C07K2317/565;;C07K2317/622;;C07K2317/73;;C07K2317/732;;C07K2317/92;;C07K2317/52;;A61P29/00;;A61P37/06;;A61P37/08;;A61P43/00;;C07K14/54;;C07K2317/92;;C07K2317/732;;C07K2317/73;;C07K2317/565;;C07K16/2866;;C07K2317/622;;C07K2317/21;;C07K2317/52,C07K/,,0,0,,,,ACTIVE
622,MY,A,MY 149448 A,148-890-305-602-040,2013-08-30,2013,MY PI20105509 A,2009-05-26,US 5550008 P,2008-05-23,INTERLEUKIN-21 RECEPTOR BINDING PROTEINS,"THE PRESENT INVENTION PROVIDES BINDING PROTEINS AND ANTIGEN-BINDING FRAGMENTS THEREOF THAT SPECIFICALLY BIND TO THE HUMAN INTERLEUKIN-21 RECEPTOR (IL-21 R). THE BINDING PROTEINS CAN ACT AS, E.G., ANTAGONISTS OF IL-21R ACTIVITY, THEREBY MODULATING IMMUNE RESPONSES IN GENERAL, AND THOSE MEDIATED BY IL-21R IN PARTICULAR. THE DISCLOSED COMPOSITIONS AND METHODS MAY BE USED, E.G., IN DIAGNOSING AND/OR TREATING IL-21R-ASSOCIATED DISORDERS, E.G., INFLAMMATORY DISORDERS, AUTOIMMUNE DISEASES, ALLERGIES, TRANSPLANT REJECTION, CANCER, AND OTHER IMMUNE SYSTEM DISORDERS.",WYETH LLC;;MEDIMMUNE LTD,LAIRD BLOOM;;DAVINDER GILL;;YULIA VUGMEYSTER;;YOUNG DEBORAH A;;DAVID LOWE;;VIIA VALGE-ARCHER,,https://lens.org/148-890-305-602-040,Granted Patent,no,0,0,22,22,0,C07K14/54;;C07K16/2866;;C07K2317/21;;C07K2317/565;;C07K2317/622;;C07K2317/73;;C07K2317/732;;C07K2317/92;;C07K2317/52;;A61P29/00;;A61P37/06;;A61P37/08;;A61P43/00;;C07K14/54;;C07K2317/92;;C07K2317/732;;C07K2317/73;;C07K2317/565;;C07K16/2866;;C07K2317/622;;C07K2317/21;;C07K2317/52,C07K16/28,,0,0,,,,ACTIVE
623,ZA,B,ZA 913366 B,121-738-610-466-368,1992-03-25,1992,ZA 913366 A,1991-05-03,US 51919290 A,1990-05-04,"SUBSTITUTED 5-(2-((2-ARYL-2-HYDROXYETHYL)AMINO)PROPYL)-1,3-BENZODIOXOLES","The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.",AMERICAN CYANAMID CO,THOMAS HARRISON CLAUS;;DOLAN JO ALENE;;CLAUS THOMAS HARRISON;;BLOOM JONATHAN DAVID;;VERN GORDON DEVRIES;;JO ALENE DOLAN;;JONATHAN DAVID BLOOM;;DEVRIES VERN GORDON;;DUTIA MINU DHANJISHA;;MINU DHANJISHA DUTIA,,https://lens.org/121-738-610-466-368,Granted Patent,no,0,0,40,44,0,C07D317/46;;C07D413/06;;A61P3/10;;A61P3/04;;A61P3/08;;C07D317/46;;C07D413/06;;C07D317/46,A61K31/335;;A61K31/357;;A61K31/36;;A61K31/42;;A23K1/16;;A61P3/04;;A61P3/08;;A61P3/10;;C07D263/04;;C07D291/04;;C07D317/46;;C07D317/58;;C07D317/62;;C07D405/06;;C07D413/06;;C07D419/06,,0,0,,,,EXPIRED
624,CA,A1,CA 2724915 A1,116-220-009-743-515,2009-11-26,2009,CA 2724915 A,2009-05-26,US 5550008 P;;US 2009/0045182 W,2008-05-23,INTERLEUKIN-21 RECEPTOR BINDING PROTEINS,"The present invention provides binding proteins and antigen-binding fragments thereof that specifically bind to the human interleukin-21 receptor (IL-21R). The binding proteins can act as, e.g., antagonists of IL-21R activity, thereby modulating immune responses in general, and those mediated by IL-21R in particular. The disclosed compositions and methods may be used, e.g., in diagnosing and/or treating IL-21R-associated disorders, e.g., inflammatory disorders, autoimmune diseases, allergies, transplant rejection, cancer, and other immune system disorders.",WYETH LLC;;MEDIMMUNE LTD,BLOOM LAIRD;;GILL DAVINDER;;VUGMEYSTER YULIA;;YOUNG DEBORAH A;;LOWE DAVID;;VALGE-ARCHER VIIA,,https://lens.org/116-220-009-743-515,Patent Application,no,0,0,22,22,248,C07K14/54;;C07K16/2866;;C07K2317/21;;C07K2317/565;;C07K2317/622;;C07K2317/73;;C07K2317/732;;C07K2317/92;;C07K2317/52;;A61P29/00;;A61P37/06;;A61P37/08;;A61P43/00;;C07K14/54;;C07K2317/92;;C07K2317/732;;C07K2317/73;;C07K2317/565;;C07K16/2866;;C07K2317/622;;C07K2317/21;;C07K2317/52,C07K14/715;;C07K16/28,,0,0,,,,DISCONTINUED
625,US,A1,US 2016/0320441 A1,152-247-478-118-005,2016-11-03,2016,US 201514837641 A,2015-08-27,US 201514837641 A;;US 201562154879 P,2015-04-30,DETECTION OF ECU GROUND FAULT WITH CAN BUS VOLTAGE MEASUREMENTS,A method is disclosed for detecting ground faults in a communications system. The method includes measuring a predetermined number of voltage points; determining if the measured voltage points represent recessive or dominant bits; identifying which of the predetermined number of voltage points represent inter-frame bits and which represent frame data bits based on whether the measured voltage points are recessive or dominant; calculating a maximum average voltage for the inter-frame bits; calculating an average frame voltage for all dominant bits within a frame; determining a high average dominant voltage count based on a number of frames for which the average frame voltage is greater than a high voltage threshold; and determining if a ground fault exists based on the average frame voltage and the high average dominant voltage count.,GM GLOBAL TECH OPERATIONS LLC,DU XINYU;;JIANG SHENGBING;;NAGOSE ATUL;;GUMPERT DAVID B;;BLOOM AARON B;;NINER ROD,GM GLOBAL TECHNOLOGY OPERATIONS LLC (2015-08-26),https://lens.org/152-247-478-118-005,Patent Application,yes,6,16,6,6,0,G01R31/50;;G01R31/52;;G01R31/52;;G01R19/00;;G01R19/003;;G01R19/0084;;G01R19/2503;;G01R31/007;;G01R31/007;;G01R31/083;;H04L1/24,G01R31/08;;G01R31/02,,0,0,,,,ACTIVE
626,US,A1,US 2006/0116340 A1,089-524-782-905-708,2006-06-01,2006,US 80804204 A,2004-03-24,US 80804204 A;;US 45727903 P,2003-03-25,Herpesvirus ribozymes and vectors,"Hammerhead ribozymes that target components critical to HSV replication (ICP4, UL20, UL30, and UL54) were synthesized and shown to efficiently cleave target RNA encoding a portion of these components in in vitro assays. Several cloned cell lines stably expressing these ribozymes were established. HSV-mediated plaque formation was dramatically reduced in cells stably transfected with an anti-HSV ribozyme compared to non-transfected cells.",LEWIN ALFRED S;;BLOOM DAVID C;;SCHULTZ GREGORY S;;TULI SONAL S;;LIU JIA,LEWIN ALFRED S;;BLOOM DAVID C;;SCHULTZ GREGORY S;;TULI SONAL S;;LIU JIA,FLORIDA RESEARCH FOUNDATION INC. UNIVERSITY OF (2006-04-14),https://lens.org/089-524-782-905-708,Patent Application,yes,2,8,2,6,18,C07K14/005;;C12N2510/02;;C12N2710/16622;;C07K14/005;;C12N2710/16622;;C12N2510/02,A61K48/00;;C07H21/02;;C12N5/06,514/44;;536/23.1;;435/325,0,0,,,,ACTIVE
627,US,A,US 6076129 A,164-689-733-184-776,2000-06-13,2000,US 86961097 A,1997-06-06,US 86961097 A;;US 59080296 A;;US 27029794 A,1994-06-30,Distributed data bus sequencing for a system bus with separate address and data bus protocols,"A data bus sequencer for use by nodes coupled to a system bus for associating data transactions and address transactions on the bus. The data bus sequencer includes means for tracking address and command transactions occurring on an address bus, the means for tracking producing a sequence number tag corresponding to each address and command transaction occurring on the address bus. Means for associating data transactions with address and command transactions stores the sequence number tags corresponding to address and command transactions for which data transactions are to be initiated by the node. Further included are means for tracking data transactions occurring on a data bus, means for comparing tracked data transactions to associated data transactions, and means for initiating data transactions on the data bus in response to the comparison. The data bus sequencer further includes means for driving the sequence tag for an address and command transaction to which a data transaction is associated on the data bus. Consistency check means includes means for tracking data transactions occurring on a data bus, and means for comparing tracked data transactions to sequence number tags driven on the data bus. The consistency check means indicates an error condition in response to the comparison if the sequence number tag most recently driven on the data bus is not equal to the counted number of data transactions which have occurred on the data bus.",DIGITAL EQUIPMENT CORP,FENWICK DAVID M;;FOLEY DENIS J;;VAN DOREN STEPHEN R;;HARTWELL DAVID W;;BLOOM ELBERT;;HETHERINGTON RICKY C,COMPAQ INFORMATION TECHNOLOGIES GROUP L.P (1999-12-09);;HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2002-10-01),https://lens.org/164-689-733-184-776,Granted Patent,yes,4,20,2,2,0,G06F11/076;;G06F13/4217;;G06F11/076;;G06F13/4217,G06F11/00;;G06F13/42,710/129;;709/253;;709/237;;714/47;;710/126,0,0,,,,EXPIRED
628,KR,A,KR 20110040773 A,025-541-903-331-353,2011-04-20,2011,KR 20107028877 A,2009-05-26,US 5550008 P,2008-05-23,INTERLEUKIN-21 RECEPTOR BINDING PROTEINS,,WYETH LLC;;MEDIMMUNE LTD,BLOOM LAIRD;;GILL DAVINDER;;VUGMEYSTER YULIA;;YOUNG DEBORAH A;;LOWE DAVID;;VALGE ARCHER VIIA,,https://lens.org/025-541-903-331-353,Patent Application,no,0,0,22,22,496,C07K14/54;;C07K16/2866;;C07K2317/21;;C07K2317/565;;C07K2317/622;;C07K2317/73;;C07K2317/732;;C07K2317/92;;C07K2317/52;;A61P29/00;;A61P37/06;;A61P37/08;;A61P43/00;;C07K14/54;;C07K2317/92;;C07K2317/732;;C07K2317/73;;C07K2317/565;;C07K16/2866;;C07K2317/622;;C07K2317/21;;C07K2317/52,C07K16/28;;C12N15/13;;G01N33/68,,0,0,,,,DISCONTINUED
629,US,B2,US 7655040 B2,032-750-346-091-469,2010-02-02,2010,US 53181904 A,2004-11-12,US 51911403 P;;US 2004/0037867 W,2003-11-12,Cardiac valve annulus reduction system,"A catheter-based, annulus reduction device and system for cardiac valve repair and method of using the same. The system is usable for treating mitral valve regurgitation and comprises a catheter, a reduction ring carried within the catheter, the reduction ring including a plurality of exit ports formed in a side wall of the reduction ring and filament received in the reduction ring. The filament includes a plurality of radially extendible barbs corresponding to the sidewall openings. The reduction ring carrying the filament is deployed adjacent a mitral valve annulus and the filament is translated relative to the reduction ring to deploy the barbs through the exit ports and into the annulus and to further translate the reduction ring with deployed barbs to reshape the annulus.",MEDTRONIC VASCULAR INC,DOUK NAREAK;;RAFIEE NASSER;;BLOOM ELIOT;;FOGG DOUGLAS A;;HUYNH RANY;;BARONE DAVID D,MEDTRONIC VASCULAR INC (2005-05-31),https://lens.org/032-750-346-091-469,Granted Patent,yes,24,130,6,6,0,A61B17/00234;;A61B17/0401;;A61B2017/00243;;A61B2017/00783;;A61B2017/0414;;A61B2017/0496;;A61B2017/06052;;A61B2017/06176;;A61F2/2445;;A61F2002/30545;;A61F2220/0016;;A61F2250/001;;A61F2/2445;;A61B17/00234;;A61B17/0401;;A61B2017/06052;;A61B2017/00243;;A61B2017/0496;;A61F2250/001;;A61B2017/0414;;A61F2220/0016;;A61F2002/30545;;A61B2017/06176;;A61B2017/00783,A61F2/24;;A61B17/00;;A61B17/04;;A61B17/06;;A61F2/04,623/2.11;;623/2.36;;623/2.37;;623/2.41;;623/1.11;;623/1.12;;606/151;;606/215;;606/217;;606/219,0,0,,,,ACTIVE
630,TW,A,TW 201000129 A,154-761-142-027-569,2010-01-01,2010,TW 98117296 A,2009-05-25,US 5550008 P,2008-05-23,Interleukin-21 receptor binding proteins,"The present invention provides binding proteins and antigen-binding fragments thereof that specifically bind to the human interleukin-21 receptor (IL-21R). The binding proteins can act as, e.g., antagonists of IL-21R activity, thereby modulating immune responses in general, and those mediated by IL-21R in particular. The disclosed compositions and methods may be used, e.g., in diagnosing and/or treating IL-21R-associated disorders, e.g., inflammatory disorders, autoimmune diseases, allergies, transplant rejection, cancer, and other immune system disorders.",WYETH CORP;;MEDIMMUNE LTD,BLOOM LAIRD;;GILL DAVINDER;;VUGMEYSTER YULIA;;YOUNG DEBORAH A;;LOWE DAVID;;VALGE-ARCHER VIIA,,https://lens.org/154-761-142-027-569,Patent of Addition,no,0,0,22,22,0,C07K14/54;;C07K16/2866;;C07K2317/21;;C07K2317/565;;C07K2317/622;;C07K2317/73;;C07K2317/732;;C07K2317/92;;C07K2317/52;;A61P29/00;;A61P37/06;;A61P37/08;;A61P43/00;;C07K14/54;;C07K2317/92;;C07K2317/732;;C07K2317/73;;C07K2317/565;;C07K16/2866;;C07K2317/622;;C07K2317/21;;C07K2317/52,A61K39/395;;C07K16/24,,0,0,,,,PENDING
631,WO,A2,WO 2004/087869 A2,185-506-915-626-35X,2004-10-14,2004,US 2004/0008926 W,2004-03-24,US 45727903 P;;US 3636508 A;;US 80804204 A,2003-03-25,HERPESVIRUS RIBOZYMES AND VECTORS,"Hammerhead ribozymes that target components critical to HSV replication (ICP4, UL20, UL30, and UL54) were synthesized and shown to efficiently cleave target RNA encoding a portion of these components in in vitro assays. Several cloned cell lines stably expressing these ribozymes were established. HSV-mediated plaque formation was dramatically reduced in cells stably transfected with an anti-HSV ribozyme compared to non&shy;transfected cells.",UNIV FLORIDA;;LEWIN ALFRED S;;BLOOM DAVID C;;SCHULTZ GREGORY S;;TULI SONAL S;;LIU JIA,LEWIN ALFRED S;;BLOOM DAVID C;;SCHULTZ GREGORY S;;TULI SONAL S;;LIU JIA,,https://lens.org/185-506-915-626-35X,Patent Application,yes,0,0,4,6,0,C07K14/005;;C12N15/1133;;C12N2310/111;;C12N2310/121;;C12N2510/02;;C12N2710/16622;;C07K14/005;;C12N2310/121;;C12N15/1133;;C12N2310/111;;C12N2510/02;;C12N2710/16622,C12N15/113,,0,0,,,,PENDING
632,DE,A1,DE 102016107923 A1,124-499-506-003-041,2016-11-03,2016,DE 102016107923 A,2016-04-28,US 201562154879 P;;US 201514837641 A,2015-04-30,Detektion eines ECU-Erdungsfehlers mit Spannungsmessungen am CAN-Bus,"Es wird ein Verfahren offenbart, um Erdungsfehler in einem Kommunikationssystem zu detektieren. Das Verfahren umfasst, dass eine vorbestimmte Anzahl von Spannungspunkten gemessen wird; dass ermittelt wird, ob die gemessenen Spannungspunkte rezessive oder dominante Bits repräsentieren; dass auf der Grundlage dessen, ob die gemessenen Spannungspunkte rezessiv oder dominant sind, identifiziert wird, welche aus der vorbestimmten Anzahl von Spannungspunkten Zwischenrahmenbits repräsentieren und welche Rahmendatenbits repräsentieren; dass eine maximale Durchschnittsspannung für die Zwischenrahmenbits berechnet wird; dass eine Durchschnittsrahmenspannung für alle dominanten Bits in einem Rahmen berechnet wird; dass ein Zählerwert für eine hohe dominante Durchschnittsspannung auf der Grundlage einer Anzahl von Rahmen ermittelt wird, bei denen die Durchschnittsrahmenspannung größer als ein hoher Spannungsschwellenwert ist; und dass auf der Grundlage der Durchschnittsrahmenspannung und des Zählerwerts für eine hohe dominante Durchschnittsspannung ermittelt wird, ob ein Erdungsfehler existiert.",GM GLOBAL TECH OPERATIONS LLC,DU XINYU;;JIANG SHENGBING;;NAGOSE ATUL;;GUMPERT DAVID B;;BLOOM AARON B;;NINER ROD,,https://lens.org/124-499-506-003-041,Patent Application,no,0,0,6,6,0,G01R19/00;;G01R19/003;;G01R19/0084;;G01R19/2503;;G01R31/083;;G01R31/50;;G01R31/007;;G01R31/52;;G01R31/007;;H04L1/24;;G01R31/52,G01R31/02,,1,0,,,ISO-11898-2,ACTIVE
633,CN,A,CN 106093673 A,113-750-263-156-550,2016-11-09,2016,CN 201610276312 A,2016-04-29,US 201562154879 P;;US 201514837641 A,2015-04-30,ECU grounding fault detection utilizing CAN bus voltage measurement,"The invention discloses a method for detecting grounding faults in a communication system. The method comprises the steps of measuring a preset number of voltage points; determining a fact that each measured voltage points represent a cryptic bit or a dominant bit; based on the cryptic potential or the dominant potential of the measured voltage point, identifying the voltage points which represent interface bit and the voltage points that represent frame data bit in the preset number of voltage points; calculating a highest average voltage of the interframe bit; calculating the average frame voltage of all dominant bits in the frame; determining a high average dominant voltage number based on the number of frames of which the average frame voltage is higher than a high voltage threshold; and determining whether ground faults exist based on the average frame voltage and the high average dominant voltage number.",GM GLOBAL TECH OPERATIONS LLC,AARON B BLOOM;;ROD NINER;;XINYU DU;;ATUL NAGOSE;;DAVID B GUMPERT;;SHENGBING JIANG,,https://lens.org/113-750-263-156-550,Patent Application,no,5,4,6,6,0,G01R31/50;;G01R31/52;;G01R31/52;;G01R19/00;;G01R19/003;;G01R19/0084;;G01R19/2503;;G01R31/007;;G01R31/007;;G01R31/083;;H04L1/24,G01R31/02;;G01R19/00;;G01R19/25;;G01R31/08,,0,0,,,,ACTIVE
634,US,A1,US 2009/0298167 A1,138-427-387-842-365,2009-12-03,2009,US 47220909 A,2009-05-26,US 47220909 A;;US 5550008 P,2008-05-23,INTERLEUKIN-21 RECEPTOR BINDING PROTEINS,"The present invention provides binding proteins and antigen-binding fragments thereof that specifically bind to the human interleukin-21 receptor (IL-21R). The binding proteins can act as, e.g., antagonists of IL-21R activity, thereby modulating immune responses in general, and those mediated by IL-21R in particular. The disclosed compositions and methods may be used, e.g., in diagnosing and/or treating IL-21R-associated disorders, e.g., inflammatory disorders, autoimmune diseases, allergies, transplant rejection, cancer, and other immune system disorders.",WYETH CORP;;MEDIMMUNE LTD,BLOOM LAIRD;;GILL DAVINDER;;VUGMEYSTER YULIA;;YOUNG DEBORAH A;;LOWE DAVID;;VALGE-ARCHER VIIA,MEDIMMUNE LIMITED (2010-02-24);;WYETH (2009-08-28),https://lens.org/138-427-387-842-365,Patent Application,yes,18,4,22,22,248,C07K14/54;;C07K16/2866;;C07K2317/21;;C07K2317/565;;C07K2317/622;;C07K2317/73;;C07K2317/732;;C07K2317/92;;C07K2317/52;;A61P29/00;;A61P37/06;;A61P37/08;;A61P43/00;;C07K14/54;;C07K2317/92;;C07K2317/732;;C07K2317/73;;C07K2317/565;;C07K16/2866;;C07K2317/622;;C07K2317/21;;C07K2317/52,C12N5/10;;C07H21/00;;C07K14/00;;C07K16/18;;C12N15/74,435/348;;530/350;;530/387.9;;536/23.1;;536/23.53;;435/320.1;;435/325;;435/252.3;;435/254.2,0,0,,,,INACTIVE
635,ES,T3,ES 2384255 T3,013-469-821-852-148,2012-07-03,2012,ES 06788580 T,2006-07-26,US 70404605 P;;US 74760406 P;;US 2006/0029062 W,2005-07-29,"Bomba de pistón alternativo con válvula de aire, retén y cabezales móviles","A poppet assembly includes a poppet housing (41) having an axis and first and second sets of housing ports (41a, 41b), which are axially spaced. A poppet seat (44) is provided in the housing, the seat having a set of seat ports (44a), and a poppet (43) is also located in the housing and is retained by the seat. The poppet has a set of poppet ports (43a), is biased against the seat in a first position and can be moved to a second position away from the seat. A poppet actuator (45), which is located in the seat, partially surrounds the poppet and is biased away from the poppet. When the poppet is in its first position, the first set of housing ports (41b) are in fluid communication with the second set of housing ports (41a) through the poppet ports (43a), and when it is in its second position, the first set of housing ports (41b) are in fluid communication with the seat ports (44a).",GRACO MINNESOTA INC,BAUCK MARK L;;ISAIS JOHN F;;WEINBERGER MARK T;;PITTMAN DAVID M;;BLOOM MICHAEL E,,https://lens.org/013-469-821-852-148,Granted Patent,no,0,0,28,28,0,F04B9/12;;F04B9/125;;F16K11/02;;F04B49/00;;F04B35/00;;F04B9/08;;F04B9/12;;F04B9/125;;F16K11/02,F04B49/00;;F04B9/08;;F04B35/02,,0,0,,,,ACTIVE
636,ES,T3,ES 2115003 T3,046-080-135-521-498,1998-06-16,1998,ES 93121091 T,1993-12-30,US 1097393 A,1993-01-29,AMINOCICLOALCANOBENZODIOXOLES COMO AGENTES ADRENERGICOS SELECTIVOS BETA-3.,"The invention is antiobesity/antidiabetic/beta-3 agonists of the formula <CHEM> wherein the substituents Ro, R1, R4, R4', R5, R6 or n are as defined in the specification.",AMERICAN CYANAMID CO,EPSTEIN JOSEPH WILLIAM;;BIRNBERG GARY HAROLD;;WALKER GARY EDWARD;;DUTIA MINU DHANJISHA;;BLOOM JONATHAN DAVID,,https://lens.org/046-080-135-521-498,Granted Patent,no,0,0,13,13,0,A61K31/36;;C07D317/70;;C07D413/04;;A61P3/10;;A61P3/04;;A61P3/08;;C07D413/04;;A61K31/36;;C07D317/70;;C07D413/04;;C07D317/70;;A61K31/36,A61K31/335;;A61K31/357;;A23K1/16;;A61K31/36;;A61P3/04;;A61P3/08;;A61P3/10;;C07D317/70;;C07D413/04,,0,0,,,,EXPIRED
637,HU,A2,HU P0104611 A2,064-233-879-574-186,2002-04-29,2002,HU P0104611 A,1999-12-06,US 20796198 A;;US 9928838 W,1998-12-09,THIOUREA INHIBITORS OF HERPES VIRUSES AND MEDICAMENTS CONTAINING THEM,"A tal lm ny (I) ltal nos képletű vegyületekre és gyógy szatilagelfogadható sóikra vonatkozik, ahol A jelentése heteroarilcsoport; R9-R12 jelentése egym stól függetlenül hidrogénatom, 1-4 szénatomosalkil-, 1-4 szénatomos perhalogénalkil-, halogénatom, 1-4 szénatomosalkoxi-, cianocsoport vagy R9 és R10 vagy R11 és R12 5-7 szénatomottartalmazó arilcsoportot alkothat; G jelentése aril- vagyheteroarilcsoport; X jelentése vegyértékk""tés, -NH-, 1-6 szénatomosalkil-, 1-6 szénatomos alkenil-, 1-6 szénatomos alkoxi-, 1-6szénatomos alkil- tio-, 1-6 szénatomos alkil-aminocsoport vagy (CH)Jltal nos képletű csoport; J jelentése 1-6 szénatomos alkil-, 3-7szénatomos cikloalkil-, fenil- vagy benzilcsoport. A vegyület aherpeszvírusok, péld ul a hum n citomegalavírusok, herpesz szimplexvírusok, Epstein-Barr vírus, varicella-zoster vírus, hum nherpeszvírus-6 és -7 és a Kaposi-herpeszvírus ltal okozott betegségekkezelésére haszn lhatók. A tal lm ny a vegyületeket tartalmazógyógyszerkészítményekre és a vegyületek alkalmaz s ra is vonatkozik. Ó",AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSEL GEORGE;;LANG STANLEY ALBERT;;O'HARA BRYAN MARK,,https://lens.org/064-233-879-574-186,Patent Application,no,0,0,17,17,0,C07D207/335;;C07D209/14;;C07D213/40;;C07D213/75;;C07D215/12;;C07D217/12;;C07D231/56;;C07D233/44;;C07D277/28;;C07D285/06;;C07D307/52;;C07D333/20;;C07D405/12;;C07D417/12;;A61P31/12;;A61P31/22;;C07D209/14;;C07D207/335;;C07D213/40;;C07D215/12;;C07D217/12;;C07D231/56;;C07D233/44;;C07D285/06;;C07D307/52;;C07D333/20;;C07D417/12,A61K31/06;;A61K31/075;;C07D295/14;;A61K31/085;;A61K31/10;;A61K31/11;;A61K31/136;;A61K31/15;;A61K31/165;;A61K31/167;;A61K31/17;;A61K31/175;;A61K31/18;;A61K31/196;;A61K31/215;;A61K31/216;;A61K31/222;;A61K31/27;;A61K31/275;;A61K31/341;;A61K31/40;;A61K31/42;;A61K31/426;;A61K31/433;;A61K31/4439;;A61K31/4453;;A61K31/4458;;A61K31/54;;A61K31/695;;A61P31/12;;A61P31/22;;C07C335/20;;C07D207/12;;C07D207/14;;C07D207/32;;C07D207/335;;C07D209/14;;C07D211/22;;C07D213/40;;C07D213/75;;C07D215/12;;C07D217/12;;C07D231/12;;C07D231/56;;C07D233/44;;C07D261/08;;C07D277/24;;C07D277/28;;C07D285/06;;C07D307/52;;C07D307/54;;C07D333/20;;C07D405/12;;C07D417/12,,0,0,,,,PENDING
638,US,A1,US 2019/0304578 A1,084-084-406-040-140,2019-10-03,2019,US 201916377968 A,2019-04-08,US 201916377968 A;;US 201816192341 A;;US 201862712063 P;;US 201862647572 P,2018-03-23,OMIC DATA AGGREGATION WITH DATA QUALITY VALUATION,"A system and method are disclosed for the collection and aggregation of genomic, medical, and other data of interest for individuals and populations that may be of interest for analysis, research, pharmaceutical development, medical treatment, and so forth. Contributors become members of a community upon creation of an account and providing of data or files. The data is received and processed, such as to analyze, structure, perform quality control, and curate the data. Value or shares in one or more community databases are computed and attributed to each contributing member. The data is controlled to avoid identification or personalization. Third parties interested in the database information may contribute value (e.g., pay) for access and use. Value flows back to the members and to a system administrative entity.",LUNAPBC,KAIN ROBERT C;;BARRY DAWN MARY;;LEWIS DAVID;;BLOOM KENNETH ROBERT;;KAHN SCOTT;;VELINOV BOJIL,,https://lens.org/084-084-406-040-140,Patent Application,yes,5,18,1,12,0,G06Q40/08;;G16H10/20;;G16H10/60;;G16H10/40;;G06N5/02;;G06N5/01;;G16H10/60;;G06F16/2379;;G06Q40/08;;G06N20/00;;G06F16/958,G16H10/60;;G06F16/23;;G06F16/958;;G06N20/00,,0,0,,,,DISCONTINUED
639,EP,A2,EP 0455006 A2,130-507-203-792-180,1991-11-06,1991,EP 91105510 A,1991-04-08,US 51919290 A,1990-05-04,"Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles.","The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.",AMERICAN CYANAMID CO,BLOOM JONATHAN DAVID;;CLAUS THOMAS HARRISON;;DEVRIES VERN GORDON;;DOLAN JO ALENE;;DUTIA MINU DHANJISHA,AMERICAN CYANAMID COMPANY (1994-01-26),https://lens.org/130-507-203-792-180,Patent Application,yes,13,62,40,44,0,C07D317/46;;C07D413/06;;A61P3/10;;A61P3/04;;A61P3/08;;C07D317/46;;C07D413/06;;C07D317/46,A23K1/16;;A61K31/335;;A61K31/357;;A61K31/36;;A61K31/42;;A61P3/04;;A61P3/08;;A61P3/10;;C07D263/04;;C07D291/04;;C07D317/46;;C07D317/58;;C07D317/62;;C07D405/06;;C07D413/06;;C07D419/06,,1,1,013-879-296-436-067,10.1021/ja00252a056,"COREY, J. AM. CHEM, SOC., vol. 109, 1987, pages 5551",EXPIRED
640,WO,A2,WO 2000/034237 A2,129-957-380-864-344,2000-06-15,2000,US 9928844 W,1999-12-06,US 20831698 A,1998-12-09,ACETAMIDE AND SUBSTITUTED ACETAMIDE-CONTAINING THIOUREA INHIBITORS OF HERPES VIRUSES,"Compounds of formula (I) wherein R1-R5 are independently selected from hydrogen, alkyl of 1 to 6 carbon atoms, alkenyl of 2 to 6 carbon atoms, alkynyl of 2 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 carbon members, aryl, heteroaryl, halogen, -CN, -NO2, -CO2R6, -COR6, -OR6, -SR6, -SOR6, -SO2R6, -CONR7R8, -NR6N(R7R8), -N(R7R8) or W-Y-(CH2)n-Z provided that at least one of R1-R5 is not hydrogen; or R2 and R3 or R3 and R4, taken together form a 3 to 7 membered heterocycloalkyl or 3 to 7 membered heteroaryl; R6 and R7 are independently hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, or aryl; R8 is hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 members, aryl or heteroaryl, or R7 and R8, taken together may form a 3 to 7 membered heterocycloalkyl; R9-R12 are independently hydrogen, alkyl of 1 to 4 carbon atoms, perhaloalkyl of 1 to 4 carbon atoms, halogen, alkoxy of 1 to 4 carbon atoms, or cyano, or R9 and R10 or R11 and R12 may be taken together to form aryl of 5 to 7 carbon atoms; G is alkyl of 1 to 6 carbon atoms; X is a bond, -NH, alkyl of 1 to 6 carbon atoms, alkenyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, thioalkyl of 1 to 6 carbon atoms, alkylamino of 1 to 6 carbon atoms, or (CH)J; J is alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 7 carbon atoms, phenyl or benzyl; and n is an integer from 1 to 6; or pharmaceutical salts thereof, are useful in the treatment of diseases associated with herpes viruses including human cytomegalovirus, herpes simplex viruses, Epstein-Barr virus, varicella-zoster virus, human herpesviruses-6 and -7, and Kaposi herpesvirus.",AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;O'HARA BRYAN MARK,,https://lens.org/129-957-380-864-344,Patent Application,yes,0,27,18,18,0,C07C335/20;;C07C335/22;;C07D207/09;;C07D207/14;;C07D211/58;;C07D261/10;;A61P31/22,A61K31/17;;C07D249/04;;A61K31/341;;A61K31/343;;A61K31/345;;A61K31/36;;A61K31/381;;A61K31/40;;A61K31/403;;A61K31/4192;;A61K31/42;;A61K31/433;;A61K31/437;;A61K31/4409;;A61K31/4468;;A61K31/47;;A61K31/4965;;A61K31/5375;;A61K31/56;;A61P31/22;;C07C335/20;;C07C335/22;;C07C337/06;;C07D207/09;;C07D207/14;;C07D207/34;;C07D209/48;;C07D211/58;;C07D213/81;;C07D215/48;;C07D217/26;;C07D221/12;;C07D241/24;;C07D261/08;;C07D261/10;;C07D265/30;;C07D285/06;;C07D295/12;;C07D307/56;;C07D307/73;;C07D307/85;;C07D317/68;;C07D333/38;;C07D333/70,,0,0,,,,PENDING
641,WO,A3,WO 2000/034237 A3,144-509-737-248-099,2000-11-23,2000,US 9928844 W,1999-12-06,US 20831698 A,1998-12-09,ACETAMIDE AND SUBSTITUTED ACETAMIDE-CONTAINING THIOUREA INHIBITORS OF HERPES VIRUSES,"Compounds of formula (I) wherein R1-R5 are independently selected from hydrogen, alkyl of 1 to 6 carbon atoms, alkenyl of 2 to 6 carbon atoms, alkynyl of 2 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 carbon members, aryl, heteroaryl, halogen, -CN, -NO2, -CO2R6, -COR6, -OR6, -SR6, -SOR6, -SO2R6, -CONR7R8, -NR6N(R7R8), -N(R7R8) or W-Y-(CH2)n-Z provided that at least one of R1-R5 is not hydrogen; or R2 and R3 or R3 and R4, taken together form a 3 to 7 membered heterocycloalkyl or 3 to 7 membered heteroaryl; R6 and R7 are independently hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, or aryl; R8 is hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 members, aryl or heteroaryl, or R7 and R8, taken together may form a 3 to 7 membered heterocycloalkyl; R9-R12 are independently hydrogen, alkyl of 1 to 4 carbon atoms, perhaloalkyl of 1 to 4 carbon atoms, halogen, alkoxy of 1 to 4 carbon atoms, or cyano, or R9 and R10 or R11 and R12 may be taken together to form aryl of 5 to 7 carbon atoms; G is alkyl of 1 to 6 carbon atoms; X is a bond, -NH, alkyl of 1 to 6 carbon atoms, alkenyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, thioalkyl of 1 to 6 carbon atoms, alkylamino of 1 to 6 carbon atoms, or (CH)J; J is alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 7 carbon atoms, phenyl or benzyl; and n is an integer from 1 to 6; or pharmaceutical salts thereof, are useful in the treatment of diseases associated with herpes viruses including human cytomegalovirus, herpes simplex viruses, Epstein-Barr virus, varicella-zoster virus, human herpesviruses-6 and -7, and Kaposi herpesvirus.",AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;O'HARA BRYAN MARK,,https://lens.org/144-509-737-248-099,Search Report,yes,1,0,18,18,0,C07C335/20;;C07C335/22;;C07D207/09;;C07D207/14;;C07D211/58;;C07D261/10;;A61P31/22,A61K31/17;;A61K31/341;;A61K31/343;;A61K31/345;;A61K31/36;;A61K31/381;;A61K31/40;;A61K31/403;;A61K31/4192;;C07D249/04;;A61K31/42;;A61K31/433;;A61K31/437;;A61K31/4409;;A61K31/4468;;A61K31/47;;A61K31/4965;;A61K31/5375;;A61K31/56;;A61P31/22;;C07C335/20;;C07C335/22;;C07C337/06;;C07D207/09;;C07D207/14;;C07D207/34;;C07D209/48;;C07D211/58;;C07D213/81;;C07D215/48;;C07D217/26;;C07D221/12;;C07D241/24;;C07D261/08;;C07D261/10;;C07D265/30;;C07D285/06;;C07D295/12;;C07D307/56;;C07D307/73;;C07D307/85;;C07D317/68;;C07D333/38;;C07D333/70,,7,3,010-544-757-030-489;;069-993-034-496-677;;015-474-749-796-258,5848621;;10.1039/jr9580002815;;4977575,"N. DAT-XUONG ET AL, ANN. INST. PASTEUR, vol. 109, no. 4, 1965, pages 600 - 604, XP000900806;;DATABASE CAOLD CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002147303;;S. ABUZAR ET AL, INDIAN J. CHEM., SECT. B, vol. 20b, no. 3, 1981, pages 230 - 233, XP000925880;;CHEMICAL ABSTRACTS, vol. 56, no. 7, 2 April 1962, Columbus, Ohio, US; abstract no. 7185a, XP002147302;;K. GANAPATHI ET AL, PROC.-INDIAN ACAD. SCI., SECT. A, vol. 37, 1953, XP000925884;;NG. PH. BUU-HOI ET AL, J. CHEM. SOC., 1958, pages 2815 - 2821, XP002128092;;E. WINKELMANN ET AL, ARZNEIM. FORSCH., vol. 19, 1969, pages 543 - 558, XP002104044",PENDING
642,NO,L,NO 975695 L,171-115-010-574-894,1997-12-05,1997,NO 975695 A,1997-12-05,US 48045995 A;;US 9609255 W,1995-06-07,Fremgangsmåte for fremstilling av en innretning for en flat diffraksjonsgitter-lysventil,"A deformable grating aparatus for modulating light is made by forming an insulating layer on a substrate, forming a first conductive layer on the insulating layer and then forming a sacrificial layer thereon. The sacrificial layer and the first conducting layer are then etched to define bit lines and busses to bonding pads. Then a layer of resilient material is formed onto the etched layers and a reflective conducting layer is formed on the resilient layer. A dielectric layer is deposited on the reflective conducting layer. The dielectric layer, the reflective conducting layer, the resilient layer and the sacrificial layer are all then etched to form a grating including a plurality of parallel elements. Thereafter the sacrificial layer is removed below the parallel elements, to suspend the parallel elements over the first conducting layer. The surface is treated to prevent the grating from adhering to the first conducting layer. A light modulator includes a substrate with an insulating layer, and a plurality of parallel conductive layers formed on the insulating layer. The ribbons are spaced apart from the conductive layers by an air space and mounted to the substrate in gaps between the conductive layers.",SILICON LIGHT MACHINES INC,BORNSTEIN JONATHAN G;;BANYAI WILLIAM C;;BLOOM DAVID M;;WHITTEN RALPH G;;STAKER BRYAN P,,https://lens.org/171-115-010-574-894,Abstract,no,0,0,16,16,0,G02B5/1828;;G02B26/0808;;Y10S359/904;;G02B5/18;;G02B5/1828;;G02B26/0808;;Y10S359/904,G02B5/18;;G02B26/08,,0,0,,,,DISCONTINUED
643,HU,B,HU 210596 B,187-458-307-554-304,1995-05-29,1995,HU 149591 A,1991-05-03,US 51919290 A,1990-05-04,"PROCESS FOR PREPARING 5-{2-[(2-ARYL-2-HYDROXYETHYL)-AMINO)-PROPYL) -1,3-BENZODIOXOLES AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM","The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.",AMERICAN CYANAMID CO,DEVRIES VERN GORDON;;BLOOM JONATHAN DAVID;;CLAUS THOMAS HARRISON;;DUTIA MINU DHANJISHA;;DOLAN JO ALENE,,https://lens.org/187-458-307-554-304,Granted Patent,no,0,0,40,44,0,C07D317/46;;C07D413/06;;A61P3/10;;A61P3/04;;A61P3/08;;C07D317/46;;C07D413/06;;C07D317/46,A61K31/335;;A61K31/357;;A23K1/16;;A61K31/36;;A61K31/42;;A61P3/04;;A61P3/08;;A61P3/10;;C07D263/04;;C07D291/04;;C07D317/46;;C07D317/58;;C07D317/62;;C07D405/06;;C07D413/06;;C07D419/06,,0,0,,,,EXPIRED
644,SK,A3,SK 7692001 A3,052-295-360-979-265,2002-09-10,2002,SK 7692001 A,1999-12-06,US 20854098 A;;US 9928892 W,1998-12-09,THIOUREA INHIBITORS OF HERPES VIRUSES,,WYETH CORP,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;O'HARA BRYAN MARK,,https://lens.org/052-295-360-979-265,Patent Application,no,0,0,21,89,0,C07D213/75;;C07D213/81;;C07D405/12;;C07D417/12;;C07D307/85;;C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81,A61K/;;A61K31/12;;A61K31/33;;A61K31/425;;A61K31/44;;A61K31/4427;;C07D213/81;;A61K31/443;;A61K31/4436;;A61K31/444;;A61P/;;A61P31/12;;A61P31/22;;C07D/;;C07D213/75;;C07D401/12;;C07D405/12;;C07D417/12,,0,0,,,,PENDING
645,AU,A,AU 1996/061564 A,045-921-535-558-318,1996-12-30,1996,AU 1996/061564 A,1996-06-05,US 48045995 A;;US 9609255 W,1995-06-07,A method of making and an apparatus for a flat diffraction g rating light valve,"A deformable grating aparatus for modulating light is made by forming an insulating layer on a substrate, forming a first conductive layer on the insulating layer and then forming a sacrificial layer thereon. The sacrificial layer and the first conducting layer are then etched to define bit lines and busses to bonding pads. Then a layer of resilient material is formed onto the etched layers and a reflective conducting layer is formed on the resilient layer. A dielectric layer is deposited on the reflective conducting layer. The dielectric layer, the reflective conducting layer, the resilient layer and the sacrificial layer are all then etched to form a grating including a plurality of parallel elements. Thereafter the sacrificial layer is removed below the parallel elements, to suspend the parallel elements over the first conducting layer. The surface is treated to prevent the grating from adhering to the first conducting layer. A light modulator includes a substrate with an insulating layer, and a plurality of parallel conductive layers formed on the insulating layer. The ribbons are spaced apart from the conductive layers by an air space and mounted to the substrate in gaps between the conductive layers.",ECHELLE INC,BORNSTEIN JONATHAN G;;BANYAI WILLIAM C;;BLOOM DAVID M;;WHITTEN RALPH G;;STAKER BRYAN P,,https://lens.org/045-921-535-558-318,Patent Application,no,0,0,16,16,0,G02B5/1828;;G02B26/0808;;Y10S359/904;;G02B5/18;;G02B5/1828;;G02B26/0808;;Y10S359/904,G02B5/18;;G02B26/08,,0,0,,,,PENDING
646,AU,A1,AU 2004/315884 A1,191-343-407-002-800,2005-09-01,2005,AU 2004/315884 A,2004-11-12,US 71356503 A;;US 2004/0038040 W,2003-11-13,Artificial synapse chip,,UNIV LELAND STANFORD JUNIOR,HOOLANDI JAAN;;PETERMAN MARK C;;BENT STACEY F;;FISHMAN HARVEY A;;BLOOM DAVID;;MEHENTI NEVILLE,,https://lens.org/191-343-407-002-800,Patent Application,no,0,0,10,10,0,A61N1/0543;;A61N1/30;;A61N1/326;;A61N1/36046;;C12N5/0619;;C12N2503/00;;C12N2535/10;;G06N3/061;;G06N3/061;;A61N1/30;;A61N1/36046;;C12N2503/00;;C12N5/0619;;A61N1/326;;C12N2535/10;;A61N1/0543,C12M1/42;;A61K9/22;;A61L27/00;;A61N1/05;;A61N1/30;;A61N1/36;;C12M3/00;;C12N5/0793;;G06N3/06,,0,0,,,,DISCONTINUED
647,NO,L,NO 20012834 L,032-521-955-950-151,2001-08-07,2001,NO 20012834 A,2001-06-08,US 20831698 A;;US 9928844 W,1998-12-09,Acetamid- og substituerte acetamid-holdige tioureainhibitorer for herpesvirus,"Forbindelser med formelen: hvori RrRs uavhengig er valgt fra hydrogen, alkyl med 1 til 6 karbonatomer, alkenyl med 2 til 6 karbonatomer, alkynyl med 2 til 6 karbonatomer, perhalogenalkyl med 1 til 6 karbonatomer. cykloalkyl med 3 til 10 karbonatomer. heterocykloalkyl med 3 til 10 karbonelementer. aryl. heteroaryl. halogen. -CN. -NO* -COzR8. -CORe. -OR6. -SR6. -SOR,. -SOjRa. -CONR7R.. -NR«N(R7FU). -N(R7R«) eller W-Y-(CH2)n-Z forutsatt at minst en av R,-RS ikke er hydrogen; eller R2 og Rs eller R3 og R«, tilsammen danner en 3- til 7-leddet heterocykloalkyl eller 3- til 7-leddet heteroaryl; R« og R7 er uavhengig hydrogen, alkyl med 1 til 6 karbonatomer. perhalogenalkyl med 1 til 6 karbonatomer eller aryl; R» er hydrogen, alkyl med 1 til 6 karbonatomer. perhalogenalkyl med 1 til 6 karbonatomer. cykloalkyl med 3 til 10 karbon- atomer. heterocykloalkyl med 3 til 10 elementer, aryl eller heteroaryl. eller R7 og Rg, danner sammen en 3- til 7-leddet heterocykloalkyl; R,rR12 er uavhengig hydrogen, alkyl med 1 til 4 karbonatomer, perhalogenalkyl med 1 til 4 karbonatomer. halogen, alkoksy med 1 til 4 karbonatomer eller cyano eller R» og R10 eller R,, og R12 kan sammen danne aryl med 5 til 7 karbonatomer; W er O. NR6 eller mangler; Y er -(CO)- eller -(CO2)- eller mangler; Z er alkyl med 1 til 4 karbonatomer, -CN, -CO2R8, COR6, -CONR7R8, -OCOR6, -NR6COR7, -OCONR,,. -OR«, -SRa. -SOR«, -S02R6, SR6N(R7R8), -N(R7R8) eller fenyl; G er alkyl med 1 til 6 karbon- atomer; og X er en binding, -NH. alkyl med 1 til 6 karbonatomer, alkenyl med 1 til 6 karbon- atomer, alkoksy med 1 til 6 karbonatomer, tioalkyl med 1 til 6 karbonatomer, alkylamino med 1 til 6 karbonatomer eller (CH)J; J er alkyl med 1 til 6 karbonatomer, cykloalkyl med 3 til 7 karbonatomer. fenyl eller benzyl; og n er et heltall fra 1 til 6; eller farmasøytiske salter derav, er anvendelige ved behandling av sykdommer i forbindelse med herpesvirus innbefattet human cytomegalovirus, herpes simplex virus, Epstein-Barr virus, varicella-zoster virus, human herpesvirus-6 og -7 og Kapsosi herpesvirus.",AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSEL GEORGE;;LANG STANLEY ALBERT;;O'HARA BRYAN MARK,,https://lens.org/032-521-955-950-151,Abstract,no,0,0,18,18,0,C07C335/20;;C07C335/22;;C07D207/09;;C07D207/14;;C07D211/58;;C07D261/10;;A61P31/22,A61K31/17;;C07D249/04;;A61K31/341;;A61K31/343;;A61K31/345;;A61K31/36;;A61K31/381;;A61K31/40;;A61K31/403;;A61K31/4192;;A61K31/42;;A61K31/433;;A61K31/437;;A61K31/4409;;A61K31/4468;;A61K31/47;;A61K31/4965;;A61K31/5375;;A61K31/56;;A61P31/22;;C07C335/20;;C07C335/22;;C07C337/06;;C07D207/09;;C07D207/14;;C07D207/34;;C07D209/48;;C07D211/58;;C07D213/81;;C07D215/48;;C07D217/26;;C07D221/12;;C07D241/24;;C07D261/08;;C07D261/10;;C07D265/30;;C07D285/06;;C07D295/12;;C07D307/56;;C07D307/73;;C07D307/85;;C07D317/68;;C07D333/38;;C07D333/70,,0,0,,,,DISCONTINUED
648,TR,T2,TR 200101598 T2,073-609-703-990-230,2001-10-22,2001,TR 200101598 T,1999-12-06,US 20854098 A,1998-12-09,Herpes virüslerinin tiüre önleyicileri.,"Formül (I)'in bilesimleri, burada R1-R5 bagimsiz olarak hidrojen, 1 ila 6 atomlu alkil, 2 ila 6 karbon atomlu alkenil, 2 ila 6 karbon atomlu alkinil, 1 ila 6 karbon atomlu perhaloalkil, 3 ila 10 karbon atomlu sikloalkil, 3 ila 10 karbon elemanli heterosikloalkil, aril, heteroaril, halojen, -CN, -NO2, -CO2R6, -COR6, -OR6, -SR6,-SO2R6,-CONR7R8,-NR6(R7R8), -N(R7R8) ya da W-Y-(CH2)n-Z'den seçilir ya da R2 ve R3 ya da R3 ve R4 birlikte alinir ve 3 ila 7 elemanli heterosikloalkil ya da 3 ila 7 elemanli heteroarilden seçilir.",AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;O'HARA BRYAN MARK,,https://lens.org/073-609-703-990-230,Patent Application,no,0,0,21,89,0,C07D213/75;;C07D213/81;;C07D405/12;;C07D417/12;;C07D307/85;;C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81,A61K/;;A61K31/12;;A61K31/33;;A61K31/425;;A61K31/44;;A61K31/4427;;C07D213/81;;A61K31/443;;A61K31/4436;;A61K31/444;;A61P/;;A61P31/12;;A61P31/22;;C07D/;;C07D213/75;;C07D401/12;;C07D405/12;;C07D417/12,,0,0,,,,PENDING
649,AU,A,AU 2000/031122 A,081-138-840-289-530,2000-06-26,2000,AU 2000/031122 A,1999-12-06,US 20854098 A;;US 9928892 W,1998-12-09,Thiourea inhibitors of herpes viruses,,WYETH CORP,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;O'HARA BRYAN MARK,WYETH (2002-10-03),https://lens.org/081-138-840-289-530,Patent Application,no,0,0,21,89,0,C07D213/75;;C07D213/81;;C07D405/12;;C07D417/12;;C07D307/85;;C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81,C07D213/81;;A61K/;;A61K31/12;;A61K31/33;;A61K31/425;;A61K31/44;;A61K31/4427;;A61K31/443;;A61K31/4436;;A61K31/444;;A61P/;;A61P31/12;;A61P31/22;;C07D/;;C07D213/75;;C07D401/12;;C07D405/12;;C07D417/12,,0,0,,,,EXPIRED
650,US,A,US 5352994 A,097-579-443-712-934,1994-10-04,1994,US 69503891 A,1991-05-01,US 69503891 A;;US 10655487 A;;US 25902788 A;;US 55835690 A;;US 68691691 A,1987-10-06,Gallium arsenide monolithically integrated nonlinear transmission line impedance transformer,"A nonlinear impedance transformer comprising a plurality of scaled L-C sections. The first section has its inductance and capacitance values selected to establish a characteristic impedance approximately equal to the output impedance of the local oscillator. The last section has its inductance and capacitance values selected to establish an output impedance which substantially matches the input impedance of whatever device to which the nonlinear impedance transformer is coupled. The impedance of each section is scaled logarithmically between the values of the input and output impedances. An FET driver can be integrated on the same substrate as integrated versions of the nonlinear impedance transformer. In such a case, the input impedance of the first section is set to the output impedance of the FET, i.e., about 10 ohms.",UNIV LELAND STANFORD JUNIOR,BLACK ALISTAIR D;;BLOOM DAVID M;;MARSLAND ROBERT A;;SHAKOURI MOHAMMAD S;;PODELL ALLEN F,BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY THE (1993-06-01),https://lens.org/097-579-443-712-934,Granted Patent,yes,16,63,1,12,0,H01L27/0605;;H03H7/325;;H03H7/325;;H01L27/0605,H01L27/06;;H03H7/32,333/33;;333/164,56,40,094-700-573-083-198;;118-148-991-034-690;;118-906-990-904-164;;167-240-924-284-39X;;102-418-415-486-476;;108-651-613-843-015;;011-464-360-811-259;;034-648-811-983-748;;108-105-863-882-158;;076-005-970-844-782;;040-932-214-113-301;;101-886-142-250-708;;054-262-910-827-840;;013-898-387-548-113;;176-025-329-124-177;;026-540-030-442-995;;092-989-508-430-883;;162-897-446-967-819;;064-165-799-233-726;;034-232-704-492-645;;070-670-309-675-885;;052-460-435-753-604;;096-022-490-964-232;;121-646-991-939-932;;130-028-198-982-271;;079-348-915-926-869;;098-767-344-948-858;;014-183-718-956-355;;150-924-603-857-919;;058-698-360-350-947;;057-917-244-068-910;;074-872-429-127-710;;013-955-110-929-659;;171-514-241-720-412;;111-104-799-438-418;;139-153-091-547-974;;139-230-985-325-058;;012-215-706-447-001;;039-326-105-487-966;;103-747-114-308-100,10.1109/proc.1973.9297;;10.1109/proc.1973.9296;;10.1049/el:19790417;;10.1109/jssc.1972.1050238;;10.1007/bf00886158;;10.1063/1.1735612;;10.1147/rd.44.0391;;10.1109/tmtt.1982.1131186;;10.1143/jpsj.51.1686;;10.1016/0038-1101(74)90024-0;;10.1007/bf00931418;;10.1007/bf00896149;;10.1109/t-ed.1975.18246;;10.1049/el:19730147;;10.1109/tmtt.1983.1131546;;10.1109/t-ed.1972.17593;;10.1109/tmtt.1976.1128910;;10.1109/euma.1983.333240;;10.1109/tmtt.1983.1131654;;10.1109/tmtt.1980.1130215;;10.1109/tmtt.1981.1130387;;10.1063/1.96709;;10.1109/jrproc.1957.278385;;10.1109/tmtt.1986.1133427;;10.1109/gaas.1989.69330;;10.1109/tmtt.1985.1133110;;10.1109/tmtt.1982.1131185;;10.1080/00207218508939060;;10.1109/22.58648;;10.1109/22.58640;;10.1049/el:19770471;;10.1109/55.724;;10.1063/1.100785;;10.1049/el:19890005;;10.1109/iedm.1988.32957;;10.1049/sbew016e;;10.1049/el:19870077;;10.1049/el:19810657;;10.1049/el:19820401;;10.1049/el:19860339,"Delay Lines With Non Linear Capacitances ; by E. Luder.;;Mier Birk and Q. A. Kerns, Engineering note number EE 922, May 22, 1963, Lawrence Radiation Laboratory, University of California, Berkeley.;;R. B. Riley; An Analysis of a Nonlinear Transmission Line , Technical Report No. 1701 1, Jan. 20, 1961.;;R. H. Freeman and A. E. Karobwiak, An Investigation of Nonlinear Transmission Lines and Shock Waves Journal of Physics, D: Applied Physics, vol. 10, 1977.;;R. Hirota and K. Suzuki, Theoretical and Experimental Studies of Lattice Solitons in Nonlinear Lumped Networks , IEEE Proc., vol. 61, No. 10, Oct., 1973, pp. 1483 1491.;;A. C. Scott, F. Y. F. Chu, D. W. McLaughlin, The Soliton, a New Concept in Applied Science , Proc. IEEE, 61 (10), 1443 (1973).;;K. J. Weingarten, et al., Picosecond Optical Sampling of GaAs Integrated Circuits , IEEE Journal of Quantum Electronics on Ultrafast Optics and Electronics, Feb., 1988.;;Bastida, E. M. et al., Periodic Slow Wave Low Loss Structures for Monolith GaAs Microwave Integrated Circuits Electronic Letters, 13th Sep. 1979, vol. 15, No. 19, pp. 581 582.;;Merkelo, et al. Broadband Thin Film Signal Sampler ; IEEE Journal of Solid State Circuits, vol. SC 7, No. 1, Feb. 1972, pp. 50 54.;;D. Jager and F. J. Tegude, Nonlinear Wave Propagation Along Periodic Loaded Transmission Line , Applied Physics 15, pp. 393 397 (1978).;;R. Landauer, Parametric Amplification Along Nonlinear Transmission Lines , Journal of Applied Physics, vol. 31, No. 3, Mar. 1960, pp. 479 484.;;R. Landauer, Shock Waves in Nonlinear Transmission Lines and Their Effect on Parametric Amplification , IBM Journal 1960, pp. 391 401.;;Ayasli, et al., A Monolithic GaAs 1 13 GHz Travelling Wave Amplifier IEEE Transactions on Microwave Theory & Techniques, vol. MTT 30, No. 7, Jul. 1982, pp. 976 981.;;D. Jager, Experiments on KdV Solitons , Journal of the Physical Society of Japan, vol. 51, No. 5, May 1982, pp. 1686 1693.;;D. Jager, W. Rabus, W. Eickhoff, Bias Dependent Small Signal Parameters of Schottky Contact Microstrip Lines , Solid State Electronics, vol. 17, 1974, pp. 777 783.;;D. Jager, Soliton Propagation Along Periodic Loaded Transmission Line , Appl. Phys., vol. 16, 1978, pp. 35 38.;;D. Jager, J. P. Becker, Distributed Variable Capacitance Microstrip Lines for Microwave Applications , Appl. Phys., vol. 12, 1977, pp. 203 107.;;G. W. Hughes, R. M. White, Microwave Properties of Nonlinear MIS and Schottky Barrier Microstrip , IEEE Transactions on Electron Devices, vol. ED 22, No. 10, Oct. 1975, pp. 945 956.;;D. Jager, et al., Bias Dependent Phase Delay of Schottky Contact Microstrip Line Electronics Letters, 17th May 1973, vol. 9, No. 10, pp. 201 203.;;Y. Fukuoka, Y. C. Shih, T. Itoh, Analysis of Slow Wave Coplanar Waveguide for Monolithic Integrated Circuits IEEE Transactions on Microwave Theory and Techniques, vol. MTT 31, No. 7, Jul. 1983, pp. 567 573.;;J. M. Jaffe, A High Frequency Variable Delay Line , IEEE Transactions on Electron Devices, Dec. 1972, pp. 1292 1294.;;D. Jager, Slow Wave Propagation Along Variable Schottky Contact Microstrip Line , IEEE Transactions on Microwave Theory and Techiques, vol. MTT 24, No. 9, Sep. 1976, pp. 566 573.;;Y. Fukuoka, T. Itoh, Design Consideration of Uniform and Periodic Coplanar Schottky Variable Phase Shifter , pp. 278 282.;;Y. Fukuoka, T. Itoh, Slow Wave Coplanar Waveguide on Periodically Doped Semiconductor Substrate , IEEE Transactions on Microwave Theory and Techniques, vol. MTT 31, No. 12, Dec. 1983, pp. 1013 1017.;;J. Perini, Periodically Loaded Transmission Lines , IEEE Transactions on Microwave Theory and Techniques, vol. MTT 28, No. 9, Sep. 1980, pp. 1029 1031.;;R. A. Pucel, Design Considerations for Monolithic Microwave Circuits , IEEE Transactions on Microwave Theory and Techniques, vol. MTT 29, No. 6, Jun. 1981, pp. 513 514.;;M. B. Ketchen et al., Generation of Subpicosecond Electrical Pulses on Coplanar Transmission Lines , Appl. Phys. Lett., vol. 48, No. 12, Mar. 24, 1986, pp. 751 753.;;R. L. Wigington, N. S. Nahman, Transient Analysis of Coaxial Cables Considering Skin Effect , Proceedings of the IRE, Feb., 1957, pp. 166 174.;;G. Hasnain, A. Dienes, J. R. Whinnery, Dispersion of Picosecond Pulses in Coplanar Transmission LInes , IEEE Transactions on Microwave Theory and Techniques, vol. MTT 34, No. 6, Jun. 1986, pp. 738 741.;;Sadler, et al., A Buried p Layer Self Aligned Process for High Yield LSI Circuits .;;Archer, J. W. & Faber, M. T., High Output, Single and Dual Diode, Millimeter Wave Frequency Doubler , IEEE Transactions, 1985, MTT 33, pp. 533 538.;;Strid, et al., A DC 12 GHz Monolithic GaAs FET Distributed Amplifier, IEEE Transactions on Microwave Theory and Techniques, vol. MTT 30, No. 7, Jul. 1982, pp. 969 975.;;D. Jager, Characteristics of Travelling Waves Along the Nonlinear Transmission Lines for Monolithic Integrated Circuits: A Review:, Int. J. Electronics, 1985, vol. 58, No. 4, pp. 649 669.;;Geissberg, et al., A New Refractory Self Aligned Gate Technology for GaAs Microwave Power FET s and MMIC s.;;Bahl, et al., GaAs IC s Fabricated with the High Performance, High Yield Multifunction Self Aligned Gate Process for Radar and EW Applications.;;Bahl, et al., Multifunction SAG Process for High Yield Low Cost GaAs Microwave Integrated Circuits .;;Gunther, Uwe, et al., Variable Capacitance MIS Microstrip Lines A.E.U. Band 27 1973 , Heft 3, Report from the Institut fur Hochfrequenztechnik der Technischen Universitat Braunschweig.;;Hasegawa, H., et al., MIS and Schottky Slow Wave Coplanar Striplines on GaAs Substrates Electronics Letters, 27th Oct. 1977, vol. 13, No. 22, pp. 663 664.;;R. V. Khokhlov, On The Theory Of Shock Radio Waves In Nonlinear Lines , Radiotekhnika I Elektronika 6, No. 6, 917 925, 1961.;;C. J. Madden, et al., Generation of 3.5 ps Fall Time Shock Waves on a Monolithic GaAs Nonlinear Transmission Line , IEEE Electron Device Letters, vol. 9, No. 6, Jun. 1988, pp. 303 305.;;C. J. Madden, et al., Hyperabrupt doped GaAs Nonlinear Transmission Line for Picosecond Shock Wave Generation , Appl. Phys. Lett. 54(11), 13 Mar. 1989, pp. 1019 1021.;;Majidi Ahy, R. & Bloom, D. Millimetre Wave Active Probe Frequency Multiplier for On Wafer Characterisation of GaAs Devices and ICs , Electronics Letters, 5th Jan. 1989, vol. 25, No. 1, pp. 6 8.;;R. A. Marsland, et al., Picosecond Electronics and Optoelectronics Summaries of papers presented at the Picosecond Electronics and Optoelectronics Topical Meeting, Mar. 8 10, 1989, Salt Lake City, Utah.;;R. A. Marsland, et al., Summary of 100 GHz GaAs MMIC Sampling Head , Continental Ballroom 12/14 at 1:30 p.m.;;J. Merkelo, A dc to 20 GHz Thin Film Signal Sampler for Microwave Instrumentation ; also Waveform Sampling with Schottky Diodes , Hewlett Packard Applications Bulletin 16.;;S. Moore, et al., Microwave Sampling Effective for Ultrabroadband Frequency Conversion , MSN&CT, Feb. 1986, pp. 113 126.;;R. S. Pengelly, Microwave Field Effect Transistors Theory, Design, and Applications , Research Studies Press, p. 420.;;W. Rabus, Uber Die Frequenzvervielfachung Langs Schottky Kontakt Leitungen , AEU, Bank 28, Heft 1, Jan. 1974, pp. 1 11.;;M. J. Rodwell, et al., Nonlinear Transmission Line for Picosecond Pulse Compression and Broadband Phase Modulation , Electronic Letters, Jan. 29, 1987, vol. 23, No. 3, pp. 109 110.;;S. Seki, et al., Cross Tie Slow Wave Coplanar Waveguide On Semi insulating GaAs Substrates , Electronics Letters, vol. 17, No. 25, Dec. 10, 1981, pp. 940 941.;;Y. Shih, et al., Analysis of Printed Transmission Lines for Monolithic Integrated Circuits , Electronics Letters, vol. 18, No. 14, Jul. 8, 1982, p. 585 586.;;D. Howard, et al., The Wideband Sampling Gate an Analysis, Characterization and Application Discussion, , pp. 1 11.;;G. E. Brehm, et al., High Capacitance Ratio Monolithic Varactor Diode , Proc. Eighth Biennial Cornell Elec. Eng. Conf. 811 13/81, pp. 53 63.;;S. Gibson, Gallium Arsenide Lowers Cost and Improves Performance of Microwave Counters , Hewlett Packard Journal, Feb. 1986, pp. 4 6.;;W. M. Grove, A DC to 12.4 GHz Feedthrough Sampler for Oscilloscopes and Other RF Systems , pp. 12 15.;;M. J. Rodwell, Gate Propagation Delay and Logic Timing of GaAs Integrate Circuits Measured by Electro Optic Sampling Standford University.",EXPIRED
651,AT,T1,AT E163930 T1,099-437-247-560-67X,1998-03-15,1998,AT 93121091 T,1993-12-30,US 1097393 A,1993-01-29,AMINOCYCLOALKANOBENZODIOXOLE ALS BETA-3 SELEKTIVE ADRENERGISCHE WIRKSTOFFE,"The invention is antiobesity/antidiabetic/beta-3 agonists of the formula <CHEM> wherein the substituents Ro, R1, R4, R4', R5, R6 or n are as defined in the specification.",AMERICAN CYANAMID CO,EPSTEIN JOSEPH WILLIAM;;BIRNBERG GARY HAROLD;;WALKER GARY EDWARD;;DUTIA MINU DHANJISHA;;BLOOM JONATHAN DAVID,,https://lens.org/099-437-247-560-67X,Granted Patent,no,0,0,13,13,0,A61K31/36;;C07D317/70;;C07D413/04;;A61P3/10;;A61P3/04;;A61P3/08;;C07D413/04;;A61K31/36;;C07D317/70;;C07D413/04;;C07D317/70;;A61K31/36,A23K1/16;;A61K31/335;;A61K31/357;;A61K31/36;;A61P3/04;;A61P3/08;;A61P3/10;;C07D317/70;;C07D413/04,,0,0,,,,DISCONTINUED
652,EP,A2,EP 1694309 A2,106-997-934-732-207,2006-08-30,2006,EP 04821504 A,2004-11-12,US 2004/0038040 W;;US 71356503 A,2003-11-13,ARTIFICIAL SYNAPSE CHIP,,UNIV LELAND STANFORD JUNIOR,FISHMAN HARVEY A;;BLOOM DAVID;;BENT STACEY F;;PETERMAN MARK C;;HOOLANDI JAAN;;MEHENTI NEVILLE,,https://lens.org/106-997-934-732-207,Patent Application,yes,0,0,10,10,0,A61N1/0543;;A61N1/30;;A61N1/326;;A61N1/36046;;C12N5/0619;;C12N2503/00;;C12N2535/10;;G06N3/061;;G06N3/061;;A61N1/30;;A61N1/36046;;C12N2503/00;;C12N5/0619;;A61N1/326;;C12N2535/10;;A61N1/0543,A61K9/22;;A61L27/00;;A61N1/05;;A61N1/30;;A61N1/36;;C12M1/42;;C12M3/00;;C12N5/0793;;G06N3/06,,0,0,,,,DISCONTINUED
653,WO,A2,WO 2008/051244 A2,145-234-399-640-499,2008-05-02,2008,US 2006/0045950 W,2006-12-01,US 74177205 P,2005-12-01,ANTHRANILIC ACID DERIVATIVES USEFUL IN TREATING INFECTION WITH HEPATITIS C VIRUS,"The present invention is directed to compounds of formula (I): wherein R 1 is selected from the group consisting of -C(O)R and (a), wherein R 6 and R 7 are independently selected from H, alkyl, cycloalkyl, heterocycloalkyl, heteroaryl or aryl, any of which may be optionally substituted, G is selected from H or hydroxyl, Y is O, NH or S, X is selected from the group consisting of H, halo, alkyl, cycloalkyl, perfluoroalkyl, alkoxy, alkylthio, amino, alkylamino, dialkylamino, and CN, and n is 0, 1, 2 or 3, or a prodrug, a pharmaceutically acceptable salt, or a pharmaceutically active metabolite thereof. This invention is also directed to compositions containing compounds of the invention and methods of using both the inventive compounds and compositions thereof to treat or prevent Hepatitis C virus infection, or to inhibit replication of a Hepatitis C virus.",WYETH CORP;;BLOOM JONATHAN DAVID;;INSAF SHABANA;;NITTOLI THOMAS;;SUTHERLAND ALAN GORDON;;CURRAN KEVIN J;;WHELESS KAREN,BLOOM JONATHAN DAVID;;INSAF SHABANA;;NITTOLI THOMAS;;SUTHERLAND ALAN GORDON;;CURRAN KEVIN J;;WHELESS KAREN,,https://lens.org/145-234-399-640-499,Patent Application,yes,0,1,8,8,1,A61P31/12;;A61P31/14;;A61P43/00;;C07D317/66;;C07C235/24;;C07C237/04;;C07C251/48;;C07C317/36,,,0,0,,,,PENDING
654,WO,A2,WO 2005/079204 A2,168-119-811-722-260,2005-09-01,2005,US 2004/0038040 W,2004-11-12,US 71356503 A,2003-11-13,ARTIFICIAL SYNAPSE CHIP,"Devices and methods are provided for administering a fluid to a neuronal site. The device comprises a reservoir, an aperture in fluid connection to the reservoir, and electrical means for moving to the fluid to or through the aperture. The electrical means may take the form of electroosmotic force, piezoelectric movement of a diaphragm or electrolysis of a solution. The electrical means may be external to the host, implanted in the host or may be photodiodes activated by light, particularly where the neuronal site is associated with the retina.",UNIV LELAND STANFORD JUNIOR,FISHMAN HARVEY A;;BLOOM DAVID;;BENT STACEY F;;PETERMAN MARK C;;HOOLANDI JAAN;;MEHENTI NEVILLE,,https://lens.org/168-119-811-722-260,Patent Application,yes,0,5,10,10,0,A61N1/0543;;A61N1/30;;A61N1/326;;A61N1/36046;;C12N5/0619;;C12N2503/00;;C12N2535/10;;G06N3/061;;G06N3/061;;A61N1/30;;A61N1/36046;;C12N2503/00;;C12N5/0619;;A61N1/326;;C12N2535/10;;A61N1/0543,A61K9/22;;A61L27/00;;A61N1/05;;A61N1/30;;A61N1/36;;C12M1/42;;C12M3/00;;C12N5/0793;;G06N3/06,,0,0,,,,PENDING
655,CZ,B6,CZ 283420 B6,160-921-739-033-723,1998-04-15,1998,CS 128591 A,1991-05-03,US 51919290 A,1990-05-04,"SUBSTITUTED 5-(2-(2-ARYL-2-HYDROXYETHYL)AMINO)PROPYL)-1,3-BENZODIOXOLES, PROCESS OF THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS BASED THEREON","The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.",AMERICAN CYANAMID CO,BLOOM JONATHAN DAVID;;CLAUS THOMAS HARRISON;;DEVRIES VERN GORDON;;DOLAN JO ALENE;;DUTIA MINU DHANJISHA,,https://lens.org/160-921-739-033-723,Granted Patent,no,0,0,40,44,0,C07D317/46;;C07D413/06;;A61P3/10;;A61P3/04;;A61P3/08;;C07D317/46;;C07D413/06;;C07D317/46,A23K1/16;;A61K31/335;;A61K31/357;;A61K31/36;;A61K31/42;;A61P3/04;;A61P3/08;;A61P3/10;;C07D263/04;;C07D291/04;;C07D317/46;;C07D317/58;;C07D317/62;;C07D405/06;;C07D413/06;;C07D419/06,,0,0,,,,EXPIRED
656,SG,A1,SG 47557 A1,023-378-415-180-074,1998-04-17,1998,SG 1996002819 A,1993-12-30,US 1097393 A,1993-01-29,Aminocycloalkanobenzodioxoles as beta-3 selective adrenergic agents,"The invention is antiobesity/antidiabetic/beta-3 agonists of the formula <CHEM> wherein the substituents Ro, R1, R4, R4', R5, R6 or n are as defined in the specification.",AMERICAN CYANAMID CO,BLOOM JONATHAN DAVID;;DUTIA MINU DHANJISHA;;WALKER GARY EDWARD;;BIRNBERG GARY HAROLD;;EPSTEIN JOSEPH WILLIAM,,https://lens.org/023-378-415-180-074,Patent Application,no,0,0,13,13,0,A61K31/36;;C07D317/70;;C07D413/04;;A61P3/10;;A61P3/04;;A61P3/08;;C07D413/04;;A61K31/36;;C07D317/70;;C07D413/04;;C07D317/70;;A61K31/36,A61K31/335;;A61K31/357;;A23K1/16;;A61K31/36;;A61P3/04;;A61P3/08;;A61P3/10;;C07D317/70;;C07D413/04,,0,0,,,,PENDING
657,WO,A1,WO 1996/041226 A1,036-147-135-463-76X,1996-12-19,1996,US 9609255 W,1996-06-05,US 48045995 A,1995-06-07,A METHOD OF MAKING AND AN APPARATUS FOR A FLAT DIFFRACTION GRATING LIGHT VALVE,"A deformable grating apparatus for modulating light is made by forming an insulating layer (402) on a substrate (400), forming a first conducting layer (406) on the insulating layer (402) and then forming a sacrificial layer thereon. The sacrificial layer and the first conducting layer are then etched to define bit lines and busses to bonding pads (306, 312, 316). Then a layer of resilient material (410) is formed onto the etched layers and a reflective conducting layer (414) is formed on the resilient layer. A dielectric layer (416) is deposited on the reflective conducting layer (414). The dielectric layer (416), the reflective conducting layer (414), the resilient layer (410) and the sacrificial layer are all then etched to form a grating including a plurality of parallel elements (304). Thereafter the sacrificial layer is removed below the parallel elements, to suspend the parallel elements (304) over the first conducting layer. The surface is treated to prevent the grating from adhering to the first conducting layer. A light modulator includes a substrate with an insulating layer, and a plurality of parallel conducting layers formed on the insulating layer. The ribbons (304) are spaced apart from the conducting layers (300, 302) by an air space and mounted to the substrate in gaps between the conducting layers.",ECHELLE INC;;BORNSTEIN JONATHAN G;;BANYAI WILLIAM C;;BLOOM DAVID M;;WHITTEN RALPH G;;STAKER BRYAN P,BORNSTEIN JONATHAN G;;BANYAI WILLIAM C;;BLOOM DAVID M;;WHITTEN RALPH G;;STAKER BRYAN P,,https://lens.org/036-147-135-463-76X,Patent Application,yes,3,6,16,16,0,G02B5/1828;;G02B26/0808;;Y10S359/904;;G02B5/18;;G02B5/1828;;G02B26/0808;;Y10S359/904,G02B5/18;;G02B26/08,,1,1,010-074-622-606-125,10.1364/ol.17.000688;;19794599,"SOLGAARD O ET AL: ""DEFORMABLE GRATING OPTICAL MODULATOR"", OPTICS LETTERS, vol. 17, no. 9, 1 May 1992 (1992-05-01), pages 688 - 690, XP000265233",PATENTED
658,DE,D1,DE 69131412 D1,095-034-344-904-436,1999-08-12,1999,DE 69131412 T,1991-04-08,US 51919290 A,1990-05-04,"Substituierte 5-[2-((2-Aryl-2-hydroxyethyl)amino)propyl]-1,3-Benzodioxole","The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.",AMERICAN CYANAMID CO,BLOOM JONATHAN DAVID;;CLAUS THOMAS HARRISON;;DEVRIES VERN GORDON;;DOLAN JO ALENE;;DUTIA MINU DHANJISHA,,https://lens.org/095-034-344-904-436,Granted Patent,no,0,0,40,44,0,C07D317/46;;C07D413/06;;A61P3/10;;A61P3/04;;A61P3/08;;C07D317/46;;C07D413/06;;C07D317/46,A23K1/16;;A61K31/335;;A61K31/357;;A61K31/36;;A61K31/42;;A61P3/04;;A61P3/08;;A61P3/10;;C07D263/04;;C07D291/04;;C07D317/46;;C07D317/58;;C07D317/62;;C07D405/06;;C07D413/06;;C07D419/06,,0,0,,,,EXPIRED
659,EP,A3,EP 0455006 A3,106-617-564-743-664,1992-04-01,1992,EP 91105510 A,1991-04-08,US 51919290 A,1990-05-04,"SUBSTITUTED 5-(2-((2-ARYL-2-HYDROXYETHYL)AMINO)PROPYL)-1,3-BENZODIOXOLES","The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.",AMERICAN CYANAMID COMPANY,"BLOOM, JONATHAN DAVID;;CLAUS, THOMAS HARRISON;;DEVRIES, VERN GORDON;;DOLAN, JO ALENE;;DUTIA, MINU DHANJISHA",AMERICAN CYANAMID COMPANY (1994-01-26),https://lens.org/106-617-564-743-664,Search Report,yes,3,0,40,44,0,C07D317/46;;C07D413/06;;A61P3/10;;A61P3/04;;A61P3/08;;C07D317/46;;C07D413/06;;C07D317/46,A23K1/16;;A61K31/335;;A61K31/357;;A61K31/36;;A61K31/42;;A61P3/04;;A61P3/08;;A61P3/10;;C07D263/04;;C07D291/04;;C07D317/46;;C07D317/58;;C07D317/62;;C07D405/06;;C07D413/06;;C07D419/06,,0,0,,,,EXPIRED
660,ZA,B,ZA 200104318 B,116-380-920-668-26X,2002-08-26,2002,ZA 200104318 A,2001-05-25,US 20796198 A,1998-12-09,Thiourea inhibitors of herpes viruses.,,WYETH CORP,BLOOM JONATHAN DAVID;;DUSHIN RUSSELL GEORGE;;O'HARA BRYAN MARK;;DIGRANDI MARTIN JOSEPH;;LANG STANLEY ALBERT,,https://lens.org/116-380-920-668-26X,Granted Patent,no,0,0,17,17,0,C07D207/335;;C07D209/14;;C07D213/40;;C07D213/75;;C07D215/12;;C07D217/12;;C07D231/56;;C07D233/44;;C07D277/28;;C07D285/06;;C07D307/52;;C07D333/20;;C07D405/12;;C07D417/12;;A61P31/12;;A61P31/22;;C07D209/14;;C07D207/335;;C07D213/40;;C07D215/12;;C07D217/12;;C07D231/56;;C07D233/44;;C07D285/06;;C07D307/52;;C07D333/20;;C07D417/12,A61K31/06;;A61K31/075;;A61K31/085;;C07D295/14;;A61K31/10;;A61K31/11;;A61K31/136;;A61K31/15;;A61K31/165;;A61K31/167;;A61K31/17;;A61K31/175;;A61K31/18;;A61K31/196;;A61K31/215;;A61K31/216;;A61K31/222;;A61K31/27;;A61K31/275;;A61K31/341;;A61K31/40;;A61K31/42;;A61K31/426;;A61K31/433;;A61K31/4439;;A61K31/4453;;A61K31/4458;;A61K31/54;;A61K31/695;;A61P31/12;;A61P31/22;;C07C335/20;;C07D207/12;;C07D207/14;;C07D207/32;;C07D207/335;;C07D209/14;;C07D211/22;;C07D213/40;;C07D213/75;;C07D215/12;;C07D217/12;;C07D231/12;;C07D231/56;;C07D233/44;;C07D261/08;;C07D277/24;;C07D277/28;;C07D285/06;;C07D307/52;;C07D307/54;;C07D333/20;;C07D405/12;;C07D417/12,,0,0,,,,EXPIRED
661,HU,A,HU T59918 A,167-386-748-142-000,1992-07-28,1992,HU 149591 A,1991-05-03,US 51919290 A,1990-05-04,"PROCESS FOR PRODUCING 5-/2-//2-ARYL-2-HYDROXY-ETHYL/-AMINO/-PROPYL/-1,3-BENZODIOXOLS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM","The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.",AMERICAN CYANAMID CO,BLOOM JONATHAN DAVID;;CLAUS THOMAS HARRISON;;DEVRIES VERN GORDON;;DOLAN JO ALENE;;DUTIA MINU DHANJISHA,,https://lens.org/167-386-748-142-000,Unknown,no,0,0,40,44,0,C07D317/46;;C07D413/06;;A61P3/10;;A61P3/04;;A61P3/08;;C07D317/46;;C07D413/06;;C07D317/46,A61K31/335;;A61K31/357;;A61K31/36;;A61K31/42;;A23K1/16;;A61P3/04;;A61P3/08;;A61P3/10;;C07D263/04;;C07D291/04;;C07D317/46;;C07D317/58;;C07D317/62;;C07D405/06;;C07D413/06;;C07D419/06,,0,0,,,,EXPIRED
662,NO,L,NO 20012837 L,005-026-941-957-494,2001-07-19,2001,NO 20012837 A,2001-06-08,US 20796198 A;;US 9928838 W,1998-12-09,Tiourea-inhibitorer for herpesvirus,"Forbindelser med formel (I) hvor A er heteroaryl; R9-R12 uavhengig er hydrogen, alkyl med 1 til 4 karbonatomer, perhalogenalkyl med 1 til 4 karbonatomer, halogen, alkoksy med 1 til 4 karbonatomer eller cyano, eller R9 og RIO eller Ru og R12 sammen kan danne aryl med 5 til 7 karbonatomer; W er O, NR6 eller er fraværende; G er aryl eller heteroaryl; X er en binding, -NH, alkyl med 1 til 6 karbonatomer, alkenyl med 1 til 6 karbonatomer, alkoksy med 1 til 6 karbonatomer, tioalkyl med 1 til 6 karbonatomer, alkylamino med 1 til 6 karbonatomer eller (CH)J; og J er alkyl med 1 til 6 karbonatomer, cykloalkyl med 3 til 7 karbonatomer, fenyl eller benzyl; og n er et helt tall fra 1 til 6; eller et farmasøytisk salt derav, som er nyttige for behandling av sykdommer assosiert med herpes-virus, innbefattet humant cytomegalovirus, herpes simplex virus, Epstein-Barr-virus, varicella-zoster virus, humant herpesvirus-6 og -7 og Kaposi herpesvirus.",AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSEL GEORGE;;LANG STANLEY ALBERT;;O'HARA BRYAN MARK,,https://lens.org/005-026-941-957-494,Abstract,no,0,0,17,17,0,C07D207/335;;C07D209/14;;C07D213/40;;C07D213/75;;C07D215/12;;C07D217/12;;C07D231/56;;C07D233/44;;C07D277/28;;C07D285/06;;C07D307/52;;C07D333/20;;C07D405/12;;C07D417/12;;A61P31/12;;A61P31/22;;C07D209/14;;C07D207/335;;C07D213/40;;C07D215/12;;C07D217/12;;C07D231/56;;C07D233/44;;C07D285/06;;C07D307/52;;C07D333/20;;C07D417/12,A61K31/06;;A61K31/075;;A61K31/085;;A61K31/10;;A61K31/11;;A61K31/136;;A61K31/15;;C07D295/14;;A61K31/165;;A61K31/167;;A61K31/17;;A61K31/175;;A61K31/18;;A61K31/196;;A61K31/215;;A61K31/216;;A61K31/222;;A61K31/27;;A61K31/275;;A61K31/341;;A61K31/40;;A61K31/42;;A61K31/426;;A61K31/433;;A61K31/4439;;A61K31/4453;;A61K31/4458;;A61K31/54;;A61K31/695;;A61P31/12;;A61P31/22;;C07C335/20;;C07D207/12;;C07D207/14;;C07D207/32;;C07D207/335;;C07D209/14;;C07D211/22;;C07D213/40;;C07D213/75;;C07D215/12;;C07D217/12;;C07D231/12;;C07D231/56;;C07D233/44;;C07D261/08;;C07D277/24;;C07D277/28;;C07D285/06;;C07D307/52;;C07D307/54;;C07D333/20;;C07D405/12;;C07D417/12,,0,0,,,,DISCONTINUED
663,EP,B1,EP 0455006 B1,001-958-408-685-018,1999-07-07,1999,EP 91105510 A,1991-04-08,US 51919290 A,1990-05-04,"Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles","The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.",AMERICAN CYANAMID CO,BLOOM JONATHAN DAVID;;CLAUS THOMAS HARRISON;;DEVRIES VERN GORDON;;DOLAN JO ALENE;;DUTIA MINU DHANJISHA,AMERICAN CYANAMID COMPANY (1994-01-26),https://lens.org/001-958-408-685-018,Granted Patent,yes,3,0,40,44,0,C07D317/46;;C07D413/06;;A61P3/10;;A61P3/04;;A61P3/08;;C07D317/46;;C07D413/06;;C07D317/46,A23K1/16;;A61K31/335;;A61K31/357;;A61K31/36;;A61K31/42;;A61P3/04;;A61P3/08;;A61P3/10;;C07D263/04;;C07D291/04;;C07D317/46;;C07D317/58;;C07D317/62;;C07D405/06;;C07D413/06;;C07D419/06,,0,0,,,,EXPIRED
664,EP,B1,EP 2162120 B1,016-175-610-496-521,2016-05-04,2016,EP 08751053 A,2008-05-26,IB 2008001352 W;;US 94175507 P,2007-06-04,NANOPARTICLES COMPRISING A NON-IONIZABLE CELLULOSIC POLYMER AND AN AMPHIPHILIC NON-IONIZABLE BLOCK COPOLYMER,,BEND RES INC,BLOOM COREY JAY;;CREW MARSHALL DAVID;;MILLER WARREN KENYON;;MORGEN MICHAEL MARK;;SMITHEY DANIEL TOD,,https://lens.org/016-175-610-496-521,Granted Patent,yes,0,0,6,6,0,A61K9/5138;;A61K9/5138;;A61K9/5161;;A61K9/5161;;A61K9/5192;;A61K9/5192;;A61K31/415;;A61K31/415;;A61K31/42;;A61K31/42;;A61K31/435;;A61K31/435;;A61K47/34;;A61K47/34;;A61K47/38;;A61K47/38;;Y10S977/773;;Y10S977/773;;Y10S977/906;;Y10S977/906,A61K9/51;;A61K31/415;;A61K31/42;;A61K31/435;;A61K47/34;;A61K47/38,,4,0,,,"CELIKKAYA E ET AL: ""Rifampicin carrying poly (D,L-lactide)/poly(ethylene glycol) microspheres: loading and release"" ARTIFICIAL ORGANS, BLACKWELL SCIENTIFIC PUBLICATIONS, INC., BOSTON, US, vol. 20, no. 7, 1 July 1996 (1996-07-01), pages 743-751, XP009106825 ISSN: 0160-564X;;SHUAI X ET AL: ""Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery"" JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 98, no. 3, 27 August 2004 (2004-08-27), pages 415-426, XP004527194 ISSN: 0168-3659;;ALIABADI H M ET AL: ""Micelles of methoxy poly(ethylene oxide)-b-poly(@?-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A"" JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 104, no. 2, 18 May 2005 (2005-05-18), pages 301-311, XP004903344 ISSN: 0168-3659;;HSIEH MING-FA ET AL: ""Nano-sized micelles of block copolymers of methoxy poly(ethylene glycol)-poly(epsilon-caprolactone)-graft-2 -hydroxyethyl cellulose for doxorubicin delivery"" JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, AMERICAN SCIENTIFIC PUBLISHERS, US, vol. 8, no. 5, 1 May 2008 (2008-05-01), pages 2362-2368, XP009106758 ISSN: 1533-4880",ACTIVE
665,DK,T3,DK 0608568 T3,025-419-735-082-386,1998-09-28,1998,DK 93121091 T,1993-12-30,US 1097393 A,1993-01-29,Aminocycloalkanobenzodioxoler som beta 3-selektiveadrenerge midler,"The invention is antiobesity/antidiabetic/beta-3 agonists of the formula <CHEM> wherein the substituents Ro, R1, R4, R4', R5, R6 or n are as defined in the specification.",AMERICAN CYANAMID CO,EPSTEIN JOSEPH WILLIAM;;DUTIA MINU DHANJISHA;;BIRNBERG GARY HAROLD;;WALKER GARY EDWARD;;BLOOM JONATHAN DAVID,,https://lens.org/025-419-735-082-386,Granted Patent,no,0,0,13,13,0,A61K31/36;;C07D317/70;;C07D413/04;;A61P3/10;;A61P3/04;;A61P3/08;;C07D413/04;;A61K31/36;;C07D317/70;;C07D413/04;;C07D317/70;;A61K31/36,A23K1/16;;A61K31/335;;A61K31/357;;A61K31/36;;A61P3/04;;A61P3/08;;A61P3/10;;C07D317/70;;C07D413/04,,0,0,,,,EXPIRED
666,NO,D0,NO 20012834 D0,016-391-642-849-711,2001-06-08,2001,NO 20012834 A,2001-06-08,US 20831698 A;;US 9928844 W,1998-12-09,Acetamid- og substituerte acetamid-holdige tioureainhibitorer for herpesvirus,,AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSEL GEORGE;;LANG STANLEY ALBERT;;O'HARA BRYAN MARK,,https://lens.org/016-391-642-849-711,Patent Application,no,0,0,18,18,0,C07C335/20;;C07C335/22;;C07D207/09;;C07D207/14;;C07D211/58;;C07D261/10;;A61P31/22,A61K31/17;;C07D249/04;;A61K31/341;;A61K31/343;;A61K31/345;;A61K31/36;;A61K31/381;;A61K31/40;;A61K31/403;;A61K31/4192;;A61K31/42;;A61K31/433;;A61K31/437;;A61K31/4409;;A61K31/4468;;A61K31/47;;A61K31/4965;;A61K31/5375;;A61K31/56;;A61P31/22;;C07C335/20;;C07C335/22;;C07C337/06;;C07D207/09;;C07D207/14;;C07D207/34;;C07D209/48;;C07D211/58;;C07D213/81;;C07D215/48;;C07D217/26;;C07D221/12;;C07D241/24;;C07D261/08;;C07D261/10;;C07D265/30;;C07D285/06;;C07D295/12;;C07D307/56;;C07D307/73;;C07D307/85;;C07D317/68;;C07D333/38;;C07D333/70,,0,0,,,,DISCONTINUED
667,PT,A,PT 97540 A,028-946-960-134-430,1992-01-31,1992,PT 9754091 A,1991-05-02,US 51919290 A,1990-05-04,"PROCESSO PARA A PREPARACAO DE 5-(2-((2-ARIL-2-HIDROXIETIL)AMINO)PROPIL)-1,3-BENZODIOXOLES SUBSTITUIDOS","The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.",AMERICAN CYANAMID CO,BLOOM JONATHAN DAVID;;CLAUS THOMAS HARRISON;;DEVRIES VERN GORDON;;DOLAN JO ALENE;;DUTIA MINU DHANJISHA,,https://lens.org/028-946-960-134-430,Patent Application,no,0,0,40,44,0,C07D317/46;;C07D413/06;;A61P3/10;;A61P3/04;;A61P3/08;;C07D317/46;;C07D413/06;;C07D317/46,A61K31/335;;A61K31/357;;A23K1/16;;A61K31/36;;A61K31/42;;A61P3/04;;A61P3/08;;A61P3/10;;C07D263/04;;C07D291/04;;C07D317/46;;C07D317/58;;C07D317/62;;C07D405/06;;C07D413/06;;C07D419/06,,0,0,,,,EXPIRED
668,EP,A2,EP 2162120 A2,034-023-252-798-510,2010-03-17,2010,EP 08751053 A,2008-05-26,IB 2008001352 W;;US 94175507 P,2007-06-04,NANOPARTICLES COMPRISING A NON-IONIZABLE CELLULOSIC POLYMER AND AN AMPHIPHILIC NON-IONIZABLE BLOCK COPOLYMER,,BEND RES INC,BLOOM COREY JAY;;CREW MARSHALL DAVID;;MILLER WARREN KENYON;;MORGEN MICHAEL MARK;;SMITHEY DANIEL TOD,,https://lens.org/034-023-252-798-510,Patent Application,yes,0,4,6,6,0,A61K9/5138;;A61K9/5138;;A61K9/5161;;A61K9/5161;;A61K9/5192;;A61K9/5192;;A61K31/415;;A61K31/415;;A61K31/42;;A61K31/42;;A61K31/435;;A61K31/435;;A61K47/34;;A61K47/34;;A61K47/38;;A61K47/38;;Y10S977/773;;Y10S977/773;;Y10S977/906;;Y10S977/906,A61K9/51;;A61K31/415;;A61K31/42;;A61K31/435;;A61K47/34;;A61K47/38,,1,0,,,See references of WO 2008149192A3,ACTIVE
669,PL,A1,PL 348177 A1,055-578-163-387-577,2002-05-06,2002,PL 34817799 A,1999-12-06,US 9928892 W;;US 20854098 A,1998-12-09,THIOUREA INHIBITORS OF HERPES VIRUSES,,AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;O'HARA BRYAN MARK,,https://lens.org/055-578-163-387-577,Patent Application,no,0,0,21,89,0,C07D213/75;;C07D213/81;;C07D405/12;;C07D417/12;;C07D307/85;;C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81,A61K/;;A61K31/12;;A61K31/33;;C07D213/81;;A61K31/425;;A61K31/44;;A61K31/4427;;A61K31/443;;A61K31/4436;;A61K31/444;;A61P/;;A61P31/12;;A61P31/22;;C07D/;;C07D213/75;;C07D401/12;;C07D405/12;;C07D417/12,,0,0,,,,DISCONTINUED
670,WO,A2,WO 2008/135829 A2,080-915-922-854-115,2008-11-13,2008,IB 2008001061 W,2008-04-21,US 91569707 P,2007-05-03,NANOPARTICLES COMPRISING COX-2 INHIBITORS AND A NON-IONIZABLE POLYMER,A pharmaceutical composition comprises nanoparticles comprising a COX-2 inhibitor and a poorly aqueous soluble non-ionizable polymer.,PFIZER PROD INC;;BLOOM COREY JAY;;CREW MARSHALL DAVID;;MILLER WARREN KENYON;;MORGEN MICHAEL MARK;;SMITHEY DANIEL TOD,BLOOM COREY JAY;;CREW MARSHALL DAVID;;MILLER WARREN KENYON;;MORGEN MICHAEL MARK;;SMITHEY DANIEL TOD,,https://lens.org/080-915-922-854-115,Patent Application,yes,0,1,2,2,0,A61K9/5123;;A61K9/5146;;A61K9/5161;;A61K9/5169;;A61K9/5192;;A61K31/415;;A61K31/42,A61K9/51;;A61K31/415;;A61K31/42,,0,0,,,,PENDING
671,NO,B,NO 177822 B,086-892-021-870-926,1995-08-21,1995,NO 911751 A,1991-05-03,US 51919290 A,1990-05-04,"Analogifremgangsmåte ved fremstilling av substituerte 5-(2-((2-aryl-2-hydroksyetyl)-amino)propyl)-1,3-benzodioksoler","The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.",AMERICAN CYANAMID CO,BLOOM JONATHAN DAVID;;CLAUS THOMAS HARRISON;;DEVRIES VERN GORDON;;DOLAN JO ALENE;;DUTIA MINU DHANJISHA,,https://lens.org/086-892-021-870-926,Unknown,no,0,0,40,44,0,C07D317/46;;C07D413/06;;A61P3/10;;A61P3/04;;A61P3/08;;C07D317/46;;C07D413/06;;C07D317/46,A61K31/335;;A61K31/357;;A23K1/16;;A61K31/36;;A61K31/42;;A61P3/04;;A61P3/08;;A61P3/10;;C07D263/04;;C07D291/04;;C07D317/46;;C07D317/58;;C07D317/62;;C07D405/06;;C07D413/06;;C07D419/06,,0,0,,,,EXPIRED
672,ID,A,ID 29064 A,109-870-639-852-821,2001-07-26,2001,ID 20011230 A,1999-12-06,US 20854098 A,1998-12-09,THIOUREA PENCEGAH-PENCEGAH VIRUS-VIRUS HERPES,,AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;O'HARA BRYN MARK,,https://lens.org/109-870-639-852-821,Patent Application,no,0,0,21,89,0,C07D213/75;;C07D213/81;;C07D405/12;;C07D417/12;;C07D307/85;;C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81,A61K/;;A61K31/12;;A61K31/33;;A61K31/425;;A61K31/44;;A61K31/4427;;C07D213/81;;A61K31/443;;A61K31/4436;;A61K31/444;;A61P/;;A61P31/12;;A61P31/22;;C07D/;;C07D213/75;;C07D401/12;;C07D405/12;;C07D417/12,,0,0,,,,PENDING
673,HU,A2,HU P0104758 A2,118-082-960-921-968,2002-04-29,2002,HU P0104758 A,1999-12-06,US 20854098 A;;US 9928892 W,1998-12-09,THIOUREA INHIBITORS OF HERPES VIRUSES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM,"A tal lm ny (I) ltal nos képletű vegyületekre és gyógy szatilagelfogadható sóikra vonatkozik, ahol R1-R5 jelentése egym stólfüggetlenül hidrogénatom, alkil-, alkenil-, alkinil-,perhalogénalkil-, cikloalkil-, heterocikloalkil-, aril-,heteroarilcsoport, halogénatom, ciano-, nitrocsoport, -CO2R6, -COR6, -OR6, -SR6, -SOR6, -SO2R6, -CONR7R8, -NR6N(R7R8), -N(R7 R8) vagy W-Y-(CH2)n-Z ltal nos képletű csoport, vagy R2 és R3 vagy R3 és R4 együtt3-7 tagú heterocikloalkilcsoportot vagy 3-7 tagú heteroarilcsoportotalkot; R6 és R7 jelentése egym stól függetlenül hidrogénatom, alkil-,perhalogénalkil-, vagy arilcsoport; R8 jelentése hidrogénatom, alkil-,perhalogénalkil-, cikloalkil-, heterocikloalkil-, aril-,heteroarilcsoport, vagy R7 és R8 együtt 3-7 tagúheterocikloalkilcsoportot alkothat; A jelentése heteroarilcsoport; Wjelentése oxigénatom, -NR6 ltal nos képletű csoport, vagy hi nyzik; Yjelentése -(CO)- vagy -(CO2)-, vagy hi nyzik; Z jelentése 1-4szénatomos alkil-, cianocsoport, -CO2R6, -COR6, -CONR7R8, -OCOR6, -NR6COR7, -OCONR6, -OR6, -SR6, -SOR6, -SO2R6, SR6N(R7R8), -N(R7R8) ltalnos képletű csoport vagy fenilcsoport; G jelentése aril- vagyheteroarilcsoport; X jelentése vegyértékk""tés, -NH-, alkil-, alkenil-,alkoxi-, alkil-tio-, 1-6 szénatomos alkil-amino-csoport vagy (CH)Jltal nos képletű csoport; J jelentése alkil-, cikloalkil-, fenil- vagybenzilcsoport; és n értéke 1-6. A vegyületek g tolj k és/vagy gyógyítjk a herpeszvírusok, péld ul a hum n citomegalovírusok, herpeszszimplex vírusok, Epstein-Barr vírus, varicella-zoster vírus, hum nherpeszvírus-6 és -7 és a Kaposi herpeszvírus ltal okozottbetegségeket. A tal lm ny a vegyületeket tartalmazógyógyszerkészítményekre és a vegyületek alkalmaz s ra is vonatkozik. Ó",AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;O'HARA BRYAN MARK,,https://lens.org/118-082-960-921-968,Patent Application,no,0,0,21,89,0,C07D213/75;;C07D213/81;;C07D405/12;;C07D417/12;;C07D307/85;;C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81,A61K/;;C07D213/81;;A61K31/12;;A61K31/33;;A61K31/425;;A61K31/44;;A61K31/4427;;A61K31/443;;A61K31/4436;;A61K31/444;;A61P/;;A61P31/12;;A61P31/22;;C07D/;;C07D213/75;;C07D401/12;;C07D405/12;;C07D417/12,,0,0,,,,PENDING
674,FI,B,FI 94862 B,142-113-358-005-51X,1995-07-31,1995,FI 912142 A,1991-05-03,US 51919290 A,1990-05-04,"Menetelmä uusien, terapeuttisesti käyttökelpoisten 5-(2-((2-aryyli-2-hydroksietyyli)amino)propyyli)-1,3-bentsodioksolijohdannaisten valmistamiseksi","The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.",AMERICAN CYANAMID CO,BLOOM JONATHAN DAVID;;CLAUS THOMAS HARRISON;;DEVRIES VERN GORDON;;DOLAN JO ALENE;;DUTIA MINU DHANJISHA,,https://lens.org/142-113-358-005-51X,Patent Application,no,0,0,40,44,0,C07D317/46;;C07D413/06;;A61P3/10;;A61P3/04;;A61P3/08;;C07D317/46;;C07D413/06;;C07D317/46,A61K31/335;;A23K1/16;;A61K31/357;;A61K31/36;;A61K31/42;;A61P3/04;;A61P3/08;;A61P3/10;;C07D263/04;;C07D291/04;;C07D317/46;;C07D317/58;;C07D317/62;;C07D405/06;;C07D413/06;;C07D419/06,,0,0,,,,EXPIRED
675,WO,A3,WO 2005/079204 A3,152-104-337-803-852,2006-06-08,2006,US 2004/0038040 W,2004-11-12,US 71356503 A,2003-11-13,ARTIFICIAL SYNAPSE CHIP,"Devices and methods are provided for administering a fluid to a neuronal site. The device comprises a reservoir, an aperture in fluid connection to the reservoir, and electrical means for moving to the fluid to or through the aperture. The electrical means may take the form of electroosmotic force, piezoelectric movement of a diaphragm or electrolysis of a solution. The electrical means may be external to the host, implanted in the host or may be photodiodes activated by light, particularly where the neuronal site is associated with the retina.",UNIV THE BOARD OF TRUSTEES OF,FISHMAN HARVEY A;;BLOOM DAVID;;BENT STACEY F;;PETERMAN MARK C;;HOOLANDI JAAN;;MEHENTI NEVILLE,,https://lens.org/152-104-337-803-852,Search Report,yes,2,0,10,10,0,A61N1/0543;;A61N1/30;;A61N1/326;;A61N1/36046;;C12N5/0619;;C12N2503/00;;C12N2535/10;;G06N3/061;;G06N3/061;;A61N1/30;;A61N1/36046;;C12N2503/00;;C12N5/0619;;A61N1/326;;C12N2535/10;;A61N1/0543,A61K9/22;;A61L27/00;;A61N1/05;;A61N1/30;;A61N1/36;;C12M1/42;;C12M3/00;;C12N5/0793;;G06N3/06,,0,0,,,,PENDING
676,WO,A3,WO 2008/149192 A3,021-539-062-802-73X,2009-02-05,2009,IB 2008001352 W,2008-05-26,US 94175507 P,2007-06-04,NANOPARTICLES COMPRISING A NON-IONIZABLE CELLULOSIC POLYMER AND AN AMPHIPHILIC NON-IONIZABLE BLOCK COPOLYMER,"A pharmaceutical composition comprises nanoparticles comprising a poorly water-soluble drug, a poorly aqueous soluble non-ionizable cellulosic polymer, and a poorly aqueous soluble polymeric amphiphilic non-ionizable block copolymer.",PFIZER PROD INC;;BLOOM COREY JAY;;CREW MARSHALL DAVID;;MILLER WARREN KENYON;;MORGEN MICHAEL MARK;;SMITHEY DANIEL TOD,BLOOM COREY JAY;;CREW MARSHALL DAVID;;MILLER WARREN KENYON;;MORGEN MICHAEL MARK;;SMITHEY DANIEL TOD,,https://lens.org/021-539-062-802-73X,Search Report,yes,0,1,6,6,0,A61K9/5138;;A61K9/5138;;A61K9/5161;;A61K9/5161;;A61K9/5192;;A61K9/5192;;A61K31/415;;A61K31/415;;A61K31/42;;A61K31/42;;A61K31/435;;A61K31/435;;A61K47/34;;A61K47/34;;A61K47/38;;A61K47/38;;Y10S977/773;;Y10S977/773;;Y10S977/906;;Y10S977/906,A61K9/51;;A61K31/415;;A61K31/42;;A61K31/435;;A61K47/34;;A61K47/38,,4,4,013-320-933-494-247;;030-636-163-258-383;;056-450-653-736-69X;;085-018-875-201-219,8828763;;10.1111/j.1525-1594.1996.tb04535.x;;15312997;;10.1016/j.jconrel.2004.06.003;;15907581;;10.1016/j.jconrel.2005.02.015;;18572650,"CELIKKAYA E ET AL: ""Rifampicin carrying poly (D,L-lactide)/poly(ethylene glycol) microspheres: loading and release"", ARTIFICIAL ORGANS, BLACKWELL SCIENTIFIC PUBLICATIONS, INC., BOSTON, US, vol. 20, no. 7, 1 July 1996 (1996-07-01), pages 743 - 751, XP009106825, ISSN: 0160-564X;;SHUAI X ET AL: ""Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery"", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 98, no. 3, 27 August 2004 (2004-08-27), pages 415 - 426, XP004527194, ISSN: 0168-3659;;ALIABADI H M ET AL: ""Micelles of methoxy poly(ethylene oxide)-b-poly(@?-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A"", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 104, no. 2, 18 May 2005 (2005-05-18), pages 301 - 311, XP004903344, ISSN: 0168-3659;;HSIEH MING-FA ET AL: ""Nano-sized micelles of block copolymers of methoxy poly(ethylene glycol)-poly(epsilon-caprolactone)-graft-2-hydroxyethyl cellulose for doxorubicin delivery"", JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, AMERICAN SCIENTIFIC PUBLISHERS, US, vol. 8, no. 5, 1 May 2008 (2008-05-01), pages 2362 - 2368, XP009106758, ISSN: 1533-4880",PENDING
677,BR,A2,BR PI0614668 A2,023-395-853-137-556,2011-04-12,2011,BR PI0614668 A,2006-07-26,US 70404605 P;;US 74760406 P;;US 2006/0029062 W,2005-07-29,"bomba de pistão alternativo com válvula de ar, detentor e cabeçote móvel","A poppet assembly includes a poppet housing (41) having an axis and first and second sets of housing ports (41a, 41b), which are axially spaced. A poppet seat (44) is provided in the housing, the seat having a set of seat ports (44a), and a poppet (43) is also located in the housing and is retained by the seat. The poppet has a set of poppet ports (43a), is biased against the seat in a first position and can be moved to a second position away from the seat. A poppet actuator (45), which is located in the seat, partially surrounds the poppet and is biased away from the poppet. When the poppet is in its first position, the first set of housing ports (41b) are in fluid communication with the second set of housing ports (41a) through the poppet ports (43a), and when it is in its second position, the first set of housing ports (41b) are in fluid communication with the seat ports (44a).",GRACO MINNESOTA INC,BAUCK MARK L;;ISAIS JOHN F;;WEINBERGER MARK T;;PITTMAN DAVID M;;BLOOM MICHAEL E,,https://lens.org/023-395-853-137-556,Patent Application,no,0,0,28,28,0,F04B9/12;;F04B9/125;;F16K11/02;;F04B49/00;;F04B35/00;;F04B9/08;;F04B9/12;;F04B9/125;;F16K11/02,F04B49/00;;F04B9/08;;F04B35/02,,0,0,,,,DISCONTINUED
678,AT,T1,AT E181914 T1,095-127-302-295-460,1999-07-15,1999,AT 91105510 T,1991-04-08,US 51919290 A,1990-05-04,"SUBSTITUIERTE 5-(2-((2-ARYL-2- HYDROXYETHYL)AMINO)PROPYL>-1,3-BENZODIOXOLE","The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.",AMERICAN CYANAMID CO,BLOOM JONATHAN DAVID;;CLAUS THOMAS HARRISON;;DEVRIES VERN GORDON;;DOLAN JO ALENE;;DUTIA MINU DHANJISHA,,https://lens.org/095-127-302-295-460,Granted Patent,no,0,0,40,44,0,C07D317/46;;C07D413/06;;A61P3/10;;A61P3/04;;A61P3/08;;C07D317/46;;C07D413/06;;C07D317/46,A23K1/16;;A61K31/335;;A61K31/357;;A61K31/36;;A61K31/42;;A61P3/04;;A61P3/08;;A61P3/10;;C07D263/04;;C07D291/04;;C07D317/46;;C07D317/58;;C07D317/62;;C07D405/06;;C07D413/06;;C07D419/06,,0,0,,,,DISCONTINUED
679,EP,A1,EP 3711059 A1,112-854-530-923-989,2020-09-23,2020,EP 18814757 A,2018-11-16,US 201762587842 P;;US 201862647572 P;;US 201862712063 P;;US 201816192341 A;;US 2018/0061419 W,2017-11-17,"PERSONAL, OMIC, AND PHENOTYPE DATA COMMUNITY AGGREGATION PLATFORM",,LUNAPBC,KAIN ROBERT C;;BARRY DAWN MARY;;LEWIS DAVID;;BLOOM KENNETH ROBERT;;KAHN SCOTT;;VELINOV BOJIL,,https://lens.org/112-854-530-923-989,Patent Application,yes,0,0,10,12,0,G16H10/20;;G06Q40/08;;Y02A90/10;;G16H10/20;;G16H10/60;;G06F16/2379;;G06F16/958;;G06N20/00;;G06Q40/08,G16H10/20,,0,0,,,,PENDING
680,HU,A9,HU 211607 A9,170-857-803-927-06X,1995-12-28,1995,HU 9500457 P,1995-06-27,US 51919290 A,1990-05-04,"SUBSTITUTED 5-(2-((2-ARYL-2-HYDROXYETHYL)AMINO)PROPYL)-1,3-BENZODIOXOLES","The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.",AMERICAN CYANAMID CO,DEVRIES VERN GORDON;;BLOOM JONATHAN DAVID;;CLAUS THOMAS HARRISON;;DOLAN JO ALENE;;DUTIA MINU DHANJISHA,,https://lens.org/170-857-803-927-06X,Unknown,no,0,0,40,44,0,C07D317/46;;C07D413/06;;A61P3/10;;A61P3/04;;A61P3/08;;C07D317/46;;C07D413/06;;C07D317/46,A61K31/335;;A61K31/357;;A23K1/16;;A61K31/36;;A61K31/42;;A61P3/04;;A61P3/08;;A61P3/10;;C07D263/04;;C07D291/04;;C07D317/46;;C07D317/58;;C07D317/62;;C07D405/06;;C07D413/06;;C07D419/06,,0,0,,,,PENDING
681,ES,T3,ES 2133273 T3,010-310-471-699-329,1999-09-16,1999,ES 91105510 T,1991-04-08,US 51919290 A,1990-05-04,"5-(2-((2-ARIL-2-HIDROXIETIL)AMINO)PROPIL)-1,3-BENZODIOXOLES SUBSTITUIDOS.","The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.",AMERICAN CYANAMID CO,BLOOM JONATHAN DAVID;;CLAUS THOMAS HARRISON;;DEVRIES VERN GORDON;;DOLAN JO ALENE;;DUTIA MINU DHANJISHA,,https://lens.org/010-310-471-699-329,Granted Patent,no,0,0,40,44,0,C07D317/46;;C07D413/06;;A61P3/10;;A61P3/04;;A61P3/08;;C07D317/46;;C07D413/06;;C07D317/46,A61K31/335;;A61K31/357;;A61K31/36;;A61K31/42;;A23K1/16;;A61P3/04;;A61P3/08;;A61P3/10;;C07D263/04;;C07D291/04;;C07D317/46;;C07D317/58;;C07D317/62;;C07D405/06;;C07D413/06;;C07D419/06,,0,0,,,,EXPIRED
682,AU,B2,AU 756043 B2,028-632-749-443-850,2003-01-02,2003,AU 2000/031122 A,1999-12-06,US 20854098 A;;US 9928892 W,1998-12-09,Thiourea inhibitors of herpes viruses,,WYETH CORP,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;O'HARA BRYAN MARK,WYETH (2002-10-03),https://lens.org/028-632-749-443-850,Granted Patent,no,0,0,21,89,0,C07D213/75;;C07D213/81;;C07D405/12;;C07D417/12;;C07D307/85;;C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81,C07D213/81;;A61K/;;A61K31/12;;A61K31/33;;A61K31/425;;A61K31/44;;A61K31/4427;;A61K31/443;;A61K31/4436;;A61K31/444;;A61P/;;A61P31/12;;A61P31/22;;C07D/;;C07D213/75;;C07D401/12;;C07D405/12;;C07D417/12,,0,0,,,,EXPIRED
683,PL,A1,PL 349131 A1,112-997-530-673-746,2002-07-01,2002,PL 34913199 A,1999-12-06,US 9928844 W;;US 20831698 A,1998-12-09,ACETAMIDE AND SUBSTITUTED ACETAMIDE-CONTAINING THIOUREA INHIBITORS OF HERPES VIRUSES,,AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;O'HARA BRYAN MARK,,https://lens.org/112-997-530-673-746,Patent Application,no,0,0,18,18,0,C07C335/20;;C07C335/22;;C07D207/09;;C07D207/14;;C07D211/58;;C07D261/10;;A61P31/22,A61K31/17;;A61K31/341;;A61K31/343;;A61K31/345;;A61K31/36;;A61K31/381;;A61K31/40;;C07D249/04;;A61K31/403;;A61K31/4192;;A61K31/42;;A61K31/433;;A61K31/437;;A61K31/4409;;A61K31/4468;;A61K31/47;;A61K31/4965;;A61K31/5375;;A61K31/56;;A61P31/22;;C07C335/20;;C07C335/22;;C07C337/06;;C07D207/09;;C07D207/14;;C07D207/34;;C07D209/48;;C07D211/58;;C07D213/81;;C07D215/48;;C07D217/26;;C07D221/12;;C07D241/24;;C07D261/08;;C07D261/10;;C07D265/30;;C07D285/06;;C07D295/12;;C07D307/56;;C07D307/73;;C07D307/85;;C07D317/68;;C07D333/38;;C07D333/70,,0,0,,,,DISCONTINUED
684,AU,A1,AU 2018/370131 A1,122-558-398-091-332,2020-06-18,2020,AU 2018/370131 A,2018-11-16,US 201862712063 P;;US 201816192341 A;;US 201762587842 P;;US 201862647572 P;;US 2018/0061419 W,2017-11-17,"Personal, OMIC, and phenotype data community aggregation platform","A system and method are disclosed for the collection and aggregation of genomic, medical, and other data of interest for individuals and populations that may be of interest for analysis, research, pharmaceutical development, medical treatment, and so forth. Contributors become members of a community upon creation of an account and providing of data or files. The data is received and processed, such as to analyze, structure, perform quality control, and curate the data. Value or shares in one or more community databases are computed and attributed to each contributing member. The data is controlled to avoid identification or personalization. Third parties interested in the database information may contribute value (e.g., pay) for access and use. Value flows back to the members and to a system administrative entity.",LUNAPBC,KAIN ROBERT C;;BARRY DAWN MARY;;LEWIS DAVID;;BLOOM KENNETH ROBERT;;KAHN SCOTT;;VELINOV BOJIL,,https://lens.org/122-558-398-091-332,Patent Application,no,0,0,10,12,0,G16H10/20;;G06Q40/08;;Y02A90/10;;G16H10/20;;G16H10/60;;G06F16/2379;;G06F16/958;;G06N20/00;;G06Q40/08,G16H10/20,,0,0,,,,DISCONTINUED
685,EP,A2,EP 1966181 A2,138-602-910-159-209,2008-09-10,2008,EP 06851777 A,2006-12-01,US 2006/0045950 W;;US 74177205 P,2005-12-01,ANTHRANILIC ACID DERIVATIVES USEFUL IN TREATING INFECTION WITH HEPATITIS C VIRUS,,WYETH CORP,BLOOM JONATHAN DAVID;;INSAF SHABANA;;NITTOLI THOMAS;;SUTHERLAND ALAN GORDON;;CURRAN KEVIN J;;WHELESS KAREN,WYETH LLC (2010-04-21),https://lens.org/138-602-910-159-209,Patent Application,yes,0,0,8,8,0,A61P31/12;;A61P31/14;;A61P43/00;;C07D317/66;;C07C235/24;;C07C237/04;;C07C251/48;;C07C317/36,C07D317/66;;A61K31/36;;A61P31/12;;C07C235/24;;C07C237/04;;C07C251/48,,1,0,,,See references of WO 2008051244A3,DISCONTINUED
686,EP,A4,EP 1694309 A4,153-216-625-297-678,2007-12-12,2007,EP 04821504 A,2004-11-12,US 2004/0038040 W;;US 71356503 A,2003-11-13,ARTIFICIAL SYNAPSE CHIP,,UNIV LELAND STANFORD JUNIOR,FISHMAN HARVEY A;;BLOOM DAVID;;BENT STACEY F;;PETERMAN MARK C;;HOOLANDI JAAN;;MEHENTI NEVILLE,,https://lens.org/153-216-625-297-678,Search Report,no,1,0,10,10,0,A61N1/0543;;A61N1/30;;A61N1/326;;A61N1/36046;;C12N5/0619;;C12N2503/00;;C12N2535/10;;G06N3/061;;G06N3/061;;A61N1/30;;A61N1/36046;;C12N2503/00;;C12N5/0619;;A61N1/326;;C12N2535/10;;A61N1/0543,A61K9/22;;A61L27/00;;A61N1/05;;A61N1/30;;A61N1/36;;C12M1/42;;C12M3/00;;C12N5/0793;;G06N3/06,,4,3,088-829-870-198-848;;027-940-803-312-957;;024-968-142-168-85X,10.1016/s0925-4005(03)00266-1;;10.1016/s0167-7799(02)01905-4;;11841863;;15218102;;pmc454196;;10.1073/pnas.0402089101,"FISHMAN H A ET AL: ""THE ARTIFICIAL SYNAPSE CHIP: MULTI - CELLULAR NEUROTRANSMITTER - BASED RETINAL STIMULATION"", ARVO ANNUAL MEETING ABSTRACT SEARCH AND PROGRAM PLANNER, XX, XX, vol. 2003, 4 May 2003 (2003-05-04) - 8 May 2003 (2003-05-08), pages ABSTRACT NO5080, XP008085066;;ANDERSSON H ET AL: ""Microfluidic devices for cellomics: a review"", SENSORS AND ACTUATORS B, ELSEVIER SEQUOIA S.A., LAUSANNE, CH, vol. 92, no. 3, 15 July 2003 (2003-07-15), pages 315 - 325, XP004427497, ISSN: 0925-4005;;CHOVAN T ET AL: ""Microfabricated devices in biotechnology and biochemical processing"", TRENDS IN BIOTECHNOLOGY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, vol. 20, no. 3, 1 March 2002 (2002-03-01), pages 116 - 122, XP004335895, ISSN: 0167-7799;;PETERMAN MARK C ET AL: ""Localized chemical release from an artificial synapse chip"", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 101, no. 27, 6 July 2004 (2004-07-06), pages 9951 - 9954, XP002456864, ISSN: 0027-8424",DISCONTINUED
687,NO,C,NO 177822 C,183-578-437-101-048,1995-11-29,1995,NO 911751 A,1991-05-03,US 51919290 A,1990-05-04,"Analogifremgangsmåte ved fremstilling av substituerte 5-(2-((2-aryl-2-hydroksyetyl)-amino)propyl)-1,3-benzodioksoler","The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.",AMERICAN CYANAMID CO,BLOOM JONATHAN DAVID;;CLAUS THOMAS HARRISON;;DEVRIES VERN GORDON;;DOLAN JO ALENE;;DUTIA MINU DHANJISHA,,https://lens.org/183-578-437-101-048,Granted Patent,no,0,0,40,44,0,C07D317/46;;C07D413/06;;A61P3/10;;A61P3/04;;A61P3/08;;C07D317/46;;C07D413/06;;C07D317/46,A61K31/335;;A61K31/357;;A23K1/16;;A61K31/36;;A61K31/42;;A61P3/04;;A61P3/08;;A61P3/10;;C07D263/04;;C07D291/04;;C07D317/46;;C07D317/58;;C07D317/62;;C07D405/06;;C07D413/06;;C07D419/06,,0,0,,,,EXPIRED
688,WO,A3,WO 2008/051244 A3,015-967-168-827-285,2008-07-17,2008,US 2006/0045950 W,2006-12-01,US 74177205 P,2005-12-01,ANTHRANILIC ACID DERIVATIVES USEFUL IN TREATING INFECTION WITH HEPATITIS C VIRUS,"The present invention is directed to compounds of formula (I): wherein R 1 is selected from the group consisting of -C(O)R and (a), wherein R 6 and R 7 are independently selected from H, alkyl, cycloalkyl, heterocycloalkyl, heteroaryl or aryl, any of which may be optionally substituted, G is selected from H or hydroxyl, Y is O, NH or S, X is selected from the group consisting of H, halo, alkyl, cycloalkyl, perfluoroalkyl, alkoxy, alkylthio, amino, alkylamino, dialkylamino, and CN, and n is 0, 1, 2 or 3, or a prodrug, a pharmaceutically acceptable salt, or a pharmaceutically active metabolite thereof. This invention is also directed to compositions containing compounds of the invention and methods of using both the inventive compounds and compositions thereof to treat or prevent Hepatitis C virus infection, or to inhibit replication of a Hepatitis C virus.",WYETH CORP;;BLOOM JONATHAN DAVID;;INSAF SHABANA;;NITTOLI THOMAS;;SUTHERLAND ALAN GORDON;;CURRAN KEVIN J;;WHELESS KAREN,BLOOM JONATHAN DAVID;;INSAF SHABANA;;NITTOLI THOMAS;;SUTHERLAND ALAN GORDON;;CURRAN KEVIN J;;WHELESS KAREN,,https://lens.org/015-967-168-827-285,Search Report,yes,1,0,8,8,1,A61P31/12;;A61P31/14;;A61P43/00;;C07D317/66;;C07C235/24;;C07C237/04;;C07C251/48;;C07C317/36,C07D317/66;;A61K31/36;;A61P31/12;;C07C235/24;;C07C237/04;;C07C251/48,,0,0,,,,PENDING
689,WO,A3,WO 2008/135829 A3,032-103-000-405-191,2009-03-12,2009,IB 2008001061 W,2008-04-21,US 91569707 P,2007-05-03,NANOPARTICLES COMPRISING COX-2 INHIBITORS AND A NON-IONIZABLE POLYMER,A pharmaceutical composition comprises nanoparticles comprising a COX-2 inhibitor and a poorly aqueous soluble non-ionizable polymer.,PFIZER PROD INC;;BLOOM COREY JAY;;CREW MARSHALL DAVID;;MILLER WARREN KENYON;;MORGEN MICHAEL MARK;;SMITHEY DANIEL TOD,BLOOM COREY JAY;;CREW MARSHALL DAVID;;MILLER WARREN KENYON;;MORGEN MICHAEL MARK;;SMITHEY DANIEL TOD,,https://lens.org/032-103-000-405-191,Search Report,yes,2,0,2,2,0,A61K9/5123;;A61K9/5146;;A61K9/5161;;A61K9/5169;;A61K9/5192;;A61K31/415;;A61K31/42,A61K9/51;;A61K31/415;;A61K31/42,,1,1,042-119-429-959-102,16980271;;10.1080/02652040600682390,"MCCARRON PAUL A ET AL: ""Celecoxib-loaded poly(D,L-lactide-co-glycolide) nanoparticles prepared using a novel and controllable combination of diffusion and emulsification steps as part of the salting-out procedure"", JOURNAL OF MICROENCAPSULATION, TAYLOR AND FRANCIS, BASINGSTOKE, GB, vol. 23, no. 5, 1 August 2006 (2006-08-01), pages 480 - 498, XP008097270, ISSN: 0265-2048",PENDING
690,WO,A2,WO 2008/149192 A2,034-322-726-570-121,2008-12-11,2008,IB 2008001352 W,2008-05-26,US 94175507 P,2007-06-04,NANOPARTICLES COMPRISING A NON-IONIZABLE CELLULOSIC POLYMER AND AN AMPHIPHILIC NON-IONIZABLE BLOCK COPOLYMER,"A pharmaceutical composition comprises nanoparticles comprising a poorly water-soluble drug, a poorly aqueous soluble non-ionizable cellulosic polymer, and a poorly aqueous soluble polymeric amphiphilic non-ionizable block copolymer.",PFIZER PROD INC;;BLOOM COREY JAY;;CREW MARSHALL DAVID;;MILLER WARREN KENYON;;MORGEN MICHAEL MARK;;SMITHEY DANIEL TOD,BLOOM COREY JAY;;CREW MARSHALL DAVID;;MILLER WARREN KENYON;;MORGEN MICHAEL MARK;;SMITHEY DANIEL TOD,,https://lens.org/034-322-726-570-121,Patent Application,yes,0,1,6,6,0,A61K9/5138;;A61K9/5138;;A61K9/5161;;A61K9/5161;;A61K9/5192;;A61K9/5192;;A61K31/415;;A61K31/415;;A61K31/42;;A61K31/42;;A61K31/435;;A61K31/435;;A61K47/34;;A61K47/34;;A61K47/38;;A61K47/38;;Y10S977/773;;Y10S977/773;;Y10S977/906;;Y10S977/906,A61K9/51;;A61K31/415;;A61K31/42;;A61K31/435;;A61K47/34;;A61K47/38,,0,0,,,,PENDING
691,HU,A2,HU P0104944 A2,061-998-372-923-522,2002-04-29,2002,HU P0104944 A,1999-12-06,US 20831698 A;;US 9928844 W,1998-12-09,ACETAMIDE AND SUBSTITUTED ACETAMIDE-CONTAINING THIOUREA INHIBITORS OF HERPES VIRUSES,"Az (1) ltal nos képletű vegyületek - a képletben R1-R5 jelentése egymstól függetlenül hidrogénatom, 1-6 szénatomos alkilcsoport, 2-6szénatomos alkenilcsoport, 2-6 szénatomos alkinilcsoport, 1-6szénatomos perhalogénalkilcsoport, 3-10 szénatomos cikloalkilcsoport,3-10 gyűrű-szénatomot tartalmazó heterocikloalkilcsoport, arilcsoport,heteroarilcsoport, halogénatom, -CN, -NO2, -CO2R6, -COR6, -OR6, -SR6,-SOR6, -SO2R6, -CONR7R8, -NR6N(R7R8), -N(R7R8) vagy W-Y-(CH2)n-Z ltalnos képletű csoport, azzal a megk""téssel, hogy az R1-R5szubsztituensek legal bb egyike hidrogénatomtól eltérő; vagy R2 és R3vagy R3 és R4 együtt 3-7 tagú heterocikloalkilcsoportot vagy 3-7 tagúheteroarilcsoportot alkotnak; R9-R12 jelentése egym stól függetlenülhidrogénatom, 1-4 szénatomos alkilcsoport, 1-4 szénatomosperhalogénalkilcsoport, halogénatom, 1-4 szénatomos alkoxicsoport vagycianocsoport, vagy R9 és R10 vagy R11 és R12 együtt 5-7 szénatomosarilcsoportot alkotnak; G jelentése 1-6 szénatomos alkilcsoport és Xjelentése kémiai k""tés, -NH, 1-6 szénatomos alkilcsoport, 1-6szénatomos alkenilcsoport, 1-6 szénatomos alkoxicsoport, 1-6szénatomos tioalkilcsoport, 1-6 szénatomos alkilaminocsoport vagy(CH)J és gyógy szatilag elfogadható sóik herpeszvírusok szaporod s t gtló aktivit ssal rendelkeznek, fenti aktivit suk k""vetkeztében gyógyszati készítmények hatóanyagaként alkalmazhatók. Ó",AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;O'HARA BRYAN MARK,,https://lens.org/061-998-372-923-522,Patent Application,no,0,0,18,18,0,C07C335/20;;C07C335/22;;C07D207/09;;C07D207/14;;C07D211/58;;C07D261/10;;A61P31/22,A61K31/17;;C07D249/04;;A61K31/341;;A61K31/343;;A61K31/345;;A61K31/36;;A61K31/381;;A61K31/40;;A61K31/403;;A61K31/4192;;A61K31/42;;A61K31/433;;A61K31/437;;A61K31/4409;;A61K31/4468;;A61K31/47;;A61K31/4965;;A61K31/5375;;A61K31/56;;A61P31/22;;C07C335/20;;C07C335/22;;C07C337/06;;C07D207/09;;C07D207/14;;C07D207/34;;C07D209/48;;C07D211/58;;C07D213/81;;C07D215/48;;C07D217/26;;C07D221/12;;C07D241/24;;C07D261/08;;C07D261/10;;C07D265/30;;C07D285/06;;C07D295/12;;C07D307/56;;C07D307/73;;C07D307/85;;C07D317/68;;C07D333/38;;C07D333/70,,0,0,,,,PENDING
692,ZA,B,ZA 200104373 B,119-019-089-764-184,2002-09-18,2002,ZA 200104373 A,2001-05-28,US 20854098 A,1998-12-09,Thiourea inhibitors of herpes viruses.,,AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;O'HARA BRYAN MARK,,https://lens.org/119-019-089-764-184,Granted Patent,no,0,0,21,89,0,C07D213/75;;C07D213/81;;C07D405/12;;C07D417/12;;C07D307/85;;C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81,A61K/;;A61K31/12;;A61K31/33;;C07D213/81;;A61K31/425;;A61K31/44;;A61K31/4427;;A61K31/443;;A61K31/4436;;A61K31/444;;A61P/;;A61P31/12;;A61P31/22;;C07D/;;C07D213/75;;C07D401/12;;C07D405/12;;C07D417/12,,0,0,,,,EXPIRED
693,SG,A1,SG 47917 A1,124-469-698-450-85X,1998-04-17,1998,SG 1996005341 A,1991-04-08,US 51919290 A,1990-05-04,Substituted 5-(2-) (2-aryl-2-hydroxyethyl)amino) pro pyl)-1 3-benzodioxoles,"The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.",AMERICAN CYANAMID CO,BLOOM JONATHAN DAVID;;CLAUS THOMAS HARRISON;;DEVRIES VERN GORDON;;DOLAN JO ALENE;;DUTIA MINU DHANJISHA,,https://lens.org/124-469-698-450-85X,Patent Application,no,0,0,40,44,0,C07D317/46;;C07D413/06;;A61P3/10;;A61P3/04;;A61P3/08;;C07D317/46;;C07D413/06;;C07D317/46,A61K31/335;;A61K31/357;;A61K31/36;;A61K31/42;;A23K1/16;;A61P3/04;;A61P3/08;;A61P3/10;;C07D263/04;;C07D291/04;;C07D317/46;;C07D317/58;;C07D317/62;;C07D405/06;;C07D413/06;;C07D419/06,,0,0,,,,PENDING
694,EP,A1,EP 1137647 A1,145-885-902-756-050,2001-10-04,2001,EP 99965131 A,1999-12-06,US 9928838 W;;US 20796198 A,1998-12-09,THIOUREA INHIBITORS OF HERPES VIRUSES,,AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;O'HARA BRYAN MARK,WYETH (2002-06-19),https://lens.org/145-885-902-756-050,Patent Application,yes,0,0,17,17,0,C07D207/335;;C07D209/14;;C07D213/40;;C07D213/75;;C07D215/12;;C07D217/12;;C07D231/56;;C07D233/44;;C07D277/28;;C07D285/06;;C07D307/52;;C07D333/20;;C07D405/12;;C07D417/12;;A61P31/12;;A61P31/22;;C07D209/14;;C07D207/335;;C07D213/40;;C07D215/12;;C07D217/12;;C07D231/56;;C07D233/44;;C07D285/06;;C07D307/52;;C07D333/20;;C07D417/12,A61K31/06;;A61K31/075;;A61K31/085;;A61K31/10;;A61K31/11;;A61K31/136;;A61K31/15;;A61K31/165;;A61K31/167;;A61K31/17;;A61K31/175;;A61K31/18;;A61K31/196;;A61K31/215;;A61K31/216;;C07D295/14;;A61K31/222;;A61K31/27;;A61K31/275;;A61K31/341;;A61K31/40;;A61K31/42;;A61K31/426;;A61K31/433;;A61K31/4439;;A61K31/4453;;A61K31/4458;;A61K31/54;;A61K31/695;;A61P31/12;;A61P31/22;;C07C335/20;;C07D207/12;;C07D207/14;;C07D207/32;;C07D207/335;;C07D209/14;;C07D211/22;;C07D213/40;;C07D213/75;;C07D215/12;;C07D217/12;;C07D231/12;;C07D231/56;;C07D233/44;;C07D261/08;;C07D277/24;;C07D277/28;;C07D285/06;;C07D307/52;;C07D307/54;;C07D333/20;;C07D405/12;;C07D417/12,,0,0,,,,DISCONTINUED
695,CA,A1,CA 2350996 A1,158-945-238-719-721,2000-06-15,2000,CA 2350996 A,1999-12-06,US 20796198 A;;US 9928838 W,1998-12-09,THIOUREA INHIBITORS OF HERPES VIRUSES,"Compounds of formula (I) wherein A is heteroaryl; R9-R12 are independently hydrogen, alkyl of 1 to 4 carbon atoms, perhaloalkyl of 1 to 4 carbon atoms, halogen, alkoxy of 1 to 4 carbon atoms, or cyano, or R9 and R10 or R11 and R 12 may be taken together to form aryl of 5 to 7 carbon atoms; W is O, NR6, or i s absent; G is aryl or heteroaryl; and X is a bond, -NH, alkyl of 1 to 6 carbo n atoms, alkenyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, thioalkyl of 1 to 6 carbon atoms, alkylamino of 1 to 6 carbon atoms, or (CH) J; and J is alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 7 carbon atoms, phenyl or benzyl; and n is an integer from 1 to 6; or a pharmaceutical salt thereof, useful in the treatment of diseases associated with herpes viruses including human cytomegalovirus, herpes simplex viruses, Epstein-Barr virus, varicella-zoster virus, human herpesviruses-6 and -7, and Kaposi herpesvirus .",AMERICAN HOME PROD,LANG STANLEY ALBERT;;O'HARA BRYAN MARK;;BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE,,https://lens.org/158-945-238-719-721,Patent Application,no,0,0,17,17,0,C07D207/335;;C07D209/14;;C07D213/40;;C07D213/75;;C07D215/12;;C07D217/12;;C07D231/56;;C07D233/44;;C07D277/28;;C07D285/06;;C07D307/52;;C07D333/20;;C07D405/12;;C07D417/12;;A61P31/12;;A61P31/22;;C07D209/14;;C07D207/335;;C07D213/40;;C07D215/12;;C07D217/12;;C07D231/56;;C07D233/44;;C07D285/06;;C07D307/52;;C07D333/20;;C07D417/12,C07D295/14;;A61K31/06;;A61K31/075;;A61K31/085;;A61K31/10;;A61K31/11;;A61K31/136;;A61K31/15;;A61K31/165;;A61K31/167;;A61K31/17;;A61K31/175;;A61K31/18;;A61K31/196;;A61K31/215;;A61K31/216;;A61K31/222;;A61K31/27;;A61K31/275;;A61K31/341;;A61K31/40;;A61K31/42;;A61K31/426;;A61K31/433;;A61K31/4439;;A61K31/4453;;A61K31/4458;;A61K31/54;;A61K31/695;;A61P31/12;;A61P31/22;;C07C335/20;;C07D207/12;;C07D207/14;;C07D207/32;;C07D207/335;;C07D209/14;;C07D211/22;;C07D213/40;;C07D213/75;;C07D215/12;;C07D217/12;;C07D231/12;;C07D231/56;;C07D233/44;;C07D261/08;;C07D277/24;;C07D277/28;;C07D285/06;;C07D307/52;;C07D307/54;;C07D333/20;;C07D405/12;;C07D417/12,,0,0,,,,DISCONTINUED
696,NO,L,NO 911751 L,175-405-809-343-57X,1991-11-05,1991,NO 911751 A,1991-05-03,US 51919290 A,1990-05-04,"SUBSTITUERTE 5-(2-((2-ARYL-2-HYDROKSYETYL)AMINO)PROPYL)-1,3-BENZODIOKSOLER.","The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.",AMERICAN CYANAMID CO,BLOOM JONATHAN DAVID;;CLAUS THOMAS HARRISON;;DEVRIES VERN GORDON;;DOLAN JO ALENE;;DUTIA MINU DHANJISHA,,https://lens.org/175-405-809-343-57X,Abstract,no,0,0,40,44,0,C07D317/46;;C07D413/06;;A61P3/10;;A61P3/04;;A61P3/08;;C07D317/46;;C07D413/06;;C07D317/46,A61K31/335;;A23K1/16;;A61K31/357;;A61K31/36;;A61K31/42;;A61P3/04;;A61P3/08;;A61P3/10;;C07D263/04;;C07D291/04;;C07D317/46;;C07D317/58;;C07D317/62;;C07D405/06;;C07D413/06;;C07D419/06,,0,0,,,,EXPIRED
697,DE,T2,DE 69317399 T2,046-765-538-000-007,1998-07-02,1998,DE 69317399 T,1993-12-30,US 1097393 A,1993-01-29,Aminocycloalkanobenzodioxole als beta-3 selektive adrenergische Wirkstoffe,"The invention is antiobesity/antidiabetic/beta-3 agonists of the formula <CHEM> wherein the substituents Ro, R1, R4, R4', R5, R6 or n are as defined in the specification.",AMERICAN CYANAMID CO,EPSTEIN JOSEPH WILLIAM;;BIRNBERG GARY HAROLD;;WALKER GARY EDWARD;;DUTIA MINU DHANJISHA;;BLOOM JONATHAN DAVID,,https://lens.org/046-765-538-000-007,Granted Patent,no,0,0,13,13,0,A61K31/36;;C07D317/70;;C07D413/04;;A61P3/10;;A61P3/04;;A61P3/08;;C07D413/04;;A61K31/36;;C07D317/70;;C07D413/04;;C07D317/70;;A61K31/36,A23K1/16;;A61K31/335;;A61K31/357;;A61K31/36;;A61P3/04;;A61P3/08;;A61P3/10;;C07D317/70;;C07D413/04,,0,0,,,,EXPIRED
698,WO,A2,WO 2008/135855 A2,079-735-903-702-18X,2008-11-13,2008,IB 2008001145 W,2008-04-23,US 91569807 P,2007-05-03,NANOPARTICLES COMPRISING A CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR AND A NONIONIZABLE POLYMER,A pharmaceutical composition comprises nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a poorly aqueous soluble non-ionizable polymer.,PFIZER PROD INC;;BLOOM COREY JAY;;CREW MARSHALL DAVID;;SMITHEY DANIEL TOD;;MILLER WARREN KENYON;;MORGEN MICHAEL MARK,BLOOM COREY JAY;;CREW MARSHALL DAVID;;SMITHEY DANIEL TOD;;MILLER WARREN KENYON;;MORGEN MICHAEL MARK,,https://lens.org/079-735-903-702-18X,Patent Application,yes,0,1,4,4,0,A61K9/5146;;A61K9/5161;;A61K9/5192;;A61K31/4706;;A61P3/00;;A61P9/00;;A61K9/5146;;A61K9/5161;;A61K31/4706;;A61K9/5192,A61K31/4706;;A61K9/51;;A61K45/08,,0,0,,,,PENDING
699,EP,A1,EP 0608568 A1,158-059-291-647-070,1994-08-03,1994,EP 93121091 A,1993-12-30,US 1097393 A,1993-01-29,Aminocycloalkanobenzodioxoles as beta-3 selective adrenergic agents.,"The invention is antiobesity/antidiabetic/beta-3 agonists of the formula
  
 wherein the substituents R o , R₁, R₄, R₄', R₅, R₆ or n are as defined in the specification.",AMERICAN CYANAMID CO,EPSTEIN JOSEPH WILLIAM;;BIRNBERG GARY HAROLD;;WALKER GARY EDWARD;;DUTIA MINU DHANJISHA;;BLOOM JONATHAN DAVID,AMERICAN CYANAMID COMPANY (1998-01-21),https://lens.org/158-059-291-647-070,Patent Application,yes,2,11,13,13,0,A61K31/36;;C07D317/70;;C07D413/04;;A61P3/10;;A61P3/04;;A61P3/08;;C07D413/04;;A61K31/36;;C07D317/70;;C07D413/04;;C07D317/70;;A61K31/36,A23K1/16;;A61K31/335;;A61K31/357;;A61K31/36;;A61P3/04;;A61P3/08;;A61P3/10;;C07D317/70;;C07D413/04,,1,1,007-016-529-199-373,10.1002/jps.2600750119;;3007731,"ROBIN D. CLARK ET AL.: ""Antihypertensive Aminotetralins Related to Labetalol and Medroxalol"", JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 75, no. 1, 1986, WASHINGTON US, pages 80 - 82",EXPIRED
700,DE,D1,DE 69317399 D1,155-369-844-395-155,1998-04-16,1998,DE 69317399 T,1993-12-30,US 1097393 A,1993-01-29,Aminocycloalkanobenzodioxole als beta-3 selektive adrenergische Wirkstoffe,"The invention is antiobesity/antidiabetic/beta-3 agonists of the formula <CHEM> wherein the substituents Ro, R1, R4, R4', R5, R6 or n are as defined in the specification.",AMERICAN CYANAMID CO,EPSTEIN JOSEPH WILLIAM;;BIRNBERG GARY HAROLD;;WALKER GARY EDWARD;;DUTIA MINU DHANJISHA;;BLOOM JONATHAN DAVID,,https://lens.org/155-369-844-395-155,Granted Patent,no,0,0,13,13,0,A61K31/36;;C07D317/70;;C07D413/04;;A61P3/10;;A61P3/04;;A61P3/08;;C07D413/04;;A61K31/36;;C07D317/70;;C07D413/04;;C07D317/70;;A61K31/36,A23K1/16;;A61K31/335;;A61K31/357;;A61K31/36;;A61P3/04;;A61P3/08;;A61P3/10;;C07D317/70;;C07D413/04,,0,0,,,,EXPIRED
701,NO,L,NO 20012836 L,187-628-288-071-495,2001-08-08,2001,NO 20012836 A,2001-06-08,US 20854098 A;;US 9928892 W,1998-12-09,Tiourea-inhibitorer for herpes virus,"Det er beskrevet forbindelser med formel (I) hvor R1-R5 er uavhengig valgt fra hydrogen, alkyl med 1 til 6 karbonatomer, alkenyl med 2 til 6 karbonatomer, alkynyl med 2 til 6 karbonatomer, perhalogen- alkyl med 1 til 6 kambonatomer, sykloalkyl med 3 til 10 karbonatomer, heterosykloalkyl med 3 til 10 karbonledd, aryl, heteroaryl, halogen, -CN, -NO2, -CO2R6, -CORe, -ORe, -SRs, -SORe, -SC^Rs, -CONR7R8. -NReNfR/Ra), -N(R7R8) eller W-Y-(CH2)n-Z forutsatt at minst en av RrRs ikke er hydrogen; eller R2 og R3, eller R3 og R* sammen danner en 3 til 7-leddet heterosykloalkyl eller 3 til 7 leddet heteroaryl; Re og R7 er uavhengig hydrogen, alkyl med 1 til 6 karbonatomer, perhalogenalkyl med 1 til 6 karbonatomer, eller aryl; Ra er hydrogen, alkyl med 1 til 6 karbonatomer, perhalogenalkyl med 1 til 6 karbon- atomer, sykloalkyl med 3 til 10 karbonatomer, heterosykloalkyl med 3 til 10 ledd, aryl eller heteroaryl, eller R7 eller Ra, sammen kan danne en 3 til 7 leddet heterosykloalkyl; W er O, NRe eller er fraværende; Y er -(CO)- eller -(CO2)- eller er fraværende; Z er alkyl med 1 til 4 karbonatomer, -CN, -CO2R6, -COR6, -CONR7R8, -OCOR6l -NR6COR7, -OCONR6, -OR6, -SR6, -SOR6, -SO2R6, SR6N(R7R8), -N(R7R8) eller fenyl; G er aryl eller kondensert bisyklisk hetero- aryl; X er en binding, -NH, alkyl med 1 til 6 karbonatomer, alkenyl med 1 til 6 karbonatomer, alkoksy med 1 til 6 karbonatomer, tioalkyl med 1 til 6 karbon- atomer, alkylamino med 1 til 6 karbonatomer, eller (CH)J; J er alkyl med 1 til 6 karbonatomer, sykloalkyl med 3 til 7 karbonatomer, fenyl eller benzyl; og n er et tall fra 1 til 6, nyttig for behandling av sykdommer assosiert med herpesvirus inkludert human cytomegalovirus, herpes simplex virus, Epstein-Barr virus, varicella-zoster virus, humane herpesviruser -6 og -7 og Kaposi herpesvirus.",AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSEL GEORGE;;LANG STANLEY ALBERT;;O'HARA BRYAN MARK,,https://lens.org/187-628-288-071-495,Abstract,no,0,0,21,89,0,C07D213/75;;C07D213/81;;C07D405/12;;C07D417/12;;C07D307/85;;C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81,A61K/;;A61K31/12;;C07D213/81;;A61K31/33;;A61K31/425;;A61K31/44;;A61K31/4427;;A61K31/443;;A61K31/4436;;A61K31/444;;A61P/;;A61P31/12;;A61P31/22;;C07D/;;C07D213/75;;C07D401/12;;C07D405/12;;C07D417/12,,0,0,,,,DISCONTINUED
702,US,A1,US 2019/0237171 A1,032-092-530-317-710,2019-08-01,2019,US 201916377957 A,2019-04-08,US 201916377957 A;;US 201816192341 A;;US 201862712063 P;;US 201862647572 P;;US 201762587842 P,2017-11-17,OMIC DATA AGGREGATION WITH DATA QUALITY CHECK,"A system and method are disclosed for the collection and aggregation of genomic, medical, and other data of interest for individuals and populations that may be of interest for analysis, research, pharmaceutical development, medical treatment, and so forth. Contributors become members of a community upon creation of an account and providing of data or files. The data is received and processed, such as to analyze, structure, perform quality control, and curate the data. Value or shares in one or more community databases are computed and attributed to each contributing member. The data is controlled to avoid identification or personalization. Third parties interested in the database information may contribute value (e.g., pay) for access and use. Value flows back to the members and to a system administrative entity.",LUNAPBC,KAIN ROBERT C;;BARRY DAWN MARY;;LEWIS DAVID;;BLOOM KENNETH ROBERT;;KAHN SCOTT;;VELINOV BOJIL,,https://lens.org/032-092-530-317-710,Patent Application,yes,7,2,10,12,0,G16H10/20;;G06Q40/08;;Y02A90/10;;G16H10/20;;G16H10/60;;G06F16/2379;;G06F16/958;;G06N20/00;;G06Q40/08,G16H10/60;;G06F16/23;;G06F16/958;;G06N20/00,,0,0,,,,DISCONTINUED
703,NZ,A,NZ 237992 A,066-460-750-087-136,1993-05-26,1993,NZ 23799291 A,1991-04-30,US 51919290 A,1990-05-04,AMINOETHYL BENZODIOXOLE DERIVATIVES AND MEDICAMENTS,"The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.",AMERICAN CYANAMID CO,BLOOM JONATHAN DAVID;;CLAUS THOMAS HARRISON;;DEVRIES VERN GORDON;;DOLAN JO ALENE;;MINU DHANJISHA DUTIA,,https://lens.org/066-460-750-087-136,Patent Application,no,0,0,40,44,0,C07D317/46;;C07D413/06;;A61P3/10;;A61P3/04;;A61P3/08;;C07D317/46;;C07D413/06;;C07D317/46,A61K31/335;;A61K31/357;;A61K31/36;;A61K31/42;;A61P3/04;;A61P3/08;;A61P3/10;;A23K1/16;;C07D263/04;;C07D291/04;;C07D317/46;;C07D317/58;;C07D317/62;;C07D405/06;;C07D413/06;;C07D419/06,,0,0,,,,PENDING
704,US,B2,US 7147865 B2,093-271-635-576-379,2006-12-12,2006,US 71356503 A,2003-11-13,US 71356503 A;;US 18421002 A;;US 30193401 P,2001-06-29,Artificial synapse chip,"Devices and methods are provided for administering a fluid to a neuronal site. The device comprises a reservoir, an aperture in fluid connection to the reservoir, and electrical means for moving to the fluid to or through the aperture. The electrical means may take the form of electroosmotic force, piezoelectric movement of a diaphragm or electrolysis of a solution. The electrical means may be external to the host, implanted in the host or may be photodiodes activated by light, particularly where the neuronal site is associated with the retina.",UNIV LELAND STANFORD JUNIOR,FISHMAN HARVEY A;;BLOOM DAVID;;BENT STACEY F;;PETERMAN MARK C;;NOOLANDI JAAN;;MEHENTI NEVILLE,BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY THE (2004-06-30),https://lens.org/093-271-635-576-379,Granted Patent,yes,11,43,10,10,0,A61N1/0543;;A61N1/30;;A61N1/326;;A61N1/36046;;C12N5/0619;;C12N2503/00;;C12N2535/10;;G06N3/061;;G06N3/061;;A61N1/30;;A61N1/36046;;C12N2503/00;;C12N5/0619;;A61N1/326;;C12N2535/10;;A61N1/0543,A61F2/14;;A61K9/22;;A61L27/00;;A61N1/05;;A61N1/30;;A61N1/36;;C12M1/42;;C12M3/00;;C12N5/0793;;G06N3/06,424/427;;424/422;;623/4.1;;623/6.63;;623/24;;623/25;;623/26;;435/395;;435/325,26,19,020-849-987-130-012;;022-535-493-415-289;;031-293-709-625-208;;045-244-593-667-111;;049-543-795-239-305;;001-831-941-176-280;;000-117-437-031-635;;093-770-441-646-769;;013-254-993-069-450;;056-066-354-227-629;;039-712-372-889-64X;;000-409-659-443-429;;052-681-725-250-166;;046-961-728-035-33X;;064-942-415-563-86X;;049-325-662-859-361;;001-329-508-866-308;;017-638-478-647-912;;030-546-208-614-902,12824264;;10.1167/iovs.02-1097;;9860180;;10.1163/156856298x00721;;10.1007/s004170050320;;10502058;;10646274;;10.1109/10.817614;;10541906;;10.1007/s004170050390;;11030816;;10.1001/archopht.118.10.1350;;10614941;;10.1016/s0142-9612(99)00164-7;;11011682;;10.1007/s004170000149;;10.1620/tjem.189.295;;10739165;;10.3109/00207459408986289;;8050852;;10.1016/s0925-4005(98)00071-9;;11248444;;10.1016/s0304-3940(01)01628-7;;10.1016/s0165-0270(98)00156-3;;10065993;;11324335;;10.1007/s004220000218;;9740002;;10.1002/(sici)1097-4636(199810)42:1<13::aid-jbm3>3.0.co;2-r;;9622516;;10.1021/bp980035r;;10.1016/s0168-9002(99)00445-3;;10.1109/7333.918281;;11482368;;10.1002/1521-396x(200011)182:1<505::aid-pssa505>3.0.co;2-#,"Fishman et al, ARVO Annual Meeting Abstract Search and Program Planner, Abstract No. 2846, vol. 2002, Annual Meeting of the Association For Research in Vision and Opthalmology. Fort Lauderdale, FL, May 5-10, 2002.;;Peterman et al., ""Localized Neurotransmitter Release for Use in Prototype Retinal Interface,"" 2003 IOVS 44, 3144.;;Maghreibi et al., ""Stretchable Micro-Electrode Array,"" Poster 149, 2<SUP>nd </SUP>Annual International IBEE-EMBS Special Topic Conference on Microtechnologies in Medicine and Biology, May 2-4, 2002, Madison, WI.;;L. Lu et al., ""Retinal pigment epithelium cell culture on this biodegradable poly(DL-lactic-co-glycolic acid) films"", J. Biomater Science Edn. vol. 9, No. 11, pp. 1187-1205 (1998).;;T. Dintelmann et al., ""Comparative study of ROS degradation by IPE and RPE cells in vitro"", Graefe's Arch Clin. Excp. Ophthalmology 1999, No. 237, pp. 830-839.;;C.D. James et al., ""Aligned Microcontact Printing of Micrometer-Scale Poly-L-Lysine Structures for Controlled Growth of cultured Neurons on Planar Microelectrode Arrays"", IEEE Transaction On Biomedical Engineering, vol. 47, No. 1, Jan. 2000, pp. 17-21.;;U. Hartmann et al., ""Human and porcine anterioe lens capsule as support for growing and grafting retinal pigment epithelium and iris pigment epithelium,"" Graefe's Arch Clin Exp Opthalmology (1999), vol. 237, pp. 940-945.;;G. Thumann et al., Transplantation of Autologous Iris Pigment Epithelium After Removal of Choroidal Neovascular Membranes, Arch Opthalomology (Oct. 2000), vol. 118, pp. 1350-1355.;;L. Lu et al., ""Retinal pigment epithelial cell function on substrates with chemically micropatterned surfaces"", Biomaterails ( Dec. 1999), vol. 20, No. 23/24, pp. 2351-2361.;;Lappas et al., ""Clinical investigation: Iris pigment epithelial cell translocation in exudative age-related mascular degeneration, A pilot study in patents"", Graefe's Archive for clinical Experimental Ophthalmology, Abstract, vol. 238 issue, pp. 1 and 2 electronic version, ISSN: 1435-702X.;;Giordano et al., ""Retinal pigment epithelium cells cultured on synthetic biodegradable polymers"", (Abstract) http://www.ncbi.nlm.nih.gov/entres/query.fcgi?cmd=Retrieve&db=PubMed&List<SUB>-</SUB>uids=897...6.;;T. Abe et al., ""Auto iris pigment epithelial cell transplantation in patients with age-related macular degeneration: short-term results"", (Abstract) http://www.n.../query.fcgi?cmd=Retrieve&dblist=PubMed&List<SUB>-</SUB>uids=10896035&dopt=Ab.;;T. Abe et al., ""Functional analysis after auto iris pigment epithelial cell transplantation in patients with age-related macular degeneration"", (Abstract) http://www.n.../query.fcgi?cmd=Retrieve&db=PubMed&List<SUB>-</SUB>uids=10739164&dopt=Abst.;;J. Nicolini et al., ""The anterior lens capsule used as support material in RPE cell-transplantation"", (Abstract) http://www.ncbi.nlm.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&List<SUB>-</SUB>uids=11C...7.;;Sandyk, R. ""Paroxysmal Itching in Multiple Sclerosis During Treatment with External Magnetic Fields"" (1994) Published in Int. J. Neurosci. 75(1-2): 65-71.;;Heuschkel, M.O. et al. Buried Microchannels in Photopolymer for Delivering of Solutions to Neurons in a Network. (1998) Published in Sensors and Actuators B 48: 356-361.;;Yeung, C.K. et al. ""Modulation of the Growth and Guidance of Rat Brain Stem Neurons Using Patterned Extracellular Matrix Proteins."" (2001) Published in Neuroscience Letters 301: 147-150.;;Maher, Michael et al. ""The Neurochip: A New Multielectrode Device for Stimulating and Recording from Cultured Neurons"" (1999) Published in Journal of Neuroscience Methods 87: 45-56.;;Jenkner, Martin et al. ""Interfacing a Silicon Chip to Pairs of Smail Neurons Connected by Electrical Synapses"" (2001) Published in Biol. Cybern 84: 239-249.;;Saneinejad, Samar et al. ""Patterned Glass Surface Direct Cell Adhesion and Process Outgrowth of Primary Neurons of the Central Nervous System"" (1998) Published in J. Biomed. Mater. Res. 42: 13-19.;;Tai, Hsin-Chien et al. ""Neurite Outgrowth and Growth Cone Morphology on Micropatterned Surfaces"" (1998) Published in Biotechnol. Prog. 14: 364-370.;;Litke, A.M. ""The Retinal Readout System: A Status Report"" (1999) Nuclear Instruments and Methods in Physics Research A 435: 242-249.;;Bernard, Andre et al. ""Printing Patterns of Proteins"" (1998) Published in Langmuir vol. 14: 1-5.;;Chow, Alan. ""Implantation of Silicon Chip Microphotodiode Arrays into the Cat Subretinal Space."" (2001) Published in IEEE vol. 9: 86-95.;;Mayne, A.H. ""Biologically Interfaced Porous Silicon Devices"" (2000) Published in Phys. Stat. Sol. 182: 505-513.;;Fishman, H.A. ""The Artificial Synapse Chip: A Novel Interface for a Retinal Prosthesis Based on Neurotransmitter Stimulation and Nerve Regeneration"" (2002) Published in ARVO.",EXPIRED
705,US,A,US 5661592 A,096-047-331-580-283,1997-08-26,1997,US 48045995 A,1995-06-07,US 48045995 A,1995-06-07,Method of making and an apparatus for a flat diffraction grating light valve,"A deformable grating aparatus for modulating light is made by forming an insulating layer on a substrate, forming a first conductive layer on the insulating layer and then forming a sacrificial layer thereon. The sacrificial layer and the first conducting layer are then etched to define bit lines and busses to bonding pads. Then a layer of resilient material is formed onto the etched layers and a reflective conducting layer is formed on the resilient layer. A dielectric layer is deposited on the reflective conducting layer. The dielectric layer, the reflective conducting layer, the resilient layer and the sacrificial layer are all then etched to form a grating including a plurality of parallel elements. Thereafter the sacrificial layer is removed below the parallel elements, to suspend the parallel elements over the first conducting layer. The surface is treated to prevent the grating from adhering to the first conducting layer. A light modulator includes a substrate with an insulating layer, and a plurality of parallel conductive layers formed on the insulating layer. The ribbons are spaced apart from the conductive layers by an air space and mounted to the substrate in gaps between the conductive layers.",SILICON LIGHT MACHINES INC,BORNSTEIN JONATHAN G;;BANYAI WILLIAM C;;BLOOM DAVID M;;WHITTEN RALPH G;;STAKER BRYAN P,SILICON LIGHT MACHINES CORPORATION (2008-06-23);;SILICON LIGHT MACHINES (1996-07-19),https://lens.org/096-047-331-580-283,Granted Patent,yes,38,239,16,16,0,G02B5/1828;;G02B26/0808;;Y10S359/904;;G02B5/18;;G02B5/1828;;G02B26/0808;;Y10S359/904,G02B5/18;;G02B26/08,359/291;;359/213;;257/415,6,3,009-286-199-765-581;;028-775-209-892-098;;009-365-280-210-861,10.1109/5.53402;;10.1117/12.19865;;10.1016/0141-9382(91)90032-9,"R. Apte, F. Sandejas, W. Banyai, D. Bloom, Grating Light Valves For High Resolution Displays , Ginzton Laboratories, Stanford University, Stanford, CA 94305 4085.;;R. Apte, Grating Light Valves For High Resolution Displays Jun., 1994.;;O. Solgaard, Integrated Semiconductor Light Modulators For Fiber Optic And Display Applications , Feb., 1992.;;J. Neff, Two Dimensional Spatial Light Modulators: A Tutorial , Proceedings of the IEEE , vol. 78, No. 5 (May 1990), pp. 826 855.;;Gerhard Multhaupt, Viscoelastic Spatial Light Modulators and Schlieren Optical Systems for HDTV Projection Displays , SPIE vol. 1255 Large Screen Projection Displays II (1990), pp. 69 78.;;Gerhard Multhaupt, Light Valve Technologies for High Definition Television Projection Displays , Displays , vol 12, No. 3/4 (1991), pp. 115 128.",EXPIRED
706,US,A1,US 2010/0323014 A1,120-501-281-636-319,2010-12-23,2010,US 45181008 A,2008-05-26,US 45181008 A;;US 94175507 P;;IB 2008001352 W,2007-06-04,NANOPARTICLES COMPRISING A NON-IONIZABLE CELLULOSIC POLYMER AND AN AMPHIPHILIC NON-IONIZABLE BLOCK COPOLYMER,"A pharmaceutical composition comprises nanoparticles comprising a poorly water-soluble drug, a poorly aqueous soluble non-ionizable cellulosic polymer, and a poorly aqueous soluble polymeric amphiphilic non-ionizable block copolymer.",BLOOM COREY JAY;;CREW MARSHALL DAVID;;MILLER WARREN KENYON;;MORGEN MICHAEL MARK;;SMITHEY DANIEL TOD,BLOOM COREY JAY;;CREW MARSHALL DAVID;;MILLER WARREN KENYON;;MORGEN MICHAEL MARK;;SMITHEY DANIEL TOD,PFIZER PRODUCTS INC (2007-07-02);;PFIZER INC (2007-07-02);;BEND RESEARCH INC (2008-11-03),https://lens.org/120-501-281-636-319,Patent Application,yes,99,15,6,6,0,A61K9/5138;;A61K9/5138;;A61K9/5161;;A61K9/5161;;A61K9/5192;;A61K9/5192;;A61K31/415;;A61K31/415;;A61K31/42;;A61K31/42;;A61K31/435;;A61K31/435;;A61K47/34;;A61K47/34;;A61K47/38;;A61K47/38;;Y10S977/773;;Y10S977/773;;Y10S977/906;;Y10S977/906,A61K31/42;;A61K9/10;;A61K9/14;;A61K31/415;;A61K31/4706,424/486;;514/378;;514/313;;514/406;;424/400;;424/484;;424/488;;977/773;;977/906,3,3,012-102-263-066-603;;119-668-941-485-878;;025-129-775-479-227,15149170;;10.1021/bc034113u;;10.1016/0168-3659(90)90103-z;;10.1021/js9605226;;9423162,"Shuai et al. Bioconjug. Chem., 2004, 15, 441-448.;;Bodmeier et al. J. Control. Release, 1990, 12, 223-233 (IDS: submitted 12/22/10);;Liggins et al. J. Pharm. Sci., 1997, 86 (12), 1458-1463.",INACTIVE
707,CA,A1,CA 2350899 A1,122-928-455-074-463,2000-06-15,2000,CA 2350899 A,1999-12-06,US 20831698 A;;US 9928844 W,1998-12-09,ACETAMIDE AND SUBSTITUTED ACETAMIDE-CONTAINING THIOUREA INHIBITORS OF HERPES VIRUSES,"Compounds of formula (I) wherein R1-R5 are independently selected from hydrogen, alkyl of 1 to 6 carbon atoms, alkenyl of 2 to 6 carbon atoms, alkynyl of 2 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 carbon members, aryl, heteroaryl, halogen, -CN, -NO2, -CO2R6, -COR6, -OR6, -SR6, - SOR6, -SO2R6, -CONR7R8, -NR6N(R7R8), -N(R7R8) or W-Y-(CH2)n-Z provided that at least one of R1-R5 is not hydrogen; or R2 and R3 or R3 and R4, taken togethe r form a 3 to 7 membered heterocycloalkyl or 3 to 7 membered heteroaryl; R6 an d R7 are independently hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, or aryl; R8 is hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 members, aryl or heteroaryl, or R7 and R8, taken together may form a 3 to 7 membered heterocycloalkyl; R9-R12 are independent ly hydrogen, alkyl of 1 to 4 carbon atoms, perhaloalkyl of 1 to 4 carbon atoms, halogen, alkoxy of 1 to 4 carbon atoms, or cyano, or R9 and R10 or R11 and R 12 may be taken together to form aryl of 5 to 7 carbon atoms; G is alkyl of 1 t o 6 carbon atoms; X is a bond, -NH, alkyl of 1 to 6 carbon atoms, alkenyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, thioalkyl of 1 to 6 carbon atoms, alkylamino of 1 to 6 carbon atoms, or (CH)J; J is alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 7 carbon atoms, phenyl or benzyl; and n is an integer from 1 to 6; or pharmaceutical salts thereof, are useful in the treatment of diseases associated with herpes viruses including human cytomegalovirus, herpes simplex viruses, Epstein-Barr virus, varicella-zoste r virus, human herpesviruses-6 and -7, and Kaposi herpesvirus.",AMERICAN HOME PROD,LANG STANLEY ALBERT;;O'HARA BRYAN MARK;;DUSHIN RUSSELL GEORGE;;BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH,,https://lens.org/122-928-455-074-463,Patent Application,no,0,0,18,18,0,C07C335/20;;C07C335/22;;C07D207/09;;C07D207/14;;C07D211/58;;C07D261/10;;A61P31/22,C07D249/04;;A61K31/17;;A61K31/341;;A61K31/343;;A61K31/345;;A61K31/36;;A61K31/381;;A61K31/40;;A61K31/403;;A61K31/4192;;A61K31/42;;A61K31/433;;A61K31/437;;A61K31/4409;;A61K31/4468;;A61K31/47;;A61K31/4965;;A61K31/5375;;A61K31/56;;A61P31/22;;C07C335/20;;C07C335/22;;C07C337/06;;C07D207/09;;C07D207/14;;C07D207/34;;C07D209/48;;C07D211/58;;C07D213/81;;C07D215/48;;C07D217/26;;C07D221/12;;C07D241/24;;C07D261/08;;C07D261/10;;C07D265/30;;C07D285/06;;C07D295/12;;C07D307/56;;C07D307/73;;C07D307/85;;C07D317/68;;C07D333/38;;C07D333/70,,0,0,,,,DISCONTINUED
708,CA,A1,CA 2351390 A1,010-424-031-148-780,2000-06-15,2000,CA 2351390 A,1999-12-06,US 20854098 A;;US 9928892 W,1998-12-09,THIOUREA INHIBITORS OF HERPES VIRUSES,"Compounds of formula (1) wherein, R1-R5 are independently selected from hydrogen, alkyl of 1 to 6 carbon atoms, alkenyl of 2 to 6 carbon atoms, alkynyl of 2 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 carbon members, aryl, heteroaryl, halogen, -CN, -NO2, -CO2R6,-COR6, -OR6, -SR6, - SOR6, -SO2R6, -CONR7R8, -NR6N(R7R8), -N(R7R8) or W-Y-(CH2)n-Z; or R2 and R3 or R3 and R4, taken together from a 3 to 7 membered heterocycloalkyl or 3 to 7 membered heteroaryl; R6 and R7 are independently hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, or aryl; R8 is hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalky l of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 members, aryl or heteroaryl, or R7 and R8, taken together may form a 3 to 7 membered heterocycloalkyl; A is heteroaryl; W is O, NR6, or is absent; Y is -(CO)- or - (CO2)-, or is absent; Z is alkyl of 1 to 4 carbon atoms, -CN, -CO2R6, COR6, - CONR7R8, -OCOR6, -NR6COR7, -OCONR6, -OR6, -SR6, -SOR6, -SO2R6, SR6N(R7R8), - N(R7R8) or phenyl; G is aryl or heteroaryl; X is a bond, -NH, alkyl of 1 to 6 carbon atoms, alkenyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, thioalkyl of 1 to 6 carbon atoms, alkylaminoof 1 to 6 carbon atoms, or (CH)J ; J is alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 7 carbon atoms, phenyl or benzyl; and n is an integer from 1 to 6; useful in the treatment of diseases associated with herpes viruses including human cytomegalovirus, herpes simplex viruses, Epstein-Barr virus, varicella-zoster virus, human herpes viruses -6 and -7, and Kaposi herpesvirus.",AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;O'HARA BRYAN MARK;;LANG STANLEY ALBERT;;DUSHIN RUSSELL GEORGE;;DIGRANDI MARTIN JOSEPH,,https://lens.org/010-424-031-148-780,Patent Application,no,0,0,21,89,0,C07D213/75;;C07D213/81;;C07D405/12;;C07D417/12;;C07D307/85;;C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81,C07D213/81;;A61K/;;A61K31/12;;A61K31/33;;A61K31/425;;A61K31/44;;A61K31/4427;;A61K31/443;;A61K31/4436;;A61K31/444;;A61P/;;A61P31/12;;A61P31/22;;C07D/;;C07D213/75;;C07D401/12;;C07D405/12;;C07D417/12,,0,0,,,,DISCONTINUED
709,WO,A1,WO 2019/099762 A1,062-295-890-241-519,2019-05-23,2019,US 2018/0061419 W,2018-11-16,US 201762587842 P;;US 201862647572 P;;US 201862712063 P;;US 201816192341 A,2017-11-17,"PERSONAL, OMIC, AND PHENOTYPE DATA COMMUNITY AGGREGATION PLATFORM","A system and method are disclosed for the collection and aggregation of genomic, medical, and other data of interest for individuals and populations that may be of interest for analysis, research, pharmaceutical development, medical treatment, and so forth. Contributors become members of a community upon creation of an account and providing of data or files. The data is received and processed, such as to analyze, structure, perform quality control, and curate the data. Value or shares in one or more community databases are computed and attributed to each contributing member. The data is controlled to avoid identification or personalization. Third parties interested in the database information may contribute value (e.g., pay) for access and use. Value flows back to the members and to a system administrative entity.",LUNAPBC,KAIN ROBERT C;;BARRY DAWN MARY;;LEWIS DAVID;;BLOOM KENNETH ROBERT;;KAHN SCOTT;;VELINOV BOJIL,,https://lens.org/062-295-890-241-519,Patent Application,yes,5,0,10,12,0,G16H10/20;;G06Q40/08;;Y02A90/10;;G16H10/20;;G16H10/60;;G06F16/2379;;G06F16/958;;G06N20/00;;G06Q40/08,G16H10/20,,0,0,,,,PENDING
710,AU,A1,AU 2006/349612 A1,101-351-172-841-030,2008-05-02,2008,AU 2006/349612 A,2006-12-01,US 74177205 P;;US 2006/0045950 W,2005-12-01,Anthranilic acid derivatives useful in treating infection with Hepatitis C virus,,WYETH CORP,INSAF SHABANA;;BLOOM JONATHAN DAVID;;WHELESS KAREN;;SUTHERLAND ALAN GORDON;;NITTOLI THOMAS;;CURRAN KEVIN J,,https://lens.org/101-351-172-841-030,Patent Application,no,0,0,8,8,0,A61P31/12;;A61P31/14;;A61P43/00;;C07D317/66;;C07C235/24;;C07C237/04;;C07C251/48;;C07C317/36,C07D317/66,,0,0,,,,DISCONTINUED
711,NO,D0,NO 975695 D0,141-102-063-747-188,1997-12-05,1997,NO 975695 A,1997-12-05,US 48045995 A;;US 9609255 W,1995-06-07,Fremgangsmåte for fremstilling av en innretning for en flat diffraksjonsgitter-lysventil,"A deformable grating aparatus for modulating light is made by forming an insulating layer on a substrate, forming a first conductive layer on the insulating layer and then forming a sacrificial layer thereon. The sacrificial layer and the first conducting layer are then etched to define bit lines and busses to bonding pads. Then a layer of resilient material is formed onto the etched layers and a reflective conducting layer is formed on the resilient layer. A dielectric layer is deposited on the reflective conducting layer. The dielectric layer, the reflective conducting layer, the resilient layer and the sacrificial layer are all then etched to form a grating including a plurality of parallel elements. Thereafter the sacrificial layer is removed below the parallel elements, to suspend the parallel elements over the first conducting layer. The surface is treated to prevent the grating from adhering to the first conducting layer. A light modulator includes a substrate with an insulating layer, and a plurality of parallel conductive layers formed on the insulating layer. The ribbons are spaced apart from the conductive layers by an air space and mounted to the substrate in gaps between the conductive layers.",SILICON LIGHT MACHINES INC,BORNSTEIN JONATHAN G;;BANYAI WILLIAM C;;BLOOM DAVID M;;WHITTEN RALPH G;;STAKER BRYAN P,,https://lens.org/141-102-063-747-188,Patent Application,no,0,0,16,16,0,G02B5/1828;;G02B26/0808;;Y10S359/904;;G02B5/18;;G02B5/1828;;G02B26/0808;;Y10S359/904,G02B5/18;;G02B26/08,,0,0,,,,DISCONTINUED
712,US,A1,US 2023/0326563 A1,036-995-536-695-934,2023-10-12,2023,US 202318163732 A,2023-02-02,US 202318163732 A;;US 201916377922 A;;US 201816192341 A;;US 201862712063 P;;US 201862647572 P;;US 201762587842 P,2017-11-17,"PERSONAL, OMIC, AND PHENOTYPE DATA COMMUNITY AGGREGATION PLATFORM","A system and method are disclosed for the collection and aggregation of genomic, medical, and other data of interest for individuals and populations that may be of interest for analysis, research, pharmaceutical development, medical treatment, and so forth. Contributors become members of a community upon creation of an account and providing of data or files. The data is received and processed, such as to analyze, structure, perform quality control, and curate the data. Value or shares in one or more community databases are computed and attributed to each contributing member. The data is controlled to avoid identification or personalization. Third parties interested in the database information may contribute value (e.g., pay) for access and use. Value flows back to the members and to a system administrative entity.",LUNAPBC,KAIN ROBERT C;;BARRY DAWN MARY;;LEWIS DAVID;;BLOOM KENNETH ROBERT;;KAHN SCOTT;;VELINOV BOJIL,,https://lens.org/036-995-536-695-934,Patent Application,yes,0,0,10,12,0,G16H10/20;;G06Q40/08;;Y02A90/10;;G16H10/20;;G16H10/60;;G06F16/2379;;G06F16/958;;G06N20/00;;G06Q40/08,G16H10/60;;G06F16/23;;G06F16/958;;G06N20/00;;G16H10/20,,0,0,,,,PENDING
713,US,B2,US 8703204 B2,027-566-496-981-159,2014-04-22,2014,US 45128808 A,2008-04-23,US 45128808 A;;US 91569807 P;;IB 2008001145 W,2007-05-03,Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer,A pharmaceutical composition comprises nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a poorly aqueous soluble non-ionizable polymer.,BLOOM COREY JAY;;CREW MARSHALL DAVID;;SMITHEY DANIEL TOD;;MILLER WARREN KENYON;;MORGEN MICHAEL MARK;;BEND RES INC,BLOOM COREY JAY;;CREW MARSHALL DAVID;;SMITHEY DANIEL TOD;;MILLER WARREN KENYON;;MORGEN MICHAEL MARK,PFIZER PRODUCTS INC (2007-05-15);;PFIZER INC (2007-05-15);;BEND RESEARCH INC (2008-11-04),https://lens.org/027-566-496-981-159,Granted Patent,yes,102,28,4,4,0,A61K9/5146;;A61K9/5161;;A61K9/5192;;A61K31/4706;;A61P3/00;;A61P9/00;;A61K9/5146;;A61K9/5161;;A61K31/4706;;A61K9/5192,A61K9/51;;A61K9/14,424/495;;424/489;;424/490;;424/491;;424/501,72,65,003-571-904-906-04X;;111-867-922-837-533;;119-668-941-485-878;;066-096-399-843-134;;054-335-292-435-771;;087-565-695-455-735;;072-037-222-430-702;;058-824-227-667-632;;092-336-664-933-089;;015-714-720-040-924;;032-505-827-034-650;;018-417-372-069-779;;024-490-053-097-930;;098-947-239-453-173;;085-251-472-468-235;;093-034-511-083-004;;169-204-991-805-559;;068-415-037-271-085;;070-947-268-845-663;;029-148-840-307-966;;119-122-859-763-459;;028-163-841-784-966;;022-128-391-256-231;;069-221-673-539-59X;;064-606-200-359-500;;174-784-131-766-662;;044-401-659-486-787;;098-861-505-143-77X;;067-814-700-972-681;;122-821-104-012-033;;121-710-804-304-151;;080-045-508-651-228;;045-658-726-355-809;;009-965-442-151-227;;001-560-172-708-040;;034-644-848-878-302;;009-807-758-506-131;;005-011-839-424-294;;026-102-898-190-657;;037-950-455-763-306;;043-082-903-697-972;;064-604-226-265-642;;068-148-200-880-216;;136-143-741-385-295;;032-363-810-864-905;;048-254-383-700-313;;120-518-535-909-315;;020-895-468-484-385;;066-394-361-307-77X;;037-134-045-861-83X;;028-217-398-100-398;;067-995-195-259-919;;004-382-489-377-69X;;022-863-115-592-125;;078-769-616-108-97X;;038-192-364-607-443;;022-719-243-940-116;;018-888-014-102-189;;081-854-827-689-406;;046-414-361-320-616;;023-530-038-077-023;;067-097-986-709-416;;007-559-457-342-628;;001-456-292-671-326;;032-753-041-706-956,10.1080/02652040310001619992;;14718187;;10.1039/b605640g;;10.1016/0168-3659(90)90103-z;;12882808;;10.1167/iovs.02-1068;;15233861;;10.1211/0022357023835;;10.1016/s0378-5173(97)00083-5;;12506087;;10.1167/iovs.01-1156;;11996827;;10.1016/s0378-5173(02)00080-7;;10.1111/j.2042-7158.1987.tb03144.x;;2894445;;10.1002/jps.2600600902;;4935981;;12881116;;10.1080/0265204031000093591;;10.3109/02652040309178075;;10.1016/s0378-5173(01)00760-8;;11472825;;13678795;;10.1016/s0928-0987(03)00178-7;;10397606;;10.1023/a:1018826103261;;10.1080/107175400455128;;11195426;;14657301;;10.1148/radiol.2293031004;;10.1016/0378-5173(89)90281-0;;3520598;;10.1533/9781855738379.1.29;;10.1016/j.ejpb.2003.10.018;;15018976;;12739765;;10.1023/a:1023290514575;;10.1016/0168-3659(85)90057-4;;10.3109/02652048609049580;;3508173;;10.1248/cpb.36.4941;;3246054;;11672871;;10.1016/s0169-409x(01)00200-9;;10.1002/marc.200500631;;10.1002/mabi.200600189;;17366516;;10.1016/s0142-9612(01)00127-2;;11761166;;14661026;;pmc2346610;;10.1038/nbt920;;7904628;;10.1111/j.2042-7158.1993.tb05614.x;;12601049;;10.1167/iovs.02-0791;;10994037;;10.1111/j.2042-7158.1994.tb05702.x;;7897587;;10.1111/j.2042-7158.1994.tb03711.x;;8201534;;10.1016/s0010-7824(00)00113-x;;10906504;;10.3109/02652049709015336;;9132474;;10.1016/s0939-6411(03)00138-3;;14602172;;15296959;;10.1016/j.ejpb.2004.02.016;;16118015;;10.1016/j.biomaterials.2005.04.041;;16045324;;10.1021/ja052594h;;10.1007/s11095-006-9609-x;;16550476;;8094245;;10.1023/a:1018977130559;;10.1016/s0142-9612(01)00284-8;;11922464;;10.3109/03639049609065914;;10.3168/jds.s0022-0302(93)77712-7;;12434408;;10.1002/jps.10227;;12102196;;10.1016/s0142-9612(02)00080-7;;10.1016/s0928-0987(02)00057-x;;12113891;;15139521;;10.1023/b:pham.0000022411.47059.76;;10.1021/ja029267j;;14611213;;10.1016/s0378-5173(99)00171-4;;10486437;;10.1016/0168-3659(93)90103-c;;8331530;;10.1002/jps.2600820608;;7168872;;10.1248/cpb.30.4479;;10.1016/s0939-6411(03)00190-5;;15018984;;10.1248/cpb.30.673;;10.1002/jps.2600691209;;7463321;;2830037;;10.1248/cpb.35.3800;;15312996;;10.1016/j.jconrel.2004.05.016;;9608398;;10.3109/02652049809006863;;11906809;;10.1016/s1350-9462(01)00017-9;;15018982;;10.1016/s0939-6411(03)00187-5;;1359070;;10.1111/j.2042-7158.1992.tb03649.x;;10.1021/la0478595;;15620331;;10.1016/0169-409x(95)00017-2,"Al-Kassas, R., ""Design and In Vitro Evaluation of Gentamicin-Eudragit Microspheres Intended for Intra-Ocular Administration,"" Journal of Microencapsulation, 21:1(2004)71-81.;;Amrite, A.C., S.P. Ayalasomayajula, and U. Kompella, ""Ocular Distribution of Intact Nano- and Micro Particles Following Subconjunctival and Systemic Routes of Administration,"" Drug Delivery Techn., vol. 2, No. 3, 2003.;;Barbu, E., L. Verestiuc, T.G. Nevell, and J. Tsibouldis, ""Polymeric Materials for Ophthalmic Drug Delivery: Trends and Perspectives,"" J. of Materials Chemistry, 16(2006)3439-3443.;;Bodmeier et al., ""Preparation and Evaluation of Drug-Containing Polymeric Nanosuspensions,"" presented at the 5th International Conference on Pharmaceutical Technology, Paris, France, 1989. Proceedings vol. 2, pp. 265-268.;;Bodmeier, et al., ""Indomethacin Polymer Nanosuspension Prepared by Microfluidization"", Journal of Controlled Release, 12 (1990) 223-233.;;Bourges, J.-L., S.E. Gautier, F. Delie, R.A. Bejjani, J.-C. Jeanny, R. Gurny, D. BenEzra, and F.F. Behar-Cohen, ""Ocular Drug Delivery Targeting the Regina and Retinal Pigment Epithelium Using Polylactide Nanoparticles,"" Investigative Ophthalmology and Visual Science, 44:8(2003)3562-3569.;;Briancon, S., H. fessi, F. Lecomet, and J. Lieto, ""Study and Scale-Up of a Nanoprecipitation Process,"" Industrial Crystallization 1999 (IChemE), pp. 1-10.;;Bucolo, C., A. Maltese, F. Maugeri, B. Busa, G. Puglisi, and R. Pignatello, ""Eudragit RL100 Nanoparticle System for the Ophthalmic Delivery of Cloricromene,"" Journal of Pharmacy and Pharmacology, 56(2004)841 846.;;Calvo, P., J.L. Vila-Jato, and M.J. Alonso, ""Evaluation of Cationic Polymer-Coated Nanocapsules as Ocular Drug Carriers,"" International Journal of Pharmaceutics, 153(1997)41-50.;;Carrasquillo, K.G., J.A. Ricker, I.K. Rigas, J.W. Miller, E.S. Gragoudas, and A.P. Adamis, ""Controlled Delivery of the Anti-VEGF Aptamer EYE001 with Poly(lactic-co-glycolic) Acid Microspheres,"" Investigative Ophthalmology and Visual Science, 44:1(2003)290-299.;;Cavalli, R., M.R. Gasco, P. Chetoni, S. Burgalassi, and M.F. Saettone, ""Solid Lipid Nanoparticles (SLN) as Ocular Delivery System for Tobramycin,"" International J. Pharmaceutics, 238(2002)241-245.;;Chen et al., ""Comparison of Albumin and Casein Microspheres as a Carrier for Doxorubicin,"" J. Pharm. Pharmaco1.39(1987)978-985.;;Chiou, W.L., and S.Riegelman, J. Pharm. Sci., 60:9(1971)1281-1302.;;Couvreur, Microspheres and Drug Therapy, Elsevier, (1984) pp. 103-115.;;De, T.K., D.J. Rodman, B.A. Holm, P.N. Prasad, and E.J. Bergey, ""Brimonidine Formulation in Polyacrylic Acid Nanoparticles for Ophthalmic Delivery,"" J. Microencapsualtion, 20:3)2003)361-374.;;Decampos, A.M., A. Sanchez, and M.J. Alonso, ""Chitosan Nanoparticles: A New Vehicle for the Improvement of the Delivery of Drugs to the Ocular Surface. Application to Cyclosporin A,"" International J. of Pharmaceutics, 224(2001)159-168.;;Decampos., A.M., A. Sanchez, R. Gref, P. Calvo, and M.J. Alonso, ""The Effect of a PGE Versus a Chitosan Coating on the Interaction of Drug Colloidal Carriers with the Ocular Mucosa,"" European Journal of Pharmaceutical Sciences, 20(2003)73-81.;;Dejaeghere, F., E. Allemann, J.-C. Leroux, W. Stevels, J. Feijen, E. Doelker, and R. Gurny, ""Formulation of Lyoprotection of Poly(Lactic Acid-Co-Ethylene Oxide) Nanoparticles: Influence on Physical Stability and in Vitro cell Uptake,"" Pharmaceutical Research, 16:6(1999)859-866.;;Desai, S.D., and J. Blanchard, ""Pluronic F127-Based Ocular Delivery System Containing Biodegradable Polyisobutylcyanoacrylate Nanocapsules of Pilocarpine,"" Drug Delivery, 7(2000)201-207.;;Fee, C.A., and R.I. Pettigrew, ""National Institute of Biomedical Imaging and Bioengineering: Poised for the Future,"" National Institute of Biomedical Imaging and Bioengineering, 229:3(2003)636-637.;;Fessi, H., F. Puisieux, J.Ph. Devissaguet, N. Ammoury, and S. Benita, ""Nanocapsule Formation by Interfacial Polymer Deposition Following Solvent Displacement,"" International J. of Pharmaceutics, 55(1989)R1-R4.;;Ford, J.L., Pharm. Acta Helv., 61:3(1986)69-87.;;Fox et al., from Proteins in Food Processing, R.Y. Yada (ed), CRC Press, 2004, Chapter 3: The Caseins pp. 29-71.;;Gavini, E., P. Chetoni, M. Cossu, M.G. Alvarez, M.F. Saettone, and P. Giunchedi, ""PLGA Microspheres for the Ocular Delivery of a Peptide Drug, Vancomycin Using Emulsification/Spray-Drying as the Preparation Method: In Vitro/In Vivo Studies,"" European Journal of Pharmaceutics and Biopharmaceutics, 57(2004)207-212.;;Giannavola, C., C. Bucolo, A. Maltese, D. Paolino, M.A. Vandelli, G. Puglisi, V.H.L. Lee, and M. Fresta, ""Influence of Preparation Conditions on Acyclovir-Loaded Poly-d,l-Lactic Acid Nanospheres and Effect of PEG Coating on Ocular Drug Bioavailability."" Pharmaceutical Research, 20:4(2003)584-590.;;Gurny, Drug Develop. Ind. Pharm. 7(1), 1-25, 1981.;;Gurny, R., T. Boye, and H. Ibrahim, ""Ocular Therapy with Nanoparticulate Systems for Controlled Drug Delivery,"" Journal of Controlled Release, 2(1985)353-361.;;Harmia, J. Microencapsulation, 1986 vol. 3, No. 1, p. 3-12.;;Hasegawa, H., et al., Chem. Pharm. Bull., 33:4(1985)1615-1619; Chem. Pharm. Bull., 34:5(1986)2183-2190; Chem. Pharm. Bull., 36:12(1988) 4941-4950.;;Herrero-Vanrell, R., and M.F. Refojo, ""Biodegradable Microspheres for Vitreoretinal Drug Delivery,"" Advanced Drug Delivery Reviews, 52(2001)5 16.;;Hornig et al., ""Novel Nanoparticles Based on Dextran Esters with Unsaturated Moieties,"" Macromolecular Rapid Commun., 2005, 26, 1908-1912.;;Hornig et al., ""Structure Design of Multifunctional Furoate and Pyroglutamate Esters of Dextran by Polymer-Analogous Reactions,"" Macromol. Biosci. 2007, 7, 297-306.;;Hsiue, G.-H., S.-H. Hsu, C.-C. Yang, S.-H. Lee,a nd I.-K. Yang, ""Preparation of Controlled Release Ophthalmic Drops, for Glaucoma Therapy Using Thermosensitive poly-N-Isopropylacrylamide,"" Biomaterials, 23(2002)457 462.;;Kim, S., Y.T. Lim, E.G. Soltesz, A.M. DeGrand, J. Lee, A. Nakayama, J.A. Parker, T. Mihaljevic, R.G. Laurence, D.M. Dor, L.H. Cohn, M.G. Bawendi, and J.V. Frangioni,""Near-Infrared Fluorescent Type II Quantum Dots for Sentinel Lymph Node Mapping,"" Nature Biotechnology, 22:1(2004)93-97.;;Knepp et al., Synthesis, Properties, and Intratumoral Evaluation of Mitoxantrone-Loaded Casein Microspheres in Lewis Lung Carcinoma, J. Pharm. Pharmacol., 45(1993)887-891.;;Kompella, U.B., N. Bandi, and S.P. Ayalasomayajula, ""Subconjunctival Nano- and Microparticles Sustain Retinal Delivery of Budesonide, A Corticosteroid Capable of Inhibiting VEGF Expression,"" Investigative Ophthalmology and Visual Science, 44:3(2003)1192-1201.;;Kumar, M.N.V., ""Nano and Microparticles as Controlled Drug Delivery devices,"" J. Pharm. Pharmaceutical Sciences, 3:2(2000)234-258.;;Latha et al., Casein as a Carrier Matrix for 5-Fluorouracil: Drug Release from Microspheres, Drug-Protein Conjugates and In-Vivo Degradation of Microspheres in Rat Muscle, J. Pharm. Pharmacol., 46(1994)858-862.;;Latha et al., Glutaraldehyde Cross-Linked Bovine Casein Microspheres as a Matrix for the Controlled Release of Theophylline: In Vitro Studies, J. Pharm. Pharmacol., 46(1994)8-13.;;Latha et al., Progesterone Release from Glutaraldehyde Cross-Linked Casein Microspheres: In Vitro Studies and In Vivo Response in Rabbits, Contraception, 61(2000)329-334.;;Lecorre, P., J.H. Rytting, V. Gajan, F. Chevanne, and R. LeVerge, ""In Vitro Controlled Release Kinetics of Local Anaesthetics from Poly(D,L-lactice) and Poly (lactice-co-glycolide) Microspheres,"" Journal of Microencapsulation, 1997, pp. 243-255.;;Lellemand, F., O. Felt-Baeyens, K. Besseghir, F. Behar-Cohen, and R. Gurny, ""Cyclosporine a Delivery to the Eye: A Pharmaceutical Challenge,"" European J. of Pharmaceutics and Biopharmaceutics, 56(2003)307 318.;;Lemarchand, C., R. Gref, and P. Couvreur, ""Polysaccharide-Decorated Nanoparticles,"" European J. of Pharmaceutics and Biopharmaceutics, 58(204,327-341, Jun. 19 2004.;;Lemarchand, et al., ""Influence of polysaccharide coating on the interactions of nanoparticles with biological systems,"" Biomaterials, 27(2006)108-118.;;Liebert, et al., ""Nanoparticles on the Basis of Highly Functionalized Dextrans,"" J. Am. Chem. Soc. 2005, 127, 10484-10485.;;Longmuir, K.J., R.T. Robertson, S.M. Haynes, J.L. Baratta, and A.J. Waring, ""Effective Targeting of Liposomes to Liver and Hepatocytes In Vivo by Incorporation of a Plasmodium Amino Acid Sequence,"" Pharmaceutical Research, 23:4(2006)759-769.;;Losa, C., L. Marchal-Heussler, F. Orallo, J.L. Vila Jato, and M.J. Alonso, ""Design of New Formulations for Topical Ocular Administration: Polymeric Nanocapsules Containing Metipranolol,"" Pharmaceutical Research, 10:1(1993)80-87.;;Merodio, M., J.M. Irache, F. Valamanesch, and M. Mirshahi, ""Ocular Disposition and Tolerance of Ganciclovir-Loaded Albumin Nanoparticles after Intravitreal Injection in Rats,"" Biomaterials, 23(2002)1587-1594.;;Mirshahi et al., Development of Drug Delivery Systems from Vegetal Proteins: Legumin Nanoparticles, Drug Dev. Indust.Pharm., 22:8(1996)841-846.;;Mora-Gutierrez et al., Modeling Calcium-Induced Solubility in Caprine Milk Caseins Using a Thermodynamic Linkage Approach, J. Dairy Sci., 76(1993)3698-3710.;;Ohio State FST 822 Class Lecture, Casein, 2006, 5 pp.;;Pignatello, R., C. Bucolo, and G. Puglisi, ""Ocular Tolerability of Eudragit RS100 and RL100 Nanosuspensions as Carriers for Ophthalmic Controlled Drug Delivery,"" Journal of Pharmaceutical Sciences, 91:12(2002)2636-2641.;;Pignatello, R., C. Bucolo, G. Spedalieri, A. Maltese, and G. Puglisi, ""Flurbiprofen-Loaded Acrylate Polymer Nanosuspensions for Ophthalmic Application,"" Biomaterials, 23(2002)3247-3255.;;Pignatello, R., C. Bucolo, P. Ferra, A. Maltese, A. Puleo, and G. Puglisi, ""Eudragit RS100 Nanosuspensions for the Ophthalmic Controlled Delivery of Ibuprofen,"" European Journal of Pharmaceutical Sciences, 16(2002)53 61.;;Qaddoumi, M.G., H. Ueda, J. Yang, J. Davda, V. Labhasetwar, and V.H.L. Lee, ""The Characteristics and Mechanisms of Uptake of PLGA Nanoparticles in Rabbit Conjuctival Epithelial Cell Layers,"" Pharmaceutical Research, 21:4(2004)641-648.;;Raveendran, P, J. Fu, and S.L. Wallen, ""Completely 'Green' Synthesis and Stabilization of Metal Nanoparticles,"" J. American Chemical Society, 125(2003)13940-13941.;;Santinho et al., Influence of Formulation on the Physiochemical Properties of Casein Microparticles, Int'l J. Pharm., 186(1999)191-198.;;Scholes, P.D., A.G.A. Coombes, L. Ilium, S.S. Savis, M. Vert, and M.C. Davies, ""The Preparation of Sub-200 nm Poly(lactide-co-glycolide) Microspheres for Site-Specific Drug Delivery,"" J. Controlled Release, 25(1993)145-153.;;Sjostrom, et al., Journal of Pharmaceutical Sciences, vol. 82, No. 6 Jun. 1993, pp. 584-589.;;Sugimoto, I., K. Sasaki, A. Kuchiki, T. Ishihara, and H. Nakagawa, Chem. Pharm. Bull, 30:12(1982)4479-4488.;;Suverkrup, R., S. Grunthal, O. Krasichkova, S. Maier, A. Weischselbaum, B. Neff, M. Diestelhorst, S. Dinslage, and A. Lux, ""The Ophthalmic Lyophilisate Carrier System (OLCS): Development of a Novel Dosage Form, Freeze-Drying Technique, and In Vitro Quality Control Tests, ""European J. Pharmaceutics and Biopharmaceutics, 57(2004)269-277.;;Takayama, K., N. Nambu, and T. Nagai., Chem. Pharm. Bull., 30:2(1982)673-678.;;Takenaka, H., Y. Kawashima and S.Y. Lin, J. Pharm. Sci., 69:12(1980)1388-1392.;;Takeuchi, H., T. Handa and Y. Kawashima, Chem. Pharm. Bull., 35:9(1987)3800-3806.;;Tuovinen, L., E. Ruhanen, T. Kinnarinen, S. Ronkko, J. Pelkonen, A. Urtti, S. Peltonen, and K. Jarvinen, ""Starch Acetate Microparticles for Drug Delivery Into Retinal Pigment Epithelium-In Vitro Study,"" J. of Controlled Release, 98(2004)407-413.;;Ueda, M., A. Iwara, and J. Kreuter, ""Influence of the Preparation Methods on the Drug Release Behaviour of Loperamide-Loaded Nanoparticles,"" J. Microencapsulation, 15:3(1998)361-372.;;University of Guelph, Dairy Chemistry and Physics, 2006, 16 pp.;;Vandamme, Th.F., ""Microemulsions as Ocular Drug Delivery Systems: Recent Developments and Future Challenges,"" Progress in Retinal and Eye Research, 21(2002)15-34.;;Vandervoort, J., and A. Ludwig, ""Preparation and Evaluation of Drug-Loaded Gelatin Nanoparticles for Topical Ophthalmic Use,"" European J. of Pharmaceutics and Biopharmaceutics, 57(2004)251-261.;;Willmott et al., Doxorubicin-Loaded Casein Microspheres: Protean Nature of Drug Incorporation J. Pharm. Pharnnacol. 42(1992)472-475.;;Zahr, A.S., M. de Villiers, and M.V. Pishko, ""Encapsulation of Drug Nanoparticles in Self-Assembled Macromolecular Nanoshells,"" Langmuir, 21(2005)503 410.;;Zimmer, A., and J. Kreuter, ""Microspheres and Nanoparticles Used in Ocular Delivery Systems,"" Advanced Drug Delivery Reviews, 16(1995)61-73.",INACTIVE
714,AU,A,AU 2000/031112 A,065-192-878-287-298,2000-06-26,2000,AU 2000/031112 A,1999-12-06,US 20831698 A;;US 9928844 W,1998-12-09,Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses,,AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;O'HARA BRYAN MARK,WYETH (2002-10-03),https://lens.org/065-192-878-287-298,Patent Application,no,0,0,18,18,0,C07C335/20;;C07C335/22;;C07D207/09;;C07D207/14;;C07D211/58;;C07D261/10;;A61P31/22,C07D249/04;;A61K31/17;;A61K31/341;;A61K31/343;;A61K31/345;;A61K31/36;;A61K31/381;;A61K31/40;;A61K31/403;;A61K31/4192;;A61K31/42;;A61K31/433;;A61K31/437;;A61K31/4409;;A61K31/4468;;A61K31/47;;A61K31/4965;;A61K31/5375;;A61K31/56;;A61P31/22;;C07C335/20;;C07C335/22;;C07C337/06;;C07D207/09;;C07D207/14;;C07D207/34;;C07D209/48;;C07D211/58;;C07D213/81;;C07D215/48;;C07D217/26;;C07D221/12;;C07D241/24;;C07D261/08;;C07D261/10;;C07D265/30;;C07D285/06;;C07D295/12;;C07D307/56;;C07D307/73;;C07D307/85;;C07D317/68;;C07D333/38;;C07D333/70,,0,0,,,,DISCONTINUED
715,EP,B1,EP 0608568 B1,086-465-326-645-483,1998-03-11,1998,EP 93121091 A,1993-12-30,US 1097393 A,1993-01-29,Aminocycloalkanobenzodioxoles as beta-3 selective adrenergic agents,"The invention is antiobesity/antidiabetic/beta-3 agonists of the formula <CHEM> wherein the substituents Ro, R1, R4, R4', R5, R6 or n are as defined in the specification.",AMERICAN CYANAMID CO,EPSTEIN JOSEPH WILLIAM;;BIRNBERG GARY HAROLD;;WALKER GARY EDWARD;;DUTIA MINU DHANJISHA;;BLOOM JONATHAN DAVID,AMERICAN CYANAMID COMPANY (1998-01-21),https://lens.org/086-465-326-645-483,Granted Patent,yes,2,0,13,13,0,A61K31/36;;C07D317/70;;C07D413/04;;A61P3/10;;A61P3/04;;A61P3/08;;C07D413/04;;A61K31/36;;C07D317/70;;C07D413/04;;C07D317/70;;A61K31/36,A23K1/16;;A61K31/335;;A61K31/357;;A61K31/36;;A61P3/04;;A61P3/08;;A61P3/10;;C07D317/70;;C07D413/04,,1,0,,,"JOURNAL OF PHARMACEUTICAL SCIENCES vol. 75, no. 1 , 1986 , WASHINGTON US pages 80 - 82 ROBIN D. CLARK ET AL. 'Antihypertensive Aminotetralins Related to Labetalol and Medroxalol'",EXPIRED
716,AT,T1,AT E183590 T1,086-918-110-282-926,1999-09-15,1999,AT 96919154 T,1996-06-05,US 48045995 A,1995-06-07,HERSTELLUNGSVERFAHREN UND VORRICHTUNG FÜR EINEN LICHTSCHALTER MIT EBENEN BEUGUNGSGITTER,"A deformable grating aparatus for modulating light is made by forming an insulating layer on a substrate, forming a first conductive layer on the insulating layer and then forming a sacrificial layer thereon. The sacrificial layer and the first conducting layer are then etched to define bit lines and busses to bonding pads. Then a layer of resilient material is formed onto the etched layers and a reflective conducting layer is formed on the resilient layer. A dielectric layer is deposited on the reflective conducting layer. The dielectric layer, the reflective conducting layer, the resilient layer and the sacrificial layer are all then etched to form a grating including a plurality of parallel elements. Thereafter the sacrificial layer is removed below the parallel elements, to suspend the parallel elements over the first conducting layer. The surface is treated to prevent the grating from adhering to the first conducting layer. A light modulator includes a substrate with an insulating layer, and a plurality of parallel conductive layers formed on the insulating layer. The ribbons are spaced apart from the conductive layers by an air space and mounted to the substrate in gaps between the conductive layers.",SILICON LIGHT MACHINES INC,BORNSTEIN JONATHAN G;;BANYAI WILLIAM C;;BLOOM DAVID M;;WHITTEN RALPH G;;STAKER BRYAN P,,https://lens.org/086-918-110-282-926,Granted Patent,no,0,0,16,16,0,G02B5/1828;;G02B26/0808;;Y10S359/904;;G02B5/18;;G02B5/1828;;G02B26/0808;;Y10S359/904,G02B5/18;;G02B26/08,,0,0,,,,EXPIRED
717,US,A1,US 2020/0035340 A1,086-783-826-995-600,2020-01-30,2020,US 201916377922 A,2019-04-08,US 201916377922 A;;US 201816192341 A;;US 201862712063 P;;US 201862647572 P;;US 201762587842 P,2017-11-17,ORIGIN PROTECTED OMIC DATA AGGREGATION PLATFORM,"A system and method are disclosed for the collection and aggregation of genomic, medical, and other data of interest for individuals and populations that may be of interest for analysis, research, pharmaceutical development, medical treatment, and so forth. Contributors become members of a community upon creation of an account and providing of data or files. The data is received and processed, such as to analyze, structure, perform quality control, and curate the data. Value or shares in one or more community databases are computed and attributed to each contributing member. The data is controlled to avoid identification or personalization. Third parties interested in the database information may contribute value (e.g., pay) for access and use. Value flows back to the members and to a system administrative entity.",LUNAPBC,KAIN ROBERT C;;BARRY DAWN MARY;;LEWIS DAVID;;BLOOM KENNETH ROBERT;;KAHN SCOTT;;VELINOV BOJIL,,https://lens.org/086-783-826-995-600,Patent Application,yes,6,2,10,12,0,G16H10/20;;G06Q40/08;;Y02A90/10;;G16H10/20;;G16H10/60;;G06F16/2379;;G06F16/958;;G06N20/00;;G06Q40/08,G16H10/60;;G06F16/23;;G06F16/958;;G06N20/00;;G16H10/20,,0,0,,,,ACTIVE
718,BR,A2,BR PI0619132 A2,006-707-213-612-842,2011-09-13,2011,BR PI0619132 A,2006-12-01,US 74177205 P;;US 2006/0045950 W,2005-12-01,"composto métodos para inibir a replicação de um vìrus de hepatite c, para tratar ou prevenir uma infecção viral de hepatite c em um mamìfero e para inibir rna polimerase dependente do rna de hepatite c, e, composição farmacêutica","COMPOSTO, MéTODOS PARA INIBIR A REPLICAçãO DE UM VìRUS DE HEPATITE C, PARA TRATAR OU PREVENIR UMA INFECçãO VIRAL DE HEPATITE C EM UM MAMìFERO E PARA INIBIR RNA POLIMERASE DEPENDENTE DO RNA DE HEPATITE C, E, COMPOSIçãO FARMACêUTICA. A presente invenção está direcionada aos compostos da fórmula (I): R^ 1^ é selecionado do grupo que consiste de -C(O)R^ 6^ e, em que R^ 6^ e R^ 7^ são independentemente selecionados de H, alquila, cicloalquila, heterocicloalquila, heteroarila ou arila, qualquer um dos quais pode ser opcionalmente substituído, G é selecionado de II ou hidroxila, Y é O, NH ou 5, X é selecionado do grupo que consiste de H, halo, alquila, cicloalquila, perfluoroalquila, alcóxi, alquiltio, amino, alquilamino, dialquilamino e CN e n é O, 1, 2 ou 3, ou uma pró-droga, um sal farmaceuticamente aceitável ou um metabólito farmaceuticamente ativo deste. Esta invenção também está direcionada à composições contendo os compostos da invenção e métodos de usar tanto os compostos da invenção quanto as composições deste para tratar ou prevenir a infecção pelo vírus de Hepatite C ou para inibir a replicação de um vírus de Hepatite C.",WYETH CORP,BLOOM JONATHAN DAVID;;INSAF SHABANA;;NITTOLI THOMAS;;SUTHERLAND ALAN GORDON;;CURRAN KEVIN J;;WHELESS KAREN,,https://lens.org/006-707-213-612-842,Patent Application,no,0,0,8,8,0,A61P31/12;;A61P31/14;;A61P43/00;;C07D317/66;;C07C235/24;;C07C237/04;;C07C251/48;;C07C317/36,C07D317/66;;A61K31/36;;A61P31/12;;C07C235/24;;C07C237/04;;C07C251/48,,0,0,,,,DISCONTINUED
719,PT,B,PT 97540 B,059-819-346-789-827,1998-08-31,1998,PT 9754091 A,1991-05-02,US 51919290 A,1990-05-04,"PROCESSO PARA A PREPARACAO DE 5-(2-((2-ARIL-2-HIDROXIETIL)AMINO)PROPIL)-1,3-BENZODIOXOLES SUBSTITUIDOS","The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.",AMERICAN CYANAMID CO,BLOOM JONATHAN DAVID;;CLAUS THOMAS HARRISON;;DEVRIES VERN GORDON;;DOLAN JO ALENE;;DUTIA MINU DHANJISHA,,https://lens.org/059-819-346-789-827,Granted Patent,no,0,0,40,44,0,C07D317/46;;C07D413/06;;A61P3/10;;A61P3/04;;A61P3/08;;C07D317/46;;C07D413/06;;C07D317/46,A61K31/335;;A61K31/357;;A61K31/36;;A61K31/42;;A23K1/16;;A61P3/04;;A61P3/08;;A61P3/10;;C07D263/04;;C07D291/04;;C07D317/46;;C07D317/58;;C07D317/62;;C07D405/06;;C07D413/06;;C07D419/06,,0,0,,,,EXPIRED
720,US,A1,US 2019/0156923 A1,097-929-985-176-117,2019-05-23,2019,US 201816192341 A,2018-11-15,US 201816192341 A;;US 201862712063 P;;US 201862647572 P;;US 201762587842 P,2017-11-17,"PERSONAL, OMIC, AND PHENOTYPE DATA COMMUNITY AGGREGATION PLATFORM","A system and method are disclosed for the collection and aggregation of genomic, medical, and other data of interest for individuals and populations that may be of interest for analysis, research, pharmaceutical development, medical treatment, and so forth. Contributors become members of a community upon creation of an account and providing of data or files. The data is received and processed, such as to analyze, structure, perform quality control, and curate the data. Value or shares in one or more community databases are computed and attributed to each contributing member. The data is controlled to avoid identification or personalization. Third parties interested in the database information may contribute value (e.g., pay) for access and use. Value flows back to the members and to a system administrative entity.",LUNAPBC,KAIN ROBERT C;;BARRY DAWN MARY;;LEWIS DAVID;;BLOOM KENNETH ROBERT;;KAHN SCOTT;;VELINOV BOJIL,LUNAPBC (2018-11-14),https://lens.org/097-929-985-176-117,Patent Application,yes,0,26,10,12,0,G16H10/20;;G06Q40/08;;Y02A90/10;;G16H10/20;;G16H10/60;;G06F16/2379;;G06F16/958;;G06N20/00;;G06Q40/08,G16H10/60;;G06F16/23;;G06F16/958;;G06N20/00,,0,0,,,,DISCONTINUED
721,AU,A,AU 2000/031111 A,124-246-913-708-422,2000-06-26,2000,AU 2000/031111 A,1999-12-06,US 20796198 A;;US 9928838 W,1998-12-09,Thiourea inhibitors of herpes viruses,,AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;O'HARA BRYAN MARK,WYETH (2002-10-03),https://lens.org/124-246-913-708-422,Patent Application,no,0,0,17,17,0,C07D207/335;;C07D209/14;;C07D213/40;;C07D213/75;;C07D215/12;;C07D217/12;;C07D231/56;;C07D233/44;;C07D277/28;;C07D285/06;;C07D307/52;;C07D333/20;;C07D405/12;;C07D417/12;;A61P31/12;;A61P31/22;;C07D209/14;;C07D207/335;;C07D213/40;;C07D215/12;;C07D217/12;;C07D231/56;;C07D233/44;;C07D285/06;;C07D307/52;;C07D333/20;;C07D417/12,C07D295/14;;A61K31/06;;A61K31/075;;A61K31/085;;A61K31/10;;A61K31/11;;A61K31/136;;A61K31/15;;A61K31/165;;A61K31/167;;A61K31/17;;A61K31/175;;A61K31/18;;A61K31/196;;A61K31/215;;A61K31/216;;A61K31/222;;A61K31/27;;A61K31/275;;A61K31/341;;A61K31/40;;A61K31/42;;A61K31/426;;A61K31/433;;A61K31/4439;;A61K31/4453;;A61K31/4458;;A61K31/54;;A61K31/695;;A61P31/12;;A61P31/22;;C07C335/20;;C07D207/12;;C07D207/14;;C07D207/32;;C07D207/335;;C07D209/14;;C07D211/22;;C07D213/40;;C07D213/75;;C07D215/12;;C07D217/12;;C07D231/12;;C07D231/56;;C07D233/44;;C07D261/08;;C07D277/24;;C07D277/28;;C07D285/06;;C07D307/52;;C07D307/54;;C07D333/20;;C07D405/12;;C07D417/12,,0,0,,,,DISCONTINUED
722,CA,A1,CA 2631024 A1,149-718-234-404-144,2008-05-02,2008,CA 2631024 A,2006-12-01,US 74177205 P;;US 2006/0045950 W,2005-12-01,ANTHRANILIC ACID DERIVATIVES USEFUL IN TREATING INFECTION WITH HEPATITIS C VIRUS,,WYETH CORP,WHELESS KAREN;;INSAF SHABANA;;NITTOLI THOMAS;;SUTHERLAND ALAN GORDON;;CURRAN KEVIN J;;BLOOM JONATHAN DAVID,,https://lens.org/149-718-234-404-144,Patent Application,no,0,0,8,8,0,A61P31/12;;A61P31/14;;A61P43/00;;C07D317/66;;C07C235/24;;C07C237/04;;C07C251/48;;C07C317/36,C07C237/04;;A61K31/196;;A61P31/14;;C07C235/24,,0,0,,,,DISCONTINUED
723,EP,B1,EP 0830629 B1,179-614-803-117-009,1999-08-18,1999,EP 96919154 A,1996-06-05,US 9609255 W;;US 48045995 A,1995-06-07,A METHOD OF MAKING AND AN APPARATUS FOR A FLAT DIFFRACTION GRATING LIGHT VALVE,"A deformable grating aparatus for modulating light is made by forming an insulating layer on a substrate, forming a first conductive layer on the insulating layer and then forming a sacrificial layer thereon. The sacrificial layer and the first conducting layer are then etched to define bit lines and busses to bonding pads. Then a layer of resilient material is formed onto the etched layers and a reflective conducting layer is formed on the resilient layer. A dielectric layer is deposited on the reflective conducting layer. The dielectric layer, the reflective conducting layer, the resilient layer and the sacrificial layer are all then etched to form a grating including a plurality of parallel elements. Thereafter the sacrificial layer is removed below the parallel elements, to suspend the parallel elements over the first conducting layer. The surface is treated to prevent the grating from adhering to the first conducting layer. A light modulator includes a substrate with an insulating layer, and a plurality of parallel conductive layers formed on the insulating layer. The ribbons are spaced apart from the conductive layers by an air space and mounted to the substrate in gaps between the conductive layers.",SILICON LIGHT MACHINES INC,BORNSTEIN JONATHAN G;;BANYAI WILLIAM C;;BLOOM DAVID M;;WHITTEN RALPH G;;STAKER BRYAN P,,https://lens.org/179-614-803-117-009,Granted Patent,yes,3,0,16,16,0,G02B5/1828;;G02B26/0808;;Y10S359/904;;G02B5/18;;G02B5/1828;;G02B26/0808;;Y10S359/904,G02B5/18;;G02B26/08,,1,0,,,"OPTICS LETTERS, vol. 17, no. 9, 1 May 1992, pages 688-690, XP000265233 SOLGAARD O ET AL: ""DEFORMABLE GRATING OPTICAL MODULATOR""",EXPIRED
724,ZA,B,ZA 200104142 B,002-641-281-420-389,2002-10-25,2002,ZA 200104142 A,2001-05-21,US 20831698 A,1998-12-09,Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses.,,AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DUSHIN RUSSEL GEORGE;;O'HARA BRYAN MARK;;DIGRANDI MARTIN JOSEPH;;LANG STANLEY ALBERT,,https://lens.org/002-641-281-420-389,Granted Patent,no,0,0,18,18,0,C07C335/20;;C07C335/22;;C07D207/09;;C07D207/14;;C07D211/58;;C07D261/10;;A61P31/22,A61K31/17;;C07D249/04;;A61K31/341;;A61K31/343;;A61K31/345;;A61K31/36;;A61K31/381;;A61K31/40;;A61K31/403;;A61K31/4192;;A61K31/42;;A61K31/433;;A61K31/437;;A61K31/4409;;A61K31/4468;;A61K31/47;;A61K31/4965;;A61K31/5375;;A61K31/56;;A61P31/22;;C07C335/20;;C07C335/22;;C07C337/06;;C07D207/09;;C07D207/14;;C07D207/34;;C07D209/48;;C07D211/58;;C07D213/81;;C07D215/48;;C07D217/26;;C07D221/12;;C07D241/24;;C07D261/08;;C07D261/10;;C07D265/30;;C07D285/06;;C07D295/12;;C07D307/56;;C07D307/73;;C07D307/85;;C07D317/68;;C07D333/38;;C07D333/70,,0,0,,,,EXPIRED
725,DK,T3,DK 0455006 T3,011-831-177-324-964,1999-11-22,1999,DK 91105510 T,1991-04-08,US 51919290 A,1990-05-04,"Substituerede 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoler","The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.",AMERICAN CYANAMID CO,BLOOM JONATHAN DAVID;;CLAUS THOMAS HARRISON;;DEVRIES VERN GORDON;;DOLAN JO ALENE;;DUTIA MINU DHANJISHA,,https://lens.org/011-831-177-324-964,Granted Patent,no,0,0,40,44,0,C07D317/46;;C07D413/06;;A61P3/10;;A61P3/04;;A61P3/08;;C07D317/46;;C07D413/06;;C07D317/46,A23K1/16;;A61K31/335;;A61K31/357;;A61K31/36;;A61K31/42;;A61P3/04;;A61P3/08;;A61P3/10;;C07D263/04;;C07D291/04;;C07D317/46;;C07D317/58;;C07D317/62;;C07D405/06;;C07D413/06;;C07D419/06,,0,0,,,,EXPIRED
726,US,B1,US 8078055 B1,067-308-014-163-559,2011-12-13,2011,US 15124908 A,2008-05-05,US 15124908 A,2008-05-05,Passive optical avionics network,"The present disclosure is directed to a passive optical avionics network system and method. A passive avionics network may comprise: (a) an optical line terminal (OLT); (b) at least one optical network unit (ONU); (c) a fiber optic bus operably coupling the OLT and the ONU; and (d) an avionics module operably coupled to the ONU. An integrated modular avionics (IMA) system may comprise: (a) a line-replaceable unit (LRU), the LRU comprising: (i) a processing unit; and (ii) an optical line terminal (OLT); (b) at least one optical network unit (ONU); (c) a fiber optic bus operably coupling the LRU and the ONU; and (d) an avionics module operably coupled to the ONU. A method for avionics network communication may comprise: (a) providing avionics data; (b) transmitting the avionics data via a fiber optic network; (c) receiving the avionics data; and (d) controlling functionality of an avionics module according to the avionics data.",MAZUK DANIEL E;;MORGAN PETER J;;MILLER DAVID A;;BLOOM NICHOLAS H;;KOVALAN MARK A;;ROCKWELL COLLINS INC,MAZUK DANIEL E;;MORGAN PETER J;;MILLER DAVID A;;BLOOM NICHOLAS H;;KOVALAN MARK A,RESOURCE COMMUNICATIONS INC (2008-05-02);;ROCKWELL COLLINS INC (2008-04-25),https://lens.org/067-308-014-163-559,Granted Patent,yes,5,12,1,2,0,H04B10/272;;H04B10/272,H04B10/20,398/66;;398/113,0,0,,,,INACTIVE
727,FI,C,FI 94862 C,069-908-885-176-082,1995-11-10,1995,FI 912142 A,1991-05-03,US 51919290 A,1990-05-04,"Menetelmä uusien, terapeuttisesti käyttökelpoisten 5-(2-((2-aryyli-2-hydroksietyyli)amino)propyyli)-1,3-bentsodioksolijohdannaisten valmistamiseksi","The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.",AMERICAN CYANAMID CO,BLOOM JONATHAN DAVID;;CLAUS THOMAS HARRISON;;DEVRIES VERN GORDON;;DOLAN JO ALENE;;DUTIA MINU DHANJISHA,,https://lens.org/069-908-885-176-082,Granted Patent,no,0,0,40,44,0,C07D317/46;;C07D413/06;;A61P3/10;;A61P3/04;;A61P3/08;;C07D317/46;;C07D413/06;;C07D317/46,A61K31/335;;A23K1/16;;A61K31/357;;A61K31/36;;A61K31/42;;A61P3/04;;A61P3/08;;A61P3/10;;C07D263/04;;C07D291/04;;C07D317/46;;C07D317/58;;C07D317/62;;C07D405/06;;C07D413/06;;C07D419/06,,0,0,,,,EXPIRED
728,US,A1,US 2008/0213105 A1,074-944-615-324-750,2008-09-04,2008,US 99644406 A,2006-07-26,US 99644406 A;;US 74760406 P;;US 70404605 P;;US 2006/0029062 W,2005-07-29,"Reciprocating Piston Pump with Air Valve, Detent and Poppets",An air valving system for a reciprocating piston pump ( 5 ) which uses piston ( 10 ) actuated poppet assemblies ( 40 ) to control the main air valve ( 16 ) shift. The valve exhaust is vented ( 50 ) directly to atmosphere rather than through the main exhaust to ensure reliability. A ramped detent ( 32 ) prevents the air valve ( 16 ) from centering.,BAUCK MARK L;;ISAIS JOHN F;;WEINBERGER MARK T;;PITTMAN DAVID M;;BLOOM MICHAEL E,BAUCK MARK L;;ISAIS JOHN F;;WEINBERGER MARK T;;PITTMAN DAVID M;;BLOOM MICHAEL E,GRACO MINNESOTA INC (2008-01-02),https://lens.org/074-944-615-324-750,Patent Application,yes,25,1,28,28,0,F04B9/12;;F04B9/125;;F16K11/02;;F04B49/00;;F04B35/00;;F04B9/08;;F04B9/12;;F04B9/125;;F16K11/02,F04B35/02;;F04B7/02;;F04B9/08;;F04B49/00;;F16K31/122,417/375;;91/271;;417/567;;251/63,0,0,,,,INACTIVE
729,US,A1,US 2010/0129447 A1,102-528-771-890-747,2010-05-27,2010,US 45128808 A,2008-04-23,US 45128808 A;;US 91569807 P;;IB 2008001145 W,2007-05-03,NANOPARTICLES COMPRISING A CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR AND ANON-IONIZABLE POLYMER,A pharmaceutical composition comprises nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a poorly aqueous soluble non-ionizable polymer.,BLOOM COREY JAY;;CREW MARSHALL DAVID;;SMITHEY DANIEL TOD;;MILLER WARREN KENYON;;MORGEN MICHAEL MARK,BLOOM COREY JAY;;CREW MARSHALL DAVID;;SMITHEY DANIEL TOD;;MILLER WARREN KENYON;;MORGEN MICHAEL MARK,PFIZER PRODUCTS INC (2007-05-15);;PFIZER INC (2007-05-15);;BEND RESEARCH INC (2008-11-04),https://lens.org/102-528-771-890-747,Patent Application,yes,101,1,4,4,0,A61K9/5146;;A61K9/5161;;A61K9/5192;;A61K31/4706;;A61P3/00;;A61P9/00;;A61K9/5146;;A61K9/5161;;A61K31/4706;;A61K9/5192,A61K31/47;;A61K9/14;;A61K9/51;;A61K31/136;;A61P3/00;;A61P9/00,424/484;;424/501;;424/499;;424/490;;514/655;;514/313;;977/773;;977/906,0,0,,,,INACTIVE
730,US,B2,US 11574712 B2,111-252-818-802-268,2023-02-07,2023,US 201916377922 A,2019-04-08,US 201916377922 A;;US 201816192341 A;;US 201862712063 P;;US 201862647572 P;;US 201762587842 P,2017-11-17,Origin protected OMIC data aggregation platform,"A system and method are disclosed for the collection and aggregation of genomic, medical, and other data of interest for individuals and populations that may be of interest for analysis, research, pharmaceutical development, medical treatment, and so forth. Contributors become members of a community upon creation of an account and providing of data or files. The data is received and processed, such as to analyze, structure, perform quality control, and curate the data. Value or shares in one or more community databases are computed and attributed to each contributing member. The data is controlled to avoid identification or personalization. Third parties interested in the database information may contribute value (e.g., pay) for access and use. Value flows back to the members and to a system administrative entity.",LUNAPBC,KAIN ROBERT C;;BARRY DAWN MARY;;LEWIS DAVID;;BLOOM KENNETH ROBERT;;KAHN SCOTT;;VELINOV BOJIL,,https://lens.org/111-252-818-802-268,Granted Patent,yes,84,0,10,12,0,G16H10/20;;G06Q40/08;;Y02A90/10;;G16H10/20;;G16H10/60;;G06F16/2379;;G06F16/958;;G06N20/00;;G06Q40/08,G16H10/60;;G06F16/23;;G06F16/958;;G06N20/00;;G06Q40/08;;G16H10/20,,4,1,058-652-871-774-668,10.1007/978-94-007-1673-5_6,"Bovenberg, Jasper A; “One Sample, One Share! A Proposal to Redress an Inequity with Equity;” Biobanks and Tissue Research. The Public, the Patient and the Regulation; Jan. 2011; 16 pages.;;International Search Report and Written Opinion for PCT/US2018/067933 dated Sep. 18, 2019; 15 pages.;;International Search Report and Written Opinion for PCT/US2018/061419 dated Feb. 25, 2019, 14 pages.;;Examination Report for Australian Application No. 2018370131 dated May 26, 2021, 6 pages.",ACTIVE
731,EP,A1,EP 0830629 A1,111-471-413-519-202,1998-03-25,1998,EP 96919154 A,1996-06-05,US 9609255 W;;US 48045995 A,1995-06-07,A METHOD OF MAKING AND AN APPARATUS FOR A FLAT DIFFRACTION GRATING LIGHT VALVE,"A deformable grating aparatus for modulating light is made by forming an insulating layer on a substrate, forming a first conductive layer on the insulating layer and then forming a sacrificial layer thereon. The sacrificial layer and the first conducting layer are then etched to define bit lines and busses to bonding pads. Then a layer of resilient material is formed onto the etched layers and a reflective conducting layer is formed on the resilient layer. A dielectric layer is deposited on the reflective conducting layer. The dielectric layer, the reflective conducting layer, the resilient layer and the sacrificial layer are all then etched to form a grating including a plurality of parallel elements. Thereafter the sacrificial layer is removed below the parallel elements, to suspend the parallel elements over the first conducting layer. The surface is treated to prevent the grating from adhering to the first conducting layer. A light modulator includes a substrate with an insulating layer, and a plurality of parallel conductive layers formed on the insulating layer. The ribbons are spaced apart from the conductive layers by an air space and mounted to the substrate in gaps between the conductive layers.",SILICON LIGHT MACHINES INC,BORNSTEIN JONATHAN G;;BANYAI WILLIAM C;;BLOOM DAVID M;;WHITTEN RALPH G;;STAKER BRYAN P,,https://lens.org/111-471-413-519-202,Patent Application,yes,0,0,16,16,0,G02B5/1828;;G02B26/0808;;Y10S359/904;;G02B5/18;;G02B5/1828;;G02B26/0808;;Y10S359/904,G02B5/18;;G02B26/08,,0,0,,,,EXPIRED
732,WO,A1,WO 2000/034268 A1,125-728-490-041-15X,2000-06-15,2000,US 9928838 W,1999-12-06,US 20796198 A,1998-12-09,THIOUREA INHIBITORS OF HERPES VIRUSES,"Compounds of formula (I) wherein A is heteroaryl; R9-R12 are independently hydrogen, alkyl of 1 to 4 carbon atoms, perhaloalkyl of 1 to 4 carbon atoms, halogen, alkoxy of 1 to 4 carbon atoms, or cyano, or R9 and R10 or R11 and R12 may be taken together to form aryl of 5 to 7 carbon atoms; W is O, NR6, or is absent; G is aryl or heteroaryl; and X is a bond, -NH, alkyl of 1 to 6 carbon atoms, alkenyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, thioalkyl of 1 to 6 carbon atoms, alkylamino of 1 to 6 carbon atoms, or (CH)J; and J is alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 7 carbon atoms, phenyl or benzyl; and n is an integer from 1 to 6; or a pharmaceutical salt thereof, useful in the treatment of diseases associated with herpes viruses including human cytomegalovirus, herpes simplex viruses, Epstein-Barr virus, varicella-zoster virus, human herpesviruses-6 and -7, and Kaposi herpesvirus.",AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;O'HARA BRYAN MARK,,https://lens.org/125-728-490-041-15X,Patent Application,yes,1,18,17,17,0,C07D207/335;;C07D209/14;;C07D213/40;;C07D213/75;;C07D215/12;;C07D217/12;;C07D231/56;;C07D233/44;;C07D277/28;;C07D285/06;;C07D307/52;;C07D333/20;;C07D405/12;;C07D417/12;;A61P31/12;;A61P31/22;;C07D209/14;;C07D207/335;;C07D213/40;;C07D215/12;;C07D217/12;;C07D231/56;;C07D233/44;;C07D285/06;;C07D307/52;;C07D333/20;;C07D417/12,A61K31/06;;A61K31/075;;A61K31/085;;A61K31/10;;A61K31/11;;A61K31/136;;A61K31/15;;A61K31/165;;A61K31/167;;A61K31/17;;A61K31/175;;A61K31/18;;A61K31/196;;A61K31/215;;A61K31/216;;C07D295/14;;A61K31/222;;A61K31/27;;A61K31/275;;A61K31/341;;A61K31/40;;A61K31/42;;A61K31/426;;A61K31/433;;A61K31/4439;;A61K31/4453;;A61K31/4458;;A61K31/54;;A61K31/695;;A61P31/12;;A61P31/22;;C07C335/20;;C07D207/12;;C07D207/14;;C07D207/32;;C07D207/335;;C07D209/14;;C07D211/22;;C07D213/40;;C07D213/75;;C07D215/12;;C07D217/12;;C07D231/12;;C07D231/56;;C07D233/44;;C07D261/08;;C07D277/24;;C07D277/28;;C07D285/06;;C07D307/52;;C07D307/54;;C07D333/20;;C07D405/12;;C07D417/12,,0,0,,,,PENDING
733,PL,A1,PL 349043 A1,139-493-240-002-646,2002-07-01,2002,PL 34904399 A,1999-12-06,US 9928838 W;;US 20796198 A,1998-12-09,THIOUREA INHIBITORS OF HERPES VIRUSES,,AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;O'HARA BRYAN MARK,,https://lens.org/139-493-240-002-646,Patent Application,no,0,0,17,17,0,C07D207/335;;C07D209/14;;C07D213/40;;C07D213/75;;C07D215/12;;C07D217/12;;C07D231/56;;C07D233/44;;C07D277/28;;C07D285/06;;C07D307/52;;C07D333/20;;C07D405/12;;C07D417/12;;A61P31/12;;A61P31/22;;C07D209/14;;C07D207/335;;C07D213/40;;C07D215/12;;C07D217/12;;C07D231/56;;C07D233/44;;C07D285/06;;C07D307/52;;C07D333/20;;C07D417/12,A61K31/06;;A61K31/075;;A61K31/085;;C07D295/14;;A61K31/10;;A61K31/11;;A61K31/136;;A61K31/15;;A61K31/165;;A61K31/167;;A61K31/17;;A61K31/175;;A61K31/18;;A61K31/196;;A61K31/215;;A61K31/216;;A61K31/222;;A61K31/27;;A61K31/275;;A61K31/341;;A61K31/40;;A61K31/42;;A61K31/426;;A61K31/433;;A61K31/4439;;A61K31/4453;;A61K31/4458;;A61K31/54;;A61K31/695;;A61P31/12;;A61P31/22;;C07C335/20;;C07D207/12;;C07D207/14;;C07D207/32;;C07D207/335;;C07D209/14;;C07D211/22;;C07D213/40;;C07D213/75;;C07D215/12;;C07D217/12;;C07D231/12;;C07D231/56;;C07D233/44;;C07D261/08;;C07D277/24;;C07D277/28;;C07D285/06;;C07D307/52;;C07D307/54;;C07D333/20;;C07D405/12;;C07D417/12,,0,0,,,,DISCONTINUED
734,EP,A2,EP 1137633 A2,165-104-698-750-911,2001-10-04,2001,EP 99965132 A,1999-12-06,US 9928844 W;;US 20831698 A,1998-12-09,ACETAMIDE AND SUBSTITUTED ACETAMIDE-CONTAINING THIOUREA INHIBITORS OF HERPES VIRUSES,,AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;O'HARA BRYAN MARK,WYETH (2002-06-19),https://lens.org/165-104-698-750-911,Patent Application,yes,0,0,18,18,0,C07C335/20;;C07C335/22;;C07D207/09;;C07D207/14;;C07D211/58;;C07D261/10;;A61P31/22,A61K31/17;;A61K31/341;;A61K31/343;;A61K31/345;;A61K31/36;;A61K31/381;;A61K31/40;;A61K31/403;;A61K31/4192;;C07D249/04;;A61K31/42;;A61K31/433;;A61K31/437;;A61K31/4409;;A61K31/4468;;A61K31/47;;A61K31/4965;;A61K31/5375;;A61K31/56;;A61P31/22;;C07C335/20;;C07C335/22;;C07C337/06;;C07D207/09;;C07D207/14;;C07D207/34;;C07D209/48;;C07D211/58;;C07D213/81;;C07D215/48;;C07D217/26;;C07D221/12;;C07D241/24;;C07D261/08;;C07D261/10;;C07D265/30;;C07D285/06;;C07D295/12;;C07D307/56;;C07D307/73;;C07D307/85;;C07D317/68;;C07D333/38;;C07D333/70,,0,0,,,,DISCONTINUED
735,AU,B2,AU 639094 B2,178-919-986-164-334,1993-07-15,1993,AU 1991/076078 A,1991-04-29,US 51919290 A,1990-05-04,"SUBSTITUTED 5-(2-((2-ARYL-2-HYDROXYETHYL)AMINO)PROPYL)-1,3-BENZODIOXOLES","The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.",AMERICAN CYANAMID COMPANY,JONATHAN DAVID BLOOM;;THOMAS HARRISON CLAUS;;VERN GORDON DEVRIES;;JO ALENE DOLAN;;MINU DHANJISHA DUTIA,,https://lens.org/178-919-986-164-334,Granted Patent,no,2,0,40,44,0,C07D317/46;;C07D413/06;;A61P3/10;;A61P3/04;;A61P3/08;;C07D317/46;;C07D413/06;;C07D317/46,A23K1/16;;A61K31/335;;A61K31/357;;A61K31/36;;A61K31/42;;A61P3/04;;A61P3/08;;A61P3/10;;C07D263/04;;C07D291/04;;C07D317/46;;C07D317/58;;C07D317/62;;C07D405/06;;C07D413/06;;C07D419/06,,0,0,,,,EXPIRED
736,HU,D0,HU 911495 D0,003-352-144-954-937,1991-11-28,1991,HU 149591 A,1991-05-03,US 51919290 A,1990-05-04,"PROCESS FOR PRODUCING 5-(2-[(2-ARYL-2-HYDROXY-ETHYL)-AMINO]-PROPYL)-1,3-BENZODIOXOLES AND PHARMACEUTICAL PREPARATIVES CONTAINING SAID COMPOUNDS","The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.",AMERICAN CYANAMID CO,BLOOM JONATHAN DAVID;;CLAUS THOMAS HARRISON;;DEVRIES VERN GORDON;;DOLAN JO ALENE;;DUTIA MINU DHANJISHA,,https://lens.org/003-352-144-954-937,Patent Application,no,0,0,40,44,0,C07D317/46;;C07D413/06;;A61P3/10;;A61P3/04;;A61P3/08;;C07D317/46;;C07D413/06;;C07D317/46,A23K1/16;;A61K31/335;;A61K31/357;;A61K31/36;;A61K31/42;;A61P3/04;;A61P3/08;;A61P3/10;;C07D263/04;;C07D291/04;;C07D317/46;;C07D317/58;;C07D317/62;;C07D405/06;;C07D413/06;;C07D419/06,,0,0,,,,EXPIRED
737,EP,A1,EP 1140913 A1,048-723-137-683-668,2001-10-10,2001,EP 99965143 A,1999-12-06,US 9928892 W;;US 20854098 A,1998-12-09,THIOUREA INHIBITORS OF HERPES VIRUSES,,AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;O'HARA BRYAN MARK,WYETH (2002-06-19),https://lens.org/048-723-137-683-668,Patent Application,yes,0,1,21,89,0,C07D213/75;;C07D213/81;;C07D405/12;;C07D417/12;;C07D307/85;;C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81,A61K/;;A61K31/12;;A61K31/33;;A61K31/425;;A61K31/44;;A61K31/4427;;C07D213/81;;A61K31/443;;A61K31/4436;;A61K31/444;;A61P/;;A61P31/12;;A61P31/22;;C07D/;;C07D213/75;;C07D401/12;;C07D405/12;;C07D417/12,,0,0,,,,DISCONTINUED
738,NO,D0,NO 911751 D0,082-962-788-074-162,1991-05-03,1991,NO 911751 A,1991-05-03,US 51919290 A,1990-05-04,"SUBSTITUERTE 5-(2-((2-ARYL-2-HYDROKSYETYL)AMINO)PROPYL)-1,3-BENZODIOKSOLER.","The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.",AMERICAN CYANAMID CO,BLOOM JONATHAN DAVID;;CLAUS THOMAS HARRISON;;DEVRIES VERN GORDON;;DOLAN JO ALENE;;DUTIA MINU DHANJISHA,,https://lens.org/082-962-788-074-162,Patent Application,no,0,0,40,44,0,C07D317/46;;C07D413/06;;A61P3/10;;A61P3/04;;A61P3/08;;C07D317/46;;C07D413/06;;C07D317/46,A61K31/335;;A23K1/16;;A61K31/357;;A61K31/36;;A61K31/42;;A61P3/04;;A61P3/08;;A61P3/10;;C07D263/04;;C07D291/04;;C07D317/46;;C07D317/58;;C07D317/62;;C07D405/06;;C07D413/06;;C07D419/06,,0,0,,,,EXPIRED
739,WO,A3,WO 2008/135855 A3,158-464-854-014-760,2009-03-12,2009,IB 2008001145 W,2008-04-23,US 91569807 P,2007-05-03,NANOPARTICLES COMPRISING A CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR AND A NONIONIZABLE POLYMER,A pharmaceutical composition comprises nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a poorly aqueous soluble non-ionizable polymer.,PFIZER PROD INC;;BLOOM COREY JAY;;CREW MARSHALL DAVID;;SMITHEY DANIEL TOD;;MILLER WARREN KENYON;;MORGEN MICHAEL MARK,BLOOM COREY JAY;;CREW MARSHALL DAVID;;SMITHEY DANIEL TOD;;MILLER WARREN KENYON;;MORGEN MICHAEL MARK,,https://lens.org/158-464-854-014-760,Search Report,yes,2,0,4,4,0,A61K9/5146;;A61K9/5161;;A61K9/5192;;A61K31/4706;;A61P3/00;;A61P9/00;;A61K9/5146;;A61K9/5161;;A61K31/4706;;A61K9/5192,A61K9/51;;A61K31/4706;;A61K45/08,,0,0,,,,PENDING
740,FI,A,FI 912142 A,161-317-403-765-811,1991-11-05,1991,FI 912142 A,1991-05-03,US 51919290 A,1990-05-04,"Menetelmä uusien, terapeuttisesti käyttökelpoisten 5-(2-((2-aryyli-2-hydroksietyyli)amino)propyyli)-1,3-bentsodioksolijohdannaisten valmistamiseksi","The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.",AMERICAN CYANAMID CO,BLOOM JONATHAN DAVID;;CLAUS THOMAS HARRISON;;DEVRIES VERN GORDON;;DOLAN JO ALENE;;DUTIA MINU DHANJISHA,,https://lens.org/161-317-403-765-811,Patent Application,no,0,0,40,44,0,C07D317/46;;C07D413/06;;A61P3/10;;A61P3/04;;A61P3/08;;C07D317/46;;C07D413/06;;C07D317/46,A61K31/335;;A23K1/16;;A61K31/357;;A61K31/36;;A61K31/42;;A61P3/04;;A61P3/08;;A61P3/10;;C07D263/04;;C07D291/04;;C07D317/46;;C07D317/58;;C07D317/62;;C07D405/06;;C07D413/06;;C07D419/06,,0,0,,,,EXPIRED
741,CA,A1,CA 2545591 A1,168-760-434-222-896,2005-09-01,2005,CA 2545591 A,2004-11-12,US 71356503 A;;US 2004/0038040 W,2003-11-13,ARTIFICIAL SYNAPSE CHIP,"Devices and methods are provided for administering a fluid to a neuronal sit e. The device comprises a reservoir, an aperture in fluid connection to the reservoir, and electrical means for moving to the fluid to or through the aperture. The electrical means may take the form of electroosmotic force, piezoelectric movement of a diaphragm or electrolysis of a solution. The electrical means may be external to the host, implanted in the host or may b e photodiodes activated by light, particularly where the neuronal site is associated with the retina.",UNIV LELAND STANFORD JUNIOR,FISHMAN HARVEY A;;BENT STACEY F;;BLOOM DAVID;;NOOLANDI JAAN;;MEHENTI NEVILLE;;PETERMAN MARK C,,https://lens.org/168-760-434-222-896,Patent Application,no,0,0,10,10,0,A61N1/0543;;A61N1/30;;A61N1/326;;A61N1/36046;;C12N5/0619;;C12N2503/00;;C12N2535/10;;G06N3/061;;G06N3/061;;A61N1/30;;A61N1/36046;;C12N2503/00;;C12N5/0619;;A61N1/326;;C12N2535/10;;A61N1/0543,A61M37/00;;A61K9/22;;A61L27/00;;A61N1/05;;A61N1/30;;A61N1/36;;B82B1/00;;C12M1/42;;C12M3/00;;C12N5/0793;;G06N3/06,,0,0,,,,DISCONTINUED
742,FI,A0,FI 912142 A0,001-303-694-867-025,1991-05-03,1991,FI 912142 A,1991-05-03,US 51919290 A,1990-05-04,"Menetelmä uusien, terapeuttisesti käyttökelpoisten 5-(2-((2-aryyli-2-hydroksietyyli)amino)propyyli)-1,3-bentsodioksolijohdannaisten valmistamiseksi","The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.",AMERICAN CYANAMID CO,BLOOM JONATHAN DAVID;;CLAUS THOMAS HARRISON;;DEVRIES VERN GORDON;;DOLAN JO ALENE;;DUTIA MINU DHANJISHA,,https://lens.org/001-303-694-867-025,Patent Application,no,0,0,40,44,0,C07D317/46;;C07D413/06;;A61P3/10;;A61P3/04;;A61P3/08;;C07D317/46;;C07D413/06;;C07D317/46,A61K31/335;;A23K1/16;;A61K31/357;;A61K31/36;;A61K31/42;;A61P3/04;;A61P3/08;;A61P3/10;;C07D263/04;;C07D291/04;;C07D317/46;;C07D317/58;;C07D317/62;;C07D405/06;;C07D413/06;;C07D419/06,,0,0,,,,EXPIRED
743,AU,A,AU 1991/076078 A,038-383-986-687-750,1991-11-07,1991,AU 1991/076078 A,1991-04-29,US 51919290 A,1990-05-04,"SUBSTITUTED 5-(2-((2-ARYL-2-HYDROXYETHYL)AMINO)PROPYL)-1,3-BENZODIOXOLES","The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.",AMERICAN CYANAMID CO,BLOOM JONATHAN DAVID;;CLAUS THOMAS HARRISON;;DEVRIES VERN GORDON;;DOLAN JO ALENE;;DUTIA MINU DHANJISHA,,https://lens.org/038-383-986-687-750,Patent Application,no,0,0,40,44,0,C07D317/46;;C07D413/06;;A61P3/10;;A61P3/04;;A61P3/08;;C07D317/46;;C07D413/06;;C07D317/46,A23K1/16;;A61K31/335;;A61K31/357;;A61K31/36;;A61K31/42;;A61P3/04;;A61P3/08;;A61P3/10;;C07D263/04;;C07D291/04;;C07D317/46;;C07D317/58;;C07D317/62;;C07D405/06;;C07D413/06;;C07D419/06,,0,0,,,,EXPIRED
744,CS,A2,CS 9101285 A2,073-510-309-887-614,1991-12-17,1991,CS 128591 A,1991-05-03,US 51919290 A,1990-05-04,"SUBSTITUTED 5-(2-((2-ARYL-2-HYDROXYETHYL)AMINO) PROPYL)-1,3-BENZODIOXOLES","The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.",AMERICAN CYANAMID CO,BLOOM JONATHAN DAVID;;CLAUS THOMAS HARRISON;;DEVRIES VERN GORDON;;DOLAN JO ALENE;;DUTIA MINU DHANJISHA,,https://lens.org/073-510-309-887-614,Patent Application,no,0,0,40,44,0,C07D317/46;;C07D413/06;;A61P3/10;;A61P3/04;;A61P3/08;;C07D317/46;;C07D413/06;;C07D317/46,A23K1/16;;A61K31/335;;A61K31/357;;A61K31/36;;A61K31/42;;A61P3/04;;A61P3/08;;A61P3/10;;C07D263/04;;C07D291/04;;C07D317/46;;C07D317/58;;C07D317/62;;C07D405/06;;C07D413/06;;C07D419/06,,0,0,,,,EXPIRED
745,NO,D0,NO 20012836 D0,118-479-339-642-616,2001-06-08,2001,NO 20012836 A,2001-06-08,US 20854098 A;;US 9928892 W,1998-12-09,Tiourea-inhibitorer for herpes virus,,AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSEL GEORGE;;LANG STANLEY ALBERT;;O'HARA BRYAN MARK,,https://lens.org/118-479-339-642-616,Patent Application,no,0,0,21,89,0,C07D213/75;;C07D213/81;;C07D405/12;;C07D417/12;;C07D307/85;;C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81,A61K/;;C07D213/81;;A61K31/12;;A61K31/33;;A61K31/425;;A61K31/44;;A61K31/4427;;A61K31/443;;A61K31/4436;;A61K31/444;;A61P/;;A61P31/12;;A61P31/22;;C07D/;;C07D213/75;;C07D401/12;;C07D405/12;;C07D417/12,,0,0,,,,DISCONTINUED
746,US,B2,US 8974827 B2,126-726-117-024-252,2015-03-10,2015,US 45181008 A,2008-05-26,US 45181008 A;;US 94175507 P;;IB 2008001352 W,2007-06-04,Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer,"A pharmaceutical composition comprises nanoparticles comprising a poorly water-soluble drug, a poorly aqueous soluble non-ionizable cellulosic polymer, and a poorly aqueous soluble polymeric amphiphilic non-ionizable block copolymer.",BLOOM COREY JAY;;CREW MARSHALL DAVID;;MILLER WARREN KENYON;;MORGEN MICHAEL MARK;;SMITHEY DANIEL TOD;;BEND RES INC,BLOOM COREY JAY;;CREW MARSHALL DAVID;;MILLER WARREN KENYON;;MORGEN MICHAEL MARK;;SMITHEY DANIEL TOD,PFIZER PRODUCTS INC (2007-07-02);;PFIZER INC (2007-07-02);;BEND RESEARCH INC (2008-11-03),https://lens.org/126-726-117-024-252,Granted Patent,yes,100,9,6,6,0,A61K9/5138;;A61K9/5138;;A61K9/5161;;A61K9/5161;;A61K9/5192;;A61K9/5192;;A61K31/415;;A61K31/415;;A61K31/42;;A61K31/42;;A61K31/435;;A61K31/435;;A61K47/34;;A61K47/34;;A61K47/38;;A61K47/38;;Y10S977/773;;Y10S977/773;;Y10S977/906;;Y10S977/906,A61K9/14;;A01N43/40;;A01N43/56;;A01N43/80;;A61K9/00;;A61K9/51;;A61K31/415;;A61K31/42;;A61K31/435;;A61K31/47;;A61K47/34;;A61K47/38,424/486;;424/400;;424/484;;424/488;;514/313;;514/378;;514/406;;977/773;;977/906,79,72,012-102-263-066-603;;119-668-941-485-878;;025-129-775-479-227;;013-320-933-494-247;;030-636-163-258-383;;056-450-653-736-69X;;085-018-875-201-219;;003-571-904-906-04X;;111-867-922-837-533;;119-668-941-485-878;;066-096-399-843-134;;054-335-292-435-771;;087-565-695-455-735;;072-037-222-430-702;;058-824-227-667-632;;092-336-664-933-089;;015-714-720-040-924;;032-505-827-034-650;;018-417-372-069-779;;024-490-053-097-930;;098-947-239-453-173;;085-251-472-468-235;;093-034-511-083-004;;169-204-991-805-559;;068-415-037-271-085;;070-947-268-845-663;;029-148-840-307-966;;119-122-859-763-459;;028-163-841-784-966;;022-128-391-256-231;;069-221-673-539-59X;;064-606-200-359-500;;174-784-131-766-662;;044-401-659-486-787;;098-861-505-143-77X;;067-814-700-972-681;;122-821-104-012-033;;121-710-804-304-151;;080-045-508-651-228;;045-658-726-355-809;;009-965-442-151-227;;001-560-172-708-040;;034-644-848-878-302;;009-807-758-506-131;;005-011-839-424-294;;026-102-898-190-657;;037-950-455-763-306;;043-082-903-697-972;;064-604-226-265-642;;068-148-200-880-216;;136-143-741-385-295;;032-363-810-864-905;;048-254-383-700-313;;120-518-535-909-315;;020-895-468-484-385;;066-394-361-307-77X;;037-134-045-861-83X;;028-217-398-100-398;;067-995-195-259-919;;004-382-489-377-69X;;022-863-115-592-125;;078-769-616-108-97X;;038-192-364-607-443;;022-719-243-940-116;;018-888-014-102-189;;081-854-827-689-406;;046-414-361-320-616;;023-530-038-077-023;;067-097-986-709-416;;007-559-457-342-628;;001-456-292-671-326;;032-753-041-706-956,15149170;;10.1021/bc034113u;;10.1016/0168-3659(90)90103-z;;10.1021/js9605226;;9423162;;8828763;;10.1111/j.1525-1594.1996.tb04535.x;;15312997;;10.1016/j.jconrel.2004.06.003;;15907581;;10.1016/j.jconrel.2005.02.015;;18572650;;10.1080/02652040310001619992;;14718187;;10.1039/b605640g;;10.1016/0168-3659(90)90103-z;;12882808;;10.1167/iovs.02-1068;;15233861;;10.1211/0022357023835;;10.1016/s0378-5173(97)00083-5;;12506087;;10.1167/iovs.01-1156;;11996827;;10.1016/s0378-5173(02)00080-7;;10.1111/j.2042-7158.1987.tb03144.x;;2894445;;10.1002/jps.2600600902;;4935981;;12881116;;10.1080/0265204031000093591;;10.3109/02652040309178075;;10.1016/s0378-5173(01)00760-8;;11472825;;13678795;;10.1016/s0928-0987(03)00178-7;;10397606;;10.1023/a:1018826103261;;10.1080/107175400455128;;11195426;;14657301;;10.1148/radiol.2293031004;;10.1016/0378-5173(89)90281-0;;3520598;;10.1533/9781855738379.1.29;;10.1016/j.ejpb.2003.10.018;;15018976;;12739765;;10.1023/a:1023290514575;;10.1016/0168-3659(85)90057-4;;10.3109/02652048609049580;;3508173;;10.1248/cpb.36.4941;;3246054;;11672871;;10.1016/s0169-409x(01)00200-9;;10.1002/marc.200500631;;10.1002/mabi.200600189;;17366516;;10.1016/s0142-9612(01)00127-2;;11761166;;14661026;;pmc2346610;;10.1038/nbt920;;7904628;;10.1111/j.2042-7158.1993.tb05614.x;;12601049;;10.1167/iovs.02-0791;;10994037;;10.1111/j.2042-7158.1994.tb05702.x;;7897587;;10.1111/j.2042-7158.1994.tb03711.x;;8201534;;10.1016/s0010-7824(00)00113-x;;10906504;;10.3109/02652049709015336;;9132474;;10.1016/s0939-6411(03)00138-3;;14602172;;15296959;;10.1016/j.ejpb.2004.02.016;;16118015;;10.1016/j.biomaterials.2005.04.041;;16045324;;10.1021/ja052594h;;10.1007/s11095-006-9609-x;;16550476;;8094245;;10.1023/a:1018977130559;;10.1016/s0142-9612(01)00284-8;;11922464;;10.3109/03639049609065914;;10.3168/jds.s0022-0302(93)77712-7;;12434408;;10.1002/jps.10227;;12102196;;10.1016/s0142-9612(02)00080-7;;10.1016/s0928-0987(02)00057-x;;12113891;;15139521;;10.1023/b:pham.0000022411.47059.76;;10.1021/ja029267j;;14611213;;10.1016/s0378-5173(99)00171-4;;10486437;;10.1016/0168-3659(93)90103-c;;8331530;;10.1002/jps.2600820608;;7168872;;10.1248/cpb.30.4479;;10.1016/s0939-6411(03)00190-5;;15018984;;10.1248/cpb.30.673;;10.1002/jps.2600691209;;7463321;;2830037;;10.1248/cpb.35.3800;;15312996;;10.1016/j.jconrel.2004.05.016;;9608398;;10.3109/02652049809006863;;11906809;;10.1016/s1350-9462(01)00017-9;;15018982;;10.1016/s0939-6411(03)00187-5;;1359070;;10.1111/j.2042-7158.1992.tb03649.x;;10.1021/la0478595;;15620331;;10.1016/0169-409x(95)00017-2,"Shuai et al. Bioconjug. Chem., 2004, 15, 441-448.;;Bodmeier et al. J. Control. Release, 1990, 12, 223-233 (IDS: submitted Dec. 22, 2010).;;Liggins et al. J. Pharm. Sci., 1997, 86 (12), 1458-1463.;;Celikkaya E et al, ""Rifampicin carrying poly (D,L-lactide)/poly(ethylene glycol) microspheres: loading and release,"" Artificial Organs, Blackwell Scientific, vol. 20, No. 7, Jul. 1, 1996.;;Shuai X et al, ""Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery,"" Journal of Controlled Release, vol. 98, No. 3, pp. 415-426, 2004.;;Aliabadi H M et al, ""Micelles of methoxy poly(ethylene oxide)-b-poly(@?-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A,"" Journal of Controlled Release, vol. 104, No. 2, pp. 301-311, 2005.;;Hsieh Ming-Fa et al, ""Nano-sized micelles of block copolymers of methoxy poly(ethylene glycol)-poly(epsilon-caprolactone)-graft-2-hydroxyethyl cellulose for doxorubicin delivery,"" Journal of Nanoscience and Nanotechnology, vol. 8, No. 5, pp. 2362-2368, 2008.;;Al-Kassas, R., ""Design and In Vitro Evaluation of Gentamicin-Eudragit Microspheres Intended for Intra-Ocular Administration,"" Journal of Microencapsulation, 21:1(2004)71-81.;;Amrite, A.C., S.P. Ayalasomayajula, and U. Kompella, ""Ocular Distribution of Intact Nano- and Micro Particles Following Subconjunctival and Systemic Routes of Administration,"" Drug Delivery Techn., vol. 2, No. 3, 2003.;;Barbu, E., L. Verestiuc, T.G. Nevell, and J. Tsibouldis, ""Polymeric Materials for Ophthalmic Drug Delivery: Trends and Perspectives,"" J. of Materials Chemistry, 16(2006)3439-3443.;;Bodmeier et al., ""Preparation and Evaluation of Drug-Containing Polymeric Nanosuspensions,"" presented at the 5th International Conference on Pharmaceutical Technology, Paris, France, 1989. Proceedings vol. 2, pp. 265-268.;;Bodmeier, et al., ""Indomethacin Polymer Nanosuspension Prepared by Microfluidization"", Journal of Controlled Release, 12 (1990) 223-233.;;Bourges, J.-L., S.E. Gautier, F. Delie, R.A. Bejjani, J.-C. Jeanny, R. Gurny, D. BenEzra, and F.F. Behar-Cohen, ""Ocular Drug Delivery Targeting the Regina and Retinal Pigment Epithelium Using Polylactide Nanoparticles,"" Investigative Ophthalmology and Visual Science, 44:8(2003)3562-3569.;;Briancon, S., H. fessi, F. Lecomet, and J. Lieto, ""Study and Scale-Up of a Nanoprecipitation Process,"" Industrial Crystallization 1999 (IChemE), pp. 1-10.;;Bucolo, C., A. Maltese, F. Maugeri, B. Busa, G. Puglisi, and R. Pignatello, ""Eudragit RL100 Nanoparticle System for the Ophthalmic Delivery of Cloricromene,"" Journal of Pharmacy and Pharmacology, 56(2004)841 846.;;Calvo, P., J.L. Vila-Jato, and M.J. Alonso, ""Evaluation of Cationic Polymer-Coated Nanocapsules as Ocular Drug Carriers,"" International Journal of Pharmaceutics, 153(1997)41-50.;;Carrasquillo, K.G., J.A. Ricker, I.K. Rigas, J.W. Miller, E.S. Gragoudas, and A.P. Adamis, ""Controlled Delivery of the Anti-VEGF Aptamer EYE001 with Poly(lactic-co-glycolic) Acid Microspheres,"" Investigative Ophthalmology and Visual Science, 44:1(2003)290-299.;;Cavalli, R., M.R. Gasco, P. Chetoni, S. Burgalassi, and M.F. Saettone, ""Solid Lipid Nanoparticles (SLN) as Ocular Delivery System for Tobramycin,"" International J. Pharmaceutics, 238(2002)241-245.;;Chen et al., ""Comparison of Albumin and Casein Microspheres as a Carrier for Doxorubicin,"" J. Pharm. Pharmaco1.39(1987)978-985.;;Chiou, W.L., and S.Riegelman, J. Pharm. Sci., 60:9(1971)1281-1302.;;Couvreur, Microspheres and Drug Therapy, Elsevier, (1984) pp. 103-115.;;De, T.K., D.J. Rodman, B.A. Holm, P.N. Prasad, and E.J. Bergey, ""Brimonidine Formulation in Polyacrylic Acid Nanoparticles for Ophthalmic Delivery,"" J. Microencapsualtion, 20:3)2003)361-374.;;Decampos, A.M., A. Sanchez, and M.J. Alonso, ""Chitosan Nanoparticles: A New Vehicle for the Improvement of the Delivery of Drugs to the Ocular Surface. Application to Cyclosporin A,"" International J. of Pharmaceutics, 224(2001)159-168.;;Decampos., A.M., A. Sanchez, R. Gref, P. Calvo, and M.J. Alonso, ""The Effect of a PGE Versus a Chitosan Coating on the Interaction of Drug Colloidal Carriers with the Ocular Mucosa,"" European Journal of Pharmaceutical Sciences, 20(2003)73-81.;;Dejaeghere, F., E. Allemann, J.-C. Leroux, W. Stevels, J. Feijen, E. Doelker, and R. Gurny, ""Formulation of Lyoprotection of Poly(Lactic Acid-Co-Ethylene Oxide) Nanoparticles: Influence on Physical Stability and in Vitro cell Uptake,"" Pharmaceutical Research, 16:6(1999)859-866.;;Desai, S.D., and J. Blanchard, ""Pluronic F127-Based Ocular Delivery System Containing Biodegradable Polyisobutylcyanoacrylate Nanocapsules of Pilocarpine,"" Drug Delivery, 7(2000)201-207.;;Fee, C.A., and R.I. Pettigrew, ""National Institute of Biomedical Imaging and Bioengineering: Poised for the Future,"" National Institute of Biomedical Imaging and Bioengineering, 229:3(2003)636-637.;;Fessi, H., F. Puisieux, J.Ph. Devissaguet, N. Ammoury, and S. Benita, ""Nanocapsule Formation by Interfacial Polymer Deposition Following Solvent Displacement,"" International J. of Pharmaceutics, 55(1989)R1-R4.;;Ford, J.L., Pharm. Acta Helv., 61:3(1986)69-87.;;Fox et al., from Proteins in Food Processing, R.Y. Yada (ed), CRC Press, 2004, Chapter 3: The Caseins pp. 29-71.;;Gavini, E., P. Chetoni, M. Cossu, M.G. Alvarez, M.F. Saettone, and P. Giunchedi, ""PLGA Microspheres for the Ocular Delivery of a Peptide Drug, Vancomycin Using Emulsification/Spray-Drying as the Preparation Method: In Vitro/In Vivo Studies,"" European Journal of Pharmaceutics and Biopharmaceutics, 57(2004)207-212.;;Giannavola, C., C. Bucolo, A. Maltese, D. Paolino, M.A. Vandelli, G. Puglisi, V.H.L. Lee, and M. Fresta, ""Influence of Preparation Conditions on Acyclovir-Loaded Poly-d,l-Lactic Acid Nanospheres and Effect of PEG Coating on Ocular Drug Bioavailability."" Pharmaceutical Research, 20:4(2003)584-590.;;Gurny, Drug Develop. Ind. Pharm. 7(1), 1-25, 1981.;;Gurny, R., T. Boye, and H. Ibrahim, ""Ocular Therapy with Nanoparticulate Systems for Controlled Drug Delivery,"" Journal of Controlled Release, 2(1985)353-361.;;Harmia, J. Microencapsulation, 1986 vol. 3, No. 1, p. 3-12.;;Hasegawa, H., et al., Chem. Pharm. Bull., 33:4(1985)1615-1619; Chem. Pharm. Bull., 34:5(1986)2183-2190; Chem. Pharm. Bull., 36:12(1988) 4941-4950.;;Herrero-Vanrell, R., and M.F. Refojo, ""Biodegradable Microspheres for Vitreoretinal Drug Delivery,"" Advanced Drug Delivery Reviews, 52(2001)5 16.;;Hornig et al., ""Novel Nanoparticles Based on Dextran Esters with Unsaturated Moieties,"" Macromolecular Rapid Commun., 2005, 26, 1908-1912.;;Hornig et al., ""Structure Design of Multifunctional Furoate and Pyroglutamate Esters of Dextran by Polymer-Analogous Reactions,"" Macromol. Biosci. 2007, 7, 297-306.;;Hsiue, G.-H., S.-H. Hsu, C.-C. Yang, S.-H. Lee,a nd I.-K. Yang, ""Preparation of Controlled Release Ophthalmic Drops, for Glaucoma Therapy Using Thermosensitive poly-N-Isopropylacrylamide,"" Biomaterials, 23(2002)457 462.;;Kim, S., Y.T. Lim, E.G. Soltesz, A.M. DeGrand, J. Lee, A. Nakayama, J.A. Parker, T. Mihaljevic, R.G. Laurence, D.M. Dor, L.H. Cohn, M.G. Bawendi, and J.V. Frangioni,""Near-Infrared Fluorescent Type II Quantum Dots for Sentinel Lymph Node Mapping,"" Nature Biotechnology, 22:1(2004)93-97.;;Knepp et al., Synthesis, Properties, and Intratumoral Evaluation of Mitoxantrone-Loaded Casein Microspheres in Lewis Lung Carcinoma, J. Pharm. Pharmacol., 45(1993)887-891.;;Kompella, U.B., N. Bandi, and S.P. Ayalasomayajula, ""Subconjunctival Nano- and Microparticles Sustain Retinal Delivery of Budesonide, A Corticosteroid Capable of Inhibiting VEGF Expression,"" Investigative Ophthalmology and Visual Science, 44:3(2003)1192-1201.;;Kumar, M.M.V., ""Nano and Microparticles as Controlled Drug Delivery devices,"" J. Pharm. Pharmaceutical Sciences, 3:2(2000)234-258.;;Latha et al., Casein as a Carrier Matrix for 5-Fluorouracil: Drug Release from Microspheres, Drug-Protein Conjugates and In-Vivo Degradation of Microspheres in Rat Muscle, J. Pharm. Pharmacol., 46(1994)858-862.;;Latha et al., Glutaraldehyde Cross-Linked Bovine Casein Microspheres as a Matrix for the Controlled Release of Theophylline: In Vitro Studies, J. Pharm. Pharmacol., 46(1994)8-13.;;Latha et al., Progesterone Release from Glutaraldehyde Cross-Linked Casein Microspheres: In Vitro Studies and In Vivo Response in Rabbits, Contraception, 61(2000)329-334.;;Lecorre, P., J.H. Rytting, V. Gajan, F. Chevanne, and R. LeVerge, ""In Vitro Controlled Release Kinetics of Local Anaesthetics from Poly(D,L-lactice) and Poly (lactice-co-glycolide) Microspheres,"" Journal of Microencapsulation, 1997, pp. 243-255.;;Lellemand, F., O. Felt-Baeyens, K. Besseghir, F. Behar-Cohen, and R. Gurny, ""Cyclosporine A Delivery to the Eye: A Pharmaceutical Challenge,"" European J. of Pharmaceutics and Biopharmaceutics, 56(2003)307 318.;;Lemarchand, C., R. Gref, and P. Couvreur, ""Polysaccharide-Decorated Nanoparticles,"" European J. of Pharmaceutics and Biopharmaceutics, 58(204,327-341, 2004.;;Lemarchand, et al., ""Influence of polysaccharide coating on the interactions of nanoparticles with biological systems,"" Biomaterials, 27(2006)108-118.;;Liebert, et al., ""Nanoparticles on the Basis of Highly Functionalized Dextrans,"" J. Am. Chem. Soc. 2005, 127, 10484-10485.;;Longmuir, K.J., R.T. Robertson, S.M. Haynes, J.L. Baratta, and A.J. Waring, ""Effective Targeting of Liposomes to Liver and Hepatocytes In Vivo by Incorporation of a Plasmodium Amino Acid Sequence,"" Pharmaceutical Research, 23:4(2006)759-769.;;Losa, C., L. Marchal-Heussler, F. Orallo, J.L. Vila Jato, and M.J. Alonso, ""Design of New Formulations for Topical Ocular Administration: Polymeric Nanocapsules Containing Metipranolol,"" Pharmaceutical Research, 10:1(1993)80-87.;;Merodio, M., J.M. Irache, F. Valamanesch, and M. Mirshahi, ""Ocular Disposition and Tolerance of Ganciclovir-Loaded Albumin Nanoparticles after Intravitreal Injection in Rats,"" Biomaterials, 23(2002)1587-1594.;;Mirshahi et al., Development of Drug Delivery Systems from Vegetal Proteins: Legumin Nanoparticles, Drug Dev. Indust.Pharm., 22:8(1996)841-846.;;Mora-Gutierrez et al., Modeling Calcium-Induced Solubility in Caprine Milk Caseins Using a Thermodynamic Linkage Approach, J. Dairy Sci., 76(1993)3698-3710.;;Ohio State FST 822 Class Lecture, Casein, 2006, 5 pp.;;Pignatello, R., C. Bucolo, and G. Puglisi, ""Ocular Tolerability of Eudragit RS100 and RL100 Nanosuspensions as Carriers for Ophthalmic Controlled Drug Delivery,"" Journal of Pharmaceutical Sciences, 91:12(2002)2636-2641.;;Pignatello, R., C. Bucolo, G. Spedalieri, A. Maltese, and G. Puglisi, ""Flurbiprofen-Loaded Acrylate Polymer Nanosuspensions for Ophthalmic Application,"" Biomaterials, 23(2002)3247-3255.;;Pignatello, R., C. Bucolo, P. Ferra, A. Maltese, A. Puleo, and G. Puglisi, ""Eudragit RS100 Nanosuspensions for the Ophthalmic Controlled Delivery of Ibuprofen,"" European Journal of Pharmaceutical Sciences, 16(2002)53 61.;;Qaddoumi, M.G., H. Ueda, J. Yang, J. Davda, V. Labhasetwar, and V.H.L. Lee, ""The Characteristics and Mechanisms of Uptake of PLGA Nanoparticles in Rabbit Conjuctival Epithelial Cell Layers,"" Pharmaceutical Research, 21:4(2004)641-648.;;Raveendran, P, J. Fu, and S.L. Wallen, ""Completely 'Green' Synthesis and Stabilization of Metal Nanoparticles,"" J. American Chemical Society, 125(2003)13940-13941.;;Santinho et al., Influence of Formulation on the Physiochemical Properties of Casein Microparticles, Int'l J. Pharm., 186(1999)191-198.;;Scholes, P.D., A.G.A. Coombes, L. Ilium, S.S. Savis, M. Vert, and M.C. Davies, ""The Preparation of Sub-200 nm Poly(lactide-co-glycolide) Microspheres for Site-Specific Drug Delivery,"" J. Controlled Release, 25(1993)145-153.;;Sjostrom, et al., Journal of Pharmaceutical Sciences, vol. 82, No. 6 Jun. 1993, pp. 584-589.;;Sugimoto, I., K. Sasaki, A. Kuchiki, T. Ishihara, and H. Nakagawa, Chem. Pharm. Bull, 30:12(1982)4479-4488.;;Suverkrup, R., S. Grunthal, O. Krasichkova, S. Maier, A. Weischselbaum, B. Neff, M. Diestelhorst, S. Dinslage, and A. Lux, ""The Ophthalmic Lyophilisate Carrier System (OLCS): Development of a Novel Dosage Form, Freeze-Drying Technique, and In Vitro Quality Control Tests,""European J. Pharmaceutics and Biopharmaceutics, 57(2004)269-277.;;Takayama, K., N. Nambu, and T. Nagai., Chem. Pharm. Bull., 30:2(1982)673-678.;;Takenaka, H., Y. Kawashima and S.Y. Lin, J. Pharm. Sci., 69:12(1980)1388-1392.;;Takeuchi, H., T. Handa and Y. Kawashima, Chem. Pharm. Bull., 35:9(1987)3800-3806.;;Tuovinen, L., E. Ruhanen, T. Kinnarinen, S. Ronkko, J. Pelkonen, A. Urtti, S. Peltonen, and K. Jarvinen, ""Starch Acetate Microparticles for Drug Delivery Into Retinal Pigment Epithelium-In Vitro Study,"" J. of Controlled Release, 98(2004)407-413.;;Ueda, M., A. Iwara, and J. Kreuter, ""Influence of the Preparation Methods on the Drug Release Behaviour of Loperamide-Loaded Nanoparticles,"" J. Microencapsulation, 15:3(1998)361-372.;;University of Guelph, Dairy Chemistry and Physics, 2006, 16 pp.;;Vandamme, Th.F., ""Microemulsions as Ocular Drug Delivery Systems: Recent Developments and Future Challenges,"" Progress in Retinal and Eye Research, 21(2002)15-34.;;Vandervoort, J., and A. Ludwig, ""Preparation and Evaluation of Drug-Loaded Gelatin Nanoparticles for Topical Ophthalmic Use,"" European J. of Pharmaceutics and Biopharmaceutics, 57(2004)251-261.;;Willmott et al., Doxorubicin-Loaded Casein Microspheres: Protean Nature of Drug Incorporation J. Pharm. Pharmacol. 42(1992)472-475.;;Zahr, A.S., M. de Villiers, and M.V. Pishko, ""Encapsulation of Drug Nanoparticles in Self-Assembled Macromolecular Nanoshells,"" Langmuir, 21(2005)503 410.;;Zimmer, A., and J. Kreuter, ""Microspheres and Nanoparticles Used in Ocular Delivery Systems,"" Advanced Drug Delivery Reviews, 16(1995)61-73.",INACTIVE
747,BR,A,BR 9915993 A,133-302-367-062-678,2001-09-04,2001,BR 9915993 A,1999-12-06,US 20796198 A;;US 9928838 W,1998-12-09,"Composto, composição farmacêutica, processo para inibir a replicação de um vìrus herpes, e, processo para tratar um paciente sofrendo de uma infecção de vìrus herpes","""COMPOSTO, COMPOSIçãO FARMACêUTICA, PROCESSO PARA INIBIR A REPLICAçãO DE UM VìRUS HERPES, E, PROCESSO PARA TRATAR UM PACIENTE SOFRENDO DE UMA INFECçãO DE VìRUS HERPES"" Os compostos de fórmula (I): em que A é heteroarila; R~ 9~ a R~ 12~ são independentemente hidrogênio, alquila de 1 a 4 átomos de carbono, per-haloalquila de 1 a 4 átomos de carbono, halogênio, alcóxi de 1 a 4 átomos de carbono, ou ciano, ou R~ 9~ e R~ 10~ ou R~ 11~ e R~ 12~ podem ser tomados juntos para formar arila de 5 a 7 átomos de carbono; W é O, NR~ 6~, ou está ausente; G é arila ou heteroarila; e X é uma ligação, -NH, alquila de 1 a 6 átomos de carbono, alquenila de 1 a 6 átomos de carbono, alcóxi de 1 a 6 átomos de carbono, tioalquila de 1 a 6 átomos de carbono, alquilamino de 1 a 6 átomos de carbono, ou (CH)J; e J é alquila de 1 a 6 átomos de carbono, cicloalquila de 3 a 7 átomos de carbono, fenila ou benzila; e n é um número inteiro de 1 a 6; ou um seu sal farmacêutico, útil no tratamento de doenças associadas com os vírus herpes, incluindo o citomegalovírus humano, o vírus do herpes simples, os vírus Epstein-Barr, o vírus varicela-zoster, o herpesvírus 6 e 7 humanos, e o herpesvírus de Kaposi.",AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;O'HARA BRYAN MARK,,https://lens.org/133-302-367-062-678,Patent Application,no,0,0,17,17,0,C07D207/335;;C07D209/14;;C07D213/40;;C07D213/75;;C07D215/12;;C07D217/12;;C07D231/56;;C07D233/44;;C07D277/28;;C07D285/06;;C07D307/52;;C07D333/20;;C07D405/12;;C07D417/12;;A61P31/12;;A61P31/22;;C07D209/14;;C07D207/335;;C07D213/40;;C07D215/12;;C07D217/12;;C07D231/56;;C07D233/44;;C07D285/06;;C07D307/52;;C07D333/20;;C07D417/12,C07D295/14;;A61K31/06;;A61K31/075;;A61K31/085;;A61K31/10;;A61K31/11;;A61K31/136;;A61K31/15;;A61K31/165;;A61K31/167;;A61K31/17;;A61K31/175;;A61K31/18;;A61K31/196;;A61K31/215;;A61K31/216;;A61K31/222;;A61K31/27;;A61K31/275;;A61K31/341;;A61K31/40;;A61K31/42;;A61K31/426;;A61K31/433;;A61K31/4439;;A61K31/4453;;A61K31/4458;;A61K31/54;;A61K31/695;;A61P31/12;;A61P31/22;;C07C335/20;;C07D207/12;;C07D207/14;;C07D207/32;;C07D207/335;;C07D209/14;;C07D211/22;;C07D213/40;;C07D213/75;;C07D215/12;;C07D217/12;;C07D231/12;;C07D231/56;;C07D233/44;;C07D261/08;;C07D277/24;;C07D277/28;;C07D285/06;;C07D307/52;;C07D307/54;;C07D333/20;;C07D405/12;;C07D417/12,,0,0,,,,DISCONTINUED
748,NO,D0,NO 20012837 D0,145-785-609-277-933,2001-06-08,2001,NO 20012837 A,2001-06-08,US 20796198 A;;US 9928838 W,1998-12-09,Tiourea-inhibitorer for herpesvirus,,AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSEL GEORGE;;LANG STANLEY ALBERT;;O'HARA BRYAN MARK,,https://lens.org/145-785-609-277-933,Patent Application,no,0,0,17,17,0,C07D207/335;;C07D209/14;;C07D213/40;;C07D213/75;;C07D215/12;;C07D217/12;;C07D231/56;;C07D233/44;;C07D277/28;;C07D285/06;;C07D307/52;;C07D333/20;;C07D405/12;;C07D417/12;;A61P31/12;;A61P31/22;;C07D209/14;;C07D207/335;;C07D213/40;;C07D215/12;;C07D217/12;;C07D231/56;;C07D233/44;;C07D285/06;;C07D307/52;;C07D333/20;;C07D417/12,A61K31/06;;C07D295/14;;A61K31/075;;A61K31/085;;A61K31/10;;A61K31/11;;A61K31/136;;A61K31/15;;A61K31/165;;A61K31/167;;A61K31/17;;A61K31/175;;A61K31/18;;A61K31/196;;A61K31/215;;A61K31/216;;A61K31/222;;A61K31/27;;A61K31/275;;A61K31/341;;A61K31/40;;A61K31/42;;A61K31/426;;A61K31/433;;A61K31/4439;;A61K31/4453;;A61K31/4458;;A61K31/54;;A61K31/695;;A61P31/12;;A61P31/22;;C07C335/20;;C07D207/12;;C07D207/14;;C07D207/32;;C07D207/335;;C07D209/14;;C07D211/22;;C07D213/40;;C07D213/75;;C07D215/12;;C07D217/12;;C07D231/12;;C07D231/56;;C07D233/44;;C07D261/08;;C07D277/24;;C07D277/28;;C07D285/06;;C07D307/52;;C07D307/54;;C07D333/20;;C07D405/12;;C07D417/12,,0,0,,,,DISCONTINUED
749,US,A1,US 2020/0035341 A1,161-078-378-865-531,2020-01-30,2020,US 201916377987 A,2019-04-08,US 201916377987 A;;US 201816192341 A;;US 201862712063 P,2018-07-30,DE-IDENTIFICATION OMIC DATA AGGREGATION PLATFORM WITH PERMITTED THIRD PARTY ACCESS,"A system and method are disclosed for the collection and aggregation of genomic, medical, and other data of interest for individuals and populations that may be of interest for analysis, research, pharmaceutical development, medical treatment, and so forth. Contributors become members of a community upon creation of an account and providing of data or files. The data is received and processed, such as to analyze, structure, perform quality control, and curate the data. Value or shares in one or more community databases are computed and attributed to each contributing member. The data is controlled to avoid identification or personalization. Third parties interested in the database information may contribute value (e.g., pay) for access and use. Value flows back to the members and to a system administrative entity.",LUNAPBC,KAIN ROBERT C;;BARRY DAWN MARY;;LEWIS DAVID;;BLOOM KENNETH ROBERT;;KAHN SCOTT;;VELINOV BOJIL,,https://lens.org/161-078-378-865-531,Patent Application,yes,6,34,1,12,0,G16H10/60;;G16H10/20;;G16B50/30;;G16H10/60;;G16H10/20;;G06Q40/08;;G06F16/2379;;G06F16/958;;G06N20/00,G16H10/60;;G06F16/23;;G06F16/958;;G06N20/00,,0,0,,,,DISCONTINUED
750,WO,A1,WO 2000/034269 A1,197-110-114-837-207,2000-06-15,2000,US 9928892 W,1999-12-06,US 20854098 A;;US 44478299 A,1998-12-09,THIOUREA INHIBITORS OF HERPES VIRUSES,"Compounds of formula (1) wherein, R1-R5 are independently selected from hydrogen, alkyl of 1 to 6 carbon atoms, alkenyl of 2 to 6 carbon atoms, alkynyl of 2 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 carbon members, aryl, heteroaryl, halogen, -CN, -NO2, -CO2R6,-COR6, -OR6, -SR6, -SOR6, -SO2R6, -CONR7R8, -NR6N(R7R8), -N(R7R8) or W-Y-(CH2)n-Z; or R2 and R3 or R3 and R4, taken together from a 3 to 7 membered heterocycloalkyl or 3 to 7 membered heteroaryl; R6 and R7 are independently hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, or aryl; R8 is hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 members, aryl or heteroaryl, or R7 and R8, taken together may form a 3 to 7 membered heterocycloalkyl; A is heteroaryl; W is O, NR6, or is absent; Y is -(CO)- or -(CO2)-, or is absent; Z is alkyl of 1 to 4 carbon atoms, -CN, -CO2R6, COR6, -CONR7R8, -OCOR6, -NR6COR7, -OCONR6, -OR6, -SR6, -SOR6, -SO2R6, SR6N(R7R8), -N(R7R8) or phenyl; G is aryl or heteroaryl; X is a bond, -NH, alkyl of 1 to 6 carbon atoms, alkenyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, thioalkyl of 1 to 6 carbon atoms, alkylamino of 1 to 6 carbon atoms, or (CH)J; J is alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 7 carbon atoms, phenyl or benzyl; and n is an integer from 1 to 6; useful in the treatment of diseases associated with herpes viruses including human cytomegalovirus, herpes simplex viruses, Epstein-Barr virus, varicella-zoster virus, human herpes viruses -6 and -7, and Kaposi herpesvirus.",AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;O'HARA BRYAN MARK,,https://lens.org/197-110-114-837-207,Patent Application,yes,2,23,1,89,0,A61P31/12;;C07D213/75;;C07D213/81;;C07D405/12;;C07D417/12,A61P31/12;;C07D213/75;;C07D213/81;;C07D405/12;;C07D417/12,,0,0,,,,PATENTED
751,UA,C2,UA 94057 C2,002-361-399-680-155,2011-04-11,2011,UA A200802596 A,2006-07-26,US 70404605 P;;US 74760406 P;;US 2006/0029062 W,2005-07-29,"PISTON PUMP WITH PNEUMATIC DISTRIBUTOR, STOPPER AND POPPETS",An air valving system for a reciprocating piston pump (5) which uses piston (10) actuated poppet assemblies (40) to control the main air valve (16) shift. The valve exhaust is vented (50) directly to atmosphere rather than through the main exhaust to ensure reliability. A ramped detent (32) prevents the air valve (16) from centering.,GRACO MINNESOTA INC,BAUCK MARK L;;ISAIS JOHN F JR;;WEINBERGER MARK T;;PITTMAN DAVID M;;BLOOM MICHAEL E,,https://lens.org/002-361-399-680-155,Limited Patent,no,0,0,28,28,0,F04B9/12;;F04B9/125;;F16K11/02;;F04B49/00;;F04B35/00;;F04B9/08;;F04B9/12;;F04B9/125;;F16K11/02,F04B49/00;;F04B9/08;;F04B35/00,,0,0,,,,EXPIRED
752,AU,B2,AU 2006/275892 B2,053-141-325-082-780,2011-09-01,2011,AU 2006/275892 A,2006-07-26,US 74760406 P;;US 70404605 P;;US 2006/0029062 W,2005-07-29,"Reciprocating piston pump with air valve, detent and poppets",An air valving system for a reciprocating piston pump (5) which uses piston (10) actuated poppet assemblies (40) to control the main air valve (16) shift. The valve exhaust is vented (50) directly to atmosphere rather than through the main exhaust to ensure reliability. A ramped detent (32) prevents the air valve (16) from centering.,GRACO MINNESOTA INC,BAUCK MARK L;;BLOOM MICHAEL E;;ISAIS JOHN F JR;;PITTMAN DAVID M;;WEINBERGER MARK T,,https://lens.org/053-141-325-082-780,Granted Patent,no,3,0,28,28,0,F04B9/12;;F04B9/125;;F16K11/02;;F04B49/00;;F04B35/00;;F04B9/08;;F04B9/12;;F04B9/125;;F16K11/02,F04B9/08;;F04B35/02;;F04B49/00,,0,0,,,,INACTIVE
753,WO,A2,WO 2007/016177 A2,000-760-027-295-681,2007-02-08,2007,US 2006/0029062 W,2006-07-26,US 70404605 P;;US 74760406 P,2005-07-29,"RECIPROCATING PISTON PUMP WITH AIR VALVE, DETENT AND POPPETS",An air valving system for a reciprocating piston pump (5) which uses piston (10) actuated poppet assemblies (40) to control the main air valve (16) shift. The valve exhaust is vented (50) directly to atmosphere rather than through the main exhaust to ensure reliability. A ramped detent (32) prevents the air valve (16) from centering.,GRACO MINNESOTA INC;;BAUCK MARK L;;ISAIS JOHN F JR;;WEINBERGER MARK T;;PITTMAN DAVID M;;BLOOM MICHAEL E,BAUCK MARK L;;ISAIS JOHN F JR;;WEINBERGER MARK T;;PITTMAN DAVID M;;BLOOM MICHAEL E,,https://lens.org/000-760-027-295-681,Patent Application,yes,1,3,28,28,0,F04B9/12;;F04B9/125;;F16K11/02;;F04B49/00;;F04B35/00;;F04B9/08;;F04B9/12;;F04B9/125;;F16K11/02,F04B7/00,,0,0,,,,PENDING
754,US,A1,US 2004/0224002 A1,052-007-027-878-728,2004-11-11,2004,US 71356503 A,2003-11-13,US 71356503 A;;US 18421002 A;;US 30193401 P,2001-06-29,Artificial synapse chip,"
   Devices and methods are provided for administering a fluid to a neuronal site. The device comprises a reservoir, an aperture in fluid connection to the reservoir, and electrical means for moving to the fluid to or through the aperture. The electrical means may take the form of electroosmotic force, piezoelectric movement of a diaphragm or electrolysis of a solution. The electrical means may be external to the host, implanted in the host or may be photodiodes activated by light, particularly where the neuronal site is associated with the retina. 
",FISHMAN HARVEY A.;;BLOOM DAVID M.;;BENT STACEY F.;;PETERMAN MARK C.;;NOOLANDI JAAN;;MEHENTI NEVILLE,FISHMAN HARVEY A;;BLOOM DAVID M;;BENT STACEY F;;PETERMAN MARK C;;NOOLANDI JAAN;;MEHENTI NEVILLE,BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY THE (2004-06-30),https://lens.org/052-007-027-878-728,Patent Application,yes,8,29,10,10,0,A61N1/0543;;A61N1/30;;A61N1/326;;A61N1/36046;;C12N5/0619;;C12N2503/00;;C12N2535/10;;G06N3/061;;G06N3/061;;A61N1/30;;A61N1/36046;;C12N2503/00;;C12N5/0619;;A61N1/326;;C12N2535/10;;A61N1/0543,A61K9/22;;A61L27/00;;A61N1/05;;A61N1/30;;A61N1/36;;C12M1/42;;C12M3/00;;C12N5/0793;;G06N3/06,424/423,0,0,,,,EXPIRED
755,EP,B1,EP 2426387 B1,133-838-091-734-79X,2014-10-29,2014,EP 11186124 A,2006-07-26,EP 06788580 A;;US 70404605 P;;US 74760406 P,2005-07-29,"Reciprocating piston pump with air valve, detent and poppets","A poppet assembly includes a poppet housing (41) having an axis and first and second sets of housing ports (41a, 41b), which are axially spaced. A poppet seat (44) is provided in the housing, the seat having a set of seat ports (44a), and a poppet (43) is also located in the housing and is retained by the seat. The poppet has a set of poppet ports (43a), is biased against the seat in a first position and can be moved to a second position away from the seat. A poppet actuator (45), which is located in the seat, partially surrounds the poppet and is biased away from the poppet. When the poppet is in its first position, the first set of housing ports (41b) are in fluid communication with the second set of housing ports (41a) through the poppet ports (43a), and when it is in its second position, the first set of housing ports (41b) are in fluid communication with the seat ports (44a).",GRACO MINNESOTA INC,BAUCK MARK L;;ISAIS JOHN F JR;;WEINBERGER MARK T;;PITTMAN DAVID M;;BLOOM MICHAEL E,,https://lens.org/133-838-091-734-79X,Granted Patent,yes,3,0,28,28,0,F04B9/12;;F04B9/125;;F16K11/02;;F04B49/00;;F04B35/00;;F04B9/08;;F04B9/12;;F04B9/125;;F16K11/02,F16K11/02,,0,0,,,,ACTIVE
756,EP,A4,EP 1910679 A4,037-678-407-274-970,2009-09-16,2009,EP 06788580 A,2006-07-26,US 2006/0029062 W;;US 70404605 P;;US 74760406 P,2005-07-29,"RECIPROCATING PISTON PUMP WITH AIR VALVE, DETENT AND POPPETS","A poppet assembly includes a poppet housing (41) having an axis and first and second sets of housing ports (41a, 41b), which are axially spaced. A poppet seat (44) is provided in the housing, the seat having a set of seat ports (44a), and a poppet (43) is also located in the housing and is retained by the seat. The poppet has a set of poppet ports (43a), is biased against the seat in a first position and can be moved to a second position away from the seat. A poppet actuator (45), which is located in the seat, partially surrounds the poppet and is biased away from the poppet. When the poppet is in its first position, the first set of housing ports (41b) are in fluid communication with the second set of housing ports (41a) through the poppet ports (43a), and when it is in its second position, the first set of housing ports (41b) are in fluid communication with the seat ports (44a).",GRACO MINNESOTA INC,BAUCK MARK L;;ISAIS JOHN F JR;;WEINBERGER MARK T;;PITTMAN DAVID M;;BLOOM MICHAEL E,,https://lens.org/037-678-407-274-970,Search Report,no,4,0,28,28,0,F04B9/12;;F04B9/125;;F16K11/02;;F04B49/00;;F04B35/00;;F04B9/08;;F04B9/12;;F04B9/125;;F16K11/02,F04B49/00;;F04B9/08;;F04B35/02,,0,0,,,,ACTIVE
757,US,A,US 5969372 A,063-678-287-488-140,1999-10-19,1999,US 94950797 A,1997-10-14,US 94950797 A,1997-10-14,Film scanner with dust and scratch correction by use of dark-field illumination,"A method and apparatus for detecting surface defects and artifacts on a transmissive image in an optical image scanner and correcting the resulting scanned image. In one scan, the image is scanned normally. Surface defects and artifacts such as dust, scratches and finger prints are detected by providing a separate scan using infrared light or by measuring light (white or infrared) that is scattered or diffracted by the defects and artifacts. Separate optical paths for illumination may be used, or separate optical paths for intensity measurement may be used. Image processing may then be used to correct areas in the normal scan corresponding to defects identified in the separate scan.",HEWLETT PACKARD CO,STAVELY DONALD J;;BLOOM DANIEL M;;BATTLES AMY E;;CAMPBELL DAVID K;;HERRERA E OSCAR R,HEWLETT-PACKARD COMPANY (1998-05-20);;HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2003-01-31),https://lens.org/063-678-287-488-140,Granted Patent,yes,9,134,5,5,0,G01N21/8806;;G01N21/8806;;H04N1/00023;;H04N1/00037;;G01N21/8806,G01N21/88;;G06T1/00;;G01B11/30,250/559.42;;356/239,2,1,024-257-823-803-846,10.1364/josaa.2.001857,"Automated Digital Visual Inspection With Dark Field Microscopy , by Jorge L.C. Sanz, Fritz Merkle and Kwan Y. Wong. 1985 Optical Society Of America, Nov. 1985, vol. 2, No. 11.;;Designing A Scanner With Color Vision , by K. Douglas Gennetten and Michael J. Steinle. Aug. 1993 Hewlett Packard Journal.",EXPIRED
758,US,B2,US 8568112 B2,101-859-931-641-740,2013-10-29,2013,US 99644406 A,2006-07-26,US 99644406 A;;US 74760406 P;;US 70404605 P;;US 2006/0029062 W,2005-07-29,"Reciprocating piston pump with air valve, detent and poppets",An air valving system for a reciprocating piston pump ( 5 ) which uses piston ( 10 ) actuated poppet assemblies ( 40 ) to control the main air valve ( 16 ) shift. The valve exhaust is vented ( 50 ) directly to atmosphere rather than through the main exhaust to ensure reliability. A ramped detent ( 32 ) prevents the air valve ( 16 ) from centering.,BAUCK MARK L;;ISAIS JR JOHN F;;WEINBERGER MARK T;;PITTMAN DAVID M;;BLOOM MICHAEL E;;GRACO MINNESOTA INC,BAUCK MARK L;;ISAIS JR JOHN F;;WEINBERGER MARK T;;PITTMAN DAVID M;;BLOOM MICHAEL E,GRACO MINNESOTA INC (2008-01-02),https://lens.org/101-859-931-641-740,Granted Patent,yes,25,0,28,28,0,F04B9/12;;F04B9/125;;F16K11/02;;F04B49/00;;F04B35/00;;F04B9/08;;F04B9/12;;F04B9/125;;F16K11/02,F04B17/00;;F04B35/00,417/390;;417/375,0,0,,,,INACTIVE
759,US,B2,US 8020251 B2,092-764-886-591-927,2011-09-20,2011,US 33322606 A,2006-01-18,US 33322606 A;;US 64402005 P;;US 67335905 P,2005-01-18,Vacuum cleaner with collapsible handle,"A vacuum cleaner having a base adapted to be moved on a surface to be cleaned, an inlet nozzle disposed on a lower surface of the base, a vacuum source, and a dirt receptacle. A lower handle is pivotally attached to the base at a lower pivot, and an upper handle is pivotally attached to the lower handle at an upper pivot. In one aspect, the vacuum cleaner includes an automatically-operated lower pivot lock that can restrict relative rotation between the lower handle and the base, and a manually-operated upper pivot lock that can restrict relative rotation between the upper handle and the lower handle. In another aspect, the vacuum cleaner includes a telescoping upper handle with electrical controls attached to the upper telescopic section of the upper handle. In still another aspect, the vacuum cleaner includes an exhaust vent located on an upwardly-facing surface of the base.",ELECTROLUX HOME CARE PROD NA,LUEBBERING GREGORY W;;HAMPTON LEONARD;;BOBROSKY VINCENT;;SEPKE ARNOLD;;SMITH JEFFREY;;BLOOM SCOTT;;VOIGTS DAVID A,ELECTROLUX HOME CARE PRODUCTS NORTH AMERICA (2006-02-07),https://lens.org/092-764-886-591-927,Granted Patent,yes,113,84,12,12,0,A47L5/30;;A47L9/0009;;A47L9/1472;;A47L9/2821;;A47L9/2842;;A47L9/2857;;A47L9/2878;;A47L9/2889;;A47L9/325;;A47L9/32;;A47L9/32;;A47L9/325;;A47L9/2857;;A47L9/2878;;A47L9/1472;;A47L5/30;;A47L9/0009;;A47L9/2821;;A47L9/2842;;A47L9/2889,A47L9/32,15/410,2,0,,,"Intensity Vacuum Cleaner [online], [retrieved on Feb. 27, 2007]. Retrieved from the internet .;;Photographs of Eureka Model 210 (6 pages).",INACTIVE
760,KR,A,KR 20080038139 A,186-297-618-179-782,2008-05-02,2008,KR 20087002252 A,2006-07-26,US 2006/0029062 W;;US 70404605 P;;US 74760406 P,2005-07-29,"RECIPROCATING PISTON PUMP WITH AIR VALVE, DETENT AND POPPETS",An air valving system for a reciprocating piston pump (5) which uses piston (10) actuated poppet assemblies (40) to control the main air valve (16) shift. The valve exhaust is vented (50) directly to atmosphere rather than through the main exhaust to ensure reliability. A ramped detent (32) prevents the air valve (16) from centering.,GRACO MINNESOTA INC,BAUCK MARK L;;ISAIS JOHN F JR;;WEINBERGER MARK T;;PITTMAN DAVID M;;BLOOM MICHAEL E,,https://lens.org/186-297-618-179-782,Patent Application,no,0,0,28,28,0,F04B9/12;;F04B9/125;;F16K11/02;;F04B49/00;;F04B35/00;;F04B9/08;;F04B9/12;;F04B9/125;;F16K11/02,F04B49/00;;F04B9/08;;F04B35/02,,0,0,,,,ACTIVE
761,MX,B,MX 340667 B,001-766-940-040-324,2016-07-19,2016,MX 2012003589 A,2006-07-26,US 70404605 P;;US 74760406 P;;US 2006/0029062 W,2005-07-29,"RECIPROCATING PISTON PUMP WITH AIR VALVE, DETENT AND POPPETS.",An air valving system for a reciprocating piston pump (5) which uses piston (10) actuated poppet assemblies (40) to control the main air valve (16) shift. The valve exhaust is vented (50) directly to atmosphere rather than through the main exhaust to ensure reliability. A ramped detent (32) prevents the air valve (16) from centering.,GRACO MINNESOTA INC,BAUCK MARK L;;WEINBERGER MARK T;;ISAIS JOHN F JR;;PITTMAN DAVID M;;BLOOM MICHAEL E,,https://lens.org/001-766-940-040-324,Granted Patent,no,0,0,28,28,0,F04B9/12;;F04B9/125;;F16K11/02;;F04B49/00;;F04B35/00;;F04B9/08;;F04B9/12;;F04B9/125;;F16K11/02,F16K11/02,,0,0,,,,ACTIVE
762,EP,B1,EP 1910679 B1,060-633-979-731-078,2012-04-11,2012,EP 06788580 A,2006-07-26,US 2006/0029062 W;;US 70404605 P;;US 74760406 P,2005-07-29,"RECIPROCATING PISTON PUMP WITH AIR VALVE, DETENT AND POPPETS","A poppet assembly includes a poppet housing (41) having an axis and first and second sets of housing ports (41a, 41b), which are axially spaced. A poppet seat (44) is provided in the housing, the seat having a set of seat ports (44a), and a poppet (43) is also located in the housing and is retained by the seat. The poppet has a set of poppet ports (43a), is biased against the seat in a first position and can be moved to a second position away from the seat. A poppet actuator (45), which is located in the seat, partially surrounds the poppet and is biased away from the poppet. When the poppet is in its first position, the first set of housing ports (41b) are in fluid communication with the second set of housing ports (41a) through the poppet ports (43a), and when it is in its second position, the first set of housing ports (41b) are in fluid communication with the seat ports (44a).",GRACO MINNESOTA INC,BAUCK MARK L;;ISAIS JOHN F JR;;WEINBERGER MARK T;;PITTMAN DAVID M;;BLOOM MICHAEL E,,https://lens.org/060-633-979-731-078,Granted Patent,yes,6,0,28,28,0,F04B9/12;;F04B9/125;;F16K11/02;;F04B49/00;;F04B35/00;;F04B9/08;;F04B9/12;;F04B9/125;;F16K11/02,F04B49/00;;F04B9/08;;F04B35/02,,0,0,,,,ACTIVE
763,EP,A2,EP 1910679 A2,077-008-583-652-537,2008-04-16,2008,EP 06788580 A,2006-07-26,US 2006/0029062 W;;US 70404605 P;;US 74760406 P,2005-07-29,"RECIPROCATING PISTON PUMP WITH AIR VALVE, DETENT AND POPPETS","A poppet assembly includes a poppet housing (41) having an axis and first and second sets of housing ports (41a, 41b), which are axially spaced. A poppet seat (44) is provided in the housing, the seat having a set of seat ports (44a), and a poppet (43) is also located in the housing and is retained by the seat. The poppet has a set of poppet ports (43a), is biased against the seat in a first position and can be moved to a second position away from the seat. A poppet actuator (45), which is located in the seat, partially surrounds the poppet and is biased away from the poppet. When the poppet is in its first position, the first set of housing ports (41b) are in fluid communication with the second set of housing ports (41a) through the poppet ports (43a), and when it is in its second position, the first set of housing ports (41b) are in fluid communication with the seat ports (44a).",GRACO MINNESOTA INC,BAUCK MARK L;;ISAIS JOHN F JR;;WEINBERGER MARK T;;PITTMAN DAVID M;;BLOOM MICHAEL E,,https://lens.org/077-008-583-652-537,Patent Application,yes,0,0,28,28,0,F04B9/12;;F04B9/125;;F16K11/02;;F04B49/00;;F04B35/00;;F04B9/08;;F04B9/12;;F04B9/125;;F16K11/02,F04B49/00;;F04B9/08;;F04B35/02,,0,0,,,,ACTIVE
764,EP,A1,EP 2398416 A1,044-770-253-946-214,2011-12-28,2011,EP 10744466 A,2010-02-23,US 2010/0025058 W;;US 15462309 P,2009-02-23,FLUID-ASSISTED ELECTROSURGICAL DEVICE,,SALIENT SURGICAL TECH INC,GREELEY ROGER D;;EARLES DONALD;;FLANAGAN DAVID;;BLOOM ELIOT T;;CONLEY BRIAN M;;BARRY JONATHAN J,MEDTRONIC ADVANCED ENERGY LLC (2013-05-08),https://lens.org/044-770-253-946-214,Patent Application,yes,0,0,13,13,0,A61B18/1402;;A61B18/148;;A61B2018/00029;;A61B2018/00345;;A61B2018/00404;;A61B2018/00434;;A61B2018/00589;;A61B2018/00601;;A61B2018/00619;;A61B2018/0063;;A61B2018/00642;;A61B2018/00702;;A61B2018/00791;;A61B2018/00875;;A61B2018/1253;;A61B2018/126;;A61B2018/1412;;A61B2018/1415;;A61B2018/1467;;A61B2018/1472;;A61B2218/002;;A61B18/1402;;A61B18/148;;A61B2018/00029;;A61B2018/00345;;A61B2018/00404;;A61B2018/00434;;A61B2018/00589;;A61B2018/00601;;A61B2018/00619;;A61B2018/0063;;A61B2018/00642;;A61B2018/00702;;A61B2018/00791;;A61B2018/00875;;A61B2018/1253;;A61B2018/126;;A61B2018/1412;;A61B2018/1415;;A61B2018/1467;;A61B2018/1472;;A61B2218/002;;A61B18/18,A61B18/14,,0,0,,,,ACTIVE
765,WO,A3,WO 2007/016177 A3,072-720-218-403-564,2007-06-21,2007,US 2006/0029062 W,2006-07-26,US 70404605 P;;US 74760406 P,2005-07-29,"RECIPROCATING PISTON PUMP WITH AIR VALVE, DETENT AND POPPETS",An air valving system for a reciprocating piston pump (5) which uses piston (10) actuated poppet assemblies (40) to control the main air valve (16) shift. The valve exhaust is vented (50) directly to atmosphere rather than through the main exhaust to ensure reliability. A ramped detent (32) prevents the air valve (16) from centering.,GRACO MINNESOTA INC;;BAUCK MARK L;;ISAIS JOHN F JR;;WEINBERGER MARK T;;PITTMAN DAVID M;;BLOOM MICHAEL E,BAUCK MARK L;;ISAIS JOHN F JR;;WEINBERGER MARK T;;PITTMAN DAVID M;;BLOOM MICHAEL E,,https://lens.org/072-720-218-403-564,Search Report,yes,2,0,28,28,0,F04B9/12;;F04B9/125;;F16K11/02;;F04B49/00;;F04B35/00;;F04B9/08;;F04B9/12;;F04B9/125;;F16K11/02,F04B9/08;;F04B49/00;;F04B35/02,,0,0,,,,PENDING
766,EP,A1,EP 2426387 A1,085-453-224-522-250,2012-03-07,2012,EP 11186124 A,2006-07-26,EP 06788580 A;;US 70404605 P;;US 74760406 P,2005-07-29,"Reciprocating piston pump with air valve, detent and poppets","A poppet assembly includes a poppet housing (41) having an axis and first and second sets of housing ports (41a, 41b), which are axially spaced. A poppet seat (44) is provided in the housing, the seat having a set of seat ports (44a), and a poppet (43) is also located in the housing and is retained by the seat. The poppet has a set of poppet ports (43a), is biased against the seat in a first position and can be moved to a second position away from the seat. A poppet actuator (45), which is located in the seat, partially surrounds the poppet and is biased away from the poppet. When the poppet is in its first position, the first set of housing ports (41b) are in fluid communication with the second set of housing ports (41a) through the poppet ports (43a), and when it is in its second position, the first set of housing ports (41b) are in fluid communication with the seat ports (44a).
",GRACO MINNESOTA INC,BAUCK MARK L;;ISAIS JOHN F JR;;WEINBERGER MARK T;;PITTMAN DAVID M;;BLOOM MICHAEL E,,https://lens.org/085-453-224-522-250,Patent Application,yes,3,0,28,28,0,F04B9/12;;F04B9/125;;F16K11/02;;F04B49/00;;F04B35/00;;F04B9/08;;F04B9/12;;F04B9/125;;F16K11/02,F16K11/02,,0,0,,,,ACTIVE
767,AU,A1,AU 2006/275892 A1,113-404-452-702-248,2007-02-08,2007,AU 2006/275892 A,2006-07-26,US 74760406 P;;US 70404605 P;;US 2006/0029062 W,2005-07-29,"Reciprocating piston pump with air valve, detent and poppets","A poppet assembly includes a poppet housing (41) having an axis and first and second sets of housing ports (41a, 41b), which are axially spaced. A poppet seat (44) is provided in the housing, the seat having a set of seat ports (44a), and a poppet (43) is also located in the housing and is retained by the seat. The poppet has a set of poppet ports (43a), is biased against the seat in a first position and can be moved to a second position away from the seat. A poppet actuator (45), which is located in the seat, partially surrounds the poppet and is biased away from the poppet. When the poppet is in its first position, the first set of housing ports (41b) are in fluid communication with the second set of housing ports (41a) through the poppet ports (43a), and when it is in its second position, the first set of housing ports (41b) are in fluid communication with the seat ports (44a).",GRACO MINNESOTA INC,BAUCK MARK L;;BLOOM MICHAEL E;;ISAIS JOHN F JR;;PITTMAN DAVID M;;WEINBERGER MARK T,,https://lens.org/113-404-452-702-248,Patent Application,no,0,0,28,28,0,F04B9/12;;F04B9/125;;F16K11/02;;F04B49/00;;F04B35/00;;F04B9/08;;F04B9/12;;F04B9/125;;F16K11/02,F04B9/08;;F04B35/02;;F04B49/00,,0,0,,,,INACTIVE
768,EP,B1,EP 2398416 B1,122-666-634-596-139,2015-10-28,2015,EP 10744466 A,2010-02-23,US 2010/0025058 W;;US 15462309 P,2009-02-23,FLUID-ASSISTED ELECTROSURGICAL DEVICE,,MEDTRONIC ADVANCED ENERGY LLC,GREELEY ROGER D;;EARLES DONALD;;FLANAGAN DAVID;;BLOOM ELIOT T;;CONLEY BRIAN M;;BARRY JONATHAN J,MEDTRONIC ADVANCED ENERGY LLC (2013-05-08),https://lens.org/122-666-634-596-139,Granted Patent,yes,14,0,13,13,0,A61B18/1402;;A61B18/148;;A61B2018/00029;;A61B2018/00345;;A61B2018/00404;;A61B2018/00434;;A61B2018/00589;;A61B2018/00601;;A61B2018/00619;;A61B2018/0063;;A61B2018/00642;;A61B2018/00702;;A61B2018/00791;;A61B2018/00875;;A61B2018/1253;;A61B2018/126;;A61B2018/1412;;A61B2018/1415;;A61B2018/1467;;A61B2018/1472;;A61B2218/002;;A61B18/1402;;A61B18/148;;A61B2018/00029;;A61B2018/00345;;A61B2018/00404;;A61B2018/00434;;A61B2018/00589;;A61B2018/00601;;A61B2018/00619;;A61B2018/0063;;A61B2018/00642;;A61B2018/00702;;A61B2018/00791;;A61B2018/00875;;A61B2018/1253;;A61B2018/126;;A61B2018/1412;;A61B2018/1415;;A61B2018/1467;;A61B2018/1472;;A61B2218/002;;A61B18/18,A61B18/14,,0,0,,,,ACTIVE
769,CZ,A3,CZ 20012060 A3,048-187-094-793-35X,2001-11-14,2001,CZ 20012060 A,1999-12-06,US 20831698 A,1998-12-09,"Thiourea compounds containing acetamide and substituted acetamide, and functioning as inhibitors of herpes viruses",,AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;O HARA BRYAN MARK,,https://lens.org/048-187-094-793-35X,Patent Application,no,0,0,18,18,0,C07C335/20;;C07C335/22;;C07D207/09;;C07D207/14;;C07D211/58;;C07D261/10;;A61P31/22,A61K31/17;;A61K31/341;;A61K31/343;;A61K31/345;;C07D249/04;;A61K31/36;;A61K31/381;;A61K31/40;;A61K31/403;;A61K31/4192;;A61K31/42;;A61K31/433;;A61K31/437;;A61K31/4409;;A61K31/4468;;A61K31/47;;A61K31/4965;;A61K31/5375;;A61K31/56;;A61P31/22;;C07C335/20;;C07C335/22;;C07C337/06;;C07D207/09;;C07D207/14;;C07D207/34;;C07D209/48;;C07D211/58;;C07D213/81;;C07D215/48;;C07D217/26;;C07D221/12;;C07D241/24;;C07D261/08;;C07D261/10;;C07D265/30;;C07D285/06;;C07D295/12;;C07D307/56;;C07D307/73;;C07D307/85;;C07D317/68;;C07D333/38;;C07D333/70,,0,0,,,,PENDING
770,CZ,A3,CZ 20012057 A3,063-793-037-531-39X,2001-11-14,2001,CZ 20012057 A,1999-12-06,US 20796198 A,1998-12-09,Thiourea compounds functioning as inhibitors of herpes viruses 199,,AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;O HARA BRYAN MARK,,https://lens.org/063-793-037-531-39X,Patent Application,no,0,0,17,17,0,C07D207/335;;C07D209/14;;C07D213/40;;C07D213/75;;C07D215/12;;C07D217/12;;C07D231/56;;C07D233/44;;C07D277/28;;C07D285/06;;C07D307/52;;C07D333/20;;C07D405/12;;C07D417/12;;A61P31/12;;A61P31/22;;C07D209/14;;C07D207/335;;C07D213/40;;C07D215/12;;C07D217/12;;C07D231/56;;C07D233/44;;C07D285/06;;C07D307/52;;C07D333/20;;C07D417/12,A61K31/06;;A61K31/075;;A61K31/085;;A61K31/10;;A61K31/11;;A61K31/136;;A61K31/15;;A61K31/165;;A61K31/167;;A61K31/17;;A61K31/175;;A61K31/18;;A61K31/196;;A61K31/215;;A61K31/216;;A61K31/222;;A61K31/27;;C07D295/14;;A61K31/275;;A61K31/341;;A61K31/40;;A61K31/42;;A61K31/426;;A61K31/433;;A61K31/4439;;A61K31/4453;;A61K31/4458;;A61K31/54;;A61K31/695;;A61P31/12;;A61P31/22;;C07C335/20;;C07D207/12;;C07D207/14;;C07D207/32;;C07D207/335;;C07D209/14;;C07D211/22;;C07D213/40;;C07D213/75;;C07D215/12;;C07D217/12;;C07D231/12;;C07D231/56;;C07D233/44;;C07D261/08;;C07D277/24;;C07D277/28;;C07D285/06;;C07D307/52;;C07D307/54;;C07D333/20;;C07D405/12;;C07D417/12,,0,0,,,,PENDING
771,CZ,A3,CZ 20011958 A3,009-385-513-464-730,2001-10-17,2001,CZ 20011958 A,1999-12-06,US 20854098 A,1998-12-09,Thiourea compounds functioning as inhibitors of herpes viruses,,AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;O HARA BRYAN MARK,,https://lens.org/009-385-513-464-730,Patent Application,no,0,0,21,89,0,C07D213/75;;C07D213/81;;C07D405/12;;C07D417/12;;C07D307/85;;C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81,A61K/;;A61K31/12;;A61K31/33;;A61K31/425;;A61K31/44;;A61K31/4427;;A61K31/443;;C07D213/81;;A61K31/4436;;A61K31/444;;A61P/;;A61P31/12;;A61P31/22;;C07D/;;C07D213/75;;C07D401/12;;C07D405/12;;C07D417/12,,0,0,,,,PENDING
772,CN,B,CN 101233323 B,087-280-535-776-24X,2011-03-30,2011,CN 200680027923 A,2006-07-26,US 2006/0029062 W;;US 70404605 P;;US 74760406 P,2005-07-29,"Reciprocating piston pump with air valve, detent and poppets",An air valving system for a reciprocating piston pump (5) which uses piston (10) actuated poppet assemblies (40) to control the main air valve (16) shift. The valve exhaust is vented (50) directly to atmosphere rather than through the main exhaust to ensure reliability. A ramped detent (32) prevents the air valve (16) from centering.,GRACO MINNESOTA INC,WEINBERGER MARK T;;BLOOM MICHAEL E;;BAUCK MARK L;;PITTMAN DAVID M;;ISAIS JOHN F JR,,https://lens.org/087-280-535-776-24X,Granted Patent,no,0,0,28,28,0,F04B9/12;;F04B9/125;;F16K11/02;;F04B49/00;;F04B35/00;;F04B9/08;;F04B9/12;;F04B9/125;;F16K11/02,F04B49/00;;F04B9/08;;F04B35/02,,0,0,,,,INACTIVE
773,ES,T3,ES 2528341 T3,113-126-626-305-406,2015-02-09,2015,ES 11186124 T,2006-07-26,US 70404605 P;;US 74760406 P,2005-07-29,Bomba de pistón alternativo con retén de válvula de aire y obturadores,"A poppet assembly includes a poppet housing (41) having an axis and first and second sets of housing ports (41a, 41b), which are axially spaced. A poppet seat (44) is provided in the housing, the seat having a set of seat ports (44a), and a poppet (43) is also located in the housing and is retained by the seat. The poppet has a set of poppet ports (43a), is biased against the seat in a first position and can be moved to a second position away from the seat. A poppet actuator (45), which is located in the seat, partially surrounds the poppet and is biased away from the poppet. When the poppet is in its first position, the first set of housing ports (41b) are in fluid communication with the second set of housing ports (41a) through the poppet ports (43a), and when it is in its second position, the first set of housing ports (41b) are in fluid communication with the seat ports (44a).",GRACO MINNESOTA INC,BAUCK MARK L;;ISAIS JOHN F JR;;WEINBERGER MARK T;;PITTMAN DAVID M;;BLOOM MICHAEL E,,https://lens.org/113-126-626-305-406,Granted Patent,no,0,0,28,28,0,F04B9/12;;F04B9/125;;F16K11/02;;F04B49/00;;F04B35/00;;F04B9/08;;F04B9/12;;F04B9/125;;F16K11/02,F16K11/02,,0,0,,,,ACTIVE
774,WO,A9,WO 2007/016177 A9,136-477-375-038-647,2007-04-12,2007,US 2006/0029062 W,2006-07-26,US 70404605 P;;US 74760406 P,2005-07-29,"RECIPROCATING PISTON PUMP WITH AIR VALVE, DETENT AND POPPETS",An air valving system for a reciprocating piston pump (5) which uses piston (10) actuated poppet assemblies (40) to control the main air valve (16) shift. The valve exhaust is vented (50) directly to atmosphere rather than through the main exhaust to ensure reliability. A ramped detent (32) prevents the air valve (16) from centering.,GRACO MINNESOTA INC;;BAUCK MARK L;;ISAIS JOHN F JR;;WEINBERGER MARK T;;PITTMAN DAVID M;;BLOOM MICHAEL E,BAUCK MARK L;;ISAIS JOHN F JR;;WEINBERGER MARK T;;PITTMAN DAVID M;;BLOOM MICHAEL E,,https://lens.org/136-477-375-038-647,Patent Application,no,0,0,28,28,0,F04B9/12;;F04B9/125;;F16K11/02;;F04B49/00;;F04B35/00;;F04B9/08;;F04B9/12;;F04B9/125;;F16K11/02,F04B49/00;;F04B9/08;;F04B35/02,,0,0,,,,PENDING
775,US,B2,US 9238102 B2,076-232-329-440-432,2016-01-19,2016,US 201013395627 A,2010-09-10,US 201013395627 A;;US 24137509 P;;US 24488409 P;;US 26733409 P;;US 29524710 P;;US 2010/0048489 W,2009-09-10,Low profile actuator and improved method of caregiver controlled administration of therapeutics,"A polymer actuator, power supply and method of using the activation are described.",BANISTER MARK;;BLOOM WILLIAM G;;GERONOV YORDAN M;;MCWILLIAMS MARK D;;SWENSON DAVID;;VAN VEEN MARK A;;MEDIPACS INC,BANISTER MARK;;BLOOM WILLIAM G;;GERONOV YORDAN M;;MCWILLIAMS MARK D;;SWENSON DAVID;;VAN VEEN MARK A,MEDIPACS INC (2012-03-08),https://lens.org/076-232-329-440-432,Granted Patent,yes,100,0,4,4,0,A61M5/1723;;A61M5/1723;;A61M5/14244;;A61M5/14244;;A61M5/148;;A61M5/148;;A61M2205/0272;;A61M2205/0272;;A61M2205/0277;;A61M2205/0277;;A61M2205/18;;A61M2205/502;;A61M2230/201;;A61M2230/202;;A61M2230/205;;A61M2230/30;;A61M2230/42,A61M31/00;;A61M5/142;;A61M5/148;;A61M5/172,,82,1,008-993-513-025-925,10.1007/bf02412145,"Office Action issued Nov. 23, 2012 in U.S. Appl. No. 12/745,880 (26 pgs.).;;""An Electrochemical Microactuator: Principle and First Results"", Neagu et al. Journal of Microelectromechanical Systems, vol. 5, No. 1. Mar. 1996 (7 pgs).;;""ElectroActive Polymers-EAPs,"" downloaded from http://www.azom.com on Dec. 16, 2013 (5 pgs).;;""Epoxy-Based Electroactive Polymer Gels"", Yoshioka Y and Calvert P, Experimental Mechanics, vol. 42, No. 4, Dec. 2002, pp. 404-408 (5 pgs).;;""Magnetic Driven Compression Cascade and Packaging"", IBM Technical Disclosure Bulletin, IBM Corp., col. 38, co. 1, Jan. 1995 (3 pgs).;;""Micro-Dispensing Positive Displacement Pump"", Anonymous, Research Disclosure, Mason Publications, Hampshire GB, vol. 374, No. 4, Jun. 1995 (9 pgs).;;""Structure and Mechanism of Two Types of Micro-Pump Using Polymer Gel"", Hattori et al., Micro Electro Mechanical Systems, 1992, MEMS 92, Proceedings. An Investigation of Micro Structures, Sensors, Actuators, Machines and Robot, IEEE Travemunde, Germany, Feb. 1992 (6 pgs).;;Bar-Cohen, Y., ""Electroactive polymers (EAP) actuators as artificial muscles: reality, potential and challenges,"" SPIE Press, 2001, 671 pgs, (book description only, 4 pgs).;;Canadian Official Action issued in Appln. No. 2,557,325, dated Feb. 8, 2011 (5 pgs).;;Chinese Notification of ReExamination and English translation, Appln. or Pat. No. 200580048306.3; dated Aug. 22, 2014 (11 pgs).;;Chinese Office Action (w/English translation) issued in corresponding application No. 200780032137.3, dated Mar. 12, 2013 (14 pgs).;;Chinese Office Action and Translation dated Jul. 6, 2011 issued in Chinese Patent Appln. No. 200780032137.3 (7 pgs).;;Chinese Office Action issued Jul. 1, 2014 with English translation, Appln. No. or Patent No. 201180007957.3 (17 pgs).;;Chinese Office Action, Application/Patent No. 200780032137.3, dated Dec. 23, 2011 (6 pgs).;;Chinese Official Action + translation dated Feb. 1, 2011 issued in Appln. No. 200780032137.3, (8 pgs).;;Chinese Official Action dated Mar. 17, 2011, Appln. No. 200580048306.3 (5 pgs).;;Chinese Official Action issued in corresponding Chinese Patent Appln. Serial No. 200580048306.3 dated Nov. 4, 2011 (5 pgs).;;European Office Action dated Sep. 14, 2010, Appln. No. 07 872 242.8-2102, (6 pgs).;;European Official Action issued in Appln. No. 04714231.0, dated May 11, 2011 (2 pgs).;;European Official Action issued in Appln. No. 04714231.0-2315/1611353, dated Oct. 4, 2010 (4 pgs).;;European Official Action, Apr. 6, 2011 issued in Appln. No. 07 872 242.8-2102 (4 pages).;;European Official Action, Aug. 29, 2011 issued in Appln. No. 07 872 242.8-2102 (6 pages).;;European Search Report dated Feb. 18, 2011 issued in corresponding Appln. No. 10014840.2-2315 (7 pgs).;;European Search Report dated Jun. 8, 2009, Serial No. 07872242.8-2102 (7 pgs).;;First Examination Report dated Dec. 31, 2013, Indian Patent Application No. 3011/CHENP/2007 (2 pgs).;;Indian Examination Report; Indian Patent Application Serial No. 2371/CHENP/2005, dated Sep. 7, 2006 (2 pgs).;;International Preliminary Report on Patentability issued in PCT/US10/48489 dated Mar. 13, 2012 (12 pgs).;;International Search Report and Written Opinion issued in corresponding PCT Patent Appln. Serial No. PCT/US2012/057129 dated Apr. 1, 2014 ( 7 pgs).;;International Search Report and Written Opinion of the International Search Authority issued in PCT/US09/34557, dated Apr. 13, 2009 (6 pgs).;;Japanese Office Action with translation, Patent Appln. 2009-519642, dated Jul. 9, 2012 (9 pgs).;;Office Action issued in related U.S. Appl. No. 10/786,718, dated Mar. 5, 2008 (41 pgs).;;Office Action issued in related U.S. Appl. No. 10/786,718, dated Sep. 16, 2008 (8 pgs).;;Office Action issued in related U.S. Appl. No. 10/786,718, dated Jan. 2, 2009 (9 pgs).;;Office Action issued in related U.S. Appl. No. 10/786,718, dated Jul. 1, 2009 (7 pgs).;;Office Action issued in related U.S. Appl. No. 10/786,718, dated Dec. 28, 2009 (6 pgs).;;Office Action issued in related U.S. Appl. No. 10/786,718, dated May 5, 2010 (7 pgs).;;Office Action issued in related U.S. Appl. No. 10/786,718, dated Sep. 15, 2010 (8 pgs).;;Office Action issued in related U.S. Appl. No. 10/786,718, dated Nov. 23, 2010 (10 pgs).;;Office Action issued in related U.S. Appl. No. 11/254,537, dated Sep. 17, 2007 (8 pgs).;;Office Action issued in related U.S. Appl. No. 11/254,537, dated Mar. 4, 2008 (8 pgs).;;Office Action issued in related U.S. Appl. No. 11/254,537, dated Jul. 21, 2008 (10 pgs).;;Office Action issued in related U.S. Appl. No. 11/254,537, dated Dec. 15, 2008 (8 pgs).;;Office Action issued in related U.S. Appl. No. 12/373,245, dated Feb. 2, 2011 (13 pgs).;;Office Action issued in related U.S. Appl. No. 12/373,245, dated Jul. 22, 2011 (11 pgs).;;Office Action issued in related U.S. Appl. No. 12/373,245, dated Jun. 30, 2014 (18 pgs).;;Office Action issued in related U.S. Appl. No. 12/414,536, dated Nov. 29, 2010 (8 pgs).;;Office Action issued in related U.S. Appl. No. 12/978,152, dated May 23, 2011 (9 pgs).;;Office Action issued in related U.S. Appl. No. 13/018,024, dated Aug. 7, 2014 (17 pgs).;;Office Action issued in related U.S. Appl. No. 13/093,648, dated Aug. 29, 2013 (5 pgs).;;Office Action issued in related U.S. Appl. No. 13/424,172, dated Jun. 27, 2012 (14 pgs).;;Office Action issued in related U.S. Appl. No. 13/424,172, dated Nov. 9, 2012 (6 pgs).;;Office Action issued in related U.S. Appl. No. 14/071,371, dated Aug. 21, 2014 (16 pgs).;;Office Action issued in related U.S. Appl. No. 12/745,880, dated Jun. 3, 2013 (8 pgs).;;Official Action received in corresponding Chinese Application No. 200480010203.3, Sep. 14, 2007 (19 pgs).;;Official Action received in corresponding Chinese Application No. 200480010203.3, Nov. 14, 2008 (5 pgs).;;Official Action received in corresponding EPO Application. No. 04 714 231.0-2315, Nov. 13, 2008 (5 pgs).;;Official Action, U.S. Appl. No. 11/721,800, dated Aug. 27, 2010 (13 pgs).;;PCT International Preliminary Report on Patentability, dated Aug. 26, 2005, PCT/US04/005922 (11 pgs).;;PCT International Search Report and Written Opinion, dated Oct. 22, 2004, PCT/US04/005922 (17 pgs).;;PCT International Search Report and International Preliminary Report on Patentability, dated Oct. 25, 2006, PCT/US05/45210 (10 pgs).;;PCT International Search Report and International Preliminary Report on Patentability, dated Jul. 7, 2008, PCT/US07/73188 (8 pgs).;;PCT International Search Report and International Preliminary Report on Patentability, dated Feb. 19, 2009, PCT/US08/85421 (7 pgs).;;PCT International Search Report and Written Opinion dated Mar. 28, 2011 PCT/US11/23375 (10 pgs).;;PCT International Preliminary Report on Patentability issued in PCT/US2013/031062, dated Sep. 16, 2014 (9 pgs).;;Search Report and Written Opinion received in Applicant's corresponding European Patent Application Serial No. 05854009.7, Nov. 11, 2009 (8 pgs).;;Supplemental European Search Report issued in EP04714231, dated Jan. 25, 2007 (2 pgs).;;Unsolicited letter from Dr. Elson Silva, dated Oct. 21, 2010 (5 pgs).;;Yoshioka et al., ""Electrically Driven Miniature Hydrogels as Muscle-Like Acuators"", 2001; Proceedings of SPIE vol. 4329, pp. 216-222 (7 pgs).;;Office Action issued in related U.S. Appl. No. 14/071,371, dated Dec. 18, 2014 (11 pgs).;;Japanese Office Action (with translation) issued in related application No. 2012-551386, dated Jan. 28, 2015 (9 pgs).;;Office Action issued in related U.S. Appl. No. 13/395,627, dated Feb. 5, 2015 (7 pgs).;;Chinese Board Decision, Appln. No. 200580048306.3, dated Dec. 26, 2014 (14 pgs).;;Office Action issued in related U.S. Appl. No. 12/373,245, dated Feb. 9, 2015 (11 pgs).;;Office Action issued in related U.S. Appl. No. 12/918,466, dated Jul. 11, 2013 (36 pgs).;;India Hearing Notice in Reference of Application No. 3011/CHENP/2007, dated Feb. 5, 2015 (1 pg).;;Office Action issued in U.S. Appl. No. 13/018,024, dated Feb. 24, 2015 (12 pgs).;;Office Action issued in U.S. Appl. No. 13/424,172, dated Jun. 10, 2015 (14 pgs).;;Office Action issued in U.S. Appl. No. 14/347,597, dated Jun. 3, 2015 (12 pgs).;;Indian Office Action issued in application No. 137/CHENP/2009, dated Mar. 17, 2015 (2 pgs).;;Office Action issued in U.S. Appl. No. 12/745,880, dated Jul. 22, 2015 (16 pgs).;;Chinese Office Action issued in application No. 201180007957.3, dated May 22, 2015, with English translation (15 pgs).;;Office Action issued in U.S. Appl. No. 13/018,024, dated Aug. 4, 2015 (10 pgs).",ACTIVE
776,US,A1,US 2012/0191060 A1,092-169-523-979-811,2012-07-26,2012,US 201013395627 A,2010-09-10,US 201013395627 A;;US 24137509 P;;US 24488409 P;;US 26733409 P;;US 29524710 P;;US 2010/0048489 W,2009-09-10,LOW PROFILE ACTUATOR AND IMPROVED METHOD OF CAREGIVER CONTROLLED ADMINISTRATION OF THERAPEUTICS,"A polymer actuator, power supply and method of using the activation are described.",BANISTER MARK;;BLOOM WILLIAM G;;GERONOV YORDAN M;;MCWILLIAMS MARK D;;SWENSON DAVID;;VAN VEEN MARK A,BANISTER MARK;;BLOOM WILLIAM G;;GERONOV YORDAN M;;MCWILLIAMS MARK D;;SWENSON DAVID;;VAN VEEN MARK A,MEDIPACS INC (2012-03-08),https://lens.org/092-169-523-979-811,Patent Application,no,1,16,4,4,0,A61M5/1723;;A61M5/1723;;A61M5/14244;;A61M5/14244;;A61M5/148;;A61M5/148;;A61M2205/0272;;A61M2205/0272;;A61M2205/0277;;A61M2205/0277;;A61M2205/18;;A61M2205/502;;A61M2230/201;;A61M2230/202;;A61M2230/205;;A61M2230/30;;A61M2230/42,A61M5/168;;A61M5/14;;G01F13/00,604/500;;604/131;;604/66;;222/1,0,0,,,,ACTIVE
777,US,A1,US 2005/0011794 A1,109-506-518-390-519,2005-01-20,2005,US 46083803 A,2003-06-12,US 46083803 A,2003-06-12,Product sampler packet assembly with enhanced burst strength and method of manufacture,A product sampler packet assembly includes a flexible packet bonded to a carrier card by an adhesive standoff having sufficient hardness (and resistance to creep) to increase the burst strength of the assembly above that of the packet alone. The adhesive standoff is disposed between the packet and the carrier card to define a well into which the packet is at least slightly deformed under compression such that the adhesive stand off distributes the compressive force without substantial transfer to the closure seal of the packet.,MARTIN MARIETTA CORP,CALDWELL KIMBERLY M;;BETTS DALE;;BLOOM RICHARD;;CARD CHARLES;;CHICHESTER ROBERT;;DEMEO RONALD;;HEMPSON DAVID;;MAXSON CHRIS,MARIETTA CORPORATION (2003-06-23),https://lens.org/109-506-518-390-519,Patent Application,yes,28,18,2,2,0,B65D75/52;;B65D75/52,B65D75/52,206/466,0,0,,,,EXPIRED
778,US,B2,US 6929128 B2,094-411-089-211-660,2005-08-16,2005,US 46083803 A,2003-06-12,US 46083803 A,2003-06-12,Product sampler packet assembly with enhanced burst strength and method of manufacture,A product sampler packet assembly includes a flexible packet bonded to a carrier card by an adhesive standoff having sufficient hardness (and resistance to creep) to increase the burst strength of the assembly above that of the packet alone. The adhesive standoff is disposed between the packet and the carrier card to define a well into which the packet is at least slightly deformed under compression such that the adhesive stand off distributes the compressive force without substantial transfer to the closure seal of the packet.,MARTIN MARIETTA CORP,CALDWELL KIMBERLY M;;BETTS DALE;;BLOOM RICHARD;;CARD CHARLES;;CHICHESTER ROBERT;;DEMEO RONALD;;HEMPSON DAVID;;MAXSON CHRIS,MARIETTA CORPORATION (2003-06-23),https://lens.org/094-411-089-211-660,Granted Patent,yes,7,18,2,2,0,B65D75/52;;B65D75/52,B65D75/52,206/466;;206/484;;206/734,0,0,,,,EXPIRED
779,US,B2,US 8784464 B2,176-499-442-023-786,2014-07-22,2014,US 201213471381 A,2012-05-14,US 201213471381 A;;US 78189207 A;;US 12560405 A;;US 62805503 A;;US 56394600 A;;US 13883098 A;;US 18556100 P,1998-08-24,Disposable cassette for intravascular heat exchange catheter,"A heat exchange fluid supply system for supplying a heat exchange fluid to an intravascular heat exchange catheter includes a disposable cassette having a bulkhead and an external heat exchanger, and which is configured to operate in combination with a reusable master control unit. The bulkhead includes a reservoir section and a pump section. The reservoir section is provided with a means to monitor the amount of heat exchange fluid that is in the system. The bulkhead provides the mechanism for priming the system with heat exchange fluid from an external source and for circulating fluid to the catheter in a closed circuit. The pump section is configured to allow for pumping of heat exchange fluid at a constant pressure.",MACHOLD TIMOTHY R;;BLOOM NICOLE DENISE;;ROTH ALEX T;;SCOTT DAVID J;;ALEJANDRO JOSE;;OLIVER EDWARD A;;ZOLL CIRCULATION INC,MACHOLD TIMOTHY R;;BLOOM NICOLE DENISE;;ROTH ALEX T;;SCOTT DAVID J;;ALEJANDRO JOSE;;OLIVER EDWARD A,,https://lens.org/176-499-442-023-786,Granted Patent,yes,47,8,21,113,0,A61B2017/00119;;A61B2017/00123;;A61B2017/22051;;A61F7/10;;A61F7/123;;A61F2007/0054;;A61F2007/0096;;A61F2007/126;;A61M25/1011;;A61M2025/1072;;A61M2025/1086;;A61M2205/127;;A61M5/44;;F28D2021/005;;F28D1/0341;;F28F3/12;;F28F9/0246;;A61F2007/0054;;A61F2007/126;;A61B2017/00123;;A61B2017/00119;;A61F2007/0096;;A61F7/123;;A61M2025/1072;;A61M2025/1086;;A61F7/10;;A61M25/1011;;A61B2017/22051;;A61M2205/127;;A61M5/44;;A61F7/0085;;A61F7/12,A61B17/00;;A61F7/12;;A61B17/22;;A61F2/958;;A61F7/00;;A61F7/10,607/105,0,0,,,,EXPIRED
780,US,B2,US 8177824 B2,063-418-126-188-680,2012-05-15,2012,US 78189207 A,2007-07-23,US 78189207 A;;US 12560405 A;;US 62805503 A;;US 56394600 A;;US 13883098 A;;US 18556100 P,1998-08-24,Disposable cassette for intravenous heat exchange catheter,"A heat exchange fluid supply system for supplying a heat exchange fluid to an intravascular heat exchange catheter includes a disposable cassette having a bulkhead and an external heat exchanger, and which is configured to operate in combination with a reusable master control unit. The bulkhead includes a reservoir section and a pump section. The reservoir section is provided with a means to monitor the amount of heat exchange fluid that is in the system. The bulkhead provides the mechanism for priming the system with heat exchange fluid from an external source and for circulating fluid to the catheter in a closed circuit. The pump section is configured to allow for pumping of heat exchange fluid at a constant pressure.",MACHOLD TIMOTHY R;;BLOOM NICOLE DENISE;;ROTH ALEX T;;SCOTT DAVID J;;ALEJANDRO JOSE;;OLIVER EDWARD A;;ZOLL CIRCULATION INC,MACHOLD TIMOTHY R;;BLOOM NICOLE DENISE;;ROTH ALEX T;;SCOTT DAVID J;;ALEJANDRO JOSE;;OLIVER EDWARD A,BAY CITY CAPITAL FUND IV L.P (2007-09-06);;ZOLL CIRCULATION INC (2007-09-18),https://lens.org/063-418-126-188-680,Granted Patent,yes,36,7,21,113,0,A61B2017/00119;;A61B2017/00123;;A61B2017/22051;;A61F7/10;;A61F7/123;;A61F2007/0054;;A61F2007/0096;;A61F2007/126;;A61M25/1011;;A61M2025/1072;;A61M2025/1086;;A61M2205/127;;A61M5/44;;F28D2021/005;;F28D1/0341;;F28F3/12;;F28F9/0246;;A61F2007/0054;;A61F2007/126;;A61B2017/00123;;A61B2017/00119;;A61F2007/0096;;A61F7/123;;A61M2025/1072;;A61M2025/1086;;A61F7/10;;A61M25/1011;;A61B2017/22051;;A61M2205/127;;A61M5/44;;A61F7/0085;;A61F7/12,A61B17/00;;A61F7/00;;A61B17/22;;A61F2/958;;A61F7/10;;A61F7/12,607/96;;607/104,0,0,,,,EXPIRED
781,US,A1,US 2001/0055740 A1,016-102-447-390-024,2001-12-27,2001,US 77897601 A,2001-02-02,US 77897601 A;;US 17966400 P,2000-02-02,Modular furnace system,"
   A modular furnace is fabricated from at least one module having a frame, a removable cover mounted to the frame, exterior cover panels on the frame, and an insulated case fastened to the interior of the module. A conveyor assembly extends through the module. A plurality of process zones, such as heating and cooling zones, are disposed within the module. Field replaceable universal blower assemblies are associated with each process zone. The motor shaft in each blower assembly is provided with a sealed bearing in the motor housing. Insulation within each module is held in place by gas permeable fabric covering large vent openings in cover panels to allow oxygen to diffuse out of the insulation rapidly upon start up. 
",BTU INT,BLOOM DAVID;;BOUCHARD ROBERT;;HARVEY DAVID S;;NEILEY GEOFFREY C;;SECCOMBE DONALD A;;WONG TERRANCE;;TARCZON RICHARD;;PARROTT STEPHEN J;;EDGINGTON PAUL,BTU INTERNATIONAL INC (2001-02-14),https://lens.org/016-102-447-390-024,Patent Application,yes,0,35,9,9,0,B23K1/008;;B23K1/012;;F27B9/029;;F27B9/10;;F27B9/3011;;F27D17/004;;F27D2007/045;;B23K2101/40;;B23K1/012;;F27D17/004;;F27B9/029;;F27D2007/045;;F27B9/10;;B23K1/008;;F27B9/3011;;B23K2101/40,B23K1/008;;B23K1/012;;F27B9/02;;F27B9/10;;F27B9/30;;F27D7/04;;F27D17/00,432/247;;110/181;;110/336;;432/249;;432/238;;126/65,0,0,,,,EXPIRED
782,US,A1,US 2014/0364928 A1,041-992-287-819-04X,2014-12-11,2014,US 201414337066 A,2014-07-21,US 201414337066 A;;US 201213471381 A;;US 78189207 A;;US 12560405 A;;US 62805503 A;;US 56394600 A;;US 13883098 A;;US 18556100 P,1998-08-24,DISPOSABLE CASSETTE FOR INTRAVASCULAR HEAT EXCHANGE CATHETER,"A heat exchange fluid supply system for supplying a heat exchange fluid to an intravascular heat exchange catheter includes a disposable cassette having a bulkhead and an external heat exchanger, and which is configured to operate in combination with a reusable master control unit. The bulkhead includes a reservoir section and a pump section. The reservoir section is provided with a means to monitor the amount of heat exchange fluid that is in the system. The bulkhead provides the mechanism for priming the system with heat exchange fluid from an external source and for circulating fluid to the catheter in a closed circuit. The pump section is configured to allow for pumping of heat exchange fluid at a constant pressure.",ZOLL CIRCULATION INC,MACHOLD TIMOTHY R;;BLOOM NICOLE DENISE;;ROTH ALEX T;;SCOTT DAVID J;;ALEJANDRO JOSE;;OLIVER EDWARD A,,https://lens.org/041-992-287-819-04X,Patent Application,yes,0,6,21,113,0,A61B2017/00119;;A61B2017/00123;;A61B2017/22051;;A61F7/10;;A61F7/123;;A61F2007/0054;;A61F2007/0096;;A61F2007/126;;A61M25/1011;;A61M2025/1072;;A61M2025/1086;;A61M2205/127;;A61M5/44;;F28D2021/005;;F28D1/0341;;F28F3/12;;F28F9/0246;;A61F2007/0054;;A61F2007/126;;A61B2017/00123;;A61B2017/00119;;A61F2007/0096;;A61F7/123;;A61M2025/1072;;A61M2025/1086;;A61F7/10;;A61M25/1011;;A61B2017/22051;;A61M2205/127;;A61M5/44;;A61F7/0085;;A61F7/12,A61F7/12;;A61B17/00;;A61B17/22;;A61F2/958;;A61F7/00;;A61F7/10,607/106,0,0,,,,DISCONTINUED
783,DE,D1,DE 60140430 D1,087-978-439-721-753,2009-12-24,2009,DE 60140430 T,2001-02-02,US 17966400 P;;US 0103492 W,2000-02-02,MODULARES OFENSYSTEM,,BTU INTERNAT INC,BLOOM DAVID;;BOUCHARD ROBERT;;HARVEY DAVID S;;NEILEY GEOFFREY C;;SECCOMBE DONALD A;;WONG TERRANCE;;TARCZON RICHARD;;PARROTT STEPHEN J;;EDGINGTON PAUL,,https://lens.org/087-978-439-721-753,Granted Patent,no,0,0,9,9,0,B23K1/008;;B23K1/012;;F27B9/029;;F27B9/10;;F27B9/3011;;F27D17/004;;F27D2007/045;;B23K2101/40;;B23K1/012;;F27D17/004;;F27B9/029;;F27D2007/045;;F27B9/10;;B23K1/008;;F27B9/3011;;B23K2101/40,F27B9/02;;B23K1/008;;B23K1/012;;F27B9/10;;F27B9/12;;F27B9/30;;F27D7/04;;F27D17/00,,0,0,,,,EXPIRED
784,WO,A3,WO 2007/121314 A3,069-218-984-790-485,2008-02-07,2008,US 2007/0066546 W,2007-04-12,US 79155306 P;;US 79387906 P,2006-04-12,ANNULOPLASTY DEVICE HAVING A HELICAL ANCHOR AND METHODS FOR ITS USE,"A system for modifying a heart valve annulus includes a helically helical anchored annuloplasty device delivered to the annulus via an elongated delivery member (720). The helical anchors (745) of the devices disclosed herein are rotated into the valve annulus along an anchor guide (725) by using a driver (730) that is movably disposed in the delivery member. A tether (750) is disposed within an inner channel of the helical anchor and a locking device is used to secure the annuloplasty device after the valve annulus has been modified. The annuloplasty device can be delivered to the annulus using, traditional surgical approach or a minimally invasive or catheter based methods",MEDTRONIC VASCULAR INC;;DOUK NAREAK;;RAFIEE NASSER;;BLOOM ELIOT;;FINNEY MICHAEL;;HOUSE MORGAN;;HUYNH RANY;;MAC DONALD STUART;;MAS JUAN-PABLO;;BARONE DAVID,RAFIEE NASSER;;BLOOM ELIOT;;FINNEY MICHAEL;;HOUSE MORGAN;;HUYNH RANY;;MAC DONALD STUART;;MAS JUAN-PABLO;;BARONE DAVID,,https://lens.org/069-218-984-790-485,Search Report,yes,5,0,12,16,0,A61F2/2451;;A61F2/2466;;A61F2/2451,A61F2/24,,0,0,,,,PENDING
785,WO,A1,WO 2018/075865 A1,008-765-591-707-02X,2018-04-26,2018,US 2017/0057547 W,2017-10-20,US 201662411512 P,2016-10-21,COMPOSITIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES,"In one embodiment, the present application discloses methods of treating diseases and disorders with sulfasalazine, an ABCG2 inhibitor and pharmaceutical formulations of sulfasalazine where the bioavailability of the sulfasalazine is increased. In another embodiment, the present application also provides dosing regimens for treating neurodegenerative diseases and disorders with compositions comprising sulfasalazine and an ABCG2 inhibitor.",GLIALOGIX INC,REEDER THADDEUS C;;MOORE MARK W;;LYON DAVID K;;JAGER CASEY K;;LORENZ DOUG;;BLOOM COREY;;SHEPARD KIMBERLY,,https://lens.org/008-765-591-707-02X,Patent Application,yes,26,0,4,4,0,A61K45/06;;A61K9/0053;;A61K47/22;;A61K47/26;;A61K47/38;;A61K9/4866;;A61K31/355;;A61K31/635;;A61K31/77;;A61P25/28;;A61P35/00;;A61K31/353;;A61K31/4402;;A61K47/32;;A61K45/06;;A61K47/38;;A61K9/4866;;A61K47/26;;A61K31/355;;A61K9/0053;;A61K31/635;;A61K47/22;;A61K31/77;;A61P25/28;;A61P35/00;;A61K31/353;;A61K31/4402;;A61K47/32;;A61K2300/00,A61K9/00;;A61K31/635;;A61K31/355;;A61K31/77;;A61K45/06;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P43/00,,85,67,027-539-386-044-785;;157-538-183-053-39X;;051-455-243-676-103;;052-129-858-499-740;;092-193-071-905-01X;;171-109-054-798-979;;012-543-422-249-903;;085-316-051-480-724;;026-901-461-471-107;;028-033-327-659-462;;020-336-233-465-058;;016-976-012-618-269;;124-475-875-609-43X;;053-793-755-849-594;;022-016-552-373-089;;080-977-903-372-106;;023-915-720-639-372;;030-326-576-843-800;;157-907-510-549-618;;003-325-687-158-693;;055-591-763-061-753;;025-431-810-236-595;;016-100-434-168-337;;049-853-803-147-640;;063-039-750-010-499;;083-119-154-216-306;;010-361-003-829-92X;;046-406-629-335-553;;039-622-002-950-539;;148-996-224-496-800;;005-499-392-165-40X;;015-495-957-771-277;;025-198-556-932-465;;027-829-141-629-350;;020-336-233-465-058;;022-945-229-605-261;;047-977-503-004-084;;044-456-411-150-532;;018-545-921-924-368;;071-126-335-882-578;;112-894-839-471-50X;;077-406-458-693-034;;039-622-002-950-539;;124-475-875-609-43X;;023-915-720-639-372;;026-608-854-261-765;;123-459-405-287-791;;015-495-957-771-277;;020-172-903-640-006;;026-923-011-421-222;;000-471-855-970-59X;;003-325-687-158-693;;016-976-012-618-269;;049-853-803-147-640;;026-713-084-097-181;;028-543-758-391-365;;153-367-235-293-960;;148-996-224-496-800;;005-499-392-165-40X;;016-100-434-168-337;;081-627-513-521-264;;063-039-750-010-499;;013-199-006-312-21X;;055-591-763-061-753;;157-907-510-549-618;;025-431-810-236-595;;034-098-619-917-843,10.1016/s0140-6736(08)61620-7;;18970977;;18558855;;10.1146/annurev.neuro.30.051606.094313;;23007702;;10.1038/nrneurol.2012.168;;10.1038/nrn3275;;22714021;;10.1007/s00415-008-1002-8;;18317671;;10.1016/j.brainres.2012.07.054;;pmc3460523;;22884503;;22304707;;10.2174/092986712799462559;;21250988;;pmc3130160;;10.1111/j.1469-7580.2010.01339.x;;12925363;;10.1001/archneur.60.8.1082;;12474990;;10.1191/1352458502ms812oa;;10.2174/187152710791292576;;20406181;;21349440;;10.1016/s1474-4422(11)70015-1;;pmc2806318;;19951898;;10.1083/jcb.200908164;;10.1016/s1474-4422(10)70143-5;;20650402;;10.2337/db07-1274;;pmc2551692;;18633115;;23999057;;10.1016/j.pain.2013.08.030;;10.1056/nejmra1004418;;21899452;;pmc3192231;;10.1038/nm.2453;;21909104;;19078385;;10.1097/00124743-199908000-00003;;10.1002/j.1552-4604.1987.tb03009.x;;2890667;;10.2165/00003495-198600321-00003;;2877847;;10.1038/sj.clpt.6100459;;18167504;;pmc3644176;;10.1517/13543784.2012.670634;;22404218;;pmc6237285;;27658422;;10.1158/1541-7786.mcr-16-0028;;10.4103/0028-3886.128280;;24608453;;10.1212/wnl.51.5.1342;;9818858;;6105118;;10.1136/gut.21.3.232;;pmc1420362;;10.1158/1078-0432.ccr-04-0144;;15355921;;8209258;;10.1126/science.8209258;;10.1080/17482960701856300;;18273714;;10.1111/j.1471-4159.2012.07771.x;;22537108;;20348957;;10.1038/ng.557;;8894702;;10.1093/hmg/5.10.1649;;12732654;;10.1084/jem.20021603;;pmc2193967;;10.2174/187152710791292576;;20406181;;10.1186/1742-2094-6-38;;pmc2811703;;20021679;;17475885;;10.4049/jimmunol.178.10.6549;;10.1073/pnas.95.26.15665;;9861027;;pmc28101;;10.1007/s00417-011-1894-3;;22173217;;9798933;;10.1046/j.1471-4159.1998.71052079.x;;10.1523/jneurosci.2459-07.2007;;17881516;;pmc6672668;;10.1016/j.jneuroim.2006.05.019;;16828169;;8209258;;10.1126/science.8209258;;pmc2806318;;19951898;;10.1083/jcb.200908164;;10.1056/nejmra1004418;;21899452;;24223903;;10.1371/journal.pone.0079188;;pmc3817036;;20051697;;10.1159/000268641;;20348957;;10.1038/ng.557;;21191088;;10.1096/fj.10-177212;;18806690;;10.1097/wnr.0b013e328312181c;;17051202;;10.1038/nature05289;;10.1002/j.1552-4604.1987.tb03009.x;;2890667;;21349440;;10.1016/s1474-4422(11)70015-1;;pmc6237285;;27658422;;10.1158/1541-7786.mcr-16-0028;;pmc6674113;;16554485;;10.1523/jneurosci.5186-05.2006;;10.1016/j.bbrc.2004.10.009;;15522208;;pmc3820435;;10.6064/2012/857516;;24278747;;10.1080/17482960701856300;;18273714;;10.1111/j.1471-4159.2012.07771.x;;22537108;;pmc3644176;;10.1517/13543784.2012.670634;;22404218;;24806299;;10.1097/nen.0000000000000073;;10.4103/0028-3886.128280;;24608453;;pmc3700386;;23722393;;10.1167/iovs.13-11899;;10.2165/00003495-198600321-00003;;2877847;;19078385;;10.1097/00124743-199908000-00003;;10.1038/sj.clpt.6100459;;18167504;;10.1021/mp050113v;;16686369,"COMPTON ET AL., LANCET, vol. 372, 2008, pages 1502 - 1517;;TRAPP ET AL., ANNU. REV. NEUROSCI., vol. 31, 2008, pages 247 - 269;;KREMENCHUTSKY ET AL., BRAIN, vol. 129, 2006, pages 584 - 594;;LASSMANN ET AL., NAT. REV. NEUROLOGY, vol. 8, 2012, pages 647 - 656;;STYS ET AL., NAT. REV. NEUROSCIENCE, vol. 13, 2012, pages 507 - 514;;FOX ET AL., MULTIPLE SCLEROSIS JOURNAL, vol. 18, 2012, pages 1534 - 1540;;FITZNER ET AL., CURR. NEUROPHARMACOLOGY, vol. 8, 2008, pages 305 - 315;;WEINER, J., NEUROLOGY, vol. 255, no. 1, 2008, pages 3 - 11;;LASSMAN, NEUROLOGY, vol. 8, 2012, pages 647 - 656;;BURNS ET AL., BRAIN RES., vol. 1473, 2012, pages 236 - 241;;FRIGO, CURR. MEDICIN. CHEM., vol. 19, 2012, pages 1295 - 1299;;MATUTE, J. ANATOMY, vol. 219, 2011, pages 53 - 64;;SARCHIELLI ET AL., ARCH. NEUROL., vol. 60, 2003, pages 1082 - 1088;;ERIKSSON ET AL., MULT. SCLER., vol. 8, 2002, pages 495 - 499;;SVENDSEN ET AL., PAIN, vol. 114, 2004, pages 473 - 481;;BOGAERT ET AL., CNS NEUROL. DISORD. DRUG TARGETS, vol. 9, 2010, pages 297 - 304;;PHILIPS ET AL., LANCET NEUROL., vol. 10, 2011, pages 253 - 263;;ILIEVA ET AL., J. CELL BIOL., vol. 187, 2009, pages 761 - 772;;LIN ET AL., PHARMACOLOGY, vol. 85, 2010, pages 54 - 62;;BARON ET AL., LANCET NEUROLOGY, vol. 9, 2010, pages 807 - 819;;BERTI-MATTERA ET AL., DIABETES, vol. 57, 2008, pages 2801 - 2808;;UNGARDETET, PAIN, vol. 155, 2014, pages 28 - 36;;CHOI ET AL., J OF NEUROINFLAMMATION, vol. 6, pages 38 - 52;;KWAN ET AL., N ENGL J MED, vol. 365, pages 919 - 26;;BUCKINGHAM ET AL., NAT MED, vol. 17, 2011, pages 1269 - 1274;;WEAVER, J. CLIN. RHEUMATOL., vol. 5, 1999, pages 193 - 200;;PEPPERCORN, M., J. CLIN. PHARMACOL., vol. 27, 1987, pages 260 - 265;;WATKINSON, G., DRUGS, vol. 32, no. 1, 1986, pages 1 - 11;;YAMASAKI ET AL., CLINICAL PHARMACOLOGY THERAPEUTICS, vol. 84, pages 95 - 103;;SONTHEIMER, H. ET AL., EXPERT OPIN. INVESTIG. DRUGS, vol. 21, 2012, pages 575 - 578;;POLEWSKI, M ET AL., MOL. CANCER RES., vol. 14, 2016, pages 1229 - 1242;;TAKEUCHI, S. ET AL., NEUROLOGY INDIA, vol. 62, 2014, pages 42 - 47;;ALLIKMETS R ET AL., HUM MOL GENET, vol. 5, 1997, pages 1649 - 55;;DOYLE L. ET AL., PROC NATL ACAD SCI U S A, vol. 95, 1999, pages 15665 - 70;;NOSEWORTHY ET AL., NEUROLOGY, vol. 15, 1998, pages 1342 - 1352;;KHAN ET AL., GUT, vol. 21, 1980, pages 232 - 240;;YAMASAKI ET AL., CLIN. PHARMAC. THERAP., vol. 84, 2007, pages 95 - 103;;JONG ET AL., CLIN. CANCER RES., vol. 10, 2004, pages 5889 - 5894;;BUCKINGHAM ET AL., NAT MED., vol. 17, 2011, pages 1269 - 1274;;""Remington: The Science and Practice of Pharmacy"", LIPPINCOTT, WILLIAMS & WILKINS;;RAYMOND C. ROWE ET AL.: ""Handbook of Pharmaceutical Excipients"", PHARMACEUTICAL PRESS;;""Remington's Pharmaceutical Science"", 1970, MACK PUBLISHING CO, pages: 1626 - 1678;;GURNEY ET AL., SCIENCE, vol. 264, 1994, pages 1772 - 1775;;SCOTT ET AL., AMYOTROPH. LATERAL SCLER., vol. 9, 2008, pages 4 - 15;;LINCECUM ET AL., SUPPLEMENTARY MATERIAL, NAT. GENETICS, vol. 42, 2010, pages 392 - 411;;SHIN ET AL., J. NEUROCHEM., vol. 122, 2012, pages 952 - 961;;LINCECUM ET AL., NAT. GENETICS, vol. 42, 2010, pages 392 - 411;;ZAHER ET AL., MOL. PHARMACEUTICS, vol. 3, 2005, pages 55 - 61;;MODERN PLASTICS ENCYCLOPEDIA, vol. 46, 1969, pages 62 - 70;;""Pharmaceutical Science, by Remington"", 1970, MACK PUBLISHING CO, pages: 1626 - 1678;;ALLIKMETS R ET AL.: ""Characterization of the human ABC superfamily: isolation and mapping of 21 new genes using the expressed sequence tags database"", HUM MOL GENET, vol. 5, 1997, pages 1649 - 55, XP002283347, DOI: doi:10.1093/hmg/5.10.1649;;BETTELLI, E: ""Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis"", J. EXP. MED., vol. 197, 2003, pages 1073 - 1081, XP003008390, DOI: doi:10.1084/jem.20021603;;BOGAERT, E. ET AL.: ""Amyotrophic lateral sclerosis and excitotoxicity: from pathological mechanism to therapeutic target"", CNS NEUROL. DISORD. DRUG TARGETS, vol. 9, 2010, pages 297 - 304;;CHOI, J. ET AL.: ""Cellular injury and neuroinflammation in children with chronicintractable epilepsy"", J NEUROINFLAMMATION, vol. 6, 2009, pages 38 - 52;;DOMERCQ, M. ET AL.: ""System xc- and glutamate transporter inhibition mediates microglial toxicity to oligodendrocytes"", J IMMUNOL., vol. 178, 2007, pages 6549 - 6556;;DOYLE, L. ET AL.: ""A multidrug resistance transporter from human MCF-7 breast cancer cells"", PROC NATL ACADSCI USA, vol. 95, 1999, pages 15665 - 70, XP002135024, DOI: doi:10.1073/pnas.95.26.15665;;ESFAHANI M. ET AL.: ""Memantine for axonal loss of optic neuritis"", GRAEFES ARCH CLINEXPOPHTHALMOL, vol. 250, 2012, pages 863 - 869, XP035058114, DOI: doi:10.1007/s00417-011-1894-3;;ESPEY, M. ET AL.: ""Extracellular glutamate levels are chronically elevated in brains of LP-BM5-infected mice: A mechanism of retroviral-induced encephalopathy"", JNEUROCHEM, vol. 71, 1998, pages 2079 - 2087;;FOGAL, B. ET AL.: ""System xc. activity and astrocytes are necessary for interleukin-lb-mediated hypoxic neuronal injury"", JNEUROSCI, vol. 27, 2007, pages 10094 - 10105;;GUAN, Y. ET AL.: ""Retinal ganglion cell damage induced by spontaneous autoimmune optic neuritis in MOG-specific TCR transgenic mice"", J. NEUROIMMUNOL., vol. 178, 2006, pages 40 - 48, XP025039407, DOI: doi:10.1016/j.jneuroim.2006.05.019;;GURNEY M ET AL.: ""Motor neuron degeneration in mice that express a human Cu/Zn superoxide dismutase mutation"", SCIENCE, vol. 264, 1994, pages 1772 - 1775, XP000564091, DOI: doi:10.1126/science.8209258;;ILIEVA, H. ET AL.: ""Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond"", J. CELL BIOL., vol. 187, 2009, pages 761 - 772;;KWAN, P. ET AL.: ""Drug-Resistant Epilepsy"", N ENGL J MED, vol. 365, 2011, pages 919 - 926;;LIDSTER, K. ET AL.: ""Neuroprotection in a novel mouse model of multiple sclerosis"", PLOS, vol. 8, 2013, pages e79188;;LIN, L. ET AL.: ""The interaction of the neuroprotective compounds riluzole and phenobarbital with AMPA-type glutamate receptors: a patch-clamp study"", PHARMACOLOGY, vol. 85, 2010, pages 54 - 62;;LINCECUM, J. ET AL.: ""From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis"", NAT. GENETICS, vol. 42, 2010, pages 392 - 411;;MASSIE, A. ET AL.: ""Dopaminergic neurons of system xc. deficient mice are protected against 6-OHDA induced toxicity"", FASEB J., 29 December 2010 (2010-12-29);;MASSIE, A. ET AL.: ""Time-dependent changes in striatal xCT protein expression in hemi-Parkinson rats"", MOLNEUROSCI, vol. 19, 2008, pages 1589 - 1592;;PALOP, J; MUCKE, L: ""A network dysfunction perspective on neurodegenerative diseases"", NATURE, vol. 443, 2006, pages 768 - 773;;PEPPERCORN, M: ""Sulfasalazine and related new drugs"", J CLINPHARMACOL, vol. 27, 1987, pages 260 - 265;;PHILIPS. T. ET AL.: ""Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease"", LANCET NEUROL., vol. 10, 2011, pages 253 - 263;;POLEWSKI, M. ET AL.: ""Increased expression of system xc- in glioblastoma confers an alteredmetabolic state and temozolomide resistance"", MOL. CANCER RES., vol. 14, 2016, pages 1229 - 1242;;QIN, S. ET AL.: ""System xc- and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid-beta peptide 1-40"", J NEUROSCI, vol. 26, 2006, pages 3345 - 3356;;SATO, H. ET AL.: ""Transcriptional control of the cystine/glutamate transporter gene by amino acid deprivation"", BIOCHEM. BIOPHYS. RES. COMM., vol. 325, 2004, pages 109 - 116, XP005027208, DOI: doi:10.1016/j.bbrc.2004.10.009;;SCHONTHAL, A: ""Endoplasmic reticulum stress: its role in disease and novel prospects for therapy"", SCIENTIFICA (CAIRO), 2012;;SCOTT S ET AL.: ""Design, power, and interpretation of studies in the standard murine model of ALS"", AMYOTROPH LATERAL SCLER, vol. 9, 2008, pages 4 - 15;;SHIN, J. ET AL.: ""Concurrent blockade of free radical and microsomal prostaglandin E synthase-1-mediated PGE(2) production improves safety and efficacy in a mouse model of amyotrophic lateral sclerosis"", J. NEUROCHEM., vol. 122, 2012, pages 952 - 961, XP055117741, DOI: doi:10.1111/j.1471-4159.2012.07771.x;;SONTHEIMER, H; BRIDGES, R: ""Sulfasalazine for brain cancer fits"", EXPERT OPIN. INVESTIG. DRUGS., vol. 21, 2012, pages 575 - 578;;SUHS, K: ""N-methyl-d-aspartate receptor blockade is neuroprotective in experimental autoimmune optic neuritis"", J NEUROPATHOL EXP NEUROL, vol. 73, 2014, pages 507 - 518;;TAKEUCHI, S. ET AL.: ""Sulfasalazine and temozolomide with radiation therapy for newly diagnosed glioblastoma"", NEUROLOGY INDIA, vol. 62, 2014, pages 42 - 47;;TALLA, V. ET AL.: ""Noninvasive assessments of optic nerve neurodegeneration in transgenic mice with isolated optic neuritis"", INVEST OPHTHALMOL VIS SCI, vol. 54, 2013, pages 4440 - 4450;;WATKINSON, G: ""Sulphasalazine: a review of 40 years' experience"", DRUGS, vol. 32, no. 1, 1986, pages 1 - 11, XP009134676;;WEAVER, A. ET AL.: ""Improved gastrointestinal tolerance and patient preference of enteric-coated sulfasalazine versus uncoated sulfasalazine tablets in patients with rheumatoid arthritis"", J. CLIN. RHEUMATOLOGY., vol. 5, 1999, pages 193 - 200;;YAMASAKI, Y. ET AL.: ""Pharmacogenetic characterization of sulfasalazine disposition based on NAT2 and ABCG2 (Bcrp) gene polymorphisms in humans"", CLIN PHARMACOLOGY THERAPEUTICS, vol. 84, 2008, pages 95 - 103, XP008154212, DOI: doi:10.1038/sj.clpt.6100459;;ZAHER, H. ET AL.: ""Breast cancer resistance protein (Bcrp/abcg2) is a major determinant of sulfasalazine absorption and elimination in the mouse"", MOL. PHARMACEUTICS, vol. 3, 2005, pages 55 - 61",PENDING
786,ES,T3,ES 2224733 T3,053-667-796-485-566,2005-03-01,2005,ES 99963021 T,1999-12-06,US 20856198 A,1998-12-09,TIOUREAS ONHIBIDORAS DE LOS VIRUS DEL HERPES.,"Compuesto de fórmula: en la que R1 a R5 se seleccionan cada uno de entre hidrógeno, alquilo de 1 a 6 átomos de carbono, alquenilo de 2 a 6 átomos de carbono, alquinilo de 2 a 6 átomos de carbono, perhaloalquilo de 1 a 6 átomos de carbono, cicloalquilo de 3 a 10 átomos de carbono, heterocicloalquilo de 3 a 10 átomos de carbono, arilo, heteroarilo, halógeno, -CN, -NO2, -CO2R6, -COR6, -OR6, -SR6, -SOR6, -SO2R6, -CONR7R8, - NR6N(R7R8), -N(R7R8) o W-Y-(CH2)n-Z, con la condición que al menos uno de R1 a R5 no sea hidrógeno; o R2 y R3 ó R3 y R4, considerados conjuntamente forman un heterocicloalquilo de 3 a 7 elementos o un heteroarilo de 3 a 7 elementos; R6 y R7 son cada uno hidrógeno, alquilo de 1 a 6 átomos de carbono, perhaloalquilo de 1 a 6 átomos de carbono, o arilo; R8 es hidrógeno, alquilo de 1 a 6 átomos de carbono, perhaloalquilo de 1 a 6 átomos de carbono, cicloalquilo de 3 a 10 átomos de carbono, heterocicloalquilo de 3 a 10 átomos de carbono, arilo o heteroarilo, o R7 y R8 considerados conjuntamente pueden formar un heterocicloalquilo de 3 a 7 elementos; R9 a R12 son cada uno hidrógeno, alquilo de 1 a 4 átomos de carbono, perhaloalquilo de 1 a 4 átomos de carbono, halógeno, alcoxi de 1 a 4 átomos de carbono, o ciano, ó R9 y R10 ó R11 y R12 se pueden considerar que forman conjuntamente arilo de 5 a 7 átomos de carbono; con la condición de que al menos uno de entre R9-12 no sea hidrógeno; W es O, NR6, o está ausente; Y es ¿(CO)- ó ¿(CO2)-, o está ausente; Z es alquilo de 1 a 4 átomos de carbono, -CN, -CO2R6, COR6, -CONR7R8, -OCOR6, -NR6COR7, -OCONR6, -OR6, -SR6, -SOR6, -SO2R6, SR6N(R7R8), -N(R7R8) o fenilo; G es arilo o heteroarilo bicíclico condensado que puede estar sustituido con uno o más sustituyentes seleccionados de entre alquilo de 1 a 6 átomos de carbono, alquenilo de 2 a 6 átomos de carbono, alquinilo de 2 a 6 átomos de carbono, perhaloalquilo de 1 a 6 átomos de carbono, cicloalquilo de 3 a 10 átomos de carbono, heterocicloalquilo de 3 a 10 átomos de carbono, arilo, heteroarilo, halógeno, -CN, -NO2, - CO2R6, -COR6, -OR6, -SR6, -SOR6, -SO2R6, -CONR7R8, -NR6N(R7R8), -N(R7R8) o W-Y-(CH2)n- Z; X es un enlace, -NH-, alquileno de 1 a 6 átomos de carbono, alquenileno de hasta 6 átomos de carbono, alquilenoxi de 1 a 6 átomos de carbono, tioalquileno de 1 a 6 átomos de carbono, alquilenamino de 1 a 6 átomos de carbono, o (CH)J; J es alquilo de 1 a 6 átomos de carbono, cicloalquilo de 3 a 7 átomos de carbono, fenilo o bencilo; y n es un entero de 1 a 6, o una de las sales farmacéuticas del mismo.",WYETH CORP,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER,,https://lens.org/053-667-796-485-566,Granted Patent,no,0,0,30,30,0,C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/00,A61K31/17;;A61K31/343;;A61K31/472;;A61P31/22;;C07C275/42;;C07C335/18;;C07C335/20;;C07C335/22;;C07D217/26;;C07D295/088;;C07D307/81;;C07D307/85,,0,0,,,,EXPIRED
787,US,A1,US 2018/0110760 A1,128-249-280-416-604,2018-04-26,2018,US 201715789243 A,2017-10-20,US 201715789243 A;;US 201662411512 P,2016-10-21,COMPOSITIONS AND METHODS FOR THE TREATMENTOF NEURODEGENERATIVE AND OTHER DISEASES,"In one embodiment, the present application discloses methods of treating diseases and disorders with sulfasalazine, an ABCG2 inhibitor and pharmaceutical formulations of sulfasalazine where the bioavailability of the sulfasalazine is increased. In another embodiment, the present application also provides dosing regimens for treating neurodegenerative diseases and disorders with compositions comprising sulfasalazine and an ABCG2 inhibitor.",GLIALOGIX INC,REEDER THADDEUS CROMWELL;;MOORE MARK W;;LYON DAVID K;;JAGER CASEY K;;LORENZ DOUG;;BLOOM COREY;;SHEPARD KIMBERLY,BEND RESEARCH INC (2017-11-02);;GLIALOGIX INC (2017-11-01),https://lens.org/128-249-280-416-604,Patent Application,yes,0,2,4,4,0,A61K45/06;;A61K9/0053;;A61K47/22;;A61K47/26;;A61K47/38;;A61K9/4866;;A61K31/355;;A61K31/635;;A61K31/77;;A61P25/28;;A61P35/00;;A61K31/353;;A61K31/4402;;A61K47/32;;A61K45/06;;A61K47/38;;A61K9/4866;;A61K47/26;;A61K31/355;;A61K9/0053;;A61K31/635;;A61K47/22;;A61K31/77;;A61P25/28;;A61P35/00;;A61K31/353;;A61K31/4402;;A61K47/32;;A61K2300/00,A61K31/4402;;A61K31/353;;A61K47/32;;A61P25/28;;A61P35/00,,0,0,,,,DISCONTINUED
788,WO,A3,WO 2008/065506 A3,006-713-568-362-791,2009-06-25,2009,IB 2007003632 W,2007-11-16,US 86766206 P,2006-11-29,PHARMACEUTICAL COMPOSITIONS COMPRISING NANOPARTICLES COMPRISING ENTERIC POLYMERS AND CASEIN,"A pharmaceutical composition comprises nanoparticles comprising the poorly water soluble lipophilic compound (2R)-3-[[3-(4-chloro-3-ethylphenoxy)phenyl][[3-(1,1,2,2- tetrafluoroethoxy)phenyl]methyl]amino]-1,1,1-trifluoro-2-propanol, and an enteric polymer.",PFIZER PROD INC;;BEYERINCK RONALD ARTHUR;;BLOOM COREY JAY;;CREW MARSHALL DAVID;;FRIESEN DWAYNE THOMAS;;MORGEN MICHAEL MARK;;SMITHEY DANIEL TOD,BEYERINCK RONALD ARTHUR;;BLOOM COREY JAY;;CREW MARSHALL DAVID;;FRIESEN DWAYNE THOMAS;;MORGEN MICHAEL MARK;;SMITHEY DANIEL TOD,,https://lens.org/006-713-568-362-791,Search Report,yes,4,0,2,2,0,A61K31/135;;A61K9/5161;;A61K9/5169;;A61K9/5192,A61K9/16;;A61K9/50;;A61K9/51;;A61K31/135,,0,0,,,,PENDING
789,DE,D1,DE 69919023 D1,109-425-474-934-654,2004-09-02,2004,DE 69919023 T,1999-12-06,US 20856198 A;;US 9928837 W,1998-12-09,THIOHARNSTOFF-INHIBITOREN VON HERPES-VIRUS,,WYETH CORP,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI JOSEPH;;DUSHIN GEORGE;;LANG ALBERT;;NORTON BOUCHER;;ROSS ANTONIA;;O'HARA MARK,,https://lens.org/109-425-474-934-654,Granted Patent,no,0,0,30,30,0,C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/00,A61K31/17;;A61K31/343;;A61K31/472;;A61P31/22;;C07C275/42;;C07C335/18;;C07C335/20;;C07C335/22;;C07D217/26;;C07D295/088;;C07D307/81;;C07D307/85,,0,0,,,,EXPIRED
790,US,B1,US 11137830 B1,020-974-828-572-983,2021-10-05,2021,US 201816130476 A,2018-09-13,US 201816130476 A;;US 201762561718 P,2017-09-22,Interactive computing system and control device,"A control device for an interactive computing system includes a first elongated member, a second elongated member, and a biasing actuator. The first elongated member and the second elongated member are pivotably coupled at a pivot axis. The biasing actuator is coupled to the first elongated member and the second elongated member to provide an output torque between the first elongated member and the second elongated member about the pivot axis. The control device is configured to receive user input for controlling a virtual device displayed by the interactive computing system to visually resemble a physical device. The biasing actuator is controllable to provide tactile feedback to simulate physical behavior of the physical device. The control device is movable freely in space.",JACKSON BENJAMIN G;;KIM SEUNG WOOK;;BLOOM DAVID H;;BAUGH BRENTON A;;TAYLOR STEVEN J;;CORDIER MADELEINE S;;APPLE INC,JACKSON BENJAMIN G;;KIM SEUNG WOOK;;BLOOM DAVID H;;BAUGH BRENTON A;;TAYLOR STEVEN J;;CORDIER MADELEINE S,APPLE INC (2018-08-29),https://lens.org/020-974-828-572-983,Granted Patent,yes,16,0,1,1,0,A61B34/25;;A61B34/76;;A61B34/76;;G06F3/016;;G06F3/0362;;G06F3/016;;G06F3/0346;;G06F3/0346;;G06T19/006,G06F3/01;;A61B34/00;;G06F3/0346;;G06T19/00,,4,0,,,"Hatzfeld, C., et. al., “Engineering Haptic Devices: A Beginner's Guide”, Springer, Sep. 15, 2014, p. 77 (1 p).;;3DSYSTEMS, “Haptic Devices and Toolkits”, <https://web.archive.org/web/20170918181629/http://sivirt.utsa.edu/Documents/Manuals/Haptics%20Omni.pdf>, dated Sep. 18, 2017, downloaded Sep. 13, 2018, (4 pp).;;Okamura, A. M., et. al., “The Haptic Scissors: Cutting in Virtual Environments”, <http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.88.1945&rep=rep1&type=pdf>, 2003, downloaded Sep. 11, 2018, (6 pp).;;Powers, M., et. al., “Surgical Scissors Extension Adds the 7th Axis of Force Feedback to the Freedom 6S”, NRC Publications Archive (NPArC), https://nparc.nrc-cnrc.gc.ca/nparc/eng/view/object/?id=db08ba4a-b595-4039-b99a-1dcceba658fb, Proceedings of the 15th Annual Medicine Meets Virtual Reality Conference, Feb. 9, 2007 (7 pp).",ACTIVE
791,US,A1,US 2020/0344536 A1,020-768-021-299-958,2020-10-29,2020,US 202016927367 A,2020-07-13,US 202016927367 A;;US 201816055071 A;;US 201862683594 P,2018-06-11,WEARABLE INTERACTIVE AUDIO DEVICE,"Embodiments are directed to a wearable audio device, such as an earbud. The earbud may be configured to detect input using various sensors and structures. For example, the earbud may be configured to detect gestures, physical manipulations, and so forth performed along or on the earbud. In response to the detected inputs, the earbud may be configured to change various outputs, such as an audio output or a haptic output of the device. The earbud may also include a microphone to register voice commands. In some cases, the microphone may be used to control the earbud using the registered voice command in response to one or more detected gestures or physical manipulations.",APPLE INC,JACKSON BENJAMIN G;;BAUGH BRENTON A;;BLOOM DAVID H;;ROPER GEMMA A;;BARK KARLIN Y;;HULBERT THOMAS S,,https://lens.org/020-768-021-299-958,Patent Application,yes,2,16,4,4,0,H04R1/1016;;H04R2201/107;;H04R2499/11;;H04R1/1041;;H04R2420/07;;G06F3/017;;G06F2203/0339;;G06F3/0362;;G06F3/165;;G06F3/167;;H04R1/02;;H04R1/1016;;G06F3/165;;G06F3/017;;G06F3/016;;H04R3/007,H04R1/02;;G06F3/01;;G06F3/16;;H04R1/10;;H04R3/00,,0,0,,,,ACTIVE
792,WO,A1,WO 2017/223248 A1,065-378-693-988-034,2017-12-28,2017,US 2017/0038618 W,2017-06-21,US 201662353019 P,2016-06-21,METHOD FOR DELIVERING RNA TO NEURONS TO TREAT HERPES INFECTIONS,"Aspects of the application relate to methods and compositions for delivering therapeutic nucleic acids to neural cells or tissue in a subject. Additional aspects of the application relate to therapeutic nucleic acids, for example therapeutic ribozymes, that are useful for inhibiting viral reactivation in a subject.",UNIV FLORIDA;;BOARD OF SUPERVISORS OF LOUISIANA STATE UNIV & AGRICULTURAL & MECHANICAL COLLEGE,BLOOM DAVID C;;LEWIN ALFRED S;;NEUMANN DONNA M;;WATSON ZACHARY L;;TULI SONAL SANJEEV;;SCHULTZ GREGORY SCOTT,,https://lens.org/065-378-693-988-034,Patent Application,yes,5,0,4,4,69,C12N15/1133;;C12N15/86;;C12N2310/121;;C12N2320/32;;C12N2310/20;;C12N2750/14122;;C12N2750/14143;;C12N2750/14145;;A61P31/22;;C12N15/1133;;C12N15/86;;C12N2750/14143;;C12N2310/121;;C12N2320/32;;C12N2310/20;;C12N2750/14122;;C12N2750/14145;;C12N15/861;;C12N2830/008;;A61P31/22;;A61K48/0091;;C12N5/062;;C12N2510/00,A61K38/00;;A61K38/46;;A61K48/00;;C12N15/11;;C12N15/113;;C12N15/86,,0,0,,,,PENDING
793,DE,T2,DE 69919023 T2,141-579-775-317-440,2005-07-28,2005,DE 69919023 T,1999-12-06,US 20856198 A;;US 9928837 W,1998-12-09,THIOHARNSTOFF-INHIBITOREN VON HERPES-VIRUS,,WYETH CORP,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI JOSEPH;;DUSHIN GEORGE;;LANG ALBERT;;NORTON BOUCHER;;ROSS ANTONIA;;O'HARA MARK,,https://lens.org/141-579-775-317-440,Granted Patent,no,0,0,30,30,0,C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/00,A61K31/17;;A61K31/343;;A61K31/472;;A61P31/22;;C07C275/42;;C07C335/18;;C07C335/20;;C07C335/22;;C07D217/26;;C07D295/088;;C07D307/81;;C07D307/85,,0,0,,,,EXPIRED
794,WO,A1,WO 2008/065502 A1,166-462-060-381-893,2008-06-05,2008,IB 2007003608 W,2007-11-16,US 86765106 P,2006-11-29,PHARMACEUTICAL COMPOSITIONS BASED ON A) NANOPARTICLES COMPRISING ENTERIC POLYMERS AND B) CASEIN,"A pharmaceutical composition comprises nanoparticles comprising a poorly water-soluble drug and an enteric polymer, and casein.",PFIZER PROD INC;;BEYERINCK RONALD ARTHUR;;BLOOM COREY JAY;;CREW MARSHALL DAVID;;FRIESEN DWAYNE THOMAS;;MORGEN MICHAEL MARK;;SMITHEY DANIEL TOD,BEYERINCK RONALD ARTHUR;;BLOOM COREY JAY;;CREW MARSHALL DAVID;;FRIESEN DWAYNE THOMAS;;MORGEN MICHAEL MARK;;SMITHEY DANIEL TOD,,https://lens.org/166-462-060-381-893,Patent Application,yes,3,9,4,4,0,A61K9/5161;;A61K9/5169;;A61K9/5192;;A61P29/00;;A61P3/06;;A61P43/00;;A61K9/5161;;A61K9/5169;;A61K9/5192,A61K9/51;;A61K31/00,,1,1,016-260-577-759-129,10.1016/0044-8486(92)90320-k,"HOUNG-YUNG CHEN, YEONG-TAI LEU, IVO ROELANTS: ""Effective supplementation of arginine in the diets of juvenile marine shrimp, Penaeus monodon"", AQUACULTURE, vol. 108, 1992, pages 87 - 95, XP002475148",PENDING
795,US,B2,US 11351273 B2,046-265-946-173-731,2022-06-07,2022,US 201716312277 A,2017-06-21,US 201716312277 A;;US 201662353019 P;;US 2017/0038618 W,2016-06-21,Method for delivering RNA to neurons to treat herpes infections,"Aspects of the application relate to methods and compositions for delivering therapeutic nucleic acids to neural cells or tissue in a subject. Additional aspects of the application relate to therapeutic nucleic acids, for example therapeutic ribozymes, that are useful for inhibiting viral reactivation in a subject.",UNIV FLORIDA;;BOARD OF SUPERVISORS OF LOUISIANA STATE UNIV & AGRICULTURAL & MECHANICAL COLLEGE,BLOOM DAVID C;;LEWIN ALFRED S;;NEUMANN DONNA M;;WATSON ZACHARY L;;TULI SONAL SANJEEV;;SCHULTZ GREGORY SCOTT,BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY & AGRICULTURAL & MECHANICAL COLLEGE (2018-02-23);;UNIVERSITY OF FLORIDA RESEARCH FOUNDATION INCORPORATED (2017-10-09),https://lens.org/046-265-946-173-731,Granted Patent,yes,5,0,4,4,69,C12N15/1133;;C12N15/86;;C12N2310/121;;C12N2320/32;;C12N2310/20;;C12N2750/14122;;C12N2750/14143;;C12N2750/14145;;A61P31/22;;C12N15/1133;;C12N15/86;;C12N2750/14143;;C12N2310/121;;C12N2320/32;;C12N2310/20;;C12N2750/14122;;C12N2750/14145;;C12N15/861;;C12N2830/008;;A61P31/22;;A61K48/0091;;C12N5/062;;C12N2510/00,C07H21/04;;A61K48/00;;A61P31/22;;C12N5/0793;;C12N15/113;;C12N15/86,,7,5,000-941-833-924-027;;039-684-480-916-654;;098-860-043-354-34X;;050-172-230-021-064;;012-472-442-151-334,17409161;;10.1128/jvi.02701-06;;pmc1900114;;10.1016/j.drudis.2009.05.003;;19477286;;10.1128/jvi.02720-07;;pmc2493317;;18508896;;10.1016/s1525-0016(16)33737-6;;10.1038/nature06621;;18235505,"6608 Bertke et al. “Herpes simplex virus latency-associated transcript sequence downstream of the promoter influences type-specific reactivation and viral neurotropism.” Journal of virology 81.12 (2007): 6605-6613).;;Tedeschi et al. (“Hammerhead ribozymes in therapeutic target discovery and validation.” Drug discovery today 14.15-16 (2009): 776-783).;;Liu et al. (“Reduction in severity of a herpes simplex virus type 1 murine infection by treatment with a ribozyme targeting the UL20 gene RNA.” Journal of virology 82.15 (2008): 7467-7474).;;Rossmiller et al. (“132 Gene Therapy With Self-Complementary Recombinant Adeno-Associated Virus in Models of Autosomal Dominant Retinitis Pigmentosa Cause by RHO Mutations.” Molecular Therapy 23 (2015): S54).;;International Search Report and Written Opinion for Application No. PCT/US2017/038618 dated Sep. 28, 2017.;;International Preliminary Report on Patentability for Application No. PCT/US2017/038618 dated Jan. 3, 2019.;;Gupta et al., Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript. Nature. Jul. 6, 2006;442(7098):82-5. Epub May 31, 2006. Retraction: Nature. Jan. 31, 2008;451(7178):600. doi: 10.1038/nature06621.",ACTIVE
796,US,B2,US 11040869 B2,046-114-858-626-202,2021-06-22,2021,US 15777362,2018-03-22,,,Dispensing meter for fluid dispensing,"A handheld fluid meter includes a cartridge valve controlling the flow of fluid through the handheld meter. The cartridge valve includes a valve cartridge and a valve stem disposed within the valve cartridge. The cartridge valve guides the valve stem and provides the only sealing surface for the dynamic seals and control seal disposed on the valve stem. The handheld meter dispenses through a nozzle, which includes an overmolded stem tip that generates a laminar fluid flow as the fluid exits the nozzle. The overmolded stem tip is a compliant material. The handheld fluid meter includes circuitry configured to invert the orientation of a visual output provided by a display of the handheld fluid meter to facilitate installation of the handheld fluid meter for use in an oil bar application.",Graco Minnesota Inc.,Michael E. Bloom;;Mark L. Bauck;;James R. Ebben;;David J. Lorden;;Bradley G. Kahler;;Anthony J. Kuschel,GRACO MINNESOTA INC (2018-05-14),https://lens.org/046-114-858-626-202,Granted Patent,yes,53,0,1,1,0,B67D7/52;;B67D7/12;;B67D7/16;;B67D7/303;;B67D7/425;;B67D7/426;;B67D7/44;;G01F3/14;;G01F15/003;;F16K3/26;;F16K31/60,B67D7/16;;B67D7/44;;B67D7/60;;B67D7/52;;B67D7/42;;G01F15/00;;B67D7/12;;G01F3/14;;B67D7/30;;F16K3/26;;F16K31/60,,4,0,,,"International Search Report and Written Opinion for PCT Application No. PCT/US2018/023863, dated Aug. 31, 2018, 17 pages.;;International Preliminary Report on Patentability for PCT Application No. PCT/US2018/023863, dated Mar. 17, 2020, pp. 15.;;First Chinese Office Action for CN Application No. 201880026203.4, dated Nov. 16, 2020, pp. 20.;;Extended European Search Report for EP Application No. 18771643.6, dated Apr. 15, 2021, p. 9.",UNKNOWN
797,TW,A,TW 201818933 A,087-387-268-948-835,2018-06-01,2018,TW 106136138 A,2017-10-20,US 201662411512 P,2016-10-21,Compositions and methods for the treatment of neurodegenerative and other diseases,"In one embodiment, the present application discloses methods of treating diseases and disorders with sulfasalazine, an ABCG2 inhibitor and pharmaceutical formulations of sulfasalazine where the bioavailability of the sulfasalazine is increased. In another embodiment, the present application also provides dosing regimens for treating neurodegenerative diseases and disorders with compositions comprising sulfasalazine and an ABCG2 inhibitor.",GLIALOGIX INC,REEDER THADDEUS C;;MOORE MARK W;;LYON DAVID K;;JAGER CASEY K;;LORENZ DOUG;;BLOOM COREY;;SHEPARD KIMBERLY,,https://lens.org/087-387-268-948-835,Patent of Addition,no,0,1,4,4,0,A61K45/06;;A61K9/0053;;A61K47/22;;A61K47/26;;A61K47/38;;A61K9/4866;;A61K31/355;;A61K31/635;;A61K31/77;;A61P25/28;;A61P35/00;;A61K31/353;;A61K31/4402;;A61K47/32;;A61K45/06;;A61K47/38;;A61K9/4866;;A61K47/26;;A61K31/355;;A61K9/0053;;A61K31/635;;A61K47/22;;A61K31/77;;A61P25/28;;A61P35/00;;A61K31/353;;A61K31/4402;;A61K47/32;;A61K2300/00,A61K31/47;;A61K31/435;;A61K31/4985;;A61K31/506;;A61K31/7034;;A61K45/06;;A61K47/34;;A61P25/00;;A61P25/08;;A61P35/00,,0,0,,,,PENDING
798,DK,T3,DK 2010102 T3,144-465-060-397-356,2019-09-16,2019,DK 07760577 T,2007-04-12,US 79155306 P;;US 79387906 P;;US 2007/0066546 W,2006-04-12,ANNULOPLASTIANORDNING MED EN SPIRALFORMET FORANKRING,,MEDTRONIC VASCULAR INC,RAFIEE NASSER;;BLOOM ELIOT;;FINNEY MICHAEL;;HOUSE MORGAN;;HUYNH RANY;;MAC DONALD STUART;;BARONE DAVID;;MAS JUAN-PABLO,,https://lens.org/144-465-060-397-356,Granted Patent,no,0,0,12,16,0,A61F2/2451;;A61F2/2451;;A61F2/2466,A61F2/24,,0,0,,,,ACTIVE
799,US,B1,US 10757491 B1,112-457-083-585-48X,2020-08-25,2020,US 201816055071 A,2018-08-04,US 201816055071 A;;US 201862683594 P,2018-06-11,Wearable interactive audio device,"Embodiments are directed to a wearable audio device, such as an earbud. The earbud may be configured to detect input using various sensors and structures. For example, the earbud may be configured to detect gestures, physical manipulations, and so forth performed along or on the earbud. In response to the detected inputs, the earbud may be configured to change various outputs, such as an audio output or a haptic output of the device. The earbud may also include a microphone to register voice commands. In some cases, the microphone may be used to control the earbud using the registered voice command in response to one or more detected gestures or physical manipulations.",APPLE INC,JACKSON BENJAMIN G;;BAUGH BRENTON A;;BLOOM DAVID H;;ROPER GEMMA A;;BARK KARLIN Y;;HULBERT THOMAS S,APPLE INC (2018-07-31),https://lens.org/112-457-083-585-48X,Granted Patent,yes,182,31,4,4,0,H04R1/1016;;H04R2201/107;;H04R2499/11;;H04R1/1041;;H04R2420/07;;G06F3/017;;G06F2203/0339;;G06F3/0362;;G06F3/165;;G06F3/167;;H04R1/02;;H04R1/1016;;G06F3/165;;G06F3/017;;G06F3/016;;H04R3/007,H04R1/00;;G06F3/01;;G06F3/16;;H04R1/02;;H04R1/10;;H04R3/00,,6,3,014-176-897-361-30X;;067-672-443-478-090;;081-604-401-565-375,10.1117/2.1201012.003407;;10.1145/286498.286717;;10.1063/1.4806974,"Valdes et al., “How Smart Watches Work,” https://electronics.howstuffworks.com/gadgets/clocks-watches/smart-watch2.htm, 10 pages, Apr. 2005.;;Baechtle et al., “Adjustable Audio Indicator,” IBM, 2 pages, Jul. 1, 1984.;;Blankenbach et al., “Bistable Electrowetting Displays,” https://spie.org/x43687.xml, 3 pages, Jan. 3, 2011.;;Enns, Neil, “Touchpad-Based Remote Control Devices,” University of Toronto, 1998.;;Pingali et al., “Audio-Visual Tracking for Natural Interactivity,” Bell Laboratories, Lucent Technologies, pp. 373-382, Oct. 1999.;;Zhou et al., “Electrostatic Graphene Loudspeaker,” Applied Physics Letters, vol. 102, No. 223109, 5 pages, Dec. 6, 2012.",ACTIVE
800,WO,A8,WO 2018/175793 A8,173-205-805-274-432,2019-10-31,2019,US 2018/0023863 W,2018-03-22,US 201815928797 A;;US 201815928828 A;;US 201762558992 P,2017-09-15,DISPENSING METER FOR FLUID DISPENSING,"A handheld fluid meter includes a cartridge valve controlling the flow of fluid through the handheld meter. The cartridge valve includes a valve cartridge and a valve stem disposed within the valve cartridge. The cartridge valve guides the valve stem and provides the only sealing surface for the dynamic seals and control seal disposed on the valve stem. The handheld meter dispenses through a nozzle, which includes an overmolded stem tip that generates a laminar fluid flow as the fluid exits the nozzle. The overmolded stem tip is a compliant material. The handheld fluid meter includes circuitry configured to invert the orientation of a visual output provided by a display of the handheld fluid meter to facilitate installation of the handheld fluid meter for use in an oil bar application.",GRACO MINNESOTA INC,BLOOM MICHAEL;;BAUCK MARK;;EBBEN JAMES;;HIGHLAND GLENN;;KAHLER BRADLEY;;KUSCHEL ANTHONY;;LORDEN DAVID;;NORMAN SHANE;;PAAR BENJAMIN,,https://lens.org/173-205-805-274-432,Amended Application,yes,0,0,3,69,0,B67D7/20;;B67D7/16;;B67D7/303;;B67D7/36;;B67D7/42;;B67D7/425;;B67D7/426;;B67D7/44;;B67D7/54,B67D7/16;;B67D7/36;;B67D7/42,,0,0,,,,PENDING
801,EP,A2,EP 2178518 A2,047-759-971-902-306,2010-04-28,2010,EP 08776343 A,2008-06-30,IB 2008001801 W;;US 94952507 P,2007-07-13,"NANOPARTICLES COMPRISING IONIZABLE, POORLY WATER SOLUBLE CELLULOSIC POLYMERS",,BEND RES INC,BLOOM COREY JAY;;CREW MARSHALL DAVID;;FRIESEN DWAYNE THOMAS;;MILLER WARREN KENYON;;MORGEN MICHAEL MARK;;SMITHEY DANIEL TOD,,https://lens.org/047-759-971-902-306,Patent Application,yes,0,0,4,4,0,A61K9/5161;;A61K9/5161;;A61K9/5192;;A61K9/5192;;A61K47/38;;A61K47/38;;A61P43/00,A61K9/51;;A61K47/38,,1,0,,,See references of WO 2009010842A3,DISCONTINUED
802,WO,A2,WO 2007/121314 A2,064-101-971-260-716,2007-10-25,2007,US 2007/0066546 W,2007-04-12,US 79155306 P;;US 79387906 P,2006-04-12,ANNULOPLASTY DEVICE HAVING A HELICAL ANCHOR AND METHODS FOR ITS USE,"A system for modifying a heart valve annulus includes a helically helical anchored annuloplasty device delivered to the annulus via an elongated delivery member. The helical anchors of the devices disclosed herein are rotated into the valve annulus along an anchor guide by using a driver that is movably disposed in the delivery member. A tether is disposed within an inner channel of the helical anchor and a locking device is used to secure the annuloplasty device after the valve annulus has been modified. The annuloplasty device can be delivered to the annulus using, traditional surgical approach or a minimally invasive or catheter based methods",MEDTRONIC VASCULAR INC;;DOUK NAREAK;;RAFIEE NASSER;;BLOOM ELIOT;;FINNEY MICHAEL;;HOUSE MORGAN;;HUYNH RANY;;MAC DONALD STUART;;MAS JUAN-PABLO;;BARONE DAVID,RAFIEE NASSER;;BLOOM ELIOT;;FINNEY MICHAEL;;HOUSE MORGAN;;HUYNH RANY;;MAC DONALD STUART;;MAS JUAN-PABLO;;BARONE DAVID,,https://lens.org/064-101-971-260-716,Patent Application,yes,0,47,12,16,0,A61F2/2451;;A61F2/2451;;A61F2/2466,A61F2/24,,0,0,,,,PENDING
803,US,A1,US 2016/0206817 A1,081-057-447-343-081,2016-07-21,2016,US 201614997254 A,2016-01-15,US 201614997254 A;;US 201213395627 A;;US 2010/0048489 W;;US 24137509 P;;US 24488409 P;;US 26733409 P;;US 29524710 P,2009-09-10,LOW PROFILE ACTUATOR AND IMPROVED METHOD OF CAREGIVER CONTROLLED ADMINISTRATION OF THERAPEUTICS,"A polymer actuator, power supply and method of using the activation are described.",MEDIPACS INC,BANISTER MARK P;;BLOOM WILLIAM G;;GERONOV YORDAN M;;MCWILLIAMS MARK D;;SWENSON DAVID;;VAN VEEN MARK A,,https://lens.org/081-057-447-343-081,Patent Application,yes,1,0,4,4,0,A61M5/1723;;A61M5/1723;;A61M5/14244;;A61M5/14244;;A61M5/148;;A61M5/148;;A61M2205/0272;;A61M2205/0272;;A61M2205/0277;;A61M2205/0277;;A61M2205/18;;A61M2205/502;;A61M2230/201;;A61M2230/202;;A61M2230/205;;A61M2230/30;;A61M2230/42,A61M5/172;;A61M5/142;;A61M5/148,,0,0,,,,DISCONTINUED
804,US,A1,US 2020/0048068 A1,088-868-110-595-308,2020-02-13,2020,US 201815777362 A,2018-03-22,US 201815777362 A;;US 201762558992 P;;US 2018/0023863 W;;US 201815928797 A;;US 201815928828 A,2017-09-15,DISPENSING METER FOR FLUID DISPENSING,"A handheld fluid meter includes a cartridge valve controlling the flow of fluid through the handheld meter. The cartridge valve includes a valve cartridge and a valve stem disposed within the valve cartridge. The cartridge valve guides the valve stem and provides the only sealing surface for the dynamic seals and control seal disposed on the valve stem. The handheld meter dispenses through a nozzle, which includes an overmolded stem tip that generates a laminar fluid flow as the fluid exits the nozzle. The overmolded stem tip is a compliant material. The handheld fluid meter includes circuitry configured to invert the orientation of a visual output provided by a display of the handheld fluid meter to facilitate installation of the handheld fluid meter for use in an oil bar application.",GRACO MINNESOTA INC,BLOOM MICHAEL E;;BAUCK MARK L;;EBBEN JAMES R;;LORDEN DAVID J;;KAHLER BRADLEY G;;KUSCHEL ANTHONY J,GRACO MINNESOTA INC (2018-05-14),https://lens.org/088-868-110-595-308,Patent Application,yes,0,4,20,69,0,G01F15/00;;G01F15/005;;G01F22/00;;B67D7/16;;G01F3/14;;B67D7/52;;B67D7/426;;G01F15/003;;B67D7/12;;B67D7/425;;B67D7/20;;B67D7/303;;B67D7/44;;B67D7/54;;F16K39/022;;F16K3/246;;B67D7/16;;B67D7/42;;B67D7/36;;B67D7/16;;B67D7/36;;B67D7/42;;B67D7/52;;B67D7/426;;G01F15/003;;B67D7/12;;B67D7/425;;G01F3/14;;B67D7/16;;B67D7/303;;B67D7/44;;F16K3/26;;F16K31/60,B67D7/16;;B67D7/30;;B67D7/42;;B67D7/44,,0,0,,,,ACTIVE
805,US,A1,US 2010/0215747 A1,084-782-380-989-814,2010-08-26,2010,US 45181308 A,2008-06-30,US 45181308 A;;US 94952507 P;;IB 2008001801 W,2007-07-13,"NANOPARTICLES COMPRISING IONIZABLE, POORLY WATER SOLUBLE CELLULOSIC POLYMERS","A pharmaceutical composition comprises nanoparticles comprising ionizable, poorly water soluble cellulosic polymers.",BLOOM COREY JAY;;CREW MARSHALL DAVID;;FRIESEN DWAYNE T;;MILLER WARREN KENYON;;MORGEN MICHAEL MARK;;SMITHEY DANIEL TOD,BLOOM COREY JAY;;CREW MARSHALL DAVID;;FRIESEN DWAYNE T;;MILLER WARREN KENYON;;MORGEN MICHAEL MARK;;SMITHEY DANIEL TOD,BEND RESEARCH INC (2008-11-03),https://lens.org/084-782-380-989-814,Patent Application,yes,100,3,4,4,0,A61K9/5161;;A61K9/5161;;A61K9/5192;;A61K9/5192;;A61K47/38;;A61K47/38;;A61P43/00,A61K9/14;;A61K47/34;;A61K47/38;;A61P43/00,424/487;;424/488;;424/499;;514/772.4;;514/781,1,1,063-416-990-191-007,10.1016/j.ijpharm.2004.11.010;;15814246,"Pinon-Segundo et al. (""Preparation and characterization of triclosan nanoparticles for periodontal treatment"" in International Journal of Pharmaceutics 294 (2005) 217-232).",DISCONTINUED
806,WO,A4,WO 2018/175793 A4,095-884-750-277-133,2018-11-29,2018,US 2018/0023863 W,2018-03-22,US 201815928797 A;;US 201815928828 A;;US 201762558992 P,2017-09-15,DISPENSING METER FOR FLUID DISPENSING,"A handheld fluid meter includes a cartridge valve controlling the flow of fluid through the handheld meter. The cartridge valve includes a valve cartridge and a valve stem disposed within the valve cartridge. The cartridge valve guides the valve stem and provides the only sealing surface for the dynamic seals and control seal disposed on the valve stem. The handheld meter dispenses through a nozzle, which includes an overmolded stem tip that generates a laminar fluid flow as the fluid exits the nozzle. The overmolded stem tip is a compliant material. The handheld fluid meter includes circuitry configured to invert the orientation of a visual output provided by a display of the handheld fluid meter to facilitate installation of the handheld fluid meter for use in an oil bar application.",GRACO MINNESOTA INC,BLOOM MICHAEL;;BAUCK MARK;;EBBEN JAMES;;HIGHLAND GLENN;;KAHLER BRADLEY;;KUSCHEL ANTHONY;;LORDEN DAVID;;NORMAN SHANE;;PAAR BENJAMIN,,https://lens.org/095-884-750-277-133,Patent Application,yes,0,0,3,69,0,B67D7/20;;B67D7/16;;B67D7/303;;B67D7/36;;B67D7/42;;B67D7/425;;B67D7/426;;B67D7/44;;B67D7/54,B67D7/16;;B67D7/36;;B67D7/42,,0,0,,,,PENDING
807,WO,A1,WO 2011/032011 A1,096-972-906-642-560,2011-03-17,2011,US 2010/0048489 W,2010-09-10,US 24137509 P;;US 24488409 P;;US 26733409 P;;US 29524710 P,2009-09-10,LOW PROFILE ACTUATOR AND IMPROVED METHOD OF CAREGIVER CONTROLLED ADMINISTRATION OF THERAPEUTICS,"A polymer actuator, power supply and method of using the activation are described.",MEDIPACS INC;;BANISTER MARK P;;BLOOM WILLIAM G;;GERONOV YORDAN M;;MCWILLIAMS MARK D;;SWENSON DAVID;;VAN VEEN MARK A,BANISTER MARK P;;BLOOM WILLIAM G;;GERONOV YORDAN M;;MCWILLIAMS MARK D;;SWENSON DAVID;;VAN VEEN MARK A,,https://lens.org/096-972-906-642-560,Patent Application,yes,5,4,4,4,0,A61M5/1723;;A61M5/1723;;A61M5/14244;;A61M5/14244;;A61M5/148;;A61M5/148;;A61M2205/0272;;A61M2205/0272;;A61M2205/0277;;A61M2205/0277;;A61M2205/18;;A61M2205/502;;A61M2230/201;;A61M2230/202;;A61M2230/205;;A61M2230/30;;A61M2230/42,A61M5/142,,0,0,,,,PENDING
808,WO,A2,WO 2008/065506 A2,185-117-407-527-006,2008-06-05,2008,IB 2007003632 W,2007-11-16,US 86766206 P,2006-11-29,PHARMACEUTICAL COMPOSITIONS COMPRISING NANOPARTICLES COMPRISING ENTERIC POLYMERS AND CASEIN,"A pharmaceutical composition comprises nanoparticles comprising the poorly water soluble lipophilic compound (2R)-3-[[3-(4-chloro-3-ethylphenoxy)phenyl][[3-(1,1,2,2- tetrafluoroethoxy)phenyl]methyl]amino]-1,1,1-trifluoro-2-propanol, and an enteric polymer.",PFIZER PROD INC;;BEYERINCK RONALD ARTHUR;;BLOOM COREY JAY;;CREW MARSHALL DAVID;;FRIESEN DWAYNE THOMAS;;MORGEN MICHAEL MARK;;SMITHEY DANIEL TOD,BEYERINCK RONALD ARTHUR;;BLOOM COREY JAY;;CREW MARSHALL DAVID;;FRIESEN DWAYNE THOMAS;;MORGEN MICHAEL MARK;;SMITHEY DANIEL TOD,,https://lens.org/185-117-407-527-006,Patent Application,yes,0,5,2,2,0,A61K31/135;;A61K9/5161;;A61K9/5169;;A61K9/5192,A61K9/16;;A61K9/50;;A61K9/51;;A61K31/135,,0,0,,,,PENDING
809,US,A1,US 2019/0231902 A1,139-093-165-085-548,2019-08-01,2019,US 201716312277 A,2017-06-21,US 201716312277 A;;US 201662353019 P;;US 2017/0038618 W,2016-06-21,METHOD FOR DELIVERING RNA TO NEURONS TO TREAT HERPES INFECTIONS,"Aspects of the application relate to methods and compositions for delivering therapeutic nucleic acids to neural cells or tissue in a subject. Additional aspects of the application relate to therapeutic nucleic acids, for example therapeutic ribozymes, that are useful for inhibiting viral reactivation in a subject.",UNIV FLORIDA;;BOARD OF SUPERVISORS OF LOUISIANA STATE UNIV & AGRICULTURAL & MECHANICAL COLLEGE,BLOOM DAVID C;;LEWIN ALFRED S;;NEUMANN DONNA M;;WATSON ZACHARY L;;TULI SONAL SANJEEV;;SCHULTZ GREGORY SCOTT,BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY & AGRICULTURAL & MECHANICAL COLLEGE (2018-02-23);;UNIVERSITY OF FLORIDA RESEARCH FOUNDATION INCORPORATED (2017-10-09),https://lens.org/139-093-165-085-548,Patent Application,yes,0,0,4,4,69,C12N15/1133;;C12N15/86;;C12N2310/121;;C12N2320/32;;C12N2310/20;;C12N2750/14122;;C12N2750/14143;;C12N2750/14145;;A61P31/22;;C12N15/1133;;C12N15/86;;C12N2750/14143;;C12N2310/121;;C12N2320/32;;C12N2310/20;;C12N2750/14122;;C12N2750/14145;;C12N15/861;;C12N2830/008;;A61P31/22;;A61K48/0091;;C12N5/062;;C12N2510/00,A61K48/00;;A61P31/22;;C12N5/0793;;C12N15/113;;C12N15/86,,0,0,,,,ACTIVE
810,US,A1,US 2020/0009118 A1,016-937-671-578-780,2020-01-09,2020,US 201916270022 A,2019-02-07,US 201916270022 A;;US 201715789243 A;;US 201662411512 P,2016-10-21,COMPOSITIONS AND METHODS FOR THE TREATMENTOF NEURODEGENERATIVE AND OTHER DISEASES,"In one embodiment, the present application discloses methods of treating diseases and disorders with sulfasalazine, an ABCG2 inhibitor and pharmaceutical formulations of sulfasalazine where the bioavailability of the sulfasalazine is increased. In another embodiment, the present application also provides dosing regimens for treating neurodegenerative diseases and disorders with compositions comprising sulfasalazine and an ABCG2 inhibitor.",GLIALOGIX INC,REEDER THADDEUS CROMWELL;;MOORE MARK W;;LYON DAVID K;;JAGER CASEY K;;LORENZ DOUG;;BLOOM COREY;;SHEPARD KIMBERLEY,BEND RESEARCH INC (2017-11-06);;GLIALOGIX INC (2017-11-01),https://lens.org/016-937-671-578-780,Patent Application,yes,0,0,4,4,0,A61K45/06;;A61K9/0053;;A61K47/22;;A61K47/26;;A61K47/38;;A61K9/4866;;A61K31/355;;A61K31/635;;A61K31/77;;A61P25/28;;A61P35/00;;A61K31/353;;A61K31/4402;;A61K47/32;;A61K45/06;;A61K47/38;;A61K9/4866;;A61K47/26;;A61K31/355;;A61K9/0053;;A61K31/635;;A61K47/22;;A61K31/77;;A61P25/28;;A61P35/00;;A61K31/353;;A61K31/4402;;A61K47/32;;A61K2300/00,A61K31/4402;;A61K31/353;;A61K47/32;;A61P25/28;;A61P35/00,,0,0,,,,DISCONTINUED
811,WO,A1,WO 2018/175793 A1,062-289-167-917-574,2018-09-27,2018,US 2018/0023863 W,2018-03-22,US 201815928797 A;;US 201815928828 A;;US 201762558992 P,2017-09-15,DISPENSING METER FOR FLUID DISPENSING,"A handheld fluid meter includes a cartridge valve controlling the flow of fluid through the handheld meter. The cartridge valve includes a valve cartridge and a valve stem disposed within the valve cartridge. The cartridge valve guides the valve stem and provides the only sealing surface for the dynamic seals and control seal disposed on the valve stem. The handheld meter dispenses through a nozzle, which includes an overmolded stem tip that generates a laminar fluid flow as the fluid exits the nozzle. The overmolded stem tip is a compliant material. The handheld fluid meter includes circuitry configured to invert the orientation of a visual output provided by a display of the handheld fluid meter to facilitate installation of the handheld fluid meter for use in an oil bar application.",GRACO MINNESOTA INC,BLOOM MICHAEL;;BAUCK MARK;;EBBEN JAMES;;HIGHLAND GLENN;;KAHLER BRADLEY;;KUSCHEL ANTHONY;;LORDEN DAVID;;NORMAN SHANE;;PAAR BENJAMIN,,https://lens.org/062-289-167-917-574,Patent Application,yes,7,3,3,69,0,B67D7/20;;B67D7/16;;B67D7/303;;B67D7/36;;B67D7/42;;B67D7/425;;B67D7/426;;B67D7/44;;B67D7/54,B67D7/16;;B67D7/36;;B67D7/42,,1,0,,,See also references of EP 3681839A4,PENDING
812,DE,T2,DE 69917673 T2,134-470-017-726-429,2005-06-09,2005,DE 69917673 T,1999-12-06,US 20890298 A;;US 9928839 W,1998-12-09,ALPHA-METHYLBENZYL-ENTHALTENDE THIOHARNSTOFFE ALS INHIBITOREN VON HERPES-VIREN MIT EINER PHENYLENEDIAMINGRUPPE,,WYETH CORP,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI JOSEPH;;DUSHIN GEORGE;;LANG ALBERT;;NORTON BOUCHER;;ROSS ANTONIA;;O'HARA MARK,,https://lens.org/134-470-017-726-429,Granted Patent,no,0,0,28,89,0,C07C335/20;;C07D215/48;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/20,A61K31/17;;A61K31/18;;A61K31/343;;A61K31/47;;A61K31/472;;A61K31/4725;;A61P31/22;;C07C335/20;;C07D215/48;;C07D215/50;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/79;;C07D307/81;;C07D307/85;;C07D405/12;;C07D407/12,,0,0,,,,EXPIRED
813,US,A1,US 2023/0345155 A1,175-199-368-110-644,2023-10-26,2023,US 202318218433 A,2023-07-05,US 202318218433 A;;US 202016927367 A;;US 201816055071 A;;US 201862683594 P,2018-06-11,WEARABLE INTERACTIVE AUDIO DEVICE,"Embodiments are directed to a wearable audio device, such as an earbud. The earbud may be configured to detect input using various sensors and structures. For example, the earbud may be configured to detect gestures, physical manipulations, and so forth performed along or on the earbud. In response to the detected inputs, the earbud may be configured to change various outputs, such as an audio output or a haptic output of the device. The earbud may also include a microphone to register voice commands. In some cases, the microphone may be used to control the earbud using the registered voice command in response to one or more detected gestures or physical manipulations.",APPLE INC,JACKSON BENJAMIN G;;BAUGH BRENTON A;;BLOOM DAVID H;;ROPER GEMMA A;;BARK KARLIN Y;;HULBERT THOMAS S,,https://lens.org/175-199-368-110-644,Patent Application,yes,0,1,4,4,0,H04R1/1016;;H04R2201/107;;H04R2499/11;;H04R1/1041;;H04R2420/07;;G06F3/017;;G06F2203/0339;;G06F3/0362;;G06F3/165;;G06F3/167;;H04R1/02;;H04R1/1016;;G06F3/165;;G06F3/017;;G06F3/016;;H04R3/007,G06F3/01;;H04R1/02;;G06F3/16;;H04R1/10;;H04R3/00,,0,0,,,,PENDING
814,WO,A2,WO 2009/010842 A2,019-938-240-763-670,2009-01-22,2009,IB 2008001801 W,2008-06-30,US 94952507 P,2007-07-13,"NANOPARTICLES COMPRISING IONIZABLE, POORLY WATER SOLUBLE CELLULOSIC POLYMERS","A pharmaceutical composition comprises nanoparticles comprising ionizable, poorly water soluble cellulosic polymers.",PFIZER PROD INC;;BLOOM COREY JAY;;CREW MARSHALL DAVID;;FRIESEN DWAYNE THOMAS;;MILLER WARREN KENYON;;MORGEN MICHAEL MARK;;SMITHEY DANIEL TOD,BLOOM COREY JAY;;CREW MARSHALL DAVID;;FRIESEN DWAYNE THOMAS;;MILLER WARREN KENYON;;MORGEN MICHAEL MARK;;SMITHEY DANIEL TOD,,https://lens.org/019-938-240-763-670,Patent Application,yes,0,11,4,4,0,A61K9/5161;;A61K9/5161;;A61K9/5192;;A61K9/5192;;A61K47/38;;A61K47/38;;A61P43/00,A61K9/51;;A61K47/38,,0,0,,,,PENDING
815,US,B2,US 11078069 B2,042-106-685-473-918,2021-08-03,2021,US 201815777362 A,2018-03-22,US 201815777362 A;;US 201762558992 P;;US 2018/0023863 W;;US 201815928797 A;;US 201815928828 A,2017-09-15,Dispensing meter for fluid dispensing,"A handheld fluid meter includes a cartridge valve controlling the flow of fluid through the handheld meter. The cartridge valve includes a valve cartridge and a valve stem disposed within the valve cartridge. The cartridge valve guides the valve stem and provides the only sealing surface for the dynamic seals and control seal disposed on the valve stem. The handheld meter dispenses through a nozzle, which includes an overmolded stem tip that generates a laminar fluid flow as the fluid exits the nozzle. The overmolded stem tip is a compliant material. The handheld fluid meter includes circuitry configured to invert the orientation of a visual output provided by a display of the handheld fluid meter to facilitate installation of the handheld fluid meter for use in an oil bar application.",GRACO MINNESOTA INC,BLOOM MICHAEL E;;BAUCK MARK L;;EBBEN JAMES R;;LORDEN DAVID J;;KAHLER BRADLEY G;;KUSCHEL ANTHONY J,GRACO MINNESOTA INC (2018-05-14),https://lens.org/042-106-685-473-918,Granted Patent,yes,57,1,20,69,0,G01F15/00;;G01F15/005;;G01F22/00;;B67D7/16;;G01F3/14;;B67D7/52;;B67D7/426;;G01F15/003;;B67D7/12;;B67D7/425;;B67D7/20;;B67D7/303;;B67D7/44;;B67D7/54;;F16K39/022;;F16K3/246;;B67D7/16;;B67D7/42;;B67D7/36;;B67D7/16;;B67D7/36;;B67D7/42;;B67D7/52;;B67D7/426;;G01F15/003;;B67D7/12;;B67D7/425;;G01F3/14;;B67D7/16;;B67D7/303;;B67D7/44;;F16K3/26;;F16K31/60,B67D7/16;;B67D7/12;;B67D7/30;;B67D7/42;;B67D7/44;;B67D7/52;;B67D7/60;;F16K3/26;;F16K31/60;;G01F3/14;;G01F15/00,,5,0,,,"International Search Report and Written Opinion for PCT Application No. PCT/US2018/023863, dated Aug. 31, 2018, 17 pages.;;International Preliminary Report on Patentability for PCT Application No. PCT/US2018/023863, dated Mar. 17, 2020, pp. 15.;;First Chinese Office Action for CN Application No. 201880026203.4, dated Nov. 16, 2020, pp. 20.;;Extended European Search Report for EP Application No. 18771643.6, dated Apr. 15, 2021, pp. 9.;;First Chinese Office Action for CN Application No. 20188004877.0, dated May 26, 2021, pp. 20.",ACTIVE
816,EP,A2,EP 2010102 A2,055-230-628-705-356,2009-01-07,2009,EP 07760577 A,2007-04-12,US 2007/0066546 W;;US 79155306 P;;US 79387906 P,2006-04-12,ANNULOPLASTY DEVICE HAVING A HELICAL ANCHOR,,MEDTRONIC VASCULAR INC;;DOUK NAREAK,RAFIEE NASSER;;BLOOM ELIOT;;FINNEY MICHAEL;;HOUSE MORGAN;;HUYNH RANY;;MAC DONALD STUART;;MAS JUAN-PABLO;;BARONE DAVID,"MEDTRONIC VASCULAR, INC. (2019-10-02);;MEDTRONIC VASCULAR, INC., SANTA ROSA, US (2019-10-09);;MEDTRONIC VASCULAR, INC., US (2019-12-23)",https://lens.org/055-230-628-705-356,Patent Application,yes,0,0,12,16,0,A61F2/2451;;A61F2/2451;;A61F2/2466,A61F2/24,,1,0,,,See references of WO 2007121314A3,ACTIVE
817,US,B1,US 10873798 B1,182-462-733-209-511,2020-12-22,2020,US 201816055068 A,2018-08-04,US 201816055068 A;;US 201862683571 P,2018-06-11,Detecting through-body inputs at a wearable audio device,"The present disclosure describes systems, devices, and techniques related to a wearable audio device, such as an earbud or other device that is configured to detect inputs and change the operation of the wearable audio device in accordance with the inputs. In some embodiments, the wearable audio device is disposed in a structure and detects signals propagating through or within the structure. Various inputs may cause one or more signals to propagate through or within the structure, outside the structure, or some combination thereof. The wearable audio device may determine whether a detected signal was generated by an input and, if so, change its operation in accordance with the input.",APPLE INC,JACKSON BENJAMIN G;;BAUGH BRENTON A;;BLOOM DAVID H;;ROPER GEMMA A;;BARK KARLIN Y;;HULBERT THOMAS S,APPLE INC (2018-07-31),https://lens.org/182-462-733-209-511,Granted Patent,yes,168,10,1,1,0,G06F3/017;;H04R1/1016;;H04R1/46;;H04R5/02;;H04R1/025;;H04R2225/61;;H04R2201/401;;H04R2420/07;;H04R1/1016;;H04R1/46;;G06F3/011;;G06F3/017,H04R5/033;;G06F3/01;;H04R1/10;;H04R1/46,,6,3,014-176-897-361-30X;;067-672-443-478-090;;081-604-401-565-375,10.1117/2.1201012.003407;;10.1145/286498.286717;;10.1063/1.4806974,"Valdes et al., “How Smart Watches Work,” https://electronics.howstuffworks.com/gadgets/clocks-watches/smart-watch2.htm, 10 pages, Apr. 2005.;;Baechtle et al., “Adjustable Audio Indicator,” IBM, 2 pages, Jul. 1, 1984.;;Blankenbach et al., “Bistable Electrowetting Displays,” https://spie.org/x43687.xml, 3 pages, Jan. 3, 2011.;;Enns, Neil, “Touchpad-Based Remote Control Devices,” University of Toronto, 1998.;;Pingali et al., “Audio-Visual Tracking for Natural Interactivity,” Bell Laboratories, Lucent Technologies, pp. 373-382, Oct. 1999.;;Zhou et al., “Electrostatic Graphene Loudspeaker,” Applied Physics Letters, vol. 102, No. 223109, 5 pages, Dec. 6, 2012.",ACTIVE
818,US,A1,US 2010/0062073 A1,189-334-164-812-326,2010-03-11,2010,US 31252507 A,2007-11-16,US 31252507 A;;US 86765106 P;;IB 2007003608 W,2006-11-29,PHARMACEUTICAL COMPOSITIONS COMPRISING NANOPARTICLES COMPRISING ENTERIC POLYMERS CASEIN,"A pharmaceutical composition comprises nanoparticles comprising a poorly water-soluble drug and an enteric polymer, and casein.",BEYERINCK RONALD ARTHUR;;BLOOM COREY JAY;;CREW MARSHALL DAVID;;FRIESEN DWAYNE THOMAS;;MORGEN MICHAEL MARK;;SMITHEY DANIEL TOD,BEYERINCK RONALD ARTHUR;;BLOOM COREY JAY;;CREW MARSHALL DAVID;;FRIESEN DWAYNE THOMAS;;MORGEN MICHAEL MARK;;SMITHEY DANIEL TOD,BEND RESEARCH INC (2008-11-03),https://lens.org/189-334-164-812-326,Patent Application,yes,107,12,4,4,0,A61K9/5161;;A61K9/5169;;A61K9/5192;;A61P29/00;;A61P3/06;;A61P43/00;;A61K9/5161;;A61K9/5169;;A61K9/5192,A61K9/51;;A61P43/00,424/491;;424/499,0,0,,,,DISCONTINUED
819,US,A1,US 2022/0380808 A1,021-100-392-962-380,2022-12-01,2022,US 202217738987 A,2022-05-06,US 202217738987 A;;US 201816312277 A;;US 2017/0038618 W;;US 201662353019 P,2016-06-21,METHOD FOR DELIVERING RNA TO NEURONS TO TREAT HERPES INFECTIONS,"Aspects of the application relate to methods and compositions for delivering therapeutic nucleic acids to neural cells or tissue in a subject. Additional aspects of the application relate to therapeutic nucleic acids, for example therapeutic ribozymes, that are useful for inhibiting viral reactivation in a subject.",UNIV FLORIDA;;BOARD OF SUPERVISORS OF LOUISIANA STATE UNIV & AGRICULTURAL & MECHANICAL COLLEGE,BLOOM DAVID C;;LEWIN ALFRED S;;NEWMANN DONNA M;;WATSON ZACHARY L;;TULI SONAL SANJEEV;;SCHULTZ GREGORY SCOTT,BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY & AGRICULTURAL & MECHANICAL COLLEGE (2018-02-23);;UNIVERSITY OF FLORIDA RESEARCH FOUNDATION INCORPORATED (2017-10-09),https://lens.org/021-100-392-962-380,Patent Application,yes,0,0,4,4,69,C12N15/1133;;C12N15/86;;C12N2310/121;;C12N2320/32;;C12N2310/20;;C12N2750/14122;;C12N2750/14143;;C12N2750/14145;;A61P31/22;;C12N15/1133;;C12N15/86;;C12N2750/14143;;C12N2310/121;;C12N2320/32;;C12N2310/20;;C12N2750/14122;;C12N2750/14145;;C12N15/861;;C12N2830/008;;A61P31/22;;A61K48/0091;;C12N5/062;;C12N2510/00,C12N15/861;;A61P31/22,,0,0,,,,PENDING
820,WO,A3,WO 2009/010842 A3,039-290-799-684-259,2009-03-12,2009,IB 2008001801 W,2008-06-30,US 94952507 P,2007-07-13,"NANOPARTICLES COMPRISING IONIZABLE, POORLY WATER SOLUBLE CELLULOSIC POLYMERS","A pharmaceutical composition comprises nanoparticles comprising ionizable, poorly water soluble cellulosic polymers.",PFIZER PROD INC;;BLOOM COREY JAY;;CREW MARSHALL DAVID;;FRIESEN DWAYNE THOMAS;;MILLER WARREN KENYON;;MORGEN MICHAEL MARK;;SMITHEY DANIEL TOD,BLOOM COREY JAY;;CREW MARSHALL DAVID;;FRIESEN DWAYNE THOMAS;;MILLER WARREN KENYON;;MORGEN MICHAEL MARK;;SMITHEY DANIEL TOD,,https://lens.org/039-290-799-684-259,Search Report,yes,1,0,4,4,0,A61K9/5161;;A61K9/5161;;A61K9/5192;;A61K9/5192;;A61K47/38;;A61K47/38;;A61P43/00,A61K9/51;;A61K47/38,,3,3,008-682-250-815-109;;063-416-990-191-007;;099-962-773-358-987,15920772;;10.1002/jps.20352;;10.1016/j.ijpharm.2004.11.010;;15814246;;11102685;;10.1016/s0168-3659(00)00334-5,"OLVERA-MARTÍNEZ BLANCA I ET AL: ""Preparation of polymeric nanocapsules containing octyl methoxycinnamate by the emulsification-diffusion technique: penetration across the stratum corneum."", JOURNAL OF PHARMACEUTICAL SCIENCES JUL 2005, vol. 94, no. 7, July 2005 (2005-07-01), pages 1552 - 1559, XP002504840, ISSN: 0022-3549;;PINON-SEGUNDO E ET AL: ""Preparation and characterization of triclosan nanoparticles for periodontal treatment"", INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER BV, NL, vol. 294, no. 1-2, 27 April 2005 (2005-04-27), pages 217 - 232, XP004825476, ISSN: 0378-5173;;STREUBEL A ET AL: ""Bimodal drug release achieved with multi-layer matrix tablets: transport mechanisms and device design"", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 69, no. 3, 3 December 2000 (2000-12-03), pages 455 - 468, XP004221295, ISSN: 0168-3659",PENDING
821,US,B2,US 11743623 B2,162-488-696-669-198,2023-08-29,2023,US 202016927367 A,2020-07-13,US 202016927367 A;;US 201816055071 A;;US 201862683594 P,2018-06-11,Wearable interactive audio device,"Embodiments are directed to a wearable audio device, such as an earbud. The earbud may be configured to detect input using various sensors and structures. For example, the earbud may be configured to detect gestures, physical manipulations, and so forth performed along or on the earbud. In response to the detected inputs, the earbud may be configured to change various outputs, such as an audio output or a haptic output of the device. The earbud may also include a microphone to register voice commands. In some cases, the microphone may be used to control the earbud using the registered voice command in response to one or more detected gestures or physical manipulations.",APPLE INC,JACKSON BENJAMIN G;;BAUGH BRENTON A;;BLOOM DAVID H;;ROPER GEMMA A;;BARK KARLIN Y;;HULBERT THOMAS S,,https://lens.org/162-488-696-669-198,Granted Patent,yes,216,4,4,4,0,H04R1/1016;;H04R2201/107;;H04R2499/11;;H04R1/1041;;H04R2420/07;;G06F3/017;;G06F2203/0339;;G06F3/0362;;G06F3/165;;G06F3/167;;H04R1/02;;H04R1/1016;;G06F3/165;;G06F3/017;;G06F3/016;;H04R3/007,H04R1/02;;G06F3/01;;G06F3/16;;H04R1/10;;H04R3/00,,7,3,014-176-897-361-30X;;067-672-443-478-090;;081-604-401-565-375,10.1117/2.1201012.003407;;10.1145/286498.286717;;10.1063/1.4806974,"Baechtle et al., “Adjustable Audio Indicator,” IBM, 2 pages, Jul. 1, 1984.;;Blankenbach et al., “Bistable Electrowetting Displays,” https://spie.org/x43687.xml, 3 pages, Jan. 3, 2011.;;Enns, Neil, “Touchpad-Based Remote Control Devices,” University of Toronto, 1998.;;Pingali et al., “Audio-Visual Tracking for Natural Interactivity,” Bell Laboratories, Lucent Technologies, pp. 373-382, Oct. 1999.;;Valdes et al., “How Smart Watches Work,” https://electronics.howstuffworks.com/gadgets/clocks-watches/smart-watch2.htm, 10 pages, Apr. 2005.;;Zhou et al., “Electrostatic Graphene Loudspeaker,” Applied Physics Letters, vol. 102, No. 223109, 5 pages, Dec. 6, 2012.;;Min-Soo, Kim, “Apple iPhone 12 ‘notch’ disappearing . . . New Face ID Test,” https://nocutnews.co.kr/news/5232116, 5 pages, Oct. 23, 2019.",ACTIVE
822,ES,T3,ES 2221470 T3,109-398-740-492-30X,2004-12-16,2004,ES 99963022 T,1999-12-06,US 20890298 A,1998-12-09,INHIBIDORES DE VIRUS HERPES DERIVADOS DE ALFA-METILBENCIL-TIOUREA QUE CONTIENEN UN GRUPO FENILENODIAMINA.,"Compuesto que presenta la **fórmula** en el que R1-R5 se seleccionan independientemente a partir de hidrógeno, alquilo de 1 a 6 átomos de carbono, alquenilo de 2 a 6 átomos de carbono, alquinilo de 2 a 6 átomos de carbono, perhaloalquilo de 1 a 6 átomos de carbono, cicloalquilo de 3 a 10 átomos de carbono, heterocicloalquilo de 3 a 10 miembros, arilo, heteroarilo, halógeno, -CN, -NO2, -CO2R6, -COR6, -OR6, -SR6, -SOR6, -SO2R6, -CONR7R8, -NR6N(R7R8), -N(R7R8) o -W-Y- (CH2)n-Z, con la salvedad de que por lo menos uno de R1-R5 no es hidrógeno ; o R2 y R3 o R3 y R4, forman juntos un heterocicloalquilo de 3 a 7 miembros o heteroarilo de 3 a 7 miembros; R6 y R7 son, independientemente, hidrógeno, alquilo de 1 a 6 átomos de carbono, perhaloalquilo de 1 a 6 átomos de carbono, o arilo; R8 es hidrógeno, alquilo de 1 a 6 átomos de carbono, perhaloalquilo de 1 a 6 átomos de carbono, cicloalquilo de 3 a 10 átomos de carbono, heterocicloalquilo de 3 a 10 miembros, arilo o heteroarilo, o R7 y R8, puedenformar juntos un heterocicloalquilo de 3 a 7 miembros; W es O, NR6, o está ausente; Y es -(CO)- o -(CO2)-, o está ausente; Z es alquilo de 1 a 4 átomos de carbono, -CN, -CO2R6, - COR6, -CONR7R8, -OCOR6, -NR6COR7, -OR6, -SR6, - SOR6, -SO2R6, -N(R7R8) o fenilo; G es fenilo opcionalmente sustituido con uno o más sustituyentes seleccionados a partir de alquilo de 1 a 6 átomos de carbono, alquenilo de 2 a 6 átomos de carbono, alquinilo de 2 a 6 átomos de carbono, perhaloalquilo de 1 a 6 átomos de carbono, cicloalquilo de 3 a 10 átomos de carbono, heterocicloalquilo de 3 a 10 miembros, arilo, heteroarilo, halógeno, -CN, -NO2, -CO2R6, -COR6, -OR6, -SR6, -SOR6, -SO2R6, - CONR7R8, -NR6N(R7R8), -N(R7R8) o -W-Y-(CH2)n-Z; o G es quinolilo, isoquinolilo o benzofuranilo; o una sal farmacéutica de los mismos.",WYETH CORP,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER,,https://lens.org/109-398-740-492-30X,Granted Patent,no,0,0,28,89,0,C07C335/20;;C07D215/48;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/20,A61K31/17;;A61K31/18;;A61K31/343;;A61K31/47;;A61K31/472;;A61K31/4725;;A61P31/22;;C07C335/20;;C07D215/48;;C07D215/50;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/79;;C07D307/81;;C07D307/85;;C07D405/12;;C07D407/12,,0,0,,,,EXPIRED
823,DE,D1,DE 69917673 D1,193-307-627-828-481,2004-07-01,2004,DE 69917673 T,1999-12-06,US 20890298 A;;US 9928839 W,1998-12-09,ALPHA-METHYLBENZYL-ENTHALTENDE THIOHARNSTOFFE ALS INHIBITOREN VON HERPES-VIREN MIT EINER PHENYLENEDIAMINGRUPPE,,WYETH CORP,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI JOSEPH;;DUSHIN GEORGE;;LANG ALBERT;;NORTON BOUCHER;;ROSS ANTONIA;;O'HARA MARK,,https://lens.org/193-307-627-828-481,Granted Patent,no,0,0,28,89,0,C07C335/20;;C07D215/48;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/20,A61K31/17;;A61K31/18;;A61K31/343;;A61K31/47;;A61K31/472;;A61K31/4725;;A61P31/22;;C07C335/20;;C07D215/48;;C07D215/50;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/79;;C07D307/81;;C07D307/85;;C07D405/12;;C07D407/12,,0,0,,,,EXPIRED
824,JP,A,JP 2008163009 A,155-960-165-965-038,2008-07-17,2008,JP 2007306852 A,2007-11-28,US 86765106 P,2006-11-29,PHARMACEUTICAL COMPOSITION COMPRISING NANOPARTICLES CONTAINING ENTERIC POLYMER AND CASEIN,"<P>PROBLEM TO BE SOLVED: To provide a composition comprising nanoparticles containing a poorly water-soluble drug and an enteric polymer, and a casein or a pharmaceutically acceptable form thereof. <P>SOLUTION: The method provides a solid pharmaceutical composition comprising (a) nanoparticles 12 containing a poorly water-soluble drug and an enteric polymer in which (i) the poorly water-soluble drug has a solubility in water of <5 mg/mL at a pH ranging 6.5-7.5, (ii) at least 90 wt.% of the drug in the nanoparticles is in a noncrystalline form, (iii) the nanoparticles have an average size of <500 nm, and (iv) the mass ratio between the poorly water-soluble drug and the enteric polymer of <9:1, and (b) casein 16 or a pharmaceutically acceptable form thereof, wherein the mass ratio between (1) the casein and (2) the poorly water-soluble drug and the enteric polymer in total is at least 1:20. <P>COPYRIGHT: (C)2008,JPO&INPIT",PFIZER PROD INC,BEYERINCK RONALD ARTHUR;;BLOOM COREY JAY;;CREW MARSHALL DAVID;;FRIESEN DWAYNE THOMAS;;MORGEN MICHAEL MARK;;SMITHEY DANIEL TOD,,https://lens.org/155-960-165-965-038,Patent Application,no,0,5,4,4,0,A61K9/5161;;A61K9/5169;;A61K9/5192;;A61P29/00;;A61P3/06;;A61P43/00;;A61K9/5161;;A61K9/5169;;A61K9/5192,A61K9/51;;A61K9/26;;A61K31/137;;A61K31/63;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/32;;A61K47/34;;A61K47/38;;A61K47/42;;A61P3/06;;A61P29/00,,0,0,,,,PENDING
825,WO,A1,WO 2010/102065 A1,030-621-127-566-408,2010-09-10,2010,US 2010/0026127 W,2010-03-03,US 15785409 P;;US 17869009 P,2009-03-05,PHARMACEUTICAL COMPOSITIONS OF DEXTRAN POLYMER DERIVATIVES,"Pharmaceutical compositions are provided comprising an active agent and a dextran polymer derivative. The compositions include from 0.01 to 99 wt% of an active agent and from 1 to 99.99 wt% of a dextran polymer derivative. The dextran polymer derivative is selected from dextran acetate, dextran propionate, dextran succinate, dextran acetate propionate, dextran acetate succinate, dextran propionate succinate, dextran acetate propionate succinate, and mixtures thereof.",BEND RES INC;;MILLER WARREN K;;VODAK DAVID T;;DOBRY DANEIL E;;LYON DAVID K;;FRIESEN DWAYNE T;;MORGEN MICHAEL M;;BLOOM COREY J;;SMITHEY DANIEL T,MILLER WARREN K;;VODAK DAVID T;;DOBRY DANEIL E;;LYON DAVID K;;FRIESEN DWAYNE T;;MORGEN MICHAEL M;;BLOOM COREY J;;SMITHEY DANIEL T,,https://lens.org/030-621-127-566-408,Patent Application,yes,6,12,6,6,0,A61K47/36;;A61K47/36;;A61K9/0019;;A61K9/0019;;A61K9/0048;;A61K9/0048;;A61K9/0075;;A61K9/0075;;A61K9/0095;;A61K9/0095;;A61K9/10;;A61K9/10;;A61K9/1652;;A61K9/1652;;A61K9/19;;A61K9/19;;A61K9/5161;;A61K9/5161;;A61K31/57;;A61K31/57;;A61P7/00;;A61P9/10;;A61P9/12;;A61P11/00;;A61P25/00;;A61P29/00,A61K9/00;;A61K47/36,,2,1,070-572-015-994-048,18360445;;10.1364/ao.40.004087,"""Advances in Polymer Science, 205, Polysaccharides II"", vol. 205, 2006, SPRINGCR-VCRLAG;;B.J. FISKEN: ""Revisiting the method of cumulants for the analysis of dynamic light- scattering data"", APPLIED OPTICS, vol. 40, no. 24, 2001, pages 4087 - 4091",PENDING
826,US,B2,US 8685458 B2,184-569-617-581-618,2014-04-01,2014,US 201013254802 A,2010-03-03,US 201013254802 A;;US 15785409 P;;US 17869009 P;;US 2010/0026127 W,2009-03-05,Pharmaceutical compositions of dextran polymer derivatives,"Pharmaceutical compositions are provided comprising an active agent and a dextran polymer derivative. The compositions include from 0.01 to 99 wt % of an active agent and from 1 to 99.99 wt % of a dextran polymer derivative. The dextran polymer derivative is selected from dextran acetate, dextran propionate, dextran succinate, dextran acetate propionate, dextran acetate succinate, dextran propionate succinate, dextran acetate propionate succinate, and mixtures thereof.",MILLER WARREN K;;VODAK DAVID T;;DOBRY DANIEL E;;LYON DAVID K;;FRIESEN DWAYNE T;;MORGEN MICHAEL M;;BLOOM COREY J;;SMITHEY DANIEL T;;BEND RES INC,MILLER WARREN K;;VODAK DAVID T;;DOBRY DANIEL E;;LYON DAVID K;;FRIESEN DWAYNE T;;MORGEN MICHAEL M;;BLOOM COREY J;;SMITHEY DANIEL T,BEND RESEARCH INC (2010-03-11),https://lens.org/184-569-617-581-618,Granted Patent,yes,101,17,6,6,0,A61K47/36;;A61K47/36;;A61K9/0019;;A61K9/0019;;A61K9/0048;;A61K9/0048;;A61K9/0075;;A61K9/0075;;A61K9/0095;;A61K9/0095;;A61K9/10;;A61K9/10;;A61K9/1652;;A61K9/1652;;A61K9/19;;A61K9/19;;A61K9/5161;;A61K9/5161;;A61K31/57;;A61K31/57;;A61P7/00;;A61P9/10;;A61P9/12;;A61P11/00;;A61P25/00;;A61P29/00,A61P11/00;;A61K9/14;;A61K31/721;;B82Y5/00,424/489,17,13,011-062-730-311-47X;;017-937-363-784-992;;010-788-091-785-308;;036-615-972-601-044;;026-102-898-190-657;;037-950-455-763-306;;020-377-232-230-338;;025-099-322-155-866;;143-826-372-104-916;;030-291-663-197-117;;044-121-854-173-587;;045-193-210-388-530;;025-724-390-846-395,10.1016/j.carbpol.2006.12.007;;10.1007/s11095-006-9174-3;;17245651;;10.1007/12_100;;10.1023/a:1011916930655;;9833998;;16118015;;10.1016/j.biomaterials.2005.04.041;;16045324;;10.1021/ja052594h;;10.1248/yakushi1947.115.9_732;;8523267;;10.1016/j.carres.2009.04.026;;19539898;;10.1002/jps.10274;;12486680;;14706257;;10.1016/j.ijpharm.2003.09.041;;12637093;;10.1016/s0939-6411(02)00168-6;;10.1016/s0378-5173(03)00153-4;;12753754;;10.1007/bf02447862,"Stephanie Hornig and Thomas Heinze. Nanoscale structures of dextran esters. Carbohydrate Polymers 68 (2007) 280-286.;;Albert H. L. Chow, Henry H. Y. Tong, Pratibhash Chattopadhyay, and Boris Y. Shekunov. Particle Engineering for Pulmonary Drug Delivery. Pharmaceutical Research, vol. 24, No. 3, Mar. 2007, pp. 411-437.;;US 5,849,884, 12/1998, Woiszwillo et al. (withdrawn).;;Heinze et al., ""Functional Polymers Based on Dextran,"" Advances in Polymer Science, vol. 205, pp. 199-291 (Sep. 2006).;;International Search Report and Written Opinion for PCT/US2011/040222, filed Jun. 13, 2011 (mailed Dec. 6, 2011).;;Kawashima et al., ""A New Powder Design Method to Improve Inhalation Efficiency of Pranlukast Hydrate Dry Powder Aerosols by Surface Modification with Hydroxypropylmethylcellulose Phthalate Nanospheres,"" Pharmaceutical Research, vol. 15, No. 11, pp. 1748-1752 (Nov. 1998).;;Lemarchand et al., ""Influence of polysaccharide coating on the interactions of nanoparticles with biological systems,"" Biomaterials, vol. 27, Issue 1, pp. 108-118 (Jan. 2006).;;Liebert et al., ""Nanoparticles on the Basis of Highly Functionalized Dextrans,"" Journal of the American Chemical Society, vol. 127, No. 30, pp. 10484-10485 (Aug. 2005).;;Niwa et al., ""Aerosolization of Lactide/Glycolide Copolymer (PLGA) Nanospheres for Pulmonary Delivery of Peptide-drugs,"" Yakugaku Zasshi Journal of the Pharmaceutical Society of Japan, vol. 115, No. 9, pp. 732-741 (Sep. 1995).;;Prado et al., ""Preparation and characterization of a novel starch-based interpolyelectrolyte complex as matrix for controlled drug release,"" Carbohydrate Research, vol. 344, No. 11, pp. 1325-1331 (Jul. 2009).;;Rasenack et al., ""Micronization of Anti-Inflammatory Drugs for Pulmonary Delivery by a Controlled Crystallization Process,"" Journal of Pharmaceutical Sciences, vol. 92, No. 1, pp. 35-44 (Jan. 2003).;;Sham et al., ""Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung,"" International Journal of Pharmaceutics, vol. 269, Issue 2, pp. 457-467 (Jan. 2004).;;Steckel et al., ""In-situ-micronization of disodium cromoglycate for pulmonary delivery,"" European Journal of Pharmaceutics and Biopharmaceutics, vol. 55, No. 2, pp. 173-180 (Mar. 2003).;;Steckel et al., ""In vitro characterization of jet-milled and in-situ-micronized fluticasone-17-propionate,"" International Journal of Pharmaceutics, vol. 258, Issues 1-2, pp. 65-75 (Jun. 2003).;;Yamamoto et al., ""Poly(lactic-co-glycolic acid) Nanosphere Composite Prepared with Mechanofusion Dry Powder Composition System for Improving Pulmonary Insulin Delivery with Dry Powder Inhalation,"" Journal of Pharmaceutical Science and Technology, Japan, vol. 64, No. 4, pp. 245-253 (Jan. 2004).;;International Search Report and Written Opinion, dated Feb. 22, 2011, issued in related International Application No. PCT/US2010/056515.;;Cruz, et al.,, ""Peptide Synthesis Containing a B-Cell and a T-Cell Epitope on Dextran Beads and Evaluation of Humoral Response Against Bead-Peptide Construct,"" Letters in Peptide Science, 7: 229-237, 2000.",INACTIVE
827,US,A1,US 2012/0003282 A1,027-252-652-555-45X,2012-01-05,2012,US 201013254802 A,2010-03-03,US 201013254802 A;;US 15785409 P;;US 17869009 P;;US 2010/0026127 W,2009-03-05,PHARMACEUTICAL COMPOSITIONS OF DEXTRAN POLYMER DERIVATIVES,"Pharmaceutical compositions are provided comprising an active agent and a dextran polymer derivative. The compositions include from 0.01 to 99 wt % of an active agent and from 1 to 99.99 wt % of a dextran polymer derivative. The dextran polymer derivative is selected from dextran acetate, dextran propionate, dextran succinate, dextran acetate propionate, dextran acetate succinate, dextran propionate succinate, dextran acetate propionate succinate, and mixtures thereof.",MILLER WARREN K;;VODAK DAVID T;;DOBRY DANIEL E;;LYON DAVID K;;FRIESEN DWAYNE T;;MORGEN MICHAEL M;;BLOOM COREY J;;SMITHEY DANIEL T,MILLER WARREN K;;VODAK DAVID T;;DOBRY DANIEL E;;LYON DAVID K;;FRIESEN DWAYNE T;;MORGEN MICHAEL M;;BLOOM COREY J;;SMITHEY DANIEL T,BEND RESEARCH INC (2010-03-11),https://lens.org/027-252-652-555-45X,Patent Application,yes,2,1,6,6,0,A61K47/36;;A61K47/36;;A61K9/0019;;A61K9/0019;;A61K9/0048;;A61K9/0048;;A61K9/0075;;A61K9/0075;;A61K9/0095;;A61K9/0095;;A61K9/10;;A61K9/10;;A61K9/1652;;A61K9/1652;;A61K9/19;;A61K9/19;;A61K9/5161;;A61K9/5161;;A61K31/57;;A61K31/57;;A61P7/00;;A61P9/10;;A61P9/12;;A61P11/00;;A61P25/00;;A61P29/00,A61K9/14;;A61K31/216;;A61K31/428;;A61K31/56;;A61P7/00;;A61P9/10;;A61P9/12;;A61P25/00;;A61P29/00;;B82Y5/00,424/400;;514/180;;514/545;;514/367;;977/773,2,2,011-062-730-311-47X;;017-937-363-784-992,10.1016/j.carbpol.2006.12.007;;10.1007/s11095-006-9174-3;;17245651,"Stephanie Hornig and Thomas Heinze. Nanoscale structures of dextran esters. Carbohydrate Polymers 68 (2007) 280-286.;;Albert H. L. Chow, Henry H. Y. Tong, Pratibhash Chattopadhyay, and Boris Y. Shekunov. Particle Engineering for Pulmonary Drug Delivery. Pharmaceutical Research, Vol. 24, No. 3, March 2007, pages 411-437.",INACTIVE
828,EP,A4,EP 1259772 A4,095-270-853-333-808,2008-01-02,2008,EP 01906935 A,2001-02-02,US 0103492 W;;US 17966400 P,2000-02-02,MODULAR FURNACE SYSTEM,,BTU INT,BLOOM DAVID;;BOUCHARD ROBERT;;HARVEY DAVID S;;NEILEY GEOFFREY C III;;SECCOMBE DONALD A JR;;WONG TERRANCE;;TARCZON RICHARD;;PARROTT STEPHEN J;;EDGINGTON PAUL,,https://lens.org/095-270-853-333-808,Search Report,no,1,0,9,9,0,B23K1/008;;B23K1/012;;F27B9/029;;F27B9/10;;F27B9/3011;;F27D17/004;;F27D2007/045;;B23K2101/40;;B23K1/012;;F27D17/004;;F27B9/029;;F27D2007/045;;F27B9/10;;B23K1/008;;F27B9/3011;;B23K2101/40,B23K1/008;;B23K1/012;;F27B9/02;;F27B9/10;;F27B9/30;;F27D7/04;;F27D17/00,,0,0,,,,EXPIRED
829,US,A1,US 2014/0161895 A1,122-116-453-219-397,2014-06-12,2014,US 201414179480 A,2014-02-12,US 201414179480 A;;US 201113254802 A;;US 2010/0026127 W;;US 15785409 P;;US 17869009 P,2009-03-05,PHARMACEUTICAL COMPOSITIONS OF DEXTRAN POLYMER DERIVATIVES,"Pharmaceutical compositions are provided comprising an active agent and a dextran polymer derivative. The compositions include from 0.01 to 99 wt % of an active agent and from 1 to 99.99 wt % of a dextran polymer derivative. The dextran polymer derivative is selected from dextran acetate, dextran propionate, dextran succinate, dextran acetate propionate, dextran acetate succinate, dextran propionate succinate, dextran acetate propionate succinate, and mixtures thereof.",BEND RES INC,MILLER WARREN K;;VODAK DAVID T;;DOBRY DANIEL E;;LYON DAVID K;;FRIESEN DWAYNE T;;MORGEN MICHAEL M;;BLOOM COREY J;;SMITHEY DANIEL T,BEND RESEARCH INC (2010-03-11),https://lens.org/122-116-453-219-397,Patent Application,yes,7,1,6,6,0,A61K47/36;;A61K47/36;;A61K9/0019;;A61K9/0019;;A61K9/0048;;A61K9/0048;;A61K9/0075;;A61K9/0075;;A61K9/0095;;A61K9/0095;;A61K9/10;;A61K9/10;;A61K9/1652;;A61K9/1652;;A61K9/19;;A61K9/19;;A61K9/5161;;A61K9/5161;;A61K31/57;;A61K31/57;;A61P7/00;;A61P9/10;;A61P9/12;;A61P11/00;;A61P25/00;;A61P29/00,A61K47/36,424/499;;514/777,0,0,,,,INACTIVE
830,WO,A1,WO 2019/232218 A1,150-301-474-887-933,2019-12-05,2019,US 2019/0034664 W,2019-05-30,US 201862677800 P,2018-05-30,SCREENING ASSAY TO ASSESS TOPICAL DELIVERY OF BIOLOGICAL THERAPEUTIC AGENTS,"An in vivo assay to evaluate topical delivery of a biologic agent from a formulation is provided. The assay comprises treating a skin area of a CD hairless rat with tape stripping to disrupt the stratum corneum in the skin area to define a treated skin area and topically applying a formulation to the treated skin area. The formulation, in one embodiment, comprises the biologic agent and a pharmaceutically acceptable carrier. Delivery of the biologic agent into the skin from the topically applied formulation is evaluated via in vitro or in vivo techniques.",ALLERGAN INC,SHEN JIE;;HO HSIANG;;ANDREWS-JONES LYDIA;;BLOOM BETSY;;NICHOLSON GREGORY;;STEWARD LANCE;;BRIDEAU-ANDERSEN AMY;;HUNT TERRENCE;;BROIDE RON;;RUPP DAVID;;CANTY DAVID,,https://lens.org/150-301-474-887-933,Patent Application,yes,5,0,3,3,0,A61K9/0014;;A61K49/0008;;A61K9/0014;;A61K49/0008;;C12Y304/24069;;C12Y304/24069;;G01N33/5082;;G01N33/5082,A61K9/00;;A61K38/48,,6,6,007-052-265-927-303;;052-484-294-634-818;;031-618-588-237-817;;066-888-092-961-211;;074-567-780-858-288;;136-109-389-680-826,16597490;;10.1016/j.ijpharm.2006.02.046;;10.1034/j.1600-0846.2001.007001040.x;;11301640;;2886592;;10.1111/j.2042-7158.1987.tb03407.x;;23707612;;10.1016/j.toxicon.2013.05.004;;10.3390/toxins7072354;;pmc4516917;;26114335;;28389376;;10.1016/j.neuroscience.2017.03.049,"WU X M ET AL: ""Effects of pretreatment of needle puncture and sandpaper abrasion on the in vitro skin permeation of fluorescein isothiocyanate (FITC)-dextran"", INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER, NL, vol. 316, no. 1-2, 19 June 2006 (2006-06-19), pages 102 - 108, XP027972417, ISSN: 0378-5173, [retrieved on 20060619];;SAQIB J. BASHIR ET AL: ""Physical and physiological effects of stratum corneum tape stripping"", SKIN RESEARCH AND TECHNOLOGY, vol. 7, no. 1, 1 February 2001 (2001-02-01), DK, pages 40 - 48, XP055618475, ISSN: 0909-752X, DOI: 10.1034/j.1600-0846.2001.007001040.x;;AKIRA KATO ET AL: ""Effect of egg yolk lecithin on transdermal delivery of bunazosin hydrochloride"", JOURNAL OF PHARMACY AND PHARMACOLOGY, vol. 39, no. 5, 1 May 1987 (1987-05-01), LONDON; GB, pages 399 - 400, XP055618605, ISSN: 0022-3573, DOI: 10.1111/j.2042-7158.1987.tb03407.x;;BROIDE, R.S. ET AL., TOXICON, vol. 71, 2013, pages 18 - 24;;RHEAUME, C. ET AL., TOXINS (BASEL), vol. 7, no. 7, 2015, pages 2354 - 2370;;CAI, B.B. ET AL., NEUROSCIENCE, vol. 352, 2017, pages 155 - 169",PENDING
831,EP,A1,EP 1259772 A1,183-852-174-041-520,2002-11-27,2002,EP 01906935 A,2001-02-02,US 0103492 W;;US 17966400 P,2000-02-02,MODULAR FURNACE SYSTEM,,BTU INT,BLOOM DAVID;;BOUCHARD ROBERT;;HARVEY DAVID S;;NEILEY GEOFFREY C III;;SECCOMBE DONALD A JR;;WONG TERRANCE;;TARCZON RICHARD;;PARROTT STEPHEN J;;EDGINGTON PAUL,,https://lens.org/183-852-174-041-520,Patent Application,yes,0,0,9,9,0,B23K1/008;;B23K1/012;;F27B9/029;;F27B9/10;;F27B9/3011;;F27D17/004;;F27D2007/045;;B23K2101/40;;B23K1/012;;F27D17/004;;F27B9/029;;F27D2007/045;;F27B9/10;;B23K1/008;;F27B9/3011;;B23K2101/40,B23K1/008;;B23K1/012;;F27B9/02;;F27B9/10;;F27B9/30;;F27D7/04;;F27D17/00,,0,0,,,,EXPIRED
832,US,B2,US 9757464 B2,061-111-792-030-448,2017-09-12,2017,US 201414179480 A,2014-02-12,US 201414179480 A;;US 201113254802 A;;US 2010/0026127 W;;US 15785409 P;;US 17869009 P,2009-03-05,Pharmaceutical compositions of dextran polymer derivatives,"Pharmaceutical compositions are provided comprising an active agent and a dextran polymer derivative. The compositions include from 0.01 to 99 wt % of an active agent and from 1 to 99.99 wt % of a dextran polymer derivative. The dextran polymer derivative is selected from dextran acetate, dextran propionate, dextran succinate, dextran acetate propionate, dextran acetate succinate, dextran propionate succinate, dextran acetate propionate succinate, and mixtures thereof.",BEND RES INC,MILLER WARREN K;;VODAK DAVID T;;DOBRY DANIEL E;;LYON DAVID K;;FRIESEN DWAYNE T;;MORGEN MICHAEL M;;BLOOM COREY J;;SMITHEY DANIEL T,BEND RESEARCH INC (2010-03-11),https://lens.org/061-111-792-030-448,Granted Patent,yes,166,0,6,6,0,A61K47/36;;A61K47/36;;A61K9/0019;;A61K9/0019;;A61K9/0048;;A61K9/0048;;A61K9/0075;;A61K9/0075;;A61K9/0095;;A61K9/0095;;A61K9/10;;A61K9/10;;A61K9/1652;;A61K9/1652;;A61K9/19;;A61K9/19;;A61K9/5161;;A61K9/5161;;A61K31/57;;A61K31/57;;A61P7/00;;A61P9/10;;A61P9/12;;A61P11/00;;A61P25/00;;A61P29/00,A61K47/36;;A61K9/00;;A61K9/10;;A61K9/16;;A61K9/19;;A61K9/51;;A61K31/57,,17,13,017-937-363-784-992;;025-724-390-846-395;;010-788-091-785-308;;011-062-730-311-47X;;036-615-972-601-044;;026-102-898-190-657;;037-950-455-763-306;;020-377-232-230-338;;025-099-322-155-866;;143-826-372-104-916;;030-291-663-197-117;;044-121-854-173-587;;045-193-210-388-530,10.1007/s11095-006-9174-3;;17245651;;10.1007/bf02447862;;10.1007/12_100;;10.1016/j.carbpol.2006.12.007;;10.1023/a:1011916930655;;9833998;;16118015;;10.1016/j.biomaterials.2005.04.041;;16045324;;10.1021/ja052594h;;10.1248/yakushi1947.115.9_732;;8523267;;10.1016/j.carres.2009.04.026;;19539898;;10.1002/jps.10274;;12486680;;14706257;;10.1016/j.ijpharm.2003.09.041;;12637093;;10.1016/s0939-6411(02)00168-6;;10.1016/s0378-5173(03)00153-4;;12753754,"US 5,849,884, 12/1998, Woiszwillo et al. (withdrawn);;International Search Report and Written Opinion, dated Feb. 22, 2011, issued in related International Application No. PCT/US2010/056515.;;International Search Report and Written Opinion, dated Dec. 6, 2011, issued in related International Application No. PCT/2011/040222.;;Chow, et al., “Particle Engineering for Pulmonary Drug Delivery,” Phamaceutical Research, vol. 24, No. 3, pp. 411-437 (Mar. 2007).;;Cruz, et al., “Peptide Synthesis Containing a B-Cell and a T-Cell Epitope on Dextran Beads and Evaluation of Humoral Response Against Bead-Peptide Construct,” Letters in Peptide Science, 7: 229-237, 2000.;;Heinze et al., “Functional Polymers Based on Dextran,” Advances in Polymer Science, vol. 205, pp. 199-291 (Sep. 2006).;;Hornig, et al., “Nanoscale Structures of Dextran Esters,” Carbohydrate Polymers, vol. 68, pp. 280-286 (2007).;;Kawashima et al., “A New Powder Design Method to Improve Inhalation Efficiency of Pranlukast Hydrate Dry Powder Aerosols by Surface Modification with Hydroxypropylmethylcellulose Phthalate Nanospheres,” Pharmaceutical Research, vol. 15, No. 11, pp. 1748-1752 (Nov. 1998).;;Lemarchand et al., “Influence of polysaccharide coating on the interactions of nanoparticles with biological systems,” Biomaterials, vol. 27, Issue 1, pp. 108-118 (Jan. 2006).;;Liebert et al., “Nanoparticles on the Basis of Highly Functionalized Dextrans,” Journal of the American Chemical Society, vol. 127, No. 30, pp. 10484-10485 (Aug. 2005).;;Niwa et al., “Aerosolization of Lactide/Glycolide Copolymer (PLGA) Nanospheres for Pulmonary Delivery of Peptide-drugs,” Yakugaku Zasshi Journal of the Pharmaceutical Society of Japan, vol. 115, No. 9, pp. 732-741 (Sep. 1995).;;Prado et al., “Preparation and characterization of a novel starch-based interpolyelectrolyte complex as matrix for controlled drug release,” Carbohydrate Research, vol. 344, No. 11, pp. 1325-1331 (Jul. 2009).;;Rasenack et al., “Micronization of Anti-Inflammatory Drugs for Pulmonary Delivery by a Controlled Crystallization Process,” Journal of Pharmaceutical Sciences, vol. 92, No. 1, pp. 35-44 (Jan. 2003).;;Sham et al., “Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung,” International Journal of Pharmaceutics, vol. 269, Issue 2, pp. 457-467 (Jan. 2004).;;Steckel et al., “In-situ-micronization of disodium cromoglycate for pulmonary delivery,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 55, No. 2, pp. 173-180 (Mar. 2003).;;Steckel et al., “In vitro characterization of jet-milled and in-situ-micronized fluticasone-17-propionate,” International Journal of Pharmaceutics, vol. 258, Issues 1-2, pp. 65-75 (Jun. 2003).;;Yamamoto et al., “Poly(lactic-co-glycolic acid) Nanosphere Composite Prepared with Mechanofusion Dry Powder Composition System for Improving Pulmonary Insulin Delivery with Dry Powder Inhalation,” Journal of Pharmaceutical Science and Technology, Japan, vol. 64, No. 4, pp. 245-253 (Jan. 2004).",INACTIVE
833,US,B2,US 6394794 B2,118-940-616-016-203,2002-05-28,2002,US 77897601 A,2001-02-02,US 77897601 A;;US 17966400 P,2000-02-02,Modular furnace system,"
    A modular furnace is fabricated from at least one module having a frame, a removable cover mounted to the frame, exterior cover panels on the frame, and an insulated case fastened to the interior of the module. A conveyor assembly extends through the module. A plurality of process zones, such as heating and cooling zones, are disposed within the module. Field replaceable universal blower assemblies are associated with each process zone. The motor shaft in each blower assembly is provided with a sealed bearing in the motor housing. Insulation within each module is held in place by gas permeable fabric covering large vent openings in cover panels to allow oxygen to diffuse out of the insulation rapidly upon start up. 
",BTU INT,BLOOM DAVID;;BOUCHARD ROBERT;;HARVEY DAVID S;;NEILEY III GEOFFREY C;;SECCOMBE JR DONALD A;;WONG TERRANCE;;TARCZON RICHARD;;PARROTT STEPHEN J;;EDGINGTON PAUL,BTU INTERNATIONAL INC (2001-02-14),https://lens.org/118-940-616-016-203,Granted Patent,yes,7,15,9,9,0,B23K1/008;;B23K1/012;;F27B9/029;;F27B9/10;;F27B9/3011;;F27D17/004;;F27D2007/045;;B23K2101/40;;B23K1/012;;F27D17/004;;F27B9/029;;F27D2007/045;;F27B9/10;;B23K1/008;;F27B9/3011;;B23K2101/40,B23K1/008;;B23K1/012;;F27B9/02;;F27B9/10;;F27B9/30;;F27D7/04;;F27D17/00,432/128;;432/145;;432/152;;110/336,1,0,,,"Are you ready for Lead-free Reflow?, Marc Peo and Don DeAngelo, SMT, May 2000, p. 67 ff.",EXPIRED
834,EP,B1,EP 1259772 B1,186-098-859-874-573,2009-11-11,2009,EP 01906935 A,2001-02-02,US 0103492 W;;US 17966400 P,2000-02-02,MODULAR FURNACE SYSTEM,,BTU INT,BLOOM DAVID;;BOUCHARD ROBERT;;HARVEY DAVID S;;NEILEY GEOFFREY C III;;SECCOMBE DONALD A JR;;WONG TERRANCE;;TARCZON RICHARD;;PARROTT STEPHEN J;;EDGINGTON PAUL,,https://lens.org/186-098-859-874-573,Granted Patent,yes,8,0,9,9,0,B23K1/008;;B23K1/012;;F27B9/029;;F27B9/10;;F27B9/3011;;F27D17/004;;F27D2007/045;;B23K2101/40;;B23K1/012;;F27D17/004;;F27B9/029;;F27D2007/045;;F27B9/10;;B23K1/008;;F27B9/3011;;B23K2101/40,F27B9/02;;B23K1/008;;B23K1/012;;F27B9/10;;F27B9/12;;F27B9/30;;F27D7/04;;F27D17/00,,0,0,,,,EXPIRED
835,WO,A1,WO 2001/057458 A1,013-259-664-144-432,2001-08-09,2001,US 0103492 W,2001-02-02,US 17966400 P,2000-02-02,MODULAR FURNACE SYSTEM,"A modular furnace (10) is fabricated from at least one module (12) having a frame (14), a removable cover (18) mounted to the frame, exterior cover panels (20) on the frame, and an insulated case (32) fastened to the interior of the module. A conveyor (26) assembly extends through the module. A plurality of process zones (40), such as heating and cooling zones, are disposed within the module. Field replaceable universal blower assemblies (50) are associated with each process zone. The motor shaft (90) in each blower assembly is provided with a sealed bearing (94) in the motor housing. Insulation within each module is held in place by gas permeable fabric (34) covering large vent openings (38) in cover panels to allow oxygen to diffuse out of the insulation rapidly upon start up.",BTU INT,BLOOM DAVID;;BOUCHARD ROBERT;;HARVEY DAVID S;;NEILEY GEOFFREY C III;;SECCOMBE DONALD A JR;;WONG TERRANCE;;TARCZON RICHARD;;PARROTT STEPHEN J;;EDGINGTON PAUL,,https://lens.org/013-259-664-144-432,Patent Application,yes,7,6,9,9,0,B23K1/008;;B23K1/012;;F27B9/029;;F27B9/10;;F27B9/3011;;F27D17/004;;F27D2007/045;;B23K2101/40;;B23K1/012;;F27D17/004;;F27B9/029;;F27D2007/045;;F27B9/10;;B23K1/008;;F27B9/3011;;B23K2101/40,B23K1/008;;B23K1/012;;F27B9/02;;F27B9/10;;F27B9/30;;F27D7/04;;F27D17/00,,1,0,,,See also references of EP 1259772A4,PENDING
836,US,A1,US 2021/0275691 A1,112-532-756-778-217,2021-09-09,2021,US 201917058037 A,2019-05-30,US 201917058037 A;;US 201862677800 P;;US 2019/0034664 W,2018-05-30,SCREENING ASSAY TO ASSESS TOPICAL DELIVERY OF BIOLOGICAL THERAPEUTIC AGENTS,"An in vivo assay to evaluate topical delivery of a biologic agent from a formulation is provided. The assay comprises treating a skin area of a CD hairless rat with tape stripping to disrupt the stratum corneum in the skin area to define a treated skin area and topically applying a formulation to the treated skin area. The formulation, in one embodiment, comprises the biologic agent and a pharmaceutically acceptable carrier. Delivery of the biologic agent into the skin from the topically applied formulation is evaluated via in vitro or in vivo techniques.",ALLERGAN INC,SHEN JIE;;HO HSIANG;;ANDREW-JONES LYDIA;;BLOOM BETSY;;NICHOLSON GREG;;STEWARD LANCE;;BRIDEAU-ANDERSON AMY;;HUNT TERRENCE;;BROIDE RON;;RUPP DAVID;;CANTY DAVID,,https://lens.org/112-532-756-778-217,Patent Application,yes,0,0,3,3,0,A61K9/0014;;A61K49/0008;;C12Y304/24069;;G01N33/5082;;A61K9/0014;;A61K49/0008;;C12Y304/24069;;G01N33/5082,A61K49/00;;A61K9/00;;G01N33/50,,1,1,007-052-265-927-303,16597490;;10.1016/j.ijpharm.2006.02.046,"Wu, Effects of pretreatment of needle puncture and sandpaper abrasion on the in vitro skin permeation of fluorescein isothiocyanate (FITC), International Journal of Pharmaceutics 316 (2006) 102–108 (Year: 2006)",PENDING
837,DK,B1,DK 179896 B1,161-589-954-935-88X,2019-08-30,2019,DK PA201870632 A,2018-09-27,US 201862729978 P,2018-09-11,INDHOLDS-BASEREDE TAKTILE OUTPUTS,"The present disclosure generally relates to content-based tactile outputs. In some embodiments, user interfaces associated with content-based tactile outputs are described. In some embodiments, user interfaces associated with end-of-content tactile outputs are described. In some embodiments, user interfaces associated with moving a user interface in response to different types of input are described. In some embodiments, user interfaces associated with adjustable item-based tactile outputs are described. In some embodiments, user interfaces associated with input velocity-based tactile outputs are described.",APPLE INC,GARY IAN BUTCHER;;CAMILLE MOUSSETTE;;DAVID H BLOOM;;DYLAN ROSS EDWARDS;;JULES K FENNIS;;BRIAN T GLEESON;;MIAO HE,,https://lens.org/161-589-954-935-88X,Granted Patent,no,0,0,31,41,0,G06F3/016;;G06F3/01;;G06F3/0362;;G06F3/048;;G06F3/016;;G06F3/0362;;G06F3/04845;;G06F3/0485;;G06F3/04883;;G06F1/163;;G06F3/0346;;G06F3/016;;G06F1/163;;G06F3/0346;;G06F3/0362;;G06F3/04845;;G06F3/04842;;G06F3/04847;;G06F3/0485;;G06F3/04883;;G06F3/016;;G06F3/04847;;G06F3/0485;;G06F3/0487;;G06F3/04842;;G06F3/04883,G06F3/01;;G06F3/0362;;G06F3/048,,0,0,,,,INACTIVE
838,US,A1,US 2021/0344659 A1,016-120-559-817-853,2021-11-04,2021,US 202016861905 A,2020-04-29,US 202016861905 A,2020-04-29,ADAPTIVE AUTHENTICATION,"Systems and techniques for an adaptive authentication system are described herein. In an example, an adaptive authentication system is adapted to receive a request at a first entity from a second entity for secure data of a user, where the second entity is remote from the first entity. The adaptive authentication system may be further adapted to transmit a prompt to a user device associated with the user for authentication of the user and authentication of the request. The adaptive authentication system may be further adapted to receive a response to the prompt and authenticate the user and the request based on the response. The adaptive authentication system may be further adapted to transmit the secure data of the user to the second entity.",WELLES FARGO BANK N A,BLOOM HARLAN H;;BRIGNONI LIZMARI;;CASTONGUAY MARK DAVID;;CLARKE LISA MUNTER;;HANWELLA UPUL D;;NGUYEN TRACI H;;ULRICH ERICA,WELLS FARGO BANK N.A (2020-05-04),https://lens.org/016-120-559-817-853,Patent Application,yes,14,1,4,4,0,H04W12/06;;H04W12/63;;H04L63/083;;H04W12/60;;H04L67/306;;G06Q20/1085;;G06Q20/3276;;G06Q20/4012;;G06Q20/227;;G07F19/211;;G06Q20/4015;;G06Q20/3224;;H04L63/08;;H04W12/06;;G06Q20/4012;;G06Q20/3276;;G06Q20/1085,H04L29/06;;G06Q20/10;;G06Q20/32;;G06Q20/40;;H04W12/06,,0,0,,,,ACTIVE
839,DK,B1,DK 179888 B1,128-431-436-664-34X,2019-08-27,2019,DK PA201870631 A,2018-09-27,US 201862729978 P,2018-09-11,INDHOLDS-BASEREDE TAKTILE OUTPUTS,"The present disclosure generally relates to content-based tactile outputs. In some embodiments, user interfaces associated with content-based tactile outputs are described. In some embodiments, user interfaces associated with end-of-content tactile outputs are described. In some embodiments, user interfaces associated with moving a user interface in response to different types of input are described. In some embodiments, user interfaces associated with adjustable item-based tactile outputs are described. In some embodiments, user interfaces associated with input velocity-based tactile outputs are described.",APPLE INC,GARY IAN BUTCHER;;CAMILLE MOUSSETTE;;DAVID H BLOOM;;DYLAN ROSS EDWARDS;;JULES K FENNIS;;BRIAN T GLEESON;;MIAO HE,,https://lens.org/128-431-436-664-34X,Granted Patent,no,0,0,31,41,0,G06F3/016;;G06F3/01;;G06F3/0362;;G06F3/048;;G06F3/016;;G06F3/0362;;G06F3/04845;;G06F3/0485;;G06F3/04883;;G06F1/163;;G06F3/0346;;G06F3/016;;G06F1/163;;G06F3/0346;;G06F3/0362;;G06F3/04845;;G06F3/04842;;G06F3/04847;;G06F3/0485;;G06F3/04883;;G06F3/016;;G06F3/04847;;G06F3/0485;;G06F3/0487;;G06F3/04842;;G06F3/04883,G06F3/01;;G06F3/048,,0,0,,,,INACTIVE
840,DK,A1,DK 201970259 A1,187-090-944-553-985,2019-08-27,2019,DK PA201970259 A,2019-04-26,US 201862729978 P;;DK PA201870631 A,2018-09-11,CONTENT-BASED TACTILE OUTPUTS,"The present disclosure generally relates to content-based tactile outputs. In some embodiments, user interfaces associated with content-based tactile outputs are described. In some embodiments, user interfaces associated with end-of-content tactile outputs are described. In some embodiments, user interfaces associated with moving a user interface in response to different types of input are described. In some embodiments, user interfaces associated with adjustable item-based tactile outputs are described. In some embodiments, user interfaces associated with input velocity-based tactile outputs are described.",APPLE INC,GARY IAN BUTCHER;;CAMILLE MOUSSETTE;;DAVID H BLOOM;;DYLAN ROSS EDWARDS;;JULES K FENNIS;;BRIAN T GLEESON;;MIAO HE,,https://lens.org/187-090-944-553-985,Unknown,no,0,0,2,41,0,G06F3/01;;G06F3/048,G06F3/01;;G06F3/048,,0,0,,,,INACTIVE
841,DK,A1,DK 201870632 A1,041-365-021-388-331,2019-08-30,2019,DK PA201870632 A,2018-09-27,US 201862729978 P,2018-09-11,CONTENT-BASED TACTILE OUTPUTS,"The present disclosure generally relates to content-based tactile outputs. In some embodiments, user interfaces associated with content-based tactile outputs are described. In some embodiments, user interfaces associated with end-of-content tactile outputs are described. In some embodiments, user interfaces associated with moving a user interface in response to different types of input are described. In some embodiments, user interfaces associated with adjustable item-based tactile outputs are described. In some embodiments, user interfaces associated with input velocity-based tactile outputs are described.",APPLE INC,GARY IAN BUTCHER;;CAMILLE MOUSSETTE;;DAVID H BLOOM;;DYLAN ROSS EDWARDS;;JULES K FENNIS;;BRIAN T GLEESON;;MIAO HE,,https://lens.org/041-365-021-388-331,Unknown,no,0,0,31,41,0,G06F3/016;;G06F3/01;;G06F3/0362;;G06F3/048;;G06F3/016;;G06F3/0362;;G06F3/04845;;G06F3/0485;;G06F3/04883;;G06F1/163;;G06F3/0346;;G06F3/016;;G06F1/163;;G06F3/0346;;G06F3/0362;;G06F3/04845;;G06F3/04842;;G06F3/04847;;G06F3/0485;;G06F3/04883;;G06F3/016;;G06F3/04847;;G06F3/0485;;G06F3/0487;;G06F3/04842;;G06F3/04883,G06F3/01;;G06F3/0362;;G06F3/048,,0,0,,,,INACTIVE
842,US,B2,US 10712824 B2,069-919-152-159-246,2020-07-14,2020,US 201816144950 A,2018-09-27,US 201816144950 A;;US 201862729978 P,2018-09-11,Content-based tactile outputs,"The present disclosure generally relates to content-based tactile outputs. In some embodiments, user interfaces associated with content-based tactile outputs are described. In some embodiments, user interfaces associated with end-of-content tactile outputs are described. In some embodiments, user interfaces associated with moving a user interface in response to different types of input are described. In some embodiments, user interfaces associated with adjustable item-based tactile outputs are described. In some embodiments, user interfaces associated with input velocity-based tactile outputs are described.",APPLE INC,MOUSSETTE CAMILLE;;BLOOM DAVID H;;BUTCHER GARY IAN;;EDWARDS DYLAN ROSS;;FENNIS JULES K;;GLEESON BRIAN T;;HE MIAO,APPLE INC (2018-10-11),https://lens.org/069-919-152-159-246,Granted Patent,yes,702,2,31,41,0,G06F3/016;;G06F3/01;;G06F3/0362;;G06F3/048;;G06F3/016;;G06F3/0362;;G06F3/04845;;G06F3/0485;;G06F3/04883;;G06F1/163;;G06F3/0346;;G06F3/016;;G06F1/163;;G06F3/0346;;G06F3/0362;;G06F3/04845;;G06F3/04842;;G06F3/04847;;G06F3/0485;;G06F3/04883;;G06F3/016;;G06F3/04847;;G06F3/0485;;G06F3/0487;;G06F3/04842;;G06F3/04883,G06F3/01;;G06F3/0484;;G06F3/0485;;G06F3/0487;;G06F3/0488,,363,1,090-500-355-520-271,10.1007/s007790200002,"Dewsberry, Victor, “Designing for Small Screens”, AVA Publishing, 2005, 27 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2017/035325, dated Dec. 27, 2018, 9 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/641,308, dated Dec. 20, 2018, 43 pages.;;Notice of Allowance received for U.S. Appl. No. 14/913,350, dated Dec. 19, 2018, 27 pages.;;Office Action received for Australian Patent Application No. 2017276285, dated Nov. 26, 2018, 2 pages.;;Office Action received for Australian Patent Application No. 2018200289, dated Dec. 4, 2018, 4 pages.;;Search Report and Opinion received for Danish Patent Application No. PA201870631, dated Dec. 6, 2018, 8 pages.;;Search Report and Opinion received for Danish Patent Application No. PA201870632, dated Dec. 3, 2018, 8 pages.;;Advisory Action received for U.S. Appl. No. 14/841,646, dated Nov. 21, 2018, 5 pages.;;Intention to Grant received for European Patent Application No. 18157131.6, dated Jan. 9, 2019, 9 pages.;;Notice of Allowance received for U.S. Appl. No. 16/055,489, dated Jan. 9, 2019, 24 pages.;;Notice of Allowance received for U.S. Appl. No. 16/055,489, dated Jan. 25, 2019, 8 pages.;;Office Action received for Chinese Patent Application No. 201480060083.1, dated Dec. 5, 2018, 11 pages (5 pages of English Translation and 6 pages of Official Copy).;;Office Action received for European Patent Application No. 14771688.0, dated Jan. 21, 2019, 8 pages.;;Office Action received for Japanese Patent Application No. 2018-143982, pages Dec. 7, 2018, 10 pages (5 pages of English Translation and 5 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2018-7010872, dated Dec. 21, 2018, 7 pages (3 pages of English Translation and 4 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2018-7032106, dated Dec. 26, 2018, 10 pages (4 pages of English translation and 6 pages of Official Copy).;;Corrected Notice of Allowance received for U.S. Appl. No. 14/830,629, dated Feb. 13, 2019, 3 pages.;;Decision to Grant received for European Patent Application No. 15782209.9, dated Feb. 14, 2019, 2 pages.;;Non-Final Office Action received for U.S. Appl. No. 15/049,049, dated Feb. 6, 2019, 21 pages.;;Non-Final Office Action received for U.S. Appl. No. 16/147,413, dated Feb. 7, 2019, 18 pages.;;Office Action received for Australian Patent Application No. 2018200998, dated Jan. 30, 2019, 4 pages.;;Office Action received for Danish Patent Application No. PA201670580, dated Feb. 4, 2019, 2 pages.;;Office Action received for Taiwanese Patent Application No. 104107318, dated Dec. 26, 2018, 33 pages (9 pages of English Translation and 24 pages of Official Copy).;;Advisory Action received for U.S. Appl. No. 15/049,052, dated Sep. 11, 2017, 2 pages.;;Advisory Action received for U.S. Appl. No. 15/049,064, dated May 10, 2017, 3 Pages.;;Advisory Action received for U.S. Appl. No. 15/049,058, dated Oct. 18, 2017, 3 pages.;;Agarwal, Deepesh, “DexClock—Live Clock and Date Blended Into Beautiful Artwork as Your Desktop Wallpaper”, available at: https://www.megaleecher.net/DexCiock_Wallpaper_Designs, Jul. 6, 2013, 4 pages.;;Apple, “iPhone User's Guide”, Available at: http://mesnotices.20minutes.fr/manuel-notice-mode-emploi/APPLE/IPHONE%2D%5FE#, Jun. 2007, 137 pages.;;Brinkmann, Martin, “How to Zoom in Firefox”, Ghacks, Available at: https://web.archive.org/web/20130804034728/https://www.ghacks.net/2009/02/23/how-to-zoom-in-firefox/>, Feb. 23, 2009, 11 pages.;;Colt, Sam, “Here's One Way Apple's Smartwatch Could Be Better Than Anything Else”, Business Insider, Aug. 21, 2014, pp. 1-4.;;Corrected Notice of Allowance received for U.S. Appl. No. 14/641,252, dated Aug. 28, 2018, 2 pages.;;Corrected Notice of Allowance received for U.S. Appl. No. 14/641,252, dated Jul. 9, 2018, 25 Pages.;;Corrected Notice of Allowance received for U.S. Appl. No. 14/641,252, dated May 10, 2018, 10 pages.;;Corrected Notice of Allowance received for U.S. Appl. No. 14/829,573, dated Aug. 9, 2018, 3 pages.;;Corrected Notice of Allowance received for U.S. Appl. No. 14/829,573, dated Sep. 11, 2018, 3 pages.;;Corrected Notice of Allowance received for U.S. Appl. No. 14/841,656, dated Apr. 11, 2018, 2 pages.;;Corrected Notice of Allowance received for U.S. Appl. No. 14/841,656, dated May 7, 2018, 14 pages.;;Decision to Grant received for Danish Patent Application No. PA201570781, dated Jul. 17, 2017, 2 pages.;;Decision to Grant received for Danish Patent Application No. PA201670117, dated Nov. 20, 2017, 2 pages.;;Decision to Grant received for Danish Patent Application No. PA201770181, dated Mar. 7, 2018, 2 pages.;;Final Office Action received for U.S. Appl. No. 13/038,276, dated Mar. 27, 2014, 24 pages.;;Final Office Action received for U.S. Appl. No. 13/038,276, dated Mar. 11, 2016, 36 pages.;;Final Office Action received for U.S. Appl. No. 14/641,308, dated Mar. 14, 2018, 42 pages.;;Final Office Action received for U.S. Appl. No. 14/830,629, dated Apr. 16, 2018, 27 pages.;;Final Office Action received for U.S. Appl. No. 14/841,646, dated Aug. 2, 2018, 22 pages.;;Final Office Action received for U.S. Appl. No. 14/913,345, dated Oct. 26, 2018, 20 pages.;;Final Office Action received for U.S. Appl. No. 14/913,349, dated Jul. 30, 2018, 18 pages.;;Final Office Action received for U.S. Appl. No. 15/049,049 dated Jul. 12, 2018, 24 pages.;;Final Office Action received for U.S. Appl. No. 15/049,049, dated May 23, 2017, 23 pages.;;Final Office Action received for U.S. Appl. No. 15/049,052, dated Mar. 1, 2018, 15 pages.;;Final Office Action received for U.S. Appl. No. 15/049,052, dated May 17, 2017, 13 pages.;;Final Office Action received for U.S. Appl. No. 15/049,052, dated Oct. 2, 2018, 16 pages.;;Final Office Action received for U.S. Appl. No. 15/049,058, dated Aug. 8, 2018, 23 pages.;;Final Office Action received for U.S. Appl. No. 15/049,058, dated May 8, 2017, 21 pages.;;Final Office Action received for U.S. Appl. No. 15/049,064, dated Feb. 27, 2017, 13 Pages.;;Final Office Action received for U.S. Appl. No. 14/839,912, dated Sep. 13, 2018, 31 pages.;;“Headset Button Controller v7.3 APK Full APP Download for Andriod”, Blackberry, iPhone, Jan. 27, 2014, 11 pages.;;IBM, “Watchpad 1.5”, Online Available at: web.archive.org/web/20011205071448/http://www.trl.ibm.com/projects/ngm/index_e.htm>, Oct. 11, 2001, 2 pages.;;Intention to Grant received for Danish Patent Application No. PA201570781, dated Dec. 8, 2016, 2 pages.;;Intention to Grant received for Danish Patent Application No. PA201670117, dated Apr. 21, 2017, 2 pages.;;Intention to Grant received for European Patent Application No. 15782209.9, dated Sep. 28, 2018, 8 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2012/025519, dated Sep. 3, 2013, 5 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2014/053951, dated Mar. 17, 2016, 9 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2014/053957, dated Mar. 17, 2016, 8 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2014/053958, dated Mar. 17, 2016, 8 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2014/053961, dated Jul. 21, 2016, 24 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2015/019322, dated Mar. 16, 2017, 11 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2015/045936, dated Mar. 16, 2017, 9 Pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2015/045965, dated Dec. 27, 2016, 10 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2015/047704, dated Mar. 16, 2017, 19 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2015/054310, dated Sep. 14, 2017, 7 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2016/019637, dated Sep. 21, 2017, 12 pages.;;International Preliminary Report on Patentability received for PCT Patent Application no. PCT/US2015/019320, dated Mar. 16, 2017, 10 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2015/019321, dated Mar. 16, 2017, 8 Pages.;;International Search Report and Written Opinion received for PCT Application No. PCT/US2015/045936, dated Nov. 4, 2015, 12 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2012/025519, dated Jun. 11, 2012, 7 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2014/053951, dated Dec. 8, 2014, 11 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2014/053957, dated Feb. 19, 2015, 11 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2014/053958, dated Feb. 19, 2015, 10 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2015/019320, dated Jul. 2, 2015, 14 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2015/019321, dated Jun. 3, 2015, 11 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2015/019322, dated Jun. 18, 2015, 16 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2015/045965, dated Feb. 1, 2016, 20 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2015/047704, dated Feb. 22, 2016, 25 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2015/054310, dated Jan. 20, 2016, 10 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2016/019637, dated Aug. 18, 2016, 18 pages.;;International Search Report and Written Opinion Received for PCT Patent Application No. PCT/US2017/035325, dated Sep. 7, 2017, 11 pages.;;International Search Report received for PCT Patent Application No. PCT/US2014/053961, dated Jul. 11, 2016, 10 pages.;;International Written Opinion received for PCT Patent Application No. PCT/US2014/053961, dated Jul. 11, 2016, 22 pages.;;Invitation to Pay Additional Fees received for PCT Patent Application No. PCT/US2014/053961, dated Aug. 3, 2015, 6 pages.;;Invitation to Pay Additional Fees received for PCT Patent Application No. PCT/US2015/047704, dated Dec. 16, 2015, 10 pages.;;Invitation to Pay Additional Fees received for PCT Patent Application No. PCT/US2016/019637, dated Jun. 1, 2016, 6 pages.;;Kamijo, Noboru, “Next Generation Mobile System—WatchPad1.5”, Available at: http://researcher.ibm.com/researcher/view_group_subpage.php?id=5617>, retrieved on Jul. 4, 2015, 2 pages.;;Mai, Tuan, “This Watch Tells You the Time in Vibrating Morse Code”, Available at: https://web.archive.org/web/20130915060538/http://www.tomsguide.com/us/Watch-Concept-Morse-Code,news-12089.html>, Aug. 9, 2011, pp. 1-3.;;NDTV, “Sony SmartWatch 2 Launched in India for Rs. 14,990”, available at: http://gadgets.ndtv.com/others/news/sony-smartwatch-2-launched-in-india-for-rs-14990-420319>, Sep. 18, 2013, 4 pages.;;Non-Final Office Action received for U.S. Appl. No. 13/038,276, dated Jul. 29, 2015, 31 pages.;;Non-Final Office Action received for U.S. Appl. No. 13/038,276, dated Sep. 12, 2013, 24 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/641,308, dated Jun. 23, 2017, 53 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/829,573, dated Jan. 22, 2018, 26 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/830,629, dated Dec. 1, 2016, 20 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/830,629, dated Jun. 15, 2017, 24 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/839,914, dated Oct. 19, 2017, 46 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/841,646, dated Dec. 1, 2017, 23 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/841,656, dated Jul. 26, 2017, 20 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/913,345, dated Apr. 5, 2018, 15 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/913,349, dated Jan. 11, 2018, 6 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/913,350, dated May 14, 2018, 30 pages.;;Non-Final Office Action received for U.S. Appl. No. 15/049,049 dated Dec. 15, 2017, 23 pages.;;Non-Final Office Action received for U.S. Appl. No. 15/049,049, dated Nov. 9, 2016, 13 pages.;;Non-Final Office Action received for U.S. Appl. No. 15/049,052, dated May 31, 2018, 15 pages.;;Non-Final Office Action received for U.S. Appl. No. 15/049,052, dated Nov. 29, 2016, 13 pages.;;Non-Final Office Action received for U.S. Appl. No. 15/049,052, dated Sep. 21, 2017, 14 pages.;;Non-Final Office Action received for U.S. Appl. No. 15/049,058, dated Feb. 20, 2018, 21 pages.;;Non-Final Office Action received for U.S. Appl. No. 15/049,058, dated Nov. 16, 2016, 19 pages.;;Non-Final Office Action received for U.S. Appl. No. 15/049,064, dated Oct. 27, 2016, 15 pages.;;Non-Final Office Action received for U.S. Appl. No. 15/421,711, dated May 18, 2018, 25 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/839,912, dated Feb. 12, 2018, 30 pages.;;Non-Final office Action Received for U.S. Appl. No. 14/839,912, dated Jun. 8, 2017, 26 pages.;;Notice of Acceptance received for Australian Patent Application No. 2014315319, dated Oct. 12, 2017, 3 pages.;;Notice of Acceptance received for Australian Patent Application No. 2014315324, dated Sep. 28, 2017, 3 pages.;;Notice of Acceptance received for Australian Patent Application No. 2014315325, dated Apr. 19, 2017, 3 Pages.;;Notice of Allowance Action received for U.S. Appl. No. 14/841,656, dated Feb. 12, 2018, 9 pages.;;Notice of Allowance and Search Report received for Taiwanese Patent Application No. 104128687, dated Jun. 7, 2016, 4 pages (1 page of English Translation and 3 pages of Official copy).;;Notice of Allowance received for Danish Patent Application No. PA201570776, dated Feb. 8, 2017, 2 pages.;;Notice of Allowance received for Danish Patent Application No. PA201670118, dated Mar. 30, 2017, 2 pages.;;Notice of Allowance received for Japanese Patent Application No. 2016-537945, dated Aug. 3, 2018, 4 pages (1 page of English translation and 3 pages of Official copy).;;Notice of Allowance received for Japanese Patent Application No. 2016-537946, dated Mar. 26, 2018, 4 pages (1 page of English translation and 3 pages of Official copy).;;Notice of Allowance received for Japanese Patent Application No. 2016-537947, dated Jun. 5, 2017, 3 pages (Official Copy only) (See Communication under 37 CFR § 1.98(a) (3)).;;Notice of Allowance received for Korean Patent Application No. 10-2018-7002695, dated Oct. 8, 2018, 5 pages (2 pages of English translation and 3 pages of Official copy).;;Notice of Allowance received for Taiwanese Patent Application No. 103130517, dated May 14, 2018, 5 pages (2 pages of English translation and 3 pages of Official copy).;;Notice of Allowance received for Taiwanese Patent Application No. 103130518, dated May 19, 2016, 2 pages (Official Copy only) (See Communication under 37 CFR § 1.98(a) (3)).;;Notice of Allowance received for Taiwanese Patent Application No. 103130519, dated Oct. 27, 2016, 3 pages (Official Copy only) (See Communication under 37 CFR § 1.98(a) (3)).;;Notice of Allowance received for Taiwanese Patent Application No. 103130520, dated Apr. 25, 2018, 4 pages (1 page of English translation and 3 pages of Official copy).;;Notice of Allowance received for Taiwanese Patent Application No. 104107333, dated Nov. 8, 2016, 2 pages (Official Copy Only) (See Communication under 37 CFR § 1.98(a) (3)).;;Notice of Allowance received for Taiwanese Patent Application No. 104107334, dated Jan. 26, 2017, 3 pages (Official Copy Only) (See Communication under 37 CFR § 1.98(a) (3)).;;Notice of Allowance received for Taiwanese Patent Application No. 104133281, dated Mar. 29, 2018, 4 pages (1 page of English translation and 3 pages of Official copy).;;Notice of Allowance received for U.S. Appl. No. 13/038,276, dated Nov. 3, 2016, 10 pages.;;Notice of Allowance received for U.S. Appl. No. 13/038,276, dated Nov. 30, 2016, 2 pages.;;Notice of Allowance received for U.S. Appl. No. 14/641,241, dated Apr. 13, 2017, 2 pages.;;Notice of Allowance received for U.S. Appl. No. 14/641,241, dated Jan. 31, 2017, 13 pages.;;Notice of Allowance received for U.S. Appl. No. 14/641,241, dated Mar. 24, 2017, 3 Pages.;;Notice of Allowance received for U.S. Appl. No. 14/641,252, dated Apr. 11, 2018, 14 pages.;;Notice of Allowance received for U.S. Appl. No. 14/641,252, dated Jul. 18, 2018, 9 pages.;;Notice of Allowance received for U.S. Appl. No. 14/829,573, dated Apr. 25, 2018, 6 pages.;;Notice of Allowance received for U.S. Appl. No. 14/830,629, dated Oct. 17, 2018, 8 pages.;;Notice of Allowance received for UU.S. Appl. No. 14/839,914, dated Jun. 22, 2018, 12 pages.;;Notice of Allowance received for U.S. Appl. No. 14/841,656, dated Mar. 5, 2018, 3 pages.;;Notice of Allowance received for U.S. Appl. No. 15/049,064, dated Jul. 18, 2017, 24 pages.;;Notice of Allowance received for U.S. Appl. No. 15/058,996, dated Dec. 27, 2016, 10 pages.;;Notice of Allowance received for U.S. Appl. No. 15/421,711, dated Oct. 5, 2018, 10 pages.;;Notice of Allowance received for U.S. Appl. No. 16/055,489, dated Nov. 8, 2018, 28 pages.;;Nova Launcher, Available on https://web.archive.org/web/20150703231459/https://play.google.com/store/apps/details?id=com.teslacoilsw.launcher, 3 pages.;;Office Action and Search Report received for Danish Patent Application No. PA 201670118, dated Jul. 1, 2016, 7 pages.;;Office Action received for Danish Patent Application No. PA201770794, dated Dec. 19, 2017, 8 pages.;;Office Action received for Australian Patent Application No. 2014315234, dated Jul. 12, 2017, 4 pages.;;Office Action received for Australian Patent Application No. 2014315234, dated Nov. 2, 2016, 3 pages.;;Office Action received for Australian Patent Application No. 2014315319, dated Aug. 3, 2017, 3 pages.;;Office Action received for Australian Patent Application No. 2014315319, dated Oct. 17, 2016, 3 pages.;;Office Action received for Australian Patent Application No. 2014315324, dated Aug. 8, 2017, 3 pages.;;Office Action received for Australian Patent Application No. 2014315324, dated Oct. 21, 2016, 3 pages.;;Office Action received for Australian Patent Application No. 2014315325, dated Nov. 3, 2016, 3 pages.;;Office Action received for Australian Patent Application No. 2016229407, dated Aug. 15, 2018, 4 pages.;;Office Action received for Australian Patent Application No. 2017254897, dated Aug. 29, 2018, 4 pages.;;Office Action received for Australian Patent Application No. 2018200998, dated Mar. 9, 2018, 5 pages.;;Office Action received for Australian Patent Application No. 2014315234, dated Apr. 19, 2017, 4 pages.;;Office Action received for Chinese Patent Application No. 201480059543.9, dated Jan. 26, 2018, 17 pages (4 pages of English Translation and 13 pages of Official Copy).;;Office Action received for Chinese Patent Application No. 201480059543.9, dated Sep. 19, 2018, 18 pages (5 pages of English Translation and 13 pages of Official Copy).;;Office Action received for Chinese Patent Application No. 201480060044.1, dated Jan. 26, 2018, 15 pages (5 pages of English Translation and 10 pages of Official Copy).;;Office Action received for Chinese Patent Application No. 201480060044.1, dated Sep. 25, 2018, 6 pages (3 pages of English Translation and 3 pages of official copy).;;Office Action received for Chinese Patent Application No. 201480060082.7, dated Jan. 26, 2018, 15 pages (4 pages of English Translation and 11 pages of Official Copy).;;Office Action received for Chinese Patent Application No. 201480060082.7, dated Sep. 25, 2018, 6 pages (3 pages of English Translation and 3 pages of Official Copy).;;Office Action received for Danish Patent Application No. PA201570776, dated Aug. 19, 2016, 3 pages.;;Office Action received for Danish Patent Application No. PA201570781, dated Aug. 19, 2016, 3 pages.;;Office Action received for Danish Patent Application No. PA201670117, dated Jan. 12, 2017, 3 pages.;;Office Action received for Danish Patent Application No. PA201670117, dated Jun. 13, 2016, 10 pages.;;Office Action received for Danish Patent Application No. PA201670118, dated Feb. 2, 2017, 2 pages.;;Office Action received for Danish Patent Application No. PA201670118, dated Oct. 25, 2016, 3 Pages.;;Office Action received for Danish Patent Application No. PA201670580, dated Mar. 8, 2018, 3 Pages.;;Office Action received for Danish Patent Application No. PA201770181, dated Jan. 3, 2018, 2 Pages.;;Office Action received for Danish Patent Application No. PA201770181, dated Jun. 13, 2017, 6 pages.;;Office Action received for Danish Patent Application No. PA201770794, dated Apr. 5, 2018, 4 pages.;;Office Action received for Danish Patent Application No. PA201770794, dated Oct. 30, 2018, 3 pages.;;Office Action received for European Patent Application No. 14771688.0, dated May 31, 2018, 6 pages.;;Office Action received for European Patent Application No. 14771688.0, dated Nov. 30, 2017, 15 pages.;;Office Action received for European Patent Application No. 14772001.5, dated Feb. 14, 2018, 5 pages.;;Office Action received for European Patent Application No. 14772001.5, dated May 30, 2017, 10 pages.;;Office Action received for European Patent Application No. 14772002.3, dated Jul. 4, 2017, 8 pages.;;Office Action received for European Patent Application No. 14772494.2, dated Jun. 20, 2017, 7 pages.;;Office Action received for European Patent Application No. 14772494.2, dated Oct. 2, 2018, 9 pages.;;Office Action received for European Patent Application No. 18157131.6, dated May 8, 2018, 12 pages.;;Office Action received for Japanese Patent Application No. 2016-537945, dated Apr. 7, 2017, 6 pages (3 pages of English Translation and 3 pages of Official Copy).;;Office Action received for Japanese Patent Application No. 2016-537945, dated Jan. 9, 2018, 5 pages (2 pages of English Translation and 3 pages of Official copy).;;Office Action received for Japanese Patent Application No. 2016-537946, dated Aug. 7, 2017, 8 pages (4 Pages of English Translation and 4 Pages of Official Copy).;;Office Action received for Japanese Patent Application No. 2016-537946, dated Jan. 30, 2017, 12 pages (6 pages of English Translation and 6 pages of Official Copy).;;Office Action received for Japanese Patent Application No. 2016-537947, dated Feb. 24, 2017, 6 pages (3 pages of English Translation and 3 pages of Official Copy).;;Office Action received for Japanese Patent Application No. 2016-537948, dated Apr. 6, 2018, 5 pages (2 pages of English Translation and 3 pages of Official Copy).;;Office Action received for Japanese Patent Application No. 2016-537948, dated Jun. 9, 2017, 10 pages (5 pages of English Translation and 5 pages of Official Copy).;;Office Action received for Japanese Patent Application No. 2016-537948, dated Sep. 3, 2018, 4 pages (2 pages of English Translation and 2 pages of Official copy).;;Office Action received for Japanese Patent Application No. 2017-545561, dated Aug. 6, 2018, 8 pages (4 pages of English Translation and 4 pages of Official copy).;;Office Action received for Korean Patent Application No. 10-2016-7008449, dated Jan. 12, 2017, 15 pages (6 pages of English translation and 9 pages of official Copy).;;Office Action received for Korean Patent Application No. 10-2016-7008449, dated Jan. 16, 2018, 10 pages (5 pages of English Translation and 5 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2016-7008449, dated Nov. 27, 2017, 6 pages (3 pages of English Translation and 3 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2016-7008474, dated Aug. 6, 2018, 10 pages (5 pages of English Translation and 5 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2016-7008474, dated Dec. 28, 2016, 10 pages (4 pages of English Translation and 6 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2016-7008474, dated May 15, 2018, 7 pages (3 pages of English Translation and 4 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2016-7008474, dated Nov. 27, 2017, 6 pages (2 pages of English Translation and 4 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2016-7008488, dated Feb. 8, 2018, 8 pages (4 pages of English Translation and 4 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2016-7008488, dated Jan. 12, 2017, 14 pages (6 pages of English Translation and 8 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2016-7008488, dated Nov. 27, 2017, 6 pages (3 pages of English Translation and 3 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2016-7008682, dated Dec. 30, 2016, 11 pages (4 pages of English Translation and 7 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2016-7008682, dated Feb. 8, 2018, 7 pages (3 pages of English Translation and 4 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2016-7008682, dated Nov. 27, 2017, 7 pages (3 pages of English Translation and 4 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2017-7024506, dated Sep. 28, 2018, 11 pages (4 pages of English Translation and 7 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2018-7002695, dated Feb. 27, 2018, 12 pages (5 pages of English Translation and 7 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2018-7002695, dated Jun. 19, 2018, 8 pages (4 pages of English Translation and 4 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2018-7010872, dated May 21, 2018, 10 pages (4 pages of English Translation and 6 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2018-7013265, dated Aug. 10, 2018, 12 pages (5 pages of English Translation and 7 pages of Official copy).;;Office Action received for Taiwan Patent Application No. 103130517, dated Feb. 22, 2016, 7 pages (3 pages of English Translation and 4 pages of Official Copy).;;Office Action received for Taiwan Patent Application No. 103130519, dated Mar. 25, 2016, 14 pages (6 pages of English Translation and 8 pages of Official Copy).;;Office Action received for Taiwanese Patent Application No. 103130517, dated Jul. 29, 2016, 7 pages (3 pages of English Translation and 4 pages of Official Copy).;;Office Action received for Taiwanese Patent Application No. 103130517, dated Feb. 6, 2018, 5 pages (2 pages of English Translation and 3 pages of Official Copy).;;Office Action received for Taiwanese Patent Application No. 103130520, dated Apr. 17, 2017, 8 pages (3 pages of English Translation and 5 pages of Official Copy).;;Office Action received for Taiwanese Patent Application No. 103130520, dated Jan. 23, 2018, 05 pages (2 pages of English Translation and 3 pages of Official Copy).;;Office Action received for Taiwanese Patent Application No. 103130520, dated May 23, 2016, 38 pages (15 pages of English Translation and 23 pages of Official Copy).;;Office Action received for Taiwanese Patent Application No. 103130520, dated Oct. 1, 2015, 58 pages (22 pages of English translation and 36 pages of Official copy).;;Office Action received for Taiwanese Patent Application No. 103130520, dated Sep. 29, 2016, 39 pages (16 pages of English Translation and 23 pages of Official Copy).;;Office Action received for Taiwanese Patent Application No. 104107333, dated May 17, 2016, 6 pages (3 pages of English Translation and 3 pages of Official Copy).;;Office Action received for Taiwanese Patent Application No. 104107334, dated Sep. 19, 2016, 15 pages (6 pages of English Translation and 9 pages of Official Copy).;;Office Action received for Taiwanese Patent Application No. 104128701, dated Jul. 22, 2016, 25 pages (9 pages of English Translation and 16 pages of Official Copy).;;Office Action received for Taiwanese Patent Application No. 104128701, dated Mar. 16, 2017, 8 pages (3 pages of English Translation and 5 pages of Official Copy).;;Office Action received for Taiwanese Patent Application No. 104133281, dated Mar. 30, 2017, 10 Pages (4 pages of English translation and 6 pages of official copy).;;Office Action received for Taiwanese Patent Application No. 104133281, dated Sep. 1, 2016, 10 pages (4 pages of English Translation and 6 pages of Official Copy).;;Office Action received for Taiwanese Patent Application No. 104107327, dated Sep. 28, 2018, 7 pages (3 pages of English Translation and 4 pages of Official Copy).;;Office Action received for Danish Patent Application No. PA201570776, dated Jan. 26, 2016, 12 pages.;;Raghunath, et al, “User Interfaces for Applications on a Wrist Watch”, Journal of Personal and Ubiquitous Computing, vol. 6, Feb. 2002, pp. 17-30.;;Search Report and Opinion received for Danish Patent Application No. PA201670580, dated Jan. 31, 2017, 7 pages.;;Search Report received for Danish Patent Application No. PA201570781, dated Mar. 8, 2016, 10 pages.;;Search Report received for European Patent Application No. 18157131.6, dated Apr. 19, 2018, 4 pages.;;Summons to Attend Oral Proceedings received for European Patent Application No. 14772001.5, dated Nov. 14, 2018, 5 pages.;;Summons to Attend Oral Proceedings received for European Patent Application No. 14772001.5, dated Oct. 4, 2018, 15 pages.;;The Blind Life, “Double Tap Big Clock”, https://www.youttlbe.com/watch?v-=U6XMnSPCEXU, Mar. 2, 2016, 2 Pages.;;“The interview with a key person. IBM and Citizen met and applied Linux to a watch”, ASCII Corporation, vol. 25, No. 12, Dec. 12, 2001, pp. 136-143 (Official Copy Only) (See Communication under 37 CFR § 1.98(a) (3)).;;The Window Club, “How to Set GIF as Background Windows 7”, Online Available at: https://www.youtube.com/watch?v=tUec42Qd7ng>, Dec. 24, 2012, pp. 1-5.;;“Timebuzz”, Feel the Current Time on your Apple Watch with Time Buzz, Available at: https://web.archive.org/web/20160125032143/http://www.timebuzz.nl/>, Jan. 25, 2016, pp. 1-6.;;Toyssy, et al, “Telling Time by Vibration”, University of Tampere, Department of Computer Sciences, Interactive Technology, Master's Thesis, Nov. 2007, 57 Pages.;;Toyssy, Sampo, et al, “Telling Time by Vibration”, 6th International Conference, EuroHaptics 2008 Madrid, Spain, Jun. 10-11, 2008, pp. 924-929.;;“Watchpad 1.5 demo”, YouTube.com, Online Available at: https://www.youtube.com/watch?v=7xjvVbeUn80>, Uploaded on Jun. 20, 2010, 2 pages.;;Wikipedia, “Rotary encoder”, Online Available at: https://en.wikipedia.org/wiki/Rotary_encoder>, Retrieved on May 17, 2017, 17 pages (10 pages of English Translation and 7 pages of Official Copy).;;Search Report and Opinion received for Danish Patent Application No. PA201970259, dated Jul. 19, 2019, 10 pages.;;Decision to Grant received for European Patent Application No. 18157131.6, dated May 16, 2019, 2 pages.;;Notice of Allowance received for Chinese Patent Application No. 201480060044.1, dated Mar. 29, 2019, 3 pages (1 page of English Translation and 2 pages of Official Copy).;;Office Action received for Australian Patent Application No. 2019201628, dated May 13, 2019, 2 pages.;;Office Action received for Chinese Patent Application No. 201780014703.1, dated Apr. 30, 2019, 9 pages (4 pages of English Translation and 5 pages of Official Copy).;;Decision to Grant received for Danish Patent Application No. PA201870631, dated May 15, 2019, 2 pages.;;Decision to Grant received for Danish Patent Application No. PA201870632, dated May 14, 2019, 2 pages.;;Non-Final Office Action received for U.S. Appl. No. 15/049,058, dated Jun. 5, 2019, 25 pages. et al.",ACTIVE
843,US,A1,US 2021/0365922 A1,029-603-267-142-127,2021-11-25,2021,US 202016879588 A,2020-05-20,US 202016879588 A,2020-05-20,DEVICE CONTROLS,"Systems and techniques for a device controls system are described herein. In an example, a device control system for managing access to personal account data is adapted to receive, from a user device, a set of personalized transaction rules for an account of a user. Each personalized transaction rule may indicate a set of transactional parameters for permitting transactions with a service. The system may be further adapted to receive a transaction request from the service. The transaction request may include contextual data related to the transaction request. The system may be further adapted to determine that the contextual data meets the respective transactional parameters of a personalized transaction rule of the set of personalized transaction rules. The system may be further adapted to transmit, to the service, an indication of permission for the transaction request.",WELLS FARGO BANK NA,BLOOM HARLAN H;;BRIGNONI LIZMARI;;CASTONGUAY MARK DAVID;;CLARKE LISA MUNTER;;HANWELLA UPUL D;;NGUYEN TRACI H;;ULRICH ERICA,WELLS FARGO BANK N.A (2020-07-09),https://lens.org/029-603-267-142-127,Patent Application,yes,11,2,2,2,0,G06Q20/405;;G06Q20/4015;;G06Q20/4016;;G06Q20/3263;;G06N20/00;;G06N5/04;;G06N5/025;;G06Q20/3265;;G06Q20/405;;G06Q20/4093;;G06N20/00;;G06Q20/3263,G06Q20/32;;G06N20/00;;G06Q20/40,,0,0,,,,PENDING
844,US,B2,US 11677731 B2,099-201-107-916-477,2023-06-13,2023,US 202016861905 A,2020-04-29,US 202016861905 A,2020-04-29,Adaptive authentication,"Systems and techniques for an adaptive authentication system are described herein. In an example, an adaptive authentication system is adapted to receive a request at a first entity from a second entity for secure data of a user, where the second entity is remote from the first entity. The adaptive authentication system may be further adapted to transmit a prompt to a user device associated with the user for authentication of the user and authentication of the request. The adaptive authentication system may be further adapted to receive a response to the prompt and authenticate the user and the request based on the response. The adaptive authentication system may be further adapted to transmit the secure data of the user to the second entity.",WELLS FARGO BANK NA,BLOOM HARLAN H;;BRIGNONI LIZMARI;;CASTONGUAY MARK DAVID;;CLARKE LISA MUNTER;;HANWELLA UPUL D;;NGUYEN TRACI H;;ULRICH ERICA,WELLS FARGO BANK N.A (2020-05-04),https://lens.org/099-201-107-916-477,Granted Patent,yes,35,0,4,4,0,H04W12/06;;H04W12/63;;H04L63/083;;H04W12/60;;H04L67/306;;G06Q20/1085;;G06Q20/3276;;G06Q20/4012;;G06Q20/227;;G07F19/211;;G06Q20/4015;;G06Q20/3224;;H04L63/08;;H04W12/06;;G06Q20/4012;;G06Q20/3276;;G06Q20/1085,G06Q20/10;;G06Q20/32;;G06Q20/40;;H04L9/40;;H04W12/06,,2,0,,,"“Adaptive Authentication Superior User Experience and Growth Through Intelligent Security (White Paper)”, OneSpan, (2018), 13 pgs.;;“Manage Customer Identity”, Akamai Technologies, [Online]. Retrieved from the Internet: <URL: https://www.akamai.com/us/en/products/security/manage-customer-identity.jsp>, (Accessed Sep. 23, 2019), 3 pgs.",ACTIVE
845,CA,A1,CA 3106931 A1,079-439-708-803-835,2021-10-29,2021,CA 3106931 A,2021-01-25,US 202016861905 A,2020-04-29,ADAPTIVE AUTHENTICATION,"Systems and techniques for an adaptive authentication system are described herein. In an example, an adaptive authentication system is adapted to receive a request at a first entity from a second entity for secure data of a user, where the second entity is remote from the first entity. The adaptive authentication system may be further adapted to transmit a prompt to a user device associated with the user for authentication of the user and authentication of the request. The adaptive authentication system may be further adapted to receive a response to the prompt and authenticate the user and the request based on the response. The adaptive authentication system may be further adapted to transmit the secure data of the user to the second entity.",TORONTO DOMINION BANK,BLOOM HARLAN H;;BRIGNONI LIZMARI;;CASTONGUAY MARK DAVID;;CLARKE LISA MUNTER;;HANWELLA UPUL D;;NGUYEN TRACI H;;ULRICH ERICA,,https://lens.org/079-439-708-803-835,Patent Application,no,0,0,4,4,0,H04W12/06;;H04W12/63;;H04L63/083;;H04W12/60;;H04L67/306;;G06Q20/1085;;G06Q20/3276;;G06Q20/4012;;G06Q20/227;;G07F19/211;;G06Q20/4015;;G06Q20/3224;;H04L63/08;;H04W12/06;;G06Q20/4012;;G06Q20/3276;;G06Q20/1085,H04L9/32;;G06F21/31;;G07F19/00;;H04W12/065,,0,0,,,,PENDING
846,US,A1,US 2020/0081538 A1,091-617-487-779-993,2020-03-12,2020,US 201816144950 A,2018-09-27,US 201816144950 A;;US 201862729978 P,2018-09-11,CONTENT-BASED TACTILE OUTPUTS,"The present disclosure generally relates to content-based tactile outputs. In some embodiments, user interfaces associated with content-based tactile outputs are described. In some embodiments, user interfaces associated with end-of-content tactile outputs are described. In some embodiments, user interfaces associated with moving a user interface in response to different types of input are described. In some embodiments, user interfaces associated with adjustable item-based tactile outputs are described. In some embodiments, user interfaces associated with input velocity-based tactile outputs are described.",APPLE INC,MOUSSETTE CAMILLE;;BLOOM DAVID H;;BUTCHER GARY IAN;;EDWARDS DYLAN ROSS;;FENNIS JULES K;;GLEESON BRIAN T;;HE MIAO,APPLE INC (2018-10-11),https://lens.org/091-617-487-779-993,Patent Application,yes,6,20,31,41,0,G06F3/016;;G06F3/01;;G06F3/0362;;G06F3/048;;G06F3/016;;G06F3/0362;;G06F3/04845;;G06F3/0485;;G06F3/04883;;G06F1/163;;G06F3/0346;;G06F3/016;;G06F1/163;;G06F3/0346;;G06F3/0362;;G06F3/04845;;G06F3/04842;;G06F3/04847;;G06F3/0485;;G06F3/04883;;G06F3/016;;G06F3/04847;;G06F3/0485;;G06F3/0487;;G06F3/04842;;G06F3/04883,G06F3/01;;G06F3/0484;;G06F3/0485;;G06F3/0487,,0,0,,,,ACTIVE
847,US,A1,US 2023/0283599 A1,041-800-360-404-854,2023-09-07,2023,US 202318316570 A,2023-05-12,US 202318316570 A;;US 202016861905 A,2020-04-29,ADAPTIVE AUTHENTICATION,"Systems and techniques for an adaptive authentication system are described herein. In an example, an adaptive authentication system is adapted to receive a request at a first entity from a second entity for secure data of a user, where the second entity is remote from the first entity. The adaptive authentication system may be further adapted to transmit a prompt to a user device associated with the user for authentication of the user and authentication of the request. The adaptive authentication system may be further adapted to receive a response to the prompt and authenticate the user and the request based on the response. The adaptive authentication system may be further adapted to transmit the secure data of the user to the second entity.",WELLS FARGO BANK NA,BLOOM HARLAN H;;BRIGNONI LIZMARI;;CASTONGUAY MARK DAVID;;CLARKE LISA MUNTER;;HANWELLA UPUL D;;NGUYEN TRACI H;;ULRICH ERICA,WELLS FARGO BANK N.A (2020-05-04),https://lens.org/041-800-360-404-854,Patent Application,yes,8,0,4,4,0,H04W12/06;;H04W12/63;;H04L63/083;;H04W12/60;;H04L67/306;;G06Q20/1085;;G06Q20/3276;;G06Q20/4012;;G06Q20/227;;G07F19/211;;G06Q20/4015;;G06Q20/3224;;H04L63/08;;H04W12/06;;G06Q20/4012;;G06Q20/3276;;G06Q20/1085,G06Q20/10;;H04L9/40;;G06Q20/32;;G06Q20/40;;H04W12/06,,1,1,124-937-169-789-174,10.3390/cryptography2010001,"Ometov, A.; Bezzateev, S.; Mäkitalo, N.; Andreev, S.; Mikkonen, T.; Koucheryavy, Y. Multi-Factor Authentication: A Survey. Cryptography 2018, 2, 1. https://doi.org/10.3390/cryptography2010001 (Year: 2018)",PENDING
848,US,A1,US 2020/0341553 A1,151-874-569-247-474,2020-10-29,2020,US 202016926512 A,2020-07-10,US 202016926512 A;;US 201816144950 A;;US 201862729978 P,2018-09-11,CONTENT-BASED TACTILE OUTPUTS,"The present disclosure generally relates to content-based tactile outputs. In some embodiments, user interfaces associated with content-based tactile outputs are described. In some embodiments, user interfaces associated with end-of-content tactile outputs are described. In some embodiments, user interfaces associated with moving a user interface in response to different types of input are described. In some embodiments, user interfaces associated with adjustable item-based tactile outputs are described. In some embodiments, user interfaces associated with input velocity-based tactile outputs are described.",APPLE INC,MOUSSETTE CAMILLE;;BLOOM DAVID H;;BUTCHER GARY IAN;;EDWARDS DYLAN ROSS;;FENNIS JULES K;;GLEESON BRIAN T;;HE MIAO,,https://lens.org/151-874-569-247-474,Patent Application,yes,0,26,3,41,0,G06F3/016;;G06F3/04817;;G06F3/0485;;G06F3/04847;;G06F3/0362;;G06F3/016;;G06F3/0362;;G06F3/0412;;G06F3/0487;;G06F3/04845,G06F3/01;;G06F3/0362;;G06F3/041;;G06F3/0484;;G06F3/0487,,0,0,,,,ACTIVE
849,DK,A1,DK 201870631 A1,079-636-007-451-892,2019-08-27,2019,DK PA201870631 A,2018-09-27,US 201862729978 P,2018-09-11,CONTENT-BASED TACTILE OUTPUTS,"The present disclosure generally relates to content-based tactile outputs. In some embodiments, user interfaces associated with content-based tactile outputs are described. In some embodiments, user interfaces associated with end-of-content tactile outputs are described. In some embodiments, user interfaces associated with moving a user interface in response to different types of input are described. In some embodiments, user interfaces associated with adjustable item-based tactile outputs are described. In some embodiments, user interfaces associated with input velocity-based tactile outputs are described.",APPLE INC,GARY IAN BUTCHER;;CAMILLE MOUSSETTE;;DAVID H BLOOM;;DYLAN ROSS EDWARDS;;JULES K FENNIS;;BRIAN T GLEESON;;MIAO HE,,https://lens.org/079-636-007-451-892,Unknown,no,0,0,31,41,0,G06F3/016;;G06F3/01;;G06F3/0362;;G06F3/048;;G06F3/016;;G06F3/0362;;G06F3/04845;;G06F3/0485;;G06F3/04883;;G06F1/163;;G06F3/0346;;G06F3/016;;G06F1/163;;G06F3/0346;;G06F3/0362;;G06F3/04845;;G06F3/04842;;G06F3/04847;;G06F3/0485;;G06F3/04883;;G06F3/016;;G06F3/04847;;G06F3/0485;;G06F3/0487;;G06F3/04842;;G06F3/04883,G06F3/01;;G06F3/048,,0,0,,,,INACTIVE
850,CA,A1,CA 3116937 A1,118-330-789-037-645,2021-11-20,2021,CA 3116937 A,2021-05-03,US 202016879588 A,2020-05-20,DEVICE CONTROLS,"AB STRACT Systems and techniques for a device controls system are described herein. In an example, a device control system for managing access to personal account data is adapted to receive, from a user device, a set of personalized transaction rules for an account of a user. Each personalized transaction rule may indicate a set of transactional parameters for permitting transactions with a service. The system may be further adapted to receive a transaction request from the service. The transaction request may include contextual data related to the transaction request. The system may be further adapted to determine that the contextual data meets the respective transactional parameters of a personalized transaction rule of the set of personalized transaction rules. The system may be further adapted to transmit, to the service, an indication of permission for the transaction request. Attorney Docket No. 4423.338USi 26 Date Recue/Date Received 2021-05-03",TORONTO DOMINION BANK,BLOOM HARLAN H;;BRIGNONI LIZMARI;;CASTONGUAY MARK DAVID;;CLARKE LISA MUNTER;;HANWELLA UPUL D;;NGUYEN TRACI H;;ULRICH ERICA,,https://lens.org/118-330-789-037-645,Patent Application,no,0,0,2,2,0,G06Q20/405;;G06Q20/4015;;G06Q20/4016;;G06Q20/3263;;G06N20/00;;G06N5/04;;G06N5/025;;G06Q20/3265;;G06Q20/405;;G06Q20/4093;;G06N20/00;;G06Q20/3263,G06F21/60;;G06Q40/02,,0,0,,,,PENDING
851,EP,A2,EP 0460867 A2,098-038-076-689-481,1991-12-11,1991,EP 91304877 A,1991-05-30,US 53259690 A,1990-06-04,Multimedia interface and method for computer system.,"A multimedia interface presents information and receives user commands and data for a computer system. The multimedia interface operates in parallel with another application software module, such as an expert system. To add multimedia features to the application software module, the module is modified so as to generate multimedia commands at the same time as it displays text on a text monitor (58).The multimedia commands, which are held in a queue, provide additional information in the form of video images and generated speech corresponding to the displayed text. In addition, the multimedia commands are split into at least two sets: one set which is dispatched to the user substantially immediately after displaying the corresponding text, and one set which is dispatched upon request by the user. In the preferred embodiment, the multimedia interface presents information to the user through text, graphics, video, sound, speech production, and printed output. User inputs are made through a keyboard (55) and voice recognition (186). In one preferred embodiment two data processing units (165, 230) are used: one (165) for an expert system module and one (230) for a video output processing module. Each module includes its own flat VGA display (58, 86). The video module includes a digital video controller (180) which enables it to display drawings, photographs, still and animated graphics, video stills, full-motion video and motion video with graphic overlays. An optional satellite station (224) facilitates use of the system in environments where it is inconvenient or impossible to bring the complete system.",ELECTRIC POWER RES INST,QUENTIN GEORGE H;;ISLE BRIAN A;;BLOOM CHARLES P;;BUTLER ARCH W;;SPOOR DAVID;;WUNDERLIN DAVID J;;BEDROS RENEE;;CAMPOS FRANCIS M;;SWEET STEPHEN R,,https://lens.org/098-038-076-689-481,Patent Application,yes,0,17,3,3,0,G06F1/1628;;G06F3/0489;;G06F3/16;;G06Q10/10;;H04N5/765;;Y10S715/978;;G06F16/40;;H04N5/765;;G06F1/1628;;G06Q10/10;;G06F3/16;;G06F3/0489;;Y10S715/978;;Y10S706/911;;G06F16/40;;G06F16/48,G06F1/16;;G06F3/023;;G06F3/048;;G06F3/16;;G06F17/30;;G06Q10/10;;H04N5/765,,0,0,,,,DISCONTINUED
852,EP,A1,EP 3801458 A1,061-223-239-339-761,2021-04-14,2021,EP 19733244 A,2019-05-30,US 201862677800 P;;US 2019/0034664 W,2018-05-30,SCREENING ASSAY TO ASSESS TOPICAL DELIVERY OF BIOLOGICAL THERAPEUTIC AGENTS,,ALLERGAN INC,SHEN JIE;;HO HSIANG;;ANDREWS-JONES LYDIA;;BLOOM-SALDANA BETSY;;NICHOLSON GREGORY;;STEWARD LANCE;;BRIDEAU-ANDERSEN AMY;;HUNT TERRENCE;;BROIDE RON;;RUPP DAVID;;CANTY DAVID,,https://lens.org/061-223-239-339-761,Patent Application,yes,0,0,3,3,0,A61K9/0014;;A61K49/0008;;A61K9/0014;;A61K49/0008;;C12Y304/24069;;C12Y304/24069;;G01N33/5082;;G01N33/5082,A61K9/00;;A61K38/48,,1,0,,,See references of WO 2019232218A1,DISCONTINUED
853,EP,A3,EP 0460867 A3,089-420-860-036-151,1992-06-10,1992,EP 91304877 A,1991-05-30,US 53259690 A,1990-06-04,MULTIMEDIA INTERFACE AND METHOD FOR COMPUTER SYSTEM,"A multimedia interface presents information and receives user commands and data for a computer system. The multimedia interface operates in parallel with another application software module, such as an expert system. To add multimedia features to the application software module, the module is modified so as to generate multimedia commands at the same time as it displays text on a text monitor (58).The multimedia commands, which are held in a queue, provide additional information in the form of video images and generated speech corresponding to the displayed text. In addition, the multimedia commands are split into at least two sets: one set which is dispatched to the user substantially immediately after displaying the corresponding text, and one set which is dispatched upon request by the user. In the preferred embodiment, the multimedia interface presents information to the user through text, graphics, video, sound, speech production, and printed output. User inputs are made through a keyboard (55) and voice recognition (186). In one preferred embodiment two data processing units (165, 230) are used: one (165) for an expert system module and one (230) for a video output processing module. Each module includes its own flat VGA display (58, 86). The video module includes a digital video controller (180) which enables it to display drawings, photographs, still and animated graphics, video stills, full-motion video and motion video with graphic overlays. An optional satellite station (224) facilitates use of the system in environments where it is inconvenient or impossible to bring the complete system.","ELECTRIC POWER RESEARCH INSTITUTE, INC","QUENTIN, GEORGE H.;;ISLE, BRIAN A.;;BLOOM, CHARLES P.;;BUTLER, ARCH W.;;SPOOR, DAVID;;WUNDERLIN, DAVID J.;;BEDROS, RENEE;;CAMPOS, FRANCIS M.;;SWEET, STEPHEN R.",,https://lens.org/089-420-860-036-151,Search Report,yes,2,0,3,3,0,G06F1/1628;;G06F3/0489;;G06F3/16;;G06Q10/10;;H04N5/765;;Y10S715/978;;G06F16/40;;H04N5/765;;G06F1/1628;;G06Q10/10;;G06F3/16;;G06F3/0489;;Y10S715/978;;Y10S706/911;;G06F16/40;;G06F16/48,G06F1/16;;G06F3/023;;G06F3/048;;G06F3/16;;G06F17/30;;G06Q10/10;;H04N5/765,,3,2,022-278-236-929-735;;078-172-898-536-689,10.1109/60.4202;;10.1016/0165-6074(87)90027-5,"IEEE TRANSACTIONS ON ENERGY CONVERSION. vol. 3, no. 1, March 1988, NEW YORK, US pages 71 - 77; C.G. KOCH ET AL.: 'INTELLIGENT USER INTERFACE FOR EXPERT SYSTEMS APPLIED TO POWER PLANT MAINTENANCE AND TROUBLESHOOTING';;IEEE COMPUTER SOCIETY OFFICE AUTOMATION SYMPOSIUM 27 April 1987, GAITHERSBURG, MD, US pages 180 - 189; D. WOELK ET AL.: 'MULTIMEDIA APPLICATIONS AND DATABASE REQUIREMENTS';;MICROPROCESSING AND MICROPROGRAMMING. vol. 21, no. 1-5, August 1987, AMSTERDAM, NL pages 119 - 126; C. MILENKOVIC ET AL.: 'PC-BASED MULTIMEDIA MESSAGING SYSTEM'",DISCONTINUED
854,US,A,US 5208745 A,078-864-693-647-956,1993-05-04,1993,US 53259690 A,1990-06-04,US 53259690 A;;US 22349988 A,1988-07-25,Multimedia interface and method for computer system,"A multimedia interface presents information and receives user commands and data for a computer system. The multimedia interface operates in parallel with another application software module, such as an expert system. To add multimedia features to the application software module, the module is modified so as to generate multimedia commands at the same time as it displays text on a text monitor. The multimedia commands, which are held in a queue, provide additional information in the form of video images and generated speech corresponding to the displayed text. In addition, the multimedia commands are split into at least two sets: one set which is dispatched to the user substantially immediately after displaying the corresponding text, and one set which is dispatched upon request by the user. In the preferred embodiment, the multimedia interface presents information to the user through text, graphics, video, sound, speech production, and printed output. User inputs are made through a keyboard and voice recognition. In one preferred embodiment two data processing units are used: one for an expert system module and one for a video output processing module. Each module includes its own flat VGA display. The video module includes a digital video controller which enables it to display drawings, photographs, still and animated graphics, video stills, full-motion video and motion video with graphic overlays. An optional satellite station facilitates use of the system in environments where it is inconvenient or impossible to bring the complete system.",ELECTRIC POWER RES INST,QUENTIN GEORGE H;;ISLE BRIAN A;;BLOOM CHARLES P;;BUTLER ARCH W;;SPOOR DAVID;;WUNDERLIN DAVID J;;BEDROS RENEE;;CAMPOS FRANCIS M;;SWEET STEPHEN R,ELECTRIC POWER RESEARCH INSTITUTE INC (1990-07-10),https://lens.org/078-864-693-647-956,Granted Patent,yes,8,286,3,3,0,G06F1/1628;;G06F3/0489;;G06F3/16;;G06Q10/10;;H04N5/765;;Y10S715/978;;G06F16/40;;H04N5/765;;G06F1/1628;;G06Q10/10;;G06F3/16;;G06F3/0489;;Y10S715/978;;Y10S706/911;;G06F16/40;;G06F16/48,G06F1/16;;G06F3/023;;G06F3/048;;G06F3/16;;G06F17/30;;G06Q10/10;;H04N5/765,364/188;;364/551.01;;364/579;;395/11;;395/12;;395/50;;395/154;;395/161;;395/163;;395/911,4,2,022-278-236-929-735;;172-834-303-238-162,10.1109/60.4202;;10.1109/ms.1987.230090,"Koch et al. IEEE Trans. on Energy conversion vol. 3, No. 1, Mar. 1988, New York, N.Y., pp. 71 77.;;Christodoulakis et al. Browsing Within Time Driven Multimedia Documents Conference on Office Information Systems; Mar. 23, 1988, Palo Alto, Calif., pp. 219 227.;;Gibbs et al. Muse: A Multimedia Filing System ; IEEE Software; vol. 4, No. 2, Mar. 1987, New York, N.Y., p. 414.;;European Search Report/89909367.8 (US 8903111)/Apr. 21, 1992 (ref REC/AOS/P36558).",EXPIRED
855,US,A1,US 2004/0085344 A1,123-495-075-150-415,2004-05-06,2004,US 28586802 A,2002-11-01,US 28586802 A,2002-11-01,GUI for organizational environment,"
   A method and apparatus are described for providing a graphical user interface for a plurality of users under a predetermined format substantially controlled by an employer of the plurality of users. The method includes the steps of disposing a proxy server between the plurality of users and an information resource used by at least one user of the plurality of users and converting information exchanged between the predetermined format substantially controlled by the employer of the user and a predetermined format of the information resource. 
",SALEH NAYEL;;POWER MARK;;PETERS MIKE;;HODSON JEFF;;SHAMBAUGH CRAIG;;FUNCK DAVID;;JAMES ERIC;;BLOOM JOSEPH;;MOSQUERA DAVE;;DEZONNO ANTHONY,SALEH NAYEL;;POWER MARK;;PETERS MIKE;;HODSON JEFF;;SHAMBAUGH CRAIG;;FUNCK DAVID;;JAMES ERIC;;BLOOM JOSEPH;;MOSQUERA DAVE;;DEZONNO ANTHONY,FIRSTPOINT CONTACT TECHNOLOGIES LLC (2004-08-12);;ROCKWELL ELECTRONIC COMMERCE TECHNOLOGIES (2002-10-28);;WILMINGTON TRUST NATIONAL ASSOCIATION AS ADMINISTRATIVE AGENT (2014-11-07),https://lens.org/123-495-075-150-415,Patent Application,yes,18,2,2,2,0,G06F16/258;;G06F16/9577;;G06F40/154;;G06F16/9577;;G06F16/258;;G06F40/154,G06F17/22;;G06F17/30;;G09G5/00,345/733,0,0,,,,EXPIRED
856,EP,A1,EP 0729579 A1,189-674-377-159-296,1996-09-04,1996,EP 95931578 A,1995-08-23,US 9510782 W;;US 29648994 A;;US 42098795 A,1994-08-24,DEVICE FOR USE IN ANALYTE DETECTION ASSAYS,,BIOCIRCUITS CORP,CATHEY CHERYL A;;SAUL TOM;;BLOOM NICOLE D;;RIBI HANS O;;SCHWARTZ HENRY L;;LANGFORD JEFFREY B;;PAUL DAVID J,,https://lens.org/189-674-377-159-296,Patent Application,yes,0,0,6,6,0,B01L3/5027;;B01L3/50273;;B01L3/502738;;B01L7/52;;B01L2200/0684;;B01L2200/10;;B01L2200/16;;B01L2300/0681;;B01L2300/0816;;B01L2300/0867;;B01L2300/087;;B01L2400/0406;;B01L2400/0487;;B01L2400/0677;;B01L2400/0688;;B01L2400/086;;G01N33/54366;;G01N2035/00267;;Y10S436/807;;Y10S436/808;;Y10S436/81;;Y10S436/805;;Y10S435/81;;B01F33/30;;B01F33/452;;G01N33/54366;;B01L7/52;;B01L2400/0688;;B01L2400/086;;B01L3/50273;;B01L2200/0684;;B01L3/502738;;B01L2200/16;;B01L2400/0406;;B01L2400/0677;;B01L2400/0487;;B01L2300/087;;B01L2200/10;;B01L2300/0867;;B01L2300/0681;;B01L2300/0816;;G01N2035/00267;;B01L3/5027;;B01F33/30;;B01F33/452,B01F13/00;;G01N31/00;;B01F13/08;;B01L3/00;;B01L7/00;;G01N21/78;;G01N33/48;;G01N33/53;;G01N33/543;;G01N35/00,,0,0,,,,DISCONTINUED
857,EP,A4,EP 0729579 A4,183-210-703-374-159,1998-07-29,1998,EP 95931578 A,1995-08-23,US 9510782 W;;US 29648994 A;;US 42098795 A,1994-08-24,DEVICE FOR USE IN ANALYTE DETECTION ASSAYS,,BIOCIRCUITS CORP,CATHEY CHERYL A;;SAUL TOM;;BLOOM NICOLE D;;RIBI HANS O;;SCHWARTZ HENRY L;;LANGFORD JEFFREY B;;PAUL DAVID J,,https://lens.org/183-210-703-374-159,Search Report,no,0,0,6,6,0,B01L3/5027;;B01L3/50273;;B01L3/502738;;B01L7/52;;B01L2200/0684;;B01L2200/10;;B01L2200/16;;B01L2300/0681;;B01L2300/0816;;B01L2300/0867;;B01L2300/087;;B01L2400/0406;;B01L2400/0487;;B01L2400/0677;;B01L2400/0688;;B01L2400/086;;G01N33/54366;;G01N2035/00267;;Y10S436/807;;Y10S436/808;;Y10S436/81;;Y10S436/805;;Y10S435/81;;B01F33/30;;B01F33/452;;G01N33/54366;;B01L7/52;;B01L2400/0688;;B01L2400/086;;B01L3/50273;;B01L2200/0684;;B01L3/502738;;B01L2200/16;;B01L2400/0406;;B01L2400/0677;;B01L2400/0487;;B01L2300/087;;B01L2200/10;;B01L2300/0867;;B01L2300/0681;;B01L2300/0816;;G01N2035/00267;;B01L3/5027;;B01F33/30;;B01F33/452,B01F13/00;;G01N31/00;;B01F13/08;;B01L3/00;;B01L7/00;;G01N21/78;;G01N33/48;;G01N33/53;;G01N33/543;;G01N35/00,,1,0,,,No further relevant documents disclosed,DISCONTINUED
858,US,A1,US 2007/0244556 A1,158-261-815-608-38X,2007-10-18,2007,US 73456607 A,2007-04-12,US 73456607 A;;US 79155306 P;;US 79134006 P;;US 79387906 P,2006-04-12,Annuloplasty Device Having a Helical Anchor and Methods for its Use,"A system for modifying a heart valve annulus includes a helically helical anchored annuloplasty device delivered to the annulus via an elongated delivery member. The helical anchors of the devices disclosed herein are rotated into the valve annulus along an anchor guide by using a driver that is movably disposed in the delivery member. A tether is disposed within an inner channel of the helical anchor and a locking device is used to secure the annuloplasty device after the valve annulus has been modified. The annuloplasty device can be delivered to the annulus using, traditional surgical approach or a minimally invasive or catheter based methods.",MEDTRONIC VASCULAR INC,RAFIEE NASSER;;DOUK NAREAK;;BLOOM ELIOT;;FINNEY MICHAEL;;HOUSE MORGAN;;HUYNH RANY;;MAC DONALD STUART;;MAS JUAN-PABLO;;BARONE DAVID,MEDTRONIC VASCULAR INC (2007-04-23),https://lens.org/158-261-815-608-38X,Patent Application,yes,39,228,12,16,0,A61F2/2451;;A61F2/2451;;A61F2/2466,A61F2/24,623/2.11;;623/2.37,0,0,,,,DISCONTINUED
859,US,A1,US 2007/0244557 A1,075-121-582-409-30X,2007-10-18,2007,US 73460407 A,2007-04-12,US 73460407 A;;US 79155306 P;;US 79134006 P;;US 79387906 P,2006-04-12,Minimally Invasive Procedure for Implanting an Annuloplasty Device,"A method for modifying a heart valve annulus includes placing a purse string suture at a puncture site adjacent a heart valve, inserting at least one delivery member through the puncture site, positioning a distal end of the at least one delivery member adjacent a portion of a valve annulus, deploying an annuloplasty device carried within the at least one delivery member and implanting the annuloplasty device into the valve annulus. The method also includes reshaping the heart valve annulus after implantation of the at least one annuloplasty device.",MEDTRONIC VASCULAR INC,RAFIEE NASSER;;DOUK NAREAK;;BLOOM ELIOT;;FINNEY MICHAEL;;HOUSE MORGAN;;HUYNH RANY;;MAC DONALD STUART;;MAS JUAN-PABLO;;BARONE DAVID,MEDTRONIC VASCULAR INC (2007-04-23),https://lens.org/075-121-582-409-30X,Patent Application,yes,6,114,2,16,0,A61F2/2448;;A61F2/2448,A61F2/24,623/2.11;;623/2.37,0,0,,,,ACTIVE
860,EP,A1,EP 3593761 A1,059-731-225-963-394,2020-01-15,2020,EP 19179453 A,2007-04-12,US 79155306 P;;US 79387906 P;;EP 07760577 A;;US 2007/0066546 W,2006-04-12,ANNULOPLASTY DEVICE HAVING A HELICAL ANCHOR,"A system for modifying a heart valve annulus includes a helically helical anchored annuloplasty device delivered to the annulus via an elongated delivery member (720). The helical anchors (745) of the devices disclosed herein are rotated into the valve annulus along an anchor guide (725) by using a driver (730) that is movably disposed in the delivery member. A tether (750) is disposed within an inner channel of the helical anchor and a locking device is used to secure the annuloplasty device after the valve annulus has been modified. The annuloplasty device can be delivered to the annulus using, traditional surgical approach or a minimally invasive or catheter based methods.
",MEDTRONIC VASCULAR INC,RAFIEE NASSER;;BLOOM ELIOT;;FINNEY MICHAEL;;HOUSE MORGAN;;HUYNH RANY;;MAC DONALD STUART;;MAS JUAN-PABLO;;BARONE DAVID;;DOUK NAREAK,,https://lens.org/059-731-225-963-394,Patent Application,yes,6,0,12,16,0,A61F2/2451;;A61F2/2451;;A61F2/2466,A61F2/24,,0,0,,,,PENDING
861,US,A1,US 2007/0244554 A1,122-061-323-804-576,2007-10-18,2007,US 73454707 A,2007-04-12,US 73454707 A;;US 79155306 P;;US 79134006 P;;US 79387906 P,2006-04-12,Annuloplasty Device Having a Helical Anchor and Methods for its Use,"A system for modifying a heart valve annulus includes a helically helical anchored annuloplasty device delivered to the annulus via an elongated delivery member. The helical anchors of the devices disclosed herein are rotated into the valve annulus along an anchor guide by using a driver that is movably disposed in the delivery member. A tether is disposed within an inner channel of the helical anchor and a locking device is used to secure the annuloplasty device after the valve annulus has been modified. The annuloplasty device can be delivered to the annulus using, traditional surgical approach or a minimally invasive or catheter based methods.",MEDTRONIC VASCULAR INC,RAFIEE NASSER;;DOUK NAREAK;;BLOOM ELIOT;;FINNEY MICHAEL;;HOUSE MORGAN;;HUYNH RANY;;MAC DONALD STUART;;MAS JUAN-PABLO;;BARONE DAVID,MEDTRONIC VASCULAR INC (2007-04-23),https://lens.org/122-061-323-804-576,Patent Application,yes,2,188,12,16,0,A61F2/2451;;A61F2/2451;;A61F2/2466,A61F2/24,623/2.11;;623/2.36,0,0,,,,DISCONTINUED
862,WO,A1,WO 1996/006354 A1,156-963-762-114-91X,1996-02-29,1996,US 9510782 W,1995-08-23,US 29648994 A;;US 42098795 A,1994-08-24,DEVICE FOR USE IN ANALYTE DETECTION ASSAYS,"A device and method for its use in diagnostic assays are provided. The device comprises at least one assay path (2), where an assay path includes a main flow path (4), and at least one side reagent channel (6). The main flow path (4) begins at a sample addition port (10), continues through a main reagent area (12) into an incubation area (18) and ends in a waste area (20). At least one fluid interruption means (28) located at various positions along the main flow path (4) and side reagent channel (6) upstream from the incubation area provide for control over reagent interaction and fluid flow through the device.",BIOCIRCUITS CORP,CATHEY CHERYL A;;SAUL TOM;;BLOOM NICOLE D;;RIBI HANS O;;SCHWARTZ HENRY L;;LANGFORD JEFFREY B;;PAUL DAVID J,,https://lens.org/156-963-762-114-91X,Patent Application,yes,3,19,6,6,0,B01L3/5027;;B01L3/50273;;B01L3/502738;;B01L7/52;;B01L2200/0684;;B01L2200/10;;B01L2200/16;;B01L2300/0681;;B01L2300/0816;;B01L2300/0867;;B01L2300/087;;B01L2400/0406;;B01L2400/0487;;B01L2400/0677;;B01L2400/0688;;B01L2400/086;;G01N33/54366;;G01N2035/00267;;Y10S436/807;;Y10S436/808;;Y10S436/81;;Y10S436/805;;Y10S435/81;;B01F33/30;;B01F33/452;;G01N33/54366;;B01L7/52;;B01L2400/0688;;B01L2400/086;;B01L3/50273;;B01L2200/0684;;B01L3/502738;;B01L2200/16;;B01L2400/0406;;B01L2400/0677;;B01L2400/0487;;B01L2300/087;;B01L2200/10;;B01L2300/0867;;B01L2300/0681;;B01L2300/0816;;G01N2035/00267;;B01L3/5027;;B01F33/30;;B01F33/452,B01F13/00;;G01N31/00;;B01F13/08;;B01L3/00;;B01L7/00;;G01N21/78;;G01N33/48;;G01N33/53;;G01N33/543;;G01N35/00,,1,0,,,See also references of EP 0729579A4,PENDING
863,US,B2,US 7363588 B2,006-016-577-009-873,2008-04-22,2008,US 28586802 A,2002-11-01,US 28586802 A,2002-11-01,GUI for organizational environment,A method and apparatus are described for providing a graphical user interface for a plurality of users under a predetermined format substantially controlled by an employer of the plurality of users. The method includes the steps of disposing a proxy server between the plurality of users and an information resource used by at least one user of the plurality of users and converting information exchanged between the predetermined format substantially controlled by the employer of the user and a predetermined format of the information resource.,ROCKWELL ELECTRONIC COMMERCE,SALEH NAYEL;;POWERS MARK;;PETERS MIKE;;HODSON JEFF;;SHAMBAUGH CRAIG;;FUNCK DAVID;;JAMES ERIC;;BLOOM JOSEPH;;MOSQUERA DAVE;;DEZONNO ANTHONY,FIRSTPOINT CONTACT TECHNOLOGIES LLC (2004-08-12);;ROCKWELL ELECTRONIC COMMERCE TECHNOLOGIES (2002-10-28);;WILMINGTON TRUST NATIONAL ASSOCIATION AS ADMINISTRATIVE AGENT (2014-11-07),https://lens.org/006-016-577-009-873,Granted Patent,yes,41,5,2,2,0,G06F16/258;;G06F16/9577;;G06F40/154;;G06F16/9577;;G06F16/258;;G06F40/154,G09G5/00;;G06F17/22;;G06F17/30;;G06K15/00,715/746;;715/749,3,0,,,"Angel, Jonathan. IT Architect-Proxy Servers. United Business Media: Apr. 1, 1999. p. 1.;;Examiner's Automated Search Tool (EAST). United States Patent & Trademark Office. Version 2.0.1 (1999).;;Microsoft Word 2000. Microsoft Corporation. 9.0.6926 (1999).",ACTIVE
864,US,B2,US 7699892 B2,061-010-681-689-28X,2010-04-20,2010,US 73460407 A,2007-04-12,US 73460407 A;;US 79155306 P;;US 79134006 P;;US 79387906 P,2006-04-12,Minimally invasive procedure for implanting an annuloplasty device,"A method for modifying a heart valve annulus includes placing a purse string suture at a puncture site adjacent a heart valve, inserting at least one delivery member through the puncture site, positioning a distal end of the at least one delivery member adjacent a portion of a valve annulus, deploying an annuloplasty device carried within the at least one delivery member and implanting the annuloplasty device into the valve annulus. The method also includes reshaping the heart valve annulus after implantation of the at least one annuloplasty device.",MEDTRONIC VASCULAR INC,RAFIEE NASSER;;DOUK NAREAK;;BLOOM ELIOT;;FINNEY MICHAEL;;HOUSE MORGAN;;HUYNH RANY;;MAC DONALD STUART;;MAS JUAN-PABLO;;BARONE DAVID,MEDTRONIC VASCULAR INC (2007-04-23),https://lens.org/061-010-681-689-28X,Granted Patent,yes,46,176,2,16,0,A61F2/2448;;A61F2/2448,A61F2/24,623/2.37;;623/2.36;;128/898,0,0,,,,ACTIVE
865,EP,B1,EP 2010102 B1,154-321-347-637-724,2019-06-12,2019,EP 07760577 A,2007-04-12,US 2007/0066546 W;;US 79155306 P;;US 79387906 P,2006-04-12,ANNULOPLASTY DEVICE HAVING A HELICAL ANCHOR,,MEDTRONIC VASCULAR INC;;DOUK NAREAK,RAFIEE NASSER;;BLOOM ELIOT;;FINNEY MICHAEL;;HOUSE MORGAN;;HUYNH RANY;;MAC DONALD STUART;;MAS JUAN-PABLO;;BARONE DAVID;;DOUK NAREAK,"MEDTRONIC VASCULAR, INC. (2019-10-02);;MEDTRONIC VASCULAR, INC., SANTA ROSA, US (2019-10-09);;MEDTRONIC VASCULAR, INC., US (2019-12-23)",https://lens.org/154-321-347-637-724,Granted Patent,yes,5,16,12,16,0,A61F2/2451;;A61F2/2466;;A61F2/2451,A61F2/24,,0,0,,,,ACTIVE
866,US,A1,US 2007/0244555 A1,020-460-764-410-177,2007-10-18,2007,US 73455507 A,2007-04-12,US 73455507 A;;US 79155306 P;;US 79134006 P;;US 79387906 P,2006-04-12,Annuloplasty Device Having a Helical Anchor and Methods for its Use,"A system for modifying a heart valve annulus includes a helically helical anchored annuloplasty device delivered to the annulus via an elongated delivery member. The helical anchors of the devices disclosed herein are rotated into the valve annulus along an anchor guide by using a driver that is movably disposed in the delivery member. A tether is disposed within an inner channel of the helical anchor and a locking device is used to secure the annuloplasty device after the valve annulus has been modified. The annuloplasty device can be delivered to the annulus using, traditional surgical approach or a minimally invasive or catheter based methods.",MEDTRONIC VASCULAR INC,RAFIEE NASSER;;DOUK NAREAK;;BLOOM ELIOT;;FINNEY MICHAEL;;HOUSE MORGAN;;HUYNH RANY;;MAC DONALD STUART;;MAS JUAN-PABLO;;BARONE DAVID,MEDTRONIC VASCULAR INC (2007-04-23),https://lens.org/020-460-764-410-177,Patent Application,yes,24,200,1,16,0,A61F2/2445;;A61F2/2445;;A61F2/2466;;A61F2/2466,A61F2/24,623/2.11;;623/2.36,0,0,,,,DISCONTINUED
867,US,A,US 5798215 A,054-981-148-026-515,1998-08-25,1998,US 42098795 A,1995-04-06,US 42098795 A;;US 29648994 A;;US 17974994 A;;US 1946993 A,1993-02-18,Device for use in analyte detection assays,"A device and method for its use in diagnostic assays are provided. The device comprises at least one assay path, where an assay path includes a main flow path and at least one side reagent channel. The main flow path begins at a sample addition port, continues through a main reagent area into an incubation area and ends in a waste area. In fluid communication with the main flow path is at least one side reagent channel that begins at a liquid addition port, continues through a side reagent area and ends in said main channel at a region between the main reagent and waste areas, usually upstream from the incubation area. Agitation means may be included in at least one of the main and side reagent areas and/or the incubation area. At least one fluid interruption means located at various positions along the main and side reagent channels upstream from the incubation area provide for control over reagent interaction and fluid flow through the device. Applications in which the device finds use include diagnostic assays employing signal producing systems based on the interactions of specific binding pair members, where an optical signal is related to the presence of analyte.",BIOCIRCUITS CORP,CATHEY CHERYL A;;SAUL TOM;;BLOOM NICOLE D;;RIBI HANS O;;SCHWARTZ HENRY L;;LANGFORD JEFFREY B;;PAUL DAVID J,VENTURE LENDING A DIVISION OF CUPERTINO NATIONAL BANK & TRUST (1996-04-04);;BIOCIRCUITS CORPORATION (1996-04-18),https://lens.org/054-981-148-026-515,Granted Patent,yes,18,146,6,6,0,B01L3/5027;;B01L3/50273;;B01L3/502738;;B01L7/52;;B01L2200/0684;;B01L2200/10;;B01L2200/16;;B01L2300/0681;;B01L2300/0816;;B01L2300/0867;;B01L2300/087;;B01L2400/0406;;B01L2400/0487;;B01L2400/0677;;B01L2400/0688;;B01L2400/086;;G01N33/54366;;G01N2035/00267;;Y10S436/807;;Y10S436/808;;Y10S436/81;;Y10S436/805;;Y10S435/81;;B01F33/30;;B01F33/452;;G01N33/54366;;B01L7/52;;B01L2400/0688;;B01L2400/086;;B01L3/50273;;B01L2200/0684;;B01L3/502738;;B01L2200/16;;B01L2400/0406;;B01L2400/0677;;B01L2400/0487;;B01L2300/087;;B01L2200/10;;B01L2300/0867;;B01L2300/0681;;B01L2300/0816;;G01N2035/00267;;B01L3/5027;;B01F33/30;;B01F33/452,B01F13/00;;B01F13/08;;B01L3/00;;G01N31/00;;B01L7/00;;G01N21/78;;G01N33/48;;G01N33/53;;G01N33/543;;G01N35/00,435/7.9;;422/55;;422/57;;422/58;;422/61;;435/7.92;;435/7.93;;435/7.94;;435/287.1;;435/287.2;;435/288.4;;435/288.5;;435/288.7;;435/810;;436/514;;436/518;;436/524;;436/527;;436/528;;436/164;;436/172;;436/537;;436/805;;436/807;;436/808;;436/810,0,0,,,,EXPIRED
868,CA,A1,CA 2173358 A1,112-920-625-838-843,1996-02-29,1996,CA 2173358 A,1995-08-23,US 29648994 A;;US 42098795 A,1994-08-24,DEVICE FOR USE IN ANALYTE DETECTION ASSAYS,"A device and method for its use in diagnostic assays are provided. The device comprises at least one assay path (2), where an assay path includes a main flow path (4), and at least one side reagent channel (6). The main flow path (4) begins at a sample addition port (10), continues through a main reagent area (12) into an incubation area (18) and ends in a waste area (20). At least one fluid interruption means (28) located at various positions along the main flow path (4) and side reagent channel (6) upstream from the incubation area provide for control over reagent interaction and fluid flow through the device.",BIOCIRCUITS CORP,CATHEY CHERYL A;;SAUL TOM;;BLOOM NICOLE D;;RIBI HANS O;;SCHWARTZ HENRY L;;LANGFORD JEFFREY B;;PAUL DAVID J,,https://lens.org/112-920-625-838-843,Patent Application,no,0,0,6,6,0,B01L3/5027;;B01L3/50273;;B01L3/502738;;B01L7/52;;B01L2200/0684;;B01L2200/10;;B01L2200/16;;B01L2300/0681;;B01L2300/0816;;B01L2300/0867;;B01L2300/087;;B01L2400/0406;;B01L2400/0487;;B01L2400/0677;;B01L2400/0688;;B01L2400/086;;G01N33/54366;;G01N2035/00267;;Y10S436/807;;Y10S436/808;;Y10S436/81;;Y10S436/805;;Y10S435/81;;B01F33/30;;B01F33/452;;G01N33/54366;;B01L7/52;;B01L2400/0688;;B01L2400/086;;B01L3/50273;;B01L2200/0684;;B01L3/502738;;B01L2200/16;;B01L2400/0406;;B01L2400/0677;;B01L2400/0487;;B01L2300/087;;B01L2200/10;;B01L2300/0867;;B01L2300/0681;;B01L2300/0816;;G01N2035/00267;;B01L3/5027;;B01F33/30;;B01F33/452,G01N31/00;;B01F13/00;;B01F13/08;;B01L3/00;;B01L7/00;;G01N21/78;;G01N33/48;;G01N33/53;;G01N33/543;;G01N35/00,,0,0,,,,DISCONTINUED
869,US,A1,US 2007/0244553 A1,115-922-818-777-731,2007-10-18,2007,US 73453607 A,2007-04-12,US 73453607 A;;US 79155306 P;;US 79134006 P;;US 79387906 P,2006-04-12,Annuloplasty Device Having a Helical Anchor and Methods for its Use,"A system for modifying a heart valve annulus includes a helically helical anchored annuloplasty device delivered to the annulus via an elongated delivery member. The helical anchors of the devices disclosed herein are rotated into the valve annulus along an anchor guide by using a driver that is movably disposed in the delivery member. A tether is disposed within an inner channel of the helical anchor and a locking device is used to secure the annuloplasty device after the valve annulus has been modified. The annuloplasty device can be delivered to the annulus using, traditional surgical approach or a minimally invasive or catheter based methods.",MEDTRONIC VASCULAR INC,RAFIEE NASSER;;DOUK NAREAK;;BLOOM ELIOT;;FINNEY MICHAEL;;HOUSE MORGAN;;HUYNH RANY;;MAC DONALD STUART;;MAS JUAN-PABLO;;BARONE DAVID,MEDTRONIC VASCULAR INC (2007-04-23),https://lens.org/115-922-818-777-731,Patent Application,yes,44,154,12,16,0,A61F2/2451;;A61F2/2451;;A61F2/2466,A61F2/24,623/2.11;;623/2.36,0,0,,,,ACTIVE
870,US,B2,US 8454683 B2,148-037-724-304-453,2013-06-04,2013,US 73453607 A,2007-04-12,US 73453607 A;;US 79155306 P;;US 79134006 P;;US 79387906 P,2006-04-12,Annuloplasty device having a helical anchor and methods for its use,"A system for modifying a heart valve annulus includes a helically helical anchored annuloplasty device delivered to the annulus via an elongated delivery member. The helical anchors of the devices disclosed herein are rotated into the valve annulus along an anchor guide by using a driver that is movably disposed in the delivery member. A tether is disposed within an inner channel of the helical anchor and a locking device is used to secure the annuloplasty device after the valve annulus has been modified. The annuloplasty device can be delivered to the annulus using, traditional surgical approach or a minimally invasive or catheter based methods.",RAFIEE NASSER;;DOUK NAREAK;;BLOOM ELIOT;;FINNEY MICHAEL;;HOUSE MORGAN;;HUYNH RANY;;MAC DONALD STUART;;MAS JUAN-PABLO;;BARONE DAVID;;MEDTRONIC VASCULAR INC,RAFIEE NASSER;;DOUK NAREAK;;BLOOM ELIOT;;FINNEY MICHAEL;;HOUSE MORGAN;;HUYNH RANY;;MAC DONALD STUART;;MAS JUAN-PABLO;;BARONE DAVID,MEDTRONIC VASCULAR INC (2007-04-23),https://lens.org/148-037-724-304-453,Granted Patent,yes,52,47,12,16,0,A61F2/2451;;A61F2/2451;;A61F2/2466,A61F2/24,623/2.11,0,0,,,,ACTIVE
871,CR,A,CR 20140228 A,186-597-209-371-591,2014-08-21,2014,CR 20140228 A,2014-05-14,US 201161547620 P;;US 201261606207 P,2011-10-14,DISPERSIÓN SÓLIDA,"En el presente documento se describe una dispersión sólida de N4-(4-([1,2,4] triazolo [1,5-a]piridina-7-iloxi)-3-metilfenil)-N6-(4,4-dimetil-4,5-dihidrooxazol-2-il) quinazolina-4,6-diamina y los procesos para preparar la dispersión sólida. Además, se des",ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/186-597-209-371-591,Patent Application,no,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/14;;A61K9/20;;A61K31/498;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,PENDING
872,AU,C1,AU 2017/210499 C1,177-215-443-609-948,2021-04-29,2021,AU 2017/210499 A,2017-07-31,AU 2017/210499 A;;AU 2012/322039 A;;US 201161547620 P;;US 201261606207 P;;US 2012/0060044 W,2011-10-14,SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR,"[0001581 A solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3 methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3 methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.",ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/177-215-443-609-948,Amended Patent,no,3,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/14;;A61K9/20;;A61K31/498;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,ACTIVE
873,CA,A1,CA 2451580 A1,194-346-488-518-94X,2003-01-09,2003,CA 2451580 A,2002-06-25,US 30193401 P;;US 0220526 W,2001-06-29,ARTIFICIAL SYNAPSE CHIP INTERFACE FOR ELECTRONIC PROSTHETIC RETINA,The invention provides microfabricated devices and methods for directing the growth of a cell process to form an artificial synapse. The devices are call ed artificial synapse chips. The artificial synapse comprises a nanofabricated aperture (about 50-100 nm in size) that connects the cell process to a chemical or electrical means of neuronal excitation. Such an aperture width mimics the length scales of a natural synapse and thus emphasizes the localized spatial relationship between a neuron and a stimulation source. Th e invention further provides devices and methods for regenerating a nerve fibe r into an electrode. The invention thus provides a regeneration electrode that uses a novel neural interface for stimulation and that uses novel surface methods for directing neuronal growth making possible in vivo connection of the devices to neural circuitry in a retina and other anatomical locations.< /SDOAB>,UNIV LELAND STANFORD JUNIOR,ZIEBARTH JONATHAN M;;PETERMAN MARK C;;BENT STACEY FRANCINE;;BLOOM DAVID M;;LEE CHRISTINE;;LENG THEODORE;;BLUMENKRANZ MARK;;FISHMAN HARVEY A,,https://lens.org/194-346-488-518-94X,Patent Application,no,0,0,15,15,0,A61N1/0543;;A61N1/326;;A61N1/36046;;C12M35/00;;C12M35/02;;C12M35/08;;C12N5/0619;;C12N2503/00;;C12N2535/10;;A61N1/36046;;A61N1/0543;;C12M35/00;;C12M35/02;;C12M35/08;;A61N1/326;;C12N5/0619;;C12N2503/00;;C12N2535/10,A61K9/22;;A61L27/00;;A61N1/05;;A61N1/36;;C12M1/42;;C12M3/00;;C12N5/0793,,0,0,,,,DISCONTINUED
874,US,A1,US 2003/0032946 A1,083-009-050-701-967,2003-02-13,2003,US 18421002 A,2002-06-27,US 18421002 A;;US 30193401 P,2001-06-29,Artificial synapse chip interface for electronic prosthetic retina,"
    The invention provides microfabricated devices and methods for directing the growth of a cell process to form an artificial synapse. The devices are called artificial synapse chips. The artificial synapse comprises a nanofabricated aperture (about 50 - 100  nm in size) that connects the cell process to a chemical or electrical means of neuronal excitation. Such an aperture width mimics the length scales of a natural synapse and thus emphasizes the localized spatial relationship between a neuron and a stimulation source. The invention further provides devices and methods for regenerating a nerve fiber into an electrode. The invention thus provides a regeneration electrode that uses a novel neural interface for stimulation and that uses novel surface methods for directing neuronal growth making possible in vivo connection of the devices to neural circuitry in a retina and other anatomical locations. 
",FISHMAN HARVEY A.;;BLUMENKRANZ MARK;;BENT STACEY F.;;BLOOM DAVID M.;;PETERMAN MARK C.;;ZIEBARTH JONATHAN M.;;LEE CHRISTINA;;LENG THEODORE,FISHMAN HARVEY A;;BLUMENKRANZ MARK;;BENT STACEY F;;BLOOM DAVID M;;PETERMAN MARK C;;ZIEBARTH JONATHAN M;;LEE CHRISTINA;;LENG THEODORE,BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY THE (2002-08-31),https://lens.org/083-009-050-701-967,Patent Application,yes,4,53,15,15,0,A61N1/0543;;A61N1/326;;A61N1/36046;;C12M35/00;;C12M35/02;;C12M35/08;;C12N5/0619;;C12N2503/00;;C12N2535/10;;A61N1/36046;;A61N1/0543;;C12M35/00;;C12M35/02;;C12M35/08;;A61N1/326;;C12N5/0619;;C12N2503/00;;C12N2535/10,A61K9/22;;A61L27/00;;A61N1/05;;A61N1/36;;C12M1/42;;C12M3/00;;C12N5/0793,604/890.1;;435/289.1,0,0,,,,EXPIRED
875,BR,A2,BR 112014009092 A2,082-039-872-629-061,2017-04-18,2017,BR 112014009092 A,2012-10-12,US 2012/0060044 W;;US 201161547620 P;;US 201261606207 P,2011-10-14,dispersão sólida,"abstract a solid dispersion of n4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-n6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. also, a pharmaceutical composition comprising a solid dispersion of n4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-n6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein. ___________________________________ tradução do resumo resumo patente de invenção: ""dispersão sólida"". uma dispersão sólida de n4-(4-([1,2,4]triazol[1,5-a]piridino-7-ilóxi)-3-metilfenil)-n6-(4,4-dimetil-4,5-diidrooxazol-2-ilo)quinazolina-4,6-diamina e processos de preparação a dispersão sólida estão aqui fornecidos. além disso, uma composição farmacêutica que compreen-de uma dispersão sólida de n4- (4- ([1,2,4]triazol[1,5-a]piridino-7-ilóxi)-3-metilfenil)-n6-(4,4-dimetil-4,5-diidrooxazol-2-ilo)quinazolina-4,6-diamina e respectivas utilizações são fornecidas neste documento.",ARRAY BIOPHARMA INC,CHRISTOPHER DONAVAN CRAIG;;CHRISTOPHER M LINDEMANN;;COREY JAY BLOOM;;DAN SMITHEY;;DAVID SHANK FRY;;DEVON BREVARD DUBOSE;;JEFF GAUTSCHI;;MICHAEL PREIGH,,https://lens.org/082-039-872-629-061,Patent Application,no,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/14;;A61K9/20;;A61K31/498;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,ACTIVE
876,AU,B2,AU 2003/200737 B2,156-682-778-099-987,2009-11-19,2009,AU 2003/200737 A,2003-02-28,US 11448702 A,2002-04-02,Contact center data integration with enterprise applications,,FIRSTPOINT CONTACT TECHNOLOGIES LLC,HODSON JEFFREY;;POWER MARK J;;SHAMBAUGH CRAIG;;FUNCK DAVID;;BLOOM JOSEPH;;JAMES ERIC;;MOSQUERA DAVE;;SALEH NAYEL;;PETERS MICHAEL;;DEZONNO ANTHONY,"ROCKWELL ELECTRONIC COMMERCE TECHNOLOGIES, LLC (2005-04-14)",https://lens.org/156-682-778-099-987,Granted Patent,no,2,0,7,7,0,H04M3/42068;;H04M3/523;;H04M2201/38;;H04M3/523;;H04M2201/38;;H04M3/42068,H04M3/523,,0,0,,,,EXPIRED
877,KR,A,KR 20140075798 A,160-827-005-474-473,2014-06-19,2014,KR 20147012944 A,2012-10-12,US 201161547620 P;;US 201261606207 P;;US 2012/0060044 W,2011-10-14,SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR,,ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/160-827-005-474-473,Patent Application,no,2,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K47/32;;A61K9/14;;A61K31/498;;A61K47/38,,0,0,,,,ACTIVE
878,CN,A,CN 108498465 A,186-685-228-585-464,2018-09-07,2018,CN 201810490376 A,2012-10-12,US 201161547620 P;;US 201261606207 P;;CN 201280061909 A;;US 2012/0060044 W,2011-10-14,Solid dispersions of a Erb2 (HER2) inhibitor,"A solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion areprovided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.",ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/186-685-228-585-464,Patent Application,no,3,2,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/16;;A61K31/517;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,ACTIVE
879,AU,A1,AU 2003/200674 A1,192-075-780-421-622,2003-09-25,2003,AU 2003/200674 A,2003-02-26,US 9049902 A,2002-03-04,Intelligent interactive voice response unit,,ROCKWELL ELECTRONIC COMMERCE,SALEH NAYEL;;SHAMBAUGH CRAIG;;PETERS MICHAEL;;FUNCK DAVID;;HODSON JEFFREY;;MOSQUERA DAVE;;POWER MARK J;;JAMES ERIC;;BLOOM JOSEPH;;DEZONNO ANTHONY,"ROCKWELL ELECTRONIC COMMERCE TECHNOLOGIES, LLC (2005-04-14)",https://lens.org/192-075-780-421-622,Patent Application,no,0,0,6,6,0,H04M3/4938;;H04M3/5166;;H04M3/5191;;H04M3/4938;;H04M3/5166;;H04M3/5191,H04M3/493;;H04M3/51,,0,0,,,,EXPIRED
880,CA,C,CA 2852058 C,013-774-398-161-219,2021-06-01,2021,CA 2852058 A,2012-10-12,US 201161547620 P;;US 201261606207 P;;US 2012/0060044 W,2011-10-14,"A SOLID DISPERSION OF N4-(4-([1,2,4]TRIAZOLO[1,5-A]PYRIDIN-7-YLOXY)-3-METHYLPHENYL)-N6-(4,4-DIMETHYL-4,5-DIHYDROOXAZOL-2-YL)QUINAZOLINE-4,6-DIAMINE","A solid dispersion of N4-(4-([1, 2, 4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3- methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.",ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/013-774-398-161-219,Granted Patent,no,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,ACTIVE
881,CA,A1,CA 2852058 A1,024-392-299-480-762,2013-04-18,2013,CA 2852058 A,2012-10-12,US 201161547620 P;;US 201261606207 P;;US 2012/0060044 W,2011-10-14,SOLID DISPERSION,"A solid dispersion of N4-(4-([1, 2, 4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3- methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.",ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/024-392-299-480-762,Patent Application,no,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/14;;A61K9/20;;A61K31/498;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,ACTIVE
882,MY,A,MY 169072 A,072-010-770-613-411,2019-02-12,2019,MY PI2014700908 A,2012-10-12,US 201161547620 P;;US 201261606207 P,2011-10-14,SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR,"A solid dispersion of N4-(4-([l,2,4]triazolo[l,5-a]pyridin-7-yloxy)-3-methylphenyl)- N6-( 4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([l,2,4]triazolo[l,5-a]pyridin-7-yloxy)-3- methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.",ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/072-010-770-613-411,Granted Patent,no,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,,,0,0,,,,ACTIVE
883,ME,B,ME 02913 B,173-872-124-288-889,2018-04-20,2018,ME P2017256 A,2012-10-12,US 201161547620 P;;US 201261606207 P;;EP 12809373 A;;US 2012/0060044 W,2011-10-14,SOLID DISPERSION,,ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/173-872-124-288-889,Granted Patent,no,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/10;;A61K9/14;;A61K9/16;;A61K9/20;;A61K31/498;;A61K31/517;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,ACTIVE
884,JP,A,JP 2016027062 A,193-791-803-983-825,2016-02-18,2016,JP 2015223018 A,2015-11-13,US 201161547620 P;;US 201261606207 P,2011-10-14,SOLID DISPERSION,"PROBLEM TO BE SOLVED: To provide a solid dispersion.SOLUTION: A solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. In addition, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.SELECTED DRAWING: Figure 1",ARRAY BIOPHARMA INC,DAVID SHANK FRY;;CHRISTOPHER M LINDEMANN;;MICHAEL PREIGH;;COREY JAY BLOOM;;CHRISTOPHER DONOVAN CRAIG;;DEVON BREVARD DUBOSE;;JEFF GAUTSCHI;;DAN SMITHEY,,https://lens.org/193-791-803-983-825,Patent Application,no,3,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K31/517;;A61K9/14;;A61K9/20;;A61K47/02;;A61K47/32;;A61K47/34;;A61K47/38;;A61P35/00,,3,0,,,"JPN6009001016; 岡本浩一: '製剤関係分野シンポジウムレポート' ＰＨＡＲＭ ＴＥＣＨ ＪＡＰＡＮ ８月号 Ｖｏｌ．２０， Ｎｏ．９, ｐ．１７８３-１７８５;;JPN6013023554; ＦＲＩＳＥＮ．Ｄ．Ｔ． ｅｔ ａｌ．: 'Ｈｙｄｒｏｘｙｐｒｏｐｙｌ Ｍｅｔｈｙｌｃｅｌｌｕｌｏｓｅ Ａｃｅｔａｔｅ Ｓｕｃｃｉｎａｔｅ-Ｂａｓｅｄ Ｓｐｒａｙ-Ｄｒｉｅｄ Ｄｉｓｐｅｒｓｉｏｎｓ： Ａｎ Ｏｖｅｒｖｉｅｗ' Ｍｏｌｅｃｕｌａｒ Ｐｈａｒｍａｃｅｕｔｉｃｓ Ｖｏ．５， Ｎｏ．６, ｐ．１００３-１０１９;;JPN6013023555; ＬＥＵＮＥＲ，Ｃ． ｅｔ ａｌ．: 'Ｉｍｐｒｏｖｉｎｇ ｄｒｕｇ ｓｏｌｕｂｉｌｉｔｙ ｆｏｒ ｏｒａｌ ｄｅｌｉｖｅｒｙ ｕｓｉｎｇ ｓｏｌｉｄ ｄｉｓｐｅｒｓｉｏｎｓ' Ｅｕｒｏｐｅａｎ Ｊｏｕｒｎａｌ ｏｆ Ｐｈａｒｍａｃｅｕｔｉｃｓ ａｎｄ Ｂｉｏｐｈａｒｍａｃｅｕｔｉｃｓ Ｖｏｌ．５０， Ｎｏ．１, 2000, ｐ．４７-６０",PENDING
885,BR,B1,BR 112014009092 B1,010-755-324-716-215,2022-01-18,2022,BR 112014009092 A,2012-10-12,US 2012/0060044 W;;US 201161547620 P;;US 201261606207 P,2011-10-14,"Dispersão sólida, composição farmacêutica compreendendo a referida dispersão, usos da composição farmacêutica e processo de preparação de uma dispersão sólida","dispersão sólida. uma dispersão sólida de n4-(4-([1,2,4]triazol[1,5-a]piridino-7-ilóxi)-3-metilfenil)-n6-(4,4-dimetil-4,5-diidrooxazol-2-ilo)quinazolina-4,6-diamina e processos de preparação a dispersão sólida estão aqui fornecidos. além disso, uma composição farmacêutica que compreen-de uma dispersão sólida de n4- (4- ([1,2,4]triazol[1,5-a]piridino-7-ilóxi)-3-metilfenil)-n6-(4,4-dimetil-4,5-diidrooxazol-2-ilo)quinazolina-4,6-diamina e respectivas utilizações são fornecidas neste documento.",ARRAY BIOPHARMA INC,CHRISTOPHER DONAVAN CRAIG;;CHRISTOPHER M LINDEMANN;;COREY JAY BLOOM;;SMITHEY DAN;;DAVID SHANK FRY;;DEVON BREVARD DUBOSE;;GAUTSCHI JEFF;;PREIGH MICHAEL,,https://lens.org/010-755-324-716-215,Granted Patent,no,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/14;;A61K9/20;;A61K31/498;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,ACTIVE
886,TW,A,TW 201330876 A,014-904-337-875-743,2013-08-01,2013,TW 101137971 A,2012-10-15,US 201161547620 P;;US 201261606207 P,2011-10-14,Solid dispersion,"A solid dispersion of N4-(4-([1, 2, 4]triazolo[1, 5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4, 4-dimethyl-4, 5-dihydrooxazol-2-yl)quinazoline-4, 6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1, 2, 4]triazolo[1, 5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4, 4-dimethyl-4, 5-dihydrooxazol-2-yl)quinazoline-4, 6-diamine and uses thereof are provided herein.",ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;GAUTSCHI JEFF;;SMITHEY DAN;;DUBOSE DEVON BREVARD,,https://lens.org/014-904-337-875-743,Patent of Addition,no,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/14;;A61K9/20;;A61K31/517;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,ACTIVE
887,AU,B2,AU 2003/200674 B2,074-268-885-542-925,2007-06-07,2007,AU 2003/200674 A,2003-02-26,US 9049902 A,2002-03-04,Intelligent interactive voice response unit,,ROCKWELL ELECTRONIC COMMERCE TECHNOLOGIES LLC,DEZONNO ANTHONY;;PETERS MICHAEL;;HODSON JEFFREY;;JAMES ERIC;;SHAMBAUGH CRAIG;;POWER MARK J;;BLOOM JOSEPH;;FUNCK DAVID;;MOSQUERA DAVE;;SALEH NAYEL,"ROCKWELL ELECTRONIC COMMERCE TECHNOLOGIES, LLC (2005-04-14)",https://lens.org/074-268-885-542-925,Granted Patent,no,1,1,6,6,0,H04M3/4938;;H04M3/5166;;H04M3/5191;;H04M3/4938;;H04M3/5166;;H04M3/5191,H04M3/493;;H04M3/51,,2,0,,,"I Brodsky, ""The Net finds its voice"", Network World;;T Olavsrud, ""Start-up aims to revolutionize Tech Support Call centres""",EXPIRED
888,TW,A,TW 202131902 A,115-808-498-928-019,2021-09-01,2021,TW 109141025 A,2012-10-15,US 201161547620 P;;US 201261606207 P,2011-10-14,Solid dispersion,"A solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.",ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;GAUTSCHI JEFF;;SMITHEY DAN;;DUBOSE DEVON BREVARD,,https://lens.org/115-808-498-928-019,Patent of Addition,no,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/16;;A61K9/20;;A61K31/517,,0,0,,,,ACTIVE
889,US,A1,US 2015/0173827 A1,137-455-688-642-668,2015-06-25,2015,US 201414579579 A,2014-12-22,US 201414579579 A;;US 201361920412 P;;US 201461933521 P,2013-12-23,ELECTROSURGICAL CUTTING INSTRUMENT,"An electrosurgical device having a tubular outer shaft and an inner shaft is disclosed. The tubular outer shaft includes an axis and a distal end region. The distal end region includes a distal-most tip and a cutting edge defining a window in the outer shaft proximal along the axis to the distal-most tip. The inner shaft inner shaft coaxially maintained within the outer shaft such that the inner shaft is movable about the axis with respect to the outer shaft and wherein a portion of the inner shaft is exposed in the window of the outer shaft. A first electrode is disposed on the outer shaft in a region proximal along the axis to the window, and a second electrode is electrically isolated from the first electrode and disposed on the inner shaft. The second electrode is exposed in the window of the outer shaft.",MEDTRONIC ADVANCED ENERGY LLC,BLOOM ELIOT F;;BERMAN PHILIP;;LI WENJENG;;LITTLE DAVID J;;OLIVER DANA A;;PRISCO JOHN R;;BROWN PHILLIP P;;RICHART PATRICK,MEDTRONIC ADVANCED ENERGY LLC (2015-01-13),https://lens.org/137-455-688-642-668,Patent Application,yes,24,34,2,2,0,A61B18/148;;A61B18/148;;A61B2018/00148;;A61B2018/00148;;A61B2018/00202;;A61B2018/00202;;A61B2018/00208;;A61B2018/00208;;A61B2018/00565;;A61B2018/00565;;A61B2018/00601;;A61B2018/00601;;A61B2018/126;;A61B2018/126;;A61B2218/002;;A61B2218/002;;A61B2218/007;;A61B2218/007,A61B18/14;;A61B18/12,,0,0,,,,ACTIVE
890,US,A1,US 2021/0220361 A1,144-975-611-014-017,2021-07-22,2021,US 202017133094 A,2020-12-23,US 202017133094 A;;US 201916353951 A;;US 201615275163 A;;US 201414351840 A;;US 2012/0060044 W;;US 201261606207 P;;US 201161547620 P,2011-10-14,SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR,"A solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.",ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,ARRAY BIOPHARMA INC (2013-01-10),https://lens.org/144-975-611-014-017,Patent Application,yes,0,2,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K31/517;;A61K9/00;;A61K9/10;;A61K9/16;;A61K9/20;;A61K47/32;;A61K47/38,,0,0,,,,DISCONTINUED
891,AU,B2,AU 2012/322039 B2,181-513-003-239-875,2017-08-17,2017,AU 2012/322039 A,2012-10-12,US 201161547620 P;;US 201261606207 P;;US 2012/0060044 W,2011-10-14,Solid dispersions of a Erb2 (HER2) inhibitor,"A solid dispersion of N4-(4-([1, 2, 4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-α]pyridin-7-yloxy)-3- methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.",ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/181-513-003-239-875,Granted Patent,no,2,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/14;;A61K9/20;;A61K31/498;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,ACTIVE
892,TW,B,TW I594769 B,160-777-234-962-734,2017-08-11,2017,TW 101137971 A,2012-10-15,US 201161547620 P;;US 201261606207 P,2011-10-14,Solid dispersion,,ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;GAUTSCHI JEFF;;SMITHEY DAN;;DUBOSE DEVON BREVARD,,https://lens.org/160-777-234-962-734,Granted Patent,no,4,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,,,0,0,,,,ACTIVE
893,US,A1,US 2023/0097309 A1,002-703-258-049-914,2023-03-30,2023,US 202217895951 A,2022-08-25,US 202217895951 A;;US 202017133094 A;;US 201916353951 A;;US 201615275163 A;;US 201414351840 A;;US 2012/0060044 W;;US 201261606207 P;;US 201161547620 P,2011-10-14,SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR,"A solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.",ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,ARRAY BIOPHARMA INC (2013-01-10),https://lens.org/002-703-258-049-914,Patent Application,yes,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K31/517;;A61K9/00;;A61K9/10;;A61K9/16;;A61K9/20;;A61K47/32;;A61K47/38,,0,0,,,,PENDING
894,EP,A2,EP 2765990 A2,055-814-104-730-920,2014-08-20,2014,EP 12809373 A,2012-10-12,US 201161547620 P;;US 201261606207 P;;US 2012/0060044 W,2011-10-14,SOLID DISPERSION,,ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/055-814-104-730-920,Patent Application,yes,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/10;;A61K9/14;;A61K9/16;;A61K9/20;;A61K31/498;;A61K31/517;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,ACTIVE
895,SG,A,SG 11201401459Y A,184-528-394-530-053,2014-07-30,2014,SG 11201401459Y A,2012-10-12,US 201161547620 P;;US 201261606207 P;;US 2012/0060044 W,2011-10-14,SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR,,ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/184-528-394-530-053,Unknown,no,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/14;;A61K9/20;;A61K31/498;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,PENDING
896,HU,T2,HU E035247 T2,027-025-016-266-008,2018-05-02,2018,HU E12809373 A,2012-10-12,US 201161547620 P;;US 201261606207 P,2011-10-14,SOLID DISPERSION,,ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/027-025-016-266-008,Amended Patent,no,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/10;;A61K9/14;;A61K9/16;;A61K9/20;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,PENDING
897,AU,C1,AU 2012/322039 C1,040-432-825-845-041,2021-04-29,2021,AU 2012/322039 A,2012-10-12,US 201161547620 P;;US 201261606207 P;;US 2012/0060044 W,2011-10-14,Solid dispersions of a Erb2 (HER2) inhibitor,"A solid dispersion of N4-(4-([1, 2, 4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-α]pyridin-7-yloxy)-3- methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.",ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/040-432-825-845-041,Amended Patent,no,2,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/14;;A61K9/20;;A61K31/498;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,ACTIVE
898,ES,T3,ES 2650608 T3,004-446-134-597-060,2018-01-19,2018,ES 12809373 T,2012-10-12,US 201161547620 P;;US 201261606207 P;;US 2012/0060044 W,2011-10-14,Dispersión sólida,"Dispersión sólida que comprende N4-(4-([1,2,4]triazolo[1,5-a]piridin-7-iloxi)-3-metilfenil)-N6-(4,4-dimetil-4,5- dihidrooxazol-2-il)quinazolin-4,6-diamina y un polímero de dispersión.",ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/004-446-134-597-060,Granted Patent,no,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/10;;A61K9/14;;A61K9/16;;A61K9/20;;A61K31/498;;A61K31/517;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,ACTIVE
899,BR,B1,BR 122020010643 B1,032-115-190-582-460,2022-05-17,2022,BR 122020010643 A,2012-10-12,US 2012/0060044 W;;US 201161547620 P;;US 201261606207 P;;BR 112014009092 A,2011-10-14,"Dispersão sólida, composições farmacêuticas compreendendo a referida dispersão, usos das composições farmacêuticas e processo de preparação de uma dispersão sólida","a presente invenção refere-se a uma dispersão sólida de n4-(4-([1,2,4]triazol[1,5-a]piridino-7-ilóxi)-3-metilfenil)-n6-(4,4-dimetil-4,5-di-idro-oxazol-2-ilo)quinazolina-4,6-diamina e aos processos de preparação a dispersão sólida que estão aqui fornecidos. além disso, uma composição farmacêutica que compreende uma dispersão sólida de n4-(4-([1,2,4]triazol[1,5-a]piridino-7-ilóxi)-3-metilfenil)-n6-(4,4-dimetil-4,5-di-idro-oxazol-2-ilo)quinazolina-4,6-diamina e as respectivas utilizações são fornecidas neste documento.",ARRAY BIOPHARMA INC,CHRISTOPHER DONAVAN CRAIG;;CHRISTOPHER M LINDEMANN;;COREY JAY BLOOM;;SMITHEY DAN;;DAVID SHANK FRY;;DEVON BREVARD DUBOSE;;GAUTSCHI JEFF;;PREIGH MICHAEL,,https://lens.org/032-115-190-582-460,Granted Patent,no,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/14;;A61K9/20;;A61K31/498;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,ACTIVE
900,CA,A1,CA 3114454 A1,092-456-698-179-885,2013-04-18,2013,CA 3114454 A,2012-10-12,US 201161547620 P;;US 201261606207 P;;CA 2852058 A,2011-10-14,"A SOLID DISPERSION OF N4-(4-([1,2,4]TRIAZOLO[1,5-.ALPHA.]PYRIDIN-7-YLOXY)-3-METHYLPHENYL)-N6-(4,4-DIMETHYL-4,5-DIHYDROOXAZOL-2-YL)QUINAZOLINE-4,6-DIAMINE","A solid dispersion of N4-(4-([1, 2, 4]triazolo[1,5-a]pyridin-7-yloxy)-3- methylpheny1)-N6-(4,4- dimethy1-4,5-dihydrooxazol-2-y1)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4- (4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3- methylpheny1)-N6-(4,4-dimethy1- 4,5-dihydrooxazol-2- yl)quinazoline-4,6-diamine and uses thereof are provided herein.",ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/092-456-698-179-885,Patent Application,no,0,1,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,C07D471/04;;A61K31/513,,0,0,,,,PENDING
901,AU,A1,AU 2017/210499 A1,141-432-553-479-157,2017-08-17,2017,AU 2017/210499 A,2017-07-31,AU 2017/210499 A;;AU 2012/322039 A;;US 201161547620 P;;US 201261606207 P;;US 2012/0060044 W,2011-10-14,SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR,"[0001581 A solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3 methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3 methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.",ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/141-432-553-479-157,Patent Application,no,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/14;;A61K9/20;;A61K31/498;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,ACTIVE
902,WO,A3,WO 2003/002710 A3,001-545-776-168-975,2004-02-05,2004,US 0220526 W,2002-06-25,US 30193401 P,2001-06-29,ARTIFICIAL SYNAPSE CHIP INTERFACE FOR ELECTRONIC PROSTHETIC RETINA,The invention provides microfabricated devices and methods for directing the growth of a cell process to form an artificial synapse. The devices are called artificial synapse chips. The artificial synapse comprises a nanofabricated aperture (about 50-100 nm in size) that connects the cell process to a chemical or electrical means of neuronal excitation. Such an aperture width mimics the length scales of a natural synapse and thus emphasizes the localized spatial relationship between a neuron and a stimulation source. The invention further provides devices and methods for regenerating a nerve fiber into an electrode. The invention thus provides a regeneration electrode that uses a novel neural interface for stimulation and that uses novel surface methods for directing neuronal growth making possible in vivo connection of the devices to neural circuitry in a retina and other anatomical locations.,UNIV LELAND STANFORD JUNIOR,FISHMAN HARVEY A;;BLUMENKRANZ MARK;;BENT STACEY FRANCINE;;BLOOM DAVID M;;PETERMAN MARK C;;ZIEBARTH JONATHAN M;;LEE CHRISTINE;;LENG THEODORE,,https://lens.org/001-545-776-168-975,Search Report,yes,2,0,15,15,0,A61N1/0543;;A61N1/326;;A61N1/36046;;C12M35/00;;C12M35/02;;C12M35/08;;C12N5/0619;;C12N2503/00;;C12N2535/10;;A61N1/36046;;A61N1/0543;;C12M35/00;;C12M35/02;;C12M35/08;;A61N1/326;;C12N5/0619;;C12N2503/00;;C12N2535/10,A61K9/22;;A61L27/00;;A61N1/05;;A61N1/36;;C12M1/42;;C12M3/00;;C12N5/0793,,10,8,052-681-725-250-166;;039-712-372-889-64X;;000-409-659-443-429;;064-942-415-563-86X;;049-325-662-859-361;;001-329-508-866-308;;030-546-208-614-902;;046-961-728-035-33X,10.1016/s0165-0270(98)00156-3;;10065993;;10.1016/s0925-4005(98)00071-9;;11248444;;10.1016/s0304-3940(01)01628-7;;9740002;;10.1002/(sici)1097-4636(199810)42:1<13::aid-jbm3>3.0.co;2-r;;9622516;;10.1021/bp980035r;;10.1016/s0168-9002(99)00445-3;;10.1002/1521-396x(200011)182:1<505::aid-pssa505>3.0.co;2-#;;11324335;;10.1007/s004220000218,"MAHER M P ET AL: ""The neurochip: a new multielectrode device for stimulating and recording from cultured neurons."", JOURNAL OF NEUROSCIENCE METHODS. NL, vol. 87, no. 1, 1 February 1999 (1999-02-01), pages 45 - 56, XP002256001, ISSN: 0165-0270;;HEUSCHKEL M O ET AL: ""Buried microchannels in photopolymer for delivering of solutions to neurons in a network"", SENSORS AND ACTUATORS B, ELSEVIER SEQUOIA S.A., LAUSANNE, CH, vol. 48, no. 1-3, 30 May 1998 (1998-05-30), pages 356 - 361, XP004147365, ISSN: 0925-4005;;YEUNG C K ET AL: ""Modulation of the growth and guidance of rat brain stem neurons using patterned extracellular matrix proteins"", NEUROSCIENCE LETTERS, LIMERICK, IE, vol. 301, no. 2, 30 March 2001 (2001-03-30), pages 147 - 150, XP002228113, ISSN: 0304-3940;;SANEINEJAD S ET AL: ""PATTERNED GLASS SURFACES DIRECT CELL ADHESION AND PROCESS OUTGROWTH OF PRIMARY NEURONS OF THE CENTRAL NERVOUS SYSTEM"", JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, WILEY, NEW YORK, NY, US, 1998, pages 13 - 19, XP002944531, ISSN: 0021-9304;;TAI H-C ET AL: ""NEURITE OUTGROWTH AND GROWTH CONE MORPHOLOGY ON MICROPATTERNED SURFACES"", BIOTECHNOLOGY PROGRESS,, vol. 14, no. 3, 1998, pages 364 - 370, XP002944533, ISSN: 8756-7938;;LITKE A M: ""The Retinal Readout System: a status report"", NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH, SECTION - A: ACCELERATORS, SPECTROMETERS, DETECTORS AND ASSOCIATED EQUIPMENT, NORTH-HOLLAND PUBLISHING COMPANY. AMSTERDAM, NL, vol. 435, no. 1-2, 1 October 1999 (1999-10-01), pages 242 - 249, XP004181178, ISSN: 0168-9002;;MAYNE A. ET AL.: ""Biologically interfaced porous silicon devices"", PHYSICA STATUS SOLIDI (A), WILEY-VCH VERLAG, WEINHEIM, DE, vol. 182, no. 1, November 2000 (2000-11-01), pages 505 - 513, XP008022668;;JENKNER MARTIN ET AL: ""Interfacing a silicon chip to pairs of snail neurons connected by electrical synapses."", BIOLOGICAL CYBERNETICS, vol. 84, no. 4, April 2001 (2001-04-01), pages 239 - 249, XP002256175, ISSN: 0340-1200;;DATABASE MEDLINE/NLM [online] March 1994 (1994-03-01), SANDYK R.: ""Paroxysmal itching in multiple sclerosis during treatment with external magnetic fields"", XP002256176, Database accession no. NLM8050852;;BERNARD A. ET AL.: ""Printing Patterns of Proteins"", LANGMUIR, THE ACS JOURNAL OF SURFACES AND COLLOIDS, AMERICAN CHEMICAL SOCIETY, vol. 14, no. 9, 28 April 1998 (1998-04-28), US, XP002256002",PATENTED
903,MX,A,MX 2014004551 A,014-121-995-135-228,2015-02-12,2015,MX 2014004551 A,2012-10-12,US 201161547620 P;;US 201261606207 P;;US 2012/0060044 W,2011-10-14,SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR.,"A solid dispersion of N4-(4-([1, 2, 4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimet hyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-Î±]pyridin-7-yloxy)-3- methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoli ne-4,6-diamine and uses thereof are provided herein.",ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/014-121-995-135-228,Patent Application,no,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/14;;A61K9/20;;A61K31/498;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,ACTIVE
904,US,B2,US 9457093 B2,034-047-224-963-482,2016-10-04,2016,US 201214351840 A,2012-10-12,US 201214351840 A;;US 201161547620 P;;US 201261606207 P;;US 2012/0060044 W,2011-10-14,Solid dispersions of a ERB2 (HER2) inhibitor,"A solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-α]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.",ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,ARRAY BIOPHARMA INC (2013-01-10),https://lens.org/034-047-224-963-482,Granted Patent,yes,19,11,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K47/38;;A61K9/10;;A61K9/16;;A61K9/20;;A61K31/517;;A61K47/32,,21,5,007-941-550-134-396;;054-986-390-387-231;;074-225-865-565-732;;052-341-218-844-882;;129-225-457-867-639,19040386;;10.1021/mp8000793;;10840192;;10.1016/s0939-6411(00)00076-x;;18061887;;10.1016/j.drudis.2007.09.005;;10.1158/1538-7445.am2012-852;;21834778;;10.2174/187221111797200551,"fda.gov. ""Background Information for the Oct. 2002 ACPS Meeting Scientific Considerations of Polymorphism in Pharmaceutical Solids: Abbreviated New Drug Applications."" Retrieved on Oct. 6, 2015. Retrieved from the Internet .;;MedKo Biosciences. ""Irbinitinib (ARRY-380)."" Retrieved on Oct. 6, 2015. Retrieved from the Internet .;;Friesen et al., ""Hydroxypropyl Methylcellulose Acetate Succinate-Based Spray-Dried Dispersions: An Overview"", Molecular Pharmaceutics vol. 5 (6), 1003-1019 (2008).;;Koch, ""ARRY-380: A Selective, Oral HER2 inhibitor for the Treatment of Solid Tumors""XP002692140, http://www.arraybiopharma.com/-documents/Publication/PubAttachment462.pdf, 29 pages (2011).;;Leuner et al., ""Improving drug solubility for oral delivery using solid dispersions"", European Journal of Pharmaceutics and Biopharmaceutics 50, 47-60 (2000).;;Lindemann et al. ""Amorphous Dispersion Development of ARRY-380, an ErbB2 Selective Inhibitor."" American Association of Pharmaceutical Scientists, Annual Meeting and Exposition. Oct. 17, 2012.;;Lindemann et al. ""Solid-State Characterization of Seven Isomorphic Solvates of ARRY-380."" American Association of Pharmaceutical Scientists, Annual Meeting and Exposition. Oct. 17, 2012.;;Okamoto, ""PSWC2004 Symposium Report on Pharmaceutical Field"", Pharm Tech Japan 8, vol. 20 (9), 1783-1785 (2004). [English Translation].;;Patent Cooperation Treaty, International Searching Authority, Search Report and Written Opinion for PCT/US2012/060044, 16 pages, May 16, 2013.;;Tiwari et al., ""Solid Dispersions: An Overview to Modify Bioavailability of Poorly Water Soluble Drugs"", International Journal of PharmTech Research, vol. 1 (4), 1338-1349 (2009).;;Vasconcelos et al., ""Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs"", Drug Discovery Today, vol. 12 (23-24), 1068-1075 (2007).;;Ansel, Howard C., et al. Pharmaceutical Dosage Forms and Drug Delivery Systems. p. 91. Philadelphia: Lippincott Williams & Wilkins, 7th Edition 1999.;;Chia, S.K.L. et al. ""A Phase 1 Study to Assess the Safety, Tolerability and PK of ARRY-380-an Oral Inhibitor of ErbB2."" San Antonio Breast Cancer Symposium, Dec. 9-13, 2009.;;Dinkel, Victoria, et al. ""ARRY-380, a potent, small molecule inhibitor of ErbB2, increases survival in intracranial ErbB2+ xenograft models in mice."" American Association for Cancer Research, Apr. 1, 2012.;;Lee, Patrice, et al. ""In Vivo Activity of ARRY-380, a Potent, Small Molecule Inhibitor of ErbB2 in Combination with Trastuzumab, Docetaxel or Bevacizumab."" San Antonio Breast Cancer Symposium, Dec. 9-13, 2009.;;Lee, Patrice, et al. ""In Vivo Activity of ARRY-380, a Potent, Small Molecule Inhibitor of ErbB2 in Combination with Trastuzumab or Docetaxel in BT-474 Human Breast Carcinoma Xenograft Model."" Association for Cancer Research, Apr. 18-22, 2009.;;Morrow, PK, et al. ""A Phase 1 Study to Assess the Safety, Tolerability and PK of ARRY-380-an Oral Inhibitor of HER2."" American Society of Clinical Oncologists, Oct. 1, 2010.;;Moulder, S.L., et al. ""ARRY-380, a Selective HER2 Inhibitor: From Drug Design to Clinical Evaluation."" AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, Nov. 14, 2011.;;Moulder, SL, et al. ""Data from a Completed Phase 1 Study to Assess the Safety, Tolerability and PK of ARRY-380-an Oral Inhibitor of HER2."" San Antonio Breast Cancer Symposium, Dec. 10, 2010.;;Pheneger, Tracy, et al. ""In Vitro and In Vivo Activity of ARRY-380: a Potent, Small Molecule Inhibitor of ErbB2."" American Association for Cancer Research, Apr. 18-22, 2009.;;Iqbal, et al., ""Recent advances and patents in solid dispersion technology"", Recent Pat Drug Deliv Formul. 5 (3), 244-264 (2011).",ACTIVE
905,EP,A2,EP 1421172 A2,107-352-619-512-990,2004-05-26,2004,EP 02744712 A,2002-06-25,US 0220526 W;;US 30193401 P,2001-06-29,ARTIFICIAL SYNAPSE CHIP INTERFACE FOR ELECTRONIC PROSTHETIC RETINA,The invention provides microfabricated devices and methods for directing the growth of a cell process to form an artificial synapse. The devices are called artificial synapse chips. The artificial synapse comprises a nanofabricated aperture (about 50-100 nm in size) that connects the cell process to a chemical or electrical means of neuronal excitation. Such an aperture width mimics the length scales of a natural synapse and thus emphasizes the localized spatial relationship between a neuron and a stimulation source. The invention further provides devices and methods for regenerating a nerve fiber into an electrode. The invention thus provides a regeneration electrode that uses a novel neural interface for stimulation and that uses novel surface methods for directing neuronal growth making possible in vivo connection of the devices to neural circuitry in a retina and other anatomical locations.,UNIV LELAND STANFORD JUNIOR,FISHMAN HARVEY A;;BLUMENKRANZ MARK;;BENT STACEY FRANCINE;;BLOOM DAVID M;;PETERMAN MARK C;;ZIEBARTH JONATHAN M;;LEE CHRISTINE;;LENG THEODORE,,https://lens.org/107-352-619-512-990,Patent Application,yes,0,0,15,15,0,A61N1/0543;;A61N1/326;;A61N1/36046;;C12M35/00;;C12M35/02;;C12M35/08;;C12N5/0619;;C12N2503/00;;C12N2535/10;;A61N1/36046;;A61N1/0543;;C12M35/00;;C12M35/02;;C12M35/08;;A61N1/326;;C12N5/0619;;C12N2503/00;;C12N2535/10,C12M3/00;;A61K9/22;;A61L27/00;;A61N1/05;;A61N1/36;;C12M1/42;;C12N5/0793;;G01N33/487,,0,0,,,,EXPIRED
906,CA,C,CA 3114454 C,137-093-576-951-735,2022-11-29,2022,CA 3114454 A,2012-10-12,US 201161547620 P;;US 201261606207 P;;CA 2852058 A,2011-10-14,"A SOLID DISPERSION OF N4-(4-([1,2,4]TRIAZOLO[1,5-.ALPHA.]PYRIDIN-7-YLOXY)-3-METHYLPHENYL)-N6-(4,4-DIMETHYL-4,5-DIHYDROOXAZOL-2-YL)QUINAZOLINE-4,6-DIAMINE","A solid dispersion of N4-(4-([1, 2, 4]triazolo[1,5-a]pyridin-7-yloxy)-3- methylpheny1)-N6-(4,4- dimethy1-4,5-dihydrooxazol-2-y1)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4- (4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3- methylpheny1)-N6-(4,4-dimethy1- 4,5-dihydrooxazol-2- yl)quinazoline-4,6-diamine and uses thereof are provided herein.",ARRAY BIOPHARMA INC,LINDEMANN CHRISTOPHER M;;BLOOM COREY JAY;;DUBOSE DEVON BREVARD;;FRY DAVID SHANK;;PREIGH MICHAEL;;CRAIG CHRISTOPHER DONOVAN;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/137-093-576-951-735,Granted Patent,no,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,C07D471/04;;A61K31/513,,0,0,,,,PENDING
907,CN,A,CN 111051234 A,164-989-692-800-257,2020-04-21,2020,CN 201880048747 A,2018-03-22,US 201762558992 P;;US 2018/0023863 W,2017-09-15,DISPENSING METER FOR FLUID DISPENSING,"A handheld fluid meter includes a cartridge valve controlling the flow of fluid through the handheld meter. The cartridge valve includes a valve cartridge and a valve stem disposed within the valve cartridge. The cartridge valve guides the valve stem and provides the only sealing surface for the dynamic seals and control seal disposed on the valve stem. The handheld meter dispenses through a nozzle, which includes an overmolded stem tip that generates a laminar fluid flow as the fluid exits the nozzle. The overmolded stem tip is a compliant material. The handheld fluid meter includes circuitryconfigured to invert the orientation of a visual output provided by a display of the handheld fluid meter to facilitate installation of the handheld fluid meter for use in an oil bar application.",GRACO MINNESOTA INC,BLOOM MICHAEL E;;BAUCK MARK L;;EBBEN JAMES R;;HIGHLAND GLENN E;;KAHLER BRADLEY G;;KUSCHEL ANTHONY J;;LORDEN DAVID J,,https://lens.org/164-989-692-800-257,Patent Application,no,12,0,20,69,0,G01F15/00;;G01F15/005;;G01F22/00;;B67D7/16;;G01F3/14;;B67D7/52;;B67D7/426;;G01F15/003;;B67D7/12;;B67D7/425;;B67D7/20;;B67D7/303;;B67D7/44;;B67D7/54;;F16K39/022;;F16K3/246;;B67D7/16;;B67D7/42;;B67D7/36;;B67D7/16;;B67D7/36;;B67D7/42;;B67D7/52;;B67D7/426;;G01F15/003;;B67D7/12;;B67D7/425;;G01F3/14;;B67D7/16;;B67D7/303;;B67D7/44;;F16K3/26;;F16K31/60,B67D7/16;;B67D7/36;;B67D7/42,,1,0,,,"王文然等: ""迷宫式高差压调节阀研制"", 《石油机械》",ACTIVE
908,AU,A1,AU 2019/200243 A1,144-712-262-081-515,2019-01-31,2019,AU 2019/200243 A,2019-01-15,AU 2019/200243 A;;AU 2017/210499 A;;AU 2012/322039 A;;US 201161547620 P;;US 201261606207 P;;US 2012/0060044 W,2011-10-14,SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR,"[0001581 A solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3 methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3 methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.",ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/144-712-262-081-515,Patent Application,no,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/14;;A61K9/20;;A61K31/498;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,ACTIVE
909,AU,B2,AU 2017/210499 B2,012-518-482-912-450,2019-01-24,2019,AU 2017/210499 A,2017-07-31,AU 2017/210499 A;;AU 2012/322039 A;;US 201161547620 P;;US 201261606207 P;;US 2012/0060044 W,2011-10-14,SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR,"[0001581 A solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3 methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3 methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.",ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/012-518-482-912-450,Granted Patent,no,3,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/14;;A61K9/20;;A61K31/498;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,ACTIVE
910,WO,A2,WO 2013/056108 A2,049-010-452-495-778,2013-04-18,2013,US 2012/0060044 W,2012-10-12,US 201161547620 P;;US 201261606207 P,2011-10-14,SOLID DISPERSION,"A solid dispersion of N4 -(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)- N 6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N 4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)- N 6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.",ARRAY BIOPHARMA INC;;FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/049-010-452-495-778,Patent Application,yes,1,13,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00,,6,1,031-426-665-625-666,10.1007/s11095-004-1185-3;;15783065,"KOCH, KEVIN: ""ARRY-380: A Selective, Oral HER2 Inhibitor for the Treatment of Solid Tumors"", AMERICAN ASSOCIATION OF CANCER RESEARCH 102ND ANNUAL MEETING, 3 April 2011 (2011-04-03);;""Perry's Chemical Engineers' Handbook"", 2007, MCGRAW-HILL;;ANSEL, HOWARD C. ET AL.: ""Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems"", 2004, LIPPINCOTT, WILLIAMS & WILKINS;;ALFONSO R. ET AL.: ""Remington: The Science and Practice of Pharmacy"", 2000, LIPPINCOTT, WILLIAMS & WILKINS;;ROWE, RAYMOND C.: ""Handbook of Pharmaceutical Excipients"", 2005, PHARMACEUTICAL PRESS;;ZHOU, RONG ET AL.: ""pH-Dependent Dissolution in Vitro and Absorption in Vivo of Weakly Basic Drugs: Development of a Canine Model"", PHARM. RES, vol. 22, no. 2, February 2005 (2005-02-01), pages 188 - 192",PENDING
911,SI,T1,SI 2765990 T1,107-779-777-619-585,2017-11-30,2017,SI 201231101 T,2012-10-12,US 201161547620 P;;US 201261606207 P;;US 2012/0060044 W;;EP 12809373 A,2011-10-14,SOLID DISPERSION,,ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/107-779-777-619-585,Granted Patent,no,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K31/00;;A61K47/00;;A61P35/00,,0,0,,,,ACTIVE
912,EP,B1,EP 2765990 B1,132-886-777-686-470,2017-09-06,2017,EP 12809373 A,2012-10-12,US 201161547620 P;;US 201261606207 P;;US 2012/0060044 W,2011-10-14,SOLID DISPERSION,,ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/132-886-777-686-470,Granted Patent,yes,1,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/10;;A61K9/14;;A61K9/16;;A61K9/20;;A61K31/498;;A61K31/517;;A61K47/32;;A61K47/38;;A61P35/00,,2,0,,,"Koch, Kevin: ""ARRY-380: A Selective, Oral HER2 inhibitor for the Treatment of Solid Tumors"", Array BioPharma , 3 April 2011 (2011-04-03), XP002692140, Retrieved from the Internet: URL:http://www.arraybiopharma.com/_documen ts/Publication/PubAttachment462.pdf [retrieved on 2013-02-14] cited in the application;;VASCONCELOS ET AL: ""Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs"", DRUG DISCOVERY TODAY, ELSEVIER, RAHWAY, NJ, US, vol. 12, no. 23-24, 30 October 2007 (2007-10-30), pages 1068-1075, XP022370275, ISSN: 1359-6446",ACTIVE
913,US,A1,US 2017/0136022 A1,159-033-702-646-939,2017-05-18,2017,US 201615275163 A,2016-09-23,US 201615275163 A;;US 201414351840 A;;US 2012/0060044 W;;US 201161547620 P;;US 201261606207 P,2011-10-14,SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR,"A solid dispersion of N4-(4-([1,2,4]triazolo[1,5-α]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-α]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.",ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,ARRAY BIOPHARMA INC (2013-01-10),https://lens.org/159-033-702-646-939,Patent Application,yes,6,6,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K31/517;;A61K9/00;;A61K9/16;;A61K9/20,,2,0,,,"Medkoo Bioscience. “Tucatinib"". Retrieved on 8 June 2017. Retrieved from the internet <URL: http://www.medkoo.com/products/5248>.;;Medkoo Bioscience. “Tucatinib"". Retrieved on 8 June 2017. Retrieved from the internet <URL: http://www.medkoo.com/products/5248>.",DISCONTINUED
914,TW,B,TW I788733 B,052-380-821-355-508,2023-01-01,2023,TW 109141025 A,2012-10-15,US 201161547620 P;;US 201261606207 P,2011-10-14,Solid dispersion,,ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;GAUTSCHI JEFF;;SMITHEY DAN;;DUBOSE DEVON BREVARD,,https://lens.org/052-380-821-355-508,Granted Patent,no,3,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,,,0,0,,,,ACTIVE
915,CO,A2,CO 6960547 A2,088-746-468-458-222,2014-05-30,2014,CO 14103943 A,2014-05-14,US 201161547620 P;;US 201261606207 P,2011-10-14,Dispersión sólida de un inhibidor erb2 (her2),,ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/088-746-468-458-222,Patent Application,no,0,1,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00,,0,0,,,,PENDING
916,AU,B2,AU 2019/200243 B2,188-734-395-707-001,2020-06-11,2020,AU 2019/200243 A,2019-01-15,AU 2019/200243 A;;AU 2017/210499 A;;AU 2012/322039 A;;US 201161547620 P;;US 201261606207 P;;US 2012/0060044 W,2011-10-14,SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR,"[0001581 A solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3 methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3 methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.",ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/188-734-395-707-001,Granted Patent,no,1,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/14;;A61K9/20;;A61K31/498;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,ACTIVE
917,CY,T1,CY 1119837 T1,042-102-015-059-373,2018-06-27,2018,CY 171101121 T,2017-10-30,US 201161547620 P;;US 201261606207 P;;US 2012/0060044 W,2011-10-14,ΣΤΕΡΕΑ ΔΙΑΣΠΟΡΑ,"Στο παρόν παρέχονται στερεά διασπορά Ν4- (4-( [1,2,4]τριαζολο[1,5-α]πυριδιv-7-υλοξυ)-3-μεθυλοφαινυλ)-Ν6- (4,4-διμεθυλ-4, 5-διϋδροοξαζολ-2-υλ) κιναζολιν-4,6-διαμίνης και διεργασίες για την παρασκευή της στερεάς διασποράς. Επίσης, στο παρόν παρέχονται φαρμακευτική σύνθεση που περιλαμβάνει στερεά διασπορά Ν4- (4-([1,2,4]τριαζολο[1,5-α]πυριδιv-7-υλοξυ)-3-μεθυλοφαινυλ) -Ν6- (4,4-διμεθυλ-4,5-διϋδροοξαζολ-2-υλ)κιναζολιν-4, 6-διαμίνης και χρήσεις αυτής.",ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/042-102-015-059-373,Granted Patent,no,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/10;;A61K9/14;;A61K9/16;;A61K9/20;;A61K31/498;;A61K31/517;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,ACTIVE
918,EP,B1,EP 1421172 B1,100-843-637-169-163,2006-09-27,2006,EP 02744712 A,2002-06-25,US 0220526 W;;US 30193401 P,2001-06-29,ARTIFICIAL SYNAPSE CHIP INTERFACE FOR ELECTRONIC PROSTHETIC RETINA,The invention provides microfabricated devices and methods for directing the growth of a cell process to form an artificial synapse. The devices are called artificial synapse chips. The artificial synapse comprises a nanofabricated aperture (about 50-100 nm in size) that connects the cell process to a chemical or electrical means of neuronal excitation. Such an aperture width mimics the length scales of a natural synapse and thus emphasizes the localized spatial relationship between a neuron and a stimulation source. The invention further provides devices and methods for regenerating a nerve fiber into an electrode. The invention thus provides a regeneration electrode that uses a novel neural interface for stimulation and that uses novel surface methods for directing neuronal growth making possible in vivo connection of the devices to neural circuitry in a retina and other anatomical locations.,UNIV LELAND STANFORD JUNIOR,FISHMAN HARVEY A;;BLUMENKRANZ MARK;;BENT STACEY FRANCINE;;BLOOM DAVID M;;PETERMAN MARK C;;ZIEBARTH JONATHAN M;;LEE CHRISTINE;;LENG THEODORE,,https://lens.org/100-843-637-169-163,Granted Patent,yes,2,0,15,15,0,A61N1/0543;;A61N1/326;;A61N1/36046;;C12M35/00;;C12M35/02;;C12M35/08;;C12N5/0619;;C12N2503/00;;C12N2535/10;;A61N1/36046;;A61N1/0543;;C12M35/00;;C12M35/02;;C12M35/08;;A61N1/326;;C12N5/0619;;C12N2503/00;;C12N2535/10,C12M3/00;;A61K9/22;;A61L27/00;;A61N1/05;;A61N1/36;;C12M1/42;;C12N5/0793;;G01N33/487,,10,0,,,"MAHER M P ET AL: ""The neurochip: a new multielectrode device for stimulating and recording from cultured neurons."" JOURNAL OF NEUROSCIENCE METHODS. NL , vol. 87, no. 1, 1 February 1999 (1999-02-01), pages 45-56, XP002256001 ISSN: 0165-0270;;HEUSCHKEL M O ET AL: ""Buried microchannels in photopolymer for delivering of solutions to neurons in a network"" SENSORS AND ACTUATORS B, ELSEVIER SEQUOIA S.A., LAUSANNE, CH, vol. 48, no. 1-3, 30 May 1998 (1998-05-30), pages 356-361, XP004147365 ISSN: 0925-4005;;YEUNG C K ET AL: ""Modulation of the growth and guidance of rat brain stem neurons using patterned extracellular matrix proteins"" NEUROSCIENCE LETTERS, LIMERICK, IE, vol. 301, no. 2, 30 March 2001 (2001-03-30), pages 147-150, XP002228113 ISSN: 0304-3940;;SANEINEJAD S ET AL: ""PATTERNED GLASS SURFACES DIRECT CELL ADHESION AND PROCESS OUTGROWTH OF PRIMARY NEURONS OF THE CENTRAL NERVOUS SYSTEM"" JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, WILEY, NEW YORK, NY, US, 1998, pages 13-19, XP002944531 ISSN: 0021-9304;;TAI H-C ET AL: ""NEURITE OUTGROWTH AND GROWTH CONE MORPHOLOGY ON MICROPATTERNED SURFACES"" BIOTECHNOLOGY PROGRESS, , vol. 14, no. 3, 1998, pages 364-370, XP002944533 ISSN: 8756-7938;;LITKE A M: ""The Retinal Readout System: a status report"" NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH, SECTION - A: ACCELERATORS, SPECTROMETERS, DETECTORS AND ASSOCIATED EQUIPMENT, NORTH-HOLLAND PUBLISHING COMPANY. AMSTERDAM, NL, vol. 435, no. 1-2, 1 October 1999 (1999-10-01), pages 242-249, XP004181178 ISSN: 0168-9002;;MAYNE A. ET AL.: ""Biologically interfaced porous silicon devices"" PHYSICA STATUS SOLIDI (A), WILEY-VCH VERLAG, WEINHEIM, DE, vol. 182, no. 1, November 2000 (2000-11), pages 505-513, XP008022668;;JENKNER MARTIN ET AL: ""Interfacing a silicon chip to pairs of snail neurons connected by electrical synapses."" BIOLOGICAL CYBERNETICS, vol. 84, no. 4, April 2001 (2001-04), pages 239-249, XP002256175 ISSN: 0340-1200;;DATABASE MEDLINE/NLM [Online] March 1994 (1994-03) SANDYK R.: ""Paroxysmal itching in multiple sclerosis during treatment with external magnetic fields"" Database accession no. NLM8050852 XP002256176;;BERNARD A. ET AL.: ""Printing Patterns of Proteins"" LANGMUIR, THE ACS JOURNAL OF SURFACES AND COLLOIDS, AMERICAN CHEMICAL SOCIETY, vol. 14, no. 9, 28 April 1998 (1998-04-28), XP002256002 US",EXPIRED
919,LT,T,LT 2765990 T,182-889-656-856-67X,2018-01-25,2018,LT 12809373 T,2012-10-12,US 201161547620 P;;US 201261606207 P;;US 2012/0060044 W,2011-10-14,SOLID DISPERSION,,ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/182-889-656-856-67X,Unknown,no,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/10;;A61K9/14;;A61K9/16;;A61K9/20;;A61K31/498;;A61K31/517;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,PENDING
920,AU,A1,AU 2003/200737 A1,177-082-661-931-576,2003-10-23,2003,AU 2003/200737 A,2003-02-28,US 11448702 A,2002-04-02,Contact center data integration with enterprise applications,,ROCKWELL ELECTRONIC COMMERCE,HODSON JEFFREY;;MOSQUERA DAVE;;POWER MARK J;;JAMES ERIC;;BLOOM JOSEPH;;DEZONNO ANTHONY;;SALEH NAYEL;;SHAMBAUGH CRAIG;;PETERS MICHAEL;;FUNCK DAVID,"ROCKWELL ELECTRONIC COMMERCE TECHNOLOGIES, LLC (2005-04-14)",https://lens.org/177-082-661-931-576,Patent Application,no,0,0,7,7,0,H04M3/42068;;H04M3/523;;H04M2201/38;;H04M3/523;;H04M2201/38;;H04M3/42068,H04M3/523,,0,0,,,,EXPIRED
921,PL,T3,PL 2765990 T3,027-982-919-685-603,2018-01-31,2018,PL 12809373 T,2012-10-12,US 201161547620 P;;US 201261606207 P;;EP 12809373 A;;US 2012/0060044 W,2011-10-14,SOLID DISPERSION,,ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/027-982-919-685-603,Patent Application,no,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/10;;A61K9/14;;A61K9/16;;A61K9/20;;A61K31/498;;A61K31/517;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,PENDING
922,HR,T1,HR P20171578 T1,048-970-747-850-353,2017-12-01,2017,HR P20171578 T,2017-10-17,US 201161547620 P;;US 201261606207 P;;EP 12809373 A;;US 2012/0060044 W,2011-10-14,SOLID DISPERSION,,ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/048-970-747-850-353,Granted Patent,no,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/10;;A61K9/14;;A61K9/16;;A61K9/20;;A61K31/498;;A61K31/517;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,ACTIVE
923,US,A1,US 2014/0296267 A1,148-404-403-011-109,2014-10-02,2014,US 201214351840 A,2012-10-12,US 201214351840 A;;US 201161547620 P;;US 201261606207 P;;US 2012/0060044 W,2011-10-14,SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR,"A solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-α]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.",ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,ARRAY BIOPHARMA INC (2013-01-10),https://lens.org/148-404-403-011-109,Patent Application,yes,1,35,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K47/38;;A61K9/10;;A61K31/517;;A61K47/32,514/266.21,2,0,,,"FDA.GOV. ""Background Information for the October 2002 ACPS Meeting Scientific Considerations of Polymorphism in Pharmaceutical Solids: Abbreviated New Drug Applications."" Retrieved on 6 October 2015. Retrieved from the Internet .;;MedKo Biosciences. ""Irbinitinib (ARRY-380)."" Retrieved on 6 October 2015. Retrieved from the Internet .",ACTIVE
924,WO,A2,WO 2003/002710 A2,171-013-315-892-298,2003-01-09,2003,US 0220526 W,2002-06-25,US 30193401 P,2001-06-29,ARTIFICIAL SYNAPSE CHIP INTERFACE FOR ELECTRONIC PROSTHETIC RETINA,The invention provides microfabricated devices and methods for directing the growth of a cell process to form an artificial synapse. The devices are called artificial synapse chips. The artificial synapse comprises a nanofabricated aperture (about 50-100 nm in size) that connects the cell process to a chemical or electrical means of neuronal excitation. Such an aperture width mimics the length scales of a natural synapse and thus emphasizes the localized spatial relationship between a neuron and a stimulation source. The invention further provides devices and methods for regenerating a nerve fiber into an electrode. The invention thus provides a regeneration electrode that uses a novel neural interface for stimulation and that uses novel surface methods for directing neuronal growth making possible in vivo connection of the devices to neural circuitry in a retina and other anatomical locations.,UNIV LELAND STANFORD JUNIOR,FISHMAN HARVEY A;;BLUMENKRANZ MARK;;BENT STACEY FRANCINE;;BLOOM DAVID M;;PETERMAN MARK C;;ZIEBARTH JONATHAN M;;LEE CHRISTINE;;LENG THEODORE,,https://lens.org/171-013-315-892-298,Patent Application,yes,5,0,15,15,0,A61N1/0543;;A61N1/326;;A61N1/36046;;C12M35/00;;C12M35/02;;C12M35/08;;C12N5/0619;;C12N2503/00;;C12N2535/10;;A61N1/36046;;A61N1/0543;;C12M35/00;;C12M35/02;;C12M35/08;;A61N1/326;;C12N5/0619;;C12N2503/00;;C12N2535/10,A61K9/22;;A61L27/00;;A61N1/05;;A61N1/36;;C12M1/42;;C12M3/00;;C12N5/0793,,0,0,,,,PATENTED
925,RS,B1,RS 56608 B1,191-981-798-040-340,2018-02-28,2018,RS P20171188 A,2012-10-12,US 201161547620 P;;US 201261606207 P;;US 2012/0060044 W;;EP 12809373 A,2011-10-14,SOLID DISPERSION,,ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/191-981-798-040-340,Granted Patent,no,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/10;;A61K9/14;;A61K9/16;;A61K9/20;;A61K31/498;;A61K31/517;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,ACTIVE
926,NZ,A,NZ 624942 A,187-753-443-547-012,2016-06-24,2016,NZ 62494212 A,2012-10-12,US 2012/0060044 W;;US 201161547620 P;;US 201261606207 P,2011-10-14,Solid dispersions of a erb2 (her2) inhibitor,"Disclosed is a solid dispersion of the selective ErbB2 (HER2) inhibitor N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine (ARRY -380) and processes for preparing the solid dispersion. Also disclosed are pharmaceutical compositions comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-α]pyridin-7-yloxy)-3- methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine for treating cancer.",ARRAY BIOPHARMA INC,LINDEMANN CHRISTOPHER M;;FRY DAVID SHANK;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/187-753-443-547-012,Patent Application,no,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/14;;A61K9/20;;A61K31/437;;A61K31/498;;A61K47/32;;A61K47/38;;A61P35/00;;C07D239/94,,0,0,,,,PENDING
927,TW,A,TW 201728323 A,055-821-613-976-65X,2017-08-16,2017,TW 106116008 A,2012-10-15,US 201161547620 P;;US 201261606207 P,2011-10-14,Solid dispersion,"A solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.",ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;GAUTSCHI JEFF;;SMITHEY DAN;;DUBOSE DEVON BREVARD,,https://lens.org/055-821-613-976-65X,Patent of Addition,no,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/14;;A61K9/20;;A61K31/517;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,ACTIVE
928,US,A1,US 2019/0275043 A1,059-972-962-738-32X,2019-09-12,2019,US 201916353951 A,2019-03-14,US 201916353951 A;;US 201615275163 A;;US 201414351840 A;;US 2012/0060044 W;;US 201261606207 P;;US 201161547620 P,2011-10-14,SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR,"A solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.",ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,ARRAY BIOPHARMA INC (2013-01-10),https://lens.org/059-972-962-738-32X,Patent Application,yes,3,4,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K31/517;;A61K9/00;;A61K9/10;;A61K9/16;;A61K9/20;;A61K47/32;;A61K47/38,,0,0,,,,DISCONTINUED
929,CN,A,CN 103998023 A,084-125-316-768-371,2014-08-20,2014,CN 201280061909 A,2012-10-12,US 2012/0060044 W;;US 201161547620 P;;US 201261606207 P,2011-10-14,Solid dispersions of a ErbB2 (HER2) inhibitor,"A solid dispersion of N4-(4-([1, 2, 4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-[alpha]]pyridin-7-yloxy)-3- methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.",ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/084-125-316-768-371,Patent Application,no,5,6,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/14;;A61K9/20;;A61K31/498;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,ACTIVE
930,DK,T3,DK 2765990 T3,197-255-098-118-719,2017-11-13,2017,DK 12809373 T,2012-10-12,US 201161547620 P;;US 201261606207 P;;US 2012/0060044 W,2011-10-14,FASTSTOFDISPERSION,,ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/197-255-098-118-719,Granted Patent,no,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/10;;A61K9/14;;A61K9/16;;A61K9/20;;A61K31/498;;A61K31/517;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,ACTIVE
931,PT,T,PT 2765990 T,024-879-776-469-713,2017-11-14,2017,PT 12809373 T,2012-10-12,US 201161547620 P;;US 201261606207 P,2011-10-14,SOLID DISPERSION,,ARRAY BIOPHARMA INC,DAVID SHANK FRY;;CHRISTOPHER M LINDEMANN;;MICHAEL PREIGH;;COREY JAY BLOOM;;CHRISTOPHER DONOVAN CRAIG;;DEVON BREVARD DUBOSE;;JEFF GAUTSCHI;;DAN SMITHEY,,https://lens.org/024-879-776-469-713,Patent Application,no,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/10;;A61K9/14;;A61K9/16;;A61K9/20;;A61K31/498;;A61K31/517;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,PENDING
932,TW,B,TW I722189 B,066-818-337-438-004,2021-03-21,2021,TW 106116008 A,2012-10-15,US 201161547620 P;;US 201261606207 P,2011-10-14,Solid dispersion,,ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;GAUTSCHI JEFF;;SMITHEY DAN;;DUBOSE DEVON BREVARD,,https://lens.org/066-818-337-438-004,Granted Patent,no,4,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,,,0,0,,,,ACTIVE
933,UA,C2,UA 111383 C2,123-264-529-862-196,2016-04-25,2016,UA A201405085 A,2012-10-12,US 201161547620 P;;US 2012/0060044 W,2011-10-14,SOLID DISPERSION,"Винахід належить до галузі фармацевтики і стосується твердої дисперсії N-(4-([1,2,4]триазоло[1,5-a]піридин-7-ілокси)-3-метилфеніл)-N6-(4,4-диметил-4,5-дигідрооксазол-2-іл)хіназолін-4,6-діаміну, способу її отримання, фармацевтичних композицій, які її містять, їх застосування та способу лікування раку.",ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/123-264-529-862-196,Limited Patent,no,0,0,2,69,0,,A61K9/10;;A61K31/517;;A61K47/30;;A61P35/00,,0,0,,,,EXPIRED
934,AU,A1,AU 2012/322039 A1,126-276-100-685-817,2014-06-05,2014,AU 2012/322039 A,2012-10-12,US 201161547620 P;;US 201261606207 P;;US 2012/0060044 W,2011-10-14,Solid dispersions of a Erb2 (HER2) inhibitor,"A solid dispersion of N4-(4-([1, 2, 4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-α]pyridin-7-yloxy)-3- methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.",ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/126-276-100-685-817,Patent Application,no,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/14;;A61K9/20;;A61K31/498;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,ACTIVE
935,MX,B,MX 353970 B,034-114-309-280-493,2018-02-07,2018,MX 2014004551 A,2012-10-12,US 201161547620 P;;US 201261606207 P;;US 2012/0060044 W,2011-10-14,SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR.,"A solid dispersion of N4-(4-([1, 2, 4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimet hyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-Î±]pyridin-7-yloxy)-3- methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoli ne-4,6-diamine and uses thereof are provided herein.",ARRAY BIOPHARMA INC,DAVID SHANK FRY;;CHRISTOPHER M LINDEMANN;;MICHAEL PREIGH;;COREY JAY BLOOM;;CHRISTOPHER DONOVAN CRAIG;;DEVON BREVARD DUBOSE;;JEFF GAUTSCHI;;DAN SMITHEY,,https://lens.org/034-114-309-280-493,Granted Patent,no,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K31/517;;A61K9/00;;A61K9/10;;A61K9/14;;A61K9/16;;A61K9/20;;A61K31/498;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,ACTIVE
936,AU,C1,AU 2019/200243 C1,027-761-894-897-992,2021-04-29,2021,AU 2019/200243 A,2019-01-15,AU 2019/200243 A;;AU 2017/210499 A;;AU 2012/322039 A;;US 201161547620 P;;US 201261606207 P;;US 2012/0060044 W,2011-10-14,SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR,"[0001581 A solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3 methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3 methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.",ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/027-761-894-897-992,Amended Patent,no,1,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/14;;A61K9/20;;A61K31/498;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,ACTIVE
937,US,B2,US 10314647 B2,090-647-395-045-838,2019-06-11,2019,US 201414579579 A,2014-12-22,US 201414579579 A;;US 201361920412 P;;US 201461933521 P,2013-12-23,Electrosurgical cutting instrument,"An electrosurgical device having a tubular outer shaft and an inner shaft is disclosed. The tubular outer shaft includes an axis and a distal end region. The distal end region includes a distal-most tip and a cutting edge defining a window in the outer shaft proximal along the axis to the distal-most tip. The inner shaft inner shaft coaxially maintained within the outer shaft such that the inner shaft is movable about the axis with respect to the outer shaft and wherein a portion of the inner shaft is exposed in the window of the outer shaft. A first electrode is disposed on the outer shaft in a region proximal along the axis to the window, and a second electrode is electrically isolated from the first electrode and disposed on the inner shaft. The second electrode is exposed in the window of the outer shaft.",MEDTRONIC ADVANCED ENERGY LLC,BLOOM ELIOT F;;BERMAN PHILLIP;;LI WENJENG;;LITTLE DAVID J;;OLIVER DANA A;;PRISCO JOHN R;;BROWN PHILLIP P;;RICHART PATRICK,MEDTRONIC ADVANCED ENERGY LLC (2015-01-13),https://lens.org/090-647-395-045-838,Granted Patent,yes,342,1,2,2,0,A61B18/148;;A61B18/148;;A61B2018/00148;;A61B2018/00148;;A61B2018/00202;;A61B2018/00202;;A61B2018/00208;;A61B2018/00208;;A61B2018/00565;;A61B2018/00565;;A61B2018/00601;;A61B2018/00601;;A61B2018/126;;A61B2018/126;;A61B2218/002;;A61B2218/002;;A61B2218/007;;A61B2218/007,A61B18/14;;A61B18/00;;A61B18/12,,4,2,030-372-146-387-259;;075-788-055-054-258,10.1097/01.mlg.0000205140.44181.45;;16652079;;10.1001/archotol.134.8.819;;18711054,"MicroPenning: How It Works: MicroPen Technologies, http://www.micropen.com/Micropenning/how_it_works.php, Exhibit in Case IPR2016-01405, Sep. 13, 2010, 3 pgs.;;Lee et al, Comparative Study on the Long-Term Effectiveness Between Coblation-and Microdebrider-Assisted partial Turbinoplasty, Laryngoscope 116:May 2006 pp. 729-734.;;Berger et al., Histopathological Changes After Coblation Inferior Turbinate Reduction, Arch Otolaryngol Head Neck Surg. 2008;134(8):819-823.;;Arthrocare PROcise EZ View Sinus Wand with integrated ablation, suction, and bipolar hemostasis (1 page) admitted prior art document.",ACTIVE
938,AT,T1,AT E340852 T1,127-517-662-454-00X,2006-10-15,2006,AT 02744712 T,2002-06-25,US 30193401 P,2001-06-29,KUNSTMÄSSIGE CHIP-SCHNITTSTELLENVERBINDUNG FÜR ELEKTRONISCHE REITINAIMPLANTAT,The invention provides microfabricated devices and methods for directing the growth of a cell process to form an artificial synapse. The devices are called artificial synapse chips. The artificial synapse comprises a nanofabricated aperture (about 50-100 nm in size) that connects the cell process to a chemical or electrical means of neuronal excitation. Such an aperture width mimics the length scales of a natural synapse and thus emphasizes the localized spatial relationship between a neuron and a stimulation source. The invention further provides devices and methods for regenerating a nerve fiber into an electrode. The invention thus provides a regeneration electrode that uses a novel neural interface for stimulation and that uses novel surface methods for directing neuronal growth making possible in vivo connection of the devices to neural circuitry in a retina and other anatomical locations.,UNIV LELAND STANFORD JUNIOR,FISHMAN HARVEY A;;BLUMENKRANZ MARK;;BENT STACEY FRANCINE;;BLOOM DAVID M;;PETERMAN MARK C;;ZIEBARTH JONATHAN M;;LEE CHRISTINE;;LENG THEODORE,,https://lens.org/127-517-662-454-00X,Granted Patent,no,0,0,15,15,0,A61N1/0543;;A61N1/326;;A61N1/36046;;C12M35/00;;C12M35/02;;C12M35/08;;C12N5/0619;;C12N2503/00;;C12N2535/10;;A61N1/36046;;A61N1/0543;;C12M35/00;;C12M35/02;;C12M35/08;;A61N1/326;;C12N5/0619;;C12N2503/00;;C12N2535/10,A61K9/22;;A61L27/00;;A61N1/05;;A61N1/36;;C12M1/42;;C12M3/00;;C12N5/0793,,0,0,,,,EXPIRED
939,WO,A3,WO 2013/056108 A3,135-539-760-601-55X,2013-06-27,2013,US 2012/0060044 W,2012-10-12,US 201161547620 P;;US 201261606207 P,2011-10-14,SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR,"A solid dispersion of N4-(4-([1, 2, 4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-alpha]pyridin-7-yloxy)-3- methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.",ARRAY BIOPHARMA INC;;FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/135-539-760-601-55X,Search Report,no,1,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/00;;A61K9/14;;A61K9/20;;A61K31/498;;A61K47/32;;A61K47/38;;A61P35/00,,2,1,074-225-865-565-732,18061887;;10.1016/j.drudis.2007.09.005,"KOCH, KEVIN: ""ARRY-380: A Selective, Oral HER2 inhibitor for the Treatment of Solid Tumors"", 3 April 2011 (2011-04-03), XP002692140, Retrieved from the Internet <URL:http://www.arraybiopharma.com/_documents/Publication/PubAttachment462.pdf> [retrieved on 20130214];;VASCONCELOS ET AL: ""Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs"", DRUG DISCOVERY TODAY, ELSEVIER, RAHWAY, NJ, US, vol. 12, no. 23-24, 30 October 2007 (2007-10-30), pages 1068 - 1075, XP022370275, ISSN: 1359-6446",PENDING
940,ZA,B,ZA 201606123 B,172-254-900-356-975,2021-05-26,2021,ZA 201606123 A,2016-09-05,US 201161547620 P;;US 201261606207 P,2011-10-14,PHARMACEUTICAL COMPOSITIONS OF A ERB2 (HER2) INHIBITOR,,ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREIGH MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BREVARD;;GAUTSCHI JEFF;;SMITHEY DAN,,https://lens.org/172-254-900-356-975,Granted Patent,no,0,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,,,0,0,,,,ACTIVE
941,US,B2,US 11435830 B2,018-176-661-015-625,2022-09-06,2022,US 202016926512 A,2020-07-10,US 202016926512 A;;US 201816144950 A;;US 201862729978 P,2018-09-11,Content-based tactile outputs,"The present disclosure generally relates to content-based tactile outputs. In some embodiments, user interfaces associated with content-based tactile outputs are described. In some embodiments, user interfaces associated with end-of-content tactile outputs are described. In some embodiments, user interfaces associated with moving a user interface in response to different types of input are described. In some embodiments, user interfaces associated with adjustable item-based tactile outputs are described. In some embodiments, user interfaces associated with input velocity-based tactile outputs are described.",APPLE INC,MOUSSETTE CAMILLE;;BLOOM DAVID H;;BUTCHER GARY IAN;;EDWARDS DYLAN ROSS;;FENNIS JULES K;;GLEESON BRIAN T;;HE MIAO;;DYE ALAN C,,https://lens.org/018-176-661-015-625,Granted Patent,yes,1171,2,3,41,0,G06F3/016;;G06F3/04817;;G06F3/0485;;G06F3/04847;;G06F3/0362;;G06F3/016;;G06F3/0362;;G06F3/0412;;G06F3/0487;;G06F3/04845,G06F3/01;;G06F3/0362;;G06F3/041;;G06F3/04845;;G06F3/0487,,638,3,159-239-488-146-709;;090-500-355-520-271;;078-053-085-611-619,10.1109/istas.2013.6613119;;10.1007/s007790200002;;10.1117/12.561263,"Corrected Notice of Allowance received for U.S. Appl. No. 15/930,300, dated Dec. 24, 2020, 3 pages.;;“Little Ben—Elegant Quarter Chime Clock App for your iPhone & iPad”, Online available at: www.curveddesign.com, Oct. 29, 2013, 8 pages.;;“Little Ben—Time haptics for your Apple Watch, Like a Cuckoo Clock”, Online available at: https://www.producthunt.com/posts/little-ben, Nov. 25, 2017, 2 pages.;;Non-Final Office Action received for U.S. Appl. No. 16/814,801, dated Dec. 15, 2020, 17 pages.;;Notice of Acceptance received for Australian Patent Application No. 2019206101, dated Dec. 11, 2020, 3 pages.;;Office Action received for Chinese Patent Application No. 201580077206.7, dated Nov. 11, 2020, 11 pages (5 pages of English Translation and 6 pages of Official Copy).;;Ask Different, “Time—Is It Not Possible to Make Apple Watch Chime on the Hour?”, Online available at: https://apple.stackexchange.com/questions/347805/is-it-not-possible-to-make-apple-watch-chime-on-the-hour, Jan. 7, 2019, 3 pages.;;“Use Accessibility features on your Apple Watch”, Online available at: https://support.apple.com/en-us/HT204576, Oct. 30, 2018, 5 pages.;;Timebuzz, “Introducing Time Buzz, an Apple Watch App that Allows You to Tell the Time Using the Taptic Engine”, Online available at: https://www.applevis.com/forum/watchos-apple-watch-apps/introducing-timebuzz-apple-watch-app-allows-you-tell-time-using, Dec. 22, 2015, 10 pages.;;Zibreg, Christian, “Howto select Siri voices for VoiceOver, Speak Screen and Speak Selection features”, Available online at: https://www.idownloadblog.com/2016/02/17 /how-to-select-siri-voices-for-voiceover/, Feb. 17, 2016, 22 pages.;;Accepted Outlook Meetings Move to Deleted Folder, Available online at: —https://social.technet.microsoft.com/Forums/office/en-US/f3301c9a-a93f-49f7-be13-c642e285f150/accepted-outlook-meetings-move-to-deleted-folder?forum=outlook, Jan. 13, 2011, 4 pages.;;Advisory Action received for U.S. Appl. No. 14/752,776, dated Aug. 31, 2018, 3 pages.;;Android 2.3.4 User's Guide, Online available at: https://static.googleusercontent.com/media/www.google.com/en//help/hc/pdfs/mobile/AndroidUsersGuide-2.3.4.pdf, May 20, 2011, 384 pages.;;Applicant Initiated Interview Summary received for U.S. Appl. No. 16/265,938, dated Mar. 11, 2020, 5 pages.;;Applicant-Initiated Interview Summary received for U.S. Appl. No. 16/265,938, dated May 28, 2020, 5 pages.;;Applicant-Initiated Interview Summary received for U.S. Appl. No. 17/103,436, dated Sep. 22, 2021, 2 pages.;;Decision to Grant received for European Patent Application No. 15739110.3, dated Sep. 19, 2019, 2 pages.;;Extended European Search Report (includes Partial European Search Report and European Search Opinion) received for European Patent Application No. 16190252.3, dated Mar. 1, 2017, 10 pages.;;Extended European Search Report for European Application No. 19185318.3, dated Nov. 20, 2019, 8 pages.;;Final Office Action received for U.S. Appl. No. 14/752,776, dated May 29, 2018, 36 pages.;;Final Office Action received for U.S. Appl. No. 16/265,938, dated Apr. 7, 2020, 45 pages.;;Intention to Grant received for European Patent Application No. 15739110.3, dated Mar. 7, 2019, 8 pages.;;Intention to Grant received for European Patent Application No. 15739110.3, dated Sep. 11, 2019, 6 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2015/038173, dated Jan. 5, 2017, 10 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2015/038174, dated Jan. 5, 2017, 27 pages.;;Microsoft Outlook 2010(TM) A Beginners Guide, Available online at: —http://www.reading.ac.uk/web/files/its/outlook2010.pdf, Apr. 1, 2012, 24 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/752,776, dated Jan. 2, 2018, 30 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/752,776, dated Nov. 5, 2018, 48 Pages.;;Non-Final Office Action received for U.S. Appl. No. 16/265,938, dated Nov. 4, 2019, 28 pages.;;Non-Final Office Action received for U.S. Appl. No. 17/103,436, dated Aug. 18, 2021, 16 pages.;;Non-Final Office Action received for U.S. Appl. No. 17/212,850, dated Oct. 8, 2021, 14 pages.;;Notice of Acceptance received for Australian Patent Application No. 2015279544, dated Mar. 1, 2018, 3 pages.;;Notice of Acceptance received for Australian Patent Application No. 2016231598, dated Mar. 1, 2018., 3 Pages.;;Notice of Acceptance received for Australian Patent Application No. 2018204286, dated Feb. 27, 2020, 3 pages.;;Notice of Acceptance received for Australian Patent Application No. 2020203919, dated Sep. 3, 2021, 3 pages.;;Notice of Acceptance received for Australian Patent Application No. 2015279545, dated Feb. 9, 2018, 3 Pages.;;Notice of Allowance received for Chinese Patent Application No. 201580029054.3, dated Jul. 19, 2019, 2 pages (1 page of English Translation and 1 page of Official Copy).;;Notice of Allowance received for U.S. Appl. No. 16/265,938, dated Oct. 15, 2020, 8 pages.;;Office Action received for Australian Patent Application No. 2015279544, dated Apr. 18, 2017, 4 pages.;;Office Action received for Australian Patent Application No. 2015279544, dated Feb. 13, 2018, 5 pages.;;Office Action received for Australian Patent Application No. 2016231598, dated Apr. 7, 2017., 5 Pages.;;Office Action received for Australian Patent Application No. 2018204286, dated Apr. 17, 2019, 5 pages.;;Office Action received for Australian Patent Application No. 2018204286, dated Nov. 12, 2019, 5 pages.;;Office Action received for Australian Patent Application No. 2018204286, dated Sep. 5, 2019, 5 pages.;;Office Action received for Australian Patent Application No. 2020203919, dated Dec. 23, 2020, 5 pages.;;Office Action received for Australian Patent Application No. 2020203919, dated Jul. 19, 2021, 7 pages.;;Office Action received for Australian Patent Application No. 2020203919, dated Mar. 30, 2021, 5 pages.;;Office Action received for Australian Patent Application No. 2020203919, dated Oct. 19, 2020, 5 pages.;;Office Action received for Australian Patent Application No. 2015279545, dated Apr. 13, 2017, 3 pages.;;Office Action received for Chinese Patent Application No. 201580029054.3, dated Dec. 5, 2018, 12 pages (6 pages of English Translation and 6 pages of Official Copy).;;Office Action Received for European Patent Application No. 15739109.5, dated Jan. 31, 2018, 7 pages.;;Office Action Received for European Patent Application No. 15739110.3, dated Jan. 31, 2018, 8 pages.;;Office Action received for European Patent Application No. 16190252.3, dated Feb. 19, 2018, 7 pages.;;Remote Phone Call, Available online at: <https://web.archive.org/web/20140625104844/https://www.justremotephone.com/>, Jun. 25, 2014, 22 pages.;;Responding to a meeting invitation, Available online at: —https://web.archive.org/web/20121128174157/https://www.zimbra.com/desktop7/help/en_US/Calendar/Responding_to_an_invitation.htm, Nov. 28, 2012, 1 page.;;Summons to Attend Oral Proceedings received for European Patent Application No. 15739109.5, mailed on Aug. 23, 2018, 9 pages.;;Summons to Attend Oral Proceedings received for European Patent Application No. 15739109.5, mailed on Oct. 4, 2018, 3 Pages.;;Summons to Attend Oral Proceedings received for European Patent Application No. 15739110.3, mailed on Aug. 23, 2018, 10 pages.;;Summons to Attend Oral Proceedings received for European Patent Application No. 15739110.3, mailed on Oct. 2, 2018, 3 pages.;;Summons to Attend Oral Proceedings received for European Patent Application No. 16190252.3, mailed on Jan. 8, 2019, 3 pages.;;Summons to Attend Oral Proceedings received for European Patent Application No. 16190252.3, mailed on Oct. 30, 2018, 13 pages.;;Office Action received for Taiwanese Patent Application No. 104120843, dated Jan. 30, 2016, 5 pages (1 page of English Translation of Search Report and 4 pages of Official Copy).;;Ellis Benus, “Use a Phone Number in the Google Calendar Where Line for One Click Calling”, Available online at: https://ellisbenus.com/ellis-benus/use-a-phone-number-in-the-google-calender-where-line-for-one-click-calling, Ellis Benus—Small Business Web Guru, Oct. 3, 2012, 2 pages.;;Jepson Tom, “How to auto-forward specific emails in gmail?”, Available online at: <http://www.tomjepson.co.uk/how-to-auto-forward-specific-emails-in-gmail/>, May 19, 2013, 7 pages.;;Lyons et al., “Facet: A Multi-Segment Wrist Worn System”, Online available at: <http://fetlab.io/publications/2012Faceta%20multisegment%20wrist%20worn%20system.pdf>, Oct. 7-10, 2012, pp. 123-129.;;Netsapiens, “Click to Call in MS Outlook”, Available online at: <https://netsapiens.com/click-to-call-in-ms-outlook-windows-apps/>, May 4, 2012, 8 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2015/038173 dated Sep. 25, 2015, 13 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2015/038174, dated Jan. 18, 2016, 38 pages.;;Invitation to Pay Additional Fees received for PCT Patent Application No. PCT/US2015/038174, dated Oct. 5, 2015., 5 pages.;;Clock & Calendar for Smart Watch 2, https://www.youtube.com/watch?v=Uj-K2vMnrj8, Nov. 20, 2013, 2 Pages.;;Tablet Talk, “Tablet Talk App: Frequently Asked Questions—Tablet Talk.”, available at https://web.archive.org/web/20140625102903/http:/1www.tablettal app.com/faq, Jun. 25, 2014, pp. 1-6.;;Corrected Notice of Allowance received for U.S. Appl. No. 16/147,413, dated Jan. 8, 2021, 7 pages.;;Non-Final Office Action received for U.S. Appl. No. 16/734,173, dated Jan. 6, 2021, 14 pages.;;Notice of Acceptance received for Australian Patent Application No. 2019272034, dated Dec. 14, 2020, 3 pages.;;Notice of Allowance received for Chinese Patent Application No. 201810074876.9, dated Jan. 12, 2021, 2 pages (1 page of English Translation and 1 page of Official Copy).;;Notice of Allowance received for U.S. Appl. No. 16/358,483, dated Jan. 19, 2021, 9 pages.;;Office Action received for European Patent Application No. 19206249.5, dated Jan. 11, 2021, 8 pages.;;Applicant-Initiated Interview Summary received for U.S. Appl. No. 15/818,500, dated Oct. 13, 2020, 4 pages.;;Applicant-Initiated Interview Summary received for U.S. Appl. No. 16/358,483, dated Sep. 28, 2020, 6 pages.;;Applicant Initiated Interview Summary received for U.S. Appl. No. 16/871,995, dated Dec. 6, 2021, 4 pages.;;Corrected Notice of Allowance received for U.S. Appl. No. 17/103,436, dated Dec. 22, 2021, 2 pages.;;Intention to Grant received for European Patent Application No. 19185318.3, dated Dec. 10, 2021, 12 pages.;;Notice of Acceptance received for Australian Patent Application No. 2019337519, dated Dec. 15, 2021, 3 pages.;;Notice of Allowance received for U.S. Appl. No. 17/103,436, dated Dec. 8, 2021, 12 pages.;;Office Action received for European Patent Application No. 19217240.1, dated Dec. 17, 2021, 8 pages.;;Non-Final Office Action received for U.S. Appl. No. 15/655,253, dated Sep. 10, 2020, 17 pages.;;Office Action received for Korean Patent Application No. 10-2020-7019035, dated Aug. 28, 2020, 6 pages (2 pages of English Translation and 4 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2020-7022802, dated Aug. 28, 2020, 7 pages (2 pages of English Translation and 5 pages of Official Copy).;;Office Action received for Taiwanese Patent Application No. 104107329, dated Jul. 24, 2020, 7 pages (3 pages of English Translation and 4 pages of Official Copy).;;Applicant-Initiated Interview Summary received for U.S. Appl. No. 15/655,253, dated Nov. 30, 2020, 5 pages.;;Applicant-Initiated Interview Summary received for U.S. Appl. No. 16/263,280, dated Nov. 25, 2020, 3 pages.;;Corrected Notice of Allowance received for U.S. Appl. No. 16/147,413, dated Nov. 25, 2020, 7 pages.;;Non-Final Office Action received for U.S. Appl. No. 16/775,528, dated Nov. 20, 2020, 15 pages.;;Office Action received for Danish Patent Application No. PA201970259, dated Nov. 23, 2020, 3 pages.;;Askabouttech, “How to Change Android Smartwatch Wallpaper”, also online available at: —https://www.youtube.com/watch?v=SBYrsyuHqBA (Year: 2014), Jul. 12, 2014, 5 pages.;;Applicant-Initiated Interview Summary received for U.S. Appl. No. 16/734,173, dated Feb. 25, 2021, 3 pages.;;Final Office Action received for U.S. Appl. No. 16/263,280, dated Mar. 4, 2021, 13 pages.;;Office Action received for Chinese Patent Application No. 201910164962.3, dated Jan. 12, 2021, 14 pages (7 pages of English Translation and 7 pages of Official Copy).;;Office Action received for Chinese Patent Application No. 201911127193.6, dated Dec. 17, 2020, 21 pages (10 pages of English Translation and 11 pages of Official Copy).;;Office Action received for European Patent Application No. 17813779.0, dated Mar. 4, 2021, 7 pages.;;Supplemental Notice of Allowance received for U.S. Appl. No. 15/818,500, dated Mar. 5, 2021, 2 pages.;;Applicant-Initiated Interview Summary received for U.S. Appl. No. 16/775,528, dated Aug. 30, 2021, 6 pages.;;Android Central, “Gmail on iOS versus Android”, Online Available at: https://www.youtube.com/watch?v=w2aVeZLxU5Q&t=80s, Nov. 2, 2011, 3 pages.;;Final Office Action received for U.S. Appl. No. 16/871,995, dated Aug. 20, 2021, 25 pages.;;Notice of Allowance received for Korean Patent Application No. 10-2021-7005523, dated Aug. 26, 2021, 4 pages (1 page of English Translation and 3 pages of Official Copy).;;Applicant Initiated Interview Summary received for U.S. Appl. No. 16/384,726, dated Nov. 5, 2020, 3 pages.;;Extended European Search Report received for European Patent Application No. 20190670.8, dated Nov. 2, 2020, 10 pages.;;Notice of Allowance received for Chinese Patent Application No. 201910454069.4, dated Nov. 2, 2020, 7 pages (3 pages of English Translation and 4 pages of Official Copy).;;Notice of Allowance received for U.S. Appl. No. 16/147,413, dated Nov. 5, 2020, 10 pages.;;Notice of Allowance received for U.S. Appl. No. 16/525,082, dated Nov. 17, 2020, 7 pages.;;Office Action received for Chinese Patent Application No. 201580046339.8, dated Oct. 19, 2020, 12 pages (4 pages of English Translation and 8 pages of Official Copy).;;Office Action received for Chinese Patent Application No. 201910454076.4, dated Oct. 16, 2020, 14 pages (8 pages of English Translation and 6 pages of Official Copy).;;Office Action received for Japanese Patent Application No. 2019-116590, dated Oct. 5, 2020, 6 pages (3 pages of English Translation and 3 pages of Official Copy).;;Applicant-Initiated Interview Summary received for U.S. Appl. No. 16/263,280, dated Apr. 26, 2021, 2 pages.;;Non-Final Office Action received for U.S. Appl. No. 16/871,995, dated Apr. 26, 2021, 14 pages.;;Office Action received for Australian Patent Application No. 2019257521, dated Apr. 8, 2021, 6 pages.;;Office Action received for Korean Patent Application No. 10-2021-7001482, dated Apr. 9, 2021, 10 pages (4 pages of English Translation and 6 pages of Official Copy).;;Advisory Action received for U.S. Appl. No. 15/655,253, dated May 11, 2021, 6 pages.;;Notice of Allowance received for U.S. Appl. No. 16/358,483, dated May 17, 2021, 5 pages.;;Office Action received for European Patent Application No. 20217518.8, dated Apr. 30, 2021, 8 pages.;;Office Action received for Japanese Patent Application No. 2019-088503, dated Apr. 2, 2021, 6 pages (3 pages of English Translation and 3 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2021-7001918, dated May 7, 2021, 5 pages (2 pages of English Translation and 3 pages of Official Copy).;;Notice of Allowance received for U.S. Appl. No. 16/525,082, dated Aug. 20, 2020, 5 pages.;;Office Action received for Australian Patent Application No. 2019257521, dated Aug. 7, 2020, 5 pages.;;Office Action received for Chinese Patent Application No. 201680012759.9, dated Jun. 19, 2020, 20 pages (9 pages of English Translation and 11 pages of Official Copy).;;Office Action received for Chinese Patent Application No. 201910454069.4, dated Jul. 24, 2020, 8 pages (5 pages of English Translation and 3 pages of Official Copy).;;Pedersen Isabel, “Ready to Wear (or Not) Examining the Rhetorical Impact of Proposed Wearable Devices”, 2013 IEEE International Symposium on Technology and Society (ISTAS) Social Implications of Wearable Computing and Augmediated Reality III Everyday Life, Dec. 31, 2013, pp. 201-202.;;Tong et al., “Discussion About the Influence of Wearable Device on Mobile Operators Service”, Telecom science, Oct. 31, 2014, pp. 134-142 (Official Copy Only) (See Communication under 37 CFR § 1.98(a) (3)).;;Advisory Action received for U.S. Appl. No. 16/734,173, dated Oct. 14, 2021, 3 pages.;;Office Action received for Australian Patent Application No. 2019337519, dated Oct. 8, 2021, 7 pages.;;Final Office Action received for U.S. Appl. No. 16/775,528, dated May 25, 2021, 15 pages.;;Notice of Allowance received for Chinese Patent Application No. 201911127193.6, dated May 8, 2021, 4 pages (1 page of English Translation and 3 pages of Official Copy).;;Non-Final Office Action received for U.S. Appl. No. 16/734,173, dated Nov. 2, 2021, 13 pages.;;Notice of Allowance received for Taiwanese Patent Application No. 104107318, dated Oct. 19, 2021, 5 pages (2 page of English Translation and 3 pages of Official Copy).;;Office Action received for Indian Patent Application No. 202018012249, dated Nov. 1, 2021, 6 pages.;;Office Action received for Japanese Patent Application No. 2021-510409, dated Oct. 8, 2021, 9 pages (5 pages of English Translation and 4 pages of Official Copy).;;Decision of Appeal received for Korean Patent Application No. 10-2019-7028736, mailed on May 24, 2021, 16 pages (2 pages of English Translation and 14 pages of Official Copy).;;Notice of Allowance received for U.S. Appl. No. 16/263,280, dated Jun. 8, 2021, 8 pages.;;Advisory Action received for U.S. Appl. No. 14/641,308, dated Nov. 14, 2019, 4 pages.;;Advisory Action received for U.S. Appl. No. 14/839,912, dated Nov. 14, 2019, 6 pages.;;Advisory Action received for U.S. Appl. No. 14/841,646, dated Nov. 21, 2018, 5 pages.;;Advisory Action received for U.S. Appl. No. 14/913,349, dated Oct. 29, 2019, 4 pages.;;Advisory Action received for U.S. Appl. No. 15/049,052, dated Sep. 11, 2017, 2 pages.;;Advisory Action received for U.S. Appl. No. 15/049,058, dated Oct. 18, 2017, 3 pages.;;Advisory Action received for U.S. Appl. No. 15/049,064, dated May 10, 2017, 3 pages.;;Advisory Action received for U.S. Appl. No. 16/144,950, dated Feb. 20, 2020, 5 pages.;;Advisory Action received for U.S. Appl. No. 16/147,413, dated Nov. 25, 2019, 2019, 6 pages.;;Agarwal, Deepesh, “DexClock—Live Clock and Date Blended Into Beautiful Artwork as Your Desktop Wallpaper”, available at: https://www.megaleecher.net/DexCiock_Wallpaper_Designs, Jul. 6, 2013, 4 pages.;;Apple, “iPhone User's Guide”, Available at <http://mesnotices.20minutes.fr/manuel-notice-mode-emploi/APPLE/IPHONE%2D%5FE#>, Retrieved on Mar. 27, 2008, Jun. 2007, 137 pages.;;Applicant Initiated Interview Summary received for U.S. Appl. No. 14/913,345, dated Nov. 4, 2019, 5 pages.;;Applicant Initiated Interview Summary received for U.S. Appl. No. 14/913,349, dated Oct. 7, 2019, 4 pages.;;Applicant Initiated Interview Summary received for U.S. Appl. No. 15/655,253, dated Nov. 12, 2019, 3 pages.;;Applicant Initiated Interview Summary received for U.S. Appl. No. 16/144,950, dated Jan. 29, 2020, 5 pages.;;Applicant Initiated Interview Summary received for U.S. Appl. No. 16/147,413, dated Oct. 28, 2019, 5 pages.;;Applicant Initiated Interview Summary received for U.S. Appl. No. 14/839,912, dated Nov. 5, 2019, 5 pages.;;Applicant-Initiated Interview Summary received for U.S. Appl. No. 14/641,308, dated Oct. 10, 2019, 5 pages.;;Applicant-Initiated Interview Summary received for U.S. Appl. No. 15/818,500, dated Jan. 30, 2020, 5 pages.;;Brinkmann, Martin, “How to Zoom in Firefox, Ghacks”, Available at <https://web.archive.org/web/20130804034728/https://www.ghacks.net/2009/02/23/how-to-zoom-in-firefox/>, Feb. 23, 2009, 11 pages.;;Colt, Sam, “Here's One Way Apple's Smartwatch Could Be Better Than Anything Else”, Business Insider, Aug. 21, 2014, pp. 1-4.;;Corrected Notice of Allowance received for U.S. Appl. No. 14/641,252, dated Aug. 28, 2018, 2 pages.;;Corrected Notice of Allowance received for U.S. Appl. No. 14/641,252, dated Jul. 9, 2018, 25 pages.;;Corrected Notice of Allowance received for U.S. Appl. No. 14/641,252, dated May 10, 2018, 10 pages.;;Corrected Notice of Allowance received for U.S. Appl. No. 14/829,573, dated Aug. 9, 2018, 3 pages.;;Corrected Notice of Allowance received for U.S. Appl. No. 14/829,573, dated Sep. 11, 2018, 3 pages.;;Corrected Notice of Allowance received for U.S. Appl. No. 14/830,629, dated Feb. 13, 2019, 3 pages.;;Corrected Notice of Allowance received for U.S. Appl. No. 14/841,656, dated Apr. 11, 2018, 2 pages.;;Corrected Notice of Allowance received for U.S. Appl. No. 14/841,656, dated May 7, 2018, 14 pages.;;Corrected Notice of Allowance received for U.S. Appl. No. 15/927,768, dated Aug. 7, 2019, 2 pages.;;Corrected Notice of Allowance received for U.S. Appl. No. 15/927,768, dated Jul. 9, 2019, 2 pages.;;Corrected Notice of Allowance received for U.S. Appl. No. 16/055,489, dated Feb. 26, 2019, 2 pages.;;Corrected Notice of Allowance received for U.S. Appl. No. 16/109,120, dated Nov. 12, 2019, 2 pages.;;Decision on Appeal received for Korean Patent Application No. 10-2016-7008449, mailed on Jul. 30, 2019, 29 pages.;;Decision on Appeal received for Korean Patent Application No. 10-2016-7008474, mailed on Jan. 29, 2020, 21 pages.;;Decision on Appeal received for Korean Patent Application No. 10-2016-7008488, mailed on Oct. 18, 2019, 33 pages.;;Decision on Appeal received for Korean Patent Application No. 10-2018-7010872, mailed on Jan. 20, 2020, 20 pages.;;Decision to Grant received for Danish Patent Application No. PA201570781, dated Jul. 17, 2017, 2 pages.;;Decision to Grant received for Danish Patent Application No. PA201670117, dated Nov. 20, 2017, 2 pages.;;Decision to Grant received for Danish Patent Application No. PA201770181, dated Mar. 7, 2018, 2 pages.;;Decision to Grant received for Danish Patent Application No. PA201770794, dated Nov. 11, 2019, 2 pages.;;Decision to Grant received for Danish Patent Application No. PA201870631, dated May 15, 2019, 2 pages.;;Decision to Grant received for Danish Patent Application No. PA201870632, dated May 14, 2019, 2 pages.;;Decision to Grant received for European Patent Application No. 14772001.5, dated Dec. 5, 2019, 2 pages.;;Decision to Grant received for European Patent Application No. 14772002.3, dated Feb. 20, 2020, 2 pages.;;Decision to Grant received for European Patent Application No. 15782209.9, dated Feb. 14, 2019, 2 pages.;;Decision to Grant received for European Patent Application No. 18157131.6, dated May 16, 2019, 2 pages.;;Dewsberry, Victor, “Designing for Small Screens”, AVA Publishing, 2005, 27 pages.;;European Search Report received for European Patent Application No. 19173371.6, dated Oct. 30, 2019, 7 pages.;;European Search Report received for European Patent Application No. 19173886.3, dated Oct. 30, 2019, 8 pages.;;European Search Report received for European Patent Application No. 19199004.3, dated Nov. 12, 2019, 6 pages.;;European Search Report received for European Patent Application No. 19206249.5, dated Dec. 19, 2019, 4 pages.;;Extended European Search Report received for European Patent Application No. 17813779.0, dated Oct. 29, 2019, 8 pages.;;Extended European Search Report received for European Patent Application No. 19156614.0, dated May 28, 2019, 9 pages.;;Extended European Search Report received for European Patent Application No. 19195247.2, dated Mar. 9, 2020, 7 pages.;;Final Office Action received for U.S. Appl. No. 13/038,276, dated Mar. 27, 2014, 24 pages.;;Final Office Action received for U.S. Appl. No. 13/038,276, dated Mar. 11, 2016, 36 pages.;;Final Office Action received for U.S. Appl. No. 14/641,308, dated Jul. 1, 2019, 46 pages.;;Final Office Action received for U.S. Appl. No. 14/641,308, dated Mar. 14, 2018, 42 pages.;;Final Office Action received for U.S. Appl. No. 14/830,629, dated Apr. 16, 2018, 27 pages.;;Final Office Action received for U.S. Appl. No. 14/841,646, dated Aug. 2, 2018, 22 pages.;;Final Office Action received for U.S. Appl. No. 14/913,345, dated Oct. 26, 2018, 20 pages.;;Final Office Action received for U.S. Appl. No. 14/913,349, dated Jul. 22, 2019, 20 pages.;;Final Office Action received for U.S. Appl. No. 14/913,349, dated Jul. 30, 2018, 18 pages.;;Final Office Action received for U.S. Appl. No. 15/049,049 dated Jul. 12, 2018, 24 pages.;;Final Office Action received for U.S. Appl. No. 15/049,049, dated May 23, 2017, 23 pages.;;Final Office Action received for U.S. Appl. No. 15/049,052, dated Mar. 1, 2018, 15 pages.;;Final Office Action received for U.S. Appl. No. 15/049,052, dated May 17, 2017, 13 pages.;;Final Office Action received for U.S. Appl. No. 15/049,052, dated Oct. 2, 2018, 16 pages.;;Final Office Action received for U.S. Appl. No. 15/049,058, dated Aug. 8, 2018, 23 pages.;;Final Office Action received for U.S. Appl. No. 15/049,058, dated May 8, 2017, 21 pages.;;Final Office Action received for U.S. Appl. No. 15/049,064, dated Feb. 27, 2017, 13 pages.;;Final Office Action received for U.S. Appl. No. 15/655,253, dated Feb. 4, 2020, 20 pages.;;Final Office Action received for U.S. Appl. No. 16/144,950, dated Nov. 25, 2019, 24 pages.;;Final Office Action received for U.S. Appl. No. 16/147,413, dated Sep. 3, 2019, 19 pages.;;Final Office Action received for U.S. Appl. No. 14/839,912, dated Jul. 30, 2019, 42 pages.;;Final Office Action received for U.S. Appl. No. 14/839,912, dated Sep. 13, 2018, 31 pages.;;“Headset Button Controller v7.3 APK Full APP Download for Andriod”, Blackberry, iPhone, Available online at: http://fullappdownload.com/headset-button-controller-v7-3-apk/, Jan. 27, 2014, 11 pages.;;Intention to Grant received for Danish Patent Application No. PA201570781, dated Dec. 8, 2016, 2 pages.;;Intention to Grant received for Danish Patent Application No. PA201670117, dated Apr. 21, 2017, 2 pages.;;Intention to Grant received for Danish Patent Application No. PA201770794, dated Aug. 15, 2019, 2 pages.;;Intention to Grant received for Danish Patent Application No. PA201870631, dated Apr. 5, 2019, 2 pages.;;Intention to Grant received for Danish Patent Application No. PA201870632, dated Apr. 5, 2019, 2 pages.;;Intention to Grant received for European Patent Application No. 14772001.5, dated Jul. 18, 2019, 16 pages.;;Intention to Grant received for European Patent Application No. 14772001.5, dated Mar. 22, 2019, 17 pages.;;Intention to Grant received for European Patent Application No. 14772002.3, dated Jun. 24, 2019, 9 pages.;;Intention to Grant received for European Patent Application No. 14772002.3, dated Nov. 6, 2019, 9 pages.;;Intention to Grant received for European Patent Application No. 15782209.9, dated Sep. 28, 2018, 8 pages.;;Intention to Grant received for European Patent Application No. 18157131.6, dated Jan. 9, 2019, 9 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2012/025519, dated Sep. 12, 2013, 6 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2014/053951, dated Mar. 17, 2016, 9 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2014/053957, dated Mar. 17, 2016, 8 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2014/053958, dated Mar. 17, 2016, 8 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2014/053961, dated Jul. 21, 2016, 24 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2015/019322, dated Mar. 16, 2017, 11 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2015/045936, dated Mar. 16, 2017, 9 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2015/045965, dated Dec. 27, 2016, 10 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2015/047704, dated Mar. 16, 2017, 19 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2015/054310, dated Sep. 14, 2017, 7 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2016/019637, dated Sep. 21, 2017, 12 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2017/035325, dated Dec. 27, 2018, 9 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2015/019320, dated Mar. 16, 2017, 10 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2015/019321, dated Mar. 16, 2017, 8 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2012/025519, dated Jun. 11, 2012, 7 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2014/053951, dated Dec. 8, 2014, 11 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2014/053957, dated Feb. 19, 2015, 11 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2014/053958, dated Feb. 19, 2015, 10 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2015/019320, dated Jul. 2, 2015, 14 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2015/019321, dated Jun. 3, 2015, 11 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2015/019322, dated Jun. 18, 2015, 16 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2015/045936, dated Nov. 4, 2015, 12 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2015/045965, dated Feb. 1, 2016, 20 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2015/047704, dated Feb. 22, 2016, 25 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2015/054310, dated Jan. 20, 2016, 10 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2016/019637, dated Aug. 18, 2016, 18 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2017/035325, dated Sep. 7, 2017, 11 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2019/049237, dated Jan. 8, 2020, 21 pages.;;International Search Report received for PCT Patent Application No. PCT/US2014/053961, dated Jul. 11, 2016, 10 pages.;;International Written Opinion received for PCT Patent Application No. PCT/US2014/053961, dated Jul. 11, 2016, 22 pages.;;Invitation to Pay Additional Fees received for PCT Patent Application No. PCT/US2014/053961, dated Aug. 3, 2015, 6 pages.;;Invitation to Pay Additional Fees received for PCT Patent Application No. PCT/US2015/047704, dated Dec. 16, 2015, 10 pages.;;Invitation to Pay Additional Fees received for PCT Patent Application No. PCT/US2016/019637, dated Jun. 1, 2016, 6 pages.;;Invitation to Pay Additional Fees received for PCT Patent Application No. PCT/US2019/049237, dated Oct. 31, 2019, 18 pages.;;Kamijo, Noboru, “Next Generation Mobile System—WatchPad1.5”, Available at <http://researcher.ibm.com/researcher/view_group_subpage.php?id=5617>, retrieved on Jul. 4, 2015, 2 pages.;;Mai, Tuan, “This Watch Tells You the Time in Vibrating Morse Code”, Available at <https://web.archive.org/web/20130915060538/http://www.tomsguide.com/us/Watch-Concept-Morse-Code,news-12089.html>, Aug. 9, 2011, pp. 1-3.;;NDTV, “Sony SmartWatch 2 Launched in India for Rs. 14,990”, available at <http://gadgets.ndtv.com/others/news/sony-smartwatch-2-launched-in-india-for-rs-14990-420319>, Sep. 18, 2013, 4 pages.;;Non-Final Office Action received for U.S. Appl. No. 13/038,276, dated Jul. 29, 2015, 31 pages. et al.",ACTIVE
942,GB,A,GB 2386289 A,071-942-724-187-064,2003-09-10,2003,GB 0304712 A,2003-02-28,US 9049902 A,2002-03-04,Intelligent interactive voice response for call centres,"The present invention discloses a system for processing calls in a call centre provided for support of enterprise activities of an organisation. The method includes the steps of receiving a query about the enterprise activities of the organisation from a caller through the call centre, translating the query into voice extensible mark-up language (VXML), forming an answer to the translated query within an artificial intelligence engine and providing the determined answer to the caller. Another embodiment of the invention discloses processing calls in a call centre comprising receiving a text-based question, converting the question into a metaprogramming language understood by an artificial intelligence engine, and forming an answer to the question.",ROCKWELL ELECTRONIC COMMERCE,DEZONNO ANTHONY;;FUNCK DAVID;;POWER MARK J;;HODSON JEFFREY;;BLOOM JOSEPH;;JAMES ERIC;;PETERS MICHAEL;;SHAMBAUGH CRAIG R;;MOSQUERA DAVE;;SALEH NAYEL,,https://lens.org/071-942-724-187-064,Patent Application,no,4,8,6,6,0,H04M3/4938;;H04M3/5166;;H04M3/5191;;H04M3/4938;;H04M3/5166;;H04M3/5191,H04M3/493;;H04M3/51,H4K KF50A         KF50A,2,0,,,"T Olavsrud, ""start-up aims to revolutionise Tech support Call centers"" published Feb 15, 2002. www.internetnews.co./infr/article.php/975991;;I Brodsky, ""The 'Net finds its voice"", Network world, published 23/10/00. www.nwfusion.com/columnists/2000/1023brodsky.html",EXPIRED
943,US,B2,US 7369653 B2,093-090-311-622-68X,2008-05-06,2008,US 1157801 A,2001-11-05,US 1157801 A,2001-11-05,Method of delivering enterprise data through a call center,"A method and apparatus are described for providing enterprise information to a client through a call center of the enterprise. The method includes the steps of detecting an identity of the client based upon call associated information received through a call connection between the client and the call center, presenting the client with a plurality of options based upon the identity of the client and presenting the client with enterprise information based upon a selected option of the plurality of options.",ROCKWELL ELECTRONIC COMMERCE,DEZONNO ANTHONY;;HODSON JEFFREY;;BLOOM JOSEPH;;FUNCK DAVID;;JAMES ERIC;;PETERS MICHAEL;;POWER MARK J;;SHAMBAUGH CRAIG R;;MOSQUERA DAVE;;SALEH NAYEL,FIRSTPOINT CONTACT TECHNOLOGIES LLC (2004-08-12);;ROCKWELL ELECTRONIC COMMERICE CORP (2001-10-22);;WILMINGTON TRUST NATIONAL ASSOCIATION AS ADMINISTRATIVE AGENT (2014-11-07),https://lens.org/093-090-311-622-68X,Granted Patent,yes,31,19,2,2,0,H04M3/42059;;H04M3/493;;H04M3/523;;H04M3/523;;H04M3/493;;H04M3/42059,H04M3/00;;H04M3/493;;H04M3/523;;H04M5/00,379/265.02;;379/265.01,0,0,,,,EXPIRED
944,CN,A,CN 110888523 A,177-392-062-318-60X,2020-03-17,2020,CN 201910443317 A,2018-09-28,DK PA201870631 A;;DK PA201870632 A;;US 201862729978 P;;US 201816144950 A;;US 201816147413 A,2018-09-11,CONTENT-BASED TACTILE OUTPUTS,"The present disclosure generally relates to content-based tactile outputs. In some embodiments, user interfaces associated with content-based tactile outputs are described. In some embodiments, user interfaces associated with end-of-content tactile outputs are described. In some embodiments, user interfaces associated with moving a user interface in response to different types of input are described. In some embodiments, user interfaces associated with adjustable item-based tactile outputs are described. In some embodiments, user interfaces associated with input velocity-based tactile outputsare described.",APPLE INC,MOUSSETTE CAMILLE;;BLOOM DAVID H;;BUTCHER GARY IAN;;EDWARDS DYLAN ROSS;;FENNIS JULES K;;GLEESON BRIAN T;;HE MIAO;;SUNDSTROM MATTHEW J,,https://lens.org/177-392-062-318-60X,Patent Application,no,0,0,31,41,0,G06F3/016;;G06F3/01;;G06F3/0362;;G06F3/048;;G06F3/016;;G06F3/0362;;G06F3/04845;;G06F3/0485;;G06F3/04883;;G06F1/163;;G06F3/0346;;G06F3/016;;G06F1/163;;G06F3/0346;;G06F3/0362;;G06F3/04845;;G06F3/04842;;G06F3/04847;;G06F3/0485;;G06F3/04883;;G06F3/016;;G06F3/04847;;G06F3/0485;;G06F3/0487;;G06F3/04842;;G06F3/04883,G06F3/01,,0,0,,,,PENDING
945,GB,B,GB 2386289 B,154-530-253-542-557,2005-06-22,2005,GB 0304712 A,2003-02-28,US 9049902 A,2002-03-04,Intelligent interactive voice response unit,,ROCKWELL ELECTRONIC COMMERCE,DEZONNO ANTHONY;;FUNCK DAVID;;POWER MARK J;;HODSON JEFFREY;;BLOOM JOSEPH;;JAMES ERIC;;PETERS MICHAEL;;SHAMBAUGH CRAIG R;;MOSQUERA DAVE;;SALEH NAYEL,,https://lens.org/154-530-253-542-557,Granted Patent,no,4,0,6,6,0,H04M3/4938;;H04M3/5166;;H04M3/5191;;H04M3/4938;;H04M3/5166;;H04M3/5191,H04M3/493;;H04M3/51,H4K KF50A         KF50A,2,0,,,"T Olavsrud, ""start-up aims to revolutionise Tech support Call centers"" published Feb 15, 2002. www.internetnews.co./infr/article.php/975991;;I Brodsky, ""The 'Net finds its voice"", Network world, published 23/10/00. www.nwfusion.com/columnists/2000/1023brodsky.html",EXPIRED
946,US,A1,US 2020/0081539 A1,001-889-611-737-462,2020-03-12,2020,US 201816147413 A,2018-09-28,US 201816147413 A;;US 201862729978 P,2018-09-11,CONTENT-BASED TACTILE OUTPUTS,"The present disclosure generally relates to content-based tactile outputs. In some embodiments, user interfaces associated with content-based tactile outputs are described. In some embodiments, user interfaces associated with end-of-content tactile outputs are described. In some embodiments, user interfaces associated with moving a user interface in response to different types of input are described. In some embodiments, user interfaces associated with adjustable item-based tactile outputs are described. In some embodiments, user interfaces associated with input velocity-based tactile outputs are described.",APPLE INC,MOUSSETTE CAMILLE;;BLOOM DAVID H;;BUTCHER GARY IAN;;EDWARDS DYLAN ROSS;;FENNIS JULES K;;GLEESON BRIAN T;;HE MIAO;;SUNDSTROM MATTHEW J,APPLE INC (2018-10-11),https://lens.org/001-889-611-737-462,Patent Application,yes,6,18,31,41,0,G06F3/016;;G06F3/01;;G06F3/0362;;G06F3/048;;G06F3/016;;G06F3/0362;;G06F3/04845;;G06F3/0485;;G06F3/04883;;G06F1/163;;G06F3/0346;;G06F3/016;;G06F1/163;;G06F3/0346;;G06F3/0362;;G06F3/04845;;G06F3/04842;;G06F3/04847;;G06F3/0485;;G06F3/04883;;G06F3/016;;G06F3/04847;;G06F3/0485;;G06F3/0487;;G06F3/04842;;G06F3/04883,G06F3/01;;G06F3/0484;;G06F3/0488,,0,0,,,,ACTIVE
947,EP,A1,EP 3623909 A1,067-417-029-431-221,2020-03-18,2020,EP 19173371 A,2019-05-08,US 201862729978 P;;US 201816144950 A;;DK PA201870631 A;;DK PA201870632 A;;US 201816147413 A,2018-09-11,CONTENT-BASED TACTILE OUTPUTS,"The present disclosure generally relates to content-based tactile outputs. In some embodiments, user interfaces associated with content-based tactile outputs are described. In some embodiments, user interfaces associated with end-of-content tactile outputs are described. In some embodiments, user interfaces associated with moving a user interface in response to different types of input are described. In some embodiments, user interfaces associated with adjustable item-based tactile outputs are described. In some embodiments, user interfaces associated with input velocity-based tactile outputs are described.
",APPLE INC,MOUSSETTE CAMILLE;;BLOOM DAVID H;;BUTCHER GARY IAN;;EDWARDS DYLAN ROSS;;FENNIS JULES K;;GLEESON BRIAN T;;HE MIAO;;SUNDSTROM MATTHEW J,,https://lens.org/067-417-029-431-221,Patent Application,yes,34,0,31,41,0,G06F3/016;;G06F3/01;;G06F3/0362;;G06F3/048;;G06F3/016;;G06F3/0362;;G06F3/04845;;G06F3/0485;;G06F3/04883;;G06F1/163;;G06F3/0346;;G06F3/016;;G06F1/163;;G06F3/0346;;G06F3/0362;;G06F3/04845;;G06F3/04842;;G06F3/04847;;G06F3/0485;;G06F3/04883;;G06F3/016;;G06F3/04847;;G06F3/0485;;G06F3/0487;;G06F3/04842;;G06F3/04883,G06F3/01;;G06F3/0362;;G06F3/0484;;G06F3/0485;;G06F3/0488,,0,0,,,,PENDING
948,US,A1,US 2003/0086557 A1,091-934-214-770-917,2003-05-08,2003,US 99236701 A,2001-11-06,US 99236701 A,2001-11-06,Method of optimizing call center resources based upon statistics,"
   A method and apparatus are provided for allocating resources within a call center based upon a predetermined business rule of an enterprise controlling the call center. The method includes the steps of analyzing records from a plurality of call transactions based upon the predetermined business rule, recognizing a correlation among the call transaction records based upon the predetermined business rule and adjusting a resource of the call transactions based upon the recognized correlation and predetermined business rule. 
",SHAMBAUGH CRAIG R.;;BLOOM JOSEPH;;DEZONNO ANTHONY;;FUNCK DAVID;;HODSON JEFFREY;;JAMES ERIC;;PETERS MICHAEL;;POWER MARK J.;;MOSQUERA DAVE;;SALEH NAYEL,SHAMBAUGH CRAIG R;;BLOOM JOSEPH;;DEZONNO ANTHONY;;FUNCK DAVID;;HODSON JEFFREY;;JAMES ERIC;;PETERS MICHAEL;;POWER MARK J;;MOSQUERA DAVE;;SALEH NAYEL,ROCKWELL ELECTRONIC COMMERCE CORP (2001-10-23);;FIRSTPOINT CONTACT TECHNOLOGIES LLC (2004-08-12);;WILMINGTON TRUST NATIONAL ASSOCIATION AS ADMINISTRATIVE AGENT (2014-11-07),https://lens.org/091-934-214-770-917,Patent Application,yes,4,33,2,2,0,H04M3/5232;;H04M3/5232;;H04M3/5175;;H04M3/5175;;H04M3/5183;;H04M3/5183;;H04M3/5233;;H04M3/5233,H04M3/51;;H04M3/523,379/266.07;;379/265.02,0,0,,,,EXPIRED
949,US,B2,US 10928907 B2,027-718-969-089-719,2021-02-23,2021,US 201816147413 A,2018-09-28,US 201816147413 A;;US 201862729978 P,2018-09-11,Content-based tactile outputs,"The present disclosure generally relates to content-based tactile outputs. In some embodiments, user interfaces associated with content-based tactile outputs are described. In some embodiments, user interfaces associated with end-of-content tactile outputs are described. In some embodiments, user interfaces associated with moving a user interface in response to different types of input are described. In some embodiments, user interfaces associated with adjustable item-based tactile outputs are described. In some embodiments, user interfaces associated with input velocity-based tactile outputs are described.",APPLE INC,MOUSSETTE CAMILLE;;BLOOM DAVID H;;BUTCHER GARY IAN;;EDWARDS DYLAN ROSS;;FENNIS JULES K;;GLEESON BRIAN T;;HE MIAO;;SUNDSTROM MATTHEW J,APPLE INC (2018-10-11),https://lens.org/027-718-969-089-719,Granted Patent,yes,880,1,31,41,0,G06F3/016;;G06F3/01;;G06F3/0362;;G06F3/048;;G06F3/016;;G06F3/0362;;G06F3/04845;;G06F3/0485;;G06F3/04883;;G06F1/163;;G06F3/0346;;G06F3/016;;G06F1/163;;G06F3/0346;;G06F3/0362;;G06F3/04845;;G06F3/04842;;G06F3/04847;;G06F3/0485;;G06F3/04883;;G06F3/016;;G06F3/04847;;G06F3/0485;;G06F3/0487;;G06F3/04842;;G06F3/04883,G06F3/01;;G06F3/0484;;G06F3/0485;;G06F3/0487;;G06F3/0488,,411,2,090-500-355-520-271;;159-239-488-146-709,10.1007/s007790200002;;10.1109/istas.2013.6613119,"Notice of Allowance received for U.S. Appl. No. 14/913,350, dated Dec. 19, 2018, 27 pages.;;Office Action received for Australian Patent Application No. 2017276285, dated Nov. 26, 2018, 2 pages.;;Office Action received for Australian Patent Application No. 2018200289, dated Dec. 4, 2018, 4 pages.;;Search Report and opinion received for Danish Patent Application No. PA201870631, dated Dec. 6, 2018, 8 pages.;;Search Report and Opinion received for Danish Patent Application No. PA201870632, dated Dec. 3, 2018, 8 pages.;;Advisory Action received for U.S. Appl. No. 15/049,052, dated Sep. 11, 2017, 2 pages.;;Advisory Action received for U.S. Appl. No. 15/049,064, dated May 10, 2017, 3 Pages.;;Advisory Action received for U.S. Appl. No. 15/049,058, dated Oct. 18, 2017, 3 pages.;;Agarwal, Deepesh, “DexClock—Live Clock and Date Blended Into Beautiful Artwork as Your Desktop Wallpaper”, available at: https://www.megaleecher.net/DexCiock_Wallpaper_Designs, Jul. 6, 2013, 4 pages.;;Apple, “iPhone User's Guide”, Available at: http://mesnotices.20minutes.fr/manuel-notice-mode-emploi/APPLE/IPHONE%2D%5FE#, Jun. 2007, 137 pages.;;Brinkmann, Martin, “How to Zoom in Firefox”, Ghacks, Available at: https://web.archive.org/web/20130804034728/https://www.ghacks.net/2009/02/23/how-to-zoom-in-firefox/>, Feb. 23, 2009, 11 pages.;;Colt, Sam, “Here's One Way Apple's Smartwatch Could Be Better Than Anything Else”, Business Insider, Aug. 21, 2014, pp. 1-4.;;Corrected Notice of Allowance received for U.S. Appl. No. 14/641,252, dated Aug. 28, 2018, 2 pages.;;Corrected Notice of Allowance received for U.S. Appl. No. 14/641,252, dated Jul. 9, 2018, 25 Pages.;;Corrected Notice of Allowance received for U.S. Appl. No. 14/641,252, dated May 10, 2018, 10 pages.;;Corrected Notice of Allowance received for U.S. Appl. No. 14/829,573, dated Aug. 9, 2018, 3 pages.;;Corrected Notice of Allowance received for U.S. Appl. No. 14/829,573, dated Sep. 11, 2018, 3 pages.;;Corrected Notice of Allowance received for U.S. Appl. No. 14/841,656, dated Apr. 11, 2018, 2 pages.;;Corrected Notice of Allowance received for U.S. Appl. No. 14/841,656, dated May 7, 2018, 14 pages.;;Decision to Grant received for Danish Patent Application No. PA201570781, dated Jul. 17, 2017, 2 pages.;;Decision to Grant received for Danish Patent Application No. PA201670117, dated Nov. 20, 2017, 2 pages.;;Decision to Grant received for Danish Patent Application No. PA201770181, dated Mar. 7, 2018, 2 pages.;;Final Office Action received for U.S. Appl. No. 13/038,276, dated Mar. 27, 2014, 24 pages.;;Final Office Action received for U.S. Appl. No. 13/038,276, dated Mar. 11, 2016, 36 pages.;;Final Office Action received for U.S. Appl. No. 14/641,308, dated Mar. 14, 2018, 42 pages.;;Final Office Action received for U.S. Appl. No. 14/830,629, dated Apr. 16, 2018, 27 pages.;;Final Office Action received for U.S. Appl. No. 14/841,646, dated Aug. 2, 2018, 22 pages.;;Final Office Action received for U.S. Appl. No. 14/913,345, dated Oct. 26, 2018, 20 pages.;;Final Office Action received for U.S. Appl. No. 14/913,349, dated Jul. 30, 2018, 18 pages.;;Final Office Action received for U.S. Appl. No. 15/049,049 dated Jul. 12, 2018, 24 pages.;;Final Office Action received for U.S. Appl. No. 15/049,049, dated May 23, 2017, 23 pages.;;Final Office Action received for U.S. Appl. No. 15/049,052, dated Mar. 1, 2018, 15 pages.;;Final Office Action received for U.S. Appl. No. 15/049,052, dated May 17, 2017, 13 pages.;;Final Office Action received for U.S. Appl. No. 15/049,052, dated Oct. 2, 2018, 16 pages.;;Final Office Action received for U.S. Appl. No. 15/049,058, dated Aug. 8, 2018, 23 pages.;;Final Office Action received for U.S. Appl. No. 15/049,058, dated May 8, 2017, 21 pages.;;Final Office Action received for U.S. Appl. No. 15/049,064, dated Feb. 27, 2017, 13 Pages.;;Final Office Action received for U.S. Appl. No. 14/839,912, dated Sep. 13, 2018, 31 pages.;;“Headset Button Controller v7.3 APK Full App Download for Andriod”, Blackberry, iPhone, Jan. 27, 2014, 11 pages.;;IBM, “Watchpad 1.5”, Online Available at: web.archive.org/web/20011205071448/http://www.trl.ibm.com/projects/ngm/index_e.htm>, Oct. 11, 2001, 2 pages.;;Intention to Grant received for Danish Patent Application No. PA201570781, dated Dec. 8, 2016, 2 pages.;;Intention to Grant received for Danish Patent Application No. PA201670117, dated Apr. 21, 2017, 2 pages.;;Intention to Grant received for European Patent Application No. 15782209.9, dated Sep. 28, 2018, 8 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2012/025519, dated Sep. 3, 2013, 5 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2014/053951, dated Mar. 17, 2016, 9 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2014/053957, dated Mar. 17, 2016, 8 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2014/053958, dated Mar. 17, 2016, 8 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2014/053961, dated Jul. 21, 2016, 24 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2015/019322, dated Mar. 16, 2017, 11 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2015/045936, dated Mar. 16, 2017, 9 Pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2015/045965, dated Dec. 27, 2016, 10 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2015/047704, dated Mar. 16, 2017, 19 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2015/054310, dated Sep. 14, 2017, 7 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2016/019637, dated Sep. 21, 2017, 12 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2015/019320, dated Mar. 16, 2017, 10 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2015/019321, dated Mar. 16, 2017, 8 Pages.;;International Search Report and Written Opinion received for PCT Application No. PCT/US2015/045936, dated Nov. 4, 2015, 12 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2012/025519, dated Jun. 11, 2012, 7 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2014/053951, dated Dec. 8, 2014, 11 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2014/053957, dated Feb. 19, 2015, 11 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2014/053958, dated Feb. 19, 2015, 10 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2015/019320, dated Jul. 2, 2015, 14 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2015/019321, dated Jun. 3, 2015, 11 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2015/019322, dated Jun. 18, 2015, 16 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2015/045965, dated Feb. 1, 2016, 20 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2015/047704, dated Feb. 22, 2016, 25 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2015/054310, dated Jan. 20, 2016, 10 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2016/019637, dated Aug. 18, 2016, 18 pages.;;International Search Report and Written Opinion Received for PCT Patent Application No. PCT/US2017/035325, dated Sep. 7, 2017, 11 pages.;;International Search Report received for PCT Patent Application No. PCT/US2014/053961, dated Jul. 11, 2016, 10 pages.;;International Written Opinion received for PCT Patent Application No. PCT/US2014/053961, dated Jul. 11, 2016, 22 pages.;;Invitation to Pay Additional Fees received for PCT Patent Application No. PCT/US2014/053961, dated Aug. 3, 2015, 6 pages.;;Invitation to Pay Additional Fees received for PCT Patent Application No. PCT/US2015/047704, dated Dec. 16, 2015, 10 pages.;;Invitation to Pay Additional Fees received for PCT Patent Application No. PCT/US2016/019637, dated Jun. 1, 2016, 6 pages.;;Kamijo, Noboru, “Next Generation Mobile System—WatchPad1.5”, Available at: http://researcher.ibm.com/researcher/view_group_subpage.php?id=5617>, retrieved on Jul. 4, 2015, 2 pages.;;Mai, Tuan, “This Watch Tells You the Time in Vibrating Morse Code”, Available at: https://web.archive.org/web/20130915060538/http://www.tomsguide.com/us/Watch-Concept-Morse-Code,news-12089.html>, Aug. 9, 2011, pp. 1-3.;;NDTV, “Sony SmartWatch 2 Launched in India for Rs. 14,990”, available at: http://gadgets.ndtv.com/others/news/sony-smartwatch-2-launched-in-india-for-rs-14990-420319>, Sep. 18, 2013, 4 pages.;;Non-Final Office Action received for U.S. Appl. No. 13/038,276, dated Jul. 29, 2015, 31 pages.;;Non-Final Office Action received for U.S. Appl. No. 13/038,276, dated Sep. 12, 2013, 24 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/641,308, dated Jun. 23, 2017, 53 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/829,573, dated Jan. 22, 2018, 26 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/830,629, dated Dec. 1, 2016, 20 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/830,629, dated Jun. 15, 2017, 24 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/839,914, dated Oct. 19, 2017, 46 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/841,646, dated Dec. 1, 2017, 23 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/841,656, dated Jul. 26, 2017, 20 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/913,345, dated Apr. 5, 2018, 15 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/913,349, dated Jan. 11, 2018, 6 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/913,350, dated May 14, 2018, 30 pages.;;Non-Final Office Action received for U.S. Appl. No. 15/049,049 dated Dec. 15, 2017, 23 pages.;;Non-Final Office Action received for U.S. Appl. No. 15/049,049, dated Nov. 9, 2016, 13 pages.;;Non-Final Office Action received for U.S. Appl. No. 15/049,052, dated May 31, 2018, 15 pages.;;Non-Final Office Action received for U.S. Appl. No. 15/049,052, dated Nov. 29, 2016, 13 pages.;;Non-Final Office Action received for U.S. Appl. No. 15/049,052, dated Sep. 21, 2017, 14 pages.;;Non-Final Office Action received for U.S. Appl. No. 15/049,058, dated Feb. 20, 2018, 21 pages.;;Non-Final Office Action received for U.S. Appl. No. 15/049,058, dated Nov. 16, 2016, 19 pages.;;Non-Final Office Action received for U.S. Appl. No. 15/049,064, dated Oct. 27, 2016, 15 pages.;;Non-Final Office Action received for U.S. Appl. No. 15/421,711, dated May 18, 2018, 25 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/839,912, dated Feb. 12, 2018, 30 pages.;;Non-Final office Action Received for U.S. Appl. No. 14/839,912, dated Jun. 8, 2017, 26 pages.;;Notice of Acceptance received for Australian Patent Application No. 2014315319, dated Oct. 12, 2017, 3 pages.;;Notice of Acceptance received for Australian Patent Application No. 2014315324, dated Sep. 28, 2017, 3 pages.;;Notice of Acceptance received for Australian Patent Application No. 2014315325, dated Apr. 19, 2017, 3 Pages.;;Notice of Allowance Action received for U.S. Appl. No. 14/841,656, dated Feb. 12, 2018, 9 pages.;;Notice of Allowance and Search Report received for Taiwanese Patent Application No. 104128687, dated Jun. 7, 2016, 4 pages (1 page of English Translation and 3 pages of Official copy).;;Notice of Allowance received for Danish Patent Application No. PA201570776, dated Feb. 8, 2017, 2 pages.;;Notice of Allowance received for Danish Patent Application No. PA201670118, dated Mar. 30, 2017, 2 pages.;;Notice of Allowance received for Japanese Patent Application No. 2016-537945, dated Aug. 3, 2018, 4 pages (1 page of English translation and 3 pages of Official copy).;;Notice of Allowance received for Japanese Patent Application No. 2016-537946, dated Mar. 26, 2018, 4 pages (1 page of English Translation and 3 pages of Official Copy).;;Notice of Allowance received for Japanese Patent Application No. 2016-537947, dated Jun. 5, 2017, 3 pages (Official Copy only) (See Communication under 37 CFR § 1.98(a) (3)).;;Notice of Allowance received for Korean Patent Application No. 10-2018-7002695, dated Oct. 8, 2018, 5 pages (2 pages of English Translation and 3 pages of Official Copy).;;Notice of Allowance received for Taiwanese Patent Application No. 103130517, dated May 14, 2018, 5 pages (2 pages of English Translation and 3 pages of Official Copy).;;Notice of Allowance received for Taiwanese Patent Application No. 103130518, dated May 19, 2016, 2 pages (Official Copy only) (See Communication under 37 CFR § 1.98(a) (3)).;;Notice of Allowance received for Taiwanese Patent Application No. 103130519, dated Oct. 27, 2016, 3 pages (Official Copy only) (See Communication under 37 CFR § 1.98(a) (3)).;;Notice of Allowance received for Taiwanese Patent Application No. 103130520, dated Apr. 25, 2018, 4 pages (1 page of English Translation and 3 pages of Official copy).;;Notice of Allowance received for Taiwanese Patent Application No. 104107333, dated Nov. 8, 2016, 2 pages (Official Copy Only) (See Communication under 37 CFR § 1.98(a) (3)).;;Notice of Allowance received for Taiwanese Patent Application No. 104107334, dated Jan. 26, 2017, 3 pages (Official Copy Only) (See Communication under 37 CFR § 1.98(a) (3)).;;Notice of Allowance received for Taiwanese Patent Application No. 104133281, dated Mar. 29, 2018, 4 pages (1 page of English Translation and 3 pages of Official copy).;;Notice of Allowance received for U.S. Appl. No. 13/038,276, dated Nov. 3, 2016, 10 pages.;;Notice of Allowance received for U.S. Appl. No. 13/038,276, dated Nov. 30, 2016, 2 pages.;;Notice of Allowance received for U.S. Appl. No. 14/641,241, dated Apr. 13, 2017, 2 pages.;;Notice of Allowance received for U.S. Appl. No. 14/641,241, dated Jan. 31, 2017, 13 pages.;;Notice of Allowance received for U.S. Appl. No. 14/641,241, dated Mar. 24, 2017, 3 Pages.;;Notice of Allowance received for U.S. Appl. No. 14/641,252, dated Apr. 11, 2018, 14 pages.;;Notice of Allowance received for U.S. Appl. No. 14/641,252, dated Jul. 18, 2018, 9 pages.;;Notice of Allowance received for U.S. Appl. No. 14/829,573, dated Apr. 25, 2018, 6 pages.;;Notice of Allowance received for U.S. Appl. No. 14/830,629, dated Oct. 17, 2018, 8 pages.;;Notice of Allowance received for U.S. Appl. No. 14/839,914, dated Jun. 22, 2018, 12 pages.;;Notice of Allowance received for U.S. Appl. No. 14/841,656, dated Mar. 5, 2018, 3 pages.;;Notice of Allowance received for U.S. Appl. No. 15/049,064, dated Jul. 18, 2017, 24 pages.;;Notice of Allowance received for U.S. Appl. No. 15/058,996, dated Dec. 27, 2016, 10 pages.;;Notice of Allowance received for U.S. Appl. No. 15/421,711, dated Oct. 5, 2018, 10 pages.;;Notice of Allowance received for U.S. Appl. No. 16/055,489, dated Nov. 8, 2018, 28 pages.;;Nova Launcher, Available on https://web.archive.org/web/20150703231459/https://play.google.com/store/apps/details?id=com.teslacoilsw.launcher, 3 pages.;;Office Action and Search Report received for Danish Patent Application No. PA201670118, dated Jul. 1, 2016, 7 pages.;;Office Action received for Danish Patent Application No. PA201770794, dated Dec. 19, 2017, 8 pages.;;Office Action received for Australian Patent Application No. 2014315234, dated Jul. 12, 2017, 4 pages.;;Office Action received for Australian Patent Application No. 2014315234, dated Nov. 2, 2016, 3 pages.;;Office Action received for Australian Patent Application No. 2014315319, dated Aug. 3, 2017, 3 pages.;;Office Action received for Australian Patent Application No. 2014315319, dated Oct. 17, 2016, 3 pages.;;Office Action received for Australian Patent Application No. 2014315324, dated Aug. 8, 2017, 3 pages.;;Office Action received for Australian Patent Application No. 2014315324, dated Oct. 21, 2016, 3 pages.;;Office Action received for Australian Patent Application No. 2014315325, dated Nov. 3, 2016, 3 pages.;;Office Action received for Australian Patent Application No. 2016229407, dated Aug. 15, 2018, 4 pages.;;Office Action received for Australian Patent Application No. 2017254897, dated Aug. 29, 2018, 4 pages.;;Office Action received for Australian Patent Application No. 2018200998, dated Mar. 9, 2018, 5 pages.;;Office Action received for Australian Patent Application No. 2014315234, dated Apr. 19, 2017, 4 pages.;;Office Action received for Chinese Patent Application No. 201480059543.9, dated Jan. 26, 2018, 17 pages (4 pages of English Translation and 13 pages of Official Copy).;;Office Action received for Chinese Patent Application No. 201480059543.9, dated Sep. 19, 2018, 18 pages (5 pages of English Translation and 13 pages of Official Copy).;;Office Action received for Chinese Patent Application No. 201480060044.1, dated Jan. 26, 2018, 15 pages (5 pages of English translation and 10 pages of Official Copy).;;Office Action received for Chinese Patent Application No. 201480060044.1, dated Sep. 25, 2018, 6 pages (3 pages of English translation and 3 pages of official copy).;;Office Action received for Chinese Patent Application No. 201480060082.7, dated Jan. 26, 2018, 15 pages (4 pages of English translation and 11 pages of Official Copy).;;Office Action received for Chinese Patent Application No. 201480060082.7, dated Sep. 25, 2018, 6 pages (3 pages of English Translation and 3 pages of Official copy).;;Office Action received for Danish Patent Application No. PA201570776, dated Aug. 19, 2016, 3 pages.;;Office Action received for Danish Patent Application No. PA201570781, dated Aug. 19, 2016, 3 pages.;;Office Action received for Danish Patent Application No. PA201670117, dated Jan. 12, 2017, 3 pages.;;Office Action received for Danish Patent Application No. PA201670117, dated Jun. 13, 2016, 10 pages.;;Office Action received for Danish Patent Application No. PA201670118, dated Feb. 2, 2017, 2 pages.;;Office Action received for Danish Patent Application No. PA201670118, dated Oct. 25, 2016, 3 Pages.;;Office Action received for Danish Patent Application No. PA201670580, dated Mar. 8, 2018, 3 Pages.;;Office Action received for Danish Patent Application No. PA201770181, dated Jan. 3, 2018, 2 Pages.;;Office Action received for Danish Patent Application No. PA201770181, dated Jun. 13, 2017, 6 pages.;;Office Action received for Danish Patent Application No. PA201770794, dated Apr. 5, 2018, 4 pages.;;Office Action received for Danish Patent Application No. PA201770794, dated Oct. 30, 2018, 3 pages.;;Office Action received for European Patent Application No. 14771688.0, dated May 31, 2018, 6 pages.;;Office Action received for European Patent Application No. 14771688.0, dated Nov. 30, 2017, 15 pages.;;Office Action received for European Patent Application No. 14772001.5, dated Feb. 14, 2018, 5 pages.;;Office Action received for European Patent Application No. 14772001.5, dated May 30, 2017, 10 pages.;;Office Action received for European Patent Application No. 14772002.3, dated Jul. 4, 2017, 8 pages.;;Office Action received for European Patent Application No. 14772494.2, dated Jun. 20, 2017, 7 pages.;;Office Action received for European Patent Application No. 14772494.2, dated Oct. 2, 2018, 9 pages.;;Office Action received for European Patent Application No. 18157131.6, dated May 8, 2018, 12 pages.;;Office Action received for Japanese Patent Application No. 2016-537945, dated Apr. 7, 2017, 6 pages (3 pages of English Translation and 3 pages of Official Copy).;;Office Action received for Japanese Patent Application No. 2016-537945, dated Jan. 9, 2018, 5 pages (2 page of English Translation and 3 pages of Official copy).;;Office Action received for Japanese Patent Application No. 2016-537946, dated Aug. 7, 2017, 8 pages (4 Pages of English Translation and 4 Pages of Official Copy).;;Office Action received for Japanese Patent Application No. 2016-537946, dated Jan. 30, 2017, 12 pages (6 pages of English Translation and 6 pages of Official Copy).;;Office Action received for Japanese Patent Application No. 2016-537947, dated Feb. 24, 2017, 6 pages (3 pages of English Translation and 3 pages of Official Copy).;;Office Action received for Japanese Patent Application No. 2016-537948, dated Apr. 6, 2018, 5 pages (2 pages of English Translation and 3 pages of Official Copy).;;Office Action received for Japanese Patent Application No. 2016-537948, dated Jun. 9, 2017, 10 pages (5 pages of English Translation and 5 pages of Official Copy).;;Office Action received for Japanese Patent Application No. 2016-537948, dated Sep. 3, 2018, 4 pages (2 pages of English Translation and 2 pages of Official copy).;;Office Action received for Japanese Patent Application No. 2017-545561, dated Aug. 6, 2018, 8 pages (4 pages of English Translation and 4 pages of Official copy).;;Office Action received for Korean Patent Application No. 10-2016-7008449, dated Jan. 12, 2017, 15 pages (6 pages of English translation and 9 pages of official Copy).;;Office Action received for Korean Patent Application No. 10-2016-7008449, dated Jan. 16, 2018, 10 pages (5 pages of English Translation and 5 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2016-7008449, dated Nov. 27, 2017, 6 pages (3 pages of English Translation and 3 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2016-7008474, dated Aug. 6, 2018, 10 pages (5 pages of English Translation and 5 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2016-7008474, dated Dec. 28, 2016, 10 pages (4 pages of English Translation and 6 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2016-7008474, dated May 15, 2018, 7 pages (3 pages of English Translation and 4 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2016-7008474, dated Nov. 27, 2017, 6 pages (2 pages of English Translation and 4 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2016-7008488, dated Feb. 8, 2018, 8 pages (4 pages of English Translation and 4 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2016-7008488, dated Jan. 12, 2017, 14 pages (6 pages of English Translation and 8 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2016-7008488, dated Nov. 27, 2017, 6 pages (3 pages of English Translation and 3 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2016-7008682, dated Dec. 30, 2016, 11 pages (4 pages of English Translation and 7 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2016-7008682, dated Feb. 8, 2018, 7 pages (3 pages of English Translation and 4 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2016-7008682, dated Nov. 27, 2017, 7 pages (3 page of English Translation and 4 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2017-7024506, dated Sep. 28, 2018, 11 pages (4 pages of English Translation and 7 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2018-7002695, dated Feb. 27, 2018, 12 pages (5 pages of English Translation and 7 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2018-7002695, dated Jun. 19, 2018, 8 pages (4 pages of English Translation and 4 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2018-7010872, dated May 21, 2018, 10 pages (4 pages of English Translation and 6 pages of Official Copy).;;Office Action received for Korean Patent Application No. 10-2018-7013265, dated Aug. 10, 2018, 12 pages (5 pages of English Translation and 7 pages of Official copy).;;Office Action received for Taiwan Patent Application No. 103130517, dated Feb. 22, 2016, 7 pages (3 pages of English Translation and 4 pages of Official Copy).;;Office Action received for Taiwan Patent Application No. 103130519, dated Mar. 25, 2016, 14 pages (6 pages of English Translation and 8 pages of Official Copy).;;Office Action received for Taiwanese Patent Application No. 103130517, dated Jul. 29, 2016, 7 pages (3 pages of English Translation and 4 pages of Official Copy).;;Office Action received for Taiwanese Patent Application No. 103130517, dated Feb. 6, 2018, 5 pages (2 pages of English Translation and 3 pages of Official Copy).;;Office Action received for Taiwanese Patent Application No. 103130520, dated Apr. 17, 2017, 8 pages (3 pages of English Translation and 5 pages of Official Copy).;;Office Action received for Taiwanese Patent Application No. 103130520, dated Jan. 23, 2018, 05 pages (2 pages of English Translation and 3 pages of Official Copy).;;Office Action received for Taiwanese Patent Application No. 103130520, dated May 23, 2016, 38 pages (15 pages of English Translation and 23 pages of Official Copy).;;Office Action received for Taiwanese Patent Application No. 103130520, dated Oct. 1, 2015, 58 pages (22 pages of English translation and 36 pages of Official copy).;;Office Action received for Taiwanese Patent Application No. 103130520, dated Sep. 29, 2016, 39 pages (16 pages of English Translation and 23 pages of Official Copy).;;Office Action received for Taiwanese Patent Application No. 104107333, dated May 17, 2016, 6 pages (3 pages of English Translation and 3 pages of Official Copy).;;Office Action received for Taiwanese Patent Application No. 104107334, dated Sep. 19, 2016, 15 pages (6 pages of English Translation and 9 pages of Official Copy).;;Office Action received for Taiwanese Patent Application No. 104128701, dated Jul. 22, 2016, 25 pages (9 pages of English Translation and 16 pages of Official Copy).;;Office Action received for Taiwanese Patent Application No. 104128701, dated Mar. 16, 2017, 8 pages (3 pages of English Translation and 5 pages of Official Copy).;;Office Action received for Taiwanese Patent Application No. 104133281, dated Mar. 30, 2017, 10 Pages (4 pages of English translation and 6 pages of official copy).;;Office Action received for Taiwanese Patent Application No. 104133281, dated Sep. 1, 2016, 10 pages (4 pages of English Translation and 6 pages of Official Copy).;;Office Action received for Taiwanese Patent Application No. 104107327, dated Sep. 28, 2018, 7 pages (3 pages of English Translation and 4 pages of Official Copy).;;Office Action received for Danish Patent Application No. PA201570776, dated Jan. 26, 2016, 12 pages.;;Raghunath, et al, “User Interfaces for Applications on a Wrist Watch”, Journal of Personal and Ubiquitous Computing, vol. 6, Feb. 2002, pp. 17-30.;;Search Report and Opinion received for Danish Patent Application No. PA201670580, dated Jan. 31, 2017, 7 pages.;;Search Report received for Danish Patent Application No. PA201570781, dated Mar. 8, 2016, 10 pages.;;Search Report received for European Patent Application No. 18157131.6, dated Apr. 19, 2018, 4 pages.;;Summons to Attend Oral Proceedings received for European Patent Application No. 14772001.5, mailed on Nov. 14, 2018, 5 pages.;;Summons to Attend Oral Proceedings received for European Patent Application No. 14772001.5, mailed on Oct. 4, 2018, 15 pages.;;The Blind Life, “Double Tap Big Clock”, https://www.youttlbe.com/watch?v-=U6XMnSPCEXU, Mar. 2, 2016, 2 Pages.;;“The interview with a key person. IBM and Citizen met and applied Linux to a watch”, ASCII Corporation, vol. 25, No. 12, Dec. 12, 2001, pp. 136-143 (Official Copy Only) (See Communication under 37 CFR § 1.98(a) (3)).;;The Window Club, “How to Set GIF as Background Windows 7”, Online Available at: https://www.youtube.com/watch?v=tUec42Qd7ng>, Dec. 24, 2012, pp. 1-5.;;“Timebuzz”, Feel the Current Time on your Apple Watch with Time Buzz, Available at: https://web.archive.org/web/20160125032143/http://www.timebuzz.nl/>, Jan. 25, 2016, pp. 1-6.;;Toyssy, et al, “Telling Time by Vibration”, University of Tampere, Department of Computer Sciences, Interactive Technology, Master's Thesis, Nov. 2007, 57 Pages.;;Toyssy, Sampo, et al, “Telling Time by Vibration”, 6th International Conference, EuroHaptics 2008 Madrid, Spain, Jun. 10-11, 2008, pp. 924-929.;;“Watchpad 1.5 demo”, YouTube.com, Online Available at: https://www.youtube.com/watch?v=7xjvVbeUn80>, Uploaded on Jun. 20, 2010, 2 pages.;;Wikipedia, “Rotary encoder”, Online Available at: https://en.wikipedia.org/wiki/Rotary_encoder>, Retrieved on May 17, 2017, 17 pages (10 pages of English Translation and 7 pages of Official Copy).;;Dewsberry, Victor, “Designing for Small Screens”, AVA Publishing, 2005, 27 pages.;;International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2017/035325, dated Dec. 27, 2018, 9 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/641,308, dated Dec. 20, 2018, 43 pages.;;Intention to Grant received for Danish Patent Application No. PA201870631, dated Apr. 5, 2019, 2 pages.;;Intention to Grant received for Danish Patent Application No. PA201870632, dated Apr. 5, 2019, 2 pages.;;Notice of Acceptance received for Australian Patent Application No. 2017276285, dated Apr. 3, 2019, 3 pages.;;Notice of Allowance received for Japanese Patent Application No. 2018-143982, dated Apr. 8, 2019, 4 pages (1 page of English Translation and 3 pages of Official Copy).;;Notice of Allowance received for U.S. Appl. No. 14/841,646, dated Apr. 18, 2019, 7 pages.;;Office Action received for Australian Patent Application No. 2018200289, dated Apr. 9, 2019, 5 pages.;;Decision to Grant received for Danish Patent Application No. PA201870631, dated May 15, 2019, 2 pages.;;Decision to Grant received for Danish Patent Application No. PA201870632, dated May 14, 2019, 2 pages.;;Non-Final Office Action received for U.S. Appl. No. 15/049,058, dated Jun. 5, 2019, 25 pages.;;Notice of Allowance received for Japanese Patent Application No. 2018-090084, dated May 24, 2019, 4 pages (1 page of English Translation and 3 pages of Official Copy).;;Notice of Allowance received for U.S. Appl. No. 15/927,768, dated May 31, 2019, 13 pages.;;Office Action received for Australian Patent Application No. 2016229407, dated May 27, 2019, 4 pages.;;Intention to Grant received for European Patent Application No. 14772001.5, dated Mar. 22, 2019, 17 pages.;;Non-Final Office Action received for U.S. Appl. No. 14/913,349, dated Apr. 2, 2019, 15 pages.;;Notice of Allowance received for Chinese Patent Application No. 201480060082.7, dated Mar. 12, 2019, 2 pages (1 page of English Translation and 1 page of Official Copy).;;Office Action received for Chinese Patent Application No. 201480059543.9, dated Feb. 28, 2019, 16 pages (4 pages of English Translation and 12 pages of Official Copy).;;Office Action received for Chinese Patent Application No. 201580046339.8, dated Feb. 26, 2019, 18 pages (6 pages of English Translation and 12 pages of Official Copy).;;Office Action received for Japanese Patent Application No. 2018-090084, dated Feb. 15, 2019, 6 pages (3 pages of English Translation and 3 pages of Official copy).;;Final Office Action received for U.S. Appl. No. 14/913,349, dated Jul. 22, 2019, 20 pages.;;Final Office Action received for U.S. Appl. No. 14/839,912, dated Jul. 30, 2019, 42 pages.;;Intention to Grant received for European Patent Application No. 14772001.5, dated Jul. 18, 2019, 16 pages.;;Notice of Allowance received for Japanese Patent Application No. 2017-545561, dated Jul. 12, 2019, 4 pages (1 page of English Translation and 3 pages of Official Copy).;;Notice of Allowance received for Japanese Patent Application No. 2018-083313, dated Jul. 1, 2019, 4 pages (1 page of English Translation and 3 pages of Official Copy).;;Notice of Allowance received for U.S. Appl. No. 15/049,049, dated Jul. 25, 2019, 8 pages. et al.",ACTIVE
950,US,A1,US 2021/0014611 A1,057-440-159-899-298,2021-01-14,2021,US 202017028936 A,2020-09-22,US 202017028936 A;;US 202016920303 A;;US 202063033058 P;;US 201962907525 P;;US 201962897819 P;;US 201962871634 P,2019-07-08,"Systems, Methods, and User Interfaces for Headphone Fit Adjustment and Audio Output Control","A wearable audio output device in a physical environment includes an input device and one or more microphones. While ambient sound from the physical environment is being detected by the microphone(s), the wearable audio output device: while in a first mode, provides a first audio output including one or more pass-through audio components selected so as to increase audio pass-through of the ambient sound; detects an input via the input device; in response to detecting the input, and in accordance with a determination that the input is a first type of gesture, transitions from the first mode to a second mode; and, while in the second mode, provides a second audio output including one or more cancellation audio components selected so as to increase audio cancellation of the ambient sound.",APPLE INC,CARRIGAN TAYLOR G;;GRAHAM DAVID C;;HULBERT THOMAS S;;HATFIELD DUSTIN A;;ROPER GEMMA A;;BARK KARLIN Y;;BLOOM DAVID H;;JACKSON BENJAMIN G;;BAUGH BRENTON A;;AOYAGI SHOTA,APPLE INC (2020-12-31),https://lens.org/057-440-159-899-298,Patent Application,yes,0,7,37,37,0,G06F3/04847;;G06F3/165;;G06F3/167;;H04R1/1041;;H04R29/001;;H04R2460/15;;H04R2430/01;;H04R1/1016;;H04R1/1091;;H04R29/00;;H04R2460/15;;G06F3/04847;;G06F3/165;;H04R1/1041;;H04R1/1091;;H04R29/001;;H04R2460/15;;H04S2400/13;;G06F3/167;;H04R1/1083;;H04R1/1016;;H04R2460/01;;G06F3/165;;G06F3/011;;G06F3/0481;;G06F3/0484;;G06F1/163;;G06F11/327;;H04R1/1016;;H04R1/1041;;H04R3/005;;H04R29/008;;H04R2420/07;;H04R3/12;;G06F3/165;;H04R1/1016;;H04R1/1008,H04R3/12;;G06F3/16;;H04R1/10,,0,0,,,,ACTIVE
951,DK,A1,DK 202070718 A1,100-927-773-174-23X,2021-03-01,2021,DK PA202070718 A,2020-10-30,US 201962871634 P;;US 201962897819 P;;US 201962907525 P;;US 202063033058 P;;US 202016920303 A;;DK PA202070630 A,2019-07-08,"SYSTEMS, METHODS, AND USER INTERFACES FOR HEADPHONE FIT ADJUSTMENT AND AUDIO OUTPUT CONTROL","A wearable audio output device in a physical environment includes an input device and one or more microphones. While ambient sound from the physical environment is being detected by the microphone(s), the wearable audio output device: while in a first mode, provides a first audio output including one or more pass-through audio components selected so as to increase audio pass-through of the ambient sound; detects an input via the input device; in response to detecting the input, and in accordance with a determination that the input is a first type of gesture, transitions from the first mode to a second mode; and, while in the second mode, provides a second audio output including one or more cancellation audio components selected so as to increase audio cancellation of the ambient sound.",APPLE INC,THOMAS S HULBERT;;TAYLOR G CARRIGAN;;DAVID C GRAHAM;;DUSTIN A HATFIELD;;GEMMA A ROPER;;KARLIN Y BARK;;DAVID H BLOOM;;BENJAMIN G JACKSON;;BRENTON A BAUGH;;SHOTA AOYAGI,,https://lens.org/100-927-773-174-23X,Unknown,no,0,0,37,37,0,G06F3/04847;;G06F3/165;;G06F3/167;;H04R1/1041;;H04R29/001;;H04R2460/15;;H04R2430/01;;H04R1/1016;;H04R1/1091;;H04R29/00;;H04R2460/15;;G06F3/04847;;G06F3/165;;H04R1/1041;;H04R1/1091;;H04R29/001;;H04R2460/15;;H04S2400/13;;G06F3/167;;H04R1/1083;;H04R1/1016;;H04R2460/01;;G06F3/165;;G06F3/011;;G06F3/0481;;G06F3/0484;;G06F1/163;;G06F11/327;;H04R1/1016;;H04R1/1041;;H04R3/005;;H04R29/008;;H04R2420/07;;H04R3/12;;G06F3/165;;H04R1/1016;;H04R1/1008,H04R1/10;;G10K11/00;;G10K11/175;;G10K11/178;;H04R29/00,,0,0,,,,ACTIVE
952,DK,B1,DK 180955 B1,143-433-072-049-575,2022-08-11,2022,DK PA202070718 A,2020-10-30,US 201962871634 P;;US 201962897819 P;;US 201962907525 P;;US 202063033058 P;;US 202016920303 A;;DK PA202070630 A,2019-07-08,"SYSTEMS, METHODS, AND USER INTERFACES FOR HEADPHONE FIT ADJUSTMENT AND AUDIO OUTPUT CONTROL","A wearable audio output device in a physical environment includes an input device and one or more microphones. While ambient sound from the physical environment is being detected by the microphone(s), the wearable audio output device: while in a first mode, provides a first audio output including one or more pass-through audio components selected so as to increase audio pass-through of the ambient sound; detects an input via the input device; in response to detecting the input, and in accordance with a determination that the input is a first type of gesture, transitions from the first mode to a second mode; and, while in the second mode, provides a second audio output including one or more cancellation audio components selected so as to increase audio cancellation of the ambient sound.",APPLE INC,THOMAS S HULBERT;;TAYLOR G CARRIGAN;;DAVID C GRAHAM;;DUSTIN A HATFIELD;;GEMMA A ROPER;;KARLIN Y BARK;;DAVID H BLOOM;;BENJAMIN G JACKSON;;BRENTON A BAUGH;;SHOTA AOYAGI,,https://lens.org/143-433-072-049-575,Granted Patent,no,0,0,37,37,0,G06F3/04847;;G06F3/165;;G06F3/167;;H04R1/1041;;H04R29/001;;H04R2460/15;;H04R2430/01;;H04R1/1016;;H04R1/1091;;H04R29/00;;H04R2460/15;;G06F3/04847;;G06F3/165;;H04R1/1041;;H04R1/1091;;H04R29/001;;H04R2460/15;;H04S2400/13;;G06F3/167;;H04R1/1083;;H04R1/1016;;H04R2460/01;;G06F3/165;;G06F3/011;;G06F3/0481;;G06F3/0484;;G06F1/163;;G06F11/327;;H04R1/1016;;H04R1/1041;;H04R3/005;;H04R29/008;;H04R2420/07;;H04R3/12;;G06F3/165;;H04R1/1016;;H04R1/1008,H04R1/10;;G10K11/00;;G10K11/175;;G10K11/178;;H04R29/00,,0,0,,,,ACTIVE
953,US,B2,US 11184708 B2,121-777-839-700-943,2021-11-23,2021,US 202017028936 A,2020-09-22,US 202017028936 A;;US 202016920303 A;;US 202063033058 P;;US 201962907525 P;;US 201962897819 P;;US 201962871634 P,2019-07-08,"Systems, methods, and user interfaces for headphone fit adjustment and audio output control","A wearable audio output device in a physical environment includes an input device and one or more microphones. While ambient sound from the physical environment is being detected by the microphone(s), the wearable audio output device: while in a first mode, provides a first audio output including one or more pass-through audio components selected so as to increase audio pass-through of the ambient sound; detects an input via the input device; in response to detecting the input, and in accordance with a determination that the input is a first type of gesture, transitions from the first mode to a second mode; and, while in the second mode, provides a second audio output including one or more cancellation audio components selected so as to increase audio cancellation of the ambient sound.",APPLE INC,CARRIGAN TAYLOR G;;GRAHAM DAVID C;;HULBERT THOMAS S;;HATFIELD DUSTIN A;;ROPER GEMMA A;;BARK KARLIN Y;;BLOOM DAVID H;;JACKSON BENJAMIN G;;BAUGH BRENTON A;;AOYAGI SHOTA,APPLE INC (2020-12-31),https://lens.org/121-777-839-700-943,Granted Patent,yes,40,0,37,37,0,G06F3/04847;;G06F3/165;;G06F3/167;;H04R1/1041;;H04R29/001;;H04R2460/15;;H04R2430/01;;H04R1/1016;;H04R1/1091;;H04R29/00;;H04R2460/15;;G06F3/04847;;G06F3/165;;H04R1/1041;;H04R1/1091;;H04R29/001;;H04R2460/15;;H04S2400/13;;G06F3/167;;H04R1/1083;;H04R1/1016;;H04R2460/01;;G06F3/165;;G06F3/011;;G06F3/0481;;G06F3/0484;;G06F1/163;;G06F11/327;;H04R1/1016;;H04R1/1041;;H04R3/005;;H04R29/008;;H04R2420/07;;H04R3/12;;G06F3/165;;H04R1/1016;;H04R1/1008,H04R3/12;;G06F3/16;;H04R1/10,,15,0,,,"Office Action, dated Dec. 24, 2020, received in U.S. Appl. No. 17/028,947, 10 pages.;;Invitation to Pay Additional Fees, dated Oct. 8, 2020, received in International Patent Application No. PCT/2020/041074, which corresponds with U.S. Appl. No. 16/920,303, 24 pages.;;International Search Report and Written Opinion, dated Dec. 3, 2020, received in International Patent Application No. PCT/US2020/041074, which corresponds with U.S. Appl. No. 16/920,303, 28 pages.;;Office Action, dated Dec. 21, 2020, received in Danish Patent Application No. 2020-70630, which corresponds with U.S. Appl. No. 16/920,303, 8 pages.;;Office Action, dated Mar. 3, 2021, received in Danish Patent Application No. 2020-70630, which corresponds with U.S. Appl. No. 16/920,303, 2 pages.;;Office Action, dated Jan. 29, 2021, received in Danish Patent Application No. 2020-70718, which corresponds with U.S. Appl. No. 17/028,936, 7 pages.;;Office Action, dated Jan. 29, 2021, received in Danish Patent Application No. 2020-70719, which corresponds with U.S. Appl. No. 17/028,936, 7 pages.;;Office Action, dated Feb. 2, 2021, received in Danish Patent Application No. 202070720, which corresponds with U.S. Appl. No. 17/028,947, 3 pages.;;Office Action, dated Jun. 24, 2021, received in U.S. Appl. No. 16/920,303, 5 pages.;;Notice of Allowance, dated Jun. 10, 2021, received in Danish Patent Application No. 2020-70630, which corresponds with U.S. Appl. No. 16/920,303, 2 pages.;;Final Office Action, dated Mar. 17, 2021, received in U.S. Appl. No. 17/028,947, 8 pages.;;Intention to Grant, dated Aug. 27, 2021, received in Danish Patent Application No. 2020-70719, which corresponds with U.S. Appl. No. 17/028,936, 2 pages.;;Office Action, dated Sep. 10, 2021, received in Australian Patent Application No. 2020-239693, which corresponds with U.S. Appl. No. 16/920,303, 2 pages.;;Office Action, dated Sep. 14, 2021, received in U.S. Appl. No. 16/920,303, 7 pages.;;Office Action, dated Sep. 27, 2021, received in U.S. Appl. No. 17/028,947, 10 pages.",ACTIVE
954,US,A1,US 2003/0185381 A1,089-046-031-162-831,2003-10-02,2003,US 11448702 A,2002-04-02,US 11448702 A,2002-04-02,Contact center data integration with enterprise applications,"
   A method and apparatus are provided for processing a call with a client detected by a call center to an agent of the call center. The method includes the step of providing a call object for the call, collecting attributes of the call within the call object, associating an agent object with the call object and displaying client data to an agent of the call center based upon a view process of the associated agent object. 
",POWER MARK J.;;MOSQUERA DAVE;;DEZONNO ANTHONY;;HODSON JEFFREY D.;;BLOOM JOSEPH;;FUNCK DAVID;;JAMES ERIC;;PETERS MICHAEL;;SHAMBAUGH CRAIG R.;;SALEH NAYEL,POWER MARK J;;MOSQUERA DAVE;;DEZONNO ANTHONY;;HODSON JEFFREY D;;BLOOM JOSEPH;;FUNCK DAVID;;JAMES ERIC;;PETERS MICHAEL;;SHAMBAUGH CRAIG R;;SALEH NAYEL,FIRSTPOINT CONTACT TECHNOLOGIES LLC (2004-08-12);;WILMINGTON TRUST NATIONAL ASSOCIATION AS ADMINISTRATIVE AGENT (2014-11-07),https://lens.org/089-046-031-162-831,Patent Application,yes,8,6,7,7,0,H04M3/42068;;H04M3/523;;H04M2201/38;;H04M3/523;;H04M2201/38;;H04M3/42068,H04M3/523,379/265.09,0,0,,,,EXPIRED
955,US,B2,US 6870926 B2,125-762-565-905-004,2005-03-22,2005,US 99236701 A,2001-11-06,US 99236701 A,2001-11-06,Method of optimizing call center resources based upon statistics,"A method and apparatus are provided for allocating resources within a call center based upon a predetermined business rule of an enterprise controlling the call center. The method includes the steps of analyzing records from a plurality of call transactions based upon the predetermined business rule, recognizing a correlation among the call transaction records based upon the predetermined business rule and adjusting a resource of the call transactions based upon the recognized correlation and predetermined business rule.",ROCKWELL ELECTRONIC COMMERCE,SHAMBAUGH CRAIG R;;BLOOM JOE;;DEZONNO ANTHONY J;;FUNCK DAVID;;HODSON JEFF;;JAMES ERIC;;PETERS MICHAEL;;POWER MARK J;;MOSQUERA DAVE;;SALEH NAYEL,ROCKWELL ELECTRONIC COMMERCE CORP (2001-10-23);;FIRSTPOINT CONTACT TECHNOLOGIES LLC (2004-08-12);;WILMINGTON TRUST NATIONAL ASSOCIATION AS ADMINISTRATIVE AGENT (2014-11-07),https://lens.org/125-762-565-905-004,Granted Patent,yes,4,18,2,2,0,H04M3/5232;;H04M3/5232;;H04M3/5175;;H04M3/5175;;H04M3/5183;;H04M3/5183;;H04M3/5233;;H04M3/5233,H04M3/51;;H04M3/523,379/265.05;;379/265.02;;379/266.1,0,0,,,,EXPIRED
956,GB,B,GB 2387738 B,161-636-826-922-936,2005-03-09,2005,GB 0305179 A,2003-03-07,US 11448702 A,2002-04-02,Contact centre data integration with enterprise applications,,ROCKWELL ELECTRONIC COMMERCE,DEZONNO ANTHONY J;;FUNCK DAVID;;POWER MARK J;;HODSON JEFFREY;;BLOOM JOSEPH;;JAMES ERIC;;PETERS MICHAEL;;SHAMBAUGH CRAIG R;;MOSQUERA DAVE;;SALEH NAYEL,,https://lens.org/161-636-826-922-936,Granted Patent,no,2,0,7,7,0,H04M3/42068;;H04M3/523;;H04M2201/38;;H04M3/523;;H04M2201/38;;H04M3/42068,H04M3/523,H4K KF50E         KF50E,0,0,,,,EXPIRED
957,US,A1,US 2014/0245347 A1,009-903-287-751-981,2014-08-28,2014,US 201414171496 A,2014-02-03,US 201414171496 A;;AU 2010/201379 A;;US 201213486716 A;;US 75695610 A;;US 201313759886 A;;US 201113245786 A;;US 77060010 A;;US 40667506 A;;US 23810009 P;;US 67312805 P,2005-04-20,CONTROL LAYER INDEXED PLAYBACK,"A method and system for controlling a playback experience for one or more videos is disclosed. Actions are specified in control documents for the one or more videos. The actions specify start time and duration for each action, optional introductory or confirmation messages or interface controls, optional gestures, and/or intents that are triggered by the actions. The various control documents are compiled into a single control document that includes a link to the one or more videos and the actions various. Multiple parties can control the playback experience with multiple control documents to provide a multi-layered control experience.",LIMELIGHT NETWORKS INC,ANDERSON SCOTT;;MAHYARI ABBAS;;MALIK KENAN;;DONOHOE AIDAN PATRICK;;VARAMBALLY GOURI SHIVANI;;COBB JONATHAN;;ROWLEY DAVID;;DOLGOV NIKITA;;RIVAS CARL;;BLOOM RYAN B,LIMELIGHT NETWORKS INC (2012-05-31),https://lens.org/009-903-287-751-981,Patent Application,yes,4,5,1,34,0,H04N21/23439;;H04N21/26258;;H04N21/2668;;H04N21/6547;;H04N21/8456;;G11B27/10;;G06Q30/0251;;H04N21/812;;H04N21/812;;H04N21/2668;;H04N21/8456;;H04N21/23439;;H04N21/6547;;G11B27/10;;G06Q30/0251;;H04N21/26258,H04N21/45;;H04N21/81,725/32,0,0,,,,DISCONTINUED
958,CN,A,CN 114886853 A,186-060-046-405-100,2022-08-12,2022,CN 202210434174 A,2012-10-12,US 201161547620 P;;US 201261606207 P;;CN 201280061909 A;;US 2012/0060044 W,2011-10-14,Solid dispersions of ErbB2 (HER2) inhibitors,"Provided herein are solid dispersions of N4-(4-([1, 2, 4] triazolo [1, 5-a] pyridin-7-yloxy)-3-methylphenyl)-N6-(4, 4-dimethyl-4, 5-dihydrooxazol-2-yl) quinazoline-4, 6-diamine and methods of making the solid dispersions. In addition, provided herein are pharmaceutical compositions comprising a solid dispersion of N4-(4-([1, 2, 4] triazolo [1, 5-a] pyridin-7-yloxy)-3-methylphenyl)-N6-(4, 4-dimethyl-4, 5-dihydrooxazol-2-yl) quinazoline-4, 6-diamine, and uses thereof.",ARRAY BIOPHARMA INC,FRY DAVID SHANK;;LINDEMANN CHRISTOPHER M;;PREI MICHAEL;;BLOOM COREY JAY;;CRAIG CHRISTOPHER DONOVAN;;DUBOSE DEVON BRADLEY;;GAUTSCHI J ¨ 1 RGEN;;SMITH DANIEL,,https://lens.org/186-060-046-405-100,Patent Application,no,3,0,67,69,0,A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61P35/00;;A61K47/00;;A61K9/14;;A61K31/498;;A61K9/2009;;A61K9/2027;;A61K9/2054;;A61K9/1635;;A61K9/1652;;A61K9/2077;;A61K31/517;;A61K9/10;;A61K47/32;;A61K47/38;;A61K9/0053,A61K9/14;;A61K31/517;;A61K47/32;;A61K47/38;;A61P35/00,,0,0,,,,PENDING
959,NZ,A,NZ 512108 A,052-671-637-998-423,2003-09-26,2003,NZ 51210899 A,1999-12-06,US 20856198 A;;US 9928837 W,1998-12-09,Thiourea inhibitors of herpes viruses,"Compounds of formula (I), wherein: R1-R5 are independently H, alkyl, alkenyl, alkynyl, perhaloalkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, halo, -CN, -NO2, -CO2R6, -COR6, -OR6, -SR6, - SOR6, -SO2R6, -CONR7R8, -NR6N(R7R8), -N(R7R8) or W-Y-(CH2)n- Z, R9-R12 are independently H, alkyl, perhaloalkyl, halo, alkoxy, or cyano, or R9 and R10 or R11 and R12 may together form aryl, G is optionally substituted aryl or fused bicyclic heteroaryl, and X is a bond, -NH, alkylene, alkenylene, alkyleneoxy, thioalkylene, alkyleneamino. The compounds are used in the manufacture of medicaments for inhibiting the replication of a herpes virus.",WYETH CORP,O'HARA BRYAN MARK;;BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSPEH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELLGEORGE;;LANG STANLEY ALBERT;;ROSS ADMA ANTONIA;;NORTON EMILY BOUCHER,,https://lens.org/052-671-637-998-423,Patent Application,no,0,0,30,30,0,C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/00,A61K31/17;;A61K31/343;;A61K31/472;;A61P31/22;;C07C275/42;;C07C335/18;;C07C335/20;;C07C335/22;;C07D217/26;;C07D295/088;;C07D307/81;;C07D307/85,,0,0,,,,PENDING
960,GB,A,GB 2387738 A,171-683-043-780-884,2003-10-22,2003,GB 0305179 A,2003-03-07,US 11448702 A,2002-04-02,Contact centre data integration with enterprise applications,"A method and apparatus are provided for processing a call with a client detected by a call center to an agent of the call center. The method includes the step of providing a call object for the call, collecting attributes of the call within the call object, associating an agent object with the call object and displaying client data to an agent of the call center based upon a view process of the associated agent object.",ROCKWELL ELECTRONIC COMMERCE,DEZONNO ANTHONY J;;FUNCK DAVID;;POWER MARK J;;HODSON JEFFREY;;BLOOM JOSEPH;;JAMES ERIC;;PETERS MICHAEL;;SHAMBAUGH CRAIG R;;MOSQUERA DAVE;;SALEH NAYEL,,https://lens.org/171-683-043-780-884,Patent Application,no,2,0,7,7,0,H04M3/42068;;H04M3/523;;H04M2201/38;;H04M3/523;;H04M2201/38;;H04M3/42068,H04M3/523,H4K KF50E         KF50E,0,0,,,,EXPIRED
961,CA,A1,CA 2351403 A1,176-944-724-000-374,2000-06-15,2000,CA 2351403 A,1999-12-06,US 20856198 A;;US 9928837 W,1998-12-09,THIOUREA INHIBITORS OF HERPES VIRUSES,"Compounds of formula (I), wherein R1-R5 are independently selected from hydrogen, alkyl of 1 to 6 carbon atoms, alkenyl of 2 to 6 carbon atoms, alkynyl of 2 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 carbon members, aryl, heteroaryl, halogen, -CN, -NO2, -CO2R6, -COR6, -OR6, -SR6, - SOR6, -SO2R6, -CONR7R8, -NR6N(R7R8), -N(R7R8) or W-Y-(CH2)n-Z provided that at least one of R1-R5 is not hydrogen; or R2 and R3 or R3 and R4, taken togethe r form a 3 to 7 membered heterocycloalkyl or 3 to 7 membered heteroaryl; R6 an d R7 are independently hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, or aryl; R8 is hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 members, aryl or heteroaryl, or R7 and R8, taken together may form a 3 to 7 membered heterocycloalkyl; R9-R12 are independent ly hydrogen, alkyl of 1 to 4 carbon atoms, perhaloalkyl of 1 to 4 carbon atoms, halogen, alkoxy of 1 to 4 carbon atoms, or cyano, or R9 and R10 or R11 and R 12 may be taken together to form aryl of 5 to 7 carbon atoms; provided that at least one of R9-12 is not hydrogen; W is O, NR6, or is absent; Y is -(CO)- o r - (CO2)-, or is absent; Zis alkyl of 1 to 4 carbon atoms, -CN, -CO2R6, COR6, - CONR7R8, -OCOR6, -NR6COR7, -OCONR6, -OR6, -SR6, -SOR6, -SO2R6, SR6N(R7R8), - N(R7R8) or phenyl; G is aryl or fused bicyclic heteroaryl; and X is a bond, - NH, alkyl of 1 to 6 carbon atoms, alkenyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, thioalkyl of 1 to 6 carbon atoms, alkylamino of 1 to 6 carbon atoms, or (CH)J; J is alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 t o 7 carbon atoms, phenyl or benzyl; and n is an integer from 1 to 6, in the treatment of diseases associated with herpes viruses including human cytomegalovirus, herpes simplex viruses, Epstein-Barr virus, varicella-zoste r virus, human herpesviruses-6 and -7, and Kaposi herpes virus.",AMERICAN HOME PROD,NORTON EMILY BOUCHER;;ROSS ADMA ANTONIA;;O'HARA BRYAN MARK;;DUSHIN RUSSELL GEORGE;;DIGRANDI MARTIN JOSEPH;;BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;LANG STANLEY ALBERT,,https://lens.org/176-944-724-000-374,Patent Application,no,0,0,30,30,0,C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/00,A61K31/17;;A61K31/343;;A61K31/472;;A61P31/22;;C07C275/42;;C07C335/18;;C07C335/20;;C07C335/22;;C07D217/26;;C07D295/088;;C07D307/81;;C07D307/85,,0,0,,,,DISCONTINUED
962,NO,L,NO 20012838 L,065-065-651-183-88X,2001-08-08,2001,NO 20012838 A,2001-06-08,US 20856198 A;;US 9928837 W,1998-12-09,Tiourea-inhibitorer for herpesvirus,,AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSEL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER;;ROSS ADMA ANTONIA;;O'HARA BRYAN MARK,,https://lens.org/065-065-651-183-88X,Abstract,no,0,0,30,30,0,C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/00,A61K31/17;;A61K31/343;;A61K31/472;;A61P31/22;;C07C275/42;;C07C335/18;;C07C335/20;;C07C335/22;;C07D217/26;;C07D295/088;;C07D307/81;;C07D307/85,,0,0,,,,DISCONTINUED
963,US,A1,US 2003/0097339 A1,105-067-760-748-227,2003-05-22,2003,US 99213801 A,2001-11-16,US 99213801 A,2001-11-16,Method and apparatus for sharing customer data,"
   A telecommunication system for transmitting customer data corresponding to a customer, to an agent of an automatic call distributor (ACD) is described. The ACD is connected to the telecommunication system through a public switched telephone network (PSTN). The telecommunication system includes a customer data processor configured to maintain two way communication between the customer and the agent of the ACD, where the customer data processor stores and processes customer data provided by the customer. A data encrypter operatively coupled to the customer data processor encrypts the customer data. The customer data processor transmits the encrypted customer data to the ACD upon receiving a predetermined signal. A customer data interpreter is operatively coupled to the ACD and receives and decrypts the encrypted customer data to facilitate presentation of the customer data to the agent. 
",FUNCK DAVID A.;;DEZONNO ANTHONY J.;;HODSON JEFF;;BLOOM JOSEPH;;JAMES ERIC;;PETERS MICHAEL;;POWER MARK J.;;SHAMBAUGH CRAIG R.;;MOSQUERA DAVE;;SALEH NAYEL,FUNCK DAVID A;;DEZONNO ANTHONY J;;HODSON JEFF;;BLOOM JOSEPH;;JAMES ERIC;;PETERS MICHAEL;;POWER MARK J;;SHAMBAUGH CRAIG R;;MOSQUERA DAVE;;SALEH NAYEL,ROCKWELL ELECTRONIC COMMERCE CORP (2001-12-14);;FIRSTPOINT CONTACT TECHNOLOGIES LLC (2004-08-12);;WILMINGTON TRUST NATIONAL ASSOCIATION AS ADMINISTRATIVE AGENT (2014-11-07),https://lens.org/105-067-760-748-227,Patent Application,yes,25,14,1,1,0,G06Q20/382;;H04M3/523;;H04M7/006;;H04M3/523;;H04M7/006;;G06Q20/382,H04M3/523;;H04M7/00,705/64,0,0,,,,DISCONTINUED
964,PT,E,PT 1137632 E,199-413-109-296-478,2004-11-30,2004,PT 99963021 T,1999-12-06,US 20856198 A,1998-12-09,TIOUREIAS INIBIDORAS DE VIRUS HERPES,,WYETH CORP,CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER;;ROSS ADMA ANTONIA;;BLOOM JONATHAN DAVID;;O'HARA BRYAN MARK,,https://lens.org/199-413-109-296-478,Granted Patent,no,0,0,30,30,0,C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/00,A61K31/17;;A61K31/343;;A61K31/472;;A61P31/22;;C07C275/42;;C07C335/18;;C07C335/20;;C07C335/22;;C07D217/26;;C07D295/088;;C07D307/81;;C07D307/85,,0,0,,,,EXPIRED
965,DK,T3,DK 1137632 T3,012-581-893-463-751,2004-11-01,2004,DK 99963021 T,1999-12-06,EP 99963021 A;;US 20856198 A,1998-12-09,Thiourinstofinhibitorer af herpesvira,,WYETH CORP,CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER;;ROSS ADMA ANTONIA;;BLOOM JONATHAN DAVID;;O'HARA BRYAN MARK,,https://lens.org/012-581-893-463-751,Granted Patent,no,0,0,30,30,0,C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/00,A61K31/17;;A61K31/343;;A61K31/472;;A61P31/22;;C07C275/42;;C07C335/18;;C07C335/20;;C07C335/22;;C07D217/26;;C07D295/088;;C07D307/81;;C07D307/85,,0,0,,,,EXPIRED
966,AU,A,AU 2000/019346 A,023-426-482-717-293,2000-06-26,2000,AU 2000/019346 A,1999-12-06,US 20890298 A;;US 9928839 W,1998-12-09,Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing aphenylenediamine group,,AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER;;ROSS ADMA ANTONIA;;O'HARA BRYAN MARK,WYETH (2002-10-03),https://lens.org/023-426-482-717-293,Patent Application,no,0,0,28,89,0,C07C335/20;;C07D215/48;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/20,A61K31/17;;A61K31/18;;A61K31/343;;A61K31/47;;A61K31/472;;A61K31/4725;;A61P31/22;;C07C335/20;;C07D215/48;;C07D215/50;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/79;;C07D307/81;;C07D307/85;;C07D405/12;;C07D407/12,,0,0,,,,DISCONTINUED
967,US,A1,US 2004/0203629 A1,013-933-842-024-030,2004-10-14,2004,US 9049902 A,2002-03-04,US 9049902 A,2002-03-04,Intelligent interactive voice response unit,"
   A method and apparatus for processing calls in a call processing center provided for support of enterprise activities of an organization. The method includes the steps of receiving a query about the enterprise activities of the organization from a caller through the call center, translating the query into voice extensible mark-up language, forming an answer to the translated query within an artificial intelligence engine and providing the determined answer to the caller. 
",DEZONNO ANTHONY J.;;HODSON JEFFREY D.;;BLOOM JOSEPH;;FUNCK DAVID;;JAMES ERIC;;PETERS MICHAEL;;POWERS MARK J.;;SHAMBAUGH CRAIG R.;;MOSQUERA DAVE;;SALEH NAYEL,DEZONNO ANTHONY J;;HODSON JEFFREY D;;BLOOM JOSEPH;;FUNCK DAVID;;JAMES ERIC;;PETERS MICHAEL;;POWERS MARK J;;SHAMBAUGH CRAIG R;;MOSQUERA DAVE;;SALEH NAYEL,ROCKWELL ELECTRONIC COMMERCE CORP (2002-03-01);;FIRSTPOINT CONTACT TECHNOLOGIES LLC (2004-08-12);;WILMINGTON TRUST NATIONAL ASSOCIATION AS ADMINISTRATIVE AGENT (2014-11-07),https://lens.org/013-933-842-024-030,Patent Application,yes,46,28,6,6,0,H04M3/4938;;H04M3/5166;;H04M3/5191;;H04M3/4938;;H04M3/5166;;H04M3/5191,H04M3/493;;H04M3/51,455/414.1;;455/415,0,0,,,,DISCONTINUED
968,SI,T1,SI 1137645 T1,117-773-246-039-448,2004-08-31,2004,SI 9930583 T,1999-12-06,EP 99963022 A;;US 9928839 W;;US 20890298 A,1998-12-09,ALPHA-METHYLBENZYL-CONTAINING THIOUREA INHIBITORS OF HERPES VIRUSES CONTAINING A PHENYLENEDIAMINE GROUP,,WYETH CORP,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER;;ROSS ADMA ANTONIA;;O'HARA BRYAN MARK,,https://lens.org/117-773-246-039-448,Granted Patent,no,0,0,1,89,0,,C07D285/06;;C07D307/68;;C07D335/20,,0,0,,,,EXPIRED
969,BR,A,BR 9916086 A,146-832-788-727-471,2001-09-04,2001,BR 9916086 A,1999-12-06,US 20856198 A;;US 9928837 W,1998-12-09,"Composto, composição farmacêutica, método para inibir a replicação de um vìrus do herpes, método para tratar um paciente sofrendo de uma infecção por vìrus do herpes","""COMPOSTO, COMPOSIçãO FARMACêUTICA, MéTODO PARA INIBIR A REPLICAçãO DE UM VìRUS DO HERPES, MéTODO PARA TRATAR UM PACIENTE SOFRENDO DE UMA INFECçãO POR VìRUS DO HERPES"" Compostos de fórmula (I): em que R~ 1~-R~ 5~ são independentemente selecionados dentre hidrogênio, alquila de 1 a 6 átomos de carbono, alquenila de 2 a 6 átomos de carbono, alquinila de 2 a 6 átomos de carbono, perhaloalquila de 1 a 6 átomos de carbono, cicloalquila de 3 a 10 átomos de carbono, heterocicloalquila de 3 a 10 membros de carbono, arila, heteroarila, halogênio,-CN,-NO~ 2~,-CO~ 2~R~ 6~,-COR~ 6~,-OR~ 6~,-SR~ 6~,-SOR~ 6~,-SO~ 2~R~ 6~,-CONR~ 7~R~ 8~,-NR~ 6~N (R~ 7~R~ 8~),-N (R~ 7~R~ 8~) ou W-Y-(CH~ 2~)~ n~-Z desde que pelo menos um dentre R~ 1~-R~ 5~ não seja hidrogênio; ou R~ 2~ e R~ 3~ ou R~ 3~ e R~ 4~, tomados juntos, formam uma heterocicloalquila de 3 a 7 membros ou heteroarila de 3 a 7 membros; R~ 6~ e R~ 7~ são independentemente hidrogênio, alquila de 1 a 6 átomos de carbono, perhaloalquila de 1 a 6 átomos de carbono, ou arila; R~ 8~ é hidrogênio, alquila de 1 a 6 átomos de carbono, perhaloalquila de 1 a 6 átomos de carbono, cicloalquila de 3 a 10 átomos de carbono, heterocicloalquila de 3 a 10 membros, arila ou heteroarila, ou R~ 7~ e R~ 8~, tomados juntos podem formar uma heterocicloalquila de 3 a 7 membros; R~ 9~-R~ 12~ são independentemente hidrogênio, alquila de 1 a 4 átomos de carbono, perhaloalquila de 1 a 4 átomos de carbono, halogênio, alcoxi de 1 a 4 átomos de carbono, ou ciano, ou R~ 9~ e R~ 10~ ou R~ 11~ e R~ 12~ tomados juntos podem formar arila de 5 a 7 átomos de carbono; desde que pelo menos um dentre R9-12 não seja hidrogênio; W é O, NR~ 6~, ou está ausente; Y é -(CO)- ou -(CO~ 2~)-, ou está ausente; Z é alquila de 1 a 4 átomos de carbono,-CN,-CO~ 2~R~ 6~, COR~ 6~,-CONR~ 7~R~ 8~,-OCOR~ 6~,-NR~ 6~COR~ 7~-OCONR~ 6~,-OR~ 6~-SR~ 6~,-SOR~ 6~,-SO~ 2~R~ 6~, SR~ 6~N (R~ 7~R~ 8~),-N (R~ 7~R~ 8~) ou fenila; G é arila ou heteroarila bicíclica fundida, X é uma ligação, -NH, alquila de 1 6 átomos de carbono, alquenila de 1 a 6 átomos de carbono, alcoxi de 1 a 6 átomos de carbono, tioalquila de 1 a 6 átomos de carbono, alquilamino de 1 a 6 átomos de carbono, ou (CH) J; J é alquila de 1 a 6 átomos de carbono, cicloalquila de 3 a 7 átomos de carbono, fenila ou benzila; e n é um número inteiro de 1 a 6; no tratamento de doenças associadas com vírus do herpes incluindo citomegalovírus humano, vírus do herpes simples, vírus Epstein-Barr, vírus da varicela-zoster, vírus do herpes humano 6 e 7, e vírus do herpes de Kaposi.",AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER;;ROSS ADMA ANTONIA;;O'HARA BRYAN MARK,,https://lens.org/146-832-788-727-471,Patent Application,no,0,0,30,30,0,C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/00,A61K31/17;;A61K31/343;;A61K31/472;;A61P31/22;;C07C275/42;;C07C335/18;;C07C335/20;;C07C335/22;;C07D217/26;;C07D295/088;;C07D307/81;;C07D307/85,,0,0,,,,DISCONTINUED
970,ZA,B,ZA 200104144 B,110-006-246-512-803,2002-08-21,2002,ZA 200104144 A,2001-05-21,US 20856198 A,1998-12-09,Thiourea inhibitors of herpes viruses.,,WYETH CORP,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;LANG STANLEY ALBERT;;ROSS ADMA ANTONIA;;CURRAN KEVIN JOSEPH;;DUSHIN RUSSELL GEORGE;;NORTON EMILY BOUCHER;;O'HARA BRYAN MARK,,https://lens.org/110-006-246-512-803,Granted Patent,no,0,0,30,30,0,C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/00,A61K31/17;;A61K31/343;;A61K31/472;;A61P31/22;;C07C275/42;;C07C335/18;;C07C335/20;;C07C335/22;;C07D217/26;;C07D295/088;;C07D307/81;;C07D307/85,,0,0,,,,EXPIRED
971,ID,A,ID 30287 A,063-366-414-827-262,2001-11-15,2001,ID 20011228 A,1999-12-06,US 20856198 A,1998-12-09,THIOUREA PENCEGAH-PENCEGAH VIRUS-VIRUS HERPES,,AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER;;ROSS ADMA ANTONIA;;O'HARA BRYAN MARK,,https://lens.org/063-366-414-827-262,Patent Application,no,0,0,30,30,0,C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/00,A61K31/17;;A61K31/343;;A61K31/472;;A61P31/22;;C07C275/42;;C07C335/18;;C07C335/20;;C07C335/22;;C07D217/26;;C07D295/088;;C07D307/81;;C07D307/85,,0,0,,,,PENDING
972,SK,A3,SK 7702001 A3,078-621-359-636-753,2002-04-04,2002,SK 7702001 A,1999-12-06,US 20856198 A;;US 9928837 W,1998-12-09,THIOUREA INHIBITORS OF HERPES VIRUSES,,AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER;;ROSS ADMA ANTONIA;;O'HARA BRYAN MARK,,https://lens.org/078-621-359-636-753,Patent Application,no,0,0,30,30,0,C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/00,A61K31/17;;A61K31/343;;A61K31/472;;A61P31/22;;C07C275/42;;C07C335/18;;C07C335/20;;C07C335/22;;C07D217/26;;C07D295/088;;C07D307/81;;C07D307/85,,0,0,,,,PENDING
973,HU,A2,HU P0104763 A2,087-618-655-479-317,2002-04-29,2002,HU P0104763 A,1999-12-06,US 20856198 A;;US 9928837 W,1998-12-09,THIOUREA INHIBITORS OF HERPES VIRUSES,"A tal lm ny (I) ltal nos képletű vegyületekre és gyógy szatilagelfogadható sóikra vonatkozik, ahol R4-R5 jelentése egym stólfüggetlenül hidrogénatom, alkil-, alkenil-, alkinil-,perhalogénalkil-, cikloalkil-, heterocikloalkil-, aril-,heteroarilcsoport, halogénatom, ciano-, nitrocsoport, -CO2R6, -COR6, -OR6, -SR6, -SOR6, -SO2R6, -CONR7R8, -NR6N(R7R8), -N(R7R8) vagy W-Y- -(CH2)n-Z ltal nos képletű csoport, vagy R2 és R3 vagy R3 és R4 együtt3-7 tagú heterocikloalkilcsoportot vagy 3-7 tagú heteroarilcsoportotalkot; R6 és R7 jelentése egym stól függetlenül hidrogénatom, alkil-,perhalogénalkil-, vagy arilcsoport; R8 jelentése hidrogénatom, alkil-,perhalogénalkil-, cikloalkil-, heterocikloalkil-, aril-,heteroarilcsoport, vagy R7 és R8 együtt 3-7 tagúheterocikloalkilcsoportot alkothat; R9-R12 jelentése egym stólfüggetlenül hidrogénatom, alkil-, perhalogénalkilcsoport, halogénatom,alkoxi-, cianocsoport vagy R9 és R10 vagy R11 és R12 5-7 szénatomottartalmazó arilcsoportot alkothat, azzal a megk""téssel, hogy az R9 -R12 csoportok k""zül legal bb egynek a jelentése nem hidrogénatom; Wjelentése oxigénatom, -NR6 ltal nos képletű csoport, vagy hi nyzik; Yjelentése -(CO)- vagy -(CO2)-, vagy hi nyzik; Z jelentése alkil-,cianocsoport, -CO2R6, -COR6, -CONR7R8, -OCOR6, -NR6COR7, -OCONR6, -OR6, -SR6, -SOR6, -SO2R6, SR6N(R7R8), -N(R7R8) ltal nos képletűcsoport vagy fenilcsoport; G jelentése aril- vagy kondenz ltbiciklusos heteroarilcsoport; X jelentése vegyértékk""tés, -NH, alkil-,alkenil-, alkoxi-, alkil-tio-, alkil-aminocsoport vagy (CH)J ltal nosképletű csoport; J jelentése alkil-, cikloalkil-, fenil- vagybenzilcsoport; és n értéke 1-6. A vegyületek g tolj k és/vagy gyógyítjk a herpeszvírusok, péld ul a hum n citomegalovírusok, herpeszszimplex vírusok, Epstein-Barr vírus, varicella-zoster vírus, hum nherpeszvírus-6 és -7 és a Kaposi-herpeszvírus ltal okozottbetegségeket. A tal lm ny a vegyületeket tartalmazógyógyszerkészítményekre és a vegyületek alkalmaz s ra is vonatkozik. Ó",AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER;;O'HARA BRYAN MARK;;ROSS ADMA ANTONIA,,https://lens.org/087-618-655-479-317,Patent Application,no,0,0,30,30,0,C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/00,A61K31/17;;A61K31/343;;A61K31/472;;A61P31/22;;C07C275/42;;C07C335/18;;C07C335/20;;C07C335/22;;C07D217/26;;C07D295/088;;C07D307/81;;C07D307/85,,0,0,,,,PENDING
974,EP,A2,EP 1137645 A2,145-297-087-320-830,2001-10-04,2001,EP 99963022 A,1999-12-06,US 9928839 W;;US 20890298 A,1998-12-09,ALPHA-METHYLBENZYL-CONTAINING THIOUREA INHIBITORS OF HERPES VIRUSES CONTAINING A PHENYLENEDIAMINE GROUP,,AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER;;ROSS ADMA ANTONIA;;O'HARA BRYAN MARK,WYETH (2002-06-19),https://lens.org/145-297-087-320-830,Patent Application,yes,0,0,28,89,0,C07C335/20;;C07D215/48;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/20,A61K31/17;;A61K31/18;;A61K31/343;;A61K31/47;;A61K31/472;;A61K31/4725;;A61P31/22;;C07C335/20;;C07D215/48;;C07D215/50;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/79;;C07D307/81;;C07D307/85;;C07D405/12;;C07D407/12,,0,0,,,,EXPIRED
975,AT,T1,AT E272052 T1,000-733-361-416-019,2004-08-15,2004,AT 99963021 T,1999-12-06,US 20856198 A;;US 9928837 W,1998-12-09,THIOHARNSTOFF-INHIBITOREN VON HERPES-VIRUS,,WYETH CORP,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER;;ROSS ADMA ANTONIA;;O'HARA BRYAN MARK,,https://lens.org/000-733-361-416-019,Granted Patent,no,0,0,30,30,0,C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/00,A61K31/17;;A61K31/343;;A61K31/472;;A61P31/22;;C07C275/42;;C07C335/18;;C07C335/20;;C07C335/22;;C07D217/26;;C07D295/088;;C07D307/81;;C07D307/85,,0,0,,,,DISCONTINUED
976,ZA,B,ZA 200104376 B,001-951-338-242-884,2002-08-28,2002,ZA 200104376 A,2001-05-28,US 20890298 A,1998-12-09,Alpha-methybenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine groups.,,WYETH CORP,BLOOM JONATHAN DAVID;;DIGRANDI MARTIN JOSEPH;;LANG STANLEY ALBERT;;ROSS ADMA ANTONIA;;CURRAN KEVIN JOSEPH;;DUSHIN RUSSEL GEORGE;;NORTON EMILY BOUCHER;;O'HARA BRYAN MARK,,https://lens.org/001-951-338-242-884,Granted Patent,no,0,0,28,89,0,C07C335/20;;C07D215/48;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/20,A61K31/17;;A61K31/18;;A61K31/343;;A61K31/47;;A61K31/472;;A61K31/4725;;A61P31/22;;C07C335/20;;C07D215/48;;C07D215/50;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/79;;C07D307/81;;C07D307/85;;C07D405/12;;C07D407/12,,0,0,,,,EXPIRED
977,CA,A1,CA 2350833 A1,028-557-090-367-206,2000-06-15,2000,CA 2350833 A,1999-12-06,US 20890298 A;;US 9928839 W,1998-12-09,ALPHA-METHYLBENZYL-CONTAINING THIOUREA INHIBITORS OF HERPES VIRUSES CONTAINING A PHENYLENEDIAMINE GROUP,"Compounds having formula (I) wherein R1-R5 are independently selected from hydrogen, alkyl of 1 to 6 carbon atoms, alkenyl of 2 to 6 carbon atoms, alkynyl of 2 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 carbon members, aryl, heteroaryl, halogen,-CN,-NO2,-CO2R6,-COR6,-OR6,-SR6,-SOR6,- SO2R6,-CONR7R8,-NR6N(R7R8),-N(R7R8) or W-Y-(CH2)n-Z provided that at least o ne of R1-R5 is not hydrogen; or R2 and R3, or R3 and R4, taken together to form a 3 to 7 membered heterocycloalkyl or 3 to 7 membered heteroaryl; R6 and R7 ar e independently hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, or aryl; R8 is hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 members, aryl or heteroaryl, or R7 and R8, taken together may form a 3 to 7 membered heterocycloalkyl; W is O, NR6, or is absent; Y is -(CO)- or-(CO2)-, or is absent; Z is alkyl of 1 to 4 carbon atoms,-CN,-CO2R6, COR6,-CONR7R8,-OCOR6,-NR6COR7,-OCONR6,-OR6,-SR6,-SOR6,- SO2R6, SR6N(R7R8),-N(R7R8) or phenyl; G is aryl or fused bicyclic heteroaryl ; X is a bond,-NH, alkyl of 1 to 6 carbon atoms, alkenyl of 1 to 6 carbon atom s, alkoxy of 1 to 6 carbon atoms, thioalkylof 1 to 6 carbon atoms, alkylamino o f 1 to 6 carbon atoms, or (CH)J; J is alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 7 carbon atoms, phenyl or benzyl; and n is an integer from 1 to 6; useful in the treatment of diseases associated with herpes viruses including human cytomegalovirus, herpes simplex viruses, Epstein-Barr virus, varicella - zoster virus, human herpesviruses-6 and-7, and Kaposi herpesvirus.",AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;O'HARA BRYAN MARK;;NORTON EMILY BOUCHER;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;DIGRANDI MARTIN JOSEPH;;ROSS ADMA ANTONIA,,https://lens.org/028-557-090-367-206,Patent Application,no,0,0,28,89,0,C07C335/20;;C07D215/48;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/20,A61K31/17;;A61K31/18;;A61K31/343;;A61K31/47;;A61K31/472;;A61K31/4725;;A61P31/22;;C07C335/20;;C07D215/48;;C07D215/50;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/79;;C07D307/81;;C07D307/85;;C07D405/12;;C07D407/12,,0,0,,,,DISCONTINUED
978,WO,A1,WO 2000/034238 A1,048-039-164-277-138,2000-06-15,2000,US 9928837 W,1999-12-06,US 20856198 A,1998-12-09,THIOUREA INHIBITORS OF HERPES VIRUSES,"Compounds of formula (I), wherein R1-R5 are independently selected from hydrogen, alkyl of 1 to 6 carbon atoms, alkenyl of 2 to 6 carbon atoms, alkynyl of 2 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 carbon members, aryl, heteroaryl, halogen, -CN, -NO2, -CO2R6, -COR6, -OR6, -SR6, -SOR6, -SO2R6, -CONR7R8, -NR6N(R7R8), -N(R7R8) or W-Y-(CH2)n-Z provided that at least one of R1-R5 is not hydrogen; or R2 and R3 or R3 and R4, taken together form a 3 to 7 membered heterocycloalkyl or 3 to 7 membered heteroaryl; R6 and R7 are independently hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, or aryl; R8 is hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 members, aryl or heteroaryl, or R7 and R8, taken together may form a 3 to 7 membered heterocycloalkyl; R9-R12 are independently hydrogen, alkyl of 1 to 4 carbon atoms, perhaloalkyl of 1 to 4 carbon atoms, halogen, alkoxy of 1 to 4 carbon atoms, or cyano, or R9 and R10 or R11 and R12 may be taken together to form aryl of 5 to 7 carbon atoms; provided that at least one of R9-12 is not hydrogen; W is O, NR6, or is absent; Y is -(CO)- or -(CO2)-, or is absent; Z is alkyl of 1 to 4 carbon atoms, -CN, -CO2R6, COR6, -CONR7R8, -OCOR6, -NR6COR7, -OCONR6, -OR6, -SR6, -SOR6, -SO2R6, SR6N(R7R8), -N(R7R8) or phenyl; G is aryl or fused bicyclic heteroaryl; and X is a bond, -NH, alkyl of 1 to 6 carbon atoms, alkenyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, thioalkyl of 1 to 6 carbon atoms, alkylamino of 1 to 6 carbon atoms, or (CH)J; J is alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 7 carbon atoms, phenyl or benzyl; and n is an integer from 1 to 6, in the treatment of diseases associated with herpes viruses including human cytomegalovirus, herpes simplex viruses, Epstein-Barr virus, varicella-zoster virus, human herpesviruses-6 and -7, and Kaposi herpes virus.",AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER;;ROSS ADMA ANTONIA;;O'HARA BRYAN MARK,,https://lens.org/048-039-164-277-138,Patent Application,yes,4,27,30,30,0,C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/00,A61K31/17;;A61K31/343;;A61K31/472;;A61P31/22;;C07C275/42;;C07C335/18;;C07C335/20;;C07C335/22;;C07D217/26;;C07D295/088;;C07D307/81;;C07D307/85,,0,0,,,,PATENTED
979,TR,T2,TR 200101597 T2,127-968-929-763-585,2001-10-22,2001,TR 200101597 T,1999-12-06,US 20856198 A,1998-12-09,Herpes virüslerinin tiüre önleyicileri.,"Formül (I)'in bilesimleri, burada R1-R5 bagimsiz olarak hidrojen, 1 ila 6 atomlu alkil, 2 ila 6 karbon atomlu alkenil, 2 ila 6 karbon atomlu alkinil, 1 ila 6 karbon atomlu perhaloalkil, 3 ila 10 karbon atomlu sikloalkil, 3 ila 10 karbon elemanli heterosikloalkil, aril heteroaril, halojen, -CN, -NO2, -CO2R6, -COR6, -OR6, -SR6, -SO2R6, -CONR7R8, -NR6(R7R8), -N(R7R8) ya da W-Y-(CH2)n-Z'den seçilir; su sartla ki R1-R5'in en azindan biri hidrojen degildir; ya da R2 ve R3 ya da R3 ve R4 birlikte alinir ve 3 ila 7 elemanli heterosikloalkil ya da 3 ila 7 elemanli heteroarilden seçilir. (FORMÜL VAR)",AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER;;ROSS ADMA ANTONIA;;O'HARA BRYAN MARK,,https://lens.org/127-968-929-763-585,Patent Application,no,0,0,30,30,0,C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/00,A61K31/17;;A61K31/343;;A61K31/472;;A61P31/22;;C07C275/42;;C07C335/18;;C07C335/20;;C07C335/22;;C07D217/26;;C07D295/088;;C07D307/81;;C07D307/85,,0,0,,,,PENDING
980,PT,E,PT 1137645 E,188-904-995-794-822,2004-09-30,2004,PT 99963022 T,1999-12-06,US 20890298 A,1998-12-09,INIBIDORES VIRUS DE HERPES A BASE DE TIOUREIA ALFA-METILBENZILADA CONTENDO UM GRUPO FENILENODIAMINA,,WYETH CORP,O'HARA BRIAN MARK;;BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER;;ROSS ADMA ANTONIA,,https://lens.org/188-904-995-794-822,Granted Patent,no,0,0,28,89,0,C07C335/20;;C07D215/48;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/20,A61K31/17;;A61K31/18;;A61K31/343;;A61K31/47;;A61K31/472;;A61K31/4725;;A61P31/22;;C07C335/20;;C07D215/48;;C07D215/50;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/79;;C07D307/81;;C07D307/85;;C07D405/12;;C07D407/12,,0,0,,,,EXPIRED
981,EP,B1,EP 1137632 B1,134-319-393-828-427,2004-07-28,2004,EP 99963021 A,1999-12-06,US 9928837 W;;US 20856198 A,1998-12-09,THIOUREA INHIBITORS OF HERPES VIRUSES,,WYETH CORP,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER;;ROSS ADMA ANTONIA;;O'HARA BRYAN MARK,WYETH (2002-06-19),https://lens.org/134-319-393-828-427,Granted Patent,yes,4,0,30,30,0,C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/00,A61K31/17;;A61K31/343;;A61K31/472;;A61P31/22;;C07C275/42;;C07C335/18;;C07C335/20;;C07C335/22;;C07D217/26;;C07D295/088;;C07D307/81;;C07D307/85,,0,0,,,,EXPIRED
982,US,B2,US 6961419 B2,130-487-668-231-986,2005-11-01,2005,US 11448702 A,2002-04-02,US 11448702 A,2002-04-02,Contact center data integration with enterprise applications,"A method and apparatus are provided for processing a call with a client detected by a call center to an agent of the call center. The method includes the step of providing a call object for the call, collecting attributes of the call within the call object, associating an agent object with the call object and displaying client data to an agent of the call center based upon a view process of the associated agent object.",ROCKWELL ELECTRONIC COMMERCE,POWER MARK J;;MOSQUERA DAVE;;DEZONNO ANTHONY J;;HODSON JEFFREY D;;BLOOM JOSEPH;;FUNCK DAVID;;JAMES ERIC;;PETERS MICHAEL;;SHAMBAUGH CRAIG R;;SALEH NAYEL,FIRSTPOINT CONTACT TECHNOLOGIES LLC (2004-08-12);;WILMINGTON TRUST NATIONAL ASSOCIATION AS ADMINISTRATIVE AGENT (2014-11-07),https://lens.org/130-487-668-231-986,Granted Patent,yes,13,13,7,7,0,H04M3/42068;;H04M3/523;;H04M2201/38;;H04M3/523;;H04M2201/38;;H04M3/42068,H04M3/523,379/265.09,1,0,,,"Merriam Webster's Collegiate Dictionary, 10th Edition, p. 801.",EXPIRED
983,EP,B1,EP 1137645 B1,010-486-147-822-638,2004-05-26,2004,EP 99963022 A,1999-12-06,US 9928839 W;;US 20890298 A,1998-12-09,ALPHA-METHYLBENZYL-CONTAINING THIOUREA INHIBITORS OF HERPES VIRUSES CONTAINING A PHENYLENEDIAMINE GROUP,,WYETH CORP,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER;;ROSS ADMA ANTONIA;;O'HARA BRYAN MARK,WYETH (2002-06-19),https://lens.org/010-486-147-822-638,Granted Patent,yes,4,0,28,89,0,C07C335/20;;C07D215/48;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/20,A61K31/17;;A61K31/18;;A61K31/343;;A61K31/47;;A61K31/472;;A61K31/4725;;A61P31/22;;C07C335/20;;C07D215/48;;C07D215/50;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/79;;C07D307/81;;C07D307/85;;C07D405/12;;C07D407/12,,0,0,,,,EXPIRED
984,EA,B1,EA 004205 B1,033-155-473-746-093,2004-02-26,2004,EA 200100638 A,1999-12-06,US 20890298 A;;US 9928839 W,1998-12-09,ALPHA-METHYLBENZYL-CONTAINING THIOUREA INHIBITORS OF HERPES VIRUSES CONTAINING A PHENYLENEDIAMINE GROUP,"1. A compound having the formula: wherein R1-R5 are independently selected from hydrogen, alkyl of 1 to 6 carbon atoms, alkenyl of 2 to 6 carbon atoms, alkynyl of 2 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 carbon members, aryl, heteroaryl, halogen, -CN, -NO2, -CO2R6, -COR6, -OR6, -SR6, -SOR6, -SO2R6, -CONR7R8, -NR6N(R7R8), -N(R7R8) or W-Y-(CH2)n-Z provided that at least one of R1-R5 is not hydrogen; or R2 and R3 or R3 and R4, taken together form a 3 to 7 membered heterocycloalkyl or 3 to 7 membered heteroaryl; R6 and R7 are independently hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, or aryl; R8 is hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 members, aryl or heteroaryl, or R7 and R8, taken together may form a 3 to 7 membered heterocycloalkyl; W is O, NR6, or is absent; Y is -(CO)- or -(CO2)-, or is absent; Z is alkyl of 1 to 4 carbon atoms, -CN, -CO2R6, COR6, -CONR7R8, -OCOR6, -NR6COR7, -OCONR6, -OR6, -SR6, -SOR6, -SO2R6, SR6N(R7R8), -N(R7R8) or phenyl; G is aryl or fused bicyclic heteroaryl; X is a bond, -NH, alkyl of 1 to 6 carbon atoms, alkenyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, thioalkyl of 1 to 6 carbon atoms, alkylamino of 1 to 6 carbon atoms, or (CH)J; J is alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 7 carbon atoms, phenyl or benzyl; and n is an integer from 1 to 6; ""aryl"" means an aromatic mono or bicyclic ring of 5 to 10 carbon atoms; ""Heteroaryl"" means an aromatic mono or bicyclic ring of 5 to 10 members having 1 to 3 heteroatoms selected from N, S or O; ""heterocycloalkyl"" means saturated mono or bicyclic ring system of 3 to 10 members having 1 to 3 heteroatoms selected from N, S and O, and wherein alkyl, alkenyl, aryl, and heteroaryl groups in above mentioned values are optionally substituted; or a pharmaceutical salt thereof. 2. A compound of Claim 1 wherein R1-R5 are independently, alkyl of 1 to 6 carbon atoms, halogen, perhaloalkyl of 1 to 6 carbon atoms, OR6 or N(R7R8). 3. A compound of Claim 1 wherein R4 is halogen, trifluoromethyl or cyano. 4. A compound of Claim 1 wherein G is substituted by one or more groups selected from alkyl of 1 to 6 carbon atoms, alkenyl of 2 to 6 carbon atoms, alkynyl of 2 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 carbon members, aryl, heteroaryl, halogen, -CN, -NO2, -CO2R6, -COR6, -OR6, -SR6, -SOR6, -SO2R6, -CONR7R8, -NR6N(R7R8), -N(R7R8) or W-Y-(CH2)n-Z. 5. A compound of Claim 1 wherein G is phenyl. 6. A compound of Claim 5 wherein G is substituted phenyl. 7. A compound of Claim 4 wherein G is substituted by one or more groups selected from alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, halogen, -SR6, -SOR6, N(R7R8) or -W-Y-(CH2)n-Z. 8. A compound of Claim 1 wherein G is 2-fluorophenyl. 9. A compound of Claim 1 wherein G is a fused bicyclic heteroaryl. 10. A compound of Claim 9 wherein G is quinoline, isoquinoline or benzofuran. 11. A compound of Claim 1 wherein X is a bond. 12. A compound of Claim 1 wherein X is straight chain alkyl. 13. A compound of Claim 1 wherein X is straight chain alkyl of 1 to 4 carbon atoms. 14. A compound of Claim 1 wherein X is CH(J). 15. A compound of Claim 1 wherein J is methyl. 16. A compound of Claim 1 selected from N-{4-[3-(1-Benzofuran-2-yl-ethyl)-thioureido]-phenyl}-2-trifluoromethyl-benzamide, N-(4-Fluoro-phenyl)-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido}-benzamide, Isoquinoline-1-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido}-phenyl)-amide, Isoquinoline-1-carboxylic acid {4-[3-(1-benzofuran-2-yl-ethyl)-thioureido]-phenyl}-amide, Isoquinoline-1-carboxylic acid (4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido}-phenyl)-amide, Isoquinoline-1-carboxylic acid (4-{3-[1-(4-cyano-phenyl)-ethyl]-thioureido}-phenyl)-amide, Benzofuran-2-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido}-phenyl)-amide, Benzofuran-2-carboxylic acid {4-[3-(1-benzofuran-2-yl-ethyl)-thioureido]-phenyl}-amide, Benzofuran-2-carboxylic acid (4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido}-phenyl)-amide, Benzofuran-2-carboxylic acid (4-{3-[1-(4-cyano-phenyl)-ethyl]-thioureido}-phenyl)-amide, Isoquinoline-3-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido}phenyl)-amide, Isoquinoline-3-carboxylic acid {4-[3-(1-benzofuran-2-yl-ethyl)-thioureido]-phenyl}-amide, Isoquinoline-3-carboxylic acid (4-{3-[1-(4-cyano-phenyl)-ethyl]-thioureido}-phenyl)-amide, Isoquinoline-3-carboxylic acid (4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido}-phenyl)-amide, Quinoline-3-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido}-phenyl)-amide, Quinoline-4-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido}-phenyl)-amide, Quinoline-6-carboxylic acid (4-{3-[1-{4-fluoro-phenyl)-ethyl]-thioureido}-phenyl)-amide, Quinoline-8-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido}phenyl)-amide, N-(4-{3-[1-(4-Fluoro-phenyl)-ethyl]-thioureido}-phenyl)-2-trifluoromethyl-benzamide, 2-Cyano-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido}-phenyl)-benzamide, N-{4-[3-(3-Chloro-4-isobutoxy-phenyl)-thioureido]-phenyl}-2-fluoro-benzamide, 2-Fluoro-N-{4-[3-(3-fluoro-4-methoxy-phenyl)-thioureido]-phenyl}-benzamide, N-(4-{3-[3-Chloro-4-(2-methoxy-ethoxy)-phenyl]-thioureido}-phenyl)-2-fluoro-benzamide, 2-Fluoro-N-{4-[3-(3-fluoro-4-methyl-phenyl)-thioureido]-phenyl}-benzamide, 2-Fluoro-N-{4-[3-(4-methoxy-3-trifluoromethyl-phenyl)-thioureido]-phenyl}-benzamide, N-{4-[3-(2-Amino-5-trifluoromethyl-phenyl)-thioureido]-phenyl}-2-fluoro-benzamide, N-(4-{3-[1-(3-Chloro-4-methoxy-phenyl)-ethyl]-thioureido}-phenyl)-2-fluoro-benzamide, N-{4-[3-(5-Chloro-2-hydroxy-phenyl)-thioureido]-phenyl}-2-fluoro-benzamide, N-{4-[3-{1-Benzofuran-2-yl-ethyl)-thioureido]-phenyl}-2-fluoro-benzamide, 2-Fluoro-N-{4-[3-(4-methyl-3-trifluoromethyl-phenyl)-thioureido]-phenyl}-benzamide, (S)-N-(4-{3-[1-(4-Bromo-phenyl}-ethyl]-thioureido}-phenyl)-2-fluoro-benzamide, N-(4-{3-[(1R)-1-(4-Bromo-phenyl)-ethyl]-thioureido}-phenyl)-2-fluoro-benzamide, 2-Fluoro-N-(4-{3-[2-methoxy-4-(2,2,2-trifluoro-ethoxy)-phenyl]-thioureido}phenyl)-benzamide, N-{4-[3-(2-Amino-5-fluoro-phenyl)-thioureido]-phenyl}-2-fluoro-benzamide, N-(4-{3-[1-(4-Dimethylsulfamoyl-phenyl)-ethyl]-thioureido}-phenyl)-2-fluoro-benzamide, 2-Fluoro-N-[4-(3-{1-[4-(piperidine-1-sulfonyl)-phenyl]-ethyl}-thioureido)-phenyl]-benzamide, N-(4-{3-[2,4-Bis-(2,2,2-trifluoro-ethoxy)-phenyl]-thioureido}-phenyl)-2-fluoro-benzamide, 2-Fluoro-N-{4-[3-((1S)-1-p-tolyl-ethyl)-thioureido]-phenyl}-benzamide, 2-Fluoro-N-{4-[3-((1R)-1-p-tolyl-ethyl)-thioureido]-phenyl}-benzamide, 2-Fluoro-N-{4-[3-((1S)-1-phenyl-ethyl)-thioureido]-phenyl}-benzamide, N-(4-{3-[{1R)-1-(4-Chloro-phenyl)-ethyl]-thioureido}-phenyl)-2-fluoro-benzamide, N-(4-{3-[(1S)-1-(4-Chloro-phenyl)-ethyl]-thioureido}-phenyl)-2-fluoro-benzamide, 2-Fluoro-N-{4-[3-((1R)-1-phenyl-ethyl)-thioureido]-phenyl}-benzamide, N-(4-{3-[1-{4-Cyano-phenyl)-ethyl]-thioureido}-phenyl)-2-methoxy-benzamide, N-{4-[3-(1-Benzofuran-2-yl-ethyl)-thioureido]-phenyl}-2-methoxy-benzamide, N-(4-{3-[1-(4-Bromo-phenyl)-ethyl]-thioureido}-phenyl)-2-methoxy-benzamide, 3-Cyano-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido}-phenyl)-benzamide, N-(4-{3-[1-(4-Fluoro-phenyl)-ethyl]-thioureido}-phenyl)-4-trifluoromethyl-benzamide, 4-Cyano-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido}-phenyl)-benzamide, N-(4-{3-[1-(4-Bromo-phenyl)-ethyl]-thioureido}-phenyl)-2-fluoro-benzamide, N-{4-{3-[(1S)-1-(4-Bromo-phenyl)-ethyl]-thioureido}-phenyl)-4-fluoro-benzamide, N-(4-{3-[(1S)-1-(4-Bromo-phenyl}-ethyl]-thioureido}-phenyl)-2-methoxy-benzamide, N-(4-{3-[(1R)-1-(4-Bromo-phenyl)-ethyl]-thioureido}-phenyl)-2-methoxy-benzamide, 2-fluoro-N-(4-{[({1-[2-fluoro-4-(trifluoromethyl)phenyl]ethyl}amino)carbothioyl]amino}phenyl)benzamide, Isoquinoline-1-carboxylic acid (4-{3-[(1S)-1-(4-bromo-phenyl)-ethyl]-thioureido}-phenyl)-amide, Isoquinoline-3-carboxylic acid (4-{3-[(1S)-1-(4-bromo-phenyl)-ethyl]-thioureido}-phenyl)-amide, Isoquinoline-1-carboxylic acid (4-{3-[(1S)-1-(4-chloro-phenyl)-ethyl]-thioureido}-phenyl)-amide, Isoquinoline-1-carboxylic acid (4-{3-[1-{4-fluoro-phenyl)-ethyl]-thioureido}-phenyl)-amide, and N-{4-[({[(1S)-1-(4-cyanophenyl)ethyl]amino}carbothioyl)amino]phenyl}-1-nophenyl)ethyl]amino}carbothioyl)amino]phenyl}-1-isoquinolinecarboxamide, and pharmaceutical salts thereof. 17. A pharmaceutical composition comprising a compound of claim 1 or a pharmaceutical salt thereof, and a pharmaceutically acceptable carrier or diluent. 18. A method of inhibiting the replication of a herpes virus comprising contacting a compound of claim 1 or a pharmaceutical salt thereof, with a herpes virus. 19. The method of Claim 18 wherein the herpes virus is human cytomegalovirus. 20. The method of Claim 18 wherein the herpes virus is varicella zoster virus. 21. The method of Claim 20 wherein the compound is substantially pure (S) optical isomer. 22. The method of Claim 18 wherein the herpes virus is herpes simplex virus. 23. A method of treating a patient suffering from a herpes virus infection comprising administering to the patient a therapeutically effective amount of a compound of formula 1 or a pharmaceutical salt thereof. 24. The method of Claim 23 wherein the herpes virus is human cytomegalovirus. 25. The method of Claim 23 wherein the herpes virus is varicella zoster virus. 26. The method of Claim 25 wherein the compound is substantially pure (S) isomer. 27. The method of Claim 23 wherein the herpes virus is herpes simplex virus.",WYETH CORP,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER;;ROSS ADMA ANTONIA;;O'HARA BRYAN MARK,,https://lens.org/033-155-473-746-093,Granted Patent,no,0,0,28,89,0,C07C335/20;;C07D215/48;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/20,A61K31/17;;A61K31/18;;A61K31/343;;A61K31/47;;A61K31/472;;A61K31/4725;;A61P31/22;;C07C335/20;;C07D215/48;;C07D215/50;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/79;;C07D307/81;;C07D307/85;;C07D405/12;;C07D407/12,,0,0,,,,EXPIRED
985,WO,A3,WO 2000/034260 A3,050-054-969-382-688,2000-09-08,2000,US 9928839 W,1999-12-06,US 20890298 A,1998-12-09,ALPHA-METHYLBENZYL-CONTAINING THIOUREA INHIBITORS OF HERPES VIRUSES CONTAINING A PHENYLENEDIAMINE GROUP,"Compounds having formula (I) wherein R1-R5 are independently selected from hydrogen, alkyl of 1 to 6 carbon atoms, alkenyl of 2 to 6 carbon atoms, alkynyl of 2 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 carbon members, aryl, heteroaryl, halogen,-CN,-NO2,-CO2R6,-COR6,-OR6,-SR6,-SOR6,-SO2R6,-CONR7R8,-NR6N(R7R8),-N(R7R8) or W-Y-(CH2)n-Z provided that at least one of R1-R5 is not hydrogen; or R2 and R3, or R3 and R4, taken together to form a 3 to 7 membered heterocycloalkyl or 3 to 7 membered heteroaryl; R6 and R7 are independently hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, or aryl; R8 is hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 members, aryl or heteroaryl, or R7 and R8, taken together may form a 3 to 7 membered heterocycloalkyl; W is O, NR6, or is absent; Y is -(CO)- or-(CO2)-, or is absent; Z is alkyl of 1 to 4 carbon atoms,-CN,-CO2R6, COR6,-CONR7R8,-OCOR6,-NR6COR7,-OCONR6,-OR6,-SR6,-SOR6,-SO2R6, SR6N(R7R8),-N(R7R8) or phenyl; G is aryl or fused bicyclic heteroaryl; X is a bond,-NH, alkyl of 1 to 6 carbon atoms, alkenyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, thioalkyl of 1 to 6 carbon atoms, alkylamino of 1 to 6 carbon atoms, or (CH)J; J is alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 7 carbon atoms, phenyl or benzyl; and n is an integer from 1 to 6; useful in the treatment of diseases associated with herpes viruses including human cytomegalovirus, herpes simplex viruses, Epstein-Barr virus, varicella-zoster virus, human herpesviruses-6 and-7, and Kaposi herpesvirus.",AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER;;ROSS ADMA ANTONIA;;O'HARA BRYAN MARK,,https://lens.org/050-054-969-382-688,Search Report,yes,4,0,28,89,0,C07C335/20;;C07D215/48;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/20,A61K31/17;;A61K31/18;;A61K31/343;;A61K31/47;;A61K31/472;;A61K31/4725;;A61P31/22;;C07C335/20;;C07D215/48;;C07D215/50;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/79;;C07D307/81;;C07D307/85;;C07D405/12;;C07D407/12,,0,0,,,,PATENTED
986,NO,D0,NO 20012838 D0,101-605-613-665-579,2001-06-08,2001,NO 20012838 A,2001-06-08,US 20856198 A;;US 9928837 W,1998-12-09,Tiourea-inhibitorer for herpesvirus,,AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSEL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER;;ROSS ADMA ANTONIA;;O'HARA BRYAN MARK,,https://lens.org/101-605-613-665-579,Patent Application,no,0,0,30,30,0,C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/00,A61K31/17;;A61K31/343;;A61K31/472;;A61P31/22;;C07C275/42;;C07C335/18;;C07C335/20;;C07C335/22;;C07D217/26;;C07D295/088;;C07D307/81;;C07D307/85,,0,0,,,,DISCONTINUED
987,NO,L,NO 20012833 L,153-175-421-975-547,2001-08-02,2001,NO 20012833 A,2001-06-08,US 20890298 A;;US 9928839 W,1998-12-09,<Alfa>-metylbenzyl-holdige tiourea-inhibitorer for herpesvirus inneholdende en fenylendiamingruppe,,AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSEL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER;;ROSS ADMA ANTONIA;;O'HARA BRYAN MARK,,https://lens.org/153-175-421-975-547,Abstract,no,0,0,28,89,0,C07C335/20;;C07D215/48;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/20,A61K31/17;;A61K31/18;;A61K31/343;;A61K31/47;;A61K31/472;;A61K31/4725;;A61P31/22;;C07C335/20;;C07D215/48;;C07D215/50;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/79;;C07D307/81;;C07D307/85;;C07D405/12;;C07D407/12,,0,0,,,,DISCONTINUED
988,DK,T3,DK 1137645 T3,018-641-867-375-432,2004-08-09,2004,DK 99963022 T,1999-12-06,US 20890298 A,1998-12-09,Alfa-methylbenzylholdige thiourinstofinhibitorer af herpesvira indeholdende en phenylendiamingruppe,,WYETH CORP,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DUSHIN RUSSELL GEORGE;;NORTON EMILY BOUCHER;;ROSS ADMA ANTONIA;;DIGRANDI MARTIN JOSEPH;;LANG STANLEY ALBERT;;O'HARA BRYAN MARK,,https://lens.org/018-641-867-375-432,Granted Patent,no,0,0,28,89,0,C07C335/20;;C07D215/48;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/20,A61K31/17;;A61K31/18;;A61K31/343;;A61K31/47;;A61K31/472;;A61K31/4725;;A61P31/22;;C07C335/20;;C07D215/48;;C07D215/50;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/79;;C07D307/81;;C07D307/85;;C07D405/12;;C07D407/12,,0,0,,,,EXPIRED
989,AU,A,AU 2000/019345 A,019-087-932-737-745,2000-06-26,2000,AU 2000/019345 A,1999-12-06,US 20856198 A;;US 9928837 W,1998-12-09,Thiourea inhibitors of herpes viruses,,WYETH CORP,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER;;ROSS ADMA ANTONIA;;O'HARA BRYAN MARK,WYETH (2002-10-03),https://lens.org/019-087-932-737-745,Patent Application,no,0,0,30,30,0,C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/00,A61K31/17;;A61K31/343;;A61K31/472;;A61P31/22;;C07C275/42;;C07C335/18;;C07C335/20;;C07C335/22;;C07D217/26;;C07D295/088;;C07D307/81;;C07D307/85,,0,0,,,,DISCONTINUED
990,HU,A2,HU P0104492 A2,038-590-026-847-325,2002-04-29,2002,HU P0104492 A,1999-12-06,US 20890298 A;;US 9928839 W,1998-12-09,ALPHA-METHYLBENZYL-CONTAINING THIOUREA INHIBITORS OF HERPES VIRUSES CONTAINING A PHENYLENEDIAMINE GROUP,"A tal lm ny (I) ltal nos képletű vegyületekre és gyógy szatilagelfogadható sóikra vonatkozik, ahol R1-R5 jelentése egym stólfüggetlenül hidrogénatom, alkil-, alkenil-, alkinil-,perhalogénalkil-, cikloalkil-, heterocikloalkil-, aril-,heteroarilcsoport, halogénatom, ciano-, nitrocsoport, -CO2R6, -COR6, -OR6, -SR6, -SOR6, -SO2R6, -CONR7R8, -NR6N(R7R8), -N(R7R8) vagy W-Y-(CH2)n-Z ltal nos képletű csoport, azzal a megk""téssel, hogy az R1 -R5csoportok k""zül legal bb egy nem hidrogénatom; vagy R2 és R3 vagy R3és R4 együtt 3-7 tagú heterocikloalkilcsoportot vagy 3-7 tagúheteroarilcsoportot alkot; R6 és R7 jelentése egym stól függetlenülhidrogénatom, alkil-, perhalogénalkil-, vagy arilcsoport; R8 jelentésehidrogénatom, alkil-, perhalogénalkil-, cikloalkil-,heterocikloalkil-, aril-, heteroarilcsoport, vagy R7 és R8 együtt 3-7tagú heterocikloalkilcsoportot alkothat; W jelentése oxigénatom, -NR6ltal nos képletű csoport, vagy hi nyzik; Y jelentése -(CO)- vagy -(CO2)-, vagy hi nyzik; Z jelentése alkil-, cianocsoport, -CO2R6, -COR6, -CONR7R8, -OCOR6, -NR6COR7, -OCONR6, -OR6, -SR6, -SOR6, -SO2R6,SR6N(R7R8), -N(R7R8) ltal nos képletű csoport vagy fenilcsoport; Gjelentése aril- vagy kondenz lt biciklusos heteroarilcsoport; Xjelentése vegyértékk""tés, -NH, alkil-, alkenil-, alkoxi-, alkil-tio-,alkil-aminocsoport vagy (CH)J ltal nos képletű csoport; J jelentésealkil-, cikloalkil-, fenil- vagy benzilcsoport; és n értéke 1-6. Avegyületek g tolj k és/vagy gyógyítj k a herpeszvírusok, péld ul a humn citomegalovírusok, herpesz szimplex vírusok, Epstein-Barr vírus,varicella-zoster vírus, hum n herpeszvírus-6 és -7 és a Kaposiherpeszvírus ltal okozott betegségeket. A tal lm ny a vegyületekettartalmazó gyógyszerkészítményekre és a vegyületek alkalmaz s ra isvonatkozik. Ó",AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSEL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER;;O'HARA BRYAN MARK;;ROSS ADMA ANTONIA,,https://lens.org/038-590-026-847-325,Patent Application,no,0,0,28,89,0,C07C335/20;;C07D215/48;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/20,A61K31/17;;A61K31/18;;A61K31/343;;A61K31/47;;A61K31/472;;A61K31/4725;;A61P31/22;;C07C335/20;;C07D215/48;;C07D215/50;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/79;;C07D307/81;;C07D307/85;;C07D405/12;;C07D407/12,,0,0,,,,PENDING
991,NO,D0,NO 20012833 D0,089-941-873-026-212,2001-06-08,2001,NO 20012833 A,2001-06-08,US 20890298 A;;US 9928839 W,1998-12-09,<Alfa>-metylbenzyl-holdige tiourea-inhibitorer for herpesvirus inneholdende en fenylendiamingruppe,,AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSEL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER;;ROSS ADMA ANTONIA;;O'HARA BRYAN MARK,,https://lens.org/089-941-873-026-212,Patent Application,no,0,0,28,89,0,C07C335/20;;C07D215/48;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/20,A61K31/17;;A61K31/18;;A61K31/343;;A61K31/47;;A61K31/472;;A61K31/4725;;A61P31/22;;C07C335/20;;C07D215/48;;C07D215/50;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/79;;C07D307/81;;C07D307/85;;C07D405/12;;C07D407/12,,0,0,,,,DISCONTINUED
992,WO,A2,WO 2000/034260 A2,166-979-722-532-921,2000-06-15,2000,US 9928839 W,1999-12-06,US 20890298 A,1998-12-09,ALPHA-METHYLBENZYL-CONTAINING THIOUREA INHIBITORS OF HERPES VIRUSES CONTAINING A PHENYLENEDIAMINE GROUP,"Compounds having formula (I) wherein R1-R5 are independently selected from hydrogen, alkyl of 1 to 6 carbon atoms, alkenyl of 2 to 6 carbon atoms, alkynyl of 2 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 carbon members, aryl, heteroaryl, halogen,-CN,-NO2,-CO2R6,-COR6,-OR6,-SR6,-SOR6,-SO2R6,-CONR7R8,-NR6N(R7R8),-N(R7R8) or W-Y-(CH2)n-Z provided that at least one of R1-R5 is not hydrogen; or R2 and R3, or R3 and R4, taken together to form a 3 to 7 membered heterocycloalkyl or 3 to 7 membered heteroaryl; R6 and R7 are independently hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, or aryl; R8 is hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 members, aryl or heteroaryl, or R7 and R8, taken together may form a 3 to 7 membered heterocycloalkyl; W is O, NR6, or is absent; Y is -(CO)- or-(CO2)-, or is absent; Z is alkyl of 1 to 4 carbon atoms,-CN,-CO2R6, COR6,-CONR7R8,-OCOR6,-NR6COR7,-OCONR6,-OR6,-SR6,-SOR6,-SO2R6, SR6N(R7R8),-N(R7R8) or phenyl; G is aryl or fused bicyclic heteroaryl; X is a bond,-NH, alkyl of 1 to 6 carbon atoms, alkenyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, thioalkyl of 1 to 6 carbon atoms, alkylamino of 1 to 6 carbon atoms, or (CH)J; J is alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 7 carbon atoms, phenyl or benzyl; and n is an integer from 1 to 6; useful in the treatment of diseases associated with herpes viruses including human cytomegalovirus, herpes simplex viruses, Epstein-Barr virus, varicella-zoster virus, human herpesviruses-6 and-7, and Kaposi herpesvirus.",AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER;;ROSS ADMA ANTONIA;;O'HARA BRYAN MARK,,https://lens.org/166-979-722-532-921,Patent Application,yes,0,18,28,89,0,C07C335/20;;C07D215/48;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/20,A61K31/17;;A61K31/18;;A61K31/343;;A61K31/47;;A61K31/472;;A61K31/4725;;A61P31/22;;C07C335/20;;C07D215/48;;C07D215/50;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/79;;C07D307/81;;C07D307/85;;C07D405/12;;C07D407/12,,0,0,,,,PATENTED
993,US,A1,US 2003/0086553 A1,004-491-819-798-554,2003-05-08,2003,US 1157801 A,2001-11-05,US 1157801 A,2001-11-05,Method of delivering enterprise data through a call center,"
   A method and apparatus are described for providing enterprise information to a client through a call center of the enterprise. The method includes the steps of detecting an identity of the client based upon call associated information received through a call connection between the client and the call center, presenting the client with a plurality of options based upon the identity of the client and presenting the client with enterprise information based upon a selected option of the plurality of options. 
",DEZONNO ANTHONY J.;;HODSON JEFFREY D.;;BLOOM JOSEPH;;FUNCK DAVID;;JAMES ERIC;;PETERS MICHAEL;;POWER MARK J.;;SHAMBAUGH CRAIG R.;;MOSQUERA DAVE;;SALEH NAYEL,DEZONNO ANTHONY J;;HODSON JEFFREY D;;BLOOM JOSEPH;;FUNCK DAVID;;JAMES ERIC;;PETERS MICHAEL;;POWER MARK J;;SHAMBAUGH CRAIG R;;MOSQUERA DAVE;;SALEH NAYEL,FIRSTPOINT CONTACT TECHNOLOGIES LLC (2004-08-12);;ROCKWELL ELECTRONIC COMMERICE CORP (2001-10-22);;WILMINGTON TRUST NATIONAL ASSOCIATION AS ADMINISTRATIVE AGENT (2014-11-07),https://lens.org/004-491-819-798-554,Patent Application,yes,8,6,2,2,0,H04M3/42059;;H04M3/493;;H04M3/523;;H04M3/523;;H04M3/493;;H04M3/42059,H04M3/493;;H04M3/523,379/265.02;;379/266.02,0,0,,,,EXPIRED
994,PL,A1,PL 348178 A1,109-737-661-889-484,2002-05-06,2002,PL 34817899 A,1999-12-06,US 9928837 W;;US 20856198 A,1998-12-09,THIOUREA INHIBITORS OF HERPES VIRUSES,,AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER;;ROSS ADMA ANTONIA;;O'HARA BRYAN MARK,,https://lens.org/109-737-661-889-484,Patent Application,no,0,0,30,30,0,C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/00,A61K31/17;;A61K31/343;;A61K31/472;;A61P31/22;;C07C275/42;;C07C335/18;;C07C335/20;;C07C335/22;;C07D217/26;;C07D295/088;;C07D307/81;;C07D307/85,,0,0,,,,DISCONTINUED
995,BR,A,BR 9916084 A,151-788-585-040-245,2001-09-04,2001,BR 9916084 A,1999-12-06,US 20890298 A;;US 9928839 W,1998-12-09,"Composto, composição farmacêutica, e, processos para inibir a replicação de um vìrus da herpes, e para tratar um paciente sofrendo de uma infecção por vìrus da herpes","""COMPOSTO, COMPOSIçãO FARMACêUTICA, E, PROCESSOS PARA INIBIR A REPLICAçãO DE UM VìRUS DA HERPES, E PARA TRATAR UM PACIENTE SOFRENDO DE UMA INFECçãO POR VìRUS DA HERPES"". Compostos tendo a fórmula (I) em que R~ 1~ - R~ 5~ são independentemente selecionados dentre hidrogênio, alquila de 1 a 6 átomos de carbono, alquenila de 2 a 6 átomos de carbono, alquinila de 2 a 6 átomos de carbono, perhaloalquila de 1 a 6 átomos de carbono, cicloalquila de 3 a 10 átomos de carbono, heterocicloalquila de 3 a 10 membros de carbono, arila, heteroarila, halogênio, -CN, -NO~ 2~, -CO~ 2~R~ 6~, -COR~ 6~, -OR~ 6~, -SR~ 6~, -SOR~ 6~, -SO~ 2~R~ 6~, -CONR~ 7~R~ 8~, -NR~ 6~N (R~ 7~R~ 8~), -N (R~ 7~R~8~) ou W-Y- (CH~ 2~)~ n~ -Z desde que pelo menos um dentre R~ 1~ - R~ 5~ não é hidrogênio; ou R~ 2~ e R~ 3~ ou R~ 3~ e R~ 4~, tomados juntos formam um membro heterocicloalquila de 3 a 7 ou heteroarila de 3 a 7 membros; R~ 6~ e R~ 7~ são independentemente hidrogênio, alquila de 1 a 6 átomos de carbono, perhaloalquila de 1 a 6 átomos de carbono, ou arila; R~ 8~ é hidrogênio, alquila de 1 a 6 átomos de carbono, perhaloalquila de 1 a 6 átomos de carbono, cicloalquila de 3 a 10 átomos de carbono, heterocicloalquila de 3 a 10 membros, arila ou heteroarila, ou R~ 7~ e R~ 8~, tomados juntos, podem formar uma heterocicloalquila de 3 a 7 membros; W é O, NR~ 6~, ou está ausente; Y é -(CO)- ou -(CO~ 2~)-, ou está ausente; Z é alquila de 1 a 4 átomos de carbono, -CN, -CO~ 2~R~ 6~, COR~ 6~, -CONR~ 7~R~ 8~, -OCOR~ 6~, -NR~ 6~COR~ 7~, -OCONR~ 6~, -OR~ 6~, -SR~ 6~, -SOR~ 6~, -SO~ 2~R~ 6~, SR6N (R7R8), -N (R~ 7~R~ 8~) ou fenila; G é arila ou heteroarila bicíclica fundida; X é uma ligação, -NH, alquila de 1 6 átomos de carbono, alquenila de 1 a 6 átomos de carbono, alcoxi de 1 a 6 átomos de carbono, tioalquila de 1 a 6 átomos de carbono, alquilamino de 1 a 6 átomos de carbono, ou (CH) J; J é alquila de 1 a 6 átomos de carbono, cicloalquila de 3 a 7 átomos de carbono, fenila ou benzila; e n é um número inteiro de 1 a 6; utilizável no tratamento de doenças associadas com vírus da herpes incluindo citomegalovírus humano, vírus da herpes simplex, vírus Epstein-Barr, vírus da varicela-zoster, vírus da herpes humano 6 e 7, e vírus da herpes Kaposi.",AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER;;ROSS ADMA ANTONIA;;O'HARA BRYAN MARK,,https://lens.org/151-788-585-040-245,Patent Application,no,0,0,28,89,0,C07C335/20;;C07D215/48;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/20,A61K31/17;;A61K31/18;;A61K31/343;;A61K31/47;;A61K31/472;;A61K31/4725;;A61P31/22;;C07C335/20;;C07D215/48;;C07D215/50;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/79;;C07D307/81;;C07D307/85;;C07D405/12;;C07D407/12,,0,0,,,,DISCONTINUED
996,EP,A1,EP 1137632 A1,091-192-112-565-752,2001-10-04,2001,EP 99963021 A,1999-12-06,US 9928837 W;;US 20856198 A,1998-12-09,THIOUREA INHIBITORS OF HERPES VIRUSES,,AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER;;ROSS ADMA ANTONIA;;O'HARA BRYAN MARK,WYETH (2002-06-19),https://lens.org/091-192-112-565-752,Patent Application,yes,0,0,30,30,0,C07C335/20;;C07C335/22;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/00,A61K31/17;;A61K31/343;;A61K31/472;;A61P31/22;;C07C275/42;;C07C335/18;;C07C335/20;;C07C335/22;;C07D217/26;;C07D295/088;;C07D307/81;;C07D307/85,,0,0,,,,EXPIRED
997,CN,A,CN 115608356 A,187-379-406-437-36X,2023-01-17,2023,CN 202210810487 A,2022-07-11,US 202163203400 P;;CN 202110782230 A,2021-07-12,Anionic PGM carboxylate assisted PGM nanoparticle synthesis for exhaust gas treatment applications,"A method of making a catalyst article, the method comprising: providing an anionic complex comprising PGM and carboxylate ions; providing a carrier material; applying the anionic complex to the support material to form a supported support material; placing the carried carrier material on a substrate; and heating the carried support material to form the PGM nanoparticles on the support material.",JOHNSON MATTHEY PLC;;JOHNSON MATTHEY SHANGHAI CHEMICAL CO LTD,BLOOM JEREMY;;CHANG HSIAO-LAN;;CHEN HAI-YING;;COLLIS NATHAN;;GABRIELSSON JOHAN;;MOHAM GRAHAM;;MORESAN NATALIE;;QIAO DONGSHENG;;SCHOFIELD ERIC;;THOMPSETT DAVID;;WAN YAPING,,https://lens.org/187-379-406-437-36X,Patent Application,no,10,0,3,3,0,B01J23/63;;B01J23/002;;B01J29/7415;;B01D53/94;;F01N3/101;;F01N3/103;;F01N3/20;;F01N3/2803;;F01N3/035;;B01D2258/01;;B01J2523/00;;B01J21/066;;B01J23/464;;B01J23/63;;B01J37/0203;;B01J37/038;;B01J37/0246;;B01D53/945;;B01D2255/1023;;B01D2255/1025;;B01D2255/407;;B01D2258/014;;Y02T10/12;;B01J35/19;;B01J35/56;;B01D53/945;;B01D2255/1023;;B01D2255/1025;;B01J21/04;;B01J23/10;;B01J23/44;;B01J23/464;;B01J37/0219;;B01J37/086;;F01N3/101;;F01N3/2803;;F01N3/2842;;F01N2370/04;;B01J35/23;;B01J35/56,B01J23/63;;B01D53/94;;B01J29/74;;F01N3/035;;F01N3/10;;F01N3/20;;F01N3/28,,0,0,,,,PENDING
998,AT,T1,AT E267824 T1,028-005-911-172-188,2004-06-15,2004,AT 99963022 T,1999-12-06,US 20890298 A;;US 9928839 W,1998-12-09,ALPHA-METHYLBENZYL-ENTHALTENDE THIOHARNSTOFFE ALS INHIBITOREN VON HERPES-VIREN MIT EINER PHENYLENEDIAMINGRUPPE,,WYETH CORP,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER;;ROSS ADMA ANTONIA;;O'HARA BRYAN MARK,,https://lens.org/028-005-911-172-188,Granted Patent,no,0,0,28,89,0,C07C335/20;;C07D215/48;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/20,A61K31/17;;A61K31/18;;A61K31/343;;A61K31/47;;A61K31/472;;A61K31/4725;;A61P31/22;;C07C335/20;;C07D215/48;;C07D215/50;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/79;;C07D307/81;;C07D307/85;;C07D405/12;;C07D407/12,,0,0,,,,DISCONTINUED
999,US,A1,US 2023/0004227 A1,000-257-879-572-329,2023-01-05,2023,US 202217901559 A,2022-09-01,US 202217901559 A;;US 202016926512 A;;US 201816144950 A;;US 201862729978 P,2018-09-11,CONTENT-BASED TACTILE OUTPUTS,"The present disclosure generally relates to content-based tactile outputs. In some embodiments, user interfaces associated with content-based tactile outputs are described. In some embodiments, user interfaces associated with end-of-content tactile outputs are described. In some embodiments, user interfaces associated with moving a user interface in response to different types of input are described. In some embodiments, user interfaces associated with adjustable item-based tactile outputs are described. In some embodiments, user interfaces associated with input velocity-based tactile outputs are described.",APPLE INC,MOUSSETTE CAMILLE;;BLOOM DAVID H;;BUTCHER GARY IAN;;DYE ALAN C;;EDWARDS DYLAN ROSS;;FENNIS JULES K;;GLEESON BRIAN T;;HE MIAO;;SUNDSTROM MATTHEW J,,https://lens.org/000-257-879-572-329,Patent Application,yes,10,3,3,41,0,G06F3/016;;G06F3/04817;;G06F3/0485;;G06F3/04847;;G06F3/0362;;G06F3/016;;G06F3/0362;;G06F3/0412;;G06F3/0487;;G06F3/04845,G06F3/01;;G06F3/0362;;G06F3/041;;G06F3/04845;;G06F3/0487,,0,0,,,,ACTIVE
1000,CZ,A3,CZ 20012067 A3,160-655-030-913-345,2001-10-17,2001,CZ 20012067 A,1999-12-06,US 20890298 A,1998-12-09,Thiourea compounds containing alpha methylbenzyl group and phenylene diamine group functioning as inhibitors of herpes viruses,,AMERICAN HOME PROD,BLOOM JONATHAN DAVID;;CURRAN KEVIN JOSEPH;;DIGRANDI MARTIN JOSEPH;;DUSHIN RUSSELL GEORGE;;LANG STANLEY ALBERT;;NORTON EMILY BOUCHER;;ROSS ADMA ANTONIA;;O HARA BRYAN MARK,,https://lens.org/160-655-030-913-345,Patent Application,no,0,0,28,89,0,C07C335/20;;C07D215/48;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/81;;C07D307/85;;A61P31/22;;C07C335/20,A61K31/17;;A61K31/18;;A61K31/343;;A61K31/47;;A61K31/472;;A61K31/4725;;A61P31/22;;C07C335/20;;C07D215/48;;C07D215/50;;C07D215/54;;C07D217/06;;C07D217/26;;C07D307/79;;C07D307/81;;C07D307/85;;C07D405/12;;C07D407/12,,0,0,,,,PENDING
